PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	D'Emic, MD				D'Emic, M. D.			Comment on "Evidence for mesothermy in dinosaurs"	SCIENCE			English	Editorial Material							BONE-GROWTH; EVOLUTION; RATES; PHYSIOLOGY	Grady et al. (Reports, 13 June 2014, p. 1268) suggested that nonavian dinosaur metabolism was neither endothermic nor ectothermic but an intermediate physiology termed "mesothermic." However, rates were improperly scaled and phylogenetic, physiological, and temporal categories of animals were conflated during analyses. Accounting for these issues suggests that nonavian dinosaurs were on average as endothermic as extant placental mammals.	SUNY Stony Brook, Hlth Sci Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	D'Emic, MD (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Anat Sci, Stony Brook, NY 11794 USA.	michael.demic@stonybrook.edu		Myhrvold, Nathan/0000-0003-3994-5143				Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Cubo J, 2012, PALEOBIOLOGY, V38, P335, DOI 10.1666/08093.1; D'Emic MD, 2013, BONE, V57, P300, DOI 10.1016/j.bone.2013.08.010; Gingerich PD, 2009, ANNU REV ECOL EVOL S, V40, P657, DOI 10.1146/annurev.ecolsys.39.110707.173457; Grady JM, 2014, SCIENCE, V344, P1268, DOI 10.1126/science.1253143; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Lee AH, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P217; Myhrvold NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081917; SADLER PM, 1981, J GEOL, V89, P569, DOI 10.1086/628623; Starck J. M., 1998, AVIAN GROWTH DEV EVO, V8, P381; Stein KWH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077109; Weishampel DB., 2004, DINOSAURIA	13	10	10	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238								10.1126/science.1260061	http://dx.doi.org/10.1126/science.1260061			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	26023131				2022-12-28	WOS:000355276600034
J	Brubaker, SW; Monack, DM				Brubaker, Sky W.; Monack, Denise M.			Microbial metabolite triggers antimicrobial defense	SCIENCE			English	Editorial Material							PATTERN-RECOGNITION; TIFA; IMMUNITY; HEPTOSE; PATHWAY; TRAF6		[Brubaker, Sky W.; Monack, Denise M.] Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA	Stanford University	Brubaker, SW (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA.	dmonack@stanford.edu		Monack, Denise/0000-0003-3804-2209	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Ea CK, 2004, P NATL ACAD SCI USA, V101, P15318, DOI 10.1073/pnas.0404132101; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gaudet RG, 2015, SCIENCE, V348, P1251, DOI 10.1126/science.aaa4921; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Janeway Jr C. A., 1989, QUANT BIOL, V54, P1; Kneidinger B, 2002, J BACTERIOL, V184, P363, DOI 10.1128/JB.184.2.363-369.2002; Malott RJ, 2013, P NATL ACAD SCI USA, V110, P10234, DOI 10.1073/pnas.1303738110; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Takatsuna H, 2003, J BIOL CHEM, V278, P12144, DOI 10.1074/jbc.M300720200	10	1	1	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1207	1208		10.1126/science.aac5835	http://dx.doi.org/10.1126/science.aac5835			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068833				2022-12-28	WOS:000356011500029
J	Murray, F; Stern, S				Murray, Fiona; Stern, Scott			Linking and leveraging	SCIENCE			English	Editorial Material									[Murray, Fiona; Stern, Scott] MIT, Cambridge, MA 02139 USA; [Murray, Fiona; Stern, Scott] Natl Bur Econ Res, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); National Bureau of Economic Research	Stern, S (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	stern@mit.edu						Guzman J, 2015, SCIENCE, V347, P606, DOI 10.1126/science.aaa0201	1	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1203	1203		10.1126/science.aac5843	http://dx.doi.org/10.1126/science.aac5843			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068830				2022-12-28	WOS:000356011500026
J	Yang, WS; Noh, JH; Jeon, NJ; Kim, YC; Ryu, S; Seo, J; Seok, SI				Yang, Woon Seok; Noh, Jun Hong; Jeon, Nam Joong; Kim, Young Chan; Ryu, Seungchan; Seo, Jangwon; Seok, Sang Il			High-performance photovoltaic perovskite layers fabricated through intramolecular exchange	SCIENCE			English	Article							SOLUTION-PROCESSED PEROVSKITE; SOLAR-CELLS; SEQUENTIAL DEPOSITION; EFFICIENT; CH3NH3PBI3; COMPOUND; FILM	The band gap of formamidinium lead iodide (FAPbI(3)) perovskites allows broader absorption of the solar spectrum relative to conventional methylammonium lead iodide (MAPbI(3)). Because the optoelectronic properties of perovskite films are closely related to film quality, deposition of dense and uniform films is crucial for fabricating high-performance perovskite solar cells (PSCs). We report an approach for depositing high-quality FAPbI(3) films, involving FAPbI(3) crystallization by the direct intramolecular exchange of dimethylsulfoxide (DMSO) molecules intercalated in PbI2 with formamidinium iodide. This process produces FAPbI(3) films with (111)-preferred crystallographic orientation, large-grained dense microstructures, and flat surfaces without residual PbI2. Using films prepared by this technique, we fabricated FAPbI(3)-based PSCs with maximum power conversion efficiency greater than 20%.	[Yang, Woon Seok; Noh, Jun Hong; Jeon, Nam Joong; Kim, Young Chan; Ryu, Seungchan; Seo, Jangwon; Seok, Sang Il] Korea Res Inst Chem Technol, Div Adv Mat, Taejon 305600, South Korea; [Seok, Sang Il] Sungkyunkwan Univ, Dept Energy Sci, Suwon 440746, South Korea	Korea Research Institute of Chemical Technology (KRICT); Sungkyunkwan University (SKKU)	Seok, SI (corresponding author), Korea Res Inst Chem Technol, Div Adv Mat, 141 Gajeong Ro, Taejon 305600, South Korea.	seoksi@krict.re.kr	Noh, Jun Hong/A-7769-2010; Seok, Sang Il/R-2778-2016	Noh, Jun Hong/0000-0002-1143-5822; Seok, Sang Il/0000-0001-9976-6628	Global Research Laboratory Program; Global Frontier R&D Program on Center for Multiscale Energy System - National Research Foundation in Korea; KRICT Program for Future Technology of the Korea Research Institute of Chemical Technology; SKKU-KRICT DRC	Global Research Laboratory Program; Global Frontier R&D Program on Center for Multiscale Energy System - National Research Foundation in Korea; KRICT Program for Future Technology of the Korea Research Institute of Chemical Technology; SKKU-KRICT DRC	Supported by the Global Research Laboratory Program, the Global Frontier R&D Program on Center for Multiscale Energy System funded by the National Research Foundation in Korea, and a grant from the KRICT 2020 Program for Future Technology of the Korea Research Institute of Chemical Technology and SKKU-KRICT DRC program.	Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Chen Q, 2014, J AM CHEM SOC, V136, P622, DOI 10.1021/ja411509g; Eperon GE, 2014, ENERG ENVIRON SCI, V7, P982, DOI 10.1039/c3ee43822h; Frost JM, 2014, NANO LETT, V14, P2584, DOI 10.1021/nl500390f; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI [10.1038/NPHOTON.2013.80, 10.1038/nphoton.2013.80]; Hu L, 2014, ACS PHOTONICS, V1, P547, DOI 10.1021/ph5000067; Im JH, 2014, NAT NANOTECHNOL, V9, P927, DOI [10.1038/nnano.2014.181, 10.1038/NNANO.2014.181]; Jeon NJ, 2015, NATURE, V517, P476, DOI 10.1038/nature14133; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/NMAT4014, 10.1038/nmat4014]; Jeon YJ, 2014, SCI REP-UK, V4, DOI [10.1038/srep06953, 10.1038/srep06668]; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Koh TM, 2014, J PHYS CHEM C, V118, P16458, DOI 10.1021/jp411112k; Lee JW, 2014, ADV MATER, V26, P4991, DOI 10.1002/adma.201401137; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Liang PW, 2014, ADV MATER, V26, P3748, DOI 10.1002/adma.201400231; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; MIYAMAE H, 1980, CHEM LETT, P663, DOI 10.1246/cl.1980.663; Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Pang SP, 2014, CHEM MATER, V26, P1485, DOI 10.1021/cm404006p; Pellet N, 2014, ANGEW CHEM INT EDIT, V53, P3151, DOI 10.1002/anie.201309361; SELBIN J, 1961, J INORG NUCL CHEM, V16, P219, DOI 10.1016/0022-1902(61)80493-4; Snaith HJ, 2014, J PHYS CHEM LETT, V5, P1511, DOI 10.1021/jz500113x; Wang F, 2015, ADV FUNCT MATER, V25, P1120, DOI 10.1002/adfm.201404007; Wu YZ, 2014, ENERG ENVIRON SCI, V7, P2934, DOI 10.1039/c4ee01624f	24	5011	5116	147	4502	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1234	1237		10.1126/science.aaa9272	http://dx.doi.org/10.1126/science.aaa9272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	25999372				2022-12-28	WOS:000356011500049
J	Gostin, LO				Gostin, Lawrence O.			The Americans With Disabilities Act at 25 The Highest Expression of American Values	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Abrams Jim, 2012, HUFFINGTON POST; Bagenstos SR, 2015, JAMA-J AM MED ASSOC, V313, P2217, DOI 10.1001/jama.2015.4268; Brault M.W., AM DISABILITIES 2010; Burnim I, 2015, JAMA-J AM MED ASSOC, V313, P2223, DOI 10.1001/jama.2015.4015; Clayton EW, 2015, JAMA-J AM MED ASSOC, V313, P2225, DOI 10.1001/jama.2015.3419; DEGENER T, 2000, PRINC PRACT INT DIS; Driedger D., 1989, LAST CIVIL RIGHTS MO; Field MJ, 2007, FUTURE DISABILITY AM; Fleischer D., 2001, DISABILITY RIGHTS MO; Hargrove LJ, 2015, JAMA-J AM MED ASSOC, V313, P2244, DOI 10.1001/jama.2015.4527; Hill E, 2015, JAMA-J AM MED ASSOC, V313, P2227, DOI 10.1001/jama.2015.4936; Iezzoni LI, 2011, HEALTH AFFAIR, V30, P1947, DOI 10.1377/hlthaff.2011.0613; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; JIMENEZ R, 2000, ALA LAW REV, V52, P419; Kaiser Family Foundation, HLTH INS COV TOT POP; Kanter A.S., 2003, SYRACUSE J INT LAW C, V30, P241; Musumeci M, 2014, OLMSTEADS ROLE COMMU; National Council on Disability, 2009, CURR STAT HLTH CAR P; National Council on Disability, 2008, FIND GAPS COMP AN DI; Olson W, 2010, ADAS 20 ANNIVERSARY; PFEIFFER D, 1993, POLICY STUD J, V21, P724, DOI 10.1111/j.1541-0072.1993.tb02169.x; Rosenbaum S., 2007, FUTURE DISABILITY AM; Rosland AM, 2008, JAMA-J AM MED ASSOC, V299, P144, DOI 10.1001/jama.2007.54-b; Rothstein L, 2015, JAMA-J AM MED ASSOC, V313, P2219, DOI 10.1001/jama.2015.4602; Rothstein MA, 2015, JAMA-J AM MED ASSOC, V313, P2221, DOI 10.1001/jama.2015.3417; Searcy CA, 2015, JAMA-J AM MED ASSOC, V313, P2253, DOI 10.1001/jama.2015.5511; Shapiro J.P., 1994, NO PITY; Switzer Jacqueline Vaughn, 2003, DISABLED RIGHTS AM D; Thomas VL, 2009, JAMA-J AM MED ASSOC, V301, P95, DOI 10.1001/jama.2008.912; Triano S, 2010, SAN JOSE MERCUR 0723	30	12	12	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2231	2235		10.1001/jama.2015.6405	http://dx.doi.org/10.1001/jama.2015.6405			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1VH	26057283				2022-12-28	WOS:000355995300016
J	Chughtai, B; Mao, JL; Buck, J; Kaplan, S; Sedrakyan, A				Chughtai, Bilal; Mao, Jialin; Buck, Jessica; Kaplan, Steven; Sedrakyan, Art			Use and risks of surgical mesh for pelvic organ prolapse surgery in women in New York state: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRANSVAGINAL MESH; FLOOR DISORDERS; PREVALENCE; OUTCOMES	OBJECTIVE To assess the use of mesh in pelvic organ prolapse surgery, and compare short term outcomes between procedures using and not using mesh. DESIGN All inclusive, population based cohort study. SETTING Statewide surgical care captured in the New York Statewide Planning and Research Cooperative System. PARTICIPANTS Women who underwent prolapse repair procedures in New York state from 2008 to 2011. MAIN OUTCOMES MEASURES 90 day safety events and reinterventions within one year, after propensity score matching. Categorical, time to event, and subgroup analyses (<65 and >= 65 year age groups) were conducted. RESULTS Of 27 991 patients in total, 7338 and 20 653 underwent prolapse repair procedures with and without mesh, respectively. Mesh use increased by 44.7%, from 1461 procedures in 2008 to 2114 procedures in 2011. Most patients in the cohort were younger than 65 years (62.3% (n=17 424/27 991)). However, more patients were aged 65 years and older in the mesh group than in the non-mesh group (44.3% (n=3249) v 35.4% (n=7318)). Complications after surgery were not common, irrespective of the use or non-use of mesh. After propensity score matching, patients who received the surgery with mesh had a higher chance of having a reintervention within one year (mesh 3.3% v no mesh 2.2%, hazard ratio 1.47 (95% confidence interval 1.21 to 1.79)) and were more likely to have urinary retention within 90 days (mesh 7.5% v no mesh 5.6%, risk ratio 1.33 (95% confidence interval 1.18 to 1.51)), compared with those who received surgery without mesh. In subgroup analyses based on age, mesh use was associated with an increased risk of reintervention within one year in patients under age 65 years, and increased risk of urinary retention in patients aged 65 years and over. CONCLUSIONS Despite multiple warnings released by the US Food and Drug Administration since 2008, use of mesh in pelvic organ prolapse surgery continues to grow. In this statewide comprehensive study, mesh procedures were associated with an increased risk of reinterventions within one year and urinary retention after surgery.	[Chughtai, Bilal; Buck, Jessica; Kaplan, Steven] Cornell Univ, Dept Urol, Weill Med Coll, New York Presbyterian Hosp, New York, NY 10021 USA; [Mao, Jialin; Sedrakyan, Art] Weill Cornell Med Coll & New York Presbyterian, Patient Centered Comparat Effectiveness Program, New York, NY 10065 USA; [Mao, Jialin; Sedrakyan, Art] Weill Cornell Med Coll & New York Presbyterian, MDEpiNet Sci & Infrastruct Ctr, Dept Healthcare Policy & Res, New York, NY 10065 USA	Cornell University; NewYork-Presbyterian Hospital	Sedrakyan, A (corresponding author), Weill Cornell Med Coll & New York Presbyterian, Patient Centered Comparat Effectiveness Program, New York, NY 10065 USA.	ars2013@med.cornell.edu	Mao, Jialin/AAA-4433-2021	Mao, Jialin/0000-0001-6671-3474	US National Institutes of Health [NIH-1U01FD004494-01]; FDA; FOOD AND DRUG ADMINISTRATION [U01FD004494] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FDA(United States Department of Health & Human Services); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	The study was funded in part through a UO1 grant (NIH-1U01FD004494-01) from the US National Institutes of Health and the FDA.	Altman D, 2011, NEW ENGL J MED, V364, P1826, DOI 10.1056/NEJMoa1009521; Anger JT, 2014, UROLOGY, V83, P768, DOI 10.1016/j.urology.2013.10.072; [Anonymous], 2008, PUBL HLTH NOT SER CO; Boyles SH, 2003, AM J OBSTET GYNECOL, V188, P108, DOI 10.1067/mob.2003.101; Cook JA, 2013, BMJ-BRIT MED J, V346, pf2820; Cummings P, 2003, ACCIDENT ANAL PREV, V35, P131, DOI 10.1016/S0001-4575(01)00108-7; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FDA, 2011, UR SURG MESH UPD SAF; FDA, 2014, FDA ISS PROP ADDR RI; FDA, 2011, UPD SER COMPL ASS TR; FDA, 2015, SEC MAUD MAN US FAC; FDA, 2011, SURG MESH TREATM WOM; Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8; Hiltunen R, 2007, OBSTET GYNECOL, V110, P455, DOI 10.1097/01.AOG.0000261899.87638.0a; Kaufman Y, 2011, INT UROGYNECOL J, V22, P307, DOI 10.1007/s00192-010-1270-6; Khan AA, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.025; Kongoasa N, 2014, OBSTET GYNECOL S1, V123, p1S; Koski ME, 2014, UROLOGY, V84, P575, DOI 10.1016/j.urology.2014.03.051; Maher C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub5; Makela KT, 2014, BMJ-BRIT MED J, V348, pf7592; Margulies RU, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.049; Meier B., 2012, FDA ORDERS SURG MESH; Mettu JR, 2014, CURR OPIN UROL, V24, P370, DOI 10.1097/MOU.0000000000000063; Mistrangelo E, 2007, J MINIM INVAS GYN, V14, P564, DOI 10.1016/j.jmig.2007.04.017; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Pelvic Mesh Lawyers, SURG MESH LAW OFF FR; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; Reynolds WS, 2013, NEUROUROL URODYNAM, V32, P330, DOI 10.1002/nau.22318; Rogo-Gupta L, 2012, OBSTET GYNECOL, V120, P1105, DOI [10.1097/AOG.0b013e31826ebcc2, http://10.1097/AOG.0b013e31826ebcc2]; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Sokol AI, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.08.003; Sung VW, 2008, OBSTET GYNECOL, V112, P1131, DOI 10.1097/AOG.0b013e3181898ba9; Ura A, 2014, WOMWN WANT TEXAS HEL; Wu JM, 2009, OBSTET GYNECOL, V114, P1278, DOI 10.1097/AOG.0b013e3181c2ce96	35	29	30	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2015	350								h2685	10.1136/bmj.h2685	http://dx.doi.org/10.1136/bmj.h2685			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK0TW	26037077	hybrid, Green Published			2022-12-28	WOS:000355918900007
J	Dafny, LS; Lee, TH				Dafny, Leemore S.; Lee, Thomas H.			The Good Merger	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONSOLIDATION		[Dafny, Leemore S.] Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA; [Lee, Thomas H.] Press Ganey, Wakefield, MA USA; [Lee, Thomas H.] Harvard Univ, Sch Med, Boston, MA USA	Northwestern University; Harvard University; Harvard Medical School	Dafny, LS (corresponding author), Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA.							Dafny L, 2014, NEW ENGL J MED, V370, P198, DOI 10.1056/NEJMp1313948; Porter ME, 2015, NEW ENGL J MED, V372, P1681, DOI 10.1056/NEJMp1502419; Ramirez JDE, 2014, NEW ENGL J MED, V371, P2245, DOI 10.1056/NEJMp1408009; Tsai TC, 2014, JAMA-J AM MED ASSOC, V312, P29, DOI 10.1001/jama.2014.4692	4	22	22	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2015	372	22					2077	2079		10.1056/NEJMp1502338	http://dx.doi.org/10.1056/NEJMp1502338			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ0EI	26017820				2022-12-28	WOS:000355146800001
J	Wagner, EF; Petruzzelli, M				Wagner, Erwin F.; Petruzzelli, Michele			CANCER METABOLISM A waste of insulin interference	NATURE			English	Editorial Material							CACHEXIA; MECHANISMS		[Wagner, Erwin F.] CNIO, Canc Cell Biol Programme, Madrid 28029, Spain; [Petruzzelli, Michele] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 0QQ, England	Centro Nacional de Investigaciones Oncologicas (CNIO); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Wagner, EF (corresponding author), CNIO, Canc Cell Biol Programme, Madrid 28029, Spain.	ewagner@cnio.es; mp753@cam.ac.uk		Wagner, Erwin F/0000-0001-7872-0196				Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Figueroa-Clarevega A, 2015, DEV CELL, V33, P47, DOI 10.1016/j.devcel.2015.03.001; Kir S, 2014, NATURE, V513, P100, DOI 10.1038/nature13528; Kwon Y, 2015, DEV CELL, V33, P36, DOI 10.1016/j.devcel.2015.02.012; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Strassburger K, 2012, DEV BIOL, V367, P187, DOI 10.1016/j.ydbio.2012.05.008; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008	10	28	29	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					430	431		10.1038/521430a	http://dx.doi.org/10.1038/521430a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	26017439				2022-12-28	WOS:000355286600027
J	Dubb, SS				Dubb, Sukhpreet Singh			PERSONAL VIEW It doesn't "come with the job": violence against doctors at work must stop	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EMERGENCY-DEPARTMENTS; PHYSICIANS; ACCIDENT		Univ London Imperial Coll Sci Technol & Med, Dept Invest Med & Acad Surg, London SW7 2AZ, England	Imperial College London	Dubb, SS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Invest Med & Acad Surg, London SW7 2AZ, England.	ssd05@ic.ac.uk						Belayachi J, 2010, J OCCUP MED TOXICOL, V5, DOI 10.1186/1745-6673-5-27; Evers Will, 2002, Int J Ment Health Nurs, V11, P2, DOI 10.1046/j.1440-0979.2002.00219.x; Jenkins MG, 1998, J ACCID EMERG MED, V15, P262; Joa TS, 2012, SCAND J PRIM HEALTH, V30, P55, DOI 10.3109/02813432.2012.651570; Kelloway EK, 2006, HDB WORKPLACE VIOLEN; Kowalenko T, 2005, ANN EMERG MED, V46, P142, DOI 10.1016/j.annemergmed.2004.10.010; NHS, 2014, NHS STAFF SURV 2014; NHS Business Services Authority, REP PHYS ASS NHS STA; NHS Employers, VIOL STAFF; Ryan Denis, 2006, J Nurs Manag, V14, P106, DOI 10.1111/j.1365-2934.2006.00571.x; Winstanley S, 2002, ACTA PSYCHIAT SCAND, V106, P144, DOI 10.1034/j.1600-0447.106.s412.31.x	11	11	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2015	350								h2780	10.1136/bmj.h2780	http://dx.doi.org/10.1136/bmj.h2780			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0AF	26013379				2022-12-28	WOS:000355132600014
J	Ghani, KR; Miller, DC				Ghani, Khurshid R.; Miller, David C.			Variation in Prostate Cancer Care Physician Variation in Management of Low-Risk Prostate Cancer: A Population-Based Cohort Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								IMPORTANCE Up-front treatment of older men with low-risk prostate cancer can cause morbidity without clear survival benefit; however, most such patients receive treatment instead of observation. The impact of physicians on the management approach is uncertain. OBJECTIVE To determine the impact of physicians on the management of low-risk prostate cancer with up-front treatment vs observation. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort of men 66 years and older with low-risk prostate cancer diagnosed from 2006 through 2009. Patient and tumor characteristics were obtained from the Surveillance, Epidemiology, and End Results cancer registries. The diagnosing urologist, consulting radiation oncologist, cancer-directed therapy, and comorbid medical conditions were determined from linked Medicare claims. Physician characteristics were obtained from the American Medical Association Physician Masterfile. Mixed-effects models were used to evaluate management variation and factors associated with observation. MAIN OUTCOMES AND MEASURES No cancer-directed therapy within 12 months of diagnosis (observation). RESULTS A total of 2145 urologists diagnosed low-risk prostate cancer in 12 068 men, of whom 80.1% received treatment and 19.9% were observed. The case-adjusted rate of observation varied widely across urologists, ranging from 4.5% to 64.2% of patients. The diagnosing urologist accounted for 16.1% of the variation in up-front treatment vs observation, whereas patient and tumor characteristics accounted for 7.9% of this variation. After adjustment for patient and tumor characteristics, urologists who treat non-low-risk prostate cancer (adjusted odds ratio [aOR], 0.71 [95% CI, 0.55-0.92]; P = .01) and graduated in earlier decades (P =.004) were less likely to manage low-risk disease with observation. Treated patients were more likely to undergo prostatectomy (aOR, 1.71 [95% CI, 1.45-2.01]; P < .001), cryotherapy (aOR, 28.2 [95% CI, 19.5-40.9]; P < .001), brachytherapy (aOR, 3.41 [95% CI, 2.96-3.93]; P < .001), or external-beam radiotherapy (aOR, 1.31 [95% CI, 1.08-1.58]; P = .005) if their urologist billed for that treatment. Case-adjusted rates of observation also varied across consulting radiation oncologists, ranging from 2.2% to 46.8% of patients. CONCLUSIONS AND RELEVANCE Rates of management of low-risk prostate cancer with observation varied widely across urologists and radiation oncologists. Patients whose diagnosis was made by urologists who treated prostate cancer were more likely to receive up-front treatment and, when treated, more likely to receive a treatment that their urologist performed. Public reporting of physicians' cancer management profiles would enable informed selection of physicians to diagnose and manage prostate cancer.	Univ Michigan, Dow Div Hlth Serv Res, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Miller, DC (corresponding author), Dept Urol, 2800 Plymouth Rd,NCRC Bldg 16,First Floor, Ann Arbor, MI 48109 USA.	dcmiller@med.umich.edu						Birkmeyer JD, 2013, LANCET, V382, P1121, DOI 10.1016/S0140-6736(13)61215-5; Hoffman KE, 2014, JAMA INTERN MED, V174, P1450, DOI 10.1001/jamainternmed.2014.3021; Jacobs BL, 2013, JAMA-J AM MED ASSOC, V309, P2587, DOI 10.1001/jama.2013.6882; Kim SP, 2014, MED CARE, V52, P579, DOI 10.1097/MLR.0000000000000155; Lee EO, 2013, NEW ENGL J MED, V368, P6, DOI 10.1056/NEJMp1209500; Mohler JL, 2014, J NATL COMPR CANC NE, V12, P686, DOI 10.6004/jnccn.2014.0072; Ross I, 2015, J UROLOGY, V193, P1159, DOI 10.1016/j.juro.2014.10.102	7	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2015	313	20					2066	+		10.1001/jama.2015.0607	http://dx.doi.org/10.1001/jama.2015.0607			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0DC	26010635				2022-12-28	WOS:000355142400020
J	Kipfer, S; Frigerio, S; Hench, J; Aussy, A; Boyer, O				Kipfer, Stefan; Frigerio, Susanna; Hench, Juergen; Aussy, Audrey; Boyer, Olivier			Immune-mediated necrotising myopathy linked to statin use	LANCET			English	Editorial Material									[Kipfer, Stefan; Frigerio, Susanna] Kantonsspital Olten, Dept Internal Med & Neurol, CH-4600 Olten, Switzerland; [Hench, Juergen] Univ Basel Hosp, Dept Neuropathol, Inst Pathol, Basel, Switzerland; [Aussy, Audrey; Boyer, Olivier] INSERM, U905, Rouen, France; [Aussy, Audrey; Boyer, Olivier] Normandy Univ, Inst Res & Innovat Biomed, Rouen, France; [Aussy, Audrey; Boyer, Olivier] Rouen Univ Hosp, Immunol Lab, Rouen, France	Kantonsspital Olten; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen	Kipfer, S (corresponding author), Kantonsspital Olten, Dept Internal Med & Neurol, Baslerstr 150, CH-4600 Olten, Switzerland.	s.kipfer@gmx.ch	Boyer, Olivier/N-6552-2013	Boyer, Olivier/0000-0002-7591-307X					0	6	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 31	2015	386	10005					E26	E26		10.1016/S0140-6736(15)60068-X	http://dx.doi.org/10.1016/S0140-6736(15)60068-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV0WK	26074381	Bronze			2022-12-28	WOS:000363974200003
J	Gres, AT; Kirby, KA; KewalRamani, VN; Tanner, JJ; Pornillos, O; Sarafianos, SG				Gres, Anna T.; Kirby, Karen A.; KewalRamani, Vineet N.; Tanner, John J.; Pornillos, Owen; Sarafianos, Stefan G.			X-ray crystal structures of native HIV-1 capsid protein reveal conformational variability	SCIENCE			English	Article							ASSEMBLY INHIBITOR; DIMERIZATION DOMAIN; NUCLEAR ENTRY; BINDING; INFECTION; DYNAMICS; COMPLEX; MODEL; CPSF6	The detailed molecular interactions between native HIV-1 capsid protein (CA) hexamers that shield the viral genome and proteins have been elusive. We report crystal structures describing interactions between CA monomers related by sixfold symmetry within hexamers (intrahexamer) and threefold and twofold symmetry between neighboring hexamers (interhexamer). The structures describe how CA builds hexagonal lattices, the foundation of mature capsids. Lattice structure depends on an adaptable hydration layer modulating interactions among CA molecules. Disruption of this layer alters interhexamer interfaces, highlighting an inherent structural variability. A CA-targeting antiviral affects capsid stability by binding across CA molecules and subtly altering interhexamer interfaces remote to the ligand-binding site. Inherent structural plasticity, hydration layer rearrangement, and effector binding affect capsid stability and have functional implications for the retroviral life cycle.	[Gres, Anna T.; Kirby, Karen A.; Sarafianos, Stefan G.] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Gres, Anna T.; Tanner, John J.] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Kirby, Karen A.; Sarafianos, Stefan G.] Univ Missouri, Dept Mol Microbiol & Immunol, Sch Med, Columbia, MO 65211 USA; [KewalRamani, Vineet N.] NCI, Basic Res Lab, Ctr Canc Res, Frederick, MD 21702 USA; [Tanner, John J.; Sarafianos, Stefan G.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Pornillos, Owen] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Missouri System; University of Missouri Columbia; University of Virginia	Sarafianos, SG (corresponding author), Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA.	sarafianoss@missouri.edu	KewalRamani, Vineet/V-5084-2019	Gres, Anna/0000-0002-6915-5903; Tanner, John/0000-0001-8314-113X; Kirby, Karen A./0000-0003-2468-4796; Sarafianos, Stefan G/0000-0002-5840-154X	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; NIH [AI112417, AI120860, GM103368, AI076119, AI099284, AI100890, GM066087]; NATIONAL CANCER INSTITUTE [ZIABC010487, ZIABC010488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI112417, R01AI076119, R01AI120860, R01AI100890, R01AI099284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM103368, R01GM066087] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Nix of Advanced Light Source (ALS) beamline 4.2.2 for assistance with data collection. ALS is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract DE-AC02-05CH11231. single-wavelength anomalous diffraction phasing and initial model building were carried out at the workshop entitled "CCP4/APS School in Macromolecular Crystallography: From Data Collection to Structure Refinement and Beyond" at the Argonne National Laboratory in June 2014 (www.ccp4.ac.uk/schools/APS-2014/index.php). We also thank all the lecturers of the workshop and the staff of Advanced Photon Source Sector 23 (GM/CA-CAT) for helpful discussions regarding data collection, processing, refinement, and validation strategies. We also thank C. Tang for providing a CA-expressing plasmid. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Final coordinates and structure factors have been deposited in the Protein Data Bank (PDB) and are available under accession codes 4XFX (CA), 4XFY (dCA), and 4XFZ (CAPF74). This work was supported in whole or in part by NIH grants AI112417, AI120860, GM103368, AI076119, AI099284, and AI100890 (S.G.S.) and GM066087 (O.P.).	Ambrose Z, 2014, VIROLOGY, V454, P371, DOI 10.1016/j.virol.2014.02.004; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Bhattacharya A, 2014, P NATL ACAD SCI USA, V111, P18625, DOI 10.1073/pnas.1419945112; Blair WS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001220; Curreli F, 2011, BIOORGAN MED CHEM, V19, P77, DOI 10.1016/j.bmc.2010.11.045; Deshmukh L, 2013, J AM CHEM SOC, V135, P16133, DOI 10.1021/ja406246z; Dimonte S, 2014, VIRUS GENES, V48, P429, DOI 10.1007/s11262-014-1039-y; Du SC, 2011, J MOL BIOL, V406, P371, DOI 10.1016/j.jmb.2010.11.027; Fricke T, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0120-x; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; Hilditch L, 2014, CURR OPIN VIROL, V4, P32, DOI 10.1016/j.coviro.2013.11.003; Jiang JY, 2011, VIROLOGY, V421, P253, DOI 10.1016/j.virol.2011.09.012; Joshi A, 2006, J VIROL, V80, P7939, DOI 10.1128/JVI.00355-06; Kelly BN, 2007, J MOL BIOL, V373, P355, DOI 10.1016/j.jmb.2007.07.070; Kelly BN, 2006, BIOCHEMISTRY-US, V45, P11257, DOI 10.1021/bi060927x; Lamorte L, 2013, ANTIMICROB AGENTS CH, V57, P4622, DOI 10.1128/AAC.00985-13; Matreyek KA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003693; Meng X, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002886; Obal G, 2015, SCIENCE, V349, P95, DOI 10.1126/science.aaa5182; Peng K, 2014, ELIFE, V3, DOI 10.7554/eLife.04114; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Price AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004459; Rihn SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003461; Shi J, 2011, J VIROL, V85, P542, DOI 10.1128/JVI.01406-10; Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	34	160	162	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					99	103		10.1126/science.aaa5936	http://dx.doi.org/10.1126/science.aaa5936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26044298	Green Submitted, Green Accepted			2022-12-28	WOS:000357280800068
J	Jutzi, M; Asphaug, E				Jutzi, M.; Asphaug, E.			The shape and structure of cometary nuclei as a result of low-velocity accretion	SCIENCE			English	Article							SCATTERED DISK; SIMULATIONS; DENSITY; ORIGIN; FAMILY	Cometary nuclei imaged from flyby and rendezvous spacecraft show common evidence of layered structures and bilobed shapes. But how and when these features formed is much debated, with distinct implications for solar system formation, dynamics, and geology. We show that these features could be a direct result of accretionary collisions, based on three-dimensional impact simulations using realistic constitutive properties. We identify two regimes of interest: layer-forming splats and mergers resulting in bilobed shapes. For bodies with low tensile strength, our results can explain key morphologies of cometary nuclei, as well as their low bulk densities. This advances the hypothesis that nuclei formed by collisional coagulation-either out of cometesimals accreting in the early solar system or, alternatively, out of comparable-sized debris clumps paired in the aftermath of major collisions.	[Jutzi, M.] Univ Bern, Inst Phys, Space Res & Planetary Sci, Ctr Space & Habitabil, CH-3012 Bern, Switzerland; [Asphaug, E.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA	University of Bern; Arizona State University; Arizona State University-Tempe	Jutzi, M (corresponding author), Univ Bern, Inst Phys, Space Res & Planetary Sci, Ctr Space & Habitabil, Sidlerstr 5, CH-3012 Bern, Switzerland.	martin.jutzi@space.unibe.ch	Asphaug, Erik/AAC-9455-2020	Jutzi, Martin/0000-0002-1800-2974	Swiss National Science Foundation through the Ambizione program; NASA's Planetary Geology and Geophysics Program	Swiss National Science Foundation through the Ambizione program; NASA's Planetary Geology and Geophysics Program(National Aeronautics & Space Administration (NASA))	M.J. acknowledges support from the Swiss National Science Foundation through the Ambizione program. The work was carried out partly within the frame of the National Centre for Competence in Research "PlanetS." E.A. was supported by NASA's Planetary Geology and Geophysics Program. We thank the anonymous reviewers for valuable comments. The 3D images were produced using Vapor (www.vapor.ucar.edu). SPH data are available as supplementary materials.	A'Hearn MF, 2011, ANNU REV ASTRON ASTR, V49, P281, DOI 10.1146/annurev-astro-081710-102506; Arakawa M, 2011, ICARUS, V216, P1, DOI 10.1016/j.icarus.2011.08.018; Asphaug E, 2006, NATURE, V439, P155, DOI 10.1038/nature04311; ASPHAUG E, 1994, NATURE, V370, P120, DOI 10.1038/370120a0; Asphaug E, 2013, ICARUS, V223, P544, DOI 10.1016/j.icarus.2012.12.009; Belton MJS, 2007, ICARUS, V187, P332, DOI 10.1016/j.icarus.2006.09.005; Belton MJS, 2014, ICARUS, V231, P168, DOI 10.1016/j.icarus.2013.12.001; Belton MJS, 2010, ICARUS, V210, P881, DOI 10.1016/j.icarus.2010.07.007; Boehnhardt H, 2004, SPACE SCI S, P301; Canup RM, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/2/35; Cuzzi JN, 2010, ICARUS, V208, P518, DOI 10.1016/j.icarus.2010.03.005; Donn B., 1986, 20th ESLAB Symposium on the Exploration of Halley's Comet. Proceedings of the International Symposium (ESA-SP-250), P523; Durda DD, 2000, ICARUS, V145, P220, DOI 10.1006/icar.1999.6333; Durham WB, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023484; Jutzi M, 2011, NATURE, V476, P69, DOI 10.1038/nature10289; Jutzi M., 2015, ASTEROIDS IN PRESS; Jutzi M, 2008, ICARUS, V198, P242, DOI 10.1016/j.icarus.2008.06.013; Jutzi M, 2015, PLANET SPACE SCI, V107, P3, DOI 10.1016/j.pss.2014.09.012; Leinhardt ZM, 2000, ICARUS, V146, P133, DOI 10.1006/icar.2000.6370; Leinhardt ZEM, 2010, ASTROPHYS J, V714, P1789, DOI 10.1088/0004-637X/714/2/1789; Levison HF, 2006, ICARUS, V184, P619, DOI 10.1016/j.icarus.2006.05.008; Mottola S, 2014, ASTRON ASTROPHYS, V569, DOI 10.1051/0004-6361/201424590; Mumma M. J., 1993, PROTOSTARS PLANETS, P1177; Schlichting HE, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/2/36; Sierks H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa1044; Skorov Y, 2012, ICARUS, V221, P1, DOI 10.1016/j.icarus.2012.01.012; Tanga P, 2009, ASTROPHYS J LETT, V706, pL197, DOI 10.1088/0004-637X/706/1/L197; Thomas N, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0440; Weidenschilling SJ, 1997, ICARUS, V127, P290, DOI 10.1006/icar.1997.5712; WEISSMAN PR, 1986, NATURE, V320, P242, DOI 10.1038/320242a0; Weissman PR, 2004, SPACE SCI S, P337	33	56	57	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 19	2015	348	6241					1355	1358		10.1126/science.aaa4747	http://dx.doi.org/10.1126/science.aaa4747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7XK	26022415				2022-12-28	WOS:000356449500049
J	Yancy, WS; Mayer, SB; Coffman, CJ; Smith, VA; Kolotkin, RL; Geiselman, PJ; McVay, MA; Oddone, EZ; Voils, CI				Yancy, William S., Jr.; Mayer, Stephanie B.; Coffman, Cynthia J.; Smith, Valerie A.; Kolotkin, Ronette L.; Geiselman, Paula J.; McVay, Megan A.; Oddone, Eugene Z.; Voils, Corrine I.			Effect of Allowing Choice of Diet on Weight Loss A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-CARBOHYDRATE DIET; LOW-FAT DIET; OBESE ADULTS; RISK-FACTORS; OVERWEIGHT; QUESTIONNAIRE; PREFERENCE; IMPACT; RELIABILITY; MANAGEMENT	Background: Choosing a diet rather than being prescribed one could improve weight loss. Objective: To examine whether offering choice of diet improves weight loss. Design: Double-randomized preference trial of choice between 2 diets (choice) versus random assignment to a diet (comparator) over 48 weeks. (ClinicalTrials.gov: NCT01152359) Setting: Outpatient clinic at a Veterans Affairs medical center. Patients: Outpatients with a body mass index of at least 30 kg/m(2). Intervention: Choice participants received information about their food preferences and 2 diet options (low-carbohydrate diet [LCD] or low-fat diet [LFD]) before choosing and were allowed to switch diets at 12 weeks. Comparator participants were randomly assigned to 1 diet for 48 weeks. Both groups received group and telephone counseling for 48 weeks. Measurements: The primary outcome was weight at 48 weeks. Results: Of 105 choice participants, 61 (58%) chose the LCD and 44 (42%) chose the LFD; 5 (3 on the LCD and 2 on the LFD) switched diets at 12 weeks, and 87 (83%) completed measurements at 48 weeks. Of 102 comparator participants, 53 (52%) were randomly assigned to the LCD and 49 (48%) were assigned to the LFD; 88 (86%) completed measurements. At 48 weeks, estimated mean weight loss was 5.7 kg (95% CI, 4.3 to 7.0 kg) in the choice group and 6.7 kg (CI, 5.4 to 8.0 kg) in the comparator group (mean difference, -1.1 kg [CI, -2.9 to 0.8 kg]; P = 0.26). Secondary outcomes of dietary adherence, physical activity, and weight-related quality of life were similar between groups at 48 weeks. Limitations: Only 2 diet options were provided. Results from this sample of older veterans might not be generalizable to other populations. Conclusion: Contrary to expectations, the opportunity to choose a diet did not improve weight loss.	Vet Adm Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA; Duke Univ, Med Ctr, Durham, NC USA; Virginia Commonwealth Univ, Richmond, VA USA; Sogn Og Fjordane Univ Coll, Forde, Norway; Forde Cent Hosp, Forde, Norway; Vestfold Hosp Trust, Tonsberg, Norway; Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; Virginia Commonwealth University; Western Norway University of Applied Sciences; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Yancy, WS (corresponding author), Durham VA Med Ctr, 152,508 Fulton St, Durham, NC 27705 USA.	yancy006@mc.duke.edu		Smith, Valerie/0000-0001-5170-9819; Kolotkin, Ronette/0000-0002-1300-2131; Mayer, Stephanie B./0000-0003-2437-347X	Department of Veterans Affairs [IIR 09-381]; Veterans Affairs [I01HX000263] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	Grant Support: By the Department of Veterans Affairs (IIR 09-381).	American Heart Association, 2011, NO FAD DIET; [Anonymous], 1999, STAT MED, V18, P1905; [Anonymous], NEW ATKINS NEW YOU; Bazzano LA, 2014, ANN INTERN MED, V161, P309, DOI 10.7326/M14-0180; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Borradaile KE, 2012, OBESITY, V20, P1218, DOI 10.1038/oby.2011.216; Borushek A, 2007, CALORIE KING CALORIE; Burke LE, 2008, INT J OBESITY, V32, P166, DOI 10.1038/sj.ijo.0803706; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; DREWNOWSKI A, 1992, DIETARY FATS, P59; Foster GD, 2010, ANN INTERN MED, V153, P147, DOI 10.7326/0003-4819-153-3-201008030-00005; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Geiselman PJ, 1998, PHYSIOL BEHAV, V63, P919, DOI 10.1016/S0031-9384(97)00542-8; GEISELMAN PJ, 1988, APPETITE, V11, P26, DOI 10.1016/S0195-6663(88)80043-6; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Hartman AM, 1996, NUTR CANCER, V25, P305, DOI 10.1080/01635589609514454; Harvey JR, 2014, PREV MED, V68, P71, DOI 10.1016/j.ypmed.2014.05.015; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Kolotkin RL, 2002, QUAL LIFE RES, V11, P157, DOI 10.1023/A:1015081805439; Kolotkin RL, 2001, OBES RES, V9, P102, DOI 10.1038/oby.2001.13; Marcus SM, 2012, PSYCHOL METHODS, V17, P244, DOI 10.1037/a0028031; McVay MA, 2014, APPETITE, V83, P117, DOI 10.1016/j.appet.2014.08.023; National Institutes of Health, 2000, PRACT GUID ID EV TRE; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Pagoto SL, 2013, JAMA-J AM MED ASSOC, V310, P687, DOI 10.1001/jama.2013.8601; Pagoto SL, 2012, OBESITY, V20, P1234, DOI 10.1038/oby.2011.140; Rollnick S, 1995, BEHAV COGN PSYCHOTH, V23, P325, DOI DOI 10.1017/S135246580001643X; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; SPITZER L, 1981, APPETITE, V2, P293, DOI 10.1016/S0195-6663(81)80018-9; Stern L, 2004, ANN INTERN MED, V140, P778, DOI 10.7326/0003-4819-140-10-200405180-00007; WYANT KW, 1984, J AM DIET ASSOC, V84, P169; Yancy WS, 2013, CONTEMP CLIN TRIALS, V35, P106, DOI 10.1016/j.cct.2013.03.002; Yancy WS, 2010, ARCH INTERN MED, V170, P136, DOI 10.1001/archinternmed.2009.492; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006	42	30	30	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12					805	+		10.7326/M14-2358	http://dx.doi.org/10.7326/M14-2358			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	26075751	Green Accepted			2022-12-28	WOS:000356516300015
J	Hendricks, MP; Campos, MP; Cleveland, GT; Jen-La Plante, I; Owen, JS				Hendricks, Mark P.; Campos, Michael P.; Cleveland, Gregory T.; Jen-La Plante, Ilan; Owen, Jonathan S.			A tunable library of substituted thiourea precursors to metal sulfide nanocrystals	SCIENCE			English	Article							SILVER-HALIDE PARTICLES; SPONTANEOUS NUCLEATION; PBS NANOCRYSTALS; MONODISPERSE; REACTIVITY; STOICHIOMETRY; CARBOXYLATE; MORPHOLOGY; INSIGHTS; KINETICS	Controlling the size of colloidal nanocrystals is essential to optimizing their performance in optoelectronic devices, catalysis, and imaging applications. Traditional synthetic methods control size by terminating the growth, an approach that limits the reaction yield and causes batch-to-batch variability. Herein we report a library of thioureas whose substitution pattern tunes their conversion reactivity over more than five orders of magnitude and demonstrate that faster thiourea conversion kinetics increases the extent of crystal nucleation. Tunable kinetics thereby allows the nanocrystal concentration to be adjusted and a desired crystal size to be prepared at full conversion. Controlled precursor reactivity and quantitative conversion improve the batch-to-batch consistency of the final nanocrystal size at industrially relevant reaction scales.	[Hendricks, Mark P.; Campos, Michael P.; Cleveland, Gregory T.; Jen-La Plante, Ilan; Owen, Jonathan S.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University	Owen, JS (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	jso2115@columbia.edu		Owen, Jonathan/0000-0001-5502-3267	Center for Re-Defining Photovoltaic Efficiency Through Molecule Scale Control, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001085]; Department of Energy [DE-SC0006410]; Empire State Development's Division of Science, Technology and Innovation; National Center for Research Resources, NIH [C06 RR017528-01-CEM]; Center for Functional Nanomaterials, Brookhaven National Laboratory, Office of Basic Energy Sciences [DE-AC02-98CH10886]	Center for Re-Defining Photovoltaic Efficiency Through Molecule Scale Control, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); Empire State Development's Division of Science, Technology and Innovation; National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Center for Functional Nanomaterials, Brookhaven National Laboratory, Office of Basic Energy Sciences	Precursor design and kinetics studies were supported by the Center for Re-Defining Photovoltaic Efficiency Through Molecule Scale Control, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under award no. DE-SC0001085. Large-scale syntheses and surface chemistry measurements were supported by the Department of Energy under grant no. DE-SC0006410. The authors thank A. N. Beecher and E. Auyeung for assistance with transmission electron microscopy, which was carried out in part at the New York Structural Biology Center, supported by Empire State Development's Division of Science, Technology and Innovation and the National Center for Research Resources, NIH, grant no. C06 RR017528-01-CEM. We also thank E. Busby and M. Sfier for assistance with near-infrared (NIR) photoluminescence, which was carried out in part at the Center for Functional Nanomaterials, Brookhaven National Laboratory, Office of Basic Energy Sciences, under contract no. DE-AC02-98CH10886. Z. M. Norman is thanked for assistance with Fourier transform-infrared spectroscopy studies and A. S. R. Chesman for helpful advice concerning the synthesis and characterization of copper zinc tin sulfide. A series of patent applications on this subject have been filed.	Abe S, 2012, ACS NANO, V6, P42, DOI 10.1021/nn204008q; Anderson NC, 2013, J AM CHEM SOC, V135, P18536, DOI 10.1021/ja4086758; Chuang CHM, 2014, NAT MATER, V13, P796, DOI [10.1038/nmat3984, 10.1038/NMAT3984]; Garcia-Rodriguez R, 2013, CHEM MATER, V25, P1233, DOI 10.1021/cm3035642; Guo YJ, 2013, ACS NANO, V7, P3616, DOI 10.1021/nn400596e; Hendricks MP, 2012, ACS NANO, V6, P10054, DOI 10.1021/nn303769h; LAMER VK, 1950, J AM CHEM SOC, V72, P4847, DOI 10.1021/ja01167a001; Liu HT, 2007, J AM CHEM SOC, V129, P305, DOI 10.1021/ja0656696; Marcotrigiano G., 1972, J CHEM SOC P2, V1972, P1539; Moreels I, 2009, ACS NANO, V3, P3023, DOI 10.1021/nn900863a; Owen JS, 2010, J AM CHEM SOC, V132, P18206, DOI 10.1021/ja106777j; Rempel JY, 2009, J AM CHEM SOC, V131, P4479, DOI 10.1021/ja809156t; RITCHIE CD, 1964, PROG PHYS ORG CHEM, V2, P323, DOI 10.1002/9780470171813.ch6; Ruberu TPA, 2012, ACS NANO, V6, P5348, DOI 10.1021/nn301182h; Sugimoto T, 2000, COLLOID SURFACE A, V164, P183, DOI 10.1016/S0927-7757(99)00366-0; Sugimoto T, 2000, COLLOID SURFACE A, V164, P205, DOI 10.1016/S0927-7757(99)00365-9; Wang FD, 2012, J AM CHEM SOC, V134, P5369, DOI 10.1021/ja300135c; Weidman MC, 2014, ACS NANO, V8, P6363, DOI 10.1021/nn5018654; Yordanov GG, 2008, COLLOID SURFACE A, V316, P37, DOI 10.1016/j.colsurfa.2007.08.014; Zherebetskyy D, 2014, SCIENCE, V344, P1380, DOI 10.1126/science.1252727	20	262	268	7	252	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1226	1230		10.1126/science.aaa2951	http://dx.doi.org/10.1126/science.aaa2951			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068846				2022-12-28	WOS:000356011500047
J	Amari, T; Luciani, JF; Aly, JJ				Amari, Tahar; Luciani, Jean-Francois; Aly, Jean-Jacques			Small-scale dynamo magnetism as the driver for heating the solar atmosphere	NATURE			English	Article							QUIET SUN MAGNETISM; TRANSITION REGION; CORONAL CLOSURE; SIMULATIONS; CONVECTION; SPICULES; FIELDS; FLUX; PHOTOSPHERE; PLASMA	The long-standing problem of how the solar atmosphere is heated has been addressed by many theoretical studies, which have stressed the relevance of two specific mechanisms, involving magnetic reconnection and waves, as well as the necessity of treating the chromosphere and corona together(1-7). But a fully consistent model has not yet been constructed and debate continues, in particular about the possibility of coronal plasma being heated by energetic phenomena observed in the chromosphere(2,3,8-11). Here we report modelling of the heating of the quiet Sun, in which magnetic fields are generated by a subphotospheric fluid dynamo intrinsically connected to granulation. We find that the fields expand into the chromosphere, where plasma is heated at the rate required to match observations (4,500 watts per square metre) by small-scale eruptions that release magnetic energy and drive sonic motions. Some energetic eruptions can even reach heights of 10 million metres above the surface of the Sun, thereby affecting the very low corona. Extending the model by also taking into account the vertical weak network magnetic field allows for the existence of a mechanism able to heat the corona above, while leaving unchanged the physics of chromospheric eruptions. Such a mechanism rests on the eventual dissipation of Alfven waves generated inside the chromosphere and that carry upwards the required energy flux of 300 watts per square metre. The model shows a topologically complex magnetic field of 160 gauss on the Sun's surface, agreeing with inferences obtained from spectropolarimetric observations(12-14), chromospheric features (contributing only weakly to the coronal heating) that can be identified with observed spicules(9) and blinkers(10,11), and vortices that may be possibly associated with observed solar tornadoes(8).	[Amari, Tahar; Luciani, Jean-Francois] Ecole Polytech, Ctr Phys Theor, CNRS, F-91128 Palaiseau, France; [Aly, Jean-Jacques] Univ Paris 07, Ctr Etud Saclay, AIM Unite Mixte Rech CEA CNRS, UMR 7158, F-91191 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; CEA; Universite Paris Saclay	Amari, T (corresponding author), Ecole Polytech, Ctr Phys Theor, CNRS, F-91128 Palaiseau, France.	tahar.amari@polytechnique.edu			Centre National d'Etudes Spatiales (CNES)	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales)	We thank A. L. Ariste for information about measurement heights and values of magnetic fields in the Sun's photosphere, B. Lites for providing the heights at which the magnetic fields were measured in ref. 13, M. Aschwanden for information about observational properties of loops in the solar atmosphere, and A. Canou for help in dealing with IRIS data. Many thanks go to M. Cheung and Y. Fan for discussion, as well as to A. van Ballegooijen. The numerical simulations performed in this paper were done on the set of computers of the Centre de Physique Theorique (CNRS/Ecole Polytechnique) and of the institute IDRIS of the Centre National de la Recherche Scientifique. We thank the Centre National d'Etudes Spatiales (CNES) for financial support. IRIS is a NASA small explorer mission developed and operated by LMSAL with mission operations executed at NASA Ames Research Center and major contributions to downlink communications funded by the Norwegian Space Center (NSC, Norway) through an ESA PRODEX contract.	Abbett WP, 2007, ASTROPHYS J, V665, P1469, DOI 10.1086/519788; Amari T, 2008, ASTROPHYS J LETT, V681, pL45, DOI 10.1086/590323; Amari T, 2003, ASTROPHYS J, V595, P1231, DOI 10.1086/377444; Amari T, 2000, ASTROPHYS J, V529, pL49, DOI 10.1086/312444; Amari T, 2005, ASTROPHYS J, V629, pL37, DOI 10.1086/444357; Amari T, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L27; Amari T, 1999, SIAM J SCI COMPUT, V21, P970, DOI 10.1137/S1064827596304824; Amari T, 2014, NATURE, V514, P465, DOI 10.1038/nature13815; Aschwanden MJ, 2007, ASTROPHYS J, V659, P1673, DOI 10.1086/513070; Balmaceda L, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/200913584; Beeck B, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201118252; Bingert S, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201016019; Brandenburg A, 2002, COMPUT PHYS COMMUN, V147, P471, DOI 10.1016/S0010-4655(02)00334-X; Bushby PJ, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322993; Cattaneo F, 2003, ASTROPHYS J, V588, P1183, DOI 10.1086/374313; Cattaneo F, 1999, ASTROPHYS J, V515, pL39, DOI 10.1086/311962; Centeno R, 2010, ASTROPHYS J, V708, P1579, DOI 10.1088/0004-637X/708/2/1579; Danilovic S, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/200913379; De Pontieu B, 2007, ASTROPHYS J, V655, P624, DOI 10.1086/509070; De Pontieu B, 2012, ASTROPHYS J LETT, V752, DOI [10.1088/2041-8205/752/1/L12, 10.1088/2041-8205/752/1/L12L12]; De Pontieu B, 2011, SCIENCE, V331, P55, DOI 10.1126/science.1197738; De Pontieu B, 2003, ASTROPHYS J, V590, P502, DOI 10.1086/374928; Freytag B, 2012, J COMPUT PHYS, V231, P919, DOI 10.1016/j.jcp.2011.09.026; Galsgaard K, 1996, J GEOPHYS RES-SPACE, V101, P13445, DOI 10.1029/96JA00428; Gudiksen BV, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201116520; Gudiksen BV, 2005, ASTROPHYS J, V618, P1020, DOI 10.1086/426063; Hansteen VH, 2010, ASTROPHYS J, V718, P1070, DOI 10.1088/0004-637X/718/2/1070; Jess DB, 2009, SCIENCE, V323, P1582, DOI 10.1126/science.1168680; Judge PG, 2011, ASTROPHYS J LETT, V730, DOI 10.1088/2041-8205/730/1/L4; Klimchuk JA, 2006, SOL PHYS, V234, P41, DOI 10.1007/s11207-006-0055-z; Klimchuk JA, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0256; Lites BW, 2008, ASTROPHYS J, V672, P1237, DOI 10.1086/522922; Martinez-Sykora J, 2009, ASTROPHYS J, V701, P1569, DOI 10.1088/0004-637X/701/2/1569; McIntosh SW, 2011, NATURE, V475, P477, DOI 10.1038/nature10235; PARKER EN, 1983, ASTROPHYS J, V264, P635, DOI 10.1086/160636; Pereira TMD, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/18; Priest ER, 2002, ASTROPHYS J, V576, P533, DOI 10.1086/341539; Rempel M, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/132; Rempel M, 2009, ASTROPHYS J, V691, P640, DOI 10.1088/0004-637X/691/1/640; Schrijver CJ, 2003, ASTROPHYS J, V597, pL165, DOI 10.1086/379870; Schrijver CJ, 2002, SOL PHYS, V207, P223, DOI 10.1023/A:1016295516408; Subramanian S, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201117877; Trujillo Bueno J, 2004, NATURE, V430, P326, DOI 10.1038/nature02669; VERNAZZA JE, 1981, ASTROPHYS J SUPPL S, V45, P635, DOI 10.1086/190731; Vogler A, 2007, ASTRON ASTROPHYS, V465, pL43, DOI 10.1051/0004-6361:20077253; Vogler A, 2005, ASTRON ASTROPHYS, V429, P335, DOI 10.1051/0004-6361:20041507; Wedemeyer S, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu086; Wedemeyer-Bohm S, 2009, SPACE SCI REV, V144, P317, DOI 10.1007/s11214-008-9447-8; Wedemeyer-Bohm S, 2012, NATURE, V486, P505, DOI 10.1038/nature11202	49	27	27	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					188	+		10.1038/nature14478	http://dx.doi.org/10.1038/nature14478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	26062509				2022-12-28	WOS:000356016700033
J	Leshem, E; Tate, JE; Steiner, CA; Curns, AT; Lopman, BA; Parashar, UD				Leshem, Eyal; Tate, Jacqueline E.; Steiner, Claudia A.; Curns, Aaron T.; Lopman, Ben A.; Parashar, Umesh D.			Acute Gastroenteritis Hospitalizations Among US Children Following Implementation of the Rotavirus Vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							HEALTH-CARE UTILIZATION; UNITED-STATES; DIARRHEA		[Leshem, Eyal; Tate, Jacqueline E.; Curns, Aaron T.; Lopman, Ben A.; Parashar, Umesh D.] US Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA 30333 USA; [Steiner, Claudia A.] Agcy Healthcare Res & Qual, Healthcare Cost & Utilizat Project, Rockville, MD USA	Centers for Disease Control & Prevention - USA; Agency for Healthcare Research & Quality	Leshem, E (corresponding author), US Ctr Dis Control & Prevent, Div Viral Dis, 1600 Clifton Rd NE,Mail Stop A-34, Atlanta, GA 30333 USA.	eleshem@cdc.gov		Leshem, Eyal/0000-0003-1267-6131				Cortes JE, 2011, NEW ENGL J MED, V365, P1108, DOI 10.1056/NEJMoa1000446; Cortese Margaret M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Curns AT, 2010, J INFECT DIS, V201, P1617, DOI 10.1086/652403; Elam-Evans LD, 2014, MMWR-MORBID MORTAL W, V63, P741; Leshem E, 2014, PEDIATRICS, V134, P15, DOI 10.1542/peds.2013-3849; US Centers for Disease Control and Prevention, BRIDG RAC POP EST DA	6	49	50	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2282	2284		10.1001/jama.2015.5571	http://dx.doi.org/10.1001/jama.2015.5571			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1VH	26057291	Bronze			2022-12-28	WOS:000355995300024
J	Plunkett, A; Tong, J				Plunkett, Adrian; Tong, Jeremy			Sepsis in children	BMJ-BRITISH MEDICAL JOURNAL			English	Review							NEONATAL SEPTIC SHOCK; PEDIATRIC SEPSIS; ANTIMICROBIAL THERAPY; HEMODYNAMIC SUPPORT; PRACTICE PARAMETERS; NATIONAL INSTITUTE; MEDICAL PROGRESS; BLOOD CULTURE; ONSET SEPSIS; MANAGEMENT	This clinical review has been developed for The BMJ in collaboration with BMJ Best Practice, based on a regularly updated web/mobile topic that supports evidence-based decision making at the point of care. To view the complete and current version, please refer to the Sepsis in children (http://bestpractice.bmj.com/best-practice/monograph/1201.html) topic on the BMJ Best Practice website.	[Plunkett, Adrian] Birmingham Childrens Hosp, Birmingham, W Midlands, England; [Tong, Jeremy] Univ Hosp Leicester NHS Trust, Leicester, Leics, England	University of Birmingham; University Hospitals of Leicester NHS Trust; University of Leicester	Plunkett, A (corresponding author), Birmingham Childrens Hosp, Birmingham, W Midlands, England.	adrian.plunkett@bch.nhs.uk		Plunkett, Adrian/0000-0003-0703-2649				Akech S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4416; Aneja R, 2007, ARCH DIS CHILD, V92, P165, DOI 10.1136/adc.2005.088450; [Anonymous], CRIT CARE MED; [Anonymous], 2012, NEUTR SEPS PREV MAN, P1; Bion J, 2013, BMJ QUAL SAF, V22, P110, DOI 10.1136/bmjqs-2012-001325; Bizzarro MJ, 2005, PEDIATRICS, V116, P595, DOI 10.1542/peds.2005-0552; Bone RC, 1996, CLIN CHEST MED, V17, P175, DOI 10.1016/S0272-5231(05)70307-5; Brierley J, 2008, PEDIATRICS, V122, P752, DOI 10.1542/peds.2007-1979; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Carcillo JA, 2014, CURR OPIN CRIT CARE, V20, P396, DOI 10.1097/MCC.0000000000000119; Daniels R, 2011, EMERG MED J, V28, P507, DOI 10.1136/emj.2010.095067; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; DROP LJ, 1975, ANESTHESIOLOGY, V43, P300, DOI 10.1097/00000542-197509000-00005; Fiser Richard T, 2005, Pediatr Crit Care Med, V6, P531, DOI 10.1097/01.PCC.0000165560.90814.59; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Garcia-Prats JA, 2000, PEDIATRICS, V105, P523, DOI 10.1542/peds.105.3.523; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Goldstein SL, 2005, KIDNEY INT, V67, P653, DOI 10.1111/j.1523-1755.2005.67121.x; Greenhow TL, 2012, PEDIATRICS, V129, pE590, DOI 10.1542/peds.2011-1546; Han YY, 2003, PEDIATRICS, V112, P793, DOI 10.1542/peds.112.4.793; Hartman ME, 2013, PEDIATR CRIT CARE ME, V14, P686, DOI 10.1097/PCC.0b013e3182917fad; Hollenberg SM, 2004, CRIT CARE MED, V32, P1928, DOI 10.1097/01.CCM.0000139761.05492.D6; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Inwald DP, 2009, ARCH DIS CHILD, V94, P348, DOI 10.1136/adc.2008.153064; Kaplan JM, 2011, PEDIATR CRIT CARE ME, V12, P165, DOI 10.1097/PCC.0b013e3181e28876; Karam O, 2011, PEDIATR CRIT CARE ME, V12, P512, DOI 10.1097/PCC.0b013e3181fe344b; Kayange N, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-39; Kissoon N, 2014, CRIT CARE, V18, DOI [10.1186/cc13784, 10.1186/cc13774]; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lee CY, 2009, J MICROBIOL IMMUNOL, V42, P160; Levi M, 2009, BRIT J HAEMATOL, V145, P24, DOI [10.1111/j.1365-2141.2009.07600.x, 10.1111/j.1365-2141.2008.07445.x]; Levine MM, 2002, BRIT MED BULL, V62, P1, DOI 10.1093/bmb/62.1.1; Levy MM, 2015, CRIT CARE MED, V43, P3, DOI [10.1097/CCM.0000000000000723, 10.1007/s00134-014-3496-0]; Macrae D, 2014, NEW ENGL J MED, V370, P107, DOI 10.1056/NEJMoa1302564; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Ninis N, 2005, BRIT MED J, V330, P1475, DOI 10.1136/bmj.330.7506.1475; Paul R, 2014, PEDIATRICS, V133, pE1358, DOI 10.1542/peds.2013-3871; Paul R, 2012, PEDIATRICS, V130, pE273, DOI 10.1542/peds.2012-0094; Pearson G., 2008, WHY CHILDREN DIE PIL; Perel P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub6; Polin RA, 2012, PEDIATRICS, V129, P1006, DOI 10.1542/peds.2012-0541; Posfay-Barbe KM, 2009, SEMIN FETAL NEONAT M, V14, P228, DOI 10.1016/j.siny.2009.01.006; Reingold A., 2007, Morbidity and Mortality Weekly Report, V56, P701; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Ruth A, 2014, PEDIATR CRIT CARE ME, V15, P828, DOI 10.1097/PCC.0000000000000254; Schrag Stephanie, 2002, MMWR Recomm Rep, V51, P1; Shekerdemian L, 1999, ARCH DIS CHILD, V80, P475, DOI 10.1136/adc.80.5.475; Simmons ML, 2012, AACN ADV CRIT CARE, V23, P437, DOI 10.1097/NCI.0b013e31826ddccd; Soeorg H, 2013, PEDIATR INFECT DIS J, V32, P389, DOI 10.1097/INF.0b013e3182791abd; Stoll BJ, 1996, J PEDIATR-US, V129, P63, DOI 10.1016/S0022-3476(96)70191-9; Stoll BJ, 1996, J PEDIATR-US, V129, P72, DOI 10.1016/S0022-3476(96)70192-0; Sutherland SM, 2010, AM J KIDNEY DIS, V55, P316, DOI 10.1053/j.ajkd.2009.10.048; van de Wetering MD, 2013, COCHRANE DB SYST REV, V11; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Vergnano S, 2005, ARCH DIS CHILD-FETAL, V90, P220, DOI 10.1136/adc.2002.022863; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Wang Xiao-dong, 2013, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V25, P207, DOI 10.3760/cma.j.issn.2095-4352.2013.04.007; Watson R Scott, 2005, Pediatr Crit Care Med, V6, pS3; Watson RS, 2003, AM J RESP CRIT CARE, V167, P695, DOI 10.1164/rccm.200207-682OC; Weiss SL, 2014, CRIT CARE MED, V42, P2409, DOI 10.1097/CCM.0000000000000509; Weiss SL, 2012, PEDIATR CRIT CARE ME, V13, pE219, DOI 10.1097/PCC.0b013e31823c98da; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; WHO, 1996, WORLD HLTH REP 1996; *WHO GLOB HLTH OBS, 2013, CAUS CHILD MORT; Wong HR, 2012, CRIT CARE, V16, DOI 10.1186/cc11652; World Health Organization, 2015, DEC VACC GLOB VACC A; Zimmerman JJ, 2007, PEDIATR CRIT CARE ME, V8, P530, DOI 10.1097/01.PCC.0000288710.11834.E6; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	72	43	46	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2015	350								h3017	10.1136/bmj.h3017	http://dx.doi.org/10.1136/bmj.h3017			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK7CV	26060188				2022-12-28	WOS:000356389100004
J	Borooah, S; Dhillon, A; Dhillon, B				Borooah, Shyamanga; Dhillon, Arjun; Dhillon, Baljean			Gradual loss of vision in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Borooah, Shyamanga; Dhillon, Baljean] Univ Edinburgh, Princess Alexandra Eye Pavil, Ophthalmol, Edinburgh EH3 9HA, Midlothian, Scotland; [Dhillon, Arjun] Argyle Surg, Ophthalmol, London, England; [Dhillon, Arjun] Ealing Clin Commissioning Grp, Ophthalmol, South Greenford, Middx, England	University of Edinburgh	Borooah, S (corresponding author), Univ Edinburgh, Princess Alexandra Eye Pavil, Ophthalmol, Edinburgh EH3 9HA, Midlothian, Scotland.	shyamanga@aol.com	Borooah, Shyamanga/AAM-6581-2021					Afshari NA, 2001, INT OPHTHALMOL CLIN, V41, P151, DOI 10.1097/00004397-200101000-00014; DVLA, 2015, DRIV EYES RUL; The Royal College of Ophthalmologists, 2010, CAT SURG GUID	3	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2015	350								h2093	10.1136/bmj.h2093	http://dx.doi.org/10.1136/bmj.h2093			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK7CK	26055964				2022-12-28	WOS:000356387800001
J	Hone, J; Carpick, RW				Hone, James; Carpick, Robert W.			Slippery when dry	SCIENCE			English	Editorial Material							ATOMICALLY THIN SHEETS; FRICTION		[Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Carpick, Robert W.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA	Columbia University; University of Pennsylvania	Hone, J (corresponding author), Columbia Univ, Dept Mech Engn, New York, NY 10027 USA.	jh2228@columbia.edu	Hone, James C/E-1879-2011	Hone, James C/0000-0002-8084-3301				Berman D, 2015, SCIENCE, V348, P1118, DOI 10.1126/science.1262024; Dienwiebel M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126101; Egberts P, 2014, ACS NANO, V8, P5010, DOI 10.1021/nn501085g; Erdemir A., 2007, SUPERLUBRICITY; Holmberg K, 2012, TRIBOL INT, V47, P221, DOI 10.1016/j.triboint.2011.11.022; Jost HP, 2005, TRIBOL LUBR TECHNOL, V61, P18; Lee C, 2010, SCIENCE, V328, P76, DOI 10.1126/science.1184167; Liu Z, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.205503; Marchetto D, 2012, TRIBOL LETT, V48, P77, DOI 10.1007/s11249-012-9945-4; Wahlisch F, 2013, WEAR, V300, P78, DOI 10.1016/j.wear.2013.01.108; Zhang RF, 2013, NAT NANOTECHNOL, V8, P912, DOI [10.1038/nnano.2013.217, 10.1038/NNANO.2013.217]	11	13	13	2	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1087	1088		10.1126/science.aab3233	http://dx.doi.org/10.1126/science.aab3233			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045420				2022-12-28	WOS:000355590500022
J	Kenyon, SJ				Kenyon, Scott J.			ASTRONOMY Pluto leads the way in planet formation	NATURE			English	Editorial Material							CHARON; IMPACT; ORIGIN; NIX	Images from the Hubble Space Telescope cast new light on the orbits, shapes and sizes of Pluto's small satellites. The analysis comes just before a planned reconnaissance by the first spacecraft to visit them. See Article p.45	Smithsonian Astrophys Observ, Dept Solar Stellar & Planetary Phys, Cambridge, MA 02138 USA	Harvard University; Smithsonian Institution	Kenyon, SJ (corresponding author), Smithsonian Astrophys Observ, Dept Solar Stellar & Planetary Phys, Cambridge, MA 02138 USA.	skenyon@cfa.harvard.edu		Kenyon, Scott/0000-0003-0214-609X				Canup RM, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/2/35; Cheng WH, 2014, ICARUS, V241, P180, DOI 10.1016/j.icarus.2014.07.006; Desch SJ, 2015, ICARUS, V246, P37, DOI 10.1016/j.icarus.2014.07.034; Fabrycky DC, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/146; Kenyon SJ, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/1/8; Showalter MR, 2015, NATURE, V522, P45, DOI 10.1038/nature14469; Stern SA, 2008, SPACE SCI REV, V140, P3, DOI 10.1007/s11214-007-9295-y; Youdin AN, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/17	8	0	1	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					40	41		10.1038/522040a	http://dx.doi.org/10.1038/522040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	26040888				2022-12-28	WOS:000355543400023
J	Lilly, E; Srivastava, B				Lilly, Evelyn; Srivastava, Bhaskar			Measles	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lilly, Evelyn; Srivastava, Bhaskar] Yale Univ, New Haven, CT 06520 USA	Yale University	Lilly, E (corresponding author), Yale Univ, New Haven, CT 06520 USA.	bhaskar.srivastava02@gmail.com							0	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2015	372	23					2217	2217		10.1056/NEJMicm1407399	http://dx.doi.org/10.1056/NEJMicm1407399			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1GK	26039602				2022-12-28	WOS:000355955100007
J	Salluh, JIF; Wang, H; Schneider, EB; Nagaraja, N; Yenokyan, G; Damluji, A; Serafim, RB; Stevens, RD				Salluh, Jorge I. F.; Wang, Han; Schneider, Eric B.; Nagaraja, Neeraja; Yenokyan, Gayane; Damluji, Abdulla; Serafim, Rodrigo B.; Stevens, Robert D.			Outcome of delirium in critically ill patients: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INTENSIVE-CARE-UNIT; MECHANICALLY VENTILATED PATIENTS; CONFUSION ASSESSMENT METHOD; TERM COGNITIVE IMPAIRMENT; IN-HOSPITAL MORTALITY; RISK-FACTORS; CAM-ICU; ELDERLY-PATIENTS; HALOPERIDOL PROPHYLAXIS; SCREENING CHECKLIST	OBJECTIVES To determine the relation between delirium in critically ill patients and their outcomes in the short term (in the intensive care unit and in hospital) and after discharge from hospital. DESIGN Systematic review and meta-analysis of published studies. DATA SOURCES PubMed, Embase, CINAHL, Cochrane Library, and PsychINFO, with no language restrictions, up to 1 January 2015. ELIGIBILITY CRITERIA FOR SELECTION STUDIES Reports were eligible for inclusion if they were prospective observational cohorts or clinical trials of adults in intensive care units who were assessed with a validated delirium screening or rating system, and if the association was measured between delirium and at least one of four clinical endpoints (death during admission, length of stay, duration of mechanical ventilation, and any outcome after hospital discharge). Studies were excluded if they primarily enrolled patients with a neurological disorder or patients admitted to intensive care after cardiac surgery or organ/tissue transplantation, or centered on sedation management or alcohol or substance withdrawal. Data were extracted on characteristics of studies, populations sampled, identification of delirium, and outcomes. Random effects models and meta-regression analyses were used to pool data from individual studies. RESULTS Delirium was identified in 5280 of 16 595 (31.8%) critically ill patients reported in 42 studies. When compared with control patients without delirium, patients with delirium had significantly higher mortality during admission (risk ratio 2.19, 94% confidence interval 1.78 to 2.70; P< 0.001) as well as longer durations of mechanical ventilation and lengths of stay in the intensive care unit and in hospital (standard mean differences 1.79 (95% confidence interval 0.31 to 3.27; P< 0.001), 1.38 (0.99 to 1.77; P< 0.001), and 0.97 (0.61 to 1.33; P< 0.001), respectively). Available studies indicated an association between delirium and cognitive impairment after discharge. CONCLUSIONS Nearly a third of patients admitted to an intensive care unit develop delirium, and these patients are at increased risk of dying during admission, longer stays in hospital, and cognitive impairment after discharge.	[Salluh, Jorge I. F.; Serafim, Rodrigo B.] DOR Inst Res & Educ, Rio De Janeiro, Brazil; [Wang, Han; Schneider, Eric B.; Nagaraja, Neeraja] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Yenokyan, Gayane] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Damluji, Abdulla] Univ Miami, Miller Sch Med, Elaine & Sydney Sussman Cardiac Catheterizat Labs, Cardiovasc Div, Miami, FL 33136 USA; [Serafim, Rodrigo B.] Univ Fed Rio de Janeiro, Dept Internal Med, Rio De Janeiro, Brazil; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med Neurol Neurosurg, Baltimore, MD 21287 USA	IDOR - Instituto D'Or de Ensino e Pesquisa; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Miami; Universidade Federal do Rio de Janeiro; Johns Hopkins University	Stevens, RD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med Neurol Neurosurg, Baltimore, MD 21287 USA.	rstevens@jhmi.edu	Damluji, Abdulla A/AAC-1054-2020; dantas, vicente c souza/L-2648-2013; Salluh, Jorge/AAF-2682-2021	Damluji, Abdulla A/0000-0002-8774-6416; Salluh, Jorge/0000-0002-8164-1453; Yenokyan, Gayane/0000-0003-1482-5612				Aldemir M, 2001, CRIT CARE, V5, P265, DOI 10.1186/cc1044; Almeida ICT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085332; Angles EM, 2008, AM J SURG, V196, P864, DOI 10.1016/j.amjsurg.2008.07.037; Balas MC, 2009, CHEST, V135, P18, DOI 10.1378/chest.08-1456; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Brummel NE, 2014, CRIT CARE MED, V42, P369, DOI 10.1097/CCM.0b013e3182a645bd; Buss MK, 2007, J PALLIAT MED, V10, P1083, DOI 10.1089/jpm.2006.0253; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devlin JW, 2010, CRIT CARE MED, V38, P419, DOI 10.1097/CCM.0b013e3181b9e302; Dubois MJ, 2001, INTENS CARE MED, V27, P1297, DOI 10.1007/s001340101017; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Fraser GL, 2013, CRIT CARE MED, V41, pS30, DOI 10.1097/CCM.0b013e3182a16898; Friedrich JO, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-5; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Heymann A, 2010, J INT MED RES, V38, P1584, DOI 10.1177/147323001003800503; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hsieh SJ, 2015, AM J RESP CRIT CARE, V191, P71, DOI 10.1164/rccm.201409-1690OC; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; INOUYE SK, 1993, ANN INTERN MED, V119, P474, DOI 10.7326/0003-4819-119-6-199309150-00005; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Kalisvaart KJ, 2005, J AM GERIATR SOC, V53, P1658, DOI 10.1111/j.1532-5415.2005.53503.x; Kamdar BB, 2013, CRIT CARE MED, V41, P800, DOI 10.1097/CCM.0b013e3182746442; KISHI Y, 1995, GEN HOSP PSYCHIAT, V17, P371, DOI 10.1016/0163-8343(95)00056-W; Klein PMC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6652; Lahariya S, 2014, GEN HOSP PSYCHIAT, V36, P156, DOI 10.1016/j.genhosppsych.2013.10.010; Lat I, 2009, CRIT CARE MED, V37, P1898, DOI 10.1097/CCM.0b013e31819ffe38; Lawlor PG, 2000, ARCH INTERN MED, V160, P786, DOI 10.1001/archinte.160.6.786; Leslie DL, 2008, ARCH INTERN MED, V168, P27, DOI 10.1001/archinternmed.2007.4; LEVKOFF SE, 1992, ARCH INTERN MED, V152, P334, DOI 10.1001/archinte.152.2.334; Lin SM, 2008, J CRIT CARE, V23, P372, DOI 10.1016/j.jcrc.2006.09.001; Lin SM, 2004, CRIT CARE MED, V32, P2254, DOI 10.1097/01.CCM.0000145587.16421.BB; Marquis F, 2007, CRIT CARE MED, V35, P2533, DOI 10.1097/01.CCM.0000284506.43390.F3; Mehta S, 2015, CRIT CARE MED, V43, P557, DOI 10.1097/CCM.0000000000000727; Micek ST, 2005, CRIT CARE MED, V33, P1260, DOI 10.1097/01.CCM.0000164540.58515.BF; Milbrandt EB, 2004, CRIT CARE MED, V32, P955, DOI 10.1097/01.CCM.0000119429.16055.92; Neelon VJ, 1996, NURS RES, V45, P324, DOI 10.1097/00006199-199611000-00002; OKeeffe S, 1997, J AM GERIATR SOC, V45, P174, DOI 10.1111/j.1532-5415.1997.tb04503.x; Ouimet S, 2007, INTENS CARE MED, V33, P66, DOI 10.1007/s00134-006-0399-8; Page VJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7714; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Patel SB, 2014, AM J RESP CRIT CARE, V189, P658, DOI 10.1164/rccm.201310-1815OC; Philbrook HT, 2007, J CLIN EPIDEMIOL, V60, P228, DOI 10.1016/j.jclinepi.2006.06.018; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Plaschke K, 2008, INTENS CARE MED, V34, P431, DOI 10.1007/s00134-007-0920-8; POMPEI P, 1994, J AM GERIATR SOC, V42, P809, DOI 10.1111/j.1532-5415.1994.tb06551.x; Ranhoff AH, 2006, AGING CLIN EXP RES, V18, P440; Reston JT, 2013, ANN INTERN MED, V158, P375, DOI 10.7326/0003-4819-158-5-201303051-00003; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Roberts Brigit, 2005, Aust Crit Care, V18, P8, DOI 10.1016/S1036-7314(05)80019-0; Salluh JI, 2010, CRIT CARE, V14, DOI 10.1186/cc9333; Sankey SS, 1996, COMMUN STAT SIMULAT, V25, P1031, DOI 10.1080/03610919608813357; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Serafim RB, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-51; Shankar KN, 2014, J AM GERIATR SOC, V62, P276, DOI 10.1111/jgs.12657; Sharma A, 2012, GEN HOSP PSYCHIAT, V34, P639, DOI 10.1016/j.genhosppsych.2012.06.009; Shehabi Y, 2010, CRIT CARE MED, V38, P2311, DOI 10.1097/CCM.0b013e3181f85759; Sieber FE, 2010, MAYO CLIN PROC, V85, P18, DOI 10.4065/mcp.2009.0469; Spronk PE, 2009, INTENS CARE MED, V35, P1276, DOI 10.1007/s00134-009-1466-8; Stevens RD, 2013, BRAIN DISORDERS IN CRITICAL ILLNESS: MECHANISMS, DIAGNOSIS, AND TREATMENT, P1, DOI 10.1017/CBO9781139248822; Stevens RD, 2007, INTENS CARE MED, V33, P1876, DOI 10.1007/s00134-007-0772-2; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Task Force on DSM-IV, 2000, DIAGN STAT MAN MENT; Thomason JWW, 2005, CRIT CARE, V9, pR375, DOI 10.1186/cc3729; Tomasi CD, 2012, J CRIT CARE, V27, P212, DOI 10.1016/j.jcrc.2011.05.015; Tsuruta R, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.01.021; Tsuruta R, 2010, GEN HOSP PSYCHIAT, V32, P607, DOI 10.1016/j.genhosppsych.2010.09.001; van den Boogaard M, 2014, INTENS CARE MED, V40, P361, DOI 10.1007/s00134-013-3202-7; van den Boogaard M, 2011, CRIT CARE, V15, DOI 10.1186/cc10598; van den Boogaard M, 2012, CRIT CARE MED, V40, P112, DOI 10.1097/CCM.0b013e31822e9fc9; van den Boogaard M, 2010, CRIT CARE, V14, DOI 10.1186/cc9214; van Eijk MMJ, 2009, CRIT CARE MED, V37, P1881, DOI 10.1097/CCM.0b013e3181a00118; Van Rompaey B, 2009, J CLIN NURS, V18, P3349, DOI 10.1111/j.1365-2702.2009.02933.x; Van Rompaey B, 2008, CRIT CARE, V12, DOI 10.1186/cc6790; Wang W, 2012, CRIT CARE MED, V40, P731, DOI 10.1097/CCM.0b013e3182376e4f; Wells G., 2000, NEWCASTLE OTTAWA SCA; Widmann CN, 2014, LANCET NEUROL, V13, P630, DOI 10.1016/S1474-4422(14)70017-1; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Wolters AE, 2014, CRIT CARE, V18, DOI 10.1186/cc13929; Yamaguchi T, 2014, GEN HOSP PSYCHIAT, V36, P634, DOI 10.1016/j.genhosppsych.2014.09.006; Zhang ZG, 2013, GEN HOSP PSYCHIAT, V35, P105, DOI 10.1016/j.genhosppsych.2012.11.003	88	453	486	6	65	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2015	350								h2538	10.1136/bmj.h2538	http://dx.doi.org/10.1136/bmj.h2538			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK0TY	26041151	hybrid, Green Published			2022-12-28	WOS:000355919100002
J	[Anonymous]				[Anonymous]			New Clues to a Second Genetic System (Reprinted from JAMA, vol 192, pg 33-34, 1965)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		1965, JAMA, V192, P33	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2187	2187		10.1001/jama.2014.11786	http://dx.doi.org/10.1001/jama.2014.11786			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ4CC	26034969				2022-12-28	WOS:000355430900034
J	Grady, JM; Enquist, BJ; Dettweiler-Robinson, E; Wright, NA; Smith, FA				Grady, John M.; Enquist, Brian J.; Dettweiler-Robinson, Eva; Wright, Natalie A.; Smith, Felisa A.			Response to Comments on "Evidence for mesothermy in dinosaurs"	SCIENCE			English	Editorial Material							GROWTH-RATES; PHYSIOLOGY; PATTERNS; ECOLOGY	D'Emic and Myhrvold raise a number of statistical and methodological issues with our recent analysis of dinosaur growth and energetics. However, their critiques and suggested improvements lack biological and statistical justification.	[Grady, John M.; Dettweiler-Robinson, Eva; Wright, Natalie A.; Smith, Felisa A.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Enquist, Brian J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Enquist, Brian J.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of New Mexico; University of Arizona; The Santa Fe Institute	Grady, JM (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	jgrady@unm.edu	Smith, Felisa/ABE-6160-2021; Enquist, Brian J/B-6436-2008	Smith, Felisa/0000-0001-6262-436X; Enquist, Brian J/0000-0002-6124-7096; Grady, John/0000-0001-6444-3300; Dettweiler-Robinson, Eva/0000-0002-9742-3434				Andrews R.M., 1982, Biology of Reptilia, V13, P273; Arbab AI., 2009, PROGR PHYS, V1, P8; Bjorndal KA, 2000, ECOL APPL, V10, P269, DOI 10.2307/2641001; BROWN EB, 1973, ECOLOGY, V54, P1103; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Chinsamy A, 1995, PALEOBIOLOGY, V21, P561, DOI 10.1017/S0094837300013543; D'Emic MD, 2015, SCIENCE, V348, DOI [10.1126/science.1260410, 10.1126/science.1260061]; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 1999, NATURE, V398, P205, DOI 10.1038/18343; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; GARDNER TW, 1987, GEOLOGY, V15, P259, DOI 10.1130/0091-7613(1987)15<259:GATPRE>2.0.CO;2; GINGERICH PD, 1993, AM J SCI, V293A, P453, DOI 10.2475/ajs.293.A.453; Grady JM, 2014, SCIENCE, V344, P1268, DOI 10.1126/science.1253143; HUTTON JM, 1987, J ANIM ECOL, V56, P25, DOI 10.2307/4797; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Peters R., 1991, CRITIQUE ECOLOGY, P41; PRAIRIE YT, 1989, OECOLOGIA, V81, P285, DOI 10.1007/BF00379817; Ricker W.E., 1979, BIOENERGETICS GROWTH, VVIII, P677, DOI DOI 10.1016/S1546-5098(08)60034-5; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.es.18.110187.002103; Smith FA, 2011, NAT GEOSCI, V4, P272, DOI 10.1038/ngeo1149; Sokal RR, 1995, BIOMETRY; ZULLINGER EM, 1984, J MAMMAL, V65, P607, DOI 10.2307/1380844	23	3	3	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238								10.1126/science.1260299	http://dx.doi.org/10.1126/science.1260299			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	26023132				2022-12-28	WOS:000355276600036
J	Chin, J; Jensen, TS; Ashby, L; Hermansen, J; Hutter, JD; Conway, PH				Chin, Joseph; Jensen, Tamara Syrek; Ashby, Lori; Hermansen, Jamie; Hutter, Joseph D.; Conway, Patrick H.			Screening for Lung Cancer with Low-Dose CT - Translating Science into Medicare Coverage Policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRIAL		[Chin, Joseph; Jensen, Tamara Syrek; Ashby, Lori; Hermansen, Jamie; Hutter, Joseph D.; Conway, Patrick H.] Ctr Medicare & Medicaid Serv, Ctr Clin Stand & Qual, Woodlawn, MD 21244 USA	Centers for Medicare & Medicaid Services	Chin, J (corresponding author), Ctr Medicare & Medicaid Serv, Ctr Clin Stand & Qual, Woodlawn, MD 21244 USA.							Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Infante M, 2009, AM J RESP CRIT CARE, V180, P445, DOI 10.1164/rccm.200901-0076OC; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT FACT SHEET	5	24	25	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2015	372	22					2083	2085		10.1056/NEJMp1502598	http://dx.doi.org/10.1056/NEJMp1502598			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ0EI	26017822				2022-12-28	WOS:000355146800003
J	Deroy, O				Deroy, Ophelia			Eat insects for fun, not to help the environment	NATURE			English	Editorial Material									Univ London, Sch Adv Study, Ctr Study Senses, London WC1E 7HU, England	University of London; University of London School of Advanced Study	Deroy, O (corresponding author), Univ London, Sch Adv Study, Ctr Study Senses, London WC1E 7HU, England.	ophelia.deroy@sas.ac.uk		Deroy, Ophelia/0000-0001-9431-3136	Arts and Humanities Research Council [AH/L007053/1] Funding Source: researchfish; AHRC [AH/L007053/1] Funding Source: UKRI	Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))		Megido RC, 2014, J SENS STUD, V29, P14, DOI 10.1111/joss.12077	1	6	6	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					395	395		10.1038/521395a	http://dx.doi.org/10.1038/521395a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	26017408	Bronze			2022-12-28	WOS:000355286600004
J	Topalian, SL				Topalian, Suzanne L.			On Breakthroughs and Evolution	CELL			English	News Item									Johns Hopkins Kimmel Canc Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Topalian, SL (corresponding author), Johns Hopkins Kimmel Canc Ctr, Baltimore, MD USA.				NATIONAL CANCER INSTITUTE [P30CA008748, ZIABC010984] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC010984-01] Funding Source: Medline; NCI NIH HHS [P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	71	80	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					185	185						1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	26042237				2022-12-28	WOS:000352708300001
J	Horton, R; Ceschia, A				Horton, Richard; Ceschia, Audrey			Making women count	LANCET			English	Editorial Material									[Horton, Richard; Ceschia, Audrey] Lancet, London EC2Y 5AS, England		Horton, R (corresponding author), Lancet, London EC2Y 5AS, England.			Barker, Gary/0000-0001-7120-3639				Langer A, 2015, LANCET	1	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2015	386	9999					1112	1114		10.1016/S0140-6736(15)60964-3	http://dx.doi.org/10.1016/S0140-6736(15)60964-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR5GE	26051369				2022-12-28	WOS:000361368000008
J	Coleman, R; Hadji, P				Coleman, Robert; Hadji, Peyman			Denosumab and fracture risk in women with breast cancer	LANCET			English	Editorial Material							ZOLEDRONIC ACID; POSTMENOPAUSAL WOMEN; PREVENTION; EFFICACY		[Coleman, Robert] Weston Pk Hosp, Sheffield Canc Res Ctr, Sheffield S10 2SJ, S Yorkshire, England; [Hadji, Peyman] Krankenhaus NW Frankfurt, Frankfurt, Germany	Weston Park Hospital; Krankenhaus Nordwest	Coleman, R (corresponding author), Weston Pk Hosp, Sheffield Canc Res Ctr, Sheffield S10 2SJ, S Yorkshire, England.	r.e.coleman@sheffield.ac.uk	Coleman, Robert/E-4346-2019					Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Coleman R, 2014, ANN ONCOL, V25, P124, DOI 10.1093/annonc/mdu103; Coleman R, 2013, ANN ONCOL, V24, P398, DOI 10.1093/annonc/mds277; Coleman R, 2015, LANCET IN PRESS; Coleman R, 2014, LANCET ONCOL, V15, P997, DOI 10.1016/S1470-2045(14)70302-X; Coleman RE, 2013, NAT REV RHEUMATOL, V9, P365, DOI 10.1038/nrrheum.2013.36; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Gnant M, 2015, LANCET; Lipton A, 2012, EUR J CANCER, V48, P3082, DOI 10.1016/j.ejca.2012.08.002; Miller PD, 2010, CALCIFIED TISSUE INT, V87, P305, DOI 10.1007/s00223-010-9403-y; Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003	11	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					409	410		10.1016/S0140-6736(15)61032-7	http://dx.doi.org/10.1016/S0140-6736(15)61032-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26040500				2022-12-28	WOS:000358761700006
J	Louveau, A; Smirnov, I; Keyes, TJ; Eccles, JD; Rouhani, SJ; Peske, JD; Derecki, NC; Castle, D; Mandell, JW; Lee, KS; Harris, TH; Kipnis, J				Louveau, Antoine; Smirnov, Igor; Keyes, Timothy J.; Eccles, Jacob D.; Rouhani, Sherin J.; Peske, J. David; Derecki, Noel C.; Castle, David; Mandell, James W.; Lee, Kevin S.; Harris, Tajie H.; Kipnis, Jonathan			Structural and functional features of central nervous system lymphatic vessels	NATURE			English	Article							CEREBROSPINAL-FLUID; CERVICAL LYMPH; VASCULATURE; DRAINAGE; BRAIN; TRAFFICKING; HEALTH; SITES; CELLS; CNS	One of the characteristics of the central nervous system is the lack of a classical lymphatic drainage system. Although it is now accepted that the central nervous system undergoes constant immune surveillance that takes place within the meningeal compartment(1-3), the mechanisms governing the entrance and exit of immune cells from the central nervous system remain poorly understood(4-6). In searching for T-cell gateways into and out of the meninges, we discovered functional lymphatic vessels lining the dural sinuses. These structures express all of the molecular hallmarks of lymphatic endothelial cells, are able to carry both fluid and immune cells from the cerebrospinal fluid, and are connected to the deep cervical lymph nodes. The unique location of these vessels may have impeded their discovery to date, thereby contributing to the long-held concept of the absence of lymphatic vasculature in the central nervous system. The discovery of the central nervous system lymphatic system may call for a reassessment of basic assumptions in neuroimmunology and sheds new light on the aetiology of neuroinflammatory and neurodegenerative diseases associated with immune system dysfunction.	[Louveau, Antoine; Smirnov, Igor; Keyes, Timothy J.; Derecki, Noel C.; Lee, Kevin S.; Harris, Tajie H.; Kipnis, Jonathan] Univ Virginia, Sch Med, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA; [Louveau, Antoine; Smirnov, Igor; Keyes, Timothy J.; Derecki, Noel C.; Lee, Kevin S.; Harris, Tajie H.; Kipnis, Jonathan] Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; [Eccles, Jacob D.; Rouhani, Sherin J.; Peske, J. David; Kipnis, Jonathan] Univ Virginia, Sch Med, Med Scientist Training Program, Charlottesville, VA 22908 USA; [Eccles, Jacob D.; Rouhani, Sherin J.; Peske, J. David] Univ Virginia, Sch Med, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Eccles, Jacob D.] Univ Virginia, Sch Med, Dept Med, Div Allergy, Charlottesville, VA 22908 USA; [Rouhani, Sherin J.; Peske, J. David] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Castle, David] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Mandell, James W.] Univ Virginia, Sch Med, Dept Pathol Neuropathol, Charlottesville, VA 22908 USA; [Lee, Kevin S.] Univ Virginia, Sch Med, Dept Neurosurg, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Louveau, A (corresponding author), Univ Virginia, Sch Med, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA.	al2hk@virginia.edu; kipnis@virginia.edu	Rouhani, Sherin Juliet/GQI-0914-2022; Kipnis, Jonathan/AGG-9735-2022; Louveau, Antoine/AAW-2944-2020; Peske, J David/HII-8405-2022	Rouhani, Sherin Juliet/0000-0001-7248-847X; Kipnis, Jonathan/0000-0002-3714-517X; ECCLES, Jacob/0000-0002-4202-0355; Keyes, Timothy/0000-0003-0423-9679; Harris, Tajie/0000-0002-1355-2109	Fondation pour la Recherche Medicale; National Institutes of Health [R01AG034113, R01NS061973]; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099620, R01NS061973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034113] Funding Source: NIH RePORTER	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Smith for editing the manuscript; V. Engelhard for initial discussions and suggestions on lymphatic endothelial cell specific markers. We also thank the members of the Kipnis laboratory, Brain Immunology and Glia (BIG) center, and the Department of Neuroscience at the University of Virginia (especially J. Lukens) for their valuable comments during multiple discussions of this work. L. Holland and B. Lopes provided the human samples. This work was funded by "Fondation pour la Recherche Medicale'' to A.L. and by The National Institutes of Health (R01AG034113 and R01NS061973) to J.K.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Berton M, 2015, J AM ACAD DERMATOL, V72, P333, DOI 10.1016/j.jaad.2014.10.033; CSERR HF, 1992, BRAIN PATHOL, V2, P269, DOI 10.1111/j.1750-3639.1992.tb00703.x; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Goldmann J, 2006, J LEUKOCYTE BIOL, V80, P797, DOI 10.1189/jlb.0306176; Harris MG, 2014, SCI REP-UK, V4, DOI 10.1038/srep04422; Hohlfeld R, 2001, CURR OPIN NEUROL, V14, P299, DOI 10.1097/00019052-200106000-00006; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Kaminski M, 2012, J LEUKOCYTE BIOL, V92, P31, DOI 10.1189/jlb.0511241; Kerjaschki D, 2014, J CLIN INVEST, V124, P874, DOI 10.1172/JCI74854; KIDA S, 1993, NEUROPATH APPL NEURO, V19, P480, DOI 10.1111/j.1365-2990.1993.tb00476.x; Kipnis J, 2012, NAT REV IMMUNOL, V12, P662, DOI 10.1038/nri3280; Koina ME, 2015, INVEST OPHTH VIS SCI, V56, P1310, DOI 10.1167/iovs.14-15705; Laman JD, 2013, J NEUROIMMUNE PHARM, V8, P840, DOI 10.1007/s11481-013-9470-8; Liu NF, 2009, J VASC SURG, V49, P980, DOI 10.1016/j.jvs.2008.11.029; Mathieu E, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-35; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Schneider M, 2006, PLOS MED, V3, P970, DOI 10.1371/journal.pmed.0030264; Shechter R, 2013, NAT REV IMMUNOL, V13, P206, DOI 10.1038/nri3391; Wang YD, 2010, GENE DEV, V24, P2115, DOI 10.1101/gad.1955910; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Weller R O, 2010, Pathophysiology, V17, P295, DOI 10.1016/j.pathophys.2009.10.007; Weller RO, 2009, ACTA NEUROPATHOL, V117, P1, DOI 10.1007/s00401-008-0457-0; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yang LJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-107	30	2176	2278	17	427	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					337	+		10.1038/nature14432	http://dx.doi.org/10.1038/nature14432			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26030524	Green Accepted			2022-12-28	WOS:000357950900040
J	Sanghavi, DM; Conway, PH				Sanghavi, Darshak M.; Conway, Patrick H.			Paying for Prevention A Novel Test of Medicare Value-Based Payment for Cardiovascular Risk Reduction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sanghavi, Darshak M.] Ctr Medicare & Medicaid Serv, Prevent & Populat Hlth Models Grp, 7500 Secur Blvd,WB-08-27, Baltimore, MD 21244 USA; [Conway, Patrick H.] Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Sanghavi, DM (corresponding author), Ctr Medicare & Medicaid Serv, Prevent & Populat Hlth Models Grp, 7500 Secur Blvd,WB-08-27, Baltimore, MD 21244 USA.	darshak.sanghavi@cms.hhs.gov						Ashley EA, 2015, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2015-3595, DOI 10.1001/JAMA.2015-3595]; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Office of the Associate Director of Policy-Prevention US Centers for Disease Control and Prevention (CDC), 2015, CDC PREV CHECKL; U.S. Department of Health and Human Services, BETT SMART HLTH HIST	4	21	21	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2015	314	2					123	124		10.1001/jama.2015.6681	http://dx.doi.org/10.1001/jama.2015.6681			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM7JI	26021568				2022-12-28	WOS:000357867500008
J	Rich, JD; Adashi, EY				Rich, Josiah D.; Adashi, Eli Y.			Ideological Anachronism Involving Needle and Syringe Exchange Programs Lessons From the Indiana HIV Outbreak	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rich, Josiah D.] Brown Univ, Med & Epidemiol, Providence, RI USA; [Rich, Josiah D.; Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Ctr Prisoner Hlth & Human Rights, Providence, RI USA; [Adashi, Eli Y.] Brown Univ, Med Sci, Providence, RI USA	Brown University; Brown University; Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, Med Sci, 101 Dudley St, Providence, RI 02912 USA.	eli_adashi@brown.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA022112] Funding Source: NIH RePORTER; NIAID NIH HHS [P30-AI-42853, P30 AI042853] Funding Source: Medline; NIDA NIH HHS [K24DA022112, K24 DA022112] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		[Anonymous], 2015, WASHINGTON POST; Benavie Arthur., 2009, DRUGS AM HOLY WAR; Centers for Disease Control and Prevention, 2015, EM PREP RESP OUTBR R; Centers for Disease Control and Prevention (CDC), 2015, HIV US GLANC; Conrad C, 2015, MMWR-MORBID MORTAL W, V64, P443; LawAtlas, 2015, SYR POSS LAWS; Vlahov D, 1998, Public Health Rep, V113 Suppl 1, P75; Wheeler Eliza, 2012, Morbidity and Mortality Weekly Report, V61, P101	8	40	40	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2015	314	1					23	24		10.1001/jama.2015.6303	http://dx.doi.org/10.1001/jama.2015.6303			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1QR	26000661	Green Accepted			2022-12-28	WOS:000357455900008
J	Khaminets, A; Heinrich, T; Mari, M; Grumati, P; Huebner, AK; Akutsu, M; Liebmann, L; Stolz, A; Nietzsche, S; Koch, N; Mauthe, M; Katona, I; Qualmann, B; Weis, J; Reggiori, F; Kurth, I; Hubner, CA; Dikic, I				Khaminets, Aliaksandr; Heinrich, Theresa; Mari, Muriel; Grumati, Paolo; Huebner, Antje K.; Akutsu, Masato; Liebmann, Lutz; Stolz, Alexandra; Nietzsche, Sandor; Koch, Nicole; Mauthe, Mario; Katona, Istvan; Qualmann, Britta; Weis, Joachim; Reggiori, Fulvio; Kurth, Ingo; Huebner, Christian A.; Dikic, Ivan			Regulation of endoplasmic reticulum turnover by selective autophagy	NATURE			English	Article							PROTEIN; DEGRADATION; PHOSPHORYLATION; LOCALIZATION	The endoplasmic reticulum (ER) is the largest intracellular endomembrane system, enabling protein and lipid synthesis, ion homeostasis, quality control of newly synthesized proteins and organelle communication(1). Constant ER turnover and modulation is needed to meet different cellular requirements and autophagy has an important role in this process(2-8). However, its underlying regulatory mechanisms remain unexplained. Here we show that members of the FAM134 reticulon protein family are ER-resident receptors that bind to autophagy modifiers LC3 and GABARAP, and facilitate ER degradation by autophagy ('ER-phagy'). Downregulation of FAM134B protein in human cells causes an expansion of the ER, while FAM134B overexpression results in ER fragmentation and lysosomal degradation. Mutant FAM134B proteins that cause sensory neuropathy in humans(9) are unable to act as ER-phagy receptors. Consistently, disruption of Fam134b in mice causes expansion of the ER, inhibits ER turnover, sensitizes cells to stress-induced apoptotic cell death and leads to degeneration of sensory neurons. Therefore, selective ER-phagy via FAM134 proteins is indispensable for mammalian cell homeostasis and controls ER morphology and turnover in mice and humans.	[Khaminets, Aliaksandr; Grumati, Paolo; Stolz, Alexandra; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany; [Heinrich, Theresa; Huebner, Antje K.; Liebmann, Lutz; Kurth, Ingo; Huebner, Christian A.] Univ Jena, Inst Human Genet, Jena Univ Hosp, D-07743 Jena, Germany; [Mari, Muriel; Mauthe, Mario; Reggiori, Fulvio] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Mari, Muriel; Reggiori, Fulvio] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands; [Akutsu, Masato] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, D-60438 Frankfurt, Germany; [Nietzsche, Sandor] Univ Jena, Jena Univ Hosp, Electron Microscopy Ctr, D-07743 Jena, Germany; [Koch, Nicole; Qualmann, Britta] Univ Jena, Jena Univ Hosp, Inst Biochem 1, D-07743 Jena, Germany; [Katona, Istvan; Weis, Joachim] RWTH Aachen Univ Hosp, Inst Neuropathol, D-52074 Aachen, Germany; [Dikic, Ivan] Univ Split, Sch Med, Inst Immunol, Mestrovicevo Setaliste B 21000, Split, Croatia	Goethe University Frankfurt; Friedrich Schiller University of Jena; Utrecht University; Utrecht University Medical Center; University of Groningen; Goethe University Frankfurt; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; RWTH Aachen University; RWTH Aachen University Hospital; University of Split	Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Ingo.Kurth@med.uni-jena.de; Christian.Huebner@med.uni-jena.de; Ivan.Dikic@biochem2.de	akutsu, masato/L-4095-2016; Stolz, Alexandra/ABF-6261-2021; Hübner, Christian/A-2950-2017; Katona, Istvan/I-6704-2016; Weis, Joachim/G-1984-2014; Reggiori, Fulvio/U-8327-2019; Grumati, Paolo/AAA-5787-2019; Dikic, Ivan/O-4650-2015	akutsu, masato/0000-0002-9839-3345; Stolz, Alexandra/0000-0002-3340-439X; Hübner, Christian/0000-0002-1030-4943; Katona, Istvan/0000-0002-0955-8911; Weis, Joachim/0000-0003-3280-6773; Reggiori, Fulvio/0000-0003-2652-2686; Dikic, Ivan/0000-0001-8156-9511; Kurth, Ingo/0000-0002-5642-8378; Mauthe, Mario/0000-0003-0049-7961; Khaminets, Aliaksandr/0000-0001-9143-8312; Mari, Muriel/0000-0002-2677-6945	Deutsche Forschungsgemeinschaft [DI 931/3-1, KU 1587/2-1, KU 1587/3-1, KU 1587/4-1, HU 800/5-1]; RTG [1715, HU 800/6-1, HU 800/7-1, QU116/6-2, RTG1715, WE1406/13-1]; Cluster of Excellence 'Macromolecular Complexes' of the Goethe University Frankfurt [EXC115]; LOEWE grant Ub-Net; LOEWE Centrum for Gene and Cell therapy Frankfurt; European Research Council/ERC [250241-LineUb]; ECHO [700.59.003]; ALW Open Program [821.02.017, 822.02.014]; DFG-NWO cooperation [DN82-303]; ZonMW VICI [016.130.606]; 7.FP, COFUND, Goethe International Postdoc Programme GO-IN [291776]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); RTG; Cluster of Excellence 'Macromolecular Complexes' of the Goethe University Frankfurt; LOEWE grant Ub-Net; LOEWE Centrum for Gene and Cell therapy Frankfurt; European Research Council/ERC(European Research Council (ERC)); ECHO; ALW Open Program; DFG-NWO cooperation; ZonMW VICI; 7.FP, COFUND, Goethe International Postdoc Programme GO-IN	We would like to thank S. Horwitz, K. Rajalingam, C. Behrends and J. Lippincott-Schwartz for cell lines and vectors, N. Mizushima for Atg5<SUP>-/-</SUP> and control immortalized MEFs, H.-P. Hauri and H. Farhan for vectors, and S. Giesselmann and K. Schorr for excellent technical assistance. We acknowledge D. McEwan, D. Hoeller, D. Popovic and K. Koch for critical reading of the manuscript and valuable insights. We also thank M. M. Kessels for support. This work was supported by grants from the Deutsche Forschungsgemeinschaft to I.D. (DI 931/3-1), I. K. (KU 1587/2-1, KU 1587/3-1, KU 1587/4-1), C. A. H. (HU 800/5-1, RTG 1715, HU 800/6-1, HU 800/7-1), B.Q. (QU116/6-2, RTG1715), J.W. (WE1406/13-1), the Cluster of Excellence 'Macromolecular Complexes' of the Goethe University Frankfurt (EXC115), LOEWE grant Ub-Net and LOEWE Centrum for Gene and Cell therapy Frankfurt and the European Research Council/ERC grant agreement number (250241-LineUb) to I. D. F.R. is supported by ECHO (700.59.003), ALW Open Program (821.02.017 and 822.02.014), DFG-NWO cooperation (DN82-303) and ZonMW VICI (016.130.606) grants. P.G. is supported by the 7.FP, COFUND, Goethe International Postdoc Programme GO-IN, No. 291776.	Altan-Bonnet N, 2006, MOL BIOL CELL, V17, P990, DOI 10.1091/mbc.E05-02-0155; Beetz C, 2013, J CLIN INVEST, V123, P4273, DOI 10.1172/JCI65665; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Cebollero Eduardo, 2012, Int J Cell Biol, V2012, P182834, DOI 10.1155/2012/182834; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hamasaki M, 2005, TRAFFIC, V6, P56, DOI 10.1111/j.1600-0854.2004.00245.x; Hubner CA, 2014, BRAIN, V137, P3109, DOI 10.1093/brain/awu287; Khundadze M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003988; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kurth I, 2009, NAT GENET, V41, P1179, DOI 10.1038/ng.464; Le Bars D, 2001, PHARMACOL REV, V53, P597; Maiuolo J, 2011, P NATL ACAD SCI USA, V108, P7832, DOI 10.1073/pnas.1101379108; Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024; Mochida K., 2015, NATURE; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Renvoise B, 2010, CURR OPIN NEUROBIOL, V20, P531, DOI 10.1016/j.conb.2010.07.001; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rogov VV, 2013, BIOCHEM J, V454, P459, DOI 10.1042/BJ20121907; Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; SPOERRI PE, 1980, ACTA ANAT, V107, P221; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Tasdemir E, 2007, CELL CYCLE, V6, P2263, DOI 10.4161/cc.6.18.4681; Verheije MH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000088; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970; Yorimitsu T, 2007, TRENDS CELL BIOL, V17, P279, DOI 10.1016/j.tcb.2007.04.005	38	510	529	6	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					354	+		10.1038/nature14498	http://dx.doi.org/10.1038/nature14498			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26040720				2022-12-28	WOS:000356425400056
J	Ji, ZJ; Gao, HS; Yu, HT				Ji, Zhejian; Gao, Haishan; Yu, Hongtao			Kinetochore attachment sensed by competitive Mps1 and microtubule binding to Ndc80C	SCIENCE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; AURORA-B; KINASE MPS1; PROTEIN; BUB1; PHOSPHORYLATION; LOCALIZATION; RECRUITMENT; HEC1; REVEALS	The spindle checkpoint of the cell division cycle senses kinetochores that are not attached to microtubules and prevents precocious onset of anaphase, which can lead to aneuploidy. The nuclear division cycle 80 complex (Ndc80C) is a major microtubule receptor at the kinetochore. Ndc80C also mediates the kinetochore recruitment of checkpoint proteins. We found that the checkpoint protein kinase monopolar spindle 1 (Mps1) directly bound to Ndc80C through two independent interactions. Both interactions involved the microtubule-binding surfaces of Ndc80C and were directly inhibited in the presence of microtubules. Elimination of one such interaction in human cells caused checkpoint defects expected from a failure to detect unattached kinetochores. Competition between Mps1 and microtubules for Ndc80C binding thus constitutes a direct mechanism for the detection of unattached kinetochores.	[Ji, Zhejian; Gao, Haishan; Yu, Hongtao] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Pharmacol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yu, HT (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	hongtao.yu@utsouthwestern.edu	JI, ZHEJIAN/AGP-7635-2022; Ji, Zhejian/AAA-6987-2020	JI, ZHEJIAN/0000-0002-6835-0854; Yu, Hongtao/0000-0002-8861-049X	Cancer Prevention and Research Institute of Texas [RP110465-P3, RP120717-P2]; Welch Foundation [I-1441]	Cancer Prevention and Research Institute of Texas; Welch Foundation(The Welch Foundation)	We thank C. Brautigam for assistance with isothermal titration calorimetry and microscale thermophoresis, H. Ball for peptide synthesis, and the Animal Resource Center on campus for antibody production. H.Y. is an investigator with the Howard Hughes Medical Institute. This work is supported by the Cancer Prevention and Research Institute of Texas (RP110465-P3 and RP120717-P2) and the Welch Foundation (I-1441).	Alushin GM, 2012, NAT STRUCT MOL BIOL, V19, P1161, DOI 10.1038/nsmb.2411; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kemmler S, 2009, EMBO J, V28, P1099, DOI 10.1038/emboj.2009.62; Kim S, 2015, J CELL BIOL, V208, P181, DOI 10.1083/jcb.201407074; Kim SJ, 2012, P NATL ACAD SCI USA, V109, P6549, DOI 10.1073/pnas.1118210109; London N, 2014, GENE DEV, V28, P140, DOI 10.1101/gad.233700.113; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; Primorac I, 2013, ELIFE, V2, DOI 10.7554/eLife.01030; Rischitor PE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001342; Sacristan C, 2015, TRENDS CELL BIOL, V25, P21, DOI 10.1016/j.tcb.2014.08.006; Shepperd LA, 2012, CURR BIOL, V22, P891, DOI 10.1016/j.cub.2012.03.051; Stucke VM, 2004, CHROMOSOMA, V113, P1, DOI 10.1007/s00412-004-0288-2; Yamagishi Y, 2012, NAT CELL BIOL, V14, P746, DOI 10.1038/ncb2515; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Zaytsev AV, 2014, J CELL BIOL, V206, P45, DOI 10.1083/jcb.201312107; Zhu TG, 2013, J BIOL CHEM, V288, P36149, DOI 10.1074/jbc.M113.507970	29	129	130	5	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1260	1264		10.1126/science.aaa4029	http://dx.doi.org/10.1126/science.aaa4029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068854				2022-12-28	WOS:000356011500056
J	Hasselqvist-Ax, I; Riva, G; Herlitz, J; Rosenqvist, M; Hollenberg, J; Nordberg, P; Ringh, M; Jonsson, M; Axelsson, C; Lindqvist, J; Karlsson, T; Svensson, L				Hasselqvist-Ax, Ingela; Riva, Gabriel; Herlitz, Johan; Rosenqvist, Marten; Hollenberg, Jacob; Nordberg, Per; Ringh, Mattias; Jonsson, Martin; Axelsson, Christer; Lindqvist, Jonny; Karlsson, Thomas; Svensson, Leif			Early Cardiopulmonary Resuscitation in Out-of-Hospital Cardiac Arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN-HEART-ASSOCIATION; BASIC LIFE-SUPPORT; COUNCIL GUIDELINES; SURVIVAL; POPULATION; RATES	BACKGROUND Three million people in Sweden are trained in cardiopulmonary resuscitation (CPR). Whether this training increases the frequency of bystander CPR or the survival rate among persons who have out-of-hospital cardiac arrests has been questioned. METHODS We analyzed a total of 30,381 out-of-hospital cardiac arrests witnessed in Sweden from January 1, 1990, through December 31, 2011, to determine whether CPR was performed before the arrival of emergency medical services (EMS) and whether early CPR was correlated with survival. RESULTS CPR was performed before the arrival of EMS in 15,512 cases (51.1%) and was not performed before the arrival of EMS in 14,869 cases (48.9%). The 30-day survival rate was 10.5% when CPR was performed before EMS arrival versus 4.0% when CPR was not performed before EMS arrival (P< 0.001). When adjustment was made for a propensity score (which included the variables of age, sex, location of cardiac arrest, cause of cardiac arrest, initial cardiac rhythm, EMS response time, time from collapse to call for EMS, and year of event), CPR before the arrival of EMS was associated with an increased 30-day survival rate (odds ratio, 2.15; 95% confidence interval, 1.88 to 2.45). When the time to defibrillation in patients who were found to be in ventricular fibrillation was included in the propensity score, the results were similar. The positive correlation between early CPR and survival rate remained stable over the course of the study period. An association was also observed between the time from collapse to the start of CPR and the 30-day survival rate. CONCLUSIONS CPR performed before EMS arrival was associated with a 30-day survival rate after an out-of-hospital cardiac arrest that was more than twice as high as that associated with no CPR before EMS arrival.	[Hasselqvist-Ax, Ingela; Riva, Gabriel; Hollenberg, Jacob; Nordberg, Per; Ringh, Mattias; Jonsson, Martin; Svensson, Leif] Ctr Resuscitat Sci, Solna, Sweden; [Rosenqvist, Marten] Danderyd Hosp, Dept Clin Sci, Cardiol Sect, S-18288 Danderyd, Sweden; [Herlitz, Johan] Karolinska Inst, Stockholm, Sweden; [Herlitz, Johan] Univ Boras, Ctr Prehosp Res Western Sweden, Boras, Sweden; [Axelsson, Christer] Univ Boras, Sch Hlth Sci, Boras, Sweden; [Herlitz, Johan] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Lindqvist, Jonny] Sahlgrens Univ Hosp, Dept Metab & Cardiovasc Res, Inst Internal Med, Gothenburg, Sweden; [Karlsson, Thomas] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat, Gothenburg, Sweden	Danderyds Hospital; Karolinska Institutet; University of Boras; University of Boras; Sahlgrenska University Hospital; Sahlgrenska University Hospital; University of Gothenburg	Herlitz, J (corresponding author), Univ Boras, Ctr Prehosp Res, SE-50190 Boras, Sweden.	johan.herlitz@hb.se	Jonsson, Martin/AEF-9167-2022	Riva, Gabriel/0000-0003-3038-0027; Jonsson, Martin/0000-0002-3539-8317	Laerdal Foundation for Acute Medicine	Laerdal Foundation for Acute Medicine	Funded by the Laerdal Foundation for Acute Medicine and others.	American Heart Association, 2012, CPR SUDD CARD ARR DE; [Anonymous], 2012, CENTR GOV ACT AMB SE; Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; Bardy GH, 2011, NEW ENGL J MED, V364, P374, DOI 10.1056/NEJMe1012554; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; Christenson J, 2009, CIRCULATION, V120, P1241, DOI 10.1161/CIRCULATIONAHA.109.852202; CUMMINS RO, 1985, AM J EMERG MED, V3, P114, DOI 10.1016/0735-6757(85)90032-4; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Handley AJ, 2005, RESUSCITATION, V67, pS7, DOI 10.1016/j.resuscitation.2005.10.007; Hollenberg J, 2005, J INTERN MED, V257, P247, DOI 10.1111/j.1365-2796.2004.01447.x; Holmberg M, 2001, EUR HEART J, V22, P511, DOI 10.1053/euhj.2000.2421; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Kim C, 2001, CIRCULATION, V104, P2699, DOI 10.1161/hc4701.099784; Kitamura T, 2014, RESUSCITATION, V85, P1432, DOI 10.1016/j.resuscitation.2014.07.017; Kitamura T, 2012, CIRCULATION, V126, P2834, DOI 10.1161/CIRCULATIONAHA.112.109496; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Nordberg P, 2009, RESUSCITATION, V80, P329, DOI 10.1016/j.resuscitation.2008.11.013; Ringh M, 2015, NEW ENGL J MED, V372, P2316, DOI 10.1056/NEJMoa1406038; Statistics Sweden, 2014, POP STAT JAN JUN 201; Stromsoe A, 2013, RESUSCITATION, V84, P952, DOI 10.1016/j.resuscitation.2012.12.026; Swedish Society of Medicine, 1997, SWED IND EM MED ASS; Vaillancourt C, 2013, RESUSCITATION, V84, P1747, DOI 10.1016/j.resuscitation.2013.08.001; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Waalewijn RA, 2002, RESUSCITATION, V54, P31, DOI 10.1016/S0300-9572(02)00047-3; WEAVER WD, 1986, J AM COLL CARDIOL, V7, P752, DOI 10.1016/S0735-1097(86)80332-1; Wissenberg M, 2013, JAMA-J AM MED ASSOC, V310, P1377, DOI 10.1001/jama.2013.278483	28	507	528	3	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2015	372	24					2307	2315		10.1056/NEJMoa1405796	http://dx.doi.org/10.1056/NEJMoa1405796			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK2DB	26061835				2022-12-28	WOS:000356019200006
J	Marino, G; Rohling, EJ; Rodriguez-Sanz, L; Grant, KM; Heslop, D; Roberts, AP; Stanford, JD; Yu, J				Marino, G.; Rohling, E. J.; Rodriguez-Sanz, L.; Grant, K. M.; Heslop, D.; Roberts, A. P.; Stanford, J. D.; Yu, J.			Bipolar seesaw control on last interglacial sea level	NATURE			English	Article							LONG-TERM VARIATIONS; PENULTIMATE GLACIAL MAXIMUM; OXYGEN ISOTOPIC COMPOSITION; EPICA DOME C; ANTARCTIC TEMPERATURE; CHRONOLOGY AICC2012; CLIMATE VARIABILITY; MEDITERRANEAN SEA; ATMOSPHERIC CO2; GLOBAL CLIMATE	Our current understanding of ocean-atmosphere-cryosphere interactions at ice-age terminations relies largely on assessments of the most recent (last) glacial-interglacial transition(1-3), Termination I (T-I). But the extent to which T-I is representative of previous terminations remains unclear. Testing the consistency of termination processes requires comparison of time series of critical climate parameters with detailed absolute and relative age control. However, such age control has been lacking for even the penultimate glacial termination (T-II), which culminated in a sea-level highstand during the last interglacial period that was several metres above present(4). Here we show that Heinrich Stadial 11 (HS11), a prominent North Atlantic cold episode(5,6), occurred between 135 +/- 1 and 130 +/- 2 thousand years ago and was linked with rapid sea-level rise during T-II. Our conclusions are based on new and existing(6-9) data for T-II and the last interglacial that we collate onto a single, radiometrically constrained chronology. The HS11 cold episode(5,6) punctuated T-II and coincided directly with a major deglacial meltwater pulse, which predominantly entered the North Atlantic Ocean and accounted for about 70 per cent of the glacial-interglacial sea-level rise(8,9). We conclude that, possibly in response to stronger insolation and CO2 forcing earlier in T-II, the relationship between climate and ice-volume changes differed fundamentally from that of T-I. In T-I, the major sea-level rise clearly post-dates(3,10,11) Heinrich Stadial 1. We also find that HS11 coincided with sustained Antarctic warming, probably through a bipolar seesaw temperature response(12), and propose that this heat gain at high southern latitudes promoted Antarctic ice-sheet melting that fuelled the last interglacial sea-level peak.	[Marino, G.; Rohling, E. J.; Rodriguez-Sanz, L.; Grant, K. M.; Heslop, D.; Roberts, A. P.; Yu, J.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia; [Rohling, E. J.] Univ Southampton, Ocean & Earth Sci, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Stanford, J. D.] Swansea Univ, Dept Geog, Swansea SA2 8PP, W Glam, Wales	Australian National University; NERC National Oceanography Centre; University of Southampton; Swansea University	Marino, G (corresponding author), Australian Natl Univ, Res Sch Earth Sci, GPO Box 4, Canberra, ACT 2601, Australia.	Gianluca.Marino@anu.edu.au	Heslop, David/AGE-1592-2022; Rohling, Eelco J/B-9736-2008; Heslop, David/G-6412-2011; Roberts, Andrew P/E-6422-2010; Marino, Gianluca/AAN-3969-2020; Yu, Jimin/I-7770-2012	Heslop, David/0000-0001-8245-0555; Rohling, Eelco J/0000-0001-5349-2158; Heslop, David/0000-0001-8245-0555; Roberts, Andrew P/0000-0003-0566-8117; Marino, Gianluca/0000-0001-9795-5337; Grant, Katharine/0000-0003-4299-5504; Yu, Jimin/0000-0002-3896-1777; Rodriguez-Sanz, Laura/0000-0002-0641-0583	Australian Research Council Australian Laureate Fellowship [FL120100050]; UK-NERC [NE/I009906/1]; NERC [NE/I02044X/1, bosc01001, NE/I009906/1] Funding Source: UKRI; Natural Environment Research Council [bosc01001, NE/I02044X/1, NE/I009906/1] Funding Source: researchfish	Australian Research Council Australian Laureate Fellowship(Australian Research Council); UK-NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the International Ocean Discovery Program for providing samples from Leg 161 and W. Hale for sampling assistance. M. Charidemou contributed to a pilot study on ODP975, J. Amies to preliminary stratigraphic assessment, and J. Cali to stable isotope analyses. We thank M. Bar-Matthews for providing the updated version of the Soreq Cave chronology table, R. N. Drysdale and J. Hellstrom for helpful discussions, and B. Martrat and L. Skinner for making published data available. This study was supported by Australian Research Council Australian Laureate Fellowship FL120100050 and by UK-NERC project NE/I009906/1 (E.J.R.).	Ahn J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4723; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Badertscher S, 2011, NAT GEOSCI, V4, P236, DOI [10.1038/NGEO1106, 10.1038/ngeo1106]; Bard E, 2002, EARTH PLANET SC LETT, V202, P481, DOI 10.1016/S0012-821X(02)00788-4; Barker S, 2011, SCIENCE, V334, P347, DOI 10.1126/science.1203580; Bazin L, 2013, CLIM PAST, V9, P1715, DOI 10.5194/cp-9-1715-2013; Berger A, 1997, SURV GEOPHYS, V18, P147, DOI 10.1023/A:1006579708292; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; BERGER AL, 1978, QUATERNARY RES, V9, P139, DOI 10.1016/0033-5894(78)90064-9; Carlson AE, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000371; Casford JSL, 2003, PALAEOGEOGR PALAEOCL, V190, P103, DOI 10.1016/S0031-0182(02)00601-6; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Clark PU, 2012, P NATL ACAD SCI USA, V109, pE1134, DOI 10.1073/pnas.1116619109; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Clark PU, 2002, SCIENCE, V295, P2438; Comas M. C., 1996, P ODP INIT REP, V161; DANSGAARD W, 1964, TELLUS, V16, P436; Delmotte M, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004417; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; Drysdale RN, 2009, SCIENCE, V325, P1527, DOI 10.1126/science.1170371; Drysdale RN, 2004, EARTH PLANET SC LETT, V227, P215, DOI 10.1016/j.epsl.2004.09.010; Friedrich O., 2012, EARTH PLANET SC LETT, V319-320, P133; Grant KM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6076; Grant KM, 2012, NATURE, V491, P744, DOI 10.1038/nature11593; Grelaud M, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002288; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Incarbona A, 2011, PALAEOGEOGR PALAEOCL, V306, P243, DOI 10.1016/j.palaeo.2011.04.030; Joughin I, 2012, SCIENCE, V338, P1172, DOI 10.1126/science.1226481; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kim ST, 1997, GEOCHIM COSMOCHIM AC, V61, P3461, DOI 10.1016/S0016-7037(97)00169-5; Lachniet MS, 2009, QUATERNARY SCI REV, V28, P412, DOI 10.1016/j.quascirev.2008.10.021; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; Landais A, 2013, NAT GEOSCI, V6, P1062, DOI [10.1038/NGEO1985, 10.1038/ngeo1985]; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; LeGrande AN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026011; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Lynch-Stieglitz J, 1999, NATURE, V402, P644, DOI 10.1038/45204; Malanotte-Rizzoli P, 2014, OCEAN SCI, V10, P281, DOI 10.5194/os-10-281-2014; Marino G, 2007, GEOLOGY, V35, P675, DOI 10.1130/G23831A.1; Marino G, 2009, QUATERNARY SCI REV, V28, P3246, DOI 10.1016/j.quascirev.2009.08.011; Martrat B, 2004, SCIENCE, V306, P1762, DOI 10.1126/science.1101706; Martrat B, 2007, SCIENCE, V317, P502, DOI 10.1126/science.1139994; Martrat B, 2014, QUATERNARY SCI REV, V99, P122, DOI 10.1016/j.quascirev.2014.06.016; Masson-Delmotte V, 2010, QUATERNARY SCI REV, V29, P113, DOI 10.1016/j.quascirev.2009.09.030; Masson-Delmotte V, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P383; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Mikolajewicz U, 2011, CLIM PAST, V7, P161, DOI 10.5194/cp-7-161-2011; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Myers PG, 1998, PALEOCEANOGRAPHY, V13, P586, DOI 10.1029/98PA02736; Oppo DW, 2006, QUATERNARY SCI REV, V25, P3268, DOI 10.1016/j.quascirev.2006.07.006; Osborne AH, 2010, QUATERNARY SCI REV, V29, P2473, DOI 10.1016/j.quascirev.2010.05.015; Piccini L, 2008, INT J SPELEOL, V37, P153, DOI 10.5038/1827-806X.37.3.2; Pinardi N, 2000, PALAEOGEOGR PALAEOCL, V158, P153, DOI 10.1016/S0031-0182(00)00048-1; Pinardi N, 2015, PROG OCEANOGR, V132, P318, DOI 10.1016/j.pocean.2013.11.003; Regattieri E, 2014, QUATERNARY RES, V82, P450, DOI 10.1016/j.yqres.2014.05.005; Rogerson M, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002931; Rohling EJ, 2015, EARTH-SCI REV, V143, P62, DOI 10.1016/j.earscirev.2015.01.008; Rohling EJ, 2014, NATURE, V508, P477, DOI 10.1038/nature13230; Rohling EJ, 2009, QUATERNARY SCI REV, V28, P3291, DOI 10.1016/j.quascirev.2009.09.007; Rohling EJ, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001237; Rohling EJ, 2004, MAR MICROPALEONTOL, V50, P89, DOI 10.1016/S0377-8398(03)00068-9; Rohling EJ, 2002, EARTH PLANET SC LETT, V202, P61, DOI 10.1016/S0012-821X(02)00775-6; Rohling EJ, 1999, PALEOCEANOGRAPHY, V14, P706, DOI 10.1029/1999PA900042; ROHLING EJ, 1994, P K NED AKAD WETENSC, V97, P201; Rohling EJ, 1998, PALEOCEANOGRAPHY, V13, P316, DOI 10.1029/98PA00671; Schmitt J, 2012, SCIENCE, V336, P711, DOI 10.1126/science.1217161; Schneider R, 2013, CLIM PAST, V9, P2507, DOI 10.5194/cp-9-2507-2013; Schneider T, 2014, NATURE, V513, P45, DOI 10.1038/nature13636; Schrag DP, 2002, QUATERNARY SCI REV, V21, P331, DOI 10.1016/S0277-3791(01)00110-X; Shackleton NJ, 2003, GLOBAL PLANET CHANGE, V36, P151, DOI 10.1016/S0921-8181(02)00181-9; Skinner LC, 2006, QUATERNARY SCI REV, V25, P3312, DOI 10.1016/j.quascirev.2006.07.005; Spence P, 2014, GEOPHYS RES LETT, V41, P4601, DOI 10.1002/2014GL060613; Stenni B, 2010, QUATERNARY SCI REV, V29, P146, DOI 10.1016/j.quascirev.2009.10.009; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; van der Meer MTJ, 2007, EARTH PLANET SC LETT, V262, P594, DOI 10.1016/j.epsl.2007.08.014; Veres D, 2013, CLIM PAST, V9, P1733, DOI 10.5194/cp-9-1733-2013; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002	79	109	111	3	117	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					197	+		10.1038/nature14499	http://dx.doi.org/10.1038/nature14499			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	26062511				2022-12-28	WOS:000356016700035
J	Kontopantelis, E; Doran, T; Springate, DA; Buchan, I; Reeves, D				Kontopantelis, Evangelos; Doran, Tim; Springate, David A.; Buchan, Iain; Reeves, David			Regression based quasi-experimental approach when randomisation is not an option: interrupted time series analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; CONTROLLED-TRIALS; UK QUALITY; PERFORMANCE	Interrupted time series analysis is a quasi-experimental design that can evaluate an intervention effect, using longitudinal data. The advantages, disadvantages, and underlying assumptions of various modelling approaches are discussed using published examples	[Kontopantelis, Evangelos; Buchan, Iain] Univ Manchester, Inst Populat Hlth, Ctr Hlth Informat, Manchester M13 9GB, Lancs, England; [Kontopantelis, Evangelos; Springate, David A.; Reeves, David] Univ Manchester, NIHR Sch Primary Care Res, Ctr Primary Care, Inst Populat Hlth, Manchester M13 9GB, Lancs, England; [Doran, Tim] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Springate, David A.; Reeves, David] Univ Manchester, Inst Populat Hlth, Ctr Biostat, Manchester M13 9GB, Lancs, England	University of Manchester; University of Manchester; University of York - UK	Kontopantelis, E (corresponding author), Univ Manchester, Inst Populat Hlth, Ctr Hlth Informat, Manchester M13 9GB, Lancs, England.	e.kontopantelis@manchester.ac.uk	Buchan, Iain E/H-5767-2013; Kontopantelis, Evangelos/H-2966-2019; Reeves, David/H-6203-2014	Buchan, Iain E/0000-0003-3392-1650; Kontopantelis, Evangelos/0000-0001-6450-5815; Reeves, David/0000-0001-6377-6859	MRC Health eResearch Centre [MR/K006665/1]; National Institute for Health Research (NIHR) School for Primary Care Research (SPCR); Medical Research Council [MR/K006665/1, MC_PC_13042] Funding Source: researchfish; MRC [MR/K006665/1] Funding Source: UKRI	MRC Health eResearch Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) School for Primary Care Research (SPCR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MRC Health eResearch Centre grant MR/K006665/1 supported the time and facilities of EK and IB. DAS was funded by the National Institute for Health Research (NIHR) School for Primary Care Research (SPCR). The views expressed are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.	Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Efron B, 2000, J AM STAT ASSOC, V95, P1293, DOI 10.2307/2669773; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Grundy C, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4469; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; Kontopantelis E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g330; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Kontopantelis E, 2013, BMJ QUAL SAF, V22, P53, DOI 10.1136/bmjqs-2012-001033; Mahamat A, 2007, INT J ANTIMICROB AG, V30, P169, DOI 10.1016/j.ijantimicag.2007.04.005; O'Keeffe AG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5293; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Saunders C, 2013, DIABETIC MED, V30, P300, DOI 10.1111/dme.12047; Silverman SL, 2009, AM J MED, V122, P114, DOI 10.1016/j.amjmed.2008.09.030; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	15	427	433	9	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2015	350								h2750	10.1136/bmj.h2750	http://dx.doi.org/10.1136/bmj.h2750			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK7CV	26058820	hybrid, Green Published			2022-12-28	WOS:000356389100001
J	Rothstein, L				Rothstein, Laura			Impaired Physicians and the ADA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Louisville, Louis D Brandeis Sch Law, Louisville, KY 40208 USA	University of Louisville	Rothstein, L (corresponding author), Univ Louisville, Louis D Brandeis Sch Law, 2301 S Third St, Louisville, KY 40208 USA.	laura.rothstein@louisville.edu						Rothstein L, 1997, ST LOUIS U LJ, V41, P973	1	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2219	2220		10.1001/jama.2015.4602	http://dx.doi.org/10.1001/jama.2015.4602			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1VH	26057277				2022-12-28	WOS:000355995300010
J	Searcy, CA; Dowd, KW; Hughes, MG; Baldwin, S; Pigg, T				Searcy, Cynthia A.; Dowd, Keith W.; Hughes, Michael G.; Baldwin, Sean; Pigg, Trey			Association of MCAT Scores Obtained With Standard vs Extra Administration Time With Medical School Admission, Medical Student Performance, and Time to Graduation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WITH-DISABILITIES-ACT; PREDICTIVE-VALIDITY; TESTING ACCOMMODATIONS; LICENSING EXAMINATIONS; LEARNING-DISABILITIES; 2008 AMENDMENTS; COLLEGE; EXAM	IMPORTANCE Individuals with documented disabilities may receive accommodations on the Medical College Admission Test (MCAT). Whether such accommodations are associated with MCAT scores, medical school admission, and medical school performance is unclear. OBJECTIVE To determine the comparability of MCAT scores obtained with standard vs extra administration time with respect to likelihood of acceptance to medical school and future medical student performance. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of applicants to US medical schools for the 2011-2013 entering classes who reported MCAT scores obtained with standard time (n = 133 962) vs extra time (n = 435), and of students who matriculated in US medical schools from 2000-2004 who reported MCAT scores obtained with standard time (n = 76 262) vs extra time (n = 449). EXPOSURES Standard or extra administration time during MCAT. MAIN OUTCOMES AND MEASURES Primary outcome measures were acceptance rates at US medical schools and graduation rates within 4 or 5 years after matriculation. Secondary outcome measures were pass rates on the United States Medical Licensing Examination (USMLE) Step examinations and graduation rates within 6 to 8 years after matriculation. RESULTS Acceptance rates were not significantly different for applicants who had MCAT scores obtained with standard vs extra time (44.5%[59 585/133 962] vs 43.9%[191/435]; difference, 0.6%[95% CI, -4.1 to 5.3]). Students who tested with extra time passed the Step examinations on first attempt at significantly lower rates (Step 1, 82.1%[344/419] vs 94.0% [70 188/74 668]; difference, 11.9% [95% CI, 9.6% to 14.2%]; Step 2 CK, 85.5%[349/408] vs 95.4%[70 476/73 866]; difference, 9.9%[95% CI, 7.8% to 11.9%]; Step 2 CS, 92.0% [288/313] vs 97.0%[60 039/61 882]; difference, 5.0%[95% CI, 3.1% to 6.9%]). They also graduated from medical school at significantly lower rates at different times (4 years, 67.2% [285/424] vs 86.1%[60 547/70 305]; difference, 18.9% [95% CI, 15.6% to 22.2%]; 5 years, 81.6%[346/424] vs 94.4%[66 369/70 305]; difference, 12.8%[95% CI, 10.6% to 15.0%]; 6 years, 85.4%[362/424] vs 95.8% [67 351/70 305]; difference, 10.4%[95% CI, 8.5% to 12.4%]; 7 years, 88.0%[373/424] vs 96.2%[67 639/70 305]; difference, 8.2%[95% CI, 6.4% to 10.1%]; 8 years, 88.4%[375/424] vs 96.5%[67 847/70 305]; difference, 8.1%[95% CI, 6.3% to 9.8%]). These differences remained after controlling for MCAT scores and undergraduate grade point averages. CONCLUSIONS AND RELEVANCE Among applicants to US medical schools, those with MCAT scores obtained with extra test administration time, compared with standard administration time, had no significant difference in rate of medical school admission but had lower rates of passing the USMLE Step examinations and of medical school graduation within 4 to 8 years after matriculation. These findings raise questions about the types of learning environments and support systems needed by students who test with extra time on the MCAT to enable them to succeed in medical school.	[Searcy, Cynthia A.; Dowd, Keith W.; Pigg, Trey] Assoc Amer Med Coll, Washington, DC 20001 USA; [Hughes, Michael G.; Baldwin, Sean] Human Resources Res Org, Alexandria, VA USA	Association of American Medical Colleges	Searcy, CA (corresponding author), Assoc Amer Med Coll, MCAT Res & Dev, 655 K St NW,Ste 100, Washington, DC 20001 USA.	csearcy@aamc.org			Association of American Medical Colleges	Association of American Medical Colleges	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Hughes and Baldwin reported that their organization (Human Resources Research Organization) received funds from the Association of American Medical Colleges as consulting fees to conduct analyses for this research in collaboration with Dr Searcy, Mr Dowd, and Mr Pigg. No other disclosures were reported.	Altchuler SI, 2009, ACAD MED, V84, P689, DOI 10.1097/ACM.0b013e3181a3db32; American Educational Research Association American Psychological Association Na- tional Council on Measurement in Education, 2014, STAND ED PSYCH TEST; Amodeo A, 0901 LSAC; Ballard RS., 2003, J PSYCHIAT LAW, V31, P43, DOI [10.1177/009318530303100104, DOI 10.1177/009318530303100104]; Blount A, 34 U MINN NAT CTR ED; Bolt SE, 2004, REM SPEC EDUC, V25, P141, DOI 10.1177/07419325040250030201; Cahalan C, 20025 COLL BOARD; Callahan CA, 2010, ACAD MED, V85, P980, DOI 10.1097/ACM.0b013e3181cece3d; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DeLisa J, 2011, ACAD MED, V86, P677, DOI 10.1097/ACM.0b013e318217ee74; Donnon T, 2007, ACAD MED, V82, P100, DOI 10.1097/01.ACM.0000249878.25186.b7; Dunleavy DM, 2013, ACAD MED, V88, P666, DOI 10.1097/ACM.0b013e3182864299; Group on Diversity and Inclusion, 2013, GDI NAV EXC SUMM DIS; Hollenbeck K., 2002, LARGE SCALE ASSESSME; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Julian ER, 2005, ACAD MED, V80, P910, DOI 10.1097/00001888-200510000-00010; Julian ER, 2004, ACAD MED, V79, P360, DOI 10.1097/00001888-200404000-00017; Latham P, 2010, MED STUDENTS DISABIL; Lewandowski L, 2013, J PSYCHOEDUC ASSESS, V31, P326, DOI 10.1177/0734282912462693; Mandinach E, 20058 COLL BOARD; Mann S., 2014, AAMC APPROVES NEW MC; Melnick DE, 2011, ACAD MED, V86, P674, DOI 10.1097/ACM.0b013e318217e956; Monroe A, 2013, ACAD MED, V88, P672, DOI 10.1097/ACM.0b013e31828bf252; Oppler S, 2004, 19 ANN C SOC IND ORG; Oppler S, 2010, 25 ANN C SOC IND ORG; Schwartzstein RM, 2013, ACAD MED, V88, P560, DOI 10.1097/ACM.0b013e31828c4ae0; Smith WT, 2011, ACAD MED, V86, P768, DOI 10.1097/ACM.0b013e318217e325; Stretch LS., 2005, PRACTICAL ASSESSMENT, V10, P8, DOI [10.7275/cs6a-4s02, DOI 10.7275/CS6A-4S02]; Teherani A, 2013, JAMA-J AM MED ASSOC, V310, P2309, DOI 10.1001/jama.2013.283198; Thurlow ML, 2006, HANDBOOK OF TEST DEVELOPMENT, P653; Watson JE., 2005, MEDICAL STUDENTS DIS; Zuriff GE, 2000, APPL MEAS EDUC, V13, P99, DOI 10.1207/s15324818ame1301_5	32	20	20	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2253	2262		10.1001/jama.2015.5511	http://dx.doi.org/10.1001/jama.2015.5511			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK1VH	26057286	Bronze			2022-12-28	WOS:000355995300019
J	Holubcova, Z; Blayney, M; Elder, K; Schuh, M				Holubcova, Zuzana; Blayney, Martyn; Elder, Kay; Schuh, Melina			Error-prone chromosome-mediated spindle assembly favors chromosome segregation defects in human oocytes	SCIENCE			English	Article							MITOTIC-SPINDLE; SELF-ORGANIZATION; MEIOSIS-I; ANEUPLOIDY; RAN; CENTROSOME; RCC1; AGE	Aneuploidy in human eggs is the leading cause of pregnancy loss and several genetic disorders such as Down syndrome. Most aneuploidy results from chromosome segregation errors during the meiotic divisions of an oocyte, the egg's progenitor cell. The basis for particularly error-prone chromosome segregation in human oocytes is not known. We analyzed meiosis in more than 100 live human oocytes and identified an error-prone chromosome-mediated spindle assembly mechanism as a major contributor to chromosome segregation defects. Human oocytes assembled a meiotic spindle independently of either centrosomes or other microtubule organizing centers. Instead, spindle assembly wasmediated by chromosomes and the small guanosine triphosphatase Ran in a process requiring similar to 16 hours. This unusually long spindle assembly period was marked by intrinsic spindle instability and abnormal kinetochore-microtubule attachments, which favor chromosome segregation errors and provide a possible explanation for high rates of aneuploidy in human eggs.	[Holubcova, Zuzana; Schuh, Melina] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Blayney, Martyn; Elder, Kay] Bourn Hall Clin, Cambridge CB23 2TN, England	MRC Laboratory Molecular Biology	Schuh, M (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.	mschuh@mrc-lmb.cam.ac.uk	Holubcová, Zuzana/AAC-8487-2022; Holubcová, Zuzana/AAS-4706-2021; Holubcová, Zuzana/K-2996-2015	Holubcová, Zuzana/0000-0002-4658-6161; Holubcová, Zuzana/0000-0002-4658-6161; Elder, Kay/0000-0003-3510-8268	European Research Council [337415]; Lister Institute of Preventive Medicine; MRC [MC_U105192711] Funding Source: UKRI; Medical Research Council [MC_U105192711] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Lister Institute of Preventive Medicine; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to the clinicians at Bourn Hall Clinic for their support of this study, the nursing team that was instrumental in recruiting patients and obtaining their informed consent, and the embryology team for identifying and preparing the test oocytes and for their enthusiastic support of this project from the outset. We thank T. Izzard for help in obtaining approval of this study by the UK's National Research Ethics Service, as well as S. Munro, R. Hegde, and D. Clift for comments on the manuscript. The research leading to these results has received financial support from the European Research Council under grant agreement no. 337415 and from the Lister Institute of Preventive Medicine. The data are contained in the manuscript and the supplementary materials.	Battaglia DE, 1996, MOL HUM REPROD, V2, P845, DOI 10.1093/molehr/2.11.845; Battaglia DE, 1996, HUM REPROD, V11, P2217; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Cesario J, 2011, J CELL SCI, V124, P3797, DOI 10.1242/jcs.084855; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Danylevska A, 2014, CHROMOSOME RES, V22, P365, DOI 10.1007/s10577-014-9428-6; Dumont J, 2007, J CELL BIOL, V176, P295, DOI 10.1083/jcb.200605199; GEMZELL CA, 1962, FERTIL STERIL, V13, P153; George MA, 1996, MOL HUM REPROD, V2, P445, DOI 10.1093/molehr/2.6.445; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Holubcova Z, 2013, NAT CELL BIOL, V15, P937, DOI 10.1038/ncb2802; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Knouse KA, 2014, P NATL ACAD SCI USA, V111, P13409, DOI 10.1073/pnas.1415287111; Kolano A, 2012, P NATL ACAD SCI USA, V109, pE1858, DOI 10.1073/pnas.1204686109; Manandhar G, 2005, BIOL REPROD, V72, P2, DOI 10.1095/biolreprod.104.031245; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Obradors A, 2011, CYTOGENET GENOME RES, V133, P119, DOI 10.1159/000324233; Pacchierotti F, 2007, ENVIRON RES, V104, P46, DOI 10.1016/j.envres.2006.12.001; PICKERING SJ, 1988, HUM REPROD, V3, P978, DOI 10.1093/oxfordjournals.humrep.a136828; Sathananthan AH, 2006, MICROSC RES TECHNIQ, V69, P396, DOI 10.1002/jemt.20299; Sathananthan AH, 2013, MICRON, V44, P1, DOI 10.1016/j.micron.2012.05.002; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; SZOLLOSI D, 1986, Journal of In Vitro Fertilization and Embryo Transfer, V3, P232, DOI 10.1007/BF01132810; Templado C, 2011, CYTOGENET GENOME RES, V133, P91, DOI 10.1159/000323795	29	163	165	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1143	1147		10.1126/science.aaa9529	http://dx.doi.org/10.1126/science.aaa9529			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045437	Green Accepted			2022-12-28	WOS:000355590500050
J	Zheludev, NI				Zheludev, Nikolay I.			Obtaining optical properties on demand	SCIENCE			English	Editorial Material							METAMATERIAL		[Zheludev, Nikolay I.] Univ Southampton, Optoelect Res Ctr, Ctr Photon Metamat, Southampton SO17 1BJ, Hants, England; [Zheludev, Nikolay I.] Nanyang Technol Univ, Photon Inst, Ctr Disrupt Photon Technol, Singapore 637371, Singapore	University of Southampton; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zheludev, NI (corresponding author), Univ Southampton, Optoelect Res Ctr, Ctr Photon Metamat, Southampton SO17 1BJ, Hants, England.	niz@orc.soton.ac.uk	ZHELUDEV, Nikolay I./Z-1553-2019; Metamaterials, Nanophotonics and/AAF-3156-2019; Zheludev, Nikolay I/C-2284-2014	ZHELUDEV, Nikolay I./0000-0002-1013-6636; Zheludev, Nikolay I/0000-0002-1013-6636	EPSRC [EP/G060363/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G060363/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Fang X, 2015, LIGHT-SCI APPL, V4, DOI 10.1038/lsa.2015.65; Khanikaev AB, 2013, NAT MATER, V12, P233, DOI [10.1038/nmat3520, 10.1038/NMAT3520]; Larouche S, 2012, NAT MATER, V11, P450, DOI [10.1038/NMAT3278, 10.1038/nmat3278]; Maas R, 2013, NAT PHOTONICS, V7, P907, DOI [10.1038/NPHOTON.2013.256, 10.1038/nphoton.2013.256]; Naik GV, 2013, ADV MATER, V25, P3264, DOI 10.1002/adma.201205076; Poddubny A, 2013, NAT PHOTONICS, V7, P948, DOI [10.1038/NPHOTON.2013.243, 10.1038/nphoton.2013.243]; Silva A, 2014, SCIENCE, V343, P160, DOI [10.1126/science.1242818, 10.1126/science.124405]; Valente J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8021; Wang Q, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869575; Yang YM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6753; Yu NF, 2014, NAT MATER, V13, P139, DOI [10.1038/nmat3839, 10.1038/NMAT3839]; Zheludev NI, 2012, NAT MATER, V11, P917, DOI [10.1038/NMAT3431, 10.1038/nmat3431]	12	88	88	5	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					973	974		10.1126/science.aac4360	http://dx.doi.org/10.1126/science.aac4360			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	26023123	Green Accepted			2022-12-28	WOS:000355276600025
J	Martincorena, I; Roshan, A; Gerstung, M; Ellis, P; Van Loo, P; McLaren, S; Wedge, DC; Fullam, A; Alexandrov, LB; Tubio, JM; Stebbings, L; Menzies, A; Widaa, S; Stratton, MR; Jones, PH; Campbell, PJ				Martincorena, Inigo; Roshan, Amit; Gerstung, Moritz; Ellis, Peter; Van Loo, Peter; McLaren, Stuart; Wedge, David C.; Fullam, Anthony; Alexandrov, Ludmil B.; Tubio, Jose M.; Stebbings, Lucy; Menzies, Andrew; Widaa, Sara; Stratton, Michael R.; Jones, Philip H.; Campbell, Peter J.			High burden and pervasive positive selection of somatic mutations in normal human skin	SCIENCE			English	Article							BASAL-CELL CARCINOMAS; ACTIVATING MUTATIONS; CLONAL HEMATOPOIESIS; DNA-DAMAGE; CANCER; LANDSCAPE; UV; NONMELANOMA; EVOLUTION; P53	How somatic mutations accumulate in normal cells is central to understanding cancer development but is poorly understood. We performed ultradeep sequencing of 74 cancer genes in small (0.8 to 4.7 square millimeters) biopsies of normal skin. Across 234 biopsies of sun-exposed eyelid epidermis from four individuals, the burden of somatic mutations averaged two to six mutations per megabase per cell, similar to that seen in many cancers, and exhibited characteristic signatures of exposure to ultraviolet light. Remarkably, multiple cancer genes are under strong positive selection even in physiologically normal skin, including most of the key drivers of cutaneous squamous cell carcinomas. Positively selected mutations were found in 18 to 32% of normal skin cells at a density of similar to 140 driver mutations per square centimeter. We observed variability in the driver landscape among individuals and variability in the sizes of clonal expansions across genes. Thus, aged sun-exposed skin is a patchwork of thousands of evolving clones with over a quarter of cells carrying cancer-causing mutations while maintaining the physiological functions of epidermis.	[Martincorena, Inigo; Gerstung, Moritz; Ellis, Peter; Van Loo, Peter; McLaren, Stuart; Wedge, David C.; Fullam, Anthony; Alexandrov, Ludmil B.; Tubio, Jose M.; Stebbings, Lucy; Menzies, Andrew; Widaa, Sara; Stratton, Michael R.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Roshan, Amit; Jones, Philip H.] Univ Cambridge, Hutchison MRC Res Ctr, MRC Canc Unit, Cambridge, England; [Van Loo, Peter] Francis Crick Inst, London, England; [Van Loo, Peter] Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England	Wellcome Trust Sanger Institute; Francis Crick Institute; KU Leuven; University of Cambridge	Jones, PH (corresponding author), Univ Cambridge, Hutchison MRC Res Ctr, MRC Canc Unit, Cambridge, England.	phj20@mrc-cu.cam.ac.uk; pc8@sanger.ac.uk	Tubio, Jose/AAG-7345-2019; Alexandrov, Ludmil/AAS-1454-2021; Tubio, Jose M.C./H-5076-2015; Roshan, Amit/AAV-5512-2020; Wedge, David/AAC-4977-2021	Tubio, Jose/0000-0003-3540-2459; Alexandrov, Ludmil/0000-0003-3596-4515; Tubio, Jose M.C./0000-0003-3540-2459; Roshan, Amit/0000-0002-2034-2759; Van Loo, Peter/0000-0003-0292-1949; Martincorena, Inigo/0000-0003-1122-4416; Jones, Philip H/0000-0002-5904-795X; Wedge, David/0000-0002-7572-3196; Fullam, Anthony/0000-0002-0884-8124; Gerstung, Moritz/0000-0001-6709-963X	Wellcome Trust [077012/Z/05/Z, WT088340MA]; Medical Research Council (MRC); Cancer Research UK (CRUK) [C609/A17257]; EMBO [1287-2012]; Queens' College, Cambridge; CRUK-Cambridge Cancer Centre Clinical Research Fellowship; Marie Curie Fellowship FP7-PEOPLE-IEF [328264]; MRC [MC_UU_12022/3] Funding Source: UKRI; Cancer Research UK [17257] Funding Source: researchfish; Medical Research Council [MC_UU_12022/3] Funding Source: researchfish; The Francis Crick Institute [10202] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK (CRUK)(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO)); Queens' College, Cambridge; CRUK-Cambridge Cancer Centre Clinical Research Fellowship; Marie Curie Fellowship FP7-PEOPLE-IEF; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	We thank M. S. Kolodney, R. J. Cho, and M. Dimon for kindly providing their published exome sequencing data on BCC and cSCC. This work was supported by the Wellcome Trust (grant 077012/Z/05/Z) and by a Medical Research Council (MRC) Centennial award (P.H.J.). P.J.C. has a Wellcome Trust Senior Clinical Research Fellowship (WT088340MA). P.H.J. is supported by an MRC grant in aid and Cancer Research UK (CRUK) (program grant C609/A17257). I. M. is supported by fellowships from EMBO (grant 1287-2012) and Queens' College, Cambridge. A. R. acknowledges support from the CRUK-Cambridge Cancer Centre Clinical Research Fellowship. J.M.C.T. is supported by Marie Curie Fellowship FP7-PEOPLE-2012-IEF (project number 328264), and P.J.C. holds equity in and is a paid consultant for 14M Genomics Ltd. The sequencing data have been deposited in the European Genome-Phenome Archive (accession nos. EGAS00001000860, EGAS00001000515, and EGAS00001000603). The R code used for variant calling (ShearwaterML) is available in Bioconductor (deepSNV package).	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Besaratinia A, 2007, P NATL ACAD SCI USA, V104, P5953, DOI 10.1073/pnas.0610534104; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gerstung M, 2014, BIOINFORMATICS, V30, P1198, DOI 10.1093/bioinformatics/btt750; Grachtchouk M, 2011, J CLIN INVEST, V121, P1768, DOI 10.1172/JCI46307; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Guo J, 2013, NUCLEIC ACIDS RES, V41, P7700, DOI 10.1093/nar/gkt524; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harvey I, 1996, BRIT J CANCER, V74, P1302, DOI 10.1038/bjc.1996.534; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jackson AL, 1998, GENETICS, V148, P1483; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jayaraman SS, 2014, J INVEST DERMATOL, V134, P213, DOI 10.1038/jid.2013.276; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Klein AM, 2010, P NATL ACAD SCI USA, V107, P270, DOI 10.1073/pnas.0909738107; Ling G, 2001, AM J PATHOL, V159, P1247, DOI 10.1016/S0002-9440(10)62511-4; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Logie A, 2005, HUM MOL GENET, V14, P1153, DOI 10.1093/hmg/ddi127; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; Maitra A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3873; Martincorena I, 2013, BIOESSAYS, V35, P123, DOI 10.1002/bies.201200150; McGrath JA, 2004, ROOKS TXB DERMATOLOG, V7th; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; NAKAZAWA H, 1994, P NATL ACAD SCI USA, V91, P360, DOI 10.1073/pnas.91.1.360; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pfeifer GP, 2012, PHOTOCH PHOTOBIO SCI, V11, P90, DOI 10.1039/c1pp05144j; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; South AP, 2014, J INVEST DERMATOL, V134, P2630, DOI 10.1038/jid.2014.154; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Zhang WG, 2001, P NATL ACAD SCI USA, V98, P13948, DOI 10.1073/pnas.241353198; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	48	960	969	3	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					880	886		10.1126/science.aaa6806	http://dx.doi.org/10.1126/science.aaa6806			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999502	Green Submitted, Green Accepted			2022-12-28	WOS:000354877900037
J	Chagpar, AB; Killelea, BK; Tsangaris, TN; Butler, M; Stavris, K; Li, FY; Yao, X; Bossuyt, V; Harigopal, M; Lannin, DR; Pusztai, L; Horowitz, NR				Chagpar, Anees B.; Killelea, Brigid K.; Tsangaris, Theodore N.; Butler, Meghan; Stavris, Karen; Li, Fangyong; Yao, Xiaopan; Bossuyt, Veerle; Harigopal, Malini; Lannin, Donald R.; Pusztai, Lajos; Horowitz, Nina R.			A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONSERVING SURGERY; RE-EXCISION; LUMPECTOMY; TIME; CONSERVATION; IRRADIATION; MASTECTOMY; CARCINOMA; NEED	BACKGROUND Routine resection of cavity shave margins (additional tissue circumferentially around the cavity left by partial mastectomy) may reduce the rates of positive margins (margins positive for tumor) and reexcision among patients undergoing partial mastectomy for breast cancer. METHODS In this randomized, controlled trial, we assigned, in a 1: 1 ratio, 235 patients with breast cancer of stage 0 to III who were undergoing partial mastectomy, with or without resection of selective margins, to have further cavity shave margins resected (shave group) or not to have further cavity shave margins resected (no-shave group). Randomization occurred intraoperatively after surgeons had completed standard partial mastectomy. Positive margins were defined as tumor touching the edge of the specimen that was removed in the case of invasive cancer and tumor that was within 1 mm of the edge of the specimen removed in the case of ductal carcinoma in situ. The rate of positive margins was the primary outcome measure; secondary outcome measures included cosmesis and the volume of tissue resected. RESULTS The median age of the patients was 61 years (range, 33 to 94). On final pathological testing, 54 patients (23%) had invasive cancer, 45 (19%) had ductal carcinoma in situ, and 125 (53%) had both; 11 patients had no further disease. The median size of the tumor in the greatest diameter was 1.1 cm (range, 0 to 6.5) in patients with invasive carcinoma and 1.0 cm (range, 0 to 9.3) in patients with ductal carcinoma in situ. Groups were well matched at baseline with respect to demographic and clinicopathological characteristics. The rate of positive margins after partial mastectomy (before randomization) was similar in the shave group and the no-shave group (36% and 34%, respectively; P = 0.69). After randomization, patients in the shave group had a significantly lower rate of positive margins than did those in the no-shave group (19% vs. 34%, P = 0.01), as well as a lower rate of second surgery for margin clearance (10% vs. 21%, P = 0.02). There was no significant difference in complications between the two groups. CONCLUSIONS Cavity shaving halved the rates of positive margins and reexcision among patients with partial mastectomy. (Funded by the Yale Cancer Center; ClinicalTrials.gov number, NCT01452399.)	[Chagpar, Anees B.; Killelea, Brigid K.; Butler, Meghan; Stavris, Karen; Lannin, Donald R.; Horowitz, Nina R.] Yale Univ, Sch Med, Dept Surg, New Haven, CT USA; [Bossuyt, Veerle; Harigopal, Malini] Yale Univ, Sch Med, Dept Pathol, New Haven, CT USA; [Pusztai, Lajos] Yale Univ, Sch Med, Dept Med, New Haven, CT USA; [Chagpar, Anees B.; Killelea, Brigid K.; Butler, Meghan; Stavris, Karen; Li, Fangyong; Yao, Xiaopan; Lannin, Donald R.; Pusztai, Lajos; Horowitz, Nina R.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA; [Li, Fangyong; Yao, Xiaopan] Yale Univ, Sch Med, Yale Ctr Analyt Sci, New Haven, CT USA; [Tsangaris, Theodore N.] Thomas Jefferson Univ, Dept Surg, Philadelphia, PA 19107 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Jefferson University	Chagpar, AB (corresponding author), Breast Ctr, 20 York St,1st Fl,Suit A, New Haven, CT 06510 USA.	anees.-chagpar@-yale.-edu	Pusztai, Lajos/AAB-2901-2019	Chagpar, Anees/0000-0001-7641-4443	Yale Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER	Yale Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the Yale Cancer Center; ClinicalTrials.gov number, NCT01452399.	Cao DF, 2005, AM J SURG PATHOL, V29, P1625, DOI 10.1097/01.pas.0000180448.08203.70; Feron JG, 2011, BREAST, V20, P358, DOI 10.1016/j.breast.2011.01.014; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Hequet D, 2013, EJSO-EUR J SURG ONC, V39, P899, DOI 10.1016/j.ejso.2013.05.012; Huston TL, 2006, AM J SURG, V192, P509, DOI 10.1016/j.amjsurg.2006.06.021; Jacobson AF, 2008, AM J SURG, V196, P556, DOI 10.1016/j.amjsurg.2008.06.007; Kobbermann A, 2011, ANN SURG ONCOL, V18, P1349, DOI 10.1245/s10434-010-1420-6; Kummerow KL, 2015, JAMA SURG, V150, P9, DOI 10.1001/jamasurg.2014.2895; Marudanayagam R, 2008, BREAST J, V14, P570, DOI 10.1111/j.1524-4741.2008.00649.x; McCahill LE, 2012, JAMA-J AM MED ASSOC, V307, P467, DOI 10.1001/jama.2012.43; Mook J, 2012, ANN SURG ONCOL, V19, P886, DOI 10.1245/s10434-011-1982-y; Moran MS, 2014, ANN SURG ONCOL, V21, P704, DOI 10.1245/s10434-014-3481-4; Racz JM, 2015, BREAST J, V21, P345, DOI 10.1111/tbj.12423; Tang R, 2014, AM J SURG; Tengher-Barna I, 2009, MODERN PATHOL, V22, P299, DOI 10.1038/modpathol.2008.186; Unzeitig A, 2012, INT J SURG ONCOL, V2012, DOI 10.1155/2012/725121; Vos EL, 2015, EUR J CANCER, V51, P282, DOI 10.1016/j.ejca.2014.12.003; Wilke LG, 2014, JAMA SURG, V149, P1296, DOI 10.1001/jamasurg.2014.926	18	215	220	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2015	373	6					503	510		10.1056/NEJMoa1504473	http://dx.doi.org/10.1056/NEJMoa1504473			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2LM	26028131	Green Accepted			2022-12-28	WOS:000358987700004
J	Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger, E; Bjelic-Radisic, V; Artner-Matuschek, S; Fitzal, F; Marth, C; Sevelda, P; Mlineritsch, B; Steger, GG; Manfreda, D; Exner, R; Egle, D; Bergh, J; Kainberger, F; Talbot, S; Warner, D; Fesl, C; Singer, CF				Gnant, Michael; Pfeiler, Georg; Dubsky, Peter C.; Hubalek, Michael; Greil, Richard; Jakesz, Raimund; Wette, Viktor; Balic, Marija; Haslbauer, Ferdinand; Melbinger, Elisabeth; Bjelic-Radisic, Vesna; Artner-Matuschek, Silvia; Fitzal, Florian; Marth, Christian; Sevelda, Paul; Mlineritsch, Brigitte; Steger, Guenther G.; Manfreda, Diether; Exner, Ruth; Egle, Daniel; Bergh, Jonas; Kainberger, Franz; Talbot, Susan; Warner, Douglas; Fesl, Christian; Singer, Christian F.		Austrian Breast Colorectal Canc St	Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial	LANCET			English	Article							PLUS ZOLEDRONIC ACID; POSTMENOPAUSAL WOMEN; ENDOCRINE THERAPY; AROMATASE INHIBITORS; BONE HEALTH; PREVENTION; MANAGEMENT; BISPHOSPHONATES; FRACTURES; DENSITY	Background Adjuvant endocrine therapy compromises bone health in patients with breast cancer, causing osteopenia, osteoporosis, and fractures. Antiresorptive treatments such as bisphosphonates prevent and counteract these side-effects. In this trial, we aimed to investigate the effects of the anti-RANK ligand antibody denosumab in postmenopausal, aromatase inhibitor-treated patients with early-stage hormone receptor-positive breast cancer. Methods In this prospective, double-blind, placebo-controlled, phase 3 trial, postmenopausal patients with early hormone receptor-positive breast cancer receiving treatment with aromatase inhibitors were randomly assigned in a 1: 1 ratio to receive either denosumab 60 mg or placebo administered subcutaneously every 6 months in 58 trial centres in Austria and Sweden. Patients were assigned by an interactive voice response system. The randomisation schedule used a randomly permuted block design with block sizes 2 and 4, stratified by type of hospital regarding Hologic device for DXA scans, previous aromatase inhibitor use, and baseline bone mineral density. Patients, treating physicians, investigators, data managers, and all study personnel were masked to treatment allocation. The primary endpoint was time from randomisation to first clinical fracture, analysed by intention to treat. As an additional sensitivity analysis, we also analysed the primary endpoint on the per-protocol population. Patients were treated until the prespecified number of 247 first clinical fractures was reached. This trial is ongoing (patients are in follow-up) and is registered with the European Clinical Trials Database, number 2005-005275-15, and with ClinicalTrials.gov, number NCT00556374. Findings Between Dec 18, 2006, and July 22, 2013, 3425 eligible patients were enrolled into the trial, of whom 3420 were randomly assigned to receive denosumab 60 mg (n=1711) or placebo (n=1709) subcutaneously every 6 months. Compared with the placebo group, patients in the denosumab group had a significantly delayed time to first clinical fracture (hazard ratio [HR] 0.50 [95% CI 0.39-0.65], p<0.0001). The overall lower number of fractures in the denosumab group (92) than in the placebo group (176) was similar in all patient subgroups, including in patients with a bone mineral density T-score of -1 or higher at baseline (n=1872, HR 0.44 [95% CI 0.31-0.64], p<0.0001) and in those with a bone mineral density T-score of less than -1 already at baseline (n=1548, HR 0.57 [95% CI 0.40-0.82], p=0.002). The patient incidence of adverse events in the safety analysis set (all patients who received at least one dose of study drug) did not differ between the denosumab group (1366 events, 80%) and the placebo group (1334 events, 79%), nor did the numbers of serious adverse events (521 vs 511 [30% in each group]). The main adverse events were arthralgia and other aromatase-inhibitor related symptoms; no additional toxicity from the study drug was reported. Despite proactive adjudication of every potential osteonecrosis of the jaw by an international expert panel, no cases of osteonecrosis of the jaw were reported. 93 patients (3% of the full analysis set) died during the study, of which one death (in the denosumab group) was thought to be related to the study drug. Interpretation Adjuvant denosumab 60 mg twice per year reduces the risk of clinical fractures in postmenopausal women with breast cancer receiving aromatase inhibitors, and can be administered without added toxicity. Since a main side-effect of adjuvant breast cancer treatment can be substantially reduced by the addition of denosumab, this treatment should be considered for clinical practice.	[Gnant, Michael; Dubsky, Peter C.; Jakesz, Raimund; Fitzal, Florian; Exner, Ruth] Med Univ Vienna, Dept Surg, A-1090 Vienna, Austria; [Gnant, Michael; Pfeiler, Georg; Dubsky, Peter C.; Jakesz, Raimund; Fitzal, Florian; Exner, Ruth; Singer, Christian F.] Med Univ Vienna, Ctr Comprehens Canc, A-1090 Vienna, Austria; [Pfeiler, Georg; Singer, Christian F.] Med Univ Vienna, Dept Gynecol & Obstet, A-1090 Vienna, Austria; [Steger, Guenther G.] Med Univ Vienna, Dept Internal Med 1, A-1090 Vienna, Austria; [Kainberger, Franz] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, A-1090 Vienna, Austria; [Hubalek, Michael; Marth, Christian; Egle, Daniel] Med Univ Innsbruck, Dept Gynecol, A-6020 Innsbruck, Austria; [Greil, Richard; Mlineritsch, Brigitte] Paracelsus Med Univ Salzburg, Dept Internal Med 3, Salzburg, Austria; [Greil, Richard] Salzburg Canc Res Inst, Salzburg, Austria; [Wette, Viktor] Breast Ctr, Doctors Off Wette, St Veit An Der Glan, Austria; [Balic, Marija] Med Univ Graz, Dept Oncol, Graz, Austria; [Bjelic-Radisic, Vesna] Med Univ Graz, Dept Gynecol, Graz, Austria; [Haslbauer, Ferdinand] Hosp Vocklabruck, Dept Internal Med, Vocklabruck, Austria; [Melbinger, Elisabeth] Hosp Wolfsberg, Dept Surg, Wolfsberg, Austria; [Artner-Matuschek, Silvia] Breast Ctr Hosp Hanusch Vienna, Dept Surg, Vienna, Austria; [Fitzal, Florian] Hosp Sisters Mercy Linz, Breast Hlth Ctr, Linz, Austria; [Sevelda, Paul] Hosp Hietzing, Dept Gynecol, Vienna, Austria; [Manfreda, Diether] Doctors Off, Manfreda, Klagenfurt, Austria; [Bergh, Jonas] Karolinska Inst, Karolinska Oncol, Dept Oncol Radiumhemmet, Stockholm, Sweden; [Bergh, Jonas] Univ Hosp, Stockholm, Sweden; [Talbot, Susan] Amgen Ltd, Uxbridge, Middx, England; [Warner, Douglas] Amgen Inc, Thousand Oaks, CA 91320 USA; [Fesl, Christian] Austrian Breast & Colorectal Canc Study Grp, Dept Stat, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Innsbruck; Paracelsus Private Medical University; Medical University of Graz; Medical University of Graz; WGKK - Hanusch Hospital; Hietzing Hospital; Karolinska Institutet; Amgen; Amgen Limited; Amgen	Gnant, M (corresponding author), Med Univ Vienna, Dept Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	michael.gnant@meduniwien.ac.at	Hedayati, Elham/AAK-6037-2021; Gnant, Michael/AAN-7054-2020; Schoppmann, Sebastian F. F./K-1530-2017; Schoppmann, Sebastian F./M-5831-2019; Hubalek, Michael/ABD-8041-2021; Greil, Richard F/C-7673-2017	Hedayati, Elham/0000-0003-1352-4332; Gnant, Michael/0000-0003-1002-2118; Schoppmann, Sebastian F. F./0000-0002-1725-7086; Schoppmann, Sebastian F./0000-0002-1725-7086; Greil, Richard F/0000-0002-4462-3694; Rapp, Erdmann/0000-0001-6618-2626; Piringer, Gudrun/0000-0002-2123-2148; Exner, Ruth/0000-0002-1168-1310; Bergh, Jonas/0000-0001-5526-1847; Foukakis, Theodoros/0000-0001-8952-9987; Hofstetter, Gerda/0000-0001-8912-3725; lippert, hans/0000-0002-5217-8324; Szkandera, Joanna/0000-0002-2217-893X	Sanofi-Aventis; Novartis; Roche; GlaxoSmithKline; Pfizer; Smith Medical; AstraZeneca; Nanostring Technologies; Accelsiors; Amgen; Celgene; BMS; Roche Austria; Boehringer Ingelheim; Eisai; Amomed; Janssen Cilag; Olympus Austria; TEVA; Pierre Fabre; Ratiopharm; Merck; Bayer; Abbvie	Sanofi-Aventis(Sanofi-Aventis); Novartis(Novartis); Roche(Roche Holding); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Smith Medical; AstraZeneca(AstraZeneca); Nanostring Technologies; Accelsiors; Amgen(Amgen); Celgene(Bristol-Myers SquibbCelgene Corporation); BMS(Bristol-Myers Squibb); Roche Austria(Roche Holding); Boehringer Ingelheim(Boehringer Ingelheim); Eisai(Eisai Co Ltd); Amomed; Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Olympus Austria; TEVA(Teva Pharmaceutical Industries); Pierre Fabre; Ratiopharm; Merck(Merck & Company); Bayer(Bayer AG); Abbvie(AbbVie)	MG has received grants from Sanofi-Aventis, Novartis, Roche, GlaxoSmithKline, Pfizer, and Smith Medical, and personal fees from Novartis, Roche, GlaxoSmithKline, AstraZeneca, Nanostring Technologies, and Accelsiors. GP has received personal fees from Roche, Novartis, and Amgen. PCD has received personal fees from Roche, AstraZeneca, and Pfizer, and travel or accommodation expenses reimbursement from Novartis. MH has received grants from Roche, Amgen, and Novartis; serving personal fees from Celgene and Roche; and travel or accommodation expenses reimbursement from Roche, Celgen, and Amgen. RG has received grants and personal fees from Roche and Celgene, personal fees from BMS, and grants from Amgen. CF is an employee of the ABCSG. MB has received grants from Amgen and Celgene; personal fees from Celgene, Novartis, Roche, and AstraZeneca; and travel or accommodation expenses reimbursement from Amgen, Celgene, and Roche. PS has received grants and personal fees from Amgen, Roche Austria, and AstraZeneca, and personal fees from Boehringer Ingelheim, Eisai, Amomed, Janssen Cilag, MSD, and Olympus Austria. GGS has received grants from Roche, personal fees from Amgen, Novartis, AstraZeneca, Celgene, Pfizer, TEVA, and Roche, and non-financial support from Novartis, AstraZeneca, Celgene, TEVA, and Roche. DE has received personal fees and non-financial support from Roche, Novartis, Pierre Fabre, and Ratiopharm. JB reports that Karolinska University Hospital and Karolinska Institutet have received payment for academic clinical studies and research grants for molecular biological studies or PET studies from the following companies: Amgen, AstraZeneca, Bayer, Merck, Pfizer, Roche, and Sanofi-Aventis. FK has received personal fees from Amgen and Abbvie. ST and DW are employees of Amgen. The other authors declare no competing interests.	Becker T, 2012, J AM GERIATR SOC, V60, P1761, DOI 10.1111/j.1532-5415.2012.04107.x; Blok EJ, 2015, CANCER TREAT REV, V41, P271, DOI 10.1016/j.ctrv.2015.02.004; Body Jean-Jacques, 2012, Bonekey Rep, V1, P201, DOI 10.1038/bonekey.2012.201; Body JJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-384; Bouvard B, 2012, ANN ONCOL, V23, P1151, DOI 10.1093/annonc/mdr356; Cheung AM, 2012, LANCET ONCOL, V13, P275, DOI 10.1016/S1470-2045(11)70389-8; Coates AS, 2015, ANN ONCOL, V26, P1533, DOI 10.1093/annonc/mdv221; Coleman R, 2015, LANCET IN PRESS; Coleman RE, 2011, NEW ENGL J MED, V365, P1396, DOI 10.1056/NEJMoa1105195; COX DR, 1972, J R STAT SOC B, V34, P187; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Delmas PD, 2008, J CLIN DENSITOM, V11, P325, DOI 10.1016/j.jocd.2008.02.002; Ellis GK, 2008, J CLIN ONCOL, V26, P4875, DOI 10.1200/JCO.2008.16.3832; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Gnant M, 2008, LANCET ONCOL, V9, P840, DOI 10.1016/S1470-2045(08)70204-3; Gnant M, 2014, CANCER TREAT REV, V40, P476, DOI 10.1016/j.ctrv.2013.07.003; Gnant M, 2012, CANCER TREAT REV, V38, P407, DOI 10.1016/j.ctrv.2011.09.003; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Hadji P, 2011, ANN ONCOL, V22, P2546, DOI 10.1093/annonc/mdr017; Hadji P, 2012, CANCER TREAT REV, V38, P815, DOI 10.1016/j.ctrv.2012.03.002; Harbeck N, 2013, BREAST CARE, V8, P110, DOI 10.1159/000350777; Irwin AN, 2015, PHARMACOTHERAPY, V35, P243, DOI 10.1002/phar.1554; Ito K, 2012, J CLIN ONCOL, V30, P1468, DOI 10.1200/JCO.2011.38.7001; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Orwoll E, 2012, J CLIN ENDOCR METAB, V97, P3161, DOI 10.1210/jc.2012-1569; Qi WX, 2014, INT J CLIN ONCOL, V19, P403, DOI 10.1007/s10147-013-0561-6; Rizzoli R, 2013, OSTEOPOROSIS INT, V24, P2929, DOI 10.1007/s00198-013-2530-3; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003; Soiland H, 2013, ACTA ONCOL, V52, P861, DOI 10.3109/0284186X.2012.742963; Westfall PH, 1999, MULTIPLE COMP MULTIP; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6	32	321	329	0	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					433	443		10.1016/S0140-6736(15)60995-3	http://dx.doi.org/10.1016/S0140-6736(15)60995-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26040499				2022-12-28	WOS:000358761700023
J	Chapman, KR; Burdon, JGW; Piitulainen, E; Sandhaus, RA; Seersholm, N; Stocks, JM; Stoel, BC; Huang, LP; Yao, ZL; Edelman, JM; McElvaney, NG				Chapman, Kenneth R.; Burdon, Jonathan G. W.; Piitulainen, Eeva; Sandhaus, Robert A.; Seersholm, Niels; Stocks, James M.; Stoel, Berend C.; Huang, Liping; Yao, Zhenling; Edelman, Jonathan M.; McElvaney, Noel G.		RAPID Trial Study Grp	Intravenous augmentation treatment and lung density in severe alpha 1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COMPUTED-TOMOGRAPHY DENSITOMETRY; ALPHA(1)-ANTITRYPSIN DEFICIENCY; CT DENSITOMETRY; CLINICAL-TRIAL; FOLLOW-UP; THERAPY; EMPHYSEMA; INHIBITOR; SURVIVAL	Background The efficacy of alpha 1 proteinase inhibitor (A1PI) augmentation treatment for a1 antitrypsin deficiency has not been substantiated by a randomised, placebo-controlled trial. CT-measured lung density is a more sensitive measure of disease progression in alpha 1 antitrypsin deficiency emphysema than spirometry is, so we aimed to assess the efficacy of augmentation treatment with this measure. Methods The RAPID study was a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial of A1PI treatment in patients with alpha 1 antitrypsin deficiency. We recruited eligible non-smokers (aged 18-65 years) in 28 international study centres in 13 countries if they had severe a1 antitrypsin deficiency (serum concentration <11 mu M) with a forced expiratory volume in 1 s of 35-70% (predicted). We excluded patients if they had undergone, or were on the waiting list to undergo, lung transplantation, lobectomy, or lung volume-reduction surgery, or had selective IgA deficiency. We randomly assigned patients (1: 1; done by Accovion) using a computerised pseudorandom number generator (block size of four) with centre stratification to receive A1PI intravenously 60 mg/kg per week or placebo for 24 months. All patients and study investigators (including those assessing outcomes) were unaware of treatment allocation throughout the study. Primary endpoints were CT lung density at total lung capacity (TLC) and functional residual capacity (FRC) combined, and the two separately, at 0, 3, 12, 21, and 24 months, analysed by modified intention to treat (patients needed at least one evaluable lung density measurement). This study is registered with ClinicalTrials.gov, number NCT00261833. A 2-year open-label extension study was also completed (NCT00670007). Findings Between March 1, 2006, and Nov 3, 2010, we randomly allocated 93 (52%) patients A1PI and 87 (48%) placebo, analysing 92 in the A1PI group and 85 in the placebo group. The annual rate of lung density loss at TLC and FRC combined did not differ between groups (A1PI -1.50 g/L per year [SE 0.22]; placebo -2.12 g/L per year [0.24]; difference 0.62 g/L per year [95% CI -0.02 to 1.26], p=0.06). However, the annual rate of lung density loss at TLC alone was significantly less in patients in the A1PI group (-1.45 g/L per year [SE 0.23]) than in the placebo group (-2.19 g/L per year [0.25]; difference 0.74 g/L per year [95% CI 0.06-1.42], p=0.03), but was not at FRC alone (A1PI -1.54 g/L per year [0.24]; placebo -2.02 g/L per year [0.26]; difference 0.48 g/L per year [-0.22 to 1.18], p=0.18). Treatment-emergent adverse events were similar between groups, with 1298 occurring in 92 (99%) patients in the A1PI group and 1068 occuring in 86 (99%) in the placebo group. 71 severe treatment-emergent adverse events occurred in 25 (27%) patients in the A1PI group and 58 occurred in 27 (31%) in the placebo group. One treatment-emergent adverse event leading to withdrawal from the study occurred in one patient (1%) in the A1PI group and ten occurred in four (5%) in the placebo group. One death occurred in the A1PI group (respiratory failure) and three occurred in the placebo group (sepsis, pneumonia, and metastatic breast cancer). Interpretation Measurement of lung density with CT at TLC alone provides evidence that purified A1PI augmentation slows progression of emphysema, a finding that could not be substantiated by lung density measurement at FRC alone or by the two measurements combined. These findings should prompt consideration of augmentation treatment to preserve lung parenchyma in individuals with emphysema secondary to severe a1 antitrypsin deficiency.	[Chapman, Kenneth R.] Toronto Western Hosp, Univ Hlth Network, Asthma & Airway Ctr, Toronto, ON M5T 2S8, Canada; [Chapman, Kenneth R.] Univ Toronto, Dept Med, Div Resp Med, Toronto, ON, Canada; [Burdon, Jonathan G. W.] St Vincents Hosp, Melbourne, Vic, Australia; [Piitulainen, Eeva] Lund Univ, Skane Univ Hosp, Malmo, Sweden; [Sandhaus, Robert A.] Natl Jewish Hlth, Denver, CO USA; [Seersholm, Niels] Gentofte Univ Hosp, Hellerup, Denmark; [Stocks, James M.] Univ Texas Hlth Ctr Tyler, Tyler, TX USA; [Stoel, Berend C.] Leiden Univ, Med Ctr, Div Image Proc, Radiol, Leiden, Netherlands; [Huang, Liping; Yao, Zhenling; Edelman, Jonathan M.] CSL Behring, King Of Prussia, PA USA; [McElvaney, Noel G.] Beaumont Hosp, Royal Coll Surg Ireland, Dublin 9, Ireland	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; St Vincent's Hospital Melbourne; Lund University; Skane University Hospital; National Jewish Health; University of Copenhagen; Herlev & Gentofte Hospital; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; CSL; Royal College of Surgeons - Ireland	Chapman, KR (corresponding author), Toronto Western Hosp, Univ Hlth Network, Asthma & Airway Ctr, Toronto, ON M5T 2S8, Canada.	kchapman@ca.inter.net	Yao, Zhenling/AAJ-5968-2020; Ficker, Joachim H./A-1153-2015; McElvaney, Noel/A-6809-2010	Ficker, Joachim H./0000-0002-7175-5852; mcelvaney, Noel/0000-0002-0152-4370	Amgen; AstraZeneca; Baxter; Boehringer Ingelheim; CSL Behring; Forest Labs; GlaxoSmithKline; Grifols; Novartis; Roche; Takeda; Merck Frosst; Pfizer; Canadian Institutes of Health Research	Amgen(Amgen); AstraZeneca(AstraZeneca); Baxter; Boehringer Ingelheim(Boehringer Ingelheim); CSL Behring; Forest Labs; GlaxoSmithKline(GlaxoSmithKline); Grifols; Novartis(Novartis); Roche(Roche Holding); Takeda(Takeda Pharmaceutical Company Ltd); Merck Frosst; Pfizer(Pfizer); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	KRC has received compensation for consulting with AstraZeneca, Baxter, Boehringer Ingelheim, CSL Behring, GlaxoSmithKline, Grifols, Kamada, Novartis, Nycomed, Roche, and Telacris; has done research funded by Amgen, AstraZeneca, Baxter, Boehringer Ingelheim, CSL Behring, Forest Labs, GlaxoSmithKline, Grifols, Novartis, Roche, and Takeda; and has participated in continuing medical education activities sponsored in whole or part by AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Grifols, Merck Frosst, Novartis, Pfizer, and Takeda. He is participating in research funded by the Canadian Institutes of Health Research operating grant entitled Canadian Cohort Obstructive Lung Disease. He holds the GlaxoSmithKline-Canadian Institutes of Health Research Chair in Respiratory Health Care Delivery at the University Health Network, ON, Canada. JGWB has received research funding from CSL Behring and consulted with Baxter. EP has received research funding for this study from CSL Behring. RAS reports grants and personal fees from CSL Behring during this study, other grants and personal fees from CSL Behring and Grifols, personal fees from Baxter, and non-financial support from the Alpha-1 Project (venture philanthropy) outside of the submitted work, and is employed by AlphaNet, a not-for-profit organisation providing disease management services for patients with alpha 1 antitrypsin deficiency. All other authors declare no competing interests.	ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; BURROWS B, 1983, AM REV RESPIR DIS, V127, pS42; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Campos MA, 2013, COPD, V10, P687, DOI 10.3109/15412555.2013.800852; Chapman KR, 2009, COPD, V6, P177, DOI 10.1080/15412550902905961; Dahl Morten, 2009, Clin Respir J, V3, P121, DOI 10.1111/j.1752-699X.2008.00110.x; Dawkins PA, 2003, THORAX, V58, P1020, DOI 10.1136/thorax.58.12.1020; de-Torres JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060260; Dirksen A, 2009, EUR RESPIR J, V33, P1345, DOI 10.1183/09031936.00159408; Dirksen A, 1999, AM J RESP CRIT CARE, V160, P1468, DOI 10.1164/ajrccm.160.5.9901055; GADEK JE, 1981, J CLIN INVEST, V68, P889, DOI 10.1172/JCI110344; IDELL S, 1983, CLIN CHEST MED, V4, P359; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; Molloy K, 2014, AM J RESP CRIT CARE, V189, P419, DOI 10.1164/rccm.201311-1984OC; Parr DG, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-75; Seersholm N, 1998, RESP MED, V92, P241, DOI 10.1016/S0954-6111(98)90102-0; Seersholm N, 1997, EUR RESPIR J, V10, P2260, DOI 10.1183/09031936.97.10102260; Sorheim IC, 2010, CHEST, V138, P1125, DOI 10.1378/chest.10-0746; Stockley RA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-136; Stoel Berend C, 2008, Proc Am Thorac Soc, V5, P919, DOI 10.1513/pats.200804-040QC; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Vreim CE, 1998, AM J RESP CRIT CARE, V158, P49; Wencker M, 2001, CHEST, V119, P737, DOI 10.1378/chest.119.3.737; WEWERS MD, 1987, NEW ENGL J MED, V316, P1055, DOI 10.1056/NEJM198704233161704	24	310	312	2	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2015	386	9991					360	368		10.1016/S0140-6736(15)60860-1	http://dx.doi.org/10.1016/S0140-6736(15)60860-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN5CX	26026936				2022-12-28	WOS:000358448400025
J	Naci, H; Ioannidis, JPA				Naci, Huseyin; Ioannidis, John P. A.			Evaluation of Wellness Determinants and Interventions by Citizen Scientists	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRIALS; HEALTH		[Naci, Huseyin] Univ London London Sch Econ & Polit Sci, Dept Social Policy, LSE Hlth, London WC2A 2AE, England; [Ioannidis, John P. A.] Stanford Prevent Res Ctr, Dept Med, Stanford, CA USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA	University of London; London School Economics & Political Science; Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Dept Med, Stanford Prevent Res Ctr, 1265 Welch Rd,Med Sch Off Bldg X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011					Antman EM, 2012, JAMA-J AM MED ASSOC, V308, P1743, DOI 10.1001/jama.2012.14841; Caulfield T., 2015, IS GWYNETH PALTROW W; Dal-Re R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1323; Eapen ZJ, 2014, JAMA-J AM MED ASSOC, V311, P1397, DOI 10.1001/jama.2014.1030; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P75, DOI 10.1097/EDE.0b013e31815be01c; Korownyk C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7346; Lauer MS, 2013, NEW ENGL J MED, V369, P1579, DOI 10.1056/NEJMp1310102; Naci H, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5577	8	42	45	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2015	314	2					121	122		10.1001/jama.2015.6160	http://dx.doi.org/10.1001/jama.2015.6160			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM7JI	26068643				2022-12-28	WOS:000357867500007
J	Mantel, CR; O'Leary, HA; Chitteti, BR; Huang, XX; Cooper, S; Hangoc, G; Brustovetsky, N; Srour, EF; Lee, MR; Messina-Graham, S; Haas, DM; Falah, N; Kapur, R; Pelus, LM; Bardeesy, N; Fitamant, J; Ivan, M; Kim, KS; Broxmeyer, HE				Mantel, Charlie R.; O'Leary, Heather A.; Chitteti, Brahmananda R.; Huang, XinXin; Cooper, Scott; Hangoc, Giao; Brustovetsky, Nickolay; Srour, Edward F.; Lee, Man Ryul; Messina-Graham, Steven; Haas, David M.; Falah, Nadia; Kapur, Reuben; Pelus, Louis M.; Bardeesy, Nabeel; Fitamant, Julien; Ivan, Mircea; Kim, Kye-Seong; Broxmeyer, Hal E.			Enhancing Hematopoietic Stem Cell Transplantation Efficacy by Mitigating Oxygen Shock	CELL			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; CYCLOSPORINE-A; OXIDATIVE STRESS; PROGENITOR CELLS; INNER-MEMBRANE; UMBILICAL-CORD; CYCLOPHILIN-D; BONE-MARROW; ISCHEMIA/REPERFUSION INJURY; SELF-RENEWAL	Hematopoietic stem cells (HSCs) reside in hypoxic niches within bone marrow and cord blood. Yet, essentially all HSC studies have been performed with cells isolated and processed in non-physiologic ambient air. By collecting and manipulating bone marrow and cord blood in native conditions of hypoxia, we demonstrate that brief exposure to ambient oxygen decreases recovery of long-term repopulating HSCs and increases progenitor cells, a phenomenon we term extraphysiologic oxygen shock/stress (EPHOSS). Thus, true numbers of HSCs in the bone marrow and cord blood are routinely underestimated. We linked ROS production and induction of the mitochondrial permeability transition pore (MPTP) via cyclophilin D and p53 as mechanisms of EPHOSS. The MPTP inhibitor cyclosporin A protects mouse bone marrow and human cord blood HSCs from EPHOSS during collection in air, resulting in increased recovery of transplantable HSCs. Mitigating EPHOSS during cell collection and processing by pharmacological means may be clinically advantageous for transplantation.	[Mantel, Charlie R.; O'Leary, Heather A.; Huang, XinXin; Cooper, Scott; Hangoc, Giao; Srour, Edward F.; Lee, Man Ryul; Messina-Graham, Steven; Kapur, Reuben; Pelus, Louis M.; Ivan, Mircea; Broxmeyer, Hal E.] Indiana Univ Sch Med, Dept Microbiol Immunol, Indianapolis, IN 46202 USA; [Chitteti, Brahmananda R.; Srour, Edward F.; Ivan, Mircea] Indiana Univ Sch Med, Dept Med Hematol Oncol, Indianapolis, IN 46202 USA; [Brustovetsky, Nickolay] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Srour, Edward F.; Kapur, Reuben] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Haas, David M.; Falah, Nadia] Indiana Univ Sch Med, Dept Obstet & Gynecol, Div Clin Pharmacol, Indianapolis, IN 46202 USA; [Kapur, Reuben] Indiana Univ Sch Med, Dept Biochem Mol Biol, Indianapolis, IN 46202 USA; [Lee, Man Ryul] Soonchunhyang Inst Medi Bio Sci, Chungcheongnam Do 336745, South Korea; [Bardeesy, Nabeel; Fitamant, Julien] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Kim, Kye-Seong] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Soonchunhyang University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Hanyang University	Broxmeyer, HE (corresponding author), Indiana Univ Sch Med, Dept Microbiol Immunol, Indianapolis, IN 46202 USA.	hbroxmey@iupui.edu	Ivan, Mircea/A-8109-2012	Ivan, Mircea/0000-0003-3424-6642; Huang, Xinxin/0000-0002-4298-4859; O'Leary, Heather/0000-0003-1321-1520	US Public Health Service Grants from the NIH [R01 HL67384, R01 HL056416, R01 HL112669, P30 DK090948]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2012M3A9B4028738]; Korea Health technology RD Project; Ministry of Health Welfare [A120262]; Republic of Korea; NIH [T32, DK07519, R01 NS078008]; NATIONAL CANCER INSTITUTE [R01CA134777, R01CA173852, P30CA082709] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR002529] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077177, R01HL056416, R01HL067384, R01HL112669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090948, U54DK106846, T32DK007519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078008] Funding Source: NIH RePORTER	US Public Health Service Grants from the NIH; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Korea Health technology RD Project; Ministry of Health Welfare; Republic of Korea; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research was supported by US Public Health Service Grants from the NIH (R01 HL67384, R01 HL056416, R01 HL112669, and P30 DK090948 to H.E.B.), the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2012M3A9B4028738), and a grant of the Korea Health technology R&D Project, Ministry of Health & Welfare (A120262), Republic of Korea (to K.-S.K.). H.A.O. and S.M-G. were supported by NIH T32 training grant DK07519 (to H.E.B.). N. Brustovetsky was supported by NIH grant R01 NS078008. We thank P.L. Mantel for editorial assistance. We would like to dedicate this paper to Dr. Donald Metcalf, a pioneer in the field of hematopoiesis, who recently passed away.	Anjos-Afonso F, 2013, CELL STEM CELL, V13, P161, DOI 10.1016/j.stem.2013.05.025; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Ballen KK, 2013, BLOOD, V122, P491, DOI 10.1182/blood-2013-02-453175; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; BRADLEY TR, 1978, J CELL PHYSIOL, V97, P517, DOI 10.1002/jcp.1040970327; Brown JM, 1998, CANCER RES, V58, P1408; Broxmeyer HE, 2006, METHOD ENZYMOL, V419, P439, DOI 10.1016/S0076-6879(06)19018-7; Broxmeyer HE, 2012, NAT MED, V18, P1786, DOI 10.1038/nm.2991; BROXMEYER HE, 1985, J IMMUNOL, V135, P2502; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chan SY, 2010, CELL CYCLE, V9, P1072, DOI 10.4161/cc.9.6.11006; CONNERN CP, 1994, BIOCHEM J, V302, P321, DOI 10.1042/bj3020321; Copley MR, 2012, CELL STEM CELL, V10, P690, DOI 10.1016/j.stem.2012.05.006; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Devlin C, 2011, IUBMB LIFE, V63, P94, DOI [10.1002/iub.00427, 10.1002/iub.427]; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Ergen AV, 2010, EXP GERONTOL, V45, P286, DOI 10.1016/j.exger.2009.12.010; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Halestrap AP, 2003, CURR MED CHEM, V10, P1507, DOI 10.2174/0929867033457278; Harper ME, 2004, ACTA PHYSIOL SCAND, V182, P321, DOI 10.1111/j.1365-201X.2004.01370.x; Harrison DE, 1997, BLOOD, V90, P174; Hausenloy DJ, 2012, BRIT J PHARMACOL, V165, P1235, DOI 10.1111/j.1476-5381.2011.01700.x; Hill RP, 2009, SEMIN RADIAT ONCOL, V19, P106, DOI 10.1016/j.semradonc.2008.12.002; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Junghanss C, 2012, BIOL BLOOD MARROW TR, V18, P1061, DOI 10.1016/j.bbmt.2011.12.522; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kamleh MA, 2011, CURR PHARM BIOTECHNO, V12, P976; Kikuchi T, 2012, CLIN TRANSPLANT, V26, pE544, DOI 10.1111/ctr.12016; Kim JS, 2003, CURR MOL MED, V3, P527, DOI 10.2174/1566524033479564; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lewandowski D, 2010, BLOOD, V115, P443, DOI 10.1182/blood-2009-05-222711; Lim SY, 2011, J CELL MOL MED, V15, P2443, DOI 10.1111/j.1582-4934.2010.01235.x; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LU L, 1985, EXP HEMATOL, V13, P989; Mantel C, 2008, CURR OPIN HEMATOL, V15, P326, DOI 10.1097/MOH.0b013e3283043819; Mantel C, 2007, BLOOD, V109, P4518, DOI 10.1182/blood-2006-10-054247; Mantel C, 2012, BLOOD, V120, P2589, DOI 10.1182/blood-2012-01-404004; Mantel C, 2011, CURR OPIN HEMATOL, V18, P208, DOI 10.1097/MOH.0b013e3283475ffe; Mantel C, 2010, CELL CYCLE, V9, P2008, DOI 10.4161/cc.9.10.11733; MCGUINNESS O, 1990, EUR J BIOCHEM, V194, P671, DOI 10.1111/j.1432-1033.1990.tb15667.x; Millman JR, 2009, CURR OPIN ORGAN TRAN, V14, P694, DOI 10.1097/MOT.0b013e3283329d53; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Nii T, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/903435; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Perrelli MG, 2011, WORLD J CARDIOL, V3, P186, DOI 10.4330/wjc.v3.i6.186; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Sattler M, 1999, BLOOD, V93, P2928; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; SJOSTEDT S, 1960, ARCH DIS CHILD, V35, P529, DOI 10.1136/adc.35.184.529; SMITH S, 1986, BRIT J HAEMATOL, V63, P29, DOI 10.1111/j.1365-2141.1986.tb07491.x; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Speth JM, 2014, BLOOD, V123, P203, DOI 10.1182/blood-2013-07-516336; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Tothova Z, 2009, CELL STEM CELL, V4, P196, DOI 10.1016/j.stem.2009.02.008; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Vemula S, 2012, BLOOD, V120, P2868, DOI 10.1182/blood-2011-10-384172; Wood SL, 2014, CANCER TREAT REV, V40, P139, DOI 10.1016/j.ctrv.2013.07.006; Xu XL, 2013, CELL METAB, V18, P325, DOI 10.1016/j.cmet.2013.06.005; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Zhang HJ, 2012, BLOOD, V119, P2595, DOI 10.1182/blood-2011-10-387381; Zhen YF, 2014, J CELL PHYSIOL, V229, P1475, DOI 10.1002/jcp.24589	75	197	203	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1553	1565		10.1016/j.cell.2015.04.054	http://dx.doi.org/10.1016/j.cell.2015.04.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26073944	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000356618200013
J	Hiruma, Y; Sacristan, C; Pachis, ST; Adamopoulos, A; Kuijt, T; Ubbink, M; von Castelmur, E; Perrakis, A; Kops, GJPL				Hiruma, Yoshitaka; Sacristan, Carlos; Pachis, Spyridon T.; Adamopoulos, Athanassios; Kuijt, Timo; Ubbink, Marcellus; von Castelmur, Eleonore; Perrakis, Anastassis; Kops, Geert J. P. L.			Competition between MPS1 and microtubules at kinetochores regulates spindle checkpoint signaling	SCIENCE			English	Article							ASSEMBLY CHECKPOINT; AURORA B; PHOSPHORYLATION; COMPLEX; KINASE; DYNEIN; RECRUITMENT; MITOSIS; ONSET; MAD1	Cell division progresses to anaphase only after all chromosomes are connected to spindle microtubules through kinetochores and the spindle assembly checkpoint (SAC) is satisfied. We show that the amino-terminal localization module of the SAC protein kinase MPS1 (monopolar spindle 1) directly interacts with the HEC1 (highly expressed in cancer 1) calponin homology domain in the NDC80 (nuclear division cycle 80) kinetochore complex in vitro, in a phosphorylation-dependent manner. Microtubule polymers disrupted this interaction. In cells, MPS1 binding to kinetochores or to ectopic NDC80 complexes was prevented by end-on microtubule attachment, independent of known kinetochore protein-removal mechanisms. Competition for kinetochore binding between SAC proteins and microtubules provides a direct and perhaps evolutionarily conserved way to detect a properly organized spindle ready for cell division.	[Hiruma, Yoshitaka; Adamopoulos, Athanassios; von Castelmur, Eleonore; Perrakis, Anastassis] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands; [Hiruma, Yoshitaka; Sacristan, Carlos; Pachis, Spyridon T.; Kuijt, Timo; Kops, Geert J. P. L.] Univ Med Ctr Utrecht, Mol Canc Res, NL-3584 CG Utrecht, Netherlands; [Hiruma, Yoshitaka; Sacristan, Carlos; Pachis, Spyridon T.; Kuijt, Timo; Kops, Geert J. P. L.] Univ Med Ctr Utrecht, Canc Genom Netherlands, NL-3584 CG Utrecht, Netherlands; [Ubbink, Marcellus] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands	Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University - Excl LUMC	Perrakis, A (corresponding author), Netherlands Canc Inst, Div Biochem, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.perrakis@nki.nl; g.j.p.l.kops@umcutrecht.nl	Ubbink, Marcellus/E-2158-2011; Sacristan, Carlos/GPK-5441-2022; Perrakis, Anastassis/E-8704-2013	Ubbink, Marcellus/0000-0002-2615-6914; Perrakis, Anastassis/0000-0002-1151-6227; Pachis, Spyridon Thomas/0000-0002-1413-6326; Sacristan, Carlos/0000-0003-1312-2341; Kops, Geert/0000-0003-3555-5295; von Castelmur, Eleonore/0000-0001-7061-4890; Adamopoulos, Athanassios/0000-0002-3544-4619	ERC-StG KINSIGN; NWO-Vici [865.12.004, 700.58.441]; KWF [2012-5427]; SNF [PBBSP3-133408]	ERC-StG KINSIGN; NWO-Vici(Netherlands Organization for Scientific Research (NWO)); KWF; SNF	We thank I. Cheeseman, R. Gassmann, S. Lens, R. Medema, and A. Musacchio for reagents; the Kops, Perrakis, Lens, and Biggins labs for discussions; S. Biggins for support; and H. Yu for sharing unpublished data. The work was supported by grants ERC-StG KINSIGN, NWO-Vici 865.12.004, KWF 2012-5427, SNF PBBSP3-133408, and NWO-Vici 700.58.441.	Alushin GM, 2010, NATURE, V467, P805, DOI 10.1038/nature09423; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Espert A, 2014, J CELL BIOL, V206, P833, DOI 10.1083/jcb.201406109; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Gassmann R, 2010, GENE DEV, V24, P957, DOI 10.1101/gad.1886810; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Ito D, 2012, P NATL ACAD SCI USA, V109, P209, DOI 10.1073/pnas.1114647109; Jelluma N, 2010, J CELL BIOL, V191, P281, DOI 10.1083/jcb.201003038; Kemmler S, 2009, EMBO J, V28, P1099, DOI 10.1038/emboj.2009.62; Lan WJ, 2010, J CELL BIOL, V190, P21, DOI 10.1083/jcb.201006080; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; Maldonado M, 2011, NAT CELL BIOL, V13, P475, DOI 10.1038/ncb2223; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Nijenhuis W, 2014, NAT CELL BIOL, V16, P1257, DOI 10.1038/ncb3065; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; Raaijmakers JA, 2014, CHROMOSOMA, V123, P407, DOI 10.1007/s00412-014-0468-7; Raaijmakers JA, 2013, J CELL BIOL, V201, P201, DOI 10.1083/jcb.201208098; Rosenberg JS, 2011, CURR BIOL, V21, P942, DOI 10.1016/j.cub.2011.04.011; Sacristan C, 2015, TRENDS CELL BIOL, V25, P21, DOI 10.1016/j.tcb.2014.08.006; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Saurin AT, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1319; Schmidt JC, 2012, DEV CELL, V23, P968, DOI 10.1016/j.devcel.2012.09.012; Vleugel M, 2012, DEV CELL, V23, P239, DOI 10.1016/j.devcel.2012.06.013; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Zhu TG, 2013, J BIOL CHEM, V288, P36149, DOI 10.1074/jbc.M113.507970	26	141	142	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1264	1267		10.1126/science.aaa4055	http://dx.doi.org/10.1126/science.aaa4055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068855	Green Published			2022-12-28	WOS:000356011500057
J	Abramowicz, M; Zuccotti, G; Pflomm, JM				Abramowicz, Mark; Zuccotti, Gianna; Pflomm, Jean-Marie			An Inhaled Insulin (Afrezza)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint													Pflomm, Jean-Marie/HDO-0765-2022					[Anonymous], 2014, TREAT GUIDEL MED LET, V12, P17; Mastrandrea LD, 2010, VASC HEALTH RISK MAN, V6, P47; Rosenstock J, 2010, LANCET, V375, P2244, DOI 10.1016/S0140-6736(10)60632-0	3	3	3	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2176	2177		10.1001/jama.2015.5634	http://dx.doi.org/10.1001/jama.2015.5634			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ4CC	26034959				2022-12-28	WOS:000355430900019
J	Duseja, R; Bardach, NS; Lin, GA; Yazdany, J; Dean, ML; Clay, TH; Boscardin, WJ; Dudley, RA				Duseja, Reena; Bardach, Naomi S.; Lin, Grace A.; Yazdany, Jinoos; Dean, Mitzi L.; Clay, Theodore H.; Boscardin, W. John; Dudley, R. Adams			Revisit Rates and Associated Costs After an Emergency Department Encounter A Multistate Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							RETURN VISITS; HOSPITALIZATION	Background: Return visits to the emergency department (ED) or hospital after an index ED visit strain the health system, but information about rates and determinants of revisits is limited. Objective: To describe revisit rates, variation in revisit rates by diagnosis and state, and associated costs. Design: Observational study using the Healthcare Cost and Utilization Project databases. Setting: 6 U.S. states. Patients: Adults with ED visits between 2006 and 2010. Measurements: Revisit rates and costs. Results: Within 3 days of an index ED visit, 8.2% of patients had a revisit; 32% of those revisits occurred at a different institution. Revisit rates varied by diagnosis, with skin infections having the highest rate. (23.1% [95% Cl, 22.3% to 23.9%]). Revisit rates also varied by state. For skin infections, Florida had higher risk-adjusted revisit rates (24.8% [Cl, 23.5% to 26.2%]) than Nebraska (10.6% [Cl, 9.2% to 12.1%]). In Florida, the only state with complete cost data, total revisit costs for the 19.8% of patients with a revisit within 30 days were 118% of total index ED visit costs for all patients (including those with and without a revisit). Limitation: Whether a revisit reflects inadequate access to primary care, a planned revisit, the patient's nonadherence to ED recommendations, or poor-quality care at the initial ED visit remains unknown. Conclusion: Revisits after an index ED encounter are more frequent than previously reported, in part because many occur outside the index institution. Among ED patients in Florida, more resources are spent on revisits than on index ED visits.	Univ Calif San Francisco, San Francisco, CA 94118 USA; Philip R Lee Inst Hlth Policy Studies, San Francisco, CA USA	University of California System; University of California San Francisco	Duseja, R (corresponding author), Univ Calif San Francisco, Dept Emergency Med, 3333 Calif St,Suite 265, San Francisco, CA 94118 USA.	reena.duseja@emergency.ucsf.edu			Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS020667] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	[Anonymous], 2010 CENS DAT; Berwick DM, 2011, NEW ENGL J MED, V364, DOI 10.1056/NEJMp1103602; Cook LJ, 2004, ACAD EMERG MED, V11, P256, DOI 10.1197/j.aem.2003.10.023; Demnati A., 2004, SURV METHODOL, V30, P17; Deville JC, 1999, SURV METHODOL, V28, P193; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Friedmann PD, 2001, AM J EMERG MED, V19, P125, DOI 10.1053/ajem.2001.21321; Fuda KK, 2006, ANN EMERG MED, V48, P9, DOI 10.1016/j.annemergmed.2006.03.001; Gordon JA, 1998, ANN EMERG MED, V32, P569, DOI 10.1016/S0196-0644(98)70034-4; Hackbarth GM, 2007, PAYM POL INP READM M; Hackbarth GM, 2008, REPORT C REFORMING D; Healthcare Cost and Utilization Project, 2013, CLIN CLASS SOFTW CCS; Healthcare Cost and Utilization Project, 2013, OV STAT EM DEP DAT S; Healthcare Cost and Utilization Project, 2013, HCUP SUPPL VAR REV A; KEITH KD, 1989, ANN EMERG MED, V18, P964, DOI 10.1016/S0196-0644(89)80461-5; Lin CY, 2011, J AM GERIATR SOC, V59, P1947, DOI 10.1111/j.1532-5415.2011.03572.x; Misky GJ, 2010, J HOSP MED, V5, P392, DOI 10.1002/jhm.666; New England Healthcare Institute, MATT URG RED EM DEP; Pham JC, 2011, ACAD EMERG MED, V18, P390, DOI 10.1111/j.1553-2712.2011.01042.x; PIERCE JM, 1990, ANN EMERG MED, V19, P752, DOI 10.1016/S0196-0644(05)81698-1; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Washington State Health Care Authority, IMPL EM ROOM BEST PR; Wennberg John E, 2002, Health Aff (Millwood), VSuppl Web Exclusives, pW96; Zimmerman DR, 1996, ANN EMERG MED, V28, P467, DOI 10.1016/S0196-0644(96)70107-5	24	83	83	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2015	162	11					750	756		10.7326/M14-1616	http://dx.doi.org/10.7326/M14-1616			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ5ZH	26030633				2022-12-28	WOS:000355572300002
J	Bork, P; Bowler, C; de Vargas, C; Gorsky, G; Karsenti, E; Wincker, P				Bork, P.; Bowler, C.; de Vargas, C.; Gorsky, G.; Karsenti, E.; Wincker, P.			Tara Oceans studies plankton at PLANETARY SCALE	SCIENCE			English	Editorial Material									[Bork, P.] European Mol Biol Lab, Struct & Computat Biol, D-69117 Heidelberg, Germany; [Bowler, C.] Ecole Normale Super, IBENS, F-75005 Paris, France; [Bowler, C.] Inserm U1024, F-75005 Paris, France; [Bowler, C.] CNRS UMR 8197, F-75005 Paris, France; [de Vargas, C.] CNRS, UMR 7144, Stn Biol Roscoff, F-29680 Roscoff, France; [Gorsky, G.] CNRS, UMR 7093, Lab Oceanog Villefranche Sur Mer LOV, Observ Oceanol, F-06230 Villefranche Sur Mer, France; [Karsenti, E.] EMBL, Directors Res, D-69117 Heidelberg, Germany; [Wincker, P.] Commissariat Energie Atom & Energies Alternat CEA, Inst Genom, GENOSCOPE, F-91000 Evry, France	European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; European Molecular Biology Laboratory (EMBL); CEA	Bork, P (corresponding author), European Mol Biol Lab, Struct & Computat Biol, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Bowler, Chris/AAC-6256-2019; Bork, Peer/F-1813-2013	Bork, Peer/0000-0002-2627-833X; Bowler, Chris/0000-0003-3835-6187; de Vargas, Colomban/0000-0002-6476-6019; Gorsky, Gabriel/0000-0002-1099-8711				Karsenti E., 2015, MOL SYST BIOL, V15, P6271; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Sunagawa S., 2015, MOL SYST BIOL, V15, P6272	3	128	131	6	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					873	873		10.1126/science.aac5605	http://dx.doi.org/10.1126/science.aac5605			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999501				2022-12-28	WOS:000354877900030
J	Keane, SC; Heng, X; Lu, K; Kharytonchyk, S; Ramakrishnan, V; Carter, G; Barton, S; Hosic, A; Florwick, A; Santos, J; Bolden, NC; McCowin, S; Case, DA; Johnson, BA; Salemi, M; Telesnitsky, A; Summers, MF				Keane, Sarah C.; Heng, Xiao; Lu, Kun; Kharytonchyk, Siarhei; Ramakrishnan, Venkateswaran; Carter, Gregory; Barton, Shawn; Hosic, Azra; Florwick, Alyssa; Santos, Justin; Bolden, Nicholas C.; McCowin, Sayo; Case, David A.; Johnson, Bruce A.; Salemi, Marco; Telesnitsky, Alice; Summers, Michael F.			Structure of the HIV-1 RNA packaging signal	SCIENCE			English	Article							NUCLEOCAPSID PROTEIN; DIMERIZATION; BINDING; PSI; EFFICIENCY; REVEALS; GENOMES; REGION	The 5' leader of the HIV-1 genome contains conserved elements that direct selective packaging of the unspliced, dimeric viral RNA into assembling particles. By using a H-2-edited nuclear magnetic resonance (NMR) approach, we determined the structure of a 155-nucleotide region of the leader that is independently capable of directing packaging (core encapsidation signal; Psi(CES)). The RNA adopts an unexpected tandem three-way junction structure, in which residues of the major splice donor and translation initiation sites are sequestered by long-range base pairing and guanosines essential for both packaging and high-affinity binding to the cognate Gag protein are exposed in helical junctions. The structure reveals how translation is attenuated, Gag binding promoted, and unspliced dimeric genomes selected, by the RNA conformer that directs packaging.	[Keane, Sarah C.; Heng, Xiao; Lu, Kun; Ramakrishnan, Venkateswaran; Carter, Gregory; Barton, Shawn; Hosic, Azra; Florwick, Alyssa; Santos, Justin; Bolden, Nicholas C.; McCowin, Sayo; Summers, Michael F.] Univ Maryland Baltimore Cty, HHMI, Baltimore, MD 21250 USA; [Keane, Sarah C.; Heng, Xiao; Lu, Kun; Ramakrishnan, Venkateswaran; Carter, Gregory; Barton, Shawn; Hosic, Azra; Florwick, Alyssa; Santos, Justin; Bolden, Nicholas C.; McCowin, Sayo; Summers, Michael F.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USA; [Kharytonchyk, Siarhei; Telesnitsky, Alice] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Case, David A.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Johnson, Bruce A.] One Moon Sci Inc, Westfield, NJ 07090 USA; [Johnson, Bruce A.] CUNY, Adv Sci Res Ctr, New York, NY 10031 USA; [Salemi, Marco] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Salemi, Marco] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; City University of New York (CUNY) System; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Telesnitsky, A (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	ateles@umich.edu; summers@hhmi.umbc.edu		Bolden, Nicholas/0000-0003-2134-5289; Kharytonchyk, Siarhei/0000-0001-7031-8135	National Institute of General Medical Sciences (NIGMS) [R01 GM42561, P50 GM 103297]; NIGMS [MARC U*STAR 2T34 GM008663]; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM103297, T34GM008663, R01GM042561] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1228778] Funding Source: National Science Foundation	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research was supported by grants from the National Institute of General Medical Sciences (NIGMS, R01 GM42561 to M.F.S. and A.T. and P50 GM 103297 to M.S., B.J., and D.A.C.). S.B., N.C.B., and S.M. were supported by a NIGMS grant for enhancing minority access to research careers (MARC U*STAR 2T34 GM008663), and S.B., J.S., N.C.B., and S.M. were supported by an HHMI undergraduate education grant. We thank the HHMI staff at UMBC for technical assistance and B. Rife (University of Florida) for advice regarding the phylogenetic analysis. The following reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH: pNL4-3 from M. Martin. Atomic coordinates have been deposited into the Protein Data Bank with accession code 2N1Q. NMR chemical shifts and restraints have been deposited into the Biological Magnetic Resonance Bank with accession code 25571.	Abbink TEM, 2005, BIOCHEMISTRY-US, V44, P9058, DOI 10.1021/bi0502588; Abbink TEM, 2003, J BIOL CHEM, V278, P11601, DOI 10.1074/jbc.M210291200; Abbink TEM, 2008, J VIROL, V82, P3090, DOI 10.1128/JVI.01479-07; Barton S, 2013, J BIOMOL NMR, V55, P33, DOI 10.1007/s10858-012-9683-9; BAUDIN F, 1993, J MOL BIOL, V229, P382, DOI 10.1006/jmbi.1993.1041; Berkowitz R, 1996, CURR TOP MICROBIOL, V214, P177; Chen JB, 2009, P NATL ACAD SCI USA, V106, P13535, DOI 10.1073/pnas.0906822106; Coffin J, 1997, RETROVIRUSES; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Deforges J, 2012, BIOCHIMIE, V94, P1481, DOI 10.1016/j.biochi.2012.02.009; Duss O, 2012, ADV EXP MED BIOL, V992, P121, DOI 10.1007/978-94-007-4954-2_7; Greatorex Jane, 2004, Retrovirology, V1, P22, DOI 10.1186/1742-4690-1-22; Heng X, 2012, J MOL BIOL, V417, P224, DOI 10.1016/j.jmb.2012.01.033; Jablonski JA, 2008, J VIROL, V82, P8038, DOI 10.1128/JVI.00721-08; Jouvenet N, 2011, J MOL BIOL, V410, P501, DOI 10.1016/j.jmb.2011.04.062; Kenyon JC, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt690; Koharudin LMI, 2003, J MAGN RESON, V163, P228, DOI 10.1016/S1090-7807(03)00149-6; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; Kuzembayeva M, 2014, VIROLOGY, V454, P362, DOI 10.1016/j.virol.2014.01.019; Lever AML, 2007, ADV PHARMACOL, V55, P1, DOI 10.1016/S1054-3589(07)55001-5; Lu K, 2011, SCIENCE, V334, P242, DOI 10.1126/science.1210460; Lu K, 2011, J MOL BIOL, V410, P609, DOI 10.1016/j.jmb.2011.04.029; Lu K, 2010, J BIOMOL NMR, V46, P113, DOI 10.1007/s10858-009-9375-2; Nikolaitchik O, 2006, J VIROL, V80, P4691, DOI 10.1128/JVI.80.10.4691-4697.2006; Nikolaitchik OA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003249; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; Poon DTK, 2002, VIROLOGY, V293, P368, DOI 10.1006/viro.2001.1283; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; SOUTH TL, 1993, PROTEIN SCI, V2, P3; van Hemert FJ, 2013, RNA BIOL, V10, P211, DOI 10.4161/rna.22896; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096	31	181	185	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					917	921		10.1126/science.aaa9266	http://dx.doi.org/10.1126/science.aaa9266			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999508	Green Accepted			2022-12-28	WOS:000354877900046
J	Guharoy, M; Pauwels, K; Tompa, P				Guharoy, Mainak; Pauwels, Kris; Tompa, Peter			SnapShot: Intrinsic Structural Disorder	CELL			English	Editorial Material							PROTEINS; BINDING	Many proteins (intrinsically disordered proteins, IDPs) or regions of proteins (intrinsically disordered regions, IDRs) lack a well-defined 3D structure under physiological conditions. Albeit unfolded and highly dynamic, these proteins are not denatured; rather, intrinsic structural disorder is their native, functional state.	[Guharoy, Mainak; Pauwels, Kris; Tompa, Peter] Vlaams Inst Biotechnol, VIB Struct Biol Res Ct SBRC, B-1050 Brussels, Belgium; [Guharoy, Mainak; Pauwels, Kris; Tompa, Peter] Free Univ Brussels, Struct Biol Brussels SBB, B-1050 Brussels, Belgium; [Tompa, Peter] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1117 Budapest, Hungary	Flanders Institute for Biotechnology (VIB); Universite Libre de Bruxelles; Vrije Universiteit Brussel; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Guharoy, M (corresponding author), Vlaams Inst Biotechnol, VIB Struct Biol Res Ct SBRC, B-1050 Brussels, Belgium.			Pauwels, Kris/0000-0002-7341-0890; Guharoy, Mainak/0000-0003-1354-2872; Tompa, Peter/0000-0001-8042-9939	Research Foundation Flanders (FWO) [G.0029.12]; Omics@VIB Marie Curie COFUND fellowship; FWO Pegasus long-term postdoctoral fellowship	Research Foundation Flanders (FWO)(FWO); Omics@VIB Marie Curie COFUND fellowship; FWO Pegasus long-term postdoctoral fellowship	This work was supported by the Odysseus grant G.0029.12 from Research Foundation Flanders (FWO.). M.G. is the recipient of an Omics@VIB Marie Curie COFUND fellowship; K.P. is the recipient of a FWO Pegasus long-term postdoctoral fellowship.	Krishnan N, 2014, NAT CHEM BIOL, V10, P558, DOI [10.1038/NCHEMBIO.1528, 10.1038/nchembio.1528]; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Schwalbe M, 2014, STRUCTURE, V22, P238, DOI 10.1016/j.str.2013.10.020; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003	10	15	15	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5							1230.e1	10.1016/j.cell.2015.05.024	http://dx.doi.org/10.1016/j.cell.2015.05.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000490	Green Published, Bronze			2022-12-28	WOS:000355152600029
J	Patton, GC; Romaniuk, H; Spry, E; Coffey, C; Olsson, C; Doyle, LW; Oats, J; Hearps, S; Carlin, JB; Brown, S				Patton, George C.; Romaniuk, Helena; Spry, Elizabeth; Coffey, Carolyn; Olsson, Craig; Doyle, Lex W.; Oats, Jeremy; Hearps, Stephen; Carlin, John B.; Brown, Stephanie			Prediction of perinatal depression from adolescence and before conception (VIHCS): 20-year prospective cohort study	LANCET			English	Article							COMMON MENTAL-DISORDERS; POSTNATAL DEPRESSION; RISK-FACTORS; POSTPARTUM DEPRESSION; PSYCHIATRIC-DISORDERS; MATERNAL DEPRESSION; LIFETIME PREVALENCE; EARLY-PREGNANCY; SYMPTOMS; WOMEN	Background Perinatal depression is a neglected global health priority, affecting 10-15% of women in high-income countries and a greater proportion in low-income countries. Outcomes for children include cognitive, behavioural, and emotional difficulties and, in low-income settings, perinatal depression is associated with stunting and physical illness. In the Victorian Intergenerational Health Cohort Study (VIHCS), we aimed to assess the extent to which women with perinatal depressive symptoms had a history of mental health problems before conception. Methods VIHCS is a follow-up study of participants in the Victorian Adolescent Health Cohort Study (VAHCS), which was initiated in August, 1992, in the state of Victoria, Australia. In VAHCS, participants were assessed for health outcomes at nine timepoints (waves) from age 14 years to age 29 years. Depressive symptoms were measured with the Revised Clinical Interview Schedule and the General Health Questionnaire. Enrolment to VIHCS began in September, 2006, during the ninth wave of VAHCS; depressive symptoms at this timepoint were measured with the Composite International Diagnostic Interview. We contacted women every 6 months (from age 29 years to age 35 years) to identify any pregnancies. We assessed perinatal depressive symptoms with the Edinburgh Postnatal Depression Scale (EPDS) by computer-assisted telephone interview at 32 weeks of gestation, 8 weeks after birth, and 12 months after birth. We defined perinatal depression as an EPDS score of 10 or more. Findings From a stratified random sample of 1000 female participants in VAHCS, we enrolled 384 women with 564 pregnancies. 253 (66%) of these women had a previous history of mental health problems at some point in adolescence or young adulthood. 117 women with a history of mental health problems in both adolescence and young adulthood had 168 pregnancies, and perinatal depressive symptoms were reported for 57 (34%) of these pregnancies, compared with 16 (8%) of 201 pregnancies in 131 women with no preconception history of mental health problems (adjusted odds ratio 8.36, 95% CI 3.34-20.87). Perinatal depressive symptoms were reported at one or more assessment points in 109 pregnancies; a preconception history of mental health problems was reported in 93 (85%) of these pregnancies. Interpretation Perinatal depressive symptoms are mostly preceded by mental health problems that begin before pregnancy, in adolescence or young adulthood. Women with a history of persisting common mental disorders before pregnancy are an identifiable high-risk group, deserving of clinical support throughout the childbearing years. Furthermore, the window for considering preventive intervention for perinatal depression should extend to the time before conception.	[Patton, George C.; Romaniuk, Helena; Coffey, Carolyn; Hearps, Stephen] Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Ctr Adolescent Hlth, Parkville, Vic 3052, Australia; [Romaniuk, Helena; Carlin, John B.] Univ Melbourne, Royal Childrens Hosp Melbourne, Clin Epidemiol & Biostat Unit, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Romaniuk, Helena; Carlin, John B.] Univ Melbourne, Royal Childrens Hosp Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Olsson, Craig] Univ Melbourne, Murdoch Childrens Res Inst, Psychol Sci & Paediat, Parkville, Vic 3052, Australia; [Olsson, Craig] Deakin Univ, Sch Psychol, Ctr Social & Early Emot Dev, Geelong, Vic 3217, Australia; [Doyle, Lex W.] Univ Melbourne, Royal Womens Hosp, Parkville, Vic 3052, Australia; [Doyle, Lex W.] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Doyle, Lex W.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Oats, Jeremy] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Brown, Stephanie] Univ Melbourne, Murdoch Childrens Res Inst, Healthy Mothers Healthy Families Res Grp, Parkville, Vic 3052, Australia; [Brown, Stephanie] Univ Melbourne, Murdoch Childrens Res Inst, Gen Practice & Primary Hlth Care Acad Ctr, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne; Deakin University; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne	Patton, GC (corresponding author), Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Ctr Adolescent Hlth, Parkville, Vic 3052, Australia.	george.patton@rch.org.au	Carlin, John/AAG-4332-2020; Brown, Stephanie/AAE-1662-2019; Spry, Elizabeth/J-9288-2019; Patton, George C/B-5246-2013; Hearps, Stephen/L-6853-2016; Doyle, Lex/AAJ-5205-2021; Ribeiro, Ana Cristina/HHN-7466-2022; Olsson, Craig A/AAR-5057-2020; Carlin, John B/B-3492-2012	Carlin, John/0000-0002-2694-9463; Spry, Elizabeth/0000-0003-2837-3514; Patton, George C/0000-0001-5039-8326; Doyle, Lex/0000-0002-7667-7312; Ribeiro, Ana Cristina/0000-0002-0493-8376; Olsson, Craig A/0000-0002-5927-2014; Carlin, John B/0000-0002-2694-9463; Romaniuk, Helena/0000-0002-5801-2077; Hearps, Stephen/0000-0003-2984-1172; Brown, Stephanie/0000-0001-9812-0067	National Health and Medical Research Council (Australia); Victorian Health Promotion Foundation; Colonial Foundation; Australian Rotary Health Research and Perpetual Trustees; Australia's National Health and Medical Research Council (NHMRC); Victorian Government's Operational Infrastructure Program	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Health Promotion Foundation; Colonial Foundation; Australian Rotary Health Research and Perpetual Trustees; Australia's National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Program	Funding National Health and Medical Research Council (Australia), Victorian Health Promotion Foundation, Colonial Foundation, Australian Rotary Health Research and Perpetual Trustees.; Both the Victorian Adolescent Health Cohort Study (VAHCS) and the Victorian Intergenerational Health Cohort Study (VIHCS) have been supported by a series of project grants from Australia's National Health and Medical Research Council (NHMRC), the Victorian Health Promotion Foundation, the Colonial Foundation, and Australian Rotary Health Research and Perpetual Trustees. The Murdoch Childrens Research Institute is supported by the Victorian Government's Operational Infrastructure Program. We thank the families who participated in VAHCS and VIHCS; the study research team involved in data collection and management; and Prof Anthony Mann and Prof Sir Michael Rutter for advice on study design.	[Anonymous], 1997, COMP INT DIAGN INT C; Austin MP, 2008, J AFFECT DISORDERS, V105, P35, DOI 10.1016/j.jad.2007.04.001; Australian Bureau of Statistics, 2013, 3301 0 BIRTHS AUSTR; Banti S, 2011, COMPR PSYCHIAT, V52, P343, DOI 10.1016/j.comppsych.2010.08.003; Bloch M, 2003, COMPR PSYCHIAT, V44, P234, DOI 10.1016/S0010-440X(03)00034-8; Collishaw S, 2004, J CHILD PSYCHOL PSYC, V45, P1350, DOI 10.1111/j.1469-7610.2004.00335.x; COOPER PJ, 1995, BRIT J PSYCHIAT, V166, P191, DOI 10.1192/bjp.166.2.191; Copeland W, 2011, J AM ACAD CHILD PSY, V50, P252, DOI 10.1016/j.jaac.2010.12.014; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dennis CL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006309; Dietz PM, 2007, AM J PSYCHIAT, V164, P1515, DOI 10.1176/appi.ajp.2007.06111893; Donath S, 2001, AUST NZ J PSYCHIAT, V35, P231, DOI 10.1046/j.1440-1614.2001.00869.x; Figueiredo FP, 2012, EUR PSYCHIAT, V27, P1; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Giannandrea SAM, 2013, J WOMENS HEALTH, V22, P760, DOI 10.1089/jwh.2012.4011; Gluckman PD, 2006, TRENDS ENDOCRIN MET, V17, P7, DOI 10.1016/j.tem.2005.11.006; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Goldstein Harvey, 2010, MULTILEVEL STAT MODE; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Hall M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001581; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Johnstone SJ, 2001, AUST NZ J PSYCHIAT, V35, P69, DOI 10.1046/j.1440-1614.2001.00862.x; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; Kingston D, 2012, CHILD PSYCHIAT HUM D, V43, P683, DOI 10.1007/s10578-012-0291-4; LaCoursiere DY, 2012, MATERN CHILD HLTH J, V16, P929, DOI 10.1007/s10995-011-0816-7; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Luoma I, 2001, J AM ACAD CHILD PSY, V40, P1367, DOI 10.1097/00004583-200112000-00006; Marce LV, 1858, TRAITE FOLIE FEMMES; Meltzer-Brody S, 2013, ARCH WOMEN MENT HLTH, V16, P465, DOI 10.1007/s00737-013-0372-9; Moffitt TE, 2010, PSYCHOL MED, V40, P899, DOI 10.1017/S0033291709991036; MOFFITT TE, 1988, AUST NZ J CRIMINOL, V21, P227, DOI 10.1177/000486588802100405; O'Hara MW, 2014, BEST PRACT RES CL OB, V28, P3, DOI 10.1016/j.bpobgyn.2013.09.002; O'Hara MW, 2013, ANNU REV CLIN PSYCHO, V9, P379, DOI 10.1146/annurev-clinpsy-050212-185612; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Olsson CA, 2014, J ADOLESCENT HEALTH, V54, P698, DOI 10.1016/j.jadohealth.2013.10.203; Parsons CE, 2012, BRIT MED BULL, V101, P57, DOI 10.1093/bmb/ldr047; Patton GC, 2014, LANCET, V383, P1404, DOI [10.1016/s0140-6736(13)62116-9, 10.1016/S0140-6736(13)62116-9]; PITT B, 1968, BRIT J PSYCHIAT, V114, P1325, DOI 10.1192/bjp.114.516.1325; Rich-Edwards JW, 2006, J EPIDEMIOL COMMUN H, V60, P221, DOI 10.1136/jech.2005.039370; Romaniuk H, 2014, AM J EPIDEMIOL, V180, P920, DOI 10.1093/aje/kwu224; Rowe HJ, 2008, ARCH WOMEN MENT HLTH, V11, P103, DOI 10.1007/s00737-008-0003-z; Rubertsson C, 2005, ARCH WOMEN MENT HLTH, V8, P97, DOI 10.1007/s00737-005-0078-8; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Surkan PJ, 2011, B WORLD HEALTH ORGAN, V89, P607, DOI 10.2471/BLT.11.088187; Vesga-Lopez O, 2008, ARCH GEN PSYCHIAT, V65, P805, DOI 10.1001/archpsyc.65.7.805; Wachs TD, 2009, CHILD DEV PERSPECT, V3, P51, DOI 10.1111/j.1750-8606.2008.00077.x; Woolhouse H, 2012, BJOG-INT J OBSTET GY, V119, P315, DOI 10.1111/j.1471-0528.2011.03219.x	48	77	79	1	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2015	386	9996					875	883		10.1016/S0140-6736(14)62248-0	http://dx.doi.org/10.1016/S0140-6736(14)62248-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0MJ	26072108				2022-12-28	WOS:000360290000031
J	Griffiths, CEM; Reich, K; Lebwohl, M; Van De Kerkhof, P; Paul, C; Menter, A; Cameron, GS; Erickson, J; Zhang, L; Secrest, RJ; Ball, S; Braun, DK; Osuntokun, OO; Heffernan, MP; Nickoloff, BJ; Papp, K				Griffiths, Christopher E. M.; Reich, Kristian; Lebwohl, Mark; van de Kerkhof, Peter; Paul, Carle; Menter, Alan; Cameron, Gregory S.; Erickson, Janelle; Zhang, Lu; Secrest, Roberta J.; Ball, Susan; Braun, Daniel K.; Osuntokun, Olawale O.; Heffernan, Michael P.; Nickoloff, Brian J.; Papp, Kim		UNCOVER-2 & UNCOVER-3	Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials	LANCET			English	Article							CHRONIC PLAQUE PSORIASIS; QUALITY-OF-LIFE; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; PHASE-III; SUSCEPTIBILITY LOCI; MAINTENANCE THERAPY; EFFICACY; SAFETY; SECUKINUMAB	Background Ixekizumab is a humanised monoclonal antibody against the proinflammatory cytokine interleukin 17A. We report two studies of ixekizumab compared with placebo or etanercept to assess the safety and efficacy of specifically targeting interleukin 17A in patients with widespread moderate-to-severe psoriasis. Methods In two prospective, double-blind, multicentre, phase 3 studies (UNCOVER-2 and UNCOVER-3), eligible patients were aged 18 years or older, had a confirmed diagnosis of chronic plaque psoriasis at least 6 months before baseline (randomisation), 10% or greater body-surface area involvement at both screening and baseline visits, at least a moderate clinical severity as measured by a static physician global assessment (sPGA) score of 3 or more, and a psoriasis area and severity index (PASI) score of 12. Participants were randomly assigned (1: 2: 2: 2) by computer-generated random sequence with an interactive voice response system to receive subcutaneous placebo, etanercept (50 mg twice weekly), or one injection of 80 mg ixekizumab every 2 weeks, or every 4 weeks after a 160 mg starting dose. Blinding was maintained with a double-dummy design. Coprimary efficacy endpoints were proportions of patients achieving sPGA score 0 or 1 and 75% or greater improvement in PASI at week 12. Analysis was by intention to treat. These trials are registered with ClinicalTrials.gov, numbers NCT01597245 and NCT01646177. Findings Between May 30, 2012, and Dec 30, 2013, 1224 patients in UNCOVER-2 were randomly assigned to receive subcutaneous placebo (n=168), etanercept (n=358), or ixekizumab every 2 weeks (n=351) or every 4 weeks (n=347); between Aug 11, 2012, and Feb 27, 2014, 1346 patients in UNCOVER-3 were randomly assigned to receive placebo (n=193), etanercept (n=382), ixekizumab every 2 weeks (n=385), or ixekizumab every 4 weeks (n=386). At week 12, both primary endpoints were met in both studies. For UNCOVER-2 and UNCOVER-3 respectively, in the ixekizumab every 2 weeks group, PASI 75 was achieved by 315 (response rate 89.7%; [effect size 87.4% (97.5% CI 82.9-91.8) vs placebo; 48.1% (41.2-55.0) vs etanercept]) and 336 (87.3%; [80.0% (74.4-85.7) vs placebo; 33.9% (27.0-40.7) vs etanercept]) patients; in the ixekizumab every 4 weeks group, by 269 (77.5%; [75.1% (69.5-80.8) vs placebo; 35.9% (28.2-43.6) vs etanercept]) and 325 (84.2%; [76.9% (71.0-82.8) vs placebo; 30.8% (23.7-37.9) vs etanercept]) patients; in the placebo group, by four (2.4%) and 14 (7.3%) patients; and in the etanercept group by 149 (41.6%) and 204 (53.4%) patients (all p<0.0001 vs placebo or etanercept). In the ixekizumab every 2 weeks group, sPGA 0/1 was achieved by 292 (response rate 83.2%; [effect size 80.8% (97.5% CI 75.6-86.0) vs placebo; 47.2% (39.9-54.4) vs etanercept]) and 310 (80.5%; [73.8% (67.7-79.9) vs placebo; 38.9% (31.7-46.1) vs etanercept]) patients; in the ixekizumab every 4 weeks group by 253 (72.9%; [70.5% (64.6-76.5) vs placebo; 36.9% (29.1-44.7) vs etanercept]) and 291 (75.4%; [68.7% (62.3-75.0) vs placebo; 33.8% (26.3-41.3) vs etanercept]) patients; in the placebo group by four (2.4%) and 13 (6.7%) patients; and in the etanercept group by 129 (36.0%) and 159 (41.6%) patients (all p<0.0001 vs placebo or etanercept). In combined studies, serious adverse events were reported in 14 (1.9%) of 734 patients given ixekizumab every 2 weeks, 14 (1.9%) of 729 given ixekizumab every 4 weeks, seven (1.9%) of 360 given placebo, and 14 (1.9%) of 739 given etanercept; no deaths were noted. Interpretation Both ixekizumab dose regimens had greater efficacy than placebo and etanercept over 12 weeks in two independent studies. These studies show that selectively neutralising interleukin 17A with a high affinity antibody potentially gives patients with psoriasis a new and effective biological therapy option.	[Griffiths, Christopher E. M.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Dermatol Ctr, Salford Royal NHS Fdn Trust, Manchester M6 8HD, Lancs, England; [Reich, Kristian] Dermatol Hamburg & SCIderm Res Inst, Hamburg, Germany; [Lebwohl, Mark] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA; [van de Kerkhof, Peter] Radboud Univ Nijmegen, Dept Dermatol, NL-6525 ED Nijmegen, Netherlands; [Paul, Carle] Univ Toulouse 3, Dept Dermatol, F-31062 Toulouse, France; [Menter, Alan] Univ Texas Southwestern Med Sch, Dallas, TX USA; [Cameron, Gregory S.; Erickson, Janelle; Zhang, Lu; Secrest, Roberta J.; Ball, Susan; Braun, Daniel K.; Osuntokun, Olawale O.; Heffernan, Michael P.; Nickoloff, Brian J.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Papp, Kim] Prob Med Res, Waterloo, ON, Canada	Salford Royal NHS Foundation Trust; University of Manchester; Dermatologikum Hamburg; Icahn School of Medicine at Mount Sinai; Radboud University Nijmegen; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Eli Lilly	Griffiths, CEM (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Dermatol Ctr, Salford Royal NHS Fdn Trust, Barnes Bldg, Manchester M6 8HD, Lancs, England.	christopher.griffiths@manchester.ac.uk	Estebaranz, Jose Luis Lopez/AAF-1756-2019; Nowicki, Roman J./U-3148-2018; Thaci, Prof. Dr Diamant/K-5455-2012; van de Kerkhof, P.C.M./H-8059-2014; Arenberger, Petr/C-7481-2018; Estebaranz, José Luis López/L-2920-2018; Perlamutrov, Yuri/AAL-7884-2020; Kemeny, Lajos/ABF-1339-2021; Zbranca-Toporas, Anca/U-7166-2017; Griffiths, Christopher/P-5448-2014; Gooderham, Melinda/F-2551-2017; Tiplica, George Sorin/D-3135-2016	Estebaranz, Jose Luis Lopez/0000-0002-8816-1989; Nowicki, Roman J./0000-0003-4768-1387; Arenberger, Petr/0000-0002-4800-5877; Estebaranz, José Luis López/0000-0002-8816-1989; Perlamutrov, Yuri/0000-0002-4837-8489; Kemeny, Lajos/0000-0002-2119-9501; Zbranca-Toporas, Anca/0000-0002-5474-4182; PUJOL, RAMON M/0000-0002-5622-6055; Ball, Susan/0000-0001-9866-6721; Aubin, Francois/0000-0002-1421-4996; Papp, Kim A./0000-0001-9557-3642; Grob, Jean-Jacques/0000-0002-0667-153X; Griffiths, Christopher/0000-0001-5371-4427; Padlewska, Kamila/0000-0001-6203-3367; Gooderham, Melinda/0000-0001-8926-0113; Barankin, Benjamin/0000-0002-9010-8968; Paul, Carle/0000-0003-0165-5263; Tiplica, George Sorin/0000-0002-8719-6952; Lacour, Jean-Philippe/0000-0001-7663-2053; Vender, Ronald/0000-0002-2624-2724	Eli Lilly and Co.	Eli Lilly and Co.(Eli Lilly)	Eli Lilly and Co.	Di Meglio P, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015354; Gordon KB, 2014, J AM ACAD DERMATOL, V71, P1176, DOI 10.1016/j.jaad.2014.07.048; Hongbo Y, 2005, J INVEST DERMATOL, V125, P659, DOI 10.1111/j.0022-202X.2005.23621.x; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Kimball AB, 2013, J EUR ACAD DERMATOL, V27, P1535, DOI 10.1111/jdv.12046; Kimball AB, 2008, J AM ACAD DERMATOL, V58, P1031, DOI 10.1016/j.jaad.2008.01.006; Krueger JG, 2012, J ALLERGY CLIN IMMUN, V130, P145, DOI 10.1016/j.jaci.2012.04.024; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Lewis-Beck C, 2013, PATIENT PREFER ADHER, V7, P199, DOI 10.2147/PPA.S39887; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Mazzotta A, 2009, AM J CLIN DERMATOL, V10, P319, DOI 10.2165/11310770-000000000-00000; Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010; Menter A, 2011, J AM ACAD DERMATOL, V65, P137, DOI 10.1016/j.jaad.2010.11.055; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Osamu N, 2014, J DERMATOL SCI, V75, P201, DOI 10.1016/j.jdermsci.2014.05.007; Papp KA, 2013, BRIT J DERMATOL, V168, P412, DOI 10.1111/bjd.12110; Papp KA, 2005, BRIT J DERMATOL, V152, P1304, DOI 10.1111/j.1365-2133.2005.06688.x; Papp K, 2014, J AM ACAD DERMATOL, V71, P1183, DOI 10.1016/j.jaad.2014.08.039; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Papp KA, 2012, J INVEST DERMATOL, V132, P2466, DOI 10.1038/jid.2012.163; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Pathirana D, 2009, J EUR ACAD DERMATOL, V23, P1, DOI 10.1111/j.1468-3083.2009.03389.x; Puig L, 2015, J EUR ACAD DERMATOL, V29, P645, DOI 10.1111/jdv.12817; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Reich Kristian, 2007, J Dtsch Dermatol Ges, V5, P566, DOI 10.1111/j.1610-0387.2007.06343.x; Rich P, 2013, BRIT J DERMATOL, V168, P402, DOI 10.1111/bjd.12112; Sampogna F, 2012, ACTA DERM-VENEREOL, V92, P299, DOI 10.2340/00015555-1273; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Takeshita J, 2014, J AM ACAD DERMATOL, V71, P633, DOI 10.1016/j.jaad.2014.05.001; Torii H, 2012, J DERMATOL, V39, P253, DOI 10.1111/j.1346-8138.2011.01459.x; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Viswanathan HN, 2014, J DERMATOLOG TREAT	36	589	611	3	88	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2015	386	9993					541	551		10.1016/S0140-6736(15)60125-8	http://dx.doi.org/10.1016/S0140-6736(15)60125-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8PG	26072109				2022-12-28	WOS:000359431900028
J	Hovingh, GK; Kastelein, JJP; van Deventer, SJH; Round, P; Ford, J; Saleheen, D; Rader, DJ; Brewer, HB; Barter, PJ				Hovingh, G. Kees; Kastelein, John J. P.; van Deventer, Sander J. H.; Round, Patrick; Ford, John; Saleheen, Danish; Rader, Daniel J.; Brewer, H. Bryan; Barter, Philip J.			Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial	LANCET			English	Article							EFFLUX CAPACITY; HDL CHOLESTEROL; TORCETRAPIB; RISK; LIPIDS; CETP	Background Dyslipidaemia remains a significant risk factor for cardiovascular disease and additional lipid-modifying treatments are warranted to further decrease the cardiovascular disease burden. We assessed the safety, tolerability and efficacy of a novel cholesterol esterase transfer protein (CETP) inhibitor TA-8995 in patients with mild dyslipidaemia. Methods In this randomised, double-blind, placebo-controlled, parallel-group phase 2 trial, we recruited patients (aged 18-75 years) from 17 sites (hospitals and independent clinical research organisations) in the Netherlands and Denmark with fasting LDL cholesterol levels between 2.5 mmol/L and 4.5 mmol/L, HDL cholesterol levels between 0.8 and 1.8 mmol/L and triglyceride levels below 4.5 mmol/L after washout of lipid-lowering treatments. Patients were randomly allocated (1: 1) by a computer-generated randomisation schedule to receive one of the following nine treatments: a once a day dose of 1 mg, 2.5 mg, 5 mg, or 10 mg TA-8995 or matching placebo; 10 mg TA-8995 plus 20 mg atorvastatin; 10 mg TA-8995 plus 10 mg rosuvastatin or 20 mg atorvastatin or 10 mg rosuvastatin alone. We overencapsulated statins to achieve masking. The primary outcome was percentage change in LDL cholesterol and HDL cholesterol from baseline at week 12, analysed by intention to treat. This study is registered with ClinicalTrials.gov, number NCT01970215. Findings Between Aug 15, 2013, and Jan 10, 2014, 364 patients were enrolled. At week 12, LDL cholesterol levels were reduced by 27.4% in patients assigned to the 1 mg dose, 32.7% in patients given the 2.5 mg dose, 45.3% in those given the 5 mg dose, and 45.3% in those given the 10 mg dose (p<0.0001). LDL cholesterol levels were reduced by 68.2% in patients given 10 mg TA-8995 plus atorvastatin, and by 63.3% in patients given rosuvastatin plus 10 mg TA-8995 (p<0.0001). A daily dose of 1 mg TA-8995 increased HDL cholesterol levels by 75.8%, 2.5 mg by 124.3%, 5 mg by 157.1%, and 10 mg dose by 179.0% (p<0.0001). In patients receiving 10 mg TA-8995 and 20 mg atorvastatin HDL cholesterol levels increased by 152.1% and in patients receiving 10 mg TA-8995 and 10 mg rosuvastatin by 157.5%. We recorded no serious adverse events or signs of liver or muscle toxic effects. Interpretation TA-8995, a novel CETP inhibitor, is well tolerated and has beneficial effects on lipids and apolipoproteins in patients with mild dyslipidaemia. A cardiovascular disease outcome trial is needed to translate these effects into a reduction of cardiovascular disease events.	[Hovingh, G. Kees; Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Kastelein, John J. P.; van Deventer, Sander J. H.; Round, Patrick; Ford, John] Dezima Pharma BV, Naarden, Netherlands; [van Deventer, Sander J. H.] Leiden Univ, Med Ctr, Dept Gastroenterol, Leiden, Netherlands; [Round, Patrick; Ford, John] Xention, Cambridge, England; [Saleheen, Danish; Rader, Daniel J.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Brewer, H. Bryan] Washington Hosp Ctr, MedStar Res Inst, Washington, DC 20010 USA; [Barter, Philip J.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Pennsylvania; Pennsylvania Medicine; MedStar Washington Hospital Center; University of New South Wales Sydney	Hovingh, GK (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands.	j.s.jansen@amc.nl	Kastelein, John/AAF-7950-2020		Dezima	Dezima	This study was funded by Dezima and undertaken by Xention. The authors thank Samantha Abel (Valley Writing Solutions Limited) for the initial preparation and QC check of the tables and figures; Joost Besseling and Koos Zwinderman for their assistance related to the analyses and preparation of the figures; and Vascular Strategies LLC (Plymouth Meeting, PA, USA) for conduct of the cholesterol efflux studies.	[Anonymous], 2014, AM HEART ASS SCI SES; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2012, J LIPID RES, V53, P1755, DOI 10.1194/jlr.R024075; Boekholdt SM, 2012, JAMA-J AM MED ASSOC, V307, P1302, DOI 10.1001/jama.2012.366; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Ford J, 2014, BRIT J CLIN PHARMACO, V78, P498, DOI 10.1111/bcp.12380; Gotto AM, 2014, J CARDIOVASC PHARM T, V19, P543, DOI 10.1177/1074248414529621; Hu X, 2009, ENDOCRINOLOGY, V150, P2211, DOI 10.1210/en.2008-1512; Johannsen TH, 2012, J AM COLL CARDIOL, V60, P2041, DOI 10.1016/j.jacc.2012.07.045; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Rader DJ, 2014, LANCET, V384, P618, DOI 10.1016/S0140-6736(14)61217-4; Ray KK, 2014, EUR HEART J, V35, P1792, DOI 10.1093/eurheartj/ehu105; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Simic B, 2012, EUR HEART J, V33, P1615, DOI 10.1093/eurheartj/ehr348; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2	18	135	140	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					452	460		10.1016/S0140-6736(15)60158-1	http://dx.doi.org/10.1016/S0140-6736(15)60158-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26047975	Green Published			2022-12-28	WOS:000358761700025
J	Blaho, VA; Galvani, S; Engelbrecht, E; Liu, C; Swendeman, SL; Kono, M; Proia, RL; Steinman, L; Han, MH; Hla, T				Blaho, Victoria A.; Galvani, Sylvain; Engelbrecht, Eric; Liu, Catherine; Swendeman, Steven L.; Kono, Mari; Proia, Richard L.; Steinman, Lawrence; Han, May H.; Hla, Timothy			HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation	NATURE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; HEMATOPOIETIC STEM-CELLS; SERUM-LIPID PROFILES; LYMPHOCYTE EGRESS; APOLIPOPROTEIN-M; CHOLESTEROL EFFLUX; PROGENITOR; S1P(1); EXPRESSION; BLOOD	Lipid mediators influence immunity in myriad ways. For example, circulating sphingosine-1-phosphate (S1P) is a key regulator of lymphocyte egress(1,2). Although the majority of plasma S1P is bound to apolipoprotein M (ApoM) in the high-density lipoprotein (HDL) particle(3), the immunological functions of the ApoM-S1P complex are unknown. Here we show that ApoM-S1P is dispensable for lymphocyte trafficking yet restrains lymphopoiesis by activating the S1P1 receptor on bone marrow lymphocyte progenitors. Mice that lacked ApoM (Apom(-/-)) had increased proliferation of Lin(-) Sca-1(+) cKit(+) haematopoietic progenitor cells (LSKs) and common lymphoid progenitors (CLPs) in bone marrow. Pharmacological activation or genetic overexpression of S1P(1) suppressed LSK and CLP cell proliferation in vivo. ApoM was stably associated with bone marrow CLPs, which showed active S1P(1) signalling in vivo(4). Moreover, ApoM-bound S1P, but not albumin-bound S1P, inhibited lymphopoiesis in vitro. Upon immune stimulation, Apom(-/-) mice developed more severe experimental autoimmune encephalomyelitis5, characterized by increased lymphocytes in the central nervous system and breakdown of the blood-brain barrier. Thus, the ApoM-S1P-S1P(1) signalling axis restrains the lymphocyte compartment and, subsequently, adaptive immune responses. Unique biological functions imparted by specific S1P chaperones could be exploited for novel therapeutic opportunities.	[Blaho, Victoria A.; Galvani, Sylvain; Engelbrecht, Eric; Liu, Catherine; Swendeman, Steven L.; Hla, Timothy] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, New York, NY 10065 USA; [Blaho, Victoria A.; Hla, Timothy] Cornell Univ, Weill Med Coll, Brain & Mind Res Inst, New York, NY 10065 USA; [Kono, Mari; Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Steinman, Lawrence; Han, May H.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Cornell University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Stanford University	Hla, T (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, New York, NY 10065 USA.	tih2002@med.cornell.edu	Proia, Richard L/A-7908-2012; Hla, Timothy/G-5873-2012	Blaho, Victoria/0000-0001-8499-2278; Hla, Timothy/0000-0001-8355-4065; Steinman, Lawrence/0000-0002-2437-2250; Proia, Richard/0000-0003-0456-1270; Kono, Mari/0000-0003-2447-4350	National Institutes of Health (NIH) [F32 CA14211]; New York Stem Cell Foundation [C026878]; NIH, Fondation Leducq [HL67330, HL70694, HL89934]; Intramural program of the National Institute of Diabetes and Digestive and Kidney Diseases, NIH; Fondation Leducq; Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; Lipidomics Core in the SC Lipidomics and Pathobiology COBRE [P20 RR017677]; NATIONAL CANCER INSTITUTE [P30CA138313, F32CA142117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070694, R01HL067330, R37HL067330, R01HL089934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056014, ZIADK056018, ZIADK056016, ZIADK056015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC014211] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; NIH, Fondation Leducq; Intramural program of the National Institute of Diabetes and Digestive and Kidney Diseases, NIH; Fondation Leducq(Leducq Foundation); Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina; Lipidomics Core in the SC Lipidomics and Pathobiology COBRE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank C. Nathan, G. Koretzky and R. Nachman for critical comments, C. Christoffersen and L. B. Nielsen for the Apom<SUP>-/-</SUP> and APOM<SUP>Tg</SUP> mice and discussions, V. Brinkmann and Novartis Pharma AG for gifts of FTY720 and AUY954, M. Sanson for help with HDL purification, Y. Huang for help with the EAE model and J. McCormick for assistance with fluorescence-activated cell sorting. V. A. B. is a Leon Levy Research Fellow of the Weill Cornell Medical College Brain and Mind Institute. Research was supported by grants to V. A. B. (National Institutes of Health (NIH) F32 CA14211 and New York Stem Cell Foundation C026878), T.H. (NIH HL67330, HL70694 and HL89934, Fondation Leducq), R.L.P. (Intramural program of the National Institute of Diabetes and Digestive and Kidney Diseases, NIH and Fondation Leducq), M.H. and L.S. (Fondation Leducq), the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313) and the Lipidomics Core in the SC Lipidomics and Pathobiology COBRE (P20 RR017677).	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Armstrong AJ, 2010, J IMMUNOL, V184, P173, DOI 10.4049/jimmunol.0902372; Beck T. C., 2014, J EXP MED; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Brown CR, 2003, J IMMUNOL, V171, P893, DOI 10.4049/jimmunol.171.2.893; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Christoffersen C, 2008, J BIOL CHEM, V283, P1839, DOI 10.1074/jbc.M704576200; Christoffersen C, 2006, J LIPID RES, V47, P1833, DOI 10.1194/jlr.M600055-JLR200; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Faber K, 2004, J LIPID RES, V45, P1272, DOI 10.1194/jlr.M300451-JLR200; Feng H, 2011, ARTERIOSCL THROM VAS, V31, P2543, DOI 10.1161/ATVBAHA.111.234716; Furlan Roberto, 2009, V549, P157, DOI 10.1007/978-1-60327-931-4_11; Garris CS, 2013, NAT IMMUNOL, V14, P1166, DOI 10.1038/ni.2730; Hammad SM, 2012, J LIPIDS, V2012, DOI 10.1155/2012/180705; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; Kalaitzidis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003776; Kimura T, 2001, J BIOL CHEM, V276, P31780, DOI 10.1074/jbc.M104353200; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kono M, 2014, J CLIN INVEST, V124, P2076, DOI 10.1172/JCI71194; Krutzik PO, 2005, J IMMUNOL, V175, P2357, DOI 10.4049/jimmunol.175.4.2357; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Min JK, 2002, ANAL BIOCHEM, V303, P167, DOI 10.1006/abio.2002.5579; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Thangada S, 2010, J EXP MED, V207, P1475, DOI 10.1084/jem.20091343; Tough DF, 2007, CURR PROTOC IMMUNOL; Weinstock-Guttman B, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-127; Weinstock-Guttman B, 2011, J NEUROL SCI, V311, P86, DOI 10.1016/j.jns.2011.07.024; Westerterp M, 2012, CELL STEM CELL, V11, P195, DOI 10.1016/j.stem.2012.04.024; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	48	148	151	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					342	+		10.1038/nature14462	http://dx.doi.org/10.1038/nature14462			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26053123	Green Accepted			2022-12-28	WOS:000357950900041
J	Bedford, T; Riley, S; Barr, IG; Broor, S; Chadha, M; Cox, NJ; Daniels, RS; Gunasekaran, CP; Hurt, AC; Kelso, A; Klimov, A; Lewis, NS; Li, XY; McCauley, JW; Odagiri, T; Potdar, V; Rambaut, A; Shu, YL; Skepner, E; Smith, DJ; Suchard, MA; Tashiro, M; Wang, DY; Xu, XY; Lemey, P; Russell, CA				Bedford, Trevor; Riley, Steven; Barr, Ian G.; Broor, Shobha; Chadha, Mandeep; Cox, Nancy J.; Daniels, Rodney S.; Gunasekaran, C. Palani; Hurt, Aeron C.; Kelso, Anne; Klimov, Alexander; Lewis, Nicola S.; Li, Xiyan; McCauley, John W.; Odagiri, Takato; Potdar, Varsha; Rambaut, Andrew; Shu, Yuelong; Skepner, Eugene; Smith, Derek J.; Suchard, Marc A.; Tashiro, Masato; Wang, Dayan; Xu, Xiyan; Lemey, Philippe; Russell, Colin A.			Global circulation patterns of seasonal influenza viruses vary with antigenic drift	NATURE			English	Article							DYNAMICS; EPIDEMIOLOGY; SELECTION; NETWORK; SPREAD; SITES; WAVES	Understanding the spatiotemporal patterns of emergence and circulation of new human seasonal influenza virus variants is a key scientific and public health challenge. The global circulation patterns of influenza A/H3N2 viruses are well characterized(1-7), but the patterns of A/H1N1 and B viruses have remained largely unexplored. Here we show that the global circulation patterns of A/H1N1 (up to 2009), B/Victoria, and B/Yamagata viruses differ substantially from those of A/H3N2 viruses, on the basis of analyses of 9,604 haemagglutinin sequences of human seasonal influenza viruses from 2000 to 2012. Whereas genetic variants of A/H3N2 viruses did not persist locally between epidemics and were reseeded from East and Southeast Asia, genetic variants of A/H1N1 and B viruses persisted across several seasons and exhibited complex global dynamics with East and Southeast Asia playing a limited role in disseminating new variants. The less frequent global movement of influenza A/H1N1 and B viruses coincided with slower rates of antigenic evolution, lower ages of infection, and smaller, less frequent epidemics compared to A/H3N2 viruses. Detailed epidemic models support differences in age of infection, combined with the less frequent travel of children, as probable drivers of the differences in the patterns of global circulation, suggesting a complex interaction between virus evolution, epidemiology, and human behaviour.	[Bedford, Trevor] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Riley, Steven] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London SW7 2AZ, England; [Riley, Steven; Rambaut, Andrew] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Barr, Ian G.; Hurt, Aeron C.; Kelso, Anne] WHO, Collaborating Ctr Reference & Res Influenza, Melbourne, Vic 3000, Australia; [Broor, Shobha] SGT Med Coll Hosp & Res Inst, Gurgaon 122505, Haryana, India; [Chadha, Mandeep; Potdar, Varsha] Natl Inst Virol, Pune 411001, Maharashtra, India; [Cox, Nancy J.; Klimov, Alexander; Xu, Xiyan] Ctr Dis Control & Prevent, WHO Collaborating Ctr Reference & Res Influenza, Atlanta, GA 30329 USA; [Daniels, Rodney S.; McCauley, John W.] Natl Inst Med Res, MRC, WHO Collaborating Ctr Reference & Res Influenza, London NW7 1AA, England; [Gunasekaran, C. Palani] King Inst Prevent Med & Res, Madras 600032, Tamil Nadu, India; [Hurt, Aeron C.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Parkville, Vic 3010, Australia; [Lewis, Nicola S.; Skepner, Eugene; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Li, Xiyan; Shu, Yuelong; Wang, Dayan] China CDC, WHO Collaborating Ctr Reference & Res Influenza, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China; [Odagiri, Takato; Tashiro, Masato] Natl Inst Infect Dis, WHO Collaborating Ctr Reference & Res Influenza, Tokyo 2080011, Japan; [Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Rambaut, Andrew] Univ Edinburgh, Ctr Immunol Infect & Evolut, Edinburgh EH9 3FL, Midlothian, Scotland; [Smith, Derek J.] Erasmus MC, Dept Virosci, NL-3015 Rotterdam, Netherlands; [Suchard, Marc A.] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA; [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA; [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Lemey, Philippe] KU Leuven Univ Leuven, Rega Inst, Dept Microbiol & Immunol, B-3000 Leuven, Belgium; [Russell, Colin A.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	Fred Hutchinson Cancer Center; Imperial College London; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); World Health Organization; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Centers for Disease Control & Prevention - USA; MRC National Institute for Medical Research; University of Melbourne; University of Cambridge; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; National Institute of Infectious Diseases (NIID); University of Edinburgh; University of Edinburgh; Erasmus University Rotterdam; Erasmus MC; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; KU Leuven; University of Cambridge	Russell, CA (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England.	car44@cam.ac.uk	Smith, Derek/Z-3075-2019; Potdar, Varsha/ABA-3799-2021; Russell, Colin/ABE-7106-2020; Lemey, Philippe/C-3755-2018; Broor, Shobha/AAX-4163-2021; Rambaut, Andrew/B-2481-2009	Smith, Derek/0000-0002-2393-1890; Potdar, Varsha/0000-0002-7535-7878; Lemey, Philippe/0000-0003-2826-5353; Broor, Shobha/0000-0001-9679-4180; Rambaut, Andrew/0000-0003-4337-3707; Hurt, Aeron/0000-0003-1826-4314; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Barr, Ian/0000-0002-7351-418X; Russell, Colin/0000-0002-2113-162X; Kelso, Anne/0000-0002-3166-3267; Riley, Steven/0000-0001-7904-4804	Newton International Fellowship from the Royal Society; National Institutes of Health (NIH) [U54 GM111274]; Medical Research Council (UK) [MR/J008761/1]; Wellcome Trust (UK) [093488/Z/10/Z]; Fogarty International Centre (USA) [R01 TW008246-01]; Department of Homeland Security (USA, RAPIDD program); National Institute of General Medical Sciences (USA) [MIDAS U01 GM110721-01]; National Institute for Health Research (UK, Health Protection Research Unit); Australian Government Department of Health; US Department of Health and Human Services; National Science Foundation DMS [1264153]; NIH [R01 AI 107034]; EU [278433-PREDEMICS]; ERC [260864]; Royal Society;  [U117512723]; MRC [MC_U117585868, MC_U117512723, MR/J008761/1, MR/K010174/1] Funding Source: UKRI; Medical Research Council [MC_U117585868, MR/J008761/1, MR/K010174/1B, MR/K010174/1, MC_U117512723] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish; The Francis Crick Institute [10030] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [R01TW008246] Funding Source: NIH RePORTER; National Center for Immunization and Respiratory Diseases (NCIRD) [U51IP000333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110721, U54GM111274] Funding Source: NIH RePORTER	Newton International Fellowship from the Royal Society; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (UK)(Wellcome Trust); Fogarty International Centre (USA); Department of Homeland Security (USA, RAPIDD program); National Institute of General Medical Sciences (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute for Health Research (UK, Health Protection Research Unit); Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); US Department of Health and Human Services; National Science Foundation DMS(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); ERC(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); The Francis Crick Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank National Influenza Centres worldwide for their contributions to influenza virus surveillance. T.B. was supported by a Newton International Fellowship from the Royal Society and through National Institutes of Health (NIH) U54 GM111274. S.R. was supported by Medical Research Council (UK, Project MR/J008761/1), Wellcome Trust (UK, Project 093488/Z/10/Z), Fogarty International Centre (USA, R01 TW008246-01), Department of Homeland Security (USA, RAPIDD program), National Institute of General Medical Sciences (USA, MIDAS U01 GM110721-01) and National Institute for Health Research (UK, Health Protection Research Unit funding). The Melbourne WHO Collaborating Centre for Reference and Research on Influenza was supported by the Australian Government Department of Health and thanks N. Komadina and Y.-M. Deng. The Atlanta WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza was supported by the US Department of Health and Human Services. NIV thanks A.C. Mishra, M. Chawla-Sarkar, A. M. Abraham, D. Biswas, S. Shrikhande, B. AnuKumar, and A. Jain. Influenza surveillance in India was expanded, in part, through US Cooperative Agreements (5U50C1024407 and U51IP000333) and by the Indian Council of Medical Research. M. A. S. was supported through National Science Foundation DMS 1264153 and NIH R01 AI 107034. Work of the WHO Collaborating Centre for Reference and Research on Influenza at the MRC National Institute for Medical Research was supported by U117512723. P.L., A.R. & M.A.S were supported by EU Seventh Framework Programme [FP7/2007-2013] under Grant Agreement no. 278433-PREDEMICS and ERC Grant agreement no. 260864. C.A.R. was supported by a University Research Fellowship from the Royal Society.	Bedford T, 2014, ELIFE, V3, DOI 10.7554/eLife.01914; Bedford T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-38; Bedford T, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-220; Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918; Chan J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001005; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Cox NJ, 1995, SEMIN VIROL, V6, P359, DOI 10.1016/S1044-5773(05)80013-7; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Kelly HA, 2009, MED J AUSTRALIA, V191, P146, DOI 10.5694/j.1326-5377.2009.tb02723.x; Khiabanian H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006832; Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932; Lemey P, 2012, BIOINFORMATICS, V28, P3248, DOI 10.1093/bioinformatics/bts580; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lin J, 2003, J THEOR BIOL, V222, P437, DOI 10.1016/S0022-5193(03)00056-0; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; MATROSOVICH MN, 1993, VIROLOGY, V196, P111, DOI 10.1006/viro.1993.1459; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Neuzil KM, 2006, J INFECT DIS, V194, P1032, DOI 10.1086/507309; Nobusawa E, 2006, J VIROL, V80, P3675, DOI 10.1128/JVI.80.7.3675-3678.2006; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Recker M, 2007, P NATL ACAD SCI USA, V104, P7711, DOI 10.1073/pnas.0702154104; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Zinder D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003104	38	289	310	7	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					217	U206		10.1038/nature14460	http://dx.doi.org/10.1038/nature14460			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	26053121	Green Accepted, Green Submitted			2022-12-28	WOS:000357695900036
J	Brat, DJ; Verhaak, RGW; Al-Dape, KD; Yung, WKA; Salama, SR; Cooper, LAD; Rheinbay, E; Miller, CR; Vitucci, M; Morozova, O; Robertson, AG; Noushmehr, H; Laird, PW; Cherniack, AD; Akbani, R; Huse, JT; Ciriello, G; Poisson, LM; Barnholtz-Sloan, JS; Berger, MS; Brennan, C; Colen, RR; Colman, H; Flanders, AE; Giannini, C; Grifford, M; Iavarone, A; Jain, R; Joseph, I; Kim, J; Kasaian, K; Mikkelsen, T; Murray, BA; O'Neill, BP; Pachter, L; Parsons, DW; Sougnez, C; Sulman, EP; Vandenberg, SR; Van Meir, EG; von Deimling, A; Zhang, HL; Crain, D; Lau, K; Mallery, D; Morris, S; Paulauskis, J; Penny, R; Shelton, T; Sherman, M; Yena, P; Black, A; Bowen, J; Dicostanzo, K; Gastier-Foster, J; Leraas, KM; Lichtenberg, TM; Pierson, CR; Ramirez, NC; Taylor, C; Weaver, S; Wise, L; Zmuda, E; Davidsen, T; Demchok, JA; Eley, G; Ferguson, ML; Hutter, CM; Shaw, KRM; Ozenberger, BA; Sheth, M; Sofia, HJ; Tarnuzzer, R; Wang, ZN; Yang, LM; Zenklusen, JC; Ayala, B; Baboud, J; Chudamani, S; Jensen, MA; Liu, J; Pihl, T; Raman, R; Wan, YH; Wu, Y; Ally, A; Auman, JT; Balasundaram, M; Balu, S; Baylin, SB; Beroukhim, R; Bootwalla, MS; Bowlby, R; Bristow, CA; Brooks, D; Butterfield, Y; Carlsen, R; Carter, S; Chin, L; Chu, A; Chuah, E; Cibulskis, K; Clarke, A; Coetzee, SG; Dhalla, N; Fennell, T; Fisher, S; Gabriel, S; Getz, G; Gibbs, R; Guin, R; Hadjipanayis, A; Hayes, N; Hinoue, T; Hoadley, K; Holt, RA; Hoyle, AP; Jefferys, SR; Jones, S; Jones, CD; Kucherlapati, R; Lai, PH; Lander, E; Lee, S; Lichtenstein, L; Ma, Y; Maglinte, DT; Mahadeshwar, HS; Marra, MA; Mayo, M; Meng, SW; Meyerson, ML; Mieczkowski, PA; Moore, RA; Mose, LE; Mungall, AJ; Pantazi, A; Parfenov, M; Park, PJ; Parker, JS; Perou, CM; Proto-Popov, A; Ren, XJ; Roach, J; Sabedot, TS; Schein, J; Schumacher, SE; Seidman, JG; Seth, S; Shen, H; Simons, JV; Sipahimalani, P; Soloway, MG; Song, XZ; Sun, HD; Tabak, B; Tam, A; Tan, DH; Tang, JB; Thiessen, N; Triche, T; Van den Berg, DJ; Veluvolu, U; Waring, S; Weisenberger, DJ; Wilkerson, MD; Wong, T; Wu, JY; Xi, L; Xu, AW; Yang, LX; Zack, TI; Zhang, JH; Aksoy, BA; Arachchi, H; Benz, C; Bernard, B; Carlin, D; Cho, J; DiCara, D; Frazer, S; Fuller, GN; Gao, JJ; Gehlenborg, N; Haussler, D; Heiman, DI; Iype, L; Jacobsen, A; Ju, ZL; Katzman, S; Kim, H; Knijnenburg, T; Kreisberg, RB; Lawrence, MS; Lee, W; Leinonen, K; Lin, P; Ling, SY; Liu, WB; Liu, YC; Liu, YX; Lu, YL; Mills, G; Ng, S; Noble, MS; Paull, E; Rao, A; Reynolds, S; Saksena, G; Sanborn, Z; Sander, C; Schultz, N; Senbabaoglu, Y; Shen, RL; Shmulevich, I; Sinha, R; Stuart, J; Sumer, O; Sun, YC; Tasman, N; Taylor, BS; Voet, D; Weinhold, N; Weinstein, JN; Yang, D; Yoshihara, K; Zheng, SY; Zhang, W; Zou, LH; Abel, T; Sadeghi, S; Cohen, ML; Eschbacher, J; Hattab, EM; Raghunathan, A; Schniederjan, MJ; Aziz, D; Barnett, G; Barrett, W; Bigner, DD; Boice, L; Brewer, C; Calatozzolo, C; Campos, B; Carlotti, CG; Chan, TA; Cuppini, L; Curley, E; Cuzzubbo, S; Devine, K; DiMeco, F; Duell, R; Elder, JB; Fehrenbach, A; Finocchiaro, G; Friedman, W; Fulop, J; Gardner, J; Hermes, B; Herold-Mende, C; Jungk, C; Kendler, A; Lehman, NL; Lipp, E; Liu, O; Mandt, R; McGraw, M; Mclendon, R; McPherson, C; Neder, L; Nguyen, P; Noss, A; Nunziata, R; Ostrom, QT; Palmer, C; Perin, A; Pollo, B; Potapov, A; Potapova, O; Rathmell, WK; Rotin, D; Scarpace, L; Schilero, C; Senecal, K; Shimmel, K; Shurkhay, V; Sifri, S; Singh, R; Sloan, AE; Smolenski, K; Staugaitis, SM; Steele, R; Thorne, L; Tirapelli, DPC; Unterberg, A; Vallurupalli, M; Wang, Y; Warnick, R; Williams, F; Wolinsky, Y; Bell, S; Rosenberg, M; Stewart, C; Huang, F; Grimsby, JL; Radenbaugh, AJ; Zhang, JN				Brat, Daniel J.; Verhaak, Roel G. W.; Al-dape, Kenneth D.; Yung, W. K. Alfred; Salama, Sofie R.; Cooper, Lee A. D.; Rheinbay, Esther; Miller, C. Ryan; Vitucci, Mark; Morozova, Olena; Robertson, A. Gordon; Noushmehr, Houtan; Laird, Peter W.; Cherniack, Andrew D.; Akbani, Rehan; Huse, Jason T.; Ciriello, Giovanni; Poisson, Laila M.; Barnholtz-Sloan, Jill S.; Berger, Mitchel S.; Brennan, Cameron; Colen, Rivka R.; Colman, Howard; Flanders, Adam E.; Giannini, Caterina; Grifford, Mia; Iavarone, Antonio; Jain, Rajan; Joseph, Isaac; Kim, Jaegil; Kasaian, Katayoon; Mikkelsen, Tom; Murray, Bradley A.; O'Neill, Brian Patrick; Pachter, Lior; Parsons, Donald W.; Sougnez, Carrie; Sulman, Erik P.; Vandenberg, Scott R.; Van Meir, Erwin G.; von Deimling, Andreas; Zhang, Hailei; Crain, Daniel; Lau, Kevin; Mallery, David; Morris, Scott; Paulauskis, Joseph; Penny, Robert; Shelton, Troy; Sherman, Mark; Yena, Peggy; Black, Aaron; Bowen, Jay; Dicostanzo, Katie; Gastier-Foster, Julie; Leraas, Kristen M.; Lichtenberg, Tara M.; Pierson, Christopher R.; Ramirez, Nilsa C.; Taylor, Cynthia; Weaver, Stephanie; Wise, Lisa; Zmuda, Erik; Davidsen, Tanja; Demchok, John A.; Eley, Greg; Ferguson, Martin L.; Hutter, Carolyn M.; Shaw, Kenna R. Mills; Ozenberger, Bradley A.; Sheth, Margi; Sofia, Heidi J.; Tarnuzzer, Roy; Wang, Zhining; Yang, Liming; Zenklusen, Jean Claude; Ayala, Brenda; Baboud, Julien; Chudamani, Sudha; Jensen, Mark A.; Liu, Jia; Pihl, Todd; Raman, Rohini; Wan, Yunhu; Wu, Ye; Ally, Adrian; Auman, J. Todd; Balasundaram, Miruna; Balu, Saianand; Baylin, Stephen B.; Beroukhim, Rameen; Bootwalla, Moiz S.; Bowlby, Reanne; Bristow, Christopher A.; Brooks, Denise; Butterfield, Yaron; Carlsen, Rebecca; Carter, Scott; Chin, Lynda; Chu, Andy; Chuah, Eric; Cibulskis, Kristian; Clarke, Amanda; Coetzee, Simon G.; Dhalla, Noreen; Fennell, Tim; Fisher, Sheila; Gabriel, Stacey; Getz, Gad; Gibbs, Richard; Guin, Ranabir; Hadjipanayis, Angela; Hayes, Neil; Hinoue, Toshinori; Hoadley, Katherine; Holt, Robert A.; Hoyle, Alan P.; Jefferys, Stuart R.; Jones, Steven; Jones, Corbin D.; Kucherlapati, Raju; Lai, Phillip H.; Lander, Eric; Lee, Semin; Lichtenstein, Lee; Ma, Yussanne; Maglinte, Dennis T.; Mahadeshwar, Harshad S.; Marra, Marco A.; Mayo, Michael; Meng, Shaowu; Meyerson, Matthew L.; Mieczkowski, Piotr A.; Moore, Richard A.; Mose, Lisle E.; Mungall, Andrew J.; Pantazi, Angeliki; Parfenov, Michael; Park, Peter J.; Parker, Joel S.; Perou, Charles M.; Proto-Popov, Alexei; Ren, Xiaojia; Roach, Jeffrey; Sabedot, Thas S.; Schein, Jacqueline; Schumacher, Steven E.; Seidman, Jonathan G.; Seth, Sahil; Shen, Hui; Simons, Janae V.; Sipahimalani, Payal; Soloway, Matthew G.; Song, Xingzhi; Sun, Huandong; Tabak, Barbara; Tam, Angela; Tan, Donghui; Tang, Jiabin; Thiessen, Nina; Triche, Timothy, Jr.; Van Den Berg, David J.; Veluvolu, Umadevi; Waring, Scot; Weisenberger, Daniel J.; Wilkerson, Matthew D.; Wong, Tina; Wu, Junyuan; Xi, Liu; Xu, Andrew W.; Yang, Lixing; Zack, Travis I.; Zhang, Jianhua; Aksoy, B. Arman; Arachchi, Harindra; Benz, Chris; Bernard, Brady; Carlin, Daniel; Cho, Juok; DiCara, Daniel; Frazer, Scott; Fuller, Gregory N.; Gao, JianJiong; Gehlenborg, Nils; Haussler, David; Heiman, David I.; Iype, Lisa; Jacobsen, Anders; Ju, Zhenlin; Katzman, Sol; Kim, Hoon; Knijnenburg, Theo; Kreisberg, Richard Bailey; Lawrence, Michael S.; Lee, William; Leinonen, Kalle; Lin, Pei; Ling, Shiyun; Liu, Wenbin; Liu, Yingchun; Liu, Yuexin; Lu, Yiling; Mills, Gordon; Ng, Sam; Noble, Michael S.; Paull, Evan; Rao, Arvind; Reynolds, Sheila; Saksena, Gordon; Sanborn, Zack; Sander, Chris; Schultz, Nikolaus; Senbabaoglu, Yasin; Shen, Ronglai; Shmulevich, Ilya; Sinha, Rileen; Stuart, Josh; Sumer, Onur; Sun, Yichao; Tasman, Natalie; Taylor, Barry S.; Voet, Doug; Weinhold, Nils; Weinstein, John N.; Yang, Da; Yoshihara, Kosuke; Zheng, Siyuan; Zhang, Wei; Zou, Lihua; Abel, Ty; Sadeghi, Sara; Cohen, Mark L.; Eschbacher, Jenny; Hattab, Eyas M.; Raghunathan, Aditya; Schniederjan, Matthew J.; Aziz, Dina; Barnett, Gene; Barrett, Wendi; Bigner, Darell D.; Boice, Lori; Brewer, Cathy; Calatozzolo, Chiara; Campos, Benito; Carlotti, Carlos Gilberto, Jr.; Chan, Timothy A.; Cuppini, Lucia; Curley, Erin; Cuzzubbo, Stefania; Devine, Karen; DiMeco, Francesco; Duell, Rebecca; Elder, J. Bradley; Fehrenbach, Ashley; Finocchiaro, Gaetano; Friedman, William; Fulop, Jordonna; Gardner, Johanna; Hermes, Beth; Herold-Mende, Christel; Jungk, Christine; Kendler, Ady; Lehman, Norman L.; Lipp, Eric; Liu, Ouida; Mandt, Randy; McGraw, Mary; Mclendon, Roger; McPherson, Christopher; Neder, Luciano; Nguyen, Phuong; Noss, Ardene; Nunziata, Raffaele; Ostrom, Quinn T.; Palmer, Cheryl; Perin, Alessandro; Pollo, Bianca; Potapov, Alexander; Potapova, Olga; Rathmell, W. Kimryn; Rotin, Daniil; Scarpace, Lisa; Schilero, Cathy; Senecal, Kelly; Shimmel, Kristen; Shurkhay, Vsevolod; Sifri, Suzanne; Singh, Rosy; Sloan, Andrew E.; Smolenski, Kathy; Staugaitis, Susan M.; Steele, Ruth; Thorne, Leigh; Tirapelli, Daniela P. C.; Unterberg, Andreas; Vallurupalli, Mahitha; Wang, Yun; Warnick, Ronald; Williams, Felicia; Wolinsky, Yingli; Bell, Sue; Rosenberg, Mara; Stewart, Chip; Huang, Franklin; Grimsby, Jonna L.; Radenbaugh, Amie J.; Zhang, Jianan		Canc Genome Atlas Res Network	Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERT PROMOTER MUTATIONS; MOLECULAR-GENETICS; FREQUENT ATRX; 1P/19Q LOSS; OLIGODENDROGLIOMA; CLASSIFICATION; LANDSCAPE; IDH1; CHEMOTHERAPY; TUMORS	BACKGROUND Diffuse low-grade and intermediate-grade gliomas (which together make up the lower-grade gliomas, World Health Organization grades II and III) have highly variable clinical behavior that is not adequately predicted on the basis of histologic class. Some are indolent; others quickly progress to glioblastoma. The uncertainty is compounded by interobserver variability in histologic diagnosis. Mutations in IDH, TP53, and ATRX and codeletion of chromosome arms 1p and 19q (1p/19q codeletion) have been implicated as clinically relevant markers of lower-grade gliomas. METHODS We performed genomewide analyses of 293 lower-grade gliomas from adults, incorporating exome sequence, DNA copy number, DNA methylation, messenger RNA expression, microRNA expression, and targeted protein expression. These data were integrated and tested for correlation with clinical outcomes. RESULTS Unsupervised clustering of mutations and data from RNA, DNA-copy-number, and DNA-methylation platforms uncovered concordant classification of three robust, nonoverlapping, prognostically significant subtypes of lower-grade glioma that were captured more accurately by IDH, 1p/19q, and TP53 status than by histologic class. Patients who had lower-grade gliomas with an IDH mutation and 1p/19q codeletion had the most favorable clinical outcomes. Their gliomas harbored mutations in CIC, FUBP1, NOTCH1, and the TERT promoter. Nearly all lower-grade gliomas with IDH mutations and no 1p/19q codeletion had mutations in TP53 (94%) and ATRX inactivation (86%). The large majority of lower-grade gliomas without an IDH mutation had genomic aberrations and clinical behavior strikingly similar to those found in primary glioblastoma. CONCLUSIONS The integration of genomewide data from multiple platforms delineated three molecular classes of lower-grade gliomas that were more concordant with IDH, 1p/19q, and TP53 status than with histologic class. Lower-grade gliomas with an IDH mutation either had 1p/19q codeletion or carried a TP53 mutation. Most lower-grade gliomas without an IDH mutation were molecularly and clinically similar to glioblastoma.	[Brat, Daniel J.] Emory Univ Hosp, Winship Canc Inst, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University	Brat, DJ (corresponding author), Emory Univ Hosp, Winship Canc Inst, Dept Pathol & Lab Med, G-167,1364 Clifton Rd NE, Atlanta, GA 30322 USA.	dbrat@emory.edu	Perou, Charles M/H-9934-2014; Mungall, Andrew J./U-7067-2018; Tirapelli, Daniela PC/F-9230-2012; Barnholtz-Sloan, Jill/A-4817-2011; Brennan, Cameron/R-7082-2019; Friedman, William/GLR-1220-2022; Laird, Peter W/G-8683-2012; Holt, Robert A/C-3303-2009; Gao, JianJiong/B-5673-2016; Perin, Alessandro/AAM-6299-2021; Marra, Marco A/B-5987-2008; von Deimling, Andreas/F-7774-2013; Cibulskis, Kristian/AAC-7380-2019; Kucherlapati, Raju/ABC-8807-2021; Calatozzolo, Chiara/AAM-1153-2021; Perin, Alessandro/AAC-1316-2019; Carlotti, Carlos G/C-1608-2012; Ostrom, Quinn/F-1820-2018; Colen, Rivka/Y-4062-2019; Shen, Hui/AAO-4387-2020; Verhaak, Roel/ABE-7058-2020; Sloan, Andrew/AAE-9842-2020; Zheng, sy/GRS-3136-2022; Van Den Berg, David J/G-8598-2017; Pollo, Bianca/K-5347-2018; Lehman, Norman L/A-7351-2015; Seth, Sahil/I-5809-2019; Finocchiaro, Gaetano/AAG-6791-2020; Lee, Semin/S-2629-2016; Salama, Sofie/K-6412-2019; Miller, Ryan/B-9365-2008; Shurkhay, Vsevolod/AAS-1144-2021; Colman, Howard/L-5433-2019; Giannini, Caterina/AAB-7551-2022; Schein, Jacquie E/G-3674-2015; DiMeco, Francesco/Z-5431-2019; Chan, Timothy A/ABD-5850-2021; Yung, W.K. Alfred/W-5016-2019; Cherniack, Andrew D./AAY-8132-2020; Jones, Steven J/C-3621-2009; Shurkhay, Vsevolod/G-9000-2018; Cherniack, Andrew/AAC-5310-2019; Parker, Joel/AAG-1108-2019; Schultz, Nikolaus/ABE-6347-2020; N, Houtan/C-9692-2013; Yoshihara, Kosuke/AAU-9874-2020; Lawrence, Michael/AAC-8202-2020; Hattab, Eyas M/E-9342-2016; Skanderup, Anders Jacobsen/K-1081-2013; Kim, Hoon/AAL-9283-2020; Weisenberger, Daniel/AAA-8314-2020; Cuzzubbo, Stefania/AAQ-2874-2021; Sarraf Sabedot, Thais/J-2349-2016; DiMeco, Francesco/Q-3785-2016; Coetzee, Simon Gert/C-1218-2014	Perou, Charles M/0000-0001-9827-2247; Mungall, Andrew J./0000-0002-0905-2742; Tirapelli, Daniela PC/0000-0002-1886-4988; Barnholtz-Sloan, Jill/0000-0001-6190-9304; Brennan, Cameron/0000-0003-4064-8891; Laird, Peter W/0000-0001-9117-3641; Holt, Robert A/0000-0002-7259-1247; Gao, JianJiong/0000-0002-5739-1781; Marra, Marco A/0000-0001-7146-7175; von Deimling, Andreas/0000-0002-5863-540X; Calatozzolo, Chiara/0000-0003-0165-3495; Perin, Alessandro/0000-0002-6697-9835; Carlotti, Carlos G/0000-0002-7055-0564; Ostrom, Quinn/0000-0003-3469-7558; Van Den Berg, David J/0000-0002-5404-5218; Pollo, Bianca/0000-0002-5523-4256; Seth, Sahil/0000-0003-4579-3959; Lee, Semin/0000-0002-9015-6046; Miller, Ryan/0000-0002-0096-8762; Shurkhay, Vsevolod/0000-0001-9538-4374; Cherniack, Andrew D./0000-0003-0470-0111; Jones, Steven J/0000-0003-3394-2208; Shurkhay, Vsevolod/0000-0001-9538-4374; N, Houtan/0000-0003-4051-8114; Yoshihara, Kosuke/0000-0002-2254-3378; Hattab, Eyas M/0000-0002-3660-6261; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Kim, Hoon/0000-0003-4244-6126; Weisenberger, Daniel/0000-0001-8303-2603; Stuart, Joshua/0000-0002-2171-565X; Pachter, Lior/0000-0002-9164-6231; Park, Peter/0000-0001-9378-960X; Palmer, Cheryl/0000-0001-6088-9161; Bowen, Jay/0000-0001-6861-9043; Yang, Da/0000-0002-8336-9457; Heiman, David/0000-0001-7895-4259; Hoadley, Katherine/0000-0002-1216-477X; Zheng, Siyuan/0000-0002-1031-9424; Ciriello, Giovanni/0000-0003-2021-8683; Rotin, Daniil/0000-0003-3386-0077; Tarnuzzer, Roy/0000-0002-3725-4173; Triche, Tim/0000-0001-5665-946X; Shen, Hui/0000-0001-9767-4084; Potapov, Alexander/0000-0001-8343-3511; Sulman, Erik/0000-0003-4933-9120; Raghunathan, Aditya/0000-0001-6198-7441; Auman, James/0000-0002-9328-8829; Sinha, Rileen/0000-0001-5497-5055; Iavarone, Antonio/0000-0002-0683-4634; DiMeco, Francesco/0000-0001-6213-5793; Jain, Rajan/0000-0002-4879-0457; Salama, Sofie/0000-0001-6999-7193; Cuzzubbo, Stefania/0000-0003-0288-4607; Cibulskis, Kristian/0000-0003-1343-1582; Parsons, Donald/0000-0002-8775-3501; Finocchiaro, Gaetano/0000-0003-3583-4040; Lipp, Eric/0000-0002-4372-5533; Rosenberg, Mara/0000-0001-6400-3161; Fuller, Gregory/0000-0001-9447-2647; Mieczkowski, Piotr/0000-0003-2418-0096; Vaske, Olena/0000-0002-1677-417X; Gehlenborg, Nils/0000-0003-0327-8297; Coetzee, Simon Gert/0000-0003-4267-5930; Meyerson, Matthew/0000-0002-9133-8108; Jensen, Mark/0000-0001-5215-101X; Weinstein, John/0000-0001-9401-6908	National Institutes of Health; NATIONAL CANCER INSTITUTE [U24CA180951, U01CA168394, R01CA163722, U24CA126561, U24CA143799, U24CA126551, U24CA194362, U24CA143840, U24CA126563, U24CA126544, U24CA143883, U24CA143843, U24CA126543, U24CA143835, U24CA126546, U24CA143867, U24CA126554, U24CA143866, U24CA143858, U24CA144025, P30CA016672, U24CA143845, U24CA143882, U24CA143848] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007990, U54HG003067, U54HG003079, U54HG003273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funded by the National Institutes of Health.	Aldape K, 2007, ARCH PATHOL LAB MED, V131, P242; Appin CL, 2014, CANCER J, V20, P66, DOI 10.1097/PPO.0000000000000020; Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Bourne TD, 2010, NAT REV NEUROL, V6, P695, DOI 10.1038/nrneurol.2010.159; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Cho J, 2011, CANCER RES, V71, P7587, DOI 10.1158/0008-5472.CAN-11-0821; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Cryan JB, 2014, ONCOTARGET, V5, P8083, DOI 10.18632/oncotarget.2342; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Gala K, 2014, CLIN CANCER RES, V20, P1410, DOI 10.1158/1078-0432.CCR-13-1549; Giannini C, 2008, BRAIN PATHOL, V18, P360, DOI 10.1111/j.1750-3639.2008.00129.x; Goldman M, 2013, NUCLEIC ACIDS RES, V41, pD949, DOI 10.1093/nar/gks1008; Jakola AS, 2012, JAMA-J AM MED ASSOC, V308, P1881, DOI 10.1001/jama.2012.12807; Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Killela PJ, 2014, ONCOTARGET, V5, P1452, DOI 10.18632/oncotarget.1505; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Liu XY, 2012, ACTA NEUROPATHOL, V124, P615, DOI 10.1007/s00401-012-1031-3; Louis DN, 2014, BRAIN PATHOL, V24, P429, DOI 10.1111/bpa.12171; MACDONALD DR, 1990, ANN NEUROL, V27, P573, DOI 10.1002/ana.410270519; Martin M, 2013, NAT GENET, V45, P933, DOI 10.1038/ng.2674; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Ng S, 2012, BIOINFORMATICS, V28, pI640, DOI 10.1093/bioinformatics/bts402; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Parker BC, 2013, J CLIN INVEST, V123, P855, DOI 10.1172/JCI67144; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Reuss DE, 2015, ACTA NEUROPATHOL, V129, P133, DOI 10.1007/s00401-014-1370-3; Rodriguez FJ, 2014, AM J SURG PATHOL, V38, P1058, DOI 10.1097/PAS.0000000000000221; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Sahm F, 2014, ACTA NEUROPATHOL, V128, P551, DOI 10.1007/s00401-014-1326-7; Sanai N, 2011, J NEUROSURG, V115, P948, DOI [10.3171/2011.7.JNS101238, 10.3171/2011.7.JNS10238]; Sanborn JZ, 2013, CANCER RES, V73, P6036, DOI 10.1158/0008-5472.CAN-13-0186; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; The WHO, 2020, CLASSIFICATION TUMOU; Theeler BJ, 2012, NEUROLOGY, V79, P1917, DOI 10.1212/WNL.0b013e318271f7cb; Torres-Garcia W, 2014, BIOINFORMATICS, V30, P2224, DOI 10.1093/bioinformatics/btu169; van den Bent MJ, 2014, NEURO-ONCOLOGY, V16, P1570, DOI 10.1093/neuonc/nou297; van den Bent MJ, 2013, J CLIN ONCOL, V31, P344, DOI 10.1200/JCO.2012.43.2229; van den Bent MJ, 2010, ACTA NEUROPATHOL, V120, P297, DOI 10.1007/s00401-010-0725-7; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weller M, 2012, NEURO-ONCOLOGY, V14, P100, DOI 10.1093/neuonc/nos206; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wiestler B, 2014, ACTA NEUROPATHOL, V128, P561, DOI 10.1007/s00401-014-1315-x; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yip S, 2012, J PATHOL, V226, P7, DOI 10.1002/path.2995; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zheng SY, 2013, GENE DEV, V27, P1462, DOI 10.1101/gad.213686.113	52	1836	1864	9	224	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2015	372	26					2481	2498		10.1056/NEJMoa1402121	http://dx.doi.org/10.1056/NEJMoa1402121			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL2QD	26061751	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000356788200005
J	Bergmann, O; Zdunek, S; Felker, A; Salehpour, M; Alkass, K; Bernard, S; Sjostrom, SL; Szewczykowska, M; Jackowska, T; dos Remedios, C; Malm, T; Andra, M; Jashari, R; Nyengaard, JR; Possnert, G; Jovinge, S; Druid, H; Frisen, J				Bergmann, Olaf; Zdunek, Sofia; Felker, Anastasia; Salehpour, Mehran; Alkass, Kanar; Bernard, Samuel; Sjostrom, Staffan L.; Szewczykowska, Mirosawa; Jackowska, Teresa; dos Remedios, Cris; Malm, Torsten; Andrae, Michaela; Jashari, Ramadan; Nyengaard, Jens R.; Possnert, Goran; Jovinge, Stefan; Druid, Henrik; Frisen, Jonas			Dynamics of Cell Generation and Turnover in the Human Heart	CELL			English	Article							CARDIOMYOCYTE DNA-SYNTHESIS; CARDIAC STEM-CELLS; MYOCARDIAL-INFARCTION; IN-VIVO; ADULT HEART; REGENERATION; NUCLEI; NUMBER; PROLIFERATION; MYOCYTES	The contribution of cell generation to physiological heart growth and maintenance in humans has been difficult to establish and has remained controversial. We report that the full complement of cardiomyocytes is established perinataly and remains stable over the human lifespan, whereas the numbers of both endothelial and mesenchymal cells increase substantially from birth to early adulthood. Analysis of the integration of nuclear bomb test-derived C-14 revealed a high turnover rate of endothelial cells throughout life (>15% per year) and more limited renewal of mesenchymal cells (<4% per year in adulthood). Cardiomyocyte exchange is highest in early childhood and decreases gradually throughout life to <1% per year in adulthood, with similar turnover rates in the major subdivisions of the myocardium. We provide an integrated model of cell generation and turnover in the human heart.	[Bergmann, Olaf; Zdunek, Sofia; Felker, Anastasia; Alkass, Kanar; Sjostrom, Staffan L.; Frisen, Jonas] Karolinska Inst, Dept Cellular & Mol Biol, S-17177 Stockholm, Sweden; [Salehpour, Mehran; Possnert, Goran] Uppsala Univ, Dept Phys & Astron, Div Ion Phys, S-75120 Uppsala, Sweden; [Alkass, Kanar; Druid, Henrik] Karolinska Inst, Dept Forens Med, S-17177 Stockholm, Sweden; [Bernard, Samuel] Univ Lyon, Inst Camille Jordan, Dept Math, F-69622 Villeurbanne, France; [Szewczykowska, Mirosawa; Jackowska, Teresa] Bielanski Hosp, Dept Pediat, PL-01809 Warsaw, Poland; [Jackowska, Teresa] Med Ctr Postgrad Educ, Dept Pediat, PL-01813 Warsaw, Poland; [dos Remedios, Cris] Univ Sydney, Bosch Inst, Discipline Anat, Sydney, NSW 2006, Australia; [Malm, Torsten] Skane Univ Hosp, Dept Paediat Cardiac Surg, S-22185 Lund, Sweden; [Andrae, Michaela] Med Univ Graz, Klinikum Klagenfurt, A-9020 Graz, Austria; [Andrae, Michaela] Med Univ Graz, Sect Surg Res, Dept Cardiothorac & Vasc Surg, A-9020 Graz, Austria; [Jashari, Ramadan] European Homograft Bank, B-1120 Brussels, Belgium; [Nyengaard, Jens R.] Aarhus Univ, Ctr Stochast Geometry & Adv Bioimaging, Stereol & Elect Microscopy Lab, DK-8000 Aarhus, Denmark; [Jovinge, Stefan] Spectrum Hlth Frederik Meijer Heart & Vasc Inst, Grand Rapids, MI 49503 USA; [Jovinge, Stefan] Van Andel Inst, Grand Rapids, MI 49503 USA; [Jovinge, Stefan] Lund Univ, Stem Cell Ctr, S-22184 Lund, Sweden	Karolinska Institutet; Uppsala University; Karolinska Institutet; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Centre of Postgraduate Medical Education - Poland; University of Sydney; Lund University; Skane University Hospital; Medical University of Graz; Medical University of Graz; Aarhus University; Van Andel Institute; Lund University	Bergmann, O (corresponding author), Karolinska Inst, Dept Cellular & Mol Biol, S-17177 Stockholm, Sweden.	olaf.bergmann@ki.se; jonas.frisen@ki.se	JACKOWSKA, TERESA/X-1947-2019; Bergmann, Olaf/A-5706-2009; Bernard, Samuel/A-5623-2009	Bergmann, Olaf/0000-0003-1065-4107; Bernard, Samuel/0000-0002-8442-9968; Jashari, Ramadan/0000-0002-0867-1998; Druid, Henrik/0000-0002-9198-023X; alkass, kanar/0000-0002-9154-5393; JACKOWSKA, TERESA/0000-0003-0131-7854	Swedish Research Council; Swedish Heart and Lung Foundation; Swedish Cancer Society; Karolinska Institute, Tobias Stiftelsen; Strategic Research Programs in Stem Cells and Regenerative Medicine at Karolinska Institutet (StratRegen), Torsten Soderbergs Stiftelse, Knut och Alice Wallenbergs Stiftelse; Richard and Helen DeVos Foundation; Villum Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institute, Tobias Stiftelsen; Strategic Research Programs in Stem Cells and Regenerative Medicine at Karolinska Institutet (StratRegen), Torsten Soderbergs Stiftelse, Knut och Alice Wallenbergs Stiftelse; Richard and Helen DeVos Foundation; Villum Foundation(Villum Fonden)	We thank G. Eppens, J. Panula, and E. Norlin for help with flow cytometry sorting and DNA purification, M. Toro and S. Giatrellis for assistance and advice in flow cytometry, and K. Hakansson for AMS sample preparation. We acknowledge support with SIM imaging from the Advance Light Microscopy facility at the Science for Life Laboratory. This study was supported by grants from the Swedish Research Council, The Swedish Heart and Lung Foundation, the Swedish Cancer Society, the Karolinska Institute, Tobias Stiftelsen, the Strategic Research Programs in Stem Cells and Regenerative Medicine at Karolinska Institutet (StratRegen), Torsten Soderbergs Stiftelse, Knut och Alice Wallenbergs Stiftelse, and Richard and Helen DeVos Foundation. The Centre for Stochastic Geometry and Advanced Bioimaging is supported by the Villum Foundation.	Adler C, 1991, DEV REGENERATIVE POT, P227; Ang KL, 2010, AM J PHYSIOL-CELL PH, V298, pC1603, DOI 10.1152/ajpcell.00435.2009; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2012, JOVE-J VIS EXP, DOI 10.3791/4205; Bergmann O, 2014, STEM CELL RES, V13, P523, DOI 10.1016/j.scr.2014.07.002; Bergmann O, 2011, EXP CELL RES, V317, P188, DOI 10.1016/j.yexcr.2010.08.017; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bruel A, 2005, BASIC RES CARDIOL, V100, P311, DOI 10.1007/s00395-005-0524-9; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; ConradLapostolle V, 1996, CELL BIOL TOXICOL, V12, P189, DOI 10.1007/BF00438144; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Herget GW, 1997, CARDIOVASC RES, V36, P45, DOI 10.1016/S0008-6363(97)00140-5; Hosoda T, 2009, P NATL ACAD SCI USA, V106, P17169, DOI 10.1073/pnas.0903089106; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737; MandarimDeLacerda CA, 1997, EARLY HUM DEV, V48, P249, DOI 10.1016/S0378-3782(96)01863-4; Mayhew TM, 1997, J ANAT, V191, P107, DOI 10.1046/j.1469-7580.1997.19110107.x; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Naqvi N, 2014, CELL, V157, P795, DOI 10.1016/j.cell.2014.03.035; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Uchida S, 2013, STEM CELL REP, V1, P397, DOI 10.1016/j.stemcr.2013.09.004; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005	33	607	625	8	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1566	1575		10.1016/j.cell.2015.05.026	http://dx.doi.org/10.1016/j.cell.2015.05.026			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26073943	Bronze			2022-12-28	WOS:000356618200014
J	Portman, ME				Portman, Michelle E.			You'll be OK	SCIENCE			English	Editorial Material								When I entered the workforce, at age 27, my goal was to shape environmental quality and protection in a relatively new country, Israel. My background-a bachelor's degree in political economy of natural resources from the University of California, Berkeley, and a master's degree in urban and regional planning from the Technion-Israel Institute of Technology-led to positions first in government and then at an environmental non-governmental organization. My work was meaningful and influential, and it supported my husband's studies: He had just finished military service and had no family financial backing. I hoped I would get a chance to go back to school when he finished.	Technion Israel Inst Technol, Haifa, Israel	Technion Israel Institute of Technology	Portman, ME (corresponding author), Technion Israel Inst Technol, Haifa, Israel.								0	0	0	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1282	1282		10.1126/science.348.6240.1282	http://dx.doi.org/10.1126/science.348.6240.1282			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068856				2022-12-28	WOS:000356011500060
J	Kangovi, S; Grande, D; Trinh-Shevrin, C				Kangovi, Shreya; Grande, David; Trinh-Shevrin, Chau			From Rhetoric to Reality - Community Health Workers in Post-Reform US Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kangovi, Shreya; Grande, David] Univ Penn, Div Gen Internal Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kangovi, Shreya] Univ Penn, Penn Ctr Community Hlth Workers, Philadelphia, PA 19104 USA; [Trinh-Shevrin, Chau] NYU, Sch Med, Dept Populat Hlth, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; New York University	Kangovi, S (corresponding author), Univ Penn, Div Gen Internal Med, Perelman Sch Med, Philadelphia, PA 19104 USA.		Grande, David/AAJ-8191-2021	Grande, David/0000-0002-6717-6735	NIMHD NIH HHS [U54 MD000538, P60 MD000538] Funding Source: Medline; NCCDPHP CDC HHS [U48 DP005008] Funding Source: Medline; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP005008] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD000538, P60MD000538] Funding Source: NIH RePORTER	NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NCCDPHP CDC HHS; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		[Anonymous], 2013, IMPACT MAN; O'Brien MJ, 2009, AM J PREV MED, V37, pS262, DOI 10.1016/j.amepre.2009.08.011; RICHTER RW, 1974, AM J PUBLIC HEALTH, V64, P1056, DOI 10.2105/AJPH.64.11.1056; Rifkin SB, 1996, ACTA TROP, V61, P79, DOI 10.1016/0001-706X(95)00105-N; Viswanathan M, 2010, MED CARE, V48, P792, DOI 10.1097/MLR.0b013e3181e35b51	5	58	59	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2015	372	24					2277	2279		10.1056/NEJMp1502569	http://dx.doi.org/10.1056/NEJMp1502569			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK2DB	26061832	Green Accepted			2022-12-28	WOS:000356019200001
J	O'Driscoll, L				O'Driscoll, Lorraine			Expanding on Exosomes and Ectosomes in Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[O'Driscoll, Lorraine] Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Dublin, Ireland; [O'Driscoll, Lorraine] Trinity Coll Dublin, Trinity Biomed Sci Inst, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	O'Driscoll, L (corresponding author), Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Dublin, Ireland.			O'Driscoll, Lorraine/0000-0002-9860-8262				Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; Le MTN, 2014, J CLIN INVEST, V124, P5109, DOI 10.1172/JCI75695; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Shimoda M, 2014, NAT CELL BIOL, V16, P889, DOI 10.1038/ncb3021	4	71	71	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2015	372	24					2359	2362		10.1056/NEJMcibr1503100	http://dx.doi.org/10.1056/NEJMcibr1503100			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK2DB	26061842	Green Published			2022-12-28	WOS:000356019200016
J	Berl, T				Berl, Tomas			DISORDERS OF FLUIDS AND ELECTROLYTES Vasopressin Antagonists	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							WORSENING HEART-FAILURE; ANTIDIURETIC-HORMONE; ORAL TOLVAPTAN; V-2-RECEPTOR ANTAGONIST; INAPPROPRIATE SECRETION; INTRAVENOUS CONIVAPTAN; NEPHROGENIC SYNDROME; MOLECULAR-CLONING; AQUARETIC AGENT; HIGHLY POTENT		[Berl, Tomas] Univ Colorado, Denver, CO 80202 USA	University of Colorado System; University of Colorado Denver	Berl, T (corresponding author), Div Renal Dis & Hypertens, Box C281,12700 E 19th Ave,Res 2,Rm 7014, Aurora, CO 80045 USA.	tomas.berl@ucdenver.edu						Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH; Benedetto i G, 2012, DIRECT HEALTHCARE PR; Berl T, 2010, J AM SOC NEPHROL, V21, P705, DOI 10.1681/ASN.2009080857; BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; Costello-Boerrigter LC, 2009, HEART FAIL REV, V14, P75, DOI 10.1007/s10741-008-9108-8; Cyr PL, 2004, AM J HEALTH-SYST PH, V68, P328; Decaux G, 2007, NEPHROL DIAL TRANSPL, V22, P1853, DOI 10.1093/ndt/gfm136; Decaux G, 2007, J AM SOC NEPHROL, V18, P606, DOI 10.1681/ASN.2006090987; Dominguez Manuel, 2013, Methodist Debakey Cardiovasc J, V9, P49; DUNN FL, 1973, J CLIN INVEST, V52, P3212, DOI 10.1172/JCI107521; Feldman BJ, 2005, NEW ENGL J MED, V352, P1884, DOI 10.1056/NEJMoa042743; Fenske WK, 2014, J AM SOC NEPHROL, V25, P2376, DOI 10.1681/ASN.2013080895; Food and Drug Administration, 2013, FDA SAF COMM FDA LIM; Furst H, 2000, AM J MED SCI, V319, P240, DOI 10.1097/00000441-200004000-00007; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Gheorghiade M, 2004, JAMA-J AM MED ASSOC, V291, P1963, DOI 10.1001/jama.291.16.1963; GOTTSCHALK CW, 1959, AM J PHYSIOL, V196, P927, DOI 10.1152/ajplegacy.1959.196.4.927; Greenberg A, 2015, KIDNEY INT; Hauptman PJ, 2013, J CARD FAIL, V19, P390, DOI 10.1016/j.cardfail.2013.04.001; Hoorn EJ, 2011, CLIN J AM SOC NEPHRO, V6, P951, DOI 10.2215/CJN.01210211; Howell W H, 1898, J Exp Med, V3, P245, DOI 10.1084/jem.3.2.245; Jaber BL, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2011.04.028; JEWELL PA, 1957, PHILOS T R SOC B, V240, P197, DOI 10.1098/rstb.1957.0002; Jovanovich AJ, 2013, KIDNEY INT, V83, P563, DOI 10.1038/ki.2012.402; Kengne FG, 2008, QJM-INT J MED, V101, P583, DOI 10.1093/qjmed/hcn061; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Lehrich RW, 2013, AM J KIDNEY DIS, V62, P364, DOI 10.1053/j.ajkd.2013.01.034; Macion-Dazard R, 2006, J PHARMACOL EXP THER, V316, P564, DOI 10.1124/jpet.105.095554; Malhotra I, 2014, CASE REP ENDOCRINOL, V2014, DOI 10.1155/2014/807054; MANNING M, 1989, J LAB CLIN MED, V114, P617; Musch W, 1998, QJM-MON J ASSOC PHYS, V91, P749, DOI 10.1093/qjmed/91.11.749; Nagler EV, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0231-1; OHNISHI A, 1993, J CLIN INVEST, V92, P2653, DOI 10.1172/JCI116881; Oliver G, 1895, J Physiol, V18, P277; Pinto CS, 2012, AM J PHYSIOL-RENAL, V303, pF1412, DOI 10.1152/ajprenal.00692.2011; Renneboog B, 2006, AM J MED, V119, P71, DOI [10.1016/j.amjmed.2005.09.026, DOI 10.1016/J.AMJMED.2005.09.026]; ROBERTSON GL, 1982, AM J MED, V72, P339, DOI 10.1016/0002-9343(82)90825-7; Rozen-Zvi B, 2010, AM J KIDNEY DIS, V56, P325, DOI 10.1053/j.ajkd.2010.01.013; SCHMALE H, 1984, NATURE, V308, P705, DOI 10.1038/308705a0; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; SCHRIER RW, 1979, AM J PHYSIOL, V236, pF321, DOI 10.1152/ajprenal.1979.236.4.F321; SCHWARTZ WB, 1957, AM J MED, V23, P529, DOI 10.1016/0002-9343(57)90224-3; SerradeilLeGal C, 1996, J CLIN INVEST, V98, P2729, DOI 10.1172/JCI119098; Shea AM, 2008, J AM SOC NEPHROL, V19, P764, DOI 10.1681/ASN.2007070752; Soupart A, 2012, CLIN J AM SOC NEPHRO, V7, P742, DOI 10.2215/CJN.06990711; Spasovski G, 2014, NEPHROL DIAL TRANSPL, V29, P1, DOI 10.1093/ndt/gfu040; STASSEN FL, 1983, PROG BRAIN RES, V60, P395; Steele A, 1997, ANN INTERN MED, V126, P20, DOI 10.7326/0003-4819-126-1-199701010-00003; Tahara A, 1998, N-S ARCH PHARMACOL, V357, P63; THIBONNIER M, 1994, J BIOL CHEM, V269, P3304; Thibonnier M, 2000, J PHARMACOL EXP THER, V294, P195; Thibonnier M, 2001, ANNU REV PHARMACOL, V41, P175, DOI 10.1146/annurev.pharmtox.41.1.175; Thurman J, 2008, THERAPY NEPHROLOGY H, P337; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; TURNER RA, 1951, J BIOL CHEM, V191, P21; Velez JCQ, 2010, NEPHROL DIAL TRANSPL, V25, P1524, DOI 10.1093/ndt/gfp731; Verbalis JG, 2014, CURR MED RES OPIN, V30, P1201, DOI 10.1185/03007995.2014.920314; Verbalis JG, 2013, AM J MED, V126, pS5, DOI 10.1016/j.amjmed.2013.07.006; Verbalis JG, 2011, EUR J ENDOCRINOL, V164, P725, DOI 10.1530/EJE-10-1078; VERNEY EB, 1947, PROC R SOC SER B-BIO, V135, P25, DOI 10.1098/rspb.1947.0037; Von de Velden V, 1913, HERL KILN WOCHNSCHR, V1, P2083; Yamamura Y, 1998, J PHARMACOL EXP THER, V287, P860; YAMAMURA Y, 1992, BRIT J PHARMACOL, V105, P787, DOI 10.1111/j.1476-5381.1992.tb09058.x; Yun BC, 2009, HEPATOLOGY, V49, P1610, DOI 10.1002/hep.22846; Zeltser D, 2007, AM J NEPHROL, V27, P447, DOI 10.1159/000106456	65	27	28	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2015	372	23					2207	2216		10.1056/NEJMra1403672	http://dx.doi.org/10.1056/NEJMra1403672			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1GK	26039601				2022-12-28	WOS:000355955100005
J	Chong, YT; Koh, JLY; Friesen, H; Duffy, K; Cox, MJ; Moses, A; Moffat, J; Boone, C; Andrews, BJ				Chong, Yolanda T.; Koh, Judice L. Y.; Friesen, Helena; Duffy, Kaluarachchi; Cox, Michael J.; Moses, Alan; Moffat, Jason; Boone, Charles; Andrews, Brenda J.			Yeast Proteome Dynamics from Single Cell Imaging and Automated Analysis	CELL			English	Article							DNA-DAMAGE RESPONSE; GENOMIC EXPRESSION; GENE-EXPRESSION; GLOBAL ANALYSIS; LOCALIZATION; GROWTH; REPLICATION; NETWORKS; REVEALS; ABUNDANCE	Proteomics has proved invaluable in generating large-scale quantitative data; however, the development of systems approaches for examining the proteome in vivo has lagged behind. To evaluate protein abundance and localization on a proteome scale, we exploited the yeast GFP-fusion collection in a pipeline combining automated genetics, high-throughput microscopy, and computational feature analysis. We developed an ensemble of binary classifiers to generate localization data from single-cell measurements and constructed maps of similar to 3,000 proteins connected to 16 localization classes. To survey proteome dynamics in response to different chemical and genetic stimuli, we measure proteome-wide abundance and localization and identified changes over time. We analyzed >20 million cells to identify dynamic proteins that redistribute among multiple localizations in hydroxyurea, rapamycin, and in an rpd3 Delta background. Because our localization and abundance data are quantitative, they provide the opportunity for many types of comparative studies, single cell analyses, modeling, and prediction.	[Chong, Yolanda T.; Koh, Judice L. Y.; Friesen, Helena; Duffy, Kaluarachchi; Cox, Michael J.; Moffat, Jason; Boone, Charles; Andrews, Brenda J.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S3E1, Canada; [Duffy, Kaluarachchi; Cox, Michael J.; Moffat, Jason; Boone, Charles; Andrews, Brenda J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S3E1, Canada; [Moses, Alan] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S3E1, Canada	University of Toronto; University of Toronto; University of Toronto	Andrews, BJ (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON M5S3E1, Canada.	brenda.andrews@utoronto.ca	Moffat, Jason/AAC-1110-2020	Moffat, Jason/0000-0002-5663-8586	Canadian Institutes for Health Research [MOP-97939]; Ontario Institute for Cancer Research; Canadian Foundation for Innovation; Ministry of Research and Innovation (Ontario) [21745]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research; Canadian Foundation for Innovation(Canada Foundation for Innovation); Ministry of Research and Innovation (Ontario)(Ministry of Research and Innovation, Ontario)	We thank Jeff Liu, David Wade-Farley, Quaid Morris, Lee Zamparo, Harm Van Bakel, Kyle Tsui, and Corey Nislow for technical assistance and advice. We thank Michael Costanzo for helpful discussions and comments on the manuscript. This work was supported by grant MOP-97939 from the Canadian Institutes for Health Research to B.A. and C.B., and with funds from the Ontario Institute for Cancer Research to J.M. Infrastructure for high-content imaging was acquired with funds from the Canadian Foundation for Innovation and the Ministry of Research and Innovation (Ontario) (grant 21745 to B.A. and C.B.). B.A., J.M., and C.B. are Senior Fellows in the Genetic Networks program of the Canadian Institute for Advanced Research.	Aitchison JD, 2012, GENETICS, V190, P855, DOI 10.1534/genetics.111.127803; Alejandro-Osorio AL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r57; Alvino GM, 2007, MOL CELL BIOL, V27, P6396, DOI 10.1128/MCB.00719-07; Benanti JA, 2007, NAT CELL BIOL, V9, P1184, DOI 10.1038/ncb1639; Blondel M, 2000, EMBO J, V19, P6085, DOI 10.1093/emboj/19.22.6085; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/BF00058655; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Breker M, 2013, J CELL BIOL, V200, P839, DOI 10.1083/jcb.201301120; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chong YT, 2012, ADV EXP MED BIOL, V736, P169, DOI 10.1007/978-1-4419-7210-1_8; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dechant R, 2008, CURR OPIN CELL BIOL, V20, P678, DOI 10.1016/j.ceb.2008.09.009; Denervaud N, 2013, P NATL ACAD SCI USA, V110, P15842, DOI 10.1073/pnas.1308265110; Dubacq C, 2006, MOL GENET GENOMICS, V275, P114, DOI 10.1007/s00438-005-0077-5; Duffy SK, 2012, CELL, V149, P936, DOI 10.1016/j.cell.2012.02.064; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Fournier ML, 2010, MOL CELL PROTEOMICS, V9, P271, DOI 10.1074/mcp.M900415-MCP200; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hall M., 2009, SIGKDD EXPLOR NEWSL, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Handfield LF, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003085; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Hood-DeGrenier JK, 2011, YEAST, V28, P189, DOI 10.1002/yea.1830; Howe AG, 2002, J BIOL CHEM, V277, P44100, DOI 10.1074/jbc.M206643200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kemmeren P, 2014, CELL, V157, P740, DOI 10.1016/j.cell.2014.02.054; Koh JLY, 2010, NUCLEIC ACIDS RES, V38, pD502, DOI 10.1093/nar/gkp820; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067902; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Loo LH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003504; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Mazumder A, 2013, MOL CELL BIOL, V33, P635, DOI 10.1128/MCB.01020-12; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013722; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Rees JS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002386; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; YAN H, 1993, GENE DEV, V7, P2149, DOI 10.1101/gad.7.11.2149; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	54	177	181	0	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1413	1424		10.1016/j.cell.2015.04.051	http://dx.doi.org/10.1016/j.cell.2015.04.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26046442	Bronze			2022-12-28	WOS:000355935000019
J	Sokol, DK				Sokol, Daniel K.			ETHICS MAN Once a month, or the secret to raising the status of medical ethics	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Sokol@12kbw.co.uk						Osler W, 1901, J AMER MED ASSOC, V36, P1673	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2015	350								h2883	10.1136/bmj.h2883	http://dx.doi.org/10.1136/bmj.h2883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK0TW	26037918				2022-12-28	WOS:000355918900014
J	Smith, LJ; Kalhan, R; Wise, RA; Sugar, EA; Lima, JJ; Irvin, CG; Dozor, AJ; Holbrook, JT				Smith, Lewis J.; Kalhan, Ravi; Wise, Robert A.; Sugar, Elizabeth A.; Lima, John J.; Irvin, Charles G.; Dozor, Allen J.; Holbrook, Janet T.		Amer Lung Assoc Asthma Clinical	Effect of a Soy Isoflavone Supplement on Lung Function and Clinical Outcomes in Patients With Poorly Controlled Asthma A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUINEA-PIG MODEL; DIETARY-INTAKE; VITAMIN-C; GENISTEIN; RELIABILITY; VALIDITY; RESPONSIVENESS; PHYTOESTROGENS; CHALLENGE; MAGNESIUM	IMPORTANCE Soy isoflavone supplements are used to treat several chronic diseases, although the data supporting their use are limited. Some data suggest that supplementation with soy isoflavone may be an effective treatment for patients with poor asthma control. OBJECTIVE To determine whether a soy isoflavone supplement improves asthma control in adolescent and adult patients with poorly controlled disease. DESIGN, SETTING, AND PARTICIPANTS Multicenter, randomized, double-blind, placebo-controlled trial conducted between May 2010 and August 2012 at 19 adult and pediatric pulmonary and allergy centers in the American Lung Association Asthma Clinical Research Centers network. Three hundred eighty-six adults and children aged 12 years or older with symptomatic asthma while taking a controller medicine and low dietary soy intake were randomized, and 345 (89%) completed spirometry at week 24. INTERVENTIONS Participants were randomly assigned to receive soy isoflavone supplement containing 100mg of total isoflavones (n=193) or matching placebo (n=193) in 2 divided doses administered daily for 24 weeks. MAIN OUTCOMES AND MEASURES The primary outcome measure was change in forced expiratory volume in the first second (FEV1) at 24 weeks. Secondary outcome measures were symptoms, episodes of poor asthma control, Asthma Control Test score (range, 5-25; higher scores indicate better control), and systemic and airway biomarkers of inflammation. RESULTS Mean changes in prebronchodilator FEV1 over 24 weeks were 0.03 L (95% CI, -0.01 to 0.08 L) in the placebo group and 0.01 L (95% CI, -0.07 to 0.07 L) in the soy isoflavone group, which were not significantly different (P = .36). Mean changes in symptom scores on the Asthma Control Test (placebo, 1.98 [95% CI, 1.42-2.54] vs soy isoflavones, 2.20 [95% CI, 1.53-2.87]; positive values indicate a reduction in symptoms), number of episodes of poor asthma control (placebo, 3.3 [95% CI, 2.7-4.1] vs soy isoflavones, 3.0 [95% CI, 2.4-3.7]), and changes in exhaled nitric oxide (placebo, -3.48 ppb [95% CI, -5.99 to -0.97 ppb] vs soy isoflavones, 1.39 ppb [95% CI, -1.73 to 4.51 ppb]) did not significantly improve more with the soy isoflavone supplement than with placebo. Mean plasma genistein level increased from 4.87 ng/mL to 37.67 ng/mL (P < .001) in participants receiving the supplement. CONCLUSIONS AND RELEVANCE Among adults and children aged 12 years or older with poorly controlled asthma while taking a controller medication, use of a soy isoflavone supplement, compared with placebo, did not result in improved lung function or clinical outcomes. These findings suggest that this supplement should not be used for patients with poorly controlled asthma.	[Smith, Lewis J.; Kalhan, Ravi] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Wise, Robert A.; Sugar, Elizabeth A.; Holbrook, Janet T.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Lima, John J.] Nemours Childrens Clin, Jacksonville, FL USA; [Irvin, Charles G.] Univ Vermont, Dept Med, Burlington, VT 05405 USA; [Dozor, Allen J.] New York Med Coll, Dept Pediat, Valhalla, NY 10595 USA	Northwestern University; Feinberg School of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Vermont; New York Medical College	Smith, LJ (corresponding author), Northwestern Univ, Feinberg Sch Med, 750 N Lake Shore Dr,Ste 707, Chicago, IL 60611 USA.	ljsmith@northwestern.edu		Mougey, Edward/0000-0003-1190-6660; Smith, Lewis J/0000-0002-4728-1562; , Rubin/0000-0002-1257-391X; Calhoun, William/0000-0001-7075-712X; Sumino, Kaharu/0000-0002-6214-2966; Kalhan, Ravi/0000-0003-2443-0876; Carr, Tara/0000-0002-6397-5396; Bacharier, Leonard/0000-0003-0432-2704; Land, Michael/0000-0001-8016-5419; Wise, Robert/0000-0002-8353-2349; Vickery, Brian/0000-0002-7243-5543; Bime, Christian/0000-0003-4787-2685	National Institutes of Health [U01 HL087987, U01 HL 0088367, U54TR001018]; American Lung Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001018] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087987, U01HL088367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Institutes of Health (grants U01 HL087987, U01 HL 0088367, and U54TR001018) and the American Lung Association. Archer Daniels Midland (Decatur, Illinois) provided the soy isoflavone supplement and the matching placebo.	Akinbami Lara J, 2012, NCHS Data Brief, P1; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Asmussen L, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e71; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bime C, 2012, PRIM CARE RESP J, V21, P398, DOI 10.4104/pcrj.2012.00073; Bime C, 2012, J ALLERGY CLIN IMMUN, V130, P1078, DOI 10.1016/j.jaci.2012.07.058; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; Cullen KW, 2008, J AM DIET ASSOC, V108, P862, DOI 10.1016/j.jada.2008.02.015; Devereux G, 2005, J ALLERGY CLIN IMMUN, V115, P1109, DOI 10.1016/j.jaci.2004.12.1139; Duan W, 2003, AM J RESP CRIT CARE, V167, P185, DOI 10.1164/rccm.200205-420OC; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Fogarty A, 2006, RESP MED, V100, P174, DOI 10.1016/j.rmed.2005.03.038; Fogarty A, 2003, CLIN EXP ALLERGY, V33, P1355, DOI 10.1046/j.1365-2222.2003.01777.x; Ford ES, 2004, J ASTHMA, V41, P179, DOI 10.1081/JAS-120026075; Garcia V, 2005, EUR RESPIR J, V26, P449, DOI 10.1183/09031936.05.00142104; Grievink L, 1998, THORAX, V53, P166, DOI 10.1136/thx.53.3.166; Hanania NA, 2009, NEW ENGL J MED, V360, P1487, DOI 10.1056/NEJMoa0806290; Jackson RL, 2011, NUTR REV, V69, P432, DOI 10.1111/j.1753-4887.2011.00400.x; Janssen LJ, 2001, AM J PHYSIOL-LUNG C, V280, pL930, DOI 10.1152/ajplung.2001.280.5.L930; Kalhan R, 2008, CLIN EXP ALLERGY, V38, P103, DOI 10.1111/j.1365-2222.2007.02862.x; Kishi N, 2001, ANAL SCI, V17, P709, DOI 10.2116/analsci.17.709; Lagakos SW, 2006, NEW ENGL J MED, V354, P1667, DOI 10.1056/NEJMp068070; Lampe JW, 1998, P SOC EXP BIOL MED, V217, P335; MARKS GB, 1992, J CLIN EPIDEMIOL, V45, P461, DOI 10.1016/0895-4356(92)90095-5; McKeever TM, 2004, AM J RESP CRIT CARE, V170, P725, DOI 10.1164/rccm.200405-611PP; MESSINA M, 1995, J NUTR, V125, pS567, DOI 10.1093/jn/125.3_Suppl.567S; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miyake Y, 2005, J ALLERGY CLIN IMMUN, V115, P1176, DOI 10.1016/j.jaci.2005.02.016; National Heart Lung and Blood Institute, ASTHM ACT PLAN; Pearson PJK, 2004, THORAX, V59, P652, DOI 10.1136/thx.2004.022616; Polkowski K, 2000, Acta Pol Pharm, V57, P135; RAM FS, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000993.PUB2; Raviv S, 2010, CURR OPIN PULM MED, V16, P71, DOI 10.1097/MCP.0b013e3283323b73; Regal JF, 2000, P SOC EXP BIOL MED, V223, P372, DOI 10.1046/j.1525-1373.2000.22353.x; Revicki DA, 1998, CHEST, V114, P998, DOI 10.1378/chest.114.4.998; Rufer CE, 2006, J AGR FOOD CHEM, V54, P2926, DOI 10.1021/jf053112o; Schabath MB, 2005, JAMA-J AM MED ASSOC, V294, P1493, DOI 10.1001/jama.294.12.1493; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P549, DOI 10.1016/j.jaci.2006.01.011; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, P719, DOI 10.1016/j.jaci.2009.06.053; SEATON A, 1994, THORAX, V49, P171, DOI 10.1136/thx.49.2.171; Smith LJ, 2004, J ASTHMA, V41, P833, DOI 10.1081/JAS-200038447; Stumpf K, 2000, CANCER EPIDEM BIOMAR, V9, P1369; Tepper RS, 2012, J ALLERGY CLIN IMMUN, V129, pS65, DOI 10.1016/j.jaci.2011.12.986; Wakai K, 1999, NUTR CANCER, V33, P139, DOI 10.1207/S15327914NC330204; Wang GJ, 2000, STEROIDS, V65, P339, DOI 10.1016/S0039-128X(00)00089-1; Yang Z, 2012, ANTI-CANCER AGENT ME, V12, P1264, DOI 10.2174/187152012803833107	46	33	34	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2015	313	20					2033	2043		10.1001/jama.2015.5024	http://dx.doi.org/10.1001/jama.2015.5024			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0DC	26010632	Bronze, Green Accepted			2022-12-28	WOS:000355142400017
J	Brum, JR; Ignacio-Espinoza, JC; Roux, S; Doulcier, G; Acinas, SG; Alberti, A; Chaffron, S; Cruaud, C; de Vargas, C; Gasol, JM; Gorsky, G; Gregory, AC; Guidi, L; Hingamp, P; Iudicone, D; Not, F; Ogata, H; Pesant, S; Poulos, BT; Schwenck, SM; Speich, S; Dimier, C; Kandels-Lewis, S; Picheral, M; Searson, S; Bork, P; Bowler, C; Sunagawa, S; Wincker, P; Karsenti, E; Sullivan, MB				Brum, Jennifer R.; Ignacio-Espinoza, J. Cesar; Roux, Simon; Doulcier, Guilhem; Acinas, Silvia G.; Alberti, Adriana; Chaffron, Samuel; Cruaud, Corinne; de Vargas, Colomban; Gasol, Josep M.; Gorsky, Gabriel; Gregory, Ann C.; Guidi, Lionel; Hingamp, Pascal; Iudicone, Daniele; Not, Fabrice; Ogata, Hiroyuki; Pesant, Stephane; Poulos, Bonnie T.; Schwenck, Sarah M.; Speich, Sabrina; Dimier, Celine; Kandels-Lewis, Stefanie; Picheral, Marc; Searson, Sarah; Bork, Peer; Bowler, Chris; Sunagawa, Shinichi; Wincker, Patrick; Karsenti, Eric; Sullivan, Matthew B.		Tara Oceans Coordinators	Patterns and ecological drivers of ocean viral communities	SCIENCE			English	Article							FLOW-CYTOMETRIC DETECTION; MARINE VIRUSES; COUNTING VIRUSES; PACIFIC-OCEAN; SEQUENCE; DNA; EPIFLUORESCENCE; BACTERIAL; METAGENOMICS; ENUMERATION	Viruses influence ecosystems by modulating microbial population size, diversity, metabolic outputs, and gene flow. Here, we use quantitative double-stranded DNA (dsDNA) viral-fraction metagenomes (viromes) and whole viral community morphological data sets from 43 Tara Oceans expedition samples to assess viral community patterns and structure in the upper ocean. Protein cluster cataloging defined pelagic upper-ocean viral community pan and core gene sets and suggested that this sequence space is well-sampled. Analyses of viral protein clusters, populations, and morphology revealed biogeographic patterns whereby viral communities were passively transported on oceanic currents and locally structured by environmental conditions that affect host community structure. Together, these investigations establish a global ocean dsDNA viromic data set with analyses supporting the seed-bank hypothesis to explain how oceanic viral communities maintain high local diversity.	[Brum, Jennifer R.; Roux, Simon; Doulcier, Guilhem; Poulos, Bonnie T.; Schwenck, Sarah M.; Sullivan, Matthew B.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Ignacio-Espinoza, J. Cesar; Sullivan, Matthew B.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Doulcier, Guilhem] Ecole Normale Super, CNRS, Inst Biol,UMR8197, Environm & Evolutionary Genom Sect,INSERM U1024, F-75230 Paris, France; [Acinas, Silvia G.; Gasol, Josep M.] CSIC, Inst Marine Sci ICM, Dept Marine Biol & Oceanog, E-08003 Barcelona, Spain; [Alberti, Adriana; Cruaud, Corinne; Wincker, Patrick] CEA, Genoscope, Inst Genom, F-91057 Evry, France; [Chaffron, Samuel] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, B-3000 Leuven, Belgium; [Chaffron, Samuel] VIB KU Leuven, Ctr Biol Dis, B-3000 Leuven, Belgium; [Chaffron, Samuel] Vrije Univ Brussel, Dept Appl Biol Sci, B-1050 Brussels, Belgium; [de Vargas, Colomban; Not, Fabrice; Dimier, Celine] CNRS, UMR 7144, Stn Biol Roscoff, F-29680 Roscoff, France; [de Vargas, Colomban; Not, Fabrice; Dimier, Celine] Univ Paris 06, Sorbonne Univ, F-29680 Roscoff, France; [de Vargas, Colomban; Not, Fabrice; Dimier, Celine] Stn Biol Roscoff, UMR 7144, F-29680 Roscoff, France; [Gorsky, Gabriel; Guidi, Lionel; Picheral, Marc; Searson, Sarah] CNRS, UMR 7093, LOV, Observ Oceanol, F-06230 Villefranche Sur Mer, France; [Gorsky, Gabriel; Guidi, Lionel; Picheral, Marc; Searson, Sarah] Univ Paris 06, Sorbonne Univ, UMR 7093, LOV,Observ Oceanol, F-06230 Villefranche Sur Mer, France; [Gregory, Ann C.; Sullivan, Matthew B.] Univ Arizona, Soil Water & Environm Sci, Tucson, AZ 85721 USA; [Hingamp, Pascal] Aix Marseille Univ, CNRS IGS UMR 7256, F-13288 Marseille, France; [Iudicone, Daniele] Stn Zool A Dohrn, I-80121 Naples, Italy; [Ogata, Hiroyuki] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110001, Japan; [Pesant, Stephane] Univ Bremen, Data Publisher Earth & Environm Sci, PANGAEA, D-28359 Bremen, Germany; [Pesant, Stephane] Univ Bremen, Ctr Marine Environm Sci, MARUM, D-28359 Bremen, Germany; [Speich, Sabrina] UBO IUEM, Lab Phys Oceans, F-29820 Plouzane, France; [Dimier, Celine; Bowler, Chris; Karsenti, Eric] IBENS, F-75005 Paris, France; [Dimier, Celine; Bowler, Chris; Karsenti, Eric] INSERM, U1024, F-75005 Paris, France; [Dimier, Celine; Bowler, Chris; Karsenti, Eric] CNRS, UMR 8197, F-75005 Paris, France; [Kandels-Lewis, Stefanie; Bork, Peer; Sunagawa, Shinichi] European Mol Biol Lab, Struct & Computat Biol, D-69117 Heidelberg, Germany; [Kandels-Lewis, Stefanie; Karsenti, Eric] European Mol Biol Lab, Directors Res, D-69117 Heidelberg, Germany; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Wincker, Patrick] CNRS, UMR 8030, CP5706, F-91057 Evry, France; [Wincker, Patrick] Univ Evry, UMR 8030, CP5706, F-91057 Evry, France	University of Arizona; University of Arizona; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); CEA; UDICE-French Research Universities; Universite Paris Saclay; KU Leuven; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; University of Arizona; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Stazione Zoologica Anton Dohrn di Napoli; Kyoto University; University of Bremen; University of Bremen; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA	Sullivan, MB (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	karsenti@embl.de; mbsulli@gmail.com	stemmann, lars/E-6899-2011; Chaffron, Samuel/K-1104-2019; Alberti, Adriana/E-7142-2017; Guidi, Lionel/B-3977-2012; Chaffron, Samuel/B-2300-2012; Bowler, Chris/AAC-6256-2019; Acinas, Silvia/F-7462-2016; Boss, Emmanuel/AAF-2336-2019; Bork, Peer/F-1813-2013; Hingamp, Pascal/AAO-1382-2020; Sullivan, Matthew B/H-3256-2011; Roux, Simon/ABE-6255-2020; Gasol, Josep M M/B-1709-2008; Alberti, Adriana/AAZ-2013-2021; Speich, Sabrina/L-3780-2014; Sunagawa, Shinichi/Q-5950-2019; Grimsley, Nigel/O-1359-2015; raes, jeroen/D-7835-2018	Chaffron, Samuel/0000-0001-5903-617X; Alberti, Adriana/0000-0003-3372-9423; Guidi, Lionel/0000-0002-6669-5744; Chaffron, Samuel/0000-0001-5903-617X; Acinas, Silvia/0000-0002-3439-0428; Boss, Emmanuel/0000-0002-8334-9595; Bork, Peer/0000-0002-2627-833X; Hingamp, Pascal/0000-0002-7463-2444; Sullivan, Matthew B/0000-0003-4040-9831; Roux, Simon/0000-0002-5831-5895; Gasol, Josep M M/0000-0001-5238-2387; Alberti, Adriana/0000-0003-3372-9423; Speich, Sabrina/0000-0002-5452-8287; Sunagawa, Shinichi/0000-0003-3065-0314; Grimsley, Nigel/0000-0001-9323-417X; raes, jeroen/0000-0002-1337-041X; de Vargas, Colomban/0000-0002-6476-6019; Bowler, Chris/0000-0003-3835-6187; Ignacio Espinoza, J. Cesar/0000-0001-9303-7504; stemmann, lars/0000-0001-8935-4531; Reynaud, Emmanuel/0000-0003-1502-661X; Doulcier, Guilhem/0000-0003-3720-9089; Gorsky, Gabriel/0000-0002-1099-8711; Jaillon, Olivier/0000-0002-7237-9596; Cruaud, Corinne/0000-0002-4752-7278; PESANT, Stephane/0000-0002-4936-5209; Iudicone, Daniele/0000-0002-7473-394X	CNRS [GDR3280]; European Molecular Biology Laboratory (EMBL); Genoscope/CEA; VIB KU Leuven; Stazione Zoologica Anton Dohrn; University of Milano-Bicocca; Fund for Scientific Research-Flanders; Rega Institute, KU Leuven; French Ministry of Research; French Government [ANR-11-BTBR-0008, ANR-10-INBS-09-08, ANR-10-LABX-54]; Paris Sciences et Lettres (PSL) Research University [ANR-11-IDEX-0001-02]; ANR [POSEIDON/ANR-09-BLAN-0348, PHYTBACK/ANR-2010-1709-01, PROMETHEUS/ANR-09-PCS-GENM-217, TARA-GIRUS/ANR-09-PCS-GENM-218]; European Union [287589, IHMS/HEALTH-F4-2010-261376]; European Research Council (ERC) [294823]; Gordon and Betty Moore Foundation [3790, GBMF2631, GBMF3790]; Spanish Ministry of Science and Innovation [CGL2011-26848]; Agencia de Gestio d'Ajusts Universitaris i Reserca [CONES 2010-0036]; Japan Society for the Promotion of Science KAKENHI [26430184]; Research Foundation-Flanders (FWO); Agnes B. and Etienne Bourgois; Veolia Environment Foundation; Region Bretagne; Lorient Agglomeration; World Courier; Illumina; Education for Development Foundation; Foundation for Biodiversity Research (FRB); Prince Albert II de Monaco Foundation; Tara schooner; French Ministry of Foreign Affairs; University of Arizona (UA) High Performance Computing and High Throughput Computing; foundation for France-American Cultural Exchange; UA Technology and Research Initiative Fund; Water, Environmental, and Energy Solutions Initiative	CNRS(Centre National de la Recherche Scientifique (CNRS)); European Molecular Biology Laboratory (EMBL); Genoscope/CEA; VIB KU Leuven; Stazione Zoologica Anton Dohrn; University of Milano-Bicocca; Fund for Scientific Research-Flanders(FWO); Rega Institute, KU Leuven; French Ministry of Research(Ministry of Research, FranceEuropean Commission); French Government; Paris Sciences et Lettres (PSL) Research University; ANR(French National Research Agency (ANR)); European Union(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia de Gestio d'Ajusts Universitaris i Reserca; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Foundation-Flanders (FWO)(FWO); Agnes B. and Etienne Bourgois; Veolia Environment Foundation; Region Bretagne(Region Bretagne); Lorient Agglomeration; World Courier; Illumina; Education for Development Foundation; Foundation for Biodiversity Research (FRB); Prince Albert II de Monaco Foundation; Tara schooner; French Ministry of Foreign Affairs; University of Arizona (UA) High Performance Computing and High Throughput Computing; foundation for France-American Cultural Exchange; UA Technology and Research Initiative Fund; Water, Environmental, and Energy Solutions Initiative	We thank J. Czekanski-Moir for advice on statistics and L. Coppola for assistance with validating nutrient data. We thank the commitment of the following people and sponsors: CNRS (in particular Groupement de Recherche GDR3280), European Molecular Biology Laboratory (EMBL), Genoscope/CEA, VIB KU Leuven, Stazione Zoologica Anton Dohrn, University of Milano-Bicocca, Fund for Scientific Research-Flanders, Rega Institute, KU Leuven, The French Ministry of Research, the French Government "Investissements d'Avenir" programmes OCEANOMICS (ANR-11-BTBR-0008), FRANCE GENOMIQUE (ANR-10-INBS-09-08), MEMO LIFE (ANR-10-LABX-54), Paris Sciences et Lettres (PSL) Research University (ANR-11-IDEX-0001-02), ANR (projects POSEIDON/ANR-09-BLAN-0348, PHYTBACK/ANR-2010-1709-01, PROMETHEUS/ANR-09-PCS-GENM-217, TARA-GIRUS/ANR-09-PCS-GENM-218), European Union 7th Framework Programme (MicroB3/No. 287589, IHMS/HEALTH-F4-2010-261376), European Research Council (ERC) advanced grant award to C.B. (Diatomite: 294823), Gordon and Betty Moore Foundation grant (3790) to M.B.S., Spanish Ministry of Science and Innovation grant CGL2011-26848/BOS MicroOcean PANGENOMICS to S.G.A., TANIT (CONES 2010-0036) from the Agencia de Gestio d'Ajusts Universitaris i Reserca to S.G.A., Japan Society for the Promotion of Science KAKENHI grant 26430184 to H.O., The Research Foundation-Flanders (FWO), BIO5, Biosphere 2 to M.B.S., and the Gordon and Betty Moore Foundation through grants GBMF2631 and GBMF3790 to M.B.S. We also thank the support and commitment of Agnes B. and Etienne Bourgois, the Veolia Environment Foundation, Region Bretagne, Lorient Agglomeration, World Courier, Illumina, the Education for Development Foundation, Foundation for Biodiversity Research (FRB), the Prince Albert II de Monaco Foundation, the Tara schooner and its captains and crew. We thank MERCATOR-CORIOLIS and ACRI-ST for providing daily satellite data during the expedition. We are also grateful to the French Ministry of Foreign Affairs for supporting the expedition and to the countries who graciously granted sampling permissions. Tara Oceans would not exist without continuous support from 23 institutes (http://oceans.taraexpeditions.org). We also acknowledge excellent assistance from the European Bioinformatics Institute (EBI), in particular G. Cochrane and P. ten Hoopen, as well as the EMBL Advanced Light Microscopy Facility (ALMF), in particular R. Pepperkok. The authors further declare that all data reported herein are fully and freely available from the date of publication, with no restrictions, and that all of the samples, analyses, publications, and ownership of data are free from legal entanglement or restriction of any sort by the various nations whose waters the Tara Oceans expedition sampled in. Data described herein is available at EBI (project identifiers PRJEB402 and PRJEB7988) and PANGAEA (see table S1), and the data release policy regarding future public release of Tara Oceans data is described in Pesant et al. (54). We also acknowledge support from University of Arizona (UA) High Performance Computing and High Throughput Computing; the foundation for France-American Cultural Exchange, Partner University Fund program, awarded to Ecole Normale Superieure and UA; and a grant to UA Ecosystem Genomics Institute through the UA Technology and Research Initiative Fund and the Water, Environmental, and Energy Solutions Initiative. All authors approved the final manuscript. This article is contribution number 23 of the Tara Oceans Expedition. Supplement contains additional data.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aminot A, 2009, PRACTICAL GUIDELINES, P143, DOI DOI 10.1201/9781420073072; Bettarel Y, 2000, APPL ENVIRON MICROB, V66, P2283, DOI 10.1128/AEM.66.6.2283-2289.2000; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Brum JR, 2015, NAT REV MICROBIOL, V13, P147, DOI 10.1038/nrmicro3404; Brum JR, 2013, ISME J, V7, P1738, DOI 10.1038/ismej.2013.67; Brussaard CPD, 2000, J VIROL METHODS, V85, P175, DOI 10.1016/S0166-0934(99)00167-6; Chow CET, 2014, ISME J, V8, P816, DOI 10.1038/ismej.2013.199; Dang VT, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00724; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Deng L, 2014, NATURE, V513, P242, DOI 10.1038/nature13459; Duhaime Melissa B, 2012, Environ Microbiol, V14, P2526, DOI 10.1111/j.1462-2920.2012.02791.x; Duhaime MB, 2012, VIROLOGY, V434, P181, DOI 10.1016/j.virol.2012.09.036; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; HENNES KP, 1995, LIMNOL OCEANOGR, V40, P1050, DOI 10.4319/lo.1995.40.6.1050; Hingamp P, 2013, ISME J, V7, P1678, DOI 10.1038/ismej.2013.59; Holmfeldt K, 2012, APPL ENVIRON MICROB, V78, P892, DOI 10.1128/AEM.06580-11; Hubbell Stephen P., 2001, V32, pi; Hurwitz BL, 2015, ISME J, V9, P472, DOI 10.1038/ismej.2014.143; Hurwitz BL, 2014, P NATL ACAD SCI USA, V111, P10714, DOI 10.1073/pnas.1319778111; Hurwitz BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057355; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ignacio-Espinoza JC, 2013, CURR OPIN VIROL, V3, P566, DOI 10.1016/j.coviro.2013.07.004; Jarvis DI, 2008, P NATL ACAD SCI USA, V105, P5326, DOI 10.1073/pnas.0800607105; John SG, 2011, ENV MICROBIOL REP, V3, P195, DOI 10.1111/j.1758-2229.2010.00208.x; Kang I, 2013, P NATL ACAD SCI USA, V110, P12343, DOI 10.1073/pnas.1219930110; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Kristensen DM, 2013, J BACTERIOL, V195, P941, DOI 10.1128/JB.01801-12; Kukkaro P, 2009, ENV MICROBIOL REP, V1, P71, DOI 10.1111/j.1758-2229.2008.00007.x; Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656; Labrie SJ, 2013, ENVIRON MICROBIOL, V15, P1356, DOI 10.1111/1462-2920.12053; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Mizuno CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003987; Needham DM, 2013, ISME J, V7, P1274, DOI 10.1038/ismej.2013.19; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; Oksanen J., 2022, R PACKAGE VERSION; OLSON DB, 1986, DEEP-SEA RES, V33, P27, DOI 10.1016/0198-0149(86)90106-8; Pesant S., 2015, OPEN SCIENCE RESOURC; R Development Core Team, 2009, R LANG ENV STAT COMP; Ras J, 2008, BIOGEOSCIENCES, V5, P353, DOI 10.5194/bg-5-353-2008; Rohwer F, 2000, LIMNOL OCEANOGR, V45, P408, DOI 10.4319/lo.2000.45.2.0408; Roux S, 2014, ELIFE, V3, DOI 10.7554/eLife.03125; Roux S, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130160; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Solonenko SA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-320; Steward GF, 2013, ISME J, V7, P672, DOI 10.1038/ismej.2012.121; Sul WJ, 2013, P NATL ACAD SCI USA, V110, P2342, DOI 10.1073/pnas.1212424110; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Talley L.D., 2011, DESCRIPTIVE PHYS OCE, V6; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tomaru Y, 2007, J OCEANOGR, V63, P215, DOI 10.1007/s10872-007-0023-8; Van Heukelem L, 2001, J CHROMATOGR A, V910, P31, DOI 10.1016/S0378-4347(00)00603-4; Villar E, 2015, SCIENCE, V348, DOI 10.1126/science.1261447; Weinbauer MG, 1997, AQUAT MICROB ECOL, V13, P225, DOI 10.3354/ame013225; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zhao YL, 2013, NATURE, V494, P357, DOI 10.1038/nature11921	69	383	394	37	411	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237							1261498	10.1126/science.1261498	http://dx.doi.org/10.1126/science.1261498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999515	Green Submitted			2022-12-28	WOS:000354877900033
J	DiMaio, F; Yu, X; Rensen, E; Krupovic, M; Prangishvili, D; Egelman, EH				DiMaio, Frank; Yu, Xiong; Rensen, Elena; Krupovic, Mart; Prangishvili, David; Egelman, Edward H.			A virus that infects a hyperthermophile encapsidates A-form DNA	SCIENCE			English	Article							SOLUBLE SPORE PROTEINS; ARCHAEAL VIRUSES; RELEASE MECHANISM; IN-VITRO; ACID; BACILLUS; GENOMICS; CONFORMATION; PROTECTION; BACTERIAL	Extremophiles, microorganisms thriving in extreme environmental conditions, must have proteins and nucleic acids that are stable at extremes of temperature and pH. The nonenveloped, rod-shaped virus SIRV2 (Sulfolobus islandicus rod-shaped virus 2) infects the hyperthermophilic acidophile Sulfolobus islandicus, which lives at 80 degrees C and pH 3. We have used cryo-electron microscopy to generate a three-dimensional reconstruction of the SIRV2 virion at similar to 4 angstrom resolution, which revealed a previously unknown form of virion organization. Although almost half of the capsid protein is unstructured in solution, this unstructured region folds in the virion into a single extended a helix that wraps around the DNA. The DNA is entirely in the A-form, which suggests a common mechanism with bacterial spores for protecting DNA in the most adverse environments.	[DiMaio, Frank] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Yu, Xiong; Egelman, Edward H.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Rensen, Elena; Krupovic, Mart] Inst Pasteur, Dept Microbiol, F-75015 Paris, France	University of Washington; University of Washington Seattle; University of Virginia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Prangishvili, D (corresponding author), Inst Pasteur, Dept Microbiol, 25 Rue Dr Roux, F-75015 Paris, France.	david.prangishvili@pasteur.fr; egelman@virginia.edu	Krupovic, Mart/ABD-6255-2021; Krupovic, Mart/I-4209-2012	Krupovic, Mart/0000-0001-5486-0098; Krupovic, Mart/0000-0001-5486-0098; Egelman, Edward/0000-0003-4844-5212; Rensen, Elena Ilka/0000-0002-3355-1744	NIH [GM035269]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035269] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM035269 (to E.H.E.). The map and model have been deposited in the Electron Microscopy Data Bank (accession number EMD-6310) and in PDB (ID 3J9X), respectively. We thank K. Dryden for assistance with the microscopy.	Baker-Austin C, 2007, TRENDS MICROBIOL, V15, P165, DOI 10.1016/j.tim.2007.02.005; Bize A, 2009, P NATL ACAD SCI USA, V106, P11306, DOI 10.1073/pnas.0901238106; DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/nmeth.3286, 10.1038/NMETH.3286]; EARNSHAW W, 1976, J MOL BIOL, V104, P387, DOI 10.1016/0022-2836(76)90278-3; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Hayes CS, 1998, J BACTERIOL, V180, P2694, DOI 10.1128/JB.180.10.2694-2700.1998; Hayes CS, 1997, J BACTERIOL, V179, P6020, DOI 10.1128/jb.179.19.6020-6027.1997; Hayes CS, 2001, J BIOL CHEM, V276, P2267, DOI 10.1074/jbc.M007858200; Hayes DS, 2000, J BIOL CHEM, V275, P35040, DOI 10.1074/jbc.M005669200; Jaubert C, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130010; Krupovic M, 2012, ADV VIRUS RES, V82, P33, DOI 10.1016/B978-0-12-394621-8.00012-1; Krupovic M, 2011, MICROBIOL MOL BIOL R, V75, P610, DOI 10.1128/MMBR.00011-11; Lee KS, 2008, P NATL ACAD SCI USA, V105, P2806, DOI 10.1073/pnas.0708244105; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; LUBBEN M, 1989, J BACTERIOL, V171, P6106; MOHR SC, 1991, P NATL ACAD SCI USA, V88, P77, DOI 10.1073/pnas.88.1.77; Overman SA, 1998, BIOSPECTROSCOPY, V4, pS47, DOI 10.1002/(SICI)1520-6343(1998)4:5+<S47::AID-BSPY6>3.0.CO;2-7; Prangishvili D, 1999, GENETICS, V152, P1387; Prangishvili D, 2013, ANNU REV MICROBIOL, V67, P565, DOI 10.1146/annurev-micro-092412-155633; Prangishvili D, 2011, CURR OPIN MICROBIOL, V14, P315, DOI 10.1016/j.mib.2011.04.006; Prangishvill D, 2006, VIRUS RES, V117, P52, DOI 10.1016/j.virusres.2006.01.007; Quemin ERJ, 2013, J VIROL, V87, P13379, DOI 10.1128/JVI.02742-13; SETLOW B, 1995, J BACTERIOL, V177, P4149, DOI 10.1128/jb.177.14.4149-4151.1995; Setlow P, 2007, TRENDS MICROBIOL, V15, P172, DOI 10.1016/j.tim.2007.02.004; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Szymczyna BR, 2009, STRUCTURE, V17, P499, DOI 10.1016/j.str.2009.03.001; Whelan DR, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0454; Yu TY, 2008, J MOL BIOL, V382, P1031, DOI 10.1016/j.jmb.2008.07.077	28	77	78	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					914	917		10.1126/science.aaa4181	http://dx.doi.org/10.1126/science.aaa4181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999507	Green Accepted			2022-12-28	WOS:000354877900045
J	Mino, T; Murakawa, Y; Fukao, A; Vandenbon, A; Wessels, HH; Ori, D; Uehata, T; Tartey, S; Akira, S; Suzuki, Y; Vinuesa, CG; Ohler, U; Standley, DM; Landthaler, M; Fujiwara, T; Takeuchi, O				Mino, Takashi; Murakawa, Yasuhiro; Fukao, Akira; Vandenbon, Alexis; Wessels, Hans-Hermann; Ori, Daisuke; Uehata, Takuya; Tartey, Sarang; Akira, Shizuo; Suzuki, Yutaka; Vinuesa, Carola G.; Ohler, Uwe; Standley, Daron M.; Landthaler, Markus; Fujiwara, Toshinobu; Takeuchi, Osamu			Regnase-1 and Roquin Regulate a Common Element in Inflammatory mRNAs by Spatiotemporally Distinct Mechanisms	CELL			English	Article							HELPER T-CELLS; ENDONUCLEOLYTIC CLEAVAGE; UPF1 BINDING; 3' UTRS; DECAY; DEGRADATION; AUTOIMMUNITY; RECOGNITION; DIFFERENTIATION; RECEPTORS	Regnase-1 and Roquin are RNA binding proteins essential for degradation of inflammation-related mRNAs and maintenance of immune homeostasis. However, their mechanistic relationship has yet to be clarified. Here, we show that, although Regnase-1 and Roquin regulate an overlapping set of mRNAs via a common stem-loop structure, they function in distinct subcellular locations: ribosome/endoplasmic reticulum and processing-body/stress granules, respectively. Moreover, Regnase-1 specifically cleaves and degrades translationally active mRNAs and requires the helicase activity of UPF1, similar to the decay mechanisms of nonsense mRNAs. In contrast, Roquin controls translationally inactive mRNAs, independent of UPF1. Defects in both Regnase-1 and Roquin lead to large increases in their target mRNAs, although Regnase-1 tends to control the early phase of inflammation when mRNAs are more actively translated. Our findings reveal that differential regulation of mRNAs by Regnase-1 and Roquin depends on their translation status and enables elaborate control of inflammation.	[Mino, Takashi; Ori, Daisuke; Uehata, Takuya; Tartey, Sarang; Takeuchi, Osamu] Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Kyoto 6068507, Japan; [Mino, Takashi; Ori, Daisuke; Tartey, Sarang; Takeuchi, Osamu] JST, CREST, Kyoto 6068507, Japan; [Murakawa, Yasuhiro; Wessels, Hans-Hermann; Ohler, Uwe; Landthaler, Markus] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, D-13125 Berlin, Germany; [Fukao, Akira; Fujiwara, Toshinobu] Nagoya City Univ, Grad Sch Pharmaceut Sci, Lab Hyg Chem, Nagoya, Aichi 4678603, Japan; [Vandenbon, Alexis; Standley, Daron M.] Osaka Univ, Lab Syst Immunol, Suita, Osaka 5650871, Japan; [Vandenbon, Alexis] Osaka Univ, Immunogenom Res Unit, Suita, Osaka 5650871, Japan; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Host Def, Suita, Osaka 5650871, Japan; [Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Lab Funct Genom, Chiba 2778562, Japan; [Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Pathogens & Immun, Canberra, ACT 0200, Australia; [Standley, Daron M.] Kyoto Univ, Inst Virus Res, Lab Integrated Biol Informat, Kyoto 6068507, Japan	Kyoto University; Japan Science & Technology Agency (JST); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Nagoya City University; Osaka University; Osaka University; Osaka University; Osaka University; University of Tokyo; Australian National University; John Curtin School of Medical Research; Kyoto University	Takeuchi, O (corresponding author), Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Kyoto 6068507, Japan.	otake@virus.kyoto-u.ac.jp	Tartey, Sarang/M-1778-2019; Akira, Shizuo/C-3134-2009; Vandenbon, Alexis/A-8430-2017; Vandenbon, Alexis/N-4428-2019; Landthaler, Markus/A-1427-2010; Takeuchi, Osamu/AAG-9359-2019; Tartey, Sarang/O-6704-2018; Mino, Takashi/GRO-0332-2022; Vinuesa, Carola G/B-1108-2010	Tartey, Sarang/0000-0002-7957-9208; Landthaler, Markus/0000-0002-1075-8734; Takeuchi, Osamu/0000-0002-1260-6232; Tartey, Sarang/0000-0002-7957-9208; Mino, Takashi/0000-0002-9562-008X; Vinuesa, Carola G/0000-0001-9799-0298	JSPS through Core-to-Core Program [221S0002]; Takeda Science Foundation; Daiichi Sankyo Foundation of Life Science; Shimizu Foundation for Immunology and Neuroscience	JSPS through Core-to-Core Program; Takeda Science Foundation(Takeda Science Foundation (TSF)); Daiichi Sankyo Foundation of Life Science; Shimizu Foundation for Immunology and Neuroscience	We thank G. Stoecklin, A. Yamashita, and Y. Mishima for plasmids; K. Saito, H. Omori, M. Kitabatake, and M. Ohno for experiments. We thank all members of our laboratory for discussions. This work was supported by the JSPS through Core-to-Core Program, Grant-in-Aid for Young Scientists (B) (to T.M.), for Scientific Research on Innovative Areas "Genome Science'' (221S0002), and grants from Takeda Science Foundation, Daiichi Sankyo Foundation of Life Science (to O.T.), and the Shimizu Foundation for Immunology and Neuroscience (to T.M.).	Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Athanasopoulos V, 2010, FEBS J, V277, P2109, DOI 10.1111/j.1742-4658.2010.07628.x; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Franks TM, 2010, CELL, V143, P938, DOI 10.1016/j.cell.2010.11.043; Hogg JR, 2010, CELL, V143, P379, DOI 10.1016/j.cell.2010.10.005; Hurt JA, 2013, GENOME RES, V23, P1636, DOI 10.1101/gr.157354.113; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Jeltsch KM, 2014, NAT IMMUNOL, V15, P1079, DOI 10.1038/ni.3008; Kafasla P, 2014, NAT IMMUNOL, V15, P492, DOI 10.1038/ni.2884; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kurosaki T, 2013, P NATL ACAD SCI USA, V110, P3357, DOI 10.1073/pnas.1219908110; Leppek K, 2013, CELL, V153, P869, DOI 10.1016/j.cell.2013.04.016; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Loh B, 2013, GENE DEV, V27, P2125, DOI 10.1101/gad.226951.113; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; Park E, 2013, P NATL ACAD SCI USA, V110, P405, DOI 10.1073/pnas.1213508110; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Pratama A, 2013, IMMUNITY, V38, P669, DOI 10.1016/j.immuni.2013.01.011; Schuetz A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6701; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan DZ, 2014, NAT STRUCT MOL BIOL, V21, P679, DOI 10.1038/nsmb.2857; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogel KU, 2013, IMMUNITY, V38, P655, DOI 10.1016/j.immuni.2012.12.004; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Zund D, 2013, NAT STRUCT MOL BIOL, V20, P936, DOI 10.1038/nsmb.2635	34	233	240	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1058	1073		10.1016/j.cell.2015.04.029	http://dx.doi.org/10.1016/j.cell.2015.04.029			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000482	Green Published, Bronze			2022-12-28	WOS:000355152600014
J	Long, GV; Stroyakovskiy, D; Gogas, H; Levchenko, E; de Braud, F; Larkin, J; Garbe, C; Jouary, T; Hauschild, A; Grob, JJ; Chiarion-Sileni, V; Lebbe, C; Mandala, M; Millward, M; Arance, A; Bondarenko, I; Haanen, JBAG; Hansson, J; Utikal, J; Ferraresi, V; Kovalenko, N; Mohr, P; Probachai, V; Schadendorf, D; Nathan, P; Robert, C; Ribas, A; DeMarini, DJ; Irani, JG; Swann, S; Legos, JJ; Jin, F; Mookerjee, B; Flaherty, K				Long, Georgina V.; Stroyakovskiy, Daniil; Gogas, Helen; Levchenko, Evgeny; de Braud, Filippo; Larkin, James; Garbe, Claus; Jouary, Thomas; Hauschild, Axel; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Lebbe, Celeste; Mandala, Mario; Millward, Michael; Arance, Ana; Bondarenko, Igor; Haanen, John B. A. G.; Hansson, Johan; Utikal, Jochen; Ferraresi, Virginia; Kovalenko, Nadezhda; Mohr, Peter; Probachai, Volodymr; Schadendorf, Dirk; Nathan, Paul; Robert, Caroline; Ribas, Antoni; DeMarini, Douglas J.; Irani, Jhangir G.; Swann, Suzanne; Legos, Jeffrey J.; Jin, Fan; Mookerjee, Bijoyesh; Flaherty, Keith			Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial	LANCET			English	Article							CLINICAL-TRIALS; MEK INHIBITION; VEMURAFENIB; COBIMETINIB; MUTATIONS	Background Previously, a study of ours showed that the combination of dabrafenib and trametinib improves progression-free survival compared with dabrafenib and placebo in patients with BRAF Val600Lys/Glu mutation-positive metastatic melanoma. The study was continued to assess the secondary endpoint of overall survival, which we report in this Article. Methods We did this double-blind phase 3 study at 113 sites in 14 countries. We enrolled previously untreated patients with BRAF Val600Glu or Val600Lys mutation-positive unresectable stage IIIC or stage IV melanoma. Participants were computer-randomised (1:1) to receive a combination of dabrafenib (150 mg orally twice daily) and trametinib (2 mg orally once daily), or dabrafenib and placebo. The primary endpoint was progression-free survival and overall survival was a secondary endpoint. This study is registered with ClinicalTrials.gov, number NCT01584648. Findings Between May 4, 2012, and Nov 30, 2012, we screened 947 patients for eligibility, of whom 423 were randomly assigned to receive dabrafenib and trametinib (n=211) or dabrafenib only (n=212). The final data cutoff was Jan 12, 2015, at which time 222 patients had died. Median overall survival was 25.1 months (95% CI 19.2-not reached) in the dabrafenib and trametinib group versus 18.7 months (15.2-23.7) in the dabrafenib only group (hazard ratio [HR] 0.71, 95% CI 0.55-0.92; p=0.0107). Overall survival was 74% at 1 year and 51% at 2 years in the dabrafenib and trametinib group versus 68% and 42%, respectively, in the dabrafenib only group. Based on 301 events, median progression-free survival was 11.0 months (95% CI 8.0-13.9) in the dabrafenib and trametinib group and 8.8 months (5.9-9.3) in the dabrafenib only group (HR 0.67, 95% CI 0.53-0.84; p=0.0004; unadjusted for multiple testing). Treatment-related adverse events occurred in 181 (87%) of 209 patients in the dabrafenib and trametinib group and 189 (90%) of 211 patients in the dabrafenib only group; the most common was pyrexia (108 patients, 52%) in the dabrafenib and trametinib group, and hyperkeratosis (70 patients, 33%) in the dabrafenib only group. Grade 3 or 4 adverse events occurred in 67 (32%) patients in the dabrafenib and trametinib group and 66 (31%) patients in the dabrafenib only group. Interpretation The improvement in overall survival establishes the combination of dabrafenib and trametinib as the standard targeted treatment for BRAF Val600 mutation-positive melanoma. Studies assessing dabrafenib and trametinib in combination with immunotherapies are ongoing.	[Long, Georgina V.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW 2006, Australia; [Long, Georgina V.] Mater Hosp, Sydney, NSW, Australia; [Stroyakovskiy, Daniil] Moscow City Oncol Hosp, Moscow, Russia; [Gogas, Helen] Univ Athens, Sch Med, Dept Med, GR-11527 Athens, Greece; [Levchenko, Evgeny] Petrov Res Inst Oncol, St Petersburg, Russia; [de Braud, Filippo] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Larkin, James] Royal Marsden Hosp, London SW3 6JJ, England; [Garbe, Claus] Univ Hosp Tuebingen, Dept Dermatol, Tubingen, Germany; [Jouary, Thomas] CHU Bordeaux, Hop St Andre, Dept Dermatol, Bordeaux, France; [Hauschild, Axel] Univ Hosp Schleswig Holstein, Kiel, Germany; [Grob, Jean-Jacques] Aix Marseille Univ, Marseille, France; [Grob, Jean-Jacques] APHM Hosp CHU Timone, Marseille, France; [Chiarion-Sileni, Vanna] Veneto Oncol Inst IRCCS, Melanoma & Oesophageal Oncol Unit, Padua, Italy; [Lebbe, Celeste] Univ Paris Diderot, INSERM U976, APHP Dermatol CIC Hop St Louis, Paris, France; [Mandala, Mario] Papa Giovanni XXIII Canc Ctr Hosp, Bergamo, Italy; [Millward, Michael] Sir Charles Gairdner Hosp, Perth, WA, Australia; [Arance, Ana] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain; [Arance, Ana] Translat Genom & Targeted Therapeut Solid Tumors, Barcelona, Spain; [Bondarenko, Igor] Dnepropetrovsk State Med Acad, Dnepropetrovsk, Ukraine; [Haanen, John B. A. G.] Netherlands Canc Inst, Amsterdam, Netherlands; [Hansson, Johan] Karolinska Inst, Karolinska Univ Hosp Solna, Stockholm, Sweden; [Utikal, Jochen] Heidelberg Univ, Univ Med Ctr Mannheim, Mannheim, Germany; [Utikal, Jochen] German Canc Res Ctr, Heidelberg, Germany; [Ferraresi, Virginia] Ist Nazl Tumori Regina Elena, Rome, Italy; [Kovalenko, Nadezhda] Volograd Reg Oncol Dispensary 3, Volzhsky, Russia; [Mohr, Peter] Elbe Klinikum Stade, Stade, Germany; [Probachai, Volodymr] Dnipropetrovsk State Council, Dnipropetrovsk Clin Oncol Ctr, Dnepropetrovsk, Ukraine; [Schadendorf, Dirk] Univ Hosp Essen, Essen, Germany; [Nathan, Paul] Mt Vernon Canc Ctr, Northwood, Middx, England; [Robert, Caroline] Gustave Roussy, Villejuif Paris Sud, France; [Robert, Caroline] Univ Paris Sud, F-94275 Le Kremlin Bicetre, France; [Ribas, Antoni] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [DeMarini, Douglas J.; Irani, Jhangir G.; Swann, Suzanne; Legos, Jeffrey J.; Mookerjee, Bijoyesh] Novartis Pharmaceut, E Hanover, NJ USA; [Jin, Fan] Merck & Co Inc, Kenilworth, NJ USA; [Flaherty, Keith] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA	Melanoma Institute Australia; University of Sydney; Athens Medical School; National & Kapodistrian University of Athens; N.N. Petrov Research Institute of Oncology; Fondazione IRCCS Istituto Nazionale Tumori Milan; Royal Marsden NHS Foundation Trust; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; CHU Bordeaux; University of Kiel; Schleswig Holstein University Hospital; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; IRCCS Istituto Oncologico Veneto (IOV); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; ASST Papa Giovanni XXIII; University of Western Australia; University of Barcelona; Hospital Clinic de Barcelona; Dnipro State Medical University; Netherlands Cancer Institute; Karolinska Institutet; Karolinska University Hospital; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Duisburg Essen; Mount Vernon Cancer Centre; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Novartis; Merck & Company; Harvard University; Massachusetts General Hospital	Long, GV (corresponding author), Melanoma Inst Australia, 40 Rocklands Rd, Sydney, NSW 2060, Australia.	georgina.long@sydney.edu.au	Haanen, John/AAD-8578-2022; Robert, Caroline/G-6157-2018; Long, Georgina V/C-1771-2013; mandala, mario/AAB-8637-2022; ferraresi, virginia/ABH-7898-2020; Bondarenko, Igor N/GQP-1497-2022; Schadendorf, Dirk/AAE-8206-2019; Mandala', Mario/AAA-4258-2019; Ferraresi, Virginia/A-2075-2019; Haanen, John/AAD-8534-2022; de Braud, Filippo/B-9997-2017; Bondarenko, Igor/U-5156-2017; sileni, vanna chiarion/B-9042-2018; Levchenko, Evgeny/X-8697-2018; Garbe, Claus/ABH-2128-2021; Kovalenko, Nadezhda/AAG-6298-2021; Bondarenko, Igor/W-9412-2019	Robert, Caroline/0000-0002-9493-0238; Long, Georgina V/0000-0001-8894-3545; ferraresi, virginia/0000-0001-6419-1668; Bondarenko, Igor N/0000-0002-7071-2471; Haanen, John/0000-0001-5884-7704; de Braud, Filippo/0000-0003-0103-730X; Bondarenko, Igor/0000-0002-7071-2471; sileni, vanna chiarion/0000-0001-9191-9124; Levchenko, Evgeny/0000-0003-3837-2515; Garbe, Claus/0000-0001-8530-780X; Bondarenko, Igor/0000-0002-7071-2471; Utikal, Jochen/0000-0001-5316-0241; Arance, Ana/0000-0003-2896-1957; Nathan, Paul/0000-0002-2327-3250; Larkin, James/0000-0001-5569-9523; Stroyakovskiy, Daniil/0000-0003-1973-1092; Grob, Jean-Jacques/0000-0002-0667-153X	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This study was funded by GlaxoSmithKline. Most importantly we thank the patients who participated in this study and their families. We also thank the investigators and study staff who contributed to the study, and members of the steering committee and independent data monitoring committee. SciMentum provided editorial support in the form of graphic services.	Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Flaherty K, 2014, ASCO M, V32, P9010; Flaherty K, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.9010; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Institute NC, 2010, COMMON TERMINOLOGY C; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Menzies AM, 2015, ANN ONCOL, V26, P415, DOI 10.1093/annonc/mdu529; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Ribas A, 2014, LANCET ONCOL, V15, P954, DOI 10.1016/S1470-2045(14)70301-8; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358	16	897	917	3	48	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					444	451		10.1016/S0140-6736(15)60898-4	http://dx.doi.org/10.1016/S0140-6736(15)60898-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26037941				2022-12-28	WOS:000358761700024
J	Ray, KK; Vallejo-Vaz, AJ				Ray, Kausik K.; Vallejo-Vaz, Antonio J.			The evolving role of CETP inhibition: beyond HDL cholesterol	LANCET			English	Editorial Material							ACUTE CORONARY SYNDROME; CARDIOVASCULAR EVENTS; LDL CHOLESTEROL; HIGH-RISK; DISEASE; LIPOPROTEIN; ANACETRAPIB; STATINS; LIPIDS; TRIAL		[Ray, Kausik K.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London W6 8RP, England; [Vallejo-Vaz, Antonio J.] St Georges Univ London, Cardiovasc Sci Cardiovasc & Cell Sci Res Inst, London, England	Imperial College London; St Georges University London	Ray, KK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London W6 8RP, England.	k.ray@imperial.ac.uk	Ray, Kausik/Z-2055-2019; Vallejo-Vaz, Antonio J./AAT-9301-2021	Vallejo-Vaz, Antonio J./0000-0001-7954-1253				Anderson TJ, 2015, CAN J CARDIOL, V31, P585, DOI 10.1016/j.cjca.2015.03.019; [Anonymous], 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI [DOI 10.1001/jama.2009.1619, DOI 10.1001/JAMA.2009.1619]; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Hovingh GK, 2015, LANCET; Nicholls SJ, 2011, JAMA-J AM MED ASSOC, V306, P2099, DOI 10.1001/jama.2011.1649; Ray KK, 2014, EUR HEART J, V35, P1792, DOI 10.1093/eurheartj/ehu105; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P1430, DOI 10.1161/ATVBAHA.110.207142	14	8	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					412	414		10.1016/S0140-6736(15)60608-0	http://dx.doi.org/10.1016/S0140-6736(15)60608-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26047976	Green Submitted			2022-12-28	WOS:000358761700008
J	Nishimura, T; Sato, T; Yamamoto, Y; Watakabe, I; Ohkawa, Y; Suyama, M; Kobayashi, S; Tanaka, M				Nishimura, Toshiya; Sato, Tetsuya; Yamamoto, Yasuhiro; Watakabe, Ikuko; Ohkawa, Yasuyuki; Suyama, Mikita; Kobayashi, Satoru; Tanaka, Minoru			foxl3 is a germ cell-intrinsic factor involved in sperm-egg fate decision in medaka	SCIENCE			English	Article							ORYZIAS-LATIPES; SEX-DIFFERENTIATION; OVARY; PARALOGS; DMRT1; GONAD	Sex determination is an essential step in the commitment of a germ cell to a sperm or egg. However, the intrinsic factors that determine the sexual fate of vertebrate germ cells are unknown. Here, we show that foxl3, which is expressed in germ cells but not somatic cells in the gonad, is involved in sperm-egg fate decision in medaka fish. Adult XX medaka with disrupted foxl3 developed functional sperm in the expanded germinal epithelium of a histologically functional ovary. In chimeric medaka, mutant germ cells initiated spermatogenesis in female wild-type gonad. These results indicate that a germ cell-intrinsic cue for the sperm-egg fate decision is present in medaka and that spermatogenesis can proceed in a female gonadal environment.	[Nishimura, Toshiya; Yamamoto, Yasuhiro; Watakabe, Ikuko; Tanaka, Minoru] Natl Inst Basic Biol, Lab Mol Genet Reprod, Okazaki, Aichi 4448787, Japan; [Nishimura, Toshiya; Kobayashi, Satoru; Tanaka, Minoru] Grad Univ Adv Studies SOKENDAI, Okazaki, Aichi 4448585, Japan; [Sato, Tetsuya; Suyama, Mikita] Kyushu Univ, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Sato, Tetsuya; Suyama, Mikita] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Fukuoka 8128582, Japan; [Ohkawa, Yasuyuki] Kyushu Univ, Fac Med, JST CREST, Dept Adv Med Initiat, Fukuoka 8128582, Japan; [Kobayashi, Satoru] Natl Inst Basic Biol, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Kyushu University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Kyushu University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Tanaka, M (corresponding author), Natl Inst Basic Biol, Lab Mol Genet Reprod, Okazaki, Aichi 4448787, Japan.	mtanaka@nibb.ac.jp	Ohkawa, Yasuyuki/ABG-1839-2021; Ohkawa, Yasuyuki/C-4087-2016	Ohkawa, Yasuyuki/0000-0001-6440-9954; Ohkawa, Yasuyuki/0000-0001-6440-9954; TANAKA, MINORU/0000-0001-9100-1487; Suyama, Mikita/0000-0001-9526-3193	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry [26047A];  [22132007];  [25251034]; Grants-in-Aid for Scientific Research [25116010, 25251034, 26290064] Funding Source: KAKEN	Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the National BioResource Project Medaka for supplying cDNAs, BAC, and fosmids. We are grateful to K. Suzuki and C. Kinoshita for fish maintenance. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (22132007), a Grant-in-Aid for Scientific Research (A) (25251034), and the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (26047A). T.N. and M.T. are authors on a patent applied for by the National Institute of Natural Sciences (provisional patent application number JP2014-241331) that relates to the function of foxl3.	Baron D, 2004, J MOL ENDOCRINOL, V33, P705, DOI 10.1677/jme.1.01566; Crespo B, 2013, GEN COMP ENDOCR, V194, P81, DOI 10.1016/j.ygcen.2013.08.016; Geraldo MT, 2013, HEREDITY, V111, P57, DOI 10.1038/hdy.2013.19; Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104; Li MH, 2013, ENDOCRINOLOGY, V154, P4814, DOI 10.1210/en.2013-1451; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Nakamura S, 2012, DEVELOPMENT, V139, P2283, DOI 10.1242/dev.076307; Nakamura S, 2010, SCIENCE, V328, P1561, DOI 10.1126/science.1185473; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Nishimura T, 2014, SEX DEV, V8, P252, DOI 10.1159/000364924; Ottolenghi C, 2005, HUM MOL GENET, V14, P2053, DOI 10.1093/hmg/ddi210; Saiki A, 1997, DEV GROWTH DIFFER, V39, P337, DOI 10.1046/j.1440-169X.1997.t01-2-00009.x; Saito D, 2007, DEV BIOL, V310, P280, DOI 10.1016/j.ydbio.2007.07.039; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Suzuki A, 2004, J EXP ZOOL PART A, V301A, P266, DOI 10.1002/jez.a.20027; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021	16	82	89	10	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		328	331		10.1126/science.aaa2657	http://dx.doi.org/10.1126/science.aaa2657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26067255				2022-12-28	WOS:000358218600057
J	Tchasovnikarova, IA; Timms, RT; Matheson, NJ; Wals, K; Antrobus, R; Gottgens, B; Dougan, G; Dawson, MA; Lehner, PJ				Tchasovnikarova, Iva A.; Timms, Richard T.; Matheson, Nicholas J.; Wals, Kim; Antrobus, Robin; Goettgens, Berthold; Dougan, Gordon; Dawson, Mark A.; Lehner, Paul J.			Epigenetic silencing by the HUSH complex mediates position-effect variegation in human cells	SCIENCE			English	Article							HISTONE H3; DROSOPHILA-MELANOGASTER; CHROMOSOMAL-PROTEIN; LYSINE 9; HETEROCHROMATIN; BINDING; GENE; SITE	Forward genetic screens in Drosophila melanogaster for modifiers of position-effect variegation have revealed the basis of much of our understanding of heterochromatin. We took an analogous approach to identify genes required for epigenetic repression in human cells. A nonlethal forward genetic screen in near-haploid KBM7 cells identified the HUSH (human silencing hub) complex, comprising three poorly characterized proteins, TASOR, MPP8, and periphilin; this complex is absent from Drosophila but is conserved from fish to humans. Loss of HUSH components resulted in decreased H3K9me3 both at endogenous genomic loci and at retroviruses integrated into heterochromatin. Our results suggest that the HUSH complex is recruited to genomic loci rich in H3K9me3, where subsequent recruitment of the methyltransferase SETDB1 is required for further H3K9me3 deposition to maintain transcriptional silencing.	[Tchasovnikarova, Iva A.; Timms, Richard T.; Matheson, Nicholas J.; Wals, Kim; Antrobus, Robin; Lehner, Paul J.] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med, Cambridge CB2 0XY, England; [Goettgens, Berthold] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; [Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Dawson, Mark A.] Peter MacCallum Canc Ctr, East Melbourne, Vic 3002, Australia	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Peter Maccallum Cancer Center	Lehner, PJ (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med, Cambridge CB2 0XY, England.	pjl30@cam.ac.uk	Dawson, Mark A/B-9317-2017	Dawson, Mark A/0000-0002-5464-5029; Lehner, Paul Joseph/0000-0001-9383-1054; Gottgens, Berthold/0000-0001-6302-5705; Tchasovnikarova, Iva/0000-0002-0477-0956; Matheson, Nicholas/0000-0002-3318-1851	Wellcome Trust [101835/Z/13/Z]; MRC; Cambridge Biomedical Research Centre; BBSRC [BB/I00050X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Medical Research Council [MC_PC_12009] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge Biomedical Research Centre(General Electric); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Sinclair, L. Dolken, A. Schuldt, N. Wilson, and F. Calero-Nieto for helpful discussion; R. Schulte and his team for FACS; M. Gratian, M. Bowen, and K. Jayawardena (Cambridge Institute for Medical Research); N. Smerdon (Wellcome Trust Sanger Institute); and S. Andrews (Babraham Institute) for SeqMonk customization. Supported by Wellcome Trust Principal Research Fellowship 101835/Z/13/Z (P.J.L.), a Wellcome Trust studentship (I.A.T.), an MRC Centenary Award (R.T.T.), and the Cambridge Biomedical Research Centre. The Cambridge Institute for Medical Research is in receipt of a Wellcome Trust Strategic Award. Raw sequence data are archived at Gene Expression Omnibus (GSE60056 and GSE63116) and Sequence Read Archive (PRJNA257239).	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chang YQ, 2011, J MOL BIOL, V408, P807, DOI 10.1016/j.jmb.2011.03.018; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Elgin SCR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017780; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Kokura K, 2010, EMBO J, V29, P3673, DOI 10.1038/emboj.2010.239; Kungulovski G, 2014, GENOME RES, V24, P1842, DOI 10.1101/gr.170985.113; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025104; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; REUTER G, 1986, MOL GEN GENET, V202, P481, DOI 10.1007/BF00333281; Schotta G, 2003, SEMIN CELL DEV BIOL, V14, P67, DOI 10.1016/S1084-9521(02)00138-6; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302	17	155	159	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1481	1485		10.1126/science.aaa7227	http://dx.doi.org/10.1126/science.aaa7227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26022416	Green Accepted			2022-12-28	WOS:000356869100044
J	Capinha, C; Essl, F; Seebens, H; Moser, D; Pereira, HM				Capinha, Cesar; Essl, Franz; Seebens, Hanno; Moser, Dietmar; Pereira, Henrique Miguel			The dispersal of alien species redefines biogeography in the Anthropocene	SCIENCE			English	Article							BIOTIC HOMOGENIZATION; BIODIVERSITY CHANGE; INTRODUCTIONS; DISTRIBUTIONS; SIMILARITY; EXTINCTION; PATTERNS; REGIONS	It has been argued that globalization in human-mediated dispersal of species breaks down biogeographic boundaries, yet empirical tests are still missing. We used data on native and alien ranges of terrestrial gastropods to analyze dissimilarities in species composition among 56 globally distributed regions. We found that native ranges confirm the traditional biogeographic realms, reflecting natural dispersal limitations. However, the distributions of gastropods after human transport are primarily explained by the prevailing climate and, to a smaller extent, by distance and trade relationships. Our findings show that human-mediated dispersal is causing a breakdown of biogeographic barriers, and that climate and to some extent socioeconomic relationships will define biogeography in an era of global change.	[Capinha, Cesar; Pereira, Henrique Miguel] Univ Porto, CIBIO InBIO, Ctr Invest Biodiversidade & Recursos Genet, Catedra REFER Biodiversidade, P-4485661 Vairao, Portugal; [Capinha, Cesar] Museumsmeile Bonn, Zool Forschungsmuseum Alexander Koenig, D-53113 Bonn, Germany; [Essl, Franz; Moser, Dietmar] Univ Vienna, Fac Ctr Biodivers, Div Conservat Biol Vegetat & Landscape Ecol, A-1030 Vienna, Austria; [Seebens, Hanno] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, D-26111 Oldenburg, Germany; [Pereira, Henrique Miguel] German Ctr Integrat Biodivers Res iDiv, D-04103 Leipzig, Germany; [Pereira, Henrique Miguel] Univ Halle Wittenberg, Inst Biol, D-06108 Halle, Saale, Germany	Universidade do Porto; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of Vienna; Carl von Ossietzky Universitat Oldenburg; Martin Luther University Halle Wittenberg	Capinha, C (corresponding author), Univ Porto, CIBIO InBIO, Ctr Invest Biodiversidade & Recursos Genet, Catedra REFER Biodiversidade, Campus Agr Vairao, P-4485661 Vairao, Portugal.	ccapinha@cibio.up.pt	Capinha, César D/K-6439-2017; Pereira, Henrique/B-3975-2009; Seebens, Hanno/I-2310-2019; Essl, Franz/ABE-7064-2020	Capinha, César D/0000-0002-0666-9755; Pereira, Henrique/0000-0003-1043-1675; Seebens, Hanno/0000-0001-8993-6419; Essl, Franz/0000-0001-8253-2112; Moser, Dietmar/0000-0002-2745-7508	Portuguese Foundation for Science and Technology (FCT/MCTES); POPH/FSE (EC) [SFRH/BPD/84422/2012]; Austrian Climate and Energy Fund [KR11AC0K00355]; German VW-Foundation; German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig - German Research Foundation [FZT 118]; Catedra-REFER-Biodiversidade	Portuguese Foundation for Science and Technology (FCT/MCTES)(Portuguese Foundation for Science and Technology); POPH/FSE (EC)(European CommissionEuropean Commission Joint Research CentreEuropean Social Fund (ESF)); Austrian Climate and Energy Fund; German VW-Foundation; German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig - German Research Foundation; Catedra-REFER-Biodiversidade	We thank the many researchers who provided information on the native and current distribution of the species, particularly B. Roth, D. Herbert, D. Robinson, G. Stuffle, H. Kappes, J. Ablett, J. Gerlach, K. Hayes, O. Griffiths, R. Preece, R. Forsyth, S. Martin, T.-S. Liew, and T. A. Pearce. We highly appreciate the comments and suggestions of three anonymous reviewers. All sources of species distribution data used in this study are listed in the supplementary materials. Climate and trade data are freely available in the WorldClim (www.worldclim.org) and the UN Comtrade (http://comtrade.un.org) online databases, respectively. Supported by a postdoctoral grant from the Portuguese Foundation for Science and Technology (FCT/MCTES) and POPH/FSE (EC) grant SFRH/BPD/84422/2012 (C.C.), the Austrian Climate and Energy Fund (project no. KR11AC0K00355, SpecAdapt) (F.E.), the German VW-Foundation (H. S.), the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig funded by German Research Foundation grant FZT 118 (H.M.P.), and Catedra-REFER-Biodiversidade.	Baiser B, 2012, P ROY SOC B-BIOL SCI, V279, P4772, DOI 10.1098/rspb.2012.1651; Cassey P, 2006, OIKOS, V115, P207, DOI 10.1111/j.2006.0030-1299.15223.x; Cowie R. H., 2011, ENCY BIOL INVASIONS, P634; Cox CB, 2005, BIOGEOGRAPHY ECOLOGI; diCastri F, 1989, BIOL INVASIONS GLOBA, P1; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; ELTON CS, 1958, ECOLOGY INVASIONS PL; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Gibson L, 2013, SCIENCE, V341, P1508, DOI 10.1126/science.1240495; Helmus MR, 2014, NATURE, V513, P543, DOI 10.1038/nature13739; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Leadley P. W., 2014, CONV BIOL DIV; Leibold MA, 2010, ECOL LETT, V13, P1290, DOI 10.1111/j.1461-0248.2010.01523.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Robinson DG, 1999, MALACOLOGIA, V41, P413; Seebens H, 2013, ECOL LETT, V16, P782, DOI 10.1111/ele.12111; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Thuiller W, 2010, DIVERS DISTRIB, V16, P461, DOI 10.1111/j.1472-4642.2010.00645.x; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; Villeger S, 2011, P NATL ACAD SCI USA, V108, P18003, DOI 10.1073/pnas.1107614108; Wallace, 1876, GEOGRAPHICAL DISTRIB; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106	29	233	240	11	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1248	1251		10.1126/science.aaa8913	http://dx.doi.org/10.1126/science.aaa8913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068851				2022-12-28	WOS:000356011500053
J	Cooper, OR; Langford, AO; Parrish, DD; Fahey, DW				Cooper, Owen R.; Langford, Andrew O.; Parrish, David D.; Fahey, David W.			Challenges of a lowered US ozone standard	SCIENCE			English	Editorial Material							RELEVANT BACKGROUND OZONE; SURFACE AIR; MODELS		[Cooper, Owen R.; Parrish, David D.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Cooper, Owen R.; Langford, Andrew O.; Parrish, David D.; Fahey, David W.] NOAA, Div Chem Sci, Earth Syst Res Lab, Boulder, CO 80305 USA	University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA	Cooper, OR (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	owen.r.cooper@noaa.gov	Langford, Andrew O/D-2323-2009; Parrish, David/E-8957-2010; Cooper, Owen R/H-4875-2013; Fahey, David W/G-4499-2013	Langford, Andrew O/0000-0002-2932-7061; Parrish, David/0000-0001-6312-2724; Cooper, Owen R/0000-0001-7391-1161; Fahey, David W/0000-0003-1720-0634				Cooper OR, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016095; Cooper OR, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018261; Dentener F., 2011, AIR POLLUTION STUDIE, V17; Emery C, 2012, ATMOS ENVIRON, V47, P206, DOI 10.1016/j.atmosenv.2011.11.012; EPA, 2014, EPA452P14006; EPA, 2014, TOOLS ADDR BACKGR OZ; Fiore AM, 2014, ATMOS ENVIRON, V96, P284, DOI 10.1016/j.atmosenv.2014.07.045; Gratz LE, 2015, ATMOS ENVIRON, V109, P323, DOI 10.1016/j.atmosenv.2014.05.076; Langford AO, 2015, ATMOS ENVIRON, V109, P305, DOI 10.1016/j.atmosenv.2014.08.040; Lin MY, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018151; Lin MY, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016961; Parrish DD, 2014, J GEOPHYS RES-ATMOS, V119, P5719, DOI 10.1002/2013JD021435; U.S. EPA, 2014, EPA452R14006; Zhang L, 2011, ATMOS ENVIRON, V45, P6769, DOI 10.1016/j.atmosenv.2011.07.054	14	73	74	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1096	1097		10.1126/science.aaa5748	http://dx.doi.org/10.1126/science.aaa5748			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045425				2022-12-28	WOS:000355590500028
J	Evans, BJ; Burke, W; Jarvik, GP				Evans, Barbara J.; Burke, Wylie; Jarvik, Gail P.			The FDA and Genomic Tests - Getting Regulation Right	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Evans, Barbara J.] Univ Houston, Ctr Law, Ctr Biotechnol & Law, Houston, TX 77004 USA; [Burke, Wylie] Univ Washington, Dept Bioeth & Humanities, Seattle, WA 98195 USA; [Jarvik, Gail P.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Houston System; University of Houston; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Evans, BJ (corresponding author), Univ Houston, Ctr Law, Ctr Biotechnol & Law, Houston, TX 77004 USA.		Burke, William/C-1203-2012		NHGRI NIH HHS [U01 HG006507, U01 HG007307] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006507, U01HG007307] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Alexander L, 2015, INNOVATION HEALTHIER; [Anonymous], 2015, STRENGTH PAT CAR BUI; Center for Devices and Radiological Health U. S. Food and Drug Administration (FDA), 2012, STRENGTH OUR NAT SYS; Clement Paul D., 2015, LAB TESTING SERVICES; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine, 2011, MED DEV PUBL HLTH FD; Curnutte MA, 2014, NAT BIOTECHNOL, V32, P980, DOI 10.1038/nbt.3030; Department of Health and Human Services, 2014, CLIA PROGR HIPAA PRI; Department of Health and Human Services, 2014, FRAM REG OV LAB DEV; Department of Health and Human Services, 2014, FDA NOT MED DEV REP; Department of Health and Human Services, 2014, OPT FDAS REG OV NEXT; Department of Health and Human Services, 2015, OPT FDAS REG OV NEXT; Department of Health and Human Services Center for Devices and Radiological Health Food and Drug Administration Center for Biologics Evaluation Research, 2014, BAL PREM POSTM DAT C; Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Energy and Commerce Committee U.S. House of Representatives, 2015, 21 CENT CUR LEG PHAS; Evans JP, 2015, JAMA-J AM MED ASSOC, V313, P669, DOI 10.1001/jama.2014.18145; GenomeWeb, 2007, GENOMEWEB       0907; Government Accountability Office, 2006, CLIN LAB QUAL CMS SU; Institute of Medicine Committee on the Assessment of the U.S. Drug Safety System, 2006, FUT DRUG SAF PROM PR; Kohane IS, 2012, GENET MED, V14, P399, DOI 10.1038/gim.2011.68; Litwack D, 2015, OPTIMIZING FDAS REGU; Mini-Sentinel Operations Center, 2014, MIN SENT DISTR DAT G; Mini-Sentinel Operations Center and Clinical Trials Transformation Initiative, 2014, DEV APPR COND RAND T; National Center for Biotechnology Information U.S. National Library of Medicine, CLINVAR SUBM STAT; Pratt VM, 2015, DISCUSSION PAPER ANA; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; ROSATI KRISTEN, 2010, HIPAA COMMON RULE CO; *SECR ADV COMM GEN, 2000, ENH OV GEN TESTS REC; Sharfstein J, 2015, JAMA-J AM MED ASSOC, V313, P667, DOI 10.1001/jama.2014.18135; Shirts BH, 2014, GENET MED, V16, P529, DOI 10.1038/gim.2013.187; Thompson BM, 2015, LDT DEBATE UNDERSTAN; White House Office of the Press Secretary, 2015, FACT SHEET PRES OB P	33	65	69	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2015	372	23					2258	2264		10.1056/NEJMsr1501194	http://dx.doi.org/10.1056/NEJMsr1501194			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1GK	26014592	Bronze, Green Accepted			2022-12-28	WOS:000355955100015
J	Gerlach, P; Malet, H; Cusack, S; Reguera, J				Gerlach, Piotr; Malet, Helene; Cusack, Stephen; Reguera, Juan			Structural Insights into Bunyavirus Replication and Its Regulation by the vRNA Promoter	CELL			English	Article							RNA-DEPENDENT POLYMERASES; CRYO-EM STRUCTURE; VIRUS; REFINEMENT; COMPLEX; NUCLEOPROTEIN; TRANSCRIPTION; GENERATION; SEQUENCE; REGIONS	Segmented negative-strand RNA virus (sNSV) polymerases transcribe and replicate the viral RNA (vRNA) within a ribonucleoprotein particle (RNP). We present cryo-EM and X-ray structures of, respectively, apo-and vRNA bound La Crosse orthobunyavirus (LACV) polymerase that give atomic-resolution insight into how such RNPs perform RNA synthesis. The complementary 3' and 5' vRNA extremities are sequence specifically bound in separate sites on the polymerase. The 5' end binds as a stem-loop, allosterically structuring functionally important polymerase active site loops. Identification of distinct template and product exit tunnels allows proposal of a detailed model for template-directed replication with minimal disruption to the circularised RNP. The similar overall architecture and vRNA binding of monomeric LACV to heterotrimeric influenza polymerase, despite high sequence divergence, suggests that all sNSV polymerases have a common evolutionary origin and mechanism of RNA synthesis. These results will aid development of replication inhibitors of diverse, serious human pathogenic viruses.	[Gerlach, Piotr; Malet, Helene; Cusack, Stephen; Reguera, Juan] European Mol Biol Lab, Grenoble Outstat, F-38042 Grenoble 9, France; [Gerlach, Piotr; Malet, Helene; Cusack, Stephen; Reguera, Juan] Univ Grenoble Alpes, EMBL, CNRS, Unit Virus Host Cell Interact UMI 3265, F-38042 Grenoble 9, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL)	Cusack, S (corresponding author), European Mol Biol Lab, Grenoble Outstat, 71 Ave Martyrs,CS90181, F-38042 Grenoble 9, France.	cusack@embl.fr; jreguera@embl.fr	Reguera, Juan/A-7551-2017; Gerlach, Piotr/GQQ-5960-2022; Vidaechea, Juan J Reguera/G-7451-2012	Reguera, Juan/0000-0003-4977-7948; MALET, Helene/0000-0002-2834-7386; Gerlach, Piotr/0000-0001-9599-7322; Cusack, Stephen/0000-0002-9324-0796	FRISBI [ANR-10-INSB-05-02]; GRAL [ANR-10-LABX-49-01]; EMBO long-term Fellowships; ANR grant ArenaBunya-L; ERC Advanced Grant V-RNA [322586]	FRISBI; GRAL; EMBO long-term Fellowships; ANR grant ArenaBunya-L(French National Research Agency (ANR)); ERC Advanced Grant V-RNA	We thank Wim Hagen and John Briggs for cryo-EM data collection at EMBL Heidelberg, Leandro Estrozi, Irina Gutsche, and Guy Schoehn for advice on EM image analysis; the staff of the EMBL Eukaryotic Expression and High Throughput Crystallisation facilities, and the EMBL-ESRF JSBG staff for access to ESRF beamlines. Darren Hart helped with construct design and together with Philippe Mas and Damien Maurin with the ESPRIT analysis. Mass-spectroscopy was performed by Joanna Kirkpatrick (EMBL Proteomics Core Facility) and Luca Signor (IBS), Edman degradation by Jean-Pierre Andrieu (IBS) and Stefan Reich (EMBL) helped with RNA binding studies. This work used the platforms of the Grenoble Instruct Center (ISBG: UMS 3518 CNRS-CEA-UJF-EMBL) within the Grenoble Partnership for Structural Biology (PSB), with support from FRISBI (ANR-10-INSB-05-02), GRAL (ANR-10-LABX-49-01) and, for the EM facility, the Rhone-Alpes Region and the Fondation Recherche Medicale (FRM). H.M. and J.R. were supported by EMBO long-term Fellowships for some of this work. S.C. acknowledges support by ANR grant ArenaBunya-L and ERC Advanced Grant V-RNA (322586).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Barr JN, 2004, J VIROL, V78, P1129, DOI 10.1128/JVI.78.3.1129-1138.2004; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chang SH, 2015, MOL CELL, V57, P925, DOI 10.1016/j.molcel.2014.12.031; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Fodor E, 2013, ACTA VIROL, V57, P113, DOI 10.4149/av_2013_02_113; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Guu TSY, 2012, ADV EXP MED BIOL, V726, P245, DOI 10.1007/978-1-4614-0980-9_11; Haddow AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006145; Jorba N, 2008, J GEN VIROL, V89, P520, DOI 10.1099/vir.0.83387-0; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kohl A, 2004, J GEN VIROL, V85, P3269, DOI 10.1099/vir.0.80407-0; Kranzusch PJ, 2010, P NATL ACAD SCI USA, V107, P20069, DOI 10.1073/pnas.1007152107; Lehmann M, 2014, J VIROL, V88, P8713, DOI 10.1128/JVI.00652-14; Morin B, 2013, CURR OPIN VIROL, V3, P103, DOI 10.1016/j.coviro.2013.03.008; Morin B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001038; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; RAJU R, 1989, J VIROL, V63, P122, DOI 10.1128/JVI.63.1.122-128.1989; Reguera J, 2014, CURR OPIN VIROL, V5, P7, DOI 10.1016/j.coviro.2014.01.003; Reguera J, 2013, P NATL ACAD SCI USA, V110, P7246, DOI 10.1073/pnas.1302298110; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39; te Velthuis AJW, 2014, CELL MOL LIFE SCI, V71, P4403, DOI 10.1007/s00018-014-1695-z; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; York A, 2013, P NATL ACAD SCI USA, V110, pE4238, DOI 10.1073/pnas.1315068110	30	118	119	1	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1267	1279		10.1016/j.cell.2015.05.006	http://dx.doi.org/10.1016/j.cell.2015.05.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26004069	Green Published, hybrid			2022-12-28	WOS:000355935000008
J	Spoor, F				Spoor, Fred			PALAEOANTHROPOLOGY The middle Pliocene gets crowded	NATURE			English	Editorial Material							EASTERN AFRICA; HOMININ; ETHIOPIA		[Spoor, Fred] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Spoor, Fred] Max Planck Inst Evolutionare Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany	University of London; University College London; Max Planck Society	Spoor, F (corresponding author), UCL, Dept Cell & Dev Biol, London WC1E 6BT, England.	f.spoor@ucl.ac.uk						Brunet M, 1996, CR ACAD SCI II A, V322, P907; Granger D. E., 2015, NATURE; Guy F, 2008, J HUM EVOL, V55, P37, DOI 10.1016/j.jhevol.2007.12.003; Haile-Selassie Y, 2015, NATURE, V521, P483, DOI 10.1038/nature14448; Haile-Selassie Y, 2012, NATURE, V483, P565, DOI 10.1038/nature10922; Harmand S, 2015, NATURE, V521, P310, DOI 10.1038/nature14464; Kimbel WH, 2009, YEARB PHYS ANTHROPOL, V52, P2, DOI 10.1002/ajpa.21183; Leakey MG, 2001, NATURE, V410, P433, DOI 10.1038/35068500; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Spoor F, 2010, PHILOS T R SOC B, V365, P3377, DOI 10.1098/rstb.2010.0042	10	7	7	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					432	433		10.1038/521432a	http://dx.doi.org/10.1038/521432a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	26017440				2022-12-28	WOS:000355286600029
J	Blum, MR; Bauer, DC; Collet, TH; Fink, HA; Cappola, AR; da Costa, BR; Wirth, CD; Peeters, RP; Asvold, BO; den Elzen, WPJ; Luben, RN; Imaizumi, M; Bremner, AP; Gogakos, A; Eastell, R; Kearney, PM; Strotmeyer, ES; Wallace, ER; Hoff, M; Ceresini, G; Rivadeneira, F; Uitterlinden, AG; Stott, DJ; Westendorp, RGJ; Khaw, KT; Langhammer, A; Ferrucci, L; Gussekloo, J; Williams, GR; Walsh, JP; Juni, P; Aujesky, D; Rodondi, N				Blum, Manuel R.; Bauer, Douglas C.; Collet, Tinh-Hai; Fink, Howard A.; Cappola, Anne R.; da Costa, Bruno R.; Wirth, Christina D.; Peeters, Robin P.; Asvold, Bjorn O.; den Elzen, Wendy P. J.; Luben, Robert N.; Imaizumi, Misa; Bremner, Alexandra P.; Gogakos, Apostolos; Eastell, Richard; Kearney, Patricia M.; Strotmeyer, Elsa S.; Wallace, Erin R.; Hoff, Mari; Ceresini, Graziano; Rivadeneira, Fernando; Uitterlinden, Andre G.; Stott, David J.; Westendorp, Rudi G. J.; Khaw, Kay-Tee; Langhammer, Arnuf; Ferrucci, Luigi; Gussekloo, Jacobijn; Williams, Graham R.; Walsh, John P.; Jueni, Peter; Aujesky, Drahomir; Rodondi, Nicolas		Thyroid Studies Collaboration	Subclinical Thyroid Dysfunction and Fracture Risk A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; PARTICIPANT DATA-ANALYSIS; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; CARDIOVASCULAR-DISEASE; STIMULATING HORMONE; SYSTEMATIC REVIEWS; RANDOMIZED-TRIALS; FOLLOW-UP; HYPERTHYROIDISM	IMPORTANCE Associations between subclinical thyroid dysfunction and fractures are unclear and clinical trials are lacking. OBJECTIVE To assess the association of subclinical thyroid dysfunction with hip, nonspine, spine, or any fractures. DATA SOURCES AND STUDY SELECTION The databases of MEDLINE and EMBASE (inception to March 26, 2015) were searched without language restrictions for prospective cohort studies with thyroid function data and subsequent fractures. DATA EXTRACTION Individual participant data were obtained from 13 prospective cohorts in the United States, Europe, Australia, and Japan. Levels of thyroid function were defined as euthyroidism (thyroid-stimulating hormone [TSH], 0.45-4.49 mIU/L), subclinical hyperthyroidism (TSH <0.45 mIU/L), and subclinical hypothyroidism (TSH >= 4.50-19.99 mIU/L) with normal thyroxine concentrations. MAIN OUTCOME AND MEASURES The primary outcome was hip fracture. Any fractures, nonspine fractures, and clinical spine fractures were secondary outcomes. RESULTS Among 70 298 participants, 4092 (5.8%) had subclinical hypothyroidism and 2219 (3.2%) had subclinical hyperthyroidism. During 762 401 person-years of follow-up, hip fracture occurred in 2975 participants (4.6%; 12 studies), any fracture in 2528 participants (9.0%; 8 studies), nonspine fracture in 2018 participants (8.4%; 8 studies), and spine fracture in 296 participants (1.3%; 6 studies). In age-and sex-adjusted analyses, the hazard ratio (HR) for subclinical hyperthyroidism vs euthyroidismwas 1.36 for hip fracture (95% CI, 1.13-1.64; 146 events in 2082 participants vs 2534 in 56 471); for any fracture, HRwas 1.28 (95% CI, 1.06-1.53; 121 events in 888 participants vs 2203 in 25 901); for nonspine fracture, HRwas 1.16 (95% CI, 0.95-1.41; 107 events in 946 participants vs 1745 in 21 722); and for spine fracture, HRwas 1.51 (95% CI, 0.93-2.45; 17 events in 732 participants vs 255 in 20 328). Lower TSHwas associated with higher fracture rates: for TSH of less than 0.10 mIU/L, HRwas 1.61 for hip fracture (95% CI, 1.21-2.15; 47 events in 510 participants); for any fracture, HRwas 1.98 (95% CI, 1.41-2.78; 44 events in 212 participants); for nonspine fracture, HRwas 1.61 (95% CI, 0.96-2.71; 32 events in 185 participants); and for spine fracture, HRwas 3.57 (95% CI, 1.88-6.78; 8 events in 162 participants). Risks were similar after adjustment for other fracture risk factors. Endogenous subclinical hyperthyroidism (excluding thyroid medication users) was associated with HRs of 1.52 (95% CI, 1.19-1.93) for hip fracture, 1.42 (95% CI, 1.16-1.74) for any fracture, and 1.74 (95% CI, 1.01-2.99) for spine fracture. No association was found between subclinical hypothyroidism and fracture risk. CONCLUSIONS AND RELEVANCE Subclinical hyperthyroidism was associated with an increased risk of hip and other fractures, particularly among those with TSH levels of less than 0.10 mIU/L and those with endogenous subclinical hyperthyroidism. Further study is needed to determine whether treating subclinical hyperthyroidism can prevent fractures.	[Blum, Manuel R.; Wirth, Christina D.; Aujesky, Drahomir; Rodondi, Nicolas] Univ Hosp Bern, Inselspital, Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Bauer, Douglas C.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Bauer, Douglas C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Collet, Tinh-Hai] Univ Lausanne Hosp, Serv Endocrinol Diabet & Metab, Lausanne, Switzerland; [Fink, Howard A.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Fink, Howard A.] VA Med Ctr, Geriatr Res Educ & Clin Ctr, Minneapolis, MN USA; [Cappola, Anne R.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [da Costa, Bruno R.] Florida Int Univ, Nicole Wertheim Coll Nursing & Hlth Sci, Dept Phys Therapy, Miami, FL 33199 USA; [Peeters, Robin P.; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Peeters, Robin P.; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Asvold, Bjorn O.; Hoff, Mari; Langhammer, Arnuf] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Asvold, Bjorn O.] Univ Trondheim Hosp, St Olavs Hosp, Dept Endocrinol, Trondheim, Norway; [den Elzen, Wendy P. J.; Gussekloo, Jacobijn] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Luben, Robert N.; Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Imaizumi, Misa] Radiat Effects Res Fdn, Nagasaki, Japan; [Bremner, Alexandra P.] Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia; [Gogakos, Apostolos; Williams, Graham R.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Eastell, Richard] Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England; [Kearney, Patricia M.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Strotmeyer, Elsa S.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Wallace, Erin R.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Hoff, Mari] Nord Trondelag Hosp Trust, Levanger Hosp, Levanger, Norway; [Ceresini, Graziano] Univ Hosp Parma, Dept Clin & Expt Med, Geriatr Endocrine Unit, Parma, Italy; [Stott, David J.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Westendorp, Rudi G. J.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Ferrucci, Luigi] NIA, NIH, Baltimore, MD 21224 USA; [Walsh, John P.] Univ Western Australia, Crawley, WA, Australia; [Walsh, John P.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA 6009, Australia; [Jueni, Peter] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	University of Bern; University Hospital of Bern; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Minnesota System; University of Minnesota Twin Cities; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Pennsylvania; State University System of Florida; Florida International University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cambridge; Radiation Effects Research Foundation - Japan; University of Western Australia; Imperial College London; University of Sheffield; University College Cork; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of Parma; University Hospital of Parma; University of Glasgow; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Western Australia; University of Western Australia; University of Bern	Rodondi, N (corresponding author), Univ Bern, Inselspital, Dept Gen Internal Med, CH-3010 Bern, Switzerland.	nicolas.rodondi@insel.ch	Rivadeneira, Fernando/O-5385-2015; Collet, Tinh-Hai/I-4462-2019; Juni, Peter/Q-8700-2016; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022; Kearney, Patricia M/AAE-8501-2020; Gussekloo, Jacobijn/ABE-3879-2021; Khaw, Kay-Tee/AAZ-3209-2021; Eastell, Richard/G-5851-2011; Walsh, John/GQI-2785-2022; Hoff, Mari/AAZ-7302-2021; Luben, Robert N/H-5519-2015; Blum, Manuel/P-9840-2016	Rivadeneira, Fernando/0000-0001-9435-9441; Collet, Tinh-Hai/0000-0002-3243-1222; Juni, Peter/0000-0002-5985-0670; Gussekloo, Jacobijn/0000-0001-7186-8278; Eastell, Richard/0000-0002-0323-3366; Luben, Robert N/0000-0002-5088-6343; Bremner, Alexandra/0000-0002-4068-4860; R. da Costa, Bruno/0000-0002-1786-6332; Walsh, John/0000-0002-1766-2612; Rodondi, Nicolas/0000-0001-9083-6896; Peeters, Robin/0000-0001-7732-9371; Kearney, Patricia/0000-0001-9599-3540; Schmidt-Wirth, Christina Doris/0000-0003-2604-6253; den Elzen, Wendy/0000-0002-6774-4077; Blum, Manuel/0000-0003-4638-775X; Strotmeyer, Elsa/0000-0002-4093-6036; Hoff, Mari/0000-0002-9992-8663	Swiss National Science Foundation [SNSF 320030-138267, 320030-150025]; Swiss Heart Foundation; National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, U01HL080295]; National Institute of Neurological Disorders and Stroke (NINDS); NIA [R01AG023629, N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, R01-AG028050]; American Heart Association; NINR [R01-NR012459]; Medical Research Council UK; Cancer Research UK; NIH; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Center for Advancing Translational Sciences (NCATS); NIH Roadmap for Medical Research [U01AG027810, U01AG042124, U01AG042139, U01AG042140, U01AG042143, U01AG042145, U01AG042168, U01AR066160, UL1TR000128]; Wallac Oy (Turku, Finland); Dutch Ministry of Health, Welfare and Sports; Bristol-Myers Squibb; Erasmus MC; Erasmus University, Rotterdam, the Netherlands; Netherlands Organisation for Scientific Research (NWO); Netherlands Organisation for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Dutch Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; sanofi-aventis; Eli Lilly; Novartis; Pfizer; Procter & Gamble Pharmaceuticals; Roche; Netherlands Organization for Scientific Research [NGI/NWO 911-03-016]; Swiss National Science Foundation; Swiss Foundation for Grants in Biology and Medicine [PBLAP3-145870, P3SMP3-155318]; Medical Research Council [G0401527, MR/K006312/1, G1000143] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10073, NF-SI-0512-10114] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085080, N01HC085083, N01HC085086, N01HC085082, N01HC055222, N01HC085081, N01HC085079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL085083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR051895, U01AR066160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062106, U01AG042168, N01AG062103, U01AG027810, U01AG042143, U01AG042145, R01AG028050, U01AG042139, N01AG062101, U01AG042124, R01AG023629, U01AG042140] Funding Source: NIH RePORTER; MRC [MR/K006312/1] Funding Source: UKRI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Heart Foundation; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); NINR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wallac Oy (Turku, Finland); Dutch Ministry of Health, Welfare and Sports; Bristol-Myers Squibb(Bristol-Myers Squibb); Erasmus MC; Erasmus University, Rotterdam, the Netherlands(Netherlands Government); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Dutch Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; sanofi-aventis(Sanofi-Aventis); Eli Lilly(Eli Lilly); Novartis(Novartis); Pfizer(Pfizer); Procter & Gamble Pharmaceuticals(Procter & Gamble); Roche(Roche Holding); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Grants in Biology and Medicine; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was supported by grants from the Swiss National Science Foundation (SNSF 320030-138267 and 320030-150025) and partially supported by a grant from the Swiss Heart Foundation (Dr Rodondi). The Cardiovascular Health Study was supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) (HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086; and grant U01HL080295) with an additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided by the NIA (R01AG023629). The thyroid measurements in the Cardiovascular Health Study were supported by an American Heart Association Grant-in-Aid (Dr Fried). The Health, Aging, and Body Composition Study was supported by the NIA (contract numbers: N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106; and grant R01-AG028050); and an NINR grant (R01-NR012459). The NIA funded the Health, Aging, and Body Composition Study, reviewed the manuscript, and approved its publication. This research was supported in part by the NIA. The EPIC (European Prospective Investigation of Cancer)-Norfolk Study was supported by research grants from the Medical Research Council UK and Cancer Research UK. The Osteoporotic Fractures in Men (MrOS) Study is supported by NIH funding. The following institutes provided support: the NIA, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Center for Advancing Translational Sciences (NCATS), and NIH Roadmap for Medical Research (grant numbers: U01AG027810, U01AG042124, U01AG042139, U01AG042140, U01AG042143, U01AG042145, U01AG042168, U01AR066160, and UL1TR000128). The Nord-Trondelag Health Study (HUNT Study) is a collaborative effort of the Faculty of Medicine, Norwegian University of Science and Technology; the Norwegian Institute of Public Health; and the Nord-Trondelag County Council. Thyroid function testing in the HUNT Study was financially supported by Wallac Oy (Turku, Finland). The Leiden 85-plus Study was partly funded by the Dutch Ministry of Health, Welfare and Sports. The original PROSPER study was supported by an unrestricted, investigator-initiated grant from Bristol-Myers Squibb. The Rotterdam Study is funded by Erasmus MC and Erasmus University, Rotterdam, the Netherlands; the Netherlands Organisation for Scientific Research (NWO); the Netherlands Organisation for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture and Science; the Dutch Ministry for Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. The original OPUS study was supported by sanofi-aventis, Eli Lilly, Novartis, Pfizer, Procter & Gamble Pharmaceuticals, and Roche. Dr Westendorp is supported by the Netherlands Organization for Scientific Research (NGI/NWO 911-03-016). Dr Collet reports receipt of research support from grants from the Swiss National Science Foundation and the Swiss Foundation for Grants in Biology and Medicine (PBLAP3-145870, P3SMP3-155318).	Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; [Anonymous], 2013, SEARCH FILT MEDL COH; Bahn RS, 2011, THYROID, V21, P593, DOI 10.1089/thy.2010.0417; Barrett-Connor E, 2009, OSTEOPOROSIS INT, V20, P715, DOI 10.1007/s00198-008-0748-2; Bassett JHD, 2008, BONE, V43, P418, DOI 10.1016/j.bone.2008.05.007; Bauer DC, 2001, ANN INTERN MED, V134, P561, DOI 10.7326/0003-4819-134-7-200104030-00009; Boekholdt SM, 2010, CLIN ENDOCRINOL, V72, P404, DOI 10.1111/j.1365-2265.2009.03640.x; Brennan MD, 2006, THYROID, V16, P375, DOI 10.1089/thy.2006.16.375; Buscemi S, 2007, J ENDOCRINOL INVEST, V30, P230, DOI 10.1007/BF03347430; Cardiovascular Health Study-National Heart Lung and Blood Institute, CARD HLTH STUD; Ceresini G, 2013, J AM GERIATR SOC, V61, P868, DOI 10.1111/jgs.12267; Collet TH, 2014, J CLIN ENDOCR METAB, V99, P3353, DOI 10.1210/jc.2014-1250; Collet TH, 2012, ARCH INTERN MED, V172, P799, DOI 10.1001/archinternmed.2012.402; da Costa BR, 2014, EUR HEART J, V35, P3336, DOI 10.1093/eurheartj/ehu424; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Drake MT, 2012, J CLIN ENDOCR METAB, V97, P1861, DOI 10.1210/jc.2011-3058; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2001, SYSTEMATIC REV HLTH; Finigan J, 2008, J BONE MINER RES, V23, P75, DOI 10.1359/JBMR.070814; Fink HA, 2005, J BONE MINER RES, V20, P1216, DOI 10.1359/JBMR.050314; Flynn RW, 2010, J CLIN ENDOCR METAB, V95, P186, DOI 10.1210/jc.2009-1625; Gencer B, 2012, CIRCULATION, V126, P1040, DOI 10.1161/CIRCULATIONAHA.112.096024; Goichot B, 2009, CLIN CHEM, V55, P420, DOI 10.1373/clinchem.2008.110627; Greenspan SL, 1999, ANN INTERN MED, V130, P750, DOI 10.7326/0003-4819-130-9-199905040-00016; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Heinze G, 2001, BIOMETRICS, V57, P114, DOI 10.1111/j.0006-341X.2001.00114.x; Helfand M, 2008, PRINCIPLES DEV APPL; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Imaizumi M, 2004, J CLIN ENDOCR METAB, V89, P3365, DOI 10.1210/jc.2003-031089; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P155, DOI 10.1007/s00198-004-1640-3; Lee JS, 2010, ARCH INTERN MED, V170, P1876, DOI 10.1001/archinternmed.2010.424; Meier C, 2004, OSTEOPOROSIS INT, V15, P209, DOI 10.1007/s00198-003-1527-8; Meyerovitch J, 2007, ARCH INTERN MED, V167, P1533, DOI 10.1001/archinte.167.14.1533; Murphy E, 2010, J CLIN ENDOCR METAB, V95, P3173, DOI 10.1210/jc.2009-2630; Nanchen D, 2012, J CLIN ENDOCR METAB, V97, P852, DOI 10.1210/jc.2011-1978; Nevitt MC, 1998, ANN INTERN MED, V128, P793, DOI 10.7326/0003-4819-128-10-199805150-00001; Nicholls JJ, 2012, J ENDOCRINOL, V213, P209, DOI 10.1530/JOE-12-0059; PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Rochon PA, 2011, BMJ-BRIT MED J, V342, pd2238; Rodondi N, 2005, ARCH INTERN MED, V165, P2460, DOI 10.1001/archinte.165.21.2460; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; Rosario PW, 2010, CLIN ENDOCRINOL, V72, P685, DOI 10.1111/j.1365-2265.2009.03696.x; ROSS DS, 1993, AM J MED, V95, P385, DOI 10.1016/0002-9343(93)90307-B; Schneider R, 2003, EXP CLIN ENDOCR DIAB, V111, P455; SCHOENFELD D, 1980, BIOMETRIKA, V67, P145; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Svare A, 2013, EUR J ENDOCRINOL, V169, P845, DOI 10.1530/EJE-13-0546; Vestergaard P, 2003, THYROID, V13, P585, DOI 10.1089/105072503322238854; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Walsh JP, 2010, J CLIN ENDOCR METAB, V95, P1095, DOI 10.1210/jc.2009-1977; Walsh JP, 2005, ARCH INTERN MED, V165, P2467, DOI 10.1001/archinte.165.21.2467; Waring AC, 2013, J BONE MINER RES, V28, P472, DOI 10.1002/jbmr.1774; Waring AC, 2012, J CLIN ENDOCR METAB, V97, P3944, DOI 10.1210/jc.2012-2481; Wells G., NEWCASTLE OTTAWA SCA; Wirth CD, 2014, ANN INTERN MED, V161, P189, DOI 10.7326/M14-0125; Yonem O, 2002, ENDOCR J, V49, P307, DOI 10.1507/endocrj.49.307	59	182	194	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2015	313	20					2055	2065		10.1001/jama.2015.5161	http://dx.doi.org/10.1001/jama.2015.5161			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0DC	26010634	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000355142400019
J	Ouyang, HL				Ouyang, Helen			The Art of Discharge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY 10027 USA	Columbia University; NewYork-Presbyterian Hospital	Ouyang, HL (corresponding author), Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY 10027 USA.	ho2216@columbia.edu						Engel KG, 2009, ANN EMERG MED, V53, P454, DOI 10.1016/j.annemergmed.2008.05.016; Horwitz LI, 2013, JAMA INTERN MED, V173, P1715, DOI 10.1001/jamainternmed.2013.9318; Howard T, 2013, J HEALTH COMMUN, V18, P991, DOI 10.1080/10810730.2012.757398; Institute of Medicine, 2014, DYING AM IMPR QUAL H	4	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2015	313	20					2027	2028		10.1001/jama.2015.2569	http://dx.doi.org/10.1001/jama.2015.2569			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0DC	26010629				2022-12-28	WOS:000355142400014
J	Blonde, L; Jendle, J; Gross, J; Woo, V; Jiang, HH; Fahrbach, JL; Milicevic, Z				Blonde, Lawrence; Jendle, Johan; Gross, Jorge; Woo, Vincent; Jiang, Honghua; Fahrbach, Jessie L.; Milicevic, Zvonko			Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study	LANCET			English	Article							PLUS ORAL-AGENTS; GLP-1 RECEPTOR AGONIST; BASAL-BOLUS REGIMEN; TO-TARGET TRIAL; DOUBLE-BLIND; GLYCEMIC CONTROL; METFORMIN; EFFICACY; MONOTHERAPY; EXENATIDE	Background For patients with type 2 diabetes who do not achieve target glycaemic control with conventional insulin treatment, advancing to a basal-bolus insulin regimen is often recommended. We aimed to compare the efficacy and safety of long-acting glucagon-like peptide-1 receptor agonist dulaglutide with that of insulin glargine, both combined with prandial insulin lispro, in patients with type 2 diabetes. Methods We did this 52 week, randomised, open-label, phase 3, non-inferiority trial at 105 study sites in 15 countries. Patients (aged >= 18 years) with type 2 diabetes inadequately controlled with conventional insulin treatment were randomly assigned (1: 1: 1), via a computer-generated randomisation sequence with an interactive voice-response system, to receive once-weekly dulaglutide 1.5 mg, dulaglutide 0.75 mg, or daily bedtime glargine. Randomisation was stratified by country and metformin use. Participants and study investigators were not masked to treatment allocation, but were unaware of dulaglutide dose assignment. The primary outcome was a change in glycated haemoglobin A(1c) (HbA(1c)) from baseline to week 26, with a 0 .4% non-inferiority margin. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT01191268. Findings Between Dec 9, 2010, and Sept 21, 2012, we randomly assigned 884 patients to receive dulaglutide 1.5 mg (n=295), dulaglutide 0.75 mg (n=293), or glargine (n=296). At 26 weeks, the adjusted mean change in HbA(1c) was greater in patients receiving dulaglutide 1.5 mg (-1.64% [95% CI -1.78 to -1.50], -17.93 mmol/mol [-19.44 to -16.42]) and dulaglutide 0.75 mg (-1.59% [-1.73 to -1.45], -17.38 mmol/mol [-18.89 to -15.87]) than in those receiving glargine (-1.41% [-1.55 to -1.27], -15.41 mmol/mol [-16.92 to -13.90]). The adjusted mean difference versus glargine was -0.22% (95% CI -0.38 to -0.07, -2.40 mmol/mol [-4.15 to -0.77]; p=0 .005) for dulaglutide 1.5 mg and -0.17% (-0.33 to -0.02, -1.86 mmol/mol [-3.61 to -0.22]; p=0 .015) for dulaglutide 0.75 mg. Five (< 1%) patients died after randomisation because of septicaemia (n=1 in the dulaglutide 1.5 mg group); pneumonia (n=1 in the dulaglutide 0.75 mg group); cardiogenic shock; ventricular fibrillation; and an unknown cause (n=3 in the glargine group). We recorded serious adverse events in 27 (9%) patients in the dulaglutide 1.5 mg group, 44 (15%) patients in the dulaglutide 0.75 mg group, and 54 (18%) patients in the glargine group. The most frequent adverse events, arising more often with dulaglutide than glargine, were nausea, diarrhoea, and vomiting. Interpretation Dulaglutide in combination with lispro resulted in a significantly greater improvement in glycaemic control than did glargine and represents a new treatment option for patients unable to achieve glycaemic targets with conventional insulin treatment.	[Blonde, Lawrence] Ochsner Med Ctr, Dept Endocrinol, New Orleans, LA USA; [Jendle, Johan] Ochsner Med Ctr, Dept Endocrinol, New Orleans, LA USA; [Gross, Jorge] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Woo, Vincent] Univ Manitoba, Sect Endocrinol & Metab, Winnipeg, MB, Canada; [Jiang, Honghua; Fahrbach, Jessie L.] Eli Lilly & Co, Lilly Diabet, Indianapolis, IN 46285 USA; [Milicevic, Zvonko] Lilly Res Labs, Vienna, Austria	Ochsner Health System; Ochsner Health System; Universidade Federal do Rio Grande do Sul; University of Manitoba; Eli Lilly; Eli Lilly	Milicevic, Z (corresponding author), Eli Lilly Reg Operat, A-1030 Vienna, Austria.	milicevic_zvonko@lilly.com	Jendle, Johan/AAN-3375-2020; Jendle, Johan/H-8310-2019	Jendle, Johan/0000-0003-1025-1682; 	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	Funding Eli Lilly and Company.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 1997, JAMA-J AM MED ASSOC, V277, P925; Bergenstal RM, 2008, DIABETES CARE, V31, P1305, DOI 10.2337/dc07-2137; Blevins T, 2011, J CLIN ENDOCR METAB, V96, P1301, DOI 10.1210/jc.2010-2081; Childs BP, 2005, DIABETES CARE, V28, P1245; DeVries JH, 2012, DIABETES CARE, V35, P1446, DOI 10.2337/dc11-1928; Diamant M, 2014, DIABETES CARE, V37, P2763, DOI 10.2337/dc14-0876; Dmitrienko A, 2008, BIOMETRICAL J, V50, P667, DOI 10.1002/bimj.200710464; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Dungan KM, 2014, LANCET, V384, P1349, DOI 10.1016/S0140-6736(14)60976-4; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Garber AJ, 2013, ENDOCR PRACT, V19, P100, DOI 10.4158/EP12325.OR; Grunberger G, 2012, DIABETIC MED, V29, P1260, DOI 10.1111/j.1464-5491.2012.03745.x; Hollander P, 2008, CLIN THER, V30, P1976, DOI 10.1016/j.clinthera.2008.11.001; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Meneghini LF, 2011, J CLIN ENDOCR METAB, V96, P3337, DOI 10.1210/jc.2011-1074; Moretto TJ, 2008, CLIN THER, V30, P1448, DOI 10.1016/j.clinthera.2008.08.006; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nauck M, 2014, DIABETES CARE, V37, P2149, DOI 10.2337/dc13-2761; Porte D, 2001, DIABETES, V50, pS160, DOI 10.2337/diabetes.50.2007.S160; Raskin P, 2009, DIABETES-METAB RES, V25, P542, DOI 10.1002/dmrr.989; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Rosenstock J, 2008, DIABETES CARE, V31, P20, DOI 10.2337/dc07-1122; Rosenstock J, 2014, DIABETES CARE, V37, P2317, DOI 10.2337/dc14-0001; Rosenstock J, 2012, DIABETES, V61, pA15; Skrivanek Z, 2014, DIABETES OBES METAB, V16, P748, DOI 10.1111/dom.12305; Steinberg W, 2012, GASTROENTEROLOGY, V142, pS850; Umpierrez GE, 2011, DIABETES OBES METAB, V13, P418, DOI 10.1111/j.1463-1326.2011.01366.x; Umpierrez G, 2014, DIABETES CARE, V37, P2168, DOI 10.2337/dc13-2759; Weinstock R, 2013, AM DIAB ASS 73 ANN M; Wysham C, 2014, DIABETES CARE, V37, P2159, DOI [10.2337/dc13-2760, 10.2337/dc15-er07b]	31	151	157	2	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2057	2066		10.1016/S0140-6736(15)60936-9	http://dx.doi.org/10.1016/S0140-6736(15)60936-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI7XK	26009229				2022-12-28	WOS:000354979100025
J	Gui, JH; Pan, CM; Jin, Y; Qin, T; Lo, JC; Lee, BJ; Spergel, SH; Mertzman, ME; Pitts, WJ; La Cruz, TE; Schmidt, MA; Darvatkar, N; Natarajan, SR; Baran, PS				Gui, Jinghan; Pan, Chung-Mao; Jin, Ying; Qin, Tian; Lo, Julian C.; Lee, Bryan J.; Spergel, Steven H.; Mertzman, Michael E.; Pitts, William J.; La Cruz, Thomas E.; Schmidt, Michael A.; Darvatkar, Nitin; Natarajan, Swaminathan R.; Baran, Phil S.			Practical olefin hydroamination with nitroarenes	SCIENCE			English	Article							TRANSITION-METAL-FREE; N-TERT-BUTYLATION; NITRO-COMPOUNDS; AMINATION; ARYLATION; AMINES; HYDROGENATION; CONVENIENT; REDUCTION; MECHANISM	The synthesis and functionalization of amines are fundamentally important in a vast range of chemical contexts. We present an amine synthesis that repurposes two simple feedstock building blocks: olefins and nitro( hetero) arenes. Using readily available reactants in an operationally simple procedure, the protocol smoothly yields secondary amines in a formal olefin hydroamination. Because of the presumed radical nature of the process, hindered amines can easily be accessed in a highly chemoselective transformation. A screen of more than 100 substrate combinations showcases tolerance of numerous unprotected functional groups such as alcohols, amines, and even boronic acids. This process is orthogonal to other aryl amine syntheses, such as the Buchwald-Hartwig, Ullmann, and classical amine-carbonyl reductive aminations, as it tolerates aryl halides and carbonyl compounds.	[Gui, Jinghan; Pan, Chung-Mao; Jin, Ying; Qin, Tian; Lo, Julian C.; Lee, Bryan J.; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Spergel, Steven H.; Mertzman, Michael E.; Pitts, William J.] Bristol Myers Squibb Co, Discovery Chem, Princeton, NJ 08543 USA; [La Cruz, Thomas E.; Schmidt, Michael A.] Bristol Myers Squibb, Chem Dev, New Brunswick, NJ 08903 USA; [Darvatkar, Nitin; Natarajan, Swaminathan R.] Kemxtree LLC, Somerset, NJ 08873 USA	Scripps Research Institute; Bristol-Myers Squibb; Bristol-Myers Squibb	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	pbaran@scripps.edu	Jin, Ying/AAL-4096-2020	Spergel, Steven/0000-0002-5190-3942; Pitts, William/0000-0002-1034-6043	Shanghai Institute of Organic Chemistry; Zhejiang Medicine Co.; Pharmaron; China Scholarship Council; Jilin Medical College; NSF; National Institute of General Medical Sciences [GM-097444]; Sigma-Aldrich; Bristol-Myers Squibb; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097444] Funding Source: NIH RePORTER	Shanghai Institute of Organic Chemistry; Zhejiang Medicine Co.; Pharmaron; China Scholarship Council(China Scholarship Council); Jilin Medical College; NSF(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Sigma-Aldrich; Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by a postdoctoral fellowship from the Shanghai Institute of Organic Chemistry, Zhejiang Medicine Co., and Pharmaron (J.G.); a China Scholarship Council and Jilin Medical College visiting scholar fellowship (Y.J.); a NSF graduate fellowship (J.C.L.); and National Institute of General Medical Sciences grant GM-097444, Sigma-Aldrich, and Bristol-Myers Squibb. We thank D.-H. Huang and L. Pasternack for assistance with NMR spectroscopy; A. Rheingold, C. E. Moore, and M. A. Galella for x-ray crystallographic analysis; and M. Eastgate, K. Chen, J. Kadow, and B. Maxwell for helpful discussions. Metrical parameters for the structures of 93 and 121 are available free of charge from the Cambridge Crystallographic Data Center under reference numbers CCDC-1050751 and CCDC-1050750, respectively.	Barker TJ, 2012, J AM CHEM SOC, V134, P13588, DOI 10.1021/ja3063716; Bartoli G, 2014, CHEM SOC REV, V43, P4728, DOI 10.1039/c4cs00045e; Baxter E. W., 2002, ORGANIC REACTIONS, V59, P1, DOI [DOI 10.1002/0471264180.OR059.01, DOI 10.1002/0471264180.0R059.01]; Bladh H. D., 2007, PCT Int. Appl., Patent No. [WO2007046747 A1, 2007046747]; BOGER DL, 1984, TETRAHEDRON LETT, V25, P3175; CADOGAN JIG, 1965, J CHEM SOC, P4831, DOI 10.1039/jr9650004831; COREY EJ, 1985, J ORG CHEM, V50, P5391, DOI 10.1021/jo00225a082; Cran JW, 2014, SYNLETT, V25, P1550, DOI 10.1055/s-0033-1339107; Crossley SWM, 2014, J AM CHEM SOC, V136, P16788, DOI 10.1021/ja5105602; GAGE JR, 1995, J ORG CHEM, V60, P2613, DOI 10.1021/jo00113a047; Gant TG, 2014, J MED CHEM, V57, P3595, DOI 10.1021/jm4007998; Gao HY, 2014, ANGEW CHEM INT EDIT, V53, P2701, DOI 10.1002/anie.201309973; Gao HY, 2013, J AM CHEM SOC, V135, P7086, DOI 10.1021/ja400897u; GINGRAS BA, 1954, J CHEM SOC, P1920, DOI 10.1039/jr9540001920; Guillena G, 2010, CHEM REV, V110, P1611, DOI 10.1021/cr9002159; Hartwig JF, 2008, ACCOUNTS CHEM RES, V41, P1534, DOI 10.1021/ar800098p; HOSOGAI T, 1971, J CHEM SOC C, P3399, DOI 10.1039/j39710003399; INAMOTO N, 1958, J ORG CHEM, V23, P408, DOI 10.1021/jo01097a022; ISAYAMA S, 1989, CHEM LETT, P1071, DOI 10.1246/cl.1989.1071; Ishihara Y., 2013, PORTABLE CHEM CONSUL; Iwasaki K, 2014, J AM CHEM SOC, V136, P1300, DOI 10.1021/ja412342g; JANZEN EG, 1971, ACCOUNTS CHEM RES, V4, P31, DOI 10.1021/ar50037a005; King SM, 2014, J AM CHEM SOC, V136, P6884, DOI 10.1021/ja502885c; Leggans EK, 2012, ORG LETT, V14, P1428, DOI 10.1021/ol300173v; Ley SV, 2003, ANGEW CHEM INT EDIT, V42, P5400, DOI 10.1002/anie.200300594; Lo JCL, 2014, NATURE, V516, P343, DOI 10.1038/nature14006; Lo JC, 2014, J AM CHEM SOC, V136, P1304, DOI 10.1021/ja4117632; Magnus P, 2000, TETRAHEDRON LETT, V41, P9731, DOI 10.1016/S0040-4039(00)01728-7; Marson C. M., 2005, COMPREHENSIVE ORGANI, V2, P255; Ono N., 2001, NITRO GROUP ORGANIC; Romero DL, 1996, J MED CHEM, V39, P3769, DOI 10.1021/jm960158n; Roughley SD, 2011, J MED CHEM, V54, P3451, DOI 10.1021/jm200187y; Rucker RP, 2012, J AM CHEM SOC, V134, P6571, DOI 10.1021/ja3023829; Ruiz-Castillo P, 2015, J AM CHEM SOC, V137, P3085, DOI 10.1021/ja512903g; RUSSELL GA, 1993, HETEROATOM CHEM, V4, P433, DOI 10.1002/hc.520040505; Schunk S., 2008, PCT Int. Appl., Patent No. [WO 2008101659, 2008101659]; Surry DS, 2008, ANGEW CHEM INT EDIT, V47, P6338, DOI 10.1002/anie.200800497; Waser J, 2006, J AM CHEM SOC, V128, P11693, DOI 10.1021/ja062355+; Xu QL, 2013, J AM CHEM SOC, V135, P14048, DOI 10.1021/ja4074563; Zhu DJ, 2015, ANGEW CHEM INT EDIT, V54, P2497, DOI 10.1002/anie.201408651; Zhu SL, 2013, J AM CHEM SOC, V135, P15746, DOI 10.1021/ja4092819	41	317	318	9	336	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					886	891		10.1126/science.aab0245	http://dx.doi.org/10.1126/science.aab0245			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999503				2022-12-28	WOS:000354877900038
J	Shine, B; McKnight, RF; Leaver, L; Geddes, JR				Shine, Brian; McKnight, Rebecca F.; Leaver, Laurence; Geddes, John R.			Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data	LANCET			English	Article							NEPHROGENIC DIABETES-INSIPIDUS; BIPOLAR DISORDER; NEPHROTOXICITY; PREVENTION; TOXICITY; THERAPY	Background Lithium is a widely used and highly effective treatment for mood disorders, but causes poorly characterised adverse effects in kidney and endocrine systems. We aimed to analyse laboratory information system data to determine the incidence of renal, thyroid, and parathyroid dysfunction associated with lithium use. Methods In a retrospective analysis of laboratory data from Oxford University Hospitals National Health Service Trust (Oxfordshire, UK), we investigated the incidence of renal, thyroid, and parathyroid dysfunction in patients (aged >= 18 years) who had at least two creatinine, thyrotropin, calcium, glycated haemoglobin, or lithium measurements between Oct 1, 1982, and March 31, 2014, compared with controls who had not had lithium measurements taken. We used survival analysis and Cox regression to estimate the hazard ratio (HR) for each event with lithium use, age, sex, and diabetes as covariates. Findings Adjusting for age, sex, and diabetes, presence of lithium in serum was associated with an increased risk of stage three chronic kidney disease (HR 1.93, 95% CI 1.76-2.12; p<0.0001), hypothyroidism (2.31, 2.05-2.60; p<0.0001), and raised total serum calcium concentration (1.43, 1.21-1.69; p<0.0001), but not with hyperthyroidism (1.22, 0.96-1.55; p=0.1010) or raised adjusted calcium concentration (1.08, 0.88-1.34; p=0.4602). Women were at greater risk of development of renal and thyroid disorders than were men, with younger women at higher risk than older women. The adverse effects occurred early in treatment (HR <1 for length of treatment with lithium). Higher than median lithium concentrations were associated with increased risk of all adverse outcomes. Interpretation Lithium treatment is associated with a decline in renal function, hypothyroidism, and hypercalcaemia. Women younger than 60 years and people with lithium concentrations higher than median are at greatest risk. Because lithium remains a treatment of choice for bipolar disorder, patients need baseline measures of renal, thyroid, and parathyroid function and regular long-term monitoring.	[Shine, Brian] John Radcliffe Hosp, Oxford OX3 9DU, England; [McKnight, Rebecca F.; Geddes, John R.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Leaver, Laurence] Jericho Hlth Ctr, Oxford, England	University of Oxford; University of Oxford	McKnight, RF (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	rebecca.mcknight@psych.ox.ac.uk	Geddes, John/B-8240-2011	Geddes, John/0000-0002-5281-5960; Shine, Brian/0000-0002-1016-8638				Albert U, 2013, J AFFECT DISORDERS, V151, P786, DOI 10.1016/j.jad.2013.06.046; [Anonymous], 2003, NORD J PSYCHIAT, V57, P68; AURELL M, 1981, KIDNEY INT, V20, P663, DOI 10.1038/ki.1981.191; Bedford JJ, 2008, CLIN J AM SOC NEPHRO, V3, P1324, DOI 10.2215/CJN.01640408; Bendz H, 2010, KIDNEY INT, V77, P219, DOI 10.1038/ki.2009.433; Bocchetta A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-33; Cipriani A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3646; Close H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090169; Farres MT, 2003, RADIOLOGY, V229, P570, DOI 10.1148/radiol.2292020758; Geddes JR, 2013, LANCET, V381, P1672, DOI 10.1016/S0140-6736(13)60857-0; Geddes JR, 2010, LANCET, V375, P385, DOI 10.1016/S0140-6736(09)61828-6; Geddes JR, 2004, AM J PSYCHIAT, V161, P217, DOI 10.1176/appi.ajp.161.2.217; Grunfeld JP, 2009, NAT REV NEPHROL, V5, P270, DOI 10.1038/nrneph.2009.43; HESTBECH J, 1977, KIDNEY INT, V12, P205, DOI 10.1038/ki.1977.102; Kalita P, 2013, NEPHROLOGY, V18, P57; Kalita P, 2013, NEPHROLOGY, V18, P37; Karaosmanoglu AD, 2013, DIAGN INTERV RADIOL, V19, P299, DOI 10.5152/dir.2013.097; Malhi GS, 2011, CNS DRUGS, V25, P289, DOI 10.2165/11586970-000000000-00000; McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X; Minay J, 2013, GEN HOSP PSYCHIAT, V35, P631, DOI 10.1016/j.genhosppsych.2012.10.016; Miura T, 2014, LANCET PSYCHIAT, V1, P351, DOI 10.1016/S2215-0366(14)70314-1; R Development Core Team, 2009, R LANG ENV STAT COMP; Rej S, 2013, DRUG AGING, V30, P409, DOI 10.1007/s40266-013-0068-x; Rej S, 2012, J GERIATR PSYCH NEUR, V25, P51, DOI 10.1177/0891988712436690; Roxanas M, 2014, MED J AUSTRALIA, V200, P226, DOI 10.5694/mja13.10435; SOUZA FGM, 1991, J AFFECT DISORDERS, V22, P165, DOI 10.1016/0165-0327(91)90050-3; Tredget J, 2010, J AFFECT DISORDERS, V126, P436, DOI 10.1016/j.jad.2010.04.018; WHO, 2013, GLOB BURD DIS 2013	28	154	155	2	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					461	468		10.1016/S0140-6736(14)61842-0	http://dx.doi.org/10.1016/S0140-6736(14)61842-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26003379	hybrid			2022-12-28	WOS:000358761700026
J	Crowley, JS; Nevins, GR; Thompson, M				Crowley, Jeffrey S.; Nevins, Gregory R.; Thompson, Melanie			The Americans With Disabilities Act and HIV/AIDS Discrimination Unfinished Business	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Crowley, Jeffrey S.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Nevins, Gregory R.] Lambda Legal, Atlanta, GA USA; [Thompson, Melanie] AIDS Res Consortium Atlanta, Atlanta, GA USA	Georgetown University	Crowley, JS (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	jeffrey.crowley@law.georgetown.edu						Jacobs DB, 2015, NEW ENGL J MED, V372, P399, DOI 10.1056/NEJMp1411376; Kates J., 2014, ASSESSING IMPACT AFF; Lehman JS, 2014, AIDS BEHAV, V18, P997, DOI 10.1007/s10461-014-0724-0; National Alliance of State and Territorial AIDS Directors and National Coalition of STD Directors, 2014, ADDR STIGM BLUEPR IM; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355	5	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2015	314	3					227	228		10.1001/jama.2015.6637	http://dx.doi.org/10.1001/jama.2015.6637			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN2CM	26056767				2022-12-28	WOS:000358228000013
J	Rubinsztein, DC				Rubinsztein, David C.			CELL BIOLOGY Receptors for selective recycling	NATURE			English	Editorial Material							AUTOPHAGY		Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Cambridge	Rubinsztein, DC (corresponding author), Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Cambridge CB2 0XY, England.	dcr1000@cam.ac.uk	Rubinsztein, David C/C-3472-2011		Wellcome Trust [095317, 100140] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Kurth I, 2009, NAT GENET, V41, P1179, DOI 10.1038/ng.464; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Randow F, 2014, CELL HOST MICROBE, V15, P404, DOI 10.1016/j.chom.2014.03.012; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963	9	13	13	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					291	292		10.1038/nature14532	http://dx.doi.org/10.1038/nature14532			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26040721				2022-12-28	WOS:000356425400039
J	Khullar, D; Chokshi, DA; Kocher, R; Reddy, A; Basu, K; Conway, PH; Rajkumar, R				Khullar, Dhruv; Chokshi, Dave A.; Kocher, Robert; Reddy, Ashok; Basu, Karna; Conway, Patrick H.; Rajkumar, Rahul			Behavioral Economics and Physician Compensation - Promise and Challenges	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH-CARE		[Khullar, Dhruv] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Chokshi, Dave A.] New York City Hlth & Hosp Corp, New York, NY USA; [Chokshi, Dave A.] NYU, Langone Med Ctr, Dept Populat Hlth, New York, NY USA; [Basu, Karna] CUNY, Hunter Coll, Dept Econ, New York, NY 10021 USA; [Basu, Karna] CUNY, Grad Ctr, New York, NY USA; [Kocher, Robert] Venrock Partners, Palo Alto, CA USA; [Reddy, Ashok] Univ Penn, Robert Wood Johnson Fdn, Clin Scholars Program, Philadelphia, PA 19104 USA; [Conway, Patrick H.; Rajkumar, Rahul] Ctr Medicare & Medicaid Serv, Baltimore, MD USA	Harvard University; Massachusetts General Hospital; New York University; NYU Langone Medical Center; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Robert Wood Johnson Foundation (RWJF); University of Pennsylvania; Centers for Medicare & Medicaid Services	Khullar, D (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.			Chokshi, Dave/0000-0001-7467-4591				Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; Grant AM, 2011, PSYCHOL SCI, V22, P1494, DOI 10.1177/0956797611419172; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; Patel MS, 2014, ANN INTERN MED, V161, pS44, DOI 10.7326/M13-3001; Torchiana DF, 2013, HEALTH AFFAIR, V32, P1748, DOI 10.1377/hlthaff.2013.0377	5	51	54	2	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2015	372	24					2281	2283		10.1056/NEJMp1502312	http://dx.doi.org/10.1056/NEJMp1502312			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK2DB	26061834				2022-12-28	WOS:000356019200003
J	Tham, WH; Kennedy, AT				Tham, Wai-Hong; Kennedy, Alexander T.			MALARIA A master lock for deadly parasites	NATURE			English	Editorial Material							COMPLEMENT RECEPTOR 1; PLASMODIUM-FALCIPARUM; INVASION; ERYTHROCYTE		[Tham, Wai-Hong; Kennedy, Alexander T.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Tham, Wai-Hong; Kennedy, Alexander T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; University of Melbourne	Tham, WH (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	tham@wehi.edu.au	Tham, Wai-Hong/L-3173-2018; Tham, Wai-Hong/P-6474-2019	Tham, Wai-Hong/0000-0001-7950-8699; Tham, Wai-Hong/0000-0001-7950-8699				Biryukov S, 2014, TRENDS MOL MED, V20, P293, DOI 10.1016/j.molmed.2014.01.001; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Douglas AD, 2015, CELL HOST MICROBE, V17, P130, DOI 10.1016/j.chom.2014.11.017; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Egan ES, 2015, SCIENCE, V348, P711, DOI 10.1126/science.aaa3526; Glodek AM, 2010, BLOOD, V116, P6063, DOI 10.1182/blood-2010-04-273904; Karnchanaphanurach P, 2009, J CLIN INVEST, V119, P788, DOI 10.1172/JCI36088; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107	10	7	7	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					158	159		10.1038/522158a	http://dx.doi.org/10.1038/522158a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	26062503	Bronze			2022-12-28	WOS:000356016700023
J	Hargrove, LJ; Young, AJ; Simon, AM; Fey, NP; Lipschutz, RD; Finucane, SB; Halsne, EG; Ingraham, KA; Kuiken, TA				Hargrove, Levi J.; Young, Aaron J.; Simon, Ann M.; Fey, Nicholas P.; Lipschutz, Robert D.; Finucane, Suzanne B.; Halsne, Elizabeth G.; Ingraham, Kimberly A.; Kuiken, Todd A.			Intuitive Control of a Powered Prosthetic Leg During Ambulation A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TARGETED MUSCLE REINNERVATION; LOWER-LIMB PROSTHESIS; INTENT RECOGNITION; AMPUTEE; KNEE	IMPORTANCE Some patients with lower leg amputations may be candidates for motorized prosthetic limbs. Optimal control of such devices requires accurate classification of the patient's ambulation mode (eg, on level ground or ascending stairs) and natural transitions between different ambulation modes. OBJECTIVE To determine the effect of including electromyographic (EMG) data and historical information from prior gait strides in a real-time control system for a powered prosthetic leg capable of level-ground walking, stair ascent and descent, ramp ascent and descent, and natural transitions between these ambulation modes. DESIGN, SETTING, AND PARTICIPANTS Blinded, randomized crossover clinical trial conducted between August 2012 and November 2013 in a research laboratory at the Rehabilitation Institute of Chicago. Participants were 7 patients with unilateral above-knee (n = 6) or knee-disarticulation (n = 1) amputations. All patients were capable of ambulation within their home and community using a passive prosthesis (ie, one that does not provide external power). INTERVENTIONS Electrodes were placed over 9 residual limb muscles and EMG signals were recorded as patients ambulated and completed 20 circuit trials involving level-ground walking, ramp ascent and descent, and stair ascent and descent. Data were acquired simultaneously from 13 mechanical sensors embedded on the prosthesis. Two real-time pattern recognition algorithms, using either (1) mechanical sensor data alone or (2) mechanical sensor data in combination with EMG data and historical information from earlier in the gait cycle, were evaluated. The order in which patients used each configuration was randomized (1:1 blocked randomization) and double-blinded so patients and experimenters did not know which control configuration was being used. MAIN OUTCOMES AND MEASURES The main outcome of the study was classification error for each real-time control system. Classification error is defined as the percentage of steps incorrectly predicted by the control system. RESULTS Including EMG signals and historical information in the real-time control system resulted in significantly lower classification error (mean, 7.9% [95% CI, 6.1%-9.7%]) across a mean of 683 steps (range, 640-756 steps) compared with using mechanical sensor data only (mean, 14.1%[95% CI, 9.3%-18.9%]) across a mean of 692 steps (range, 631-775 steps), with a mean difference between groups of 6.2%(95% CI, 2.7%-9.7%] (P =.01). CONCLUSIONS AND RELEVANCE In this study of 7 patients with lower limb amputations, inclusion of EMG signals and temporal gait information reduced classification error across ambulation modes and during transitions between ambulation modes. These preliminary findings, if confirmed, have the potential to improve the control of powered leg prostheses.	[Hargrove, Levi J.; Young, Aaron J.; Simon, Ann M.; Fey, Nicholas P.; Lipschutz, Robert D.; Finucane, Suzanne B.; Halsne, Elizabeth G.; Ingraham, Kimberly A.; Kuiken, Todd A.] Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA; [Hargrove, Levi J.; Simon, Ann M.; Fey, Nicholas P.; Lipschutz, Robert D.; Kuiken, Todd A.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Hargrove, Levi J.; Young, Aaron J.; Kuiken, Todd A.] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University; Northwestern University	Hargrove, LJ (corresponding author), Rehabil Inst Chicago, Ctr Bion Med, 345 E Super St,Room 1309, Chicago, IL 60611 USA.	l-hargrove@northwestern.edu	Halsne, Elizabeth/ABD-1819-2020	Halsne, Elizabeth/0000-0003-0640-1051; Simon, Ann/0000-0002-6431-0329	Telemedicine and Advanced Technology Research Center (TATRC) [W81XWH-09-2-0020]	Telemedicine and Advanced Technology Research Center (TATRC)	This work was supported by the Telemedicine and Advanced Technology Research Center (TATRC) under award W81XWH-09-2-0020. TATRC is an office of the headquarters of the United States Army Medical Research and Materiel Command and fosters research on health informatics, telemedicine/m-Health, medical training systems, and computational biology, and promotes and manages science and engineering in other key portfolios.	Bellmann M, 2012, ARCH PHYS MED REHAB, V93, P541, DOI 10.1016/j.apmr.2011.10.017; Bionic Technology, THE POW KNEE; Gailey RS, 2002, ARCH PHYS MED REHAB, V83, P613, DOI 10.1053/ampr.2002.32309; Goldfarb M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007312; Hargrove LJ, 2013, NEW ENGL J MED, V369, P1237, DOI 10.1056/NEJMoa1300126; Huang H, 2011, IEEE T BIO-MED ENG, V58, P2867, DOI 10.1109/TBME.2011.2161671; Huang H, 2009, IEEE T BIO-MED ENG, V56, P65, DOI 10.1109/TBME.2008.2003293; Katz MH., 2011, MULTIVARIABLE ANAL A; Kim PS, 2012, J HAND SURG-AM, V37A, P1609, DOI 10.1016/j.jhsa.2012.04.044; Krueger CA, 2012, J TRAUMA ACUTE CARE, V73, pS438, DOI 10.1097/TA.0b013e318275469c; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Lock B., 2005, MYOELECTRIC CONTR S, P122; Parker P, 2006, J ELECTROMYOGR KINES, V16, P541, DOI 10.1016/j.jelekin.2006.08.006; Simon AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099387; Souza JM, 2014, CLIN ORTHOP RELAT R, V472, P2984, DOI 10.1007/s11999-014-3528-7; Sup F, 2008, P IEEE RAS-EMBS INT, P523, DOI 10.1109/BIOROB.2008.4762811; Varol HA, 2010, IEEE T BIO-MED ENG, V57, P542, DOI 10.1109/TBME.2009.2034734; Young AJ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056021; Young AJ, 2014, IEEE T NEUR SYS REH, V22, P671, DOI 10.1109/TNSRE.2013.2285101; Young AJ, 2014, ANN BIOMED ENG, V42, P631, DOI 10.1007/s10439-013-0909-0; Zhang F, 2012, 34 ANN INT C IEEE EM; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	22	91	98	0	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2244	2252		10.1001/jama.2015.4527	http://dx.doi.org/10.1001/jama.2015.4527			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1VH	26057285	Bronze			2022-12-28	WOS:000355995300018
J	van Durme, CMPG; Wechalekar, MD; Landewe, RBM				van Durme, Caroline M. P. G.; Wechalekar, Mihir D.; Landewe, Robert B. M.			Nonsteroidal Anti-inflammatory Drugs for Treatment of Acute Gout	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MANAGEMENT	CLINICAL QUESTION Are nonsteroidal anti-inflammatory drugs ( NSAIDs) associated with better outcomes than cyclooxygenase inhibitors, glucocorticoids, IL-1 inhibitors or placebo in the treatment of acute gout? BOTTOM LINE NSAIDs are not significantly associated with a difference in pain reduction compared with cyclooxygenase inhibitors and glucocorticoids for treating acute gout. However, NSAIDs are associated with higher rates of adverse events and higher rates of withdrawal due to adverse events compared with cyclooxygenase inhibitors.	[van Durme, Caroline M. P. G.] Maastricht Univ, Med Ctr, Dept Internal Med, NL-6202 AZ Maastricht, Netherlands; [van Durme, Caroline M. P. G.] Ctr Hosp Chretien, Liege, Belgium; [Wechalekar, Mihir D.] Repatriat Gen Hosp, Rheumatol Res Unit, Daw Pk, Australia; [Wechalekar, Mihir D.] Flinders Univ S Australia, Bedford Pk, SA 5042, Australia; [Landewe, Robert B. M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1012 WX Amsterdam, Netherlands; [Landewe, Robert B. M.] Atrium Med Ctr, Dept Rheumatol, Heerlen, Netherlands	Maastricht University; Flinders University South Australia; University of Amsterdam; Academic Medical Center Amsterdam; Atrium Medical Center	van Durme, CMPG (corresponding author), Maastricht Univ, Med Ctr, Postbus 5800, NL-6202 AZ Maastricht, Netherlands.	c.van.durme@mumc.nl	Wechalekar, Mihir/H-8114-2013; LANDEWE, ROBERT B.M./ABD-7388-2021	Wechalekar, Mihir/0000-0001-6668-9638; LANDEWE, ROBERT B.M./0000-0002-0577-6620				Borer JS, 2005, ARTHRITIS RES THER, V7, pS14, DOI 10.1186/ar1794; Khanna D, 2012, ARTHRIT CARE RES, V64, P1447, DOI 10.1002/acr.21773; Van Durme C, 2014, COCHRANE DB SYST REV, V9; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269	4	6	6	3	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2276	2277		10.1001/jama.2015.1881	http://dx.doi.org/10.1001/jama.2015.1881			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1VH	26057289				2022-12-28	WOS:000355995300022
J	Schreiber, SL; Kotz, JD; Li, M; Aube, J; Austin, CP; Reed, JC; Rosen, H; White, EL; Sklar, LA; Lindsley, CW; Alexander, BR; Bittker, JA; Clemons, PA; De Souza, A; Foley, MA; Palmer, M; Shamji, AF; Wawer, MJ; McManus, O; Wu, M; Zou, BY; Yu, HB; Golden, JE; Schoenen, FJ; Simeonov, A; Jadhav, A; Jackson, MR; Pinkerton, AB; Chung, TDY; Griffin, PR; Cravatt, BF; Hodder, PS; Roush, WR; Roberts, E; Chung, DH; Jonsson, CB; Noah, JW; Severson, WE; Ananthan, S; Edwards, B; Oprea, TI; Conn, PJ; Hopkins, CR; Wood, MR; Stauffer, SR; Emmitte, KA				Schreiber, Stuart L.; Kotz, Joanne D.; Li, Min; Aube, Jeffrey; Austin, Christopher P.; Reed, John C.; Rosen, Hugh; White, E. Lucile; Sklar, Larry A.; Lindsley, Craig W.; Alexander, Benjamin R.; Bittker, Joshua A.; Clemons, Paul A.; De Souza, Andrea; Foley, Michael A.; Palmer, Michelle; Shamji, Alykhan F.; Wawer, Mathias J.; McManus, Owen; Wu, Meng; Zou, Beiyan; Yu, Haibo; Golden, Jennifer E.; Schoenen, Frank J.; Simeonov, Anton; Jadhav, Ajit; Jackson, Michael R.; Pinkerton, Anthony B.; Chung, Thomas D. Y.; Griffin, Patrick R.; Cravatt, Benjamin F.; Hodder, Peter S.; Roush, William R.; Roberts, Edward; Chung, Dong-Hoon; Jonsson, Colleen B.; Noah, James W.; Severson, William E.; Ananthan, Subramaniam; Edwards, Bruce; Oprea, Tudor I.; Conn, P. Jeffrey; Hopkins, Corey R.; Wood, Michael R.; Stauffer, Shaun R.; Emmitte, Kyle A.		NIH Mol Lib Project Team	Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes	CELL			English	Review							PYRUVATE-KINASE; PPAR-GAMMA; GAUCHER-DISEASE; DRUG DISCOVERY; ALLOSTERIC MODULATORS; SELECTIVE INHIBITORS; ALZHEIMERS-DISEASE; S1P(4)-R AGONISTS; TARGET ENGAGEMENT; FLUID RETENTION	Small-molecule probes can illuminate biological processes and aid in the assessment of emerging therapeutic targets by perturbing biological systems in a manner distinct from other experimental approaches. Despite the tremendous promise of chemical tools for investigating biology and disease, small-molecule probes were unavailable for most targets and pathways as recently as a decade ago. In 2005, the NIH launched the decade-long Molecular Libraries Program with the intent of innovating in and broadening access to small-molecule science. This Perspective describes how novel small-molecule probes identified through the program are enabling the exploration of biological pathways and therapeutic hypotheses not otherwise testable. These experiences illustrate how small-molecule probes can help bridge the chasm between biological research and the development of medicines but also highlight the need to innovate the science of therapeutic discovery.	[Schreiber, Stuart L.; Kotz, Joanne D.; Alexander, Benjamin R.; Bittker, Joshua A.; Clemons, Paul A.; De Souza, Andrea; Foley, Michael A.; Palmer, Michelle; Shamji, Alykhan F.; Wawer, Mathias J.] Broad Inst Harvard & MIT, Probe Dev Ctr, Cambridge, MA 02142 USA; [Schreiber, Stuart L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Schreiber, Stuart L.] Broad Inst Harvard & MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Schreiber, Stuart L.; Kotz, Joanne D.; Clemons, Paul A.; Shamji, Alykhan F.; Wawer, Mathias J.] Broad Inst Harvard & MIT, Ctr Sci Therapeut, Cambridge, MA 02142 USA; [Bittker, Joshua A.] Broad Inst Harvard & MIT, Ctr Dev Therapeut, Cambridge, MA 02142 USA; [Alexander, Benjamin R.] Broad Inst Harvard & MIT, Med & Populat Genet, Cambridge, MA 02142 USA; [Li, Min; McManus, Owen; Wu, Meng; Zou, Beiyan; Yu, Haibo] Johns Hopkins Sch Med, Ion Channel Ctr, Baltimore, MD 21205 USA; [Aube, Jeffrey; Golden, Jennifer E.; Schoenen, Frank J.] Univ Kansas, Specialized Chem Ctr, Lawrence, KS 66045 USA; [Aube, Jeffrey] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Austin, Christopher P.; Simeonov, Anton; Jadhav, Ajit] NIH, NIH Chem Genom Ctr, Rockville, MD 20850 USA; [Austin, Christopher P.; Simeonov, Anton; Jadhav, Ajit] Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Reed, John C.; Jackson, Michael R.; Pinkerton, Anthony B.; Chung, Thomas D. Y.] Sanford Burnham Med Res Inst, Conrad Prebys Ctr Chem Genom, La Jolla, CA 92037 USA; [Reed, John C.; Jackson, Michael R.; Pinkerton, Anthony B.; Chung, Thomas D. Y.] Sanford Burnham Med Res Inst, Conrad Prebys Ctr Chem Genom, Lake Nona, FL 32827 USA; [Rosen, Hugh; Griffin, Patrick R.; Cravatt, Benjamin F.; Hodder, Peter S.; Roush, William R.; Roberts, Edward] Scripps Res Inst, Mol Screening Ctr, La Jolla, CA 92037 USA; [Rosen, Hugh; Griffin, Patrick R.; Cravatt, Benjamin F.; Hodder, Peter S.; Roush, William R.; Roberts, Edward] Scripps Res Inst, Mol Screening Ctr, Jupiter, FL 33458 USA; [Rosen, Hugh; Cravatt, Benjamin F.] Scripps Res Inst, Dept Chem Physiol, La Jolla, CA 92037 USA; [Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Roush, William R.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [White, E. Lucile; Chung, Dong-Hoon; Jonsson, Colleen B.; Noah, James W.; Severson, William E.; Ananthan, Subramaniam] So Res Inst, Southern Res Specialized Biocontainment Screening, Birmingham, AL 35205 USA; [Sklar, Larry A.; Edwards, Bruce; Oprea, Tudor I.] Univ New Mexico, Ctr Mol Discovery, Albuquerque, NM 87131 USA; [Sklar, Larry A.; Edwards, Bruce] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA; [Oprea, Tudor I.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Lindsley, Craig W.; Conn, P. Jeffrey; Hopkins, Corey R.; Wood, Michael R.; Stauffer, Shaun R.; Emmitte, Kyle A.] Vanderbilt Univ, Med Ctr, Vanderbilt Specialized Chem Ctr Accelerated Probe, Nashville, TN 37232 USA; [Lindsley, Craig W.; Conn, P. Jeffrey; Hopkins, Corey R.; Wood, Michael R.; Emmitte, Kyle A.] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johns Hopkins University; Johns Hopkins Medicine; University of Kansas; University of Kansas; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of New Mexico; University of New Mexico; University of New Mexico; Vanderbilt University; Vanderbilt University	Schreiber, SL (corresponding author), Broad Inst Harvard & MIT, Probe Dev Ctr, Cambridge, MA 02142 USA.	stuart_schreiber@harvard.edu; jkotz@broadinstitute.org	Margolis, Ronald N/O-7773-2015; Alexander, Benjamin/M-7471-2015; Jonsson, Colleen/X-2360-2019; Jonsson, Colleen/GPC-4424-2022; Oprea, Tudor/A-5746-2011	Margolis, Ronald N/0000-0002-8956-0455; Alexander, Benjamin/0000-0002-0960-6119; Jonsson, Colleen/0000-0002-2640-7672; Pillai, Ajay/0000-0002-9789-7189; Golden, Jennifer/0000-0002-6813-3710; Pinkerton, Anthony/0000-0003-4571-152X; Oprea, Tudor/0000-0002-6195-6976; Jadhav, Ajit/0000-0001-7955-1451; Schoenen, Frank/0000-0003-2711-1117; Wu, Meng/0000-0003-2222-0736	NIH [U54 MH084681-01, 1 U54 HG005033-01, U54 MH084512-01, 1 U54 HG005032-01, 1 U54 HG005034-01, U54 MH084690-01, U54 MH084691-01, 1 U54 HG005031-01, U54 MH084659-01]; Janssen; Bristol-Myers Squibb; AstraZeneca; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005034, U54HG005031, U54HG005033, U54HG005032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512, U54MH084659, U54MH084691, U54MH084690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R13NS084681] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors wish to thank Matthew Boxer, Sivaraman Dandapani, Richard Y. Ebright, Juan Marugan, Andrew Phillips, Craig Thomas, Matthew Vander Heiden, and Bridget Wagner for thoughtful discussion and critical reading of the manuscript and Katie Ris-Vicari for assistance with figure design. Centers in the MLPCN were funded via the NIH grants U54 MH084681-01 (NIH Chemical Genomics Center), 1 U54 HG005033-01 (Conrad Prebys Center for Chemical Genomics), U54 MH084512-01 (The Scripps Research Institute Molecular Screening Center), 1 U54 HG005032-01 (Broad Institute Probe Development Center), 1 U54 HG005034-01 (Southern Research Specialized Biocontainment Screening Center), U54 MH084690-01 (University of New Mexico Center for Molecular Discovery), U54 MH084691-01 (Johns Hopkins School of Medicine Ion Channel Center), 1 U54 HG005031-01 (University of Kansas Specialized Chemistry Center) and U54 MH084659-01 (The Vanderbilt Specialized Chemistry Center for Accelerated Probe Development). J.A. and F.J.S. have a financial interest in Cleave Biosciences. H.R. is a scientific founder of and consultant to Receptos, which has licensed RPC-1063. B.F.C. is a scientific founder of and advisor to Abide Therapeutics, a company that is interested in developing serine hydrolase inhibitors as therapeutic agents. L.A.S. and B.E. are scientific cofounders of Intellicyt, which sells instrumentation for high-throughput flow cytometry. All of the authors from Vanderbilt University receive funding from Janssen, Bristol-Myers Squibb, and AstraZeneca for the development of GPCR allosteric modulators for CNS disorders.	Adibekian A, 2012, J AM CHEM SOC, V134, P10345, DOI 10.1021/ja303400u; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375; Aubert RE, 2010, DIABETES OBES METAB, V12, P716, DOI 10.1111/j.1463-1326.2010.01225.x; Austin CP, 2004, SCIENCE, V306, P1138, DOI 10.1126/science.1105511; Bachovchin DA, 2011, P NATL ACAD SCI USA, V108, P6811, DOI 10.1073/pnas.1015248108; Bachovchin DA, 2009, NAT BIOTECHNOL, V27, P387, DOI 10.1038/nbt.1531; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bern C, 2011, NEW ENGL J MED, V364, P2527, DOI 10.1056/NEJMct1014204; Boxer MB, 2010, J MED CHEM, V53, P1048, DOI 10.1021/jm901577g; Bridges T. M., 2010, PROBE REPORTS NIH MO; Carmody LC, 2010, PROBE REPORTS NIH MO; Chen JK, 1999, CHEM BIOL, V6, P221, DOI 10.1016/S1074-5521(99)80038-6; Choi JH, 2014, GENE DEV, V28, P2361, DOI 10.1101/gad.249367.114; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Dandapani S, 2014, ACS MED CHEM LETT, V5, P149, DOI 10.1021/ml400403u; Dillon MBC, 2012, ACS CHEM BIOL, V7, P1198, DOI 10.1021/cb300024c; Edwards AM, 2015, NAT REV DRUG DISCOV, V14, P149, DOI 10.1038/nrd4565; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Fidock DA, 2013, SCIENCE, V340, P1531, DOI 10.1126/science.1240539; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Gentry PR, 2013, BIOORG MED CHEM LETT, V23, P2996, DOI 10.1016/j.bmcl.2013.03.032; Gerard B, 2011, ACS COMB SCI, V13, P365, DOI 10.1021/co2000218; Goldin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029861; Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783; Guerrero M., 2014, PROBE REPORTS NIH MO; Guerrero M, 2012, BIOORG MED CHEM LETT, V22, P537, DOI 10.1016/j.bmcl.2011.10.096; Guerrero M, 2011, BIOORG MED CHEM LETT, V21, P3632, DOI 10.1016/j.bmcl.2011.04.097; Gustafsdottir SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080999; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Heidebrecht RW, 2012, ACS MED CHEM LETT, V3, P112, DOI 10.1021/ml200244k; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Jo EJ, 2012, ACS CHEM BIOL, V7, P1975, DOI 10.1021/cb300392z; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kamenecka T. M., 2010, PROBE REPORTS NIH MO; Knuckley B, 2010, CHEM COMMUN, V46, P7175, DOI 10.1039/c0cc02634d; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Larsen SD, 2012, J LIPID RES, V53, P282, DOI 10.1194/jlr.M021261; Le U, 2013, BIOORG MED CHEM LETT, V23, P346, DOI 10.1016/j.bmcl.2012.10.073; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; Lowe JT, 2012, J ORG CHEM, V77, P7187, DOI 10.1021/jo300974j; Lukens AK, 2015, J INFECT DIS, V211, P1097, DOI 10.1093/infdis/jiu565; Lunt SY, 2015, MOL CELL, V57, P95, DOI 10.1016/j.molcel.2014.10.027; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Marcaurelle LA, 2010, J AM CHEM SOC, V132, P16962, DOI 10.1021/ja105119r; Marciano DP, 2014, CURR OPIN STRUC BIOL, V28, P105, DOI 10.1016/j.sbi.2014.08.007; Marciano DP, 2014, CELL METAB, V19, P193, DOI 10.1016/j.cmet.2013.12.009; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Niswender C.M., 2010, PROBE REPORTS NIH MO; Nomura DK, 2010, NAT REV CANCER, V10, P630, DOI 10.1038/nrc2901; Oldstone M., 2010, PROBE REPORTS NIH MO; Oprea TI, 2009, NAT CHEM BIOL, V5, P441, DOI 10.1038/nchembio0709-441; Ortolano S, 2014, RECENT PATENTS ENDOC, V8, P9, DOI 10.2174/1872214808666140115111350; Orvisky E, 2002, MOL GENET METAB, V76, P262, DOI 10.1016/S1096-7192(02)00117-8; Panicker LM, 2012, P NATL ACAD SCI USA, V109, P18054, DOI 10.1073/pnas.1207889109; Patnaik S, 2012, J MED CHEM, V55, P5734, DOI 10.1021/jm300063b; Petrone FM, 2012, ACS CHEM BIOL, V7, P1399, DOI 10.1021/cb3001028; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Reed JC, 2012, NAT BIOTECHNOL, V30, P16, DOI 10.1038/nbt.2087; Reid PR, 2011, BIOORG MED CHEM LETT, V21, P2697, DOI 10.1016/j.bmcl.2010.12.015; Rogers S., 2010, PROBE REPORTS NIH MO; Rosen H, 2008, IMMUNOL REV, V223, P221, DOI 10.1111/j.1600-065X.2008.00645.x; Rosen H, 2013, ANNU REV BIOCHEM, V82, P637, DOI 10.1146/annurev-biochem-062411-130916; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Satsu H, 2013, BIOORGAN MED CHEM, V21, P5373, DOI 10.1016/j.bmc.2013.06.012; Simon GM, 2013, NAT CHEM BIOL, V9, P200, DOI 10.1038/nchembio.1211; Staels B, 2005, CELL METAB, V2, P77, DOI 10.1016/j.cmet.2005.08.001; Suzuki Y, 2013, BRAIN DEV-JPN, V35, P515, DOI 10.1016/j.braindev.2012.12.002; Tarr JC, 2012, ACS CHEM NEUROSCI, V3, P884, DOI 10.1021/cn300068s; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Thiel P, 2012, ANGEW CHEM INT EDIT, V51, P2012, DOI 10.1002/anie.201107616; Tsuboi K, 2011, J AM CHEM SOC, V133, P16605, DOI 10.1021/ja2066972; Urbano M, 2013, BIOORG MED CHEM LETT, V23, P6377, DOI 10.1016/j.bmcl.2013.09.058; Urbano M, 2011, BIOORG MED CHEM LETT, V21, P6739, DOI 10.1016/j.bmcl.2011.09.049; Urbano M, 2011, BIOORG MED CHEM LETT, V21, P5470, DOI 10.1016/j.bmcl.2011.06.132; Walsh KB, 2011, IMMUNOL RES, V51, P15, DOI 10.1007/s12026-011-8240-z; Wawer MJ, 2014, J BIOMOL SCREEN, V19, P738, DOI 10.1177/1087057114530783; Wawer MJ, 2014, P NATL ACAD SCI USA, V111, P10911, DOI 10.1073/pnas.1410933111; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Weiwer M., 2010, PROBE REPORTS NIH MO; Wenthur CJ, 2014, ANNU REV PHARMACOL, V54, P165, DOI 10.1146/annurev-pharmtox-010611-134525; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53; Yu JG, 2002, DIABETES, V51, P2968, DOI 10.2337/diabetes.51.10.2968; Zanella A, 2007, BLOOD REV, V21, P217, DOI 10.1016/j.blre.2007.01.001; Zuhl AM, 2012, J AM CHEM SOC, V134, P5068, DOI 10.1021/ja300799t	94	109	109	6	135	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1252	1265		10.1016/j.cell.2015.05.023	http://dx.doi.org/10.1016/j.cell.2015.05.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26046436	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000355935000007
J	Chavda, SJ; Iyengar, S; Dearden, C				Chavda, S. J.; Iyengar, S.; Dearden, C.			CASE REVIEW An unusual case of severe anaemia and lymphocytosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RED-CELL APLASIA; LEUKEMIA; DIAGNOSIS; THERAPY		[Chavda, S. J.; Iyengar, S.; Dearden, C.] Royal Marsden NHS Fdn Trust, Dept Haematooncol, Sutton SM2 5PT, Surrey, England	Royal Marsden NHS Foundation Trust	Chavda, SJ (corresponding author), Royal Marsden NHS Fdn Trust, Dept Haematooncol, Sutton SM2 5PT, Surrey, England.	selinachavda@doctors.org.uk	Iyengar, Sunil/AAB-8611-2020	Iyengar, Sunil/0000-0003-4863-4160				Badar T, 2014, EXPERT REV HEMATOL, V7, P705, DOI 10.1586/17474086.2014.977862; Bain B, 2009, BONE MARROW PATHOLOG, V4th, P311; Basquiera AL, 2004, ANN ONCOL, V15, P539, DOI 10.1093/annonc/mdh114; Bene MC, 2011, LEUKEMIA, V25, P567, DOI 10.1038/leu.2010.312; Cheson BD, 2012, J CLIN ONCOL, V30, P2820, DOI 10.1200/JCO.2012.43.3748; Cortes J, 2001, CANCER-AM CANCER SOC, V92, P2016, DOI 10.1002/1097-0142(20011015)92:8<2016::AID-CNCR1539>3.0.CO;2-E; Crabol Y, 2013, CLIN INFECT DIS, V56, P968, DOI 10.1093/cid/cis1046; Ghazal H, 2002, BLOOD, V99, P1092, DOI 10.1182/blood.V99.3.1092; Gribben JG, 2010, BLOOD, V115, P2; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hallek M, 2010, ANN ONCOL, V21, P154, DOI 10.1093/annonc/mdq373; Jamroziak K, 2015, LEUK LYMPHOMA; Matutes E, 2007, BEST PRACT RES CL HA, V20, P367, DOI 10.1016/j.beha.2007.03.001; Mauro FR, 2000, BLOOD, V95, P2786, DOI 10.1182/blood.V95.9.2786.009k30_2786_2792; Moreau EJ, 1997, AM J CLIN PATHOL, V108, P378; Nowakowski GS, 2009, J CLIN ONCOL, V27, P1844, DOI 10.1200/JCO.2008.17.0795; Oscier D, 2013, BRIT COMMITTEE STAND; PLUNKETT W, 1993, SEMIN ONCOL, V20, P2; Provan D, 2009, OXFORD HDB CLIN HAEM, V3rd, P154	19	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2015	350								h2673	10.1136/bmj.h2673	http://dx.doi.org/10.1136/bmj.h2673			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK0TW	26037254				2022-12-28	WOS:000355918900006
J	James, RD				James, Richard D.			Taming the temperamental metal transformation	SCIENCE			English	Editorial Material							PHASE-TRANSFORMATION		Univ Minnesota, Dept Aerosp Engn & Mech, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	James, RD (corresponding author), Univ Minnesota, Dept Aerosp Engn & Mech, Minneapolis, MN 55455 USA.	james@umn.edu		James, Richard/0000-0001-6019-6613				Bhattacharya K., 2003, MICROSTRUCTURE MARTE; Chen X, 2013, J MECH PHYS SOLIDS, V61, P2566, DOI 10.1016/j.jmps.2013.08.004; Chluba C, 2015, SCIENCE, V348, P1004, DOI 10.1126/science.1261164; Kainuma R, 2006, NATURE, V439, P957, DOI 10.1038/nature04493; Karaca HE, 2009, ADV FUNCT MATER, V19, P983, DOI 10.1002/adfm.200801322; Krulevitch P, 1996, J MICROELECTROMECH S, V5, P270, DOI 10.1109/84.546407; Liu J, 2012, NAT MATER, V11, P620, DOI [10.1038/NMAT3334, 10.1038/nmat3334]; Song YT, 2013, NATURE, V502, P85, DOI 10.1038/nature12532; Spaldin NA, 2005, SCIENCE, V309, P391, DOI 10.1126/science.1113357	9	13	13	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					968	969		10.1126/science.aab3273	http://dx.doi.org/10.1126/science.aab3273			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	26023120				2022-12-28	WOS:000355276600022
J	Rhodes, RH; Brook, EJ; Chiang, JCH; Blunier, T; Maselli, OJ; McConnell, JR; Romanini, D; Severinghaus, JP				Rhodes, Rachael H.; Brook, Edward J.; Chiang, John C. H.; Blunier, Thomas; Maselli, Olivia J.; McConnell, Joseph R.; Romanini, Daniele; Severinghaus, Jeffrey P.			Enhanced tropical methane production in response to iceberg discharge in the North Atlantic	SCIENCE			English	Article							ATMOSPHERIC METHANE; HULU CAVE; CLIMATE; RECORD; MONSOON; SHIFTS	The causal mechanisms responsible for the abrupt climate changes of the Last Glacial Period remain unclear. One major difficulty is dating ice-rafted debris deposits associated with Heinrich events: Extensive iceberg influxes into the North Atlantic Ocean linked to global impacts on climate and biogeochemistry. In a new ice core record of atmospheric methane with ultrahigh temporal resolution, we find abrupt methane increases within Heinrich stadials 1, 2, 4, and 5 that, uniquely, have no counterparts in Greenland temperature proxies. Using a heuristic model of tropical rainfall distribution, we propose that Hudson Strait Heinrich events caused rainfall intensification over Southern Hemisphere land areas, thereby producing excess methane in tropical wetlands. Our findings suggest that the climatic impacts of Heinrich events persisted for 740 to 1520 years.	[Rhodes, Rachael H.; Brook, Edward J.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, CEOAS Adm 104, Corvallis, OR 97331 USA; [Chiang, John C. H.] Univ Calif Berkeley, Dept Geog, Berkeley, CA 94720 USA; [Chiang, John C. H.] Univ Calif Berkeley, Berkeley Atmospher Sci Ctr, Berkeley, CA 94720 USA; [Blunier, Thomas] Univ Copenhagen, Niels Bohr Inst, Ctr Ice & Climate, DK-2100 Copenhagen, Denmark; [Maselli, Olivia J.; McConnell, Joseph R.] Desert Res Inst, Div Hydrol Sci, Reno, NV 89512 USA; [Romanini, Daniele] Univ Grenoble 1, CNRS, LIPhy UMR 5588, F-38041 Grenoble, France; [Severinghaus, Jeffrey P.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Oregon State University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Copenhagen; Niels Bohr Institute; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of California System; University of California San Diego; Scripps Institution of Oceanography	Rhodes, RH (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, CEOAS Adm 104, Corvallis, OR 97331 USA.	rhodesra@geo.oregonstate.edu	Brook, Edward/AAB-7807-2021; Chiang, John/AAK-6169-2021; Blunier, Thomas/M-4609-2014	Blunier, Thomas/0000-0002-6065-7747; Rhodes, Rachael/0000-0001-7511-1969	NSF [1043518, 1142041, 0944552, 0839093, 1142166, 0230396, 0440817, 0944348, 0944266]; Ice Drilling Program Office; Ice Drilling Design and Operations group; National Ice Core Laboratory; Raytheon Polar Services; 109th New York Air National Guard; Directorate For Geosciences [1043522] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1142166, 0944348] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Ice Drilling Program Office; Ice Drilling Design and Operations group; National Ice Core Laboratory; Raytheon Polar Services; 109th New York Air National Guard; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by NSF grants 1043518, 1142041, 0944552, 0839093, and 1142166. Data will be made available at http://nsidc.org/data/ and http://ncdc.noaa.gov/paleo/. L. Layman, N. Chellman, D. Pasteris, M. Sigl, and C. Stowasser assisted with measurements. Thanks to J. Ahn for collated Siple Dome CH<INF>4</INF> data, J. Rosen for use of the Oregon State University firn air model, and T. Sowers for fruitful discussion. The authors appreciate the support of the WAIS Divide Science Coordination Office at the Desert Research Institute of Reno Nevada and the University of New Hampshire for the collection and distribution of the WAIS Divide ice core and related tasks (NSF grants 0230396, 0440817, 0944348, and 0944266). We are grateful to all participants in the field effort led by K. Taylor. The NSF Office of Polar Programs also funded the Ice Drilling Program Office and Ice Drilling Design and Operations group, the National Ice Core Laboratory, Raytheon Polar Services, and the 109th New York Air National Guard.	Bergamaschi P, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012287; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; BROECKER WS, 1994, NATURE, V372, P421, DOI 10.1038/372421a0; Brook EJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P559, DOI 10.1029/1999GB001182; Buizert C, 2015, CLIM PAST, V11, P153, DOI 10.5194/cp-11-153-2015; Carolin SA, 2013, SCIENCE, V340, P1564, DOI 10.1126/science.1233797; Chappellaz J, 2013, CLIM PAST, V9, P2579, DOI 10.5194/cp-9-2579-2013; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Clark P.U., 2007, OCEAN CIRCULATION ME, V173, P209, DOI [10.1029/173GM15, DOI 10.1029/173GM15]; Collins JA, 2013, CLIM PAST, V9, P1181, DOI 10.5194/cp-9-1181-2013; Cvijanovic I, 2013, J CLIMATE, V26, P4121, DOI 10.1175/JCLI-D-12-00279.1; Deplazes G, 2013, NAT GEOSCI, V6, P213, DOI 10.1038/ngeo1712; Guillevic M, 2014, CLIM PAST, V10, P2115, DOI 10.5194/cp-10-2115-2014; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Hodell DA, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001591; Kageyama M, 2013, CLIM PAST, V9, P935, DOI 10.5194/cp-9-935-2013; Kanner LC, 2012, SCIENCE, V335, P570, DOI 10.1126/science.1213397; Kindler P, 2014, CLIM PAST, V10, P887, DOI 10.5194/cp-10-887-2014; Marcott SA, 2014, NATURE, V514, P616, DOI 10.1038/nature13799; Muller J, 2008, QUATERNARY SCI REV, V27, P468, DOI 10.1016/j.quascirev.2007.11.006; Parsons LA, 2014, GEOPHYS RES LETT, V41, P146, DOI 10.1002/2013GL058454; Rhodes RH, 2013, EARTH PLANET SC LETT, V368, P9, DOI 10.1016/j.epsl.2013.02.034; Severinghaus JP, 2009, SCIENCE, V324, P1431, DOI 10.1126/science.1169473; Southon J, 2012, QUATERNARY SCI REV, V33, P32, DOI 10.1016/j.quascirev.2011.11.022; Stern JV, 2013, GEOPHYS RES LETT, V40, P3693, DOI 10.1002/grl.50679; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Walter BP, 2001, J GEOPHYS RES-ATMOS, V106, P34207, DOI 10.1029/2001JD900164; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wolff EW, 2009, NAT GEOSCI, V2, P206, DOI 10.1038/NGEO442	30	84	87	3	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					1016	1019		10.1126/science.1262005	http://dx.doi.org/10.1126/science.1262005			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	26023138	Green Submitted			2022-12-28	WOS:000355276600044
J	Rosen, MJ; Davison, M; Bhaya, D; Fisher, DS				Rosen, Michael J.; Davison, Michelle; Bhaya, Devaki; Fisher, Daniel S.			Fine-scale diversity and extensive recombination in a quasisexual bacterial population occupying a broad niche	SCIENCE			English	Article							YELLOWSTONE-NATIONAL-PARK; MICROBIAL MAT COMMUNITY; THERMOPHILIC CYANOBACTERIA; EVOLUTION; SEQUENCES; GENOMICS; PROCHLOROCOCCUS; PATTERNS; ECOTYPES; IMPACT	Extensive fine-scale genetic diversity is found in many microbial species across varied environments, but for most, the evolutionary scenarios that generate the observed variation remain unclear. Deep sequencing of a thermophilic cyanobacterial population and analysis of the statistics of synonymous single-nucleotide polymorphisms revealed a high rate of homologous recombination and departures from neutral drift consistent with the effects of genetic hitchhiking. A sequenced isolate genome resembled an unlinked random mixture of the allelic diversity at the sampled loci. These observations suggested a quasisexual microbial population that occupies a broad ecological niche, with selection driving frequencies of alleles rather than whole genomes.	[Rosen, Michael J.; Fisher, Daniel S.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Davison, Michelle; Bhaya, Devaki] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Fisher, Daniel S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Carnegie Institution for Science; Stanford University	Bhaya, D (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.	dbhaya@stanford.edu; dsfisher@stanford.edu	Davison, Michelle/AAE-2573-2021	Fisher, Daniel/0000-0002-5559-2491	NSF [DMS-1120699, MCB-1024155, FIBR EF-0328698]; Carnegie Institution for Science; Stanford Graduate Fellowship; IBM Fellowship; National Center for Biotechnology Information [PRJNA268121]	NSF(National Science Foundation (NSF)); Carnegie Institution for Science; Stanford Graduate Fellowship(Stanford University); IBM Fellowship(International Business Machines (IBM)); National Center for Biotechnology Information	We thank J. Blundell and B. Callahan for valuable suggestions and comments. Funding for this work was provided by NSF grants DMS-1120699 (D.S.F.), MCB-1024155 (D.B.), and FIBR EF-0328698 (D.B.), and by the Carnegie Institution for Science (D.B.). M.J.R. was partially supported by a Stanford Graduate Fellowship and an IBM Fellowship. Raw sequences have been deposited in National Center for Biotechnology Information (BioProject PRJNA268121).	Becraft ED, 2011, APPL ENVIRON MICROB, V77, P7689, DOI 10.1128/AEM.05927-11; Bhaya D, 2007, ISME J, V1, P703, DOI 10.1038/ismej.2007.46; Cadillo-Quiroz H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001265; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; Cordero OX, 2014, NAT REV MICROBIOL, V12, P263, DOI 10.1038/nrmicro3218; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Didelot X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-256; Didelot X, 2010, TRENDS MICROBIOL, V18, P315, DOI 10.1016/j.tim.2010.04.002; Doroghazi JR, 2010, ISME J, V4, P1136, DOI 10.1038/ismej.2010.45; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gomez-Garcia MR, 2013, J BACTERIOL, V195, P3309, DOI 10.1128/JB.00207-13; Gomez-Garcia MR, 2011, ISME J, V5, P141, DOI 10.1038/ismej.2010.96; Hanage WP, 2006, PHILOS T R SOC B, V361, P1917, DOI 10.1098/rstb.2006.1917; Heidelberg JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004169; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Jolley KA, 2005, MOL BIOL EVOL, V22, P562, DOI 10.1093/molbev/msi041; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Majewski J, 2001, FEMS MICROBIOL LETT, V199, P161, DOI 10.1016/S0378-1097(01)00183-5; McVean G, 2002, GENETICS, V160, P1231; Melendrez MC, 2011, APPL ENVIRON MICROB, V77, P1359, DOI 10.1128/AEM.02032-10; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Nelson WC, 2011, APPL ENVIRON MICROB, V77, P5458, DOI 10.1128/AEM.05090-11; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Rosen MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-283; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Smyth RP, 2010, GENE, V469, P45, DOI 10.1016/j.gene.2010.08.009; Song YS, 2007, THEOR POPUL BIOL, V71, P49, DOI 10.1016/j.tpb.2006.09.001; Takuno S, 2012, MOL BIOL EVOL, V29, P797, DOI 10.1093/molbev/msr249; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Ward DM, 2006, PHILOS T R SOC B, V361, P1997, DOI 10.1098/rstb.2006.1919	32	71	74	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					1019	1023		10.1126/science.aaa4456	http://dx.doi.org/10.1126/science.aaa4456			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	26023139				2022-12-28	WOS:000355276600045
J	Gulev, SK; Latif, M				Gulev, Sergey K.; Latif, Mojib			OCEAN SCIENCE The origins of a climate oscillation	NATURE			English	Editorial Material							NORTH-ATLANTIC OSCILLATION; THERMOHALINE CIRCULATION; VARIABILITY		[Gulev, Sergey K.] Russian Acad Sci, PP Shirshov Inst Oceanol, Moscow 117997, Russia; [Gulev, Sergey K.] Moscow MV Lomonosov State Univ, Moscow, Russia; [Latif, Mojib] GEOMAR Helmholtz Zentrum Ozeanforsch Kiel, D-24105 Kiel, Germany; [Latif, Mojib] Univ Kiel, Kiel, Germany	Russian Academy of Sciences; Shirshov Institute of Oceanology; Lomonosov Moscow State University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel	Gulev, SK (corresponding author), Russian Acad Sci, PP Shirshov Inst Oceanol, Moscow 117997, Russia.		Latif, Mojib/C-2428-2016; Gulev, Sergey/A-4994-2014	Latif, Mojib/0000-0003-1079-5604; 				Booth BBB, 2012, NATURE, V484, P228, DOI 10.1038/nature10946; Curry RG, 2001, J PHYS OCEANOGR, V31, P3374, DOI 10.1175/1520-0485(2001)031<3374:OGCCAW>2.0.CO;2; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; Gulev SK, 2013, NATURE, V499, P464, DOI 10.1038/nature12268; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Latif M, 2004, J CLIMATE, V17, P1605, DOI 10.1175/1520-0442(2004)017<1605:RMAPMC>2.0.CO;2; Latif M., 2013, OCEAN CIRCULATION CL, V2nd; McCarthy GD, 2015, NATURE, V521, P508, DOI 10.1038/nature14491; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Zhang R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026267	11	12	12	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					428	430		10.1038/521428a	http://dx.doi.org/10.1038/521428a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	26017438				2022-12-28	WOS:000355286600026
J	Meyer, ET; Georganopoulos, M; Sparks, WB; Perlman, E; van der Marel, RP; Anderson, J; Sohn, ST; Biretta, J; Norman, C; Chiaberge, M				Meyer, Eileen T.; Georganopoulos, Markos; Sparks, William B.; Perlman, Eric; van der Marel, Roeland P.; Anderson, Jay; Sohn, Sangmo Tony; Biretta, John; Norman, Colin; Chiaberge, Marco			A kiloparsec-scale internal shock collision in the jet of a nearby radio galaxy	NATURE			English	Article							GAMMA-RAY BURSTS; HUBBLE-SPACE-TELESCOPE; M87 JET; 3C 264; EMISSION; MOTION; MODEL	Jets of highly energized plasma with relativistic velocities are associated with black holes ranging in mass from a few times that of the Sun to the billion-solar-mass black holes at the centres of galaxies(1). A popular but unconfirmed hypothesis to explain how the plasma is energized is the 'internal shock model', in which the relativistic flow is unsteady(2). Faster components in the jet catch up to and collide with slower ones, leading to internal shocks that accelerate particles and generate magnetic fields(3). This mechanism can explain the variable, high-energy emission from a diverse set of objects(4-7), with the best indirect evidence being the unseen fast relativistic flow inferred to energize slower components in X-ray binary jets(8,9). Mapping of the kinematic profiles in resolved jets has revealed precessing and helical patterns in X-ray binaries(10,11), apparent superluminal motions(12,13), and the ejection of knots (bright components) from standing shocks in the jets of active galaxies(14,15). Observations revealing the structure and evolution of an internal shock in action have, however, remained elusive, hindering measurement of the physical parameters and ultimate efficiency of the mechanism. Here we report observations of a collision between two knots in the jet of nearby radio galaxy 3C 264. Abright knot with an apparent speed of (7.0 +/- 0.8)c, where c is the speed of light in a vacuum, is in the incipient stages of a collision with a slower-moving knot of speed (1.8 +/- 0.5)c just downstream, resulting in brightening of both knots-as seen in the most recent epoch of imaging.	[Meyer, Eileen T.; Sparks, William B.; van der Marel, Roeland P.; Anderson, Jay; Biretta, John; Norman, Colin; Chiaberge, Marco] Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA; [Meyer, Eileen T.; Georganopoulos, Markos] Univ Maryland Baltimore Cty, Baltimore, MD 21250 USA; [Georganopoulos, Markos] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Perlman, Eric] Florida Inst Technol, Melbourne, FL 32901 USA; [Sohn, Sangmo Tony; Norman, Colin; Chiaberge, Marco] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Chiaberge, Marco] Ist Radio Astron, Ist Nazl Astrofis, I-40129 Bologna, Italy	Space Telescope Science Institute; University System of Maryland; University of Maryland Baltimore County; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Florida Institute of Technology; Johns Hopkins University; Istituto Nazionale Astrofisica (INAF)	Meyer, ET (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	eileen.meyer@gmail.com		van der Marel, Roeland/0000-0001-7827-7825; Norman, Colin/0000-0002-5222-5717; Sohn, Sangmo Tony/0000-0001-8368-0221	HST [GO-13327]	HST	E.T.M. acknowledges HST grant GO-13327.	ABELL GO, 1979, NATURE, V279, P701, DOI 10.1038/279701a0; Baum SA, 1997, ASTROPHYS J, V483, P178, DOI 10.1086/304221; Biretta JA, 1999, ASTROPHYS J, V520, P621, DOI 10.1086/307499; Cheung CC, 2007, ASTROPHYS J, V663, pL65, DOI 10.1086/520510; CRANE P, 1993, ASTROPHYS J, V402, pL37, DOI 10.1086/186694; Dhawan V, 2000, ASTROPHYS J, V543, P373, DOI 10.1086/317088; Fender RP, 2004, MON NOT R ASTRON SOC, V355, P1105, DOI 10.1111/j.1365-2966.2004.08384.x; Fomalont EB, 2001, ASTROPHYS J, V558, P283, DOI 10.1086/322479; GOFFE WL, 1994, J ECONOMETRICS, V60, P65, DOI 10.1016/0304-4076(94)90038-8; Harris DE, 2002, ASTROPHYS J, V565, P244, DOI 10.1086/324544; HJELLMING RM, 1995, NATURE, V375, P464, DOI 10.1038/375464a0; Kobayashi S, 1997, ASTROPHYS J, V490, P92, DOI 10.1086/512791; Krist J. E., 2001, P SPIE, V8127; Lara L, 1999, ASTROPHYS J, V513, P197, DOI 10.1086/306852; Lara L, 2004, ASTRON ASTROPHYS, V415, P905, DOI 10.1051/0004-6361:20034317; Livio M, 1999, PHYS REP, V311, P225, DOI 10.1016/S0370-1573(98)00102-1; Marscher AP, 2010, ASTROPHYS J LETT, V710, pL126, DOI 10.1088/2041-8205/710/2/L126; Medvedev MV, 1999, ASTROPHYS J, V526, P697, DOI 10.1086/308038; Meyer ET, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/2/L21; Migliari S, 2002, SCIENCE, V297, P1673, DOI 10.1126/science.1073660; MIRABEL IF, 1994, NATURE, V371, P46, DOI 10.1038/371046a0; PACZYNSKI B, 1994, ASTROPHYS J, V427, P708, DOI 10.1086/174178; Perlman ES, 2010, ASTROPHYS J, V708, P171, DOI 10.1088/0004-637X/708/1/171; Rees M. J., 1978, MNRAS, V184, P61; REES MJ, 1994, ASTROPHYS J, V430, pL93, DOI 10.1086/187446; Spada M, 2001, MON NOT R ASTRON SOC, V325, P1559, DOI 10.1046/j.1365-8711.2001.04557.x; Sparks WB, 2000, ASTROPHYS J, V542, P667, DOI 10.1086/317064; Stawarz L, 2006, MON NOT R ASTRON SOC, V370, P981, DOI 10.1111/j.1365-2966.2006.10525.x	28	17	17	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					495	+		10.1038/nature14481	http://dx.doi.org/10.1038/nature14481			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8BN	26017450	Green Submitted			2022-12-28	WOS:000371582000002
J	Liu, JL; Lee, J; Hernandez, MAS; Mazitschek, R; Ozcan, U				Liu, Junli; Lee, Jaemin; Hernandez, Mario Andres Salazar; Mazitschek, Ralph; Ozcan, Umut			Treatment of Obesity with Celastrol	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; GLUCOSE-HOMEOSTASIS; ENERGY-BALANCE; ER STRESS; RESISTANCE; WEIGHT	Despite all modern advances in medicine, an effective drug treatment of obesity has not been found yet. Discovery of leptin two decades ago created hopes for treatment of obesity. However, development of leptin resistance has been a big obstacle, mitigating a leptin-centric treatment of obesity. Here, by using in silico drug-screening methods, we discovered that Celastrol, a pentacyclic triterpene extracted from the roots of Tripterygium Wilfordi (thunder god vine) plant, is a powerful anti-obesity agent. Celastrol suppresses food intake, blocks reduction of energy expenditure, and leads to up to 45% weight loss in hyperleptinemic diet-induced obese (DIO) mice by increasing leptin sensitivity, but it is ineffective in leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mouse models. These results indicate that Celastrol is a leptin sensitizer and a promising agent for the pharmacological treatment of obesity.	[Liu, Junli; Lee, Jaemin; Hernandez, Mario Andres Salazar; Ozcan, Umut] Harvard Univ, Boston Childrens Hosp, Sch Med, Div Endocrinol, Boston, MA 02130 USA; [Mazitschek, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Mazitschek, Ralph] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ozcan, U (corresponding author), Harvard Univ, Boston Childrens Hosp, Sch Med, Div Endocrinol, Boston, MA 02130 USA.	umut.ozcan@childrens.harvard.edu	Salazar, Mario/GSN-2646-2022; Lee, Jaemin/AAP-4875-2021	Lee, Jaemin/0000-0002-0224-7141; Liu, Junli/0000-0001-8861-3706	Department of Medicine, Boston Children's Hospital; National Institutes of Health [R01DK098496]; American Diabetes Association Career Development grant [7-09-CD-10]; Fidelity Biosciences Research Initiative; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098496] Funding Source: NIH RePORTER	Department of Medicine, Boston Children's Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Career Development grant; Fidelity Biosciences Research Initiative; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We greatly appreciate the time of Morris F. White and Joseph A. Majzoub for critical reading of our manuscript and for their contributions and suggestions. We thank Serkan Cabi, Isin Cakir, and Safak Mert for their experimental contributions to this work. This work was mainly supported by the funds provided to U.O. from Department of Medicine, Boston Children's Hospital and also by grant R01DK098496 provided to U.O. by the National Institutes of Health, American Diabetes Association Career Development grant #7-09-CD-10, and support from Fidelity Biosciences Research Initiative. U.O. is a scientific founder, shareholder, and scientific advisory board and board of directors member of ERX Pharmaceuticals Inc.	COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; de Almeida SF, 2007, J BIOL CHEM, V282, P27905, DOI 10.1074/jbc.M702672200; Dietrich MO, 2013, TRENDS NEUROSCI, V36, P65, DOI 10.1016/j.tins.2012.12.005; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Mokadem M, 2014, MOL METAB, V3, P191, DOI 10.1016/j.molmet.2013.11.010; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Park SW, 2013, SEMIN IMMUNOPATHOL, V35, P351, DOI 10.1007/s00281-013-0370-z; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryan KK, 2014, NATURE, V509, P183, DOI 10.1038/nature13135; Williams KW, 2014, CELL METAB, V20, P471, DOI 10.1016/j.cmet.2014.06.002; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	30	418	460	17	206	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					999	1011		10.1016/j.cell.2015.05.011	http://dx.doi.org/10.1016/j.cell.2015.05.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000480	Bronze, Green Accepted			2022-12-28	WOS:000355152600009
J	Persat, A; Nadell, CD; Kim, MK; Ingremeau, F; Siryaporn, A; Drescher, K; Wingreen, NS; Bassler, BL; Gitai, Z; Stone, HA				Persat, Alexandre; Nadell, Carey D.; Kim, Minyoung Kevin; Ingremeau, Francois; Siryaporn, Albert; Drescher, Knut; Wingreen, Ned S.; Bassler, Bonnie L.; Gitai, Zemer; Stone, Howard A.			The Mechanical World of Bacteria	CELL			English	Review							IV PILI; STAPHYLOCOCCUS-AUREUS; PHYSIOLOGICAL HETEROGENEITY; XYLELLA-FASTIDIOSA; BIOFILM FORMATION; IN-VITRO; ADHESION; SHEAR; FLOW; SURFACE	In the wild, bacteria are predominantly associated with surfaces as opposed to existing as free-swimming, isolated organisms. They are thus subject to surface-specific mechanics, including hydrodynamic forces, adhesive forces, the rheology of their surroundings, and transport rules that define their encounters with nutrients and signaling molecules. Here, we highlight the effects of mechanics on bacterial behaviors on surfaces at multiple length scales, from single bacteria to the development of multicellular bacterial communities such as biofilms.	[Persat, Alexandre; Nadell, Carey D.; Siryaporn, Albert; Bassler, Bonnie L.; Gitai, Zemer] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Nadell, Carey D.; Drescher, Knut] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Kim, Minyoung Kevin] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Ingremeau, Francois; Stone, Howard A.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Wingreen, Ned S.] Princeton Univ, Lewis Sigler Inst, Princeton, NJ 08544 USA; [Bassler, Bonnie L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Princeton University; Max Planck Society; Princeton University; Princeton University; Princeton University; Howard Hughes Medical Institute	Gitai, Z (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	zgitai@princeton.edu; hastone@princeton.edu	Gitai, Zemer/AAI-6989-2021; Drescher, Knut/N-6730-2015; Kim, Minyoung Kevin/AAM-1770-2021	Drescher, Knut/0000-0002-7340-2444; Persat, Alexandre/0000-0001-8426-8255; Ingremeau, Francois/0000-0003-1493-0068; Bassler, Bonnie/0000-0002-0043-746X; Kim, Minyoung Kevin/0000-0003-4826-3232	Gordon and Betty Moore Foundation [GBMF 2550.02]; NSF [CBET-1330288, MCB-1119232]; Howard Hughes Medical Institute; NIH [R01GM065859]; STX fellowship; Human Frontier Science Program; Max Planck Society; Direct For Biological Sciences [1119232] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065859, R01GM107384, R01GM065859] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STX fellowship; Human Frontier Science Program(Human Frontier Science Program); Max Planck Society(Max Planck SocietyFoundation CELLEX); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Gordon and Betty Moore Foundation through grant GBMF 2550.02 to the Life Sciences Research Foundation (A.P.), the NSF grant CBET-1330288 (Z.G. and H.A.S.), the NSF grant MCB-1119232 (B.L.B., H.A.S., and N.S.W.), the Howard Hughes Medical Institute (B.L.B. and C.D.N.), the NIH grant R01GM065859 (B.L.B.), the STX fellowship (M.K.K.), the Human Frontier Science Program (K.D.), and the Max Planck Society (K.D. and C.D.N.).	Asally M, 2012, P NATL ACAD SCI USA, V109, P18891, DOI 10.1073/pnas.1212429109; Bakker DP, 2004, APPL ENVIRON MICROB, V70, P3758, DOI 10.1128/AEM.70.6.3758-3760.2004; Berg, 2018, RANDOM WALKS BIOL; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Berk V, 2012, SCIENCE, V337, P236, DOI 10.1126/science.1222981; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Chew SC, 2014, MBIO, V5, DOI 10.1128/mBio.01536-14; Comolli JC, 1999, INFECT IMMUN, V67, P3625, DOI 10.1128/IAI.67.7.3625-3630.1999; Cornforth DM, 2014, P NATL ACAD SCI USA, V111, P4280, DOI 10.1073/pnas.1319175111; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; De Kievit TR, 2001, APPL ENVIRON MICROB, V67, P1865, DOI 10.1128/AEM.67.4.1865-1873.2001; De la Fuente L, 2007, APPL ENVIRON MICROB, V73, P2690, DOI 10.1128/AEM.02649-06; Drescher K, 2014, CURR BIOL, V24, P50, DOI 10.1016/j.cub.2013.10.030; Drescher K, 2013, P NATL ACAD SCI USA, V110, P4345, DOI 10.1073/pnas.1300321110; Driscoll WW, 2010, EVOLUTION, V64, P2682, DOI 10.1111/j.1558-5646.2010.01002.x; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fritton SP, 2009, ANNU REV FLUID MECH, V41, P347, DOI 10.1146/annurev.fluid.010908.165136; Garrett TR, 2008, PROG NAT SCI-MATER, V18, P1049, DOI 10.1016/j.pnsc.2008.04.001; Gibiansky ML, 2010, SCIENCE, V330, P197, DOI 10.1126/science.1194238; GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P637, DOI 10.1016/0009-2509(67)80047-2; Guasto JS, 2012, ANNU REV FLUID MECH, V44, P373, DOI 10.1146/annurev-fluid-120710-101156; Guttenplan SB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001243; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Kempes CP, 2014, P NATL ACAD SCI USA, V111, P208, DOI 10.1073/pnas.1315521110; Kim MK, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/6/065024; Kostenko V, 2010, FEMS IMMUNOL MED MIC, V59, P421, DOI 10.1111/j.1574-695X.2010.00694.x; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Lecuyer S, 2011, BIOPHYS J, V100, P341, DOI 10.1016/j.bpj.2010.11.078; Lele PP, 2013, P NATL ACAD SCI USA, V110, P11839, DOI 10.1073/pnas.1305885110; Li GL, 2012, MOL MICROBIOL, V83, P41, DOI 10.1111/j.1365-2958.2011.07909.x; Lichter JA, 2008, BIOMACROMOLECULES, V9, P1571, DOI 10.1021/bm701430y; Liu Y, 2002, WATER RES, V36, P1653, DOI 10.1016/S0043-1354(01)00379-7; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; Meng YZ, 2005, J BACTERIOL, V187, P5560, DOI 10.1128/JB.187.16.5560-5567.2005; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Millet YA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004405; Mitri S, 2013, ANNU REV GENET, V47, P247, DOI 10.1146/annurev-genet-111212-133307; Nadell C.D., 2015, ISME J; Nadell CD, 2011, P NATL ACAD SCI USA, V108, P14181, DOI 10.1073/pnas.1111147108; Nilsson LM, 2006, J BIOL CHEM, V281, P16656, DOI 10.1074/jbc.M511496200; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; Pappelbaum KI, 2013, CIRCULATION, V128, P50, DOI 10.1161/CIRCULATIONAHA.113.002008; Parry JD, 2004, ADV APPL MICROBIOL, V54, P167, DOI 10.1016/S0065-2164(04)54007-8; Persat A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4824; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Pruitt BL, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001996; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Purevdorj B, 2002, APPL ENVIRON MICROB, V68, P4457, DOI 10.1128/AEM.68.9.4457-4464.2002; Rangel DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065563; Rogers SS, 2008, LANGMUIR, V24, P13549, DOI 10.1021/la802442d; Rusconi R, 2014, ANNU REV BIOPHYS, V43, P65, DOI 10.1146/annurev-biophys-051013-022916; Rusconi R, 2011, BIOPHYS J, V100, P1392, DOI 10.1016/j.bpj.2011.01.065; Rusconi R, 2010, J R SOC INTERFACE, V7, P1293, DOI 10.1098/rsif.2010.0096; Shen Y, 2012, BIOPHYS J, V103, P146, DOI 10.1016/j.bpj.2012.05.045; Siryaporn A, 2015, CURR BIOL, V25, P1201, DOI 10.1016/j.cub.2015.02.074; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Squires TM, 2008, NAT BIOTECHNOL, V26, P417, DOI 10.1038/nbt1388; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stewart PS, 2012, BIOFOULING, V28, P187, DOI 10.1080/08927014.2012.662641; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; Stoodley P, 1999, BIOTECHNOL BIOENG, V65, P83, DOI 10.1002/(SICI)1097-0290(19991005)65:1<83::AID-BIT10>3.0.CO;2-B; Stoodley P, 2002, J IND MICROBIOL BIOT, V29, P361, DOI 10.1038/sj.jim.7000282; Sycuro LK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002603; Tchesnokova V, 2010, MOL MICROBIOL, V76, P489, DOI 10.1111/j.1365-2958.2010.07116.x; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Thomas W, 2008, ANNU REV BIOMED ENG, V10, P39, DOI 10.1146/annurev.bioeng.10.061807.160427; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Trejo M, 2013, P NATL ACAD SCI USA, V110, P2011, DOI 10.1073/pnas.1217178110; Tsang PH, 2006, P NATL ACAD SCI USA, V103, P5764, DOI 10.1073/pnas.0601705103; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; van Gestel J, 2014, ISME J, V8, P2069, DOI 10.1038/ismej.2014.52; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Weaver WM, 2011, LAB CHIP, V11, P883, DOI 10.1039/c01c00414f; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Whitfield MJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003971; Wilking JN, 2013, P NATL ACAD SCI USA, V110, P848, DOI 10.1073/pnas.1216376110; Wilking JN, 2011, MRS BULL, V36, P385, DOI 10.1557/mrs.2011.71; Wloka M, 2004, COLLOID POLYM SCI, V282, P1067, DOI 10.1007/s00396-003-1033-8; Xu KD, 1998, APPL ENVIRON MICROB, V64, P4035; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; Zhao K, 2013, NATURE, V497, P388, DOI 10.1038/nature12155	89	262	265	6	289	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					988	997		10.1016/j.cell.2015.05.005	http://dx.doi.org/10.1016/j.cell.2015.05.005			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000479	Green Accepted, Bronze			2022-12-28	WOS:000355152600008
J	Boehncke, WH; Schon, MP				Boehncke, Wolf-Henning; Schoen, Michael P.			Psoriasis	LANCET			English	Article							ENDOTHELIAL GROWTH-FACTOR; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; METABOLIC SYNDROME; PLAQUE PSORIASIS; SEVERITY INDEX; NAIL PSORIASIS; INCREASED RISK; ARTHRITIS	Psoriasis is an immune-mediated, genetic disease manifesting in the skin or joints or both. A diverse team of clinicians with a range of expertise is often needed to treat the disease. Psoriasis provides many challenges including high prevalence, chronicity, disfiguration, disability, and associated comorbidity. Understanding the role of immune function in psoriasis and the interplay between the innate and adaptive immune system has helped to manage this complex disease, which affects patients far beyond the skin. In this Seminar, we highlight the clinical diversity of psoriasis and associated comorbid diseases. We describe recent developments in psoriasis epidemiology, pathogenesis, and genetics to better understand present trends in psoriasis management. Our key objective is to raise awareness of the complexity of this multifaceted disease, the potential of state-of-the-art therapeutic approaches, and the need for early diagnosis and comprehensive management of patients with psoriasis.	[Boehncke, Wolf-Henning] Univ Hosp Geneva, Dept Dermatol & Venereol, Geneva, Switzerland; [Boehncke, Wolf-Henning] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Schoen, Michael P.] Univ Gottingen, Univ Med Ctr, Dept Dermatol Venereol & Allergol, D-37073 Gottingen, Germany	University of Geneva; University of Geneva; University of Gottingen	Boehncke, WH (corresponding author), Univ Geneva, Dept Dermatol & Venereol, Geneva, Switzerland.	michael.schoen@med.uni-goettingen.de			AbbVie; Biogen Idec	AbbVie(AbbVie); Biogen Idec(Biogen)	W-HB has received honoraria as a speaker or adviser for Abbvie, Biogen Idec, Covagen, Galderma, Janssen, Leo, Lilly, MSD, Novartis, Pantec Biosolutions, Pfizer, Celgene and UCB. MPS has received honoraria as a speaker or adviser for Abbvie, Biogen Idec, Janssen, Leo, Lilly, MSD, Novartis, Pfizer, and Celgene. MPS has received research funding from AbbVie and Biogen Idec and serves as an adviser of the Deutsche Psoriasis Bund, a patient self-help organisation. Neither author has had, within the past 3 years, stocks, shares, or equity in a relevant company, nor a contract of employment or named position on a company board.	Abuabara K, 2010, BRIT J DERMATOL, V163, P586, DOI 10.1111/j.1365-2133.2010.09941.x; Ahern T, 2013, J EUR ACAD DERMATOL, V27, P1440, DOI 10.1111/j.1468-3083.2012.04609.x; Ahlehoff O, 2013, J INTERN MED, V273, P197, DOI 10.1111/j.1365-2796.2012.02593.x; Amherd-Hoekstra A, 2010, J DTSCH DERMATOL GES, V8, P332, DOI 10.1111/j.1610-0387.2009.07334.x; Armstrong AW, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.26; Armstrong AW, 2014, CURR PHARM DESIGN, V20, P500, DOI 10.2174/138161282004140213123505; Armstrong AW, 2013, J HYPERTENS, V31, P433, DOI 10.1097/HJH.0b013e32835bcce1; Armstrong AW, 2011, EXP DERMATOL, V20, P544, DOI 10.1111/j.1600-0625.2011.01308.x; Armstrong EJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000062; Asumalahti K, 2003, J INVEST DERMATOL, V120, P627, DOI 10.1046/j.1523-1747.2003.12094.x; Augustin M, 2008, DERMATOLOGY, V216, P366, DOI 10.1159/000119415; Augustin M, 2010, BRIT J DERMATOL, V162, P633, DOI 10.1111/j.1365-2133.2009.09593.x; Augustin M, 2014, J DTSCH DERMATOL GES, V12, P48, DOI 10.1111/ddg.12233; Balato N, 2013, OCCUP ENVIRON MED, V70, P600, DOI 10.1136/oemed-2013-101505; Baran R, 2010, DERMATOLOGY, V221, P1, DOI 10.1159/000316169; Basavaraj KH, 2010, INT J DERMATOL, V49, P1351, DOI 10.1111/j.1365-4632.2010.04570.x; Besgen P, 2010, J IMMUNOL, V184, P5392, DOI 10.4049/jimmunol.0903520; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Boehncke S, 2011, J EUR ACAD DERMATOL, V25, P1187, DOI 10.1111/j.1468-3083.2010.03947.x; Boehncke WH, 2011, EXP DERMATOL, V20, P303, DOI 10.1111/j.1600-0625.2011.01261.x; Boehncke WH, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5666; Brezinski EA, 2014, CURR PHARM DESIGN, V20, P513, DOI 10.2174/138161282004140213123852; Buchau AS, 2007, CLIN DERMATOL, V25, P616, DOI 10.1016/j.clindermatol.2007.08.016; Buerger C, 2012, J INVEST DERMATOL, V132, P2206, DOI 10.1038/jid.2012.123; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Capon F, 2012, J INVEST DERMATOL, V132, P915, DOI 10.1038/jid.2011.395; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Christophers E, 2001, CLIN EXP DERMATOL, V26, P314, DOI 10.1046/j.1365-2230.2001.00832.x; Coates LC, 2013, BRIT J DERMATOL, V168, P802, DOI 10.1111/bjd.12190; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Coto-Segura P, 2013, BRIT J DERMATOL, V169, P783, DOI 10.1111/bjd.12473; Dauden E, 2013, J EUR ACAD DERMATOL, V27, P1387, DOI 10.1111/jdv.12024; de Vries AC, 2013, COCHRANE DB SYST REV, V1; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Dowlatshahi EA, 2013, J INVEST DERMATOL, V133, P2347, DOI 10.1038/jid.2013.131; Dubertret L, 2006, BRIT J DERMATOL, V155, P729, DOI 10.1111/j.1365-2133.2006.07405.x; Elder JT, 2009, GENES IMMUN, V10, P201, DOI 10.1038/gene.2009.11; Elder JT, 2010, J INVEST DERMATOL, V130, P1213, DOI 10.1038/jid.2009.319; Elias PM, 2008, AM J PATHOL, V173, P689, DOI 10.2353/ajpath.2008.080088; FARBER EM, 1974, DERMATOLOGICA, V148, P1, DOI 10.1159/000251595; Fotiadou C, 2014, ADOLESC HEALTH MED T, V5, P25, DOI 10.2147/AHMT.S36672; Fry L, 2007, CLIN DERMATOL, V25, P606, DOI 10.1016/j.clindermatol.2007.08.015; Gelfand JM, 2006, J INVEST DERMATOL, V126, P2194, DOI 10.1038/sj.jid.5700410; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gerdes S, 2008, BRIT J DERMATOL, V159, P1116, DOI 10.1111/j.1365-2133.2008.08786.x; Gisondi P, 2007, BRIT J DERMATOL, V157, P68, DOI 10.1111/j.1365-2133.2007.07986.x; Gottlieb AB, 2013, J RHEUMATOL, V40, P1428, DOI 10.3899/jrheum.130456; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Gu WJ, 2013, INT J CARDIOL, V168, P4992, DOI 10.1016/j.ijcard.2013.07.127; Gupta Y, 2013, EXP DERMATOL, V22, P552, DOI 10.1111/exd.12192; Hagg D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063619; Haider AS, 2008, J INVEST DERMATOL, V128, P606, DOI 10.1038/sj.jid.5701067; Hall JMF, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/403908; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hebert HL, 2012, BRIT J DERMATOL, V166, P474, DOI 10.1111/j.1365-2133.2011.10712.x; Heidenreich R, 2008, DRUG NEWS PERSPECT, V21, P97, DOI 10.1358/dnp.2008.21.2.1188196; Henes JC, 2014, RHEUMATOL INT, V34, P227, DOI 10.1007/s00296-013-2876-z; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; Hoffmann JHO, 2011, BRIT J DERMATOL, V165, P1355, DOI 10.1111/j.1365-2133.2011.10555.x; Horreau C, 2013, J EUR ACAD DERMATOL, V27, P12, DOI 10.1111/jdv.12163; Hsu L, 2014, BRIT J DERMATOL, V170, P261, DOI 10.1111/bjd.12654; Hsu S, 2012, ARCH DERMATOL, V148, P95, DOI 10.1001/archdermatol.2011.1410; Jacobson CC, 2011, J AM ACAD DERMATOL, V65, P870, DOI 10.1016/j.jaad.2009.05.047; Joyau C, 2012, CLIN EXP RHEUMATOL, V30, P700; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Keijsers RRMC, 2014, J INVEST DERMATOL, V134, P1276, DOI 10.1038/jid.2013.526; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Kumari S, 2013, IMMUNITY, V39, P899, DOI 10.1016/j.immuni.2013.10.009; Langley RG, 2004, J AM ACAD DERMATOL, V51, P563, DOI 10.1016/j.jaad.2004.04.012; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Ludwig RJ, 2007, BRIT J DERMATOL, V156, P271, DOI 10.1111/j.1365-2133.2006.07562.x; Madva EN, 2013, BRAIN BEHAV IMMUN, V34, P1, DOI 10.1016/j.bbi.2013.03.006; Mahler V, 2014, J DTSCH DERMATOL GES, V12, P519, DOI 10.1111/ddg.12262; Mallbris L, 2004, EUR J EPIDEMIOL, V19, P225, DOI 10.1023/B:EJEP.0000020447.59150.f9; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Martin BA, 1996, ARCH DERMATOL, V132, P717, DOI 10.1001/archderm.1996.03890300147032; Mason AR, 2013, BRIT J DERMATOL, V169, P519, DOI 10.1111/bjd.12393; Miller IM, 2013, J AM ACAD DERMATOL, V69, P1014, DOI 10.1016/j.jaad.2013.06.053; Mrowietz U, 2011, ARCH DERMATOL RES, V303, P1, DOI 10.1007/s00403-010-1080-1; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nast A, 2012, J DTSCH DERMATOL GES, V10, DOI 10.1111/j.1610-0387.2012.07919.x; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Neurath MF, 2007, NAT MED, V13, P26, DOI 10.1038/nm0107-26; Nickoloff BJ, 2007, CLIN REV ALLERG IMMU, V33, P45, DOI 10.1007/s12016-007-0039-2; Nijsten T, 2009, J INVEST DERMATOL, V129, P1601, DOI 10.1038/jid.2009.55; Ortonne JP, 2009, J EUR ACAD DERMATOL, V23, P1435, DOI 10.1111/j.1468-3083.2009.03372.x; Papp KA, 2013, J EUR ACAD DERMATOL, V27, pe376, DOI 10.1111/j.1468-3083.2012.04716.x; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pathirana D, 2009, J EUR ACAD DERMATOL, V23, P1, DOI 10.1111/j.1468-3083.2009.03389.x; Rahman P, 2009, J RHEUMATOL, V36, P137, DOI 10.3899/jrheum.080458; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Raut AS, 2013, CRIT REV THER DRUG, V30, P183, DOI 10.1615/CritRevTherDrugCarrierSyst.2013005268; Reich K, 2012, J EUR ACAD DERMATOL, V26, P3, DOI 10.1111/j.1468-3083.2011.04410.x; Reich K, 2009, J EUR ACAD DERMATOL, V23, P15, DOI 10.1111/j.1468-3083.2009.03364.x; Rosenberger C, 2007, J INVEST DERMATOL, V127, P2445, DOI 10.1038/sj.jid.5700874; RUNNE U, 1993, HAUTARZT, V44, P691; Ryan C, 2014, J AM ACAD DERMATOL, V70, P146, DOI 10.1016/j.jaad.2013.08.042; Sabat R, 2007, EXP DERMATOL, V16, P779, DOI 10.1111/j.1600-0625.2007.00629.x; Samarasekera EJ, 2013, J INVEST DERMATOL, V133, P2340, DOI 10.1038/jid.2013.149; Saurat JH, 2008, BRIT J DERMATOL, V158, P558, DOI 10.1111/j.1365-2133.2007.08315.x; Schmitt J, 2005, DERMATOLOGY, V210, P194, DOI 10.1159/000083509; Schon MP, 2011, BRIT J DERMATOL, V165, P1160, DOI 10.1111/j.1365-2133.2011.10677.x; Schon MP, 2008, EXP DERMATOL, V17, P703, DOI 10.1111/j.1600-0625.2008.00751.x; Schon MP, 2014, EXP DERMATOL, V23, P804, DOI 10.1111/exd.12541; Schon MP, 2003, J INVEST DERMATOL, V121, P951, DOI 10.1046/j.1523-1747.2003.12563.x; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Shmidt E, 2012, J AM ACAD DERMATOL, V67, pE179, DOI 10.1016/j.jaad.2011.05.038; Singh TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051752; Stahle M, 2010, J DTSCH DERMATOL GES, V8, P812, DOI 10.1111/j.1610-0387.2010.07507.x; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Sticherling M, 2011, J DTSCH DERMATOL GES, V9, P815, DOI 10.1111/j.1610-0387.2011.07668.x; Sugiura K, 2014, J DERMATOL SCI, V74, P187, DOI 10.1016/j.jdermsci.2014.02.006; Talamonti M, 2013, BRIT J DERMATOL, V169, P458, DOI 10.1111/bjd.12331; Tan EST, 2012, AM J CLIN DERMATOL, V13, P375, DOI 10.2165/11597000-000000000-00000; Teige I, 2009, J INVEST DERMATOL, V129, P1437, DOI 10.1038/jid.2008.375; Tejasvi T, 2012, J INVEST DERMATOL, V132, P593, DOI 10.1038/jid.2011.376; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; van der Voort EAM, 2014, J AM ACAD DERMATOL, V70, P517, DOI 10.1016/j.jaad.2013.10.044; Veale DJ, 2002, CLIN EXP RHEUMATOL, V20, pS27; Villanova F, 2013, ANN RHEUM DIS, V72, P104, DOI 10.1136/annrheumdis-2012-203037; WHO, 2013, WORLD PSOR DAY DOC E; Wohlrab J, 2013, ARCH DERMATOL RES, V305, P91, DOI 10.1007/s00403-013-1318-9; Wolf N, 2008, J MED GENET, V45, P114, DOI 10.1136/jmg.2007.053595; Woth K, 2013, EXP DERMATOL, V22, P714, DOI 10.1111/exd.12235; Wozel G, 2008, CLIN DERMATOL, V26, P448, DOI 10.1016/j.clindermatol.2007.10.026; Xu N, 2013, J IMMUNOL, V190, P678, DOI 10.4049/jimmunol.1202695; Xu T, 2012, BRIT J DERMATOL, V167, P1345, DOI 10.1111/bjd.12002; Young HS, 2004, J INVEST DERMATOL, V122, P209, DOI 10.1046/j.0022-202X.2003.22107.x; Zibert JR, 2011, J CLIN INVEST, V121, P410, DOI 10.1172/JCI41295	137	1310	1377	45	320	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2015	386	9997					983	994		10.1016/S0140-6736(14)61909-7	http://dx.doi.org/10.1016/S0140-6736(14)61909-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR2TE	26025581				2022-12-28	WOS:000361182700031
J	Levey, AS; Inker, LA; Coresh, J				Levey, Andrew S.; Inker, Lesley A.; Coresh, Josef			Chronic Kidney Disease in Older People	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADULTS; MODEL; RISK		[Levey, Andrew S.; Inker, Lesley A.] Tufts Med Ctr, Div Nephrol, Boston, MA 02111 USA; [Coresh, Josef] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Coresh, Josef] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Coresh, Josef] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	Tufts Medical Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Levey, AS (corresponding author), Tufts Med Ctr, Box 391,850 Washington St, Boston, MA 02111 USA.	alevey@tuftsmedicalcenter.org			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Bansal N, 2015, CLIN J AM SOC NEPHRO, V10, P363, DOI 10.2215/CJN.04650514; CKD Work Group, 2013, KIDNEY INT, V3, P1; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Hsu C, 2000, AM J KIDNEY DIS, V36, P415, DOI 10.1053/ajkd.2000.8996; Labarthe DR, 2009, EPIDEMIOLOGY PREVENT; Levey AS, 2015, JAMA-J AM MED ASSOC, V313, P837, DOI 10.1001/jama.2015.0602; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Tangri N, 2013, ANN INTERN MED, V158, P596, DOI 10.7326/0003-4819-158-8-201304160-00004; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Uhlig K, 2012, ANN INTERN MED, V156, P599, DOI [10.7326/0003-4819-156-8-201204170-00012, 10.7326/0003-4819-156-8-201204170-00009]	10	73	74	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2015	314	6					557	558		10.1001/jama.2015.6753	http://dx.doi.org/10.1001/jama.2015.6753			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8BD	26023868				2022-12-28	WOS:000359388600010
J	Tanouchi, Y; Pai, A; Park, H; Huang, SQ; Stamatov, R; Buchler, NE; You, LC				Tanouchi, Yu; Pai, Anand; Park, Heungwon; Huang, Shuqiang; Stamatov, Rumen; Buchler, Nicolas E.; You, Lingchong			A noisy linear map underlies oscillations in cell size and gene expression in bacteria	NATURE			English	Article							CHROMOSOME-REPLICATION; SINGLE-CELL; GROWTH; METABOLISM	During bacterial growth, a cell approximately doubles in size before division, after which it splits into two daughter cells. This process is subjected to the inherent perturbations of cellular noise(1,2) and thus requires regulation for cell-size homeostasis. The mechanisms underlying the control and dynamics of cell size remain poorly understood owing to the difficulty in sizing individual bacteria over long periods of time in a high-throughput manner. Here we measure and analyse long-term, single-cell growth and division across different Escherichia coli strains and growth conditions(3). We show that a subset of cells in a population exhibit transient oscillations in cell size with periods that stretch across several (more than ten) generations. Our analysis reveals that a simple law governing cell-size control-a noisy linear map-explains the origins of these cell-size oscillations across all strains. This noisy linear map implements a negative feedback on cell-size control: a cell with a larger initial size tends to divide earlier, whereas one with a smaller initial size tends to divide later. Combining simulations of cell growth and division with experimental data, we demonstrate that this noisy linear map generates transient oscillations, not just in cell size, but also in constitutive gene expression. Our work provides new insights into the dynamics of bacterial cell-size regulation with implications for the physiological processes involved.	[Tanouchi, Yu; Pai, Anand; Huang, Shuqiang; You, Lingchong] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Park, Heungwon; Buchler, Nicolas E.] Duke Univ, Dept Phys, Durham, NC 27708 USA; [Park, Heungwon; Buchler, Nicolas E.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Stamatov, Rumen] Duke Univ, Computat Biol & Bioinformat, Durham, NC 27708 USA; [Buchler, Nicolas E.; You, Lingchong] Duke Univ, Ctr Genom & Computat Biol, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University; Duke University	You, LC (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.	you@duke.edu	Buchler, Nicolas/H-3988-2019	Buchler, Nicolas/0000-0003-3940-3432	National Science Foundation; National Institutes of Health [R01GM098642, R01GM110494]; DuPont Young Professorship; David and Lucile Packard Fellowship; DARPA Biochronicity Grant [DARPA-BAA-11-66]; NIH [DP2 OD008654-01]; Burroughs Wellcome Fund [BWF 1005769.01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098642, R01GM110494] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008654] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DuPont Young Professorship; David and Lucile Packard Fellowship(The David & Lucile Packard Foundation); DARPA Biochronicity Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Jun for providing the original mother machine and P. Cluzel for providing their data set on E. coli and B. subtilis growth. We also thank the Light Microscopy Core Facility at Duke University for their help in conducting microscopy experiments. This work was partially supported by a National Science Foundation Career Award (L.Y.), the National Institutes of Health (NIH) (L.Y., R01GM098642, R01GM110494), a DuPont Young Professorship (L.Y.), a David and Lucile Packard Fellowship (L.Y.), a DARPA Biochronicity Grant (DARPA-BAA-11-66, N.E.B.), a NIH Director's New Innovator Award (DP2 OD008654-01, N.E.B.), and a Burroughs Wellcome Fund CASI Award (BWF 1005769.01, N.E.B.).	Amir A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.208102; Campos M, 2014, CELL, V159, P1433, DOI 10.1016/j.cell.2014.11.022; Cookson NA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.94; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; Donachie WD, 2003, CURR OPIN MICROBIOL, V6, P146, DOI 10.1016/S1369-5274(03)00026-2; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/NMETH.1452, 10.1038/nmeth.1452]; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Hui S, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145697; Kitagawa G., 2010, INTRO TIME SERIES MO; Kiviet DJ, 2014, NATURE, V514, P376, DOI 10.1038/nature13582; Kvarnstrom M, 2008, OPT EXPRESS, V16, P12943, DOI 10.1364/OE.16.012943; Levine JH, 2013, SCIENCE, V342, P1193, DOI 10.1126/science.1239999; Marguet P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011909; Moffitt JR, 2012, LAB CHIP, V12, P1487, DOI 10.1039/c2lc00009a; Mondragon-Palomino O, 2011, SCIENCE, V333, P1315, DOI 10.1126/science.1205369; Nobs JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093466; Osella M, 2014, P NATL ACAD SCI USA, V111, P3431, DOI 10.1073/pnas.1313715111; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Reyes-Lamothe R, 2012, ANNU REV GENET, V46, P121, DOI 10.1146/annurev-genet-110711-155421; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Taheri-Araghi S, 2015, CURR BIOL, V25, P385, DOI 10.1016/j.cub.2014.12.009; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; You CH, 2013, NATURE, V500, P301, DOI 10.1038/nature12446	30	95	95	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					357	+		10.1038/nature14562	http://dx.doi.org/10.1038/nature14562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26040722	Green Submitted, Green Accepted			2022-12-28	WOS:000357950900044
J	Gaudet, RG; Sintsova, A; Buckwalter, CM; Leung, N; Cochrane, A; Li, JJ; Cox, AD; Moffat, J; Gray-Owen, SD				Gaudet, Ryan G.; Sintsova, Anna; Buckwalter, Carolyn M.; Leung, Nelly; Cochrane, Alan; Li, Jianjun; Cox, Andrew D.; Moffat, Jason; Gray-Owen, Scott D.			Cytosolic detection of the bacterial metabolite HBP activates TIFA-dependent innate immunity	SCIENCE			English	Article							NF-KAPPA-B; ADAPTER PROTEIN; BIOSYNTHESIS; STIMULATION; INHIBITORS; RECEPTORS; VIRULENCE; HEPTOSE; PATHWAY; BINDING	Host recognition of pathogen-associated molecular patterns (PAMPs) initiates an innate immune response that is critical for pathogen elimination and engagement of adaptive immunity. Here we show that mammalian cells can detect and respond to the bacterial-derived monosaccharide heptose-1,7-bisphosphate (HBP). A metabolic intermediate in lipopolysaccharide biosynthesis, HBP is highly conserved in Gram-negative bacteria, yet absent from eukaryotic cells. Detection of HBP within the host cytosol activated the nuclear factor kappa B pathway in vitro and induced innate and adaptive immune responses in vivo. Moreover, we used a genome-wide RNA interference screen to uncover an innate immune signaling axis, mediated by phosphorylation-dependent oligomerization of the TRAF-interacting protein with forkhead-associated domain (TIFA) that is triggered by HBP. Thus, HBP is a PAMP that activates TIFA-dependent immunity to Gram-negative bacteria.	[Gaudet, Ryan G.; Sintsova, Anna; Buckwalter, Carolyn M.; Leung, Nelly; Cochrane, Alan; Moffat, Jason; Gray-Owen, Scott D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Li, Jianjun; Cox, Andrew D.] CNR, Vaccine Program, Ottawa, ON K1A 0R6, Canada; [Moffat, Jason] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Moffat, Jason] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada	University of Toronto; National Research Council Canada; University of Toronto; University of Toronto	Gray-Owen, SD (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	scott.gray.owen@utoronto.ca	Gaudet, Ryan/AAP-8875-2021; Moffat, Jason/AAC-1110-2020; Gray-Owen, Scott/AFL-7380-2022; Gray-Owen, Scott/AAG-7337-2022	Gaudet, Ryan/0000-0001-8496-3653; Moffat, Jason/0000-0002-5663-8586; Gray-Owen, Scott D./0000-0002-1477-3616; Li, Jianjun/0000-0002-6531-3687; Cox, Andrew/0000-0002-8397-9271	Canadian Institutes of Health Research (CIHR)-Canada Graduate Scholarship Doctoral Award; CIHR [MOP-15499, HOP-13769]	Canadian Institutes of Health Research (CIHR)-Canada Graduate Scholarship Doctoral Award; CIHR(Canadian Institutes of Health Research (CIHR))	We thank G. McSheffrey, E. Islam, S. McCaw, D. White, L. Zhang, J. Krieger, F. St. Michael, R. Molinaro, and C. Lai for technical help and T. Moraes, R. Malott, A. Aman, S. E. Girardin, and T. Ketela for helpful discussions and support. R. G. G. was supported by a Canadian Institutes of Health Research (CIHR)-Canada Graduate Scholarship Doctoral Award. The data reported in this paper are tabulated in the main text and supplementary materials. This work was supported by CIHR grants MOP-15499 and HOP-13769. Illumina microarray data have been deposited with the NCBI Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) under accession number GSE67840. R.G.G. and S.D.G.-O. have filed a provisional patent (U.S. patent application 62/062413) pertaining to biological applications relating to the use of heptose-1,7-bisphosphate in modulating immune system responses.	AGUILARCORDOVA E, 1994, AIDS RES HUM RETROV, V10, P295, DOI 10.1089/aid.1994.10.295; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; Desroy N, 2013, J MED CHEM, V56, P1418, DOI 10.1021/jm301499r; Ea CK, 2004, P NATL ACAD SCI USA, V101, P15318, DOI 10.1073/pnas.0404132101; EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205; Ferrao R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003124; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Huang CCF, 2012, MOL CELL BIOL, V32, P2664, DOI 10.1128/MCB.00438-12; Kanamori M, 2002, BIOCHEM BIOPH RES CO, V290, P1108, DOI 10.1006/bbrc.2001.6315; Kneidinger B, 2002, J BACTERIOL, V184, P363, DOI 10.1128/JB.184.2.363-369.2002; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Malott RJ, 2013, P NATL ACAD SCI USA, V110, P10234, DOI 10.1073/pnas.1303738110; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Plant L, 2006, INFECT IMMUN, V74, P1360, DOI 10.1128/IAI.74.2.1360-1367.2006; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Takatsuna H, 2003, J BIOL CHEM, V278, P12144, DOI 10.1074/jbc.M300720200	26	95	101	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1251	1255		10.1126/science.aaa4921	http://dx.doi.org/10.1126/science.aaa4921			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068852				2022-12-28	WOS:000356011500054
J	Burke, B				Burke, Brian			CELL BIOLOGY Nuclear dilemma resolved	NATURE			English	Editorial Material							STEPS		Inst Med Biol, Singapore 138648, Singapore	Agency for Science Technology & Research (ASTAR); A*STAR - Institute of Medical Biology (IMB)	Burke, B (corresponding author), Inst Med Biol, Singapore 138648, Singapore.	brian.burke@imb.a-star.edu.sg						de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; Henne WM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016766; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Macaulay C, 1996, J CELL BIOL, V132, P5, DOI 10.1083/jcb.132.1.5; Olmos Y, 2015, NATURE, V522, P236, DOI 10.1038/nature14503; Pawliczek T, 2009, J VIROL, V83, P11254, DOI 10.1128/JVI.00574-09; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Vietri M, 2015, NATURE, V522, P231, DOI 10.1038/nature14408; Wandke C, 2013, CELL, V152, P1222, DOI 10.1016/j.cell.2013.02.046; Webster BM, 2014, CELL, V159, P388, DOI 10.1016/j.cell.2014.09.012; Wilson KL, 2011, J CELL BIOL, V195, P171, DOI 10.1083/jcb.201103171	12	1	1	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					159	160		10.1038/nature14527	http://dx.doi.org/10.1038/nature14527			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	26040718				2022-12-28	WOS:000356016700024
J	Rinella, ME				Rinella, Mary E.			Nonalcoholic Fatty Liver Disease A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PLACEBO-CONTROLLED TRIAL; LIFE-STYLE MODIFICATION; VITAMIN-E; HEPATOCELLULAR-CARCINOMA; FIBROSIS PROGRESSION; INSULIN-RESISTANCE; HEPATIC STEATOSIS; RANDOMIZED-TRIALS; BARIATRIC SURGERY; BLADDER-CANCER	IMPORTANCE Nonalcoholic fatty liver disease and its subtype nonalcoholic steatohepatitis affect approximately 30% and 5%, respectively, of the US population. In patients with nonalcoholic steatohepatitis, half of deaths are due to cardiovascular disease and malignancy, yet awareness of this remains low. Cirrhosis, the third leading cause of death in patients with nonalcoholic fatty liver disease, is predicted to become the most common indication for liver transplantation. OBJECTIVES To illustrate how to identify patients with nonalcoholic fatty liver disease at greatest risk of nonalcoholic steatohepatitis and cirrhosis; to discuss the role and limitations of current diagnostics and liver biopsy to diagnose nonalcoholic steatohepatitis; and to provide an outline for the management of patients across the spectrum of nonalcoholic fatty liver disease. EVIDENCE REVIEW PubMed was queried for published articles through February 28, 2015, using the search terms NAFLD and cirrhosis, mortality, biomarkers, and treatment. A total of 88 references were selected, including 16 randomized clinical trials, 44 cohort or case-control studies, 6 population-based studies, and 7 meta-analyses. FINDINGS Sixty-six percent of patients older than 50 years with diabetes or obesity are thought to have nonalcoholic steatohepatitis with advanced fibrosis. Even though the ability to identify the nonalcoholic steatohepatitis subtype within those with nonalcoholic fatty liver disease still requires liver biopsy, biomarkers to detect advanced fibrosis are increasingly reliable. Lifestyle modification is the foundation of treatment for patients with nonalcoholic steatosis. Available treatments with proven benefit include vitamin E, pioglitazone, and obeticholic acid; however, the effect size is modest (<50%) and none is approved by the US Food and Drug Administration. The association between nonalcoholic steatohepatitis and cardiovascular disease is clear, though causality remains to be proven in well-controlled prospective studies. The incidence of nonalcoholic fatty liver disease-related hepatocellular carcinoma is increasing and up to 50% of cases may occur in the absence of cirrhosis. CONCLUSIONS AND RELEVANCE Between 75 million and 100 million individuals in the United States are estimated to have nonalcoholic fatty liver disease and its potential morbidity extends beyond the liver. It is important that primary care physicians, endocrinologists, and other specialists be aware of the scope and long-term effects of the disease. Early identification of patients with nonalcoholic steatohepatitis may help improve patient outcomes through treatment intervention, including transplantation for those with decompensated cirrhosis.	Northwestern Univ, Div Gastroenterol & Hepatol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Rinella, ME (corresponding author), Northwestern Univ, Div Gastroenterol & Hepatol, Feinberg Sch Med, 676 N St Clair, Chicago, IL 60611 USA.	m-rinella@northwestern.edu	rinella, mary/AAJ-4065-2021	rinella, mary/0000-0003-0620-9705				Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Aithal GP, 2008, GASTROENTEROLOGY, V135, P1176, DOI 10.1053/j.gastro.2008.06.047; Amarapurkar Deepak N, 2004, Trop Gastroenterol, V25, P130; Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Angulo P, 2010, HEPATOLOGY, V51, P373, DOI 10.1002/hep.23521; [Anonymous], NAFLD FIBR SCOR; Arulanandan A, CLIN GASTROENTEROL H, DOI [10.1016/j.cgh.2015.01.027, DOI 10.1016/J.CGH.2015]; Aubert RE, 2010, DIABETES OBES METAB, V12, P716, DOI 10.1111/j.1463-1326.2010.01225.x; Bae JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046819; Bastati N, 2014, RADIOLOGY, V271, P739, DOI 10.1148/radiol.14131890; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Boursier J, 2015, J HEPATOL, V62, P807, DOI 10.1016/j.jhep.2014.10.042; Browning JD, 2011, AM J CLIN NUTR, V93, P1048, DOI 10.3945/ajcn.110.007674; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chang Y, 2013, AM J GASTROENTEROL, V108, P1861, DOI 10.1038/ajg.2013.349; Cheung O, 2007, HEPATOLOGY, V46, P1091, DOI 10.1002/hep.21803; Cusi K, 2014, J HEPATOL, V60, P167, DOI 10.1016/j.jhep.2013.07.042; Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001; Eckard C, 2013, THER ADV GASTROENTER, V6, P249, DOI 10.1177/1756283X13484078; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Gee PT, 2011, GENES NUTR, V6, P5, DOI 10.1007/s12263-010-0180-z; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guha IN, 2008, HEPATOLOGY, V47, P455, DOI 10.1002/hep.21984; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2485, DOI 10.1111/j.1572-0241.2003.08699.x; Harrison SA, 2009, HEPATOLOGY, V49, P80, DOI 10.1002/hep.22575; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Johnson NA, 2009, HEPATOLOGY, V50, P1105, DOI 10.1002/hep.23129; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Levin D, 2015, DIABETOLOGIA; Levin D, 2015, DIABETOLOGIA, V58, P493, DOI 10.1007/s00125-014-3456-9; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Lin SC, 2015, CLIN GASTROENTEROL H, V13, P1337, DOI 10.1016/j.cgh.2014.11.027; Loomba R, 2014, HEPATOLOGY, V60, P1920, DOI 10.1002/hep.27362; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Mahady SE, 2011, J HEPATOL, V55, P1383, DOI 10.1016/j.jhep.2011.03.016; Mathurin P, 2009, GASTROENTEROLOGY, V137, P532, DOI 10.1053/j.gastro.2009.04.052; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Maximos M, 2015, HEPATOLOGY, V61, P153, DOI 10.1002/hep.27395; McCarthy EM, 2012, J ACAD NUTR DIET, V112, P401, DOI 10.1016/j.jada.2011.10.007; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; McPherson S, 2010, GUT, V59, P1265, DOI 10.1136/gut.2010.216077; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Musso G, 2010, HEPATOLOGY, V52, P79, DOI 10.1002/hep.23623; Myers RP, 2010, CAN J GASTROENTEROL, V24, P661, DOI 10.1155/2010/153986; Nascimbeni F, 2013, J HEPATOL, V59, P859, DOI 10.1016/j.jhep.2013.05.044; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Oh S, 2015, HEPATOLOGY, V61, P1205, DOI 10.1002/hep.27544; Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027; Portillo Sanchez Paola, 2014, J Clin Endocrinol Metab, V100, DOI 10.1210/jc.2014-2739; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Ratziu V, 2000, GASTROENTEROLOGY, V118, P1117, DOI 10.1016/S0016-5085(00)70364-7; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Ratziu V, 2012, J HEPATOL, V57, P376, DOI 10.1016/j.jhep.2012.03.019; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Ripoll C, 2007, GASTROENTEROLOGY, V133, P481, DOI 10.1053/j.gastro.2007.05.024; Ripoll C, 2009, J HEPATOL, V50, P923, DOI 10.1016/j.jhep.2009.01.014; Ruhl CE, 2015, ALIMENT PHARM THER, V41, P65, DOI 10.1111/apt.13012; Ryan MC, 2013, J HEPATOL, V59, P138, DOI 10.1016/j.jhep.2013.02.012; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Sanyal AJ, 2006, HEPATOLOGY, V43, P682, DOI 10.1002/hep.21103; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Sasso M, 2012, CLIN RES HEPATOL GAS, V36, P13, DOI 10.1016/j.clinre.2011.08.001; Schurks M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5702; Shen JY, 2012, J HEPATOL, V56, P1363, DOI 10.1016/j.jhep.2011.12.025; Singal AG, 2014, AM J GASTROENTEROL, V109, P325, DOI 10.1038/ajg.2013.476; Singh S, 2015, CLIN GASTROENTEROL H, V13, P9; Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014; Slentz CA, 2011, AM J PHYSIOL-ENDOC M, V301, pE1033, DOI 10.1152/ajpendo.00291.2011; Smidt Nynke, 2006, BMC Med Res Methodol, V6, P12, DOI 10.1186/1471-2288-6-12; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taitano AA, 2015, J GASTROINTEST SURG, V19, P429, DOI 10.1007/s11605-014-2678-y; Tamimi TIAR, 2011, J HEPATOL, V54, P1224, DOI 10.1016/j.jhep.2010.08.023; Trust for America's Health, AD OB US; Van Wagner LB, 2011, ANN HEPATOL, V10, P277, DOI 10.1016/S1665-2681(19)31539-X; VanWagner LB, 2012, HEPATOLOGY, V56, P1741, DOI 10.1002/hep.25855; Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wong VWS, 2013, J HEPATOL, V59, P536, DOI 10.1016/j.jhep.2013.04.013; Wu WC, 2012, ALIMENT PHARM THER, V36, P560, DOI 10.1111/j.1365-2036.2012.05224.x; Yasui K, 2011, CLIN GASTROENTEROL H, V9, P428, DOI 10.1016/j.cgh.2011.01.023; Zein CO, 2011, HEPATOLOGY, V54, P1610, DOI 10.1002/hep.24544	90	1394	1485	32	439	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2263	2273		10.1001/jama.2015.5370	http://dx.doi.org/10.1001/jama.2015.5370			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1VH	26057287				2022-12-28	WOS:000355995300020
J	Gkountela, S; Zhang, KX; Shafiq, TA; Liao, WW; Hargan-Calvopina, J; Chen, PY; Clark, AT				Gkountela, Sofia; Zhang, Kelvin X.; Shafiq, Tiasha A.; Liao, Wen-Wei; Hargan-Calvopina, Joseph; Chen, Pao-Yang; Clark, Amander T.			DNA Demethylation Dynamics in the Human Prenatal Germline	CELL			English	Article							EMBRYONIC STEM-CELLS; DIFFERENTIAL EXPRESSION ANALYSIS; GROUND-STATE; TRANSCRIPTION; METHYLATION; PLURIPOTENCY; INDUCTION; METHYLOME; LINEAGE; SOX17	Global DNA demethylation in humans is a fundamental process that occurs in pre-implantation embryos and reversion to naive ground state pluripotent stem cells (PSCs). However, the extent of DNA methylation reprogramming in human germline cells is unknown. Here, we performed whole-genome bisulfite sequencing (WGBS) and RNA-sequencing (RNA-seq) of human prenatal germline cells from 53 to 137 days of development. We discovered that the transcriptome and methylome of human germline is distinct from both human PSCs and the inner cell mass (ICM) of human blastocysts. Using this resource to monitor the outcome of global DNA demethylation with reversion of primed PSCs to the naive ground state, we uncovered hotspots of ultra-low methylation at transposons that are protected from demethylation in the germline and ICM. Taken together, the human germline serves as a valuable in vivo tool for monitoring the epigenome of cells that have emerged from a global DNA demethylation event.	[Gkountela, Sofia; Shafiq, Tiasha A.; Hargan-Calvopina, Joseph; Clark, Amander T.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Zhang, Kelvin X.; Clark, Amander T.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Clark, Amander T.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Clark, Amander T.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Clark, Amander T.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Liao, Wen-Wei; Chen, Pao-Yang] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Academia Sinica - Taiwan	Chen, PY (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	paoyang@gate.sinica.edu.tw; clarka@ucla.edu	Chen, Pao-Yang/ABG-9939-2020	Chen, Pao-Yang/0000-0002-7402-3075; Liao, Wen-Wei/0000-0001-8183-213X	NIH [NIH/NICHD HD058047, NIH/NICHD HD079546]; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; Academia Sinica; National Health Research Institutes, Taiwan [NHR-IEXI03-10324SC]; California Institute for Regenerative Medicine (CIRM) [TG2-01169]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058047, R01HD079546] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; Academia Sinica(Academia Sinica - Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank the UCLA BSCRC flow cytometry core for flow and FACS assistance and BSCRC High Throughput Sequencing core. This work was supported by grants from the NIH (NIH/NICHD HD058047 and NIH/NICHD HD079546) awarded to A.T.C., as well as the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and by grants from Academia Sinica and National Health Research Institutes, Taiwan (NHR-IEXI03-10324SC) to P.-Y.C. We would also like to acknowledge the support of the California Institute for Regenerative Medicine (CIRM) Predoctoral training grant (TG2-01169) for funding J.H.-C.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aramaki S, 2013, DEV CELL, V27, P516, DOI 10.1016/j.devcel.2013.11.001; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen PY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r62; Choi EY, 2012, STEM CELLS, V30, P2297, DOI 10.1002/stem.1192; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Ficz G, 2013, CELL STEM CELL, V13, P351, DOI 10.1016/j.stem.2013.06.004; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gkountela S, 2013, NAT CELL BIOL, V15, P113, DOI 10.1038/ncb2638; Goke J, 2015, CELL STEM CELL, V16, P135, DOI 10.1016/j.stem.2015.01.005; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Guo WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-774; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hajkova P, 2011, PHILOS T R SOC B, V366, P2266, DOI 10.1098/rstb.2011.0042; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Kobayashi H, 2013, GENOME RES, V23, P616, DOI 10.1101/gr.148023.112; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Nakajima-Takagi Y, 2013, BLOOD, V121, P447, DOI 10.1182/blood-2012-05-431403; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Rebollo R, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R89, 10.1186/gb-2012-13-10-r89]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Valamehr B, 2014, STEM CELL REP, V2, P366, DOI 10.1016/j.stemcr.2014.01.014; Vincent JJ, 2013, CELL STEM CELL, V12, P470, DOI 10.1016/j.stem.2013.01.016; Walser JC, 2008, GENOME RES, V18, P1403, DOI 10.1101/gr.076455.108; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Yamaguchi S, 2013, CELL RES, V23, P329, DOI 10.1038/cr.2013.22; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660	42	225	232	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1425	1436		10.1016/j.cell.2015.05.012	http://dx.doi.org/10.1016/j.cell.2015.05.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26004067	Green Accepted, Bronze			2022-12-28	WOS:000355935000020
J	Rehm, HL; Berg, JS; Brooks, LD; Bustamante, CD; Evans, JP; Landrum, MJ; Ledbetter, DH; Maglott, DR; Martin, CL; Nussbaum, RL; Plon, SE; Ramos, EM; Sherry, ST; Watson, MS				Rehm, Heidi L.; Berg, Jonathan S.; Brooks, Lisa D.; Bustamante, Carlos D.; Evans, James P.; Landrum, Melissa J.; Ledbetter, David H.; Maglott, Donna R.; Martin, Christa Lese; Nussbaum, Robert L.; Plon, Sharon E.; Ramos, Erin M.; Sherry, Stephen T.; Watson, Michael S.		ClinGen	ClinGen - The Clinical Genome Resource	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN-COLLEGE; GENETIC-VARIANTS; MEDICAL GENETICS; ASSOCIATION; GUIDELINES; STANDARDS; PHENOTYPE	On autopsy, a patient is found to have hypertrophic cardiomyopathy. The patient's family pursues genetic testing that shows a "likely pathogenic" variant for the condition on the basis of a study in an original research publication. Given the dominant inheritance of the condition and the risk of sudden cardiac death, other family members are tested for the genetic variant to determine their risk. Several family members test negative and are told that they are not at risk for hypertrophic cardiomyopathy and sudden cardiac death, and those who test positive are told that they need to be regularly monitored for cardiomyopathy on echocardiography. Five years later, during a routine clinic visit of one of the genotype-positive family members, the cardiologist queries a database for current knowledge on the genetic variant and discovers that the variant is now interpreted as "likely benign" by another laboratory that uses more recently derived population-frequency data. A newly available testing panel for additional genes that are implicated in hypertrophic cardiomyopathy is initiated on an affected family member, and a different variant is found that is determined to be pathogenic. Family members are retested, and one member who previously tested negative is now found to be positive for this new variant. An immediate clinical workup detects evidence of cardiomyopathy, and an intracardiac defibrillator is implanted to reduce the risk of sudden cardiac death.	[Rehm, Heidi L.] Harvard Univ, Sch Med, Boston, MA USA; [Rehm, Heidi L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Rehm, Heidi L.] Partners HealthCare, Boston, MA USA; [Berg, Jonathan S.; Evans, James P.] Univ N Carolina, Chapel Hill, NC USA; [Brooks, Lisa D.; Ramos, Erin M.] NHGRI, NIH, Bethesda, MD 20892 USA; [Landrum, Melissa J.; Maglott, Donna R.; Sherry, Stephen T.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Watson, Michael S.] Amer Coll Med Genet & Genom, Bethesda, MD USA; [Bustamante, Carlos D.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Nussbaum, Robert L.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Ledbetter, David H.; Martin, Christa Lese] Geisinger Hlth Syst, Danville, PA USA; [Plon, Sharon E.] Baylor Coll Med, Houston, TX 77030 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Partners Healthcare System; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Stanford University; University of California System; University of California San Francisco; Geisinger Health System; Baylor College of Medicine	Rehm, HL (corresponding author), Partners HealthCare Personalized Med, Mol Med Lab, 65 Landsdowne St, Cambridge, MA 02139 USA.	hrehm@partners.org	Strande, Natasha T./H-9894-2019; Ingles, Jodie/J-3113-2019; Relling, Mary/N-5032-2018; Taylor, Casey Overby/V-1271-2018; De Backer, Julie/B-2897-2014	Strande, Natasha T./0000-0001-5148-9772; Ingles, Jodie/0000-0002-4846-7676; Taylor, Casey Overby/0000-0001-9302-5968; De Backer, Julie/0000-0001-8878-1507; McGarvey, Peter/0000-0002-8312-6017; Schloss, Jeffery/0000-0003-4646-3652; novelli, valeria/0000-0002-4859-0826; Sirota, Marina/0000-0002-7246-6083; Montgomery, Stephen/0000-0002-5200-3903; Klein, Teri/0000-0001-5527-6475; Bustamante, Carlos D./0000-0002-4187-7920; Hershberger, Ray/0000-0001-5683-6526; Lebo, Matthew/0000-0002-9733-5207; Berg, Jonathan/0000-0003-2360-2664; Serrano, Moises/0000-0002-1037-9304; Irving, Stephanie/0000-0001-7437-6797; Rehm, Heidi L./0000-0002-6025-0015; Eilbeck, Karen/0000-0002-0831-6427; Coughlin II, Curtis/0000-0002-3545-7903; Ormond, Kelly/0000-0002-1033-0818; Sherry, Stephen/0000-0002-7982-076X	National Human Genome Research Institute; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute [U41 HG006834, U01 HG007436, U01 HG007437, HHSN261200800001E]; Intramural Research Program of the NIH, National Library of Medicine; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006834, U41HG009650, U01HG007437, U01HG007436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007124, ZIHLM200888] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, National Library of Medicine; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	ClinGen is funded by the National Human Genome Research Institute, with additional funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Cancer Institute (U41 HG006834, U01 HG007436, U01 HG007437, HHSN261200800001E). ClinVar is supported by the Intramural Research Program of the NIH, National Library of Medicine.	1000 Genomes Project, 1000 GEN DEEP CAT HU; Andreasen C, 2013, EUR J HUM GENET, V21, P918, DOI 10.1038/ejhg.2012.283; Aronson SJ, 2012, GENET MED, V14, P713, DOI 10.1038/gim.2012.19; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Berg JS, 2013, GENET MED, V15, P36, DOI 10.1038/gim.2012.112; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; den Dunnen JT, 2009, HUM MUTAT, V30, P493, DOI 10.1002/humu.20977; Food and Drug Administration, 2015, OPT FDAS REG OV NEXT; Gersh BJ, 2011, J AM COLL CARDIOL, V58, P2703, DOI 10.1016/j.jacc.2011.10.825; Girdea M, 2013, HUM MUTAT, V34, P1057, DOI 10.1002/humu.22347; Hamosh A, 2013, HUM MUTAT, V34, P566, DOI 10.1002/humu.22283; Hindorff LA, CATALOG PUBLISHED GE; Human Genome Variation Society, 2013, NOM DESCR SEQ VAR; Kearney HM, 2011, GENET MED, V13, P680, DOI 10.1097/GIM.0b013e3182217a3a; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; McKusick-Nathans Institute of Genetic Medicine Johns Hopkins Medicine, ONL MEND INH MAN OMI; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; National Cancer Institute, CANC GEN ATL; National Research Council, 2003, SHAR PUBL REL DAT MA; Paltoo DN, 2014, NAT GENET, V46, P934, DOI 10.1038/ng.3062; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Thompson BA, 2014, NAT GENET, V46, P107, DOI 10.1038/ng.2854; Thorn Caroline F, 2013, Methods Mol Biol, V1015, P311, DOI 10.1007/978-1-62703-435-7_20	25	642	660	0	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2015	372	23					2235	2242		10.1056/NEJMsr1406261	http://dx.doi.org/10.1056/NEJMsr1406261			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1GK	26014595	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000355955100013
J	Hutton, B; Salanti, G; Caldwell, DM; Chaimani, A; Schmid, CH; Cameron, C; Ioannidis, JPA; Straus, S; Thorlund, K; Jansen, JP; Mulrow, C; Catala-Lopez, F; Gotzsche, PC; Dickersin, K; Boutron, I; Altman, DG; Moher, D				Hutton, Brian; Salanti, Georgia; Caldwell, Deborah M.; Chaimani, Anna; Schmid, Christopher H.; Cameron, Chris; Ioannidis, John P. A.; Straus, Sharon; Thorlund, Kristian; Jansen, Jeroen P.; Mulrow, Cynthia; Catala-Lopez, Ferran; Gotzsche, Peter C.; Dickersin, Kay; Boutron, Isabelle; Altman, Douglas G.; Moher, David			The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations	ANNALS OF INTERNAL MEDICINE			English	Article							MIXED TREATMENT COMPARISONS; ISPOR TASK-FORCE; DECISION-MAKING; MULTIPLE-TREATMENTS; INCONSISTENCY; TRIALS; CONSISTENCY; GUIDELINES; PAIRWISE; MODELS	The PRISMA statement is a reporting guideline designed to improve the completeness of reporting of systematic reviews and meta-analyses. Authors have used this guideline worldwide to prepare their reviews for publication. In the past, these reports typically compared 2 treatment alternatives: With the evolution of systematic reviews that compare multiple treatments, some of them only indirectly, authors face novel challenges for conducting and reporting their reviews. This extension of the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) statement was developed specifically to improve the reporting of systematic reviews incorporating network meta-analyses. A group of experts participated in a systematic review, Delphi survey, and face-to-face discussion and consensus meeting to establish new checklist items for this extension statement. Cur-rent PRISMA items were also clarified. A modified, 32-item PRISMA extension checklist was developed to address what the group considered to be immediately relevant to the reporting of network meta-analyses. This document presents the extension and provides examples of good reporting, as well as elaborations regarding the rationale for new checklist items and the modification of previously existing items from the PRISMA statement. It also highlights educational information related to key considerations in the practice of network meta-analysis. The target audience includes authors and readers of network meta-analyses, as well as journal editors and peer reviewers.	Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; Univ Ioannina, GR-45110 Ioannina, Greece; Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; Brown Univ, Ctr Evidence Based Med, Sch Publ Hlth, Providence, RI 02912 USA; Stanford Univ, Metares Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA; St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; Univ Toronto, Toronto, ON, Canada; McMaster Univ, Hamilton, ON, Canada; Tufts Univ, Sch Med, Boston, MA 02111 USA; Amer Coll Physicians, Philadelphia, PA USA; Spanish Med & Healthcare Prod Agcy, Madrid, Spain; Nord Cochrane Ctr, Copenhagen, Denmark; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Univ Paris 05, INSERM, Paris, France; Ctr Stat Med, Oxford, England; Univ Oxford, Oxford, England	University of Ottawa; Ottawa Hospital Research Institute; University of Ioannina; University of Bristol; Brown University; Stanford University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; McMaster University; Tufts University; American College of Physicians; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oxford; University of Oxford	Hutton, B (corresponding author), Ottawa Hosp, Res Inst, Ctr Practice Changing Res, Ottawa Hosp Gen Campus,501 Smyth Rd,POB 201B, Ottawa, ON K1H 8L6, Canada.	bhutton@ohri.ca	Schmid, Christopher H./J-2398-2014; Chaimani, Anna/AAA-3048-2020; Ioannidis, John P. A./G-9836-2011; Moher, David/I-3408-2019; Catalá-López, Ferrán/N-6018-2018	Schmid, Christopher H./0000-0002-0855-5313; Chaimani, Anna/0000-0003-2828-6832; Moher, David/0000-0003-2434-4206; Catalá-López, Ferrán/0000-0002-3833-9312; , Deborah/0000-0001-8014-7480; Boutron, Isabelle/0000-0002-5263-6241; Salanti, Georgia/0000-0002-3830-8508; Hutton, Brian/0000-0001-5662-8647; Jansen, Jeroen Paul/0000-0003-2686-9217	Canadian Agency for Drugs and Technologies in Health; Pfizer Canada; Canadian Institutes of Health Research; Drug Safety and Effectiveness Network; Medical Research Council Population Health Science Fellowship [G0902118]; Vanier Canada Graduate Scholarship from the Canadian Institutes of Health Research [CGV 121171]; Canadian Institutes of Health Research Drug Safety and Effectiveness Network team grant [116573]; Laura and John Arnold Foundation; MRC [G0902118, MR/K023233/1] Funding Source: UKRI; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MR/K023233/1, G0902118] Funding Source: researchfish	Canadian Agency for Drugs and Technologies in Health; Pfizer Canada(Pfizer); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Drug Safety and Effectiveness Network; Medical Research Council Population Health Science Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Vanier Canada Graduate Scholarship from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research Drug Safety and Effectiveness Network team grant(Canadian Institutes of Health Research (CIHR)); Laura and John Arnold Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	By the Canadian Agency for Drugs and Technologies in Health and Pfizer Canada for the development of this work. Dr. Hutton is supported by a New Investigator Award from the Canadian Institutes of Health Research and the Drug Safety and Effectiveness Network. Dr. Caldwell is supported by a Medical Research Council Population Health Science Fellowship award (G0902118). Mr. Cameron is a recipient of a Vanier Canada Graduate Scholarship from the Canadian Institutes of Health Research (funding reference number CGV 121171) and is a trainee on the Canadian Institutes of Health Research Drug Safety and Effectiveness Network team grant (funding reference number 116573). The Meta-Research Innovation Center at Stanford (METRICS) is funded by a grant from the Laura and John Arnold Foundation.	Achana FA, 2013, STAT MED, V32, P752, DOI 10.1002/sim.5539; Ades AE, 2012, 7 DSU NAT I HLTH CAR; [Anonymous], 2010, VALUE HEALTH, DOI DOI 10.1111/J.1524-4733; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Chaimani A, 2012, RES SYNTH METHODS, V3, P161, DOI 10.1002/jrsm.57; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Cooper NJ, 2009, STAT MED, V28, P1861, DOI 10.1002/sim.3594; Del Giovane C, 2013, STAT MED, V32, P25, DOI 10.1002/sim.5512; Dias S, 2010, J R STAT SOC A STAT, V173, P613, DOI 10.1111/j.1467-985X.2010.00639.x; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2013, MED DECIS MAKING, V33, P618, DOI 10.1177/0272989X13485157; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Donegan S, 2013, RES SYNTH METHODS, V4, P291, DOI 10.1002/jrsm.1085; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Hutton B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092508; Ioannidis JPA, 2009, CAN MED ASSOC J, V181, P488, DOI 10.1503/cmaj.081086; Jackson D, 2014, STAT MED, V33, P3639, DOI 10.1002/sim.6188; Jansen JP, 2014, VALUE HEALTH, V17, P157, DOI 10.1016/j.jval.2014.01.004; Jansen JP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-159; Jansen JP, 2012, RES SYNTH METHODS, V3, P177, DOI 10.1002/jrsm.1048; Jansen JP, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-152; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Jones B, 2011, PHARM STAT, V10, P523, DOI 10.1002/pst.533; Lee AW, 2014, J CLIN EPIDEMIOL, V67, P138, DOI 10.1016/j.jclinepi.2013.07.014; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lindsley K, 2013, 21 COCHR C QUEB CAN; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; Lu GB, 2009, BIOSTATISTICS, V10, P792, DOI 10.1093/biostatistics/kxp032; Mills EJ, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5195; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Mills Edward J, 2011, Clin Epidemiol, V3, P193, DOI 10.2147/CLEP.S16526; Moher D, 2011, J CLIN EPIDEMIOL, V64, P718, DOI 10.1016/j.jclinepi.2010.09.013; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nikolakopoulou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086754; Panic N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083138; Salanti G, 2008, ANN INTERN MED, V148, P544, DOI 10.7326/0003-4819-148-7-200804010-00011; Salanti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099682; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Salanti G, 2010, STAT MED, V29, P2369, DOI 10.1002/sim.4001; Salanti G, 2009, J CLIN EPIDEMIOL, V62, P857, DOI 10.1016/j.jclinepi.2008.10.001; Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x; Sutton A, 2008, PHARMACOECONOMICS, V26, P753, DOI 10.2165/00019053-200826090-00006; Thorlund K, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-2; Thorlund K, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-41; Thorlund Kristian, 2012, Clin Epidemiol, V4, P75, DOI 10.2147/CLEP.S29470; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; Welch V, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001333; Wen J, 2008, J CLIN EPIDEMIOL, V61, P770, DOI 10.1016/j.jclinepi.2007.10.008; Woods BS, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-54	58	3101	3149	22	134	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2015	162	11					777	784		10.7326/M14-2385	http://dx.doi.org/10.7326/M14-2385			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ5ZH	26030634				2022-12-28	WOS:000355572300005
J	Bhandari, N				Bhandari, Neena			TRADITIONAL MEDICINE Is ayurveda the key to universal healthcare in India?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DOUBLE-BLIND					neena@india-voice.com						Central Council of Indian Medicine, 2012, NOT; Central Council of Indian Medicine, 2012, MIN STAND ED IND MED; Chopra A, 2013, RHEUMATOLOGY, V52, P1408, DOI 10.1093/rheumatology/kes414; Furst DE, 2011, JCR-J CLIN RHEUMATOL, V17, P185, DOI 10.1097/RHU.0b013e31821c0310; Johns Hopkins Medicine, AYURV; Ministry of Health and Family Welfare, 2014, NAT HLTH POL DRAFT 2; Narahari SR, 2013, T ROY SOC TROP MED H, V107, P566, DOI 10.1093/trstmh/trt054; University of Maryland Medical Center, AYURVEDA; WHO, 2014, WHO TRADITIONAL MED, P1	9	6	6	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2015	350								h2879	10.1136/bmj.h2879	http://dx.doi.org/10.1136/bmj.h2879			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ5UP	26022091				2022-12-28	WOS:000355557100006
J	Lane, R				Lane, Richard			Ana Langer: global leader in women's health Profile	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2015	386	9999					1127	1127		10.1016/S0140-6736(15)60727-9	http://dx.doi.org/10.1016/S0140-6736(15)60727-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR5GE	26051366				2022-12-28	WOS:000361368000014
J	Kehoe, S; Hook, J; Nankivell, M; Jayson, GC; Kitchener, H; Lopes, T; Luesley, D; Perren, T; Bannoo, S; Mascarenhas, M; Dobbs, S; Essapen, S; Twigg, J; Herod, J; McCluggage, G; Parmar, M; Swart, AM				Kehoe, Sean; Hook, Jane; Nankivell, Matthew; Jayson, Gordon C.; Kitchener, Henry; Lopes, Tito; Luesley, David; Perren, Timothy; Bannoo, Selina; Mascarenhas, Monica; Dobbs, Stephen; Essapen, Sharadah; Twigg, Jeremy; Herod, Jonathan; McCluggage, Glenn; Parmar, Mahesh; Swart, Ann-Marie			Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial	LANCET			English	Article							PRIMARY CYTOREDUCTIVE SURGERY; NEOADJUVANT CHEMOTHERAPY; SURGICAL CYTOREDUCTION; DEBULKING SURGERY; SURVIVAL; MULTICENTER; GUIDELINES; MORTALITY; CARCINOMA	Background The international standard of care for women with suspected advanced ovarian cancer is surgical debulking followed by platinum-based chemotherapy. We aimed to establish whether use of platinum-based primary chemotherapy followed by delayed surgery was an effective and safe alternative treatment regimen. Methods In this phase 3, non-inferiority, randomised, controlled trial (CHORUS) undertaken in 87 hospitals in the UK and New Zealand, we enrolled women with suspected stage III or IV ovarian cancer. We randomly assigned women (1: 1) either to undergo primary surgery followed by six cycles of chemotherapy, or to three cycles of primary chemotherapy, then surgery, followed by three more cycles of completion chemotherapy. Each 3-week cycle consisted of carboplatin AUC5 or AUC6 plus paclitaxel 175 mg/m(2), or an alternative carboplatin combination regimen, or carboplatin monotherapy. We did the random assignment by use of a minimisation method with a random element, and stratified participants according to the randomising centre, largest radiological tumour size, clinical stage, and prespecified chemotherapy regimen. Patients and investigators were not masked to group assignment. The primary outcome measure was overall survival. Primary analyses were done in the intention-to-treat population. To establish non-inferiority, the upper bound of a one-sided 90% CI for the hazard ratio (HR) had to be less than 1.18. This trial is registered, number ISRCTN74802813, and is closed to new participants. Findings Between March 1, 2004, and Aug 30, 2010, we randomly assigned 552 women to treatment. Of the 550 women who were eligible, 276 were assigned to primary surgery and 274 to primary chemotherapy. All were included in the intention-to-treat analysis; 251 assigned to primary surgery and 253 to primary chemotherapy were included in the per-protocol analysis. As of May 31, 2014, 451 deaths had occurred: 231 in the primary-surgery group versus 220 in the primary-chemotherapy group. Median overall survival was 22.6 months in the primary-surgery group versus 24.1 months in primary chemotherapy. The HR for death was 0.87 in favour of primary chemotherapy, with the upper bound of the one-sided 90% CI 0.98 (95% CI 0.72-1.05). Grade 3 or 4 postoperative adverse events and deaths within 28 days after surgery were more common in the primary-surgery group than in the primary-chemotherapy group (60 [24%] of 252 women vs 30 [14%] of 209, p=0.0007, and 14 women [6%] vs 1 woman [<1%], p=0.001). The most common grade 3 or 4 postoperative adverse event was haemorrhage in both groups (8 women [3%] in the primary-surgery group vs 14 [6%] in the primary-chemotherapy group). 110 (49%) of 225 women receiving primary surgery and 102 (40%) of 253 receiving primary chemotherapy had a grade 3 or 4 chemotherapy related toxic effect (p=0.0654), mostly uncomplicated neutropenia (20% and 16%, respectively). One fatal toxic effect, neutropenic sepsis, occurred in the primary-chemotherapy group. Interpretation In women with stage III or IV ovarian cancer, survival with primary chemotherapy is non-inferior to primary surgery. In this study population, giving primary chemotherapy before surgery is an acceptable standard of care for women with advanced ovarian cancer.	[Kehoe, Sean] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England; [Hook, Jane; Nankivell, Matthew; Bannoo, Selina; Mascarenhas, Monica; Parmar, Mahesh; Swart, Ann-Marie] UCL, MRC, Clin Trials Unit, London WC2B 6NH, England; [Jayson, Gordon C.] Christie Hosp, Dept Med Oncol, Manchester, Lancs, England; [Jayson, Gordon C.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Kitchener, Henry] Univ Manchester, Inst Canc Sci, Manchester, Lancs, England; [Lopes, Tito] Royal Cornwall NHS Trust, Truro, England; [Luesley, David] City Hosp, Pan Birmingham Gynaecol Canc Ctr, Birmingham, W Midlands, England; [Perren, Timothy] St James Univ Hosp, Inst Oncol, Leeds, W Yorkshire, England; [Dobbs, Stephen] Belfast City Hosp, Dept Gynaecol Oncol, Belfast BT9 7AD, Antrim, North Ireland; [Essapen, Sharadah] Royal Surrey Cty Hosp, St Lukes Canc Ctr, Guildford, Surrey, England; [Twigg, Jeremy] James Cook Univ Hosp, Middlesbrough, Cleveland, England; [Herod, Jonathan] Liverpool Womens Hosp, Dept Gynaecol, Liverpool, Merseyside, England; [McCluggage, Glenn] Belfast Hlth & Social Care Trust, Dept Pathol, Belfast, Antrim, North Ireland; [Swart, Ann-Marie] Univ E Anglia, Dept Med, Norwich NR4 7TJ, Norfolk, England	University of Birmingham; Medical Research Council Clinical Trials Unit; University of London; University College London; Christie NHS Foundation Trust; Christie Hospital; University of Manchester; University of Manchester; Royal Cornwall Hospital; University of Birmingham; Saint James's University Hospital; Belfast City Hospital; Royal Surrey County Hospital; James Cook University Hospital; University of Liverpool; University of East Anglia	Nankivell, M (corresponding author), UCL, MRC Clin Trials Unit, Inst Clin Trials & Methodol, Aviat House, London WC2B 6NH, England.	m.nankivell@ucl.ac.uk	de Barros Lopes, Alberto/B-2116-2018; Jayson, Gordon C/O-8224-2015; Perren, Timothy J/D-5387-2013	de Barros Lopes, Alberto/0000-0002-8796-3891; Jayson, Gordon C/0000-0002-8515-8944; Perren, Timothy J/0000-0001-8472-8856; Mascarenhas, Monica/0000-0002-4623-3147	Cancer Research UK; Royal College of Obstetricians and Gynaecologists; RCOG; core MRC CTU funding; MRC; Medical Research Council [MC_U122861379, MC_UU_12023/28, 1447122, MC_UU_12023/9] Funding Source: researchfish; MRC [MC_UU_12023/28, MC_U122861379, MC_UU_12023/9] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Royal College of Obstetricians and Gynaecologists; RCOG; core MRC CTU funding(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Cancer Research UK and the Royal College of Obstetricians and Gynaecologists.; Funding was provided by Cancer Research UK. Funding for a pilot phase of the trial was provided by the RCOG and supported by core MRC CTU funding. The trial sponsor was the MRC and the trial was conducted and analysed at the MRC CTU. We thank all the women and their families who agreed to participate in CHORUS, and the investigators and research staff at the trial centres and the MRC CTU.	Ang C, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007697.pub2; Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Bristow RE, 2006, GYNECOL ONCOL, V103, P1070, DOI 10.1016/j.ygyno.2006.06.025; Cancer Research UK, 2011, CANC STAT REP OV CAN; du Bois A, 2009, CANCER-AM CANCER SOC, V115, P1234, DOI 10.1002/cncr.24149; du Bois A, 2009, GYNECOL ONCOL, V112, P422, DOI 10.1016/j.ygyno.2008.09.036; Fayers P, 2001, EORTC QLQ C30 SCORIN, P86; Fayers PM, 2001, EUR J CANCER, V37, P1331, DOI 10.1016/S0959-8049(01)00127-7; Gerestein CG, 2009, GYNECOL ONCOL, V114, P523, DOI 10.1016/j.ygyno.2009.03.011; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; GRIFFITHS CT, 1975, NATL CANCER I MONOGR, P101; Hou JY, 2007, GYNECOL ONCOL, V105, P211, DOI 10.1016/j.ygyno.2006.11.025; Junor EJ, 1999, BRIT J OBSTET GYNAEC, V106, P1130, DOI 10.1111/j.1471-0528.1999.tb08137.x; Kang S, 2009, ANN SURG ONCOL, V16, P2315, DOI 10.1245/s10434-009-0558-6; Kehoe S, 2013, J CLIN ONCOL, V31; National Institute of Clinical Excellence, 2005, GUID US PACL TREATM; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Pignata S, 2014, LANCET ONCOL, V15, P396, DOI 10.1016/S1470-2045(14)70049-X; Polterauer S, 2012, INT J GYNECOL CANCER, V22, P380, DOI 10.1097/IGC.0b013e31823de6ae; Rose PG, 2004, NEW ENGL J MED, V351, P2489, DOI 10.1056/NEJMoa041125; Thrall MM, 2011, OBSTET GYNECOL, V118, P537, DOI 10.1097/AOG.0b013e31822a6d56; Trope C, 2006, EJSO-EUR J SURG ONC, V32, P844, DOI 10.1016/j.ejso.2006.03.036; VANDERBURG MEL, 1995, NEW ENGL J MED, V332, P629, DOI 10.1056/NEJM199503093321002; Vergote I, 1998, GYNECOL ONCOL, V71, P431, DOI 10.1006/gyno.1998.5213; Vergote I, 2000, J NATL CANCER I, V92, P1534, DOI 10.1093/jnci/92.18.1534; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; WHO, 1979, WHO HDB REP RES CANC; Winter WE, 2008, J CLIN ONCOL, V26, P83, DOI 10.1200/JCO.2007.13.1953; Winter WE, 2007, J CLIN ONCOL, V25, P3621, DOI 10.1200/JCO.2006.10.2517; YEDEMA CA, 1992, TUMOR BIOL, V13, P18, DOI 10.1159/000217748	33	763	799	5	65	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2015	386	9990					249	257		10.1016/S0140-6736(14)62223-6	http://dx.doi.org/10.1016/S0140-6736(14)62223-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN1XI	26002111				2022-12-28	WOS:000358213700029
J	Green, JB; Bethel, MA; Armstrong, PW; Buse, JB; Engel, SS; Garg, J; Josse, R; Kaufman, KD; Koglin, J; Korn, S; Lachin, JM; McGuire, DK; Pencina, MJ; Standl, E; Stein, PP; Suryawanshi, S; Van de Werf, F; Peterson, ED; Holman, RR				Green, Jennifer B.; Bethel, M. Angelyn; Armstrong, Paul W.; Buse, John B.; Engel, Samuel S.; Garg, Jyotsna; Josse, Robert; Kaufman, Keith D.; Koglin, Joerg; Korn, Scott; Lachin, John M.; McGuire, Darren K.; Pencina, Michael J.; Standl, Eberhard; Stein, Peter P.; Suryawanshi, Shailaja; Van de Werf, Frans; Peterson, Eric D.; Holman, Rury R.		TECOS Study Grp	Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLUCOSE-LOWERING DRUGS; STRATEGIES; TRIAL; RISK	BACKGROUND Data are lacking on the long-term effect on cardiovascular events of adding sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and cardiovascular disease. METHODS In this randomized, double-blind study, we assigned 14,671 patients to add either sitagliptin or placebo to their existing therapy. Open-label use of antihyperglycemic therapy was encouraged as required, aimed at reaching individually appropriate glycemic targets in all patients. To determine whether sitagliptin was noninferior to placebo, we used a relative risk of 1.3 as the marginal upper boundary. The primary cardiovascular outcome was a composite of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for unstable angina. RESULTS During a median follow-up of 3.0 years, there was a small difference in glycated hemoglobin levels (least-squares mean difference for sitagliptin vs. placebo, -0.29 percentage points; 95% confidence interval [CI], -0.32 to -0.27). Overall, the primary outcome occurred in 839 patients in the sitagliptin group (11.4%; 4.06 per 100 person-years) and 851 patients in the placebo group (11.6%; 4.17 per 100 person-years). Sitagliptin was noninferior to placebo for the primary composite cardiovascular outcome (hazard ratio, 0.98; 95% CI, 0.88 to 1.09; P<0.001). Rates of hospitalization for heart failure did not differ between the two groups (hazard ratio, 1.00; 95% CI, 0.83 to 1.20; P = 0.98). There were no significant between-group differences in rates of acute pancreatitis (P = 0.07) or pancreatic cancer (P = 0.32). CONCLUSIONS Among patients with type 2 diabetes and established cardiovascular disease, adding sitagliptin to usual care did not appear to increase the risk of major adverse cardiovascular events, hospitalization for heart failure, or other adverse events.	[Green, Jennifer B.; Garg, Jyotsna; Peterson, Eric D.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Buse, John B.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Bethel, M. Angelyn; Holman, Rury R.] Univ Oxford, Diabet Trials Unit, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Armstrong, Paul W.] Univ Alberta, Canadian VIGOUR Ctr, Edmonton, AB, Canada; [Josse, Robert] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada; [Engel, Samuel S.; Kaufman, Keith D.; Koglin, Joerg; Korn, Scott; Stein, Peter P.; Suryawanshi, Shailaja] Merck, Kenilworth, NJ USA; [Lachin, John M.] George Washington Univ, Biostat Ctr, Rockville, MD USA; [McGuire, Darren K.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Standl, Eberhard] Helm Holtz Ctr, Munich Diabet Res Grp, Neuherberg, Germany; [Van de Werf, Frans] Univ Leuven, Leuven, Belgium	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Oxford; University of Alberta; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Merck & Company; George Washington University; University of Texas System; University of Texas Southwestern Medical Center Dallas; KU Leuven	Holman, RR (corresponding author), Churchill Hosp, Diabet Trials Unit, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England.	rury.holman@dtu.ox.ac.uk	Hramiak, Irene/G-3305-2011; Pekarskiy, Stanislav/B-3631-2016; Skrha, Jan/C-3095-2017; Greiver, Michelle/N-8764-2015; Zadionchenko, Vladimir/A-7445-2016; Buse, John Bernard/J-9742-2019; Urina-Triana, Miguel A/H-2605-2016; McGuire, Darren K./AAL-4172-2021; Couffinhal, Thierry/M-6857-2014; Dalan, Rinkoo/C-1099-2019; Carmen, Team2/Y-7383-2019; Gerstein, Hertzel/ABB-8781-2020; Morales, Cristobal/T-5071-2019; Peterson, Eric David/ABF-5033-2021; Mondillo, Sergio/Q-9354-2018; Mustafina, Svetlana/Q-9286-2017	Pekarskiy, Stanislav/0000-0002-4008-4021; Skrha, Jan/0000-0001-8012-8802; Greiver, Michelle/0000-0001-8957-0285; Zadionchenko, Vladimir/0000-0003-2377-5266; Buse, John Bernard/0000-0002-9723-3876; Urina-Triana, Miguel A/0000-0001-6003-4622; Couffinhal, Thierry/0000-0002-9217-2533; Dalan, Rinkoo/0000-0001-9769-2696; Carmen, Team2/0000-0001-9867-5724; Gerstein, Hertzel/0000-0001-8072-2836; Morales, Cristobal/0000-0003-0348-826X; Mondillo, Sergio/0000-0002-5490-2769; Lab, Carmen/0000-0002-5935-3236; YOO, SOON JIB/0000-0002-9932-4130; Armstrong, Paul/0000-0002-0460-3445; Lanas, Fernando/0000-0003-3595-9759; Sgarbi, Jose/0000-0001-7187-984X; Tinahones, Francisco J/0000-0001-6871-4403; Keymeulen, Bart/0000-0002-8671-4527; S, Paramesh/0000-0002-0693-4483; Ceponis, Jonas/0000-0003-4261-5014; Lachin, John/0000-0001-9838-2841; Kietselaer, Bas/0000-0002-0096-8594; Fosbol, Emil/0000-0002-2048-4167; DEMIN, Aleksandr/0000-0003-1052-1451; Mustafina, Svetlana/0000-0003-4716-876X; Jaap, Alan/0000-0001-8289-704X; Valeeva, Farida/0000-0001-6000-8002; Lindsay, Robert/0000-0002-9868-5217; Ohlow, Marc-Alexander/0000-0001-9674-2129	Merck Sharp Dohme - Merck	Merck Sharp Dohme - Merck(Merck & Company)	Supported by Merck Sharp & Dohme, a subsidiary of Merck.	[Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; [Anonymous], 2010, GUID CLIN INV MED PR; [Anonymous], 2008, GUID IND DIAB MELL E; Bethel MA, 2015, DIABETES OBES METAB, V17, P395, DOI 10.1111/dom.12441; Clifton P, 2014, CLIN THER, V36, P2072, DOI 10.1016/j.clinthera.2014.10.009; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; Egan AG, 2014, NEW ENGL J MED, V370, P794, DOI 10.1056/NEJMp1314078; Green JB, 2013, AM HEART J, V166, P983, DOI 10.1016/j.ahj.2013.09.003; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2014, LANCET, V383, P2008, DOI 10.1016/S0140-6736(14)60794-7; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Robins JM, 2000, BIOMETRICS, V56, P779, DOI 10.1111/j.0006-341X.2000.00779.x; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Udell JA, 2015, LANCET DIABETES ENDO, V3, P356, DOI 10.1016/S2213-8587(15)00044-3; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Zannad F, 2015, LANCET, V385, P2067, DOI 10.1016/S0140-6736(14)62225-X	17	1770	1847	4	178	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2015	373	3					232	242		10.1056/NEJMoa1501352	http://dx.doi.org/10.1056/NEJMoa1501352			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MS	26052984	Green Published			2022-12-28	WOS:000357956200006
J	Overton, ET; Chan, ES; Brown, TT; Tebas, P; McComsey, GA; Melbourne, KM; Napoli, A; Hardin, WR; Ribaudo, HJ; Yin, MT				Overton, Edgar Turner; Chan, Ellen S.; Brown, Todd T.; Tebas, Pablo; McComsey, Grace A.; Melbourne, Kathleen M.; Napoli, Andrew; Hardin, William Royce; Ribaudo, Heather J.; Yin, Michael T.			Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							TREATED HIV-INFECTION; PLACEBO-CONTROLLED TRIAL; MINERAL DENSITY; D DEFICIENCY; ABACAVIR-LAMIVUDINE; D SUPPLEMENTATION; NAIVE PATIENTS; TENOFOVIR DF; EFAVIRENZ; EMTRICITABINE	Background: Antiretroviral therapy initiation for HIV-1 infection is associated with 2% to 6% loss of bone mineral density (BMD). Objective: To evaluate the effect of vitamin D-3 plus calcium supplementation on bone loss associated with antiretroviral therapy initiation. Design: 48-week prospective, randomized, double-blind, placebo-controlled study. (ClinicalTrials.gov: NCT01403051) Setting: 39 AIDS Clinical Trials Group units. Patients: Adults with antiretroviral therapy-naive HIV. Measurements: BMD by dual-energy x-ray absorptiometry, 25-hydroxyvitamin D levels, and other laboratory assessments. Results: 165 eligible patients were randomly assigned (79 received vitamin D-3 plus calcium and 86 received placebo). The study groups were well-balanced at baseline: 90% were men, 33% were non-Hispanic black, and the median CD4 count was 0.341 x 10(9) cells/L. At 48 weeks, the percentage of decline in total hip BMD was smaller in the vitamin D-3 plus calcium group than in the placebo group: Medians were -1.36% (interquartile range [IQR], -3.43% to 0.50%) and -3.22% (IQR, -5.56% to -0.88%), respectively (P = 0.004). Similar results were seen at the lumbar spine. At 48 weeks, 90% of patients achieved HIV-1 RNA levels less than 50 copies/mL. Levels of 25-hydroxyvitamin D-3 increased with vitamin D-3 plus calcium but not with placebo: Median change was 61.2 nmol/L (IQR, 36.4 to 94.3) versus 1.7 nmol/L (IQR, -13.2 to 10.7) (P < 0.001). Overall, 103 patients (62%) reported 1 or more adverse event, with similar distribution between groups; no cases of hypercalcemia and 1 case of nephrolithiasis were reported in the placebo group. Limitation: No international sites were included, and follow-up was only 48 weeks. Conclusion: Vitamin D-3 plus calcium supplementation mitigates the BMD loss seen with initiation of efavirenz/emtricitabine/tenofovir disoproxil fumarate.	[Overton, Edgar Turner] Univ Alabama Birmingham, Sch Med, Div Infect Dis, Birmingham, AL 35213 USA; [Chan, Ellen S.; Ribaudo, Heather J.] Harvard Univ, Sch Publ Hlth, Stat & Data Anal Ctr, Boston, MA 02115 USA; [Brown, Todd T.] Johns Hopkins Univ, Div Endocrinol & Metab, Baltimore, MD 21287 USA; [Tebas, Pablo] Univ Penn, Div Infect Dis, Philadelphia, PA 19104 USA; [McComsey, Grace A.] Case Western Reserve Univ, Div Infect Dis, Cleveland, OH 44106 USA; [Melbourne, Kathleen M.] Gilead Sci Inc, Warwick, RI 02889 USA; [Napoli, Andrew] Bristol Myers Squibb Co, Plainsboro, NJ 08536 USA; [Hardin, William Royce] Duke Univ, Community Advisory Board, Durham, NC 27705 USA; [Yin, Michael T.] Columbia Univ, Div Infect Dis, Med Ctr, New York, NY 10032 USA	University of Alabama System; University of Alabama Birmingham; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; University of Pennsylvania; Case Western Reserve University; Gilead Sciences; Bristol-Myers Squibb; Duke University; Columbia University	Overton, ET (corresponding author), Univ Alabama Birmingham, Sch Med, 908 20th St South,CCB RM 330A, Birmingham, AL 35213 USA.	toverton@uab.edu		Yin, Michael T/0000-0002-9346-9056; Tebas, Pablo/0000-0001-5345-7942; Overton, Edgar/0000-0002-4013-536X	National Institute of Allergy and Infectious Diseases [U01AI068636]; Bristol-Myers Squibb; Gilead; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069534, U01AI069452, K24AI120834, U01AI068636, UM1AI068634, UM1AI069470, P30AI045008] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grant Support: By the National Institute of Allergy and Infectious Diseases (award number U01AI068636). Bristol-Myers Squibb and Gilead funded the DXA scans and ancillary laboratory testing. Study medications were provided by Bristol-Myers Squibb, Gilead Sciences, and Tishcon.	Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Aloia JF, 2013, J CLIN ENDOCR METAB, V98, pE1702, DOI 10.1210/jc.2013-2121; Beard JA, 2011, J CLIN VIROL, V50, P194, DOI 10.1016/j.jcv.2010.12.006; Bedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192ae; Bolland MJ, 2007, J CLIN ENDOCR METAB, V92, P4522, DOI 10.1210/jc.2007-1660; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Brown TT, 2011, ANTIVIR THER, V16, P1063, DOI 10.3851/IMP1874; Brown TT, 2010, ANTIVIR THER, V15, P425, DOI [10.3851/IMP1502, 10.3851/IMP15021]; Cotter AG, 2014, CURR OPIN HIV AIDS, V9, P17, DOI 10.1097/COH.0000000000000028; Duvivier C, 2009, AIDS, V23, P817, DOI 10.1097/QAD.0b013e328328f789; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Grant PM, 2013, CLIN INFECT DIS, V57, P1483, DOI 10.1093/cid/cit538; Hansen ABE, 2012, AIDS, V26, P285, DOI 10.1097/QAD.0b013e32834ed8a7; Hathcock JN, 2007, AM J CLIN NUTR, V85, P6, DOI 10.1093/ajcn/85.1.6; Havens PL, 2013, ANTIMICROB AGENTS CH, V57, P5619, DOI 10.1128/AAC.01096-13; Havens PL, 2012, CLIN INFECT DIS, V54, P1013, DOI 10.1093/cid/cir968; Hernandez-Vallejo SJ, 2013, AGING CELL, V12, P955, DOI 10.1111/acel.12119; Jeng L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-28; Jones G, 2014, J LIPID RES, V55, P13, DOI 10.1194/jlr.R031534; Kaplan RC, 2011, ATHEROSCLEROSIS, V217, P207, DOI 10.1016/j.atherosclerosis.2011.03.011; Kelesidis T, 2012, J INFECT DIS, V206, P1558, DOI 10.1093/infdis/jis545; Khoo AL, 2012, CRIT REV MICROBIOL, V38, P122, DOI 10.3109/1040841X.2011.622716; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Kumar A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/484378; Lang C.-L., 2014, ISRN Endocrinol, V2014, P1, DOI [DOI 10.1155/2014/105456, 10.1155/2014/105456]; Lederman MM, 2013, ADV IMMUNOL, V119, P51, DOI 10.1016/B978-0-12-407707-2.00002-3; Liu AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023688; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Longenecker CT, 2014, AIDS, V28, P969, DOI 10.1097/QAD.0000000000000158; Longenecker CT, 2012, ANTIVIR THER, V17, P613, DOI 10.3851/IMP1983; McComsey GA, 2012, AIDS, V26, P1371, DOI 10.1097/QAD.0b013e328354f4fb; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; McComsey GA, 2010, CLIN INFECT DIS, V51, P937, DOI 10.1086/656412; Mitka M, 2009, JAMA-J AM MED ASSOC, V302, P2527, DOI 10.1001/jama.2009.1788; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Recker R, 2000, J BONE MINER RES, V15, P1965, DOI 10.1359/jbmr.2000.15.10.1965; Rosenvinge MM, 2010, JAIDS-J ACQ IMM DEF, V54, P496, DOI 10.1097/QAI.0b013e3181caebaa; Siberry GK, 2014, TOPICS ANTIVIRAL MED, V22, P35; Standing Committee on the Scientific Evaluation of Dietary Reference Intakes FNB Institute of Medicine, 1997, DIET REF INT CALC PH; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; Tebas P, 2000, AIDS, V14, pF63, DOI 10.1097/00002030-200003100-00005; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Vieth R, 2007, AM J CLIN NUTR, V85, P649, DOI 10.1093/ajcn/85.3.649; Vikulina T, 2010, P NATL ACAD SCI USA, V107, P13848, DOI 10.1073/pnas.1003020107; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; Welz T, 2010, AIDS, V24, P1923, DOI 10.1097/QAD.0b013e32833c3281; Wohl DA, 2014, ANTIVIR THER, V19, P191, DOI 10.3851/IMP2721; Womack JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017217; Yin MT, 2014, AIDS, V28, P345, DOI 10.1097/QAD.0000000000000070; Yin MT, 2012, AIDS, V26, P2175, DOI 10.1097/QAD.0b013e328359a8ca; Young B, 2011, CLIN INFECT DIS, V52, P1061, DOI 10.1093/cid/ciq242	53	86	89	1	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12					815	+		10.7326/M14-1409	http://dx.doi.org/10.7326/M14-1409			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	26075752	Green Accepted			2022-12-28	WOS:000356516300016
J	Kloosterman, WP				Kloosterman, Wigard P.			Making heads or tails of shattered chromosomes	SCIENCE			English	Editorial Material							REARRANGEMENTS; CHROMOTHRIPSIS; MECHANISMS		Univ Med Ctr Utrecht, Dept Med Genet, Ctr Mol Med, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Kloosterman, WP (corresponding author), Univ Med Ctr Utrecht, Dept Med Genet, Ctr Mol Med, NL-3584 CG Utrecht, Netherlands.	w.kloosterman@umcutrecht.nl						Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Holland AJ, 2012, NAT MED, V18, P1630, DOI 10.1038/nm.2988; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Zhang C.-Z., 2015, NATURE, DOI 10.1038/nature14493	9	4	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1205	1206		10.1126/science.aac5277	http://dx.doi.org/10.1126/science.aac5277			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068832				2022-12-28	WOS:000356011500028
J	Richiardi, J; Altmann, A; Milazzo, AC; Chang, C; Chakravarty, MM; Banaschewski, T; Barker, GJ; Bokde, ALW; Bromberg, U; Buchel, C; Conrod, P; Fauth-Buhler, M; Flor, H; Frouin, V; Gallinat, J; Garavan, H; Gowland, P; Heinz, A; Lemaitre, H; Mann, KF; Martinot, JL; Nees, F; Paus, T; Pausova, Z; Rietschel, M; Robbins, TW; Smolka, MN; Spanagel, R; Strohle, A; Schumann, G; Hawrylycz, M; Poline, JB; Greicius, MD				Richiardi, Jonas; Altmann, Andre; Milazzo, Anna-Clare; Chang, Catie; Chakravarty, M. Mallar; Banaschewski, Tobias; Barker, Gareth J.; Bokde, Arun L. W.; Bromberg, Uli; Buechel, Christian; Conrod, Patricia; Fauth-Buehler, Mira; Flor, Herta; Frouin, Vincent; Gallinat, Juergen; Garavan, Hugh; Gowland, Penny; Heinz, Andreas; Lemaitre, Herve; Mann, Karl F.; Martinot, Jean-Luc; Nees, Frauke; Paus, Tomas; Pausova, Zdenka; Rietschel, Marcella; Robbins, Trevor W.; Smolka, Michael N.; Spanagel, Rainer; Stroehle, Andreas; Schumann, Gunter; Hawrylycz, Mike; Poline, Jean-Baptiste; Greicius, Michael D.		IMAGEN Consortium	Correlated gene expression supports synchronous activity in brain networks	SCIENCE			English	Article							RESTING STATE NETWORKS; MOUSE-BRAIN; TRANSCRIPTOME; CONNECTIVITY; ATLAS	During rest, brain activity is synchronized between different regions widely distributed throughout the brain, forming functional networks. However, the molecular mechanisms supporting functional connectivity remain undefined. We show that functional brain networks defined with resting-state functional magnetic resonance imaging can be recapitulated by using measures of correlated gene expression in a post mortem brain tissue data set. The set of 136 genes we identify is significantly enriched for ion channels. Polymorphisms in this set of genes significantly affect resting-state functional connectivity in a large sample of healthy adolescents. Expression levels of these genes are also significantly associated with axonal connectivity in the mouse. The results provide convergent, multimodal evidence that resting-state functional networks correlate with the orchestrated activity of dozens of genes linked to ion channel activity and synaptic function.	[Richiardi, Jonas; Altmann, Andre; Milazzo, Anna-Clare; Greicius, Michael D.] Stanford Univ, Dept Neurol & Neurol Sci, Funct Imaging Neuropsychiat Disorders Lab, Stanford, CA 94305 USA; [Richiardi, Jonas] Univ Geneva, Dept Neurosci, Lab Neurol & Imaging Cognit, Geneva, Switzerland; [Milazzo, Anna-Clare] VA Palo Alto Hlth Care Syst, War Related Illness & Injury Study Ctr, Palo Alto, CA USA; [Chang, Catie] NINDS, Adv MRI Sect, Lab Funct & Mol Imaging, NIH, Bethesda, MD 20892 USA; [Chakravarty, M. Mallar] Douglas Mental Hlth Univ Inst, Cerebral Imaging Ctr, Montreal, PQ, Canada; [Chakravarty, M. Mallar] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Chakravarty, M. Mallar] McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada; [Banaschewski, Tobias] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat, Mannheim, Germany; [Barker, Gareth J.; Conrod, Patricia; Schumann, Gunter] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Bokde, Arun L. W.; Garavan, Hugh] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Bromberg, Uli; Buechel, Christian] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany; [Conrod, Patricia] Univ Montreal, Dept Psychiat, Ctr Hosp Univ CHU, Ste Justine Hosp, Montreal, PQ H3C 3J7, Canada; [Fauth-Buehler, Mira; Mann, Karl F.] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Addict Behav & Addict Med, Mannheim, Germany; [Flor, Herta; Nees, Frauke] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neurosci, Mannheim, Germany; [Frouin, Vincent] Commissariat Energie Atom & Energies Alternat, Neurospin, Paris, France; [Gallinat, Juergen; Heinz, Andreas; Stroehle, Andreas] Charite, Campus Charite Mitte, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Garavan, Hugh] Univ Vermont, Dept Psychiat, Burlington, VT USA; [Garavan, Hugh] Univ Vermont, Dept Psychol, Burlington, VT 05405 USA; [Gowland, Penny] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England; [Lemaitre, Herve; Martinot, Jean-Luc] Univ Paris Sud, INSERM, U1000, Neuroimaging & Psychiat, F-91405 Orsay, France; [Lemaitre, Herve; Martinot, Jean-Luc] Univ Paris 05, Cochin Hosp, APHP, INSERM,U1000,Maison Solenn,Sorbonne Paris Cite, Paris, France; [Paus, Tomas] Univ Toronto, Rotman Res Inst, Toronto, ON, Canada; [Paus, Tomas] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Robbins, Trevor W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Robbins, Trevor W.] Univ Cambridge, Dept Psychol, Cambridge, England; [Smolka, Michael N.] Tech Univ Dresden, Dept Psychiat & Psychotherapy, D-01062 Dresden, Germany; [Smolka, Michael N.] Tech Univ Dresden, Neuroimaging Ctr, D-01062 Dresden, Germany; [Spanagel, Rainer] Fac Clin Med Mannheim, Cent Inst Mental Hlth, Dept Psychopharmacol, Mannheim, Germany; [Schumann, Gunter] MRC, Social Genet & Dev Psychiat SGDP Ctr, London, England; [Hawrylycz, Mike] Allen Inst Brain Sci, Seattle, WA USA; [Poline, Jean-Baptiste] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Stanford University; University of Geneva; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); McGill University; McGill University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of London; King's College London; Trinity College Dublin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Universite de Montreal; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; CEA; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Vermont; University of Vermont; University of Nottingham; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; Baycrest; University of Nottingham; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Cambridge; University of Cambridge; Technische Universitat Dresden; Technische Universitat Dresden; Central Institute of Mental Health; Allen Institute for Brain Science; University of California System; University of California Berkeley	Richiardi, J (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Funct Imaging Neuropsychiat Disorders Lab, Stanford, CA 94305 USA.	jonas.richiardi@unige.ch; greicius@stanford.edu	Heinz, Andreas/ABB-7736-2020; Nees, Frauke/AAZ-2150-2020; Gowland, Penny A./I-9016-2012; Conrod, Patricia J/P-4187-2018; Banaschewski, Tobias/ABE-5985-2020; Altmann, Andre/ABF-1675-2020; Lawrence, Claire/P-1058-2018; Williams, Steve C/D-6979-2011; Lubbe, Steven/L-8261-2013; Artiges, Eric/AAT-7219-2021; Barker, Gareth J/C-9616-2009; Martinot, Jean-Luc/N-3704-2018; Robbins, Trevor W/A-7551-2008; Artiges, Eric/C-2815-2019; Poustka, Luise/D-9299-2017; Jia, Tianye/AAC-3925-2019; Lemaitre, Herve/ABB-5427-2020; Vollstädt-Klein, Sabine/C-6744-2012	Heinz, Andreas/0000-0001-5405-9065; Gowland, Penny A./0000-0002-4900-4817; Banaschewski, Tobias/0000-0003-4595-1144; Altmann, Andre/0000-0002-9265-2393; Lawrence, Claire/0000-0001-6787-9716; Williams, Steve C/0000-0003-4299-1941; Lubbe, Steven/0000-0002-7103-6671; Artiges, Eric/0000-0003-4461-7646; Barker, Gareth J/0000-0002-5214-7421; Artiges, Eric/0000-0003-4461-7646; Jia, Tianye/0000-0001-5399-2953; Lemaitre, Herve/0000-0002-5952-076X; Vollstädt-Klein, Sabine/0000-0002-6210-672X; Nees, Frauke/0000-0002-7796-8234; boddaert, nathalie/0000-0003-0991-7774; Dalley, Jeffrey/0000-0002-2282-3660; Bokde, Arun/0000-0003-0114-4914; Robbins, Trevor/0000-0003-0642-5977; MIRANDA, RUBEN/0000-0002-9445-7348; Flor, Herta/0000-0003-4809-5398	European Union [299500, LSHM-CT-2007-037286, 602450, 603016]; Feldman Family Foundation; National Institutes of Health [RO1NS073498]; Innovative Medicine Initiative Project EU-AIMS [115300-2]; Medical Research Council [93558]; Swedish funding agency FORMAS; Medical Research Council; Wellcome Trust (Behavioral and Clinical Neuroscience Institute, University of Cambridge); National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London; Bundesministerium fur Bildung und Forschung (BMBF) [01GS08152, 01EV0711, eMED SysAlc01ZX1311A]; Bundesministerium fur Bildung und Forschung (BMBF Forschungsnetz AERIAL); Deutsche Forschungsgemeinschaft (DFG) [FOR 1617, EXC 257, SM 80/7-1, SM 80/7-2, SFB 940/1]; U.S. National Institutes of Health [RO1 MH085772-01A1]; Eranet-Neuron grant [AF12-NEUR0008-01 - WM2NA]; MILDECA; Fondation pour la Recherche Medicale; NIH [U54 EB020403]; Allen Institute for Brain Science; MRC [G0901858] Funding Source: UKRI; Medical Research Council [G9817803B, G0901858] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073498] Funding Source: NIH RePORTER	European Union(European Commission); Feldman Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Innovative Medicine Initiative Project EU-AIMS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish funding agency FORMAS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (Behavioral and Clinical Neuroscience Institute, University of Cambridge); National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London(General Electric); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Bundesministerium fur Bildung und Forschung (BMBF Forschungsnetz AERIAL)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eranet-Neuron grant; MILDECA; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allen Institute for Brain Science; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C.-K. Lee for help with AIBS data normalization and C. Quairiaux for help with mouse brain anatomy. Functional networks imaging data are at http://findlab.stanford.edu/functional_ROIs.html. Human microarray data are at http://human.brain-map.org. IMAGEN data are available by application to consortium coordinator G. Schumann (http://imagen-europe.com) after evaluation according to an established procedure. Mouse gene expression data are at http://mouse.brain-map.org. Connectivity model data are from (23). J.R. is supported by a Marie Curie Fellowship from the European Union (299500). M.D.G. is supported by grants from the Feldman Family Foundation and the National Institutes of Health (RO1NS073498). This work received additional support from the following sources: the European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behavior in normal brain function and psychopathology) (LSHM-CT-2007-037286), the FP7 projects IMAGEMEND (602450; IMAging GEnetics for MENtal Disorders) and MATRICS (603016), the Innovative Medicine Initiative Project EU-AIMS (115300-2), a Medical Research Council Programme Grant "Developmental pathways into adolescent substance abuse" (93558), the Swedish funding agency FORMAS, the Medical Research Council and the Wellcome Trust (Behavioral and Clinical Neuroscience Institute, University of Cambridge), the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, the Bundesministerium fur Bildung und Forschung (BMBF; grants 01GS08152, 01EV0711, eMED SysAlc01ZX1311A, and Forschungsnetz AERIAL), the Deutsche Forschungsgemeinschaft (DFG; grants FOR 1617, EXC 257, SM 80/7-1, SM 80/7-2, and SFB 940/1), the U.S. National Institutes of Health (Axon, Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1), Eranet-Neuron grant (project AF12-NEUR0008-01 - WM2NA), MILDECA, Fondation pour la Recherche Medicale, NIH Consortium grant U54 EB020403, which is supported by a cross-NIH alliance that funds Big Data to Knowledge Centers of Excellence, and the Allen Institute for Brain Science.	Birn RM, 2012, NEUROIMAGE, V62, P864, DOI 10.1016/j.neuroimage.2012.01.016; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Golland Y, 2008, NEUROPSYCHOLOGIA, V46, P540, DOI 10.1016/j.neuropsychologia.2007.10.003; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Heck A, 2014, NEURON, V81, P1203, DOI 10.1016/j.neuron.2014.01.010; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Nam D, 2010, NUCLEIC ACIDS RES, V38, pW749, DOI 10.1093/nar/gkq428; Natarajan L, 2012, ANN APPL STAT, V6, P521, DOI 10.1214/11-AOAS510; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Pletikos M, 2014, NEURON, V81, P321, DOI 10.1016/j.neuron.2013.11.018; Richiardi J, 2013, INT WORKSHOP PATTERN, P70, DOI 10.1109/PRNI.2013.27; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Schumann G, 2010, MOL PSYCHIATR, V15, P1128, DOI 10.1038/mp.2010.4; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Wolf L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002040; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	27	327	334	8	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1241	1244		10.1126/science.1255905	http://dx.doi.org/10.1126/science.1255905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068849	Green Accepted, Green Submitted			2022-12-28	WOS:000356011500051
J	Allentoft, ME; Sikora, M; Sjogren, KG; Rasmussen, S; Rasmussen, M; Stenderup, J; Damgaard, PB; Schroeder, H; Ahlstrom, T; Vinner, L; Malaspinas, AS; Margaryan, A; Higham, T; Chivall, D; Lynnerup, N; Harvig, L; Baron, J; Della Casa, P; Dabrowski, P; Duffy, PR; Ebel, AV; Epimakhov, A; Frei, K; Furmanek, M; Gralak, T; Gromov, A; Gronkiewicz, S; Grupe, G; Hajdu, T; Jarysz, R; Khartanovich, V; Khokhlov, A; Kiss, V; Kolar, J; Kriiska, A; Lasak, I; Longhi, C; McGlynn, G; Merkevicius, A; Merkyte, I; Metspalu, M; Mkrtchyan, R; Moiseyev, V; Paja, L; Palfi, G; Pokutta, D; Pospieszny, L; Price, TD; Saag, L; Sablin, M; Shishlina, N; Smrcka, V; Soenov, VI; Szeverenyi, V; Toth, G; Trifanova, SV; Varul, L; Vicze, M; Yepiskoposyan, L; Zhitenev, V; Orlando, L; Sicheritz-Ponten, T; Brunak, S; Nielsen, R; Kristiansen, K; Willerslev, E				Allentoft, Morten E.; Sikora, Martin; Sjogren, Karl-Goran; Rasmussen, Simon; Rasmussen, Morten; Stenderup, Jesper; Damgaard, Peter B.; Schroeder, Hannes; Ahlstrom, Torbjorn; Vinner, Lasse; Malaspinas, Anna-Sapfo; Margaryan, Ashot; Higham, Tom; Chivall, David; Lynnerup, Niels; Harvig, Lise; Baron, Justyna; Della Casa, Philippe; Dabrowski, Pawel; Duffy, Paul R.; Ebel, Alexander V.; Epimakhov, Andrey; Frei, Karin; Furmanek, Miroslaw; Gralak, Tomasz; Gromov, Andrey; Gronkiewicz, Stanislaw; Grupe, Gisela; Hajdu, Tamas; Jarysz, Radoslaw; Khartanovich, Valeri; Khokhlov, Alexandr; Kiss, Viktoria; Kolar, Jan; Kriiska, Aivar; Lasak, Irena; Longhi, Cristina; McGlynn, George; Merkevicius, Algimantas; Merkyte, Inga; Metspalu, Mait; Mkrtchyan, Ruzan; Moiseyev, Vyacheslav; Paja, Laszlo; Palfi, Gyoergy; Pokutta, Dalia; Pospieszny, Lukasz; Price, T. Douglas; Saag, Lehti; Sablin, Mikhail; Shishlina, Natalia; Smrcka, Vaclav; Soenov, Vasilii I.; Szeverenyi, Vajk; Toth, Gusztav; Trifanova, Synaru V.; Varul, Liivi; Vicze, Magdolna; Yepiskoposyan, Levon; Zhitenev, Vladislav; Orlando, Ludovic; Sicheritz-Ponten, Thomas; Brunak, Soren; Nielsen, Rasmus; Kristiansen, Kristian; Willerslev, Eske			Population genomics of Bronze Age Eurasia	NATURE			English	Article							HUNTER-GATHERERS; SEQUENCE; EUROPE	The Bronze Age of Eurasia (around 3000-1000 BC) was a period of major cultural changes. However, there is debate about whether these changes resulted from the circulation of ideas or from human migrations, potentially also facilitating the spread of languages and certain phenotypic traits. We investigated this by using new, improved methods to sequence low-coverage genomes from 101 ancient humans from across Eurasia. We show that the Bronze Age was a highly dynamic period involving large-scale population migrations and replacements, responsible for shaping major parts of present-day demographic structure in both Europe and Asia. Our findings are consistent with the hypothesized spread of Indo-European languages during the Early Bronze Age. We also demonstrate that light skin pigmentation in Europeans was already present at high frequency in the Bronze Age, but not lactose tolerance, indicating a more recent onset of positive selection on lactose tolerance than previously thought.	[Allentoft, Morten E.; Sikora, Martin; Rasmussen, Morten; Stenderup, Jesper; Damgaard, Peter B.; Schroeder, Hannes; Vinner, Lasse; Malaspinas, Anna-Sapfo; Margaryan, Ashot; Orlando, Ludovic; Willerslev, Eske] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum, DK-1350 Copenhagen K, Denmark; [Sjogren, Karl-Goran; Pokutta, Dalia; Kristiansen, Kristian] Univ Gothenburg, Dept Hist Studies, S-40530 Gothenburg, Sweden; [Rasmussen, Simon; Sicheritz-Ponten, Thomas; Brunak, Soren] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Schroeder, Hannes] Leiden Univ, Fac Archaeol, NL-2300 Leiden, Netherlands; [Ahlstrom, Torbjorn] Lund Univ, Dept Archaeol & Ancient Hist, S-22100 Lund, Sweden; [Higham, Tom; Chivall, David] Univ Oxford, Oxford Radiocarbon Accelerator Unit, Oxford OX1 3QY, England; [Lynnerup, Niels; Harvig, Lise] Univ Copenhagen, Dept Forens Med, Unit Forens Anthropol, DK-2100 Copenhagen, Denmark; [Baron, Justyna; Furmanek, Miroslaw; Gralak, Tomasz; Lasak, Irena] Univ Wroclaw, Inst Archaeol, PL-50139 Wroclaw, Poland; [Della Casa, Philippe] Univ Zurich, Archaeol Inst, CH-8006 Zurich, Switzerland; [Dabrowski, Pawel] Wroclaw Med Univ, Dept Anat, PL-50368 Wroclaw, Poland; [Duffy, Paul R.] Univ Toronto, Dept Anthropol, Toronto, ON M5S 2S2, Canada; [Ebel, Alexander V.] Gorno Altaisk State Univ, Dept Archeol & Gen Hist, Gorno Altaisk 649000, Russia; [Epimakhov, Andrey] South Ural State Univ, South Ural Dept, Inst Hist & Archaeol RAS, Chelyabinsk 454080, Russia; [Frei, Karin] Natl Museum Denmark, Environm Res & Mat Sci, DK-1471 Copenhagen K, Denmark; [Frei, Karin] Natl Museum Denmark, Ctr Text Res, DK-1471 Copenhagen K, Denmark; [Gromov, Andrey; Khartanovich, Valeri; Moiseyev, Vyacheslav] Peter Great Museum Anthropol & Ethnog Kunstkamera, St Petersburg 199034, Russia; [Gronkiewicz, Stanislaw] Polish Acad Sci, Dept Anthropol, PL-50449 Wroclaw, Poland; [Grupe, Gisela; McGlynn, George] Univ Munich, Bioctr, D-82152 Munich, Germany; [Hajdu, Tamas] Eotvos Lorand Univ, Inst Biol, Dept Biol Anthropol, H-1117 Budapest, Hungary; [Hajdu, Tamas] Hungarian Nat Hist Museum, Dept Anthropol, H-1083 Budapest, Hungary; [Jarysz, Radoslaw] Archaeol Museum Wroclaw, PL-50077 Wroclaw, Poland; [Khokhlov, Alexandr] Samara State Acad Social Sci & Humanities, Samara 443099, Russia; [Kiss, Viktoria; Szeverenyi, Vajk] Hungarian Acad Sci, Res Ctr Humanities, Inst Archaeol, H-1250 Budapest, Hungary; [Kolar, Jan] Masaryk Univ, Fac Arts, Inst Archaeol & Museol, CZ-60200 Brno, Czech Republic; [Kolar, Jan] Acad Sci Czech Republ, Inst Bot, Dept Vegetat Ecol, CZ-60200 Brno, Czech Republic; [Kriiska, Aivar; Varul, Liivi] Univ Tartu, Dept Archaeol, EE-51003 Tartu, Estonia; [Longhi, Cristina] Archaeol Superintendence Lombardy, I-20123 Milan, Italy; [Merkevicius, Algimantas] Vilnius State Univ, Dept Archaeol, LT-01513 Vilnius, Lithuania; [Merkyte, Inga] Univ Copenhagen, SAXO Inst, DK-2300 Copenhagen S, Denmark; [Metspalu, Mait; Saag, Lehti] Estonian Bioctr, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Metspalu, Mait; Saag, Lehti] Univ Tartu, EE-51010 Tartu, Estonia; [Mkrtchyan, Ruzan] Yerevan State Univ, Dept Hist, Yerevan 0025, Armenia; [Paja, Laszlo] Hungarian Natl Museum, H-1083 Budapest, Hungary; [Paja, Laszlo; Palfi, Gyoergy] Univ Szeged, Dept Biol Anthropol, H-6726 Szeged, Hungary; [Pospieszny, Lukasz] Polish Acad Sci, Inst Archaeol & Ethnol, PL-61612 Poznan, Poland; [Price, T. Douglas] Univ Wisconsin, Lab Archaeol Chem, Madison, WI 53706 USA; [Sablin, Mikhail] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia; [Shishlina, Natalia] State Hist Museum, Dept Archaeol, Moscow 109012, Russia; [Smrcka, Vaclav] Charles Univ Prague, Fac Med 1, Inst Hist Med & Foreign Languages, Prague 12108, Czech Republic; [Soenov, Vasilii I.; Trifanova, Synaru V.] Gorno Altaisk State Univ, Res Ctr Hist & Culture Turk Peoples, Gorno Altaisk 649000, Russia; [Toth, Gusztav] Eotvos Lorand Univ, Fac Humanities, Inst Archaeol Sci, Dept Pre & Early Hist, H-1088 Budapest, Hungary; [Vicze, Magdolna] Matrica Museum, H-2440 Szazhalombatta, Hungary; [Yepiskoposyan, Levon] Natl Acad Sci, Inst Mol Biol, Lab Ethnogen, Yerevan 0014, Armenia; [Zhitenev, Vladislav] Moscow MV Lomonosov State Univ, Fac Hist, Dept Archaeol, Moscow 119991, Russia; [Brunak, Soren] Univ Copenhagen, Ctr Prot Res, Novo Nordisk Fdn, DK-2200 Copenhagen, Denmark; [Nielsen, Rasmus] Univ Calif Berkeley, Ctr Theoret Evolutionary Genet, Berkeley, CA 94720 USA	University of Copenhagen; University of Gothenburg; Technical University of Denmark; Leiden University; Leiden University - Excl LUMC; Lund University; University of Oxford; University of Copenhagen; University of Wroclaw; University of Zurich; Wroclaw Medical University; University of Toronto; Gorno-Altaisk State University; Institute of History & Archaeology of the Ural Branch of the Russian Academy of Sciences; South Ural State University; Russian Academy of Sciences; The Kunstkamera; Polish Academy of Sciences; University of Munich; Eotvos Lorand University; Samara State University of Social Sciences & Education; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for the Humanities; Masaryk University Brno; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Tartu; Vilnius University; University of Copenhagen; Estonian Biocentre; University of Tartu; Yerevan State University; Szeged University; Polish Academy of Sciences; Institute of Archaeology & Ethnology of the Polish Academy of Sciences; University of Wisconsin System; University of Wisconsin Madison; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; Charles University Prague; Gorno-Altaisk State University; Eotvos Lorand University; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; Lomonosov Moscow State University; Novo Nordisk Foundation; University of Copenhagen; University of California System; University of California Berkeley	Willerslev, E (corresponding author), Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.	ewillerslev@snm.ku.dk	Kiss, Viktória/GLT-7205-2022; Soenov, Vasilii/M-5851-2019; Soenov, Vasilii I/C-1148-2013; Chivall, David/N-6967-2013; Schroeder, Hannes/B-9444-2015; Higham, Tom/Y-2707-2019; Nielsen, Rasmus/D-4405-2009; Kolar, Jan/P-6436-2016; Khartanovich, Valeri I/H-1872-2017; Trifanova, Synaru/C-1673-2013; Pokutta, Dalia/AAV-2218-2020; Metspalu, Mait/G-8671-2015; Rasmussen, Simon/AAA-2308-2020; Saag, Lehti/AAT-5535-2020; Ebel, Alexander/C-1256-2013; Mikhail, Sablin/K-7835-2013; Shishlina, Natalia I/R-5248-2016; Trifanova, Synaru/P-8320-2017; Furmanek, Mirosław/L-7419-2018; Epimakhov, Andrey V/N-8603-2014; Pálfi, György/M-3555-2018; Willerslev, Eske/AAA-5686-2019; Khokhlov, Aleksander/F-4737-2017; Willerslev, Eske/A-9619-2011; Orlando, Ludovic/A-8932-2013; Pálfi, György/AAL-7268-2020; Sikora, Martin/C-8609-2015; Pospieszny, Łukasz/AAM-1919-2020; Rasmussen, Simon/G-6258-2016; Zhitenev, Vladislav/AAO-3108-2020; Smrcka, Vaclav/V-4764-2017; Moiseyev, Vyacheslav/AAD-2659-2019; Sicheritz-Ponten, Thomas/A-4325-2017; Brunak, Soren/O-6621-2016; Hajdu, Tamas/C-8856-2013	Kiss, Viktória/0000-0002-6577-9081; Soenov, Vasilii/0000-0003-4224-0427; Soenov, Vasilii I/0000-0003-4224-0427; Chivall, David/0000-0003-4961-3847; Schroeder, Hannes/0000-0002-6743-0270; Higham, Tom/0000-0002-5949-598X; Nielsen, Rasmus/0000-0003-0513-6591; Kolar, Jan/0000-0001-8013-6992; Khartanovich, Valeri I/0000-0002-5533-0686; Trifanova, Synaru/0000-0002-2153-2589; Pokutta, Dalia/0000-0003-2049-6886; Metspalu, Mait/0000-0003-3099-9161; Rasmussen, Simon/0000-0001-6323-9041; Saag, Lehti/0000-0002-2274-8138; Ebel, Alexander/0000-0001-6060-1332; Mikhail, Sablin/0000-0002-2773-7454; Shishlina, Natalia I/0000-0001-9638-0156; Trifanova, Synaru/0000-0002-2153-2589; Furmanek, Mirosław/0000-0002-3558-3440; Epimakhov, Andrey V/0000-0002-0141-1026; Pálfi, György/0000-0003-0989-4090; Khokhlov, Aleksander/0000-0003-0442-9616; Willerslev, Eske/0000-0002-7081-6748; Orlando, Ludovic/0000-0003-3936-1850; Sikora, Martin/0000-0003-2818-8319; Pospieszny, Łukasz/0000-0003-4676-5802; Rasmussen, Simon/0000-0001-6323-9041; Zhitenev, Vladislav/0000-0003-1105-9318; Smrcka, Vaclav/0000-0001-8286-511X; Della Casa, Philippe/0000-0002-9787-0082; Baron, Justyna/0000-0001-6429-2872; Sjogren, Karl-Goran/0000-0003-1791-3175; Malaspinas, Anna-Sapfo/0000-0003-1001-7511; Margaryan, Ashot/0000-0002-2576-2429; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Dabrowski, Pawel/0000-0001-6016-9201; Allentoft, Morten/0000-0003-4424-3568; Brunak, Soren/0000-0003-0316-5866; Vinner, Lasse/0000-0002-3081-3702; Hajdu, Tamas/0000-0002-3604-1125; Gralak, Tomasz/0000-0002-8140-7245; Gromov, Andrey/0000-0002-3263-3801	European Research Council [269442]; University of Copenhagen; Marie Curie Actions of the European Union [300554]; Villum Foundation [10120]; Miller Institute, University of California, Berkeley; Lundbeck Foundation; Danish National Research Foundation; Lundbeck Foundation [R109-2012-9995, R24-2008-2527, R38-2008-3048, R70-2010-6286, R155-2013-16338] Funding Source: researchfish; Villum Fonden [00010120] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); University of Copenhagen; Marie Curie Actions of the European Union(European Commission); Villum Foundation(Villum Fonden); Miller Institute, University of California, Berkeley(University of California System); Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Villum Fonden(Villum Fonden)	We thank K. Magnussen, L. A. Petersen, C. D. Mortensen and A. Seguin-Orlando at the Danish National Sequencing Centre for help with the sequencing. We thank C. G. Zacho for technical assistance. The project was funded by The European Research Council (FP/2007-2013, grant no. 269442, The Rise), The University of Copenhagen (KU2016 programme), Marie Curie Actions of the European Union(FP7/2007-2013, grant no. 300554), The Villum Foundation(Young Investigator Programme, grant no. 10120), Frederik Paulsen, The Miller Institute, University of California, Berkeley, The Lundbeck Foundation, and The Danish National Research Foundation.	Adler CJ, 2011, J ARCHAEOL SCI, V38, P956, DOI 10.1016/j.jas.2010.11.010; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bendezu-Sarmiento J., 2007, AGE BRONZE AGE FER K; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Carpenter ML, 2013, AM J HUM GENET, V93, P852, DOI 10.1016/j.ajhg.2013.10.002; Damgaard P., 2015, IMPROVING ACCESS END; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Grigoriev S. A., 2002, ANCIENT INDO EUROPEA; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Hanks BK, 2007, ANTIQUITY, V81, P353, DOI 10.1017/S0003598X00095235; Harrison R, 2007, PRAEHIST Z, V82, P129, DOI 10.1515/PZ.2007.010; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Jonsson H, 2013, BIOINFORMATICS; Keyser C, 2009, HUM GENET, V126, P395, DOI 10.1007/s00439-009-0683-0; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Koryakova L, 2007, CAMB WOR ARCHAEOL, P1, DOI 10.1017/CBO9780511618451; Kozintsev AG, 1999, AM J PHYS ANTHROPOL, V108, P193, DOI 10.1002/(SICI)1096-8644(199902)108:2<193::AID-AJPA5>3.3.CO;2-M; Kristiansen K., 2005, RISE BRONZE AGE SOC; Kuznetsov PF, 2006, ANTIQUITY, V80, P638, DOI 10.1017/S0003598X00094096; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Malaspinas AS, 2014, CURR BIOL, V24, pR1035, DOI 10.1016/j.cub.2014.09.078; Mallory J., 1987, SEARCH INDO EUROPEAN; Mallory JP., 2000, TARIM MUMMIES ANCIEN; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Meyer M., 2010, COLD SPRING HARB PRO; Nystrom V, 2012, MOL ECOL, V21, P3391, DOI 10.1111/j.1365-294X.2012.05525.x; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Orlando L, 2011, GENOME RES, V21, P1705, DOI 10.1101/gr.122747.111; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Renfrew AC, 1987, ARCHAEOLOGY LANGUAGE; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Seguin-Orlando A, 2014, SCIENCE, V346, P1113, DOI 10.1126/science.aaa0114; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Vandkilde H., 2007, CULTURE CHANGE CENTR; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813	54	775	800	14	337	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					167	+		10.1038/nature14507	http://dx.doi.org/10.1038/nature14507			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CK2CI	26062507	Green Published, Green Submitted			2022-12-28	WOS:000356016700029
J	Blustein, J; Liu, JM				Blustein, Jan; Liu, Jianmeng			Time to consider the risks of caesarean delivery for long term child health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SECTION; BIRTH; MODE; METAANALYSIS; ASSOCIATION; ASTHMA		[Blustein, Jan] NYU, Wagner Grad Sch, New York, NY 10012 USA; [Blustein, Jan] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Blustein, Jan] NYU, Sch Med, Dept Med, New York, NY USA; [Liu, Jianmeng] Peking Univ, Sch Publ Hlth, Inst Reprod & Child Hlth, Key Lab Reprod Hlth,Minist Hlth, Beijing 100871, Peoples R China; [Liu, Jianmeng] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China	New York University; New York University; New York University; Peking University; Peking University	Blustein, J (corresponding author), NYU, Wagner Grad Sch, 550 1St Ave, New York, NY 10012 USA.	jan.blustein@wagner.nyu.edu; liujm@pku.edu.cn			NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038, UL1TR001445] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Almqvist C, 2012, CLIN EXP ALLERGY, V42, P1369, DOI 10.1111/j.1365-2222.2012.04021.x; American College of Obstetricians and Gynecologists, 2013, OBSTET GYNECOL, V121, P904, DOI 10.1097/01.AOG.0000428647.67925.d3; Barker DJP, 1994, BMJ; Braback L, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-14; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Hyde MJ, 2012, EARLY HUM DEV, V88, P943, DOI 10.1016/j.earlhumdev.2012.09.006; Khashan AS, 2014, PEDIATRICS, V134, pE806, DOI 10.1542/peds.2014-0819; Lavender T, 2005, BMJ-BRIT MED J, V331, P490, DOI 10.1136/bmj.38560.572639.3A; Li H, 2014, PEDIATR OBES, V9, P10, DOI 10.1111/j.2047-6310.2013.00151.x; Li HT, 2013, INT J OBESITY, V37, P893, DOI 10.1038/ijo.2012.195; Lucas DN, 2000, J ROY SOC MED, V93, P346, DOI 10.1177/014107680009300703; Montgomery AA, 2007, BMJ-BRIT MED J, V334, P1307, DOI 10.1136/bmj.39217.671019.55; National Institute of Health and Care Excellence (NICE), 2011, CAES SECT CLIN GUID, V132; Royal College of Obstetrics and Gynecology, CLIN IND PROJ; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Thomas J, 2001, NATL SENTINEL CAESAR; Whyte H, 2004, AM J OBSTET GYNECOL, V191, P864, DOI 10.1016/j.ajog.2004.06.056	18	64	66	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2015	350								h2410	10.1136/bmj.h2410	http://dx.doi.org/10.1136/bmj.h2410			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK7CZ	26063685	Green Published			2022-12-28	WOS:000356389600001
J	Carmody, D; Naylor, RN; Philipson, LH				Carmody, David; Naylor, Rochelle N.; Philipson, Louis H.			Insulin Dosing in Pediatric Diabetic Ketoacidosis Where to Start?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DOSE INSULIN; CHILDREN	IMPORTANCE The standard recommended dose (0.1 U/kg per hour) of insulin in diabetic ketoacidosis (DKA) guidelines is not backed by strong clinical evidence. Physiologic dose-effect studies have found that even lower doses could adequately normalize ketonemia and acidosis. Lowering the insulin dose may be advantageous in the initial hours of therapy when a gradual decrease in glucose, electrolytes, and resultant osmolality is desired. OBJECTIVE To compare the efficacy and safety of low-dose insulin against the standard dose in children with DKA. DESIGN, SETTING, AND PARTICIPANTS This was a prospective, open-label randomized clinical trial conducted in the pediatric emergency department and intensive care unit of a tertiary care teaching hospital in northern India from November 1, 2011, through December 31, 2012. A total of 50 consecutive children 12 years or younger with a diagnosis of DKA were randomized to low-dose (n = 25) and standard-dose (n = 25) groups. INTERVENTIONS Low-dose (0.05 U/kg per hour) vs standard-dose (0.1 U/kg per hour) insulin infusion. MAIN OUTCOMES AND MEASURES The primary outcome was the rate of decrease in blood glucose until a level of 250 mg/dL or less is reached (to convert to millimoles per liter, multiply by 0.0555). The secondary outcomes included time to resolution of acidosis, episodes of treatment failures, and incidences of hypokalemia and hypoglycemia. RESULTS The mean (SD) rate of blood glucose decrease until a level of 250mg/dL or less is reached (45.1 [17.6] vs 52.2 [23.4] mg/dL/h) and the mean (SD) time taken to achieve this target (6.0 [3.3] vs 6.2 [2.2] hours) were similar in the low-and standard-dose groups, respectively. Mean (SD) length of time to achieve resolution of acidosis (low vs standard dose: 16.5 [7.2] vs 17.2 [7.7] hours; P = .73) and rate of resolution of acidosis were also similar in the groups. Hypokalemia was seen in 12 children (48%) receiving the standard dose vs 5 (20%) of those receiving the low dose (P = .07); the tendency was more pronounced in malnourished children (7 [88%] vs 2 [28%]). Five children (20%) and 1 child (4%) receiving standard-and low-dose infusion (P = .17), respectively, developed hypoglycemia. Treatment failure was rare and comparable. One child in the standard-dose group developed cerebral edema, and no deaths occurred during the study period. CONCLUSIONS AND RELEVANCE Low dose is noninferior to standard dose with respect to rate of blood glucose decrease and resolution of acidosis. We advocate a superiority trial with a larger sample size before 0.05 U/kg per hour replaces 0.1 U/kg per hour in the practice recommendations.	Univ Chicago, Dept Med, Sect Adult & Pediat Endocrinol Diabet & Metab, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Sect Adult & Pediat Endocrinol Diabet & Metab, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Philipson, LH (corresponding author), Univ Chicago, Dept Med, 900 E 57th St, Chicago, IL 60637 USA.	l-philipson@uchicago.edu		Carmody, David/0000-0002-8287-2560				Dunger DB, 2004, PEDIATRICS, V113, P133; Hekkala A, 2007, DIABETES CARE, V30, P861, DOI 10.2337/dc06-2281; KRANE EJ, 1985, NEW ENGL J MED, V312, P1147, DOI 10.1056/NEJM198505023121803; Nallasamy K, 2014, JAMA PEDIATR, V168, P999, DOI 10.1001/jamapediatrics.2014.1211; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Vanelli Maurizio, 2007, Diabetes Care, V30, pe12, DOI 10.2337/dc07-0059; Wagner A, 1999, DIABETES CARE, V22, P674, DOI 10.2337/diacare.22.5.674; White NH, 2000, ENDOCRIN METAB CLIN, V29, P657, DOI 10.1016/S0889-8529(05)70158-4; Wolfsdorf J, 2006, DIABETES CARE, V29, P1150, DOI 10.2337/dc06-9909	9	0	0	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2274	+		10.1001/jama.2015.135	http://dx.doi.org/10.1001/jama.2015.135			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1VH	26057288				2022-12-28	WOS:000355995300021
J	Heckman, EJ; O'Connor, GT				Heckman, Eric J.; O'Connor, George T.			Pulmonary Function Tests for Diagnosing Lung Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIFFUSING-CAPACITY; STANDARDIZATION		[Heckman, Eric J.; O'Connor, George T.] Boston Univ, Sch Med, Ctr Pulm, Dept Med, Boston, MA 02118 USA	Boston University	O'Connor, GT (corresponding author), Boston Univ, Sch Med, Ctr Pulm, 72 E Concord St,R-304 Med Campus, Boston, MA 02118 USA.	goconnor@bu.edu			NIGMS NIH HHS [T32 GM86308, T32 GM086308] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM086308] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2014, PHYS FEE SCHED SEARC; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Global initiative of chronic obstructive lung disease, 2015, GLOB STRAT DIAGN MAN; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hughes JMB, 2012, AM J RESP CRIT CARE, V186, P132, DOI 10.1164/rccm.201112-2160CI; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005	10	9	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2278	2279		10.1001/jama.2015.4466	http://dx.doi.org/10.1001/jama.2015.4466			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1VH	26057290	Green Accepted			2022-12-28	WOS:000355995300023
J	Xu, GJ; Kula, T; Xu, QK; Li, MZ; Vernon, SD; Ndung'u, T; Ruxrungtham, K; Sanchez, J; Brander, C; Chung, RT; O'Connor, KC; Walker, B; Larman, HB; Elledge, SJ				Xu, George J.; Kula, Tomasz; Xu, Qikai; Li, Mamie Z.; Vernon, Suzanne D.; Ndung'u, Thumbi; Ruxrungtham, Kiat; Sanchez, Jorge; Brander, Christian; Chung, Raymond T.; O'Connor, Kevin C.; Walker, Bruce; Larman, H. Benjamin; Elledge, Stephen J.			Comprehensive serological profiling of human populations using a synthetic human virome	SCIENCE			English	Article							VIRAL-INFECTIONS; UNITED-STATES; RISK-FACTORS; SEROPREVALENCE; HUMAN-HERPESVIRUS-8; PREVALENCE; DISCOVERY; DISEASE; GENOME; TYPE-1	The human virome plays important roles in health and immunity. However, current methods for detecting viral infections and antiviral responses have limited throughput and coverage. Here, we present VirScan, a high-throughput method to comprehensively analyze antiviral antibodies using immunoprecipitation and massively parallel DNA sequencing of a bacteriophage library displaying proteome-wide peptides from all human viruses. We assayed over 108 antibody-peptide interactions in 569 humans across four continents, nearly doubling the number of previously established viral epitopes. We detected antibodies to an average of 10 viral species per person and 84 species in at least two individuals. Although rates of specific virus exposure were heterogeneous across populations, antibody responses targeted strongly conserved "public epitopes" for each virus, suggesting that they may elicit highly similar antibodies. VirScan is a powerful approach for studying interactions between the virome and the immune system.	[Xu, George J.] Harvard Univ, Program Biophys, Cambridge, MA 02115 USA; [Xu, George J.] Harvard Massachusetts Inst Technol MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Xu, George J.; Kula, Tomasz; Xu, Qikai; Li, Mamie Z.; Elledge, Stephen J.] Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Med, Div Genet, Boston, MA 02115 USA; [Xu, George J.; Kula, Tomasz; Xu, Qikai; Li, Mamie Z.; Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Kula, Tomasz] Harvard Univ, Program Biol & Biomed Sci, Cambridge, MA 02115 USA; [Vernon, Suzanne D.; Elledge, Stephen J.] Solve ME CFS Initiat, Los Angeles, CA 90036 USA; [Ndung'u, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Ndung'u, Thumbi; Walker, Bruce] Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Ndung'u, Thumbi; Walker, Bruce] MIT, Ragon Inst Massachusetts Gen Hosp, Cambridge, MA 02139 USA; [Ndung'u, Thumbi; Walker, Bruce] Harvard Univ, Cambridge, MA 02139 USA; [Ndung'u, Thumbi] Max Planck Inst Infect Biol, D-10117 Berlin, Germany; [Ruxrungtham, Kiat] Chulalongkorn Univ, Fac Med, Dept Med, Vaccine & Cellular Immunol Lab, Bangkok 10330, Thailand; [Ruxrungtham, Kiat] Chulalongkorn Univ, Chula Vaccine Res Ctr, Bangkok 10330, Thailand; [Sanchez, Jorge] Asociac Civil IMPACTA Salud & Educ, Lima, Peru; [Brander, Christian] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, AIDS Res Inst IrsiCaixa, Badalona, Spain; [Brander, Christian] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, AIDS Unit, Badalona, Spain; [Brander, Christian] ICREA, Barcelona, Spain; [Chung, Raymond T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [O'Connor, Kevin C.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; [Larman, H. Benjamin] Johns Hopkins Univ, Dept Pathol, Div Immunol, Baltimore, MD 21205 USA	Harvard University; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; University of Kwazulu Natal; University of Kwazulu Natal; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Max Planck Society; Chulalongkorn University; Chulalongkorn University; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; ICREA; Harvard University; Massachusetts General Hospital; Yale University; Johns Hopkins University	Elledge, SJ (corresponding author), Brigham & Womens Hosp, Howard Hughes Med Inst, Dept Med, Div Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu		Brander, Christian/0000-0002-0548-5778; Ruxrungtham, Kiat/0000-0001-7348-2352; Ndung'u, Thumbi/0000-0003-2962-3992	NIH [R37AI067073, N01-AI-30024, N01-AI-15422, N01-A1-30024]; International AIDS Vaccine Initiative [UKZNRSA1001]; South African Research Chairs Initiative; Victor Daitz Foundation; International Early Career Scientist Award from the Howard Hughes Medical Institute; NIH-National Institute of Dental and Craniofacial Research [R01 DE018925-04]; HIVACAT program; CUTHIVAC [241904]; TRF Senior Research Scholar, the Thailand Research Fund; Chulalongkorn University Research Professor Program, Thailand; NSF Graduate Research Fellowships Program;  [NIH DA033541];  [AI082630]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030024, R37AI067073, U19AI082630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033541] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; South African Research Chairs Initiative; Victor Daitz Foundation; International Early Career Scientist Award from the Howard Hughes Medical Institute; NIH-National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); HIVACAT program; CUTHIVAC; TRF Senior Research Scholar, the Thailand Research Fund; Chulalongkorn University Research Professor Program, Thailand; NSF Graduate Research Fellowships Program(National Science Foundation (NSF)); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); ICREA(ICREA)	We thank E. Unger and S. Buranapraditkun for providing reagents, K. Wucherpfennig (Harvard) and H. Ploegh (MIT) for critical reading of the manuscript, and TWIST Bioscience for providing access to their advanced oligonucleotide synthesis technology. The cohort in Durban, South Africa, was funded by the NIH (R37AI067073) and the International AIDS Vaccine Initiative (UKZNRSA1001). T.N. received additional funding from the South African Research Chairs Initiative, the Victor Daitz Foundation, and an International Early Career Scientist Award from the Howard Hughes Medical Institute. R.T.C. was funded by grants NIH DA033541 and AI082630. C.B. and J.S. were supported by NIH N01-AI-30024 and N01-AI-15422, NIH-National Institute of Dental and Craniofacial Research R01 DE018925-04, the HIVACAT program, and CUTHIVAC 241904. K.R. is supported by TRF Senior Research Scholar, the Thailand Research Fund; the Chulalongkorn University Research Professor Program, Thailand; and NIH grant N01-A1-30024. G.J.X. and T.K. were supported by the NSF Graduate Research Fellowships Program. S.J.E. and B.W. are Investigators with the Howard Hughes Medical Institute. G.J.X., T.K., H.B.L., and S.J.E. are inventors on a patent application (application no. PCT/US14/70902) filed by Brigham and Women's Hospital, Incorporated that covers the use of phage display libraries to detect antiviral antibodies.	Ablashi D, 1999, BRIT J CANCER, V81, P893, DOI 10.1038/sj.bjc.6690782; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Aydar Y, 2005, J IMMUNOL, V174, P5358, DOI 10.4049/jimmunol.174.9.5358; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; BIALECKI C, 1989, J AM ACAD DERMATOL, V21, P891, DOI 10.1016/S0190-9622(89)70275-9; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Dong LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095612; Duerkop BA, 2013, NAT IMMUNOL, V14, P654, DOI 10.1038/ni.2614; Engels EA, 2007, J INFECT DIS, V196, P199, DOI 10.1086/518791; Foxman EF, 2011, NAT REV MICROBIOL, V9, P254, DOI 10.1038/nrmicro2541; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Heit A, 2004, J IMMUNOL, V172, P1501, DOI 10.4049/jimmunol.172.3.1501; Jackson KJL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00263; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larman HB, 2013, J AUTOIMMUN, V43, P1, DOI 10.1016/j.jaut.2013.01.013; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Lecuit M, 2013, TRENDS MICROBIOL, V21, P510, DOI 10.1016/j.tim.2013.07.001; Lee JH, 1997, J HEPATOL, V26, P1001, DOI 10.1016/S0168-8278(97)80108-0; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Mohanna S, 2007, CLIN INFECT DIS, V44, P558, DOI 10.1086/511044; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Parameswaran P, 2013, CELL HOST MICROBE, V13, P691, DOI 10.1016/j.chom.2013.05.008; Patel P, 2012, SEX TRANSM DIS, V39, P154, DOI 10.1097/OLQ.0b013e318239d7fd; Quigley MF, 2010, P NATL ACAD SCI USA, V107, P19414, DOI 10.1073/pnas.1010586107; Reynolds MA, 2010, PUBLIC HEALTH REP, V125, P860, DOI 10.1177/003335491012500613; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062216; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Stover CT, 2003, J INFECT DIS, V187, P1388, DOI 10.1086/374649; Urwijitaroon Y, 1993, Southeast Asian J Trop Med Public Health, V24 Suppl 1, P180; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang M, 1999, J VIROL METHODS, V78, P171, DOI 10.1016/S0166-0934(98)00180-3; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Wylie KM, 2012, TRANSL RES, V160, P283, DOI 10.1016/j.trsl.2012.03.006; Zhu J, 2013, NAT BIOTECHNOL, V31, P331, DOI 10.1038/nbt.2539	37	235	249	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239							aaa0698	10.1126/science.aaa0698	http://dx.doi.org/10.1126/science.aaa0698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045439	Green Accepted			2022-12-28	WOS:000355590500039
J	Ceci, C				Ceci, Chiara			Take concepts of chemistry out of the classroom	NATURE			English	Editorial Material									Royal Soc Chem, Cambridge, England		Ceci, C (corresponding author), Royal Soc Chem, Cambridge, England.	cecic@rsc.org							0	3	3	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					7	7		10.1038/522007a	http://dx.doi.org/10.1038/522007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ5QP	26040860	Bronze			2022-12-28	WOS:000355543400004
J	Ito, HT; Zhang, SJ; Witter, MP; Moser, EI; Moser, MB				Ito, Hiroshi T.; Zhang, Sheng-Jia; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt			A prefrontal-thalamo-hippocampal circuit for goal-directed spatial navigation	NATURE			English	Article							NUCLEUS-REUNIENS-THALAMI; SEQUENTIAL-CONTEXT; GRID CELLS; MEMORY; CORTEX; PARIETAL; NEURONS; RAT; REPRESENTATION; MODULATION	Spatial navigation requires information about the relationship between current and future positions. The activity of hippocampal neurons appears to reflect such a relationship, representing not only instantaneous position but also the path towards a goal location. However, how the hippocampus obtains information about goal direction is poorly understood. Here we report a prefrontal-thalamic neural circuit that is required for hippocampal representation of routes or trajectories through the environment. Trajectory-dependent firing was observed in medial prefrontal cortex, the nucleus reuniens of the thalamus, and the CA1 region of the hippocampus in rats. Lesioning or optogenetic silencing of the nucleus reuniens substantially reduced trajectory-dependent CA1 firing. Trajectory-dependent activity was almost absent in CA3, which does not receive nucleus reuniens input. The data suggest that projections from medial prefrontal cortex, via the nucleus reuniens, are crucial for representation of the future path during goal-directed behaviour and point to the thalamus as a key node in networks for long-range communication between cortical regions involved in navigation.	[Ito, Hiroshi T.; Zhang, Sheng-Jia; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, MTFS, Kavli Inst Syst Neurosci, N-7491 Trondheim, Norway; [Ito, Hiroshi T.; Zhang, Sheng-Jia; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, MTFS, Ctr Neural Computat, N-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Ito, HT (corresponding author), Norwegian Univ Sci & Technol, MTFS, Kavli Inst Syst Neurosci, Olav Kyrres Gate 9, N-7491 Trondheim, Norway.	hiroshi.ito@ntnu.no; may-britt.moser@ntnu.no			European Research Council [232608, 268598]; Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway (Centre for the Biology of Memory); Centre of Excellence scheme of the Research Council of Norway (Centre for Neural Computation)	European Research Council(European Research Council (ERC)European Commission); Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway (Centre for the Biology of Memory); Centre of Excellence scheme of the Research Council of Norway (Centre for Neural Computation)	We thank A.M. Amundsgard, K. Haugen, K. Jenssen, E. Krakvik and H. Waade for technical assistance, M. Andresen, E. Harstad and G. Jakobsen for taking care of animals, J. Ye and J. Wu for help with immunostaining of brain sections, K. Deisseroth for providing eNpHR3.0 plasmids, and A. Treves and A. Tsao and other members of the Moser laboratory for discussion. This work was supported by two Advanced Investigator grants from the European Research Council ('CIRCUIT', Grant Agreement no. 232608; 'ENSEMBLE', Grant Agreement no. 268598), the Kavli Foundation, the Centre of Excellence scheme of the Research Council of Norway ( Centre for the Biology of Memory and Centre for Neural Computation).	Ainge JA, 2007, HIPPOCAMPUS, V17, P988, DOI 10.1002/hipo.20301; ANDERSEN RA, 1983, J NEUROSCI, V3, P532; Anderson MI, 2003, J NEUROSCI, V23, P8827; [Anonymous], 1999, COGNITIVE MAP; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Bower MR, 2005, J NEUROSCI, V25, P1313, DOI 10.1523/JNEUROSCI.2901-04.2005; BURGESS N, 1994, NEURAL NETWORKS, V7, P1065, DOI 10.1016/S0893-6080(05)80159-5; Cassel JC, 2013, PROG NEUROBIOL, V111, P34, DOI 10.1016/j.pneurobio.2013.08.006; Catanese J, 2014, J NEUROSCI, V34, P13163, DOI 10.1523/JNEUROSCI.0819-14.2014; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; DollemanVanderWeel MJ, 1996, J COMP NEUROL, V364, P637; Euston DR, 2006, J NEUROSCI, V26, P13143, DOI 10.1523/JNEUROSCI.3803-06.2006; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Foster DJ, 2000, HIPPOCAMPUS, V10, P1, DOI 10.1002/(SICI)1098-1063(2000)10:1<1::AID-HIPO1>3.0.CO;2-1; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Hembrook JR, 2011, HIPPOCAMPUS, V21, P815, DOI 10.1002/hipo.20797; HERKENHAM M, 1978, J COMP NEUROL, V177, P589, DOI 10.1002/cne.901770405; Hok V, 2005, P NATL ACAD SCI USA, V102, P4602, DOI 10.1073/pnas.0407332102; Hyman JM, 2012, P NATL ACAD SCI USA, V109, P5086, DOI 10.1073/pnas.1114415109; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Jones BF, 2007, HIPPOCAMPUS, V17, P957, DOI 10.1002/hipo.20330; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Komorowski RW, 2009, J NEUROSCI, V29, P9918, DOI 10.1523/JNEUROSCI.1378-09.2009; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lu L, 2013, NAT NEUROSCI, V16, P1085, DOI 10.1038/nn.3462; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Moser EI, 2014, NAT REV NEUROSCI, V15, P466, DOI 10.1038/nrn3766; OKEEFE J, 1979, BEHAV BRAIN SCI, V2, P487, DOI 10.1017/S0140525X00063949; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Salinas E, 2001, Prog Brain Res, V130, P175; Salinas E, 2001, NEUROSCIENTIST, V7, P430, DOI 10.1177/107385840100700512; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sherman, 2006, EXPLORING THALAMUS I, P357; Shimazaki H, 2010, J COMPUT NEUROSCI, V29, P171, DOI 10.1007/s10827-009-0180-4; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; Vertes R. P., 2014, RAT NERVOUS SYSTEM; Vertes RP, 2007, BRAIN RES BULL, V71, P601, DOI 10.1016/j.brainresbull.2006.12.002; Warden MR, 2010, J NEUROSCI, V30, P15801, DOI 10.1523/JNEUROSCI.1569-10.2010; Whitlock JR, 2012, NEURON, V73, P789, DOI 10.1016/j.neuron.2011.12.028; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; WOUTERLOOD FG, 1990, J COMP NEUROL, V296, P179, DOI 10.1002/cne.902960202; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627	51	245	250	6	107	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					50	U82		10.1038/nature14396	http://dx.doi.org/10.1038/nature14396			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	26017312	Green Accepted			2022-12-28	WOS:000355543400027
J	Navedo, M; Redondo, P				Navedo, Maria; Redondo, Pedro			Enlarged Pinna	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Navedo, Maria; Redondo, Pedro] Univ Navarra Clin, Pamplona, Spain	University of Navarra	Navedo, M (corresponding author), Univ Navarra Clin, Pamplona, Spain.	predondo@unav.es	REDONDO, PEDRO/H-7989-2017	REDONDO, PEDRO/0000-0001-7899-2511					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2015	372	23							e31	10.1056/NEJMicm1408553	http://dx.doi.org/10.1056/NEJMicm1408553			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1GK	26039622				2022-12-28	WOS:000355955100008
J	Hussey, PS; Timbie, JW; Burgette, LF; Wenger, NS; Nyweide, DJ; Kahn, KL				Hussey, Peter S.; Timbie, Justin W.; Burgette, Lane F.; Wenger, Neil S.; Nyweide, David J.; Kahn, Katherine L.			Appropriateness of Advanced Diagnostic Imaging Ordering Before and After Implementation of Clinical Decision Support Systems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Hussey, Peter S.] RAND Corp, Boston, MA 02116 USA; [Timbie, Justin W.; Burgette, Lane F.] RAND Corp, Arlington, VA USA; [Wenger, Neil S.; Kahn, Katherine L.] RAND UCLA, Los Angeles, CA USA; [Nyweide, David J.] Ctr Medicare Serv, Baltimore, MD USA; [Nyweide, David J.] Ctr Medicaid Serv, Baltimore, MD USA	RAND Corporation; RAND Corporation; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Hussey, PS (corresponding author), RAND Corp, 20 Pk Plaza, Boston, MA 02116 USA.	hussey@rand.org	Kahn, Katherine/AAE-2857-2020	Kahn, Katherine/0000-0002-6605-1455; Burgette, Lane/0000-0001-5945-1760				Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Centers for Medicare & Medicaid Services, MED IM DEM; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Lewin Group Inc, 2014, MED APPR US IM DEM I	4	32	32	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2181	2182		10.1001/jama.2015.5089	http://dx.doi.org/10.1001/jama.2015.5089			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ4CC	26034960	Bronze			2022-12-28	WOS:000355430900020
J	[Anonymous]				[Anonymous]			Silicon smarts	NATURE			English	Editorial Material																			0	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					394	394		10.1038/521394b	http://dx.doi.org/10.1038/521394b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	26017407	Bronze			2022-12-28	WOS:000355286600003
J	Armbrust, EV; Palumbi, SR				Armbrust, E. Virginia; Palumbi, Stephen R.			Uncovering hidden worlds of ocean biodiversity A 3-year expedition yields a treasure trove of data on microorganisms and small animals in the world's oceans	SCIENCE			English	Editorial Material									[Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Palumbi, Stephen R.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	University of Washington; University of Washington Seattle; Stanford University	Armbrust, EV (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	armbrust@uw.edu; spalumbi@stanford.edu						Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Brum JR, 2015, SCIENCE, V348, DOI 10.1126/science.1261498; Cermeno P, 2009, SCIENCE, V325, P1539, DOI 10.1126/science.1174159; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Hurwitz BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057355; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Villar E, 2015, SCIENCE, V348, DOI 10.1126/science.1261447; Yoon HS, 2011, SCIENCE, V332, P714, DOI 10.1126/science.1203163; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	15	19	20	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					865	867		10.1126/science.aaa7378	http://dx.doi.org/10.1126/science.aaa7378			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999494				2022-12-28	WOS:000354877900020
J	Brash, DE				Brash, Douglas E.			Preprocancer Normal skin harbors cancer-causing mutations	SCIENCE			English	Editorial Material							HISTORY; FATE; P53		[Brash, Douglas E.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Brash, Douglas E.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA	Yale University; Yale University	Brash, DE (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA.	douglas.brash@yale.edu						Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Deng GR, 1996, SCIENCE, V274, P2057, DOI 10.1126/science.274.5295.2057; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; FOULDS L, 1958, J Chronic Dis, V8, P2, DOI 10.1016/0021-9681(58)90039-0; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Klein AM, 2010, P NATL ACAD SCI USA, V107, P270, DOI 10.1073/pnas.0909738107; LOEB LA, 1991, CANCER RES, V51, P3075; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; SHERLEY JL, 1995, P NATL ACAD SCI USA, V92, P136, DOI 10.1073/pnas.92.1.136; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	15	11	12	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					867	868		10.1126/science.aac4435	http://dx.doi.org/10.1126/science.aac4435			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999495				2022-12-28	WOS:000354877900021
J	Karkazis, K; Jordan-Young, R				Karkazis, Katrina; Jordan-Young, Rebecca			Debating a testosterone "sex gap" Policies unfairly exclude some women athletes from competition	SCIENCE			English	Editorial Material							EXERCISE-INDUCED CHANGES; GENDER VERIFICATION; HYPERANDROGENISM; HEALTH		[Karkazis, Katrina] Stanford Univ, Stanford, CA 94305 USA; [Jordan-Young, Rebecca] Columbia Univ Barnard Coll, New York, NY 10027 USA	Stanford University; Columbia University	Karkazis, K (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	karkazis@stanford.edu	Karkazis, Katrina/AAE-7276-2019	Karkazis, Katrina/0000-0001-9103-2881	Direct For Social, Behav & Economic Scie [1331123] Funding Source: National Science Foundation	Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Bermon S, 2014, J CLIN ENDOCR METAB, V99, P4328, DOI 10.1210/jc.2014-1391; Bermon S, 2013, AM J BIOETHICS, V13, P63, DOI 10.1080/15265161.2013.776129; Cook CJ, 2012, HORM BEHAV, V61, P17, DOI 10.1016/j.yhbeh.2011.09.006; Elsas LJ, 2000, GENET MED, V2, P249, DOI 10.1097/00125817-200007000-00008; Enea C, 2011, SPORTS MED, V41, P1, DOI 10.2165/11536920-000000000-00000; Ginsburg GS, 2001, CLIN CHIM ACTA, V305, P131, DOI 10.1016/S0009-8981(00)00427-7; Healy ML, 2014, CLIN ENDOCRINOL, V81, P294, DOI 10.1111/cen.12445; Jordan-Young RM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2926; Lee PA, 2006, PEDIATRICS, V118, pE488, DOI 10.1542/peds.2006-0738; LJUNGQVIST A, 1992, JAMA-J AM MED ASSOC, V267, P850, DOI 10.1001/jama.267.6.850; Padmadeo V. B., 2014, INDIAN EXPRESS; Ritzen M, 2015, CLIN ENDOCRINOL, V82, P307, DOI 10.1111/cen.12531; Schweber N., 2012, NY TIMES; Simpson JL, 2000, JAMA-J AM MED ASSOC, V284, P1568, DOI 10.1001/jama.284.12.1568; van Anders SM, 2006, PSYCHONEUROENDOCRINO, V31, P715, DOI 10.1016/j.psyneuen.2006.01.008; Vingren JL, 2010, SPORTS MED, V40, P1037, DOI 10.2165/11536910-000000000-00000; Women's Sports Foundation, 2011, PART INT ATHL WOM SP, P1	17	19	19	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					858	860		10.1126/science.aab1057	http://dx.doi.org/10.1126/science.aab1057			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI6NW	25999490	Green Submitted			2022-12-28	WOS:000354877900016
J	Vos, T; Barber, RM; Bell, B; Bertozzi-Villa, A; Biryukov, S; Bolliger, I; Charlson, F; Davis, A; Degenhardt, L; Dicker, D; Duan, L; Erskine, H; Feigin, VL; Ferrari, AJ; Fitzmaurice, C; Fleming, T; Graetz, N; Guinovart, C; Haagsma, J; Hansen, GM; Hanson, SW; Heuton, KR; Higashi, H; Kassebaum, N; Kyu, H; Laurie, E; Liang, XF; Lofgren, K; Lozano, R; MacIntyre, MF; Moradi-Lakeh, M; Naghavi, M; Nguyen, G; Odell, S; Ortblad, K; Roberts, DA; Roth, GA; Sandar, L; Serina, PT; Stanaway, JD; Steiner, C; Thomas, B; Vollset, SE; Whiteford, H; Wolock, TM; Ye, PP; Zhou, MG; Avila, MA; Aasvang, GM; Abbafati, C; Ozgoren, AA; Abd-Allah, F; Aziz, MIA; Abera, SF; Aboyans, V; Abraham, JP; Abraham, B; Abubakar, I; Abu-Raddad, LJ; Abu-Rmeileh, NME; Aburto, TC; Achoki, T; Ackerman, IN; Adelekan, A; Ademi, Z; Adou, AK; Adsuar, JC; Arnlov, J; Agardh, EE; Al Khabouri, MJ; Alam, SS; Alasfoor, D; Albittar, MI; Alegretti, MA; Aleman, AV; Alemu, ZA; Alfonso-Cristancho, R; Alhabib, S; Ali, R; Alla, F; Allebeck, P; Allen, PJ; AlMazroa, MA; Alsharif, U; Alvarez, E; Alvis-Guzman, N; Ameli, O; Amini, H; Ammar, W; Anderson, BO; Anderson, HR; Antonio, CAT; Anwari, P; Apfel, H; Arsenijevic, VSA; Artaman, A; Asghar, RJ; Assadi, R; Atkins, LS; Atkinson, C; Badawi, A; Bahit, MC; Bakfalouni, T; Balakrishnan, K; Balalla, S; Banerjee, A; Barker-Collo, SL; Barquera, S; Barregard, L; Barrero, LH; Basu, S; Basu, A; Baxter, A; Beardsley, J; Bedi, N; Beghi, E; Bekele, T; Bell, ML; Benjet, C; Bennett, DA; Bensenor, IM; Benzian, H; Bernabe, E; Beyene, TJ; Bhala, N; Bhalla, A; Bhutta, ZQ; Bienhoff, K; Bikbov, B; Bin Abdulhak, A; Blore, JD; Blyth, FM; Bohensky, MA; Basara, BB; Borges, G; Bornstein, NM; Bose, D; Boufous, S; Bourne, RR; Boyers, LN; Brainin, M; Brauer, M; Brayne, CEG; Brazinova, A; Breitborde, NJK; Brenner, H; Briggs, ADM; Brooks, PM; Brown, J; Brugha, TS; Buchbinder, R; Buckle, GC; Bukhman, G; Bulloch, AG; Burch, M; Burnett, R; Cardenas, R; Cabral, NL; Nonato, IRC; Campuzano, JC; Carapetis, JR; Carpenter, DO; Caso, V; Castaneda-Orjuela, CA; Catala-Lopez, F; Chadha, VK; Chang, JC; Chen, HL; Chen, WQ; Chiang, PP; Chimed-Ochir, O; Chowdhury, R; Christensen, H; Christophi, CA; Chugh, SS; Cirillo, M; Coggeshall, M; Cohen, A; Colistro, V; Colquhoun, SM; Contreras, AG; Cooper, LT; Cooper, C; Cooperrider, K; Coresh, J; Cortinovis, M; Criqui, MH; Crump, JA; Cuevas-Nasu, L; Dandona, R; Dandona, L; Dansereau, E; Dantes, HG; Dargan, PI; Davey, G; Davitoiu, DV; Dayama, A; De la Cruz-Gongora, V; de la Vega, SF; De Leo, D; del Pozo-Cruz, B; Dellavalle, RP; Deribe, K; Derrett, S; Des Jarlais, DC; Dessalegn, M; de Veber, GA; Dharmaratne, SD; Diaz-Torne, C; Ding, EL; Dokova, K; Dorsey, ER; Driscoll, TR; Duber, H; Durrani, AM; Edmond, KM; Ellenbogen, RG; Endres, M; Ermakov, SP; Eshrati, B; Esteghamati, A; Estep, K; Fahimi, S; Farzadfar, F; Fay, DFJ; Felson, DT; Fereshtehnejad, SM; Fernandes, JG; Ferri, CP; Flaxman, A; Foigt, N; Foreman, KJ; Fowkes, FGR; Franklin, RC; Furst, T; Futran, ND; Gabbe, BJ; Gankpe, FG; Garcia-Guerra, FA; Geleijnse, JM; Gessner, BD; Gibney, KB; Gillum, RF; Ginawi, IA; Giroud, M; Giussani, G; Goenka, S; Goginashvili, K; Gona, P; de Cosio, TG; Gosselin, RA; Gotay, CC; Goto, A; Gouda, HN; Guerrant, RL; Gugnani, HC; Gunnell, D; Gupta, R; Gupta, R; Gutierrez, RA; Hafezi-Nejad, N; Hagan, H; Halasa, Y; Hamadeh, RR; Hamavid, H; Hammami, M; Hankey, GJ; Hao, YT; Harb, HL; Haro, JM; Havmoeller, R; Hay, RJ; Hay, S; Hedayati, MT; Pi, IBH; Heydarpour, P; Hijar, M; Hoek, HW; Hoffman, HJ; Hornberger, JC; Hosgood, HD; Hossain, M; Hotez, PJ; Hoy, DG; Hsairi, M; Hu, H; Hu, GQ; Huang, JJ; Huang, C; Huiart, L; Husseini, A; Iannarone, M; Iburg, KM; Innos, K; Inoue, M; Jacobsen, KH; Jassal, SK; Jeemon, P; Jensen, PN; Jha, V; Jiang, G; Jiang, Y; Jonas, JB; Joseph, J; Juel, K; Kan, HD; Karch, A; Karimkhani, C; Karthikeyan, G; Katz, R; Kaul, A; Kawakami, N; Kazi, DS; Kemp, AH; Kengne, AP; Khader, YS; Khalifa, SEAH; Khan, EA; Khan, G; Khang, YH; Khonelidze, I; Kieling, C; Kim, D; Kim, S; Kimokoti, RW; Kinfu, Y; Kinge, JM; Kissela, BM; Kivipelto, M; Knibbs, L; Knudsen, AK; Kokubo, Y; Kosen, S; Kramer, A; Kravchenko, M; Krishnamurthi, RV; Krishnaswami, S; Defo, BK; Bicer, BK; Kuipers, EJ; Kulkarni, VS; Kumar, K; Kumar, GA; Kwan, GF; Lai, T; Lalloo, R; Lam, H; Lan, Q; Lansingh, VC; Larson, H; Larsson, A; Lawrynowicz, AEB; Leasher, JL; Lee, JT; Leigh, J; Leung, R; Levi, M; Li, B; Li, YC; Li, YM; Liang, J; Lim, S; Lin, HH; Lind, M; Lindsay, MP; Lipshultz, SE; Liu, SW; Lloyd, BK; Ohno, SL; Logroscino, G; Looker, KJ; Lopez, AD; Lopez-Olmedo, N; Lortet-Tieulent, J; Lotufo, PA; Low, N; Lucas, RM; Lunevicius, R; Lyons, RA; Ma, JX; Ma, S; Mackay, MT; Majdan, M; Malekzadeh, R; Mapoma, CC; Marcenes, W; March, LM; Margono, C; Marks, GB; Marzan, MB; Masci, JR; Mason-Jones, AJ; Matzopoulos, RG; Mayosi, BM; Mazorodze, TT; McGill, NW; McGrath, JJ; McKee, M; McLain, A; McMahon, BJ; Meaney, PA; Mehndiratta, MM; Mejia-Rodriguez, F; Mekonnen, W; Melaku, YA; Meltzer, M; Memish, ZA; Mensah, G; Meretoja, A; Mhimbira, FA; Micha, R; Miller, TR; Mills, EJ; Mitchell, PB; Mock, CN; Moffitt, TE; Ibrahim, NM; Mohammad, KA; Mokdad, AH; Mola, GL; Monasta, L; Montico, M; Montine, TJ; Moore, AR; Moran, AE; Morawska, L; Mori, R; Moschandreas, J; Moturi, WN; Moyer, M; Mozaffarian, D; Mueller, UO; Mukaigawara, M; Murdoch, ME; Murray, J; Murthy, KS; Naghavi, P; Nahas, Z; Naheed, A; Naidoo, KS; Naldi, L; Nand, D; Nangia, V; Narayan, KMV; Nash, D; Nejjari, C; Neupane, SP; Newman, LM; Newton, CR; Ng, M; Ngalesoni, FN; Nhung, NT; Nisar, MI; Nolte, S; Norheim, OF; Norman, RE; Norrving, B; Nyakarahuka, L; Oh, IH; Ohkubo, T; Omer, SB; Opio, JN; Ortiz, A; Pandian, JD; Panelo, CIA; Papachristou, C; Park, EK; Parry, CD; Caicedo, AJP; Patten, SB; Paul, VK; Pavlin, BI; Pearce, N; Pedraza, LS; Pellegrini, CA; Pereira, DM; Perez-Ruiz, FP; Perico, N; Pervaiz, A; Pesudovs, K; Peterson, CB; Petzold, M; Phillips, MR; Phillips, D; Phillips, B; Piel, FB; Plass, D; Poenaru, D; Polanczyk, GV; Polinder, S; Pope, CA; Popova, S; Poulton, RG; Pourmalek, F; Prabhakaran, D; Prasad, NM; Qato, D; Quistberg, DA; Rafay, A; Rahimi, K; Rahimi-Movaghar, V; Rahman, SU; Raju, M; Rakovac, I; Rana, SM; Razavi, H; Refaat, A; Rehm, J; Remuzzi, G; Resnikoff, S; Ribeiro, AL; Riccio, PM; Richardson, L; Richardus, JH; Riederer, AM; Robinson, M; Roca, A; Rodriguez, A; Rojas-Rueda, D; Ronfani, L; Rothenbacher, D; Roy, N; Ruhago, GM; Sabin, N; Sacco, RL; Ksoreide, K; Saha, S; Sahathevan, R; Sahraian, MA; Sampson, U; Sanabria, JR; Sanchez-Riera, L; Santos, IS; Satpathy, M; Saunders, JE; Sawhney, M; Saylan, MI; Scarborough, P; Schoettker, B; Schneider, IJ; Schwebel, DC; Scott, JG; Seedat, S; Sepanlou, SG; Serdar, B; Servan-Mori, EE; Shackelford, K; Shaheen, A; Shahraz, S; Levy, TS; Shangguan, S; She, J; Sheikhbahaei, S; Shepard, DS; Shi, PL; Shibuya, K; Shinohara, Y; Shiri, R; Shishani, K; Shiue, I; Shrime, MG; Sigfusdottir, ID; Silberberg, DH; Simard, EP; Sindi, S; Singh, JA; Singh, L; Skirbekk, V; Sliwa, K; Soljak, M; Soneji, S; Soshnikov, SS; Speyer, P; Sposato, LA; Sreeramareddy, CT; Stoeckl, H; Stathopoulou, VK; Steckling, N; Stein, MB; Stein, DJ; Steiner, TJ; Stewart, A; Stork, E; Stovner, LJ; Stroumpoulis, K; Sturua, L; Sunguya, BF; Swaroop, M; Sykes, BL; Tabb, KM; Takahashi, K; Tan, F; Tandon, N; Tanne, D; Tanner, M; Tavakkoli, M; Taylor, HR; Ao, BJT; Temesgen, AM; Ten Have, M; Tenkorang, EY; Terkawi, AS; Theadom, AM; Thomas, E; Thorne-Lyman, AL; Thrift, AG; Tleyjeh, IM; Tonelli, M; Topouzis, F; Towbin, JA; Toyoshima, H; Traebert, J; Tran, BX; Trasande, L; Trillini, M; Truelsen, T; Trujillo, U; Tsilimbaris, M; Tuzcu, EM; Ukwaja, KN; Undurraga, EA; Uzun, SB; van Brakel, WH; de Vijver, SV; Van Dingenen, R; van Gool, CH; Varakin, YY; Vasankari, TJ; Vavilala, MS; Veerman, LJ; Velasquez-Melendez, G; Venketasubramanian, N; Vijayakumar, L; Villalpando, S; Violante, FS; Vlassov, VV; Waller, S; Wallin, MT; Wan, X; Wang, LH; Wang, JL; Wang, YP; Warouw, TS; Weichenthal, S; Weiderpass, E; Weintraub, RG; Werdecker, A; Wessells, KRR; Westerman, R; Wilkinson, JD; Williams, HC; Williams, TN; Woldeyohannes, SM; Wolfe, CDA; Wong, JQ; Wong, HD; Woolf, AD; Wright, JL; Wurtz, B; Xu, GL; Yang, GH; Yano, Y; Yenesew, MA; Yentur, GK; Yip, P; Yonemoto, N; Yoon, SJ; Younis, M; Yu, CH; Kim, KY; Zaki, MES; Zhang, Y; Zhao, Z; Zhao, Y; Zhu, J; Zonies, D; Zunt, JR; Salomon, JA; Murray, CJL				Vos, Theo; Barber, Ryan M.; Bell, Brad; Bertozzi-Villa, Amelia; Biryukov, Stan; Bolliger, Ian; Charlson, Fiona; Davis, Adrian; Degenhardt, Louisa; Dicker, Daniel; Duan, Leilei; Erskine, Holly; Feigin, Valery L.; Ferrari, Alize J.; Fitzmaurice, Christina; Fleming, Thomas; Graetz, Nicholas; Guinovart, Caterina; Haagsma, Juanita; Hansen, Gillian M.; Hanson, Sarah Wulf; Heuton, Kyle R.; Higashi, Hideki; Kassebaum, Nicholas; Kyu, Hmwe; Laurie, Evan; Liang, Xiofeng; Lofgren, Katherine; Lozano, Rafael; MacIntyre, Michael F.; Moradi-Lakeh, Maziar; Naghavi, Mohsen; Nguyen, Grant; Odell, Shaun; Ortblad, Katrina; Roberts, David Allen; Roth, Gregory A.; Sandar, Logan; Serina, Peter T.; Stanaway, Jeffrey D.; Steiner, Caitlyn; Thomas, Bernadette; Vollset, Stein Emil; Whiteford, Harvey; Wolock, Timothy M.; Ye, Pengpeng; Zhou, Maigeng; Avila, Marco A.; Aasvang, Gunn Marit; Abbafati, Cristiana; Ozgoren, Ayse Abbasoglu; Abd-Allah, Foad; Aziz, Muna I. Abdel; Abera, Semaw F.; Aboyans, Victor; Abraham, Jerry P.; Abraham, Biju; Abubakar, Ibrahim; Abu-Raddad, Laith J.; Abu-Rmeileh, Niveen M. E.; Aburto, Tania C.; Achoki, Tom; Ackerman, Ilana N.; Adelekan, Ademola; Ademi, Zanfina; Adou, Arsene K.; Adsuar, Josef C.; Arnlov, Johan; Agardh, Emilie E.; Al Khabouri, Mazin J.; Alam, Sayed Saidul; Alasfoor, Deena; Albittar, Mohammed I.; Alegretti, Miguel A.; Aleman, Alicia V.; Alemu, Zewdie A.; Alfonso-Cristancho, Rafael; Alhabib, Samia; Ali, Raghib; Alla, Francois; Allebeck, Peter; Allen, Peter J.; AlMazroa, Mohammad AbdulAziz; Alsharif, Ubai; Alvarez, Elena; Alvis-Guzman, Nelson; Ameli, Omid; Amini, Heresh; Ammar, Walid; Anderson, Benjamin O.; Anderson, H. Ross; Antonio, Carl Abelardo T.; Anwari, Palwasha; Apfel, Henry; Arsenijevic, Valentain S. Arsic; Artaman, Al; Asghar, Rana J.; Assadi, Reza; Atkins, Lydia S.; Atkinson, Charles; Badawi, Alaa; Bahit, Maria C.; Bakfalouni, Talal; Balakrishnan, Kalpana; Balalla, Shivanthi; Banerjee, Amitava; Barker-Collo, Suzanne L.; Barquera, Simon; Barregard, Lars; Barrero, Lope H.; Basu, Sanjay; Basu, Arindam; Baxter, Amanda; Beardsley, Justin; Bedi, Neeraj; Beghi, Ettore; Bekele, Tolesa; Bell, Michelle L.; Benjet, Corina; Bennett, Derrick A.; Bensenor, Isabela M.; Benzian, Habib; Bernabe, Eduardo; Beyene, Tariku J.; Bhala, Neeraj; Bhalla, Ashish; Bhutta, Zulfi Qar; Bienhoff, Kelly; Bikbov, Boris; Bin Abdulhak, Aref; Blore, Jed D.; Blyth, Fiona M.; Bohensky, Megan A.; Basara, Berrak Bora; Borges, Guilherme; Bornstein, Natan M.; Bose, Dipan; Boufous, Soufiane; Bourne, Rupert R.; Boyers, Lindsay N.; Brainin, Michael; Brauer, Michael; Brayne, Carol E. G.; Brazinova, Alexandra; Breitborde, Nicholas J. K.; Brenner, Hermann; Briggs, Adam D. M.; Brooks, Peter M.; Brown, Jonathan; Brugha, Traolach S.; Buchbinder, Rachelle; Buckle, Geoffrey C.; Bukhman, Gene; Bulloch, Andrew G.; Burch, Michael; Burnett, Richard; Cardenas, Rosario; Cabral, Norberto L.; Nonato, Ismael R. Campos; Campuzano, Julio C.; Carapetis, Jonathan R.; Carpenter, David O.; Caso, Valeria; Castaneda-Orjuela, Carlos A.; Catala-Lopez, Ferran; Chadha, Vineet K.; Chang, Jung-Chen; Chen, Honglei; Chen, Wanqing; Chiang, Peggy P.; Chimed-Ochir, Odgerel; Chowdhury, Rajiv; Christensen, Hanne; Christophi, Costas A.; Chugh, Sumeet S.; Cirillo, Massimo; Coggeshall, Megan; Cohen, Aaron; Colistro, Valentina; Colquhoun, Samantha M.; Contreras, Alejandra G.; Cooper, Leslie T.; Cooper, Cyrus; Cooperrider, Kimberly; Coresh, Josef; Cortinovis, Monica; Criqui, Michael H.; Crump, John A.; Cuevas-Nasu, Lucia; Dandona, Rakhi; Dandona, Lalit; Dansereau, Emily; Dantes, Hector G.; Dargan, Paul I.; Davey, Gail; Davitoiu, Dragos V.; Dayama, Anand; De la Cruz-Gongora, Vanessa; de la Vega, Shelley F.; De Leo, Diego; del Pozo-Cruz, Borja; Dellavalle, Robert P.; Deribe, Kebede; Derrett, Sarah; Des Jarlais, Don C.; Dessalegn, Muluken; de Veber, Gabrielle A.; Dharmaratne, Samath D.; Diaz-Torne, Cesar; Ding, Eric L.; Dokova, Klara; Dorsey, E. R.; Driscoll, Tim R.; Duber, Herbert; Durrani, Adnan M.; Edmond, Karen M.; Ellenbogen, Richard G.; Endres, Matthias; Ermakov, Sergey P.; Eshrati, Babak; Esteghamati, Alireza; Estep, Kara; Fahimi, Saman; Farzadfar, Farshad; Fay, Derek F. J.; Felson, David T.; Fereshtehnejad, Seyed-Mohammad; Fernandes, Jefferson G.; Ferri, Cluesa P.; Flaxman, Abraham; Foigt, Nataliya; Foreman, Kyle J.; Fowkes, F. Gerry R.; Franklin, Richard C.; Furst, Thomas; Futran, Neal D.; Gabbe, Belinda J.; Gankpe, Fortune G.; Garcia-Guerra, Francisco A.; Geleijnse, Johanna M.; Gessner, Bradford D.; Gibney, Katherine B.; Gillum, Richard F.; Ginawi, Ibrahim A.; Giroud, Maurice; Giussani, Giorgia; Goenka, Shifalika; Goginashvili, Ketevan; Gona, Philimon; de Cosio, Teresita Gonzalez; Gosselin, Richard A.; Gotay, Carolyn C.; Goto, Atsushi; Gouda, Hebe N.; Guerrant, Richard L.; Gugnani, Harish C.; Gunnell, David; Gupta, Rajeev; Gupta, Rahul; Gutierrez, Reyna A.; Hafezi-Nejad, Nima; Hagan, Holly; Halasa, Yara; Hamadeh, Randah R.; Hamavid, Hannah; Hammami, Mouhanad; Hankey, Graeme J.; Hao, Yuantao; Harb, Hilda L.; Haro, Josep Maria; Havmoeller, Rasmus; Hay, Roderick J.; Hay, Simon; Hedayati, Mohammad T.; Pi, Ileana B. Heredia; Heydarpour, Pouria; Hijar, Martha; Hoek, Hans W.; Hoffman, Howard J.; Hornberger, John C.; Hosgood, H. Dean; Hossain, Mazeda; Hotez, Peter J.; Hoy, Damian G.; Hsairi, Mohamed; Hu, Howard; Hu, Guoqing; Huang, John J.; Huang, Cheng; Huiart, Laetitia; Husseini, Abdullatif; Iannarone, Marissa; Iburg, Kim M.; Innos, Kaire; Inoue, Manami; Jacobsen, Kathryn H.; Jassal, Simerjot K.; Jeemon, Panniyammakal; Jensen, Paul N.; Jha, Vivekanand; Jiang, Guohong; Jiang, Ying; Jonas, Jost B.; Joseph, Jonathan; Juel, Knud; Kan, Haidong; Karch, Andre; Karimkhani, Chante; Karthikeyan, Ganesan; Katz, Ronit; Kaul, Anil; Kawakami, Norito; Kazi, Dhruv S.; Kemp, Andrew H.; Kengne, Andre P.; Khader, Yousef S.; Khalifa, Shams Eldin A. H.; Khan, Ejaz A.; Khan, Gulfaraz; Khang, Young-Ho; Khonelidze, Irma; Kieling, Christian; Kim, Daniel; Kim, Sungroul; Kimokoti, Ruth W.; Kinfu, Yohannes; Kinge, Jonas M.; Kissela, Brett M.; Kivipelto, Miia; Knibbs, Luke; Knudsen, Ann Kristin; Kokubo, Yoshihiro; Kosen, Soewarta; Kramer, Alexander; Kravchenko, Michael; Krishnamurthi, Rita V.; Krishnaswami, Sanjay; Defo, Barthelemy Kuate; Bicer, Burcu Kucuk; Kuipers, Ernst J.; Kulkarni, Veena S.; Kumar, Kaushalendra; Kumar, G. Anil; Kwan, Gene F.; Lai, Taavi; Lalloo, Ratilal; Lam, Hilton; Lan, Qing; Lansingh, Van C.; Larson, Heidi; Larsson, Anders; Lawrynowicz, Alicia E. B.; Leasher, Janet L.; Lee, Jong-Tae; Leigh, James; Leung, Ricky; Levi, Miriam; Li, Bin; Li, Yichong; Li, Yongmei; Liang, Juan; Lim, Stephen; Lin, Hsien-Ho; Lind, Margaret; Lindsay, M. Patrice; Lipshultz, Steven E.; Liu, Shiwei; Lloyd, Belinda K.; Ohno, Summer Lockett; Logroscino, Giancarlo; Looker, Katharine J.; Lopez, Alan D.; Lopez-Olmedo, Nancy; Lortet-Tieulent, Joannie; Lotufo, Paulo A.; Low, Nicola; Lucas, Robyn M.; Lunevicius, Raimundas; Lyons, Ronan A.; Ma, Jixiang; Ma, Stefan; Mackay, Mark T.; Majdan, Marek; Malekzadeh, Reza; Mapoma, Christopher C.; Marcenes, Wagner; March, Lyn M.; Margono, Chris; Marks, Guy B.; Marzan, Melvin B.; Masci, Joseph R.; Mason-Jones, Amanda J.; Matzopoulos, Richard G.; Mayosi, Bongani M.; Mazorodze, Tasara T.; McGill, Neil W.; McGrath, John J.; McKee, Martin; McLain, Abby; McMahon, Brian J.; Meaney, Peter A.; Mehndiratta, Man Mohan; Mejia-Rodriguez, Fabiola; Mekonnen, Wubegzier; Melaku, Yohannes A.; Meltzer, Michele; Memish, Ziad A.; Mensah, George; Meretoja, Atte; Mhimbira, Francis A.; Micha, Renata; Miller, Ted R.; Mills, Edward J.; Mitchell, Philip B.; Mock, Charles N.; Moffitt, Terrie E.; Ibrahim, Norlinah Mohamed; Mohammad, Karzan A.; Mokdad, Ali H.; Mola, Glen L.; Monasta, Lorenzo; Montico, Marcella; Montine, Thomas J.; Moore, Ami R.; Moran, Andrew E.; Morawska, Lidia; Mori, Rintaro; Moschandreas, Joanna; Moturi, Wilkister N.; Moyer, Madeline; Mozaffarian, Dariush; Mueller, Ulrich O.; Mukaigawara, Mitsuru; Murdoch, Michele E.; Murray, Joseph; Murthy, Kinnari S.; Naghavi, Paria; Nahas, Ziad; Naheed, Aliya; Naidoo, Kovin S.; Naldi, Luigi; Nand, Devina; Nangia, Vinay; Narayan, K. M. Venkat; Nash, Denis; Nejjari, Chakib; Neupane, Sudan P.; Newman, Lori M.; Newton, Charles R.; Ng, Marie; Ngalesoni, Frida N.; Nhung, Nguyen T.; Nisar, Muhammad I.; Nolte, Sandra; Norheim, Ole F.; Norman, Rosana E.; Norrving, Bo; Nyakarahuka, Luke; Oh, In Hwan; Ohkubo, Takayoshi; Omer, Saad B.; Opio, John Nelson; Ortiz, Alberto; Pandian, Jeyaraj D.; Panelo, Carlo Irwin A.; Papachristou, Christina; Park, Eun-Kee; Parry, Charles D.; Caicedo, Angel J. Paternina; Patten, Scott B.; Paul, Vinod K.; Pavlin, Boris I.; Pearce, Neil; Pedraza, Lilia S.; Pellegrini, Carlos A.; Pereira, David M.; Perez-Ruiz, Fernando P.; Perico, Norberto; Pervaiz, Aslam; Pesudovs, Konrad; Peterson, Carrie B.; Petzold, Max; Phillips, Michael R.; Phillips, David; Phillips, Bryan; Piel, Frederic B.; Plass, Dietrich; Poenaru, Dan; Polanczyk, Guilherme V.; Polinder, Suzanne; Pope, C. A., III; Popova, Svetlana; Poulton, Richie G.; Pourmalek, Farshad; Prabhakaran, Dorairaj; Prasad, Noela M.; Qato, Dima; Quistberg, D. A.; Rafay, Anwar; Rahimi, Kazem; Rahimi-Movaghar, Vafa; Rahman, Sajjad Ur; Raju, Murugesan; Rakovac, Ivo; Rana, Saleem M.; Razavi, Homie; Refaat, Amany; Rehm, Jurgen; Remuzzi, Giuseppe; Resnikoff, Serge; Ribeiro, Antonio L.; Riccio, Patricia M.; Richardson, Lee; Richardus, Jan Hendrik; Riederer, Anne M.; Robinson, Margot; Roca, Anna; Rodriguez, Alina; Rojas-Rueda, David; Ronfani, Luca; Rothenbacher, Dietrich; Roy, Nobhojit; Ruhago, George M.; Sabin, Nsanzimana; Sacco, Ralph L.; Ksoreide, Kjetil; Saha, Sukanta; Sahathevan, Ramesh; Sahraian, Mohammad Ali; Sampson, Uchechukwu; Sanabria, Juan R.; Sanchez-Riera, Lidia; Santos, Itamar S.; Satpathy, Maheswar; Saunders, James E.; Sawhney, Monika; Saylan, Mete I.; Scarborough, Peter; Schoettker, Ben; Schneider, Ione J. C.; Schwebel, David C.; Scott, James G.; Seedat, Soraya; Sepanlou, Sadaf G.; Serdar, Berrin; Servan-Mori, Edson E.; Shackelford, Katya; Shaheen, Amira; Shahraz, Saeid; Levy, Teresa Shamah; Shangguan, Siyi; She, Jun; Sheikhbahaei, Sara; Shepard, Donald S.; Shi, Peilin; Shibuya, Kenji; Shinohara, Yukito; Shiri, Rahman; Shishani, Kawkab; Shiue, Ivy; Shrime, Mark G.; Sigfusdottir, Inga D.; Silberberg, Donald H.; Simard, Edgar P.; Sindi, Shireen; Singh, Jasvinder A.; Singh, Lavanya; Skirbekk, Vegard; Sliwa, Karen; Soljak, Michael; Soneji, Samir; Soshnikov, Sergey S.; Speyer, Peter; Sposato, Luciano A.; Sreeramareddy, Chandrashekhar T.; Stoeckl, Heidi; Stathopoulou, Vasiliki Kalliopi; Steckling, Nadine; Stein, Murray B.; Stein, Dan J.; Steiner, Timothy J.; Stewart, Andrea; Stork, Eden; Stovner, Lars J.; Stroumpoulis, Konstantinos; Sturua, Lela; Sunguya, Bruno F.; Swaroop, Mamta; Sykes, Bryan L.; Tabb, Karen M.; Takahashi, Ken; Tan, Feng; Tandon, Nikhil; Tanne, David; Tanner, Marcel; Tavakkoli, Mohammad; Taylor, Hugh R.; Ao, Braden J. Te; Temesgen, Awoke Misganaw; Ten Have, Margreet; Tenkorang, Eric Yeboah; Terkawi, Abdullah Sulieman; Theadom, Alice M.; Thomas, Elissa; Thorne-Lyman, Andrew L.; Thrift, Amanda G.; Tleyjeh, Imad M.; Tonelli, Marcello; Topouzis, Fotis; Towbin, Jeffrey A.; Toyoshima, Hideaki; Traebert, Jefferson; Tran, Bach X.; Trasande, Leonardo; Trillini, Matias; Truelsen, Thomas; Trujillo, Ulises; Tsilimbaris, Miltiadis; Tuzcu, Emin M.; Ukwaja, Kingsley N.; Undurraga, Eduardo A.; Uzun, Selen B.; van Brakel, Wim H.; de Vijver, Steven van; Van Dingenen, Rita; van Gool, Coen H.; Varakin, Yuri Y.; Vasankari, Tommi J.; Vavilala, Monica S.; Veerman, Lennert J.; Velasquez-Melendez, Gustavo; Venketasubramanian, Narayanaswamy; Vijayakumar, Lakshmi; Villalpando, Salvador; Violante, Francesco S.; Vlassov, Vasiliy V.; Waller, Stephen; Wallin, Mitchell T.; Wan, Xia; Wang, Linhong; Wang, JianLi; Wang, Yanping; Warouw, Tati S.; Weichenthal, Scott; Weiderpass, Elisabete; Weintraub, Robert G.; Werdecker, Andrea; Wessells, K. Ryan R.; Westerman, Ronny; Wilkinson, James D.; Williams, Hywel C.; Williams, Thomas N.; Woldeyohannes, Solomon M.; Wolfe, Charles D. A.; Wong, John Q.; Wong, Haidong; Woolf, Anthony D.; Wright, Jonathan L.; Wurtz, Brittany; Xu, Gelin; Yang, Gonghuan; Yano, Yuichiro; Yenesew, Muluken A.; Yentur, Gokalp K.; Yip, Paul; Yonemoto, Naohiro; Yoon, Seok-Jun; Younis, Mustafa; Yu, Chuanhua; Kim, Kim Yun; Zaki, Maysaa El Sayed; Zhang, Yong; Zhao, Zheng; Zhao, Yong; Zhu, Jun; Zonies, David; Zunt, Joseph R.; Salomon, Joshua A.; Murray, Christopher J. L.		Global Burden Dis Study	Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013	LANCET			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CONDUCT DISORDER; IRON-DEFICIENCY; HEALTH OUTCOMES; OTITIS-MEDIA; WEIGHTS; EPIDEMIOLOGY; POPULATION; RISK; OSTEOARTHRITIS	Background Up-to-date evidence about levels and trends in disease and injury incidence, prevalence, and years lived with disability (YLDs) is an essential input into global, regional, and national health policies. In the Global Burden of Disease Study 2013 (GBD 2013), we estimated these quantities for acute and chronic diseases and injuries for 188 countries between 1990 and 2013. Methods Estimates were calculated for disease and injury incidence, prevalence, and YLDs using GBD 2010 methods with some important refinements. Results for incidence of acute disorders and prevalence of chronic disorders are new additions to the analysis. Key improvements include expansion to the cause and sequelae list, updated systematic reviews, use of detailed injury codes, improvements to the Bayesian meta-regression method (DisMod-MR), and use of severity splits for various causes. An index of data representativeness, showing data availability, was calculated for each cause and impairment during three periods globally and at the country level for 2013. In total, 35 620 distinct sources of data were used and documented to calculated estimates for 301 diseases and injuries and 2337 sequelae. The comorbidity simulation provides estimates for the number of sequelae, concurrently, by individuals by country, year, age, and sex. Disability weights were updated with the addition of new population-based survey data from four countries. Findings Disease and injury were highly prevalent; only a small fraction of individuals had no sequelae. Comorbidity rose substantially with age and in absolute terms from 1990 to 2013. Incidence of acute sequelae were predominantly infectious diseases and short-term injuries, with over 2 billion cases of upper respiratory infections and diarrhoeal disease episodes in 2013, with the notable exception of tooth pain due to permanent caries with more than 200 million incident cases in 2013. Conversely, leading chronic sequelae were largely attributable to non-communicable diseases, with prevalence estimates for asymptomatic permanent caries and tension-type headache of 2.4 billion and 1.6 billion, respectively. The distribution of the number of sequelae in populations varied widely across regions, with an expected relation between age and disease prevalence. YLDs for both sexes increased from 537.6 million in 1990 to 764.8 million in 2013 due to population growth and ageing, whereas the age-standardised rate decreased little from 114.87 per 1000 people to 110.31 per 1000 people between 1990 and 2013. Leading causes of YLDs included low back pain and major depressive disorder among the top ten causes of YLDs in every country. YLD rates per person, by major cause groups, indicated the main drivers of increases were due to musculoskeletal, mental, and substance use disorders, neurological disorders, and chronic respiratory diseases; however HIV/AIDS was a notable driver of increasing YLDs in sub-Saharan Africa. Also, the proportion of disability-adjusted life years due to YLDs increased globally from 21.1% in 1990 to 31.2% in 2013. Interpretation Ageing of the world's population is leading to a substantial increase in the numbers of individuals with sequelae of diseases and injuries. Rates of YLDs are declining much more slowly than mortality rates. The non-fatal dimensions of disease and injury will require more and more attention from health systems. The transition to non-fatal outcomes as the dominant source of burden of disease is occurring rapidly outside of sub-Saharan Africa. Our results can guide future health initiatives through examination of epidemiological trends and a better understanding of variation across countries.	[Vos, Theo; Barber, Ryan M.; Bell, Brad; Bertozzi-Villa, Amelia; Biryukov, Stan; Bolliger, Ian; Dicker, Daniel; Fitzmaurice, Christina; Fleming, Thomas; Graetz, Nicholas; Haagsma, Juanita; Hansen, Gillian M.; Hanson, Sarah Wulf; Heuton, Kyle R.; Higashi, Hideki; Kyu, Hmwe; Laurie, Evan; Lofgren, Katherine; Lozano, Rafael; MacIntyre, Michael F.; Moradi-Lakeh, Maziar; Naghavi, Mohsen; Nguyen, Grant; Odell, Shaun; Ortblad, Katrina; Roberts, David Allen; Roth, Gregory A.; Sandar, Logan; Serina, Peter T.; Stanaway, Jeffrey D.; Steiner, Caitlyn; Thomas, Bernadette; Vollset, Stein Emil; Wolock, Timothy M.; Achoki, Tom; Apfel, Henry; Atkinson, Charles; Bienhoff, Kelly; Blore, Jed D.; Brown, Jonathan; Coggeshall, Megan; Cohen, Aaron; Cooperrider, Kimberly; Dandona, Lalit; Dansereau, Emily; Duber, Herbert; Estep, Kara; Flaxman, Abraham; Foreman, Kyle J.; Hamavid, Hannah; Iannarone, Marissa; Joseph, Jonathan; Lim, Stephen; Lind, Margaret; Ohno, Summer Lockett; Lopez, Alan D.; Margono, Chris; McLain, Abby; Mokdad, Ali H.; Moyer, Madeline; Naghavi, Paria; Phillips, David; Phillips, Bryan; Richardson, Lee; Robinson, Margot; Shackelford, Katya; Singh, Lavanya; Speyer, Peter; Stewart, Andrea; Stork, Eden; Thomas, Elissa; Wong, Haidong; Wurtz, Brittany; Murray, Christopher J. L.] Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA; [Ellenbogen, Richard G.] Harborview Hosp, Seattle, WA USA; [Ellenbogen, Richard G.] Childrens Hosp, Dept Med, Seattle, WA USA; [Kassebaum, Nicholas] Childrens Hosp, Seattle, WA USA; [Katz, Ronit] Kidney Res Inst, Seattle, WA USA; [Alfonso-Cristancho, Rafael; Anderson, Benjamin O.; Futran, Neal D.; Jensen, Paul N.; Mock, Charles N.; Montine, Thomas J.; Pellegrini, Carlos A.; Quistberg, D. A.; Riederer, Anne M.; Vavilala, Monica S.; Zunt, Joseph R.] Univ Washington, Sch Med, Seattle, WA USA; [Hoy, Damian G.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Scott, James G.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Charlson, Fiona; Erskine, Holly; Ferrari, Alize J.; Whiteford, Harvey; Gouda, Hebe N.; Knibbs, Luke; McGrath, John J.; Norman, Rosana E.; Veerman, Lennert J.] Publ Hlth England, London, England; [Boufous, Soufiane] Univ New S Wales, Transport & Rd Safety TARS Res, Sydney, NSW, Australia; [Degenhardt, Louisa; Mitchell, Philip B.; Satpathy, Maheswar] Univ New S Wales, Sydney, NSW, Australia; [Duan, Leilei; Liang, Xiofeng; Ye, Pengpeng; Zhou, Maigeng; Li, Yichong; Liu, Shiwei; Ma, Jixiang; Wang, Linhong] Chinese Ctr Dis Control, Natl Centers Chron & Noncommunible Dis Control &, Beijing, Peoples R China; [Feigin, Valery L.; Balalla, Shivanthi] Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Krishnamurthi, Rita V.; Ao, Braden J. Te; Theadom, Alice M.] Auckland Univ Technol, Auckland, New Zealand; [Guinovart, Caterina] PATH, Seattle, WA USA; [Lozano, Rafael; Avila, Marco A.; Aburto, Tania C.; Barquera, Simon; Nonato, Ismael R. Campos; Campuzano, Julio C.; Contreras, Alejandra G.; Cuevas-Nasu, Lucia; Dantes, Hector G.; De la Cruz-Gongora, Vanessa; Garcia-Guerra, Francisco A.; de Cosio, Teresita Gonzalez; Pi, Ileana B. Heredia; Lopez-Olmedo, Nancy; Mejia-Rodriguez, Fabiola; Pedraza, Lilia S.; Servan-Mori, Edson E.; Levy, Teresa Shamah; Villalpando, Salvador] Natl Inst Publ Hlth, Mexico City, DF, Mexico; [Aasvang, Gunn Marit; Kinge, Jonas M.; Knudsen, Ann Kristin; Skirbekk, Vegard] Norwegian Inst Publ Hlth, Oslo, Norway; [Abbafati, Cristiana] Univ Roma La Sapienza, I-00185 Rome, Italy; [Ozgoren, Ayse Abbasoglu] Hacettepe Univ, Inst Populat Studies, Ankara, Turkey; [Abd-Allah, Foad] Cairo Univ, Fac Med, Cairo, Egypt; [Aziz, Muna I. Abdel] Inst Publ Hlth, Khartoum, Sudan; [Abera, Semaw F.; Melaku, Yohannes A.] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Mekelle, Ethiopia; [Aboyans, Victor] Dupuytren Univ Hosp, Limoges, France; [Abraham, Biju] Oslo & Akershus Univ Coll Appl Sci HiOA, Oslo, Norway; [Abraham, Jerry P.] Univ Texas Sch Med, San Antonio, TX USA; [Benzian, Habib] UCL, Dept Epidemiol & Publ Hlth, London, England; [Abubakar, Ibrahim] UCL, London, England; [Abu-Raddad, Laith J.] Weill Cornell Med Coll Qatar, Doha, Qatar; [Abu-Rmeileh, Niveen M. E.] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Israel; [Chiang, Peggy P.] Univ Melbourne, Gen Practice & Primary Hlth Care Acad Ctr, Melbourne, Vic, Australia; [Colquhoun, Samantha M.] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Taylor, Hugh R.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Ackerman, Ilana N.; Ademi, Zanfina; Bohensky, Megan A.; Brooks, Peter M.; Lopez, Alan D.; Meretoja, Atte; Weintraub, Robert G.] Univ Melbourne, Melbourne, Vic, Australia; [Adelekan, Ademola] Publ Hlth Promot Alliance, Osogbo, Nigeria; [Adou, Arsene K.] Assoc Ivoirienne Bien Etre Familial, Abidjan, Cote Ivoire; [Adsuar, Josef C.] Univ Extremadura, Caceres, Spain; [Agardh, Emilie E.] Inst Publ Hlth Sci, Stockholm, Sweden; [Al Khabouri, Mazin J.; Alasfoor, Deena] Minist Hlth, Muskat, Oman; [Alam, Sayed Saidul; Naheed, Aliya] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Alegretti, Miguel A.] Univ Republica, Fac Med, Dept Med Prevent & Social, Montevideo, Uruguay; [Aleman, Alicia V.] Univ Republica, Sch Med, Montevideo, Uruguay; [Colistro, Valentina] Univ Republica, Dept Med, Montevideo, Uruguay; [Alemu, Zewdie A.] Debre Markos Univ, Debre Markos, Amhara, Ethiopia; [Alhabib, Samia] Natl Guard Hlth Affairs, Riyadh, Saudi Arabia; [Ali, Raghib; Bennett, Derrick A.; Briggs, Adam D. M.; Hay, Simon; Piel, Frederic B.; Rahimi, Kazem; Scarborough, Peter] Univ Oxford, Oxford, England; [Alla, Francois] Univ Lorraine, Sch Publ Hlth, Nancy, France; [Allebeck, Peter] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Fereshtehnejad, Seyed-Mohammad] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden; [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Kivipelto, Miia] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Havmoeller, Rasmus; Sindi, Shireen] Karolinska Inst, Stockholm, Sweden; [Allen, Peter J.] Minist Hlth, Belmopan, Belize; [AlMazroa, Mohammad AbdulAziz] Saudi Minist Hlth, Riyadh, Saudi Arabia; [Alsharif, Ubai; Endres, Matthias; Nolte, Sandra; Papachristou, Christina] Charite, D-13353 Berlin, Germany; [Alvarez, Elena] Govt Spain, Madrid, Spain; [Alvis-Guzman, Nelson; Caicedo, Angel J. Paternina] Univ Cartagena, Cartagena De Indias, Colombia; [Sreeramareddy, Chandrashekhar T.] Univ Groningen, Univ Med Ctr Groningen, Coll Med & Hlth Sci, Dept Epidemiol, Groningen, Netherlands; [Yenesew, Muluken A.] Bahir Dar Univ, Bahir Dar, Ethiopia; [Ameli, Omid; Felson, David T.] Boston Univ, Boston, MA 02215 USA; [Amini, Heresh] Kurdistan Univ Med Sci, Kurdistan Environm Hlth Res Ctr, Sanandaj, Kurdistan, Iran; [Amini, Heresh; Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Amini, Heresh] Univ Basel, Basel, Switzerland; [Ammar, Walid; Harb, Hilda L.] Minist Publ Hlth, Beirut, Lebanon; [Anderson, H. Ross; Marcenes, Wagner] Univ London, London, England; [Antonio, Carl Abelardo T.; Panelo, Carlo Irwin A.] Univ Philippines, Coll Publ Hlth, Manila, Philippines; [Anwari, Palwasha] United Nations Populat Fund, Kabul, Afghanistan; [Arnlov, Johan; Larsson, Anders] Uppsala Univ, Uppsala, Norway; [Arsenijevic, Valentain S. Arsic] Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Belgrade, Serbia; [Artaman, Al] Evidera Inc, Lexington, KY USA; [Asghar, Rana J.] South Asian Publ Hlth Forum, Islamabad, Pakistan; [Assadi, Reza] Mashhad Univ Med Sci, Mashhad, Iran; [Atkins, Lydia S.] Minist Hlth, Wellness Human Serv & Gender Relat, St Lucia, Qld, Australia; [Badawi, Alaa] Publ Hlth Agcy Canada, Toronto, ON, Canada; [Bahit, Maria C.] INECO Neurociencias, Rosario, Santa Fe, Argentina; [Bakfalouni, Talal] Minist Hlth, Damascus, Syria; [Balakrishnan, Kalpana] Sri Ramachandra Univ, Madras, Tamil Nadu, India; [Banerjee, Amitava] Univ Birmingham, Birmingham, W Midlands, England; [Barker-Collo, Suzanne L.] Univ Auckland, Sch Psychol, Auckland 1, New Zealand; [del Pozo-Cruz, Borja] Univ Auckland, Auckland 1, New Zealand; [Barregard, Lars] Univ Gothenburg, Dept Occupat & Environm Hlth, Gothenburg, Sweden; [Petzold, Max] Univ Gothenburg, Hlth Metr Sahlgrenska Acad, Gothenburg, Sweden; [Barrero, Lope H.] Pontificia Univ Javeriana, Dept Ind Engn, Bogota, Colombia; [Basu, Arindam] Univ Canterbury, Sch Hlth Sci, Christchurch 1, New Zealand; [Basu, Sanjay] Stanford Univ, Stanford, CA 94305 USA; [Beardsley, Justin] Univ Oxford, Ho Hi Minh City, Vietnam; [Bedi, Neeraj] Coll Publ Hlth & Trop Med, Jazan, Saudi Arabia; [Beghi, Ettore; Remuzzi, Giuseppe] Mario Negri, Milan, Italy; [Ronfani, Luca] Burlo Garofolo, Trieste, Italy; IRCCS Ist Ric Farmacol, Milan, Italy; [Bekele, Tolesa; Cortinovis, Monica; Giussani, Giorgia; Monasta, Lorenzo; Montico, Marcella; Perico, Norberto; Trillini, Matias] Madawalabu Univ, Bale Robe, Ethiopia; [Bell, Brad; Huang, John J.] Yale Univ, New Haven, CT USA; [Benjet, Corina; Borges, Guilherme; Gutierrez, Reyna A.] Natl Inst Psychiat Ramon Fuente Muniz, Mexico City, DF, Mexico; [Bensenor, Isabela M.] Univ Sao Paulo, Univ Hosp, Sao Paulo, Brazil; [Kemp, Andrew H.; Lotufo, Paulo A.; Polanczyk, Guilherme V.; Santos, Itamar S.] Univ Sao Paulo, Sao Paulo, Brazil; [Bernabe, Eduardo; Wolfe, Charles D. A.] Kings Coll London, London WC2R 2LS, England; [Beyene, Tariku J.; Deribe, Kebede] Univ Addis Ababa, Addis Ababa, Ethiopia; [Bhalla, Ashish] Wellington Hosp, Wellington, New Zealand; [Bhalla, Ashish] Postgrad Inst Med Educ & Res, Chandigarh, UT, India; [Bhutta, Zulfi Qar] Aga Khan Univ, Med Ctr, Karachi, Pakistan; [Nisar, Muhammad I.] Aga Khan Univ, Karachi, Pakistan; [Bikbov, Boris] I Evdokimov Moscow State Univ Med & Dent, Moscow, Russia; [Bin Abdulhak, Aref] Univ Missouri, Kansas City, KS USA; [Blyth, Fiona M.; Driscoll, Tim R.; Leigh, James; March, Lyn M.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Blyth, Fiona M.; Leigh, James; March, Lyn M.; Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Uzun, Selen B.] Minist Hlth, Ankara, Turkey; [Basara, Berrak Bora] Gen Directorate Hlth Res, Ankara, Turkey; [Bornstein, Natan M.] Tel Aviv Saurasky Med Ctr, Tel Aviv, Israel; [Bose, Dipan] World Bank, Washington, DC 20433 USA; [Bourne, Rupert R.] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [Boyers, Lindsay N.] Georgetown Univ, Sch Med, Washington, DC USA; [Wallin, Mitchell T.] Georgetown Univ, Dept Neurol, Washington, DC USA; [Brainin, Michael] Danube Univ Krems, Krems An Der Donau, Austria; [Brauer, Michael; Gotay, Carolyn C.; Pourmalek, Farshad] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Brayne, Carol E. G.] Cambridge Inst Publ Hlth, Cambridge, England; [Brazinova, Alexandra; Majdan, Marek] Trnava Univ, Fac Hlth Sci & Social Work, Trnava, Slovakia; [Breitborde, Nicholas J. K.] Univ Arizona, Tucson, AZ USA; [Schoettker, Ben] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Heidelberg, Germany; [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England; [Buchbinder, Rachelle] Monash Univ, Melbourne, Vic 3004, Australia; [Buchbinder, Rachelle] Cabrini Inst, Melbourne, Vic, Australia; [Buckle, Geoffrey C.; Gona, Philimon] Univ Massachusetts, Sch Med, Worcester, MA USA; [Bukhman, Gene] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Ding, Eric L.; Fahimi, Saman; Shangguan, Siyi] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; [Shrime, Mark G.; Salomon, Joshua A.] Harvard Univ, Cambridge, MA 02138 USA; [Bulloch, Andrew G.; Patten, Scott B.; Wang, JianLi] Univ Calgary, Calgary, AB, Canada; [Burch, Michael; Burnett, Richard] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Cabral, Norberto L.] Univ Joinville, Joinville, Brazil; [Carapetis, Jonathan R.] Telethon Inst Child Hlth Res, Perth, Australia; [Cardenas, Rosario] Univ Autonoma Metropolitana, Mexico City, DF, Mexico; [Carpenter, David O.] SUNY Albany, Albany, NY 12222 USA; [Caso, Valeria] Univ Perugia, Stroke Unit, I-06100 Perugia, Italy; [Castaneda-Orjuela, Carlos A.] Inst Nacl Salud, Colombian Natl Hlth Observ, Bogota, Colombia; [Catala-Lopez, Ferran] Minist Hlth, Spanish Med & Healthcare Prod Agcy AEMPS, Div Pharmacoepidemiol & Pharmacovigilance, Madrid, Spain; [Chadha, Vineet K.] Natl TB Inst, Bangalore, Karnataka, India; [Lin, Hsien-Ho] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chang, Jung-Chen] Natl Taiwan Univ, Taipei 10764, Taiwan; [Chen, Wanqing] Chinese Acad Med Sci, Inst Canc, Beijing 100021, Peoples R China; [Chen, Honglei] NIEHS, Div Intramural Res, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Jiang, Ying; Takahashi, Ken] Univ Occupat & Environm Hlth, Dept Hlth Dev, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 807, Japan; [Chimed-Ochir, Odgerel; Jiang, Ying; Takahashi, Ken] Univ Occupat & Environm Hlth, Dept Environm, Dept Environm Epidemiol, Kitakyushu, Fukuoka 807, Japan; [Chowdhury, Rajiv; Murray, Joseph] Univ Cambridge, Cambridge, England; [Christensen, Hanne] Bispebjerg Hosp, Copenhagen, Denmark; [Christophi, Costas A.] Cyprus Univ Technol, Limassol, Cyprus; [Chugh, Sumeet S.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Cirillo, Massimo] Univ Salerno, I-84100 Salerno, Italy; [Cohen, Aaron] Hlth Eff ects Inst, Boston, MA USA; [Cooper, Leslie T.; Tleyjeh, Imad M.] Mayo Clin, Rochester, MN USA; [Cooper, Cyrus] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Coresh, Josef; Tran, Bach X.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Jassal, Simerjot K.] VA San Diego, San Diego, CA USA; [Stein, Murray B.] Univ Calif San Diego, San Diego, CA 92103 USA; [Crump, John A.] Univ Otago, Dunedin Sch Med, Ctr Int Hlth, Dunedin, New Zealand; [Poulton, Richie G.] Univ Otago, Dunedin, New Zealand; [Goenka, Shifalika] Indian Inst Publ Hlth, Delhi, India; [Dandona, Rakhi; Kumar, G. Anil; Murthy, Kinnari S.] Publ Hlth Fdn India, Delhi, India; [Dargan, Paul I.] Guys & St Thomas NHS Fdn Trust, London, England; [Davey, Gail] Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Davitoiu, Dragos V.] Univ Med & Pharm Bucharest, Bucharest, Romania; [Dayama, Anand] Jacobi Med Ctr, Dept Surg, New York, NY USA; [de la Vega, Shelley F.] Natl Inst Hlth, Inst Aging, Manila, Philippines; [Lam, Hilton] Natl Inst Hlth, Inst Hlth Policy & Dev Studies, Manila, Philippines; [De Leo, Diego] Griffith Univ, Nathan, Qld 4111, Australia; [Dellavalle, Robert P.] Eastern Colorado Healthcare Syst, Dept Vet Aff, Denver, CO USA; [Derrett, Sarah] Massey Univ, Palmerston North, New Zealand; [Des Jarlais, Don C.] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Dessalegn, Muluken] Africa Med & Res Fdn Ethiopia, Addis Ababa, Ethiopia; [de Veber, Gabrielle A.] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka; [Diaz-Torne, Cesar] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Dokova, Klara] Med Univ Varna, Fac Publ Hlth, Dept Social Med, Varna, Bulgaria; [Dorsey, E. R.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Hoffman, Howard J.] NIDCD, Bethesda, MD USA; [Durrani, Adnan M.] NIH, Bethesda, MD 20892 USA; [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Edmond, Karen M.] Univ Western Australia, Crawley, WA, Australia; [Ermakov, Sergey P.] Russian Acad Sci, Inst Social & Econ Studies Populat, Chernogolovka 142432, Russia; [Eshrati, Babak] Arak Univ Med Sci & Hlth Aff airs, Arak, Markazi, Iran; [Esteghamati, Alireza; Farzadfar, Farshad; Hafezi-Nejad, Nima; Sheikhbahaei, Sara] Endocrine & Metab Res Inst, Noncommun Dis Res Ctr, Tehran, Iran; [Malekzadeh, Reza; Sepanlou, Sadaf G.] Digest Dis Res Ctr, Tehran, Iran; [Rahimi-Movaghar, Vafa] Sina Trauma & Surg Res Ctr, Tehran, Iran; [Sahraian, Mohammad Ali] MS Res Ctr, Tehran, Iran; [Heydarpour, Pouria] Univ Tehran Med Sci, Tehran, Iran; [Fernandes, Jefferson G.] German Hosp Oswaldo Cruz, Inst Educ & Sci, Sao Paulo, Brazil; [Ferri, Cluesa P.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Foigt, Nataliya] Ukraine Acad Med Sci, Inst Gerontol, UA-252655 Kiev, Ukraine; [Fowkes, F. Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Franklin, Richard C.] James Cook Univ, Townsville, Qld 4811, Australia; [Furst, Thomas] Univ London Imperial Coll Sci Technol & Med, Ctr Hlth Policy, London, England; [Furst, Thomas] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Rodriguez, Alina; Soljak, Michael] Univ London Imperial Coll Sci Technol & Med, London, England; [Lloyd, Belinda K.] Monash Univ, Eastern Hlth Clin Sch, Malvern East, Vic, Australia; [Gabbe, Belinda J.; Gibney, Katherine B.; Thrift, Amanda G.] Monash Univ, Malvern East, Vic, Australia; [Gankpe, Fortune G.] Clin Cooperat Parakou, Parakou, Borgou, Benin; [Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Gessner, Bradford D.] Agence Med Prevent, Paris, France; [Gillum, Richard F.] Howard Univ, Washington, DC 20059 USA; [Ginawi, Ibrahim A.] Univ Hail, Coll Med, Hail, Saudi Arabia; [Giroud, Maurice] Univ Hosp Dijon, Dijon, France; [Goginashvili, Ketevan] Minist Labour Hlth & Social Aff airs, Tbilisi, Georgia; [Gosselin, Richard A.; Kazi, Dhruv S.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Goto, Atsushi] Natl Ctr Global Hlth & Med, Dept Diabet Res, Tokyo, Japan; [Guerrant, Richard L.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Terkawi, Abdullah Sulieman] Univ Virginia, Dept Anesthesiol, Charlottesville, VA USA; [Gugnani, Harish C.] St James Sch Med, Willemstad, Netherlands; [Gunnell, David; Looker, Katharine J.] Univ Bristol, Bristol, Avon, England; [Gupta, Rahul] Fortis Escorts Hosp, Delhi, India; [Gupta, Rajeev] Kanawha Charleston Hlth Dept, Charleston, WV USA; [Hagan, Holly; Trasande, Leonardo] NYU, Sch Med, New York, NY USA; [Halasa, Yara; Shahraz, Saeid; Shepard, Donald S.; Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA; [Hamadeh, Randah R.] Arabian Gulf Univ, Manama, Bahrain; [Hammami, Mouhanad] Wayne Cty Dept Hlth & Human Serv, Wayne, MI USA; [Zhao, Yong] Sun Yae Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Haro, Josep Maria] Univ Barcelona, CIBERSAM, Parc Sanitari St Joan de Deu, Barcelona, Spain; [Hay, Roderick J.] Int Fdn Dermatol, London, England; [Hedayati, Mohammad T.] Mazandaran Univ Med Sci, Sari, Mazandaran, Iran; [Hijar, Martha] Fdn Entornos AC, Cuernavaca, Morelos, Mexico; [Hoek, Hans W.] Parnassia Psychiat Inst, The Hague, Netherlands; [Hornberger, John C.] Cedar Associates, Menlo Pk, CA USA; [Hosgood, H. Dean] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Hossain, Mazeda; Larson, Heidi; McKee, Martin; Pearce, Neil; Stoeckl, Heidi] London Sch Hyg & Trop Med, London WC1, England; [Hotez, Peter J.] Baylor Coll Med, Waco, TX USA; [Hsairi, Mohamed] Minist Hlth, Natl Inst Publ Hlth, Tunis, Tunisia; [Hoy, Damian G.] Secretariat Pacific Community, Publ Hlth Div, Noumea, New Caledonia; [Hu, Guoqing] Cent S Univ, Changsha, Hunan, Peoples R China; [Hu, Howard] Univ Toronto, Toronto, ON, Canada; [Huiart, Laetitia] George Washington Univ, Washington, DC USA; [Huiart, Laetitia] Ctr Hosp Univ La Reunion, Stanford, CA USA; [Husseini, Abdullatif] Qatar Univ, Publ Hlth Program, Doha, Qatar; [Iburg, Kim M.] Aarhus Univ, Aarhus, Denmark; [Innos, Kaire] Natl Inst Hlth Dev, Tallinn, Estonia; [Inoue, Manami] Univ Tokyo, Grad Sch Med, Tokyo, Japan; [Kawakami, Norito] Univ Tokyo, Sch Publ Hlth, Tokyo, Japan; [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA 22030 USA; [Jeemon, Panniyammakal; Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Jha, Vivekanand] Postgrad Inst Med Educ & Res, Chandigarh 160012, India; [Jiang, Guohong] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany; [Juel, Knud] Natl Inst Publ Hlth, Copenhagen, Denmark; [She, Jun] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Kan, Haidong] Fudan Univ, Shanghai 200433, Peoples R China; [Karch, Andre] Holtz Ctr Infect Res, Braunschweig, Germany; [Karch, Andre] German Ctr Infect Res DZIF, Hannover, Germany; [Karimkhani, Chante] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Moran, Andrew E.] Columbia Univ, New York, NY USA; [Karthikeyan, Ganesan; Paul, Vinod K.; Tandon, Nikhil] All India Inst Med Sci, New Delhi, India; [Kaul, Anil] Oklahoma State Univ, Stillwater, OK 74078 USA; [Kengne, Andre P.] South African Med Res Council, Cape Town, South Africa; [Khader, Yousef S.] Jordan Univ Sci & Technol, Irbid, Jordan; [Khalifa, Shams Eldin A. H.] Supreme Council Hlth, Doha, Qatar; [Khan, Ejaz A.] Hlth Serv Acad, Islamabad, Punjab, Pakistan; [Khan, Gulfaraz] UAE Univ, Abu Dhabi, U Arab Emirates; [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Inst Hlth Policy & Management, Seoul, South Korea; [Khonelidze, Irma; Sturua, Lela] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Kieling, Christian] Univ Fed Rio Grande do Sul, Curitiba, Parana, Brazil; [Kim, Daniel] Northeastern Univ, Boston, MA 02115 USA; [Kim, Sungroul] Soonchunhyang Univ, Asan, South Korea; [Kimokoti, Ruth W.] Simmons Coll, Boston, MA 02115 USA; [Kinfu, Yohannes] Univ Canberra, Canberra, ACT 2601, Australia; [Kissela, Brett M.] Univ Cincinnati, Cincinnati, OH USA; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka, Japan; [Kosen, Soewarta] MoH Indonesia, NIHRD, Ctr Community Empowerment Hlth Policy & Human, Jakarta, Indonesia; [Warouw, Tati S.] MoH Indonesia, NIHRD, Jakarta, Indonesia; [Kramer, Alexander] Univ Bielefeld, Sch Publ Hlth, D-33615 Bielefeld, Germany; [Plass, Dietrich] Univ Bielefeld, Dept Publ Hlth Med, D-33615 Bielefeld, Germany; [Kravchenko, Michael] Res Ctr Neurol, Moscow, Russia; [Krishnaswami, Sanjay] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Defo, Barthelemy Kuate] Univ Montreal, Montreal, PQ, Canada; [Bicer, Burcu Kucuk] Hacettepe Univ, Ankara, Turkey; [Polinder, Suzanne] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Kuipers, Ernst J.; Richardus, Jan Hendrik] Erasmus MC, Univ Med Ctr, Rotterdam, Netherlands; [Kulkarni, Veena S.] Arkansas State Univ, Jonesboro, AR USA; [Kumar, Kaushalendra] Int Inst Populat Sci, Mimbai, India; [Kwan, Gene F.] Boston Med Ctr, Boston, MA USA; [Lai, Taavi] Fourth View Consulting, Tallinn, Estonia; [Lalloo, Ratilal] Univ Adelaide, Sch Dent, ARCPOH, Gold Coast, Qld, Australia; [Lan, Qing] NCI, Rockville, MD USA; [Lansingh, Van C.] IAPB & Vis 2020 LA, Weston, FL USA; [Lawrynowicz, Alicia E. B.] Inst Nacl Epidemiol Dr Juan H Jara, Buenos Aires, DF, Argentina; [Leasher, Janet L.] Nova SE Univ, Ft Lauderdale, FL 33314 USA; [Lee, Jong-Tae; Yoon, Seok-Jun] Korea Univ, Seoul, South Korea; [Leung, Ricky] SUNY Albany, Albany, NY 12222 USA; [Levi, Miriam] Tuscany Reg Ctr Occupat Injuries & Dis, Florence, Italy; [Li, Yichong] Genentech Inc, San Francisco, CA 94080 USA; [Zhang, Yong] Jinan Cent Hosp, Dept Gerontol, Jinan, Shandong, Peoples R China; [Liang, Juan] Sichuan Univ, West China Univ Hosp 2, Natl Off Maternal & Child Hlth Surveillance, Chengdu 610064, Sichuan, Peoples R China; [Lindsay, M. Patrice] Heart & Stroke Fdn Canada, Ottawa, ON, Canada; [Lipshultz, Steven E.] Wayne State Univ, Detroit, MI USA; [Lloyd, Belinda K.] Eastern Hlth, Turning Point Alcohol & Drug Ctr, Fitzroy, Vic, Australia; [Logroscino, Giancarlo] Univ Bari, Bari, Italy; [Lortet-Tieulent, Joannie] Amer Canc Soc, Atlanta, GA 30329 USA; [Low, Nicola] Univ Bern, CH-3012 Bern, Switzerland; [Lucas, Robyn M.] Australian Natl Univ, Canberra, ACT, Australia; [Lunevicius, Raimundas] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Lyons, Ronan A.] Swansea Univ, Swansea, W Glam, Wales; [Ma, Stefan; Zhao, Zheng] Minist Hlth Singapore, Singapore, Singapore; [Weintraub, Robert G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Mackay, Mark T.] Royal Childrens Hosp Melbourne, Melbourne, Vic, Australia; [Mapoma, Christopher C.] Univ Zambia, Lusaka, Zambia; [Marzan, Melvin B.] Univ East Ramon Magsaysay Med Ctr, Quezon City, Philippines; [Masci, Joseph R.] Elmhurst Hosp Ctr, Mt Sinai Serv, Elmhurst, NY USA; [Mason-Jones, Amanda J.] Univ York, York YO10 5DD, N Yorkshire, England; [Matzopoulos, Richard G.; Parry, Charles D.] MRC, Cape Town, Western Cape, South Africa; [Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Hatter Inst Cardiovasc Res Africa, ZA-7925 Cape Town, South Africa; [Mayosi, Bongani M.; Stein, Dan J.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Mazorodze, Tasara T.] AIDC EC, Port Elizabeth, Eastern Cape, South Africa; [McGill, Neil W.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [McMahon, Brian J.] Alaska Native Tribal Hlth Consortium, Anchorage, AK USA; [Meaney, Peter A.] Univ Penn, Pereleman Sch Med, Philadelphia, PA 19104 USA; [Silberberg, Donald H.] Univ Penn, Philadelphia, PA 19104 USA; [Mehndiratta, Man Mohan] Janakpuri Superspecialty Hosp, Delhi, India; [Meltzer, Michele] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Mensah, George] NIH, Bethesda, MD 20892 USA; [Mhimbira, Francis A.] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Micha, Renata; Mozaffarian, Dariush] Friedman Sch Nutr Sci & Policy, Medford, MA USA; [Shi, Peilin] Tufts Univ, Medford, MA 02155 USA; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Miller, Ted R.] Curtin Univ, Ctr Populat Hlth Res, Perth, WA 6845, Australia; [Mills, Edward J.] Univ Ottawa, Ottawa, ON, Canada; [Moffitt, Terrie E.] Duke Univ, Durham, NC USA; [Ibrahim, Norlinah Mohamed] Univ Kebangsaan Malaysia, Med Ctr, Dept Med, Kuala Lumpur, Malaysia; [Mohammad, Karzan A.] Univ Salahaddin, Erbil, Iraq; [Mola, Glen L.] Univ Papua New Guinea, Port Moresby, Papua N Guinea; [Moore, Ami R.] Univ N Texas, Denton, TX 76203 USA; [Morawska, Lidia] Queensland Univ Technol, Int Lab Air Qual & Hlth, Brisbane, Qld 4001, Australia; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Setagaya Ku, Tokyo, Japan; [Moschandreas, Joanna; Tsilimbaris, Miltiadis] Univ Crete, Dept Med, Iraklion, Greece; [Moturi, Wilkister N.] Egerton Univ, Egerton, Rift Valley, Kenya; [Mueller, Ulrich O.] Univ Marburg, Marburg, Germany; [Mukaigawara, Mitsuru] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo, Japan; [Murdoch, Michele E.] West Hertfordshire Hosp NHS Trust, Hempstead, Herts, England; [Nahas, Ziad] Amer Univ Beirut, Med Ctr, Beirut, Lebanon; [Naidoo, Kovin S.] Univ KwaZulu Natal, Durban, Kwazulu Natal, South Africa; [Naldi, Luigi] Azienda Osped Papa Giovanni XXIII, Bergamo, Italy; [Nand, Devina] Minist Hlth Fiji, Suva, Fiji; [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India; [Simard, Edgar P.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Narayan, K. M. Venkat; Omer, Saad B.; Phillips, Michael R.] Emory Univ, Atlanta, GA 30322 USA; [Nash, Denis] CUNY, Sch Publ Hlth, New York, NY 10021 USA; [Nejjari, Chakib] Fac Med, Fes, Morocco; [Neupane, Sudan P.] Univ Oslo, Norwegian Ctr Addict Res SERAF, Oslo, Norway; [Rakovac, Ivo] WHO Reg Off Europe, Copenhagen, Denmark; [Newman, Lori M.] WHO, CH-1211 Geneva, Switzerland; [Newton, Charles R.] KEMRI Wellcome Trust, Kilifi, Kenya; [Ngalesoni, Frida N.] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania; [Nhung, Nguyen T.] Hanoi Sch Publ Hlth, Hanoi, Vietnam; [Norheim, Ole F.] Univ Bergen, Bergen, Norway; [Norrving, Bo] Lund Univ, Fac Med, Dept Clin Sci, Lund, Sweden; [Nyakarahuka, Luke] Makerere Univ, Kampala, Uganda; [Oh, In Hwan] Kyung Hee Univ, Seoul, South Korea; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Itabashi Ku, Tokyo 173, Japan; [Opio, John Nelson] Lira Municipal Council, Lira Dist Local Govt, Northern Uganda, Uganda; [Ortiz, Alberto] Fdn Jimenez Diaz, IIS, E-28040 Madrid, Spain; [Pandian, Jeyaraj D.] Christian Med Coll Ludhiana, Ludhiana, Punjab, India; [Park, Eun-Kee] Kosin Univ, Coll Med, Busan, South Korea; [Pereira, David M.] Univ Porto, Fac Farm, REQUIMTE Lab Farmacognosia, Dept Quam, P-4100 Oporto, Portugal; [Perez-Ruiz, Fernando P.] Hosp Univ Cruces, Baracaldo, Bizkaia, Spain; [Perez-Ruiz, Fernando P.] Biocruces Hlth Res Inst, Baracaldo, Bizkaia, Spain; [Pervaiz, Aslam] Postgrad Med Inst, Lahore, Pakistan; [Pesudovs, Konrad] Flinders Univ S Australia, Bedford Pk, SA 5042, Australia; [Peterson, Carrie B.] Aalborg Univ, Aalborg, Denmark; [Petzold, Max] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Phillips, Michael R.] Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China; [Poenaru, Dan] McMaster Univ, Hamilton, ON, Canada; [Pope, C. A., III] Brigham Young Univ, Provo, UT 84602 USA; [Popova, Svetlana; Rehm, Jurgen] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Prasad, Noela M.] Fred Hollows Fdn, Sydney, NSW, Australia; [Qato, Dima] Univ Illinois, Coll Pharm, Chicago, IL USA; [Rafay, Anwar] Contech Int, Lahore, Pakistan; [Rahman, Sajjad Ur] Hamad Med Corp, Doha, Qatar; [Raju, Murugesan] Univ Missouri, Columbia, MO USA; [Rana, Saleem M.] Univ Punjab, Dept Publ Hlth, Lahore, Pakistan; [Razavi, Homie] Ctr Dis Anal, Louisville, CO USA; [Refaat, Amany] Walden Univ, Minneapolis, MN USA; [Resnikoff, Serge] Int Hlth & Dev, Zurich, Switzerland; [Ribeiro, Antonio L.] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil; [Velasquez-Melendez, Gustavo] Univ Fed Minas Gerais, Escola Enfermagem, Belo Horizonte, MG, Brazil; [Riccio, Patricia M.] Univ Western Ontario, Dept Clin Neurol Sci, London Hlth Sci Ctr, London, ON, Canada; [Roca, Anna] MRC Unit, Fajara, Gambia; [Rojas-Rueda, David] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Roy, Nobhojit] BARC Hosp, Mumbai, Maharashtra, India; [Ruhago, George M.; Sunguya, Bruno F.] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Sabin, Nsanzimana] Rwanda Biomed Ctr, Kigali, Rwanda; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Saha, Sukanta] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Wacol, Qld, Australia; [Sahathevan, Ramesh] Univ Kebangsaan Malaysia, Med Ctr, Bangi 43600, Selangor, Malaysia; [Sampson, Uchechukwu] Vanderbilt Univ, Nashville, TN 37235 USA; [Sanabria, Juan R.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Sanchez-Riera, Lidia] Mafraq Hosp SEHA, Abu Dhabi, U Arab Emirates; [Saunders, James E.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Sawhney, Monika] Marshall Univ, Huntington, WV USA; [Saylan, Mete I.] Novartis, Istanbul, Turkey; [Schneider, Ione J. C.] Univ Fed Santa Catarina, Florianopolis, SC, Brazil; [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA; [Seedat, Soraya] Univ Stellenbosch, ZA-7600 Stellenbosch, South Africa; [Serdar, Berrin] Univ Colorado, Boulder, CO 80309 USA; [Shaheen, Amira] An Najah Univ, Nablus, Israel; [Shibuya, Kenji] Univ Tokyo, Tokyo, Japan; [Shinohara, Yukito] Tachikawa Hosp, Tokyo, Japan; [Shiri, Rahman] Finnish Inst Occupat Hlth, Helsinki, Finland; [Shishani, Kawkab] Washington State Univ, Pullman, WA 99164 USA; [Shiue, Ivy] Heriot Watt Univ, Edinburgh, Midlothian, Scotland; [Sigfusdottir, Inga D.] Reykjavik Univ, Reykjavik, Iceland; [Soneji, Samir] Dartmouth Coll, Hanover, NH USA; [Ksoreide, Kjetil] Stavanger Univ Hosp, Stavanger, Norway; [Soshnikov, Sergey S.] Minist Hlth Russian Federat, Fed Res Inst Hlth Org & Informat, Moscow, Russia; [Sposato, Luciano A.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; [Sreeramareddy, Chandrashekhar T.] Univ Tunku Abdul Rahman, Fac Med & Hlth Sci, Selangor, Malaysia; [Stathopoulou, Vasiliki Kalliopi] Ctr Hosp Nord Deux Sevres, Bressuire, France; [Steckling, Nadine] Univ Hosp Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Stovner, Lars J.] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Steiner, Timothy J.] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway; [Stroumpoulis, Konstantinos] Alexandra Gen Hosp Athens, KEELPNO, Ctr Dis Control, Athens, Greece; [Swaroop, Mamta] Northwestern Univ, Evanston, IL USA; [Sykes, Bryan L.] Univ Calif Irvine, Dept Criminol Law & Soc & Sociol, Irvine, CA USA; [Tabb, Karen M.] Univ Illinois, Urbana, IL 61801 USA; [Tan, Feng] China CDC, Natl Inst Occupat Hlth & Poison Control, Beijing, Peoples R China; [Tanne, David] Chaim Sheba Med Ctr, Tel Aviv, Israel; [Tanne, David] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Tavakkoli, Mohammad] Westchester Cty Med Ctr, Valhalla, NY 10595 USA; [Temesgen, Awoke Misganaw] Jhpiego, Addis Ababa, Ethiopia; [Ten Have, Margreet] Netherlands Inst Mental Hlth & Addict, Utrecht, Netherlands; [Tenkorang, Eric Yeboah] Mem Univ Newfoundland, St John, NF, Canada; [Terkawi, Abdullah Sulieman] King Fahad Med City, Dept Anesthesiol, Riyadh, Saudi Arabia; [Tleyjeh, Imad M.] King Fahad Med City, Coll Med, Riyadh, Saudi Arabia; [Thorne-Lyman, Andrew L.] Saudi Arabial WorldFish, George Town, Malaysia; [Tonelli, Marcello] Univ Alberta, Edmonton, AB, Canada; [Topouzis, Fotis] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece; [Towbin, Jeffrey A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Toyoshima, Hideaki] Anjo Kosei Hosp, Hlth Care Ctr, Anjo City, Aichi, Japan; [Traebert, Jefferson] Univ Southern Santa Catarina, Palhoca, SC, Brazil; [Truelsen, Thomas] Copenhagen Univ Hosp Herlev, Dept Neurol, Copenhagen, Denmark; [Trujillo, Ulises] Serv Canario Salud, Tenerife, Spain; [Tuzcu, Emin M.] Cleveland Clin, Cleveland, OH 44106 USA; [Ukwaja, Kingsley N.] Fed Teaching Hosp Abakaliki, Dept Internal Med, Abakaliki, Ebonyi State, Nigeria; [van Brakel, Wim H.] Netherlands Leprosy Relief, Delft, Netherlands; [de Vijver, Steven van] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Van Dingenen, Rita] Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy; [van Gool, Coen H.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Varakin, Yuri Y.] Res Ctr Neurol, Moscow, Russia; [Vasankari, Tommi J.] UKK Inst Hlth Promot Res, Tampere, Finland; [Venketasubramanian, Narayanaswamy] Raffles Hosp, Ctr Neurosci, Singapore, Singapore; [Vijayakumar, Lakshmi] Voluntary Hlth Serv, Sneha, India; [Violante, Francesco S.] Univ Bologna, Bologna, Italy; [Vlassov, Vasiliy V.] Higher Sch Econ, Moscow, Russia; [Waller, Stephen] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Wallin, Mitchell T.] VA Med Ctr, Washington, DC USA; [Wan, Xia] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Wang, Yanping] Natl Off Maternal & Childs Hlth Surveillance, Chengdu, Peoples R China; [Weichenthal, Scott] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Werdecker, Andrea] Inst Med Sociol & Social Med, Berlin, Germany; [Wessells, K. Ryan R.] Univ Calif Davis, Davis, CA 95616 USA; [Westerman, Ronny] Univ Marburg, Hessen, Germany; [Wilkinson, James D.] Univ Miami, Miami, FL USA; [Williams, Thomas N.] Univ London Imperial Coll Sci Technol & Med, London, England; [Williams, Hywel C.] Univ Nottingham, Nottingham NG7 2RD, England; [Woldeyohannes, Solomon M.] Univ Gondar, Inst Publ Hlth, Amhara, Ethiopia; [Wong, John Q.] Ateneo Sch Med & Publ Hlth, Manila, Philippines; [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, Cornwall, England; [Xu, Gelin; Yang, Gonghuan] Nanjing Univ, Sch Med, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Yano, Yuichiro] Jichi Med Univ, Sch Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Yentur, Gokalp K.] Gen Directorate Hlth Res, Ankara, Turkey; [Yip, Paul] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan; [Younis, Mustafa] Jackson State Univ, Jackson, MS USA; [Yu, Chuanhua] Wuhan Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430072, Hubei, Peoples R China; [Yu, Chuanhua] Wuhan Univ, Global Hlth Inst, Wuhan 430072, Hubei, Peoples R China; [Kim, Kim Yun] TCM Med TK SDN BHD TCM, Nusajaya, Johor Bahru, Malaysia; [Zaki, Maysaa El Sayed] Mansoura Sch Med, Mansoura, Egypt; [Zhao, Yong] Chongqing Med Univ, Chongqing, Peoples R China; [Zhu, Jun] Natl Off MCH Surveillance China, Beijing, Peoples R China; [Zonies, David] Landstuhl Reg Med Ctr, Landstuhl, Germany	Institute for Health Metrics & Evaluation; Harborview Medical Center; Seattle Children's Hospital; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Queensland; University of Queensland; Public Health England; University of New South Wales Sydney; University of New South Wales Sydney; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Auckland University of Technology; Instituto Nacional de Salud Publica; Norwegian Institute of Public Health (NIPH); Sapienza University Rome; Hacettepe University; Egyptian Knowledge Bank (EKB); Cairo University; Mekelle University; CHU Limoges; Oslo Metropolitan University (OsloMet); University of Texas System; University of Texas Health Science Center Houston; University of London; University College London; University of London; University College London; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Birzeit University; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Universidad de Extremadura; International Centre for Diarrhoeal Disease Research (ICDDR); Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Ministry of National Guard - Health Affairs; National Guard Health Affairs - Saudi Arabia; University of Oxford; Universite de Lorraine; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universidad de Cartagena; University of Groningen; Bahir Dar University; Boston University; Kurdistan University of Medical Sciences; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of London; University of the Philippines System; University of the Philippines Manila; United Nations Population Fund; Uppsala University; University of Belgrade; Evidera; Mashhad University Medical Science; Public Health Agency of Canada; Sri Ramachandra Institute of Higher Education & Research; University of Birmingham; University of Auckland; University of Auckland; University of Gothenburg; University of Gothenburg; Pontificia Universidad Javeriana; Stanford University; University of Oxford; Yale University; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Universidade de Sao Paulo; Universidade de Sao Paulo; University of London; King's College London; Addis Ababa University; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Aga Khan University; Aga Khan University; Moscow State University of Medicine & Dentistry; University of Missouri System; University of Missouri Kansas City; University of Sydney; University of Sydney; Woolcock Institute of Medical Research; Ministry of Health - Turkey; Tel Aviv University; Sackler Faculty of Medicine; The World Bank; Anglia Ruskin University; Georgetown University; Georgetown University; Danube University Krems; University of British Columbia; University of Cambridge; University of Trnava; University of Arizona; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Leicester; Monash University; Cabrini Health; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of Calgary; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Universidade da Regiao de Joinville; Telethon Kids Institute; University of Western Australia; Universidad Autonoma Metropolitana - Mexico; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Perugia; Instituto Nacional de Salud (Colombia); National Taiwan University; National Taiwan University; Chinese Academy of Medical Sciences - Peking Union Medical College; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Cambridge; University of Copenhagen; Bispebjerg Hospital; Cyprus University of Technology; Cedars Sinai Medical Center; University of Salerno; Mayo Clinic; University of Southampton; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Diego; University of Otago; University of Otago; Public Health Foundation of India; Guy's & St Thomas' NHS Foundation Trust; University of Brighton; University of Sussex; Carol Davila University of Medicine & Pharmacy; Jacobi Medical Center; Griffith University; Massey University; Harvard University; Beth Israel Deaconess Medical Center; African Medical & Research Foundation (AMREF); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Peradeniya; Hospital of Santa Creu i Sant Pau; Medical University Varna; University of Rochester; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; University of Western Australia; University of Western Australia; Russian Academy of Sciences; Tehran University of Medical Sciences; Universidade Federal de Sao Paulo (UNIFESP); National Academy of Medical Sciences of Ukraine; D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine; University of Edinburgh; James Cook University; Imperial College London; Imperial College London; Imperial College London; Monash University; Monash University; Wageningen University & Research; Agence de Medecine Preventive; Howard University; University Ha'il; CHU Dijon Bourgogne; University of California System; University of California San Francisco; National Center for Global Health & Medicine - Japan; University of Virginia; University of Virginia; University of Bristol; Fortis Escorts Hospital; New York University; Brandeis University; Arabian Gulf University; Sun Yat Sen University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Mazandaran University Medical Sciences; Parnassia Psychiatric Institute; Yeshiva University; Albert Einstein College of Medicine; University of London; London School of Hygiene & Tropical Medicine; Baylor College of Medicine; Central South University; University of Toronto; George Washington University; Qatar University; Aarhus University; National Institute for Health Development - Estonia; University of Tokyo; University of Tokyo; George Mason University; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Tianjin Center for Disease Control & Prevention; Ruprecht Karls University Heidelberg; Fudan University; Fudan University; German Center for Infection Research; Columbia University; Columbia University; All India Institute of Medical Sciences (AIIMS) New Delhi; Oklahoma State University System; Oklahoma State University - Stillwater; South African Medical Research Council; Jordan University of Science & Technology; Health Services Academy; United Arab Emirates University; Seoul National University (SNU); National Center for Disease Control & Public Health - Georgia; Universidade Federal do Rio Grande do Sul; Northeastern University; Soonchunhyang University; Simmons University; University of Canberra; University System of Ohio; University of Cincinnati; National Cerebral & Cardiovascular Center - Japan; Ministry of Health - Indonesia; National Institute of Health Research & Development (NIHRD); Ministry of Health - Indonesia; National Institute of Health Research & Development (NIHRD); University of Bielefeld; University of Bielefeld; Research Center of Neurology; Oregon Health & Science University; Universite de Montreal; Hacettepe University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Arkansas State University; International Institute for Population Sciences; Boston Medical Center; University of Adelaide; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Nova Southeastern University; Korea University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Roche Holding; Genentech; Shandong First Medical University & Shandong Academy of Medical Sciences; Sichuan University; Wayne State University; Turning Point Alcohol & Drug Centre - Australia; Universita degli Studi di Bari Aldo Moro; American Cancer Society; University of Bern; Australian National University; Aintree University Hospitals NHS Foundation Trust; Swansea University; Ministry of Health-Singapore; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Zambia; UERM Memorial Medical Center; Icahn School of Medicine at Mount Sinai; University of York - UK; University of Cape Town; University of Cape Town; University of Sydney; Alaska Native Tribal Health Consortium; University of Pennsylvania; University of Pennsylvania; Jefferson University; National Institutes of Health (NIH) - USA; Ifakara Health Institute; Tufts University; Pacific Institute for Research & Evaluation (PIRE); Curtin University; University of Ottawa; Duke University; Universiti Kebangsaan Malaysia; Salahaddin University; University of Papua New Guinea; University of North Texas System; University of North Texas Denton; Queensland University of Technology (QUT); National Center for Child Health & Development - Japan; University of Crete; Egerton University; Philipps University Marburg; Tokyo Medical & Dental University (TMDU); American University of Beirut; University of Kwazulu Natal; ASST Papa Giovanni XXIII; Suraj Eye Institute; Emory University; Rollins School Public Health; Emory University; City University of New York (CUNY) System; Mohammed First University of Oujda; Sidi Mohamed Ben Abdellah University of Fez; University of Oslo; World Health Organization; World Health Organization; Hanoi University of Public Health; University of Bergen; Lund University; Makerere University; Kyung Hee University; Teikyo University; Fundacion Jimenez Diaz; Universidade do Porto; Hospital Universitario Cruces; Flinders University South Australia; Aalborg University; University of Witwatersrand; Shanghai Jiao Tong University; McMaster University; Brigham Young University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Hamad Medical Corporation; University of Missouri System; University of Missouri Columbia; University of Punjab; Walden University; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; London Health Sciences Centre; Western University (University of Western Ontario); University of London; London School of Hygiene & Tropical Medicine; Pompeu Fabra University; Ulm University; Bhabha Atomic Research Center (BARC); Muhimbili University of Health & Allied Sciences; Rwanda Biomedical Center; University of Miami; Queensland Centre for Mental Health Research; Universiti Kebangsaan Malaysia; Vanderbilt University; Case Western Reserve University; Dartmouth College; Marshall University; Novartis; Novartis Turkey; Universidade Federal de Santa Catarina (UFSC); University of Alabama System; University of Alabama Birmingham; Stellenbosch University; University of Colorado System; University of Colorado Boulder; An Najah National University; University of Tokyo; Tachikawa Hospital; Finnish Institute of Occupational Health; Washington State University; Heriot Watt University; Reykjavik University; Dartmouth College; Stavanger University Hospital; Ministry of Health of the Russian Federation; Western University (University of Western Ontario); Universiti Tunku Abdul Rahman (UTAR); University of Munich; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Alexandra Hospital; Northwestern University; University of California System; University of California Irvine; University of Illinois System; University of Illinois Urbana-Champaign; Chinese Center for Disease Control & Prevention; National Institute of Occupational Health & Poison Control, Chinese Center for Disease Control & Prevention; Chaim Sheba Medical Center; Tel Aviv University; Westchester Medical Center; Jhpiego; Trimbos Institute; Memorial University Newfoundland; King Fahad Medical City; King Fahad Medical City; CGIAR; Worldfish; University of Alberta; Aristotle University of Thessaloniki; Cincinnati Children's Hospital Medical Center; Universidade do Sul de Santa Catarina; University of Copenhagen; Cleveland Clinic Foundation; African Population & Health Research Centre; European Commission Joint Research Centre; EC JRC ISPRA Site; Netherlands National Institute for Public Health & the Environment; Research Center of Neurology; UKK Institute; Raffles Hospital; University of Bologna; HSE University (National Research University Higher School of Economics); Uniformed Services University of the Health Sciences - USA; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Health Canada; University of California System; University of California Davis; Philipps University Marburg; University of Miami; Imperial College London; University of Nottingham; University of Gondar; Royal Cornwall Hospital; Nanjing University; Jichi Medical University; University of Hong Kong; National Center for Neurology & Psychiatry - Japan; Jackson State University; Wuhan University; Wuhan University; Egyptian Knowledge Bank (EKB); Mansoura University; Chongqing Medical University; Landstuhl Regional Medical Center	Vos, T (corresponding author), Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	tvos@uw.edu	Geleijnse, Johanna Marianna M/B-5749-2012; Levi, Miriam/AAR-8512-2020; Juel, Knud/C-8916-2013; wang, lin/GSE-3040-2022; Bin Abdulhak, Aref/AAK-4348-2020; Rojas-Rueda, David/AAK-2184-2020; Tonelli, Marcello/B-3028-2009; Krishnamurthi, Rita/AAU-7841-2021; Hu, Howard/AAV-5360-2021; wang, lin/HHM-2225-2022; Malekzadeh, Reza/U-1382-2017; PEREZ-RUIZ, FERNANDO/E-4844-2012; Knibbs, Luke/C-7865-2012; Balakrishnan, Kalpana/B-6653-2015; , Bennett/O-7998-2019; A, Naheed/AHB-2941-2022; Alsharif, Ubai/AAK-2088-2021; Marzan, Melvin/AAP-8443-2020; Kan, Haidong/AGU-0328-2022; Naldi, Luigi/K-6343-2016; wang, lili/HDL-7210-2022; Bedi, Neeraj/AGR-0606-2022; Lotufo, Paulo/A-9843-2008; Norheim, Ole Frithjof/AAC-8771-2020; assadi, reza/AAI-1124-2021; Kaul, Anil/B-2075-2016; Stein, Dan/A-1752-2008; Bin Abdulhak, Aref/AAM-9492-2020; Bernabe, Eduardo/R-3441-2017; Mckee, Martin/E-6673-2018; Pope, C. Arden/ABD-5522-2021; Scott, James G/D-5900-2012; Buchbinder, Rachelle/G-2952-2011; Ronfani, Luca/B-6668-2013; Lopez, Alan/AAA-2734-2022; Lunevicius, Raimundas/B-2528-2018; Nash, Denis/AFI-7485-2022; Heydarpour, Pouria/J-7330-2019; Newton, Charles RJC/B-7578-2014; Tanne, David/F-2560-2010; Sepanlou, Sadaf G/H-9343-2016; Varakin, Yuriy Ya/C-8634-2012; Van Dingenen, Rita/AAI-3197-2021; Adsuar, Jose C/C-6558-2008; Katz, Ronit/ABA-1880-2021; Majdan, Marek/K-5017-2012; Rahimi, Kazem/Q-1279-2015; Kemp, Andrew Haddon/C-7984-2012; Zunt, Joseph/ABD-2886-2021; Schneider, Ione J.C./J-8762-2013; Kengne, Andre Pascal/ABB-3696-2020; Hay, Simon Iain/F-8967-2015; Bikbov, Boris/I-4594-2013; Brayne, Carol/AAA-4285-2020; McKee, Marc D/E-2187-2011; Brenner, Hermann/ABE-6383-2020; Deribe, Kebede/I-5422-2019; Kinfu, Yohannes/AAC-8054-2020; Mapoma, Christopher Chabila/AAX-3368-2020; Hornberger, John/M-4932-2019; Soshnikov, Sergey/AAG-9739-2020; Singh, Jasvinder/R-6172-2019; Brauer, Michael/Y-2810-2019; Ginawi, Ibrahim Abdelmageed Mohamed/H-3260-2012; Papachristou, Christina/AAR-2187-2021; Khader, Yousef/AAE-9620-2019; Ribeiro, Antonio L/C-2707-2009; Lalloo, Ratilal/O-5624-2014; Bennett, Derrick/AAH-1220-2022; Zhao, Yong/Z-3231-2019; Defo, Barthelemy Kuate/I-4818-2017; Refaat, Amany/AAA-8470-2021; PACELLA, ROSANA E./F-2774-2010; Foigt, Nataliya/AAU-5229-2020; Ferri, Cleusa Pinheiro/B-2922-2010; Kuipers, Ernst J/H-3293-2019; saylan, Mete/B-5648-2008; Riederer, Anne/HHN-1303-2022; Carapetis, Jonathan R/H-8933-2014; Ukwaja, Kingsley N./A-7794-2013; Oh, In Hwan/AAI-9070-2020; Badawi, Alaa/ABC-1300-2021; Sacco, Ralph/Y-9278-2019; Takahashi, Ken/AAX-7705-2020; Monasta, Lorenzo/B-1388-2012; Moffitt, Terrie E/D-5295-2011; Naldi, Luigi/AFM-8982-2022; Phillips, Michael Robert/AAE-7585-2021; Naidoo, Kovin Shunmugam/AAF-5914-2020; Lopez, Alan D/F-1487-2010; Charlson, Fiona/R-8963-2019; Mozaffarian, Dariush/ABC-2822-2020; Zaki, Maysaa El Sayed/H-3049-2019; ortiz, alberto/Y-7582-2018; Villalpando, Salvador/AAS-3874-2021; Neupane, Sudan Prasad/C-8056-2011; Waller, Stephen/AAI-1787-2020; Aboyans, Victor/AAN-8308-2020; Perico, Norberto/ABH-3222-2020; Gunnell, David/ABE-6653-2020; Rana, Saleem M/Y-9791-2018; Ribeiro, Ana Cristina/HHN-7466-2022; Dokova, Klara/N-2448-2016; Chowdhury, Rajiv/AHB-1253-2022; Wallin, Mitchell T./J-8190-2019; Soshnikov, Sergey/R-7352-2016; Antonio, Carl Abelardo/AAP-4280-2020; Anderson, Hugh R/A-7417-2016; Kivipelto, Miia/AAS-3557-2021; Gona, Philimon/K-1477-2019; Karthikeyan, Ganesan/D-5767-2012; Ärnlöv, Johan/AAF-2746-2019; Amini, Heresh/B-3076-2010; Hamadeh, Randah R./AAE-9720-2020; Nyakarahuka, Luke/AGH-2432-2022; Azage, Muluken/AAF-6515-2020; Weiderpass, Elisabete/AAP-2747-2021; Alvarez, Elena/S-1068-2019; Thrift, Amanda/I-6251-2012; RUIZ, FERNANDO PEREZ/X-1980-2019; Salomon, Joshua/S-1929-2019; Giussani, Giorgia/AAA-8029-2020; Melaku, Yohannes Adama/S-2451-2019; Ameli, Omid/AAA-1209-2020; Mohammadi, Alireza/R-9202-2016; Pandian, Jeyaraj Durai/AAV-5591-2020; Davis, Adrian C/E-6022-2015; ABBASOGLU OZGOREN, AYSE/I-8707-2013; Khan, Ejaz A/B-9340-2016; Richardus, Jan Hendrik/AAE-1278-2021; Moradi-Lakeh, Maziar/ABC-9793-2021; Alvis-Guzman, Nelson/D-4913-2013; Ferrari, Alize J/G-1746-2011; Memish, Ziad Ahmed/AEJ-9424-2022; Banerjee, Amitava/D-4381-2014; Newton, Charles/V-7872-2019; Boothapati, Anil Kumar/HHS-1813-2022; GANKPE, GBETOHO FORTUNE/GLT-4476-2022; A, Naheed/AHB-2940-2022; Murray, Joseph/Z-6274-2019; Santos, Itamar/M-2208-2019; Meretoja, Atte/H-6531-2019; Díaz-Torné, César/AAG-2419-2020; Jacobsen, Kathryn H./B-5857-2008; Pesudovs, Konrad/T-9403-2019; Crump, John A./AAZ-6412-2020; Alsharif, Ubai/C-6527-2017; Kieling, Christian/U-3905-2019; Bolliger, Ian W/C-4207-2016; Zhou, Maigeng/HCH-7703-2022; Mason-Jones, Amanda/ABF-1565-2020; Sposato, Luciano A/D-7782-2012; Mokdad, Ali H./AAD-1232-2022; Venketasubramanian, Narayanaswamy/GPP-5948-2022; McGrath, John Joseph/G-5493-2010; Deribe, Kebede/K-7055-2019; Abu-Raddad, Laith J/AAY-1441-2020; Ermakov, Sergey/G-1709-2016; Bennett, Derrick/AFL-9254-2022; Higashi, Hideki/D-3797-2011; Pereira, David/M-9286-2013; Pourmalek, Farshad/A-8188-2010; Soshnikov, Sergey/AAV-8566-2020; Rahimi, Kazem/AAA-4250-2022; ABRAHAM, BIJU/AAK-2461-2020; Bedi, Neeraj/H-2838-2019; Kravchenko, Michael A/B-2596-2012; Montico, Marcella/B-5290-2013; Prabhakaran, Dorairaj/B-4147-2011; Degenhardt, Louisa J/D-4515-2012; Brenner, Hermann/B-4627-2017; Patten, Scott/B-4434-2011; Quistberg, D Alex/P-3538-2019; Violante, Francesco S/A-6934-2009; Guinovart, Caterina/ABH-2981-2020; Nolte, Sandra/B-7498-2008; Weiderpass, Elisabete/M-4029-2016; KUMAR, ANIL/ACD-8340-2022; Lortet-Tieulent, Joannie/AAE-9099-2019; Sahathevan, Ramesh/S-9302-2019; Shiri, Rahman/ABB-1780-2021; assadi, reza/AAT-6629-2020; Knudsen, Ann Kristin/AAB-2465-2019; Naohiro, Yonemoto/Y-3761-2019; Towbin, Jeffrey A./J-5595-2019; Trillini, Matias/ABA-7075-2020; Ding, Eric L./K-1118-2019; Ortblad, Katrina/ABF-9070-2020; Truelsen, Thomas/AAY-1549-2020; Beghi, Ettore/AAA-7426-2020; de la cruz, vanessa/AAH-5999-2020; Khan, Prof Dr Ejaz/GNP-1245-2022; Feigin, Valery/AAF-2313-2019; Polanczyk, Guilherme V./AAF-6142-2021; LOGROSCINO, GIANCARLO/K-5148-2016; Schwebel, David/GXH-9944-2022; Mukaigawara, Mitsuru/L-2144-2016; Trasande, Leonardo/ABE-6339-2020; Rodriguez, Alina/B-3541-2015; Marks, Guy B./F-5058-2013; Beyene, Tariku Jibat/A-6875-2017; Karch, André/D-6973-2017; Undurraga, Eduardo/I-3739-2014; CASO, VALERIA/AAC-5156-2022; Narayan, K.M. Venkat/J-9819-2012; Bicer, Burcu Kucuk/G-4922-2017; Lee, Jong-Tae/AAF-5746-2020; Giussani, Giorgia/E-8057-2017; Khan, Gulfaraz/AAC-2859-2022; Santos, Itamar S/K-7055-2012; Hossain, Mazeda/AAL-3202-2020; Satpathy, Maheswar/J-3135-2017; Castañeda-Orjuela, Carlos/N-2601-2017; Fereshtehnejad, Seyed-Mohammad/ABF-6020-2020; Nyakarahuka, Luke/W-8164-2019; Poenaru, Dan/S-2562-2017; Bose, Dipan/GRS-0467-2022; Asghar, Rana Jawad/AAF-7634-2021; Bensenor, Isabela Judith Martins/L-3306-2017; Whiteford, Harvey A/A-4840-2009; Li, Yichong/A-3559-2019; Scarborough, Peter/ABD-6111-2021; Hankey, Graeme J/H-4968-2014; Rakovac, Ivo/A-7678-2013; Matzopoulos, Richard/AAL-9965-2021; Benzian, Habib/AAN-5866-2020; Zaki, Maysaa El Sayed/C-1522-2013; Bell, Michelle/Y-4608-2018; Woldeyohannes, Solomon Meseret/E-5783-2012; Husseini, Abdullatif/E-8377-2015; Heredia-Pi, Ileana Beatriz/L-4247-2019; Brugha, Traolach/T-9326-2019; Charlson, Fiona J/F-5290-2011; Rahimi-Movaghar, Vafa/L-6339-2019; Franklin, Richard Charles/H-1731-2012; Zonies, David/B-6497-2011; Crump, John A./AAZ-6289-2020; Haro, Josep Maria/D-1423-2011; Lozano, Rafael/T-5352-2018; Salomon, Joshua A/D-3898-2009; Brazinova, Alexandra/C-4265-2016; Catalá-López, Ferrán/N-6018-2018; CT, Sreeramareddy/I-1203-2019; Saylan, Mete/AAP-1195-2020; Terkawi, Abdullah Suleiman/AAC-1113-2019; Hedayati, Mohammad T./E-2304-2017; alla, francois/D-2295-2014; wang, YA XING/K-9671-2016; Resnikoff, Serge/N-2355-2019; Polanczyk, Guilherme V/C-2345-2012; Vlassov, Valentin/F-4720-2013; Leasher, Janet/B-8889-2016; Larson, Heidi J./N-1018-2017; Erskine, Holly/K-5244-2012	Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Levi, Miriam/0000-0002-0086-3952; Rojas-Rueda, David/0000-0001-5854-2484; Tonelli, Marcello/0000-0002-0846-3187; Krishnamurthi, Rita/0000-0003-0869-2083; Malekzadeh, Reza/0000-0002-9820-6335; Balakrishnan, Kalpana/0000-0002-5905-1801; A, Naheed/0000-0002-6016-5603; Alsharif, Ubai/0000-0002-4024-3950; Marzan, Melvin/0000-0003-2696-7335; Naldi, Luigi/0000-0002-3160-2835; Bedi, Neeraj/0000-0003-4709-8423; Lotufo, Paulo/0000-0002-4856-8450; Norheim, Ole Frithjof/0000-0002-5748-5956; Stein, Dan/0000-0001-7218-7810; Bin Abdulhak, Aref/0000-0001-9988-8609; Bernabe, Eduardo/0000-0002-1858-3713; Mckee, Martin/0000-0002-0121-9683; Scott, James G/0000-0002-0744-0688; Buchbinder, Rachelle/0000-0002-0597-0933; Ronfani, Luca/0000-0001-5710-3914; Lunevicius, Raimundas/0000-0003-3295-0142; Heydarpour, Pouria/0000-0001-5644-7555; Newton, Charles RJC/0000-0002-6999-5507; Tanne, David/0000-0002-6699-2220; Sepanlou, Sadaf G/0000-0002-3669-5129; Van Dingenen, Rita/0000-0003-2521-4972; Adsuar, Jose C/0000-0001-7203-3168; Majdan, Marek/0000-0001-8037-742X; Rahimi, Kazem/0000-0002-4807-4610; Kemp, Andrew Haddon/0000-0003-1146-3791; Schneider, Ione J.C./0000-0001-6339-7832; Hay, Simon Iain/0000-0002-0611-7272; Bikbov, Boris/0000-0002-1925-7506; Brayne, Carol/0000-0001-5307-663X; McKee, Marc D/0000-0001-8349-965X; Brenner, Hermann/0000-0002-6129-1572; Deribe, Kebede/0000-0002-8526-6996; Kinfu, Yohannes/0000-0001-9607-6891; Mapoma, Christopher Chabila/0000-0001-9233-5462; Soshnikov, Sergey/0000-0002-6983-7066; Singh, Jasvinder/0000-0003-3485-0006; Brauer, Michael/0000-0002-9103-9343; Ginawi, Ibrahim Abdelmageed Mohamed/0000-0001-8628-1840; Khader, Yousef/0000-0002-7830-6857; Ribeiro, Antonio L/0000-0002-2740-0042; Lalloo, Ratilal/0000-0001-5822-1269; Bennett, Derrick/0000-0002-9170-8447; Zhao, Yong/0000-0001-9290-109X; Defo, Barthelemy Kuate/0000-0002-6589-0564; PACELLA, ROSANA E./0000-0002-9742-1957; Foigt, Nataliya/0000-0002-3613-5965; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Kuipers, Ernst J/0000-0002-0633-3098; saylan, Mete/0000-0002-8917-1775; Carapetis, Jonathan R/0000-0002-1182-9792; Ukwaja, Kingsley N./0000-0002-1974-8735; Oh, In Hwan/0000-0002-5450-9887; Takahashi, Ken/0000-0002-7310-2257; Monasta, Lorenzo/0000-0001-7774-548X; Moffitt, Terrie E/0000-0002-8589-6760; Naldi, Luigi/0000-0002-3160-2835; Phillips, Michael Robert/0000-0002-5973-2439; Lopez, Alan D/0000-0001-5818-6512; Charlson, Fiona/0000-0003-2876-5040; Zaki, Maysaa El Sayed/0000-0001-5431-0248; ortiz, alberto/0000-0002-9805-9523; Villalpando, Salvador/0000-0001-6429-3816; Perico, Norberto/0000-0002-3147-4327; Gunnell, David/0000-0002-0829-6470; Rana, Saleem M/0000-0001-6479-9235; Ribeiro, Ana Cristina/0000-0002-0493-8376; Wallin, Mitchell T./0000-0003-1061-5714; Soshnikov, Sergey/0000-0002-6983-7066; Antonio, Carl Abelardo/0000-0001-7476-0553; Karthikeyan, Ganesan/0000-0002-2073-2917; Ärnlöv, Johan/0000-0002-6933-4637; Amini, Heresh/0000-0002-4825-1322; Hamadeh, Randah R./0000-0002-4205-1354; Nyakarahuka, Luke/0000-0002-2944-9157; Azage, Muluken/0000-0003-3222-0158; Weiderpass, Elisabete/0000-0003-2237-0128; Alvarez, Elena/0000-0002-9679-2721; Thrift, Amanda/0000-0001-8533-4170; RUIZ, FERNANDO PEREZ/0000-0002-5268-1894; Salomon, Joshua/0000-0003-3929-5515; Giussani, Giorgia/0000-0003-2460-3095; Melaku, Yohannes Adama/0000-0002-3051-7313; Ameli, Omid/0000-0001-7878-0551; Mohammadi, Alireza/0000-0002-1004-5339; Davis, Adrian C/0000-0001-7134-7528; ABBASOGLU OZGOREN, AYSE/0000-0002-6106-4839; Khan, Ejaz A/0000-0002-7072-8035; Richardus, Jan Hendrik/0000-0003-0564-6313; Moradi-Lakeh, Maziar/0000-0001-7381-5305; Alvis-Guzman, Nelson/0000-0001-9458-864X; Ferrari, Alize J/0000-0002-7863-9117; Memish, Ziad Ahmed/0000-0002-5099-0714; Banerjee, Amitava/0000-0001-8741-3411; Newton, Charles/0000-0002-6999-5507; GANKPE, GBETOHO FORTUNE/0000-0002-1242-9686; A, Naheed/0000-0002-6016-5603; Murray, Joseph/0000-0002-5511-3454; Santos, Itamar/0000-0003-3212-8466; Meretoja, Atte/0000-0001-6433-1931; Díaz-Torné, César/0000-0001-6275-7699; Jacobsen, Kathryn H./0000-0002-4198-6246; Pesudovs, Konrad/0000-0002-6322-9369; Crump, John A./0000-0002-4529-102X; Alsharif, Ubai/0000-0002-4024-3950; Kieling, Christian/0000-0001-7691-4149; Bolliger, Ian W/0000-0001-8055-297X; Mason-Jones, Amanda/0000-0002-4292-3183; Sposato, Luciano A/0000-0001-6425-9343; Mokdad, Ali H./0000-0002-4994-3339; McGrath, John Joseph/0000-0002-4792-6068; Abu-Raddad, Laith J/0000-0003-0790-0506; Ermakov, Sergey/0000-0003-1072-1162; Bennett, Derrick/0000-0002-9170-8447; Higashi, Hideki/0000-0002-5534-0905; Pereira, David/0000-0003-0384-7592; Pourmalek, Farshad/0000-0002-2134-0771; Bedi, Neeraj/0000-0003-4709-8423; Kravchenko, Michael A/0000-0001-5187-5518; Montico, Marcella/0000-0003-0377-8232; Prabhakaran, Dorairaj/0000-0002-3172-834X; Degenhardt, Louisa J/0000-0002-8513-2218; Brenner, Hermann/0000-0002-6129-1572; Patten, Scott/0000-0001-9871-4041; Quistberg, D Alex/0000-0001-9730-2686; Violante, Francesco S/0000-0003-4084-2782; Nolte, Sandra/0000-0001-6185-9423; Weiderpass, Elisabete/0000-0003-2237-0128; Lortet-Tieulent, Joannie/0000-0002-8816-7475; Sahathevan, Ramesh/0000-0001-7643-0961; Shiri, Rahman/0000-0002-9312-3100; Towbin, Jeffrey A./0000-0002-6585-714X; Trillini, Matias/0000-0003-1859-1729; Ding, Eric L./0000-0002-5881-8097; Ortblad, Katrina/0000-0002-5675-8836; Beghi, Ettore/0000-0003-2542-0469; Khan, Prof Dr Ejaz/0000-0002-7072-8035; Polanczyk, Guilherme V./0000-0003-2311-3289; LOGROSCINO, GIANCARLO/0000-0003-0423-3242; Mukaigawara, Mitsuru/0000-0001-6530-2083; Rodriguez, Alina/0000-0003-1209-8802; Marks, Guy B./0000-0002-8976-8053; Beyene, Tariku Jibat/0000-0002-7474-1966; Karch, André/0000-0003-3014-8543; Undurraga, Eduardo/0000-0002-4425-1253; CASO, VALERIA/0000-0002-2020-8891; Narayan, K.M. Venkat/0000-0001-8621-5405; Bicer, Burcu Kucuk/0000-0002-5615-264X; Lee, Jong-Tae/0000-0002-8510-3054; Giussani, Giorgia/0000-0003-2460-3095; Khan, Gulfaraz/0000-0001-6836-1783; Santos, Itamar S/0000-0003-3212-8466; Hossain, Mazeda/0000-0002-1878-8145; Satpathy, Maheswar/0000-0003-3521-4781; Castañeda-Orjuela, Carlos/0000-0002-8735-6223; Fereshtehnejad, Seyed-Mohammad/0000-0001-9255-9351; Nyakarahuka, Luke/0000-0002-2944-9157; Poenaru, Dan/0000-0002-6267-6140; Whiteford, Harvey A/0000-0003-4667-6623; Li, Yichong/0000-0003-3842-475X; Scarborough, Peter/0000-0002-2378-2944; Hankey, Graeme J/0000-0002-6044-7328; Rakovac, Ivo/0000-0003-3462-2636; Matzopoulos, Richard/0000-0001-9063-6210; Benzian, Habib/0000-0003-3692-4849; Zaki, Maysaa El Sayed/0000-0001-5431-0248; Bell, Michelle/0000-0002-3965-1359; Husseini, Abdullatif/0000-0001-8767-5956; Heredia-Pi, Ileana Beatriz/0000-0002-9998-9239; Brugha, Traolach/0000-0002-9786-9591; Charlson, Fiona J/0000-0003-2876-5040; Franklin, Richard Charles/0000-0003-1864-4552; Crump, John A./0000-0002-4529-102X; Haro, Josep Maria/0000-0002-3984-277X; Lozano, Rafael/0000-0002-7356-8823; Salomon, Joshua A/0000-0003-3929-5515; Brazinova, Alexandra/0000-0003-0625-256X; Catalá-López, Ferrán/0000-0002-3833-9312; CT, Sreeramareddy/0000-0002-5693-7631; Terkawi, Abdullah Suleiman/0000-0001-8734-2748; Hedayati, Mohammad T./0000-0001-6415-4648; wang, YA XING/0000-0003-2749-7793; Resnikoff, Serge/0000-0002-5866-4446; Polanczyk, Guilherme V/0000-0003-2311-3289; Briggs, Adam/0000-0002-2314-1039; Stanaway, Jeffrey/0000-0003-2209-8478; Soljak, Michael/0000-0002-0303-1617; Nisar, Muhammad Imran/0000-0002-2378-4720; Liu, Zhi-Hong/0000-0001-6093-0726; Juel, Knud/0000-0002-4134-1173; Rothenbacher, Dietrich/0000-0002-3563-2791; Sindi, Shireen/0000-0002-3786-0552; Vlassov, Valentin/0000-0003-2845-2992; Goenka, Shifalika/0000-0001-6993-2883; Lyons, Ronan/0000-0001-5225-000X; Mhimbira, Francis/0000-0001-8989-6832; Kengne, Andre Pascal/0000-0002-5183-131X; Moturi, Wilkister Nyaora/0000-0001-6620-4856; Leasher, Janet/0000-0002-8779-5162; Contreras, Alejandra/0000-0003-1576-5922; Larson, Heidi J./0000-0002-8477-7583; Trasande, Leonardo/0000-0002-1928-597X; Shiue, Ivy/0000-0003-1788-3009; alla, francois/0000-0002-5793-7190; Kimokoti, Ruth/0000-0002-4980-3256; Khang, Young-Ho/0000-0002-9585-8266; Knudsen, Ann Kristin/0000-0002-1218-798X; Erskine, Holly/0000-0003-3119-9211; Ademi, Zanfina/0000-0002-0625-3522; Roberts, Allen/0000-0003-3660-6330; Sanchez Riera, Lidia/0000-0003-0774-2480; Christensen, Hanne/0000-0002-7472-3194; Gouda, Hebe/0000-0002-5709-4509; Meaney, Peter/0000-0001-9898-6928; Felson, David/0000-0002-2668-2447; Xu, Gelin/0000-0002-6194-0341; Achoki, Tom/0000-0001-6309-8904; Shibuya, Kenji/0000-0003-2528-7530; Aboyans, Victor/0000-0002-0322-9818; Qato, Dima/0000-0001-5411-6998; Abubakar, Ibrahim/0000-0002-0370-1430; Stockl, Heidi/0000-0002-0907-8483; Bhala, Neeraj/0000-0003-2502-1177	Lundbeck and Auckland University of Technology University; Bill AMP; Melinda Gates Foundation; Ministry of Health, Labour and Welfare of Japan; Australian National health and Medical Research Council (NHMRC) [1041742]; Japan Society of Clinical Pharmacology and Therapeutics; National Heart Foundation, Australia; Wellcome Trust [091758, 095066, 089963/Z/09/Z, 099876]; Health Protection Scotland; National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Evaluation of Interventions, and Sexual Health 24; WHO; University of Illinois, Lemann Institute for Brazilian Studies Faculty Research Grant; NIHR Oxford BRC; NIHR; CIBERSAM; Instituto de Salud Carlos III; Spanish Ministry of Economy and Competitiveness, Madrid, Spain; Qatar National Research Fund [NPRP 04-924-3-251]; joint US National Institutes of Health-National Science Foundation Ecology and Evolution of Infectious Disease program [R01 TW009237]; UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J010367/1]; UK BBSRC Zoonoses in Emerging Livestock Systems awards [BB/L017679, BB/L018926, BB/L018845]; Queensland Department of Health; VIROPHARMA; EISAI; UCB-Pharma; GlaxoSmithKline; Italian Drug Agency; Italian Ministry of Health; Sanofi-Aventis; American ALS Association; Wellcome Trust; NIHR Biomedical Research Centre at Guy's and St Thomas' National Health Service Foundation Trust and King's College London - NIHR; Abbott; ABMRF; Astrazeneca; Biocodex; Eli-Lilly; Jazz Pharmaceuticals; Johnson Johnson; Lundbeck; National Responsible Gambling Foundation; Novartis; Orion; Pfizer; Pharmacia; Roche; Servier; Solvay; Sumitomo; Sun; Takeda; Tikvah; Wyeth; Medical Research Council of South Africa; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [5T32HD057822]; Public Health Foundation of India; consortium of UK universities; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Farr Institute at CIPHER; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; Medical Research Council; National Institute of Health Research; National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientist Office (Scottish Government Health Directorates); MRC [MR/K006525/1]; Savient; Regeneron; Allergan; American College of Rheumatology's Guidelines Subcommittee of the Quality of Care Committee; Veterans Affairs Rheumatology Field Advisory Committee; National Health and Medical Research of Australia; NIH, the National Institute of Environmental Health Sciences; Brien Holden Vision Institute; Victorian Articles 56 Government; Korean Health Technology research and development project, Ministry of Health and Welfare, North Korea [HI13C0729]; NIH; Commonwealth Government of Australia; Institute of Bone and Joint Research; Crucell; Merck; Sanofi Pasteur; NIH [R01 DA 003574]; Oklahoma Center for the Advancement of Science and Technology; NIHR Career Development Fellowship; Wellcome Trust Training Fellowship [099876]; South African Medical Research Council; BBSRC [BB/J010367/1, BB/L018926/1, BB/L018845/1] Funding Source: UKRI; MRC [MR/L003120/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057822] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R01TW009237] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001088, UL1TR001079, UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003574] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/L018926/1, BB/L018845/1, BB/J010367/1] Funding Source: researchfish; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/K006525/1, MR/L003120/1, G9817803B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165, CDF-2013-06-012, NF-SI-0510-10060, RP-PG-0407-10184, ACF-2011-13-012] Funding Source: researchfish	Lundbeck and Auckland University of Technology University(Lundbeck Corporation); Bill AMP; Melinda Gates Foundation(CGIAR); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Australian National health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Japan Society of Clinical Pharmacology and Therapeutics; National Heart Foundation, Australia(National Heart Foundation of Australia); Wellcome Trust(Wellcome Trust); Health Protection Scotland; National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Evaluation of Interventions, and Sexual Health 24; WHO(World Health Organization); University of Illinois, Lemann Institute for Brazilian Studies Faculty Research Grant; NIHR Oxford BRC; NIHR(National Institute for Health Research (NIHR)); CIBERSAM; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Economy and Competitiveness, Madrid, Spain(Spanish Government); Qatar National Research Fund(Qatar National Research Fund (QNRF)); joint US National Institutes of Health-National Science Foundation Ecology and Evolution of Infectious Disease program; UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK BBSRC Zoonoses in Emerging Livestock Systems awards(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Queensland Department of Health; VIROPHARMA; EISAI(Eisai Co Ltd); UCB-Pharma(UCB Pharma SA); GlaxoSmithKline(GlaxoSmithKline); Italian Drug Agency; Italian Ministry of Health(Ministry of Health, Italy); Sanofi-Aventis(Sanofi-Aventis); American ALS Association; Wellcome Trust(Wellcome Trust); NIHR Biomedical Research Centre at Guy's and St Thomas' National Health Service Foundation Trust and King's College London - NIHR; Abbott(Abbott Laboratories); ABMRF; Astrazeneca(AstraZeneca); Biocodex; Eli-Lilly(Eli Lilly); Jazz Pharmaceuticals(Jazz Pharmaceuticals); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Lundbeck(Lundbeck Corporation); National Responsible Gambling Foundation; Novartis(Novartis); Orion; Pfizer(Pfizer); Pharmacia; Roche(Roche Holding); Servier(Servier); Solvay(Solvay SA); Sumitomo; Sun; Takeda(Takeda Pharmaceutical Company Ltd); Tikvah; Wyeth(Wyeth); Medical Research Council of South Africa(South African Medical Research Council); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Public Health Foundation of India; consortium of UK universities; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Farr Institute at CIPHER; Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientist Office (Scottish Government Health Directorates); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Savient; Regeneron(Regeneron); Allergan(AbbVieAllergan); American College of Rheumatology's Guidelines Subcommittee of the Quality of Care Committee; Veterans Affairs Rheumatology Field Advisory Committee; National Health and Medical Research of Australia; NIH, the National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Brien Holden Vision Institute; Victorian Articles 56 Government; Korean Health Technology research and development project, Ministry of Health and Welfare, North Korea; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth Government of Australia(Australian Government); Institute of Bone and Joint Research; Crucell; Merck(Merck & Company); Sanofi Pasteur; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology; NIHR Career Development Fellowship; Wellcome Trust Training Fellowship(Wellcome Trust); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Bill & Melinda Gates Foundation.r This study was funded by the Bill & Melinda Gates Foundation. VF and RK were partly supported by the unrestricted educational grant from Lundbeck and Auckland University of Technology University. RM received funding from Ministry of Health, Labour and Welfare of Japan. LD is supported by an Australian National health and Medical Research Council (NHMRC) Principal Research Fellowship (#1041742). Work by NY was supported by funding from the Japan Society of Clinical Pharmacology and Therapeutics. YK would like to thank the National Heart Foundation, Australia, for extending a special grant to the University of Canberra that enabled him to participate in the GBD 2013 study and more broadly engage in research on cardiovascular conditions in Australia. TW would like to acknowledge the Wellcome Trust, through whom he is supported through a Senior Research Fellowship number 091758. During the study, KJL received funding from Health Protection Scotland, the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Evaluation of Interventions, and Sexual Health 24. KJL received funding from WHO to conduct the review of HSV.2 seroprevalence data that informed this study. GR's contribution to this paper has been on behalf of the International Society of Nephrology (ISN), as a follow-up of the activities of the GBD 2010 Genitourinary Diseases Expert Group. KTD would like to acknowledge the following funding source of institutional support: University of Illinois, Lemann Institute for Brazilian Studies Faculty Research Grant. KR is supported by the NIHR Oxford BRC and an NIHR Career Development Fellowship. FC-L would like to thank funding support by Spanish Ministry of Economy and Competitiveness, Madrid, Spain, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness, Madrid, Spain. LJAR would like to acknowledge the support of Qatar National Research Fund (NPRP 04-924-3-251) who provided the main funding for generating the data provided to the GBD-IHME effort. MBS is a member of the board of directors of the Anxiety and Depression Association of America (a non-profit professional and consumer organization). He has in the past 24 months been a consultant for companies that either market or are conducting research involving antidepressant or antianxiety medications: Janssen, Pfizer, and Tonix Pharmaceuticals. JAC is supported by the joint US National Institutes of Health-National Science Foundation Ecology and Evolution of Infectious Disease program (R01 TW009237) and the UK Biotechnology and Biological Sciences Research Council (BBSRC) (BB/J010367/1), and by UK BBSRC Zoonoses in Emerging Livestock Systems awards BB/L017679, BB/L018926, and BB/L018845. HW, AF, FC, and HE are affiliated with the Queensland Centre for Mental Health Research, which receives funding from the Queensland Department of Health. EB has received money for board membership by VIROPHARMA and EISAI; funding for travel and speaker honoraria from UCB-Pharma and GlaxoSmithKline and funding for educational presentations from GlaxoSmithKline; grants for research activities from the Italian Drug Agency, Italian Ministry of Health, Sanofi-Aventis, and the American ALS Association. ML would like to acknowledge the institutional support received from CeRIMP, Centro Regionale Infortuni e Malattie Professionali Regione Toscana (via S.Salvi, 12 - 50135 Firenze - Italy). AB would like to acknowledge funding from the Wellcome Trust.; r r CW was supported by the NIHR Biomedical Research Centre at Guy's and St Thomas' National Health Service Foundation Trust and King's College London, funded by the NIHR. DS has received research grants or consultancy honoraria from Abbott, ABMRF, Astrazeneca, Biocodex, Eli-Lilly, GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson, Lundbeck, National Responsible Gambling Foundation, Novartis, Orion, Pfizer, Pharmacia, Roche, Servier, Solvay, Sumitomo, Sun, Takeda, Tikvah, and Wyeth. DS would like to acknowledge support by the Medical Research Council of South Africa. DAQ was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under award number 5T32HD057822. The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. PJ is supported by a career development fellowship from the Wellcome Trust, Public Health Foundation of India and a consortium of UK universities. CK receives research grants from Brazilian public funding agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS). He has also received authorship royalties from publishers Artmed and Manole. RAL is partly funded through the Farr Institute at CIPHER. The Farr Institute at CIPHER is supported by a ten-funder consortium: Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates), the Wellcome Trust, (MRC Grant No: MR/K006525/1). JAS has received research grants from Takeda and Savient and consultant fees from Savient, Takeda, Regeneron and Allergan. JAS is a member of the executive of OMERACT, an organisation that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; a member of the American College of Rheumatology's Guidelines Subcommittee of the Quality of Care Committee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. SIH is funded by a Wellcome Trust Grant (#095066). JM is funded as a Research Career Development Fellow from the Wellcome Trust (#089963/Z/09/Z). RL is supported by a National Health and Medical Research of Australia Fellowship. KK thanks the Director of International Institute for Population Sciences (IIPS) for giving KK the opportunity to do PhD at the IIPS, during which KK got the chance to become a GBD Study 2013 collaborator. HC is supported by the Intramural Research Program of the NIH, the National Institute of Environmental Health Sciences. The GBD Vision Loss Expert Group received additional funding from Brien Holden Vision Institute. NP has an honorary position with the University of Melbourne, through the Centre for Eye Research Australia (CERA), and is employed by the Fred Hollows Foundation (FHF). Access to information on population-based prevalence studies from the countries they support work in was primarily as a result of her work at FHF, and the review of the manuscript and revisions suggested were a part of her position at CERA.; r r CERA receives Operational Infrastructure CERA receives Operational Infrastructure Support funding from the Victorian Articles 56 Government. I-HO and S-JY's work was funded by a grant of the Korean Health Technology research and development project, Ministry of Health and Welfare, North Korea (grant number HI13C0729). SS is supported by grants from the NIH and employed by NRF and has honoraria from pharmaceutical companies. KD is supported by a Wellcome Trust Fellowship in Public Health and Tropical Medicine (grant number 099876). LM would like to acknowledge the Commonwealth Government of Australia and the Institute of Bone and Joint Research as funders of this work as all the original data collection for musculoskeletal was funded by these sources. BDG works for Agence de Medecine Preventive which receives grant specific support from Crucell, GlaxoSmithKline, Merck, Novartis, and Sanofi Pasteur. None of these sources contributed to the current work. MGS previously served as a consultant for Ellicon. DCDJ was supported by NIH grant R01 DA 003574. LJA-R would like to acknowledge the Qatar National Research Fund (NPRP 04-924-3-251) who provided the main funding for generating the data he provided to the GBD-IHME effort. The GBD Genitourinary Diseases Expert Group's activities with the GBD 2013 have been made on behalf of the International Society of Nephrology. AK would like to acknowledge funding support from Oklahoma Center for the Advancement of Science and Technology. KR is supported by the NIHR Oxford BRC and an NIHR Career Development Fellowship. KD is supported by a Wellcome Trust Training Fellowship (grant number 099876). KS would like to acknowledge funding from the South African Medical Research Council. IR and WHO staff acknowledge that the authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated.	Agency for Healthcare Research and Quality, US MED EXP PAN SURV; Andrews G, 2004, BRIT J PSYCHIAT, V184, P526, DOI 10.1192/bjp.184.6.526; [Anonymous], 2014, HTLH CAR EXP ARTHR O; Aregawi M, 2009, WORLD MAL REP 2009; Baltussen R, 2004, J NUTR, V134, P2678, DOI 10.1093/jn/134.10.2678; Baxter AJ, 2015, PSYCHOL MED, V45, P601, DOI 10.1017/S003329171400172X; Bethesda MD, 2014, US SEER CANC STAT RE; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bishop YM., 2007, DISCRETE MULTIVARIAT; Bittles AH, 2013, J ROY COLL PHYS EDIN, V43, P7, DOI 10.4997/JRCPE.2013.102; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Blencowe H, 2013, PEDIATR RES, V74, P4, DOI 10.1038/pr.2013.203; Bluestone CD, 1998, INT J PEDIATR OTORHI, V42, P207, DOI 10.1016/S0165-5876(97)00147-X; Boyers LN, 2014, JAMA OPHTHALMOL, DOI 10.1001/jamaophthalmol.2014.3527; Byass P, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001477; Casey GJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002146; Centers for Disease Control and Prevention ( CDC), 1999, US S CAR TRAUM BRAIN; Charlson FJ, 2013, J AFFECT DISORDERS, V151, P111, DOI 10.1016/j.jad.2013.05.060; Cheng HG, 2015, ADDICTION, V110, P761, DOI 10.1111/add.12876; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Cross M, 2014, ANN RHEUM DIS, V73, P1316, DOI 10.1136/annrheumdis-2013-204627; Degenhardt L, 2014, ADDICTION, V109, P1320, DOI 10.1111/add.12551; Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5; Degenhardt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076635; Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V117, P85, DOI 10.1016/j.drugalcdep.2010.11.032; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Driscoll T, 2014, ANN RHEUM DIS, V73, P975, DOI 10.1136/annrheumdis-2013-204631; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Erskine HE, 2014, J CHILD PSYCHOL PSYC, V55, P328, DOI 10.1111/jcpp.12186; Erskine HE, 2013, J CHILD PSYCHOL PSYC, V54, P1263, DOI 10.1111/jcpp.12144; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Flaxman A, 2014, INTEGRATED METAREGRE; Forero R, 1999, BRIT MED J, V319, P344, DOI 10.1136/bmj.319.7206.344; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Franke CR, 2002, T ROY SOC TROP MED H, V96, P236, DOI 10.1016/S0035-9203(02)90087-8; Gabbe BJ, 2013, PLOS MED, DOI 10.1136/injuryprev-2013-040936; GBD 2001 Country Collaboration, 2013, LANCET, V381, P965, DOI 10.1016/S0140-6736(13)60283-4; Haagsma JA, 2013, J DEPRESS ANXIETY, V14, P1242; Haagsma JA, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0042-4; Hansen AM, 2006, J PSYCHOSOM RES, V60, P63, DOI 10.1016/j.jpsychores.2005.06.078; HART DJ, 1993, J RHEUMATOL, V20, P331; Higashi H, 2014, ARCH DIS CHILD; Hillberg T, 2011, TRAUMA VIOLENCE ABUS, V12, P38, DOI 10.1177/1524838010386812; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Hoy D, 2014, BEST PRACT RES CL RH, V28, P377, DOI 10.1016/j.berh.2014.07.006; Hoy D, 2014, ANN RHEUM DIS, V73, P1309, DOI 10.1136/annrheumdis-2013-204431; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Hser YI, 2014, ADDICTION, V109, P1334, DOI 10.1111/add.12597; Institute for Health Metrics and Evaluation Human Development Network The World Bank, 2013, GLOB BURD DIS GEN EV, VRegional; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kates Erica Hyman, 2007, Pediatr Rev, V28, P33, DOI 10.1542/pir.28-1-33; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; KRISHNAMURTHI RV, 2013, J DENT RES, V1, pE25, DOI DOI 10.1016/S0140-6736(13)61953-4; Leonardi M, 2013, NEUROL SCI, V34, pS117, DOI 10.1007/s10072-013-1387-8; Llyod LS., 2003, BEST PRACTICES DENGU; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mathers Colin D, 2006, Popul Health Metr, V4, P4, DOI 10.1186/1478-7954-4-4; Mensah GA, 2013, J AM COLL CARDIOL, V61, pE1406, DOI 10.1016/S0735-1097(13)61406-0; Minja BM, 1996, INT J PEDIATR OTORHI, V37, P29, DOI 10.1016/0165-5876(96)01363-8; Moran A, 2013, PROG CARDIOVASC DIS, V56, P234, DOI 10.1016/j.pcad.2013.09.019; Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nord E, 2013, HEALTH POLICY, V111, P99, DOI 10.1016/j.healthpol.2013.03.019; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Pearson K., 1904, THEORY CONTINGENCY I; Pederson H, 2015, JAMA OTOLARYNGOL, V141, P67, DOI 10.1001/jamaoto.2014.2700; Pescosolido BA, 2010, AM J PSYCHIAT, V167, P1321, DOI 10.1176/appi.ajp.2010.09121743; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Rastogi T, 2002, GLOBAL BURDEN IRON D; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8; Risal A, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-51; Salomon JA, 2013, LANCET GLOB IN PRESS; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2010, B WORLD HEALTH ORGAN, V88, P879, DOI 10.2471/BLT.10.084301; Sankaranarayanan R, 2011, IARC SCI PUBLICATION, V162; Schomerus G, 2011, ALCOHOL ALCOHOLISM, V46, P105, DOI 10.1093/alcalc/agq089; Schomerus G, 2011, DRUG ALCOHOL DEPEN, V114, P12, DOI 10.1016/j.drugalcdep.2010.08.013; Smith E, 2014, ANN RHEUM DIS, V73, P1470, DOI 10.1136/annrheumdis-2013-204647; Smith E, 2014, ANN RHEUM DIS, V73, P1462, DOI 10.1136/annrheumdis-2013-204680; SPENCER S, 2013, GLOB CARDIOL SCI PRA, P115; Statistics Norway, 2006, NORW SURV LIV COND 2; Statistics Norway, 2002, NORW SURV LIV COND 2; Statistics Norway, 2013, NORW SURV LIV COND 2; Statistics Norway, 2009, NORW SURV LIV COND 2; Stovner LJ, 2014, ACTA NEUROL SCAND, V129, P1, DOI 10.1111/ane.12229; Sustainable Development, 2014, PROP SUST DEV GOALS; Taylor HR, 2013, LANCET, V381, P23, DOI 10.1016/S0140-6736(12)62081-9; van Baal Pieter H M, 2006, Popul Health Metr, V4, P1, DOI 10.1186/1478-7954-4-1; van Loey NE, 2012, J TRAUMA ACUTE CARE, V72, P513, DOI 10.1097/TA.0b013e3182199072; Voigt K, 2014, B WORLD HEALTH ORGAN, V92, P226; Vos T, 2004, ARCH GEN PSYCHIAT, V61, P1097, DOI 10.1001/archpsyc.61.11.1097; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Yu SC, 2014, BIOMED ENVIRON SCI, V27, P45, DOI 10.3967/bes2014.013	100	3493	3662	62	1550	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2015	386	9995					743	800		10.1016/S0140-6736(15)60692-4	http://dx.doi.org/10.1016/S0140-6736(15)60692-4			58	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0LR	26063472	Green Accepted, Green Submitted			2022-12-28	WOS:000360287900025
J	Bigot, B				Bigot, Bernard			Pull together for fusion	NATURE			English	Editorial Material									ITER Org, St Paul Les Durance, France	ITER	Bigot, B (corresponding author), ITER Org, St Paul Les Durance, France.	bernard.bigot@iter.org							0	10	10	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					149	151		10.1038/522149a	http://dx.doi.org/10.1038/522149a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	26062495	Bronze			2022-12-28	WOS:000356016700011
J	Lloyd, K; Franklin, C; Lutz, C; Magnuson, T				Lloyd, Kent; Franklin, Craig; Lutz, Cat; Magnuson, Terry			Use mouse biobanks or lose them	NATURE			English	Editorial Material									[Lloyd, Kent] Univ Calif Davis, MMRRC, Davis, CA 95616 USA; [Franklin, Craig] Univ Missouri, MMRRC, Columbia, MO 65211 USA; [Lutz, Cat] Jackson Lab, MMRRC, Bar Harbor, ME 04609 USA; [Magnuson, Terry] Univ N Carolina, MMRRC, Chapel Hill, NC USA	University of California System; University of California Davis; University of Missouri System; University of Missouri Columbia; Jackson Laboratory; University of North Carolina; University of North Carolina Chapel Hill	Lloyd, K (corresponding author), Univ Calif Davis, MMRRC, Davis, CA 95616 USA.	kclloyd@ucdavis.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR033193] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK092993] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD010924, U42OD010921, UM1OD023221, U42OD012210, U42OD011175] Funding Source: NIH RePORTER; NCRR NIH HHS [U42 RR033193] Funding Source: Medline; NHGRI NIH HHS [U54 HG006364] Funding Source: Medline; NIDDK NIH HHS [U24 DK092993] Funding Source: Medline; NIH HHS [UM1 OD023221, U42 OD012210, U42 OD011175, U42 OD010921, U42 OD010924] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Franklin CL, 2006, ILAR J, V47, P141, DOI 10.1093/ilar.47.2.141; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kumar V, 2013, SCIENCE, V342, P1508, DOI 10.1126/science.1245503; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Rogala AR, 2014, MAMM GENOME, V25, P95, DOI 10.1007/s00335-013-9499-2	7	17	17	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					151	153		10.1038/522151a	http://dx.doi.org/10.1038/522151a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK2CI	26062496	Green Accepted, Bronze			2022-12-28	WOS:000356016700012
J	Olmos, Y; Hodgson, L; Mantell, J; Verkade, P; Carlton, JG				Olmos, Yolanda; Hodgson, Lorna; Mantell, Judith; Verkade, Paul; Carlton, Jeremy G.			ESCRT-III controls nuclear envelope reformation	NATURE			English	Article							AURORA-B; ENDOPLASMIC-RETICULUM; HELA-CELLS; CYTOKINESIS; PROTEIN; ABSCISSION; MACHINERY; CHROMATIN; DYNAMICS; KINASE	During telophase, the nuclear envelope (NE) reforms around daughter nuclei to ensure proper segregation of nuclear and cytoplasmic contents1-4. NE reformation requires the coating of chromatin by membrane derived from the endoplasmic reticulum, and a subsequent annular fusion step to ensure that the formed envelope is sealed(1,2,4,5). How annular fusion is accomplished is unknown, but it is thought to involve the p97 AAA-ATPase complex and bears a topological equivalence to the membrane fusion event that occurs during the abscission phase of cytokinesis(1,6). Herewe show that the endosomal sorting complex required for transport-III (ESCRT-III) machinery localizes to sites of annular fusion in the forming NE in human cells, and is necessary for proper post-mitotic nucleocytoplasmic compartmentalization. The ESCRT-III component charged multivesicular body protein 2A (CHMP2A) is directed to the forming NE through binding to CHMP4B, and provides an activity essential for NE reformation. Localization also requires the p97 complex member ubiquitin fusion and degradation 1 (UFD1). Our results describe a novel role for the ESCRT machinery in cell division and demonstrate a conservation of themachineries involved in topologically equivalent mitotic membrane remodelling events.	[Olmos, Yolanda; Carlton, Jeremy G.] Kings Coll London, Sect Cell Biol & Imaging, Div Canc Studies, London SE1 1UL, England; [Hodgson, Lorna; Mantell, Judith; Verkade, Paul] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Mantell, Judith; Verkade, Paul] Univ Bristol, Wolfson Bioimaging Facil, Bristol BS8 1TD, Avon, England; [Verkade, Paul] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	University of London; King's College London; University of Bristol; University of Bristol; University of Bristol	Carlton, JG (corresponding author), Kings Coll London, Sect Cell Biol & Imaging, Div Canc Studies, London SE1 1UL, England.	jeremy.carlton@kcl.ac.uk	Verkade, Paul/N-7240-2014; Olmos, Yolanda/AAX-6661-2021; Carlton, Jeremy/X-2918-2019	Verkade, Paul/0000-0002-2497-1026; Olmos, Yolanda/0000-0002-5952-1607; Carlton, Jeremy/0000-0002-7255-1894	Biotechnology and Biological Sciences Research Council [BB/L014181/1] Funding Source: researchfish; Wellcome Trust [093603] Funding Source: Medline; BBSRC [BB/L014181/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Anderson DJ, 2008, J CELL SCI, V121, P137, DOI 10.1242/jcs.005777; Asencio C, 2012, CELL, V150, P122, DOI 10.1016/j.cell.2012.04.043; Buchkovich NJ, 2013, DEV CELL, V27, P201, DOI 10.1016/j.devcel.2013.09.009; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Burke B, 2001, NAT CELL BIOL, V3, pE273, DOI 10.1038/ncb1201-e273; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Clever M, 2012, NUCLEUS-PHILA, V3, P187, DOI 10.4161/nucl.19595; Dobrynin G, 2011, J CELL SCI, V124, P1571, DOI 10.1242/jcs.069500; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; Lee CP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002904; Lu L, 2011, J CELL BIOL, V194, P425, DOI 10.1083/jcb.201012063; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Pawliczek T, 2009, J VIROL, V83, P11254, DOI 10.1128/JVI.00574-09; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Schooley A, 2012, CHROMOSOMA, V121, P539, DOI 10.1007/s00412-012-0388-3; Sorg G, 1999, BIOTECHNIQUES, V26, P858, DOI 10.2144/99265bm12; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Stauffer DR, 2001, J CELL SCI, V114, P2383; van Weering JRT, 2010, METHOD CELL BIOL, V96, P619, DOI 10.1016/S0091-679X(10)96026-3; Webster BM, 2014, CELL, V159, P388, DOI 10.1016/j.cell.2014.09.012	32	226	233	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					236	+		10.1038/nature14503	http://dx.doi.org/10.1038/nature14503			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	26040713	Green Accepted, Green Submitted			2022-12-28	WOS:000356016700043
J	Lurie, P; Chahal, HS; Sigelman, DW; Stacy, S; Sclar, J; Ddamulira, B				Lurie, Peter; Chahal, Harinder S.; Sigelman, Daniel W.; Stacy, Sylvie; Sclar, Joshua; Ddamulira, Barbara			Comparison of content of FDA letters not approving applications for new drugs and associated public announcements from sponsors: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVES To describe the content of non-public complete response letters issued by the US Food and Drug Administration (FDA) when they do not approve marketing applications from sponsors (drug companies) and to compare them with the content any subsequent press releases issued by those sponsors Design Cross sectional study. Data sources All applications for which FDA's Center for Drug Evaluation and Research initially issued complete response letters (n=61) from 11 August 2008 to 27 June 2013. Complete response letters and press releases were divided into discrete statements related to seven domains and 64 subdomains and assessed to determine whether they matched. Results 48% (29) of complete response letters cited deficiencies in both the safety and efficacy domains, and only 13% cited neither safety nor efficacy deficiencies. No press release was issued for 18% (11) of complete response letters, and 21% (13) of press releases did not match any statements from the letters. Press release statements matched 93 of the 687 statements (14%), including 16% (30/191) of efficacy and 15% (22/150) of safety statements. Of 32 complete response letters that called for a new clinical trial for safety or efficacy, 59% (19) had matching press release statements. Seven complete response letters reported higher mortality rates in treated participants; only one associated press release mentioned this fact. Conclusions FDA generally issued complete response letters to sponsors for multiple substantive reasons, most commonly related to safety and/or efficacy deficiencies. In many cases, press releases were not issued in response to those letters and, when they were, omitted most of the statements in the complete response letters. Press releases are incomplete substitutes for the detailed information contained in complete response letters.	[Lurie, Peter; Chahal, Harinder S.; Sigelman, Daniel W.; Stacy, Sylvie; Sclar, Joshua; Ddamulira, Barbara] US FDA, Off Publ Hlth Strategy & Anal, Off Commissioner, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Lurie, P (corresponding author), US FDA, Off Publ Hlth Strategy & Anal, Off Commissioner, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	peter.lurie@fda.hhs.gov		Chahal, Harinder/0000-0002-2540-9713				[Anonymous], 2013, BLOOMBERG BUSINESSWE; [Anonymous], 2013, FULL TEXT SEARCH; [Anonymous], 2013, SEARCH ORPH DRUG DES; [Anonymous], 2013, CO SEARCH; [Anonymous], 2013, DUN BRADSTR; [Anonymous], 1995, ICH HARM TRIP GUID S; European Medicines Agency (EMA), 2013, EMA5999412012; Goldstein J., 2008, D JONES WALL STREET; Gottlieb S., 2010, D JONES WALL STREET; Harris G., 2009, NY TIMES; Lurie P, 2006, JAMA-J AM MED ASSOC, V295, P1921, DOI 10.1001/jama.295.16.1921; MedCalc Statistical Software, MEDCALC STAT SOFTWAR; Roy A., 2010, BRINGING SUNSHINE FD; Sacks LV, 2014, JAMA-J AM MED ASSOC, V311, P378, DOI 10.1001/jama.2013.282542; Small Business Administration, 2013, TABL SMALL BUS SIZ S; US Food and Drug Administration (FDA), 2010, FDA TRANSP IN DRAFT	16	23	23	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2015	350								h2758	10.1136/bmj.h2758	http://dx.doi.org/10.1136/bmj.h2758			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK7CZ	26063327	Green Published, hybrid			2022-12-28	WOS:000356389600005
J	Bylinskii, A; Gangloff, D; Vuletic, V				Bylinskii, Alexei; Gangloff, Dorian; Vuletic, Vladan			Tuning friction atom-by-atom in an ion-crystal simulator	SCIENCE			English	Article							FRENKEL-KONTOROVA MODEL; DYNAMICS	Friction between ordered, atomically smooth surfaces at the nanoscale (nanofriction) is often governed by stick-slip processes. To test long-standing atomistic models of such processes, we implemented a synthetic nanofriction interface between a laser-cooled Coulomb crystal of individually addressable ions as the moving object and a periodic light-field potential as the substrate. We show that stick-slip friction can be tuned from maximal to nearly frictionless via arrangement of the ions relative to the substrate. By varying the ion number, we also show that this strong dependence of friction on the structural mismatch, as predicted by many-particle models, already emerges at the level of two or three atoms. This model system enables a microscopic and systematic investigation of friction, potentially even into the quantum many-body regime.	[Bylinskii, Alexei; Gangloff, Dorian; Vuletic, Vladan] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Vuletic, V (corresponding author), MIT, Dept Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	vuletic@mit.edu	Gangloff, Dorian/AAE-4120-2020; Vuletic, Vladan/M-8736-2019; Bylinskii, Alexei/I-7969-2015	Gangloff, Dorian/0000-0002-7100-0847; Bylinskii, Alexei/0000-0001-8276-8256	NSF [PHY-0551153]; Canada's Natural Sciences and Engineering Research Council; Direct For Mathematical & Physical Scien [1205554] Funding Source: National Science Foundation; Division Of Physics [1125846] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Canada's Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank W. Jhe and E. Demler for stimulating discussions and W. Jhe also for critical reading of the manuscript. This work was supported by the NSF-funded Center for Ultracold Atoms (grant PHY-0551153) and Canada's Natural Sciences and Engineering Research Council Postgraduate Scholarship program. All data presented here is in the supplementary materials.	AUBRY S, 1983, PHYSICA D, V7, P240, DOI 10.1016/0167-2789(83)90129-X; Benassi A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1230; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Bohlein T, 2012, NAT MATER, V11, P126, DOI [10.1038/nmat3204, 10.1038/NMAT3204]; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Braun O. M., 2004, TEXT MONOGR; Carpick RW, 1997, CHEM REV, V97, P1163, DOI 10.1021/cr960068q; Cetina M, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/5/053001; Dienwiebel M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126101; Enderlein M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.233004; Garcia-Mata I, 2007, EUR PHYS J D, V41, P325, DOI 10.1140/epjd/e2006-00220-2; Hirano M, 1997, PHYS REV LETT, V78, P1448, DOI 10.1103/PhysRevLett.78.1448; Karpa L, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.163002; Kontorova TA, 1938, ZH EKSP TEOR FIZ, V8, P1340; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Linnet RB, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.233005; Mandelli D, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195418; MATE CM, 1987, PHYS REV LETT, V59, P1942, DOI 10.1103/PhysRevLett.59.1942; Medyanik SN, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.136106; Mizrahi J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.203001; Prandtl L, 1928, Z ANGEW MATH MECH, V8, P85, DOI 10.1002/zamm.19280080202; Pruttivarasin T, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/7/075012; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097; SHINJO K, 1993, SURF SCI, V283, P473, DOI 10.1016/0039-6028(93)91022-H; Socoliuc A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.134301; Szlufarska I, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/12/123001; Tomlinson GA, 1929, PHILOS MAG, V7, P905, DOI 10.1080/14786440608564819; Urbakh M, 2004, NATURE, V430, P525, DOI 10.1038/nature02750; Vanossi A, 2013, REV MOD PHYS, V85, P529, DOI 10.1103/RevModPhys.85.529	29	84	85	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1115	1118		10.1126/science.1261422	http://dx.doi.org/10.1126/science.1261422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045432	Green Submitted			2022-12-28	WOS:000355590500042
J	Amin, SA; Hmelo, LR; van Tol, HM; Durham, BP; Carlson, LT; Heal, KR; Morales, RL; Berthiaume, CT; Parker, MS; Djunaedi, B; Ingalls, AE; Parsek, MR; Moran, MA; Armbrust, EV				Amin, S. A.; Hmelo, L. R.; van Tol, H. M.; Durham, B. P.; Carlson, L. T.; Heal, K. R.; Morales, R. L.; Berthiaume, C. T.; Parker, M. S.; Djunaedi, B.; Ingalls, A. E.; Parsek, M. R.; Moran, M. A.; Armbrust, E. V.			Interaction and signalling between a cosmopolitan phytoplankton and associated bacteria	NATURE			English	Article							MARINE-BACTERIA; DIATOMS; GROWTH	Interactions between primary producers and bacteria impact the physiology of both partners, alter the chemistry of their environment, and shape ecosystem diversity(1,2). In marine ecosystems, these interactions are difficult to study partly because the major photosynthetic organisms are microscopic, unicellular phytoplankton(3). Coastal phytoplankton communities are dominated by diatoms, which generate approximately 40% of marine primary production and form the base of many marine food webs(4). Diatoms co-occur with specific bacterial taxa(3), but the mechanisms of potential interactions are mostly unknown. Here we tease apart a bacterial consortium associated with a globally distributed diatom and find that a Sulfitobacter species promotes diatom cell division via secretion of the hormone indole-3-acetic acid, synthesized by the bacterium using both diatom-secreted and endogenous tryptophan. Indole-3-acetic acid and tryptophan serve as signalling molecules that are part of a complex exchange of nutrients, including diatom-excreted organosulfur molecules and bacterial-excreted ammonia. The potential prevalence of this mode of signalling in the oceans is corroborated by metabolite and metatranscriptome analyses that show widespread indole-3-acetic acid production by Sulfitobacter-related bacteria, particularly in coastal environments. Our study expands on the emerging recognition that marine microbial communities are part of tightly connected networks by providing evidence that these interactions are mediated through production and exchange of infochemicals.	[Amin, S. A.; van Tol, H. M.; Carlson, L. T.; Heal, K. R.; Morales, R. L.; Berthiaume, C. T.; Parker, M. S.; Djunaedi, B.; Ingalls, A. E.; Armbrust, E. V.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Amin, S. A.] New York Univ Abu Dhabi, Chem Fac, Abu Dhabi, U Arab Emirates; [Hmelo, L. R.; Parsek, M. R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Durham, B. P.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Moran, M. A.] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Armbrust, EV (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	sa132@nyu.edu; armbrust@uw.edu		Parker, Micaela/0000-0003-1007-4612; Amin, Shady/0000-0003-3780-8102; Durham, Bryndan/0000-0002-2253-157X; Ingalls, Anitra/0000-0003-1953-7329; Moran, Mary Ann/0000-0002-0702-8167	Gordon and Betty Moore Foundation [GBMF3776]; National Science Foundation (NSF) [OCE-1228770, OCE-1205233, OCE-1342694]; NSF/National Institutes of Health Pacific Northwest Consortium; Natural Sciences and Engineering Research Council of Canada; Directorate For Geosciences [1228770] Funding Source: National Science Foundation; Division Of Ocean Sciences [1342694] Funding Source: National Science Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF/National Institutes of Health Pacific Northwest Consortium; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank U. John for the antibiotic recipe, L. Gram for providing Phaeobacter strains, J. Tsai for preparing the SA11 DNA for sequencing, the captain and crew of the R/V Kilo Moana and the R/V Thomas G. Thompson for help during the cruises, D. French for Extended Data Fig. 5, and T. Chiang for discussions. This work was supported in part by Gordon and Betty Moore Foundation grant GBMF3776 to E.V.A, and support from National Science Foundation (NSF) award OCE-1228770 to A.E.I., OCE-1205233 to E.V.A., and OCE-1342694 to M.A.M. S.A.A. was partly supported by a NSF/National Institutes of Health Pacific Northwest Consortium postdoctoral fellowship. H.M.V. was partly supported by a Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship - Master's grant.	Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; BELL W, 1972, BIOL BULL, V143, P265, DOI 10.2307/1540052; BRAND L E, 1981, Journal of Plankton Research, V3, P193, DOI 10.1093/plankt/3.2.193; Cook AM, 2006, ADV EXP MED BIOL, V583, P3; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P757, DOI 10.1111/j.1462-2920.2007.01499.x; De Smet I, 2011, PLANT PHYSIOL, V155, P209, DOI 10.1104/pp.110.168161; Durham WM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3148; Geng HF, 2010, CURR OPIN BIOTECH, V21, P332, DOI 10.1016/j.copbio.2010.03.013; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Guasto JS, 2012, ANNU REV FLUID MECH, V44, P373, DOI 10.1146/annurev-fluid-120710-101156; Guillard R.R.L., 1975, CULTURE MARINE INVER, P26, DOI DOI 10.1007/978-1-4615-8714-9_3; Heal KR, 2014, RAPID COMMUN MASS SP, V28, P2398, DOI 10.1002/rcm.7040; Hom EFY, 2014, SCIENCE, V345, P94, DOI 10.1126/science.1253320; Hubbard KA, 2008, J PHYCOL, V44, P637, DOI 10.1111/j.1529-8817.2008.00518.x; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Jonsson PR, 2009, P NATL ACAD SCI USA, V106, P11177, DOI 10.1073/pnas.0900964106; KarpBoss L, 1996, OCEANOGR MAR BIOL, V34, P71; Lau S, 2009, TRENDS PLANT SCI, V14, P182, DOI 10.1016/j.tplants.2009.01.004; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Little AEF, 2008, ANNU REV MICROBIOL, V62, P375, DOI 10.1146/annurev.micro.030608.101423; Lunau M, 2005, ENVIRON MICROBIOL, V7, P961, DOI 10.1111/j.1462-2920.2005.00767.x; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Matsuda F, 2005, BIOSCI BIOTECH BIOCH, V69, P778, DOI 10.1271/bbb.69.778; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; PRICE N M, 1988, Biological Oceanography, V6, P443; Riffell JA, 2004, P NATL ACAD SCI USA, V101, P4501, DOI 10.1073/pnas.0304594101; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roudier F, 2003, PLANT PHYSIOL, V131, P1091, DOI 10.1104/pp.102.011122; Shishlyannikov SM, 2011, LIMNOL OCEANOGR-METH, V9, P478, DOI 10.4319/lom.2011.9.478; Smith G. J., 2000, HARMFUL ALGAL BLOOMS, P324; Spaepen S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001438; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Stipanuk MH, 2006, AMINO ACIDS, V30, P251, DOI 10.1007/s00726-005-0288-4; Stocker R, 2012, MICROBIOL MOL BIOL R, V76, P792, DOI 10.1128/MMBR.00029-12; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; Suzuki T, 2004, J APPL PHYCOL, V16, P145, DOI 10.1023/B:JAPH.0000044776.04977.00; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JR, 2012, SCIENCE, V338, P675, DOI 10.1126/science.1219417; Wang D, 2012, CELL MICROBIOL, V14, P334, DOI 10.1111/j.1462-5822.2011.01736.x; Windler M, 2014, PHYCOL RES, V62, P269, DOI 10.1111/pre.12059; Yambe H, 2006, P NATL ACAD SCI USA, V103, P15370, DOI 10.1073/pnas.0604340103; Yool A, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002018; Zobell CE, 1941, J MAR RES, V4, P42	45	541	568	54	747	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					98	U253		10.1038/nature14488	http://dx.doi.org/10.1038/nature14488			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	26017307				2022-12-28	WOS:000355543400037
J	Showalter, MR; Hamilton, DP				Showalter, M. R.; Hamilton, D. P.			Resonant interactions and chaotic rotation of Pluto's small moons	NATURE			English	Article							ORBITAL RESONANCES; SATELLITES; MASSES; CHARON; SYSTEM; LARISSA; PROTEUS; ALBEDOS; PERIOD; NIX	Four small moons-Styx, Nix, Kerberos and Hydra-follow near-circular, near-equatorial orbits around the central 'binary planet' comprising Pluto and its large moon, Charon. New observational details of the system have emerged following the discoveries of Kerberos and Styx. Here we report that Styx, Nix and Hydra are tied together by a three-body resonance, which is reminiscent of the Laplace resonance linking Jupiter's moons Io, Europa and Ganymede. Perturbations by the other bodies, however, inject chaos into this otherwise stable configuration. Nix and Hydra have bright surfaces similar to that of Charon. Kerberos may be much darker, raising questions about how a heterogeneous satellite system might have formed. Nix and Hydra rotate chaotically, driven by the large torques of the Pluto-Charon binary.	[Showalter, M. R.] SETI Inst, Mountain View, CA 94043 USA; [Hamilton, D. P.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Showalter, MR (corresponding author), SETI Inst, 189 Bernardo Ave, Mountain View, CA 94043 USA.	mshowalter@seti.org			NASA [NNX12AQ11G, NNX14AO40G, NAS5-26555, NNX12AI80G]; NASA through Space Telescope Science Institute [GO-12436]	NASA(National Aeronautics & Space Administration (NASA)); NASA through Space Telescope Science Institute(Space Telescope Science Institute)	M.R.S. acknowledges NASA's Outer Planets Research Program for their support through grants NNX12AQ11G and NNX14AO40G. Support for HST programme GO-12436 was provided by NASA through a grant from the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS5-26555. D.P.H. acknowledges NASA Origins Research Program and grant NNX12AI80G.	Brozovic M, 2015, ICARUS, V246, P317, DOI 10.1016/j.icarus.2014.03.015; Buie MW, 2006, ASTRON J, V132, P290, DOI 10.1086/504422; Buie MW, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/6/152; Buie MW, 2010, ASTRON J, V139, P1128, DOI 10.1088/0004-6256/139/3/1128; Buratti BJ, 1997, ICARUS, V126, P225, DOI 10.1006/icar.1996.5644; Canup RM, 2005, SCIENCE, V307, P546, DOI 10.1126/science.1106818; DOBROVOLSKIS AR, 1995, ICARUS, V118, P181, DOI 10.1006/icar.1995.1184; French RG, 2015, ASTRON J, V149, DOI 10.1088/0004-6256/149/4/142; French RS, 2012, ICARUS, V220, P911, DOI 10.1016/j.icarus.2012.06.031; Grav T, 2003, ASTROPHYS J, V591, pL71, DOI 10.1086/377067; Grundy WM, 2005, ICARUS, V176, P184, DOI 10.1016/j.icarus.2005.01.007; HAMILTON DP, 1994, ICARUS, V109, P221, DOI 10.1006/icar.1994.1089; Hedman M. M., 2011, EUR PLANET SPACE C A, V6, P531; Kenyon SJ, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/1/8; KLAVETTER JJ, 1989, ASTRON J, V97, P570, DOI 10.1086/115006; Lacerda P, 2014, ASTROPHYS J LETT, V793, DOI 10.1088/2041-8205/793/1/L2; Lee MH, 2006, ICARUS, V184, P573, DOI 10.1016/j.icarus.2006.04.017; Levison H. F., 2014, SWIFT SOLAR SYSTEM I; LEVISON HF, 1994, ICARUS, V108, P18, DOI 10.1006/icar.1994.1039; Lithwick Y., 2008, PREPRINT; Lykawka PS, 2005, PLANET SPACE SCI, V53, P1319, DOI 10.1016/j.pss.2005.06.004; Quillen AC, 2014, MON NOT R ASTRON SOC, V445, P3959, DOI 10.1093/mnras/stu2023; Rivera EJ, 2010, ASTROPHYS J, V719, P890, DOI 10.1088/0004-637X/719/1/890; Showalter M. R, 2012, IAU CIRC, V9253; Showalter M. R., 2011, IAU CIRC, V9221; SINCLAIR AT, 1975, MON NOT R ASTRON SOC, V171, P59, DOI 10.1093/mnras/171.1.59; Space Telescope Science Institute, 2011, OBS SUPP TIN TIM HST; Stansberry J., 2007, SOLAR SYSTEM NEPTUNE, P161; Steffl A. J., 2011, IAU CIRC, V9221; Stern SA, 2009, ICARUS, V199, P571, DOI 10.1016/j.icarus.2008.10.006; Walsh K., 2015, PREPRINT; Ward WR, 2006, SCIENCE, V313, P1107, DOI 10.1126/science.1127293; Weaver H. A, 2011, IAU CIRC, V9221; Weaver HA, 2006, NATURE, V439, P943, DOI 10.1038/nature04547; Winter SMG, 2013, MON NOT R ASTRON SOC, V430, P1892, DOI 10.1093/mnras/stt015; WISDOM J, 1984, ICARUS, V58, P137, DOI 10.1016/0019-1035(84)90032-0; Youdin AN, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/17; Zhang K, 2008, ICARUS, V193, P267, DOI 10.1016/j.icarus.2007.08.024; Zhang K, 2007, ICARUS, V188, P386, DOI 10.1016/j.icarus.2006.12.002	40	63	63	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					45	U57		10.1038/nature14469	http://dx.doi.org/10.1038/nature14469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	26040889				2022-12-28	WOS:000355543400026
J	Huybrechts, KF; Bateman, BT; Palmsten, K; Desai, RJ; Patorno, E; Gopalakrishnan, C; Levin, R; Mogun, H; Hernandez-Diaz, S				Huybrechts, Krista F.; Bateman, Brian T.; Palmsten, Kristin; Desai, Rishi J.; Patorno, Elisabetta; Gopalakrishnan, Chandrasekar; Levin, Raisa; Mogun, Helen; Hernandez-Diaz, Sonia			Antidepressant Use Late in Pregnancy and Risk of Persistent Pulmonary Hypertension of the Newborn	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEROTONIN-REUPTAKE INHIBITORS; HUMAN UMBILICAL ARTERIES; NITRIC-OXIDE; MATERNAL USE; OUTCOMES; ADJUSTMENT; PGF2-ALPHA; DELIVERY; INFANT; SCORES	IMPORTANCE The association between selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and risk of persistent pulmonary hypertension of the newborn (PPHN) has been controversial since the US Food and Drug Administration issued a public health advisory in 2006. OBJECTIVE To examine the risk of PPHN associated with exposure to different antidepressant medication classes late in pregnancy. DESIGN AND SETTING Cohort study nested in the 2000-2010 Medicaid Analytic eXtract for 46 US states and Washington, DC. Last follow-up date was December 31, 2010. PARTICIPANTS A total of 3 789 330 pregnant women enrolled in Medicaid from 2 months or fewer after the date of last menstrual period through at least 1 month after delivery. The source cohort was restricted to women with a depression diagnosis and logistic regression analysis with propensity score adjustment applied to control for potential confounders. EXPOSURES FOR OBSERVATIONAL STUDIES SSRI and non-SSRI monotherapy use during the 90 days before delivery vs no use. MAIN OUTCOMES AND MEASURES Recorded diagnosis of PPHN during the first 30 days after delivery. RESULTS A total of 128 950 women (3.4%) filled at least 1 prescription for antidepressants late in pregnancy: 102 179 (2.7%) used an SSRI and 26 771 (0.7%) a non-SSRI. Overall, 7630 infants not exposed to antidepressants were diagnosed with PPHN (20.8; 95% CI, 20.4-21.3 per 10 000 births) compared with 322 infants exposed to SSRIs (31.5; 95% CI, 28.3-35.2 per 10 000 births), and 78 infants exposed to non-SSRIs (29.1; 95% CI, 23.3-36.4 per 10 000 births). Associations between antidepressant use and PPHN were attenuated with increasing levels of confounding adjustment. For SSRIs, odds ratios were 1.51 (95% CI, 1.35-1.69) unadjusted and 1.10 (95% CI, 0.94-1.29) after restricting to women with depression and adjusting for the high-dimensional propensity score. For non-SSRIs, the odds ratios were 1.40 (95% CI, 1.12-1.75) and 1.02 (95% CI, 0.77-1.35), respectively. Upon restriction of the outcome to primary PPHN, the adjusted odds ratio for SSRIs was 1.28 (95% CI, 1.01-1.64) and for non-SSRIs 1.14 (95% CI, 0.74-1.74). CONCLUSIONS AND RELEVANCE Evidence from this large study of publicly insured pregnant women may be consistent with a potential increased risk of PPHN associated with maternal use of SSRIs in late pregnancy. However, the absolute risk was small, and the risk increase appears more modest than suggested in previous studies.	[Huybrechts, Krista F.; Bateman, Brian T.; Desai, Rishi J.; Patorno, Elisabetta; Gopalakrishnan, Chandrasekar; Levin, Raisa; Mogun, Helen] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; [Huybrechts, Krista F.; Bateman, Brian T.; Patorno, Elisabetta] Harvard Univ, Sch Med, Boston, MA 02120 USA; [Bateman, Brian T.; Palmsten, Kristin] Massachusetts Gen Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02114 USA; [Hernandez-Diaz, Sonia] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Huybrechts, KF (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	khuybrechts@partners.org	Desai, Rishi/AAH-8988-2021; Austin, Eric Douglas/A-6070-2013; Gopalakrishnan, Chandrasekar/M-4117-2019	Austin, Eric Douglas/0000-0002-1709-9022; Gopalakrishnan, Chandrasekar/0000-0003-2424-2453	Agency for Healthcare Research and Quality [R01 HS018533]; National Institute of Mental Health [K01MH099141]; National Institute of Child Health and Human Development [K08HD075831]; Reproductive, Perinatal and Pediatric Epidemiology from the National Institute of Child Health and Human Development [T32HD060454]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018533] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060454, K08HD075831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100216, K01MH099141] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Reproductive, Perinatal and Pediatric Epidemiology from the National Institute of Child Health and Human Development; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by grant R01 HS018533 from the Agency for Healthcare Research and Quality. Dr Huybrechts was supported by career development grant K01MH099141 from the National Institute of Mental Health. Dr Bateman was supported by career development grant K08HD075831 from the National Institute of Child Health and Human Development. Dr Palmsten was supported by training grant T32HD060454 in Reproductive, Perinatal and Pediatric Epidemiology from the National Institute of Child Health and Human Development.	Abman SH, 1999, PEDIATR PULM, P201; Andrade SE, 2009, PHARMACOEPIDEM DR S, V18, P246, DOI 10.1002/pds.1710; BJORO K, 1986, ACTA OBSTET GYN SCAN, V65, P351, DOI 10.3109/00016348609157359; Braitman LE, 2002, ANN INTERN MED, V137, P693, DOI 10.7326/0003-4819-137-8-200210150-00015; Centers for Medicare & Medicaid Services, MED AN EXTR MAX GEN; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Clark Reese H, 2003, J Perinatol, V23, P300, DOI 10.1038/sj.jp.7210908; Clark RH, 2000, NEW ENGL J MED, V342, P469, DOI 10.1056/NEJM200002173420704; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Dakshinamurti S, 2005, PEDIATR PULM, V39, P492, DOI 10.1002/ppul.20201; Delaney Cassidy, 2012, Pulm Circ, V2, P15, DOI 10.4103/2045-8932.94818; Farrow KN, 2005, SEMIN PERINATOL, V29, P8, DOI 10.1053/j.semperi.2005.02.003; GLASS P, 1995, J PEDIATR-US, V127, P447, DOI 10.1016/S0022-3476(95)70082-X; Grigoriadis S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f6932; HAUGEN G, 1991, GYNECOL OBSTET INVES, V31, P208, DOI 10.1159/000293160; Hernandez-Diaz S, 2007, PEDIATRICS, V120, pE272, DOI 10.1542/peds.2006-3037; Huybrechts KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092778; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; Kallen B, 2008, PHARMACOEPIDEM DR S, V17, P801, DOI 10.1002/pds.1570; Kieler H, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8012; Konduri GG, 2009, PEDIATR CLIN N AM, V56, P579, DOI 10.1016/j.pcl.2009.04.004; LEVIN DL, 1979, CIRCULATION, V60, P360, DOI 10.1161/01.CIR.60.2.360; Margulis AV, 2013, PHARMACOEPIDEM DR S, V22, P16, DOI 10.1002/pds.3284; Palmsten K, 2012, 25 ANN M SOC PED PER; Palmsten K, 2014, PHARMACOEPIDEM DR S, V23, P646, DOI 10.1002/pds.3627; Palmsten K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4877; Palmsten K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067405; Puthiyachirakkal M, 2013, FRONT PEDIATR, V1, DOI 10.3389/fped.2013.00023; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Runo JR, 2003, LANCET, V361, P1533, DOI 10.1016/S0140-6736(03)13167-4; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; US Food and Drug Administration, PUBL HLTH ADV TREATM; US Food and Drug Administration, FDA DRUG SAG COMM SE; Walsh-Sukys MC, 2000, PEDIATRICS, V105, P14, DOI 10.1542/peds.105.1.14; Wichman CL, 2009, MAYO CLIN PROC, V84, P23, DOI 10.4065/84.1.23; Wilson KL, 2011, AM J PERINAT, V28, P19, DOI 10.1055/s-0030-1262507; Yaron I, 1999, ARTHRITIS RHEUM, V42, P2561, DOI 10.1002/1529-0131(199912)42:12<2561::AID-ANR8>3.0.CO;2-U	39	139	149	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2142	2151		10.1001/jama.2015.5605	http://dx.doi.org/10.1001/jama.2015.5605			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ4CC	26034955	Bronze, Green Accepted			2022-12-28	WOS:000355430900014
J	Pfeiff, J; Chapman, R				Pfeiff, James; Chapman, Rachel			An anthropology of aid in Africa	LANCET			English	Editorial Material									[Pfeiff, James] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Pfeiff, James; Chapman, Rachel] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Pfeiff, J (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	jamespf@u.washington.edu							0	17	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2144	2145		10.1016/S0140-6736(15)61013-3	http://dx.doi.org/10.1016/S0140-6736(15)61013-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ6DG	26068257				2022-12-28	WOS:000355583000015
J	Kamdar, MM; Doyle, KP; Sequist, LV; Rinehart, TJ; Maytal, G; Flores, EJ; Mino-Kenudson, M				Kamdar, Mihir M.; Doyle, Kathleen P.; Sequist, Lecia V.; Rinehart, Todd J.; Maytal, Guy; Flores, Efren J.; Mino-Kenudson, Mari			Case 17-2015: A 44-Year-Old Woman with Intractable Pain Due to Metastatic Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OPIOID-INDUCED HYPERALGESIA; PALLIATIVE SEDATION; CLINICAL-TRIAL; GUIDELINES; DELIVERY; MECHANISMS; TOLERANCE; GEFITINIB; ERLOTINIB; THERAPY		[Kamdar, Mihir M.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Kamdar, Mihir M.; Doyle, Kathleen P.; Rinehart, Todd J.] Massachusetts Gen Hosp, Dept Palliat Care, Boston, MA 02114 USA; [Sequist, Lecia V.] Massachusetts Gen Hosp, Dept Med Oncol, Boston, MA 02114 USA; [Maytal, Guy] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Flores, Efren J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Mino-Kenudson, Mari] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mino-Kenudson, Mari] Harvard Univ, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA; [Kamdar, Mihir M.; Doyle, Kathleen P.; Rinehart, Todd J.] Harvard Univ, Sch Med, Dept Palliat Care, Boston, MA USA; [Sequist, Lecia V.] Harvard Univ, Sch Med, Dept Med Oncol, Boston, MA USA; [Maytal, Guy] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Flores, Efren J.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mino-Kenudson, Mari] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kamdar, MM (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.			Flores, Efren/0000-0003-1398-0426				Allen JP, 1996, JAMA-J AM MED ASSOC, V275, P474; Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; [Anonymous], ETH PALL SED; Arcidiacono PG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007519.pub2; Chaft JE, 2011, CLIN CANCER RES, V17, P6298, DOI 10.1158/1078-0432.CCR-11-1468; Chu LF, 2008, CLIN J PAIN, V24, P479, DOI 10.1097/AJP.0b013e31816b2f43; De Graeff A, 2007, J PALLIAT MED, V10, P67, DOI 10.1089/jpm.2006.0139; Deer TR, 2011, PAIN PHYSICIAN, V14, pE283; del Rosario MAB, 2001, J PAIN SYMPTOM MANAG, V21, P439, DOI 10.1016/S0885-3924(01)00254-8; Field MJ, 1997, APPROACHING DEATH IM; Guignard B, 2000, ANESTHESIOLOGY, V93, P409, DOI 10.1097/00000542-200008000-00019; Krakauer EL, 2010, OXFORD TXB PALLIATIV; Lee M, 2011, PAIN PHYSICIAN, V14, P145; MAO JR, 1995, PAIN, V62, P259, DOI 10.1016/0304-3959(95)00073-2; Mercadante S, 2001, J PAIN SYMPTOM MANAG, V21, P338, DOI 10.1016/S0885-3924(01)00250-0; Meuser T, 2001, PAIN, V93, P247, DOI 10.1016/S0304-3959(01)00324-4; Miguel R, 2000, Cancer Control, V7, P149; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Olsen ML, 2010, MAYO CLIN PROC, V85, P949, DOI 10.4065/mcp.2010.0201; Quill TE, 2009, ANN INTERN MED, V151, P421, DOI 10.7326/0003-4819-151-6-200909150-00007; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Smith TJ, 2002, J CLIN ONCOL, V20, P4040, DOI 10.1200/JCO.2002.02.118; Swarm R, 2010, J NATL COMPR CANC NE, V8, P1046, DOI 10.6004/jnccn.2010.0076; Vargas-Schaffer G, 2010, CAN FAM PHYSICIAN, V56, P514; Wallace M, 2000, REGION ANESTH PAIN M, V25, P117; Yennurajalingam S, 2010, J PAIN SYMPTOM MANAG, V39, P930, DOI 10.1016/j.jpainsymman.2009.09.015; ZECH DFJ, 1995, PAIN, V63, P65, DOI 10.1016/0304-3959(95)00017-M	28	4	4	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2015	372	22					2137	2147		10.1056/NEJMcpc1404141	http://dx.doi.org/10.1056/NEJMcpc1404141			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0EI	26017825				2022-12-28	WOS:000355146800012
J	Kass, JI; Ferguson, BJ				Kass, Jason I.; Ferguson, Berrylin J.			Treatment of Hematoma of the Nasal Septum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kass, Jason I.; Ferguson, Berrylin J.] Univ Pittsburgh, Med Ctr, Dept Otolaryngol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ferguson, BJ (corresponding author), Univ Pittsburgh, Med Ctr, Dept Otolaryngol, Suite 500,Eye & Ear Bldg,203 Lothrop St, Pittsburgh, PA 15213 USA.	fergusonbj@upmc.edu							0	5	5	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2015	372	22							e28	10.1056/NEJMvcm1010616	http://dx.doi.org/10.1056/NEJMvcm1010616			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0EI	26017844				2022-12-28	WOS:000355146800009
J	Dong, GH; Zhang, DJ; Liu, XY; Liu, FW; Chen, FH; Jones, M				Dong, Guanghui; Zhang, Dongju; Liu, Xinyi; Liu, Fengwen; Chen, Fahu; Jones, Martin			Response to Comment on "Agriculture facilitated permanent human occupation of the Tibetan Plateau after 3600 BP"	SCIENCE			English	Editorial Material								Guedes et al. have drawn attention to a mismatch between the predictions of their "thermal niche model" and the records we have published of early barley finds in the northeastern Tibetan Plateau. Here, we consider how that mismatch usefully draws our attention to the additional variables that may account for it-namely, variations in genetic expression and agricultural practice.	[Dong, Guanghui; Zhang, Dongju; Liu, Fengwen; Chen, Fahu] Lanzhou Univ, Minist Educ, Key Lab Western Chinas Environm Syst, Lanzhou 730000, Peoples R China; [Jones, Martin] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge CB2 3ER, England; [Liu, Xinyi] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA	Lanzhou University; University of Cambridge; Washington University (WUSTL)	Dong, GH (corresponding author), Lanzhou Univ, Minist Educ, Key Lab Western Chinas Environm Syst, Lanzhou 730000, Peoples R China.	ghdong@lzu.edu.cn; liuxinyi@wustl.edu	Dong, Guanghui/C-5985-2013; liu, xinyi/GWZ-8739-2022; Fahu, Chen/B-2788-2011; Liu, Fengwen/V-7009-2019	Dong, Guanghui/0000-0001-8005-759X; Chen, Fahu/0000-0002-8874-1035				Abebe TD, 2010, HEREDITAS, V147, P154, DOI 10.1111/j.1601-5223.2010.02173.x; [Anonymous], 1985, VERT REC SHIZ EMP QI, V125; [Anonymous], 1985, VERT REC SHIZ EMP QI, V102; Chen C. H., 2008, LOCAL EC HIST TIBET; Chen FH, 2015, SCIENCE, V347, P248, DOI 10.1126/science.1259172; Cui Y. H., 1998, RECENT EC HIST QINGH; Engels J. M. M., 1994, Genetic Resources and Crop Evolution, V41, P67, DOI 10.1007/BF00053050; Guedes JD, 2015, SCIENCE, V348, DOI 10.1126/science.aaa4819; Guedes JD, 2014, QUATERN INT, V349, P29, DOI 10.1016/j.quaint.2014.08.003; Hadado TT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-121; Hu SJ., 1995, INTRO AGR TIBET; Li Z. K., 1979, RECORD LUHUO COUNTY; Liu X., 1975, JIU TANG SHU LIEZHUA; Sou N. J. Z., 2000, CLEAR MIRROR ROYAL G; STEWART DW, 1987, AGR FOREST METEOROL, V39, P37, DOI 10.1016/0168-1923(87)90014-1; The Editorial Committee of Chinese Agriculture Book, 2001, CHIN AGR BOOK QINGH	16	6	6	8	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237								10.1126/science.aaa7573	http://dx.doi.org/10.1126/science.aaa7573			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI6NW	25999500				2022-12-28	WOS:000354877900029
J	Skovran, E; Martinez-Gomez, NC				Skovran, Elizabeth; Martinez-Gomez, Norma Cecilia			Just add lanthanides Some methanol-using bacteria may depend on lanthanide elements for carbon capture and energy generation	SCIENCE			English	Editorial Material							RARE-EARTH-ELEMENTS; DEHYDROGENASE; XOXF		[Skovran, Elizabeth; Martinez-Gomez, Norma Cecilia] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA	California State University System; San Jose State University	Skovran, E (corresponding author), San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA.	elizabeth.skovran@sjsu.edu		Martinez-Gomez, Norma/0000-0002-4071-7204; Skovran, Elizabeth/0000-0002-1737-5621				Beck A., 2014, PLOS ONE, V9; Bogart JA, 2015, CHEM-EUR J, V21, P1743, DOI 10.1002/chem.201405159; Goecke F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00002; Hibi Y, 2011, J BIOSCI BIOENG, V111, P547, DOI 10.1016/j.jbiosc.2010.12.017; Horiike T, 2015, APPL ENVIRON MICROB, V81, P3062, DOI 10.1128/AEM.00300-15; Li JX, 2010, J RARE EARTH, V28, P957, DOI 10.1016/S1002-0721(09)60233-7; Pagano G, 2015, ECOTOX ENVIRON SAFE, V115, P40, DOI 10.1016/j.ecoenv.2015.01.030; Pol A, 2014, ENVIRON MICROBIOL, V16, P255, DOI 10.1111/1462-2920.12249; Rico CM, 2015, ENVIRON SCI POLLUT R, V22, P10551, DOI 10.1007/s11356-015-4243-y; Skovran E., 2015, GORD C MET BIOL VENT; Skovran E, 2011, J BACTERIOL, V193, P6032, DOI 10.1128/JB.05367-11; Wu ML, 2015, APPL ENVIRON MICROB, V81, P1442, DOI 10.1128/AEM.03292-14	12	76	80	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					862	863		10.1126/science.aaa9091	http://dx.doi.org/10.1126/science.aaa9091			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999492				2022-12-28	WOS:000354877900018
J	Robinson, D; Van Allen, EM; Wu, YM; Schultz, N; Lonigro, RJ; Mosquera, JM; Montgomery, B; Taplin, ME; Pritchard, CC; Attard, G; Beltran, H; Abida, W; Bradley, RK; Vinson, J; Cao, XH; Vats, P; Kunju, LP; Hussain, M; Feng, FY; Tomlins, SA; Cooney, KA; Smith, DC; Brennan, C; Siddiqui, J; Mehra, R; Chen, Y; Rathkopf, DE; Morris, MJ; Solomon, SB; Durack, JC; Reuter, VE; Gopalan, A; Gao, JJ; Loda, M; Lis, RT; Bowden, M; Balk, SP; Gaviola, G; Sougnez, C; Gupta, M; Yu, EY; Mostaghel, EA; Cheng, HH; Mulcahy, H; True, LD; Plymate, SR; Dvinge, H; Ferraldeschi, R; Flohr, P; Miranda, S; Zafeiriou, Z; Tunariu, N; Mateo, J; Perez-Lopez, R; Demichelis, F; Robinson, BD; Schiffman, M; Nanus, DM; Tagawa, ST; Sigaras, A; Eng, KW; Elemento, O; Sboner, A; Heath, EI; Scher, HI; Pienta, KJ; Kantoff, P; de Bono, JS; Rubin, MA; Nelson, PS; Garraway, LA; Sawyers, CL; Chinnaiyan, AM				Robinson, Dan; Van Allen, Eliezer M.; Wu, Yi-Mi; Schultz, Nikolaus; Lonigro, Robert J.; Mosquera, Juan-Miguel; Montgomery, Bruce; Taplin, Mary-Ellen; Pritchard, Colin C.; Attard, Gerhardt; Beltran, Himisha; Abida, Wassim; Bradley, Robert K.; Vinson, Jake; Cao, Xuhong; Vats, Pankaj; Kunju, Lakshmi P.; Hussain, Maha; Feng, Felix Y.; Tomlins, Scott A.; Cooney, Kathleen A.; Smith, David C.; Brennan, Christine; Siddiqui, Javed; Mehra, Rohit; Chen, Yu; Rathkopf, Dana E.; Morris, Michael J.; Solomon, Stephen B.; Durack, Jeremy C.; Reuter, Victor E.; Gopalan, Anuradha; Gao, Jianjiong; Loda, Massimo; Lis, Rosina T.; Bowden, Michaela; Balk, Stephen P.; Gaviola, Glenn; Sougnez, Carrie; Gupta, Manaswi; Yu, Evan Y.; Mostaghel, Elahe A.; Cheng, Heather H.; Mulcahy, Hyojeong; True, Lawrence D.; Plymate, Stephen R.; Dvinge, Heidi; Ferraldeschi, Roberta; Flohr, Penny; Miranda, Susana; Zafeiriou, Zafeiris; Tunariu, Nina; Mateo, Joaquin; Perez-Lopez, Raquel; Demichelis, Francesca; Robinson, Brian D.; Schiffman, Marc; Nanus, David M.; Tagawa, Scott T.; Sigaras, Alexandros; Eng, Kenneth W.; Elemento, Olivier; Sboner, Andrea; Heath, Elisabeth I.; Scher, Howard I.; Pienta, Kenneth J.; Kantoff, Philip; de Bono, Johann S.; Rubin, Mark A.; Nelson, Peter S.; Garraway, Levi A.; Sawyers, Charles L.; Chinnaiyan, Arul M.			Integrative Clinical Genomics of Advanced Prostate Cancer	CELL			English	Article							ETS GENE FUSIONS; INCREASED SURVIVAL; MUTATIONS; REARRANGEMENTS; ENZALUTAMIDE; CHEMOTHERAPY; ABIRATERONE; INHIBITION; DISCOVERY; HETEROGENEITY	Toward development of a precision medicine framework for metastatic, castration-resistant prostate cancer (mCRPC), we established a multi-institutional clinical sequencing infrastructure to conduct prospective whole-exome and transcriptome sequencing of bone or soft tissue tumor biopsies from a cohort of 150 mCRPC affected individuals. Aberrations of AR, ETS genes, TP53, and PTEN were frequent (40%-60% of cases), with TP53 and AR alterations enriched in mCRPC compared to primary prostate cancer. We identified new genomic alterations in PIK3CA/B, R-spondin, BRAF/RAF1, APC, beta-catenin, and ZBTB16/PLZF. Moreover, aberrations of BRCA2, BRCA1, and ATM were observed at substantially higher frequencies (19.3% overall) compared to those in primary prostate cancers. 89% of affected individuals harbored a clinically actionable aberration, including 62.7% with aberrations in AR, 65% in other cancer-related genes, and 8% with actionable pathogenic germline alterations. This cohort study provides clinically actionable information that could impact treatment decisions for these affected individuals.	[Robinson, Dan; Wu, Yi-Mi; Lonigro, Robert J.; Cao, Xuhong; Vats, Pankaj; Kunju, Lakshmi P.; Feng, Felix Y.; Tomlins, Scott A.; Brennan, Christine; Siddiqui, Javed; Mehra, Rohit; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Robinson, Dan; Wu, Yi-Mi; Kunju, Lakshmi P.; Tomlins, Scott A.; Mehra, Rohit; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Van Allen, Eliezer M.; Taplin, Mary-Ellen; Loda, Massimo; Lis, Rosina T.; Bowden, Michaela; Kantoff, Philip; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Van Allen, Eliezer M.; Loda, Massimo; Sougnez, Carrie; Gupta, Manaswi; Garraway, Levi A.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA 02142 USA; [Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Mosquera, Juan-Miguel; Robinson, Brian D.; Sboner, Andrea; Rubin, Mark A.] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Mosquera, Juan-Miguel; Beltran, Himisha; Demichelis, Francesca; Robinson, Brian D.; Schiffman, Marc; Nanus, David M.; Tagawa, Scott T.; Sigaras, Alexandros; Eng, Kenneth W.; Sboner, Andrea; Rubin, Mark A.] Cornell Univ, Weill Med Coll, Inst Precis Med, New York, NY 10021 USA; [Mosquera, Juan-Miguel; Beltran, Himisha; Robinson, Brian D.; Nanus, David M.; Tagawa, Scott T.; Rubin, Mark A.] New York Presbyterian Hosp, New York, NY 10021 USA; [Montgomery, Bruce; Bradley, Robert K.; Mostaghel, Elahe A.; Cheng, Heather H.; Dvinge, Heidi] Univ Washington, Computat Biol Program, Div Publ Hlth Sci, Fred Hutchinson Canc Ctr, Seattle, WA 98109 USA; [Montgomery, Bruce; Bradley, Robert K.; Mostaghel, Elahe A.; Cheng, Heather H.; Dvinge, Heidi] Univ Washington, Div Basic Sci, Fred Hutchinson Canc Ctr, Seattle, WA 98109 USA; [Montgomery, Bruce; Yu, Evan Y.; Mostaghel, Elahe A.; Cheng, Heather H.; Plymate, Stephen R.; Nelson, Peter S.] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Montgomery, Bruce; Yu, Evan Y.; Mostaghel, Elahe A.; Cheng, Heather H.; Plymate, Stephen R.; Nelson, Peter S.] Univ Washington, VAPSHCS, Seattle, WA 98109 USA; [Attard, Gerhardt; Ferraldeschi, Roberta; Flohr, Penny; Miranda, Susana; Zafeiriou, Zafeiris; Tunariu, Nina; Mateo, Joaquin; Perez-Lopez, Raquel; de Bono, Johann S.] Inst Canc Res, Div Clin Studies, Canc Biomarkers Team, London SM2 5NG, England; [Attard, Gerhardt; Ferraldeschi, Roberta; Flohr, Penny; Miranda, Susana; Zafeiriou, Zafeiris; Tunariu, Nina; Mateo, Joaquin; Perez-Lopez, Raquel; de Bono, Johann S.] Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, London SM2 5NG, England; [Attard, Gerhardt; Ferraldeschi, Roberta; Flohr, Penny; Miranda, Susana; Zafeiriou, Zafeiris; Tunariu, Nina; Mateo, Joaquin; Perez-Lopez, Raquel; de Bono, Johann S.] Royal Marsden NHS Fdn Trust, Drug Dev Unit, London SM2 5NG, England; [Beltran, Himisha; Chen, Yu; Rathkopf, Dana E.; Morris, Michael J.; Nanus, David M.; Tagawa, Scott T.; Scher, Howard I.] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA; [Abida, Wassim; Chen, Yu; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Vinson, Jake] Mem Sloan Kettering Canc Ctr, Prostate Canc Clin Trials Consortium, New York, NY 10065 USA; [Hussain, Maha; Cooney, Kathleen A.; Smith, David C.] Univ Michigan, Sch Med, Div Hematol Oncol, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kunju, Lakshmi P.; Hussain, Maha; Feng, Felix Y.; Tomlins, Scott A.; Cooney, Kathleen A.; Smith, David C.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA; [Hussain, Maha; Tomlins, Scott A.; Cooney, Kathleen A.; Smith, David C.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; [Feng, Felix Y.] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Abida, Wassim; Chen, Yu; Rathkopf, Dana E.; Morris, Michael J.; Scher, Howard I.] Mem Sloan Kettering Canc Ctr, Sidney Kimmel Ctr Prostate & Urol Canc, Dept Med, Genitourinary Oncol Serv, New York, NY 10065 USA; [Solomon, Stephen B.; Durack, Jeremy C.] Mem Sloan Kettering Canc Ctr, Dept Radiol Serv, Intervent Radiol, New York, NY 10065 USA; [Reuter, Victor E.; Gopalan, Anuradha] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Loda, Massimo; Lis, Rosina T.; Bowden, Michaela] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02215 USA; [Balk, Stephen P.] Harvard Univ, Sch Med, Div Hematol Oncol, Dept Med,Beth Israel Deaconess Canc Ctr,Beth Isra, Boston, MA 02215 USA; [Gaviola, Glenn] Brigham & Womens Hosp, Dept Musculoskeletal Radiol, Boston, MA 02115 USA; [Pritchard, Colin C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Mulcahy, Hyojeong] Univ Washington, Dept Radiol, Seattle, WA 98109 USA; [True, Lawrence D.] Univ Washington, Dept Pathol, Med Ctr, Seattle, WA 98109 USA; [Demichelis, Francesca] Univ Trento, Ctr Integrat Biol, CIBIO, Lab Computat Oncol, I-38123 Mattarello Tn, Italy; [Sigaras, Alexandros; Eng, Kenneth W.; Elemento, Olivier; Sboner, Andrea] Cornell Univ, Dept Physiol & Biophys, Inst Computat Biomed, Weill Med Coll, New York, NY 10021 USA; [Schiffman, Marc] New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Radiol, Div Intervent Radiol, New York, NY 10021 USA; [Sigaras, Alexandros; Eng, Kenneth W.] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Heath, Elisabeth I.] Wayne State Univ, Dept Oncol, Sch Med, Detroit, MI 48201 USA; [Heath, Elisabeth I.] Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48201 USA; [Pienta, Kenneth J.] Johns Hopkins Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA; [Pienta, Kenneth J.] Johns Hopkins Sch Med, Dept Urol, Baltimore, MD USA; [Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Mosquera, Juan-Miguel; Beltran, Himisha; Robinson, Brian D.; Schiffman, Marc; Nanus, David M.; Tagawa, Scott T.; Sboner, Andrea; Rubin, Mark A.; Nelson, Peter S.] Cornell Univ, Weill Med Coll, Meyer Canc, New York, NY 10021 USA; [Loda, Massimo; Bowden, Michaela] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Schultz, Nikolaus; Gao, Jianjiong] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, New York, NY 10065 USA; [Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; NewYork-Presbyterian Hospital; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Trento; Cornell University; Cornell University; NewYork-Presbyterian Hospital; Cornell University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Cornell University; Harvard University; Brigham & Women's Hospital; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Sawyers, CL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	sawyersc@mskcc.org; arul@umich.edu	Mateo, Joaquin/AAG-9213-2019; Gao, JianJiong/B-5673-2016; Schultz, Nikolaus/ABE-6347-2020; Sawyers, Charles/G-5327-2016; Vats, Pankaj/AAL-1443-2020; Demichelis, Francesca/J-9829-2016; Perez-Lopez, Raquel/AAH-1978-2019	Gao, JianJiong/0000-0002-5739-1781; Demichelis, Francesca/0000-0002-8266-8631; Kantoff, Philip/0000-0001-7275-0597; Vats, Pankaj/0000-0001-8441-7732; de Bono, Johann S/0000-0002-2034-595X; Sigaras, Alexandros/0000-0002-7607-559X; Bowden, Michaela/0000-0003-4375-7823; Attard, Gerhardt/0000-0002-4811-7983; Dvinge, Heidi/0000-0003-1741-0738; Cheng, Heather/0000-0002-1365-0702; Bradley, Robert/0000-0002-8046-1063; Tagawa, Scott/0000-0003-2777-8587; Rathkopf, Dana/0000-0002-4503-7582; Perez-Lopez, Raquel/0000-0002-9176-0130; Smith, David/0000-0002-9465-988X; Miranda, Susana/0000-0002-5936-2706; Cooney, Kathleen/0000-0003-3831-6943; Rubin, Mark/0000-0002-8321-9950; Morris, Michael J./0000-0002-9454-0096; Durack, Jeremy/0000-0002-0672-9586; Mateo, Joaquin/0000-0001-5336-2548; Balmana, Judith/0000-0002-0762-6415	Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team Translational Cancer Research Grant; NIH: Clinical Sequencing Exploratory Research (CSER) [UM1HG006508]; NIH: Early Detection Research Network grant [UO1 CA111275]; NIH: Prostate SPORE [P50 CA186786, P50 CA092629, P50 CA90381, P50 CA097186, P01 CA163227, R01 CA116337, R01 CA155169, R01 CA092629]; DoD [W81XWH-09-1-0147, DOD PC121341, PC131820]; Starr Cancer Consortium; Damon Runyon Cancer Research Foundation [CI-67-13]; PCF Young Investigator Award; NIH [1K08CA188615]; Prostate Cancer Foundation Young Investigator Awards; Movember Foundation; ECMC network from Cancer Research UK; Department of Health in the UK; BRC grant; Prostate Cancer UK, PCF; MRC [MR/M003272/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA155169, P50CA090381, U01CA111275, K08CA188615, R01CA193910, R01CA116337, P50CA069568, R01CA085912, R01CA129435, R01CA136578, P50CA092629, P50CA097186, P01CA163227, R21CA128352, P30CA008748, K08CA115927, P50CA186786, R01CA193837, P30CA006516] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107427, T32GM007266] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER; Cancer Research UK [13239] Funding Source: researchfish; Medical Research Council [MR/M003272/1] Funding Source: researchfish; National Institute for Health Research [CL-2008-22-001] Funding Source: researchfish; Prostate Cancer UK [PG12-49, CEO13_2-002] Funding Source: researchfish	Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team Translational Cancer Research Grant; NIH: Clinical Sequencing Exploratory Research (CSER)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH: Early Detection Research Network grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH: Prostate SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD(United States Department of Defense); Starr Cancer Consortium; Damon Runyon Cancer Research Foundation; PCF Young Investigator Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation Young Investigator Awards; Movember Foundation; ECMC network from Cancer Research UK; Department of Health in the UK; BRC grant; Prostate Cancer UK, PCF; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Prostate Cancer UK	We thank the affected individuals who participated in this study to better understand the feasibility and utility of precision medicine approaches for advanced prostate cancer. Individuals at our respective institutions who helped with this study are listed by institution. University of Michigan: Karen Giles, Lynda Hodges, Erica Rabban, Ning Yu, Fengyun Su, Rui Wang, Brendan Veeneman, and Moshe Talpaz. MSKCC: Brett Carver, Kristen Curtis, and Julie Filipenko. DFCI/Broad: Zhenwei Zhang, Daniele Depalo, and Joseph Kramkowski. University of Washington: Jina Taub, Hiep Nguyen, Colm Morrissey, and Robert Vessella. ICR/Royal Marsden: Suzanne Carreira, Ines Figueiredo, and Daniel Nava Rodrigues. This work was supported by a Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team Translational Cancer Research Grant. Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research (SU2C-AACR-DT0712). The project was also supported by the following NIH awards: Clinical Sequencing Exploratory Research (CSER) UM1HG006508 (A.M.C.), Early Detection Research Network grant UO1 CA111275(A.M.C.), Prostate SPORE grants P50 CA186786 (A.M.C.), P50 CA092629 (H.I.S., C.L.S., and Y.C.), P50 CA90381 (P.K.), and P50 CA097186 (P.S.N., B.M., E.A.M., and L.D.T.), P01 CA163227 (P.S.N., S.P., R.K.B., H.D.), R01 CA116337 (M.A.R., H.B., F.D.), R01 CA155169 (C.L.S.), R01 CA092629, P50 CA092629 (H.I.S., C.L.S., and Y.C.), and R01 CA155169 (C.L.S.). This work was supported by the following DoD awards: W81XWH-09-1-0147 (PCCTC) and DOD PC121341 (H.B.). This work was also supported by the Starr Cancer Consortium (N.S., M.R., C.S., Y.C., L.A.G.). A.M.C. is an A. Alfred Taubman Scholar and an American Cancer Society Professor. H.B. is supported by Damon Runyon Cancer Research Foundation CI-67-13. C.P. is supported by a PCF Young Investigator Award and DoD PC131820. E.M.V. is supported by a NIH 1K08CA188615. E.M.V., N.S., and F.Y.F. are supported by Prostate Cancer Foundation Young Investigator Awards. The RM and ICR team is supported by the Movember Foundation and Prostate Cancer UK, PCF, the ECMC network from Cancer Research UK, the Department of Health in the UK, and BRC grant funding.	American Cancer Society, 2015, CANC FACTS FIG 2015; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Assie G, 2014, NAT GENET, V46, P607, DOI 10.1038/ng.2953; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Beltran H, 2013, EUR UROL, V63, P920, DOI 10.1016/j.eururo.2012.08.053; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Cao JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077922; Carreira S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009448; Castro E, 2013, J CLIN ONCOL, V31, P1748, DOI 10.1200/JCO.2012.43.1882; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Comstock CES, 2013, ONCOGENE, V32, P5481, DOI 10.1038/onc.2013.83; Cooper CS, 2015, NAT GENET, V47, P367, DOI 10.1038/ng.3221; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Epstein JI, 2014, AM J SURG PATHOL, V38, P756, DOI 10.1097/PAS.0000000000000208; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geng C, 2013, P NATL ACAD SCI USA, V110, P6997, DOI 10.1073/pnas.1304502110; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Hieronymus H, 2014, P NATL ACAD SCI USA, V111, P11139, DOI 10.1073/pnas.1411446111; Hong MKH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7605; Hsieh C.L., 2015, CANC RES; Kaufman B, 2015, J CLIN ONCOL, V33, P244, DOI 10.1200/JCO.2014.56.2728; Kikugawa T, 2006, PROSTATE, V66, P1092, DOI 10.1002/pros.20443; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Lalonde E, 2014, LANCET ONCOL, V15, P1521, DOI 10.1016/S1470-2045(14)71021-6; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Lonigro RJ, 2011, NEOPLASIA, V13, P1019, DOI 10.1593/neo.111252; Mateo J, 2014, ANN ONCOL, V25, DOI 10.1093/annonc/mdu438.20; Mehra R, 2011, CLIN CANCER RES, V17, P3924, DOI 10.1158/1078-0432.CCR-10-3120; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Pflueger D, 2011, GENOME RES, V21, P56, DOI 10.1101/gr.110684.110; Pritchard CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5988; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Schwartz S, 2015, CANCER CELL, V27, P109, DOI 10.1016/j.ccell.2014.11.008; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; The Cancer Genome Atlas, 2015, MOL TAX PRIM PROST C; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Van Allen EM, 2014, PROSTATE CANCER P D, V17, P23, DOI 10.1038/pcan.2013.37; Van Allen EM, 2014, CANCER DISCOV, V4, P1140, DOI 10.1158/2159-8290.CD-14-0623; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Voeller HJ, 1998, CANCER RES, V58, P2520; Wang XS, 2011, CANCER DISCOV, V1, P35, DOI 10.1158/2159-8274.CD-10-0022; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Weston VJ, 2010, BLOOD, V116, P4578, DOI 10.1182/blood-2010-01-265769	64	1989	2030	6	243	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1215	1228		10.1016/j.cell.2015.05.001	http://dx.doi.org/10.1016/j.cell.2015.05.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000489	Green Accepted, Bronze			2022-12-28	WOS:000355152600026
J	Zomer, A; Maynard, C; Verweij, FJ; Kamermans, A; Schafer, R; Beerling, E; Schiffelers, RM; de Wit, E; Berenguer, J; Ellenbroek, SIJ; Wurdinger, T; Pegtel, DM; van Rheenen, J				Zomer, Anoek; Maynard, Carrie; Verweij, Frederik Johannes; Kamermans, Alwin; Schafer, Ronny; Beerling, Evelyne; Schiffelers, Raymond Michel; de Wit, Elzo; Berenguer, Jordi; Ellenbroek, Saskia Inge Johanna; Wurdinger, Thomas; Pegtel, Dirk Michiel; van Rheenen, Jacco			In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior	CELL			English	Article							EXOSOMES; CANCER; MICROVESICLES; MICROENVIRONMENT; HALLMARKS; CELLS; RNA	Most cancer cells release heterogeneous populations of extracellular vesicles (EVs) containing proteins, lipids, and nucleic acids. In vitro experiments showed that EV uptake can lead to transfer of functional mRNA and altered cellular behavior. However, similar in vivo experiments remain challenging because cells that take up EVs cannot be discriminated from non-EV-receiving cells. Here, we used the Cre-LoxP system to directly identify tumor cells that take up EVs in vivo. We show that EVs released by malignant tumor cells are taken up by less malignant tumor cells located within the same and within distant tumors and that these EVs carry mRNAs involved in migration and metastasis. By intravital imaging, we show that the less malignant tumor cells that take up EVs display enhanced migratory behavior and metastatic capacity. We postulate that tumor cells locally and systemically share molecules carried by EVs in vivo and that this affects cellular behavior.	[Zomer, Anoek; Maynard, Carrie; Kamermans, Alwin; Schafer, Ronny; Beerling, Evelyne; de Wit, Elzo; Ellenbroek, Saskia Inge Johanna; van Rheenen, Jacco] Hubrecht Inst KNAW, Canc Genom Netherlands, NL-3584 CT Utrecht, Netherlands; [Zomer, Anoek; Maynard, Carrie; Kamermans, Alwin; Schafer, Ronny; Beerling, Evelyne; de Wit, Elzo; Ellenbroek, Saskia Inge Johanna; van Rheenen, Jacco] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Verweij, Frederik Johannes; Pegtel, Dirk Michiel] Vrije Univ Amsterdam Med Ctr, Canc Ctr Amsterdam, Dept Pathol, NL-1081 HV Amsterdam, Netherlands; [Schiffelers, Raymond Michel] Univ Med Ctr Utrecht, Lab Clin Chem & Haematol, NL-3584 CX Utrecht, Netherlands; [Berenguer, Jordi; Wurdinger, Thomas] Vrije Univ Amsterdam Med Ctr, Canc Ctr Amsterdam, Dept Neurosurg, NL-1081 HV Amsterdam, Netherlands; [Wurdinger, Thomas] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Wurdinger, Thomas] Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Harvard University; Massachusetts General Hospital; Harvard University	van Rheenen, J (corresponding author), Hubrecht Inst KNAW, Canc Genom Netherlands, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	j.vanrheenen@hubrecht.eu	Wurdinger, Thomas/AAA-5645-2022; Verweij, Frederik/AAS-2744-2020; Pegtel, Dirk Michiel/ABD-5481-2021; Pegtel, Dirk m/M-8393-2015; Schiffelers, Raymond/E-8786-2011; Berenguer, Jordi/AAK-5540-2020	Pegtel, Dirk Michiel/0000-0002-7357-4406; Pegtel, Dirk m/0000-0002-7357-4406; Schiffelers, Raymond/0000-0002-1012-9815; de Wit, Elzo/0000-0003-2883-1415; Zomer, Anoek/0000-0001-7209-6476; Ellenbroek, Saskia/0000-0001-8007-2634; Verweij, Frederik/0000-0001-8879-1174; Berenguer de Felipe, Jordi/0000-0003-4007-1631	VENI fellowships [91696087, 700.10.402]; VIDI fellowships [91710330, 91711366]; Dutch Organization of Scientific Research (NWO) [823.02.017, 175.010.2007.00, 834.11.002]; Dutch Cancer Society (KWF) [HUBR 2009-4621, VU 2009-3775]; European Research Council [260627, 336540]; Association for International Cancer Research (AICR) [13-0297]	VENI fellowships; VIDI fellowships; Dutch Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society (KWF)(KWF Kankerbestrijding); European Research Council(European Research Council (ERC)European Commission); Association for International Cancer Research (AICR)	We thank all members of the van Rheenen group for critically reading this manuscript, and we thank Anko de Graaff and the Hubrecht Imaging Center for imaging support. We thank Wouter Karthaus for his help with cloning the floxed-DsRed-floxed-eGFP construct, Chloe Prunier for imaging assistance, and Marcel Fens for assistance at the nanosight. This work was supported by the VENI fellowships 91696087 (M.P.) and 700.10.402 (E.d.W.); VIDI fellowships 91710330 (J.v.R.), 91711366 (T.W.), and a research grant 823.02.017 (J.v.R. from the Dutch Organization of Scientific Research (NWO); grants from the Dutch Cancer Society (KWF): HUBR 2009-4621 (A.Z. and J.v.R.) and VU 2009-3775 (M.P. and F.V.); European Research Council Starting Researchers grants 260627 (R.S.) and 336540 (T.W.); Association for International Cancer Research (AICR; 13-0297; J.v.R.); and equipment grants (175.010.2007.00 and 834.11.002) from the Dutch Organization of Scientific Research (NWO).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Beckler MD, 2013, MOL CELL PROTEOMICS, V12, P343, DOI 10.1074/mcp.M112.022806; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bobrie A, 2013, BIOCHEM SOC T, V41, P263, DOI 10.1042/BST20120245; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Cai ZJ, 2012, J IMMUNOL, V188, P5954, DOI 10.4049/jimmunol.1103466; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; Ellenbroek SIJ, 2014, NAT REV CANCER, V14, P406, DOI 10.1038/nrc3742; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; O'Brien K, 2013, EUR J CANCER, V49, P1845, DOI 10.1016/j.ejca.2013.01.017; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Postovit LM, 2006, STEM CELLS, V24, P501, DOI 10.1634/stemcells.2005-0459; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068451; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439	29	530	555	9	154	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1046	1057		10.1016/j.cell.2015.04.042	http://dx.doi.org/10.1016/j.cell.2015.04.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000481	Green Published, hybrid			2022-12-28	WOS:000355152600013
J	Gates, M				Gates, Melinda			Valuing the health and contribution of women is central to global development	LANCET			English	Editorial Material									Bill & Melinda Gates Fdn, Seattle, WA 98109 USA	Bill & Melinda Gates Foundation	Gates, M (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98109 USA.	mariam.claeson@gatesfoundation.org						FAO, 2011, STAT FOOD AGR, DOI [10.1007/978-3-030-44988-9_8, DOI 10.1007/978-3-030-44988-9_8]; Gates M, 2015, FOREIGN POLICY; Gates MF, 2014, SCIENCE, V345, P1273, DOI 10.1126/science.1258882; Langer A, 2015, LANCET; United Nations, 2014, MILL DEV GOALS REP 2	5	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2015	386	9999					E11	E12		10.1016/S0140-6736(15)60940-0	http://dx.doi.org/10.1016/S0140-6736(15)60940-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR5GE	26051368				2022-12-28	WOS:000361368000002
J	Malhi, GS				Malhi, Gin S.			Lithium therapy in bipolar disorder: a balancing act?	LANCET			English	Editorial Material							METAANALYSIS; PREVENTION; TRIAL		[Malhi, Gin S.] Univ Sydney, Dept Psychiat, Sydney, NSW 2006, Australia; [Malhi, Gin S.] Univ Sydney, Kolling Insitute, Sydney, NSW 2006, Australia; [Malhi, Gin S.] Royal N Shore Hosp, CADE Clin, Sydney, NSW 2065, Australia	University of Sydney; University of Sydney; Royal North Shore Hospital; University of Sydney	Malhi, GS (corresponding author), Univ Sydney, Dept Psychiat, Sydney, NSW 2006, Australia.	gin.malhi@sydney.edu.au	Malhi, Gin/Z-2418-2019	Malhi, Gin/0000-0002-4524-9091				Aprahamian I, 2014, J CLIN PSYCHIAT, V75, pE672, DOI 10.4088/JCP.13m08741; Cipriani A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3646; Duffy A, 2010, CAN J PSYCHIAT, V55, P477, DOI 10.1177/070674371005500802; Geddes JR, 2010, LANCET, V375, P385, DOI 10.1016/S0140-6736(09)61828-6; Gershon S, 2009, BIPOLAR DISORD, V11, P34, DOI 10.1111/j.1399-5618.2009.00709.x; Goodwin GM, 2007, PSYCHOL MED, V37, P609, DOI 10.1017/S0033291706009305; Malhi GS, 2012, AUST NZ J PSYCHIAT, V46, P192, DOI 10.1177/0004867412437346; Malhi GS, 2011, BIPOLAR DISORD, V13, P219, DOI 10.1111/j.1399-5618.2011.00918.x; Malhi GS, 2011, CNS DRUGS, V25, P289, DOI 10.2165/11586970-000000000-00000; Marmol F, 2008, PROG NEURO-PSYCHOPH, V32, P1761, DOI 10.1016/j.pnpbp.2008.08.012; McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X; Shine B., 2015, LANCET	12	10	10	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					415	416		10.1016/S0140-6736(14)62123-1	http://dx.doi.org/10.1016/S0140-6736(14)62123-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26003378	hybrid			2022-12-28	WOS:000358761700009
J	Rich, JD; McKenzie, M; Larney, S; Wong, JB; Tran, L; Clarke, J; Noska, A; Reddy, M; Zaller, N				Rich, Josiah D.; McKenzie, Michelle; Larney, Sarah; Wong, John B.; Tran, Liem; Clarke, Jennifer; Noska, Amanda; Reddy, Manasa; Zaller, Nickolas			Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial	LANCET			English	Article							OPIOID SUBSTITUTION TREATMENT; COST-EFFECTIVENESS ANALYSIS; DRUG-USERS; MAINTENANCE TREATMENT; CLINICAL-TRIAL; GLOBAL BURDEN; CARE; HEALTH; RISK; DEPENDENCE	Background Methadone is an effective treatment for opioid dependence. When people who are receiving methadone maintenance treatment for opioid dependence are incarcerated in prison or jail, most US correctional facilities discontinue their methadone treatment, either gradually, or more often, abruptly. This discontinuation can cause uncomfortable symptoms of withdrawal and renders prisoners susceptible to relapse and overdose on release. We aimed to study the effect of forced withdrawal from methadone upon incarceration on individuals' risk behaviours and engagement with post-release treatment programmes. Methods In this randomised, open-label trial, we randomly assigned (1: 1) inmates of the Rhode Island Department of Corrections (RI, USA) who were enrolled in a methadone maintenance-treatment programme in the community at the time of arrest and wanted to remain on methadone treatment during incarceration and on release, to either continuation of their methadone treatment or to usual care-forced tapered withdrawal from methadone. Participants could be included in the study only if their incarceration would be more than 1 week but less than 6 months. We did the random assignments with a computer-generated random permutation, and urn randomisation procedures to stratify participants by sex and race. Participants in the continued-methadone group were maintained on their methadone dose at the time of their incarceration (with dose adjustments as clinically indicated). Patients in the forced-withdrawal group followed the institution's standard withdrawal protocol of receiving methadone for 1 week at the dose at the time of their incarceration, then a tapered withdrawal regimen (for those on a starting dose >100 mg, the dose was reduced by 5 mg per day to 100 mg, then reduced by 3 mg per day to 0 mg; for those on a starting dose <= 100 mg, the dose was reduced by 3 mg per day to 0 mg). The main outcomes were engagement with a methadone maintenance-treatment clinic after release from incarceration and time to engagement with methadone maintenance treatment, by intention-to-treat and as-treated analyses, which we established in a follow-up interview with the participants at 1 month after their release from incarceration. Our study paid for 10 weeks of methadone treatment after release if participants needed financial help. This trial is registered with ClinicalTrials.gov, number NCT01874964. Findings Between June 14, 2011, and April 3, 2013, we randomly assigned 283 prisoners to our study, 142 to continued methadone treatment, and 141 to forced withdrawal from methadone. Of these, 60 were excluded because they did not fit the eligibility criteria, leaving 114 in the continued-methadone group and 109 in the forced-withdrawal group (usual care). Participants assigned to continued methadone were more than twice as likely than forced-withdrawal participants to return to a community methadone clinic within 1 month of release (106 [96%] of 110 in the continued-methadone group compared with 68 [78%] of 87 in the forced-withdrawal group; adjusted hazard ratio [HR] 2.04, 95% CI 1.48-2.80). We noted no differences in serious adverse events between groups. For the continued-methadone and forced-withdrawal groups, the number of deaths were one and zero, non-fatal overdoses were one and two, admissions to hospital were one and four; and emergency-room visits were 11 and 16, respectively. Interpretation Although our study had several limitations-eg, it only included participants incarcerated for fewer than 6 months, we showed that forced withdrawal from methadone on incarceration reduced the likelihood of prisoners re-engaging in methadone maintenance after their release. Continuation of methadone maintenance during incarceration could contribute to greater treatment engagement after release, which could in turn reduce the risk of death from overdose and risk behaviours.	[Rich, Josiah D.; McKenzie, Michelle; Larney, Sarah; Clarke, Jennifer; Noska, Amanda; Reddy, Manasa] Brown Univ, Providence, RI 02912 USA; [Zaller, Nickolas] Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Little Rock, AR 72205 USA; [Rich, Josiah D.; McKenzie, Michelle; Larney, Sarah; Tran, Liem; Clarke, Jennifer; Noska, Amanda; Reddy, Manasa; Zaller, Nickolas] Miriam Hosp, Ctr Prisoner Hlth & Human Rights, Providence, RI 02906 USA; [Larney, Sarah] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; [Wong, John B.] Tufts Univ, Sch Med, Tufts Med Ctr, Boston, MA 02111 USA; [Clarke, Jennifer] Mem Hosp, Pawtucket, RI USA	Brown University; University of Arkansas System; University of Arkansas Medical Sciences; Lifespan Health Rhode Island; Miriam Hospital; University of New South Wales Sydney; Tufts Medical Center; Tufts University	Rich, JD (corresponding author), Miriam Hosp, Ctr Prisoner Hlth & Human Rights, Providence, RI 02906 USA.	jrich@lifespan.org	Larney, Sarah/AAR-1372-2020	Larney, Sarah/0000-0002-5602-4963; Wong, John/0000-0003-4203-9010; Noska, Amanda/0000-0002-9256-0042	National Institute on Drug Abuse [K24DA022112, R01DA027211]; Lifespan/Tufts/Brown Center for AIDS Research, from the National Institutes of Health, Centers for AIDS Research [P30-AI-42853]; National Health and Medical Research Council Early Career Fellowship [APP1035149]; Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027211, K24DA022112] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Lifespan/Tufts/Brown Center for AIDS Research, from the National Institutes of Health, Centers for AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund(Australian Government); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the medical and custodial staff of the Rhode Island Department of Corrections including Ashbel T Wall, Fred Vohr, Gordon Bouchard, Pat Threats, Brenda Abelli, Vincent Jacavone, Eric Lewis, J R Perez, Pauline Marcussen, Jeff Renzi, and Margaret Paquette; our research team Candelaria Barroso, Ricky Lugo, Charlotte Reels, Chandra Cannon, Maria Garcia, Skye Tirado, Christina Anastacio; Sophie Sprecht and the other study nurses; staff in all the methadone clinics in Rhode Island and, in particular, the participants in this study. This research was supported by grants from the National Institute on Drug Abuse (K24DA022112 and R01DA027211) and the Lifespan/Tufts/Brown Center for AIDS Research, from the National Institutes of Health, Centers for AIDS Research (grant P30-AI-42853). Sarah Larney is funded by a National Health and Medical Research Council Early Career Fellowship (APP1035149). The National Drug and Alcohol Research Centre at the University of New South Wales is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.	[Anonymous], 2005, MEDICATION ASSISTED; Barnett PG, 1999, ADDICTION, V94, P479, DOI 10.1046/j.1360-0443.1999.9444793.x; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Boucher R., 2003, V LAW REV, V27, P453; Boutwell Amy E, 2007, J Opioid Manag, V3, P328; Briggs AH, 1997, HEALTH ECON, V6, P327, DOI 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Cuellar AE, 2012, HEALTH AFFAIR, V31, P931, DOI 10.1377/hlthaff.2011.0501; Deck D, 2009, J ADDICT DIS, V28, P89, DOI 10.1080/10550880902772373; Degenhardt L, 2014, ADDICTION, V109, P1306, DOI 10.1111/add.12536; Degenhardt L, 2014, ADDICTION, V109, P1320, DOI 10.1111/add.12551; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Degenhardt L, 2011, ADDICTION, V106, P32, DOI 10.1111/j.1360-0443.2010.03140.x; Desgagne A, 1998, PHARMACOECONOMICS, V13, P487, DOI 10.2165/00019053-199813050-00002; Dolan KA, 2003, DRUG ALCOHOL DEPEN, V72, P59, DOI 10.1016/S0376-8716(03)00187-X; DOLE VP, 1969, NEW ENGL J MED, V280, P1372, DOI 10.1056/NEJM196906192802502; Fiscella K, 2004, J URBAN HEALTH, V81, P645, DOI 10.1093/jurban/jth147; Fu JJ, 2013, J SUBST ABUSE TREAT, V44, P502, DOI 10.1016/j.jsat.2012.10.005; Gisev N, 2014, DETERMINING IMPACT O; Gordon MS, 2008, ADDICTION, V103, P1333, DOI 10.1111/j.1360-0443.2008.002238.x; Gruber VA, 2008, DRUG ALCOHOL DEPEN, V94, P199, DOI 10.1016/j.drugalcdep.2007.11.021; GUNNE LM, 1981, DRUG ALCOHOL DEPEN, V7, P249, DOI 10.1016/0376-8716(81)90096-X; Harm Reduction International, GLOB STAT HARM RED 2; Harris A, 2012, SUBST ABUS, V33, P70, DOI 10.1080/08897077.2011.620479; Hedrich D, 2012, ADDICTION, V107, P501, DOI 10.1111/j.1360-0443.2011.03676.x; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Humber N, 2013, SOC PSYCH PSYCH EPID, V48, P1177, DOI 10.1007/s00127-012-0632-4; Kerr T, 2007, DRUG ALCOHOL DEPEN, V87, P39, DOI 10.1016/j.drugalcdep.2006.07.009; Kinlock TW, 2007, DRUG ALCOHOL DEPEN, V91, P220, DOI 10.1016/j.drugalcdep.2007.05.022; Larney S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004666; Larney S, 2012, ADDICTION, V107, P372, DOI 10.1111/j.1360-0443.2011.03618.x; Larney S, 2010, ADDICTION, V105, P216, DOI 10.1111/j.1360-0443.2009.02826.x; Larney S, 2009, EUR ADDICT RES, V15, P107, DOI 10.1159/000199046; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; Mattick RP, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002209; McKenzie M, 2012, SUBST ABUS, V33, P19, DOI 10.1080/08897077.2011.609446; McKenzie Michelle, 2009, J Opioid Manag, V5, P219; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Mitchell SG, 2009, J PSYCHOACTIVE DRUGS, V41, P145, DOI 10.1080/02791072.2009.10399907; NEWMAN RG, 1979, LANCET, V2, P485; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Ramsey S, 2005, VALUE HEALTH, V8, P521, DOI 10.1111/j.1524-4733.2005.00045.x; Rich JD, 2014, HEALTH AFFAIR, V33, P462, DOI 10.1377/hlthaff.2013.1133; Rivlin A, 2013, CRISIS, V34, P335, DOI 10.1027/0227-5910/a000205; Schwartz RP, 2007, DRUG ALCOHOL DEPEN, V86, P30, DOI 10.1016/j.drugalcdep.2006.04.017; Sees KL, 2000, JAMA-J AM MED ASSOC, V283, P1303, DOI 10.1001/jama.283.10.1303; STRAIN EC, 1993, ANN INTERN MED, V119, P23, DOI 10.7326/0003-4819-119-1-199307010-00004; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; VANICHSENI S, 1991, INT J ADDICT, V26, P1313, DOI 10.3109/10826089109062163; WEI LJ, 1988, CONTROL CLIN TRIALS, V9, P345, DOI 10.1016/0197-2456(88)90048-7; WHO, 2005, 14 MOD LIST ESS MED; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; World Health Organization, 2009, GUID PSYCH ASS PHARM; World Health Organization (WHO), 2007, HLTH PRIS WHO GUID E; YANCOVITZ SR, 1991, AM J PUBLIC HEALTH, V81, P1185, DOI 10.2105/AJPH.81.9.1185; Zaller ND, 2009, INT J ENV RES PUB HE, V6, P787, DOI 10.3390/ijerph6020787	57	131	131	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2015	386	9991					350	359		10.1016/S0140-6736(14)62338-2	http://dx.doi.org/10.1016/S0140-6736(14)62338-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN5CX	26028120	Green Accepted			2022-12-28	WOS:000358448400024
J	High, AA; Devlin, RC; Dibos, A; Polking, M; Wild, DS; Perczel, J; de Leon, NP; Lukin, MD; Park, H				High, Alexander A.; Devlin, Robert C.; Dibos, Alan; Polking, Mark; Wild, Dominik S.; Perczel, Janos; de Leon, Nathalie P.; Lukin, Mikhail D.; Park, Hongkun			Visible-frequency hyperbolic metasurface	NATURE			English	Article							NEGATIVE REFRACTION; METAMATERIALS; SILVER; EXCITATION; INDEX; MODES	Metamaterials are artificial optical media composed of subwavelength metallic and dielectric building blocks that feature optical phenomena not present in naturally occurring materials(1-7). Although they can serve as the basis for unique optical devices that mould the flow of light in unconventional ways, three-dimensional metamaterials suffer from extreme propagation losses(8,9). Two-dimensional metamaterials (metasurfaces) such as hyperbolic metasurfaces for propagating surface plasmon polaritons(10,11) have the potential to alleviate this problem. Because the surface plasmon polaritons are guided at a metal-dielectric interface (rather than passing through metallic components), these hyperbolic metasurfaces have been predicted to suffer much lower propagation loss while still exhibiting optical phenomena akin to those in three-dimensional metamaterials. Moreover, because of their planar nature, these devices enable the construction of integrated metamaterial circuits as well as easy coupling with other optoelectronic elements. Here we report the experimental realization of a visible-frequency hyperbolic metasurface using single-crystal silver nanostructures defined by lithographic and etching techniques. The resulting devices display the characteristic properties of metamaterials, such as negative refraction(1-5) and diffraction-free propagation(6,7), with device performance greatly exceeding those of previous demonstrations. Moreover, hyperbolic metasurfaces exhibit strong, dispersion-dependent spin-orbit coupling, enabling polarization-and wavelength-dependent routeing of surface plasmon polaritons and two-dimensional chiral optical components(12-15). These results open the door to realizing integrated optical meta-circuits, with wide-ranging applications in areas from imaging and sensing to quantum optics and quantum information science.	[High, Alexander A.; Polking, Mark; de Leon, Nathalie P.; Park, Hongkun] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [High, Alexander A.; Wild, Dominik S.; Perczel, Janos; de Leon, Nathalie P.; Lukin, Mikhail D.; Park, Hongkun] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Devlin, Robert C.; Dibos, Alan] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Perczel, Janos] MIT, Dept Phys, Cambridge, MA 02139 USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT)	Park, H (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	lukin@physics.harvard.edu; hongkun_park@harvard.edu	High, Alexander A/U-1307-2018; Park, Hongkun/R-9842-2019; High, Alexander A/E-2541-2012	Park, Hongkun/0000-0001-9576-8829; High, Alexander A/0000-0003-0428-5448; Perczel, Janos/0000-0003-1856-3365; Wild, Dominik/0000-0001-7994-7077; de Leon, Nathalie/0000-0003-1324-1412	ONR-MURI [FA9550-12-1-0024]; NSF-AMO [PHY-0969816]; NSF-CUA [PHY-1125846]; DARPA SPARQC [W31P4Q-12-1-0017]; Direct For Mathematical & Physical Scien [0969816, 1125846] Funding Source: National Science Foundation; Div Of Electrical, Commun & Cyber Sys [1541959] Funding Source: National Science Foundation	ONR-MURI(MURIOffice of Naval Research); NSF-AMO; NSF-CUA(National Science Foundation (NSF)); DARPA SPARQC; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We acknowledge support from ONR-MURI (FA9550-12-1-0024), NSF-AMO (PHY-0969816), NSF-CUA (PHY-1125846) and DARPA SPARQC (W31P4Q-12-1-0017). We carried out all film deposition and device fabrication at the Harvard Center for Nanoscale Systems. J.P. acknowledges I. R. Hooper for useful discussions.	BASKI AA, 1994, SURF SCI, V313, P275, DOI 10.1016/0039-6028(94)90048-5; Esfandyarpour M, 2014, NAT NANOTECHNOL, V9, P542, DOI [10.1038/NNANO.2014.117, 10.1038/nnano.2014.117]; Fan XB, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.073901; Hafezi M, 2011, NAT PHYS, V7, P907, DOI [10.1038/NPHYS2063, 10.1038/nphys2063]; Huang KCY, 2014, NAT PHOTONICS, V8, P244, DOI [10.1038/nphoton.2014.2, 10.1038/NPHOTON.2014.2]; Huang LL, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.26; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Kapitanova PV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4226; Kildishev AV, 2013, SCIENCE, V339, DOI 10.1126/science.1232009; Lee SY, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.213907; Lin J, 2013, SCIENCE, V340, P331, DOI 10.1126/science.1233746; Liu YM, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821444; Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; Naik GV, 2014, P NATL ACAD SCI USA, V111, P7546, DOI 10.1073/pnas.1319446111; Onoda M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.083901; Palik E. D., 1998, HDB OPTICAL CONSTANT, V3, P353; Park JH, 2012, ADV MATER, V24, P3988, DOI 10.1002/adma.201200812; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Poddubny A, 2013, NAT PHOTONICS, V7, P948, DOI [10.1038/NPHOTON.2013.243, 10.1038/nphoton.2013.243]; RAETHER H, 1988, SURFACE PLASMONS SMO, pCH1; Rodriguez-Fortuno FJ, 2013, SCIENCE, V340, P328, DOI 10.1126/science.1233739; Salandrino A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075103; Shalaev VM, 2007, NAT PHOTONICS, V1, P41, DOI 10.1038/nphoton.2006.49; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Silva A, 2014, SCIENCE, V343, P160, DOI [10.1126/science.1242818, 10.1126/science.124405]; Smith DR, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.077405; Wu YW, 2014, ADV MATER, V26, P6106, DOI 10.1002/adma.201401474; Yao J, 2008, SCIENCE, V321, P930, DOI 10.1126/science.1157566	30	374	381	33	794	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					192	196		10.1038/nature14477	http://dx.doi.org/10.1038/nature14477			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	26062510				2022-12-28	WOS:000356016700034
J	Ko, PJ; Yeh, ML				Ko, Po-Jui; Yeh, Ming-Lun			Congenital Adrenal Hyperplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ko, Po-Jui; Yeh, Ming-Lun] E Da Hosp, Kaohsiung, Taiwan	E-Da Hospital	Ko, PJ (corresponding author), E Da Hosp, Kaohsiung, Taiwan.	ed103434@edah.org.tw		Ko, PoJui/0000-0002-3708-9569					0	0	0	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2015	372	24							e32	10.1056/NEJMicm1403201	http://dx.doi.org/10.1056/NEJMicm1403201			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK2DB	26061858				2022-12-28	WOS:000356019200010
J	Meyer, E				Meyer, Ernst			Controlling friction atom by atom	SCIENCE			English	Editorial Material									Univ Basel, Dept Phys, CH-4056 Basel, Switzerland	University of Basel	Meyer, E (corresponding author), Univ Basel, Dept Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.	ernst.meyer@unibas.ch	Meyer, Ernst/L-3873-2016	Meyer, Ernst/0000-0001-6385-3412				Bylinskii A, 2015, SCIENCE, V348, P1115, DOI 10.1126/science.1261422; Erdemir A., 2007, SUPERLUBRICITY; Frenkel Y, 1939, J PHYS USSR, V1, P137; Kontorova TA, 1938, ZH EKSP TEOR FIZ, V8, P1340; Krylov SY, 2014, PHYS STATUS SOLIDI B, V251, P711, DOI 10.1002/pssb.201350154; Urbakh M, 2010, NAT MATER, V9, P8, DOI 10.1038/nmat2599	6	7	7	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1089	1089		10.1126/science.aab3539	http://dx.doi.org/10.1126/science.aab3539			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045421				2022-12-28	WOS:000355590500023
J	Huang, WY; Molitch, ME				Huang, Wenyu; Molitch, Mark E.			Enlarged Thymus in a Patient With Dyspnea and Weight Loss	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GRAVES-DISEASE; HYPERTHYROIDISM; HYPERPLASIA		[Huang, Wenyu; Molitch, Mark E.] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Molitch, ME (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, 645 N Michigan Ave,Ste 530, Chicago, IL 60611 USA.	molitch@northwestern.edu						Chen YK, 2011, ACAD RADIOL, V18, P1292, DOI 10.1016/j.acra.2011.05.011; Costa MD, 2014, J ENDOCRINOL INVEST, V37, P1175, DOI 10.1007/s40618-014-0157-7; HASSMAN R, 1985, ENDOCRINOLOGY, V116, P1253, DOI 10.1210/endo-116-4-1253; Kanazawa M, 2007, EUR J NEUROL, V14, P1403, DOI 10.1111/j.1468-1331.2007.01978.x; MacCalium WG, 1907, J AMER MED ASSOC, V49, P1158; MICHIE W, 1967, LANCET, V1, P691; Murakami M, 1996, J CLIN INVEST, V98, P2228, DOI 10.1172/JCI119032; Popoveniuc G, 2010, THYROID, V20, P1015, DOI 10.1089/thy.2009.0383; WORTSMAN J, 1988, AM J MED, V85, P117, DOI 10.1016/0002-9343(88)90516-5; Yacoub CA, 2009, ENDOCR PRACT, V15, P534, DOI 10.4158/EP09025.ORR	10	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2174	2175		10.1001/jama.2015.2713	http://dx.doi.org/10.1001/jama.2015.2713			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ4CC	26034958				2022-12-28	WOS:000355430900018
J	McCarthy, GD; Haigh, ID; Hirschi, JJM; Grist, JP; Smeed, DA				McCarthy, Gerard D.; Haigh, Ivan D.; Hirschi, Joel J. -M.; Grist, Jeremy P.; Smeed, David A.			Ocean impact on decadal Atlantic climate variability revealed by sea-level observations	NATURE			English	Article							SURFACE HEAT-FLUX; TRANSPORT VARIABILITY; COAST; VOLUME; RISE; CIRCULATION	Decadal variability is a notable feature of the Atlantic Ocean and the climate of the regions it influences. Prominently, this is manifested in the Atlantic Multidecadal Oscillation (AMO) in sea surface temperatures. Positive (negative) phases of the AMO coincide with warmer (colder) North Atlantic sea surface temperatures. The AMO is linked with decadal climate fluctuations, such as Indian and Sahel rainfall(1), European summer precipitation(2), Atlantic hurricanes(3) and variations in global temperatures(4). It is widely believed that ocean circulation drives the phase changes of the AMO by controlling ocean heat content(5). However, there are no direct observations of ocean circulation of sufficient length to support this, leading to questions about whether the AMO is controlled from another source(6). Here we provide observational evidence of the widely hypothesized link between ocean circulation and the AMO. We take a new approach, using sea level along the east coast of the United States to estimate ocean circulation on decadal timescales. We show that ocean circulation responds to the first mode of Atlantic atmospheric forcing, the North Atlantic Oscillation, through circulation changes between the subtropical and subpolar gyres-the intergyre region(7). These circulation changes affect the decadal evolution of North Atlantic heat content and, consequently, the phases of the AMO. The Atlantic overturning circulation is declining(8) and the AMO is moving to a negative phase. This may offer a brief respite from the persistent rise of global temperatures(4), but in the coupled system we describe, there are compensating effects. In this case, the negative AMO is associated with a continued acceleration of sea-level rise along the northeast coast of the United States(9,10).	[McCarthy, Gerard D.; Hirschi, Joel J. -M.; Grist, Jeremy P.; Smeed, David A.] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Haigh, Ivan D.] Univ Southampton, Natl Oceanog Ctr, Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England	NERC National Oceanography Centre; University of Southampton; NERC National Oceanography Centre; University of Southampton	McCarthy, GD (corresponding author), Univ Southampton, Natl Oceanog Ctr, Waterfront Campus,European Way, Southampton SO14 3ZH, Hants, England.	gerard.mccarthy@noc.ac.uk	Jeremy, Grist P/B-4517-2012	Jeremy, Grist P/0000-0003-1068-9211; McCarthy, Gerard Daniel/0000-0002-2363-0561; Smeed, David/0000-0003-1740-1778	UK Natural Environment Research Council (NERC) RAPID-WATCH programme; UK NERC consortium project iGlass [NE/I009906/1]; NERC; Natural Environment Research Council [NE/M006107/1, NE/I009906/1, noc010012, noc010010] Funding Source: researchfish; NERC [noc010010, NE/I009906/1, NE/M006107/1] Funding Source: UKRI	UK Natural Environment Research Council (NERC) RAPID-WATCH programme(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK NERC consortium project iGlass; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	G.D.M. and D.A.S. are supported by the UK Natural Environment Research Council (NERC) RAPID-WATCH programme. I.D.H. was partly supported by the UK NERC consortium project iGlass (NE/I009906/1). J.P.G. and J.J.-M.H. are supported by NERC National Capability funding.	Bingham RJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036215; Boon JD, 2012, J COASTAL RES, V28, P1437, DOI 10.2112/JCOASTRES-D-12-00102.1; Booth BBB, 2012, NATURE, V484, P228, DOI 10.1038/nature10946; Bretherton CS, 1999, J CLIMATE, V12, P1990, DOI 10.1175/1520-0442(1999)012<1990:TENOSD>2.0.CO;2; Bryden HL, 2014, OCEAN SCI, V10, P683, DOI 10.5194/os-10-683-2014; Chen XY, 2014, SCIENCE, V345, P897, DOI 10.1126/science.1254937; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; Ebisuzaki W, 1997, J CLIMATE, V10, P2147, DOI 10.1175/1520-0442(1997)010<2147:AMTETS>2.0.CO;2; Ezer T, 2013, GEOPHYS RES LETT, V40, P5439, DOI 10.1002/2013GL057952; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; Grist JP, 2010, OCEAN DYNAM, V60, P771, DOI 10.1007/s10236-010-0292-4; Gulev SK, 2013, NATURE, V499, P464, DOI 10.1038/nature12268; Hakkinen S, 2004, SCIENCE, V304, P555, DOI 10.1126/science.1094917; Hodson DLR, 2014, J CLIMATE, V27, P8229, DOI 10.1175/JCLI-D-14-00301.1; Iselin C. O., 1940, PAP PHYS OCEANOGR ME, V8, P1, DOI DOI 10.1575/1912/1048; Johns WE, 2011, J CLIMATE, V24, P2429, DOI 10.1175/2010JCLI3997.1; Kanzow T, 2009, J PHYS OCEANOGR, V39, P3091, DOI 10.1175/2009JPO4185.1; Marshall J, 2001, J CLIMATE, V14, P1399, DOI 10.1175/1520-0442(2001)014<1399:ASOTIO>2.0.CO;2; McCarthy GD, 2015, PROG OCEANOGR, V130, P91, DOI 10.1016/j.pocean.2014.10.006; Meinen CS, 2010, DEEP-SEA RES PT I, V57, P835, DOI 10.1016/j.dsr.2010.04.001; Montgomery RB, 1938, J MAR RES, V1, P165, DOI 10.1357/002224038806440584; Osterhus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022188; Robson J, 2012, J CLIMATE, V25, P4116, DOI 10.1175/JCLI-D-11-00443.1; Sallenger AH, 2012, NAT CLIM CHANGE, V2, P884, DOI [10.1038/nclimate1597, 10.1038/NCLIMATE1597]; Smeed DA, 2014, OCEAN SCI, V10, P29, DOI 10.5194/os-10-29-2014; STURGES W, 1995, J PHYS OCEANOGR, V25, P1706, DOI 10.1175/1520-0485(1995)025<1706:WFOTAT>2.0.CO;2; Sutton RT, 2012, NAT GEOSCI, V5, P788, DOI [10.1038/ngeo1595, 10.1038/NGEO1595]; Thompson PR, 2014, J GEOPHYS RES-OCEANS, V119, P5676, DOI 10.1002/2014JC009999; Wunsch C, 2008, NAT GEOSCI, V1, P165, DOI 10.1038/ngeo126; Yin JJ, 2009, NAT GEOSCI, V2, P262, DOI 10.1038/NGEO462; Zhang R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026267	31	226	230	6	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					508	U172		10.1038/nature14491	http://dx.doi.org/10.1038/nature14491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	26017453	Green Accepted			2022-12-28	WOS:000355286600040
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Medical journals and their parasitical profit	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Bergstrom TC, 2014, P NATL ACAD SCI USA, V111, P9425, DOI 10.1073/pnas.1403006111; Bohannon J, 2013, SCIENCE, V342, P60, DOI 10.1126/science.342.6154.60; Drazen JM, 2015, NEW ENGL J MED, V372, P1853, DOI 10.1056/NEJMe1503623; Goldbeck-Wood S, 1999, BMJ-BRIT MED J, V318, P44; Handel AE, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4212; Jefferson T, 2007, Cochrane Database Syst Rev, pMR000016; Pattinson D., 2015, PLOS ONE	7	2	2	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2015	350								h2832	10.1136/bmj.h2832	http://dx.doi.org/10.1136/bmj.h2832			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0AH	26017234	Bronze			2022-12-28	WOS:000355132900005
J	Ahlstrom, A; Raupach, MR; Schurgers, G; Smith, B; Arneth, A; Jung, M; Reichstein, M; Canadell, JG; Friedlingstein, P; Jain, AK; Kato, E; Poulter, B; Sitch, S; Stocker, BD; Viovy, N; Wang, YP; Wiltshire, A; Zaehle, S; Zeng, N				Ahlstrom, Anders; Raupach, Michael R.; Schurgers, Guy; Smith, Benjamin; Arneth, Almut; Jung, Martin; Reichstein, Markus; Canadell, Josep G.; Friedlingstein, Pierre; Jain, Atul K.; Kato, Etsushi; Poulter, Benjamin; Sitch, Stephen; Stocker, Benjamin D.; Viovy, Nicolas; Wang, Ying Ping; Wiltshire, Andy; Zaehle, Soenke; Zeng, Ning			The dominant role of semi-arid ecosystems in the trend and variability of the land CO2 sink	SCIENCE			English	Article							CARBON-CYCLE; TERRESTRIAL BIOSPHERE; VEGETATION DYNAMICS; CLIMATE; SENSITIVITY; GREENNESS; EXTREMES; DIOXIDE; EVENTS	The growth rate of atmospheric carbon dioxide (CO2) concentrations since industrialization is characterized by large interannual variability, mostly resulting from variability in CO2 uptake by terrestrial ecosystems (typically termed carbon sink). However, the contributions of regional ecosystems to that variability are not well known. Using an ensemble of ecosystem and land-surface models and an empirical observation-based product of global gross primary production, we show that the mean sink, trend, and interannual variability in CO2 uptake by terrestrial ecosystems are dominated by distinct biogeographic regions. Whereas the mean sink is dominated by highly productive lands (mainly tropical forests), the trend and interannual variability of the sink are dominated by semi- arid ecosystems whose carbon balance is strongly associated with circulation- driven variations in both precipitation and temperature.	[Ahlstrom, Anders; Smith, Benjamin] Lund Univ, Dept Phys Geog & Ecosyst Sci, S-22362 Lund, Sweden; [Ahlstrom, Anders] Stanford Univ, Sch Earth Energy & Environm Sci, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Raupach, Michael R.] Australian Natl Univ, Climate Change Inst, Canberra, ACT 0200, Australia; [Schurgers, Guy] Univ Copenhagen, Dept Geosci & Nat Resource Management, DK-1350 Copenhagen, Denmark; [Arneth, Almut] Karlsruhe Inst Technol, Inst Meteorol & Climate Research Atmospher Enviro, D-82476 Garmisch Partenkirchen, Germany; [Jung, Martin; Reichstein, Markus] Max Planck Inst Biogeochem, Biogeochem Intergrat Dept, D-07745 Jena, Germany; [Canadell, Josep G.] CSIRO Oceans & Atmospher Flagship, Global Carbon Project, Canberra, ACT, Australia; [Friedlingstein, Pierre] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England; [Jain, Atul K.] Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA; [Kato, Etsushi] Inst Appl Energy, Tokyo 1050003, Japan; [Poulter, Benjamin] Montana State Univ, Inst Ecosyst, Bozeman, MT 59717 USA; [Poulter, Benjamin] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Sitch, Stephen] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4RJ, Devon, England; [Stocker, Benjamin D.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Stocker, Benjamin D.] Univ Bern, Inst Phys, Climate & Environm Phys, Bern, Switzerland; [Stocker, Benjamin D.] Univ Bern, Oeschger Ctr Climate Change Res, Bern, Switzerland; [Viovy, Nicolas] CEA Saclay, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; [Wang, Ying Ping] CSIRO Ocean & Atmosphere Flagship, Aspendale, Vic 3195, Australia; [Wiltshire, Andy] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England; [Zeng, Ning] Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA; [Zeng, Ning] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA	Lund University; Stanford University; Australian National University; University of Copenhagen; Helmholtz Association; Karlsruhe Institute of Technology; Max Planck Society; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Exeter; University of Illinois System; University of Illinois Urbana-Champaign; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; University of Exeter; Imperial College London; University of Bern; University of Bern; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Met Office - UK; Hadley Centre; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Ahlstrom, A (corresponding author), Lund Univ, Dept Phys Geog & Ecosyst Sci, S-22362 Lund, Sweden.	anders.ahlstrom@nateko.lu.se	Zaehle, Sönke/C-9528-2017; Smith, Benjamin/I-1212-2016; Canadell, Pep/E-9419-2010; Sitch, Stephen A/F-8034-2015; Schurgers, Guy/K-6543-2012; Zeng, Ning/A-3130-2008; Jain, Atul/D-2851-2016; Wiltshire, Andy/C-2848-2008; Arneth, Almut/B-2702-2013; Viovy, Nicolas/S-2631-2018; Wang, Yingping/A-9765-2011; Kato, Etsushi/Q-2623-2018; Stocker, Benjamin David/K-3194-2015; Ahlström, Anders/AAC-6716-2019; Reichstein, Markus/A-7494-2011; Ahlström, Anders/F-3215-2017; Friedlingstein, Pierre/H-2700-2014; Poulter, Ben/ABB-5886-2021	Zaehle, Sönke/0000-0001-5602-7956; Smith, Benjamin/0000-0002-6987-5337; Canadell, Pep/0000-0002-8788-3218; Sitch, Stephen A/0000-0003-1821-8561; Schurgers, Guy/0000-0002-2189-1995; Zeng, Ning/0000-0002-7489-7629; Jain, Atul/0000-0002-4051-3228; Arneth, Almut/0000-0001-6616-0822; Viovy, Nicolas/0000-0002-9197-6417; Wang, Yingping/0000-0002-4614-6203; Kato, Etsushi/0000-0001-8814-804X; Stocker, Benjamin David/0000-0003-2697-9096; Ahlström, Anders/0000-0003-1642-0037; Reichstein, Markus/0000-0001-5736-1112; Ahlström, Anders/0000-0003-1642-0037; Friedlingstein, Pierre/0000-0003-3309-4739; Poulter, Ben/0000-0002-9493-8600	Royal Physiographic Society in Lund (Birgit and Hellmuth Hertz Foundation); Swedish Research Council [637-2014-6895]; Mistra-SWECIA program; EC [603542, 282672]; OCE; Australian Climate Change Science Program; NSF [AGS 12-43071, AGS-1129088]; U.S. Department of Energy [DE-SC0006706]; NASA LCLUC program [NNX14AD94G]; Ministry of Environment of Japan; CSIRO; NOAA [NA10OAR4310248, NA09NES4400006]; NERC [NE/J010154/1] Funding Source: UKRI; Office of Integrative Activities [1443108] Funding Source: National Science Foundation; Natural Environment Research Council [NE/J010154/1] Funding Source: researchfish	Royal Physiographic Society in Lund (Birgit and Hellmuth Hertz Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Mistra-SWECIA program; EC(European CommissionEuropean Commission Joint Research Centre); OCE; Australian Climate Change Science Program; NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); NASA LCLUC program; Ministry of Environment of Japan(Ministry of the Environment, Japan); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This paper is dedicated to the memory of Michael Robin Raupach (1950-2015), whose scientific integrity and novel contributions leave a long-lasting legacy in the field of carbon cycle sciences. The MODIS MOD12C1 land cover product was obtained through the online Data Pool at the NASA Land Processes Distributed Active Archive Center (LP DAAC), USGS/Earth Resources Observation and Science (EROS) Center, Sioux Falls, South Dakota (https://lpdaac.usgs.gov/data_access). Supported by the Royal Physiographic Society in Lund (Birgit and Hellmuth Hertz Foundation), Swedish Research Council grant 637-2014-6895, and the Mistra-SWECIA program (A. Ahlstrom); EC FP7 grant LUC4C (603542) (A. Arneth); OCE Distinguished Visiting Scientist to the CSIRO Ocean and Atmosphere Flagship, Canberra (B.S.); EC FP7 grant EMBRACE (282672) (A. Arneth, M.R., and B.D.S.); the Australian Climate Change Science Program (J.G.C.); NSF grant AGS 12-43071, U.S. Department of Energy grant DE-SC0006706, and NASA LCLUC program grant NNX14AD94G (A.K.J.); the Environmental Research and Technology Development Fund (S-10) of the Ministry of Environment of Japan (E.K.); CSIRO strategic research funds (Y.P.W.); and NOAA grants NA10OAR4310248 and NA09NES4400006 and NSF grant AGS-1129088 (N.Z.). This study is a contribution to the Lund Centre for Studies of Carbon Cycle and Climate Interactions (LUCCI) and the strategic research areas MERGE and BECC.	Ahlstrom A, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044008; Ahlstrom A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052336; Andela N, 2013, BIOGEOSCIENCES, V10, P6657, DOI 10.5194/bg-10-6657-2013; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Cox PM, 2013, NATURE, V494, P341, DOI 10.1038/nature11882; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Donohue RJ, 2009, GLOBAL CHANGE BIOL, V15, P1025, DOI 10.1111/j.1365-2486.2008.01746.x; Fensholt R, 2012, REMOTE SENS ENVIRON, V121, P144, DOI 10.1016/j.rse.2012.01.017; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; KEELING CD, 1995, NATURE, V375, P666, DOI 10.1038/375666a0; Le Quere C, 2014, EARTH SYST SCI DATA, V6, P235, DOI 10.5194/essd-6-235-2014; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Poulter B, 2014, NATURE, V509, P600, DOI 10.1038/nature13376; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Schaphoff S, 2006, CLIMATIC CHANGE, V74, P97, DOI 10.1007/s10584-005-9002-5; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Sitch S, 2015, BIOGEOSCIENCES, V12, P653, DOI 10.5194/bg-12-653-2015; Smith B, 2001, GLOBAL ECOL BIOGEOGR, V10, P621, DOI 10.1046/j.1466-822X.2001.00256.x; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P17, DOI 10.1038/NCLIMATE2067; Wang WL, 2013, P NATL ACAD SCI USA, V110, P13061, DOI 10.1073/pnas.1219683110; Wang XH, 2014, NATURE, V506, P212, DOI 10.1038/nature12915; Wolter K, 1993, PROC 17 CLIMATE DIAG, V52; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Zscheischler J, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/035001	31	759	782	110	683	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					895	899		10.1126/science.aaa1668	http://dx.doi.org/10.1126/science.aaa1668			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999504	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000354877900040
J	Pruszynski, JA; Diedrichsen, J				Pruszynski, J. Andrew; Diedrichsen, Joern			Reading the mind to move the body Decoding neural signals of intention and movement should guide the development of neural prosthetics	SCIENCE			English	Editorial Material									[Pruszynski, J. Andrew] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 3K7, Canada; [Diedrichsen, Joern] UCL, Inst Cognit Neurosci, London WC1E 6BT, England	Western University (University of Western Ontario); University of London; University College London	Pruszynski, JA (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 3K7, Canada.	andrew.pruszynski@uwo.ca; j.diedrichsen@ucl.ac.uk	Pruszynski, J. Andrew/E-4522-2011; Diedrichsen, Jörn/A-7789-2010; Diedrichsen, Jörn/AAQ-2242-2020	Pruszynski, J. Andrew/0000-0003-0786-0081; Diedrichsen, Jörn/0000-0003-0264-8532; Diedrichsen, Jörn/0000-0003-0264-8532				Aflalo T, 2015, SCIENCE, V348, P906, DOI 10.1126/science.aaa5417; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Gallivan JP, 2011, J NEUROSCI, V31, P17149, DOI 10.1523/JNEUROSCI.1058-11.2011; Gilja V, 2011, IEEE T BIO-MED ENG, V58, P1891, DOI 10.1109/TBME.2011.2107553; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; JONES KE, 1992, ANN BIOMED ENG, V20, P423, DOI 10.1007/BF02368134; LIBET B, 1983, ELECTROEN CLIN NEURO, V56, P367, DOI 10.1016/0013-4694(83)90262-6; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268	9	4	4	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					860	861		10.1126/science.aab3464	http://dx.doi.org/10.1126/science.aab3464			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI6NW	25999491				2022-12-28	WOS:000354877900017
J	Sunagawa, S; Coelho, LP; Chaffron, S; Kultima, JR; Labadie, K; Salazar, G; Djahanschiri, B; Zeller, G; Mende, DR; Alberti, A; Cornejo-Castillo, FM; Costea, PI; Cruaud, C; d'Ovidio, F; Engelen, S; Ferrera, I; Gasol, JM; Guidi, L; Hildebrand, F; Kokoszka, F; Lepoivre, C; Lima-Mendez, G; Poulain, J; Poulos, BT; Royo-Llonch, M; Sarmento, H; Vieira-Silva, S; Dimier, C; Picheral, M; Searson, S; Kandels-Lewis, S; Bowler, C; de Vargas, C; Gorsky, G; Grimsley, N; Hingamp, P; Iudicone, D; Jaillon, O; Not, F; Ogata, H; Pesant, S; Speich, S; Stemmann, L; Sullivan, MB; Weissenbach, J; Wincker, P; Karsenti, E; Raes, J; Acinas, SG; Bork, P				Sunagawa, Shinichi; Coelho, Luis Pedro; Chaffron, Samuel; Kultima, Jens Roat; Labadie, Karine; Salazar, Guillem; Djahanschiri, Bardya; Zeller, Georg; Mende, Daniel R.; Alberti, Adriana; Cornejo-Castillo, Francisco M.; Costea, Paul I.; Cruaud, Corinne; d'Ovidio, Francesco; Engelen, Stefan; Ferrera, Isabel; Gasol, Josep M.; Guidi, Lionel; Hildebrand, Falk; Kokoszka, Florian; Lepoivre, Cyrille; Lima-Mendez, Gipsi; Poulain, Julie; Poulos, Bonnie T.; Royo-Llonch, Marta; Sarmento, Hugo; Vieira-Silva, Sara; Dimier, Celine; Picheral, Marc; Searson, Sarah; Kandels-Lewis, Stefanie; Bowler, Chris; de Vargas, Colomban; Gorsky, Gabriel; Grimsley, Nigel; Hingamp, Pascal; Iudicone, Daniele; Jaillon, Olivier; Not, Fabrice; Ogata, Hiroyuki; Pesant, Stephane; Speich, Sabrina; Stemmann, Lars; Sullivan, Matthew B.; Weissenbach, Jean; Wincker, Patrick; Karsenti, Eric; Raes, Jeroen; Acinas, Silvia G.; Bork, Peer		Tara Oceans Coordinators	Structure and function of the global ocean microbiome	SCIENCE			English	Article							COMMUNITY STRUCTURE; DIVERSITY; PATTERNS; PROKARYOTES; DISPERSAL; EFFICIENT; RICHNESS; GRADIENT; BACTERIA; DATABASE	Microbes are dominant drivers of biogeochemical processes, yet drawing a global picture of functional diversity, microbial community structure, and their ecological determinants remains a grand challenge. We analyzed 7.2 terabases of metagenomic data from 243 Tara Oceans samples from 68 locations in epipelagic and mesopelagic waters across the globe to generate an ocean microbial reference gene catalog with >40 million nonredundant, mostly novel sequences from viruses, prokaryotes, and picoeukaryotes. Using 139 prokaryote-enriched samples, containing >35,000 species, we show vertical stratification with epipelagic community composition mostly driven by temperature rather than other environmental factors or geography. We identify ocean microbial core functionality and reveal that >73% of its abundance is shared with the human gut microbiome despite the physicochemical differences between these two ecosystems.	[Sunagawa, Shinichi; Coelho, Luis Pedro; Kultima, Jens Roat; Djahanschiri, Bardya; Zeller, Georg; Mende, Daniel R.; Costea, Paul I.; Hildebrand, Falk; Kandels-Lewis, Stefanie; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol, D-69117 Heidelberg, Germany; [Chaffron, Samuel; Lima-Mendez, Gipsi; Vieira-Silva, Sara; Raes, Jeroen] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, B-3000 Leuven, Belgium; [Chaffron, Samuel; Lima-Mendez, Gipsi; Vieira-Silva, Sara; Raes, Jeroen] VIB, Ctr Biol Dis, B-3000 Leuven, Belgium; [Chaffron, Samuel; Lima-Mendez, Gipsi; Vieira-Silva, Sara; Raes, Jeroen] Vrije Univ Brussel, Dept Appl Biol Sci, B-1050 Brussels, Belgium; [Labadie, Karine; Alberti, Adriana; Cruaud, Corinne; Engelen, Stefan; Poulain, Julie; Jaillon, Olivier; Weissenbach, Jean; Wincker, Patrick] CEA, Inst Genom, GENOSCOPE, F-91057 Evry, France; [Salazar, Guillem; Cornejo-Castillo, Francisco M.; Ferrera, Isabel; Gasol, Josep M.; Royo-Llonch, Marta; Sarmento, Hugo; Acinas, Silvia G.] CSIC, Inst Marine Sci ICM, Dept Marine Biol & Oceanog, E-08003 Barcelona, Spain; [d'Ovidio, Francesco] Univ Paris 06, Sorbonne Univ, CNRS IRD MNHN, LOCEAN Lab, F-75005 Paris, France; [Guidi, Lionel; Picheral, Marc; Searson, Sarah; Gorsky, Gabriel; Stemmann, Lars] CNRS, UMR 7093, Oceanog Lab, Observ Oceanol, F-06230 Villefranche Sur Mer, France; [Guidi, Lionel; Picheral, Marc; Searson, Sarah; Gorsky, Gabriel; Stemmann, Lars] Univ Paris 06, Sorbonne Univ, UMR 7093, LOV,Observ Oceanol, F-06230 Villefranche Sur Mer, France; [Kokoszka, Florian; Dimier, Celine; Bowler, Chris; Karsenti, Eric] Ecole Normale Super, IBENS, F-75005 Paris, France; [Kokoszka, Florian; Dimier, Celine; Bowler, Chris; Karsenti, Eric] INSERM, U1024, Paris, France; [Kokoszka, Florian; Dimier, Celine; Bowler, Chris; Karsenti, Eric] CNRS, UMR 8197, F-75005 Paris, France; [Kokoszka, Florian] Lab Phys Oceans UBO IUEM, F-29820 Plouzane, France; [Lepoivre, Cyrille; Hingamp, Pascal] Aix Marseille Univ, CNRS IGS UMR 7256, F-13288 Marseille, France; [Poulos, Bonnie T.; Sullivan, Matthew B.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Sarmento, Hugo] Univ Fed Sao Carlos UFSCar, Dept Hydrobiol, BR-13565905 Sao Paulo, Brazil; [Dimier, Celine; de Vargas, Colomban; Not, Fabrice] CNRS, UMR 7144, Stn Biol Roscoff, F-29680 Roscoff, France; [Dimier, Celine; de Vargas, Colomban; Not, Fabrice] Univ Paris 06, Sorbonne Univ, UMR 7144, Stn Biol Roscoff, F-29680 Roscoff, France; [Kandels-Lewis, Stefanie; Karsenti, Eric] European Mol Biol Lab, Directors Res, D-69117 Heidelberg, Germany; [Grimsley, Nigel] CNRS, UMR 7232, BIOM, F-66650 Banyuls Sur Mer, France; [Grimsley, Nigel] Univ Paris 06, Sorbonne Univ, OOB, F-66650 Banyuls Sur Mer, France; [Iudicone, Daniele] Stn Zool A Dohrn, I-80121 Naples, Italy; [Jaillon, Olivier; Weissenbach, Jean; Wincker, Patrick] CNRS, UMR 8030, CP5706, Evry, France; [Jaillon, Olivier; Weissenbach, Jean; Wincker, Patrick] Univ Evry, UMR 8030, CP5706, Evry, France; [Ogata, Hiroyuki] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Pesant, Stephane] Univ Bremen, Data Publisher Earth & Environm Sci, PANGAEA, D-28359 Bremen, Germany; [Pesant, Stephane] Univ Bremen, Ctr Marine Environm Sci, MARUM, D-28359 Bremen, Germany; [Speich, Sabrina] Ecole Normale Super, LMD, Dept Geosci, F-75231 Paris 05, France; [Speich, Sabrina] UBO IUEM, Lab Phys Oceans, F-29820 Plouzane, France; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	European Molecular Biology Laboratory (EMBL); KU Leuven; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; CEA; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Arizona; Universidade Federal de Sao Carlos; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Stazione Zoologica Anton Dohrn di Napoli; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Kyoto University; University of Bremen; University of Bremen; Ecole des Ponts ParisTech; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Sunagawa, S (corresponding author), European Mol Biol Lab, Struct & Computat Biol, Meyerhofstr 1, D-69117 Heidelberg, Germany.	sunagawa@embl.de; karsenti@embl.de; jeroen.raes@vib-kuleuven.be; sacinas@icm.csic.es; bork@embl.de	Alberti, Adriana/E-7142-2017; stemmann, lars/Q-8458-2019; Sarmento, Hugo/W-3805-2019; Boss, Emmanuel/AAF-2336-2019; Vieira-Silva, Sara/ABE-1247-2021; d'Ovidio, Francesco/ABA-8461-2021; Grimsley, Nigel/O-1359-2015; Labadie, Karine/AFL-7408-2022; stemmann, lars/E-6899-2011; Hingamp, Pascal/AAO-1382-2020; Royo-Llonch, Marta/H-9255-2015; Zeller, Georg/M-6484-2013; Bork, Peer/F-1813-2013; Mende, Daniel R/I-3662-2019; Kokoszka, Florian/HHN-0643-2022; Speich, Sabrina/L-3780-2014; Bowler, Chris/AAC-6256-2019; Royo-Llonch, Marta/AAA-2351-2019; Acinas, Silvia/F-7462-2016; Chaffron, Samuel/B-2300-2012; Sarmento, Hugo/A-7655-2008; Salazar, Guillem/L-5868-2014; Ferrera, Isabel/L-7200-2014; Sunagawa, Shinichi/Q-5950-2019; Gasol, Josep M M/B-1709-2008; Lima-Mendez, Gipsi/AAV-4158-2021; Guidi, Lionel/B-3977-2012; Sullivan, Matthew B/H-3256-2011; Jaillon, Olivier/GRY-6287-2022; Coelho, Luis Pedro/D-1260-2009; Labadie, Karine/AAG-7355-2022; raes, jeroen/D-7835-2018; Alberti, Adriana/AAZ-2013-2021; Chaffron, Samuel/K-1104-2019; Lima-Mendez, Gipsi/AAX-6291-2021; Hildebrand, Falk/K-1914-2014	Alberti, Adriana/0000-0003-3372-9423; stemmann, lars/0000-0001-8935-4531; Sarmento, Hugo/0000-0001-5220-7992; Boss, Emmanuel/0000-0002-8334-9595; Vieira-Silva, Sara/0000-0002-4616-7602; Grimsley, Nigel/0000-0001-9323-417X; Labadie, Karine/0000-0001-7467-8509; Hingamp, Pascal/0000-0002-7463-2444; Royo-Llonch, Marta/0000-0003-2966-9093; Zeller, Georg/0000-0003-1429-7485; Bork, Peer/0000-0002-2627-833X; Mende, Daniel R/0000-0001-6831-4557; Kokoszka, Florian/0000-0001-5346-3058; Speich, Sabrina/0000-0002-5452-8287; Royo-Llonch, Marta/0000-0003-2966-9093; Acinas, Silvia/0000-0002-3439-0428; Chaffron, Samuel/0000-0001-5903-617X; Sarmento, Hugo/0000-0001-5220-7992; Salazar, Guillem/0000-0002-9786-1493; Ferrera, Isabel/0000-0003-3484-516X; Sunagawa, Shinichi/0000-0003-3065-0314; Gasol, Josep M M/0000-0001-5238-2387; Lima-Mendez, Gipsi/0000-0002-5309-1845; Guidi, Lionel/0000-0002-6669-5744; Sullivan, Matthew B/0000-0003-4040-9831; Coelho, Luis Pedro/0000-0002-9280-7885; Labadie, Karine/0000-0001-7467-8509; raes, jeroen/0000-0002-1337-041X; Alberti, Adriana/0000-0003-3372-9423; Chaffron, Samuel/0000-0001-5903-617X; Lima-Mendez, Gipsi/0000-0002-5309-1845; Cornejo-Castillo, Francisco M./0000-0001-8431-9278; PESANT, Stephane/0000-0002-4936-5209; Hildebrand, Falk/0000-0002-0078-8948; Reynaud, Emmanuel/0000-0003-1502-661X; Engelen, Stefan/0000-0003-0003-1192; Jaillon, Olivier/0000-0002-7237-9596; Bowler, Chris/0000-0003-3835-6187; Cruaud, Corinne/0000-0002-4752-7278; de Vargas, Colomban/0000-0002-6476-6019; Djahanschiri, Bardya/0000-0002-6066-8315; d'Ovidio, Francesco/0000-0002-9664-7778; Gorsky, Gabriel/0000-0002-1099-8711; Costea, Paul Igor/0000-0003-1645-3947; Iudicone, Daniele/0000-0002-7473-394X; Poulain, Julie/0000-0002-8744-3116	CNRS [GDR3280]; European Molecular Biology Laboratory (EMBL); Genoscope/CEA; VIB; Stazione Zoologica Anton Dohrn; Universita degli Studi di Milano-Bicocca; Fund for Scientific Research-Flanders; Rega Institute, KU Leuven; French Ministry of Research; French Government [ANR-11-BTBR-0008, ANR-10-INBS-09-08, ANR-10-LABX-54]; PSL Research University [ANR-11-IDEX-0001-02]; Agence Nationale de la Recherche [PROMETHEUS/ANR-09-PCS-GENM-217, TARA GIRUS/ANR-09-PCS-GENM-218]; European Union [287589, IHMS/HEALTH-F4-2010-261376]; European Research Council [294823]; Gordon and Betty Moore Foundation [3790]; Spanish Ministry of Science and Innovation [CGL2011-26848]; Agencia de Gestio d'Ajusts Universitaris i Reserca [CONES 2010-0036]; Japan Society for the Promotion of Science [26430184]; FWO, BIO5, Biosphere 2; Agnes b. and Etienne Bourgois; Veolia Environment Foundation; Region Bretagne; Lorient Agglomeration; World Courier; Illumina; EDF Foundation; FRB; Prince Albert II de Monaco Foundation; French Ministry of Foreign Affairs; Tara schooner	CNRS(Centre National de la Recherche Scientifique (CNRS)); European Molecular Biology Laboratory (EMBL); Genoscope/CEA; VIB; Stazione Zoologica Anton Dohrn; Universita degli Studi di Milano-Bicocca; Fund for Scientific Research-Flanders(FWO); Rega Institute, KU Leuven; French Ministry of Research(Ministry of Research, FranceEuropean Commission); French Government; PSL Research University; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia de Gestio d'Ajusts Universitaris i Reserca; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); FWO, BIO5, Biosphere 2; Agnes b. and Etienne Bourgois; Veolia Environment Foundation; Region Bretagne(Region Bretagne); Lorient Agglomeration; World Courier; Illumina; EDF Foundation; FRB; Prince Albert II de Monaco Foundation; French Ministry of Foreign Affairs; Tara schooner	We thank the following individuals and sponsors for their support: CNRS (in particular Groupement de Recherche GDR3280), European Molecular Biology Laboratory (EMBL), Genoscope/CEA, VIB, Stazione Zoologica Anton Dohrn, Universita degli Studi di Milano-Bicocca, Fund for Scientific Research-Flanders, Rega Institute, KU Leuven, The French Ministry of Research, the French Government "Investissements d'Avenir" programmes OCEANOMICS (ANR-11-BTBR-0008), FRANCE GENOMIQUE (ANR-10-INBS-09-08), MEMO LIFE (ANR-10-LABX-54), PSL Research University (ANR-11-IDEX-0001-02), Agence Nationale de la Recherche (projects POSEIDON/ANR-09-BLAN-0348, PHYTBACK/ANR-2010-1709-01, PROMETHEUS/ANR-09-PCS-GENM-217, TARA GIRUS/ANR-09-PCS-GENM-218), European Union FP7 (MicroB3/no. 287589, IHMS/HEALTH-F4-2010-261376), European Research Council Advanced Grant Award to C.B. (Diatomite: 294823), Gordon and Betty Moore Foundation grant (no. 3790) to M.B.S., Spanish Ministry of Science and Innovation grant CGL2011-26848/BOS MicroOcean PANGENOMICS to S.G.A., TANIT (CONES 2010-0036) from the Agencia de Gestio d'Ajusts Universitaris i Reserca to SGA, Japan Society for the Promotion of Science KAKENHI grant no. 26430184 to H.O., and FWO, BIO5, Biosphere 2 to M.B.S. We also thank the following for their support: Agnes b. and Etienne Bourgois, the Veolia Environment Foundation, Region Bretagne, Lorient Agglomeration, World Courier, Illumina, the EDF Foundation, FRB, the Prince Albert II de Monaco Foundation, and the Tara schooner and its captain and crew. We thank MERCATOR-CORIOLIS and ACRI-ST for providing daily satellite data during the expedition. We are also grateful to the French Ministry of Foreign Affairs for supporting the expedition and to the countries that graciously granted sampling permissions. Tara Oceans would not exist without continuous support from 23 institutes (http://oceans.taraexpeditions.org). We also acknowledge excellent assistance from the European Bioinformatics Institute (EBI), in particular G. Cochrane and P. ten Hoopen, as well as the EMBL Advanced Light Microscopy Facility (ALMF), in particular R. Pepperkok. The authors further declare that all data reported herein are fully and freely available from the date of publication, with no restrictions, and that all of the samples, analyses, publications, and ownership of data are free from legal entanglement or restriction of any sort by the various nations whose waters the Tara Oceans expedition sampled. Data described herein are available at http://ocean-microbiome.embl.de/companion.html, at the EBI under the project identifiers PRJEB402 and PRJEB7988, and at PANGAEA (55-57). The data release policy regarding future public release of Tara Oceans data is described in (54). All authors approved the final manuscript. This article is contribution number 22 of Tara Oceans. Additional data are in the supplementary materials.	Amaral-Zettler Linda, 2010, P223; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; Arumugam M, 2010, BIOINFORMATICS, V26, P2977, DOI 10.1093/bioinformatics/btq536; Barberan A, 2012, MOL ECOL, V21, P1909, DOI 10.1111/j.1365-294X.2011.05383.x; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Brum JR, 2015, SCIENCE, V348, DOI 10.1126/science.1261498; Chaffron S., 2014, CONTEXTUAL ENVIRONME, DOI [10.1594/PANGAEA.840718, DOI 10.1594/PANGAEA.840718]; Chaffron S., 2014, CONTEXTUAL BIODIVERS, DOI [10.1594/PANGAEA.840698, DOI 10.1594/PANGAEA.840698]; Clerissi C, 2014, APPL ENVIRON MICROB, V80, P3150, DOI 10.1128/AEM.00123-14; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hildebrand F, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-30; Hingamp P, 2013, ISME J, V7, P1678, DOI 10.1038/ismej.2013.59; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Hurwitz BL, 2015, ISME J, V9, P472, DOI 10.1038/ismej.2014.143; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656; Ladau J, 2013, ISME J, V7, P1669, DOI 10.1038/ismej.2013.37; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073; LOCHTE K, 1988, NATURE, V333, P67, DOI 10.1038/333067a0; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Matz C, 2005, APPL ENVIRON MICROB, V71, P921, DOI 10.1128/AEM.71.2.921-929.2005; Mende DR, 2013, NAT METHODS, V10, P881, DOI [10.1038/NMETH.2575, 10.1038/nmeth.2575]; Mende DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031386; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Pesant S., 2015, OPEN SCIENCE RESOURC; Pommier T, 2010, AQUAT MICROB ECOL, V61, P212, DOI 10.3354/ame01484; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Raes J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.6; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; Sul WJ, 2013, P NATL ACAD SCI USA, V110, P2342, DOI 10.1073/pnas.1212424110; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]; Tara Oceans Consortium, 2014, REGISTRY OF SELECTED, DOI [10.1594/PANGAEA.840721, DOI 10.1594/PANGAEA.840721]; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Vieira-Silva S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000808; Villar E, 2015, SCIENCE, V348, DOI 10.1126/science.1261447; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wold H., 1982, SYSTEMS INDIRECT OBS, P1; Yawata Y, 2014, P NATL ACAD SCI USA, V111, P5622, DOI 10.1073/pnas.1318943111; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	69	1246	1278	157	1286	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237							1261359	10.1126/science.1261359	http://dx.doi.org/10.1126/science.1261359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999513	Green Submitted			2022-12-28	WOS:000354877900031
J	Villar, E; Farrant, GK; Follows, M; Garczarek, L; Speich, S; Audic, S; Bittner, L; Blanke, B; Brum, JR; Brunet, C; Casotti, R; Chase, A; Dolan, JR; d'Ortenzio, F; Gattuso, JP; Grima, N; Guidi, L; Hill, CN; Jahn, O; Jamet, JL; Le Goff, H; Lepoivre, C; Malviya, S; Pelletier, E; Romagnan, JB; Roux, S; Santini, S; Scalco, E; Schwenck, SM; Tanaka, A; Testor, P; Vannier, T; Vincent, F; Zingone, A; Dimier, C; Picheral, M; Searson, S; Kandels-Lewis, S; Acinas, SG; Bork, P; Boss, E; de Vargas, C; Gorsky, G; Ogata, H; Pesant, S; Sullivan, MB; Sunagawa, S; Wincker, P; Karsenti, E; Bowler, C; Not, F; Hingamp, P; Iudicone, D				Villar, Emilie; Farrant, Gregory K.; Follows, Michael; Garczarek, Laurence; Speich, Sabrina; Audic, Stephane; Bittner, Lucie; Blanke, Bruno; Brum, Jennifer R.; Brunet, Christophe; Casotti, Raffaella; Chase, Alison; Dolan, John R.; d'Ortenzio, Fabrizio; Gattuso, Jean-Pierre; Grima, Nicolas; Guidi, Lionel; Hill, Christopher N.; Jahn, Oliver; Jamet, Jean-Louis; Le Goff, Herve; Lepoivre, Cyrille; Malviya, Shruti; Pelletier, Eric; Romagnan, Jean-Baptiste; Roux, Simon; Santini, Sebastien; Scalco, Eleonora; Schwenck, Sarah M.; Tanaka, Atsuko; Testor, Pierre; Vannier, Thomas; Vincent, Flora; Zingone, Adriana; Dimier, Celine; Picheral, Marc; Searson, Sarah; Kandels-Lewis, Stefanie; Acinas, Silvia G.; Bork, Peer; Boss, Emmanuel; de Vargas, Colomban; Gorsky, Gabriel; Ogata, Hiroyuki; Pesant, Stephane; Sullivan, Matthew B.; Sunagawa, Shinichi; Wincker, Patrick; Karsenti, Eric; Bowler, Chris; Not, Fabrice; Hingamp, Pascal; Iudicone, Daniele		Tara Oceans Coordinators	Environmental characteristics of Agulhas rings affect interocean plankton transport	SCIENCE			English	Article							GENE FLOW; OCEAN; BIOGEOGRAPHY; BACTERIA; ATLANTIC; PATTERNS; NITRITE; LEAKAGE; MODEL	Agulhas rings provide the principal route for ocean waters to circulate from the Indo-Pacific to the Atlantic basin. Their influence on global ocean circulation is well known, but their role in plankton transport is largely unexplored. We show that, although the coarse taxonomic structure of plankton communities is continuous across the Agulhas choke point, South Atlantic plankton diversity is altered compared with Indian Ocean source populations. Modeling and in situ sampling of a young Agulhas ring indicate that strong vertical mixing drives complex nitrogen cycling, shaping community metabolism and biogeochemical signatures as the ring and associated plankton transit westward. The peculiar local environment inside Agulhas rings may provide a selective mechanism contributing to the limited dispersal of Indian Ocean plankton populations into the Atlantic.	[Villar, Emilie; Lepoivre, Cyrille; Santini, Sebastien; Ogata, Hiroyuki; Hingamp, Pascal] Aix Marseille Univ, CNRS, IGS UMR 7256, F-13288 Marseille, France; [Farrant, Gregory K.; Garczarek, Laurence; Audic, Stephane; Bittner, Lucie; Dimier, Celine; de Vargas, Colomban; Not, Fabrice] CNRS, UMR 7144, Stn Biol Roscoff, F-29680 Roscoff, France; [Farrant, Gregory K.; Garczarek, Laurence; Audic, Stephane; Bittner, Lucie; Dimier, Celine; de Vargas, Colomban; Not, Fabrice] Univ Paris 06, Sorbonne Univ, UMR 7144, Stn Biol Roscoff, F-29680 Roscoff, France; [Bittner, Lucie; Malviya, Shruti; Tanaka, Atsuko; Vincent, Flora; Dimier, Celine; Karsenti, Eric; Bowler, Chris] Ecole Normale Super, IBENS, F-75005 Paris, France; [Bittner, Lucie; Malviya, Shruti; Tanaka, Atsuko; Vincent, Flora; Dimier, Celine; Karsenti, Eric; Bowler, Chris] INSERM, U1024, F-75005 Paris, France; [Bittner, Lucie; Malviya, Shruti; Tanaka, Atsuko; Vincent, Flora; Dimier, Celine; Karsenti, Eric; Bowler, Chris] CNRS, UMR 8197, F-75005 Paris, France; [Speich, Sabrina; Blanke, Bruno; Grima, Nicolas] IFREMER, UMR 6523, LPO, CNRS,IRD,UBO, Plouzane, France; [Brum, Jennifer R.; Roux, Simon; Schwenck, Sarah M.; Sullivan, Matthew B.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Brunet, Christophe; Casotti, Raffaella; Scalco, Eleonora; Zingone, Adriana; Iudicone, Daniele] Stn Zool A Dohrn, I-80121 Naples, Italy; [Chase, Alison; Boss, Emmanuel] Univ Maine, Sch Marine Sci, Orono, ME USA; [Dolan, John R.; d'Ortenzio, Fabrizio; Gattuso, Jean-Pierre; Guidi, Lionel; Romagnan, Jean-Baptiste; Picheral, Marc; Searson, Sarah; Gorsky, Gabriel] Univ Paris 06, Sorbonne Univ, Observ Oceanol, F-06230 Villefranche Sur Mer, France; [Dolan, John R.; d'Ortenzio, Fabrizio; Gattuso, Jean-Pierre; Guidi, Lionel; Romagnan, Jean-Baptiste; Picheral, Marc; Searson, Sarah; Gorsky, Gabriel] INSU CNRS, UMR 7093, LOV, Observ Oceanol, F-06230 Villefranche Sur Mer, France; [Follows, Michael; Hill, Christopher N.; Jahn, Oliver] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA USA; [Jamet, Jean-Louis] Univ Toulon & Var, Lab PROTEE EBMA EA 3819, F-83957 La Garde, France; [Le Goff, Herve; Testor, Pierre] CNRS, UMR 7159, Lab Oceanog & Climat LOCEAN, F-75005 Paris, France; [Pelletier, Eric; Vannier, Thomas; Wincker, Patrick] Commissariat Energie Atom & Energies Alternat CEA, Inst Genom, Genoscope, F-91057 Evry, France; [Pelletier, Eric; Vannier, Thomas; Wincker, Patrick] CNRS, UMR 8030, CP5706, Evry, France; [Pelletier, Eric; Vannier, Thomas; Wincker, Patrick] Univ Evry, UMR 8030, CP5706, Evry, France; [Kandels-Lewis, Stefanie; Bork, Peer; Sunagawa, Shinichi] European Mol Biol Lab, Struct & Computat Biol, D-69117 Heidelberg, Germany; [Kandels-Lewis, Stefanie; Karsenti, Eric] European Mol Biol Lab, Directors Res, D-69117 Heidelberg, Germany; [Acinas, Silvia G.] CSIC, Inst Marine Sci ICM, Dept Marine Biol & Oceanog, E-08003 Barcelona, Spain; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Pesant, Stephane] Univ Bremen, Data Publisher Earth & Environm Sci, PANGAEA, D-28359 Bremen, Germany; [Pesant, Stephane] Univ Bremen, Ctr Marine Environm Sci, MARUM, D-28359 Bremen, Germany; [Speich, Sabrina] Ecole Normale Super, UMR 8539, LMD, Dept Geosci, F-75231 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); University of Arizona; Stazione Zoologica Anton Dohrn di Napoli; University of Maine System; University of Maine Orono; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Massachusetts Institute of Technology (MIT); Universite de Toulon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Bremen; University of Bremen; Ecole des Ponts ParisTech	Villar, E (corresponding author), Aix Marseille Univ, CNRS, IGS UMR 7256, F-13288 Marseille, France.	villar@igs.cnrs-mrs.fr; karsenti@embl.de; cbowler@biologie.ens.fr; not@sb-roscoff.fr; hingamp@igs.cnrs-mrs.fr; iudicone@szn.it	Guidi, Lionel/B-3977-2012; Blanke, Bruno/H-4280-2015; Sullivan, Matthew B/H-3256-2011; Grimsley, Nigel/O-1359-2015; Casotti, Raffaella/H-1697-2016; Bittner, Lucie/AAD-8921-2019; raes, jeroen/D-7835-2018; Dolan, John R/A-4513-2009; Speich, Sabrina/L-3780-2014; Grima, Nicolas NG/N-3252-2014; Casotti, Raffaella/I-9833-2019; Bork, Peer/F-1813-2013; Jamet, Jean-Louis JLJ/G-9893-2013; Acinas, Silvia/F-7462-2016; Hingamp, Pascal/AAO-1382-2020; Roux, Simon/ABE-6255-2020; Zingone, Adriana/E-4518-2010; Sunagawa, Shinichi/Q-5950-2019; Boss, Emmanuel/AAF-2336-2019; Farrant, Gregory/K-3394-2015; Gattuso, Jean-Pierre/AAG-8643-2019; brunet, christophe/AAD-7817-2021; Gattuso, Jean-Pierre/E-6631-2010; stemmann, lars/E-6899-2011; Bowler, Chris/AAC-6256-2019; Bittner, Lucie/ABF-4617-2020; Boss, Emmanuel/C-5765-2009	Guidi, Lionel/0000-0002-6669-5744; Blanke, Bruno/0000-0002-1309-0952; Sullivan, Matthew B/0000-0003-4040-9831; Grimsley, Nigel/0000-0001-9323-417X; Casotti, Raffaella/0000-0002-9876-4601; Bittner, Lucie/0000-0001-8291-7063; raes, jeroen/0000-0002-1337-041X; Dolan, John R/0000-0002-9454-1355; Speich, Sabrina/0000-0002-5452-8287; Grima, Nicolas NG/0000-0002-1607-8975; Casotti, Raffaella/0000-0002-9876-4601; Bork, Peer/0000-0002-2627-833X; Jamet, Jean-Louis JLJ/0000-0002-2296-6231; Acinas, Silvia/0000-0002-3439-0428; Hingamp, Pascal/0000-0002-7463-2444; Roux, Simon/0000-0002-5831-5895; Zingone, Adriana/0000-0001-5946-6532; Sunagawa, Shinichi/0000-0003-3065-0314; Boss, Emmanuel/0000-0002-8334-9595; Farrant, Gregory/0000-0002-3774-3743; Gattuso, Jean-Pierre/0000-0002-4533-4114; Gattuso, Jean-Pierre/0000-0002-4533-4114; Boss, Emmanuel/0000-0002-8334-9595; Vannier, Thomas/0000-0002-9401-8839; Tanaka, Atsuko/0000-0002-8277-1188; Reynaud, Emmanuel/0000-0003-1502-661X; VINCENT, Flora/0000-0001-6976-3004; Jahn, Oliver/0000-0002-0130-5186; Audic, Stephane/0000-0001-6193-4374; Iudicone, Daniele/0000-0002-7473-394X; PESANT, Stephane/0000-0002-4936-5209; Garczarek, Laurence/0000-0002-8191-8395; Gorsky, Gabriel/0000-0002-1099-8711; Jaillon, Olivier/0000-0002-7237-9596; Bowler, Chris/0000-0003-3835-6187; Santini, Sebastien/0000-0001-7087-1950; Pelletier, Eric/0000-0003-4228-1712; stemmann, lars/0000-0001-8935-4531	CNRS [GDR3280]; European Molecular Biology Laboratory (EMBL); Genoscope/CEA; VIB; Stazione Zoologica Anton Dohrn; UNIMIB; Fund for Scientific Research-Flanders; Rega Institute, KU Leuven; French Ministry of Research; French government [ANR-11-BTBR-0008, ANR-10-INBS-09-08, ANR-10-LABX-54]; PSL* Research University [ANR-11-IDEX-0001-02]; ANR [POSEIDON/ANR-09-BLAN-0348, PHYTBACK/ANR-2010-1709-01, PROMETHEUS/ANR-09-PCS-GENM-217, SAMOSA/ANR-13-ADAP-0010, TARAGIRUS/ANR-09-PCS-GENM-218]; European Union FP7 [287589, IHMS/HEALTH-F4-2010-261376, 311975]; ERC [294823]; Gordon and Betty Moore Foundation [3790]; Spanish Ministry of Science and Innovation [CGL2011-26848]; Agencia de Gestio d'Ajusts Universitaris i Reserca [CONES 2010-0036]; JSPS [26430184]; NASA Ocean Biology and Biogeochemistry program [NNX11AQ14G, NNX09AU43G]; Italian Research for the Sea; FWO; Agnes b. and Etienne Bourgois; Veolia Environment Foundation; Region Bretagne; Lorient Agglomeration; World Courier; Illumina; EDF Foundation; FRB; Prince Albert II de Monaco Foundation; Tara schooner; French Ministry of Foreign Affairs; CNES	CNRS(Centre National de la Recherche Scientifique (CNRS)); European Molecular Biology Laboratory (EMBL); Genoscope/CEA; VIB; Stazione Zoologica Anton Dohrn; UNIMIB; Fund for Scientific Research-Flanders(FWO); Rega Institute, KU Leuven; French Ministry of Research(Ministry of Research, FranceEuropean Commission); French government; PSL* Research University; ANR(French National Research Agency (ANR)); European Union FP7(European Commission); ERC(European Research Council (ERC)European Commission); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia de Gestio d'Ajusts Universitaris i Reserca; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NASA Ocean Biology and Biogeochemistry program(National Aeronautics & Space Administration (NASA)); Italian Research for the Sea; FWO(FWO); Agnes b. and Etienne Bourgois; Veolia Environment Foundation; Region Bretagne(Region Bretagne); Lorient Agglomeration; World Courier; Illumina; EDF Foundation; FRB; Prince Albert II de Monaco Foundation; Tara schooner; French Ministry of Foreign Affairs; CNES(Centre National D'etudes Spatiales)	We appreciate the commitment of the following people and sponsors: CNRS (in particular, Groupement de Recherche GDR3280); European Molecular Biology Laboratory (EMBL); Genoscope/CEA; VIB; Stazione Zoologica Anton Dohrn; UNIMIB; Fund for Scientific Research-Flanders; Rega Institute, KU Leuven; the French Ministry of Research; the French government Investissements d'Avenir programmes OCEANOMICS (ANR-11-BTBR-0008), FRANCE GENOMIQUE (ANR-10-INBS-09-08), MEMO LIFE (ANR-10-LABX-54), PSL* Research University (ANR-11-IDEX-0001-02), and ANR (projects POSEIDON/ANR-09-BLAN-0348, PHYTBACK/ANR-2010-1709-01, PROMETHEUS/ANR-09-PCS-GENM-217, SAMOSA/ANR-13-ADAP-0010, and TARAGIRUS/ANR-09-PCS-GENM-218); European Union FP7 (MicroB3/No. 287589, IHMS/HEALTH-F4-2010-261376, and MaCuMBA/No.311975); ERC Advanced Grant Award to C.B. (Diatomite: 294823); Gordon and Betty Moore Foundation grant (no. 3790) to M.B.S.; Spanish Ministry of Science and Innovation grant CGL2011-26848/BOS MicroOcean PANGENOMICS to S.G.A.; TANIT (CONES 2010-0036) from the Agencia de Gestio d'Ajusts Universitaris i Reserca to S.G.A.; JSPS KAKENHI grant no. 26430184 to H.O.; NASA Ocean Biology and Biogeochemistry program (NNX11AQ14G and NNX09AU43G) to E.B.; The Italian Research for the Sea (Flagship Project RITMARE) to D.I.; and FWO, BIO5, and Biosphere 2 to M.B.S. We also appreciate the support and commitment of Agnes b. and Etienne Bourgois, the Veolia Environment Foundation, Region Bretagne, Lorient Agglomeration, World Courier, Illumina, the EDF Foundation, FRB, the Prince Albert II de Monaco Foundation, and the Tara schooner and its captains and crew. We thank MERCATOR-CORIOLIS and ACRI-ST for providing daily satellite data during the expedition. We are also grateful to the French Ministry of Foreign Affairs for supporting the expedition and to the countries that graciously granted sampling permissions. Tara Oceans would not exist without continuous support from 23 institutes (http://oceans.taraexpeditions.org). We also acknowledge excellent assistance from the European Bioinformatics Institute (EBI), in particular G. Cochrane and P. ten Hoopen, as well as the EMBL Advanced Light Microscopy Facility (ALMF), in particular R. Pepperkok. We thank Y. Timsit for stimulating scientific discussions and critical help during writing of the manuscript. The altimeter products were produced by Ssalto/Duacs and CLS, with support from CNES. The authors further declare that all data reported herein are fully and freely available from the date of publication, with no restrictions, and that all of the samples, analyses, publications, and ownership of data are free from legal entanglement or restriction of any sort by the various nations whose waters the Tara Oceans expedition sampled. Data described herein are available at http://www.igs.cnrs-mrs.fr/Tara_Agulhas, at EBI under the project identifiers PRJEB402 and PRJEB7988, and at PANGAEA (57-59). The data release policy regarding future public release of Tara Oceans data is described in Pesant et al. (50). All authors approved the final manuscript. This article is contribution number 21 of Tara Oceans. The supplementary materials contain additional data. See also http://doi.pangaea.de/10.1594/PANGAEA.840721; http://doi.pangaea.de/10.1594/PANGAEA.840718; and http://doi.pangaea.de/10.1594/PANGAEA.840698	Backeberg BC, 2012, NAT CLIM CHANGE, V2, P608, DOI 10.1038/NCLIMATE1587; Beal LM, 2011, NATURE, V472, P429, DOI 10.1038/nature09983; Bernhardt JR, 2013, ANNU REV MAR SCI, V5, P371, DOI 10.1146/annurev-marine-121211-172411; Biastoch A, 2008, NATURE, V456, P489, DOI 10.1038/nature07426; Biastoch A, 2009, NATURE, V462, P495, DOI 10.1038/nature08519; Boss E., 2013, METHODS OCEANOGR, V7, P52, DOI [10.1016/j.mio.2013.11.002, DOI 10.1016/J.MIO.2013.11.002]; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Brum JR, 2015, SCIENCE, V348, DOI 10.1126/science.1261498; Casteleyn G, 2010, P NATL ACAD SCI USA, V107, P12952, DOI 10.1073/pnas.1001380107; Cermeno P, 2009, SCIENCE, V325, P1539, DOI 10.1126/science.1174159; Chaffron S., 2014, TARA OCEANS CONSORTI, DOI [10.1594/PANGAEA.840718, DOI 10.1594/PANGAEA.840718]; Chaffron S., 2014, TARA OCEANS CONSORTI, DOI [10.1594/PANGAEA.840698, DOI 10.1594/PANGAEA.840698]; Chase A., 2013, METHODS OCEANOGR, V7, P110, DOI [10.1016/j.mio.2014.02.002, DOI 10.1016/J.MIO.2014.02.002, DOI 10.1016/J.MI0.2014.02.002]; Churchill CKC, 2014, MAR BIOL, V161, P899, DOI 10.1007/s00227-014-2389-7; Clayton S., 2013, LIMNOL OCEANOGR, V3, P182, DOI [10.1215/21573689-2373515, DOI 10.1215/21573689-2373515]; Cunha RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049196; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Dutkiewicz S, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003405; Faure V, 2011, OCEAN DYNAM, V61, P1441, DOI 10.1007/s10236-011-0444-1; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; GORDON AL, 1987, DEEP-SEA RES, V34, P565, DOI 10.1016/0198-0149(87)90006-9; Gordon AL, 2003, NATURE, V421, P904, DOI 10.1038/421904a; Gorsky G, 2010, J PLANKTON RES, V32, P285, DOI 10.1093/plankt/fbp124; Hellweger FL, 2014, SCIENCE, V345, P1346, DOI 10.1126/science.1254421; Hingamp P, 2013, ISME J, V7, P1678, DOI 10.1038/ismej.2013.59; Hubert C, 2009, SCIENCE, V325, P1541, DOI 10.1126/science.1174012; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Levitus S., 2013, DATA SCI J, V12, pWDS229; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Maillet N, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S19-S10; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5753, DOI 10.1029/96JC02775; Martiny AC, 2009, P NATL ACAD SCI USA, V106, P10787, DOI 10.1073/pnas.0902532106; Mazard S, 2012, ENVIRON MICROBIOL, V14, P372, DOI 10.1111/j.1462-2920.2011.02514.x; MENEMENLIS D, 2008, MERCATOR OCEAN Q NEW, V31, P13; OLSON RJ, 1981, J MAR RES, V39, P227; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Peeters FJC, 2004, NATURE, V430, P661, DOI 10.1038/nature02785; Pesant S., 2015, OPEN SCI RESOURCES D; Ridgway KR, 2002, J ATMOS OCEAN TECH, V19, P1357, DOI 10.1175/1520-0426(2002)019<1357:OIBFDW>2.0.CO;2; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Schmid C, 2003, DEEP-SEA RES PT II, V50, P141, DOI 10.1016/S0967-0645(02)00382-X; Selje N, 2004, NATURE, V427, P445, DOI 10.1038/nature02272; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Tara Oceans Consortium Coordinators; Tara Oceans Expedition Participants, 2014, REG SEL SAMPL TAR OC, DOI [10.1594/PANGAEA.840721, DOI 10.1594/PANGAEA.840721]; van Aken HM, 2003, DEEP-SEA RES PT II, V50, P167, DOI 10.1016/S0967-0645(02)00383-1; Wang G, 2014, NAT CLIM CHANGE, V4, P988, DOI 10.1038/NCLIMATE2378; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	52	96	100	6	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237							1261447	10.1126/science.1261447	http://dx.doi.org/10.1126/science.1261447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999514	Green Accepted, Green Submitted			2022-12-28	WOS:000354877900032
J	Desideri, E; Cavallo, AL; Baccarini, M				Desideri, Enrico; Cavallo, Anna Lina; Baccarini, Manuela			Alike but Different: RAF Paralogs and Their Signaling Outputs	CELL			English	Review							ARAF MUTATIONS; B-RAF; C-RAF; CANCER; BRAF; INHIBITORS; MELANOMA; SCAFFOLD; KINASES; ROLES	RAF links RAS, one of the most potent human oncogenes, to its effector ERK and to proliferation. This role is evolutionarily conserved, but while simpler multicellular organisms express one RAF, mammals have three. This Minireview highlights common and divergent features of RAF paralogs, their signaling outputs, and roles in tumorigenesis.	[Desideri, Enrico; Cavallo, Anna Lina; Baccarini, Manuela] Univ Vienna, Ctr Mol Biol, Dept Microbiol Immunol & Genet, Max F Perutz Labs, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Baccarini, M (corresponding author), Univ Vienna, Ctr Mol Biol, Dept Microbiol Immunol & Genet, Max F Perutz Labs, Doktor Bohr Gasse 9, A-1030 Vienna, Austria.	manuela.baccarini@univie.ac.at	Desideri, Enrico/AAB-9657-2019; Baccarini, Manuela/B-6481-2014	Desideri, Enrico/0000-0002-1884-7491; Baccarini, Manuela/0000-0002-3033-391X	Austrian Research Fund [FWF W-1220, SFB-021, P-19530]; Austrian Research Promotion Agency, FFG [827500]; EU; Johanna Mahlke geb. Obermann-Stiftung of the University of Vienna	Austrian Research Fund(Austrian Science Fund (FWF)); Austrian Research Promotion Agency, FFG(Austrian Science Fund (FWF)); EU(European Commission); Johanna Mahlke geb. Obermann-Stiftung of the University of Vienna	We thank the members of the Baccarini laboratory for helpful discussions and apologize to all the colleagues whose work, for reasons of space, could not be cited in this Minireview. Work in the Baccarini lab is/was supported by grants of the Austrian Research Fund (FWF W-1220, SFB-021, P-19530), EU-project INFLACARE, Bridge project 827500 (Austrian Research Promotion Agency, FFG), and the Johanna Mahlke geb. Obermann-Stiftung of the University of Vienna.	Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Ehrenreiter K, 2009, CANCER CELL, V16, P149, DOI 10.1016/j.ccr.2009.06.008; Eser S, 2014, BRIT J CANCER, V111, P817, DOI 10.1038/bjc.2014.215; Girotti MR, 2015, CANCER CELL, V27, P85, DOI 10.1016/j.ccell.2014.11.006; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Imielinski M, 2014, J CLIN INVEST, V124, P1582, DOI 10.1172/JCI72763; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Karreth FA, 2011, CANCER DISCOV, V1, P128, DOI 10.1158/2159-8290.CD-10-0044; Kern F, 2013, ONCOGENE, V32, P2483, DOI 10.1038/onc.2012.254; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Maurer G, 2011, ONCOGENE, V30, P3477, DOI 10.1038/onc.2011.160; Rebocho AP, 2013, ONCOGENE, V32, P3207, DOI 10.1038/onc.2012.330; Sia D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7087; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317	16	64	66	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					967	970		10.1016/j.cell.2015.04.045	http://dx.doi.org/10.1016/j.cell.2015.04.045			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000477	Bronze			2022-12-28	WOS:000355152600006
J	Zhang, CZ; Spektor, A; Cornils, H; Francis, JM; Jackson, EK; Liu, SW; Meyerson, M; Pellman, D				Zhang, Cheng-Zhong; Spektor, Alexander; Cornils, Hauke; Francis, Joshua M.; Jackson, Emily K.; Liu, Shiwei; Meyerson, Matthew; Pellman, David			Chromothripsis from DNA damage in micronuclei	NATURE			English	Article							GENOMIC REARRANGEMENTS; CANCER GENOMES; DOUBLE MINUTES; MECHANISMS; EVOLUTION; REPAIR; BREAKS; AMPLIFICATION; ARCHITECTURE; CHROMOSOMES	Genome sequencing has uncovered a new mutational phenomenon in cancer and congenital disorders called chromothripsis. Chromothripsis is characterized by extensive genomic rearrangements and an oscillating pattern of DNA copy number levels, all curiously restricted to one or a few chromosomes. The mechanism for chromothripsis is unknown, but we previously proposed that it could occur through the physical isolation of chromosomes in aberrant nuclear structures called micronuclei. Here, using a combination of live cell imaging and single-cell genome sequencing, we demonstrate that micronucleus formation can indeed generate a spectrum of genomic rearrangements, some of which recapitulate all known features of chromothripsis. These events are restricted to the mis-segregated chromosome and occur within one cell division. We demonstrate that the mechanism for chromothripsis can involve the fragmentation and subsequent reassembly of a single chromatid from a micronucleus. Collectively, these experiments establish a new mutational process of which chromothripsis is one extreme outcome.	[Zhang, Cheng-Zhong; Francis, Joshua M.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Zhang, Cheng-Zhong; Spektor, Alexander; Cornils, Hauke; Jackson, Emily K.; Liu, Shiwei; Pellman, David] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Zhang, Cheng-Zhong; Francis, Joshua M.; Meyerson, Matthew; Pellman, David] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Zhang, Cheng-Zhong; Spektor, Alexander; Cornils, Hauke; Jackson, Emily K.; Liu, Shiwei; Pellman, David] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Spektor, Alexander] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Jackson, Emily K.; Pellman, David] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Pellman, D (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA.	david_pellman@dfci.harvard.edu	Liu, Shiwei/AAK-6057-2021; Liu, Shiwei/ABA-2131-2020	/0000-0002-2972-4139; Meyerson, Matthew/0000-0002-9133-8108	Bridge Project of the Dana-Farber Cancer Institute; Koch Institute of MIT; Claudia Adams Barr Program in Innovative Cancer Research; NIH [GM083299-18]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM061345, R01GM083299, R01GM061345] Funding Source: NIH RePORTER	Bridge Project of the Dana-Farber Cancer Institute; Koch Institute of MIT; Claudia Adams Barr Program in Innovative Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Beroukhim, J. Walter and N. Ganem for comments on the manuscript, V. A. Adalsteinsson and J.C. Love for help with preliminary experiments, and A. Salic and S. Rosenberg for reagents. A.S. was a resident in the American Board of Radiology Holman Research Pathway; H.C. was a fellow of the Leukemia and Lymphoma Society; C.-Z.Z., J.M.F. and M.M. were supported by the Bridge Project of the Dana-Farber Cancer Institute and the Koch Institute of MIT; M.M. and D.P. were supported by the Claudia Adams Barr Program in Innovative Cancer Research; D.P. is a HHMI investigator and is supported by NIH grant GM083299-18.	CARROLL SM, 1988, MOL CELL BIOL, V8, P1525, DOI 10.1128/MCB.8.4.1525; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; El Achkar E, 2005, P NATL ACAD SCI USA, V102, P18069, DOI 10.1073/pnas.0506497102; Francis JM, 2014, CANCER DISCOV, V4, P956, DOI 10.1158/2159-8290.CD-13-0879; Ganem NJ, 2012, J CELL BIOL, V199, P871, DOI 10.1083/jcb.201210040; Garsed DW, 2014, CANCER CELL, V26, P653, DOI 10.1016/j.ccell.2014.09.010; Hager JE, 2014, GENOME STABILITY: DNA REPAIR AND RECOMBINATION, P1; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Kinsella M, 2014, NUCLEIC ACIDS RES, V42, P8231, DOI 10.1093/nar/gku525; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Knouse KA, 2014, P NATL ACAD SCI USA, V111, P13409, DOI 10.1073/pnas.1415287111; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Liu PF, 2012, CURR OPIN GENET DEV, V22, P211, DOI 10.1016/j.gde.2012.02.012; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Malhotra A, 2013, GENOME RES, V23, P762, DOI 10.1101/gr.143677.112; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; SEN S, 1989, CANCER RES, V49, P6731; Shee C, 2013, ELIFE, V2, DOI 10.7554/eLife.01222; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Storlazzi CT, 2010, GENOME RES, V20, P1198, DOI 10.1101/gr.106252.110; Terradas M, 2010, MUTAT RES-REV MUTAT, V705, P60, DOI 10.1016/j.mrrev.2010.03.004; Uetake Y, 2010, CURR BIOL, V20, P1666, DOI 10.1016/j.cub.2010.08.018; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang CZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7822; Zhang CZ, 2013, GENE DEV, V27, P2513, DOI 10.1101/gad.229559.113	34	624	639	1	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					179	+		10.1038/nature14493	http://dx.doi.org/10.1038/nature14493			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	26017310	Green Accepted, Green Submitted			2022-12-28	WOS:000356016700031
J	Jain, NB; Ayers, GD; Peterson, EN; Harris, MB; Morse, L; O'Connor, KC; Garshick, E				Jain, Nitin B.; Ayers, Gregory D.; Peterson, Emily N.; Harris, Mitchel B.; Morse, Leslie; O'Connor, Kevin C.; Garshick, Eric			Traumatic Spinal Cord Injury in the United States, 1993-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVALENCE; EPIDEMIOLOGY; MORTALITY	IMPORTANCE Acute traumatic spinal cord injury results in disability and use of health care resources, yet data on contemporary national trends of traumatic spinal cord injury incidence and etiology are limited. OBJECTIVE To assess trends in acute traumatic spinal cord injury incidence, etiology, mortality, and associated surgical procedures in the United States from 1993 to 2012. DESIGN, SETTING, AND PARTICIPANTS Analysis of survey data from the US Nationwide Inpatient Sample databases for 1993-2012, including a total of 63 109 patients with acute traumatic spinal cord injury. MAIN OUTCOMES AND MEASURES Age-and sex-stratified incidence of acute traumatic spinal cord injury; trends in etiology and in-hospital mortality of acute traumatic spinal cord injury. RESULTS In 1993, the estimated incidence of acute spinal cord injury was 53 cases (95% CI, 52-54 cases) per 1 million persons based on 2659 actual cases. In 2012, the estimated incidence was 54 cases (95% CI, 53-55 cases) per 1 million population based on 3393 cases (average annual percentage change, 0.2%; 95% CI, -0.5% to 0.9%). Incidence rates among the younger male population declined from 1993 to 2012: for age 16 to 24 years, from 144 cases/million (2405 cases) to 87 cases/million (1770 cases) (average annual percentage change, -2.5%; 95% CI, -3.3% to -1.8%); for age 25 to 44 years, from 96 cases/million (3959 cases) to 71 cases/million persons (2930 cases), (average annual percentage change, -1.2%; 95% CI, -2.1% to -0.3%). A high rate of increase was observed in men aged 65 to 74 years (from 84 cases/million in 1993 [695 cases] to 131 cases/million [1465 cases]; average annual percentage change, 2.7%; 95% CI, 2.0%-3.5%). The percentage of spinal cord injury associated with falls increased significantly from 28%(95% CI, 26%-30%) in 1997-2000 to 66%(95% CI, 64%-68%) in 2010-2012 in those aged 65 years or older (P <.001). Although overall in-hospital mortality increased from 6.6%(95% CI, 6.1%-7.0%) in 1993-1996 to 7.5% (95% CI, 7.0%-8.0%) in 2010-2012 (P <.001), mortality decreased significantly from 24.2% (95% CI, 19.7%-28.7%) in 1993-1996 to 20.1% (95% CI, 17.0%-23.2%) in 2010-2012 (P =.003) among persons aged 85 years or older. CONCLUSIONS AND RELEVANCE Between 1993 and 2012, the incidence rate of acute traumatic spinal cord injury remained relatively stable but, reflecting an increasing population, the total number of cases increased. The largest increase in incidence was observed in older patients, largely associated with an increase in falls, and in-hospital mortality remained high, especially among elderly persons.	[Jain, Nitin B.] Vanderbilt Univ, Sch Med, Dept Phys Med & Rehabil, Nashville, TN 37202 USA; [Jain, Nitin B.] Vanderbilt Univ, Sch Med, Dept Orthopaed & Rehabil, Nashville, TN 37202 USA; [Ayers, Gregory D.; Peterson, Emily N.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37202 USA; [Harris, Mitchel B.] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Harris, Mitchel B.; Morse, Leslie; Garshick, Eric] Harvard Univ, Sch Med, Boston, MA USA; [Morse, Leslie; O'Connor, Kevin C.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Garshick, Eric] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Garshick, Eric] VA Boston Healthcare Syst, Pulm & Crit Care Med Sect, Med Serv, Boston, MA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Spaulding Rehabilitation Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jain, NB (corresponding author), Vanderbilt Univ, Sch Med, Dept Phys Med & Rehabil, 2201 Childrens Way,Ste 1318, Nashville, TN 37202 USA.	nitin.jain@vanderbilt.edu	Garshick, Eric/Y-6509-2019; Morse, Leslie R/C-9442-2015; Morse, Leslie/AAU-5608-2020	Morse, Leslie R/0000-0002-7426-6341; 	National Institute of Arthritis and Musculoskeletal and Skin Diseases [1K23AR059199]; Foundation for Physical Medicine and Rehabilitation; VA Rehabilitation Research and Development Merit Review grants [B6618R, I01RX000792]; National Institute of Health [AR059270]; US Department of Education National Institute on Disability and Rehabilitation Research grant [H133N110010]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR059199, R01AR059270] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000792] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Foundation for Physical Medicine and Rehabilitation; VA Rehabilitation Research and Development Merit Review grants; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Education National Institute on Disability and Rehabilitation Research grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	Dr Jain is supported by funding from National Institute of Arthritis and Musculoskeletal and Skin Diseases project 1K23AR059199 and the Foundation for Physical Medicine and Rehabilitation. Drs Morse and Garshick are supported by VA Rehabilitation Research and Development Merit Review grants B6618R and I01RX000792, National Institute of Health grant AR059270, and US Department of Education National Institute on Disability and Rehabilitation Research grant H133N110010.	[Anonymous], 1978, Pa Med, V81, P29; [Anonymous], 1978, PA MED, V81, P43; [Anonymous], 2014, ANN EST RES POP SEL; Barrett M, 2014, 201402 HCUP; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; BRACKEN MB, 1981, AM J EPIDEMIOL, V113, P615, DOI 10.1093/oxfordjournals.aje.a113140; Centers for Disease Control and Prevention, 2011, REC FRAM E COD GROUP; Centers for Disease Control (CDC), 1991, MMWR Morb Mortal Wkly Rep, V40, P535; Coben JH, 2006, INJURY PREV, V12, P199, DOI 10.1136/ip.2005.010512; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; DEVIVO MJ, 1980, ARCH NEUROL-CHICAGO, V37, P707, DOI 10.1001/archneur.1980.00500600055011; GRIFFIN MR, 1985, J CHRON DIS, V38, P643, DOI 10.1016/0021-9681(85)90018-9; HARVEY C, 1990, PARAPLEGIA, V28, P537, DOI 10.1038/sc.1990.73; Healthcare Cost and Utilization Project, 2014, RES SPOTL; Healthcare Cost and Utilization Project, 2014, TREND WEIGHTS 1993 2; Healthcare Cost and Utilization Project, 2002, HCUF QUAL CONTR PROC; Healthcare Cost and Utilization Project, 2013, NIS DAT DOC; Insurance Institute for Highway Safety, 2013, SAF BELT CHILD RESTR; Jena AB, 2013, CIRCULATION, V128, P2754, DOI 10.1161/CIRCULATIONAHA.113.004074; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; Kaufman JA, 2006, J VASC INTERV RADIOL, V17, P449, DOI 10.1097/01.RVI.0000203418-39769.0D; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kirshblum SC, 2002, ARCH PHYS MED REHAB, V83, pS50, DOI 10.1053/apmr.2002.32156; KIRSHBLUM SC, 2002, ARCH PHYS MED REHAB, V83, pS90; KRAUS JF, 1975, J CHRON DIS, V28, P471, DOI 10.1016/0021-9681(75)90057-0; National Cancer Institute, 2013, AV ANN PERC CHANG; National Cancer Institute, 2015, JOINP REGR PROGR VER; National Spinal Cord Injury Statistical Center, 2013, J Spinal Cord Med, V36, P1, DOI 10.1179/1079026813Z.000000000136; PRICE C, 1994, AM J EPIDEMIOL, V139, P37, DOI 10.1093/oxfordjournals.aje.a116933; Selvarajah S, 2014, J NEUROTRAUM, V31, P228, DOI 10.1089/neu.2013.3098; Surkin J, 2000, SPINE, V25, P716, DOI 10.1097/00007632-200003150-00011; THURMAN DJ, 1994, PARAPLEGIA, V32, P665, DOI 10.1038/sc.1994.107; U. S. Census Bureau, 2001, RES POP EST US AG SE; U.S. Census Bureau, 2009, ANN EST RES POP US R; Warren S, 1995, Alaska Med, V37, P11; Whalen D, 2003, 20031 HCUP; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	37	337	359	8	50	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2236	2243		10.1001/jama.2015.6250	http://dx.doi.org/10.1001/jama.2015.6250			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1VH	26057284	Bronze, Green Accepted			2022-12-28	WOS:000355995300017
J	Jack, A				Jack, Andrew			Pfizer steps up battle to defend control of pregabalin Pfizer's actions over its biggest blockbuster drug sparks confusion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				Chapman A, 2015, ASSESSING THE USE OF; Wise J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1724	2	4	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2015	350								h3119	10.1136/bmj.h3119	http://dx.doi.org/10.1136/bmj.h3119			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK7CK	26055697				2022-12-28	WOS:000356387800010
J	Mysyuk, Y; Westendorp, RGJ; Biggs, S; Lindenberg, J				Mysyuk, Yuliya; Westendorp, Rudi Gerardus Johannes; Biggs, Simon; Lindenberg, Jolanda			Listening to the voices of abused older people: should we classify system abuse?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ELDER ABUSE; CARE; NEGLECT; HEALTH; PROFESSIONALS; MISTREATMENT; EXPERIENCES; PREVALENCE		[Mysyuk, Yuliya; Lindenberg, Jolanda] Leyden Acad Vital & Ageing, NL-2333 AA Leiden, Netherlands; [Westendorp, Rudi Gerardus Johannes] Leyden Acad Vital & Ageing, Med Old Age, NL-2333 AA Leiden, Netherlands; [Mysyuk, Yuliya; Lindenberg, Jolanda] Leiden Univ, Med Ctr, Leiden, Netherlands; [Westendorp, Rudi Gerardus Johannes] Leiden Univ, Med Ctr, Med Old Age, Leiden, Netherlands; [Westendorp, Rudi Gerardus Johannes] Univ Copenhagen, Dept Publ Hlth, Med Old Age, DK-1168 Copenhagen, Denmark; [Biggs, Simon] Univ Melbourne, Sch Social & Polit Sci, Melbourne, Vic, Australia	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Copenhagen; University of Melbourne	Lindenberg, J (corresponding author), Leyden Acad Vital & Ageing, NL-2333 AA Leiden, Netherlands.	Lindenberg@leydenacademy.nl		BIGGS, SIMON/0000-0002-2808-8134; Lindenberg, Jolanda/0000-0003-2547-9903				Acierno R, 2010, AM J PUBLIC HEALTH, V100, P292, DOI 10.2105/AJPH.2009.163089; Ahmad M, 2002, CLEV CLIN J MED, V69, P801, DOI 10.3949/ccjm.69.10.801; Anand J, 2013, J ADULT PROT, V15, P280, DOI 10.1108/JAP-03-2013-0011; Anetzberger G. J., 2005, CLIN GERONTOLOGIST, V28, P1, DOI DOI 10.1300/J018V28N01_; [Anonymous], NEW DYNAMICS OLD AGE; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Benbow SM, 2008, J ADULT PROT, V10, P5, DOI 10.1108/14668203200800015; Boyle Sean, 2011, Health Syst Transit, V13, P1; Burns D, 2013, SOCIOL HEALTH ILL, V35, P514, DOI 10.1111/j.1467-9566.2012.01511.x; Butler RN, 1975, WAY SURVIVE BEING OL; Commission for Health Improvement, 2003, INV MATT AR CAR ROW; Connolly MJ, 2014, AUSTRALAS J AGEING, V33, P114, DOI 10.1111/ajag.12010; Cooper C, 2008, AGE AGEING, V37, P151, DOI 10.1093/ageing/afm194; Cooper C, 2009, AM J GERIAT PSYCHIAT, V17, P826, DOI 10.1097/JGP.0b013e3181b0fa2e; Dixon A, 2012, HEALTH ECON POLICY L, V7, P1, DOI 10.1017/S1744133111000247; Erlingsson CL, 2005, BRIEF TREAT CRISIS I, V5, P213; Gorgen T, 2002, RES LEG MED, V27, P367; Griffith DM, 2007, AM J COMMUN PSYCHOL, V39, P381, DOI 10.1007/s10464-007-9117-0; Hall P, 2002, J AM GERIATR SOC, V50, P501, DOI 10.1046/j.1532-5415.2002.50117.x; Hempton C, 2011, INT J GERIATR PSYCH, V26, P466, DOI 10.1002/gps.2549; Horl J, 2002, NATL REPORT ELDER AB; Hudson MF, 2000, J ELDER ABUSE NEGL, V12, P89, DOI 10.1300/J084v12n01_09; Hunter DJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1951; Hyde P, 2014, QUAL AGEING OLDER AD, V15, P197, DOI 10.1108/QAOA-06-2014-0010; Killick C, 2015, J ELDER ABUSE NEGL, V27, P100, DOI 10.1080/08946566.2014.997374; Lachs M., 2011, RADAR NEW YORK STATE; Lachs MS, 2004, LANCET, V364, P1263, DOI 10.1016/S0140-6736(04)17144-4; Levine JM, 2003, GERIATRICS, V58, P37; McDonald KB, 2009, SOCIOL SPECTRUM, V29, P28, DOI 10.1080/02732170802480501; McDonald P, 2015, ASIA PAC J HUM RESOU, V53, P41, DOI 10.1111/1744-7941.12046; Melchiorre MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054856; Mid Staffordshire NHS Foundation Trust Public Inquiry, 2010, EX SUMM; Mysyuk Y, THESIS LEIDEN U; Mysyuk Y, 2013, INT PSYCHOGERIATR, V25, P1267, DOI 10.1017/S1041610212002281; Naughton C, 2013, INT PSYCHOGERIATR, V25, P1257, DOI 10.1017/S1041610213000513; O'Donovan Diarmuid, 2009, COMMISSION INVESTIGA; O'Keeffe M, 2007, NURSING OLDER PEOPLE, DOI DOI 10.7748/NOP2007.10.19.8.24.C6268; Phelan A, 2009, INT J OLDER PEOPLE N, V4, P115, DOI 10.1111/j.1748-3743.2009.00164.x; Phelan A, 2008, NURS INQ, V15, P320, DOI 10.1111/j.1440-1800.2008.00423.x; Reed J, 2003, AGEING SOC, V23, P225, DOI 10.1017/S0144686X02001101; Rodriguez MA, 2006, ANN FAM MED, V4, P403, DOI 10.1370/afm.575; Ronch J.L., 2004, J GERONTOLOGICAL SOC, V43, P61, DOI DOI 10.1300/J083V43N01_06; Rosenblatt DE, 1996, J AM GERIATR SOC, V44, P65, DOI 10.1111/j.1532-5415.1996.tb05640.x; Rothgang H, 2010, TRANSFORM STATE, P1, DOI 10.1057/9780230292345; Schafer Willemijn, 2010, Health Syst Transit, V12, pv; Scodellaro C, 2006, LIEN SOCIAL POLITIQU, V55, P77; Tinker A, 2010, BORCKLEHURSTS TXB GE, P959; Triggle N, 2015, BBC NEWS; World Health Organization, 2002, MISS VOIC VIEWS OLD	49	3	3	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2015	350								h2697	10.1136/bmj.h2697	http://dx.doi.org/10.1136/bmj.h2697			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK0UD	26043975	Green Published			2022-12-28	WOS:000355919600003
J	Tang, WWC; Dietmann, S; Irie, N; Leitch, HG; Floros, VI; Bradshaw, CR; Hackett, JA; Chinnery, PF; Surani, MA				Tang, Walfred W. C.; Dietmann, Sabine; Irie, Naoko; Leitch, Harry G.; Floros, Vasileios I.; Bradshaw, Charles R.; Hackett, Jamie A.; Chinnery, Patrick F.; Surani, M. Azim			A Unique Gene Regulatory Network Resets the Human Germline Epigenome for Development	CELL			English	Article							DNA METHYLATION; EPIGENETIC INHERITANCE; TRANSCRIPTION FACTORS; CELL FATE; IN-VITRO; DYNAMICS; MICE; SPECIFICATION; MECHANISMS; ERASURE	Resetting of the epigenome in human primordial germ cells (hPGCs) is critical for development. We show that the transcriptional program of hPGCs is distinct from that in mice, with co-expression of somatic specifiers and naive pluripotency genes TFCP2L1 and KLF4. This unique gene regulatory network, established by SOX17 and BLIMP1, drives comprehensive germline DNA demethylation by repressing DNA methylation pathways and activating TET-mediated hydroxymethylation. Base-resolution methylome analysis reveals progressive DNA demethylation to basal levels in week 5-7 in vivo hPGCs. Concurrently, hPGCs undergo chromatin reorganization, X reactivation, and imprint erasure. Despite global hypomethylation, evolutionarily young and potentially hazardous retroelements, like SVA, remain methylated. Remarkably, some loci associated with metabolic and neurological disorders are also resistant to DNA demethylation, revealing potential for transgenerational epigenetic inheritance that may have phenotypic consequences. We provide comprehensive insight on early human germline transcriptional network and epigenetic reprogramming that subsequently impacts human development and disease.	[Tang, Walfred W. C.; Irie, Naoko; Bradshaw, Charles R.; Hackett, Jamie A.; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Tang, Walfred W. C.; Irie, Naoko; Hackett, Jamie A.; Surani, M. Azim] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Tang, Walfred W. C.; Dietmann, Sabine; Irie, Naoko; Leitch, Harry G.; Hackett, Jamie A.; Surani, M. Azim] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 3EG, England; [Floros, Vasileios I.; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	University of Cambridge; University of Cambridge; University of Cambridge; Newcastle University - UK	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	a.surani@gurdon.cam.ac.uk	Leitch, Harry/I-3357-2019	Leitch, Harry/0000-0002-3486-8962; Hackett, Jamie/0000-0002-6237-3684; Bradshaw, Charles/0000-0002-3528-458X; Chinnery, Patrick/0000-0002-7065-6617; Dietmann, Sabine./0000-0001-6672-8457	Croucher Foundation; Cambridge Trust; BIRAX; Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; HFSP; Wellcome Trust Investigator Award; Medical Research Council [MR/K000608/1] Funding Source: researchfish; MRC [MR/K000608/1] Funding Source: UKRI	Croucher Foundation; Cambridge Trust; BIRAX; Wellcome Trust Centre for Mitochondrial Research(Wellcome Trust); HFSP(Human Frontier Science Program); Wellcome Trust Investigator Award(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Roger Barker, Xiaoling He, and Pam Tyers for help with collection of human embryos and Andy Riddell for cell sorting. We acknowledge Nils Grabole and Roopsha Sengupta for technical advice, Toshihiro Kobayashi for making schematics, and all members of the M.A.S. lab for discussions. W.W.C.T is supported by Croucher Foundation and Cambridge Trust. N.I. is supported by BIRAX. P.F.C. is a Wellcome Trust Senior Fellow in Clinical Science (101876/Z/13/Z) and a UK NIHR Senior Investigator with additional support from the Wellcome Trust Centre for Mitochondrial Research (096919Z/11/Z). M.A.S. is supported by HFSP and a Wellcome Trust Investigator Award.	Bendsen E, 2006, HUM REPROD, V21, P30, DOI 10.1093/humrep/dei280; Burns KH, 2012, CELL, V149, P740, DOI 10.1016/j.cell.2012.04.019; Lopes SMCD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040030; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Gkountela S, 2013, NAT CELL BIOL, V15, P113, DOI 10.1038/ncb2638; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hackett JA, 2012, DEVELOPMENT, V139, P3623, DOI 10.1242/dev.081661; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hyldig SMW, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-11; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Jacobs FMJ, 2014, NATURE, V516, P242, DOI 10.1038/nature13760; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Kobayashi H, 2013, GENOME RES, V23, P616, DOI 10.1101/gr.148023.112; Leitch HG, 2013, CURR TOP DEV BIOL, V104, P149, DOI 10.1016/B978-0-12-416027-9.00005-X; Lu XY, 2014, NAT STRUCT MOL BIOL, V21, P423, DOI 10.1038/nsmb.2799; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Magnusdottir E, 2013, NAT CELL BIOL, V15, P905, DOI 10.1038/ncb2798; Miura F, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks454; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; Nowick K, 2013, TRENDS GENET, V29, P130, DOI 10.1016/j.tig.2012.11.007; Okae H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004868; Pezic D, 2014, GENE DEV, V28, P1410, DOI 10.1101/gad.240895.114; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Sasaki H, 2010, DEV GROWTH DIFFER, V52, P263, DOI 10.1111/j.1440-169X.2009.01158.x; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Sugawa F, 2015, EMBO J, V34, P1009, DOI 10.15252/embj.201488049; Sugimoto M, 2007, PLOS GENET, V3, P1309, DOI 10.1371/journal.pgen.0030116; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Wermann H, 2010, J PATHOL, V221, P433, DOI 10.1002/path.2725; Yamaguchi S, 2013, CELL RES, V23, P329, DOI 10.1038/cr.2013.22	39	413	424	6	89	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1453	1467		10.1016/j.cell.2015.04.053	http://dx.doi.org/10.1016/j.cell.2015.04.053			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26046444	Green Published, hybrid			2022-12-28	WOS:000355935000022
J	Taniguchi, C; Maitra, A				Taniguchi, Cullen; Maitra, Anirban			It's a SMAD/SMAD World	CELL			English	Editorial Material							MUCINOUS CYSTIC NEOPLASMS; ADENOCARCINOMA; PANCREAS; PROGRESSION; PATTERNS; FAILURE; CANCER	DPC4/SMAD4 mutations are associated with aggressive pancreatic cancer. In this issue of Cell, Whittle et al. demonstrate that Runx3 expression combined with Dpc4/Smad4 status can predict the metastatic propensity of pancreatic tumors, providing valuable guidance for personalized therapy for patients with pancreatic cancer.	[Taniguchi, Cullen] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Taniguchi, Cullen] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Taniguchi, Cullen] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Maitra, Anirban] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Maitra, Anirban] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Taniguchi, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.	ctaniguchi@mdanderson.org		Taniguchi, Cullen/0000-0002-8052-3316	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Biankin AV, 2002, J CLIN ONCOL, V20, P4531, DOI 10.1200/JCO.2002.12.063; Crane CH, 2011, J CLIN ONCOL, V29, P3037, DOI 10.1200/JCO.2010.33.8038; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Whittle MC, 2015, CELL, V161, P1345, DOI 10.1016/j.cell.2015.04.048; Wilentz RE, 1999, AM J SURG PATHOL, V23, P1320, DOI 10.1097/00000478-199911000-00002; Winter JM, 2013, ANN SURG, V258, P331, DOI 10.1097/SLA.0b013e31827fe9ce	8	5	6	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1245	1246		10.1016/j.cell.2015.05.030	http://dx.doi.org/10.1016/j.cell.2015.05.030			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26046433	Bronze			2022-12-28	WOS:000355935000004
J	Yoh, SM; Schneider, M; Seifried, J; Soonthornvacharin, S; Akleh, RE; Olivieri, KC; De Jesus, PD; Ruan, C; de Castro, E; Ruiz, PA; Germanaud, D; des Portes, V; Garcia-Sastre, A; Konig, R; Chanda, SK				Yoh, Sunnie M.; Schneider, Monika; Seifried, Janna; Soonthornvacharin, Stephen; Akleh, Rana E.; Olivieri, Kevin C.; De Jesus, Paul D.; Ruan, Chunhai; de Castro, Elisa; Ruiz, Pedro A.; Germanaud, David; des Portes, Vincent; Garcia-Sastre, Adolfo; Koenig, Renate; Chanda, Sumit K.			PQBP1 Is a Proximal Sensor of the cGAS-Dependent Innate Response to HIV-1	CELL			English	Article							CYCLIC GMP-AMP; LINKED MENTAL-RETARDATION; RESTRICTION FACTOR SAMHD1; DENDRITIC CELLS; CYTOSOLIC DNA; RENPENNING SYNDROME; IMMUNE RECOGNITION; PROTEIN PQBP1; INFECTION; VPX	Dendritic cells (DCs) play a critical role in the immune response to viral infection through the facilitation of cell-intrinsic antiviral activity and the activation of adaptive immunity. HIV-1 infection of DCs triggers an IRF3-dependent innate immune response, which requires the activity of cyclic GAMP synthase (cGAS). We report the results of a targeted RNAi screen utilizing primary human monocyte-derived DCs (MDDCs) to identify immune regulators that directly interface with HIV-1-encoded features to initiate this innate response. Polyglutamine binding protein 1 (PQBP1) emerged as a strong candidate through this analysis. We found that PQBP1 directly binds to reverse-transcribed HIV-1 DNA and interacts with cGAS to initiate an IRF3-dependent innate response. MDDCs derived from Renpenning syndrome patients, who harbor mutations in the PQBP1 locus, possess a severely attenuated innate immune response to HIV-1 challenge, underscoring the role of PQBP1 as a proximal innate sensor of a HIV-1 infection.	[Yoh, Sunnie M.; Schneider, Monika; Soonthornvacharin, Stephen; Akleh, Rana E.; Olivieri, Kevin C.; De Jesus, Paul D.; Ruiz, Pedro A.; Koenig, Renate; Chanda, Sumit K.] Sanford Burnham Med Res Inst, Infectious & Inflammatory Dis Ctr, La Jolla, CA 92116 USA; [Ruan, Chunhai] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [de Castro, Elisa; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol & Global Hlth, New York, NY 10029 USA; [de Castro, Elisa; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Emerging Pathogens Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Seifried, Janna; Koenig, Renate] Paul Ehrlich Inst, D-63225 Langen, Germany; [Germanaud, David] Hop Robert Debre, AP HP, Serv Neurol Pediatr & Malad Metabol, F-75019 Paris, France; [des Portes, Vincent] Univ Lyon, Natl Reference Ctr Fragile X & XLID, Biobank NeuroBioTec, Hosp Civils Lyon, F-69677 Bron, France; [des Portes, Vincent] CNRS, UMR 5304 L2C2, F-69677 Bron, France; [Koenig, Renate] German Ctr Infect Res DZIF, D-63225 Langen, Germany	Sanford Burnham Prebys Medical Discovery Institute; University of Michigan System; University of Michigan; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Paul Ehrlich Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); German Center for Infection Research	Chanda, SK (corresponding author), Sanford Burnham Med Res Inst, Infectious & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92116 USA.	schanda@sanfordburnham.org	Germanaud, David/Q-2774-2017; König, Renate/AAB-8918-2019	Germanaud, David/0000-0001-5055-4624; König, Renate/0000-0003-4882-9179; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Ruiz-Castro, Pedro Antonio/0000-0001-7528-1474; Seifried, Janna/0000-0002-7015-6647	NIH Common Funds Project at the University of Michigan [U24 DK097153]; NIAID [P01 CA177322, P01 AI090935, R01 AI105184, U19 AI106754]; NIGMS [P50 GM085764]; James B. Pendleton Charitable Trust; NATIONAL CANCER INSTITUTE [P30CA030199, P01CA177322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105184, P01AI090935, U19AI106754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033773] Funding Source: NIH RePORTER	NIH Common Funds Project at the University of Michigan; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); James B. Pendleton Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors would like to thank Ren Sun and Ting-Ting Wu for their contribution of MHV-68, John Young for review and comments, Christos Tzitzilonis for molecular cloning support, Lars Pache and Yingyao Zhou for bioinformatics and statistical support, Marianne Manchester for assistance in the metabolomics data interpretation, Sylvie Blondelle for advice on regulatory compliance, Zhijian (James) Chen for the shcGAS and shSTING THP-1 lines, and Christiane Tondera and Heike Schmitz for expert technical assistance. The work on this paper utilized Metabolomics Core Services supported by a grant from the NIH Common Funds Project at the University of Michigan (U24 DK097153). S.M.Y., S.S., K.C.O., R.E.A., E.D., P.A.R., and P.D.D. were supported by grants from NIAID (P01 CA177322, P01 AI090935, R01 AI105184, and U19 AI106754). M.S. was supported by a grant from NIGMS (P50 GM085764). This work was also supported by a generous grant from the James B. Pendleton Charitable Trust to support HIV/AIDS research. Analysis of patient samples were conducted at Paul-Ehrlich-Institut (Langen, Germany), Centre de Reference "Deficience Intellectuelle de Causes Rares'' (Lyon, France), and L'Universite Paris Descartes (Paris, France) using non-NIH-supported funds.	Abel K, 2005, J VIROL, V79, P12164, DOI 10.1128/JVI.79.19.12164-12172.2005; Arad U, 1998, BIOTECHNIQUES, V24, P760, DOI 10.2144/98245bm14; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Germanaud D, 2011, CLIN GENET, V79, P225, DOI 10.1111/j.1399-0004.2010.01551.x; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ikeuchi Y, 2013, CELL REP, V4, P879, DOI 10.1016/j.celrep.2013.07.042; Iwasaki A, 2012, IMMUNITY, V37, P389, DOI 10.1016/j.immuni.2012.08.011; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; Katsikis PD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002055; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Kranzusch PJ, 2013, IMMUNITY, V39, P992, DOI 10.1016/j.immuni.2013.11.012; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Kunde SA, 2011, HUM MOL GENET, V20, P4916, DOI 10.1093/hmg/ddr430; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahaye X, 2013, IMMUNITY, V39, P1132, DOI 10.1016/j.immuni.2013.11.002; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lenski C, 2004, AM J HUM GENET, V74, P777, DOI 10.1086/383205; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Luban J, 2012, CELL HOST MICROBE, V12, P408, DOI 10.1016/j.chom.2012.10.002; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Marubuchi S, 2005, J NEUROCHEM, V95, P858, DOI 10.1111/j.1471-4159.2005.03405.x; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Salah Z, 2012, FRONT BIOSCI-LANDMRK, V17, P331, DOI 10.2741/3930; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003	37	120	123	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1293	1305		10.1016/j.cell.2015.04.050	http://dx.doi.org/10.1016/j.cell.2015.04.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26046437	Green Accepted, Bronze			2022-12-28	WOS:000355935000010
J	Ricci, V; Nunes, VD; Murphy, MS; Cunningham, S				Ricci, Valentina; Nunes, Vanessa Delgado; Murphy, M. Stephen; Cunningham, Steve		Guideline Dev Grp Tech Team	GUIDELINES Bronchiolitis in children: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RESPIRATORY SYNCYTIAL VIRUS		[Ricci, Valentina; Nunes, Vanessa Delgado; Murphy, M. Stephen] Royal Coll Obstet & Gynaecol, London NW1 4RG, England; [Cunningham, Steve] Royal Hosp Sick Children, Dept Paediat Resp Med, Edinburgh EH9 1LF, Midlothian, Scotland		Ricci, V (corresponding author), Royal Coll Obstet & Gynaecol, London NW1 4RG, England.	vricci@rcog.org.uk		Bourke, Thomas/0000-0003-4786-962X; Cunningham, Steve/0000-0001-7342-251X				Deshpande SA, 2003, ARCH DIS CHILD, V88, P1065, DOI 10.1136/adc.88.12.1065; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; National Institute for Health and Care Excellence, 2015, BRONCH DIAGN MAN BRO	3	55	56	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2015	350								h2305	10.1136/bmj.h2305	http://dx.doi.org/10.1136/bmj.h2305			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK0TW	26037525				2022-12-28	WOS:000355918900001
J	Schweizer, ML; Chiang, HY; Septimus, E; Moody, J; Braun, B; Hafner, J; Ward, MA; Hickok, J; Perencevich, EN; Diekema, DJ; Richards, CL; Cavanaugh, JE; Perlin, JB; Herwaldt, LA				Schweizer, Marin L.; Chiang, Hsiu-Yin; Septimus, Edward; Moody, Julia; Braun, Barbara; Hafner, Joanne; Ward, Melissa A.; Hickok, Jason; Perencevich, Eli N.; Diekema, Daniel J.; Richards, Cheryl L.; Cavanaugh, Joseph E.; Perlin, Jonathan B.; Herwaldt, Loreen A.			Association of a Bundled Intervention With Surgical Site Infections Among Patients Undergoing Cardiac, Hip, or Knee Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; NASAL CARRIAGE; MUPIROCIN; DECOLONIZATION; PROPHYLAXIS; RISK; CHLORHEXIDINE; ARTHROPLASTY	IMPORTANCE Previous studies suggested that a bundled intervention was associated with lower rates of Staphylococcus aureus surgical site infections (SSIs) among patients having cardiac or orthopedic operations. OBJECTIVE To evaluate whether the implementation of an evidence-based bundle is associated with a lower risk of S aureus SSIs in patients undergoing cardiac operations or hip or knee arthroplasties. DESIGN, SETTING, AND PARTICIPANTS Twenty hospitals in 9 US states participated in this pragmatic study; rates of SSIs were collected for a median of 39 months (range, 39-43) during the preintervention period (March 1, 2009, to intervention) and a median of 21 months (range, 14-22) during the intervention period (from intervention start through March 31, 2014). INTERVENTIONS Patients whose preoperative nares screens were positive for methicillin-resistant S aureus (MRSA) or methicillin-susceptible S aureus (MSSA) were asked to apply mupirocin intranasally twice daily for up to 5 days and to bathe daily with chlorhexidine-gluconate (CHG) for up to 5 days before their operations. MRSA carriers received vancomycin and cefazolin or cefuroxime for perioperative prophylaxis; all others received cefazolin or cefuroxime. Patients who were MRSA-negative and MSSA-negative bathed with CHG the night before and morning of their operations. Patients were treated as MRSA-positive if screening results were unknown. MAIN OUTCOMES AND MEASURES The primary outcomewas complex (deep incisional or organ space) S aureus SSIs. Monthly SSI counts were analyzed using Poisson regression analysis. RESULTS After a 3-month phase-in period, bundle adherence was 83%(39% full adherence; 44% partial adherence). Overall, 101 complex S aureus SSIs occurred after 28 218 operations during the preintervention period and 29 occurred after 14 316 operations during the intervention period (mean rate per 10 000 operations, 36 for preintervention period vs 21 for intervention period, difference, -15 [95% CI, -35 to -2]; rate ratio [RR], 0.58 [95% CI, 0.37 to 0.92]). The rates of complex S aureus SSIs decreased for hip or knee arthroplasties (difference per 10 000 operations, -17 [95% CI, -39 to 0]; RR, 0.48 [95% CI, 0.29 to 0.80]) and for cardiac operations (difference per 10 000 operations, -6 [95% CI, -48 to 8]; RR, 0.86 [95% CI, 0.47 to 1.57]). CONCLUSIONS AND RELEVANCE In this multicenter study, a bundle comprising S aureus screening, decolonization, and targeted prophylaxis was associated with a modest, statistically significant decrease in complex S aureus SSIs.	[Schweizer, Marin L.; Chiang, Hsiu-Yin; Ward, Melissa A.; Perencevich, Eli N.; Diekema, Daniel J.; Herwaldt, Loreen A.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Schweizer, Marin L.; Perencevich, Eli N.] Iowa City VA Hlth Care Syst, Iowa City, IA USA; [Schweizer, Marin L.; Cavanaugh, Joseph E.; Herwaldt, Loreen A.] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA; [Septimus, Edward; Moody, Julia; Hickok, Jason; Perlin, Jonathan B.] Hosp Corp America, Nashville, TN USA; [Septimus, Edward] Texas A&M Univ, Coll Med, Texas A&M Hlth Sci Ctr, Houston, TX USA; [Braun, Barbara; Hafner, Joanne; Richards, Cheryl L.] Joint Commiss, Oak Brook Terrace, IL USA; [Herwaldt, Loreen A.] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; Hospital Corporation of America; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Iowa	Herwaldt, LA (corresponding author), Univ Iowa Hosp & Clin, Dept Internal Med, 200 Hawkins Dr, Iowa City, IA 52242 USA.	loreen-herwaldt@uiowa.edu		Chiang, Hsiu-Yin/0000-0002-4205-2787; Herwaldt, Loreen/0000-0002-9530-6859; Diekema, Daniel/0000-0003-1273-0724; Ward, Melissa/0000-0002-1054-6475; Schweizer, Marin/0000-0002-3604-0093; Perencevich, Eli/0000-0002-3721-3355	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA2902006100021I, HS022467-02]; VA Health Services Research and Development [CDA 11-211]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS022467] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services; VA Health Services Research and Development(US Department of Veterans Affairs); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was funded by the Agency for Healthcare Research and Quality (AHRQ; HHSA2902006100021I and grant HS022467-02), US Department of Health and Human Services. It also received support from the VA Health Services Research and Development (CDA 11-211; Dr Schweizer).	Ammerlaan HSM, 2009, CLIN INFECT DIS, V48, P922, DOI 10.1086/597291; Anderson DJ, 2008, INFECT CONT HOSP EP, V29, P941, DOI 10.1086/591457; Berrios-Torres SI, 2014, INFECT CONT HOSP EP, V35, P231, DOI 10.1086/675289; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Bratzler Dale W, 2013, Am J Health Syst Pharm, V70, P195, DOI 10.2146/ajhp120568; Braun BI, DEV IMPLEMENTATION C; Centers for Disease Control and Prevention, SURG SIT INF SSI EV; CLSI, METH DIL ANT SUSC TE; Courville XF, 2012, INFECT CONT HOSP EP, V33, P152, DOI 10.1086/663704; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Diekema D, 2011, INFECT CONT HOSP EP, V32, P1042, DOI 10.1086/661917; Engelman R, 2007, ANN THORAC SURG, V83, P1569, DOI 10.1016/j.athoracsur.2006.09.046; Finkelstein R, 2002, J THORAC CARDIOV SUR, V123, P326, DOI 10.1067/mtc.2002.119698; Harris AD, 2004, CLIN INFECT DIS, V38, P1586, DOI 10.1086/420936; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Healthcare Cost and Utilization Project, HEALTHC COST UT PROJ; Hetem DJ, 2013, J HOSP INFECT, V85, P249, DOI 10.1016/j.jhin.2013.09.006; Immerman I, 2012, J ARTHROPLASTY, V27, P870, DOI 10.1016/j.arth.2012.01.010; Kalra L, 2013, AM J INFECT CONTROL, V41, P1253, DOI 10.1016/j.ajic.2013.05.021; Kline S, 2014, INFECT CONT HOSP EP, V35, P880, DOI 10.1086/676866; KLUYTMANS JAJW, 1995, J INFECT DIS, V171, P216, DOI 10.1093/infdis/171.1.216; Lankiewicz JD, 2012, INFECT CONT HOSP EP, V33, P202, DOI 10.1086/663715; McDanel JS, 2013, ANTIMICROB AGENTS CH, V57, P552, DOI 10.1128/AAC.01623-12; Palepou MFI, 1998, J ANTIMICROB CHEMOTH, V42, P577, DOI 10.1093/jac/42.5.577; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Roy M., 2003, PREVENTION CONTROL N, V4th, P369; Schweizer M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2743; Schweizer ML, 2014, JAMA SURG, V149, P575, DOI 10.1001/jamasurg.2013.4663; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; TAYLOR GJ, 1990, AM J CARDIOL, V65, P309, DOI 10.1016/0002-9149(90)90293-A; The Joint Commission, 2010, SPEC MAN JOINT COMM; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Tyllianakis ME, 2010, J ARTHROPLASTY, V25, P1078, DOI 10.1016/j.arth.2010.01.105; WENZEL RP, 1995, J HOSP INFECT, V31, P13, DOI 10.1016/0195-6701(95)90079-9; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	36	167	171	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2162	2171		10.1001/jama.2015.5387	http://dx.doi.org/10.1001/jama.2015.5387			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ4CC	26034956	Bronze			2022-12-28	WOS:000355430900016
J	Eiben, AE; Smith, J				Eiben, Agoston E.; Smith, Jim			From evolutionary computation to the evolution of things	NATURE			English	Review							NONDOMINATED SORTING APPROACH; ARTIFICIAL EVOLUTION; SELF-ADAPTATION; ALGORITHM; OPTIMIZATION; DESIGN; POPULATION; LIGHT	Evolution has provided a source of inspiration for algorithm designers since the birth of computers. The resulting field, evolutionary computation, has been successful in solving engineering tasks ranging in outlook from the molecular to the astronomical. Today, the field is entering a new phase as evolutionary algorithms that take place in hardware are developed, opening up new avenues towards autonomous machines that can adapt to their environment. We discuss how evolutionary computation compares with natural evolution and what its benefits are relative to other computing approaches, and we introduce the emerging area of artificial evolution in physical systems.	[Eiben, Agoston E.] Vrije Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Smith, Jim] Univ W England, Bristol BS16 1QY, Avon, England	Vrije Universiteit Amsterdam; University of West England	Eiben, AE (corresponding author), Vrije Univ Amsterdam, de Boelelaan 1081a, NL-1081 HV Amsterdam, Netherlands.	a.e.eiben@vu.nl	Smith, Jim/M-7533-2015	Smith, Jim/0000-0001-7908-1859				Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Arias-Montano A, 2012, IEEE T EVOLUT COMPUT, V16, P662, DOI 10.1109/TEVC.2011.2169968; Ashlock D, 2006, EVOLUTIONARY COMPUTA; Back T, 2013, NAT COMPUT SER, P1, DOI 10.1007/978-3-642-40137-4; Back T., 1996, EVOLUTIONARY ALGORIT; Banzhaf W., 1998, GENETIC PROGRAMMING; Banzhaf W, 2006, NAT REV GENET, V7, P729, DOI 10.1038/nrg1921; Barros RC, 2012, IEEE T SYST MAN CY C, V42, P291, DOI 10.1109/TSMCC.2011.2157494; Bartz-Beielstein T., 2006, EXPT RES EVOLUTIONAR; Bartz-Beielstein T, 2014, NAT COMPUT SER, P205, DOI 10.1007/978-3-642-33206-7_10; Bentley P., 2002, CREATIVE EVOLUTIONAR; Bentley P.J., 1999, EVOLUTIONARY DESIGN; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Bongard J, 2014, P IEEE, V102, P899, DOI 10.1109/JPROC.2014.2312844; Bongard J, 2011, P NATL ACAD SCI USA, V108, P1234, DOI 10.1073/pnas.1015390108; Bongard JC, 2013, COMMUN ACM, V56, P74, DOI [10.1145/2493883, 10.1145/2492007.2493883]; Borenstein E, 2006, J EVOLUTION BIOL, V19, P1555, DOI 10.1111/j.1420-9101.2006.01125.x; Borenstein Y, 2014, NAT COMPUT SER, pIX; Branke J, 2015, IEEE T EVOLUT COMPUT, V19, P88, DOI 10.1109/TEVC.2014.2303783; Bredeche N, 2012, MATH COMP MODEL DYN, V18, P101, DOI 10.1080/13873954.2011.601425; Chen XS, 2011, IEEE T EVOLUT COMPUT, V15, P591, DOI 10.1109/TEVC.2011.2132725; Clune J, 2011, IEEE T EVOLUT COMPUT, V15, P346, DOI 10.1109/TEVC.2010.2104157; David Von Drehle, 2012, TIME; De Jong Kenneth A., 2006, EVOLUTIONARY COMPUTA, DOI 10.1145/1274000.1274109; Deb K., 2001, MULTIOBJECTIVE OPTIM, DOI 10.1109/tevc.2002.804322; Deb K, 2014, IEEE T EVOLUT COMPUT, V18, P577, DOI 10.1109/TEVC.2013.2281535; DEJONG KA, 1992, PARALLEL PROBLEM SOLVING FROM NATURE, 2, P3; Dennett Daniel C., 1995, DARWINS DANGEROUS ID; Doncieux S., 2011, NEW HORIZONS EVOLUTI; Eiben AE, 2012, EVOL INTELL, V5, P261, DOI 10.1007/s12065-012-0071-x; Eiben AE, 2011, SWARM EVOL COMPUT, V1, P19, DOI 10.1016/j.swevo.2011.02.001; Eiben AE, 1999, IEEE T EVOLUT COMPUT, V3, P124, DOI 10.1109/4235.771166; Eiben AE, 1999, THEOR COMPUT SCI, V229, P3, DOI 10.1016/S0304-3975(99)00089-4; Eiben AE, 2003, INTRO EVOLUTIONARY C, DOI 10.1007/978-3-662-44874-8; Eiben AE, 2014, FRONT ROBOT AI, DOI 10.3389/frobt.2014.00004; Eiben AE, 2014, LECT NOTES COMPUT SC, V8672, P24; Fernando C, 2011, PROCEDIA COMPUT SCI, V7, P73, DOI 10.1016/j.procs.2011.12.023; Fialho A, 2010, ANN MATH ARTIF INTEL, V60, P25, DOI 10.1007/s10472-010-9213-y; Filipic B, 1999, ENG APPL ARTIF INTEL, V12, P401, DOI 10.1016/S0952-1976(99)00019-6; Floreano D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000292; Floreano D, 2008, EVOL INTELL, V1, P47, DOI 10.1007/s12065-007-0002-4; Fogel D. B., 1995, EVOLUTIONARY COMPUTA; Fogel L. J., 1966, ARTIF INTELL; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Hansen N, 2001, EVOL COMPUT, V9, P159, DOI 10.1162/106365601750190398; Harman M, 2010, IEEE T SOFTWARE ENG, V36, P226, DOI 10.1109/TSE.2009.71; Hinton G. E., 1987, Complex Systems, V1, P495; Holland JH, 1975, ADOPTION NATURAL ART, Vsecond; Hornby GS, 2011, EVOL COMPUT, V19, P1, DOI 10.1162/EVCO_a_00005; Hutter F, 2009, J ARTIF INTELL RES, V36, P267, DOI 10.1613/jair.2861; Jain H, 2014, IEEE T EVOLUT COMPUT, V18, P602, DOI 10.1109/TEVC.2013.2281534; Jansen T., 2005, ANAL EVOLUTIONARY AL; Jin Y, 2005, SOFT COMPUT, V9, P3, DOI 10.1007/S00500-003-0328-5; Jin YC, 2011, SWARM EVOL COMPUT, V1, P61, DOI 10.1016/j.swevo.2011.05.001; Jin YC, 2011, IEEE T SYST MAN CY C, V41, P145, DOI 10.1109/TSMCC.2010.2057424; Karafotias G, 2015, IEEE T EVOLUT COMPUT, V19, P167, DOI 10.1109/TEVC.2014.2308294; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kennedy J., 1995, P ICNN 95 INT C NEUR, P1942; Koza JR, 2010, GENET PROGRAM EVOL M, V11, P251, DOI 10.1007/s10710-010-9112-3; Koza JR, 1992, GENETIC PROGRAMMING; Krasnogor N, 2005, IEEE T EVOLUT COMPUT, V9, P474, DOI 10.1109/TEVC.2005.850260; Lehre PK, 2012, IEEE T EVOLUT COMPUT, V16, P225, DOI 10.1109/TEVC.2011.2112665; Lobo F.G., 2007, PARAMETER SETTING EV, V54, DOI [10.1007/978-3-540-69432-8, DOI 10.1007/978-3-540-69432-8]; Loshchilov I, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P321, DOI 10.1145/2330163.2330210; Michalewicz Z., 2008, ADV EVOLUTIONARY DES; Michel O., 2013, MORPHOGENETIC ENG PR; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; O'Reilly UM, 2007, GENET PROGRAM EVOL M, V8, P163, DOI 10.1007/s10710-007-9025-y; Paenke I, 2009, ADAPT BEHAV, V17, P153, DOI 10.1177/1059712309103566; Piperno DR, 2009, P NATL ACAD SCI USA, V106, P5019, DOI 10.1073/pnas.0812525106; Posik P, 2012, EVOL COMPUT, V20, P509, DOI 10.1162/EVCO_a_00084; Preen RJ, 2015, IEEE T EVOLUT COMPUT, V19, P284, DOI 10.1109/TEVC.2014.2316199; Price K, 2006, NAT COMP SER, DOI 10.1007/3-540-31306-0; Rechenberg I, 1973, EVOLUTIONSTRATEGIE O; Romero J.J., 2008, ART ARTIFICIAL EVOLU; RUDOLPH G, 1994, IEEE T NEURAL NETWOR, V5, P96, DOI 10.1109/72.265964; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Schwefel H., 1977, NUMERICAL OPTIMIZATI; Schwefel H. -P., 1995, EVOLUTION OPTIMUM SE; Secretan J, 2011, EVOL COMPUT, V19, P373, DOI 10.1162/EVCO_a_00030; Serpell M, 2010, EVOL COMPUT, V18, P491, DOI 10.1162/EVCO_a_00006; Smith JE, 2012, IEEE T EVOLUT COMPUT, V16, P431, DOI 10.1109/TEVC.2011.2159271; SMITH JM, 1992, NATURE, V355, P772; Stanley KO, 2007, GENET PROGRAM EVOL M, V8, P131, DOI 10.1007/s10710-007-9028-8; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Turing A.M., 1969, MACHINE INTELLIGENCE, V5; Vargas PA, 2014, INTEL ROBOT AUTON AG, P1; Virgo N, 2012, ARTIF LIFE, V18, P129, DOI 10.1162/artl_a_00056; Waibel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000615; Wang C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01025; Watson RA, 2002, ROBOT AUTON SYST, V39, P1, DOI 10.1016/S0921-8890(02)00170-7; Widera P, 2010, GENET PROGRAM EVOL M, V11, P61, DOI 10.1007/s10710-009-9087-0; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Yao X, 1999, P IEEE, V87, P1423, DOI 10.1109/5.784219; Zaefferer M, 2014, GECCO'14: PROCEEDINGS OF THE 2014 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P871, DOI 10.1145/2576768.2598282; Zhang QF, 2007, IEEE T EVOLUT COMPUT, V11, P712, DOI 10.1109/TEVC.2007.892759	96	226	240	15	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					476	482		10.1038/nature14544	http://dx.doi.org/10.1038/nature14544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	26017447	Green Submitted			2022-12-28	WOS:000355286600035
J	Vockley, JG; Niederhuber, JE				Vockley, Joseph G.; Niederhuber, John E.			Diagnosis and treatment of cancer using genomics	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CAPTURE; GENE; MUTATIONS; THERAPY; DNA; EXPRESSION	The field of cancer diagnostics is in constant flux as a result of the rapid discovery of new genes associated with cancer, improvements in laboratory techniques for identifying disease causing events, and novel analytic methods that enable the integration of many different types of data. These advances have helped in the identification of novel, informative biomarkers. As more whole genome sequence data are generated and analyzed, emerging information on the baseline variability of the human genome has shown the importance of the ancestral genomic background in patients with a potential disease causing variant. The recent discovery of many novel DNA sequence variants, advances in sequencing and genomic technology, and improved analytic methods enable the impact of germline and somatic genome variation on tumorigenesis and metastasis to be determined. New molecular targets and companion diagnostics are changing the way geneticists and oncologists think about the causes, diagnosis, and treatment of cancer.	[Vockley, Joseph G.; Niederhuber, John E.] Inova Fairfax Med Ctr, Inova Translat Med Inst, Falls Church, VA 22042 USA; [Vockley, Joseph G.] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA; [Niederhuber, John E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Inova Fairfax Hospital; Virginia Commonwealth University; Johns Hopkins University	Vockley, JG (corresponding author), Inova Fairfax Med Ctr, Inova Translat Med Inst, Falls Church, VA 22042 USA.	Joe.Vockley@inova.org						Akkari L, 2014, GENE DEV, V28, P2134, DOI 10.1101/gad.249599.114; Antoniou AC, 2014, NEW ENGL J MED, V371, P497, DOI [10.1056/NEJMoa1400382, 10.1056/NEJMc1410673]; Ashfaq R, 2012, CLIN EXP METASTAS, V29, P653, DOI 10.1007/s10585-012-9483-3; Bodian DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094554; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Cancer Genome Atlas Research Network, 2013, Nat Genet, V45, P1113, DOI 10.1038/ng.2764; Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Duggan C, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju035; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Espina V, 2007, EXPERT REV MOL DIAGN, V7, P647, DOI 10.1586/14737159.7.5.647; European Commission, 2014, REV MED DEV DIR; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; Fang Wei Bin, 2014, Front Biol (Beijing), V9, P114; Gal AA, 2005, JAMA-J AM MED ASSOC, V294, P3135, DOI 10.1001/jama.294.24.3135; Gannett L, 2014, STUD HIST PHI PART C, V47, P173, DOI 10.1016/j.shpsc.2014.05.017; Genome Reference Consortium, HUM GEN OV; Gordon GJ, 2002, CANCER RES, V62, P4963; Grenade C, 2014, CLIN PHARMACOL THER, V95, P403, DOI 10.1038/clpt.2014.5; Hall MJ, 2014, J NATL COMPR CANC NE, V12, P1339, DOI 10.6004/jnccn.2014.0128; Harismendy O, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3584; Illimina, MISEQDX INSTR; Johnson JA, 2003, TRENDS GENET, V19, P660, DOI 10.1016/j.tig.2003.09.008; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LaDuca H, 2014, GENET MED, V16, P830, DOI 10.1038/gim.2014.40; Leao M, 2013, BIOCHEM PHARMACOL, V85, P1234, DOI 10.1016/j.bcp.2013.01.032; Link DC, 2011, JAMA-J AM MED ASSOC, V305, P1568, DOI 10.1001/jama.2011.473; Lonnstedt IM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0470-7; McLeod HL, 2013, SCIENCE, V339, P1563, DOI 10.1126/science.1234139; Meldrum Cliff, 2011, Clin Biochem Rev, V32, P177; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mizzi C, 2014, PHARMACOGENOMICS, V15, P1223, DOI [10.2217/PGS.14.102, 10.2217/pgs.14.102]; National Cancer Institute, 2011, TUM MARK; National Cancer Institute, GEN TEST HER CANC SY; National Cancer Institute, TUM MARK; National Center for Biotechnology Information, REFSEQ NCBI REF SEQ; NCBI, GEN TEST REG; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Olsen D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00105; Penet MF, 2014, ADV CANCER RES, V124, P235, DOI 10.1016/B978-0-12-411638-2.00007-0; Pritchard CC, 2014, J MOL DIAGN, V16, P56, DOI 10.1016/j.jmoldx.2013.08.004; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Pyeritz RE, 2012, GENET MED, V14, P171, DOI [10.1038/gim.2012.74, 10.1038/gim.2011.48]; Rook MS, 2004, AM J PATHOL, V164, P23, DOI 10.1016/S0002-9440(10)63092-1; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; Saumet A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/642916; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Song CX, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-2012; US Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Biologics Evaluation and Research, 2013, ANT DET DRAFT 2 GUID; US Food and Drug Administration, LIST CLEAR APPR COMP; US Food and Drug Administration, 2013, FDA ALL MARK 4 NEXT; US Food and Drugs Administration, 2014, PERS MED COMP DIAGN; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Wellcome Trust Sanger Institute, 2013, CANC GEN CENS; Wu XF, 2014, METHODS MOL BIOL, V1105, P183, DOI 10.1007/978-1-62703-739-6_15; Yost SE, 2013, BIOINFORMATICS, V29, P1908, DOI 10.1093/bioinformatics/btt305; Zhang Qi, 2014, Subcell Biochem, V85, P281, DOI 10.1007/978-94-017-9211-0_16; Zhang ZM, 2012, NAT GENET, V44, P1075, DOI 10.1038/ng.2412; Zhong X, 2009, CIRCULATING CELL FRE, DOI [10.3843/GLOWM.10270, DOI 10.3843/GLOWM.10270]	60	19	20	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2015	350								h1832	10.1136/bmj.h1832	http://dx.doi.org/10.1136/bmj.h1832			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ5UP	26022222				2022-12-28	WOS:000355557100001
J	Macosko, EZ; Basu, A; Satija, R; Nemesh, J; Shekhar, K; Goldman, M; Tirosh, I; Bialas, AR; Kamitaki, N; Martersteck, EM; Trombetta, JJ; Weitz, DA; Sanes, JR; Shalek, AK; Regev, A; McCarroll, SA				Macosko, Evan Z.; Basu, Anindita; Satija, Rahul; Nemesh, James; Shekhar, Karthik; Goldman, Melissa; Tirosh, Itay; Bialas, Allison R.; Kamitaki, Nolan; Martersteck, Emily M.; Trombetta, John J.; Weitz, David A.; Sanes, Joshua R.; Shalek, Alex K.; Regev, Aviv; McCarroll, Steven A.			Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets	CELL			English	Article							RNA-SEQ; AMACRINE CELLS; GENE; RETINA; LENS	Cells, the basic units of biological structure and function, vary broadly in type and state. Single-cell genomics can characterize cell identity and function, but limitations of ease and scale have prevented its broad application. Here we describe Drop-seq, a strategy for quickly profiling thousands of individual cells by separating them into nanoliter-sized aqueous droplets, associating a different barcode with each cell's RNAs, and sequencing them all together. Drop-seq analyzes mRNA transcripts from thousands of individual cells simultaneously while remembering transcripts' cell of origin. We analyzed transcriptomes from 44,808 mouse retinal cells and identified 39 transcriptionally distinct cell populations, creating a molecular atlas of gene expression for known retinal cell classes and novel candidate cell subtypes. Drop-seq will accelerate biological discovery by enabling routine transcriptional profiling at single-cell resolution.	[Macosko, Evan Z.; Nemesh, James; Goldman, Melissa; Kamitaki, Nolan; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Macosko, Evan Z.; Nemesh, James; Goldman, Melissa; Kamitaki, Nolan; McCarroll, Steven A.] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Macosko, Evan Z.; Nemesh, James; Kamitaki, Nolan; McCarroll, Steven A.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Basu, Anindita; Satija, Rahul; Shekhar, Karthik; Tirosh, Itay; Trombetta, John J.; Shalek, Alex K.; Regev, Aviv] Broad Inst Harvard & MIT, Klarman Cell Observ, Cambridge, MA 02142 USA; [Basu, Anindita; Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Satija, Rahul] New York Genome Ctr, New York, NY 10013 USA; [Satija, Rahul] NYU, Dept Biol, New York, NY 10003 USA; [Bialas, Allison R.] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Martersteck, Emily M.; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Martersteck, Emily M.; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Weitz, David A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Shalek, Alex K.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Shalek, Alex K.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Shalek, Alex K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02139 USA; [Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; New York University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard University; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Macosko, EZ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	emacosko@genetics.med.harvard.edu; mccarroll@genetics.med.harvard.edu	Macosko, Evan/X-4664-2019; Satija, Rahul/AAF-9564-2019; Shalek, Alex/Y-2434-2019	Shalek, Alex/0000-0001-5670-8778; Kamitaki, Nolan/0000-0003-0614-0189; McCarroll, Steven/0000-0002-6954-8184	Stanley Center for Psychiatric Research; MGH Psychiatry Residency Research Program; Stanley-MGH Fellowship in Psychiatric Neuroscience; Stewart Trust Fellows Award; Simons Foundation; NHGRI CEGS [P50 HG006193]; Klarman Cell Observatory; NIMH [U01MH105960, R25MH094612]; NIH [F32 HD075541]; National Science Foundation [ECS-0335765, DMR-1310266]; Harvard Materials Research Science and Engineering Center [DMR-1420570]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105960, R25MH094612] Funding Source: NIH RePORTER; Division Of Materials Research [1310266] Funding Source: National Science Foundation	Stanley Center for Psychiatric Research; MGH Psychiatry Residency Research Program; Stanley-MGH Fellowship in Psychiatric Neuroscience; Stewart Trust Fellows Award; Simons Foundation; NHGRI CEGS; Klarman Cell Observatory; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Harvard Materials Research Science and Engineering Center(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the Stanley Center for Psychiatric Research (to S.M.), the MGH Psychiatry Residency Research Program and Stanley-MGH Fellowship in Psychiatric Neuroscience (to E.Z.M.), a Stewart Trust Fellows Award (to S.M.), a grant from the Simons Foundation to the Simons Center for the Social Brain at MIT (to A.R., S.M., and D.W.), an NHGRI CEGS P50 HG006193 (to A.R.), the Klarman Cell Observatory (to A.R. and A.B.), NIMH grant U01MH105960 (to S.M., A.R. and J.R.S.), NIMH grant R25MH094612 (to E.M.), NIH F32 HD075541 (to R.S.). AR is an investigator of the Howard Hughes Medical Institute. Microfluidic device fabrication was performed at the Harvard Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network (National Science Foundation award no. ECS-0335765), with support from the National Science Foundation (DMR-1310266) and the Harvard Materials Research Science and Engineering Center (DMR-1420570). We thank Christina Usher and Leslie Gaffney for contributions to the manuscript figures and Chris Patil for helpful comments on the manuscript. We thank Connie Cepko for helpful conversations about the retina data, Beth Stevens for advice on retinal dissociations, and Assaf Rotem and Huidan Zhang for advice on microfluidics design and fabrication. A.R. is a member of the Scientific Advisory Board for Thermo Fisher Scientific and Syros Pharmaceuticals and a consultant for Driver Genomics.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Berman GJ, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0672; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; Chung NC, 2015, BIOINFORMATICS, V31, P545, DOI 10.1093/bioinformatics/btu674; Descamps FJ, 2005, FASEB J, V19, P29, DOI 10.1096/fj.04-1837com; Ester M, 1996, DENSITY BASED ALGORI; Famiglietti EV, 2010, VISUAL NEUROSCI, V27, P19, DOI 10.1017/S0952523810000052; Feigenspan A, 2001, J NEUROSCI, V21, P230, DOI 10.1523/JNEUROSCI.21-01-00230.2001; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Haverkamp S, 2004, J COMP NEUROL, V468, P251, DOI 10.1002/cne.10962; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kay JN, 2011, NAT NEUROSCI, V14, P965, DOI 10.1038/nn.2859; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Sanes J.R., 2015, ANN REV NEUROSCI; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shekhar K, 2014, P NATL ACAD SCI USA, V111, P202, DOI 10.1073/pnas.1321405111; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Sweeney NT, 2014, J NEUROSCI, V34, P5447, DOI 10.1523/JNEUROSCI.0035-14.2014; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thorsen T, 2001, PHYS REV LETT, V86, P4163, DOI 10.1103/PhysRevLett.86.4163; Umbanhowar PB, 2000, LANGMUIR, V16, P347, DOI 10.1021/la990101e; Utada AS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.094502; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; WETMUR JG, 1968, J MOL BIOL, V31, P349, DOI 10.1016/0022-2836(68)90414-2; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yang Y, 2005, J MOL BIOL, V351, P453, DOI 10.1016/j.jmb.2005.05.072; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	41	3420	3669	76	818	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1202	1214		10.1016/j.cell.2015.05.002	http://dx.doi.org/10.1016/j.cell.2015.05.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000488	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000355152600025
J	Bachelez, H				Bachelez, Herve			Interleukin-17 inhibition: a route to psoriasis clearance?	LANCET			English	Editorial Material									[Bachelez, Herve] Hop St Louis, AP HP, Dept Dermatol, F-75475 Paris 10, France; [Bachelez, Herve] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Bachelez, Herve] Inst Imagine, INSERMU1163, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Bachelez, H (corresponding author), Hop St Louis, AP HP, Dept Dermatol, F-75475 Paris 10, France.	herve.bachelez@sls.aphp.fr		bachelez, herve/0000-0003-3567-9095				Cypowyj S, 2012, EUR J IMMUNOL, V42, P2246, DOI 10.1002/eji.201242605; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Griffiths CEM, 2015, LANCET, V386, P541, DOI 10.1016/S0140-6736(15)60125-8; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Puig L, 2015, J EUR ACAD DERMATOL, V29, P645, DOI 10.1111/jdv.12817; Simon T, 2013, EUR HEART J, V34, P570, DOI 10.1093/eurheartj/ehs263	8	2	3	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2015	386	9993					510	512		10.1016/S0140-6736(15)60857-1	http://dx.doi.org/10.1016/S0140-6736(15)60857-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8PG	26072106				2022-12-28	WOS:000359431900007
J	Nanda, R; Rhodes-Kropf, M				Nanda, Ramana; Rhodes-Kropf, Matthew			Financing experiments	SCIENCE			English	Editorial Material									[Nanda, Ramana; Rhodes-Kropf, Matthew] Harvard Univ, Sch Business, Boston, MA 02163 USA; [Nanda, Ramana; Rhodes-Kropf, Matthew] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; National Bureau of Economic Research	Nanda, R (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.	rnanda@hbs.edu						Kerr WR, 2014, J ECON PERSPECT, V28, P25, DOI 10.1257/jep.28.3.25	1	0	0	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1200	1200		10.1126/science.aab4135	http://dx.doi.org/10.1126/science.aab4135			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK2AK	26068825				2022-12-28	WOS:000356011500021
J	Hamilton, DP; Skrutskie, MF; Verbiscer, AJ; Masci, FJ				Hamilton, Douglas P.; Skrutskie, Michael F.; Verbiscer, Anne J.; Masci, Frank J.			Small particles dominate Saturn's Phoebe ring to surprisingly large distances	NATURE			English	Article							JUPITERS GOSSAMER RINGS; RADIATION FORCES; DUST; SATELLITES; DYNAMICS; GALILEO; FIELDS; FATE	Saturn's faint outermost ring, discovered in 2009 (ref. 1), is probably formed by particles ejected from the distant moon Phoebe(2,3). The ring was detected(1) between distances of 128 and 207 Saturn radii (R-S 5 60,330 kilometres) from the planet, with a full vertical extent of 40R(S), making it well over ten times larger than Saturn's hitherto largest known ring, the E ring. The total radial extent of the Phoebe ring could not, however, be determined at that time, nor could particle sizes be significantly constrained. Here we report infrared imaging of the entire ring, which extends from 100R(S) out to a surprisingly distant 270R(S). We model the orbital dynamics of ring particles launched from Phoebe, and construct theoretical power-law profiles of the particle size distribution. We find that very steep profiles fit the data best, and that elevated grain temperatures, arising because of the radiative inefficiency of the smallest grains, probably contribute to the steepness. By converting our constraint on particle sizes into a form that is independent of the uncertain size distribution, we determine that particles with radii greater than ten centimetres, whose orbits do not decay appreciably inward over 4.5 billion years, contribute at most about ten per cent to the cross-sectional area of the ring's dusty component.	[Hamilton, Douglas P.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Skrutskie, Michael F.; Verbiscer, Anne J.] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Masci, Frank J.] CALTECH, Ctr Infrared Proc & Anal, Pasadena, CA 91125 USA	University System of Maryland; University of Maryland College Park; University of Virginia; California Institute of Technology	Hamilton, DP (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	dphamil@umd.edu			National Aeronautics and Space Administration; NASA Outer Planets and Origins	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); NASA Outer Planets and Origins	This publication makes use of data products from the Wide-field Infrared Survey Explorer, which is a joint project of the University of California, Los Angeles, and the Jet Propulsion Laboratory/California Institute of Technology, funded by the National Aeronautics and Space Administration. This research was supported by grants from NASA Outer Planets and Origins (D.P.H.).	Brooks SM, 2004, ICARUS, V170, P35, DOI 10.1016/j.icarus.2004.03.003; Brown MJI, 2014, PUBL ASTRON SOC AUST, V31, DOI 10.1017/pasa.2014.44; Burns J. A., 1996, ASP C SERIES, P179; BURNS JA, 1979, ICARUS, V40, P1, DOI 10.1016/0019-1035(79)90050-2; Gladman B, 2001, NATURE, V412, P163, DOI 10.1038/35084032; Hamilton DP, 2008, NATURE, V453, P72, DOI 10.1038/nature06886; HAMILTON DP, 1993, ICARUS, V103, P161; Hamilton DP, 2001, NATURE, V412, P132, DOI 10.1038/35084310; HAMILTON DP, 1993, ICARUS, V101, P244, DOI 10.1006/icar.1993.1022; Hedman MM, 2012, ICARUS, V217, P322, DOI 10.1016/j.icarus.2011.11.006; Jontof-Hutter D, 2012, ICARUS, V220, P487, DOI 10.1016/j.icarus.2012.04.032; Jontof-Hutter D, 2012, ICARUS, V218, P420, DOI 10.1016/j.icarus.2011.09.033; Showalter MR, 2008, ICARUS, V195, P361, DOI 10.1016/j.icarus.2007.12.012; Tamayo D, 2014, ICARUS, V233, P1, DOI 10.1016/j.icarus.2014.01.021; Tamayo D, 2011, ICARUS, V215, P260, DOI 10.1016/j.icarus.2011.06.027; Verbiscer AJ, 2009, NATURE, V461, P1098, DOI 10.1038/nature08515; Wright EL, 2010, ASTRON J, V140, P1868, DOI 10.1088/0004-6256/140/6/1868	17	13	14	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					185	+		10.1038/nature14476	http://dx.doi.org/10.1038/nature14476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	26062508				2022-12-28	WOS:000356016700032
J	Butt, CA				Butt, Carrie A.			AL 3 Laszlo Moholy-Nagy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2206	2207		10.1001/jama.2014.11793	http://dx.doi.org/10.1001/jama.2014.11793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1VH	26057267				2022-12-28	WOS:000355995300034
J	Rosland, AM				Rosland, Ann-Marie			Assuming the Worst	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BIAS; CARE		[Rosland, Ann-Marie] Univ Michigan, Sch Med, Div Gen Internal Med, Ann Arbor, MI 48109 USA; [Rosland, Ann-Marie] Ann Arbor VA Ctr Clin Management Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Rosland, AM (corresponding author), Univ Michigan, Sch Med, Div Gen Internal Med, Ann Arbor, MI 48109 USA.	arosland@umich.edu	Rosland, Annmarie/B-7750-2016	Rosland, Ann-Marie/0000-0002-5809-5861				Burgess D, 2007, J GEN INTERN MED, V22, P882, DOI 10.1007/s11606-007-0160-1; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Lagu T, 2014, NEW ENGL J MED, V370, P1847, DOI 10.1056/NEJMsb1315940; Smedley B, 2002, UNEQUAL TREATMENT CO, P169	4	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2229	2230		10.1001/jama.2015.2948	http://dx.doi.org/10.1001/jama.2015.2948			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1VH	26057282				2022-12-28	WOS:000355995300015
J	Rothstein, MA				Rothstein, Mark A.			Innovations of the Americans With Disabilities Act Confronting Disability Discrimination in Employment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Louisville, Sch Med, Inst Bioeth Hlth Policy & Law, Louisville, KY 40202 USA	University of Louisville	Rothstein, MA (corresponding author), Univ Louisville, Sch Med, Inst Bioeth Hlth Policy & Law, 501 E Broadway,Ste 310, Louisville, KY 40202 USA.	mark.rothstein@louisville.edu						Befort StephenF., 2010, UTAH LAW REV, V2010, P993; EEOC, ADA ENF GUID PREEMPL; Hoffman S., 2008, ALA L REV, V59, P305; Lukcso D. G, 2013, OCCUPATIONAL HLTH SE, P287; Rothstein MA, 1989, MED SCREENING EMPLOY	5	7	7	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2221	2222		10.1001/jama.2015.3417	http://dx.doi.org/10.1001/jama.2015.3417			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1VH	26057278				2022-12-28	WOS:000355995300011
J	Stearns, T				Stearns, Tim			Centrioles, in absentia	SCIENCE			English	Editorial Material							S-PHASE; CELLS		Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Stearns, T (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	stearns@stanford.edu		Stearns, Tim/0000-0002-0671-6582	NIGMS NIH HHS [R01 GM052022] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bazzi H, 2014, P NATL ACAD SCI USA, V111, pE1491, DOI 10.1073/pnas.1400568111; Carvalho-Santos Z, 2011, J CELL BIOL, V194, P165, DOI 10.1083/jcb.201011152; Firat-Karalar EN, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0460; Godinho SA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0467; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Poulton JS, 2014, DEV CELL, V30, P731, DOI 10.1016/j.devcel.2014.08.007; Sir JH, 2013, J CELL BIOL, V203, P747, DOI 10.1083/jcb.201309038; Wong YL, 2015, SCIENCE, V348, P1155, DOI 10.1126/science.aaa5111	11	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1091	1092		10.1126/science.aac4860	http://dx.doi.org/10.1126/science.aac4860			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045422				2022-12-28	WOS:000355590500025
J	Miao, YX; Li, GJ; Zhang, XL; Xu, HX; Abraham, SN				Miao, Yuxuan; Li, Guojie; Zhang, Xiaoli; Xu, Haoxing; Abraham, Soman N.			A TRP Channel Senses Lysosome Neutralization by Pathogens to Trigger Their Expulsion	CELL			English	Article							BIOGENESIS; PHAGOSOMES; TRAFFICKING; EXOCYTOSIS; BACTERIA; PROTEIN	Vertebrate cells have evolved elaborate cell-autonomous defense programs to monitor subcellular compartments for infection and to evoke counter-responses. These programs are activated by pathogen-associated pattern molecules and by various strategies intracellular pathogens employ to alter cellular microenvironments. Here, we show that, when uropathogenic E. coli (UPEC) infect bladder epithelial cells (BECs), they are targeted by autophagy but avoid degradation because of their capacity to neutralize lysosomal pH. This change is detected by mucolipin TRP channel 3 (TRPML3), a transient receptor potential cation channel localized to lyso-somes. TRPML3 activation then spontaneously initiates lysosome exocytosis, resulting in expulsion of exosome-encased bacteria. These studies reveal a cellular default system for lysosome homeostasis that has been co-opted by the autonomous defense program to clear recalcitrant pathogens.	[Miao, Yuxuan; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Li, Guojie; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Natl Univ Singapore, Program Emerging Infect Dis, Singapore 169857, Singapore; [Zhang, Xiaoli; Xu, Haoxing] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	Duke University; Duke University; Duke University; National University of Singapore; University of Michigan System; University of Michigan	Abraham, SN (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	soman.abraham@duke.edu	xu, hao/GWQ-7394-2022; Miao, Yuxuan/I-6398-2016		NIH [R01 AI096305, R01 AI35678, R01 DK077159, R01 AI50021, R37 DK50814, R21 AI056101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000561, R01AI035678, R01AI050021, R21AI056101, R01AI096305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101456, R37DK050814, R56DK095198, R01DK077159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Y. He for Atg3<SUP>f/f</SUP> and Atg3<SUP>f/f</SUP> ER-Cre mice. We thank K. Hazen and A. Crichton for collecting urine samples from UTI patients. We also thank Y. Gao for advice in light microscopy imaging. M. Plue and J. Phillips are thanked for their assistance in TEM. We thank D. Tobin and R. Valdivia for manuscript review. The authors' work is supported by NIH grants R01 AI096305, R01 AI35678, R01 DK077159, R01 AI50021, R37 DK50814, and R21 AI056101.	ABRAHAM SN, 1988, NATURE, V336, P682, DOI 10.1038/336682a0; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bishop BL, 2007, NAT MED, V13, P625, DOI 10.1038/nm1572; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; GOREN MB, 1977, ANNU REV MICROBIOL, V31, P507, DOI 10.1146/annurev.mi.31.100177.002451; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Haller T, 1996, CELL CALCIUM, V19, P157, DOI 10.1016/S0143-4160(96)90084-6; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; Lee JA, 2009, AUTOPHAGY, V5, P1070, DOI 10.4161/auto.5.7.9823; Lonnbro P, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-35; Fader CM, 2009, BBA-MOL CELL RES, V1793, P1901, DOI 10.1016/j.bbamcr.2009.09.011; Menashe O, 2008, ANTIMICROB AGENTS CH, V52, P920, DOI 10.1128/AAC.00382-07; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Song JM, 2009, P NATL ACAD SCI USA, V106, P14966, DOI 10.1073/pnas.0900527106; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Vidal M, 1997, J CELL SCI, V110, P1867; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649	32	175	177	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1306	1319		10.1016/j.cell.2015.05.009	http://dx.doi.org/10.1016/j.cell.2015.05.009			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26027738	Bronze, Green Accepted			2022-12-28	WOS:000355935000011
J	Haile-Selassie, Y; Gibert, L; Melillo, SM; Ryan, TM; Alene, M; Deino, A; Levin, NE; Scott, G; Saylor, BZ				Haile-Selassie, Yohannes; Gibert, Luis; Melillo, Stephanie M.; Ryan, Timothy M.; Alene, Mulugeta; Deino, Alan; Levin, Naomi E.; Scott, Gary; Saylor, Beverly Z.			New species from Ethiopia further expands Middle Pliocene hominin diversity	NATURE			English	Article							AUSTRALOPITHECUS-ANAMENSIS; FOSSIL HOMINIDS; HADAR FORMATION; EASTERN AFRICA; ALLIA BAY; KANAPOI; HOMO; TURKANA; MAXILLA	Middle Pliocene hominin species diversity has been a subject of debate over the past two decades, particularly after the naming of Australopithecus bahrelghazali and Kenyanthropus platyops in addition to the well-known species Australopithecus afarensis. Further analyses continue to support the proposal that several hominin species co-existed during this time period. Here we recognize a new hominin species (Australopithecus deyiremeda sp. nov.) from 3.3-3.5-million-year-old deposits in the Woranso-Mille study area, central Afar, Ethiopia. The new species from Woranso-Mille shows that there were at least two contemporaneous hominin species living in the Afar region of Ethiopia between 3.3 and 3.5 million years ago, and further confirms early hominin taxonomic diversity in eastern Africa during the Middle Pliocene epoch. The morphology of Au. deyiremeda also reinforces concerns related to dentognathic (that is, jaws and teeth) homoplasy in Plio-Pleistocene hominins, and shows that some dentognathic features traditionally associated with Paranthropus and Homo appeared in the fossil record earlier than previously thought.	[Haile-Selassie, Yohannes] Cleveland Museum Nat Hist, Cleveland, OH 44106 USA; [Haile-Selassie, Yohannes; Saylor, Beverly Z.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Gibert, Luis] Univ Barcelona, E-08028 Barcelona, Spain; [Melillo, Stephanie M.] Max Planck Inst Evolutionare Anthropol, D-04103 Leipzig, Germany; [Ryan, Timothy M.] Penn State Univ, University Pk, PA 16802 USA; [Alene, Mulugeta] Univ Addis Ababa, Addis Ababa, Ethiopia; [Deino, Alan; Scott, Gary] Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; [Levin, Naomi E.] Johns Hopkins Univ, Baltimore, MD 21218 USA	Cleveland Museum of Natural History; Case Western Reserve University; University of Barcelona; Max Planck Society; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Addis Ababa University; Berkeley Geochronolgy Center; Johns Hopkins University	Haile-Selassie, Y (corresponding author), Cleveland Museum Nat Hist, Cleveland, OH 44106 USA.	yhailese@cmnh.org	Levin, Naomi E/B-4124-2010; Gibert, Luís/L-1941-2019	Levin, Naomi E/0000-0001-5703-3717; Saylor, Beverly/0000-0002-1825-8953; Gibert, Luis/0000-0002-4207-3465; Melillo, Stephanie/0000-0002-1154-1772	LSB Leakey Foundation; National Geographic Society; Cleveland Museum of Natural History; National Science Foundation [BCS-0234320, BCS-0321893, BCS-0542037, BCS-1124705, BCS-1124713, BCS-1124716, BCS-1125157, BCS-1125345]; Direct For Social, Behav & Economic Scie [1125345, 1125157] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [1124705, 1322017] Funding Source: National Science Foundation	LSB Leakey Foundation; National Geographic Society(National Geographic Society); Cleveland Museum of Natural History; National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank the Authority for Research and Conservation of Cultural Heritage and the Afar Regional State of Ethiopia for permission to conduct field and laboratory research, the Afar people of the Woranso-Mille area for their hospitality, and the project's fieldwork crew members for their incredible contributions in our fieldwork endeavours. We would also like to thank S. W. Simpson and W. H. Kimbel for their constructive comments and discussions throughout the preparation of this manuscript; G. Suwa, T. White and B. Asfaw for access to the original Ardipithecus ramidus material; W. H. Kimbel for access to the original Australopithecus afarensis material; F. Spoor for discussion of Kenyanthropus platyops morphology and Lomekwi mandibular metrics; D. F. Su for comments and assistance with the figures. This research was financially supported by grants from the LSB Leakey Foundation, the National Geographic Society, the Cleveland Museum of Natural History, and the National Science Foundation (BCS-0234320, BCS-0321893, BCS-0542037, BCS-1124705, BCS-1124713, BCS-1124716, BCS-1125157 and BCS-1125345).	Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; Brown B, 2001, J HUM EVOL, V41, P29, DOI 10.1006/jhev.2001.0476; Brunet M, 1996, CR ACAD SCI II A, V322, P907; Guy F, 2008, J HUM EVOL, V55, P37, DOI 10.1016/j.jhevol.2007.12.003; Haile-Selassie Y, 2012, NATURE, V483, P565, DOI 10.1038/nature10922; Harrison T, 2011, VERTEBR PALEOBIOL PA, P141, DOI 10.1007/978-90-481-9962-4_7; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P545, DOI 10.1002/ajpa.1330570406; Johanson DC, 1978, NEW SPECIES GENUS AU, V28; Kimbel W.H., 2004, HUMAN EVOLUTION SERI; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Kimbel WH, 2009, YEARB PHYS ANTHROPOL, V52, P2, DOI 10.1002/ajpa.21183; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; Leakey MG, 2001, NATURE, V410, P433, DOI 10.1038/35068500; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; Manthi FK, 2012, S AFR J SCI, V108, P35, DOI 10.4102/sajs.v108i3/4.724; Olejniczak AJ, 2008, BIOL LETTERS, V4, P406, DOI 10.1098/rsbl.2008.0223; Spoor F, 2015, NATURE, V519, P83, DOI 10.1038/nature14224; Spoor F, 2010, PHILOS T R SOC B, V365, P3377, DOI 10.1098/rstb.2010.0042; Suwa G, 1997, NATURE, V389, P489, DOI 10.1038/39037; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; Villmoare B, 2015, SCIENCE, V347, P1352, DOI 10.1126/science.aaa1343; Ward CV, 2013, J HUM EVOL, V65, P501, DOI 10.1016/j.jhevol.2013.05.006; Ward CV, 2001, J HUM EVOL, V41, P255, DOI 10.1006/jhev.2001.0507; White T, 2003, SCIENCE, V299, P1994, DOI 10.1126/science.1078294; White T.D., 1983, NEW INTERPRETATIONS, P721; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; WHITE TD, 1980, AM J PHYS ANTHROPOL, V53, P487, DOI 10.1002/ajpa.1330530405; WHITE TD, 1977, AM J PHYS ANTHROPOL, V46, P197, DOI 10.1002/ajpa.1330460203; WHITE TD, 1982, AM J PHYS ANTHROPOL, V57, P501, DOI 10.1002/ajpa.1330570405; White TD, 2000, AM J PHYS ANTHROPOL, V111, P45, DOI 10.1002/(SICI)1096-8644(200001)111:1<45::AID-AJPA4>3.0.CO;2-I; Wood B, 2000, J ANAT, V197, P19, DOI 10.1046/j.1469-7580.2000.19710019.x; Wood B., 1991, HOMINID CRANIAL REMA, V4	33	70	73	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					483	U500		10.1038/nature14448	http://dx.doi.org/10.1038/nature14448			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2AN	26017448				2022-12-28	WOS:000355286600036
J	Iglehart, JK; Sommers, BD				Iglehart, John K.; Sommers, Benjamin D.			Medicaid at 50-From Welfare Program to Nation's Largest Health Insurer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE; PARTICIPATION; ELIGIBILITY; INSURANCE; ACCESS; PHYSICIANS; ADULTS; COST		[Iglehart, John K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Sommers, Benjamin D.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Iglehart, JK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							Abelson R, 2012, NY TIMES; Allen H, 2014, MILBANK Q, V92, P289, DOI 10.1111/1468-0009.12059; [Anonymous], 2010, MED PROGR GLANC; [Anonymous], 2015, LEAST 15 STAT WILL C; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Casalino LP, 2013, NEW ENGL J MED, V369, P1775, DOI 10.1056/NEJMp1310974; Cassidy A, 2012, CARE DUAL ELIGIBLES; Centers for Medicare & Medicaid Services, 2014, MED CHIP OCT 2014 MO; Cohodes S., 2014, EFFECT CHILD HLTH IN; Cunningham PJ, 2009, HEALTH AFFAIR, V28, pW17, DOI 10.1377/hlthaff.28.1.w17; Currie J, 1996, J POLIT ECON, V104, P1263, DOI 10.1086/262059; Currie J, 1996, Q J ECON, V111, P431, DOI 10.2307/2946684; Decker SL, 2012, HEALTH AFFAIR, V31, P1673, DOI 10.1377/hlthaff.2012.0294; Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation, 2015, ASPE FMAP 2015 REP F; Engel Jonathan, 2006, POOR PEOPLES MED MED; Epstein AM, 2014, HEALTH AFFAIR, V33, P2041, DOI 10.1377/hlthaff.2014.0747; Evans M., 2014, MORNING CONSULT 1111; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Frakt A, 2011, NEW ENGL J MED, V364, P31; Iglehart JK, 2007, NEW ENGL J MED, V356, P734, DOI 10.1056/NEJMhpr066650; Goodell S, 2012, MED MANAGED CARE COS; Goodnough A., 2015, NY TIMES, P16; Grannemann Thomas W., 2010, MED EVERYONE CAN COU; Hall M, 2013, HLTH CARE SAFETY NET; Hart J., 2013, COMPASSIONATE CONSER; Heberlein M., 2013, GETTING GEAR 2014 FI; Hulse C, 2015, NY TIMES, pA12; Kaiser Family Foundation, 2011, PUBL OP HLTH CAR ISS; Kaiser Family Foundation, 2015, STAT STAT ACT MED EX; Kenney GM, 2012, INQUIRY-J HEALTH CAR, V49, P231, DOI 10.5034/inquiryjrnl_49.03.08; Kronebusch K, 2001, HEALTH AFFAIR, V20, P97, DOI 10.1377/hlthaff.20.1.97; Levine P.B., 2009, FORUM HLTH EC POLICY, V12, DOI [10.2202/1558-9544.1137, 10.2202/1558-9544.1137/html, DOI 10.2202/1558-9544.1137/HTML]; Long SK, 2013, HEALTH AFFAIR, V32, P1560, DOI 10.1377/hlthaff.2012.1010; MACPAC, 2014, MED ROL PROV ASS LON; O'Connor Patrick, 2015, WALL STREET J; Polsky D, 2015, NEW ENGL J MED, V372, P537, DOI 10.1056/NEJMsa1413299; Radnofsky L, 2014, WALL STREET J; Rhodes KV, 2014, JAMA INTERN MED, V174, P861, DOI 10.1001/jamainternmed.2014.20; Robertson Campbell, 2015, NY TIMES; Rosenbaum S, 2013, NEW ENGL J MED, V369, P7, DOI 10.1056/NEJMp1304170; Rowland D, 2005, HEALTH CARE FINANC R, V27, P63; Roy A, 2013, MED FAILS POOR; Rucker P., 2015, WASHINGTON POST; Saloner B, 2014, NEW ENGL J MED, V370, P1177, DOI 10.1056/NEJMp1316370; SMITH DAVID G., 2008, MED POLITICS POLICY, P8; Sommers AS, 2011, MEDICARE MED RES REV, V1, P1, DOI DOI 10.5600/MMRR.001.02.A01; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; Sommers BD, 2010, NEW ENGL J MED, V363, P2085, DOI 10.1056/NEJMp1010866; Thompson F, 2012, MED POLITICS FEDERAL; Weil A, 2003, HEALTH AFFAIR, V22, P13, DOI 10.1377/hlthaff.22.1.13; Wiener, 2003, FEDERALISM HLTH POLI	51	23	23	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2015	372	22					2152	2159		10.1056/NEJMhpr1500791	http://dx.doi.org/10.1056/NEJMhpr1500791			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ0EI	26017826	Green Published			2022-12-28	WOS:000355146800015
J	Jafar, TH; Assam, PN				Jafar, Tazeen Hasan; Assam, Pryseley Nkouibert			Dual RAAS blockade for kidney failure: hope for the future	LANCET			English	Editorial Material							STAGE RENAL-DISEASE; INJURY; RISK; MORTALITY		[Jafar, Tazeen Hasan] Duke NUS Grad Med Sch, Hlth Serv & Syst Res, Singapore 169857, Singapore; [Assam, Pryseley Nkouibert] Duke NUS Grad Med Sch, Ctr Quantitat Med, Singapore 169857, Singapore	National University of Singapore; National University of Singapore	Jafar, TH (corresponding author), Duke NUS Grad Med Sch, Hlth Serv & Syst Res, Singapore 169857, Singapore.	tazeen.jafar@duke-nus.edu.sg						Anderson S, 2011, J AM SOC NEPHROL, V22, P28, DOI 10.1681/ASN.2010090934; Brancati FL, 1997, JAMA-J AM MED ASSOC, V278, P2069, DOI 10.1001/jama.278.23.2069; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Foley RN, 2013, CLIN J AM SOC NEPHRO, V8, P845, DOI 10.2215/CJN.06840712; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Gurley SB, 2007, SEMIN NEPHROL, V27, P144, DOI 10.1016/j.semnephrol.2007.01.009; Ingelfinger JR, 2015, NEW ENGL J MED, V372, P275, DOI 10.1056/NEJMe1414112; Inker LA, 2014, AM J KIDNEY DIS, V64, P74, DOI 10.1053/j.ajkd.2014.02.020; Palmer SC, 2015, LANCET, V385, P2047, DOI 10.1016/S0140-6736(14)62459-4; Raebel MA, 2010, J GEN INTERN MED, V25, P326, DOI 10.1007/s11606-009-1228-x; Thomas ME, 2015, KIDNEY INT, V87, P62, DOI 10.1038/ki.2014.328; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	15	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2018	2020		10.1016/S0140-6736(15)60132-5	http://dx.doi.org/10.1016/S0140-6736(15)60132-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI7XK	26009214				2022-12-28	WOS:000354979100005
J	Ostoft, SH; Christensen, M				Ostoft, Signe H.; Christensen, Mikkel			An alternative combination therapy for type 2 diabetes?	LANCET			English	Editorial Material							BEDTIME INSULIN GLARGINE; ONCE-WEEKLY DULAGLUTIDE; OPEN-LABEL; METFORMIN; EFFICACY; SAFETY; LIRAGLUTIDE; PHASE-3		[Ostoft, Signe H.; Christensen, Mikkel] Univ Copenhagen, Gentofte Hosp, Dept Med, Ctr Diabet Res, DK-2900 Hellerup, Denmark; [Christensen, Mikkel] Univ Copenhagen, Bispebjerg Hosp, Dept Clin Pharmacol, DK-2900 Hellerup, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Bispebjerg Hospital	Ostoft, SH (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Med, Ctr Diabet Res, DK-2900 Hellerup, Denmark.	s.ostoft@dadlnet.dk	Christensen, Mikkel/H-5861-2013	Christensen, Mikkel/0000-0002-8774-1797				Blonde L, 2015, LANCET, V385, P2057, DOI 10.1016/S0140-6736(15)60936-9; Dungan KM, 2014, LANCET, V384, P1349, DOI 10.1016/S0140-6736(14)60976-4; Fritsche A, 2003, ANN INTERN MED, V138, P952, DOI 10.7326/0003-4819-138-12-200306170-00006; Hare KJ, 2010, DIABETES, V59, P1765, DOI 10.2337/db09-1414; Inzucchi SE, 2015, DIABETOLOGIA, V58, P429, DOI 10.1007/s00125-014-3460-0; Kielgast U, 2011, DIABETES CARE, V34, P1463, DOI 10.2337/dc11-0096; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Nauck M, 2014, DIABETES CARE, V37, P2149, DOI 10.2337/dc13-2761; Naver S. V., 2014, Clinical Investigation, V4, P729, DOI 10.4155/cli.14.65; Rosenstock J, 2014, DIABETES CARE, V37, P2317, DOI 10.2337/dc14-0001; Umpierrez G, 2014, DIABETES CARE, V37, P2168, DOI 10.2337/dc13-2759; Wysham C, 2014, DIABETES CARE, V37, P2159, DOI [10.2337/dc13-2760, 10.2337/dc15-er07b]	12	1	1	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2020	2022		10.1016/S0140-6736(15)60615-8	http://dx.doi.org/10.1016/S0140-6736(15)60615-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI7XK	26009215				2022-12-28	WOS:000354979100006
J	Palmer, SC; Mavridis, D; Navarese, E; Craig, JC; Tonelli, M; Salanti, G; Wiebe, N; Ruospo, M; Wheeler, DC; Strippoli, GFM				Palmer, Suetonia C.; Mavridis, Dimitris; Navarese, Eliano; Craig, Jonathan C.; Tonelli, Marcello; Salanti, Georgia; Wiebe, Natasha; Ruospo, Marinella; Wheeler, David C.; Strippoli, Giovanni F. M.			Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis	LANCET			English	Article							CONVERTING ENZYME-INHIBITORS; RENAL OUTCOMES; ANGIOTENSIN; INCONSISTENCY; RISK; NEPHROPATHY; CONSISTENCY; BLOCKERS	Background The comparative efficacy and safety of pharmacological agents to lower blood pressure in adults with diabetes and kidney disease remains controversial. We aimed to investigate the benefits and harms of blood pressure-lowering drugs in this population of patients. Methods We did a network meta-analysis of randomised trials from around the world comparing blood pressure-lowering agents in adults with diabetic kidney disease. Electronic databases (the Cochrane Collaboration, Medline, and Embase) were searched systematically up to January, 2014, for trials in adults with diabetes and kidney disease comparing orally administered blood pressure-lowering drugs. Primary outcomes were all-cause mortality and end-stage kidney disease. We also assessed secondary safety and cardiovascular outcomes. We did random-effects network meta-analysis to obtain estimates for primary and secondary outcomes and we presented these estimates as odds ratios or standardised mean differences with 95% CIs. We ranked the comparative effects of all drugs against placebo with surface under the cumulative ranking (SUCRA) probabilities. Findings 157 studies comprising 43 256 participants, mostly with type 2 diabetes and chronic kidney disease, were included in the network meta-analysis. No drug regimen was more effective than placebo for reducing all-cause mortality. However, compared with placebo, end-stage renal disease was significantly less likely after dual treatment with an angiotensin-receptor blocker (ARB) and an angiotensin-converting-enzyme (ACE) inhibitor (odds ratio 0.62, 95% CI 0.43-0.90) and after ARB monotherapy (0.77, 0.65-0.92). No regimen significantly increased hyperkalaemia or acute kidney injury, although combined ACE inhibitor and ARB treatment had the lowest rank among all interventions because of borderline increases in estimated risks of these harms (odds ratio 2.69, 95% CI 0.97-7.47 for hyperkalaemia; 2.69, 0.98-7.38 for acute kidney injury). Interpretation No blood pressure-lowering strategy prolonged survival in adults with diabetes and kidney disease. ACE inhibitors and ARBs, alone or in combination, were the most effective strategies against end-stage kidney disease. Any benefits of combined ACE inhibitor and ARB treatment need to be balanced against potential harms of hyperkalaemia and acute kidney injury.	[Palmer, Suetonia C.] Univ Otago, Dept Med, Christchurch, New Zealand; [Mavridis, Dimitris] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Mavridis, Dimitris] Univ Ioannina, Dept Primary Educ, GR-45110 Ioannina, Greece; [Navarese, Eliano] Nicolaus Copernicus Univ, Coll Med, Dept Cardiol & Internal Med, Bydgoszcz, Poland; [Craig, Jonathan C.; Strippoli, Giovanni F. M.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Tonelli, Marcello] Univ Calgary, Hlth Sci Ctr, Cumming Sch Med, Calgary, AB, Canada; [Wiebe, Natasha] Univ Alberta, Dept Med, Div Nephrol & Immunol, Edmonton, AB T6G 2M7, Canada; [Ruospo, Marinella] Amedeo Avogadro Univ Eastern Piedmont, Div Nephrol & Transplantat, Dept Translat Med, Novara, Italy; [Ruospo, Marinella; Strippoli, Giovanni F. M.] Diaverum Sweden AB, Diaverum Med Scientifi c Offi, Lund, Sweden; [Strippoli, Giovanni F. M.] Univ Bari, Dept Emergency & Organ Transplantat, Bari, Italy; [Wheeler, David C.] Royal Free & Univ Coll Med Sch, London WC1E 6BT, England	University of Otago; University of Ioannina; University of Ioannina; Nicolaus Copernicus University; University of Sydney; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Alberta; University of Eastern Piedmont Amedeo Avogadro; Diaverum; Universita degli Studi di Bari Aldo Moro; University of London; University College London	Strippoli, GFM (corresponding author), Univ Bari, Dept Emergency & Organ Transplantat, I-70124 Bari, Italy.	gfmstrippoli@gmail.com	Craig, Jonathan/E-2813-2013; Mavrids, Dimitris/H-5452-2019; Tonelli, Marcello/B-3028-2009; Wiebe, Natasha/V-7803-2019	Craig, Jonathan/0000-0002-2548-4035; Mavrids, Dimitris/0000-0003-1041-4592; Tonelli, Marcello/0000-0002-0846-3187; Wiebe, Natasha/0000-0002-5613-1582; Salanti, Georgia/0000-0002-3830-8508; Navarese, Eliano/0000-0002-2355-4589	Canterbury Medical Research Foundation; Italian Medicines Agency; Canterbury Medical Research Foundation in New Zealand [13/01]; Italian Medicines Agency [FARM537JNE]; Rutherford Discovery fellowship; European Research Council [IMMA 260559]	Canterbury Medical Research Foundation; Italian Medicines Agency; Canterbury Medical Research Foundation in New Zealand; Italian Medicines Agency; Rutherford Discovery fellowship; European Research Council(European Research Council (ERC)European Commission)	Funding Canterbury Medical Research Foundation, Italian Medicines Agency.; Specific funding from the Canterbury Medical Research Foundation in New Zealand (grant 13/01) and the Italian Medicines Agency (FARM537JNE) was received for this work. SCP is supported by a Rutherford Discovery fellowship and DM and GS are both supported by the European Research Council (IMMA 260559). We thank Johannes Mann and the ONTARGET investigators for providing their data for use in this work and in an earlier study;<SUP>36</SUP> and Gianni Tognoni for assistance with this work.	Burrows NR, 2010, DIABETES CARE, V33, P73, DOI 10.2337/dc09-0343; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Higgins JPT, 2012, RES SYNTH METHODS, V3, P98, DOI 10.1002/jrsm.1044; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Ingelfinger JR, 2015, NEW ENGL J MED, V372, P275, DOI 10.1056/NEJMe1414112; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kidney Disease Improving Global Outcomes, 2012, KIDNEY INT S, V2, P363; Lambers Heerspink HJ, 2011, CIRCULATION, V123, P1049, DOI 10.1161/CIRCULATIONAHA.111.018382; Levin A, 2012, KIDNEY INT S, V2013, P1, DOI DOI 10.1038/kisup.2012.73; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Maione A, 2011, NEPHROL DIAL TRANSPL, V26, P2827, DOI 10.1093/ndt/gfq792; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Mann JFE, 2010, J AM SOC NEPHROL, V21, P527, DOI 10.1681/ASN.2009060593; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Multiple Treatments Meta-Analysis, 2015, US STATA NETW MET; National Institute of Health National Heart Lung and Blood Institute, 2004, NIH PUBLICATION, V04-5230; National Institute of Health National Heart Lung and Blood Institute, 1997, NIH PUBLICATION, V98-4080; National Kidney Foundation, 2004, KIDN DIS OUTC QUAL I; Packham DK, 2015, NEW ENGL J MED, V372, P222, DOI 10.1056/NEJMoa1411487; Ravid M, 1996, ARCH INTERN MED, V156, P286, DOI 10.1001/archinte.156.3.286; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Salanti G, 2009, J CLIN EPIDEMIOL, V62, P857, DOI 10.1016/j.jclinepi.2008.10.001; Strippoli GFM, 2004, BMJ-BRIT MED J, V329, P828, DOI 10.1136/bmj.38237.585000.7C; Turner RM, 2012, INT J EPIDEMIOL, V41, P818, DOI 10.1093/ije/dys041; United States Renal Data System, 2013, 2013 ATL CKD ESRD; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; Weir MR, 2015, NEW ENGL J MED, V372, P211, DOI 10.1056/NEJMoa1410853; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wu HY, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6008	35	260	276	3	88	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2047	2056		10.1016/S0140-6736(14)62459-4	http://dx.doi.org/10.1016/S0140-6736(14)62459-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI7XK	26009228				2022-12-28	WOS:000354979100024
J	Hawkes, N				Hawkes, Nigel			Air pollution in UK: the public health problem that won't go away	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						COMMITTEE ON THE MEDICAL EFFECTS OF AIR POLLUTANTS (COMEAP), 2010, MORT EFF LONG TERM E; Department for Environment Farming and Rural Affairs, 2014, EM AIR POLL UK 1970; Environmental Audit Committee, AIR QUAL FOLL REP SE; European Commission, 2013, CLEAN AIR PROGR EUR; House of Commons Environmental Audit Committee, 6 HOUS COMM ENV AUD	5	3	3	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2015	350								h2757	10.1136/bmj.h2757	http://dx.doi.org/10.1136/bmj.h2757			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI9ZO	26001592				2022-12-28	WOS:000355130600001
J	Rassam, P; Copeland, NA; Birkholz, O; Toth, C; Chavent, M; Duncan, AL; Cross, SJ; Housden, NG; Kaminska, R; Seger, U; Quinn, DM; Garrod, TJ; Sansom, MSP; Piehler, J; Baumann, CG; Kleanthous, C				Rassam, Patrice; Copeland, Nikki A.; Birkholz, Oliver; Toth, Csaba; Chavent, Matthieu; Duncan, Anna L.; Cross, Stephen J.; Housden, Nicholas G.; Kaminska, Renata; Seger, Urban; Quinn, Diana M.; Garrod, Tamsin J.; Sansom, Mark S. P.; Piehler, Jacob; Baumann, Christoph G.; Kleanthous, Colin			Supramolecular assemblies underpin turnover of outer membrane proteins in bacteria	NATURE			English	Article							POLYMER-SUPPORTED MEMBRANES; ESCHERICHIA-COLI; SINGLE-MOLECULE; LOCALIZE PROTEINS; RECEPTOR-BINDING; R-DOMAIN; DIFFUSION; INSERTION; DYNAMICS; CELLS	Gram-negative bacteria inhabit a broad range of ecological niches. For Escherichia coli, this includes river water as well as humans and animals, where it can be both a commensal and a pathogen(1-3). Intricate regulatory mechanisms ensure that bacteria have the right complement of beta-barrel outer membrane proteins (OMPs) to enable adaptation to a particular habitat(4,5). Yet no mechanism is known for replacing OMPs in the outer membrane, an issue that is further confounded by the lack of an energy source and the high stability(6) and abundance of OMPs(5). Here we uncover the process underpinning OMP turnover in Escherichia coli and show it to be passive and binary in nature, in which old OMPs are displaced to the poles of growing cells as new OMPs take their place. Using fluorescent colicins as OMP-specific probes, in combination with ensemble and single-molecule fluorescence microscopy in vivo and in vitro, as well as molecular dynamics simulations, we established the mechanism for binary OMP partitioning. OMPs clustered to form 0.5-mu m diameter islands, where their diffusion is restricted by promiscuous interactions with other OMPs. OMP islands were distributed throughout the cell and contained the Bam complex, which catalyses the insertion of OMPs in the outer membrane(7,8). However, OMP biogenesis occurred as a gradient that was highest at mid-cell but largely absent at cell poles. The cumulative effect is to push old OMP islands towards the poles of growing cells, leading to a binary distribution when cells divide. Hence, the outer membrane of a Gram-negative bacterium is a spatially and temporally organized structure, and this organization lies at the heart of how OMPs are turned over in the membrane.	[Rassam, Patrice; Chavent, Matthieu; Duncan, Anna L.; Housden, Nicholas G.; Kaminska, Renata; Sansom, Mark S. P.; Kleanthous, Colin] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Rassam, Patrice; Copeland, Nikki A.; Toth, Csaba; Cross, Stephen J.; Seger, Urban; Quinn, Diana M.; Garrod, Tamsin J.; Baumann, Christoph G.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Birkholz, Oliver; Piehler, Jacob] Univ Osnabruck, Dept Biol, D-49076 Osnabruck, Germany	University of Oxford; University of York - UK; University Osnabruck	Kleanthous, C (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	christoph.baumann@york.ac.uk; colin.kleanthous@bioch.ox.ac.uk	Sansom, Mark S.P./C-5157-2009; Chavent, Matthieu/AAM-9860-2020; Rassam, Patrice/P-6564-2014	Sansom, Mark S.P./0000-0001-6360-7959; Housden, Nicholas/0000-0002-4706-8278; Rassam, Patrice/0000-0002-8630-0957; Cross, Stephen/0000-0003-3565-0479; Duncan, Anna/0000-0001-9873-4552; Birkholz, Oliver/0000-0001-6551-3219; Kaminska, Renata/0000-0001-7252-379X; Copeland, Nikki/0000-0002-6204-4717; Chavent, Matthieu/0000-0003-4524-4773	Royal Society [2004/R1]; University of York (Research Priming Fund); BBSRC LoLa grant [BB/G020671/1]; Deutsche Forschungsgemeinschaft [SFB 944]; BBSRC [BB/L002558/1]; Wellcome Trust [WT092970MA]; Biotechnology and Biological Sciences Research Council [BB/H000267/1, BEP17032, BBS/B/16011, BB/I019855/1, B19456, BB/G020671/2, BB/L002558/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/L000253/1, EP/J010421/1] Funding Source: researchfish; BBSRC [BB/I019855/1, BB/G020671/2, BB/H000267/1] Funding Source: UKRI; EPSRC [EP/J010421/1, EP/L000253/1] Funding Source: UKRI	Royal Society(Royal Society of London); University of York (Research Priming Fund); BBSRC LoLa grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the University of Oxford Micron facility and the University of York Biology Technology Facility for access to microscopy facilities. The authors also thank S. Buchanan and K. Jakes for anti-BamC antibody and Colla plasmids, I. Henderson for HA-tagged BamA constructs, C. Robinson for TatA-GFP construct, K. Heurlier and J. Pullen for PCR screening of deletion strains, A. Sharma for the design of the inactivating disulfide bond in ColIa, and P. E. Milhier and his group for providing optimised PATRACK single-molecule tracking software. A.L.D. and M.C. thank T. Reddy for discussions and assistance with diffusion calculations. U.S. and C.G.B. thank the University of York Biology Electronic and Mechanical Workshops for custom fabrications, and G. Mashanov for custom image acquisition software. We also thank B. Berks for comments on the manuscript. C.G.B. acknowledges the Royal Society (2004/R1) and the University of York (Research Priming Fund) for financial support used to develop the TIRFM. P.R. acknowledges the late R. Saadia for his unwavering support. M.S.P.S. acknowledges access to the UK supercomputer ARCHER for molecular dynamics simulations. This work was supported by grants to C.K. and C.G.B. (BBSRC LoLa grant BB/G020671/1), J.P. (Deutsche Forschungsgemeinschaft SFB 944) and M.S.P.S. (BBSRC BB/L002558/1, Wellcome Trust WT092970MA).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bond PJ, 2008, BIOCHEMISTRY-US, V47, P11321, DOI 10.1021/bi800642m; Bond PJ, 2006, J AM CHEM SOC, V128, P2697, DOI 10.1021/ja0569104; Browning DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084512; Buchanan SK, 2007, EMBO J, V26, P2594, DOI 10.1038/sj.emboj.7601693; Casuso I, 2012, NAT NANOTECHNOL, V7, P525, DOI [10.1038/nnano.2012.109, 10.1038/NNANO.2012.109]; DeGrip WJ, 1998, BIOCHEM J, V330, P667; Deich J, 2004, P NATL ACAD SCI USA, V101, P15921, DOI 10.1073/pnas.0404200101; Espenel C, 2008, J CELL BIOL, V182, P765, DOI 10.1083/jcb.200803010; GarinotSchneider C, 1996, J MOL BIOL, V260, P731, DOI 10.1006/jmbi.1996.0433; Goose JE, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003033; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Housden NG, 2005, P NATL ACAD SCI USA, V102, P13849, DOI 10.1073/pnas.0503567102; Housden NG, 2013, SCIENCE, V340, P1570, DOI 10.1126/science.1237864; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ieva R, 2011, P NATL ACAD SCI USA, V108, pE383, DOI 10.1073/pnas.1103827108; Jaroslawski S, 2009, MOL MICROBIOL, V74, P1211, DOI 10.1111/j.1365-2958.2009.06926.x; Javanainen M, 2013, FARADAY DISCUSS, V161, P397, DOI 10.1039/c2fd20085f; JEANTEUR D, 1994, P NATL ACAD SCI USA, V91, P10675, DOI 10.1073/pnas.91.22.10675; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Klauda JB, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2354486; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Konovalova A, 2014, P NATL ACAD SCI USA, V111, pE4350, DOI 10.1073/pnas.1417138111; Krementsov DN, 2010, TRAFFIC, V11, P1401, DOI 10.1111/j.1600-0854.2010.01111.x; Kurisu G, 2003, NAT STRUCT BIOL, V10, P948, DOI 10.1038/nsb997; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Laloux G, 2014, J CELL SCI, V127, P11, DOI 10.1242/jcs.138628; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Mashanov GI, 2007, BIOPHYS J, V92, P2199, DOI 10.1529/biophysj.106.081117; Michaud-Agrawal N., 2011, J COMPUT CHEM; Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110; Morabito S., 2014, PATHOGENIC ESCHERICH; Mullineaux CW, 2006, J BACTERIOL, V188, P3442, DOI 10.1128/JB.188.10.3442-3448.2006; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Oddershede L, 2002, BIOPHYS J, V83, P3152, DOI 10.1016/S0006-3495(02)75318-6; Penfold CN, 2004, J BACTERIOL, V186, P4520, DOI 10.1128/JB.186.14.4520-4527.2004; Qiao S, 2014, NATURE, V511, P108, DOI 10.1038/nature13484; Ray N, 2005, J BIOL CHEM, V280, P17961, DOI 10.1074/jbc.M413521200; Roder F, 2013, J AM CHEM SOC, V135, P1189, DOI 10.1021/ja310186g; Roder F, 2011, ANAL CHEM, V83, P6792, DOI 10.1021/ac201294v; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685; SMIT J, 1978, J BACTERIOL, V135, P687, DOI 10.1128/JB.135.2.687-702.1978; Spector J, 2010, BIOPHYS J, V99, P3880, DOI 10.1016/j.bpj.2010.10.029; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Ursell TS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002680; van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80; Verhoeven GS, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-66; Vogel J, 2006, CURR OPIN MICROBIOL, V9, P605, DOI 10.1016/j.mib.2006.10.006; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Webb CT, 2012, J MOL BIOL, V422, P545, DOI 10.1016/j.jmb.2012.05.035; WHITE JC, 1973, J BIOL CHEM, V248, P3978; Yin J, 2005, P NATL ACAD SCI USA, V102, P15815, DOI 10.1073/pnas.0507705102; Zinchuk V, 2011, NAT PROTOC, V6, P1554, DOI 10.1038/nprot.2011.384	58	131	131	3	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					333	+		10.1038/nature14461	http://dx.doi.org/10.1038/nature14461			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26061769	Green Accepted			2022-12-28	WOS:000357950900039
J	Turner, NC; Ro, J; Andre, F; Loi, S; Verma, S; Iwata, H; Harbeck, N; Loibl, S; Bartlett, CH; Zhang, K; Giorgetti, C; Randolph, S; Koehler, M; Cristofanilli, M				Turner, Nicholas C.; Ro, Jungsil; Andre, Fabrice; Loi, Sherene; Verma, Sunil; Iwata, Hiroji; Harbeck, Nadia; Loibl, Sibylle; Bartlett, Cynthia Huang; Zhang, Ke; Giorgetti, Carla; Randolph, Sophia; Koehler, Maria; Cristofanilli, Massimo			Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							4/6 INHIBITOR PALBOCICLIB; ESTROGEN-RECEPTOR; CYCLIN D; FULVESTRANT; COMBINATION; MUTATIONS; TARGET	BACKGROUND Growth of hormone-receptor-positive breast cancer is dependent on cyclin-dependent kinases 4 and 6 (CDK4 and CDK6), which promote progression from the G1 phase to the S phase of the cell cycle. We assessed the efficacy of palbociclib (an inhibitor of CDK4 and CDK6) and fulvestrant in advanced breast cancer. METHODS This phase 3 study involved 521 patients with advanced hormone-receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that had relapsed or progressed during prior endocrine therapy. We randomly assigned patients in a 2: 1 ratio to receive palbociclib and fulvestrant or placebo and fulvestrant. Premenopausal or perimenopausal women also received goserelin. The primary end point was investigator-assessed progression-free survival. Secondary end points included overall survival, objective response, rate of clinical benefit, patient-reported outcomes, and safety. A preplanned interim analysis was performed by an independent data and safety monitoring committee after 195 events of disease progression or death had occurred. RESULTS The median progression-free survival was 9.2 months (95% confidence interval [CI], 7.5 to not estimable) with palbociclib-fulvestrant and 3.8 months (95% CI, 3.5 to 5.5) with placebo-fulvestrant (hazard ratio for disease progression or death, 0.42; 95% CI, 0.32 to 0.56; P<0.001). The most common grade 3 or 4 adverse events in the palbociclib-fulvestrant group were neutropenia (62.0%, vs. 0.6% in the placebo-fulvestrant group), leukopenia (25.2% vs. 0.6%), anemia (2.6% vs. 1.7%), thrombocytopenia (2.3% vs. 0%), and fatigue (2.0% vs. 1.2%). Febrile neutropenia was reported in 0.6% of palbociclib-treated patients and 0.6% of placebo-treated patients. The rate of discontinuation due to adverse events was 2.6% with palbociclib and 1.7% with placebo. CONCLUSIONS Among patients with hormone-receptor-positive metastatic breast cancer who had progression of disease during prior endocrine therapy, palbociclib combined with fulvestrant resulted in longer progression-free survival than fulvestrant alone.	[Turner, Nicholas C.] Royal Marsden Hosp, London SW3 6JJ, England; [Ro, Jungsil] Natl Canc Ctr, Goyang Si, South Korea; [Andre, Fabrice] Inst Gustave Roussy, Villejuif, France; [Loi, Sherene] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Verma, Sunil] Sunny Brook Odette Canc Ctr, Toronto, ON, Canada; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; [Harbeck, Nadia] Brustzentrum Univ Munchen, Munich, Germany; [Loibl, Sibylle] German Breast Grp Forschungs, Neu Isenburg, Germany; [Bartlett, Cynthia Huang; Koehler, Maria] Pfizer, New York, NY USA; [Cristofanilli, Massimo] Thomas Jefferson Univ, Philadelphia, PA 19107 USA	Royal Marsden NHS Foundation Trust; National Cancer Center - Korea (NCC); UNICANCER; Gustave Roussy; Peter Maccallum Cancer Center; University of Melbourne; University of Toronto; University Toronto Affiliates; Sunnybrook Health Science Center; Aichi Cancer Center; University of Munich; German Breast Group; Pfizer	Turner, NC (corresponding author), Royal Marsden Hosp, Fulham Rd, London SW3 6JJ, England.	nicholas.turner@icr.ac.uk	ANDRE, Fabrice/AAL-2683-2020; Khasraw, Mustafa/ABH-5962-2020; Loi, Sherene/H-1979-2016	ANDRE, Fabrice/0000-0001-5795-8357; Khasraw, Mustafa/0000-0003-3249-9849; Loi, Sherene/0000-0001-6137-9171; Chalasani, Pavani/0000-0002-7953-2979; Turner, Nicholas/0000-0001-8937-0873; SOTO PARRA, HECTOR/0000-0001-7966-4472; Kroep, Judith/0000-0003-2671-1903	Pfizer	Pfizer(Pfizer)	Supported by Pfizer.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; DeMichele A, 2015, CLIN CANCER RES, V21, P995, DOI 10.1158/1078-0432.CCR-14-2258; Di Leo A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt337; Di Leo A, 2010, J CLIN ONCOL, V28, P4594, DOI 10.1200/JCO.2010.28.8415; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Francis PA, 2015, NEW ENGL J MED, V372, P436, DOI 10.1056/NEJMoa1412379; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Klijn JGM, 2000, JNCI-J NATL CANCER I, V92, P903, DOI 10.1093/jnci/92.11.903; Mehta RS, 2012, NEW ENGL J MED, V367, P435, DOI 10.1056/NEJMoa1201622; Miller TW, 2011, CANCER DISCOV, V1, P338, DOI 10.1158/2159-8290.CD-11-0101; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; National Comprehensive Cancer Network, 2015, CLIN PRACT GUID ONC; Park IH, 2010, J CLIN ONCOL, V28, P2705, DOI 10.1200/JCO.2009.26.5884; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Thangavel C, 2011, ENDOCR-RELAT CANCER, V18, P333, DOI 10.1530/ERC-10-0262; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012; Zhang JJ, 2013, CLIN CANCER RES, V19, P2637, DOI 10.1158/1078-0432.CCR-12-3364	25	950	990	0	118	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2015	373	3					209	219		10.1056/NEJMoa1505270	http://dx.doi.org/10.1056/NEJMoa1505270			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM8MS	26030518	Green Published			2022-12-28	WOS:000357956200004
J	Schultz, MD; He, YP; Whitaker, JW; Hariharan, M; Mukamel, EA; Leung, D; Rajagopal, N; Nery, JR; Urich, MA; Chen, HM; Lin, S; Lin, Y; Jung, I; Schmitt, AD; Selvaraj, S; Ren, B; Sejnowski, TJ; Wang, W; Ecker, JR				Schultz, Matthew D.; He, Yupeng; Whitaker, John W.; Hariharan, Manoj; Mukamel, Eran A.; Leung, Danny; Rajagopal, Nisha; Nery, Joseph R.; Urich, Mark A.; Chen, Huaming; Lin, Shin; Lin, Yiing; Jung, Inkyung; Schmitt, Anthony D.; Selvaraj, Siddarth; Ren, Bing; Sejnowski, Terrence J.; Wang, Wei; Ecker, Joseph R.			Human body epigenome maps reveal noncanonical DNA methylation variation	NATURE			English	Article							PLURIPOTENT STEM-CELLS; CPG ISLAND SHORES; DISEASE; TISSUES; CANCER; LANDSCAPE; METHYLOME; ENHANCERS; GENOME	Understanding the diversity of human tissues is fundamental to disease and requires linking genetic information, which is identical in most of an individual's cells, with epigenetic mechanisms that could have tissue-specific roles. Surveys of DNA methylation in human tissues have established a complex landscape including both tissue-specific and invariant methylation patterns(1,2). Here we report high coverage methylomes that catalogue cytosine methylation in all contexts for the major human organ systems, integrated with matched transcriptomes and genomic sequence. By combining these diverse data types with each individuals' phased genome(3), we identified widespread tissue-specific differential CG methylation (mCG), partially methylated domains, allele-specific methylation and transcription, and the unexpected presence of non-CG methylation (mCH) in almost all human tissues. mCH correlated with tissue-specific functions, and using this mark, we made novel predictions of genes that escape X-chromosome inactivation in specific tissues. Overall, DNA methylation in several genomic contexts varies substantially among human tissues.	[Schultz, Matthew D.; He, Yupeng; Selvaraj, Siddarth] Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; [Schultz, Matthew D.; He, Yupeng; Hariharan, Manoj; Nery, Joseph R.; Urich, Mark A.; Chen, Huaming; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Whitaker, John W.; Wang, Wei] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Mukamel, Eran A.; Sejnowski, Terrence J.] Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; [Mukamel, Eran A.] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92037 USA; [Leung, Danny; Rajagopal, Nisha; Jung, Inkyung; Schmitt, Anthony D.; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Lin, Shin] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Lin, Yiing] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Inst Genom Med, La Jolla, CA 92093 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92037 USA; [Sejnowski, Terrence J.; Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Wang, Wei] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; Stanford University; Washington University (WUSTL); University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	Ecker, JR (corresponding author), Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA.	ecker@salk.edu	Hariharan, Manoj/N-2855-2015; Jung, Inkyung/CAJ-5773-2022; Ecker, Joseph R/B-9144-2008; Nery, Joseph/AAE-8422-2019; Sejnowski, Terrence/AAV-5558-2021	Hariharan, Manoj/0000-0002-1006-5372; Ecker, Joseph R/0000-0001-5799-5895; Nery, Joseph/0000-0003-0153-5659; Jung, Inkyung/0000-0002-5885-2754; Chen, Huaming/0000-0001-5289-7882; Lin, Yiing/0000-0002-0317-7608; Lin, Shin/0000-0003-0118-0413; Whitaker, John W./0000-0002-0585-9119; Mukamel, Eran/0000-0003-3203-9535; Leung, Danny Chi Yeu/0000-0002-2472-894X	National Institutes of Health (NIH) Epigenome Roadmap Project [U01 ES017166]; National Institute of Neurological Diseases and Stroke grant [R00NS080911]; Gordon and Betty Moore Foundation [GMBF3034]; Mary K. Chapman Foundation; NIH [F32HL110473, K99HL119617]; Mid-America Transplant Services, St Louis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL110473, K99HL119617] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166, R01ES024984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS080911, R00NS080911] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Epigenome Roadmap Project; National Institute of Neurological Diseases and Stroke grant; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Mary K. Chapman Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mid-America Transplant Services, St Louis; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R.J. Schmitz for critical reading of the manuscript. This work is supported by the National Institutes of Health (NIH) Epigenome Roadmap Project (U01 ES017166). E.A.M. was supported by National Institute of Neurological Diseases and Stroke grant (R00NS080911). J.R.E. was supported by the Gordon and Betty Moore Foundation (GMBF3034) and the Mary K. Chapman Foundation. T.J.S. and J.R.E. are investigators of the Howard Hughes Medical Institute. S.L. was supported by NIH fellowship grants F32HL110473 and K99HL119617. The authors acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing HPC resources that have contributed to the research results reported within this paper. The authors would also like to thank Mid-America Transplant Services, St Louis, for their support of this research effort.	Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Leung D, 2015, NATURE, V518, P350, DOI 10.1038/nature14217; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Schroeder DI, 2013, P NATL ACAD SCI USA, V110, P6037, DOI 10.1073/pnas.1215145110; Schultz MD, 2012, TRENDS GENET, V28, P583, DOI 10.1016/j.tig.2012.10.012; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Stankunas K, 2008, CIRC RES, V103, P702, DOI 10.1161/CIRCRESAHA.108.175489; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Whitaker JW, 2015, NAT METHODS, V12, P265, DOI [10.1038/NMETH.3065, 10.1038/nmeth.3065]; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yuen SL, 2009, AM J PHYSIOL-HEART C, V297, pH191, DOI 10.1152/ajpheart.00132.2009; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	30	380	385	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					212	U189		10.1038/nature14465	http://dx.doi.org/10.1038/nature14465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	26030523	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000357695900035
J	Asante, EA; Smidak, M; Grimshaw, A; Houghton, R; Tomlinson, A; Jeelani, A; Jakubcova, T; Hamdan, S; Richard-Londt, A; Linehan, JM; Brandner, S; Alpers, M; Whitfield, J; Mead, S; Wadsworth, JDF; Collinge, J				Asante, Emmanuel A.; Smidak, Michelle; Grimshaw, Andrew; Houghton, Richard; Tomlinson, Andrew; Jeelani, Asif; Jakubcova, Tatiana; Hamdan, Shyma; Richard-Londt, Angela; Linehan, Jacqueline M.; Brandner, Sebastian; Alpers, Michael; Whitfield, Jerome; Mead, Simon; Wadsworth, Jonathan D. F.; Collinge, John			A naturally occurring variant of the human prion protein completely prevents prion disease	NATURE			English	Article							CREUTZFELDT-JAKOB-DISEASE; TRANSGENIC MICE; BSE; CJD; PHENOTYPE; SUSCEPTIBILITY; STRAINS; PRP	Mammalian prions, transmissible agents causing lethal neuro-degenerative diseases, are composed of assemblies of misfolded cellular prion protein (PrP)(1). A novel PrP variant, G127V, was under positive evolutionary selection during the epidemic of kuru-an acquired prion disease epidemic of the Fore population in Papua New Guinea-and appeared to provide strong protection against disease in the heterozygous state(2). Here we have investigated the protective role of this variant and its interaction with the common, worldwide M129V PrP polymorphism. V127 was seen exclusively on a M129 PRNP allele. We demonstrate that transgenic mice expressing both variant and wild-type human PrP are completely resistant to both kuru and classical Creutzfeldt-Jakob disease (CJD) prions (which are closely similar) but can be infected with variant CJD prions, a human prion strain resulting from exposure to bovine spongiform encephalopathy prions to which the Fore were not exposed. Notably, mice expressing only PrP V127 were completely resistant to all prion strains, demonstrating a different molecular mechanism to M129V, which provides its relative protection against classical CJD and kuru in the heterozygous state. Indeed, this single amino acid substitution (G -> V) at a residue invariant in vertebrate evolution is as protective as deletion of the protein. Further study in transgenic mice expressing different ratios of variant and wild-type PrP indicates that not only is PrP V127 completely refractory to prion conversion but acts as a potent dose-dependent inhibitor of wild-type prion propagation.	[Asante, Emmanuel A.; Smidak, Michelle; Grimshaw, Andrew; Houghton, Richard; Tomlinson, Andrew; Jeelani, Asif; Jakubcova, Tatiana; Hamdan, Shyma; Richard-Londt, Angela; Linehan, Jacqueline M.; Brandner, Sebastian; Alpers, Michael; Whitfield, Jerome; Mead, Simon; Wadsworth, Jonathan D. F.; Collinge, John] UCL Inst Neurol, Dept Neurodegenerat Dis, MRC Prion Unit, London WC1N 3BG, England; [Alpers, Michael; Whitfield, Jerome] Papua New Guinea Inst Med Res, Goroka, Eastern Highlan, Papua N Guinea	University of London; University College London; PNG Institute Of Medical Research	Collinge, J (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, MRC Prion Unit, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk	Brandner, Sebastian/J-4562-2014	Brandner, Sebastian/0000-0002-9821-0342; Asante, Emmanuel A/0000-0003-3771-4843; Wadsworth, Jonathan/0000-0002-4797-2259; Mead, Simon/0000-0002-4326-1468	UK Medical Research Council; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; Medical Research Council [MC_U123192748, MC_U123160655, MC_U123160653] Funding Source: researchfish; MRC [MC_U123192748, MC_U123160655, MC_U123160653] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the UK Medical Research Council. We thank all staff at our Biological Services Facility for animal care; C. O'Malley and S. Lyall for technical support with histology; and R. Newton and R. Young for preparation of figures. We thank patients and families for consent to use human tissues. We thank UK neurological and neuropathology colleagues for providing brain tissue from CJD patients. Some of this work was undertaken at University College London Hospitals/University College London, which received a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. We thank the Fore communities and P. Siba and colleagues at the Papua New Guinea Institute of Medical Research for their long-term support. We thank the late C. Gajdusek, the late J. Gibbs, S. Landis, and their associates from the Laboratory of Central Nervous System Studies of the National Institutes of Health, Bethesda, USA, for archiving and sharing kuru samples.	Alpers MP, 2008, PHILOS T R SOC B, V363, P3707, DOI 10.1098/rstb.2008.0071; Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Asante EA, 2004, NEUROSCI LETT, V360, P33, DOI 10.1016/j.neulet.2004.01.049; Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Asante EA, 2006, P NATL ACAD SCI USA, V103, P10759, DOI 10.1073/pnas.0604292103; Asante EA, 2009, J GEN VIROL, V90, P546, DOI 10.1099/vir.0.007930-0; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; COLLINGE J, 1995, NATURE, V378, P779, DOI 10.1038/378779a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; DiSalvo S, 2011, NAT STRUCT MOL BIOL, V18, P486, DOI 10.1038/nsmb.2031; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hizume M, 2009, J BIOL CHEM, V284, P3603, DOI 10.1074/jbc.M809254200; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Mead S, 2009, NEW ENGL J MED, V361, P2056, DOI 10.1056/NEJMoa0809716; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; Shibuya S, 1998, LANCET, V351, P419, DOI 10.1016/S0140-6736(05)78358-6; Striebel JF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002275; Wadsworth JDF, 2010, NEUROPATH APPL NEURO, V36, P576, DOI 10.1111/j.1365-2990.2010.01129.x; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; Wadsworth Jonathan D. F., 2008, V459, P197, DOI 10.1007/978-1-59745-234-2_14; Wadsworth JDF, 2008, P NATL ACAD SCI USA, V105, P3885, DOI 10.1073/pnas.0800190105	30	110	112	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 25	2015	522	7557					478	+		10.1038/nature14510	http://dx.doi.org/10.1038/nature14510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2OC	26061765	Green Submitted, Green Accepted			2022-12-28	WOS:000356782900050
J	Annas, GJ; Crosby, SS				Annas, George J.; Crosby, Sondra S.			Post-9/11 Torture at CIA "Black Sites" - Physicians and Lawyers Working Together	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Annas, George J.; Crosby, Sondra S.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA; [Crosby, Sondra S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University; Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Annas GJ, 2012, NEW ENGL J MED, V367, P1653, DOI 10.1056/NEJMhle1205592; Cole D, 2015, NY TIMES, pSR6; Cumming-Bruce N, 2015, NY TIMES, pA8; Lifton RJ, 2004, NEW ENGL J MED, V351, P415, DOI 10.1056/NEJMp048065; Senate Select Committee on Intelligence, 2014, COMM STUD CENTA INT	5	8	8	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2015	372	24					2279	2281		10.1056/NEJMp1503428	http://dx.doi.org/10.1056/NEJMp1503428			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK2DB	26061833				2022-12-28	WOS:000356019200002
J	Senn, CY; Eliasziw, M; Barata, PC; Thurston, WE; Newby-Clark, IR; Radtke, HL; Hobden, KL				Senn, Charlene Y.; Eliasziw, Misha; Barata, Paula C.; Thurston, Wilfreda E.; Newby-Clark, Ian R.; Radtke, H. Lorraine; Hobden, Karen L.			Efficacy of a Sexual Assault Resistance Program for University Women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-REDUCTION PROGRAM; VIOLENCE PREVENTION; COLLEGE-WOMEN; SELF-DEFENSE; AGGRESSION; EDUCATION; RAPE	BACKGROUND Young women attending university are at substantial risk for being sexually assaulted, primarily by male acquaintances, but effective strategies to reduce this risk remain elusive. METHODS We randomly assigned first-year female students at three universities in Canada to the Enhanced Assess, Acknowledge, Act Sexual Assault Resistance program (resistance group) or to a session providing access to brochures on sexual assault, as was common university practice (control group). The resistance program consists of four 3-hour units in which information is provided and skills are taught and practiced, with the goal of being able to assess risk from acquaintances, overcome emotional barriers in acknowledging danger, and engage in effective verbal and physical self-defense. The primary outcome was completed rape, as measured by the Sexual Experiences Survey-Short Form Victimization, during 1 year of follow-up. RESULTS A total of 451 women were assigned to the resistance group and 442 women to the control group. Of the women assigned to the resistance group, 91% attended at least three of the four units. The 1-year risk of completed rape was significantly lower in the resistance group than in the control group (5.2% vs. 9.8%; relative risk reduction, 46.3% [95% confidence interval, 6.8 to 69.1]; P = 0.02). The 1-year risk of attempted rape was also significantly lower in the resistance group (3.4% vs. 9.3%, P< 0.001). CONCLUSIONS A rigorously designed and executed sexual assault resistance program was successful in decreasing the occurrence of rape, attempted rape, and other forms of victimization among first-year university women.	[Senn, Charlene Y.; Hobden, Karen L.] Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada; [Senn, Charlene Y.; Hobden, Karen L.] Univ Windsor, Womens & Gender Studies Program, Windsor, ON N9B 3P4, Canada; [Eliasziw, Misha; Thurston, Wilfreda E.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Thurston, Wilfreda E.] Univ Calgary, Dept Ecosyst & Publ Hlth, Calgary, AB, Canada; [Radtke, H. Lorraine] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada; [Barata, Paula C.; Newby-Clark, Ian R.] Univ Guelph, Dept Psychol, Guelph, ON N1G 2W1, Canada; [Eliasziw, Misha] Tufts Univ, Dept Publ Hlth & Community Med, Boston, MA 02111 USA	University of Windsor; University of Windsor; University of Calgary; University of Calgary; University of Calgary; University of Guelph; Massachusetts Department of Public Health; Tufts University	Senn, CY (corresponding author), Univ Windsor, Dept Psychol, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	csenn@uwindsor.ca		Senn, Charlene/0000-0002-3463-5704; Torgerson, David/0000-0002-1667-4275	Canadian Institutes of Health Research; University of Windsor	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Windsor	Funded by the Canadian Institutes of Health Research and the University of Windsor; SARE ClinicalTrials.gov number, NCT01338428.	[Anonymous], 2000, OUR WHOLE LIVES SEXU; Banyard VL, 2007, J COMMUNITY PSYCHOL, V35, P463, DOI 10.1002/jcop.20159; Basile Kathleen C, 2002, Violence Vict, V17, P511, DOI 10.1891/vivi.17.5.511.33717; Breitenbecher KH, 1998, J INTERPERS VIOLENCE, V13, P472, DOI 10.1177/088626098013004004; Brener ND, 1999, J CONSULT CLIN PSYCH, V67, P252, DOI 10.1037/0022-006X.67.2.252; DEKESEREDY W, 1993, CAN J SOCIOL, V18, P137, DOI 10.2307/3341255; Fisher B. S., 2000, RES REPORT; Fisher Bonnie S, 2007, Violence Vict, V22, P18, DOI 10.1891/088667007780482847; Gidycz CA, 2006, PSYCHOL WOMEN QUART, V30, P173, DOI 10.1111/j.1471-6402.2006.00280.x; Gidycz CA, 2001, J CONSULT CLIN PSYCH, V69, P1073, DOI 10.1037//0022-006X.69.6.1073; Gidycz CA, 2011, VIOLENCE AGAINST WOM, V17, P720, DOI 10.1177/1077801211409727; HANSON KA, 1993, J CONSULT CLIN PSYCH, V61, P1046, DOI 10.1037/0022-006X.61.6.1046; Kimball R.S., 2000, OUR WHOLE LIVES SEXU; Kimble M, 2008, J AM COLL HEALTH, V56, P331, DOI 10.3200/JACH.57.3.331-338; Koss MP, 2007, PSYCHOL WOMEN QUART, V31, P357, DOI 10.1111/j.1471-6402.2007.00385.x; KOSS MP, 1994, PSYCHOL WOMEN QUART, V18, P509, DOI 10.1111/j.1471-6402.1994.tb01046.x; KOSS MP, 1982, J CONSULT CLIN PSYCH, V50, P455, DOI 10.1037/0022-006X.50.3.455; Lonsway K.A., 2009, RAPE PREVENTION RISK; McInturff K. E., 2013, GAP GENDER GAP VIOLE; Morrison S, 2004, 207262 US DEP JSUT; Nation M, 2003, AM PSYCHOL, V58, P449, DOI 10.1037/0003-066X.58.6-7.449; Nurius Paula S, 1996, J Psychol Human Sex, V8, P117, DOI 10.1300/J056v08n01_09; Ontario Women's Directorate, 2013, DEV RESP SEX VIOL RE; Orchowski LM, 2008, PSYCHOL WOMEN QUART, V32, P204, DOI 10.1111/j.1471-6402.2008.00425.x; PRENTICE RL, 1978, BIOMETRICS, V34, P57, DOI 10.2307/2529588; RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311; Rozee PD, 2001, PSYCHOL WOMEN QUART, V25, P295, DOI 10.1111/1471-6402.00030; Senn C.Y., 2008, VIOLENCES FAITES FEM, P353; Senn CY, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/s12905-014-0135-4; Senn CY, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-25; Senn CY, 2011, PSYCHOL WOMEN QUART, V35, P72, DOI 10.1177/0361684310384101; Stedman MR, 2011, COMPUT METH PROG BIO, V104, P266, DOI 10.1016/j.cmpb.2011.02.001; Testa M, 2004, PSYCHOL WOMEN QUART, V28, P256, DOI 10.1111/j.1471-6402.2004.00143.x; Tharp AT, 2011, J INTERPERS VIOLENCE, V26, P3383, DOI 10.1177/0886260510393010; The White House Council on Women and Girls, 2014, RAP SEX ASS RENW CAL; Ullman SE, 1997, CRIM JUSTICE BEHAV, V24, P177, DOI 10.1177/0093854897024002003; White House Task Force to Protect Students From Sexual Assault, 2014, NOT AL TOG SEX ASS	37	177	177	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2015	372	24					2326	2335		10.1056/NEJMsa1411131	http://dx.doi.org/10.1056/NEJMsa1411131			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK2DB	26061837	Bronze, Green Published			2022-12-28	WOS:000356019200008
J	Clayton, EW				Clayton, Ellen Wright			Why the Americans With Disabilities Act Matters for Genetics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISCRIMINATION		[Clayton, Ellen Wright] Vanderbilt Univ, Ctr Biomed Eth & Soc, Nashville, TN 37235 USA	Vanderbilt University	Clayton, EW (corresponding author), Ctr Biomed Eth & Soc, 2525 West End Ave,Ste 400, Nashville, TN 37203 USA.	ellen.clayton@vanderbilt.edu						Green RC, 2015, NEW ENGL J MED, V372, P397, DOI 10.1056/NEJMp1404776; Klitzman R, 2014, JAMA-J AM MED ASSOC, V312, P1855, DOI 10.1001/jama.2014.13301; Silvers A, 2002, VANDERBILT LAW REV, V55, P1341	3	10	10	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2225	2226		10.1001/jama.2015.3419	http://dx.doi.org/10.1001/jama.2015.3419			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1VH	26057280				2022-12-28	WOS:000355995300013
J	Jameson, JL; Longo, DL				Jameson, J. Larry; Longo, Dan L.			Precision Medicine - Personalized, Problematic, and Promising	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CLINICAL-PRACTICE; THERAPY; INHIBITION; BIOMARKER; LYMPHOMA; EFFICACY; MUTATION; FUTURE; CANCER; SAFETY		[Jameson, J. Larry] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Jameson, JL (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.		Longo, Dan L./F-6022-2011	Jameson, James/0000-0001-9538-4059				Asch DA, 2012, NEW ENGL J MED, V367, P1, DOI 10.1056/NEJMp1203869; Blaser MJ, 2014, J CLIN INVEST, V124, P4162, DOI 10.1172/JCI78366; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Caudle KE, 2014, CURR DRUG METAB, V15, P209, DOI 10.2174/1389200215666140130124910; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Committee on a Framework for Developing a New Taxonomy of Disease; National Research Council, 2011, PREC MED BUILD KNOWL; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Evens AM, 2014, BLOOD, V124, P3356, DOI 10.1182/blood-2014-05-577627; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hayden EC, 2014, NATURE, V507, P294, DOI 10.1038/507294a; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Jameson JL, 2014, J CLIN INVEST, V124, P2822, DOI 10.1172/JCI77301; Kranzler HR, 2014, AM J PSYCHIAT, V171, P445, DOI 10.1176/appi.ajp.2013.13081014; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lander ES, 2015, NEW ENGL J MED, V372, P1185, DOI 10.1056/NEJMp1501964; Lerman C, 2015, LANCET RESP MED, V3, P131, DOI 10.1016/S2213-2600(14)70294-2; Leypoldt F, 2015, JAMA NEUROL, V72, P180, DOI 10.1001/jamaneurol.2014.2956; Liang TJ, 2014, NEW ENGL J MED, V370, P2043, DOI 10.1056/NEJMe1403619; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866; Moore FD, 2005, NEW ENGL J MED, V353, P1162, DOI 10.1056/NEJMe058182; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Paulson EK, 2003, NEW ENGL J MED, V348, P236, DOI 10.1056/NEJMcp013351; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ribas A, 2012, NEW ENGL J MED, V366, P2517, DOI 10.1056/NEJMe1205943; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Rubin R, 2015, JAMA-J AM MED ASSOC, V313, P1089, DOI 10.1001/jama.2015.0957; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Suthanthiran M, 2013, NEW ENGL J MED, V369, P20, DOI 10.1056/NEJMoa1215555; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0	35	598	640	5	251	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2015	372	23					2229	2234		10.1056/NEJMsb1503104	http://dx.doi.org/10.1056/NEJMsb1503104			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK1GK	26014593				2022-12-28	WOS:000355955100012
J	Drawz, P; Rahman, M				Drawz, Paul; Rahman, Mahboob			Chronic Kidney Disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DIETARY-PROTEIN RESTRICTION; GLOMERULAR-FILTRATION-RATE; TYPE-2 DIABETES-MELLITUS; BLOOD-PRESSURE CONTROL; RENAL-DISEASE; AMERICAN-COLLEGE; CARDIOVASCULAR OUTCOMES; VITAMIN-D; PROGRESSION; RISK											Agarwal R, 2009, NEPHROL DIAL TRANSPL, V24, P856, DOI 10.1093/ndt/gfn593; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], 2001, Am J Kidney Dis, V37, pS182; [Anonymous], 2001, Am J Kidney Dis, V37, pS7; [Anonymous], 2000, AM J KIDNEY DIS, V35, pS1, DOI DOI 10.1053/AJKD.2000.V35.AAJKD03517; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Arroyo V, 2011, NAT REV NEPHROL, V7, P517, DOI 10.1038/nrneph.2011.96; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Barrett BJ, 2006, NEW ENGL J MED, V354, P379, DOI 10.1056/NEJMcp050801; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Barry MJ, 1992, J UROLOGY, V148, P1564, DOI DOI 10.1016/S0022-5347(17)36966-5; Berwanger O, 2011, CIRCULATION, V124, P1250, DOI 10.1161/CIRCULATIONAHA.111.038943; Bremnor JD, 2002, AM FAM PHYSICIAN, V65, P1589; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; CHERN CJ, 1976, AM J HUM GENET, V28, P9; Coca SG, 2012, ARCH INTERN MED, V172, P761, DOI 10.1001/archinternmed.2011.2230; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; Dobre M, 2015, J AM SOC NEPHROL, V26, P515, DOI 10.1681/ASN.2014020205; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Einhorn LM, 2009, ARCH INTERN MED, V169, P1156, DOI 10.1001/archinternmed.2009.132; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Fink HA, 2012, ANN INTERN MED, V156, P570, DOI [10.7326/0003-4819-156-8-201204170-00008, 10.7326/0003-4819-156-8-201204170-00004]; Fogo A, 1997, KIDNEY INT, V51, P244, DOI 10.1038/ki.1997.29; Fried LF, 2013, NEW ENGL J MED, V369, P1892, DOI 10.1056/NEJMoa1303154; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; HAKIM RM, 1995, J AM SOC NEPHROL, V6, P1319; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Hsu CY, 2002, NEPHROL DIAL TRANSPL, V17, P1419, DOI 10.1093/ndt/17.8.1419; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kazmi WH, 2004, NEPHROL DIAL TRANSPL, V19, P1808, DOI 10.1093/ndt/gfg573; Kelly AM, 2008, ANN INTERN MED, V148, P284, DOI 10.7326/0003-4819-148-4-200802190-00007; Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT S, V5, P337, DOI DOI 10.1038/KISUP.2012.46; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT, V3, P1, DOI [10.1038/kisup.2012.73, DOI 10.1038/KISUP.2012.73]; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Krop JS, 1999, ARCH INTERN MED, V159, P1777, DOI 10.1001/archinte.159.15.1777; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, J AM SOC NEPHROL, V10, P2426; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lipska KJ, 2011, DIABETES CARE, V34, P1431, DOI 10.2337/dc10-2361; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Marenzi G, 2006, NEW ENGL J MED, V354, P2773, DOI 10.1056/NEJMoa054209; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Miettinen H, 1996, STROKE, V27, P2033, DOI 10.1161/01.STR.27.11.2033; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; National Kidney Foundation, 2004, AM J KIDNEY DIS S, V43, pS1, DOI [DOI 10.1053/J.AJKD.2004.03.003, 10.1053/j.ajkd.2004.03.003]; Orth SR, 2008, CLIN J AM SOC NEPHRO, V3, P226, DOI 10.2215/CJN.03740907; Palmer SC, 2007, ANN INTERN MED, V147, P840, DOI 10.7326/0003-4819-147-12-200712180-00004; Pedrini MT, 1996, ANN INTERN MED, V124, P627, DOI 10.7326/0003-4819-124-7-199604010-00002; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Qaseem A, 2013, ANN INTERN MED, V159, P835, DOI 10.7326/0003-4819-159-12-201312170-00726; Rahman M, 2006, ANN INTERN MED, V144, P172, DOI 10.7326/0003-4819-144-3-200602070-00005; Rocco MV, 2012, AM J KIDNEY DIS, V60, P857, DOI 10.1053/j.ajkd.2012.07.005; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Ruggenenti P, 1997, LANCET, V349, P1857; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shoben AB, 2008, J AM SOC NEPHROL, V19, P1613, DOI 10.1681/ASN.2007111164; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Stone NJ, 2014, ANN INTERN MED, V160, P339, DOI 10.7326/M14-0126; SVETKEY LP, 1990, SOUTHERN MED J, V83, P743, DOI 10.1097/00007611-199007000-00005; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Tonelli M, 2014, ANN INTERN MED, V160, P182, DOI 10.7326/M13-2453; Tseng CL, 2008, ARCH INTERN MED, V168, P55, DOI 10.1001/archinternmed.2007.9; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; US Renal Data System, 2009, NIH PUBLICATION, V09-3176; Viberti G, 2002, CIRCULATION, V106, P672, DOI 10.1161/01.CIR.0000024416.33113.0A; Whaley-Connell AT, 2008, AM J KIDNEY DIS, V51, pS13, DOI 10.1053/j.ajkd.2007.12.016; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Zand L, 2010, AM J MED, V123, P367, DOI 10.1016/j.amjmed.2009.09.030	82	84	94	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2015	162	11								10.7326/AITC201506020	http://dx.doi.org/10.7326/AITC201506020			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW0GV	26030647	Green Accepted			2022-12-28	WOS:000364668300001
J	Khoury, MJ; Evans, JP				Khoury, Muin J.; Evans, James P.			A Public Health Perspective on a National Precision Medicine Cohort Balancing Long-term Knowledge Generation With Early Health Benefit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Khoury, Muin J.] Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA 30333 USA; [Evans, James P.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Evans, James P.] Univ N Carolina, Dept Med, Chapel Hill, NC USA	Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Khoury, MJ (corresponding author), Ctr Dis Control & Prevent, Off Publ Hlth Genom, 1600 Clifton Rd, Atlanta, GA 30333 USA.	muk1@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Ashley EA., JAMA-J AM MED ASSOC, DOI [10.1001/JAMA.2015.3595, DOI 10.1001/JAMA.2015.3595]; Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Collins F., 2015, VISION COHORT PRECIS; Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Dotson WD, 2014, CLIN PHARMACOL THER, V95, P394, DOI 10.1038/clpt.2013.226; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Khoury MJ, 2012, CDC BLOG POST; Lerman C, 2015, LANCET RESP MED, V3, P131, DOI 10.1016/S2213-2600(14)70294-2	8	61	66	2	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2117	2118		10.1001/jama.2015.3382	http://dx.doi.org/10.1001/jama.2015.3382			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ4CC	26034952	Green Accepted			2022-12-28	WOS:000355430900005
J	Simon, NM				Simon, Naomi M.			Increasing Support for the Treatment of Complicated Grief in Adults of All Ages	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								IMPORTANCE Complicated grief (CG) is a debilitating condition, most prevalent in elderly persons. However, to our knowledge, no full-scale randomized clinical trial has studied CG in this population. OBJECTIVE To determine whether complicated grief treatment (CGT) produces greater improvement in CG and depressive symptoms than grief-focused interpersonal psychotherapy (IPT). DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial enrolling 151 individuals 50 years or older (mean [SD] age, 66.1 [8.9] years) scoring at least 30 on the Inventory of Complicated Grief (ICG). Participants were recruited from the New York metropolitan area from August 20, 2008, through January 7, 2013, and randomized to receive CGT or IPT. The main outcome was assessed at 20 weeks after baseline, with interim measures collected at 8, 12, and 16 weeks after baseline. INTERVENTIONS Sixteen sessions of CGT (n = 74) or IPT (n = 77) delivered approximately weekly. MAIN OUTCOMES AND MEASURES Rate of treatment response, defined as a rating from an independent evaluator of much or very much improved on the Improvement subscale of the Clinical Global Impression Scale. RESULTS Both treatments produced improvement in CG symptoms. Response rate for CGT (52 individuals [70.5%]) was more than twice that for IPT (24 [32.0%]) (relative risk, 2.20 [95% CI, 1.51-3.22]; P <.001), with the number needed to treat at 2.56. Secondary analyses of CG severity and CG symptom and impairment questionnaire measures confirmed that CGT conferred a significantly greater change in illness severity (22 individuals [35.2%] in the CGT group vs 41 [64.1%] in the IPT group were still at least moderately ill [P =.001]), rate of CG symptom reduction (1.05 ICG points per week for CGT vs 0.75 points per week for IPT [t(633) = 3.85; P <.001]), and the rate of improvement in CG impairment (0.63 work and Social Adjustment Scale points per week with CGT and 0.39 points per week with IPT [t(503) = 2.87; P =.004]). Results were not moderated by participant age. CONCLUSIONS AND RELEVANCE Complicated grief treatment produced clinically and statistically significantly greater response rates for CG symptoms than a proven efficacious treatment for depression (IPT). Results strongly support the need for physicians and other health care providers to distinguish CG from depression. Given the growing elderly population, the high prevalence of bereavement in aging individuals, and the marked physical and psychological impact of CG, clinicians need to know how to treat CG in older adults.	[Simon, Naomi M.] Massachusetts Gen Hosp, Complicated Grief Program, Boston, MA 02114 USA; [Simon, Naomi M.] Massachusetts Gen Hosp, Ctr Anxiety & Traumat Stress Disorders, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Simon, NM (corresponding author), Massachusetts Gen Hosp, One Bowdoin Sq,Sixth Floor, Boston, MA 02114 USA.	nsimon@partners.org			American Foundation for Suicide Prevention; Department of Defense; Highland Street Foundation; National Institutes of Health	American Foundation for Suicide Prevention; Department of Defense(United States Department of Defense); Highland Street Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Simon reported having received research grants from the American Foundation for Suicide Prevention, Department of Defense, Highland Street Foundation, and National Institutes of Health; having served in a speaking, education, or consulting role for Massachusetts General Hospital Psychiatry Academy and Pfizer Pharmacuticals; and her spouse having equity in Dandreon, G Zero, and Gatekeeper.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Boelen PA, 2007, J CONSULT CLIN PSYCH, V75, P277, DOI 10.1037/0022-006X.75.2.277; Bryant RA, 2014, JAMA PSYCHIAT, V71, P1332, DOI 10.1001/jamapsychiatry.2014.1600; Kersting A, 2011, J AFFECT DISORDERS, V131, P339, DOI 10.1016/j.jad.2010.11.032; Newson RS, 2011, J AFFECT DISORDERS, V132, P231, DOI 10.1016/j.jad.2011.02.021; Prigerson HG, 1995, PSYCHIAT RES, V59, P65, DOI 10.1016/0165-1781(95)02757-2; Shear K, 2005, JAMA-J AM MED ASSOC, V293, P2601, DOI 10.1001/jama.293.21.2601; Shear MK, 2014, JAMA PSYCHIAT, V71, P1287, DOI 10.1001/jamapsychiatry.2014.1242; Simon NM, 2013, JAMA-J AM MED ASSOC, V310, P416, DOI 10.1001/jama.2013.8614; Simon NM, 2012, DEPRESS ANXIETY, V29, P541, DOI 10.1002/da.21979	10	11	12	1	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2172	2173		10.1001/jama.2015.105	http://dx.doi.org/10.1001/jama.2015.105			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ4CC	26034957				2022-12-28	WOS:000355430900017
J	Feld, GB; Born, J				Feld, Gordon B.; Born, Jan			Exploiting sleep to modify bad attitudes	SCIENCE			English	Editorial Material							SLOW-WAVE SLEEP; MEMORY; FEAR; EXTINCTION		[Feld, Gordon B.; Born, Jan] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Feld, GB (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Otfried Muller Str 25, D-72076 Tubingen, Germany.	gordon.feld@uni-tuebingen.de; jan.born@uni-tuebingen.de	Born, Jan/K-2596-2016; Feld, Gordon B/B-3739-2014	Born, Jan/0000-0002-1847-6248; Feld, Gordon/0000-0002-1238-9493				Diekelmann S, 2015, SLEEP, V38, P337, DOI 10.5665/sleep.4484; Diekelmann S, 2010, NAT REV NEUROSCI, V11, DOI 10.1038/nrn2762-c2; Dunham Y, 2008, TRENDS COGN SCI, V12, P248, DOI 10.1016/j.tics.2008.04.006; Ellemers N, 2015, CURR OPIN BEHAV SCI, V3, P142, DOI 10.1016/j.cobeha.2015.04.001; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Hauner KK, 2013, NAT NEUROSCI, V16, P1553, DOI 10.1038/nn.3527; He J, 2015, SLEEP, V38, P423, DOI 10.5665/sleep.4502; Hu XQ, 2015, SCIENCE, V348, P1013, DOI 10.1126/science.aaa3841; Legault L, 2011, PSYCHOL SCI, V22, P1472, DOI 10.1177/0956797611427918; Paluck EL, 2009, ANNU REV PSYCHOL, V60, P339, DOI 10.1146/annurev.psych.60.110707.163607; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Schonauer M, 2014, J COGNITIVE NEUROSCI, V26, P143, DOI 10.1162/jocn_a_00471; Schreiner T, 2015, CEREB CORTEX, V25, P4169, DOI 10.1093/cercor/bhu139	14	2	2	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					971	972		10.1126/science.aab4048	http://dx.doi.org/10.1126/science.aab4048			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ1WU	26023122				2022-12-28	WOS:000355276600024
J	Getahun, H; Matteelli, A; Chaisson, RE; Raviglione, M				Getahun, Haileyesus; Matteelli, Alberto; Chaisson, Richard E.; Raviglione, Mario			Latent Mycobacterium tuberculosis Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GAMMA RELEASE ASSAYS; UNITED-STATES; ANTIRETROVIRAL THERAPY; PREVENT TUBERCULOSIS; 12-DOSE REGIMEN; RISK-FACTORS; HIV; CONTACTS; TB; REACTIVATION	The natural history of tuberculosis begins with the inhalation of Mycobacterium tuberculosis organisms; a period of bacterial replication and dissemination ensues, followed by immunologic containment of viable bacilli. The result of this process is asymptomatic latent tuberculosis infection, which is defined as a state of persistent bacterial viability, immune control, and no evidence of clinically manifested active tuberculosis. 1 Currently, it is not possible to directly diagnose M. tuberculosis infection in humans; therefore, latent tuberculosis infection is diagnosed by response to in vivo or in vitro stimulation by M. tuberculosis antigens with the use of the tuberculin skin test or interferon-gamma release assays (IGRAs). Studies suggest that active tuberculosis will develop in 5 to 15% of persons with latent infection during their lifetimes(2) (and a higher percentage if the persons are immunocompromised); thus, persons with latent infection serve, according to Osler, as the "seedbeds" of tuberculosis in the community.(3) This article will review the pathogenesis, epidemiology, diagnosis, and treatment of latent tuberculosis infection. It will address critical gaps in the understanding of this complex condition and propose the necessary research agenda.	[Getahun, Haileyesus; Matteelli, Alberto; Raviglione, Mario] WHO, Global TB Program, CH-1211 Geneva 27, Switzerland; [Chaisson, Richard E.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD USA	World Health Organization; Johns Hopkins University	Getahun, H (corresponding author), WHO, Global TB Program, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	getahunh@who.int	Getahun, Haileyesus/ABC-5181-2020; Matteelli, Alberto/M-8784-2015	RAVIGLIONE, Mario/0000-0002-9331-2067; Matteelli, Alberto/0000-0001-5109-9248	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI094189] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Achkar JM, 2011, J INFECT DIS, V204, pS1179, DOI 10.1093/infdis/jir451; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Al-Anazi KA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00231; Bamrah S, 2014, INT J TUBERC LUNG D, V18, P912, DOI 10.5588/ijtld.13.0028; Banfield S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038556; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Christopoulos AI, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-36; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2000, AIDS, V14, P2759, DOI 10.1097/00002030-200012010-00016; Daniel TM, 1997, J INFECT DIS, V175, P1535, DOI 10.1086/516495; Diel R, 2012, CHEST, V142, P63, DOI 10.1378/chest.11-3157; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Golub JE, 2015, CLIN INFECT DIS, V60, P639, DOI 10.1093/cid/ciu849; Haldar P, 2013, THORAX, V68, P240, DOI 10.1136/thoraxjnl-2011-200956; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Hirsch-Moverman Y, 2015, INT J TUBERC LUNG D, V19, P31, DOI 10.5588/ijtld.14.0373; Hoa NB, 2013, INT J TUBERC LUNG D, V17, P738, DOI 10.5588/ijtld.12.0200; Horsburgh CR, 2011, NEW ENGL J MED, V364, P1441, DOI 10.1056/NEJMcp1005750; Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; Katsenos S, 2011, J AM GERIATR SOC, V59, P858, DOI 10.1111/j.1532-5415.2011.03367.x; Keane J, 2008, CURR OPIN RHEUMATOL, V20, P443, DOI 10.1097/BOR.0b013e3283025ec2; Kirenga BJ, 2013, INT J TUBERC LUNG D, V17, P336, DOI 10.5588/ijtld.12.0298; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; McElroy PD, 2005, CLIN INFECT DIS, V41, P1125, DOI 10.1086/444463; Menzies D, 2008, ANN INTERN MED, V149, P689, DOI 10.7326/0003-4819-149-10-200811180-00003; Modlin RL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007402; Moss AR, 2000, AM J RESP CRIT CARE, V162, P460, DOI 10.1164/ajrccm.162.2.9910055; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Orme IM, 2014, TUBERCULOSIS, V94, P8, DOI 10.1016/j.tube.2013.07.004; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Parfitt CD, 1942, CAN MED ASSOC J, V47, P293; Piccazzo R, 2014, J RHEUMATOL, V41, P32, DOI 10.3899/jrheum.140100; Podany A, 2014, 21 C RETR OPP INF CR; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Seddon JA, 2013, CLIN INFECT DIS, V57, P1676, DOI 10.1093/cid/cit655; SELWYN PA, 1989, JAMA-J AM MED ASSOC, V261, P1289, DOI 10.1001/jama.261.9.1289; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Shanaube K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007749; Shea KM, 2014, AM J EPIDEMIOL, V179, P216, DOI 10.1093/aje/kwt246; Shepardson D, 2013, INT J TUBERC LUNG D, V17, P1531, DOI 10.5588/ijtld.13.0423; Sidhu A, 2014, TRANSPLANTATION, V98, P671, DOI 10.1097/TP.0000000000000133; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; Stagg HR, 2014, ANN INTERN MED, V161, P419, DOI 10.7326/M14-1019; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Sterling TR, 2014, 21 C RETR OPP INF CR; Ukwaja KN, 2014, NEW ENGL J MED, V370, P1661, DOI 10.1056/NEJMc1402073; Villarino ME, 2015, JAMA PEDIATR, V169, P247, DOI 10.1001/jamapediatrics.2014.3158; World Health Organization (WHO), 2015, GUIDELINES MANAGEMEN; Zhang GL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004426	58	406	438	19	164	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2015	372	22					2127	2135		10.1056/NEJMra1405427	http://dx.doi.org/10.1056/NEJMra1405427			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0EI	26017823				2022-12-28	WOS:000355146800008
J	Nogueira, L; Foerster, C; Groopman, J; Egner, P; Koshiol, J; Ferreccio, C				Nogueira, Leticia; Foerster, Claudia; Groopman, John; Egner, Patricia; Koshiol, Jill; Ferreccio, Catterina		Gallbladder Canc Chile Working Grp	Association of Aflatoxin With Gallbladder Cancer in Chile	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							B-1		[Nogueira, Leticia; Koshiol, Jill] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Foerster, Claudia; Ferreccio, Catterina] Pontificia Univ Catolica Chile, Sch Med, Santiago, Chile; [Groopman, John; Egner, Patricia] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pontificia Universidad Catolica de Chile; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ferreccio, C (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Dept Publ Hlth, Marcoleta 434, Santiago, Chile.	catferre@gmail.com	Hildesheim, Allan/B-9760-2015; Nogueira, Leticia/J-2547-2019; /X-4205-2019; Roa, Juan C./K-4749-2014; koshiol, Jill/L-8686-2014; Foerster, Claudia/H-7013-2013	Hildesheim, Allan/0000-0003-0257-2363; /0000-0003-4690-2133; Roa, Juan C./0000-0001-8313-8774; koshiol, Jill/0000-0002-3832-6204; ferreccio, catterina/0000-0001-6331-5534; Foerster, Claudia/0000-0001-8452-5362; Acevedo, Johanna/0000-0002-6341-1865	NATIONAL CANCER INSTITUTE [ZIACP010218] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA CP010218-05] Funding Source: Medline; NCI NIH HHS [P30 CA006973] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chen JG, 2013, CANCER PREV RES, V6, P1038, DOI 10.1158/1940-6207.CAPR-13-0168; Departamento de Epidemiologia, INF AN 2011 HEP B; Scholl PF, 2008, CANCER EPIDEM BIOMAR, V17, P1436, DOI 10.1158/1055-9965.EPI-07-2926; SIEBER SM, 1979, CANCER RES, V39, P4545; Tsuchiya Y, 2011, ASIAN PAC J CANCER P, V12, P471; Venniyoor A, 2008, MED HYPOTHESES, V70, P646, DOI 10.1016/j.mehy.2007.06.040	6	54	56	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2015	313	20					2075	2077		10.1001/jama.2015.4559	http://dx.doi.org/10.1001/jama.2015.4559			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0DC	26010638	Green Accepted, Bronze			2022-12-28	WOS:000355142400023
J	Gilbert, RE; Krum, H				Gilbert, Richard E.; Krum, Henry			Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy	LANCET			English	Review							ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR DYSFUNCTION; ENDOTHELIAL GROWTH-FACTOR; CARDIOVASCULAR-DISEASE; PEPTIDE-1 INFUSION; EJECTION FRACTION; SODIUM RETENTION; RENAL SODIUM; INSULIN; OUTCOMES	Individuals with diabetes are not only at high risk of developing heart failure but are also at increased risk of dying from it. Fortunately, antiheart failure therapies such as angiotensin-converting-enzyme inhibitors, beta blockers and mineralocorticoid-receptor antagonists work similarly well in individuals with diabetes as in individuals without the disease. Response to intensive glycaemic control and the various classes of antihyperglycaemic agent therapy is substantially less well understood. Insulin, for example, induces sodium retention and thiazolidinediones increase the risk of heart failure. The need for new glucose-lowering drugs to show cardiovascular safety has led to the unexpected finding of an increase in the risk of admission to hospital for heart failure in patients treated with the dipeptidylpeptidase-4 (DPP4) inhibitor, saxagliptin, compared with placebo. Here we review the relation between glycaemic control and heart failure risk, focusing on the state of knowledge for the various types of antihyperglycaemic drugs that are used at present.	[Gilbert, Richard E.] Univ Toronto, Div Endocrinol, St Michaels Hosp, Toronto, ON M5S 1A1, Canada; [Krum, Henry] Monash Univ, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Monash University	Gilbert, RE (corresponding author), St Michaels Hosp, Div Endocrinol, 61 Queen St East, Toronto, ON M5C 2T2, Canada.	richard.gilbert@utoronto.ca			Merck; AstraZeneca; Bristol-Myers Squibb; Eli Lilly; Boehringer Ingelheim	Merck(Merck & Company); AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); Boehringer Ingelheim(Boehringer Ingelheim)	RG has received consulting and lecture fees from Merck, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, and Boehringer Ingelheim and other funds through his institution from Merck, AstraZeneca, and Bristol-Myers Squibb. HK has received consulting and lecture fees from Merck, AstraZeneca, and Bristol-Myers Squibb.	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; [Anonymous], 2013, ENDOCRINOLOGIC METAB; Banerjee SK, 2010, J MOL CELL CARDIOL, V49, P683, DOI 10.1016/j.yjmcc.2010.06.003; Banerjee SK, 2009, CARDIOVASC RES, V84, P111, DOI 10.1093/cvr/cvp190; Basu A, 2006, DIABETES CARE, V29, P510, DOI 10.2337/diacare.29.03.06.dc05-2004; Bell DSH, 2003, DIABETES CARE, V26, P2433, DOI 10.2337/diacare.26.8.2433; Benbow A, 2001, BRIT MED J, V322, P236; Bubien JK, 2010, J BIOL CHEM, V285, P23527, DOI 10.1074/jbc.R109.025049; Chou E, 2002, CIRCULATION, V105, P373, DOI 10.1161/hc0302.102143; Dagenais GR, 2008, DIABETES CARE, V31, P1007, DOI 10.2337/dc07-1868; DEFRONZO RA, 1975, J CLIN INVEST, V55, P845, DOI 10.1172/JCI107996; Delea TE, 2003, DIABETES CARE, V26, P2983, DOI 10.2337/diacare.26.11.2983; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Emoto M, 2006, DIABETOLOGIA, V49, P2217, DOI 10.1007/s00125-006-0313-5; Erdmann E, 2007, DIABETES CARE, V30, P2773, DOI 10.2337/dc07-0717; Eshaghian S, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.10.008; Eurich DT, 2013, CIRC-HEART FAIL, V6, P395, DOI 10.1161/CIRCHEARTFAILURE.112.000162; Eurich DT, 2005, DIABETES CARE, V28, P2345, DOI 10.2337/diacare.28.10.2345; European Medicines Agency, 2010, ASS REP AV; Fantoni C, 2005, J AM COLL CARDIOL, V46, P1875, DOI 10.1016/j.jacc.2005.06.081; FERAILLE E, 1994, AM J PHYSIOL, V267, pF55, DOI 10.1152/ajprenal.1994.267.1.F55; FIORETTO P, 1992, KIDNEY INT, V41, P813, DOI 10.1038/ki.1992.125; Frustaci A, 2000, CIRC RES, V87, P1123, DOI 10.1161/01.RES.87.12.1123; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Fuster DG, 2007, AM J PHYSIOL-RENAL, V292, pF577, DOI 10.1152/ajprenal.00240.2006; Giamouzis G, 2010, J CARD FAIL, V16, P207, DOI 10.1016/j.cardfail.2009.12.007; GlaxoSmithKline, 52 WEEK DOUBL BLIND, V49653/211; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Green JB, 2013, AM HEART J, V166, P983, DOI 10.1016/j.ahj.2013.09.003; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; Gustafsson I, 1999, J AM COLL CARDIOL, V34, P83, DOI 10.1016/S0735-1097(99)00146-1; Haas SJ, 2003, AM HEART J, V146, P848, DOI 10.1016/S0002-8703(03)00403-4; Halbirk M, 2010, AM J PHYSIOL-HEART C, V298, pH1096, DOI 10.1152/ajpheart.00930.2009; Hoffman RP, 2007, CURR DIABETES REV, V3, P185; Horita S, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/391762; Inzucchi SE, 2005, DIABETES CARE, V28, P1680, DOI 10.2337/diacare.28.7.1680; Jackson EK, 2008, HYPERTENSION, V51, P1637, DOI 10.1161/HYPERTENSIONAHA.108.112532; Kalambokis GN, 2004, AM J KIDNEY DIS, V44, P575, DOI 10.1053/j.ajkd.2004.06.025; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Karalliedde J, 2007, DRUG SAFETY, V30, P741, DOI 10.2165/00002018-200730090-00002; Karter AJ, 2005, DIABETIC MED, V22, P986, DOI 10.1111/j.1464-5491.2005.01704.x; Komajda M, 2010, EUR HEART J, V31, P824, DOI 10.1093/eurheartj/ehp604; Krum H, 2003, LANCET, V362, P147, DOI 10.1016/S0140-6736(03)13869-X; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; Leifer A, 1928, JAMA-J AM MED ASSOC, V2, P610; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Lincoff AM, 2014, JAMA-J AM MED ASSOC, V311, P1515, DOI 10.1001/jama.2014.3321; Loke YK, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1309; MacDonald MR, 2008, EUR HEART J, V29, P1377, DOI 10.1093/eurheartj/ehn153; Mangiavacchi M, 2008, PACE, V31, P1425, DOI 10.1111/j.1540-8159.2008.01206.x; Marney A, 2010, HYPERTENSION, V56, P728, DOI 10.1161/HYPERTENSIONAHA.110.156554; Maru S, 2005, DIABETES CARE, V28, P20, DOI 10.2337/diacare.28.1.20; Masoudi FA, 2005, CIRCULATION, V111, P583, DOI 10.1161/01.CIR.0000154542.13412.B1; McAlister FA, 2008, EUR J HEART FAIL, V10, P703, DOI 10.1016/j.ejheart.2008.05.013; McMurray J, 2013, EUR HEART FAIL C; McMurray JJV, 2014, LANCET DIABETES ENDO, V2, P843, DOI 10.1016/S2213-8587(14)70031-2; Murcia AM, 2004, ARCH INTERN MED, V164, P2273, DOI 10.1001/archinte.164.20.2273; Muscelli E, 1996, AM J HYPERTENS, V9, P746, DOI 10.1016/0895-7061(96)00098-2; NAKAMURA R, 1983, J CLIN INVEST, V72, P388, DOI 10.1172/JCI110979; NATALI A, 1993, CLIN SCI, V85, P327, DOI 10.1042/cs0850327; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E; Nichols GA, 2001, DIABETES CARE, V24, P1614, DOI 10.2337/diacare.24.9.1614; Nichols GA, 2004, DIABETES CARE, V27, P1879, DOI 10.2337/diacare.27.8.1879; Nichols GA, 2005, DIABETES-METAB RES, V21, P51, DOI 10.1002/dmrr.480; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2010, EUR HEART J, V31, P773, DOI 10.1093/eurheartj/ehq016; NOSADINI R, 1993, KIDNEY INT, V44, P139, DOI 10.1038/ki.1993.224; Pantalone KM, 2009, ACTA DIABETOL, V46, P145, DOI 10.1007/s00592-008-0090-3; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pitt B, 2005, J AM COLL CARDIOL, V46, P425, DOI 10.1016/j.jacc.2005.04.038; Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555; Raskin P, 2001, DIABETES CARE, V24, P1226, DOI 10.2337/diacare.24.7.1226; ROCCHINI AP, 1989, HYPERTENSION, V14, P367, DOI 10.1161/01.HYP.14.4.367; Ruiter R, 2012, DRUG SAFETY, V35, P471, DOI 10.2165/11596950-000000000-00000; Ruiz OS, 1998, REGUL PEPTIDES, V77, P155, DOI 10.1016/S0167-0115(98)00115-3; Scirica BM, 2014, CIRCULATION, V130, P1579, DOI 10.1161/CIRCULATIONAHA.114.010389; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Seki George, 2012, World J Nephrol, V1, P146, DOI 10.5527/wjn.v1.i5.146; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Singh S, 2007, DIABETES CARE, V30, P2148, DOI 10.2337/dc07-0141; SKOTT P, 1989, DIABETOLOGIA, V32, P694; Smooke S, 2005, AM HEART J, V149, P168, DOI 10.1016/j.ahj.2004.07.005; Sokos GG, 2006, J CARD FAIL, V12, P694, DOI 10.1016/j.cardfail.2006.08.211; STONE PH, 1989, J AM COLL CARDIOL, V14, P49, DOI 10.1016/0735-1097(89)90053-3; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Takahashi N, 1996, Hypertens Res, V19 Suppl 1, pS41, DOI 10.1291/hypres.19.SupplementI_S41; The Kroc Collaborative Study Group, 1988, JAMA-J AM MED ASSOC, V260, P37, DOI [10.1001/jama.1988.03410010045032, DOI 10.1001/jama.1988.03410010045032]; Thrainsdottir Inga, 2004, Diab Vasc Dis Res, V1, P40, DOI 10.3132/dvdr.2004.005; Tomova GS, 2012, AM J CARDIOL, V109, P1767, DOI 10.1016/j.amjcard.2012.02.022; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Tzoulaki I, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4731; Waltenberger J, 2001, CARDIOVASC RES, V49, P554, DOI 10.1016/S0008-6363(00)00228-5; Weir DL, 2014, JACC-HEART FAIL, V2, P573, DOI 10.1016/j.jchf.2014.04.005; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wooltorton E, 2002, CAN MED ASSOC J, V166, P219; Wu SY, 2014, CARDIOVASC THER, V32, P147, DOI 10.1111/1755-5922.12075; Yang WY, 2014, LANCET DIABETES ENDO, V2, P46, DOI 10.1016/S2213-8587(13)70021-4; Zannad F., 2015, LANCET, V85, P2067; Zhou LB, 2003, J CELL BIOCHEM, V90, P339, DOI 10.1002/jcb.10631	104	201	208	1	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2107	2117		10.1016/S0140-6736(14)61402-1	http://dx.doi.org/10.1016/S0140-6736(14)61402-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI7XK	26009231				2022-12-28	WOS:000354979100030
J	Ofri, D				Ofri, Danielle			The art of medicine The marathon of diabetes	LANCET			English	Editorial Material									NYU, Sch Med, Bellevue Hosp, New York, NY 10016 USA	Bellevue Hospital Center; New York University	Ofri, D (corresponding author), NYU, Sch Med, Bellevue Hosp, New York, NY 10016 USA.	danielle.ofri@nyumc.org		Ofri, Danielle/0000-0001-9865-7104					0	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2039	2040		10.1016/S0140-6736(15)60982-5	http://dx.doi.org/10.1016/S0140-6736(15)60982-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI7XK	26009220				2022-12-28	WOS:000354979100015
J	Berry, JA; Cervantes-Sandoval, I; Chakraborty, M; Davis, RL				Berry, Jacob A.; Cervantes-Sandoval, Isaac; Chakraborty, Molee; Davis, Ronald L.			Sleep Facilitates Memory by Blocking Dopamine Neuron-Mediated Forgetting	CELL			English	Article							TARGETED GENE-EXPRESSION; SYNAPTIC PLASTICITY; DROSOPHILA; CONSOLIDATION; PATHWAY; BODY; TEMPERATURE; HOMEOSTASIS; INTEGRATION; BEHAVIOR	Early studies from psychology suggest that sleep facilitates memory retention by stopping ongoing retroactive interference caused by mental activity or external sensory stimuli. Neuroscience research with animal models, on the other hand, suggests that sleep facilitates retention by enhancing memory consolidation. Recently, in Drosophila, the ongoing activity of specific dopamine neurons was shown to regulate the forgetting of olfactory memories. Here, we show this ongoing dopaminergic activity is modulated with behavioral state, increasing robustly with locomotor activity and decreasing with rest. Increasing sleep-drive, with either the sleep-promoting agent Gaboxadol or by genetic stimulation of the neural circuit for sleep, decreases ongoing dopaminergic activity, while enhancing memory retention. Conversely, increasing arousal stimulates ongoing dopaminergic activity and accelerates dopaminergic-based forgetting. Therefore, forgetting is regulated by the behavioral state modulation of dopaminergic-based plasticity. Our findings integrate psychological and neuroscience research on sleep and forgetting.	[Berry, Jacob A.; Cervantes-Sandoval, Isaac; Chakraborty, Molee; Davis, Ronald L.] Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL 33458 USA	Scripps Research Institute	Davis, RL (corresponding author), Scripps Res Inst Florida, Dept Neurosci, Jupiter, FL 33458 USA.	rdavis@scripps.edu	Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608; Berry, Jacob/0000-0002-5241-1720	NIH [R37 NS19904-31, R01 NS051251-07]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS019904, R01NS019904, R01NS052351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants R37 NS19904-31 and R01 NS051251-07 from the NIH. J.A.B. is a Neuroscience Scholar of the Esther B. O'Keeffe Charitable Foundation. We especially want to thank Dr. P. Shaw for sharing his unpublished and extensive data on Gaboxadol as an effective sleep agent for flies, and for providing the R23E10-gal4 line. We also thank Dr. S. Birman for providing the pCaSpeR2-TH construct, which provided the backbone for constructing a LexA derivative. We are grateful to M. Klement (Max Planck Florida Institute) for design advice and fabrication of pieces for the fly-on-the-ball assay. We would like to acknowledge S. Harbaran for cloning the TH-lexA construct and mapping the ensuing transgenic lines. Finally, we would like to thank S. Tomchik for helpful discussions and advice.	Beck CDO, 2000, J NEUROSCI, V20, P2944; Berry JA, 2014, PROG BRAIN RES, V208, P39, DOI 10.1016/B978-0-444-63350-7.00002-4; Berry JA, 2012, NEURON, V74, P530, DOI 10.1016/j.neuron.2012.04.007; Brea J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003640; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dissel S, 2015, CURR BIOL, V25, P1270, DOI 10.1016/j.cub.2015.03.027; Donlea JM, 2014, NEURON, V81, P860, DOI 10.1016/j.neuron.2013.12.013; Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Faulhaber J, 1997, PSYCHOPHARMACOLOGY, V130, P285, DOI 10.1007/s002130050241; FOWLER MJ, 1973, SCIENCE, V179, P302, DOI 10.1126/science.179.4070.302; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Huang YY, 2004, P NATL ACAD SCI USA, V101, P3236, DOI 10.1073/pnas.0308280101; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jenkins JG, 1924, AM J PSYCHOL, V35, P605, DOI 10.2307/1414040; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Lancel M, 1996, NEUROREPORT, V7, P2241, DOI 10.1097/00001756-199609020-00036; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Liu QL, 2012, CURR BIOL, V22, P2114, DOI 10.1016/j.cub.2012.09.008; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Mednick SC, 2011, TRENDS NEUROSCI, V34, P504, DOI 10.1016/j.tins.2011.06.003; Pfeiffer BD, 2012, P NATL ACAD SCI USA, V109, P6626, DOI 10.1073/pnas.1204520109; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Pramatarova A, 2003, MOL CELL BIOL, V23, P7210, DOI 10.1128/MCB.23.20.7210-7221.2003; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shuai YC, 2010, CELL, V140, P579, DOI 10.1016/j.cell.2009.12.044; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tomchik SM, 2013, J NEUROSCI, V33, P2166, DOI 10.1523/JNEUROSCI.3933-12.2013; Tomchik SM, 2009, NEURON, V64, P510, DOI 10.1016/j.neuron.2009.09.029; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Ueno T, 2012, NAT NEUROSCI, V15, P1516, DOI 10.1038/nn.3238; van Alphen B, 2013, J NEUROSCI, V33, P6917, DOI 10.1523/JNEUROSCI.0061-13.2013; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	44	120	126	0	83	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1656	1667		10.1016/j.cell.2015.05.027	http://dx.doi.org/10.1016/j.cell.2015.05.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26073942	Green Accepted, Bronze			2022-12-28	WOS:000356618200021
J	Whitlock, EL; Kim, H; Auerbach, AD				Whitlock, Elizabeth L.; Kim, Helen; Auerbach, Andrew D.			Harms associated with single unit perioperative transfusion: retrospective population based analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-CELL TRANSFUSION; CARDIAC-SURGERY; CORONARY; OUTCOMES; MORTALITY; STROKE; RISK	Objective To determine whether perioperative transfusion of as little as one unit of packed red blood cells in the operating room or the day after surgery is associated with measurably increased odds for perioperative ischemic stroke and myocardial infarction. Design Retrospective cohort study of hospital administrative data. Setting 346 hospitals in the United States participating in the claims based Premier Perspective database from 1 January 2009 to 31 March 2012. Participants 1 583 819 adults who underwent non-cardiac, non-intracranial, non-vascular surgery and required a stay of at least one night in hospital and did not receive packed red blood cells on days two to seven after surgery. Intervention Transfusion of packed red blood cells on the day of surgery or one day after by exposure categories (none or one, two, three or four or more units). Main outcome measures The composite outcome of stroke/myocardial infarction was defined as ischemic stroke, ST elevation myocardial infarction, ventricular tachycardia, or ventricular fibrillation during index admission or as a primary diagnosis for readmission within 30 days. Ventricular tachycardia/ventricular fibrillation were included as a surrogate for myocardial infarction. Results 41 421 (2.6%) patients received at least one unit of packed red blood cells within 48 hours of surgery, and 8044 (0.51%) experienced the composite outcome of stroke/myocardial infarction. Patients who were transfused were older, more likely to be women, and had more comorbid disease. Hierarchical logistic regression adjusted for comorbidities and demographics with random effects by hospital showed that transfusion of as little as one unit was associated with an odds ratio of 2.33 (95% confidence interval 1.90 to 2.86) for perioperative stroke/myocardial infarction, and the odds of stroke/myocardial infarction markedly increased with transfusion of four or more units. Subgroup analysis limiting the cohort to one of several common surgical procedures, excluding those who received two or more units, or excluding who received transfusion on postoperative day one showed substantially similar results, as did a matched propensity score analysis. Two methods of modeling unmeasured confounders suggest an odds ratio of >10 with imbalance of up to 47% between patients who did and did not receive transfusion would be required to invalidate our results. Conclusions A perioperative transfusion of one unit of packed red blood cells is associated with increased odds of perioperative ischemic stroke and/or myocardial infarction, even after adjustment for a wide range of factors in our data and despite extensive sensitivity analyses.	[Whitlock, Elizabeth L.; Kim, Helen] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Auerbach, Andrew D.] Univ Calif San Francisco, Div Hosp Med, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Whitlock, EL (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.	elizabeth.whitlock@ucsf.edu	Whitlock, Elizabeth L./N-1860-2014	Whitlock, Elizabeth L./0000-0002-6868-4301; Auerbach, Andrew/0000-0001-8440-0527; Kim, Helen/0000-0002-1937-354X	UCSF Department of Anesthesia and Perioperative Care; National Heart, Lung and Blood Institute of the National Institutes of Health [K24HL098372]; National Institutes of Health [UL1-TR000004]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL098372] Funding Source: NIH RePORTER	UCSF Department of Anesthesia and Perioperative Care; National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	ELW received funding from the UCSF Department of Anesthesia and Perioperative Care to support this work. ADA is supported by grant number K24HL098372 from the National Heart, Lung and Blood Institute of the National Institutes of Health. Statistical consultation was supported by grant number UL1-TR000004 from the National Institutes of Health. The funding sources had no role in the study design, analysis or interpretation of data, writing of the manuscript, or decision to submit the paper for publication.	[Anonymous], 2014, MAX SURG BLOOD ORD S; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Devereaux PJ, 2011, ANN INTERN MED, V154, P523, DOI 10.7326/0003-4819-154-8-201104190-00003; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gramm J, 1996, SHOCK, V5, P190, DOI 10.1097/00024382-199603000-00004; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Holst LB, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1354; Kamel H, 2012, CIRCULATION, V126, P207, DOI 10.1161/CIRCULATIONAHA.112.094326; LaPar DJ, 2013, J THORAC CARDIOV SUR, V145, P796, DOI 10.1016/j.jtcvs.2012.12.041; Lee S, 2008, KOREAN J BLOOD TRANS, V19, P15; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; MARIK PE, 1993, JAMA-J AM MED ASSOC, V269, P3024, DOI 10.1001/jama.269.23.3024; McCartney S, 2014, TRANSFUSION, V54, P2745, DOI 10.1111/trf.12696; Musallam KM, 2013, JAMA SURG, V148, P755, DOI 10.1001/jamasurg.2013.2360; Myerburg RJ, 2012, CIRCULATION, V125, P1043, DOI 10.1161/CIRCULATIONAHA.111.023846; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Relevy H, 2008, TRANSFUSION, V48, P136, DOI 10.1111/j.1537-2995.2007.01491.x; Saager L, 2013, ANESTH ANALG, V117, P909, DOI 10.1213/ANE.0b013e31828b347d; Sharifpour M, 2013, ANESTH ANALG, V116, P424, DOI 10.1213/ANE.0b013e31826a1a32; Sherwood MW, 2014, JAMA-J AM MED ASSOC, V311, P836, DOI 10.1001/jama.2014.980; Silvain J, 2014, J AM COLL CARDIOL, V63, P1289, DOI 10.1016/j.jacc.2013.11.029; Sturmer T, 2005, AM J EPIDEMIOL, V162, P279, DOI 10.1093/aje/kwi192; Tsai AG, 2004, TRANSFUSION, V44, P1626, DOI 10.1111/j.0041-1132.2004.04128.x; Whitaker B., 2011, 2011 NATL BLOOD COLL	26	67	72	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2015	350								h3037	10.1136/bmj.h3037	http://dx.doi.org/10.1136/bmj.h3037			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK7DN	26070979	Green Published, hybrid			2022-12-28	WOS:000356391300002
J	Appleby, J				Appleby, John			DATA BRIEFING Paid for by the NHS, treated privately	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Department of Health, 1989, CM555; Duckett S., 2001, DOES MATTER OWNS HLT; Health and Social Care Information Centre, 2015, HOSP EP STAT; Health and Social Care Information Centre, 2015, HOSP OUTP ACT 2013 1	4	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2015	350								h3109	10.1136/bmj.h3109	http://dx.doi.org/10.1136/bmj.h3109			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK7CZ	26063462				2022-12-28	WOS:000356389600013
J	Salluh, J				Salluh, Jorge			Outcome of delirium in critically ill patients: systematic review and meta-analysis (vol 350, h2538, 2015)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction													Damluji, Abdulla A/AAC-1054-2020; dantas, vicente c souza/L-2648-2013; Salluh, Jorge/AAF-2682-2021	Damluji, Abdulla A/0000-0002-8774-6416; Salluh, Jorge/0000-0002-8164-1453; Yenokyan, Gayane/0000-0003-1482-5612				Salluh JIF, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.h2538, 10.1136/bmj.h3129]	1	453	486	6	65	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2015	350								h3129	10.1136/bmj.h3129	http://dx.doi.org/10.1136/bmj.h3129			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK7CK	26041151	Bronze			2022-12-28	WOS:000356387800013
J	Stambolic, V				Stambolic, Vuk			CANCER Precise control of localized signals	NATURE			English	Editorial Material							PTEN TUMOR-SUPPRESSOR; ASSOCIATION; PHOSPHATASE; MEMBRANE; ROLES	The tumour-suppressor protein PTEN is mostly found in the cell cytoplasm, tethered to endosome vesicles. This localization regulates the enzyme's activity towards specific lipids and influences its control of cell growth.	Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Stambolic, V (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.			Stambolic, Vuk/0000-0001-8853-3239				Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Chew C.L., 2015, CANC DISCOV; Georgescu MM, 2000, CANCER RES, V60, P7033; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Huang J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1919; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Kofuji S., 2015, CANC DISCOV; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Naguib A, 2015, MOL CELL, V58, P255, DOI 10.1016/j.molcel.2015.03.011; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907	13	2	2	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					38	40		10.1038/nature14531	http://dx.doi.org/10.1038/nature14531			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	26017306				2022-12-28	WOS:000355543400022
J	Ryan, TJ; Roy, DS; Pignatelli, M; Arons, A; Tonegawa, S				Ryan, Tomas J.; Roy, Dheeraj S.; Pignatelli, Michele; Arons, Autumn; Tonegawa, Susumu			Engram cells retain memory under retrograde amnesia	SCIENCE			English	Article							PROTEIN-SYNTHESIS; FEAR MEMORY; RETRIEVAL; RECONSOLIDATION; HIPPOCAMPUS; LTP; POTENTIATION; REACTIVATION; NEUROSCIENCE; MECHANISMS	Memory consolidation is the process by which a newly formed and unstable memory transforms into a stable long-term memory. It is unknown whether the process of memory consolidation occurs exclusively through the stabilization of memory engrams. By using learning-dependent cell labeling, we identified an increase of synaptic strength and dendritic spine density specifically in consolidated memory engram cells. Although these properties are lacking in engram cells under protein synthesis inhibitor-induced amnesia, direct optogenetic activation of these cells results in memory retrieval, and this correlates with retained engram cell-specific connectivity. We propose that a specific pattern of connectivity of engram cells may be crucial for memory information storage and that strengthened synapses in these cells critically contribute to the memory retrieval process.	[Ryan, Tomas J.; Roy, Dheeraj S.; Pignatelli, Michele; Arons, Autumn; Tonegawa, Susumu] MIT, Dept Biol, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Ryan, Tomas J.; Roy, Dheeraj S.; Pignatelli, Michele; Arons, Autumn; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Ryan, Tomas J.; Arons, Autumn; Tonegawa, Susumu] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Tonegawa, S (corresponding author), MIT, Dept Biol, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu		Pignatelli, Michele/0000-0002-4918-2066; Ryan, Tomas/0000-0003-0121-8514	RIKEN Brain Science Institute; Howard Hughes Medical Institute; JPB Foundation	RIKEN Brain Science Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); JPB Foundation	We thank X. Liu and B. Roth for sharing reagents; X. Zhou, Y. Wang, W. Yu, S. Huang, and T. O'Connor for technical assistance; J. Z. Young for proofreading; and other members of the Tonegawa Laboratory for their comments and support. This work was supported by the RIKEN Brain Science Institute, Howard Hughes Medical Institute, and the JPB Foundation (to S. T.). pAAV-TRE-ChR2-EYFP, pAAV-TRE-ChR2-mCherry, and pAAV-TRE-mCherry were developed by X.L., in the group of S. T., at the Massachusetts Institute of Technology; therefore, a materials transfer agreement (MTA) is required to obtain these virus plasmids.	Antoine B, 2014, BRAIN STRUCT FUNCT, V219, P415, DOI 10.1007/s00429-013-0505-y; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Chen SP, 2014, ELIFE, V3, DOI 10.7554/eLife.03896; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Cowansage KK, 2014, NEURON, V84, P432, DOI 10.1016/j.neuron.2014.09.022; Daumas S, 2008, LEARN MEMORY, V15, P625, DOI 10.1101/lm.990208; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; DUNCAN CP, 1949, J COMP PHYSIOL PSYCH, V42, P32, DOI 10.1037/h0058173; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; FLEXNER LB, 1967, SCIENCE, V155, P1377, DOI 10.1126/science.155.3768.1377; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Hall J, 2001, EUR J NEUROSCI, V13, P1453, DOI 10.1046/j.0953-816x.2001.01531.x; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Josselyn SA, 2010, J PSYCHIATR NEUROSCI, V35, P221, DOI 10.1503/jpn.100015; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; Liu X, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0142; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Miller CA, 2006, LEARN MEMORY, V13, P498, DOI 10.1101/lm.304606; Miller RR, 2006, LEARN MEMORY, V13, P491, DOI 10.1101/lm.241006; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Semon R.W., 1904, MNEME ALS ERHALTENDE; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Takeuchi T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0288; Tanaka KZ, 2014, NEURON, V84, P347, DOI 10.1016/j.neuron.2014.09.037	40	324	333	6	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					1007	1013		10.1126/science.aaa5542	http://dx.doi.org/10.1126/science.aaa5542			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	26023136	Green Accepted, Green Submitted			2022-12-28	WOS:000355276600042
J	Ghahramani, Z				Ghahramani, Zoubin			Probabilistic machine learning and artificial intelligence	NATURE			English	Review							MONTE-CARLO; STATISTICS; MODELS; ROBUST	How can a machine learn from experience? Probabilistic modelling provides a framework for understanding what learning is, and has therefore emerged as one of the principal theoretical and practical approaches for designing machines that learn from data acquired through experience. The probabilistic framework, which describes how to represent and manipulate uncertainty about models and predictions, has a central role in scientific data analysis, machine learning, robotics, cognitive science and artificial intelligence. This Review provides an introduction to this framework, and discusses some of the state-of-the-art advances in the field, namely, probabilistic programming, Bayesian optimization, data compression and automatic model discovery.	Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England	University of Cambridge	Ghahramani, Z (corresponding author), Univ Cambridge, Dept Engn, Trumpington St, Cambridge CB2 1PZ, England.	zoubin@eng.cam.ac.uk			EPSRC [EP/I036575/1]; DARPA PPAML; Google Focused Research Award; Microsoft Research; Engineering and Physical Sciences Research Council [EP/I036575/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); DARPA PPAML; Google Focused Research Award(Google Incorporated); Microsoft Research(Microsoft); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	I acknowledge an EPSRC grant EP/I036575/1, the DARPA PPAML programme, a Google Focused Research Award for the Automatic Statistician and support from Microsoft Research. I am also grateful for valuable input from D. Duvenaud, H. Ge, M. W. Hoffman, J. R. Lloyd, A. Scibior, M. Welling and D. Wolpert.	[Anonymous], 2013, TEXTS STAT SCI SERIE; [Anonymous], 2014, 2 INT C LEARN REPR I; [Anonymous], 2010, PYTHON SCI COMPUTING; Bakker B, 2004, J MACH LEARN RES, V4, P83, DOI 10.1162/153244304322765658; Bengio Y, 2003, J MACH LEARN RES, V3, P1137, DOI 10.1162/153244303322533223; Bishop C.M., 2006, PATTERN RECOGN; Bishop CM, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0222; Brochu E., 2010, PREPRINT; Cox R. T., 1961, ALGEBRA PROBABLE INF; de Finetti B., 1937, ANN I HENRI POINCARE, V7, P1; Deisenroth M., 2011, INT C MACH LEARN JAN, P465; Deneve S, 2008, NEURAL COMPUT, V20, P91, DOI 10.1162/neco.2008.20.1.91; Diaconis P., 1988, STAT DECISION THEORY, V1, P163, DOI DOI 10.1007/978-1-4613-8768-8_20; Doucet A., 2000, SEQUENTIAL MONTE CAR; Doya K., 2007, BAYESIAN BRAIN PROBA; FERGUSON TS, 1973, ANN STAT, V1, P209, DOI 10.1214/aos/1176342360; Fischer B, 2003, J FUNCT PROGRAM, V13, P483, DOI 10.1017/S0956796802004562; Ghahramani Z., P DAT COMPR IN PRESS; Ghahramani Z, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0553; Girolami M, 2011, J R STAT SOC B, V73, P123, DOI 10.1111/j.1467-9868.2010.00765.x; Goodman N., 2008, UNCERTAINTY ARTIFICI, V22, P23; Goodman N. D., 2015, DESIGN IMPLEMENTATIO; Goodman ND, 2015, PSYCHOL SCI, V26, P539, DOI 10.1177/0956797614559544; Griffiths TL, 2006, PSYCHOL SCI, V17, P767, DOI 10.1111/j.1467-9280.2006.01780.x; Grosse Roger, 2012, 28 C UNC ART INT CAT, P306; Hand D. J., 1986, ARTIFICIAL INTELLIGE; Hennig P, 2012, J MACH LEARN RES, V13, P1809; Hernandez-Lobato JM., 2014, P ADV NEUR INF PROC, V27, P918; Hinton G. E., 1986, FOUNDATIONS, V1, P77; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hjort NL, 2010, BAYESIAN NONPARAMETR; Hoffman MD, 2013, J MACH LEARN RES, V14, P1303; Houlsby N., 2012, NIPS, V3, P2096; Jaynes E.T., 2003, PROBABILITY THEORY L; JEFFERYS WH, 1992, AM SCI, V80, P64; Jones DR, 1998, J GLOBAL OPTIM, V13, P455, DOI 10.1023/A:1008306431147; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; Jordan MI, 2013, BERNOULLI, V19, P1378, DOI 10.3150/12-BEJSP17; Kemp Charles, 2006, AAAI, DOI DOI 10.1145/1837026.1837061; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; Knill DC, 1996, PERCEPTION BAYESIAN; Koller D., 1997, NAT C ART INT INN AP, P740; Koller D., 2009, PROBABILISTIC GRAPHI; Korattikara A, 2014, PR MACH LEARN RES, V32; Krizhevsky A., P 25 INT C NEUR INF, P1097; Kushner H.J., 1964, J BASIC ENG-T ASME, V86, P97, DOI 10.1115/1.3653121; Lawrence N. D., 2013, P C UNC ART INT; Li Lei, 2015, UCBEECS201512; Lloyd J. R., 2015, STAT MODEL CRITICISM; Lloyd JR, 2014, AAAI CONF ARTIF INTE, P1242; Lu C, 2015, AAAI CONF ARTIF INTE, P3811; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacKay D. J. C., 2003, INFORM THEORY INFERE; Marcus GF, 2013, PSYCHOL SCI, V24, P2351, DOI 10.1177/0956797613495418; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; Medvedovic M, 2002, BIOINFORMATICS, V18, P1194, DOI 10.1093/bioinformatics/18.9.1194; Milch B, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P1352; Miller Kurt T., 2009, NONPARAMETRIC LATENT, P1276; Minka T, 2010, INFERNET 24 MICROSOF; Minka T. P., 2001, P 17 C UNC ART INT, P362; Neal R. M., 1993, PROBABILISTIC INFERE; Neal R. M., 2010, HDB MARKOV CHAIN MON; Neal Radford M, 1996, BAYESIAN LEARNING NE; NEAL RM, 1992, FUND THEOR, V50, P197; OHAGAN A, 1991, J STAT PLAN INFER, V29, P245, DOI 10.1016/0378-3758(91)90002-V; Orbanz P., 2010, ENCY MACHINE LEARNIN, P81, DOI DOI 10.1007/978-0-387-30164-866; Paige B., 2014, ADV NEURAL INFORM PR, P3410; Perov Y., 2014, PREPRINT; Pfeffer A., 2009, FIGARO OBJECT ORIENT; Pfeffer A., 2001, P 17 INT JOINT C ART, P733; Pfeffer A., 2015, PRACTICAL PROBABILIS; Poupart P., 2010, ENCY MACHINE LEARNIN, P90; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rasmussen CE, 2009, IEEE ACM T COMPUT BI, V6, P615, DOI 10.1109/TCBB.2007.70269; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Rasmussen CE, 2001, ADV NEUR IN, V13, P294; Russell S.J., 2010, ARTIFICIAL INTELLIGE; Russell S.J., 1991, DO RIGHT THING STUDI; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Shannon C. E., 1949, MATH THEORY COMMUNIC; Snoek J., 2012, P NIPS, V12, P2960; Stan Development Team, 2022, STAN US GUID VERS 2; Sutskever I., 2014, NEURAL INFORM PROCES, P3104; Teh YW, 2006, J AM STAT ASSOC, V101, P1566, DOI 10.1198/016214506000000302; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Thornton C, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P847, DOI 10.1145/2487575.2487629; Thrun S., 2006, PROBABILISTIC ROBOTI; Van Horn KS, 2003, INT J APPROX REASON, V34, P3, DOI 10.1016/S0888-613X(03)00051-3; Welling M., 2014, ISBA B, V21; Wingate D., 2011, J MACH LEARN RES, V15, P770; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolstenholme D. E., 1988, Knowledge-Based Systems, V1, P173, DOI 10.1016/0950-7051(88)90075-5; Wood F, 2014, JMLR WORKSH CONF PRO, V33, P1024; Wood F, 2011, COMMUN ACM, V54, P91, DOI 10.1145/1897816.1897842	100	791	819	83	1034	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					452	459		10.1038/nature14541	http://dx.doi.org/10.1038/nature14541			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	26017444	Green Accepted			2022-12-28	WOS:000355286600032
J	Rus, D; Tolley, MT				Rus, Daniela; Tolley, Michael T.			Design, fabrication and control of soft robots	NATURE			English	Review							DYNAMIC-MODEL; ARM; KINEMATICS; BATTERIES; DRIVEN; EVOLUTION; ACTUATOR; POLYMER	Conventionally, engineers have employed rigid materials to fabricate precise, predictable robotic systems, which are easily modelled as rigid members connected at discrete joints. Natural systems, however, often match or exceed the performance of robotic systems with deformable bodies. Cephalopods, for example, achieve amazing feats of manipulation and locomotion without a skeleton; even vertebrates such as humans achieve dynamic gaits by storing elastic energy in their compliant bones and soft tissues. Inspired by nature, engineers have begun to explore the design and control of soft-bodied robots composed of compliant materials. This Review discusses recent developments in the emerging field of soft robotics.	[Rus, Daniela] MIT, Comp Sci & Artificial Intelligence Lab, Stata Ctr, Cambridge, MA 02139 USA; [Tolley, Michael T.] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego	Rus, D (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, Stata Ctr, Bldg 32,32 Vassar St, Cambridge, MA 02139 USA.	rus@csail.mit.edu			National Science Foundation [IIS-1226883]	National Science Foundation(National Science Foundation (NSF))	The authors would like to thank A. Marchese and R. Katzschmann for their insightful comments and suggestions in editing this paper. This work was done with partial support from the National Science Foundation grant number IIS-1226883, for which we are grateful.	Albu-Schaffer A, 2008, IEEE ROBOT AUTOM MAG, V15, P20, DOI 10.1109/MRA.2008.927979; Amend JR, 2012, IEEE T ROBOT, V28, P341, DOI 10.1109/TRO.2011.2171093; [Anonymous], 2007, BODY SHAPES WAY WE T; [Anonymous], [No title captured]; Bar-Cohen Y., 2004, ELECTROACTIVE POLYM; Brown E, 2010, P NATL ACAD SCI USA, V107, P18809, DOI 10.1073/pnas.1003250107; Calisti M, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/3/036002; Camarillo DB, 2009, IEEE T ROBOT, V25, P798, DOI 10.1109/TRO.2009.2022426; Cham JG, 2002, INT J ROBOT RES, V21, P869, DOI 10.1177/0278364902021010837; Chambers LD, 2014, PROC SPIE, V9056, DOI 10.1117/12.2045104; Cheng NG, 2014, MACROMOL MATER ENG, V299, P1279, DOI 10.1002/mame.201400017; CHIRIKJIAN GS, 1995, ADV ROBOTICS, V9, P217, DOI 10.1163/156855395X00175; Cho KJ, 2009, INT J PRECIS ENG MAN, V10, P171, DOI 10.1007/s12541-009-0064-6; Chou CP, 1996, IEEE T ROBOTIC AUTOM, V12, P90, DOI 10.1109/70.481753; Cianchetti M, 2013, IEEE INT C INT ROBOT, P3576, DOI 10.1109/IROS.2013.6696866; Correll N, 2014, EXPT ROBOTICS, P227, DOI 10.1007/978-3-642-28572-1_16; Deimel R., 2014, P ROBOT SCI SYST, P1687; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; Full R.J., 1997, HDB PHYSL 13, P853; Gaikwad AM, 2012, ADV MATER, V24, P5071, DOI 10.1002/adma.201201329; Goldfarb M, 2003, IEEE-ASME T MECH, V8, P254, DOI 10.1109/TMECH.2003.812842; Hammock ML, 2013, ADV MATER, V25, P5997, DOI 10.1002/adma.201302240; Hannan MW, 2003, J ROBOTIC SYST, V20, P45, DOI 10.1002/rob.10070; Hauser H, 2011, BIOL CYBERN, V105, P355, DOI 10.1007/s00422-012-0471-0; Hiller J, 2012, IEEE T ROBOT, V28, P457, DOI 10.1109/TRO.2011.2172702; Ieropoulos I., 2009, P SOC PHOTO-OPT INS, V7287; Ilievski F, 2011, ANGEW CHEM INT EDIT, V50, P1890, DOI 10.1002/anie.201006464; Jones BA, 2006, IEEE T ROBOT, V22, P43, DOI 10.1109/TRO.2005.861458; Jung K, 2007, BIOINSPIR BIOMIM, V2, pS42, DOI 10.1088/1748-3182/2/2/S05; Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314; Khatib O., 2004, INT J HUM ROBOT, V1, P29, DOI [DOI 10.1142/S0219843604000058, 10.1142/S0219843604000058]; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim S, 2013, TRENDS BIOTECHNOL, V31, P23, DOI 10.1016/j.tibtech.2013.03.002; Kramer RK, 2013, ADV FUNCT MATER, V23, P5292, DOI 10.1002/adfm.201203589; Kramer RK, 2011, IEEE INT CONF ROBOT, P1103, DOI 10.1109/ICRA.2011.5980082; Laschi Cecilia, 2014, Front Bioeng Biotechnol, V2, P3; Laschi C, 2012, ADV ROBOTICS, V26, P709, DOI 10.1163/156855312X626343; Li N, 2012, P NATL ACAD SCI USA, V109, P17360, DOI 10.1073/pnas.1210072109; Lin HT, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/2/026007; Lipson H., 2013, FABRICATED NEW WORLD; Lipson H, 2014, SOFT ROBOT, V1, P21, DOI 10.1089/soro.2013.0007; Luo M, 2014, SOFT ROBOT, V1, P136, DOI 10.1089/soro.2013.0011; Majidi C, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/10/105017; Majidi C, 2014, SOFT ROBOT, V1, P5, DOI 10.1089/soro.2013.0001; Majidi C, 2013, INT J ROBOT RES, V32, P1577, DOI 10.1177/0278364913498432; Marchese AD, 2015, SOFT ROBOT, V2, P7, DOI 10.1089/soro.2014.0022; Marchese AD, 2014, SOFT ROBOT, V1, P75, DOI 10.1089/soro.2013.0009; Marchese AD, 2014, IEEE INT CONF ROBOT, P2189, DOI 10.1109/ICRA.2014.6907161; Margheri L, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/2/025004; Martinez RV, 2013, ADV MATER, V25, P205, DOI 10.1002/adma.201203002; Mazzolai B, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/2/025005; McMahan W, 2006, IEEE INT CONF ROBOT, P2336, DOI 10.1109/ROBOT.2006.1642051; Menguc Y, 2014, INT J ROBOT RES, V33, P1748, DOI 10.1177/0278364914543793; Morin SA, 2012, SCIENCE, V337, P828, DOI 10.1126/science.1222149; Mosadegh B, 2014, ADV FUNCT MATER, V24, P2163, DOI 10.1002/adfm.201303288; Muth JT, 2014, ADV MATER, V26, P6307, DOI 10.1002/adma.201400334; Napp N, 2014, IEEE INT CONF ROBOT, P1440, DOI 10.1109/ICRA.2014.6907041; Nawroth JC, 2012, NAT BIOTECHNOL, V30, P792, DOI 10.1038/nbt.2269; Neppalli S, 2009, ADV ROBOTICS, V23, P2077, DOI 10.1163/016918609X12529299964101; Onal CD, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/2/026003; Park YL, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/1/016007; Paul C, 2006, ROBOT AUTON SYST, V54, P619, DOI 10.1016/j.robot.2006.03.003; Polygerinos P., 2014, ROBOT AUTON SYST; Renda F, 2014, IEEE T ROBOT, V30, P1109, DOI 10.1109/TRO.2014.2325992; Rieffel J, 2014, ARTIF LIFE, V20, P143, DOI 10.1162/ARTL_a_00101; Roche ET, 2014, ADV MATER, V26, P1200, DOI 10.1002/adma.201304018; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Rus D., 2014, P INT S EXP ROB; Rus D., J ROBOTICS IN PRESS; Sanan S, 2014, J MECH ROBOT, V6, DOI 10.1115/1.4026629; Saunders F, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/1/016001; Schulte H.F., 1961, APPL EXTERNAL POWER, P94; Seok S, 2013, IEEE-ASME T MECH, V18, P1485, DOI 10.1109/TMECH.2012.2204070; Shan WL, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/8/085005; Shepherd R.F., 2013, ANGEW CHEM, V125, P2964, DOI DOI 10.1002/ANGE.201209540; Shepherd RF, 2011, P NATL ACAD SCI USA, V108, P20400, DOI 10.1073/pnas.1116564108; SNYDER JM, 1990, J APPL MECH-T ASME, V57, P203, DOI 10.1115/1.2888305; Song YS, 2013, IEEE INT C INT ROBOT, P971, DOI 10.1109/IROS.2013.6696468; Steltz E, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P5672, DOI 10.1109/IROS.2009.5354790; Stokes AA, 2014, SOFT ROBOT, V1, P70, DOI 10.1089/soro.2013.0002; Suga T, 2009, ADV MATER, V21, P1627, DOI 10.1002/adma.200803073; Sumbre G, 2006, CURR BIOL, V16, P767, DOI 10.1016/j.cub.2006.02.069; Suzumori K., 1992, IEEE Control Systems Magazine, V12, P21, DOI 10.1109/37.120448; Suzumori K, 2007, IEEE INT CONF ROBOT, P4975, DOI 10.1109/ROBOT.2007.364246; Tatlicioglu E, 2007, IEEE INT CONF ROBOT, P1357, DOI 10.1109/ROBOT.2007.363173; Taylor R., 1996, HDB CHEM BIOL SENSOR; Tolley MT, 2014, IEEE INT C INT ROBOT, P561, DOI 10.1109/IROS.2014.6942615; Tolley MT, 2014, SOFT ROBOT, V1, P213, DOI 10.1089/soro.2014.0008; Trimmer BA., 2013, ACTA FUTURA, V6, P69, DOI [DOI 10.2420/ACT-B0K-AF, DOI 10.2420/AF06.2013.69]; Trivedi Deepak, 2008, Applied Bionics and Biomechanics, V5, P99, DOI 10.1080/11762320802557865; Vogt DM, 2013, IEEE SENS J, V13, P4056, DOI 10.1109/JSEN.2013.2272320; Wallace G. G., 2008, CONDUCTIVE ELECTROAC, DOI 10.1201/9781420067156; Wang HS, 2013, IEEE INT C INT ROBOT, P57, DOI 10.1109/IROS.2013.6696332; Webster RJ, 2010, INT J ROBOT RES, V29, P1661, DOI 10.1177/0278364910368147; Wehner M, 2014, SOFT ROBOT, V1, P263, DOI 10.1089/soro.2014.0018; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Xu S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2553; Yang SX, 2013, SENSORS-BASEL, V13, P8577, DOI 10.3390/s130708577; Yekutieli Y, 2005, J NEUROPHYSIOL, V94, P1443, DOI 10.1152/jn.00684.2004	100	2823	2891	279	2990	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					467	475		10.1038/nature14543	http://dx.doi.org/10.1038/nature14543			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	26017446	Green Submitted			2022-12-28	WOS:000355286600034
J	Aflalo, T; Kellis, S; Klaes, C; Lee, B; Shi, Y; Pejsa, K; Shanfield, K; Hayes-Jackson, S; Aisen, M; Heck, C; Liu, C; Andersen, RA				Aflalo, Tyson; Kellis, Spencer; Klaes, Christian; Lee, Brian; Shi, Ying; Pejsa, Kelsie; Shanfield, Kathleen; Hayes-Jackson, Stephanie; Aisen, Mindy; Heck, Christi; Liu, Charles; Andersen, Richard A.			Decoding motor imagery from the posterior parietal cortex of a tetraplegic human	SCIENCE			English	Article							BRAIN-MACHINE INTERFACES; OPTIC ATAXIA; REPRESENTATION; MOVEMENTS; SIGNALS; HAND	Nonhuman primate and human studies have suggested that populations of neurons in the posterior parietal cortex (PPC) may represent high-level aspects of action planning that can be used to control external devices as part of a brain-machine interface. However, there is no direct neuron-recording evidence that human PPC is involved in action planning, and the suitability of these signals for neuroprosthetic control has not been tested. We recorded neural population activity with arrays of microelectrodes implanted in the PPC of a tetraplegic subject. Motor imagery could be decoded from these neural populations, including imagined goals, trajectories, and types of movement. These findings indicate that the PPC of humans represents high-level, cognitive aspects of action and that the PPC can be a rich source for cognitive control signals for neural prosthetics that assist paralyzed patients.	[Aflalo, Tyson; Kellis, Spencer; Klaes, Christian; Shi, Ying; Pejsa, Kelsie; Andersen, Richard A.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Lee, Brian; Heck, Christi; Liu, Charles] Univ So Calif, USC Neurorestorat Ctr, Los Angeles, CA 90033 USA; [Lee, Brian; Heck, Christi; Liu, Charles] Univ So Calif, Dept Neurosurg, Los Angeles, CA 90033 USA; [Lee, Brian; Heck, Christi; Liu, Charles] Univ So Calif, Dept Neurol, Los Angeles, CA 90033 USA; [Shanfield, Kathleen; Hayes-Jackson, Stephanie; Aisen, Mindy] Rancho Los Amigos Natl Rehabil Ctr, Downey, CA 90242 USA	California Institute of Technology; University of Southern California; University of Southern California; University of Southern California	Andersen, RA (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	andersen@vis.caltech.edu	Klaes, Christian/AAJ-5843-2021	Kellis, Spencer/0000-0002-5158-1058; Aflalo, Tyson/0000-0002-0101-2455	NIH [EY013337, EY015545, P50 MH942581A]; Boswell Foundation; Center for Neurorestoration at the University of Southern California; Defense Department [N66001-10-4056]; NATIONAL EYE INSTITUTE [R01EY013337, R01EY015545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094258] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boswell Foundation; Center for Neurorestoration at the University of Southern California; Defense Department; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank EGS for his unwavering dedication and enthusiasm, which made this study possible. We acknowledge V. Shcherbatyuk for computer assistance; T. Yao, A. Berumen, and S. Oviedo, for administrative support; K. Durkin for nursing assistance; and our colleagues at the Applied Physics Laboratory at Johns Hopkins and at Blackrock Microsystems for technical support. This work was supported by the NIH under grants EY013337, EY015545, and P50 MH942581A; the Boswell Foundation; The Center for Neurorestoration at the University of Southern California; and Defense Department contract N66001-10-4056. All primary behavioral and neurophysiological data are archived in the Division of Biology and Biological Engineering at the California Institute of Technology.	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Andersen RA, 2014, CURR BIOL, V24, pR885, DOI 10.1016/j.cub.2014.07.068; Balint R, 1909, MON PSYCHIATR NEUROL, V25, P51; Chang SWC, 2008, J NEUROSCI, V28, P6128, DOI 10.1523/JNEUROSCI.1442-08.2008; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; Dangi S, 2014, NEURAL COMPUT, V26, P1811, DOI 10.1162/NECO_a_00632; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Hauschild M, 2012, P NATL ACAD SCI USA, V109, P17075, DOI 10.1073/pnas.1215092109; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Mulliken GH, 2008, P NATL ACAD SCI USA, V105, P8170, DOI 10.1073/pnas.0802602105; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Truccolo W, 2008, J NEUROSCI, V28, P1163, DOI 10.1523/JNEUROSCI.4415-07.2008; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245	22	313	318	33	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					906	910		10.1126/science.aaa5417	http://dx.doi.org/10.1126/science.aaa5417			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999506	Green Accepted			2022-12-28	WOS:000354877900043
J	Kachroo, AH; Laurent, JM; Yellman, CM; Meyer, AG; Wilke, CO; Marcotte, EM				Kachroo, Aashiq H.; Laurent, Jon M.; Yellman, Christopher M.; Meyer, Austin G.; Wilke, Claus O.; Marcotte, Edward M.			Systematic humanization of yeast genes reveals conserved functions and genetic modularity	SCIENCE			English	Article							EVOLUTION; EXPLORATION; PROTEINS; DELETION	To determine whether genes retain ancestral functions over a billion years of evolution and to identify principles of deep evolutionary divergence, we replaced 414 essential yeast genes with their human orthologs, assaying for complementation of lethal growth defects upon loss of the yeast genes. Nearly half (47%) of the yeast genes could be successfully humanized. Sequence similarity and expression only partly predicted replaceability. Instead, replaceability depended strongly on gene modules: Genes in the same process tended to be similarly replaceable (e.g., sterol biosynthesis) or not (e.g., DNA replication initiation). Simulations confirmed that selection for specific function can maintain replaceability despite extensive sequence divergence. Critical ancestral functions of many essential genes are thus retained in a pathway-specific manner, resilient to drift in sequences, splicing, and protein interfaces.	[Kachroo, Aashiq H.; Laurent, Jon M.; Yellman, Christopher M.; Meyer, Austin G.; Wilke, Claus O.; Marcotte, Edward M.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Meyer, Austin G.; Wilke, Claus O.; Marcotte, Edward M.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Wilke, Claus O.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Marcotte, Edward M.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Marcotte, EM (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	marcotte@icmb.utexas.edu	Kachroo, Aashiq/Z-2505-2019	Kachroo, Aashiq/0000-0001-9770-778X; Marcotte, Edward/0000-0001-8808-180X; Laurent, Jon/0000-0001-6583-4741; Meyer, Austin/0000-0002-0581-800X	Cancer Prevention and Research Institute of Texas (CPRIT); NIH [R01 GM088344]; Defense Threat Reduction Agency [HDTRA1-12-C-0007]; NSF Science and Technology Center BEACON funds [DBI-0939454]; NIH; NSF; CPRIT; Welch foundation [F-1515]; Direct For Biological Sciences [1237975] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076536, R01GM088344, DP1GM106408] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas (CPRIT); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NSF Science and Technology Center BEACON funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); CPRIT; Welch foundation(The Welch Foundation); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Minnix and A. Royall for assistance with cloning and assays, K. Drew for structural modeling assistance, M. Tsechansky for TANGO assistance, and C. Boone for providing the temperature-sensitive yeast strain collection. This work was supported by Cancer Prevention and Research Institute of Texas (CPRIT) research fellowships to A.H.K. and J.M.L; NIH grant R01 GM088344, Defense Threat Reduction Agency grant HDTRA1-12-C-0007, and NSF Science and Technology Center BEACON funds (DBI-0939454) to C.O.W.; and grants from the NIH, NSF, CPRIT, and the Welch foundation (F-1515) to E.M.M.	BASSON ME, 1988, MOL CELL BIOL, V8, P3797, DOI 10.1128/MCB.8.9.3797; Chen XS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002784; CORMACK BP, 1994, GENE DEV, V8, P1335, DOI 10.1101/gad.8.11.1335; Dolinski K, 2007, ANNU REV GENET, V41, P465, DOI 10.1146/annurev.genet.40.110405.090439; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Frost A, 2012, CELL, V149, P1339, DOI 10.1016/j.cell.2012.04.028; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Houten SM, 2001, MOL GENET METAB, V72, P273, DOI 10.1006/mgme.2000.3133; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kapitzky L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.107; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Marini NJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000968; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Nehrt NL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002073; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; ORR HA, 1995, GENETICS, V139, P1805; Osborn Michael J., 2007, Briefings in Functional Genomics & Proteomics, V6, P104, DOI 10.1093/bfgp/elm017; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ryan CJ, 2012, MOL CELL, V46, P691, DOI 10.1016/j.molcel.2012.05.028; Temple G, 2009, GENOME RES, V19, P2324, DOI 10.1101/gr.095976.109; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Welch JJ, 2004, EVOLUTION, V58, P1145; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	27	236	242	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					921	925		10.1126/science.aaa0769	http://dx.doi.org/10.1126/science.aaa0769			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999509	Green Accepted			2022-12-28	WOS:000354877900047
J	Sedgwick, P				Sedgwick, Philip			Measuring the detriment of treatment: number needed to harm	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, Med Stat & Med Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, Med Stat & Med Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Berlin Ivan, 2014, BMJ, V348, pg1622, DOI 10.1136/bmj.g1622; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2206; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4869	3	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2015	350								h2763	10.1136/bmj.h2763	http://dx.doi.org/10.1136/bmj.h2763			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI9ZO	26002193				2022-12-28	WOS:000355130600003
J	Luo, YP; Coskun, V; Liang, AB; Yu, JH; Cheng, LM; Ge, WH; Shi, ZP; Zhang, KS; Li, C; Cui, Y; Lin, HJ; Luo, DD; Wang, JB; Lin, C; Dai, Z; Zhu, HW; Zhang, J; Liu, J; Liu, HL; deVellis, J; Horvath, S; Sun, YE; Li, SG				Luo, Yuping; Coskun, Volkan; Liang, Aibing; Yu, Juehua; Cheng, Liming; Ge, Weihong; Shi, Zhanping; Zhang, Kunshan; Li, Chun; Cui, Yaru; Lin, Haijun; Luo, Dandan; Wang, Junbang; Lin, Connie; Dai, Zachary; Zhu, Hongwen; Zhang, Jun; Liu, Jie; Liu, Hailiang; deVellis, Jean; Horvath, Steve; Sun, Yi Eve; Li, Siguang			Single-Cell Transcriptome Analyses Reveal Signals to Activate Dormant Neural Stem Cells	CELL			English	Article							MESSENGER-RNA-SEQ; HETEROGENEITY; MAINTENANCE; MECHANISMS; EXPRESSION; QUIESCENT; EMBRYOS	The scarcity of tissue-specific stem cells and the complexity of their surrounding environment have made molecular characterization of these cells particularly challenging. Through single-cell transcriptome and weighted gene co-expression network analysis (WGCNA), we uncovered molecular properties of CD133(+)/GFAP(-) ependymal (E) cells in the adult mouse forebrain neurogenic zone. Surprisingly, prominent hub genes of the gene network unique to ependymal CD133(+)/GFAP(-) quiescent cells were enriched for immune-responsive genes, as well as genes encoding receptors for angiogenic factors. Administration of vascular endothelial growth factor (VEGF) activated CD133(+) ependymal neural stem cells (NSCs), lining not only the lateral but also the fourth ventricles and, together with basic fibroblast growth factor (bFGF), elicited subsequent neural lineage differentiation and migration. This study revealed the existence of dormant ependymal NSCs throughout the ventricular surface of the CNS, as well as signals abundant after injury for their activation.	[Luo, Yuping; Liang, Aibing; Yu, Juehua; Cheng, Liming; Shi, Zhanping; Zhang, Kunshan; Luo, Dandan; Wang, Junbang; Zhang, Jun; Liu, Jie; Liu, Hailiang; Sun, Yi Eve; Li, Siguang] Tongji Univ, Sch Med, Tongji Hosp, Stem Cell Translat Res Ctr, Shanghai 200065, Peoples R China; [Luo, Yuping; Cui, Yaru; Lin, Haijun] Nanchang Univ, Coll Life Sci, Nanchang 330031, Peoples R China; [Sun, Yi Eve; Li, Siguang] Tongji Univ, Collaborat Innovat Ctr Brain Sci, Shanghai 200092, Peoples R China; [Coskun, Volkan; Ge, Weihong; Lin, Connie; Dai, Zachary; deVellis, Jean; Sun, Yi Eve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Sun, Yi Eve] Yunnan Key Lab Primate Biomed Res, Kunming 650500, Peoples R China; [Li, Chun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Stem Cell Inst, Shanghai 200025, Peoples R China; [Zhu, Hongwen] Tianjing Hosp, Tianjin Acad Integrat Med, Tianjin 300211, Peoples R China; [Cheng, Liming] Tongji Univ, Sch Med, Tongji Hosp, Dept Spine Surg, Shanghai 200065, Peoples R China; [Horvath, Steve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	Tongji University; Nanchang University; Tongji University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Shanghai Jiao Tong University; Tongji University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sun, YE (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Stem Cell Translat Res Ctr, Shanghai 200065, Peoples R China.	yi.eve.sun@gmail.com; siguangli@163.com	cheng, liming/GMX-4116-2022; Xiao, Hu/GMX-0258-2022	Dai, Zachary/0000-0002-1997-5890	National Key Basic Research Program of China [2011CBA01106, 2011CB965102, 2010CB945202, 2012CB966300, 2010CB945600, 2011CB966204, 2014CB964602]; National Natural Foundation of China [91319309, 31271371, 81330030, 31271450, 31271375]; NIH [P01 GM081621-01A1]; Transcriptome and Epigenetics Core of Center for Study of Opioid Receptors and Drugs of Abuse (CSORDA center) [NIH-P50DA005010]; Intellectual and Developmental Disabilities Research Center (IDDRC center) at the University of California, Los Angeles [NIH-P30HD004612]; Yunnan and Shanghai local grants [2012HA013, 2014FC004, 13XD1403600, ZJ2014-ZD-002]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Transcriptome and Epigenetics Core of Center for Study of Opioid Receptors and Drugs of Abuse (CSORDA center); Intellectual and Developmental Disabilities Research Center (IDDRC center) at the University of California, Los Angeles; Yunnan and Shanghai local grants; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Gun Woo Byeon for his assistance in data analyses. We thank Xiao Chen from Jiangxi Science & Technology Normal University for making the graphical abstract and some figures. This work was supported by the National Key Basic Research Program of China (grants 2011CBA01106, 2011CB965102, 2010CB945202, 2012CB966300, 2010CB945600, 2011CB966204, and 2014CB964602); the National Natural Foundation of China (grants 91319309, 31271371, 81330030, 31271450, and 31271375); and grants from the NIH (P01 GM081621-01A1), the Transcriptome and Epigenetics Core of Center for Study of Opioid Receptors and Drugs of Abuse (CSORDA center; grant NIH-P50DA005010), and the Intellectual and Developmental Disabilities Research Center (IDDRC center; grant NIH-P30HD004612) at the University of California, Los Angeles. The project is also supported by Yunnan and Shanghai local grants 2012HA013, 2014FC004, 13XD1403600, and ZJ2014-ZD-002.	Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fischer J, 2011, NAT PROTOC, V6, P1981, DOI 10.1038/nprot.2011.412; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Kurimoto K, 2007, NAT PROTOC, V2, P739, DOI 10.1038/nprot.2007.79; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakafuku M, 2008, P NATL ACAD SCI USA, V105, P829, DOI 10.1073/pnas.0711637105; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; OLSZANSKA B, 1993, J EXP ZOOL, V265, P317, DOI 10.1002/jez.1402650313; Ramos AD, 2013, CELL STEM CELL, V12, P616, DOI 10.1016/j.stem.2013.03.003; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wu JC, 2013, BIOTECHNOL ADV, V31, P1047, DOI 10.1016/j.biotechadv.2013.09.001; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	34	169	185	25	164	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1175	1186		10.1016/j.cell.2015.04.001	http://dx.doi.org/10.1016/j.cell.2015.04.001			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000486	Green Accepted, Bronze			2022-12-28	WOS:000355152600023
J	Ganna, A; Ingelsson, E				Ganna, Andrea; Ingelsson, Erik			5 year mortality predictors in 498 103 UK Biobank participants: a prospective population-based study	LANCET			English	Article							RISK-FACTORS; LIFE-STYLE; HEALTH; ADULTS; DEATH	Background To our knowledge, a systematic comparison of predictors of mortality in middle-aged to elderly individuals has not yet been done. We investigated predictors of mortality in UK Biobank participants during a 5 year period. We aimed to investigate the associations between most of the available measurements and 5 year all-cause and cause-specific mortality, and to develop and validate a prediction score for 5 year mortality using only self-reported information. Methods Participants were enrolled in the UK Biobank from April, 2007, to July, 2010, from 21 assessment centres across England, Wales, and Scotland with standardised procedures. In this prospective population-based study, we assessed sex-specific associations of 655 measurements of demographics, health, and lifestyle with all-cause mortality and six cause-specific mortality categories in UK Biobank participants using the Cox proportional hazard model. We excluded variables that were missing in more than 80% of the participants and all cardiorespiratory fitness test measurements because summary data were not available. Validation of the prediction score was done in participants enrolled at the Scottish centres. UK life tables and census information were used to calibrate the score to the overall UK population. Findings About 500 000 participants were included in the UK Biobank. We excluded participants with more than 80% variables missing (n=746). Of 498 103 UK Biobank participants included (54% of whom were women) aged 37-73 years, 8532 (39% of whom were women) died during a median follow-up of 4.9 years (IQR 4.33-5.22). Self-reported health (C-index including age 0.74 [95% CI 0.73-0.75]) was the strongest predictor of all-cause mortality in men and a previous cancer diagnosis (0.73 [0.72-0.74]) was the strongest predictor of all-cause mortality in women. When excluding individuals with major diseases or disorders (Charlson comorbidity index >0; n=355 043), measures of smoking habits were the strongest predictors of all-cause mortality. The prognostic score including 13 self-reported predictors for men and 11 for women achieved good discrimination (0.80 [0.77-0.83] for men and 0.79 [0.76-0.83] for women) and significantly outperformed the Charlson comorbidity index (p<0.0001 in men and p=0.0007 in women). A dedicated website allows the interactive exploration of all results along with calculation of individual risk through an online questionnaire. Interpretation Measures that can simply be obtained by questionnaires and without physical examination were the strongest predictors of all-cause mortality in the UK Biobank population. The prediction score we have developed accurately predicts 5 year all-cause mortality and can be used by individuals to improve health awareness, and by health professionals and organisations to identify high-risk individuals and guide public policy.	[Ganna, Andrea] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ganna, Andrea; Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden	Karolinska Institutet; Uppsala University	Ingelsson, E (corresponding author), Dept Med Sci, Mol Epidemiol, Box 1115, S-75141 Uppsala, Sweden.	erik.ingelsson@medsci.uu.se		Ganna, Andrea/0000-0002-8147-240X	Knut and Alice Wallenberg Foundation; Swedish Research Council; Medical Research Council [MC_qA137853] Funding Source: researchfish	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Knut and Alice Wallenberg Foundation and the Swedish Research Council.	Baer HJ, 2011, AM J EPIDEMIOL, V173, P319, DOI 10.1093/aje/kwq368; Banks E, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001372; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Elbaz A, 2013, AGE, V35, P943, DOI 10.1007/s11357-012-9387-9; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Lahti RA, 2001, FORENSIC SCI INT, V115, P15, DOI 10.1016/S0379-0738(00)00300-5; Li KR, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-59; Manolio TA, 2010, JAMA-J AM MED ASSOC, V304, P2290, DOI 10.1001/jama.2010.1686; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; Maudsley G, 1996, J PUBLIC HEALTH MED, V18, P59, DOI 10.1093/oxfordjournals.pubmed.a024463; McGee DL, 1999, AM J EPIDEMIOL, V149, P41; Newman AB, 2009, J GERONTOL A-BIOL, V64, P1251, DOI 10.1093/gerona/glp127; Office for National Statistics, 2014, MORT STAT MET; Oortwijn W., 2011, SOCIAL DETERMINANTS; Palmer LJ, 2007, LANCET, V369, P1980, DOI 10.1016/S0140-6736(07)60924-6; Pavlik VN, 2003, AM J EPIDEMIOL, V157, P327, DOI 10.1093/aje/kwf209; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rizzuto D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5568; Sheridan SL, 2004, AM J PREV MED, V26, P56, DOI 10.1016/j.amepre.2003.09.011; Sillence E, 2007, SOC SCI MED, V64, P1853, DOI 10.1016/j.socscimed.2007.01.012; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; Tota-Maharaj R, 2012, EUR HEART J, V33, P2955, DOI 10.1093/eurheartj/ehs230; Varadhan R, 2014, J GERONTOL A-BIOL, V69, P165, DOI 10.1093/gerona/glt023; Walter Stefan, 2012, Am J Public Health, V102, pe3, DOI 10.2105/AJPH.2011.300596; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; White Ryen W, 2009, AMIA Annu Symp Proc, V2009, P696; White RW, 2009, ACM T INFORM SYST, V27, DOI 10.1145/1629096.1629101; Wolbers M, 2014, BIOSTATISTICS, V15, P526, DOI 10.1093/biostatistics/kxt059; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	37	215	220	5	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2015	386	9993					533	540		10.1016/S0140-6736(15)60175-1	http://dx.doi.org/10.1016/S0140-6736(15)60175-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO8PG	26049253				2022-12-28	WOS:000359431900027
J	Crystal, RG				Crystal, Ronald G.			Augmentation treatment for alpha 1 antitrypsin deficiency	LANCET			English	Editorial Material							ALPHA(1)-ANTITRYPSIN DEFICIENCY; REPLACEMENT THERAPY; ANTIPROTEASE; SERUM		Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA	Cornell University	Crystal, RG (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu						Chapman KR, 2015, LANCET; Chiuchiolo MJ, 2013, HUM GENE THER CL DEV, V24, P161, DOI 10.1089/humc.2013.168; Dawkins PA, 2003, THORAX, V58, P1020, DOI 10.1136/thorax.58.12.1020; De BP, 2008, MOL THER, V16, P203, DOI 10.1038/sj.mt.6300344; Dirksen A, 2009, EUR RESPIR J, V33, P1345, DOI 10.1183/09031936.00159408; GADEK JE, 1980, J CLIN INVEST, V66, P82, DOI 10.1172/JCI109838; GADEK JE, 1981, J CLIN INVEST, V68, P1158, DOI 10.1172/JCI110360; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; Mueller C, 2013, J CLIN INVEST, V123, P5310, DOI 10.1172/JCI70314; Stoller JK, 2012, AM J RESP CRIT CARE, V185, P246, DOI 10.1164/rccm.201108-1428CI; Wewers MD, 2013, COPD, V10, P64, DOI 10.3109/15412555.2013.764402; WEWERS MD, 1987, NEW ENGL J MED, V316, P1055, DOI 10.1056/NEJM198704233161704	12	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2015	386	9991					318	320		10.1016/S0140-6736(15)60036-8	http://dx.doi.org/10.1016/S0140-6736(15)60036-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN5CX	26026937				2022-12-28	WOS:000358448400007
J	Spencer, FA; Prasad, M; Vandvik, PO; Chetan, D; Zhou, Q; Guyatt, G				Spencer, Frederick A.; Prasad, Manya; Vandvik, Per O.; Chetan, Devin; Zhou, Qi; Guyatt, Gordon			Longer-Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							CLOPIDOGREL USE; BARE METAL; FOLLOW-UP; IMPLANTATION; GUIDELINES; QUALITY; GRADE; EFFICACY; TRIALS; OUTCOMES	Background: The appropriate duration of dual-antiplatelet therapy (DAPT) after drug-eluting stent (DES) placement remains controversial. Purpose: To summarize data on clinical outcomes with longer-versus shorter-duration DAPT after DES placement in adults with coronary artery disease. Data Sources: Ovid MEDLINE and EMBASE, 1996 to 27 March 2015, and manual screening of references. Study Selection: Randomized, controlled trials comparing longer-versus shorter-duration DAPT after DES placement. Data Extraction: Two reviewers screened potentially eligible articles; extracted data on populations, interventions, and outcomes; assessed risk of bias; and used the Grading of Recommendations Assessment, Development and Evaluation guidelines to rate overall confidence in effect estimates. Data Synthesis: Among 1010 articles identified, 9 trials including 29 531 patients were eligible; data were complete for 28 808 patients. Moderate-quality evidence showed that longer-duration DAPT decreased risk for myocardial infarction (risk ratio [RR], 0.73 [95% CI, 0.58 to 0.92]) and increased mortality (RR, 1.19 [CI, 1.04 to 1.36]). High-quality evidence showed that DAPT increased risk for major bleeding (RR, 1.63 [CI, 1.34 to 1.99]). Limitation: Confidence in estimates were decreased owing to imprecision for most outcomes (particularly myocardial infarction), risk of bias from limited blinding in 7 of 9 studies, indirectness due to variability in use of first-and second-generation stents, and off-protocol use of DAPT in some studies. Conclusion: Extended DAPT is associated with approximately 8 fewer myocardial infarctions per 1000 treated patients per year but 6 more major bleeding events than shorter-duration DAPT. Because absolute effects are very small and closely balanced, decisions regarding the duration of DAPT therapy must take into account patients' values and preference.	McMaster Univ, Hamilton, ON L8N 4A6, Canada; Pt Bhagwat Dayal Sharma Postgrad Inst Med Sci, Rohtak, Haryana, India; Innlandet Hosp Trust, Gjovik, Norway	McMaster University; Pt. B.D. Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak; Innlandet Hospital Trust	Spencer, FA (corresponding author), McMaster Univ, Dept Med, Fac Hlth Sci, 50 Charlton Ave East, Hamilton, ON L8N 4A6, Canada.	fspence@mcmaster.ca	Zhou, Qi/GSM-9583-2022; Prasad, Manya/AAQ-6436-2021					Akl EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057132; Akl EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2809; Borenstein M, 2008, INTRO METAANALYSIS; Collet JP, 2014, LANCET, V384, P1577, DOI 10.1016/S0140-6736(14)60612-7; Colombo A, 2014, J AM COLL CARDIOL, V64, P2086, DOI 10.1016/j.jacc.2014.09.008; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Fajadet J, 2006, CIRCULATION, V114, P798, DOI 10.1161/CIRCULATIONAHA.105.591206; Faxon DP, 2012, CIRC-CARDIOVASC INTE, V5, P372, DOI 10.1161/CIRCINTERVENTIONS.111.967257; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Gilard M, 2015, J AM COLL CARDIOL, V65, P777, DOI 10.1016/j.jacc.2014.11.008; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1277, DOI 10.1016/j.jclinepi.2011.01.011; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Kirtane AJ, 2013, JACC-CARDIOVASC INTE, V6, P325, DOI 10.1016/j.jcin.2012.12.123; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Lee CW, 2014, CIRCULATION, V129, P304, DOI 10.1161/CIRCULATIONAHA.113.003303; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Lim E, 2008, ANN INTERN MED, V149, P612, DOI 10.7326/0003-4819-149-9-200811040-00004; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Palmerini T, 2015, LANCET, V385, P2371, DOI 10.1016/S0140-6736(15)60263-X; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Schulz-Schupke S, 2015, EUR HEART J, V36, P1252, DOI 10.1093/eurheartj/ehu523; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Valgimigli M, 2013, EUR HEART J, V34, P909, DOI 10.1093/eurheartj/ehs460; Vandvik O, 2012, CHEST, V141, pE637S, DOI 10.1378/chest.11-2306; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	36	43	45	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2					118	+		10.7326/M15-0083	http://dx.doi.org/10.7326/M15-0083			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	26005909				2022-12-28	WOS:000358407500019
J	Mittal, S; Hafezi, M				Mittal, Sunil; Hafezi, Mohammad			MATERIALS SCIENCE Round the bend with microwaves	NATURE			English	Editorial Material							STATES		[Mittal, Sunil; Hafezi, Mohammad] Univ Maryland, Dept Elect & Comp Engn, IREAP, Joint Quantum Inst, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Mittal, S (corresponding author), Univ Maryland, Dept Elect & Comp Engn, IREAP, Joint Quantum Inst, College Pk, MD 20742 USA.	hafezi@umd.edu	Hafezi, Mohammad/A-1197-2008	Hafezi, Mohammad/0000-0003-1679-4880				Chen WJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6782; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; Hafezi M, 2011, NAT PHYS, V7, P907, DOI [10.1038/NPHYS2063, 10.1038/nphys2063]; Haldane FDM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013904; Jia N., 2015, J PREPRINT; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Ma T, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.127401; Mittal S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.087403; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293	11	0	0	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					292	293		10.1038/nature14533	http://dx.doi.org/10.1038/nature14533			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26040714				2022-12-28	WOS:000356425400040
J	Spellman, T; Rigotti, M; Ahmari, SE; Fusi, S; Gogos, JA; Gordon, JA				Spellman, Timothy; Rigotti, Mattia; Ahmari, Susanne E.; Fusi, Stefano; Gogos, Joseph A.; Gordon, Joshua A.			Hippocampal-prefrontal input supports spatial encoding in working memory	NATURE			English	Article							VENTRAL HIPPOCAMPUS; THETA-OSCILLATIONS; DORSAL HIPPOCAMPUS; POPULATION CODE; CORTEX; RATS; PERFORMANCE; LESIONS; TASK; REPRESENTATIONS	Spatial working memory, the caching of behaviourally relevant spatial cues on a timescale of seconds, is a fundamental constituent of cognition. Although the prefrontal cortex and hippocampus are known to contribute jointly to successful spatial working memory, the anatomical pathway and temporal window for the interaction of these structures critical to spatial working memory has not yet been established. Here we find that direct hippocampal-prefrontal afferents are critical for encoding, but not for maintenance or retrieval, of spatial cues in mice. These cues are represented by the activity of individual prefrontal units in a manner that is dependent on hippocampal input only during the cue-encoding phase of a spatial working memory task. Successful encoding of these cues appears to be mediated by gamma-frequency synchrony between the two structures. These findings indicate a critical role for the direct hippocampal-prefrontal afferent pathway in the continuous updating of task-related spatial information during spatial working memory.	[Spellman, Timothy; Gogos, Joseph A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Rigotti, Mattia; Fusi, Stefano; Gogos, Joseph A.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Rigotti, Mattia] IBM Corp, TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Rigotti, Mattia] Columbia Univ, Italian Acad Adv Studies Amer, New York, NY 10032 USA; [Ahmari, Susanne E.] Univ Pittsburgh, Dept Psychiat, Translat Neurosci Program, Pittsburgh, PA 15219 USA; [Ahmari, Susanne E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15261 USA; [Ahmari, Susanne E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15261 USA; [Fusi, Stefano] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; [Gordon, Joshua A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Gordon, Joshua A.] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; International Business Machines (IBM); Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; Columbia University; New York State Psychiatry Institute	Gordon, JA (corresponding author), Columbia Univ, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA.	jg343@columbia.edu	Fusi, Stefano/E-9109-2011; Ahmari, Susanne E./J-5812-2013; Core, Vector/CAF-4832-2022; Rigotti, Mattia/H-7252-2019	Fusi, Stefano/0000-0002-3035-6652; Ahmari, Susanne E./0000-0003-4576-076X; Rigotti, Mattia/0000-0001-6466-2810	National Institutes of Health [MH096274, MH081968]; Hope for Depression Research Foundation; International Mental Health Research Organization; Gatsby Charitable Foundation; Swartz Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH087718, R01MH096274, R01MH081968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Depression Research Foundation; International Mental Health Research Organization; Gatsby Charitable Foundation; Swartz Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to thank M. Topiwala for technical assistance, M. Kheirbek for advice and assistance with the design of fibre optics, and M. Shapiro for advice with regards to designing the four-arm T-maze. This work was supported by grants from the National Institutes of Health (MH096274 and MH081968), the Hope for Depression Research Foundation, the International Mental Health Research Organization, the Gatsby Charitable Foundation and the Swartz Foundation.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Andrade J, 2001, WORKING MEMORY PERSP; ANLAUF JK, 1989, EUROPHYS LETT, V10, P687, DOI 10.1209/0295-5075/10/7/014; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A.D., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/s0079-7421(08)60452-1]; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Barak O, 2011, NEURAL COMPUT, V23, P1935, DOI 10.1162/NECO_a_00152; Burton BG, 2009, BEHAV BRAIN RES, V199, P222, DOI 10.1016/j.bbr.2008.11.045; Carr MF, 2012, NEURON, V75, P700, DOI 10.1016/j.neuron.2012.06.014; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Cowan N, 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; Curtis Clayton E., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P528, DOI 10.3758/CABN.4.4.528; de Zubicaray GI, 2001, LEARN MEMORY, V8, P243, DOI 10.1101/lm.40301; Dietterich T. G., 1991, P AAAI, V91, P572; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Horst NK, 2012, J NEUROPHYSIOL, V108, P3276, DOI 10.1152/jn.01192.2011; Hyman JM, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/neuro.07.002.2010; Izaki Y, 2008, EUR J NEUROSCI, V27, P3029, DOI 10.1111/j.1460-9568.2008.06284.x; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jung MW, 1998, CEREB CORTEX, V8, P437, DOI 10.1093/cercor/8.5.437; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Klauer KC, 2004, J EXP PSYCHOL GEN, V133, P355, DOI 10.1037/0096-3445.133.3.355; Komorowski RW, 2013, J NEUROSCI, V33, P8079, DOI 10.1523/JNEUROSCI.5458-12.2013; KRAUTH W, 1987, J PHYS A-MATH GEN, V20, pL745, DOI 10.1088/0305-4470/20/11/013; Lee I, 2003, J NEUROSCI, V23, P1517, DOI 10.1523/JNEUROSCI.23-04-01517.2003; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; O'Neill PK, 2013, J NEUROSCI, V33, P14211, DOI 10.1523/JNEUROSCI.2378-13.2013; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Patel J, 2012, NEURON, V75, P410, DOI 10.1016/j.neuron.2012.07.015; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; ROGERS DC, 1992, BEHAV BRAIN RES, V49, P231, DOI 10.1016/S0166-4328(05)80169-X; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Ruediger S, 2012, NAT NEUROSCI, V15, P1563, DOI 10.1038/nn.3224; Seamans JK, 2008, NEUROTOX RES, V14, P249, DOI 10.1007/BF03033814; SHAW C, 1993, BEHAV BRAIN RES, V54, P91, DOI 10.1016/0166-4328(93)90051-Q; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Sloan HL, 2006, BEHAV BRAIN RES, V171, P116, DOI 10.1016/j.bbr.2006.03.030; Vinck M, 2010, NEUROIMAGE, V51, P112, DOI 10.1016/j.neuroimage.2010.01.073; Wang GW, 2006, BEHAV BRAIN RES, V175, P329, DOI 10.1016/j.bbr.2006.09.002; Yamamoto J, 2014, CELL, V157, P845, DOI 10.1016/j.cell.2014.04.009	49	370	380	10	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					309	+		10.1038/nature14445	http://dx.doi.org/10.1038/nature14445			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26053122	Green Accepted			2022-12-28	WOS:000356425400046
J	Colombo, MG; Franzoni, C; Rossi-Lamastra, C				Colombo, Massimo G.; Franzoni, Chiara; Rossi-Lamastra, Cristina			Cash from the crowd	SCIENCE			English	Editorial Material									[Colombo, Massimo G.; Franzoni, Chiara; Rossi-Lamastra, Cristina] Polytech Univ Milan, Sch Management, I-20156 Milan, Italy	Polytechnic University of Milan	Franzoni, C (corresponding author), Polytech Univ Milan, Sch Management, I-20156 Milan, Italy.	chiara.franzoni@polimi.it	Franzoni, Chiara/AAH-3119-2019	Franzoni, Chiara/0000-0002-6092-0074; Colombo, Massimo G./0000-0003-0373-1565				Colombo MG, 2015, ENTREP THEORY PRACT, V39, P75, DOI 10.1111/etap.12118	1	11	11	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1201	1202		10.1126/science.aab3832	http://dx.doi.org/10.1126/science.aab3832			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK2AK	26068827				2022-12-28	WOS:000356011500023
J	Hochberg, YV; Serrano, C; Ziedonis, R				Hochberg, Yael V.; Serrano, Carlos; Ziedonis, Rosemarie			Intangible but bankable	SCIENCE			English	Editorial Material									[Hochberg, Yael V.] Rice Univ, Houston, TX 77251 USA; [Hochberg, Yael V.] MIT, Cambridge, MA 02139 USA; [Hochberg, Yael V.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Serrano, Carlos] Univ Pompeu Fabra, Barcelona 08005, Spain; [Serrano, Carlos] Barcelona GSE, Barcelona 08005, Spain; [Serrano, Carlos] Banco Espana, Barcelona 08002, Spain; [Ziedonis, Rosemarie] Boston Univ, Boston, MA 02215 USA; [Ziedonis, Rosemarie] Stanford Univ, Hoover Inst, Stanford, CA 94305 USA	Rice University; Massachusetts Institute of Technology (MIT); National Bureau of Economic Research; Pompeu Fabra University; Barcelona School of Economics; Banco de Espana; Boston University; Stanford University	Serrano, C (corresponding author), Univ Pompeu Fabra, Barcelona 08005, Spain.	carlos.serrano@upf.edu	Serrano, Carlos/R-9871-2018	Serrano, Carlos/0000-0002-5792-5210; Ziedonis, Rosemarie/0000-0002-8555-8980				Hochberg Y. V., 2014, 20587 NAT BUR EC RES	1	6	6	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1202	1202		10.1126/science.aac4837	http://dx.doi.org/10.1126/science.aac4837			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK2AK	26068828				2022-12-28	WOS:000356011500024
J	Bagenstos, SR				Bagenstos, Samuel R.			The ADA and the Supreme Court A Mixed Record	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bagenstos, SR (corresponding author), Univ Michigan, Sch Law, 314 Hutchins Hall, Ann Arbor, MI 48109 USA.	sambagen@umich.edu						Bagenstos Samuel R., 2012, CARDOZO LAW REV, V34, P1; Bagenstos SR, 2014, DISABILITY RIGHTS LA, P33; Barry KM, 2013, EMP RTS EMP POLY J, V17, P5; Colker Ruth, 2007, WM MARY L REV, V49, P1; Gostin LO, 1999, JAMA-J AM MED ASSOC, V281, P745, DOI 10.1001/jama.281.8.745; KRIEGER LH, 2003, BACKLASH ADA REINTER	6	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2217	2218		10.1001/jama.2015.4268	http://dx.doi.org/10.1001/jama.2015.4268			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1VH	26057276				2022-12-28	WOS:000355995300009
J	Hooper, R; Bourke, L				Hooper, Richard; Bourke, Liam			Cluster randomised trials with repeated cross sections: alternatives to parallel group designs	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS; STATISTICS; BINARY		[Hooper, Richard] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London E1 2AB, England; [Bourke, Liam] Sheffield Hallam Univ, Hlth & Wellbeing Res Inst, Sheffield S1 1WB, S Yorkshire, England	University of London; Queen Mary University London; Sheffield Hallam University	Hooper, R (corresponding author), Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London E1 2AB, England.	r.l.hooper@qmul.ac.uk		Hooper, Richard/0000-0002-1063-0917	UK National Institute for Health Research; Higher Education Funding Council for England	UK National Institute for Health Research(National Institute for Health Research (NIHR)); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE))	The work summarised in this article was not funded by a specific grant. RH is supported by the UK National Institute for Health Research as part of its funding for the Pragmatic Clinical Trials Unit at Barts & the London School of Medicine & Dentistry. LB is supported by the Higher Education Funding Council for England.	ALTMAN DG, 1980, BRIT MED J, V281, P1336, DOI 10.1136/bmj.281.6251.1336; CAMPBELL MJ, 1995, BRIT MED J, V311, P1145, DOI 10.1136/bmj.311.7013.1145; Donner A, 2000, STAT METHODS MED RES, V9, P79, DOI 10.1191/096228000669355658; Eldridge S, 2012, PRACTICAL GUIDE CLUS, P85; FRISON L, 1992, STAT MED, V11, P1685, DOI 10.1002/sim.4780111304; Gagne JJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6802; Hemming K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h391; Hemming K, 2015, STAT MED, V34, P181, DOI 10.1002/sim.6325; Hooper R, 2014, INT J EPIDEMIOL, V43, P930, DOI 10.1093/ije/dyt281; Hrobjartsson A, 1998, BRIT MED J, V317, P1243, DOI 10.1136/bmj.317.7167.1243; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; Kerry SM, 1998, BRIT MED J, V316, P1455, DOI 10.1136/bmj.316.7142.1455; Machin DCMTS, 2009, SAMPLE SIZE TABLES C, Vthird; MARSHALL G, 1948, LANCET, V254, P582; Mdege ND, 2011, J CLIN EPIDEMIOL, V64, P936, DOI 10.1016/j.jclinepi.2010.12.003; Murphy S, 2011, PUBLIC HEALTH NUTR, V14, P219, DOI 10.1017/S1368980010001886; Ridout MS, 1999, BIOMETRICS, V55, P137, DOI 10.1111/j.0006-341X.1999.00137.x; Teerenstra S, 2012, STAT MED, V31, P2169, DOI 10.1002/sim.5352	19	51	51	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2015	350								h2925	10.1136/bmj.h2925	http://dx.doi.org/10.1136/bmj.h2925			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK7CK	26055828	Bronze, Green Accepted			2022-12-28	WOS:000356387800002
J	Nguyen, TA; Jo, MH; Choi, YG; Park, J; Kwon, SC; Hohng, S; Kim, VN; Woo, JS				Tuan Anh Nguyen; Jo, Myung Hyun; Choi, Yeon-Gil; Park, Joha; Kwon, S. Chul; Hohng, Sungchul; Kim, V. Narry; Woo, Jae-Sung			Functional Anatomy of the Human Microprocessor	CELL			English	Article							PRIMARY MICRORNAS; DROSHA-DGCR8 COMPLEX; PRIMARY TRANSCRIPTS; DGCR8; DICER; RNA; RECOGNITION; BINDING; PROTEIN; HEME	MicroRNA (miRNA) maturation is initiated by Microprocessor composed of RNase III DROSHA and its cofactor DGCR8, whose fidelity is critical for generation of functional miRNAs. To understand how Microprocessor recognizes pri-miRNAs, we here reconstitute human Microprocessor with purified recombinant proteins. We find that Microprocessor is an similar to 364 kDa heterotrimeric complex of one DROSHA and two DGCR8 molecules. Together with a 23-amino acid peptide from DGCR8, DROSHA constitutes a minimal functional core. DROSHA serves as a "ruler'' by measuring 11 bp from the basal ssRNA-dsRNA junction. DGCR8 interacts with the stem and apical elements through its dsRNA-binding domains and RNA-binding heme domain, respectively, allowing efficient and accurate processing. DROSHA and DGCR8, respectively, recognize the basal UG and apical UGU motifs, which ensure proper orientation of the complex. These findings clarify controversies over the action mechanism of DROSHA and allow us to build a general model for pri-miRNA processing.	[Tuan Anh Nguyen; Choi, Yeon-Gil; Park, Joha; Kwon, S. Chul; Kim, V. Narry; Woo, Jae-Sung] Ctr RNA Res, Inst Basic Sci, Seoul 151742, South Korea; [Tuan Anh Nguyen; Choi, Yeon-Gil; Park, Joha; Kwon, S. Chul; Kim, V. Narry; Woo, Jae-Sung] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Jo, Myung Hyun; Hohng, Sungchul] Seoul Natl Univ, Dept Phys & Astron, Seoul 151742, South Korea; [Jo, Myung Hyun; Hohng, Sungchul] Seoul Natl Univ, Natl Ctr Creat Res Initiat, Seoul 151742, South Korea; [Jo, Myung Hyun; Hohng, Sungchul] Seoul Natl Univ, Inst Appl Phys, Seoul 151742, South Korea; [Hohng, Sungchul] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul 151742, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, VN (corresponding author), Ctr RNA Res, Inst Basic Sci, Seoul 151742, South Korea.	narrykim@snu.ac.kr; jaesungwoo@snu.ac.kr	Woo, Jae-Sung/T-2343-2019; Kwon, S. Chul/ABG-9415-2020; Woo, Jae-Sung/J-4531-2017; Kwon, S. Chul/K-2515-2017	Woo, Jae-Sung/0000-0001-9163-3433; Woo, Jae-Sung/0000-0001-9163-3433; Kwon, S. Chul/0000-0002-9519-5132; Nguyen, Tuan Anh/0000-0001-7793-2699; Jo, Myung Hyun/0000-0003-2745-2843; Hohng, Sungchul/0000-0002-7131-2138; Park, Joha/0000-0001-5153-9725	Institute for Basic Science from the Ministry of Science, ICT, and Future Planning of Korea [IBS-R008-D1]; BK21 Research Fellowships from the Ministry of Education of Korea; Creative Research Initiatives of the National Research Foundation of Korea [2009-0081562]	Institute for Basic Science from the Ministry of Science, ICT, and Future Planning of Korea; BK21 Research Fellowships from the Ministry of Education of Korea(Ministry of Education (MOE), Republic of Korea); Creative Research Initiatives of the National Research Foundation of Korea(National Research Foundation of Korea)	We are grateful to members of our laboratory for discussion and technical help, especially Eunhye Shin, Eunji Kim, Sunah Kim, and Ahyoung Cho for their technical assistance. We thank Dr. Yeon-Soo Seo for the gift of the pET-28a plasmid. This work was supported by IBS-R008-D1 of Institute for Basic Science from the Ministry of Science, ICT, and Future Planning of Korea (T.A.N., Y.-G.C., J.P., S.C.K., J.-S.W., and V.N.K.), the BK21 Research Fellowships from the Ministry of Education of Korea (J.P.), and Creative Research Initiatives (2009-0081562) of the National Research Foundation of Korea (M.H.J. and S.H.).	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beisel CL, 2011, NUCLEIC ACIDS RES, V39, P2981, DOI 10.1093/nar/gkq954; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Faller M, 2010, RNA, V16, P1570, DOI 10.1261/rna.2111310; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Ma HM, 2013, P NATL ACAD SCI USA, V110, P20687, DOI 10.1073/pnas.1311639110; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Quick-Cleveland J, 2014, CELL REP, V7, P1994, DOI 10.1016/j.celrep.2014.05.013; Roth BM, 2013, J BIOL CHEM, V288, P26785, DOI 10.1074/jbc.M112.446880; Sohn SY, 2007, NAT STRUCT MOL BIOL, V14, P847, DOI 10.1038/nsmb1294; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Weitz SH, 2014, P NATL ACAD SCI USA, V111, P1861, DOI 10.1073/pnas.1309915111; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhang XX, 2010, NUCLEIC ACIDS RES, V38, P7689, DOI 10.1093/nar/gkq645	26	219	226	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1374	1387		10.1016/j.cell.2015.05.010	http://dx.doi.org/10.1016/j.cell.2015.05.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26027739	Bronze			2022-12-28	WOS:000355935000016
J	Pilling, S; Marcus, E; Whittington, C; Murphy, G				Pilling, Stephen; Marcus, Elena; Whittington, Craig; Murphy, Glynis		Guideline Dev Grp	GUIDELINES Challenging behaviour and learning disabilities: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VALIDITY; SCHIZOPHRENIA; RELIABILITY; ADULTS		[Pilling, Stephen; Marcus, Elena; Whittington, Craig] UCL, Natl Collaborating Ctr Mental Hlth, London WC1E 7HB, England; [Pilling, Stephen; Marcus, Elena; Whittington, Craig] UCL, Ctr Outcomes Res & Effectiveness, London WC1E 6BT, England; [Murphy, Glynis] Univ Kent, Tizard Ctr, Canterbury, Kent, England	University of London; University College London; University of London; University College London; University of Kent	Pilling, S (corresponding author), UCL, Natl Collaborating Ctr Mental Hlth, London WC1E 7HB, England.	s.pilling@ucl.ac.uk	MAVRANEZOULI, IFIGENEIA/C-2430-2008; Marcus, Elena/AAC-4693-2022; Whittington, Craig/B-1380-2008	MAVRANEZOULI, IFIGENEIA/0000-0001-9095-3566; Marcus, Elena/0000-0003-0900-8976; Whittington, Craig/0000-0002-1950-0334	Department of Health Funding Source: Medline	Department of Health		[Anonymous], 2010, CARD HLTH CHECK PROT; Bamburg JW, 2001, J DEV PHYS DISABIL, V13, P319, DOI 10.1023/A:1012218611103; BRYLEWSKI J, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000377.PUB2; Department of Health, 2012, TRANSF CAR NAT RESP; Durand V.M., 1992, MOTIVATION ASSESSMEN; Emerson E., 2011, CHALLENGING BEHAV; Griffith GM, 2014, J APPL RES INTELLECT, V27, P401, DOI 10.1111/jar.12073; Griffith GM, 2013, CLIN PSYCHOL-SCI PR, V20, P469, DOI 10.1111/cpsp.12053; Iwata BA, 2013, J APPL BEHAV ANAL, V46, P271, DOI 10.1002/jaba.31; LINAKER OM, 1994, RES DEV DISABIL, V15, P473, DOI 10.1016/0891-4222(94)90030-2; Lowe K, 2007, J INTELL DISABIL RES, V51, P625, DOI 10.1111/j.1365-2788.2006.00948.x; MacDonald A, 2013, J DEV PHYS DISABIL, V25, P17, DOI 10.1007/s10882-012-9327-8; McIntyre RS, 2001, J CLIN PSYCHIAT, V62, P23; Moss S, 1998, J INTELL DISABIL RES, V42, P173, DOI 10.1046/j.1365-2788.1998.00116.x; National Institute for Health and Care Excellence (NICE), 2015, CHALL BEH LEARN DIS; Sanders MR, 2014, CLIN PSYCHOL REV, V34, P337, DOI 10.1016/j.cpr.2014.04.003; Webster-Stratton C., 2012, INCREDIBLE YEARS PAR	17	6	6	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2015	350								h2652	10.1136/bmj.h2652	http://dx.doi.org/10.1136/bmj.h2652			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK0TW	26037204	Green Accepted			2022-12-28	WOS:000355918900005
J	Bilbe, G				Bilbe, Graeme			Overcoming neglect of kinetoplastid diseases	SCIENCE			English	Editorial Material							VISCERAL LEISHMANIASIS; AFRICA		Drugs Neglected Dis Initiat, CH-1202 Geneva, Switzerland		Bilbe, G (corresponding author), Drugs Neglected Dis Initiat, 15 Chemin Louis Dunant, CH-1202 Geneva, Switzerland.	gbilbe@dndi.org						Arce A, 2013, EUROSURVEILLANCE, V18, P5, DOI 10.2807/1560-7917.ES2013.18.30.20546; DNDi, 2013, DRUG TRIAL LEAD PAR; Eperon G, 2014, EXPERT REV ANTI-INFE, V12, P1407, DOI 10.1586/14787210.2014.959496; Hailu A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000709; Khalil EAG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002613; Lewis MD, 2014, CELL MICROBIOL, V16, P1285, DOI 10.1111/cmi.12297; McCarthy JS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024413, 10.1371/journal.pone.0021914]; Molina I, 2014, NEW ENGL J MED, V370, P1899, DOI 10.1056/NEJMoa1313122; Monge-Maillo B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003021; Pedrique B, 2013, LANCET GLOB HEALTH, V1, pE371, DOI 10.1016/S2214-109X(13)70078-0; WHO/Department of control of neglected tropical diseases, 2015, 3 WHO DEP CONTR NEGL	11	23	24	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					974	976		10.1126/science.aaa3683	http://dx.doi.org/10.1126/science.aaa3683			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	26023124				2022-12-28	WOS:000355276600026
J	Floreano, D; Wood, RJ				Floreano, Dario; Wood, Robert J.			Science, technology and the future of small autonomous drones	NATURE			English	Review							AERIAL; SYSTEM; FLIGHT; LOCALIZATION; NAVIGATION; BEHAVIOR; DESIGN; MOTION; OCELLI; SPEED	We are witnessing the advent of a new era of robots - drones - that can autonomously fly in natural and man-made environments. These robots, often associated with defence applications, could have a major impact on civilian tasks, including transportation, communication, agriculture, disaster mitigation and environment preservation. Autonomous flight in confined spaces presents great scientific and technical challenges owing to the energetic cost of staying airborne and to the perceptual intelligence required to negotiate complex environments. We identify scientific and technological advances that are expected to translate, within appropriate regulatory frameworks, into pervasive use of autonomous drones for civilian applications.	[Floreano, Dario] Ecole Polytech Fed Lausanne, Lab Intelligent Syst, CH-1015 Lausanne, Switzerland; [Wood, Robert J.] Harvard Univ, Microrobot Lab, Cambridge, MA 02138 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Harvard University	Floreano, D (corresponding author), Ecole Polytech Fed Lausanne, Lab Intelligent Syst, Stn 11, CH-1015 Lausanne, Switzerland.	dario.floreano@epfl.ch						[Anonymous], 2014, COMM COMM EUR PARL C; Bachmann RJ, 2009, MECH MACH THEORY, V44, P513, DOI 10.1016/j.mechmachtheory.2008.08.008; Bachrach A, 2009, INT J MICRO AIR VEH, V1, P217, DOI 10.1260/175682909790291492; Baird E, 2005, J EXP BIOL, V208, P3895, DOI 10.1242/jeb.01818; Baird E, 2013, P NATL ACAD SCI USA, V110, P18686, DOI 10.1073/pnas.1314311110; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Barron A, 2006, J EXP BIOL, V209, P978, DOI 10.1242/jeb.02085; Basiri M., 2014, P INT C ROB AUT; Beyeler A, 2009, AUTON ROBOT, V27, P201, DOI 10.1007/s10514-009-9139-6; Bouabdallah S., 2007, EPFL THESIS, V3727, DOI [10.5075/epfl-thesis-3727, DOI 10.5075/EPFL-THESIS-3727]; Brescianini D, 2013, IEEE INT C INT ROBOT, P3472, DOI 10.1109/IROS.2013.6696851; Briod A., 2013, P WORKSH VIS BAS CLO; Briod A, 2014, J FIELD ROBOT, V31, P496, DOI 10.1002/rob.21495; Bry A., 2012, P IEEE INT C ROB AUT; Chahl JS, 2004, INT J ROBOT RES, V23, P101, DOI 10.1177/0278364904041320; Chan WP, 1998, SCIENCE, V280, P289, DOI 10.1126/science.280.5361.289; COLLETT TS, 1980, J COMP PHYSIOL, V138, P271, DOI 10.1007/BF00657045; Conroy J, 2009, AUTON ROBOT, V27, P189, DOI 10.1007/s10514-009-9140-0; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Daler L., 2013, P INT C ROB AUT, P4418; Daler L, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/1/016005; Davison AJ, 2002, IEEE T PATTERN ANAL, V24, P865, DOI 10.1109/TPAMI.2002.1017615; de Croon GCHE, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/2/025003; De Wagter C, 2014, IEEE INT CONF ROBOT, P4982, DOI 10.1109/ICRA.2014.6907589; Desbiens AL, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/2/025009; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Duhamel PEJ, 2013, IEEE-ASME T MECH, V18, P556, DOI 10.1109/TMECH.2012.2225635; EGELHAAF M, 1993, J NEUROSCI, V13, P4563; Finio BM, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/4/045006; Floreano D, 2009, FLYING INSECTS AND ROBOTS, P1; Floreano D, 2013, P NATL ACAD SCI USA, V110, P9267, DOI 10.1073/pnas.1219068110; Franceschini N., 1989, P360; Fraundorfer F, 2012, IEEE ROBOT AUTOM MAG, V19, P78, DOI 10.1109/MRA.2012.2182810; Fuller SB, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0281; Gabrielli G., 1950, MECH ENG ASME, V72, P775; Garratt MA, 2008, J FIELD ROBOT, V25, P284, DOI 10.1002/rob.20239; Gibson JJ, 1950, PERCEPTION VISUAL WO; Gremillion G, 2014, BIOL CYBERN, V108, P735, DOI 10.1007/s00422-014-0610-x; Griffiths S, 2006, IEEE ROBOT AUTOM MAG, V13, P34, DOI 10.1109/MRA.2006.1678137; Haddon DR, 2003, AERONAUT J, V107, P79; Hauert S., 2011, 2011 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2011), P5015, DOI 10.1109/IROS.2011.6048729; Heng L, 2014, J FIELD ROBOT, V31, P654, DOI 10.1002/rob.21520; International Organization for Standardization, 2012, 83732012EN ISO; Itasse M, 2011, INT J MICRO AIR VEH, V3, P229, DOI 10.1260/1756-8293.3.4.229; Kendoul F, 2009, ROBOT AUTON SYST, V57, P591, DOI 10.1016/j.robot.2009.02.001; KOENDERINK JJ, 1986, VISION RES, V26, P161, DOI 10.1016/0042-6989(86)90078-7; Kovac M, 2007, IEEE INT CONF ROBOT, P367, DOI 10.1109/ROBOT.2007.363814; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; Kumar V, 2012, INT J ROBOT RES, V31, P1279, DOI 10.1177/0278364912455954; Ladson C., 1996, TM19964741 NASA; Land MF, 2002, ANIMAL EYES; LEHRER M, 1988, NATURE, V332, P356, DOI 10.1038/332356a0; Ma KY, 2013, SCIENCE, V340, P603, DOI 10.1126/science.1231806; Mellinger D, 2012, INT J ROBOT RES, V31, P664, DOI 10.1177/0278364911434236; Ministere de l'Ecologie du Developpement Durable des Transports et du Logement, 2012, TEXTE9SUR308 MIN EC; Moore J, 2011, IEEE INT C INT ROBOT, P2700, DOI 10.1109/IROS.2011.6048785; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Peterson K, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/046008; Phys. org, 2004, WORLDS LIGHT MICR RO; Portelli G, 2010, J COMP PHYSIOL A, V196, P307, DOI 10.1007/s00359-010-0510-z; Reynolds C.W., 1987, ACM SIGGRAPH COMPUTE, V21, P25, DOI DOI 10.1145/37402.37406; Riskin DK, 2005, NATURE, V434, P292, DOI 10.1038/434292a; Roberts JF, 2012, AUTON ROBOT, V33, P5, DOI 10.1007/s10514-012-9277-0; Roubieu FL, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/036003; Ruffier F, 2005, ROBOT AUTON SYST, V50, P177, DOI 10.1016/j.robot.2004.09.016; Ruffier F, 2003, PROCEEDINGS OF THE 2003 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOL III, P846; Ruffier F., 2014, J INTELL ROBOT SYST; Scaramuzza D, 2014, IEEE ROBOT AUTOM MAG, V21, P26, DOI 10.1109/MRA.2014.2322295; Scaramuzza D, 2011, IEEE ROBOT AUTOM MAG, V18, P80, DOI 10.1109/MRA.2011.943233; Schauwecker K, 2014, J INTELL ROBOT SYST, V74, P1, DOI 10.1007/s10846-013-9907-6; SCHUPPE H, 1993, J COMP PHYSIOL A, V173, P143, DOI 10.1007/BF00192973; Serres JR, 2008, NATURWISSENSCHAFTEN, V95, P1181, DOI 10.1007/s00114-008-0440-6; Shen S., 2013, P ROB SCI SYST; Shintake J., 2014, IEEE ASME T MECHATRO; Siddall R, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/031001; Song YM, 2013, NATURE, V497, P95, DOI 10.1038/nature12083; Sreetharan PS, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/5/055027; Srinivasan Mandyam V., 1993, Reviews of Oculomotor Research, V5, P139; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Straw AD, 2010, CURR BIOL, V20, P1550, DOI 10.1016/j.cub.2010.07.025; Swiss Federal Office of Civil Aviation, 2014, DRON AIRCR MOD; Tammero LF, 2002, J EXP BIOL, V205, P327; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; TRIMMER WSN, 1989, SENSOR ACTUATOR, V19, P267, DOI 10.1016/0250-6874(89)87079-9; UK Civil Aviation Authority, 2012, 722 CAP UK CIV AV AU; US Department of Transportation, 2013, INT CIV UNM AIRCR SY; Vidyasagar A, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/2/025006; Virgh C., 2014, BIOINSPIR BIOMIM, V9; WAGNER H, 1982, NATURE, V297, P147, DOI 10.1038/297147a0; Wei G.-Y., 2013, SCI AM, V308; Won H., 2012, P AIAA AER SCI M; Wood RJ, 2012, INT J ROBOT RES, V31, P1292, DOI 10.1177/0278364912455073; Wood RJ, 2005, SENSOR ACTUAT A-PHYS, V119, P476, DOI 10.1016/j.sna.2004.10.024; Woodward MA, 2014, INT J ROBOT RES, V33, P1511, DOI 10.1177/0278364914541301; Zufferey J. C., 2013, HDB COLLECTIVE ROBOT, P609, DOI DOI 10.1201/B14908-21; Zufferey JC, 2007, ADV ROBOTICS, V21, P1671, DOI 10.1163/156855307782227417	97	604	636	57	708	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					460	466		10.1038/nature14542	http://dx.doi.org/10.1038/nature14542			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	26017445	Green Published			2022-12-28	WOS:000355286600033
J	Mannik, K; Magi, R; Mace, A; Guyatt, AL; Shihab, HA; Maillard, AM; Alavere, H; Kolk, A; Reigo, A; Mihailov, E; Leitsalu, L; Ferreira, AM; Noukas, M; Teumer, A; Salvi, E; Cusi, D; Mcgue, M; Iacono, WG; Gaunt, T; Beckmann, JS; Jacquemont, S; Kutalik, Z; Pankratz, N; Timpson, N; Metspalu, A; Reymond, A				Maennik, Katrin; Maegi, Reedik; Mace, Aurelien; Guyatt, Anna L.; Shihab, Hashem A.; Maillard, Anne M.; Alavere, Helene; Kolk, Anneli; Reigo, Anu; Mihailov, Evelin; Leitsalu, Liis; Ferreira, Anne-Maud; Noukas, Margit; Teumer, Alexander; Salvi, Erika; Cusi, Daniele; McGue, Matt; Iacono, William G.; Gaunt, Tomr.; Beckmann, Jacques S.; Jacquemont, Sebastien; Kutalik, Zoltan; Pankratz, Nathan; Timpson, Nicholas; Metspalu, Andres; Reymond, Alexandre			Copy Number Variations and Cognitive Phenotypes in Unselected Populations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOMIC DISORDERS; VARIANTS; 16P11.2; ASSOCIATION; INTELLIGENCE; COMMON; HERITABILITY; TRANSMISSION; NUCLEOTIDE; DELETIONS	IMPORTANCE The association of copy number variations (CNVs), differing numbers of copies of genetic sequence at locations in the genome, with phenotypes such as intellectual disability has been almost exclusively evaluated using clinically ascertained cohorts. The contribution of these genetic variants to cognitive phenotypes in the general population remains unclear. OBJECTIVE To investigate the clinical features conferred by CNVs associated with known syndromes in adult carriers without clinical preselection and to assess the genome-wide consequences of rare CNVs (frequency <= 0.05%; size >= 250 kilobase pairs [kb]) on carriers' educational attainment and intellectual disability prevalence in the general population. DESIGN, SETTING, AND PARTICIPANTS The population biobank of Estonia contains 52 000 participants enrolled from 2002 through 2010. General practitioners examined participants and filled out a questionnaire of health-and lifestyle-related questions, as well as reported diagnoses. Copy number variant analysis was conducted on a random sample of 7877 individuals and genotype-phenotype associations with education and disease traits were evaluated. Our results were replicated on a high-functioning group of 993 Estonians and 3 geographically distinct populations in the United Kingdom, the United States, and Italy. MAIN OUTCOMES AND MEASURES Phenotypes of genomic disorders in the general population, prevalence of autosomal CNVs, and association of these variants with educational attainment (from less than primary school through scientific degree) and prevalence of intellectual disability. RESULTS Of the 7877 in the Estonian cohort, we identified 56 carriers of CNVs associated with known syndromes. Their phenotypes, including cognitive and psychiatric problems, epilepsy, neuropathies, obesity, and congenital malformations are similar to those described for carriers of identical rearrangements ascertained in clinical cohorts. A genome-wide evaluation of rare autosomal CNVs (frequency, <= 0.05%; >= 250 kb) identified 831 carriers (10.5%) of the screened general population. Eleven of 216 (5.1%) carriers of a deletion of at least 250 kb (odds ratio [OR], 3.16; 95% CI, 1.51-5.98; P = 1.5e-03) and 6 of 102 (5.9%) carriers of a duplication of at least 1Mb (OR, 3.67; 95% CI, 1.29-8.54; P = .008) had an intellectual disability compared with 114 of 6819 (1.7%) in the Estonian cohort. The mean education attainment was 3.81 (P = 1.06e-04) among 248 (>= 250 kb) deletion carriers and 3.69 (P = 5.024e-05) among 115 duplication carriers (>= 1 Mb). Of the deletion carriers, 33.5% did not graduate from high school (OR, 1.48; 95% CI, 1.12-1.95; P = .005) and 39.1% of duplication carriers did not graduate high school (OR, 1.89; 95% CI, 1.27-2.8; P = 1.6e-03). Evidence for an association between rare CNVs and lower educational attainment was supported by analyses of cohorts of adults from Italy and the United States and adolescents from the United Kingdom. CONCLUSIONS AND RELEVANCE Known pathogenic CNVs in unselected, but assumed to be healthy, adult populations may be associated with unrecognized clinical sequelae. Additionally, individually rare but collectively common intermediate-size CNVs may be negatively associated with educational attainment. Replication of these findings in additional population groups is warranted given the potential implications of this observation for genomics research, clinical care, and public health.	[Maennik, Katrin; Ferreira, Anne-Maud; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Maennik, Katrin; Maegi, Reedik; Alavere, Helene; Kolk, Anneli; Reigo, Anu; Mihailov, Evelin; Leitsalu, Liis; Noukas, Margit; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Mace, Aurelien; Maillard, Anne M.; Jacquemont, Sebastien; Kutalik, Zoltan] Univ Lausanne, Dept Med Genet, CH-1015 Lausanne, Switzerland; [Mace, Aurelien; Ferreira, Anne-Maud; Beckmann, Jacques S.; Kutalik, Zoltan] Swiss Inst Bioinformat, Lausanne, Switzerland; [Pankratz, Nathan] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Guyatt, Anna L.; Shihab, Hashem A.; Gaunt, Tomr.; Timpson, Nicholas] Univ Bristol, Sch Social & Community Med, Bristol Genet Epidemiol Labs, Bristol, Avon, England; [Shihab, Hashem A.; Gaunt, Tomr.; Timpson, Nicholas] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Kolk, Anneli] Tartu Univ Hosp, Childrens Clin, Dept Neurol & Neurorehabil, Tartu, Estonia; [Leitsalu, Liis; Noukas, Margit; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Teumer, Alexander] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Salvi, Erika; Cusi, Daniele] Univ Milan, Dept Hlth Sci, Milan, Italy; [Cusi, Daniele] Italian Natl Res Council, Inst Biomed Technol, Milan, Italy; [McGue, Matt; Iacono, William G.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Kutalik, Zoltan] Lausanne Univ Hosp CHUV, Inst Social & Prevent Med, Lausanne, Switzerland	University of Lausanne; University of Tartu; University of Lausanne; Swiss Institute of Bioinformatics; University of Minnesota System; University of Minnesota Twin Cities; University of Bristol; University of Bristol; University of Tartu; Greifswald Medical School; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Minnesota System; University of Minnesota Twin Cities; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Reymond, A (corresponding author), Univ Lausanne, Ctr Integrat Genom, Genopode Bldg, CH-1015 Lausanne, Switzerland.	alexandre.reymond@unil.ch	Timpson, Nicholas John/O-7548-2015; Mägi, Reedik/AAJ-9679-2021; Teumer, Alexander/S-7438-2019; Salvi, Erika/AAA-1415-2019; Jacquemont, Sebastien/AAS-5060-2021; Fox, Laura J/C-6249-2016; Kutalik, Zoltan/HHZ-5697-2022; Gaunt, Tom R/O-3918-2014; Maillard, Anne/N-4779-2017; Ferreira, Anne-Maud/GQO-7731-2022; Attrill, Lauren/V-1688-2018; Beckmann, Jacques S/A-9772-2008	Timpson, Nicholas John/0000-0002-7141-9189; Teumer, Alexander/0000-0002-8309-094X; Salvi, Erika/0000-0002-2724-2291; Jacquemont, Sebastien/0000-0001-6838-8767; Kutalik, Zoltan/0000-0001-8285-7523; Gaunt, Tom R/0000-0003-0924-3247; Maillard, Anne/0000-0002-4811-0693; Ferreira, Anne-Maud/0000-0002-4749-746X; Beckmann, Jacques S/0000-0002-9741-1900; Reymond, Alexandre/0000-0003-1030-8327; Pankratz, Nathan/0000-0001-5958-693X; Guyatt, Anna/0000-0003-1860-6337; Magi, Reedik/0000-0002-2964-6011	Swiss Scientific Exchange New Member State of the European Union Program; Wellcome Trust [102433/Z/13/Z]; SNSF [31003A_160203]; SNSF Sinergia grant [CRSII33-133044]; Simons Foundation Autism Research Initiative [SFARI274424]; Leenaards Foundation Prizes; European Commission [278913, 306031, 313010]; Center of Excellence in Genomics (EXCEGEN); University of Tartu [SP1GVARENG]; Estonian Research Council [IUT20-60]; US Public Health Service grants from the National Institute on Alcohol Abuse and Alcoholism [AA09367, AA11886]; National Institute on Drug Abuse [DA05147, DA13240, DA024417]; National Institute of Mental Health [MH066140]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA009367, R01AA011886, R01AA009367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024417, U01DA024417, R01DA036216, R37DA005147, R01DA013240, R01DA005147] Funding Source: NIH RePORTER; MRC [MC_UU_12013/3, MC_UU_12013/8] Funding Source: UKRI; Medical Research Council [MC_UU_12013/3, MC_UU_12013/8, MC_PC_15018] Funding Source: researchfish	Swiss Scientific Exchange New Member State of the European Union Program; Wellcome Trust(Wellcome TrustEuropean Commission); SNSF(Swiss National Science Foundation (SNSF)); SNSF Sinergia grant; Simons Foundation Autism Research Initiative; Leenaards Foundation Prizes; European Commission(European CommissionEuropean Commission Joint Research Centre); Center of Excellence in Genomics (EXCEGEN); University of Tartu; Estonian Research Council(Estonian Research Council); US Public Health Service grants from the National Institute on Alcohol Abuse and Alcoholism; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr Mannik is a grantee of a scholarship from the Swiss Scientific Exchange New Member State of the European Union Program. Ms Guyatt is funded by a PhD studentship from the Wellcome Trust (grant 102433/Z/13/Z). Dr Jacquemont is a Bursary Professor of the Swiss National Science Foundation (SNSF). This study is supported by 2 SNSF grants (31003A_160203, Drs Reymond, and Kutalik), a specific 16p11.2 SNSF Sinergia grant (CRSII33-133044, Dr Reymond), the Simons Foundation Autism Research Initiative (SFARI274424, Dr Reymond), Leenaards Foundation Prizes (Drs Jacquemont, Reymond, and Kutalik), European Commission Framework Program 7 grants (278913, 306031, and 313010) (Dr Metspalu), Center of Excellence in Genomics (EXCEGEN) and University of Tartu (SP1GVARENG, Dr Metspalu), Estonian Research Council Grant (IUT20-60, Dr Metspalu), US Public Health Service grants from the National Institute on Alcohol Abuse and Alcoholism (AA09367 and AA11886, Dr Pankratz), the National Institute on Drug Abuse (DA05147, DA13240, and DA024417, Dr Pankratz), and the National Institute of Mental Health (MH066140, Dr Pankratz).	Bagshaw ATM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055208; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Brody N, 1997, AM PSYCHOL, V52, P1046, DOI 10.1037/0003-066X.52.10.1046; Chaignat E, 2011, GENOME RES, V21, P106, DOI 10.1101/gr.112748.110; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Davies G, 2015, MOL PSYCHIATR, V20, P183, DOI 10.1038/mp.2014.188; Deary IJ, 2012, ANNU REV PSYCHOL, V63, P453, DOI 10.1146/annurev-psych-120710-100353; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Desachy G, 2015, MOL PSYCHIATR, V20, P170, DOI 10.1038/mp.2014.179; Devlin B, 1997, NATURE, V388, P468, DOI 10.1038/41319; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Dittwald P, 2013, GENOME RES, V23, P1395, DOI 10.1101/gr.152454.112; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Flint J, 2013, SCIENCE, V340, P1416, DOI 10.1126/science.1240684; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Iacono WG, 1999, DEV PSYCHOPATHOL, V11, P869, DOI 10.1017/S0954579499002369; Jacquemont S, 2014, AM J HUM GENET, V94, P415, DOI 10.1016/j.ajhg.2014.02.001; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kirkpatrick RM, 2014, INTELLIGENCE, V42, P98, DOI 10.1016/j.intell.2013.11.005; Krumm N, 2013, AM J HUM GENET, V93, P595, DOI 10.1016/j.ajhg.2013.07.024; Leitsalu L, 2015, INT J EPIDEMIOL, V44, P1137, DOI 10.1093/ije/dyt268; Levacic R., 2005, ESTIMATING RELATIONS; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Maillard AM, 2015, MOL PSYCHIATR, V20, P140, DOI 10.1038/mp.2014.145; Makino T, 2010, P NATL ACAD SCI USA, V107, P9270, DOI 10.1073/pnas.0914697107; MATARAZZO JD, 1984, J CONSULT CLIN PSYCH, V52, P631, DOI 10.1037/0022-006X.52.4.631; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Mcgue M, 2007, BEHAV GENET, V37, P449, DOI 10.1007/s10519-007-9142-7; McRae AF, 2013, BEHAV GENET, V43, P202, DOI 10.1007/s10519-013-9587-9; Need AC, 2009, HUM MOL GENET, V18, P4650, DOI 10.1093/hmg/ddp413; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Pietilainen OPH, 2011, HUM MOL GENET, V20, P2686, DOI 10.1093/hmg/ddr162; Reymond A, 2007, CURR OPIN GENET DEV, V17, P381, DOI 10.1016/j.gde.2007.08.009; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Salvi E, 2012, HYPERTENSION, V59, P248, DOI 10.1161/HYPERTENSIONAHA.111.181990; Sattler J. M., 1974, ASSESSMENT CHILDREN; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Swaminathan GJ, 2012, HUM MOL GENET, V21, pR37, DOI 10.1093/hmg/dds362; Vinkhuyzen AAE, 2012, BEHAV GENET, V42, P187, DOI 10.1007/s10519-011-9507-9; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Walters RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058048; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Ward ME, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100248, 10.1371/journal.pone.0103448]; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Zufferey F, 2012, J MED GENET, V49, P660, DOI 10.1136/jmedgenet-2012-101203	59	100	101	2	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2015	313	20					2044	2054		10.1001/jama.2015.4845	http://dx.doi.org/10.1001/jama.2015.4845			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ0DC	26010633	Green Accepted, Bronze			2022-12-28	WOS:000355142400018
J	Hezelgrave, NL; Shennan, AH; David, AL				Hezelgrave, N. L.; Shennan, A. H.; David, A. L.			RATIONAL TESTING Tests to predict imminent delivery in threatened preterm labour	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FETAL FIBRONECTIN; BIRTH; ACCURACY; RISK		[Hezelgrave, N. L.] Kings Coll London, Womens Hlth Acad Ctr, London WC2R 2LS, England; [Shennan, A. H.] Kings Coll London, Womens Hlth Acad Ctr, Obstet, London WC2R 2LS, England; [David, A. L.] UCL, Inst Womens Hlth, London, England; [David, A. L.] UCL, Inst Womens Hlth, Obstet & Maternal Fetal Med, London, England	University of London; King's College London; University of London; King's College London; University of London; University College London; University of London; University College London	David, AL (corresponding author), UCL, Inst Womens Hlth, London, England.	a.david@ucl.ac.uk		Shennan, Andrew/0000-0001-5273-3132; David, Anna/0000-0002-0199-6140	National Institute for Health Research [ACF-2009-17-019, DRF-2013-06-171] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Abbott DS, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.10.890; Akercan F, 2004, J REPROD MED, V49, P368; Berghella V, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006843.pub2; Cooper S, 2012, J PERINATOL, V32, P460, DOI 10.1038/jp.2011.133; DeFranco EA, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.015; Fuchs IB, 2004, ULTRASOUND OBST GYN, V24, P554, DOI 10.1002/uog.1714; Goldenberg RL, 1996, OBSTET GYNECOL, V87, P643, DOI 10.1016/0029-7844(96)00035-X; Honest H, 2004, J Obstet Gynaecol, V24, P343, DOI 10.1080/01443610410001685439; Honest H, 2002, BMJ-BRIT MED J, V325, P301, DOI 10.1136/bmj.325.7359.301; Honest H, 2012, CURR OPIN OBSTET GYN, V24, P422, DOI 10.1097/GCO.0b013e328359823a; IAMS JD, 1995, AM J OBSTET GYNECOL, V173, P141, DOI 10.1016/0002-9378(95)90182-5; McKinlay CJD, 2012, AM J OBSTET GYNECOL, V206, P187, DOI 10.1016/j.ajog.2011.07.042; Nikolova T, 2014, J PERINAT MED, V42, P473, DOI 10.1515/jpm-2013-0234; Peaceman AM, 1997, AM J OBSTET GYNECOL, V177, P13, DOI 10.1016/S0002-9378(97)70431-9; Petrunin D D, 1977, Akush Ginekol (Mosk), P62; Roberts D, 2008, COCHRANE DB SYST REV, V3; Sotiriadis A, 2010, ULTRASOUND OBST GYN, V35, P54, DOI 10.1002/uog.7457	17	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2015	350								h2183	10.1136/bmj.h2183	http://dx.doi.org/10.1136/bmj.h2183			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI9ZD	25999466				2022-12-28	WOS:000355129300001
J	Rosbash, M				Rosbash, Michael			Ronald J. Konopka (1947-2015) Obituary	CELL			English	Biographical-Item									Brandeis Univ, Dept Biol, Waltham, MA 02453 USA	Brandeis University	Rosbash, M (corresponding author), Brandeis Univ, Dept Biol, 415 South St, Waltham, MA 02453 USA.	rosbash@brandeis.edu						KONOPKA RJ, PNAS, V68, P2112	1	5	5	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 9	2015	161	2					187	188		10.1016/j.cell.2015.03.038	http://dx.doi.org/10.1016/j.cell.2015.03.038			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CF7AL	26042238	Bronze			2022-12-28	WOS:000352708300007
J	Langer, A; Meleis, A; Knaul, FM; Atun, R; Aran, M; Arreola-Ornelas, H; Bhutta, ZQA; Binagwaho, A; Bonita, R; Caglia, JM; Claeson, M; Davies, J; Donnay, FA; Gausman, JM; Glickman, C; Kearns, AD; Kendall, T; Lozano, R; Seboni, N; Sen, G; Sindhu, S; Temin, M; Frenk, J				Langer, Ana; Meleis, Afaf; Knaul, Felicia M.; Atun, Rifat; Aran, Meltem; Arreola-Ornelas, Hector; Bhutta, Zulfi Qar A.; Binagwaho, Agnes; Bonita, Ruth; Caglia, Jacquelyn M.; Claeson, Mariam; Davies, Justine; Donnay, France A.; Gausman, Jewel M.; Glickman, Caroline; Kearns, Annie D.; Kendall, Tamil; Lozano, Rafael; Seboni, Naomi; Sen, Gita; Sindhu, Siriorn; Temin, Miriam; Frenk, Julio			Women and Health: the key for sustainable development	LANCET			English	Review							REPRODUCTIVE HEALTH; DEVELOPING-COUNTRIES; PUBLIC-HEALTH; CLIMACTERIC SYMPTOMS; CHILD UNDERNUTRITION; MATERNAL MORTALITY; BREAST-CANCER; FETAL ORIGINS; ADULT HEALTH; LOW-INCOME		[Langer, Ana; Caglia, Jacquelyn M.; Gausman, Jewel M.; Kearns, Annie D.; Kendall, Tamil] Harvard Univ, TH Chan Sch Publ Hlth, Women & Hlth Initiat, Boston, MA 02115 USA; [Meleis, Afaf; Glickman, Caroline] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Knaul, Felicia M.] Harvard Univ, Sch Med, Harvard Global Equity Initiat, Boston, MA USA; [Atun, Rifat; Frenk, Julio] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Aran, Meltem] Dev Analyt, Istanbul, Turkey; [Arreola-Ornelas, Hector] Fdn Mexicana Salud, Tlalpan, Mexico; [Bhutta, Zulfi Qar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada; [Binagwaho, Agnes] Minist Hlth, Kigali, Rwanda; [Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [Claeson, Mariam; Donnay, France A.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Davies, Justine] Lancet, London, England; [Lozano, Rafael] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; [Seboni, Naomi] Int Planned Parenthood Federat Governing Council, London, England; [Sen, Gita] Indian Inst Management, Bangalore, Karnataka, India; [Sindhu, Siriorn] Mahidol Univ, Salaya, Thailand; [Temin, Miriam] Ctr Global Dev, Washington, DC USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Auckland; Bill & Melinda Gates Foundation; Instituto Nacional de Salud Publica; Indian Institute of Management (IIM System); Indian Institute of Management Bangalore; Mahidol University	Langer, A (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Women & Hlth Initiat, Boston, MA 02115 USA.	alanger@hsph.harvard.edu	Lozano, Rafael/T-5352-2018; Arreola Ornelas, Héctor/HCG-9350-2022; Gausman, Jewel/T-6071-2018; Atun, Rifat/AAH-5537-2021	Lozano, Rafael/0000-0002-7356-8823; Arreola Ornelas, Héctor/0000-0002-7615-6218; Gausman, Jewel/0000-0002-9880-2591; Atun, Rifat/0000-0002-1531-5983; Knaul, Felicia/0000-0002-0512-4788; Davies, Justine/0000-0001-6834-1838	Bill & Melinda Gates Foundation (Seattle, WA, USA); John D and Catherine T MacArthur Foundation (Chicago, IL, USA); Josiah Macy Jr Foundation (New York, NY, USA); University of Pennsylvania; Josiah Macy Jr Foundation; Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation (Seattle, WA, USA)(Bill & Melinda Gates Foundation); John D and Catherine T MacArthur Foundation (Chicago, IL, USA); Josiah Macy Jr Foundation (New York, NY, USA); University of Pennsylvania; Josiah Macy Jr Foundation; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The work of the Commission on Women and Health was supported by the Bill & Melinda Gates Foundation (Seattle, WA, USA), the John D and Catherine T MacArthur Foundation (Chicago, IL, USA), and the Josiah Macy Jr Foundation (New York, NY, USA). These grants covered travel, accommodation, and meal expenses for the Commission and writing team meetings as well as research team time for background papers and original research. The Commission also received in-kind support from the John D Rockefeller Bellagio Conference Center, which included meeting space, accommodation, and meals for one of the Commission meetings. AM is Advisory Board Member at Orbis Education, Educational Advisory Committee Member at Harvard School of Public Health, Advisory Committee Member at University of Texas Southwestern Medical Center, Co-chair of the Global Health and Microbiology Interest Group at the Institute of Medicine, External Advisory Committee Member of the PhD Program in Health Sciences from University of Coimbra, Founding Board Member of the Academy of Women's Health, Board Member of the Faculty Scholars Program at the Josiah Macy Jr Foundation, and is a member of the Advisory Committee on Research on Women's Health at National Institutes of Health; and declares personal fees from University of Pennsylvania and Josiah Macy Jr Foundation, outside the submitted work. TK declares grants from the Bill & Melinda Gates Foundation; and personal fees and support for travel from the non-governmental organization Balance whose mandate is promotion of women's sexual and reproductive health and rights in the 36 months preceding publication of this manuscript. JD was an editor at The Lancet when the work was started and is now Editor in Chief of The Lancet Diabetes and Endocrinology. MC and FAD are employees of the Bill & Melinda Gates Foundation and declare no competing interests. AB is Minister of Health for Rwanda and declares no competing interests. MT was compensated as a consultant for her writing and editing contributions and declares no competing interests. AL, RA, MA, HAO, ZAB, RB, JMC, FMK, CG, RL, NS, JMG, GS, ADK, SS, and JF declare no competing interests.	Adanu RMK, 2009, INT J GYNECOL OBSTET, V106, P179, DOI 10.1016/j.ijgo.2009.03.036; Agosti JM, 2007, NEW ENGL J MED, V356, P1908, DOI 10.1056/NEJMp078053; Agyei-Mensah S, 2010, J URBAN HEALTH, V87, P879, DOI 10.1007/s11524-010-9492-y; Ahlgren M, 2004, NEW ENGL J MED, V351, P1619, DOI 10.1056/NEJMoa040576; Al-Rodhan N.R.F., 2006, DEFINITIONS GLOBALIZ; Alam K, 2012, HEALTH POLICY PLANN, V27, P477, DOI 10.1093/heapol/czr059; Alcala M, 2006, STATE WORLD POPULATI; Alderman H., 2003, Household decisions, gender, and development: a synthesis of recent research, P61; Alleyne G, 2013, LANCET, V381, P566, DOI 10.1016/S0140-6736(12)61806-6; Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Amos A, 2012, TOB CONTROL, V21, P236, DOI 10.1136/tobaccocontrol-2011-050280; Annan J, 2010, SOC SCI MED, V70, P152, DOI 10.1016/j.socscimed.2009.09.027; Anoko J., 2008, GENDER EQUITY PROTEC; [Anonymous], 2000, EC GLOBALIZATION TRE; [Anonymous], 2011, WORLD POP PROSP 2010; [Anonymous], 2010, UNAIDS EXP BUS CAS E; [Anonymous], 2008, WORLDWIDE PREVALENCE; [Anonymous], 2008, SEX EDUC-SEX SOC LEA, DOI DOI 10.1080/14681810701811878; Atun R, 2015, LANCET, V385, P1230, DOI 10.1016/S0140-6736(14)61646-9; Atun R, 2013, LANCET, V382, P65, DOI 10.1016/S0140-6736(13)61051-X; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Austin SB, 2008, J WOMENS HEALTH, V17, P597, DOI 10.1089/jwh.2007.0450; Avison M, 2015, J POPUL RES, V32, P45, DOI 10.1007/s12546-014-9140-6; Azenha GS, 2013, B WORLD HEALTH ORGAN, V91, P704, DOI 10.2471/BLT.13.117622; Bach S., 2006, INT MOBILITY HLTH PR; Baird S, 2009, SHORT TERM IMPACTS S; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Barros FC, 2015, JAMA PEDIATR, V169, P220, DOI 10.1001/jamapediatrics.2014.3040; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Bartram J, 2005, LANCET, V365, P810, DOI 10.1016/S0140-6736(05)71007-2; Basa Charito, 2011, GENDER DEV, V19, P11; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Behrman JR, 2009, CASE STUDY IFPRI CON; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Blaauw D, 2010, B WORLD HEALTH ORGAN, V88, P350, DOI 10.2471/BLT.09.072918; Black BO, 2014, OBSTET GYNAECOL, V16, P153, DOI 10.1111/tog.12114; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Blake S., 2013, MALAWI PRESIDENT JOY; Blanc AK, 2001, STUD FAMILY PLANN, V32, P189, DOI 10.1111/j.1728-4465.2001.00189.x; Blanc AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059864; Bloom D., 2003, DEMOGRAPHIC DIVIDEND; Bloom D. E., 2004, Finance & Development, V41, P10; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; BONGAARTS J, 1994, SCIENCE, V263, P771, DOI 10.1126/science.8303293; Bonita R, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23742; Brown G., 2012, OUT WEDLOCK SCH COMB; Budlender D., 2009, COMPENSATION CONTRIB; Buvinic M, 2010, INVESTING GENDER EQU; Callaway M, 2007, J PAIN SYMPTOM MANAG, V33, P509, DOI 10.1016/j.jpainsymman.2007.02.003; Carnes M, 2008, J WOMENS HEALTH, V17, P1453, DOI 10.1089/jwh.2007.0688; Case A, 2009, ECON HUM BIOL, V7, P271, DOI 10.1016/j.ehb.2009.07.002; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; CCSS, 2013, CAJ COST SEG SOC MEM; Charmes J., 2006, GENDER TIME USE POVE, P39; Chattopadhyay R, 2004, ECONOMETRICA, V72, P1409, DOI 10.1111/j.1468-0262.2004.00539.x; Chi BH, 2013, CURR HIV-AIDS REP, V10, P124, DOI 10.1007/s11904-013-0154-z; Chirawatkul S, 2012, THAI J NURSING COUNC, V27, P26; Cochran SD, 2001, AM J PUBLIC HEALTH, V91, P591, DOI 10.2105/AJPH.91.4.591; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Conde-Agudelo A, 2005, AM J OBSTET GYNECOL, V192, P342, DOI 10.1016/j.ajog.2004.10.593; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Cottingham J, 2010, B WORLD HEALTH ORGAN, V88, P551, DOI 10.2471/BLT.09.063412; Cotula L, 2006, LAND WATER RIGHTS SA; CSO MOH TDRC University of Zambia, 2009, ZAMB DEM HLTH SURV 2; Dankelman I, 2005, GENDER CLIMATE CHANG; Darroch Jacqueline E., 2011, ESTIMATING UNINTENDE; Dasgupta PS, 2013, SCIENCE, V340, P324, DOI 10.1126/science.1224664; Davidson P, 2014, CONTEXTS OF NURSING, P233; Devereux S., 2004, I DEV STUDIES WORKIN, DOI DOI 10.4324/9780203842812; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Dhont N, 2011, HUM REPROD, V26, P623, DOI 10.1093/humrep/deq373; Dinkelman T, 2011, AM ECON REV, V101, P3078, DOI 10.1257/aer.101.7.3078; DNP, 2008, PROGR FAM ACC IMP CA; Douthwaite M, 2005, HEALTH POLICY PLANN, V20, P117, DOI 10.1093/heapol/czi014; Downs JA, 2014, ACAD MED, V89, P1103, DOI 10.1097/ACM.0000000000000369; Dratva J, 2009, MENOPAUSE, V16, P385, DOI 10.1097/gme.0b013e31818aefef; Eddy KT, 2007, J NERV MENT DIS, V195, P196, DOI 10.1097/01.nmd.0000243922.49394.7d; Eiken S., 2010, MEDICAID LONG TERM C; ETUC, 2011, WORK TIM HLTH SECT E; European Commission, 2011, EUR ED STAT; Evans T., 2006, WORLD HLTH REPORT 20; FAO, 2011, QOPEN, DOI DOI 10.1093/QOPEN/QOAA003; Feinberg L., 2011, VALUING INVALUABLE G; Fogel RobertWilliam, 1997, HDB POPULATION FAM A, V1, P433, DOI [DOI 10.1016/S1574-003X(97)80026-8, 10.1016/s1574-003x(97)80026-8]; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Francavilla F, 2011, USE TIME VALUE UNPAI; Frenk J, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-42; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Fuentes-Nieva R., 2014, WORKING FEW POLITICA; Fuse K, 2006, SOC SCI MED, V62, P360, DOI 10.1016/j.socscimed.2005.06.006; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Garcia-Moreno C, 2011, WOMENS HLTH WORLDS C; George A, 2008, Glob Public Health, V3 Suppl 1, P75, DOI 10.1080/17441690801892240; George A., 2007, HUMAN RESOURCES HLTH; George G, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-15; Gerber W., 2013, GLOBAL HLTH IMPACT; Ghana Statistical Service Ghana Health Service ICF Macro, 2009, GHAN DEM HLTH SURV; Giannelli GC, 2012, APPL ECON, V44, P2111, DOI 10.1080/00036846.2011.558485; Gibson Mary Jo, 2007, Issue Brief (Public Policy Inst (Am Assoc Retired Pers)), P1; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Global Thematic Consultation on Education, 2013, WORLD WE WANT ED POS; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Goldstein M, 2005, PROFITS POWER LAND R; Gonzalez de la Rocha M, 2008, METODO CIENTIFICO PO, P129; Gross B., 2001, LINKING SUSTAINABILI; Grown C., 2005, TAKING ACTION ACHIEV; Guilmoto Christophe Z., 2012, SEX IMBALANCES BIRTH; Harpham T., 2007, BACKGROUND PAPER IMP; Hausmann R., 2012, GLOBAL GENDER GAP RE; Hawkes S, 2013, LANCET, V381, P1783, DOI 10.1016/S0140-6736(13)60253-6; Head MG, 2013, LANCET INFECT DIS, V13, P55, DOI 10.1016/S1473-3099(12)70261-X; Healthy Newborn Network, 2009, NEWB NUMB; Heidari S, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18608; Heise L., 2002, WORLD REPORT VIOLENC, V1, P87, DOI DOI 10.1503/CMAJ.1150071; Hequembourg AL, 2013, VIOLENCE AGAINST WOM, V19, P634, DOI 10.1177/1077801213490557; Hernandez B, 2005, EVALUACION EXTERNA I, P73; Hingson RW, 2006, ARCH PEDIAT ADOL MED, V160, P739, DOI 10.1001/archpedi.160.7.739; HOFFMAN KL, 1994, J MARRIAGE FAM, V56, P131, DOI 10.2307/352709; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Horton R, 2014, LANCET, V383, P2196, DOI 10.1016/S0140-6736(14)61046-1; Hunter LM, 2014, SWIMMING GENDERED VU; IFPRI, 2010, GEN GOV RUR SERV INS; IHME, 2013, GBD ARR DIAGR; IHME, 2013, GBD 2010 LIF EXP PRO; Ilahi N, 2000, ECON DEV CULT CHANGE, V49, P45, DOI 10.1086/452490; ILO, 2013, DOMESTIC WORKERS WOR; ILO, 2013, KEY IND LAB MARK, V8th; Institut National de la Statistique (INSTAT) et ICF Macro, 2010, ENQ DEM SANT MAD 200; Institute for Health Metrics and Evaluation (IHME), 2013, GBD HEATM; Institute for Health MetricsEvaluation (IHME), 2013, GBD CAUS PATT; Institute of Medicine, 2011, FUT NURS LEAD CHANG; Institute of Medicine Committee on Integrating the Science of Early Childhood Development and Board on Children Youth and Families, 2000, NEUR NEIGHB SCI EARL; International Labour Office (ILO), 2008, GLOB EMPL TRENDS WOM; IOM, 2010, GEND MIGR REM; Irshad H, 2012, DISASTERS, V36, P452, DOI 10.1111/j.1467-7717.2011.01265.x; Irwin A., 2009, HOME TRUTHS FACING F; Iyer A, 2008, Glob Public Health, V3 Suppl 1, P13, DOI 10.1080/17441690801892174; JAFAREY SN, 1993, SOC SCI MED, V36, P371, DOI 10.1016/0277-9536(93)90021-U; Jalal S, 2011, EUR J PUBLIC HEALTH, V21, P143, DOI 10.1093/eurpub/ckq199; Jamison DT, 2005, HEALTH AND ECONOMIC GROWTH: FINDINGS AND POLICY IMPLICATIONS, P67; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson JH, 1995, FAM PLANN PERSPECT, V27, P254, DOI 10.2307/2136178; Jutting J. P., 2009, IS INFORMAL NORMAL M; Kabeer N, 2013, GENDER EQUALITY EC G; Kapur P, 2009, MENOPAUSE, V16, P378, DOI 10.1097/gme.0b013e31818a2be9; Karim R, 2013, LANCET, V381, P1690, DOI 10.1016/S0140-6736(13)60904-6; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Katz I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017166; Katz SJ, 2000, JAMA-J AM MED ASSOC, V284, P3022, DOI 10.1001/jama.284.23.3022; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kimani-Murage EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-158; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; KIRBY D, 1994, PUBLIC HEALTH REP, V109, P339; Kirigia Joses M, 2006, Afr J Health Sci, V13, P86; Knaul F. M., 2012, FINANCING HLTH LATIN; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; KRIEGER N, 1994, INT J HEALTH SERV, V24, P265, DOI 10.2190/LWLH-NMCJ-UACL-U80Y; Kruk ME, 2008, TROP MED INT HEALTH, V13, P1442, DOI 10.1111/j.1365-3156.2008.02173.x; Kruk ME, 2009, HEALTH AFFAIR, V28, P1056, DOI 10.1377/hlthaff.28.4.1056; Kvaerner KJ, 1999, BRIT MED J, V318, P91; Lagarde M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008137; LaLiberte P, 2014, INT J LAB RES, V6, P1; Landivar L. C., 2013, MEN NURSING OCCUPATI; Langer A, 2006, LANCET, V368, P1753, DOI 10.1016/S0140-6736(06)69527-5; Langer A, 2012, LANCET, V380, P631, DOI 10.1016/S0140-6736(11)60742-3; Langston EL, 2008, REPORT 19 BOARD TRUS; Larson EB, 2013, NEW ENGL J MED, V369, P2275, DOI 10.1056/NEJMp1311405; LASLETT B, 1989, ANNU REV SOCIOL, V15, P381, DOI 10.1146/annurev.so.15.080189.002121; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lehavot K, 2013, J GEN INTERN MED, V28, pS609, DOI 10.1007/s11606-012-2291-2; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Lesthaeghe R, 2010, POPUL DEV REV, V36, P211, DOI 10.1111/j.1728-4457.2010.00328.x; Levitt Peggy, 1996, SOCIAL REMITTANCES C; Lewis M.A., 2006, INEXCUSABLE ABSENCE; Liefbroer AC, 2005, EUR J POPUL, V21, P367, DOI 10.1007/s10680-005-2610-y; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Lindau ST, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c810; Liu A, 2011, MT SINAI J MED, V78, P419, DOI 10.1002/msj.20260; Lloyd C. B., 2009, NEW LESSONS POWER ED; Lloyd Cynthia B., 2005, GROWING GLOBAL CHANG; Lovell V., 2006, SOLVING NURSING SHOR; Madsen E. L., 2010, EFFECTS AGE STRUCTUR; Maitre B, 2013, CRITICAL EVALUATION; Malmberg CC, 1994, CASE STUDY ROLE WOME; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Marphatia AA, 2013, INT J EDUC DEV, V33, P585, DOI 10.1016/j.ijedudev.2013.05.005; Mascarenhas MN, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-17; Matthews Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000327; Mayoux L., 2008, WOMEN ENDING POVERTY; McCabe SE, 2009, ADDICTION, V104, P1333, DOI 10.1111/j.1360-0443.2009.02596.x; Mccord A, 2005, J VOCAT EDUC TRAIN, V57, P563, DOI 10.1080/13636820500200302; McMurray Julia E, 2002, J Am Med Womens Assoc (1972), V57, P185; Meleis AI, 2011, CITY 21ST CENTURY, P1; Messing K, 2006, GENDER EQUALITY WORK; Migration Policy Institute, 2011, MIGRATION REV, V39, P45; Miller AR, 2011, J POPUL ECON, V24, P1071, DOI 10.1007/s00148-009-0296-x; Miranda V., 2011, CARING VOLUNTEERING; Molyneux Maxine., 2009, CONDITIONAL CASH TRA; Mumtaz Z, 2009, SOC SCI MED, V68, P1349, DOI 10.1016/j.socscimed.2009.01.025; Muralidharan K, 2013, CYCLING SCH INCREASI; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nahar P, 2012, HUM FERTIL, V15, P18, DOI 10.3109/14647273.2012.658111; Oomman N, 2013, LANCET, V381, P1336, DOI 10.1016/S0140-6736(13)60847-8; National Bureau of Statistics and Office of the Chief Government Statistician-Zanzibar, 2005, TANZ DEM HLTH SURV 2; Navaie-Waliser M, 2002, MED CARE, V40, P1249, DOI 10.1097/00005650-200212000-00012; Newman P, 2011, RELEASING POTENTIAL; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Norway Ministry of Labour and Social Aff airs, 2005, POL PLATF MAJ GOV IS; Nove A, 2014, LANCET GLOB HEALTH, V2, pE155, DOI 10.1016/S2214-109X(13)70179-7; NPC and ICF Macro, 2009, NIG DEM HLTH SURV 20; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Obeisat S, 2012, FERTIL STERIL, V98, P444, DOI 10.1016/j.fertnstert.2012.04.036; Ogden J, 2006, HEALTH POLICY PLANN, V21, P333, DOI 10.1093/heapol/czl025; Ombelet W, 2008, HUM REPROD UPDATE, V14, P605, DOI 10.1093/humupd/dmn042; Opdahl S, 2011, BRIT J CANCER, V105, P731, DOI 10.1038/bjc.2011.286; Organization WH, 2016, GLOBAL STATUS REPORT; Orozco M., 2006, GENDER SPECIFIC DETE; Palacios S, 2010, CLIMACTERIC, V13, P419, DOI 10.3109/13697137.2010.507886; Pande V, 2015, AFRICA FIGHT POVERTY; Pastrana T, 2012, ATLAS CUIDADOS PALIA; Patel S., 2011, WOMENS HLTH WORLDS C; PEARCE D, 1978, URBAN SOC CHANGE REV, V11, P28; Pettifor A, 2012, AIDS BEHAV, V16, P1729, DOI 10.1007/s10461-012-0240-z; Phillips SP, 2009, JAMA-J AM MED ASSOC, V301, P863, DOI 10.1001/jama.2009.155; Pickbourn LJ, 2011, THESIS U MASSACHUSET; Pitt MM, 1998, J POLIT ECON, V106, P958, DOI 10.1086/250037; Popkin BM, 2003, OBES RES, V11, P1325, DOI 10.1038/oby.2003.179; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Quick Jonathan, 2014, PLoS Med, V11, pe1001580, DOI 10.1371/journal.pmed.1001580; Raine R, 2000, J Health Serv Res Policy, V5, P237; Ram U, 2013, LANCET GLOB HEALTH, V1, pE219, DOI 10.1016/S2214-109X(13)70073-1; Ramakrishnan A, 2014, J WOMENS HEALTH, V23, P927, DOI 10.1089/jwh.2014.4736; Ramirez C, 2005, CROSSING BORDERS REM; Rani M, 2008, INT J QUAL HEALTH C, V20, P62, DOI 10.1093/intqhc/mzm052; Ranis G, 2000, WORLD DEV, V28, P197, DOI 10.1016/S0305-750X(99)00131-X; Reca IC, 2010, INVISIBLE EC GENDER, P167; Rehn E, 2002, WAR WOMENS HLTH WOME; Rich-Edwards JW, 2014, EPIDEMIOL REV, V36, P57, DOI 10.1093/epirev/mxt006; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Robine J. M., 2007, REPORT EXCESS MORTAL; Rogow D, 2013, REPROD HEALTH MATTER, V21, P154, DOI 10.1016/S0968-8080(13)41699-3; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Ronsmans C, 2010, LANCET, V375, P2024, DOI 10.1016/S0140-6736(10)60704-0; Rose P., 2012, ED ALL GLOBAL MONITO; ROSENFIELD A, 1985, LANCET, V2, P83; Rothman EF, 2011, TRAUMA VIOLENCE ABUS, V12, P55, DOI 10.1177/1524838010390707; Roy BCS, 2008, CONNECTING COMMUNITI, P209; Roy JL, 2005, INT WORKSH AFR WAT L; Royston E, 1989, PREVENTING MATERNAL; Salim Z., 1991, AHFAD J, V8, P37; Save the Children, 2008, SAV LIV MOTH NEWB AF; Sawyer CC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001287; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Schultz TP, 2002, WORLD DEV, V30, P207; SEDESOL Mexico, 2012, OP 15 YEARS RES; SEN G, 1995, ENVIRONMENT, V37, P10, DOI 10.1080/00139157.1995.9929209; Sen G, 1995, ENVIRONMENT, V37, P34; Sen M., 2004, IMPACT ENERGY WOMENS; Shah I, 2010, REPROD HEALTH MATTER, V18, P90, DOI 10.1016/S0968-8080(10)36537-2; Shaji K S, 2012, Indian J Psychol Med, V34, P303, DOI 10.4103/0253-7176.108191; Shuster LT, 2010, MATURITAS, V65, P161, DOI 10.1016/j.maturitas.2009.08.003; Sindhu S, 2014, CASE MANAGEMENT HYPE, P242; Sindhu S, 2010, COLLEGIAN, V17, P93, DOI 10.1016/j.colegn.2010.05.003; Smink FRE, 2012, CURR PSYCHIAT REP, V14, P406, DOI 10.1007/s11920-012-0282-y; Smith KR, 2003, INT J HYG ENVIR HEAL, V206, P279, DOI 10.1078/1438-4639-00224; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Standing H., 2000, HUMAN RESOURCES HLTH, V4, P27; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Suarez-Orozco C, 2009, YOUTH SOC, V41, P151, DOI 10.1177/0044118X09333647; Sugiura Keiko, 2004, Nihon Koshu Eisei Zasshi, V51, P240; SutherlandAddy E, 2008, WOR BANK WORK PAPER, P1, DOI 10.1596/978-0-8213-7505-1; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; Temin M., 2013, GIRLS MOVE ADOLESCEN; Temin M., 2009, START GIRL NEW AGEND; Thomas TN, 2014, CONTRACEPTION, V90, pS32, DOI 10.1016/j.contraception.2014.06.026; Torchalla I, 2012, WOMEN HEALTH, V52, P32, DOI 10.1080/03630242.2011.637611; Torres-Duque Carlos, 2008, Proc Am Thorac Soc, V5, P577, DOI 10.1513/pats.200707-100RP; UN, 2014, ROAD DIGN 2030 END P; UN, 2015, SUSTAINABLE DEV GOAL; UN Women, 4 ANN C WOM PLATF AC; UNAIDS, 2013, UPD AFR TURN AIDS; UNDESA, 2012, WORLD URB PROSP 2011; UNDESA, 2011, SEX DIFF CHILDH MORT; UNFPA, 2014, STAT WORLDS MIDW 201; UNFPA, PROM GEND EQ PROT WO; UNFPA, 2012, CHOIC NOT CHANC FAM; UNICEF, 2012, S AFR CHILD SUPP GRA; UNIFEM, 2005, UNIFEM RESP TSUN TRA; United Nations, 2000, MILL DEV GOALS; United Nations Development Programme (UNDP), 2014, HUM DEV REP 2013 RIS; United Nations Fund for Population Activities (UNFPA), 2014, FRAM ACT FOLL UP PRO; United Nations Population Fund (UNFPA), 2007, UNL POT URB GROWTH; Upadhyay UD, 2014, SOC SCI MED, V115, P111, DOI 10.1016/j.socscimed.2014.06.014; Uraz A, 2010, RECENT TRENDS FEMALE; vanWijk CMTG, 1996, SOC SCI MED, V43, P707, DOI 10.1016/0277-9536(96)00115-3; Vega J, 2013, LANCET, V381, P179, DOI 10.1016/S0140-6736(13)60062-8; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2013, LANCET, V381, P1693, DOI 10.1016/S0140-6736(13)61029-6; Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X; Wagstaff A, 2009, J HEALTH ECON, V28, P1, DOI 10.1016/j.jhealeco.2008.10.007; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; Wall LL, 2006, LANCET, V368, P1201, DOI 10.1016/S0140-6736(06)69476-2; Webster PC, 2013, LANCET, V381, P891, DOI 10.1016/S0140-6736(13)60658-3; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, GENDER, WOMEN, AND THE TOBACCO EPIDEMIC, P1; WHO, 2002, INT PARTN VIOL FACT; WHO, 2014, HLTH WORLDS AD 2 CHA; WHO, 2010, UNS AB GLOB REG EST; WHO, 2006, GLOB HLTH ATL; Woloski-Wruble AC, 2010, J SEX MED, V7, P2401, DOI 10.1111/j.1743-6109.2010.01747.x; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Bank, INT MIGR WOM FACT SH; World Commission on Environment and Development (WCED), 1987, OUR COMMON FUTURE; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; World Health Organization, 2013, UNS AB GLOB REG EST; World Health Organization, 2014, EV WOM EV CHILD POST; World Health Organization, 2014, ENS HUM RIGHTS PROV; World Health Organization, 2014, EV NEWB ACT PLAN END; World Health Organization, 2013, ESS NUTR ACT IMPR MA; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; World Health Organization (WHO), 2011, BURD BEST BUYS RED E; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Yamin AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071674; Yardley J., 2009, NY TIMES; Zeleke BM, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-236; Zervoudis S, 2014, WORLD J CLIN ONCOL, V5, P359, DOI 10.5306/wjco.v5.i3.359; Zontini E., 2003, MEDITERRANEAN PASSAG, P231	343	193	195	1	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2015	386	9999					1165	1210		10.1016/S0140-6736(15)60497-4	http://dx.doi.org/10.1016/S0140-6736(15)60497-4			46	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR5GE	26051370				2022-12-28	WOS:000361368000031
J	Naimi, TS; Mosher, JF				Naimi, Timothy S.; Mosher, James F.			Powdered Alcohol Products New Challenge in an Era of Needed Regulation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							US		[Naimi, Timothy S.] Boston Med Ctr, Gen Internal Med Sect, One Boston Med Ctr Pl, Boston, MA 02118 USA; [Mosher, James F.] Alcohol Policy Consultat, Felton, CA USA	Boston Medical Center	Naimi, TS (corresponding author), Boston Med Ctr, Gen Internal Med Sect, One Boston Med Ctr Pl, Boston, MA 02118 USA.	tim.naimi@bmc.org		Naimi, Timothy/0000-0001-9849-4413				Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045; Centers for Disease Control and Prevention, 2015, ALC REL DIS IMP ARDI; Centers for Disease Control and Prevention (CDC), FACT SHEETS CAFF ALC; Federal Trade Commission, 2014, SELF REG ALC IND REP; Kerr WC, 2013, AM J PREV MED, V44, P459, DOI 10.1016/j.amepre.2013.01.007; Naimi TS, 2011, AM J PREV MED, V41, P546, DOI 10.1016/j.amepre.2011.08.001; National Alcohol Beverage Control Association (NABCA), 2015, POWD ALC ENC; National Conference of State Legislatures (NCSL), 2015, POWD ALC 2015 LEG; US Food and Drug Administration, 2015, FDA CLAR ITS ROL PAL	9	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2015	314	2					119	120		10.1001/jama.2015.6450	http://dx.doi.org/10.1001/jama.2015.6450			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM7JI	26075642				2022-12-28	WOS:000357867500006
J	Bayefsky, MJ; Saylor, KW; Berkman, BE				Bayefsky, Michelle J.; Saylor, Katherine W.; Berkman, Benjamin E.			Parental Consent for the Use of Residual Newborn Screening Bloodspots Respecting Individual Liberty vs Ensuring Public Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bayefsky, Michelle J.; Berkman, Benjamin E.] NIH, Ctr Clin, Dept Bioeth, 10 Ctr Dr,Bldg 10,Room 1C118, Bethesda, MD 20892 USA; [Saylor, Katherine W.] NHGRI, Div Policy Commun & Educ, NIH, Bethesda, MD 20892 USA; [Berkman, Benjamin E.] NHGRI, Bioeth Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Berkman, BE (corresponding author), NIH, Ctr Clin, Dept Bioeth, 10 Ctr Dr,Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	berkmanbe@mail.nih.gov		Saylor, Katherine/0000-0002-7092-7739	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Botkin JR, 2012, PEDIATRICS, V129, P231, DOI 10.1542/peds.2011-0970; Goldenberg AJ, 2012, JAMA-J AM MED ASSOC, V307, P461, DOI 10.1001/jama.2012.68; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V309, P1215, DOI 10.1001/jama.2013.2087; Tarini BA, 2010, PUBLIC HEALTH GENOM, V13, P125, DOI 10.1159/000228724	4	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2015	314	1					21	22		10.1001/jama.2015.6175	http://dx.doi.org/10.1001/jama.2015.6175			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM1QR	26053685				2022-12-28	WOS:000357455900007
J	Huang, XQ; Zhao, ZP; Cao, L; Chen, Y; Zhu, EB; Lin, ZY; Li, MF; Yan, AM; Zettl, A; Wang, YM; Duan, XF; Mueller, T; Huang, Y				Huang, Xiaoqing; Zhao, Zipeng; Cao, Liang; Chen, Yu; Zhu, Enbo; Lin, Zhaoyang; Li, Mufan; Yan, Aiming; Zettl, Alex; Wang, Y. Morris; Duan, Xiangfeng; Mueller, Tim; Huang, Yu			High-performance transition metal-doped Pt3Ni octahedra for oxygen reduction reaction	SCIENCE			English	Article							ALLOY NANOPARTICLES; PLATINUM; NANOCRYSTALS; NI; CATALYSIS; STRATEGY	Bimetallic platinum-nickel (Pt-Ni) nanostructures represent an emerging class of electrocatalysts for oxygen reduction reaction (ORR) in fuel cells, but practical applications have been limited by catalytic activity and durability. We surface-doped Pt3Ni octahedra supported on carbon with transition metals, termed M-Pt3Ni/C, where M is vanadium, chromium, manganese, iron, cobalt, molybdenum (Mo), tungsten, or rhenium. The Mo-Pt3Ni/C showed the best ORR performance, with a specific activity of 10.3 mA/cm(2) and mass activity of 6.98 A/mg(Pt), which are 81- and 73-fold enhancements compared with the commercial Pt/C catalyst (0.127 mA/cm(2) and 0.096 A/mg(Pt)). Theoretical calculations suggest that Mo prefers subsurface positions near the particle edges in vacuum and surface vertex/edge sites in oxidizing conditions, where it enhances both the performance and the stability of the Pt3Ni catalyst.	[Huang, Xiaoqing; Zhao, Zipeng; Chen, Yu; Zhu, Enbo; Huang, Yu] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Huang, Xiaoqing; Zhao, Zipeng; Chen, Yu; Zhu, Enbo; Duan, Xiangfeng; Huang, Yu] Univ Calif Los Angeles, Calif NanoSyst Inst CNSI, Los Angeles, CA 90095 USA; [Cao, Liang] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Lin, Zhaoyang; Li, Mufan; Duan, Xiangfeng] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Yan, Aiming; Zettl, Alex] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Yan, Aiming; Zettl, Alex] Univ Calif Berkeley, Ctr Integrated Nanomech Syst, Berkeley, CA 94720 USA; [Yan, Aiming; Zettl, Alex] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Yan, Aiming; Zettl, Alex] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Yan, Aiming; Zettl, Alex] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Wang, Y. Morris] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Mueller, Tim] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Johns Hopkins University; University of California System; University of California Los Angeles; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Johns Hopkins University	Mueller, T (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA.	tmueller@jhu.edu; yhuang@seas.ucla.edu	Duan, Xiangfeng/AAQ-9674-2020; Zhu, Enbo/V-4845-2018; Lin, Zhaoyang/Y-2489-2019; Huang, Yu/AAZ-9747-2020; Zettl, Alex K/O-4925-2016; Wang, Y. Morris/F-2249-2010; Zhao, Zipeng/H-4983-2014; Duan, Xiangfeng/E-7522-2011; chen, yu/D-7673-2011; Cao, Liang/S-3908-2017; Mueller, Tim/G-3435-2011	Duan, Xiangfeng/0000-0002-4321-6288; Zhu, Enbo/0000-0001-8600-8553; Huang, Yu/0000-0003-1793-0741; Zettl, Alex K/0000-0001-6330-136X; Zhao, Zipeng/0000-0003-1135-6742; Duan, Xiangfeng/0000-0002-4321-6288; chen, yu/0000-0001-7999-7808; Cao, Liang/0000-0003-4452-022X; Wang, Yinmin (MORRIS)/0000-0003-0393-5154	National Science Foundation (NSF) [DMR-1437263]; Office of Naval Research (ONR) [N00014-15-1-2146]; NSF [DMR-1352373]; Extreme Science and Engineering Development Environment (XSEDE) [DMR130056, DMR140068]; Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences and Engineering Division of the U.S. Department of Energy [DE-AC02-05CH11231]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering [DE-SC0008055]; U.S. Department of Energy [DE-AC52-07NA27344]; NSF within Center of Integrated Nanomechanical Systems [EEC-083219]; Electron Imaging Center of Nanomachines at CNSI; Direct For Mathematical & Physical Scien [1352373] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Naval Research (ONR)(Office of Naval Research); NSF(National Science Foundation (NSF)); Extreme Science and Engineering Development Environment (XSEDE); Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences and Engineering Division of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); NSF within Center of Integrated Nanomechanical Systems; Electron Imaging Center of Nanomachines at CNSI; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge support from the National Science Foundation (NSF) through award DMR-1437263 on catalysis studies and the Office of Naval Research (ONR) under award N00014-15-1-2146 for synthesis efforts. Computational studies were supported by the NSF through award DMR-1352373 and using computational resources provided by Extreme Science and Engineering Development Environment (XSEDE) through awards DMR130056 and DMR140068. Atomic-scale structural images were generated by using VESTA (38). We thank the Director, Office of Energy Research, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, of the U.S. Department of Energy under contract DE-AC02-05CH11231, under the sp<SUP>2</SUP>-bonded materials program, for TEM analytical measurements performed at the National Center for Electron Microscopy at the Lawrence Berkeley National Laboratory. X.D. acknowledges support from the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering through award DE-SC0008055. The work at LLNL was performed under the auspices of the U.S. Department of Energy under contract DE-AC52-07NA27344. A.Y. and A.Z. received additional support from NSF grant EEC-083219 within the Center of Integrated Nanomechanical Systems. We also thank the Electron Imaging Center of Nanomachines at CNSI for TEM support.	Ahrenstorf K, 2007, SMALL, V3, P271, DOI 10.1002/smll.200600486; Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Bing YH, 2010, CHEM SOC REV, V39, P2184, DOI 10.1039/b912552c; Carpenter MK, 2012, J AM CHEM SOC, V134, P8535, DOI 10.1021/ja300756y; Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Chen JY, 2009, NANO TODAY, V4, P81, DOI 10.1016/j.nantod.2008.09.002; Chen ZW, 2011, ENERG ENVIRON SCI, V4, P3167, DOI 10.1039/c0ee00558d; Choi SI, 2013, NANO LETT, V13, P3420, DOI 10.1021/nl401881z; Cui CH, 2013, NAT MATER, V12, P765, DOI [10.1038/NMAT3668, 10.1038/nmat3668]; de Bruijn FA, 2008, FUEL CELLS, V8, P3, DOI 10.1002/fuce.200700053; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; Gasteiger HA, 2009, SCIENCE, V324, P48, DOI 10.1126/science.1172083; Greeley J, 2009, NAT CHEM, V1, P552, DOI [10.1038/NCHEM.367, 10.1038/nchem.367]; Guo SJ, 2013, ANGEW CHEM INT EDIT, V52, P8526, DOI 10.1002/anie.201207186; Huang XQ, 2013, ADV MATER, V25, P2974, DOI 10.1002/adma.201205315; Kang YJ, 2010, J AM CHEM SOC, V132, P7568, DOI [10.1021/ja100705j, 10.1021/ja100705J]; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Lim B, 2009, SCIENCE, V324, P1302, DOI 10.1126/science.1170377; Liu Z, 2009, J AM CHEM SOC, V131, P6924, DOI 10.1021/ja901303d; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Momma K, 2008, J APPL CRYSTALLOGR, V41, P653, DOI 10.1107/S0021889808012016; Mueller T, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.024103; Norskov JK, 2009, NAT CHEM, V1, P37, DOI [10.1038/nchem.121, 10.1038/NCHEM.121]; Porter NS, 2013, ACCOUNTS CHEM RES, V46, P1867, DOI 10.1021/ar3002238; Rossmeisl J, 2008, FARADAY DISCUSS, V140, P337, DOI 10.1039/b802129e; SANCHEZ JM, 1984, PHYSICA A, V128, P334, DOI 10.1016/0378-4371(84)90096-7; Snyder J, 2012, J AM CHEM SOC, V134, P8633, DOI 10.1021/ja3019498; Stamenkovic VR, 2007, NAT MATER, V6, P241, DOI 10.1038/nmat1840; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Su DS, 2011, ANGEW CHEM INT EDIT, V50, P11570, DOI 10.1002/anie.201106166; Wang DL, 2013, NAT MATER, V12, P81, DOI [10.1038/NMAT3458, 10.1038/nmat3458]; Wu JB, 2013, ACCOUNTS CHEM RES, V46, P1848, DOI 10.1021/ar300359w; Wu JB, 2011, NANO LETT, V11, P798, DOI 10.1021/nl104094p; Wu YE, 2012, ANGEW CHEM INT EDIT, V51, P12524, DOI 10.1002/anie.201207491; Wu YE, 2012, J AM CHEM SOC, V134, P8975, DOI 10.1021/ja302606d; Zhang J, 2010, NANO LETT, V10, P638, DOI 10.1021/nl903717z; Zhang J, 2009, J AM CHEM SOC, V131, P18543, DOI 10.1021/ja908245r; Zhu HY, 2013, J AM CHEM SOC, V135, P7130, DOI 10.1021/ja403041g	38	1329	1350	89	2204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1230	1234		10.1126/science.aaa8765	http://dx.doi.org/10.1126/science.aaa8765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068847	Green Submitted			2022-12-28	WOS:000356011500048
J	[Anonymous]				[Anonymous]			Response to Comment on "Human-like hand use in Australopithecus africanus"	SCIENCE			English	Editorial Material													Tsegai, Zewdi/AAB-9996-2019; Stephens, Nicholas/J-5162-2017; Skinner, Matthew/D-1104-2010	Tsegai, Zewdi/0000-0001-9041-4829; Nguyen, Nhu Huynh/0000-0001-5493-3752; Pahr, Dieter/0000-0002-5822-2082; Stephens, Nicholas/0000-0002-2838-5606; Skinner, Matthew/0000-0001-8321-3543	European Research Council [336301] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)			0	10	10	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239								10.1126/science.aaa8931	http://dx.doi.org/10.1126/science.aaa8931			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045429	Green Accepted			2022-12-28	WOS:000355590500036
J	Khachatryan, V; Sirunyan, AM; Tumasyan, A; Adam, W; Bergauer, T; Dragicevic, M; Ero, J; Friedl, M; Fruhwirth, R; Ghete, VM; Hartl, C; Hormann, N; Hrubec, J; Jeitler, M; Kiesenhofer, W; Knunz, V; Krammer, M; Kratschmer, I; Liko, D; Mikulec, I; Rabady, D; Rahbaran, B; Rohringer, H; Schofbeck, R; Strauss, J; Treberer-Treberspurg, W; Waltenberger, W; Wulz, CE; Mossolov, V; Shumeiko, N; Gonzalez, JS; Alderweireldt, S; Bansal, S; Cornelis, T; De Wolf, EA; Janssen, X; Knutsson, A; Lauwers, J; Luyckx, S; Ochesanu, S; Rougny, R; Van De Klundert, M; Van Haevermaet, H; Van Mechelen, P; Van Remortel, N; Van Spilbeeck, A; Blekman, F; Blyweert, S; D'Hondt, J; Daci, N; Heracleous, N; Keaveney, J; Lowette, S; Maes, M; Olbrechts, A; Python, Q; Strom, D; Tavernier, S; Van Doninck, W; Van Mulders, P; Van Onsem, GP; Villella, I; Caillol, C; Clerbaux, B; De Lentdecker, G; Dobur, D; Favart, L; Gay, APR; Grebenyuk, A; Leonard, A; Mohammadi, A; Pernie, L; Randle-conde, A; Reis, T; Seva, T; Thomas, L; Vander Velde, C; Vanlaer, P; Wang, J; Zenoni, F; Adler, V; Beernaert, K; Benucci, L; Cimmino, A; Costantini, S; Crucy, S; Dildick, S; Fagot, A; Garcia, G; Mccartin, J; Rios, AAO; Ryckbosch, D; Diblen, SS; Sigamani, M; Strobbe, N; Thyssen, F; Tytgat, M; Yazgan, E; Zaganidis, N; Basegmez, S; Beluffi, C; Bruno, G; Castello, R; Caudron, A; Ceard, L; Da Silveira, GG; Delaere, C; du Pree, T; Favart, D; Forthomme, L; Giammanco, A; Hollar, J; Jafari, A; Jez, P; Komm, M; Lemaitre, V; Nuttens, C; Pagano, D; Perrini, L; Pin, A; Piotrzkowski, K; Popov, A; Quertenmont, L; Selvaggi, M; Marono, MV; Garcia, JMV; Beliy, N; Caebergs, T; Daubie, E; Hammad, GH; Alda, WL; Alves, GA; Brito, L; Martins, MC; Martins, TD; Herrera, CM; Pol, ME; Teles, PR; Carvalho, W; Chinellato, J; Custodio, A; Da Costa, EM; Damiao, DD; Martins, CD; De Souza, SF; Malbouisson, H; Figueiredo, DM; Mundim, L; Nogima, H; Da Silva, WLP; Santaolalla, J; Santoro, A; Sznajder, A; Manganote, EJT; Pereira, AV; Bernardes, CA; Dogra, S; Tomei, TRFP; Gregores, EM; Mercadante, PG; Novaes, SF; Padula, SS; Aleksandrov, A; Genchev, V; Hadjiiska, R; Iaydjiev, P; Marinov, A; Piperov, S; Rodozov, M; Sultanov, G; Vutova, M; Dimitrov, A; Glushkov, I; Litov, L; Pavlov, B; Petkov, P; Bian, JG; Chen, GM; Chen, HS; Chen, M; Cheng, T; Du, R; Jiang, CH; Plestina, R; Romeo, F; Tao, J; Wang, Z; Asawatangtrakuldee, C; Ban, Y; Li, Q; Liu, S; Mao, Y; Qian, SJ; Wang, D; Xu, Z; Zou, W; Avila, C; Cabrera, A; Sierra, LFC; Florez, C; Gomez, JP; Moreno, BG; Sanabria, JC; Godinovic, N; Lelas, D; Polic, D; Puljak, I; Antunovic, Z; Kovac, M; Brigljevic, V; Kadija, K; Luetic, J; Mekterovic, D; Sudic, L; Attikis, A; Mavromanolakis, G; Mousa, J; Nicolaou, C; Ptochos, F; Razis, PA; Bodlak, M; Finger, M; Finger, M; Assran, Y; Kamel, AE; Mahmoud, MA; Radi, A; Kadastik, M; Murumaa, M; Raidal, M; Tiko, A; Eerola, P; Fedi, G; Voutilainen, M; Harkonen, J; Karimaki, V; Kinnunen, R; Kortelainen, MJ; Lampen, T; Lassila-Perini, K; Lehti, S; Linden, T; Luukka, P; Maenpaa, T; Peltola, T; Tuominen, E; Tuominiemi, J; Tuovinen, E; Wendland, L; Talvitie, J; Tuuva, T; Besancon, M; Couderc, F; Dejardin, M; Denegri, D; Fabbro, B; Faure, JL; Favaro, C; Ferri, F; Ganjour, S; Givernaud, A; Gras, P; de Monchenault, GH; Jarry, P; Locci, E; Malcles, J; Rander, J; Rosowsky, A; Titov, M; Baffioni, S; Beaudette, F; Busson, P; Charlot, C; Dahms, T; Dalchenko, M; Dobrzynski, L; Filipovic, N; Florent, A; de Cassagnac, RG; Mastrolorenzo, L; Mine, P; Mironov, C; Naranjo, IN; Nguyen, M; Ochando, C; Ortona, G; Paganini, P; Regnard, S; Salerno, R; Sauvan, JB; Sirois, Y; Veelken, C; Yilmaz, Y; Zabi, A; Agram, JL; Andrea, J; Aubin, A; Bloch, D; Brom, JM; Chabert, EC; Collard, C; Conte, E; Fontaine, JC; Gele, D; Goerlach, U; Goetzmann, C; Le Bihan, AC; Skovpen, K; Van Hove, P; Gadrat, S; Beauceron, S; Beaupere, N; Boudoul, G; Bouvier, E; Brochet, S; Montoya, CAC; Chasserat, J; Chierici, R; Contardo, D; Depasse, P; El Mamouni, H; Fan, J; Fay, J; Gascon, S; Gouzevitch, M; Ille, B; Kurca, T; Lethuillier, M; Mirabito, L; Perries, S; Alvarez, JDR; Sabes, D; Sgandurra, L; Sordini, V; Vander Donckt, M; Verdier, P; Viret, S; Xiao, H; Tsamalaidze, Z; Autermann, C; Beranek, S; Bontenackels, M; Edelhoff, M; Feld, L; Heister, A; Hindrichs, O; Klein, K; Ostapchuk, A; Raupach, F; Sammet, J; Schael, S; Schulte, JF; Weber, H; Wittmer, B; Zhukov, V; Ata, M; Brodski, M; Dietz-Laursonn, E; Duchardt, D; Erdmann, M; Fischer, R; Guth, A; Hebbeker, T; Heidemann, C; Hoepfner, K; Klingebiel, D; Knutzen, S; Kreuzer, P; Merschmeyer, M; Meyer, A; Millet, P; Olschewski, M; Padeken, K; Papacz, P; Reithler, H; Schmitz, SA; Sonnenschein, L; Teyssier, D; Thuer, S; Weber, M; Cherepanov, V; Erdogan, Y; Flugge, G; Geenen, H; Geisler, M; Ahmad, WH; Hoehle, F; Kargoll, B; Kress, T; Kuessel, Y; Kunsken, A; Lingemann, J; Nowack, A; Nugent, IM; Pooth, O; Stahl, A; Martin, MA; Asin, I; Bartosik, N; Behr, J; Behrens, U; Bell, AJ; Bethani, A; Borras, K; Burgmeier, A; Cakir, A; Calligaris, L; Campbell, A; Choudhury, S; Costanza, F; Pardos, CD; Dolinska, G; Dooling, S; Dorland, T; Eckerlin, G; Eckstein, D; Eichhorn, T; Flucke, G; Garcia, JG; Geiser, A; Gunnellini, P; Hauk, J; Hempel, M; Jung, H; Kalogeropoulos, A; Kasemann, M; Katsas, P; Kieseler, J; Kleinwort, C; Korol, I; Krucker, D; Lange, W; Leonard, J; Lipka, K; Lobanov, A; Lohmann, W; Lutz, B; Mankel, R; Marfin, I; Melzer-Pellmann, IA; Meyer, AB; Mittag, G; Mnich, J; Mussgiller, A; Naumann-Emme, S; Nayak, A; Ntomari, E; Perrey, H; Pitzl, D; Placakyte, R; Raspereza, A; Cipriano, PMR; Roland, B; Ron, E; Sahin, MO; Salfeld-Nebgen, J; Saxena, P; Schoerner-Sadenius, T; Schroder, M; Seitz, C; Spannagel, S; Trevino, ADRV; Walsh, R; Wissing, C; Blobel, V; Vignali, MC; Draeger, AR; Erfle, J; Garutti, E; Goebel, K; Gorner, M; Haller, J; Hoffmann, M; Hoing, RS; Junkes, A; Kirschenmann, H; Klanner, R; Kogler, R; Lange, J; Lapsien, T; Lenz, T; Marchesini, I; Ott, J; Peiffer, T; Perieanu, A; Pietsch, N; Poehlsen, J; Poehlsen, T; Rathjens, D; Sander, C; Schettler, H; Schleper, P; Schlieckau, E; Schmidt, A; Seidel, M; Sola, V; Stadie, H; Steinbruck, G; Troendle, D; Usai, E; Vanelderen, L; Vanhoefer, A; Barth, C; Baus, C; Berger, J; Boser, C; Butz, E; Chwalek, T; De Boer, W; Descroix, A; Dierlamm, A; Feindt, M; Frensch, F; Giffels, M; Gilbert, A; Hartmann, F; Hauth, T; Husemann, U; Katkov, I; Kornmayer, A; Kuznetsova, E; Pardo, PL; Mozer, MU; Muller, T; Muller, T; Nurnberg, A; Quast, G; Rabbertz, K; Rocker, S; Simonis, HJ; Stober, FM; Ulrich, R; Wagner-Kuhr, J; Wayand, S; Weiler, T; Wolf, R; Anagnostou, G; Daskalakis, G; Geralis, T; Giakoumopoulou, VA; Kyriakis, A; Loukas, D; Markou, A; Markou, C; Psallidas, A; Topsis-Giotis, I; Agapitos, A; Kesisoglou, S; Panagiotou, A; Saoulidou, N; Stiliaris, E; Aslanoglou, X; Evangelou, I; Flouris, G; Foudas, C; Kokkas, P; Manthos, N; Papadopoulos, I; Paradas, E; Strologas, J; Bencze, G; Hajdu, C; Hidas, P; Horvath, D; Sikler, F; Veszpremi, V; Vesztergombi, G; Zsigmond, AJ; Beni, N; Czellar, S; Karancsi, J; Molnar, J; Palinkas, J; Szillasi, Z; Makovec, A; Raics, P; Trocsanyi, ZL; Ujvari, B; Sahoo, N; Swain, SK; Beri, SB; Bhatnagar, V; Gupta, R; Bhawandeep, U; Kalsi, AK; Kaur, M; Kumar, R; Mittal, M; Nishu, N; Singh, JB; Kumar, A; Kumar, A; Ahuja, S; Bhardwaj, A; Choudhary, BC; Kumar, A; Malhotra, S; Naimuddin, M; Ranjan, K; Sharma, V; Banerjee, S; Bhattacharya, S; Chatterjee, K; Dutta, S; Gomber, B; Jain, S; Jain, S; Khurana, R; Modak, A; Mukherjee, S; Roy, D; Sarkar, S; Sharan, M; Abdulsalam, A; Dutta, D; Kailas, S; Kumar, V; Mohanty, AK; Pant, LM; Shukla, P; Topkar, A; Aziz, T; Banerjee, S; Bhowmik, S; Chatterjee, RM; Dewanjee, RK; Dugad, S; Ganguly, S; Ghosh, S; Guchait, M; Gurtu, A; Kole, G; Kumar, S; Maity, M; Majumder, G; Mazumdar, K; Mohanty, GB; Parida, B; Sudhakar, K; Wickramage, N; Bakhshiansohi, H; Behnamian, H; Etesami, SM; Fahim, A; Goldouzian, R; Khakzad, M; Najafabadi, MM; Naseri, M; Mehdiabadi, SP; Hosseinabadi, FR; Safarzadeh, B; Zeinali, M; Felcini, M; Grunewald, M; Abbrescia, M; Calabria, C; Chhibra, SS; Colaleo, A; Creanza, D; De Filippis, N; De Palma, M; Fiore, L; Iaselli, G; Maggi, G; Maggi, M; My, S; Nuzzo, S; Pompili, A; Pugliese, G; Radogna, R; Selvaggi, G; Sharma, A; Silvestris, L; Venditti, R; Verwilligen, P; Abbiendi, G; Benvenuti, AC; Bonacorsi, D; Braibant-Giacomelli, S; Brigliadori, L; Campanini, R; Capiluppi, P; Castro, A; Cavallo, FR; Codispoti, G; Cuffiani, M; Dallavalle, GM; Fabbri, F; Fanfani, A; Fasanella, D; Giacomelli, P; Grandi, C; Guiducci, L; Marcellini, S; Masetti, G; Montanari, A; Navarria, FL; Perrotta, A; Primavera, F; Rossi, AM; Rovelli, T; Siroli, GP; Tosi, N; Travaglini, R; Albergo, S; Cappello, G; Chiorboli, M; Costa, S; Giordano, F; Potenza, R; Tricomi, A; Tuve, C; Barbagli, G; Ciulli, V; Civinini, C; D'Alessandro, R; Focardi, E; Gallo, E; Gonzi, S; Gori, V; Lenzi, P; Meschini, M; Paoletti, S; Sguazzoni, G; Tropiano, A; Benussi, L; Bianco, S; Fabbri, F; Piccolo, D; Ferretti, R; Ferro, F; Lo Vetere, M; Robutti, E; Tosi, S; Dinardo, ME; Fiorendi, S; Gennai, S; Gerosa, R; Ghezzi, A; Govoni, P; Lucchini, MT; Malvezzi, S; Manzoni, RA; Martelli, A; Marzocchi, B; Menasce, D; Moroni, L; Paganoni, M; Pedrini, D; Ragazzi, S; Redaelli, N; de Fatis, TT; Buontempo, S; Cavallo, N; Di Guida, S; Fabozzi, F; Iorio, AOM; Lista, L; Meola, S; Merola, M; Paolucci, P; Azzi, P; Bacchetta, N; Bisello, D; Branca, A; Carlin, R; Checchia, P; Dall'Osso, M; Dorigo, T; Dosselli, U; Gasparini, F; Gasparini, U; Giubilato, P; Gozzelino, A; Kanishchev, K; Lacaprara, S; Margoni, M; Meneguzzo, AT; Pazzini, J; Pozzobon, N; Ronchese, P; Simonetto, F; Torassa, E; Tosi, M; Zotto, P; Zucchetta, A; Zumerle, G; Gabusi, M; Ratti, SP; Re, V; Riccardi, C; Salvini, P; Vitulo, P; Biasini, M; Bilei, GM; Ciangottini, D; Fano, L; Lariccia, P; Mantovani, G; Menichelli, M; Saha, A; Santocchia, A; Spiezia, A; Androsov, K; Azzurri, P; Bagliesi, G; Bernardini, J; Boccali, T; Broccolo, G; Castaldi, R; Ciocci, MA; Dell'Orso, R; Donato, S; Fiori, F; Foa, L; Giassi, A; Grippo, MT; Ligabue, F; Lomtadze, T; Martini, L; Messineo, A; Moon, CS; Palla, F; Rizzi, A; Savoy-Navarro, A; Serban, AT; Spagnolo, P; Squillacioti, P; Tenchini, R; Tonelli, G; Venturi, A; Verdini, PG; Vernieri, C; Barone, L; Cavallari, F; D'imperio, G; Del Re, D; Diemoz, M; Jorda, C; Longo, E; Margaroli, F; Meridiani, P; Micheli, F; Nourbakhsh, S; Organtini, G; Paramatti, R; Rahatlou, S; Rovelli, C; Santanastasio, F; Soffi, L; Traczyk, P; Amapane, N; Arcidiacono, R; Argiro, S; Arneodo, M; Bellan, R; Biino, C; Cartiglia, N; Casasso, S; Costa, M; Degano, A; Demaria, N; Finco, L; Mariotti, C; Maselli, S; Migliore, E; Monaco, V; Musich, M; Obertino, MM; Pacher, L; Pastrone, N; Pelliccioni, M; Angioni, GLP; Potenza, A; Romero, A; Ruspa, M; Sacchi, R; Solano, A; Staiano, A; Tamponi, U; Belforte, S; Candelise, V; Casarsa, M; Cossutti, F; Della Ricca, G; Gobbo, B; La Licata, C; Marone, M; Schizzi, A; Umer, T; Zanetti, A; Chang, S; Kropivnitskaya, A; Nam, SK; Kim, DH; Kim, GN; Kim, MS; Kong, DJ; Lee, S; Oh, YD; Park, H; Sakharov, A; Son, DC; Kim, TJ; Kim, JY; Song, S; Choi, S; Gyun, D; Hong, B; Jo, M; Kim, H; Kim, Y; Lee, B; Lee, KS; Park, SK; Roh, Y; Yoo, HD; Choi, M; Kim, JH; Park, IC; Ryu, G; Ryu, MS; Choi, Y; Choi, YK; Goh, J; Kim, D; Kwon, E; Lee, J; Yu, I; Juodagalvis, A; Komaragiri, JR; Ali, MABM; Linares, EC; Castilla-Valdez, H; De La Cruz-Burelo, E; Heredia-de la Cruz, I; Hernandez-Almada, A; Lopez-Fernandez, R; Sanchez-Hernandez, A; Moreno, SC; Valencia, FV; Pedraza, I; Ibarguen, HAS; Pineda, AM; Krofcheck, D; Butler, PH; Reucroft, S; Ahmad, A; Ahmad, M; Hassan, Q; Hoorani, HR; Khan, WA; Khurshid, T; Shoaib, M; Bialkowska, H; Bluj, M; Boimska, B; Frueboes, T; Gorski, M; Kazana, M; Nawrocki, K; Romanowska-Rybinska, K; Szleper, M; Zalewski, P; Brona, G; Bunkowski, K; Cwiok, M; Dominik, W; Doroba, K; Kalinowski, A; Konecki, M; Krolikowski, J; Misiura, M; Olszewski, M; Wolszczak, W; Bargassa, P; Silva, CBDE; Faccioli, P; Parracho, PGF; Gallinaro, M; Iglesias, LL; Nguyen, F; Antunes, JR; Seixas, J; Varela, J; Vischia, P; Afanasiev, S; Bunin, P; Gavrilenko, M; Golutvin, I; Gorbunov, I; Kamenev, A; Karjavin, V; Konoplyanikov, V; Lanev, A; Malakhov, A; Matveev, V; Moisenz, P; Palichik, V; Perelygin, V; Shmatov, S; Skatchkov, N; Smirnov, V; Zarubin, A; Golovtsov, V; Ivanov, Y; Kim, V; Levchenko, P; Murzin, V; Oreshkin, V; Smirnov, I; Sulimov, V; Uvarov, L; Vavilov, S; Vorobyev, A; Vorobyev, A; Andreev, Y; Dermenev, A; Gninenko, S; Golubev, N; Kirsanov, M; Krasnikov, N; Pashenkov, A; Tlisov, D; Toropin, A; Epshteyn, V; Gavrilov, V; Lychkovskaya, N; Popov, V; Pozdnyakov, I; Safronov, G; Semenov, S; Spiridonov, A; Stolin, V; Vlasov, E; Zhokin, A; Andreev, V; Azarkin, M; Dremin, I; Kirakosyan, M; Leonidov, A; Mesyats, G; Rusakov, SV; Vinogradov, A; Belyaev, A; Boos, E; Dubinin, M; Dudko, L; Ershov, A; Gribushin, A; Klyukhin, V; Kodolova, O; Lokhtin, I; Obraztsov, S; Petrushanko, S; Savrin, V; Snigirev, A; Azhgirey, I; Bayshev, I; Bitioukov, S; Kachanov, V; Kalinin, A; Konstantinov, D; Krychkine, V; Petrov, V; Ryutin, R; Sobol, A; Tourtchanovitch, L; Troshin, S; Tyurin, N; Uzunian, A; Volkov, A; Adzic, P; Ekmedzic, M; Milosevic, J; Rekovic, V; Maestre, JA; Battilana, C; Calvo, E; Cerrada, M; Llatas, MC; Colino, N; De La Cruz, B; Peris, AD; Vazquez, DD; Del Valle, AE; Bedoya, CF; Ramos, JPF; Flix, J; Fouz, MC; Garcia-Abia, P; Lopez, OG; Lopez, SG; Hernandez, JM; Josa, MI; De Martino, EN; Yzquierdo, APC; Pelayo, JP; Olmeda, AQ; Redondo, I; Romero, L; Soares, MS; Albajar, C; de Troconiz, JF; Missiroli, M; Moran, D; Brun, H; Cuevas, J; Menendez, JF; Folgueras, S; Caballero, IG; Cifuentes, JAB; Cabrillo, IJ; Calderon, A; Campderros, JD; Fernandez, M; Gomez, G; Graziano, A; Virto, AL; Marco, J; Marco, R; Rivero, CM; Matorras, F; Sanchez, FJM; Gomez, JP; Rodrigo, T; Rodriguez-Marrero, AY; Ruiz-Jimeno, A; Scodellaro, L; Vila, I; Cortabitarte, RV; Abbaneo, D; Auffray, E; Auzinger, G; Bachtis, M; Baillon, P; Ball, AH; Barney, D; Benaglia, A; Bendavid, J; Benhabib, L; Benitez, JF; Bernet, C; Bloch, P; Bocci, A; Bonato, A; Bondu, O; Botta, C; Breuker, H; Camporesi, T; Cerminara, G; Colafranceschi, S; D'Alfonso, M; d'Enterria, D; Dabrowski, A; David, A; De Guio, F; De Roeck, A; De Visscher, S; Di Marco, E; Dobson, M; Dordevic, M; Dupont-Sagorin, N; Elliott-Peisert, A; Franzoni, G; Funk, W; Gigi, D; Gill, K; Giordano, D; Girone, M; Glege, F; Guida, R; Gundacker, S; Guthoff, M; Hammer, J; Hansen, M; Harris, P; Hegeman, J; Innocente, V; Janot, P; Kousouris, K; Krajczar, K; Lecoq, P; Loureno, C; Magini, N; Malgeri, L; Mannelli, M; Marrouche, J; Masetti, L; Meijers, F; Mersi, S; Meschi, E; Moortgat, F; Morovic, S; Mulders, M; Orsini, L; Pape, L; Perez, E; Perrozzi, L; Petrilli, A; Petrucciani, G; Pfeiffer, A; Pimia, M; Piparo, D; Plagge, M; Racz, A; Rolandi, G; Rovere, M; Sakulin, H; Schafer, C; Schwick, C; Sharma, A; Siegrist, P; Silva, P; Simon, M; Sphicas, P; Spiga, D; Steggemann, J; Stieger, B; Stoye, M; Takahashi, Y; Treille, D; Tsirou, A; Veres, GI; Wardle, N; Wohri, HK; Wollny, H; Zeuner, WD; Bertl, W; Deiters, K; Erdmann, W; Horisberger, R; Ingram, Q; Kaestli, HC; Kotlinski, D; Renker, D; Rohe, T; Bachmair, F; Bani, L; Bianchini, L; Buchmann, MA; Casal, B; Chanon, N; Dissertori, G; Dittmar, M; Donega, M; Dunser, M; Eller, P; Grab, C; Hits, D; Hoss, J; Lustermann, W; Mangano, B; Marini, AC; Marionneau, M; del Arbol, PMR; Masciovecchio, M; Meister, D; Mohr, N; Musella, P; Nageli, C; Nessi-Tedaldi, F; Pandolfi, F; Pauss, F; Peruzzi, M; Quittnat, M; Rebane, L; Rossini, M; Starodumov, A; Takahashi, M; Theofilatos, K; Wallny, R; Weber, HA; Amsler, C; Canelli, MF; Chiochia, V; De Cosa, A; Hinzmann, A; Hreus, T; Kilminster, B; Lange, C; Mejias, BM; Ngadiuba, J; Pinna, D; Robmann, P; Ronga, FJ; Taroni, S; Verzetti, M; Yang, Y; Cardaci, M; Chen, KH; Ferro, C; Kuo, CM; Lin, W; Lu, YJ; Volpe, R; Yu, SS; Chang, P; Chang, YH; Chang, YW; Chao, Y; Chen, KF; Chen, PH; Dietz, C; Grundler, U; Hou, WS; Kao, KY; Liu, YF; Lu, RS; Majumder, D; Petrakou, E; Tzeng, YM; Wilken, R; Asavapibhop, B; Singh, G; Srimanobhas, N; Suwonjandee, N; Adiguzel, A; Bakirci, MN; Cerci, S; Dozen, C; Dumanoglu, I; Eskut, E; Girgis, S; Gokbulut, G; Gurpinar, E; Hos, I; Kangal, EE; Topaksu, AK; Onengut, G; Ozdemir, K; Ozturk, S; Polatoz, A; Cerci, DS; Tali, B; Topakli, H; Vergili, M; Akin, IV; Bilin, B; Bilmis, S; Gamsizkan, H; Isildak, B; Karapinar, G; Ocalan, K; Sekmen, S; Surat, UE; Yalvac, M; Zeyrek, M; Albayrak, EA; Gulmez, E; Kaya, M; Kaya, O; Yetkin, T; Cankocak, K; Vardarli, FI; Levchuk, L; Sorokin, P; Brooke, JJ; Clement, E; Cussans, D; Flacher, H; Goldstein, J; Grimes, M; Heath, GP; Heath, HF; Jacob, J; Kreczko, L; Lucas, C; Meng, Z; Newbold, DM; Paramesvaran, S; Poll, A; Sakuma, T; Senkin, S; Smith, VJ; Bell, KW; Belyaev, A; Brew, C; Brown, RM; Cockerill, DJA; Coughlan, JA; Harder, K; Harper, S; Olaiya, E; Petyt, D; Shepherd-Themistocleous, CH; Thea, A; Tomalin, IR; Williams, T; Womersley, WJ; Worm, SD; Baber, M; Bainbridge, R; Buchmuller, O; Burton, D; Colling, D; Cripps, N; Dauncey, P; Davies, G; Della Negra, M; Dunne, P; Ferguson, W; Fulcher, J; Futyan, D; Hall, G; Iles, G; Jarvis, M; Karapostoli, G; Kenzie, M; Lane, R; Lucas, R; Lyons, L; Magnan, AM; Malik, S; Mathias, B; Nash, J; Nikitenko, A; Pela, J; Pesaresi, M; Petridis, K; Raymond, DM; Rogerson, S; Rose, A; Seez, C; Sharp, P; Tapper, A; Acosta, MV; Virdee, T; Zenz, SC; Cole, JE; Hobson, PR; Khan, A; Kyberd, P; Leggat, D; Leslie, D; Reid, ID; Symonds, P; Teodorescu, L; Turner, M; Dittmann, J; Hatakeyama, K; Kasmi, A; Liu, H; Scarborough, T; Charaf, O; Cooper, SI; Henderson, C; Rumerio, P; Avetisyan, A; Bose, T; Fantasia, C; Lawson, P; Richardson, C; Rohlf, J; St John, J; Sulak, L; Alimena, J; Berry, E; Bhattacharya, S; Christopher, G; Cutts, D; Demiragli, Z; Dhingra, N; Ferapontov, A; Garabedian, A; Heintz, U; Kukartsev, G; Laird, E; Landsberg, G; Luk, M; Narain, M; Segala, M; Sinthuprasith, T; Speer, T; Swanson, J; Breedon, R; Breto, G; Sanchez, MCD; Chauhan, S; Chertok, M; Conway, J; Conway, R; Cox, PT; Erbacher, R; Gardner, M; Ko, W; Lander, R; Mulhearn, M; Pellett, D; Pilot, J; Ricci-Tam, F; Shalhout, S; Smith, J; Squires, M; Stolp, D; Tripathi, M; Wilbur, S; Yohay, R; Cousins, R; Everaerts, P; Farrell, C; Hauser, J; Ignatenko, M; Rakness, G; Takasugi, E; Valuev, V; Weber, M; Burt, K; Clare, R; Ellison, J; Gary, JW; Hanson, G; Heilman, J; Rikova, MI; Jandir, P; Kennedy, E; Lacroix, F; Long, OR; Luthra, A; Malberti, M; Negrete, MO; Shrinivas, A; Sumowidagdo, S; Wimpenny, S; Branson, JG; Cerati, GB; Cittolin, S; D'Agnolo, RT; Holzner, A; Kelley, R; Klein, D; Kovalskyi, D; Letts, J; Macneill, I; Olivito, D; Padhi, S; Palmer, C; Pieri, M; Sani, M; Sharma, V; Simon, S; Tu, Y; Vartak, A; Welke, C; Wurthwein, F; Yagil, A; Barge, D; Bradmiller-Feld, J; Campagnari, C; Danielson, T; Dishaw, A; Dutta, V; Flowers, K; Sevilla, MF; Geffert, P; George, C; Golf, F; Gouskos, L; Incandela, J; Justus, C; Mccoll, N; Richman, J; Stuart, D; To, W; West, C; Yoo, J; Apresyan, A; Bornheim, A; Bunn, J; Chen, Y; Duarte, J; Mott, A; Newman, HB; Pena, C; Pierini, M; Spiropulu, M; Vlimant, JR; Wilkinson, R; Xie, S; Zhu, RY; Azzolini, V; Calamba, A; Carlson, B; Ferguson, T; Iiyama, Y; Paulini, M; Russ, J; Vogel, H; Vorobiev, I; Cumalat, JP; Ford, WT; Gaz, A; Krohn, M; Lopez, EL; Nauenberg, U; Smith, JG; Stenson, K; Wagner, SR; Alexander, J; Chatterjee, A; Chaves, J; Chu, J; Dittmer, S; Eggert, N; Mirman, N; Kaufman, GN; Patterson, JR; Ryd, A; Salvati, E; Skinnari, L; Sun, W; Teo, WD; Thom, J; Thompson, J; Tucker, J; Weng, Y; Winstrom, L; Wittich, P; Winn, D; Abdullin, S; Albrow, M; Anderson, J; Apollinari, G; Bauerdick, LAT; Beretvas, A; Berryhill, J; Bhat, PC; Bolla, G; Burkett, K; Butler, JN; Cheung, HWK; Chlebana, F; Cihangir, S; Elvira, VD; Fisk, I; Freeman, J; Gao, Y; Gottschalk, E; Gray, L; Green, D; Gruenendahl, S; Gutsche, O; Hanlon, J; Hare, D; Harris, RM; Hirschauer, J; Hooberman, B; Jindariani, S; Johnson, M; Joshi, U; Kaadze, K; Klima, B; Kreis, B; Kwan, S; Linacre, J; Lincoln, D; Lipton, R; Liu, T; Lykken, J; Maeshima, K; Marraffino, JM; Outschoorn, VIM; Maruyama, S; Mason, D; McBride, P; Merkel, P; Mishra, K; Mrenna, S; Nahn, S; Newman-Holmes, C; O'Dell, V; Prokofyev, O; Sexton-Kennedy, E; Sharma, S; Soha, A; Spalding, WJ; Spiegel, L; Taylor, L; Tkaczyk, S; Tran, NV; Uplegger, L; Vaandering, EW; Vidal, R; Whitbeck, A; Whitmore, J; Yang, F; Acosta, D; Avery, P; Bortignon, P; Bourilkov, D; Carver, M; Curry, D; Das, S; De Gruttola, M; Di Giovanni, GP; Field, RD; Fisher, M; Furic, IK; Hugon, J; Konigsberg, J; Korytov, A; Kypreos, T; Low, JF; Matchev, K; Mei, H; Milenovic, P; Mitselmakher, G; Muniz, L; Rinkevicius, A; Shchutska, L; Snowball, M; Sperka, D; Yelton, J; Zakaria, M; Hewamanage, S; Linn, S; Markowitz, P; Martinez, G; Rodriguez, JL; Adams, T; Askew, A; Bochenek, J; Diamond, B; Haas, J; Hagopian, S; Hagopian, V; Johnson, KF; Prosper, H; Veeraraghavan, V; Weinberg, M; Baarmand, MM; Hohlmann, M; Kalakhety, H; Yumiceva, F; Adams, MR; Apanasevich, L; Berry, D; Betts, RR; Bucinskaite, I; Cavanaugh, R; Evdokimov, O; Gauthier, L; Gerber, CE; Hofman, DJ; Kurt, P; Moon, DH; O'Brien, C; Gonzalez, IDS; Silkworth, C; Turner, P; Varelas, N; Bilki, B; Clarida, W; Dilsiz, K; Haytmyradov, M; Merlo, JP; Mermerkaya, H; Mestvirishvili, A; Moeller, A; Nachtman, J; Ogul, H; Onel, Y; Ozok, F; Penzo, A; Rahmat, R; Sen, S; Tan, P; Tiras, E; Wetzel, J; Yi, K; Barnett, BA; Blumenfeld, B; Bolognesi, S; Fehling, D; Gritsan, AV; Maksimovic, P; Martin, C; Swartz, M; Baringer, P; Bean, A; Benelli, G; Bruner, C; Kenny, RP; Malek, M; Murray, M; Noonan, D; Sanders, S; Sekaric, J; Stringer, R; Wang, Q; Wood, JS; Chakaberia, I; Ivanov, A; Khalil, S; Makouski, M; Maravin, Y; Saini, LK; Skhirtladze, N; Svintradze, I; Gronberg, J; Lange, D; Rebassoo, F; Wright, D; Baden, A; Belloni, A; Calvert, B; Eno, SC; Gomez, JA; Hadley, NJ; Kellogg, RG; Kolberg, T; Lu, Y; Mignerey, AC; Pedro, K; Skuja, A; Tonjes, MB; Tonwar, SC; Apyan, A; Barbieri, R; Bauer, G; Busza, W; Cali, IA; Chan, M; Di Matteo, L; Ceballos, GG; Goncharov, M; Gulhan, D; Klute, M; Lai, YS; Lee, YJ; Levin, A; Luckey, PD; Ma, T; Paus, C; Ralph, D; Roland, C; Roland, G; Stephans, GSF; Sumorok, K; Velicanu, D; Veverka, J; Wyslouch, B; Yang, M; Zanetti, M; Zhukova, V; Dahmes, B; Gude, A; Kao, SC; Klapoetke, K; Kubota, Y; Mans, J; Pastika, N; Rusack, R; Singovsky, A; Tambe, N; Turkewitz, J; Acosta, JG; Oliveros, S; Avdeeva, E; Bloom, K; Bose, S; Claes, DR; Dominguez, A; Suarez, RG; Keller, J; Knowlton, D; Kravchenko, I; Lazo-Flores, J; Meier, F; Ratnikov, F; Snow, GR; Zvada, M; Dolen, J; Godshalk, A; Iashvili, I; Kharchilava, A; Kumar, A; Rappoccio, S; Alverson, G; Barberis, E; Baumgartel, D; Chasco, M; Massironi, A; Morse, DM; Nash, D; Orimoto, T; Trocino, D; Wang, RJ; Wood, D; Zhang, J; Hahn, KA; Kubik, A; Mucia, N; Odell, N; Pollack, B; Pozdnyakov, A; Schmitt, M; Stoynev, S; Sung, K; Velasco, M; Won, S; Brinkerhoff, A; Chan, KM; Drozdetskiy, A; Hildreth, M; Jessop, C; Karmgard, DJ; Kellams, N; Lannon, K; Lynch, S; Marinelli, N; Musienko, Y; Pearson, T; Planer, M; Ruchti, R; Smith, G; Valls, N; Wayne, M; Wolf, M; Woodard, A; Antonelli, L; Brinson, J; Bylsma, B; Durkin, LS; Flowers, S; Hart, A; Hill, C; Hughes, R; Kotov, K; Ling, TY; Luo, W; Puigh, D; Rodenburg, M; Winer, BL; Wolfe, H; Wulsin, HW; Driga, O; Elmer, P; Hardenbrook, J; Hebda, P; Hunt, A; Koay, SA; Lujan, P; Marlow, D; Medvedeva, T; Mooney, M; Olsen, J; Piroue, P; Quan, X; Saka, H; Stickland, D; Tully, C; Werner, JS; Zuranski, A; Brownson, E; Malik, S; Mendez, H; Vargas, JER; Barnes, VE; Benedetti, D; Bortoletto, D; De Mattia, M; Gutay, L; Hu, Z; Jha, MK; Jones, M; Jung, K; Kress, M; Leonardo, N; Miller, DH; Neumeister, N; Radburn-Smith, BC; Shi, X; Shipsey, I; Silvers, D; Svyatkovskiy, A; Wang, F; Xie, W; Xu, L; Zablocki, J; Parashar, N; Stupak, J; Adair, A; Akgun, B; Ecklund, KM; Geurts, FJM; Li, W; Michlin, B; Padley, BP; Redjimi, R; Roberts, J; Zabel, J; Betchart, B; Bodek, A; Covarelli, R; De Barbaro, P; Demina, R; Eshaq, Y; Ferbel, T; Garcia-Bellido, A; Goldenzweig, P; Han, J; Harel, A; Khukhunaishvili, A; Korjenevski, S; Petrillo, G; Vishnevskiy, D; Ciesielski, R; Demortier, L; Goulianos, K; Mesropian, C; Arora, S; Barker, A; Chou, JP; Contreras-Campana, C; Contreras-Campana, E; Duggan, D; Ferencek, D; Gershtein, Y; Gray, R; Halkiadakis, E; Hidas, D; Kaplan, S; Lath, A; Panwalkar, S; Park, M; Patel, R; Salur, S; Schnetzer, S; Somalwar, S; Stone, R; Thomas, S; Thomassen, P; Walker, M; Rose, K; Spanier, S; York, A; Bouhali, O; Hernandez, AC; Eusebi, R; Flanagan, W; Gilmore, J; Kamon, T; Khotilovich, V; Krutelyov, V; Montalvo, R; Osipenkov, I; Pakhotin, Y; Perloff, A; Roe, J; Rose, A; Safonov, A; Suarez, I; Tatarinov, A; Ulmer, KA; Akchurin, N; Cowden, C; Damgov, J; Dragoiu, C; Dudero, PR; Faulkner, J; Kovitanggoon, K; Kunori, S; Lee, SW; Libeiro, T; Volobouev, I; Appelt, E; Delannoy, AG; Greene, S; Gurrola, A; Johns, W; Maguire, C; Mao, Y; Melo, A; Sharma, M; Sheldon, P; Snook, B; Tuo, S; Velkovska, J; Arenton, MW; Boutle, S; Cox, B; Francis, B; Goodell, J; Hirosky, R; Ledovskoy, A; Li, H; Lin, C; Neu, C; Wood, J; Clarke, C; Harr, R; Karchin, PE; Don, CKK; Lamichhane, P; Sturdy, J; Belknap, DA; Carlsmith, D; Cepeda, M; Dasu, S; Dodd, L; Duric, S; Friis, E; Hall-Wilton, R; Herndon, M; Herve, A; Klabbers, P; Lanaro, A; Lazaridis, C; Levine, A; Loveless, R; Mohapatra, A; Ojalvo, I; Perry, T; Pierro, GA; Polese, G; Ross, I; Sarangi, T; Savin, A; Smith, WH; Taylor, D; Vuosalo, C; Woods, N; Bediaga, I; De Miranda, JM; Rodrigues, FF; Gomes, A; Massafferri, A; Dos Reis, AC; Rodrigues, AB; Amato, S; Akiba, KC; De Paula, L; Francisco, O; Gandelman, M; Hicheur, A; Lopes, JH; Tostes, DM; Nasteva, I; Goicochea, JMO; Polycarpo, E; Potterat, C; Rangel, MS; Guimaraes, VS; De Paula, BS; Vieira, D; An, L; Gao, Y; Jing, F; Li, Y; Yang, Z; Yuan, X; Zhang, Y; Zhong, L; Beaucourt, L; Chefdeville, M; Decamp, D; Deleage, N; Ghez, P; Lees, JP; Marchand, JF; Minard, MN; Pietrzyk, B; Qian, W; T'Jampens, S; Tisserand, V; Tournefier, E; Ajaltouni, Z; Baalouch, M; Cogneras, E; Deschamps, O; El Rifai, I; Gandara, MG; Henrard, P; Hoballah, M; Lefevre, R; Maratas, J; Monteil, S; Niess, V; Perret, P; Adrover, C; Akar, S; Aslanides, E; Cogan, J; Kanso, W; Le Gac, R; Leroy, O; Mancinelli, G; Morda, A; Perrin-Terrin, M; Serrano, J; Tsaregorodtsev, A; Amhis, Y; Barsuk, S; Borsato, M; Kochebina, O; Lefrancois, J; Machefert, F; Sanchez, AM; Nicol, M; Robbe, P; Schune, MH; Teklishyn, M; Vallier, A; Viaud, B; Wormser, G; Ben-Haim, E; Charles, M; Coquereau, S; David, P; Del Buono, L; Henry, L; Polci, F; Albrecht, J; Brambach, T; Cauet, C; Deckenhoff, M; Eitschberger, U; Ekelhof, R; Gavardi, L; Kruse, F; Meier, F; Niet, R; Parkinson, CJ; Schlupp, M; Shires, A; Spaan, B; Swientek, S; Wishahi, J; Gutierrez, OA; Blouw, J; Britsch, M; Fontana, M; Popov, D; Schmelling, M; Volyanskyy, D; Zavertyaev, M; Bachmann, S; Bien, A; Comerma-Montells, A; De Cian, M; Dordei, F; Esen, S; Farber, C; Gersabeck, E; Grillo, L; Han, X; Hansmann-Menzemer, S; Jaeger, A; Kolpin, M; Kreplin, K; Krocker, G; Leverington, B; Marks, J; Meissner, M; Neuner, M; Nikodem, T; Seyfert, P; Stahl, M; Stahl, S; Uwer, U; Vesterinen, M; Wandernoth, S; Wiedner, D; Zhelezov, A; McNulty, R; Wallace, R; Zhang, WC; Palano, A; Carbone, A; Falabella, A; Galli, D; Marconi, U; Moggi, N; Mussini, M; Perazzini, S; Vagnoni, V; Valenti, G; Zangoli, M; Bonivento, W; Cadeddu, S; Cardini, A; Cogoni, V; Contu, A; Lai, A; Liu, B; Manca, G; Oldeman, R; Saitta, B; Vacca, C; Andreotti, M; Baldini, W; Bozzi, C; Calabrese, R; Corvo, M; Fiore, M; Fiorini, M; Luppi, E; Pappalardo, LL; Shapoval, I; Tellarini, G; Tomassetti, L; Vecchi, S; Anderlini, L; Bizzeti, A; Frosini, M; Graziani, G; Passaleva, G; Veltri, M; Bencivenni, G; Campana, P; De Simone, P; Lanfranchi, G; Palutan, M; Rama, M; Sarti, A; Sciascia, B; Gomez, RV; Cardinale, R; Fontanelli, F; Gambetta, S; Patrignani, C; Petrolini, A; Pistone, A; Calvi, M; Cassina, L; Gotti, C; Khanji, B; Kucharczyk, M; Matteuzzi, C; Fu, J; Geraci, A; Neri, N; Palombo, F; Amerio, S; Collazuol, G; Gallorini, S; Gianelle, A; Lucchesi, D; Lupato, A; Morandin, M; Rotondo, M; Sestini, L; Simi, G; Stroili, R; Bedeschi, F; Cenci, R; Leo, S; Marino, P; Morello, MJ; Punzi, G; Stracka, S; Walsh, J; Carboni, G; Furfaro, E; Santovetti, E; Satta, A; Alves, AA; Auriemma, G; Bocci, V; Martellotti, G; Penso, G; Pinci, D; Santacesaria, R; Satriano, C; Sciubba, A; Dziurda, A; Kucewicz, W; Lesiak, T; Rachwal, B; Witek, M; Firlej, M; Fiutowski, T; Idzik, M; Morawski, P; Moron, J; Oblakowska-Mucha, A; Swientek, K; Szumlak, T; Batozskaya, V; Klimaszewski, K; Kurek, K; Szczekowski, M; Ukleja, A; Wislicki, W; Cojocariu, L; Giubega, L; Grecu, A; Maciuc, F; Orlandea, M; Popovici, B; Stoica, S; Straticiuc, M; Alkhazov, G; Bondar, N; Dzyuba, A; Maev, O; Sagidova, N; Shcheglov, Y; Vorobyev, A; Belogurov, S; Belyaev, I; Egorychev, V; Golubkov, D; Kvaratskheliya, T; Machikhiliyan, IV; Polyakov, I; Savrina, D; Semennikov, A; Zhokhov, A; Berezhnoy, A; Korolev, M; Leflat, A; Nikitin, N; Filippov, S; Gushchin, E; Kravchuk, L; Bondar, A; Eidelman, S; Krokovny, P; Kudryavtsev, V; Shekhtman, L; Vorobyev, V; Artamonov, A; Belous, K; Dzhelyadin, R; Guz, Y; Novoselov, A; Obraztsov, V; Popov, A; Romanovsky, V; Shapkin, M; Stenyakin, O; Yushchenko, O; Badalov, A; Gomez, MC; Garrido, L; Gascon, D; Diaz, RG; Grauges, E; Benito, CM; Olloqui, EP; Molina, VR; Ruiz, H; Vilasis-Cardona, X; Adeva, B; Cartelle, PA; Suarez, AD; Albor, VF; Torreira, AG; Pardinas, JG; Morata, JAH; Casasus, MP; Vidal, AR; Silva, JJS; Sedes, BS; Rios, CS; Regueiro, PV; Sierra, CV; Diaz, MV; Alessio, F; Archilli, F; Barschel, C; Benson, S; Buytaert, J; Perez, DC; Garcia, LC; Cattaneo, M; Charpentier, P; Vidal, XC; Clemencic, M; Closier, J; Coco, V; Collins, P; Corti, G; Couturier, B; D'Ambrosio, C; Dettori, F; Di Canto, A; Dijkstra, H; Durante, P; Ferro-Luzzi, M; Forty, R; Frank, M; Frei, C; Gaspar, C; Gligorov, VV; Cardoso, LAG; Gys, T; Haen, C; He, J; Head, T; van Herwijnen, E; Jacobsson, R; Johnson, D; Joram, C; Jost, B; Karacson, M; Karbach, TM; Lacarrere, D; Langhans, B; Lindner, R; Linn, C; Lohn, S; Mapelli, A; Matev, R; Mathe, Z; Neubert, S; Neufeld, N; Otto, A; Panman, J; Altarelli, MP; Rauschmayr, N; Rihl, M; Roiser, S; Ruf, T; Schindler, H; Schmidt, B; Schopper, A; Schwemmer, R; Sridharan, S; Stagni, F; Subbiah, VK; Teubert, F; Thomas, E; Tonelli, D; Trisovic, A; Garcia, MU; Wicht, J; Wyllie, K; Battista, V; Bay, A; Blanc, F; Dorigo, M; Dupertuis, F; Fitzpatrick, C; Giani, S; Haefeli, G; Jaton, P; Khurewathanakul, C; Komarov, I; La Thi, VN; Lopez-March, N; Marki, R; Martinelli, M; Muster, B; Nakada, T; Nguyen, AD; Nguyen, TD; Nguyen-Mau, C; Prisciandaro, J; Navarro, AP; Rakotomiaramanana, B; Rouvinet, J; Schneider, O; Soomro, F; Szczypka, P; Tobin, M; Tourneur, S; Tran, MT; Veneziano, G; Xu, Z; Anderson, J; Bernet, R; Bowen, E; Bursche, A; Chiapolini, N; Chrzaszcz, M; Elsasser, C; Graverini, E; Lionetto, F; Lowdon, P; Muller, K; Serra, N; Steinkamp, O; Storaci, B; Straumann, U; Tresch, M; Vollhardt, A; Aaij, R; Ali, S; Van Beuzekom, M; David, PNY; De Bruyn, K; Farinelli, C; Heijne, V; Hulsbergen, W; Jans, E; Koppenburg, P; Kozlinskiy, A; van Leerdam, J; Merk, M; Oggero, S; Pellegrino, A; Snoek, H; van Tilburg, J; Tsopelas, P; Tuning, N; de Vries, JA; Ketel, T; Koopman, RF; Lambert, RW; Santos, DM; Raven, G; Schiller, M; Syropoulos, V; Tolk, S; Dovbnya, A; Kandybei, S; Raniuk, I; Okhrimenko, O; Pugatch, V; Bifani, S; Farley, N; Griffith, P; Kenyon, IR; Lazzeroni, C; Mazurov, A; McCarthy, J; Pescatore, L; Watson, NK; Williams, MP; Adinolfi, M; Benton, J; Brook, NH; Cook, A; Coombes, M; Dalseno, J; Hampson, T; Harnew, ST; Naik, P; Price, E; Prouve, C; Rademacker, JH; Richards, S; Saunders, DM; Skidmore, N; Souza, D; Velthuis, JJ; Voong, D; Barter, W; Bettler, MO; Cliff, HV; Evans, HM; Tico, JG; Gibson, V; Gregson, S; Haines, SC; Jones, CR; Sirendi, M; Smith, J; Ward, DR; Wotton, SA; Wright, S; Back, JJ; Blake, T; Craik, DC; Crocombe, AC; Dossett, D; Gershon, T; Kreps, M; Langenbruch, C; Latham, T; O'Hanlon, DP; Pilar, T; Poluektov, A; Reid, MM; Coutinho, RS; Wallace, C; Whitehead, M; Easo, S; Nandakumar, R; Papanestis, A; Ricciardi, S; Wilson, FF; Carson, L; Clarke, PEL; Cowan, GA; Eisenhardt, S; Ferguson, D; Lambert, D; Luo, H; Morris, AB; Muheim, F; Needham, M; Playfer, S; Alexander, M; Beddow, J; Dean, CT; Eklund, L; Hynds, D; Karodia, S; Longstaff, I; Ogilvy, S; Pappagallo, M; Sail, P; Skillicorn, I; Soler, FJP; Spradlin, P; Affolder, A; Bowcock, TJV; Brown, H; Casse, G; Donleavy, S; Dreimanis, K; Farry, S; Fay, R; Hennessy, K; Hutchcroft, D; Liles, M; McSkelly, B; Patel, GD; Price, JD; Pritchard, A; Rinnert, K; Shears, T; Smith, NA; Ciezarek, G; Cunliffe, S; Currie, R; Egede, U; Fol, P; Golutvin, A; Hall, S; McCann, M; Owen, P; Patel, M; Petridis, K; Redi, F; Sepp, I; Smith, E; Sutcliffe, W; Websdale, D; Appleby, RB; Barlow, RJ; Bird, T; Bjomstad, PM; Borghi, S; Brett, D; Brodzicka, J; Capriotti, L; Chen, S; De Capua, S; Dujany, G; Gersabeck, M; Harrison, J; Hombach, C; Klaver, S; Lafferty, G; McNab, A; Parkes, C; Pearce, A; Reichert, S; Rodrigues, E; Perez, PR; Smith, M; Cheung, SF; Derkach, D; Evans, T; Gauld, R; Greening, E; Harnew, N; Hill, D; Hunt, P; Hussain, N; Jalocha, J; John, M; Lupton, O; Malde, S; Smith, E; Stevenson, S; Thomas, C; Topp-Joergensen, S; Torr, N; Wilkinson, G; Counts, I; Ilten, P; Williams, M; Andreassen, R; Davis, A; De Silva, W; Meadows, B; Sokoloff, MD; Sun, L; Todd, J; Andrews, JE; Hamilton, B; Jawahery, A; Wimberley, J; Artuso, M; Blusk, S; Borgia, A; Britton, T; Ely, S; Gandini, P; Garofoli, J; Gui, B; Hadjivasiliou, C; Jurik, N; Kelsey, M; Mountain, R; Pal, BK; Skwarnicki, T; Stone, S; Wang, J; Xing, Z; Zhang, L; Baesso, C; Torres, MC; Gobel, C; Rodriguez, JM; Xie, Y; Milanes, DA; Grunberg, O; Hess, M; Voss, C; Waldi, R; Likhomanenko, T; Malinin, A; Shevchenko, V; Ustyuzhanin, A; Vidal, FM; Oyanguren, A; Valls, PR; Mayordomo, CS; Onderwater, CJG; Wilschut, HW; Pesen, E				Khachatryan, V.; Sirunyan, A. M.; Tumasyan, A.; Adam, W.; Bergauer, T.; Dragicevic, M.; Eroe, J.; Friedl, M.; Fruehwirth, R.; Ghete, V. M.; Hartl, C.; Hoermann, N.; Hrubec, J.; Jeitler, M.; Kiesenhofer, W.; Knuenz, V.; Krammer, M.; Kraetschmer, I.; Liko, D.; Mikulec, I.; Rabady, D.; Rahbaran, B.; Rohringer, H.; Schoefbeck, R.; Strauss, J.; Treberer-Treberspurg, W.; Waltenberger, W.; Wulz, C-E.; Mossolov, V.; Shumeiko, N.; Suarez Gonzalez, J.; Alderweireldt, S.; Bansal, S.; Cornelis, T.; De Wolf, E. A.; Janssen, X.; Knutsson, A.; Lauwers, J.; Luyckx, S.; Ochesanu, S.; Rougny, R.; Van De Klundert, M.; Van Haevermaet, H.; Van Mechelen, P.; Van Remortel, N.; Van Spilbeeck, A.; Blekman, F.; Blyweert, S.; D'Hondt, J.; Daci, N.; Heracleous, N.; Keaveney, J.; Lowette, S.; Maes, M.; Olbrechts, A.; Python, Q.; Strom, D.; Tavernier, S.; Van Doninck, W.; Van Mulders, P.; Van Onsem, G. P.; Villella, I.; Caillol, C.; Clerbaux, B.; De Lentdecker, G.; Dobur, D.; Favart, L.; Gay, A. P. R.; Grebenyuk, A.; Leonard, A.; Mohammadi, A.; Pernie, L.; Randle-Conde, A.; Reis, T.; Seva, T.; Thomas, L.; Vander Velde, C.; Vanlaer, P.; Wang, J.; Zenoni, F.; Adler, V.; Beernaert, K.; Benucci, L.; Cimmino, A.; Costantini, S.; Crucy, S.; Dildick, S.; Fagot, A.; Garcia, G.; Mccartin, J.; Ocampo Rios, A. A.; Ryckbosch, D.; Diblen, S. Salva; Sigamani, M.; Strobbe, N.; Thyssen, F.; Tytgat, M.; Yazgan, E.; Zaganidis, N.; Basegmez, S.; Beluffi, C.; Bruno, G.; Castello, R.; Caudron, A.; Ceard, L.; Da Silveira, G. G.; Delaere, C.; du Pree, T.; Favart, D.; Forthomme, L.; Giammanco, A.; Hollar, J.; Jafari, A.; Jez, P.; Komm, M.; Lemaitre, V.; Nuttens, C.; Pagano, D.; Perrini, L.; Pin, A.; Piotrzkowski, K.; Popov, A.; Quertenmont, L.; Selvaggi, M.; Marono, M. Vidal; Garcia, J. M. Vizan; Beliy, N.; Caebergs, T.; Daubie, E.; Hammad, G. H.; Alda Junior, W. L.; Alves, G. A.; Brito, L.; Correa Martins Junior, M.; Dos Reis Martins, T.; Mora Herrera, C.; Pol, M. E.; Rebello Teles, P.; Carvalho, W.; Chinellato, J.; Custodio, A.; Da Costa, E. M.; De Jesus Damiao, D.; De Oliveira Martins, C.; Fonseca De Souza, S.; Malbouisson, H.; Matos Figueiredo, D.; Mundim, L.; Nogima, H.; Prado Da Silva, W. L.; Santaolalla, J.; Santoro, A.; Sznajder, A.; Tonelli Manganote, E. J.; Vilela Pereira, A.; Bernardes, C. A.; Dogra, S.; Fernandez Perez Tomei, T. R.; Gregores, E. M.; Mercadante, P. G.; Novaes, S. F.; Padula, Sandra S.; Aleksandrov, A.; Genchev, V.; Hadjiiska, R.; Iaydjiev, P.; Marinov, A.; Piperov, S.; Rodozov, M.; Sultanov, G.; Vutova, M.; Dimitrov, A.; Glushkov, I.; Litov, L.; Pavlov, B.; Petkov, P.; Bian, J. G.; Chen, G. M.; Chen, H. S.; Chen, M.; Cheng, T.; Du, R.; Jiang, C. H.; Plestina, R.; Romeo, F.; Tao, J.; Wang, Z.; Asawatangtrakuldee, C.; Ban, Y.; Li, Q.; Liu, S.; Mao, Y.; Qian, S. J.; Wang, D.; Xu, Z.; Zou, W.; Avila, C.; Cabrera, A.; Chaparro Sierra, L. F.; Florez, C.; Gomez, J. P.; Gomez Moreno, B.; Sanabria, J. C.; Godinovic, N.; Lelas, D.; Polic, D.; Puljak, I.; Antunovic, Z.; Kovac, M.; Brigljevic, V.; Kadija, K.; Luetic, J.; Mekterovic, D.; Sudic, L.; Attikis, A.; Mavromanolakis, G.; Mousa, J.; Nicolaou, C.; Ptochos, F.; Razis, P. A.; Bodlak, M.; Finger, M.; Finger, M., Jr.; Assran, Y.; Ellithi Kamel, A.; Mahmoud, M. A.; Radi, A.; Kadastik, M.; Murumaa, M.; Raidal, M.; Tiko, A.; Eerola, P.; Fedi, G.; Voutilainen, M.; Harkonen, J.; Karimaki, V.; Kinnunen, R.; Kortelainen, M. J.; Lampen, T.; Lassila-Perini, K.; Lehti, S.; Linden, T.; Luukka, P.; Maenpaa, T.; Peltola, T.; Tuominen, E.; Tuominiemi, J.; Tuovinen, E.; Wendland, L.; Talvitie, J.; Tuuva, T.; Besancon, M.; Couderc, F.; Dejardin, M.; Denegri, D.; Fabbro, B.; Faure, J. L.; Favaro, C.; Ferri, F.; Ganjour, S.; Givernaud, A.; Gras, P.; Hamel de Monchenault, G.; Jarry, P.; Locci, E.; Malcles, J.; Rander, J.; Rosowsky, A.; Titov, M.; Baffioni, S.; Beaudette, F.; Busson, P.; Charlot, C.; Dahms, T.; Dalchenko, M.; Dobrzynski, L.; Filipovic, N.; Florent, A.; Granier de Cassagnac, R.; Mastrolorenzo, L.; Mine, P.; Mironov, C.; Naranjo, I. N.; Nguyen, M.; Ochando, C.; Ortona, G.; Paganini, P.; Regnard, S.; Salerno, R.; Sauvan, J. B.; Sirois, Y.; Veelken, C.; Yilmaz, Y.; Zabi, A.; Agram, J-L; Andrea, J.; Aubin, A.; Bloch, D.; Brom, J-M.; Chabert, E. C.; Collard, C.; Conte, E.; Fontaine, J-C.; Gele, D.; Goerlach, U.; Goetzmann, C.; Le Bihan, A-C.; Skovpen, K.; Van Hove, P.; Gadrat, S.; Beauceron, S.; Beaupere, N.; Boudoul, G.; Bouvier, E.; Brochet, S.; Carrillo Montoya, C. A.; Chasserat, J.; Chierici, R.; Contardo, D.; Depasse, P.; El Mamouni, H.; Fan, J.; Fay, J.; Gascon, S.; Gouzevitch, M.; Ille, B.; Kurca, T.; Lethuillier, M.; Mirabito, L.; Perries, S.; Ruiz Alvarez, J. D.; Sabes, D.; Sgandurra, L.; Sordini, V.; Vander Donckt, M.; Verdier, P.; Viret, S.; Xiao, H.; Tsamalaidze, Z.; Autermann, C.; Beranek, S.; Bontenackels, M.; Edelhoff, M.; Feld, L.; Heister, A.; Hindrichs, O.; Klein, K.; Ostapchuk, A.; Raupach, F.; Sammet, J.; Schael, S.; Schulte, J. F.; Weber, H.; Wittmer, B.; Zhukov, V.; Ata, M.; Brodski, M.; Dietz-Laursonn, E.; Duchardt, D.; Erdmann, M.; Fischer, R.; Gueth, A.; Hebbeker, T.; Heidemann, C.; Hoepfner, K.; Klingebiel, D.; Knutzen, S.; Kreuzer, P.; Merschmeyer, M.; Meyer, A.; Millet, P.; Olschewski, M.; Padeken, K.; Papacz, P.; Reithler, H.; Schmitz, S. A.; Sonnenschein, L.; Teyssier, D.; Thueer, S.; Weber, M.; Cherepanov, V.; Erdogan, Y.; Fluegge, G.; Geenen, H.; Geisler, M.; Ahmad, W. Haj; Hoehle, F.; Kargoll, B.; Kress, T.; Kuessel, Y.; Kuensken, A.; Lingemann, J.; Nowack, A.; Nugent, I. M.; Pooth, O.; Stahl, A.; Martin, M. Aldaya; Asin, I.; Bartosik, N.; Behr, J.; Behrens, U.; Bell, A. J.; Bethani, A.; Borras, K.; Burgmeier, A.; Cakir, A.; Calligaris, L.; Campbell, A.; Choudhury, S.; Costanza, F.; Pardos, C. Diez; Dolinska, G.; Dooling, S.; Dorland, T.; Eckerlin, G.; Eckstein, D.; Eichhorn, T.; Flucke, G.; Garcia, J. Garay; Geiser, A.; Gunnellini, P.; Hauk, J.; Hempel, M.; Jung, H.; Kalogeropoulos, A.; Kasemann, M.; Katsas, P.; Kieseler, J.; Kleinwort, C.; Korol, I.; Kruecker, D.; Lange, W.; Leonard, J.; Lipka, K.; Lobanov, A.; Lohmann, W.; Lutz, B.; Mankel, R.; Marfin, I.; Melzer-Pellmann, I-A.; Meyer, A. B.; Mittag, G.; Mnich, J.; Mussgiller, A.; Naumann-Emme, S.; Nayak, A.; Ntomari, E.; Perrey, H.; Pitzl, D.; Placakyte, R.; Raspereza, A.; Ribeiro Cipriano, P. M.; Roland, B.; Ron, E.; Sahin, M. Oe; Salfeld-Nebgen, J.; Saxena, P.; Schoerner-Sadenius, T.; Schroeder, M.; Seitz, C.; Spannagel, S.; Vargas Trevino, A. D. R.; Walsh, R.; Wissing, C.; Blobel, V.; Centis Vignali, M.; Draeger, A. R.; Erfle, J.; Garutti, E.; Goebel, K.; Goerner, M.; Haller, J.; Hoffmann, M.; Hoeing, R. S.; Junkes, A.; Kirschenmann, H.; Klanner, R.; Kogler, R.; Lange, J.; Lapsien, T.; Lenz, T.; Marchesini, I.; Ott, J.; Peiffer, T.; Perieanu, A.; Pietsch, N.; Poehlsen, J.; Poehlsen, T.; Rathjens, D.; Sander, C.; Schettler, H.; Schleper, P.; Schlieckau, E.; Schmidt, A.; Seidel, M.; Sola, V.; Stadie, H.; Steinbrueck, G.; Troendle, D.; Usai, E.; Vanelderen, L.; Vanhoefer, A.; Barth, C.; Baus, C.; Berger, J.; Boeser, C.; Butz, E.; Chwalek, T.; De Boer, W.; Descroix, A.; Dierlamm, A.; Feindt, M.; Frensch, F.; Giffels, M.; Gilbert, A.; Hartmann, F.; Hauth, T.; Husemann, U.; Katkov, I.; Kornmayer, A.; Kuznetsova, E.; Pardo, P. Lobelle; Mozer, M. U.; Mueller, T.; Mueller, Th.; Nuernberg, A.; Quast, G.; Rabbertz, K.; Roecker, S.; Simonis, H. J.; Stober, F. M.; Ulrich, R.; Wagner-Kuhr, J.; Wayand, S.; Weiler, T.; Wolf, R.; Anagnostou, G.; Daskalakis, G.; Geralis, T.; Giakoumopoulou, V. A.; Kyriakis, A.; Loukas, D.; Markou, A.; Markou, C.; Psallidas, A.; Topsis-Giotis, I.; Agapitos, A.; Kesisoglou, S.; Panagiotou, A.; Saoulidou, N.; Stiliaris, E.; Aslanoglou, X.; Evangelou, I.; Flouris, G.; Foudas, C.; Kokkas, P.; Manthos, N.; Papadopoulos, I.; Paradas, E.; Strologas, J.; Bencze, G.; Hajdu, C.; Hidas, P.; Horvath, D.; Sikler, F.; Veszpremi, V.; Vesztergombi, G.; Zsigmond, A. J.; Beni, N.; Czellar, S.; Karancsi, J.; Molnar, J.; Palinkas, J.; Szillasi, Z.; Makovec, A.; Raics, P.; Trocsanyi, Z. L.; Ujvari, B.; Sahoo, N.; Swain, S. K.; Beri, S. B.; Bhatnagar, V.; Gupta, R.; Bhawandeep, U.; Kalsi, A. K.; Kaur, M.; Kumar, R.; Mittal, M.; Nishu, N.; Singh, J. B.; Kumar, Ashok; Kumar, Arun; Ahuja, S.; Bhardwaj, A.; Choudhary, B. C.; Kumar, A.; Malhotra, S.; Naimuddin, M.; Ranjan, K.; Sharma, V.; Banerjee, S.; Bhattacharya, S.; Chatterjee, K.; Dutta, S.; Gomber, B.; Jain, Sa.; Jain, Sh.; Khurana, R.; Modak, A.; Mukherjee, S.; Roy, D.; Sarkar, S.; Sharan, M.; Abdulsalam, A.; Dutta, D.; Kailas, S.; Kumar, V.; Mohanty, A. K.; Pant, L. M.; Shukla, P.; Topkar, A.; Aziz, T.; Banerjee, S.; Bhowmik, S.; Chatterjee, R. M.; Dewanjee, R. K.; Dugad, S.; Ganguly, S.; Ghosh, S.; Guchait, M.; Gurtu, A.; Kole, G.; Kumar, S.; Maity, M.; Majumder, G.; Mazumdar, K.; Mohanty, G. B.; Parida, B.; Sudhakar, K.; Wickramage, N.; Bakhshiansohi, H.; Behnamian, H.; Etesami, S. M.; Fahim, A.; Goldouzian, R.; Khakzad, M.; Najafabadi, M. Mohammadi; Naseri, M.; Mehdiabadi, S. Paktinat; Hosseinabadi, F. Rezaei; Safarzadeh, B.; Zeinali, M.; Felcini, M.; Grunewald, M.; Abbrescia, M.; Calabria, C.; Chhibra, S. S.; Colaleo, A.; Creanza, D.; De Filippis, N.; De Palma, M.; Fiore, L.; Iaselli, G.; Maggi, G.; Maggi, M.; My, S.; Nuzzo, S.; Pompili, A.; Pugliese, G.; Radogna, R.; Selvaggi, G.; Sharma, A.; Silvestris, L.; Venditti, R.; Verwilligen, P.; Abbiendi, G.; Benvenuti, A. C.; Bonacorsi, D.; Braibant-Giacomelli, S.; Brigliadori, L.; Campanini, R.; Capiluppi, P.; Castro, A.; Cavallo, F. R.; Codispoti, G.; Cuffiani, M.; Dallavalle, G. M.; Fabbri, F.; Fanfani, A.; Fasanella, D.; Giacomelli, P.; Grandi, C.; Guiducci, L.; Marcellini, S.; Masetti, G.; Montanari, A.; Navarria, F. L.; Perrotta, A.; Primavera, F.; Rossi, A. M.; Rovelli, T.; Siroli, G. P.; Tosi, N.; Travaglini, R.; Albergo, S.; Cappello, G.; Chiorboli, M.; Costa, S.; Giordano, F.; Potenza, R.; Tricomi, A.; Tuve, C.; Barbagli, G.; Ciulli, V.; Civinini, C.; D'Alessandro, R.; Focardi, E.; Gallo, E.; Gonzi, S.; Gori, V.; Lenzi, P.; Meschini, M.; Paoletti, S.; Sguazzoni, G.; Tropiano, A.; Benussi, L.; Bianco, S.; Fabbri, F.; Piccolo, D.; Ferretti, R.; Ferro, F.; Lo Vetere, M.; Robutti, E.; Tosi, S.; Dinardo, M. E.; Fiorendi, S.; Gennai, S.; Gerosa, R.; Ghezzi, A.; Govoni, P.; Lucchini, M. T.; Malvezzi, S.; Manzoni, R. A.; Martelli, A.; Marzocchi, B.; Menasce, D.; Moroni, L.; Paganoni, M.; Pedrini, D.; Ragazzi, S.; Redaelli, N.; Tabarelli de Fatis, T.; Buontempo, S.; Cavallo, N.; Di Guida, S.; Fabozzi, F.; Iorio, A. O. M.; Lista, L.; Meola, S.; Merola, M.; Paolucci, P.; Azzi, P.; Bacchetta, N.; Bisello, D.; Branca, A.; Carlin, R.; Checchia, P.; Dall'Osso, M.; Dorigo, T.; Dosselli, U.; Gasparini, F.; Gasparini, U.; Giubilato, P.; Gozzelino, A.; Kanishchev, K.; Lacaprara, S.; Margoni, M.; Meneguzzo, A. T.; Pazzini, J.; Pozzobon, N.; Ronchese, P.; Simonetto, F.; Torassa, E.; Tosi, M.; Zotto, P.; Zucchetta, A.; Zumerle, G.; Gabusi, M.; Ratti, S. P.; Re, V.; Riccardi, C.; Salvini, P.; Vitulo, P.; Biasini, M.; Bilei, G. M.; Ciangottini, D.; Fano, L.; Lariccia, P.; Mantovani, G.; Menichelli, M.; Saha, A.; Santocchia, A.; Spiezia, A.; Androsov, K.; Azzurri, P.; Bagliesi, G.; Bernardini, J.; Boccali, T.; Broccolo, G.; Castaldi, R.; Ciocci, M. A.; Dell'Orso, R.; Donato, S.; Fiori, F.; Foa, L.; Giassi, A.; Grippo, M. T.; Ligabue, F.; Lomtadze, T.; Martini, L.; Messineo, A.; Moon, C. S.; Palla, F.; Rizzi, A.; Savoy-Navarro, A.; Serban, A. T.; Spagnolo, P.; Squillacioti, P.; Tenchini, R.; Tonelli, G.; Venturi, A.; Verdini, P. G.; Vernieri, C.; Barone, L.; Cavallari, F.; D'imperio, G.; Del Re, D.; Diemoz, M.; Jorda, C.; Longo, E.; Margaroli, F.; Meridiani, P. M.; Micheli, F.; Nourbakhsh, S.; Organtini, G.; Paramatti, R.; Rahatlou, S.; Rovelli, C.; Santanastasio, F.; Soffi, L.; Traczyk, P.; Amapane, N.; Arcidiacono, R.; Argiro, S.; Arneodo, M.; Bellan, R.; Biino, C.; Cartiglia, N.; Casasso, S.; Costa, M.; Degano, A.; Demaria, N.; Finco, L.; Mariotti, C.; Maselli, S.; Migliore, E.; Monaco, V.; Musich, M.; Obertino, M. M.; Pacher, L.; Pastrone, N.; Pelliccioni, M.; Angioni, G. L. Pinna; Potenza, A.; Romero, A.; Ruspa, M.; Sacchi, R.; Solano, A.; Staiano, A.; Tamponi, U.; Belforte, S.; Candelise, V.; Casarsa, M.; Cossutti, F.; Della Ricca, G.; Gobbo, B.; La Licata, C.; Marone, M.; Schizzi, A.; Umer, T.; Zanetti, A.; Chang, S.; Kropivnitskaya, A.; Nam, S. K.; Kim, D. H.; Kim, G. N.; Kim, M. S.; Kong, D. J.; Lee, S.; Oh, Y. D.; Park, H.; Sakharov, A.; Son, D. C.; Kim, T. J.; Kim, J. Y.; Song, S.; Choi, S.; Gyun, D.; Hong, B.; Jo, M.; Kim, H.; Kim, Y.; Lee, B.; Lee, K. S.; Park, S. K.; Roh, Y.; Yoo, H. D.; Choi, M.; Kim, J. H.; Park, I. C.; Ryu, G.; Ryu, M. S.; Choi, Y.; Choi, Y. K.; Goh, J.; Kim, D.; Kwon, E.; Lee, J.; Yu, I.; Juodagalvis, A.; Komaragiri, J. R.; Ali, M. A. B. Md; Linares, E. Casimiro; Castilla-Valdez, H.; De La Cruz-Burelo, E.; Heredia-de la Cruz, I.; Hernandez-Almada, A.; Lopez-Fernandez, R.; Sanchez-Hernandez, A.; Carrillo Moreno, S.; Vazquez Valencia, F.; Pedraza, I.; Salazar Ibarguen, H. A.; Morelos Pineda, A.; Krofcheck, D.; Butler, P. H.; Reucroft, S.; Ahmad, A.; Ahmad, M.; Hassan, Q.; Hoorani, H. R.; Khan, W. A.; Khurshid, T.; Shoaib, M.; Bialkowska, H.; Bluj, M.; Boimska, B.; Frueboes, T.; Gorski, M.; Kazana, M.; Nawrocki, K.; Romanowska-Rybinska, K.; Szleper, M.; Zalewski, P.; Brona, G.; Bunkowski, K.; Cwiok, M.; Dominik, W.; Doroba, K.; Kalinowski, A.; Konecki, M.; Krolikowski, J.; Misiura, M.; Olszewski, M.; Wolszczak, W.; Bargassa, P.; Beirao Da Cruz E Silva, C.; Faccioli, P.; Ferreira Parracho, P. G.; Gallinaro, M.; Lloret Iglesias, L.; Nguyen, F.; Rodrigues Antunes, J.; Seixas, J.; Varela, J.; Vischia, P.; Afanasiev, S.; Bunin, P.; Gavrilenko, M.; Golutvin, I.; Gorbunov, I.; Kamenev, A.; Karjavin, V.; Konoplyanikov, V.; Lanev, A.; Malakhov, A.; Matveev, V.; Moisenz, P.; Palichik, V.; Perelygin, V.; Shmatov, S.; Skatchkov, N.; Smirnov, V.; Zarubin, A.; Golovtsov, V.; Ivanov, Y.; Kim, V.; Levchenko, P.; Murzin, V.; Oreshkin, V.; Smirnov, I.; Sulimov, V.; Uvarov, L.; Vavilov, S.; Vorobyev, A.; Vorobyev, An.; Andreev, Yu.; Dermenev, A.; Gninenko, S.; Golubev, N.; Kirsanov, M.; Krasnikov, N.; Pashenkov, A.; Tlisov, D.; Toropin, A.; Epshteyn, V.; Gavrilov, V.; Lychkovskaya, N.; Popov, V.; Pozdnyakov, I.; Safronov, G.; Semenov, S.; Spiridonov, A.; Stolin, V.; Vlasov, E.; Zhokin, A.; Andreev, V.; Azarkin, M.; Dremin, I.; Kirakosyan, M.; Leonidov, A.; Mesyats, G.; Rusakov, S. V.; Vinogradov, A.; Belyaev, A.; Boos, E.; Dubinin, M.; Dudko, L.; Ershov, A.; Gribushin, A.; Klyukhin, V.; Kodolova, O.; Lokhtin, I.; Obraztsov, S.; Petrushanko, S.; Savrin, V.; Snigirev, A.; Azhgirey, I.; Bayshev, I.; Bitioukov, S.; Kachanov, V.; Kalinin, A.; Konstantinov, D.; Krychkine, V.; Petrov, V.; Ryutin, R.; Sobol, A.; Tourtchanovitch, L.; Troshin, S.; Tyurin, N.; Uzunian, A.; Volkov, A.; Adzic, P.; Ekmedzic, M.; Milosevic, J.; Rekovic, V.; Alcaraz Maestre, J.; Battilana, C.; Calvo, E.; Cerrada, M.; Llatas, M. Chamizo; Colino, N.; De La Cruz, B.; Delgado Peris, A.; Dominguez Vazquez, D.; Escalante Del Valle, A.; Fernandez Bedoya, C.; Fernandez Ramos, J. P.; Flix, J.; Fouz, M. C.; Garcia-Abia, P.; Gonzalez Lopez, O.; Goy Lopez, S.; Hernandez, J. M.; Josa, M. I.; Navarro De Martino, E.; Perez-Calero Yzquierdo, A.; Puerta Pelayo, J.; Quintario Olmeda, A.; Redondo, I.; Romero, L.; Soares, M. S.; Albajar, C.; de Troconiz, J. F.; Missiroli, M.; Moran, D.; Brun, H.; Cuevas, J.; Menendez, J. Fernandez; Folgueras, S.; Gonzalez Caballero, I.; Brochero Cifuentes, J. A.; Cabrillo, I. J.; Calderon, A.; Duarte Campderros, J.; Fernandez, M.; Gomez, G.; Graziano, A.; Lopez Virto, A.; Marco, J.; Marco, R.; Martinez Rivero, C.; Matorras, F.; Munoz Sanchez, F. J.; Piedra Gomez, J.; Rodrigo, T.; Rodriguez-Marrero, A. Y.; Ruiz-Jimeno, A.; Scodellaro, L.; Vila, I.; Vilar Cortabitarte, R.; Abbaneo, D.; Auffray, E.; Auzinger, G.; Bachtis, M.; Baillon, P.; Ball, A. H.; Barney, D.; Benaglia, A.; Bendavid, J.; Benhabib, L.; Benitez, J. F.; Bernet, C.; Bloch, P.; Bocci, A.; Bonato, A.; Bondu, O.; Botta, C.; Breuker, H.; Camporesi, T.; Cerminara, G.; Colafranceschi, S.; D'Alfonso, M.; d'Enterria, D.; Dabrowski, A.; David, A.; De Guio, F.; De Roeck, A.; De Visscher, S.; Di Marco, E.; Dobson, M.; Dordevic, M.; Dupont-Sagorin, N.; Elliott-Peisert, A.; Franzoni, G.; Funk, W.; Gigi, D.; Gill, K.; Giordano, D.; Girone, M.; Glege, F.; Guida, R.; Gundacker, S.; Guthoff, M.; Hammer, J.; Hansen, M.; Harris, P.; Hegeman, J.; Innocente, V.; Janot, P.; Kousouris, K.; Krajczar, K.; Lecoq, P.; Loureno, C.; Magini, N.; Malgeri, L.; Mannelli, M.; Marrouche, J.; Masetti, L.; Meijers, F.; Mersi, S.; Meschi, E.; Moortgat, F.; Morovic, S.; Mulders, M.; Orsini, L.; Pape, L.; Perez, E.; Perrozzi, L.; Petrilli, A.; Petrucciani, G.; Pfeiffer, A.; Pimiae, M.; Piparo, D.; Plagge, M.; Racz, A.; Rolandi, G.; Rovere, M.; Sakulin, H.; Schaefer, C.; Schwick, C.; Sharma, A.; Siegrist, P.; Silva, P.; Simon, M.; Sphicas, P.; Spiga, D.; Steggemann, J.; Stieger, B.; Stoye, M.; Takahashi, Y.; Treille, D.; Tsirou, A.; Veres, G. I.; Wardle, N.; Woehri, H. K.; Wollny, H.; Zeuner, W. D.; Bertl, W.; Deiters, K.; Erdmann, W.; Horisberger, R.; Ingram, Q.; Kaestli, H. C.; Kotlinski, D.; Renker, D.; Rohe, T.; Bachmair, F.; Baeni, L.; Bianchini, L.; Buchmann, M. A.; Casal, B.; Chanon, N.; Dissertori, G.; Dittmar, M.; Donega, M.; Duenser, M.; Eller, P.; Grab, C.; Hits, D.; Hoss, J.; Lustermann, W.; Mangano, B.; Marini, A. C.; Marionneau, M.; Martinez Ruiz del Arbol, P.; Masciovecchio, M.; Meister, D.; Mohr, N.; Musella, P.; Naegeli, C.; Nessi-Tedaldi, F.; Pandolfi, F.; Pauss, F.; Peruzzi, M.; Quittnat, M.; Rebane, L.; Rossini, M.; Starodumov, A.; Takahashi, M.; Theofilatos, K.; Wallny, R.; Weber, H. A.; Amsler, C.; Canelli, M. F.; Chiochia, V.; De Cosa, A.; Hinzmann, A.; Hreus, T.; Kilminster, B.; Lange, C.; Millan Mejias, B.; Ngadiuba, J.; Pinna, D.; Robmann, P.; Ronga, F. J.; Taroni, S.; Verzetti, M.; Yang, Y.; Cardaci, M.; Chen, K. H.; Ferro, C.; Kuo, C. M.; Lin, W.; Lu, Y. J.; Volpe, R.; Yu, S. S.; Chang, P.; Chang, Y. H.; Chang, Y. W.; Chao, Y.; Chen, K. F.; Chen, P. H.; Dietz, C.; Grundler, U.; Hou, W-S.; Kao, K. Y.; Liu, Y. F.; Lu, R-S.; Majumder, D.; Petrakou, E.; Tzeng, Y. M.; Wilken, R.; Asavapibhop, B.; Singh, G.; Srimanobhas, N.; Suwonjandee, N.; Adiguzel, A.; Bakirci, M. N.; Cerci, S.; Dozen, C.; Dumanoglu, I.; Eskut, E.; Girgis, S.; Gokbulut, G.; Gurpinar, E.; Hos, I.; Kangal, E. E.; Topaksu, A. Kayis; Onengut, G.; Ozdemir, K.; Ozturk, S.; Polatoz, A.; Cerci, D. Sunar; Tali, B.; Topakli, H.; Vergili, M.; Akin, I. V.; Bilin, B.; Bilmis, S.; Gamsizkan, H.; Isildak, B.; Karapinar, G.; Ocalan, K.; Sekmen, S.; Surat, U. E.; Yalvac, M.; Zeyrek, M.; Albayrak, E. A.; Guelmez, E.; Kaya, M.; Kaya, O.; Yetkin, T.; Cankocak, K.; Vardarli, F. I.; Levchuk, L.; Sorokin, P.; Brooke, J. J.; Clement, E.; Cussans, D.; Flacher, H.; Goldstein, J.; Grimes, M.; Heath, G. P.; Heath, H. F.; Jacob, J.; Kreczko, L.; Lucas, C.; Meng, Z.; Newbold, D. M.; Paramesvaran, S.; Poll, A.; Sakuma, T.; Senkin, S.; Smith, V. J.; Bell, K. W.; Belyaev, A.; Brew, C.; Brown, R. M.; Cockerill, D. J. A.; Coughlan, J. A.; Harder, K.; Harper, S.; Olaiya, E.; Petyt, D.; Shepherd-Themistocleous, C. H.; Thea, A.; Tomalin, I. R.; Williams, T.; Womersley, W. J.; Worm, S. D.; Baber, M.; Bainbridge, R.; Buchmuller, O.; Burton, D.; Colling, D.; Cripps, N.; Dauncey, P.; Davies, G.; Della Negra, M.; Dunne, P.; Ferguson, W.; Fulcher, J.; Futyan, D.; Hall, G.; Iles, G.; Jarvis, M.; Karapostoli, G.; Kenzie, M.; Lane, R.; Lucas, R.; Lyons, L.; Magnan, A-M.; Malik, S.; Mathias, B.; Nash, J.; Nikitenko, A.; Pela, J.; Pesaresi, M.; Petridis, K.; Raymond, D. M.; Rogerson, S.; Rose, A.; Seez, C.; Sharp, P.; Tapper, A.; Vazquez Acosta, M.; Virdee, T.; Zenz, S. C.; Cole, J. E.; Hobson, P. R.; Khan, A.; Kyberd, P.; Leggat, D.; Leslie, D.; Reid, I. D.; Symonds, P.; Teodorescu, L.; Turner, M.; Dittmann, J.; Hatakeyama, K.; Kasmi, A.; Liu, H.; Scarborough, T.; Charaf, O.; Cooper, S. I.; Henderson, C.; Rumerio, P.; Avetisyan, A.; Bose, T.; Fantasia, C.; Lawson, P.; Richardson, C.; Rohlf, J.; St John, J.; Sulak, L.; Alimena, J.; Berry, E.; Bhattacharya, S.; Christopher, G.; Cutts, D.; Demiragli, Z.; Dhingra, N.; Ferapontov, A.; Garabedian, A.; Heintz, U.; Kukartsev, G.; Laird, E.; Landsberg, G.; Luk, M.; Narain, M.; Segala, M.; Sinthuprasith, T.; Speer, T.; Swanson, J.; Breedon, R.; Breto, G.; Calderon De La Barca Sanchez, M.; Chauhan, S.; Chertok, M.; Conway, J.; Conway, R.; Cox, P. T.; Erbacher, R.; Gardner, M.; Ko, W.; Lander, R.; Mulhearn, M.; Pellett, D.; Pilot, J.; Ricci-Tam, F.; Shalhout, S.; Smith, J.; Squires, M.; Stolp, D.; Tripathi, M.; Wilbur, S.; Yohay, R.; Cousins, R.; Everaerts, P.; Farrell, C.; Hauser, J.; Ignatenko, M.; Rakness, G.; Takasugi, E.; Valuev, V.; Weber, M.; Burt, K.; Clare, R.; Ellison, J.; Gary, J. W.; Hanson, G.; Heilman, J.; Rikova, M. Ivova; Jandir, P.; Kennedy, E.; Lacroix, F.; Long, O. R.; Luthra, A.; Malberti, M.; Olmedo Negrete, M.; Shrinivas, A.; Sumowidagdo, S.; Wimpenny, S.; Branson, J. G.; Cerati, G. B.; Cittolin, S.; D'Agnolo, R. T.; Holzner, A.; Kelley, R.; Klein, D.; Kovalskyi, D.; Letts, J.; Macneill, I.; Olivito, D.; Padhi, S.; Palmer, C.; Pieri, M.; Sani, M.; Sharma, V.; Simon, S.; Tu, Y.; Vartak, A.; Welke, C.; Wuerthwein, F.; Yagil, A.; Barge, D.; Bradmiller-Feld, J.; Campagnari, C.; Danielson, T.; Dishaw, A.; Dutta, V.; Flowers, K.; Sevilla, M. Franco; Geffert, P.; George, C.; Golf, F.; Gouskos, L.; Incandela, J.; Justus, C.; Mccoll, N.; Richman, J.; Stuart, D.; To, W.; West, C.; Yoo, J.; Apresyan, A.; Bornheim, A.; Bunn, J.; Chen, Y.; Duarte, J.; Mott, A.; Newman, H. B.; Pena, C.; Pierini, M.; Spiropulu, M.; Vlimant, J. R.; Wilkinson, R.; Xie, S.; Zhu, R. Y.; Azzolini, V.; Calamba, A.; Carlson, B.; Ferguson, T.; Iiyama, Y.; Paulini, M.; Russ, J.; Vogel, H.; Vorobiev, I.; Cumalat, J. P.; Ford, W. T.; Gaz, A.; Krohn, M.; Luiggi Lopez, E.; Nauenberg, U.; Smith, J. G.; Stenson, K.; Wagner, S. R.; Alexander, J.; Chatterjee, A.; Chaves, J.; Chu, J.; Dittmer, S.; Eggert, N.; Mirman, N.; Kaufman, G. Nicolas; Patterson, J. R.; Ryd, A.; Salvati, E.; Skinnari, L.; Sun, W.; Teo, W. D.; Thom, J.; Thompson, J.; Tucker, J.; Weng, Y.; Winstrom, L.; Wittich, P.; Winn, D.; Abdullin, S.; Albrow, M.; Anderson, J.; Apollinari, G.; Bauerdick, L. A. T.; Beretvas, A.; Berryhill, J.; Bhat, P. C.; Bolla, G.; Burkett, K.; Butler, J. N.; Cheung, H. W. K.; Chlebana, F.; Cihangir, S.; Elvira, V. D.; Fisk, I.; Freeman, J.; Gao, Y.; Gottschalk, E.; Gray, L.; Green, D.; Gruenendahl, S.; Gutsche, O.; Hanlon, J.; Hare, D.; Harris, R. M.; Hirschauer, J.; Hooberman, B.; Jindariani, S.; Johnson, M.; Joshi, U.; Kaadze, K.; Klima, B.; Kreis, B.; Kwan, S.; Linacre, J.; Lincoln, D.; Lipton, R.; Liu, T.; Lykken, J.; Maeshima, K.; Marraffino, J. M.; Outschoorn, V. I. Martinez; Maruyama, S.; Mason, D.; McBride, P.; Merkel, P.; Mishra, K.; Mrenna, S.; Nahn, S.; Newman-Holmes, C.; O'Dell, V.; Prokofyev, O.; Sexton-Kennedy, E.; Sharma, S.; Soha, A.; Spalding, W. J.; Spiegel, L.; Taylor, L.; Tkaczyk, S.; Tran, N. V.; Uplegger, L.; Vaandering, E. W.; Vidal, R.; Whitbeck, A.; Whitmore, J.; Yang, F.; Acosta, D.; Avery, P.; Bortignon, P.; Bourilkov, D.; Carver, M.; Curry, D.; Das, S.; De Gruttola, M.; Di Giovanni, G. P.; Field, R. D.; Fisher, M.; Furic, I. K.; Hugon, J.; Konigsberg, J.; Korytov, A.; Kypreos, T.; Low, J. F.; Matchev, K.; Mei, H.; Milenovic, P.; Mitselmakher, G.; Muniz, L.; Rinkevicius, A.; Shchutska, L.; Snowball, M.; Sperka, D.; Yelton, J.; Zakaria, M.; Hewamanage, S.; Linn, S.; Markowitz, P.; Martinez, G.; Rodriguez, J. L.; Adams, T.; Askew, A.; Bochenek, J.; Diamond, B.; Haas, J.; Hagopian, S.; Hagopian, V.; Johnson, K. F.; Prosper, H.; Veeraraghavan, V.; Weinberg, M.; Baarmand, M. M.; Hohlmann, M.; Kalakhety, H.; Yumiceva, F.; Adams, M. R.; Apanasevich, L.; Berry, D.; Betts, R. R.; Bucinskaite, I.; Cavanaugh, R.; Evdokimov, O.; Gauthier, L.; Gerber, C. E.; Hofman, D. J.; Kurt, P.; Moon, D. H.; O'Brien, C.; Gonzalez, I. D. Sandoval; Silkworth, C.; Turner, P.; Varelas, N.; Bilki, B.; Clarida, W.; Dilsiz, K.; Haytmyradov, M.; Merlo, J-P.; Mermerkaya, H.; Mestvirishvili, A.; Moeller, A.; Nachtman, J.; Ogul, H.; Onel, Y.; Ozok, F.; Penzo, A.; Rahmat, R.; Sen, S.; Tan, P.; Tiras, E.; Wetzel, J.; Yi, K.; Barnett, B. A.; Blumenfeld, B.; Bolognesi, S.; Fehling, D.; Gritsan, A. V.; Maksimovic, P.; Martin, C.; Swartz, M.; Baringer, P.; Bean, A.; Benelli, G.; Bruner, C.; Kenny, R. P., III; Malek, M.; Murray, M.; Noonan, D.; Sanders, S.; Sekaric, J.; Stringer, R.; Wang, Q.; Wood, J. S.; Chakaberia, I.; Ivanov, A.; Khalil, S.; Makouski, M.; Maravin, Y.; Saini, L. K.; Skhirtladze, N.; Svintradze, I.; Gronberg, J.; Lange, D.; Rebassoo, F.; Wright, D.; Baden, A.; Belloni, A.; Calvert, B.; Eno, S. C.; Gomez, J. A.; Hadley, N. J.; Kellogg, R. G.; Kolberg, T.; Lu, Y.; Mignerey, A. C.; Pedro, K.; Skuja, A.; Tonjes, M. B.; Tonwar, S. C.; Apyan, A.; Barbieri, R.; Bauer, G.; Busza, W.; Cali, I. A.; Chan, M.; Di Matteo, L.; Gomez Ceballos, G.; Goncharov, M.; Gulhan, D.; Klute, M.; Lai, Y. S.; Lee, Y-J.; Levin, A.; Luckey, P. D.; Ma, T.; Paus, C.; Ralph, D.; Roland, C.; Roland, G.; Stephans, G. S. F.; Sumorok, K.; Velicanu, D.; Veverka, J.; Wyslouch, B.; Yang, M.; Zanetti, M.; Zhukova, V.; Dahmes, B.; Gude, A.; Kao, S. C.; Klapoetke, K.; Kubota, Y.; Mans, J.; Pastika, N.; Rusack, R.; Singovsky, A.; Tambe, N.; Turkewitz, J.; Acosta, J. G.; Oliveros, S.; Avdeeva, E.; Bloom, K.; Bose, S.; Claes, D. R.; Dominguez, A.; Suarez, R. Gonzalez; Keller, J.; Knowlton, D.; Kravchenko, I.; Lazo-Flores, J.; Meier, F.; Ratnikov, F.; Snow, G. R.; Zvada, M.; Dolen, J.; Godshalk, A.; Iashvili, I.; Kharchilava, A.; Kumar, A.; Rappoccio, S.; Alverson, G.; Barberis, E.; Baumgartel, D.; Chasco, M.; Massironi, A.; Morse, D. M.; Nash, D.; Orimoto, T.; Trocino, D.; Wang, R-J; Wood, D.; Zhang, J.; Hahn, K. A.; Kubik, A.; Mucia, N.; Odell, N.; Pollack, B.; Pozdnyakov, A.; Schmitt, M.; Stoynev, S.; Sung, K.; Velasco, M.; Won, S.; Brinkerhoff, A.; Chan, K. M.; Drozdetskiy, A.; Hildreth, M.; Jessop, C.; Karmgard, D. J.; Kellams, N.; Lannon, K.; Lynch, S.; Marinelli, N.; Musienko, Y.; Pearson, T.; Planer, M.; Ruchti, R.; Smith, G.; Valls, N.; Wayne, M.; Wolf, M.; Woodard, A.; Antonelli, L.; Brinson, J.; Bylsma, B.; Durkin, L. S.; Flowers, S.; Hart, A.; Hill, C.; Hughes, R.; Kotov, K.; Ling, T. Y.; Luo, W.; Puigh, D.; Rodenburg, M.; Winer, B. L.; Wolfe, H.; Wulsin, H. W.; Driga, O.; Elmer, P.; Hardenbrook, J.; Hebda, P.; Hunt, A.; Koay, S. A.; Lujan, P.; Marlow, D.; Medvedeva, T.; Mooney, M.; Olsen, J.; Piroue, P.; Quan, X.; Saka, H.; Stickland, D.; Tully, C.; Werner, J. S.; Zuranski, A.; Brownson, E.; Malik, S.; Mendez, H.; Vargas, J. E. Ramirez; Barnes, V. E.; Benedetti, D.; Bortoletto, D.; De Mattia, M.; Gutay, L.; Hu, Z.; Jha, M. K.; Jones, M.; Jung, K.; Kress, M.; Leonardo, N.; Miller, D. H.; Neumeister, N.; Radburn-Smith, B. C.; Shi, X.; Shipsey, I.; Silvers, D.; Svyatkovskiy, A.; Wang, F.; Xie, W.; Xu, L.; Zablocki, J.; Parashar, N.; Stupak, J.; Adair, A.; Akgun, B.; Ecklund, K. M.; Geurts, F. J. M.; Li, W.; Michlin, B.; Padley, B. P.; Redjimi, R.; Roberts, J.; Zabel, J.; Betchart, B.; Bodek, A.; Covarelli, R.; De Barbaro, P.; Demina, R.; Eshaq, Y.; Ferbel, T.; Garcia-Bellido, A.; Goldenzweig, P.; Han, J.; Harel, A.; Khukhunaishvili, A.; Korjenevski, S.; Petrillo, G.; Vishnevskiy, D.; Ciesielski, R.; Demortier, L.; Goulianos, K.; Mesropian, C.; Arora, S.; Barker, A.; Chou, J. P.; Contreras-Campana, C.; Contreras-Campana, E.; Duggan, D.; Ferencek, D.; Gershtein, Y.; Gray, R.; Halkiadakis, E.; Hidas, D.; Kaplan, S.; Lath, A.; Panwalkar, S.; Park, M.; Patel, R.; Salur, S.; Schnetzer, S.; Somalwar, S.; Stone, R.; Thomas, S.; Thomassen, P.; Walker, M.; Rose, K.; Spanier, S.; York, A.; Bouhali, O.; Hernandez, A. Castaneda; Eusebi, R.; Flanagan, W.; Gilmore, J.; Kamon, T.; Khotilovich, V.; Krutelyov, V.; Montalvo, R.; Osipenkov, I.; Pakhotin, Y.; Perloff, A.; Roe, J.; Rose, A.; Safonov, A.; Suarez, I.; Tatarinov, A.; Ulmer, K. A.; Akchurin, N.; Cowden, C.; Damgov, J.; Dragoiu, C.; Dudero, P. R.; Faulkner, J.; Kovitanggoon, K.; Kunori, S.; Lee, S. W.; Libeiro, T.; Volobouev, I.; Appelt, E.; Delannoy, A. G.; Greene, S.; Gurrola, A.; Johns, W.; Maguire, C.; Mao, Y.; Melo, A.; Sharma, M.; Sheldon, P.; Snook, B.; Tuo, S.; Velkovska, J.; Arenton, M. W.; Boutle, S.; Cox, B.; Francis, B.; Goodell, J.; Hirosky, R.; Ledovskoy, A.; Li, H.; Lin, C.; Neu, C.; Wood, J.; Clarke, C.; Harr, R.; Karchin, P. E.; Don, C. Kottachchi Kankanamge; Lamichhane, P.; Sturdy, J.; Belknap, D. A.; Carlsmith, D.; Cepeda, M.; Dasu, S.; Dodd, L.; Duric, S.; Friis, E.; Hall-Wilton, R.; Herndon, M.; Herve, A.; Klabbers, P.; Lanaro, A.; Lazaridis, C.; Levine, A.; Loveless, R.; Mohapatra, A.; Ojalvo, I.; Perry, T.; Pierro, G. A.; Polese, G.; Ross, I.; Sarangi, T.; Savin, A.; Smith, W. H.; Taylor, D.; Vuosalo, C.; Woods, N.; Bediaga, I.; De Miranda, J. M.; Rodrigues, F. Ferreira; Gomes, A.; Massafferri, A.; Dos Reis, A. C.; Rodrigues, A. B.; Amato, S.; Akiba, K. Carvalho; De Paula, L.; Francisco, O.; Gandelman, M.; Hicheur, A.; Lopes, J. H.; Tostes, D. Martins; Nasteva, I.; Goicochea, J. M. Otalora; Polycarpo, E.; Potterat, C.; Rangel, M. S.; Guimaraes, V. Salustino; De Paula, B. Souza; Vieira, D.; An, L.; Gao, Y.; Jing, F.; Li, Y.; Yang, Z.; Yuan, X.; Zhang, Y.; Zhong, L.; Beaucourt, L.; Chefdeville, M.; Decamp, D.; Deleage, N.; Ghez, Ph.; Lees, J-P.; Marchand, J. F.; Minard, M-N.; Pietrzyk, B.; Qian, W.; T'Jampens, S.; Tisserand, V.; Tournefier, E.; Ajaltouni, Z.; Baalouch, M.; Cogneras, E.; Deschamps, O.; El Rifai, I.; Grabalosa Gandara, M.; Henrard, P.; Hoballah, M.; Lefevre, R.; Maratas, J.; Monteil, S.; Niess, V.; Perret, P.; Adrover, C.; Akar, S.; Aslanides, E.; Cogan, J.; Kanso, W.; Le Gac, R.; Leroy, O.; Mancinelli, G.; Morda, A.; Perrin-Terrin, M.; Serrano, J.; Tsaregorodtsev, A.; Amhis, Y.; Barsuk, S.; Borsato, M.; Kochebina, O.; Lefrancois, J.; Machefert, F.; Martin Sanchez, A.; Nicol, M.; Robbe, P.; Schune, M-H.; Teklishyn, M.; Vallier, A.; Viaud, B.; Wormser, G.; Ben-Haim, E.; Charles, M.; Coquereau, S.; David, P.; Del Buono, L.; Henry, L.; Polci, F.; Albrecht, J.; Brambach, T.; Cauet, Ch.; Deckenhoff, M.; Eitschberger, U.; Ekelhof, R.; Gavardi, L.; Kruse, F.; Meier, F.; Niet, R.; Parkinson, C. J.; Schlupp, M.; Shires, A.; Spaan, B.; Swientek, S.; Wishahi, J.; Gutierrez, O. Aquines; Blouw, J.; Britsch, M.; Fontana, M.; Popov, D.; Schmelling, M.; Volyanskyy, D.; Zavertyaev, M.; Bachmann, S.; Bien, A.; Comerma-Montells, A.; De Cian, M.; Dordei, F.; Esen, S.; Faerber, C.; Gersabeck, E.; Grillo, L.; Han, X.; Hansmann-Menzemer, S.; Jaeger, A.; Kolpin, M.; Kreplin, K.; Krocker, G.; Leverington, B.; Marks, J.; Meissner, M.; Neuner, M.; Nikodem, T.; Seyfert, P.; Stahl, M.; Stahl, S.; Uwer, U.; Vesterinen, M.; Wandernoth, S.; Wiedner, D.; Zhelezov, A.; McNulty, R.; Wallace, R.; Zhang, W. C.; Palano, A.; Carbone, A.; Falabella, A.; Galli, D.; Marconi, U.; Moggi, N.; Mussini, M.; Perazzini, S.; Vagnoni, V.; Valenti, G.; Zangoli, M.; Bonivento, W.; Cadeddu, S.; Cardini, A.; Cogoni, V.; Contu, A.; Lai, A.; Liu, B.; Manca, G.; Oldeman, R.; Saitta, B.; Vacca, C.; Andreotti, M.; Baldini, W.; Bozzi, C.; Calabrese, R.; Corvo, M.; Fiore, M.; Fiorini, M.; Luppi, E.; Pappalardo, L. L.; Shapoval, I.; Tellarini, G.; Tomassetti, L.; Vecchi, S.; Anderlini, L.; Bizzeti, A.; Frosini, M.; Graziani, G.; Passaleva, G.; Veltri, M.; Bencivenni, G.; Campana, P.; De Simone, P.; Lanfranchi, G.; Palutan, M.; Rama, M.; Sarti, A.; Sciascia, B.; Gomez, R. Vazquez; Cardinale, R.; Fontanelli, F.; Gambetta, S.; Patrignani, C.; Petrolini, A.; Pistone, A.; Calvi, M.; Cassina, L.; Gotti, C.; Khanji, B.; Kucharczyk, M.; Matteuzzi, C.; Fu, J.; Geraci, A.; Neri, N.; Palombo, F.; Amerio, S.; Collazuol, G.; Gallorini, S.; Gianelle, A.; Lucchesi, D.; Lupato, A.; Morandin, M.; Rotondo, M.; Sestini, L.; Simi, G.; Stroili, R.; Bedeschi, F.; Cenci, R.; Leo, S.; Marino, P.; Morello, M. J.; Punzi, G.; Stracka, S.; Walsh, J.; Carboni, G.; Furfaro, E.; Santovetti, E.; Satta, A.; Alves, A. A., Jr.; Auriemma, G.; Bocci, V.; Martellotti, G.; Penso, G.; Pinci, D.; Santacesaria, R.; Satriano, C.; Sciubba, A.; Dziurda, A.; Kucewicz, W.; Lesiak, T.; Rachwal, B.; Witek, M.; Firlej, M.; Fiutowski, T.; Idzik, M.; Morawski, P.; Moron, J.; Oblakowska-Mucha, A.; Swientek, K.; Szumlak, T.; Batozskaya, V.; Klimaszewski, K.; Kurek, K.; Szczekowski, M.; Ukleja, A.; Wislicki, W.; Cojocariu, L.; Giubega, L.; Grecu, A.; Maciuc, F.; Orlandea, M.; Popovici, B.; Stoica, S.; Straticiuc, M.; Alkhazov, G.; Bondar, N.; Dzyuba, A.; Maev, O.; Sagidova, N.; Shcheglov, Y.; Vorobyev, A.; Belogurov, S.; Belyaev, I.; Egorychev, V.; Golubkov, D.; Kvaratskheliya, T.; Machikhiliyan, I. V.; Polyakov, I.; Savrina, D.; Semennikov, A.; Zhokhov, A.; Berezhnoy, A.; Korolev, M.; Leflat, A.; Nikitin, N.; Filippov, S.; Gushchin, E.; Kravchuk, L.; Bondar, A.; Eidelman, S.; Krokovny, P.; Kudryavtsev, V.; Shekhtman, L.; Vorobyev, V.; Artamonov, A.; Belous, K.; Dzhelyadin, R.; Guz, Yu.; Novoselov, A.; Obraztsov, V.; Popov, A.; Romanovsky, V.; Shapkin, M.; Stenyakin, O.; Yushchenko, O.; Badalov, A.; Gomez, M. Calvo; Garrido, L.; Gascon, D.; Diaz, R. Graciani; Grauges, E.; Benito, C. Marin; Olloqui, E. Picatoste; Molina, V. Rives; Ruiz, H.; Vilasis-Cardona, X.; Adeva, B.; Cartelle, P. Alvarez; Suarez, A. Dosil; Albor, V. Fernandez; Torreira, A. Gallas; Pardinas, J. Garcia; Morata, J. A. Hernando; Casasus, M. Plo; Vidal, A. Romero; Silva, J. J. Saborido; Sedes, B. Sanmartin; Rios, C. Santamarina; Regueiro, P. Vazquez; Sierra, C. Vazquez; Diaz, M. Vieites; Alessio, F.; Archilli, F.; Barschel, C.; Benson, S.; Buytaert, J.; Perez, D. Campora; Garcia, L. Castillo; Cattaneo, M.; Charpentier, Ph.; Vidal, X. Cid; Clemencic, M.; Closier, J.; Coco, V.; Collins, P.; Corti, G.; Couturier, B.; D'Ambrosio, C.; Dettori, F.; Di Canto, A.; Dijkstra, H.; Durante, P.; Ferro-Luzzi, M.; Forty, R.; Frank, M.; Frei, C.; Gaspar, C.; Gligorov, V. V.; Cardoso, L. A. Granado; Gys, T.; Haen, C.; He, J.; Head, T.; van Herwijnen, E.; Jacobsson, R.; Johnson, D.; Joram, C.; Jost, B.; Karacson, M.; Karbach, T. M.; Lacarrere, D.; Langhans, B.; Lindner, R.; Linn, C.; Lohn, S.; Mapelli, A.; Matev, R.; Mathe, Z.; Neubert, S.; Neufeld, N.; Otto, A.; Panman, J.; Altarelli, M. Pepe; Rauschmayr, N.; Rihl, M.; Roiser, S.; Ruf, T.; Schindler, H.; Schmidt, B.; Schopper, A.; Schwemmer, R.; Sridharan, S.; Stagni, F.; Subbiah, V. K.; Teubert, F.; Thomas, E.; Tonelli, D.; Trisovic, A.; Garcia, M. Ubeda; Wicht, J.; Wyllie, K.; Battista, V.; Bay, A.; Blanc, F.; Dorigo, M.; Dupertuis, F.; Fitzpatrick, C.; Giani, S.; Haefeli, G.; Jaton, P.; Khurewathanakul, C.; Komarov, I.; La Thi, V. N.; Lopez-March, N.; Maerki, R.; Martinelli, M.; Muster, B.; Nakada, T.; Nguyen, A. D.; Nguyen, T. D.; Nguyen-Mau, C.; Prisciandaro, J.; Navarro, A. Puig; Rakotomiaramanana, B.; Rouvinet, J.; Schneider, O.; Soomro, F.; Szczypka, P.; Tobin, M.; Tourneur, S.; Tran, M. T.; Veneziano, G.; Xu, Z.; Anderson, J.; Bernet, R.; Bowen, E.; Bursche, A.; Chiapolini, N.; Chrzaszcz, M.; Elsasser, Ch.; Graverini, E.; Lionetto, F.; Lowdon, P.; Mueller, K.; Serra, N.; Steinkamp, O.; Storaci, B.; Straumann, U.; Tresch, M.; Vollhardt, A.; Aaij, R.; Ali, S.; Van Beuzekom, M.; David, P. N. Y.; De Bruyn, K.; Farinelli, C.; Heijne, V.; Hulsbergen, W.; Jans, E.; Koppenburg, P.; Kozlinskiy, A.; van Leerdam, J.; Merk, M.; Oggero, S.; Pellegrino, A.; Snoek, H.; van Tilburg, J.; Tsopelas, P.; Tuning, N.; de Vries, J. A.; Ketel, T.; Koopman, R. F.; Lambert, R. W.; Santos, D. Martinez; Raven, G.; Schiller, M.; Syropoulos, V.; Tolk, S.; Dovbnya, A.; Kandybei, S.; Raniuk, I.; Okhrimenko, O.; Pugatch, V.; Bifani, S.; Farley, N.; Griffith, P.; Kenyon, I. R.; Lazzeroni, C.; Mazurov, A.; McCarthy, J.; Pescatore, L.; Watson, N. K.; Williams, M. P.; Adinolfi, M.; Benton, J.; Brook, N. H.; Cook, A.; Coombes, M.; Dalseno, J.; Hampson, T.; Harnew, S. T.; Naik, P.; Price, E.; Prouve, C.; Rademacker, J. H.; Richards, S.; Saunders, D. M.; Skidmore, N.; Souza, D.; Velthuis, J. J.; Voong, D.; Barter, W.; Bettler, M-O.; Cliff, H. V.; Evans, H. -M.; Tico, J. Garra; Gibson, V.; Gregson, S.; Haines, S. C.; Jones, C. R.; Sirendi, M.; Smith, J.; Ward, D. R.; Wotton, S. A.; Wright, S.; Back, J. J.; Blake, T.; Craik, D. C.; Crocombe, A. C.; Dossett, D.; Gershon, T.; Kreps, M.; Langenbruch, C.; Latham, T.; O'Hanlon, D. P.; Pilar, T.; Poluektov, A.; Reid, M. M.; Coutinho, R. Silva; Wallace, C.; Whitehead, M.; Easo, S.; Nandakumar, R.; Papanestis, A.; Ricciardi, S.; Wilson, F. F.; Carson, L.; Clarke, P. E. L.; Cowan, G. A.; Eisenhardt, S.; Ferguson, D.; Lambert, D.; Luo, H.; Morris, A. -B.; Muheim, F.; Needham, M.; Playfer, S.; Alexander, M.; Beddow, J.; Dean, C-T.; Eklund, L.; Hynds, D.; Karodia, S.; Longstaff, I.; Ogilvy, S.; Pappagallo, M.; Sail, P.; Skillicorn, I.; Soler, F. J. P.; Spradlin, P.; Affolder, A.; Bowcock, T. J. V.; Brown, H.; Casse, G.; Donleavy, S.; Dreimanis, K.; Farry, S.; Fay, R.; Hennessy, K.; Hutchcroft, D.; Liles, M.; McSkelly, B.; Patel, G. D.; Price, J. D.; Pritchard, A.; Rinnert, K.; Shears, T.; Smith, N. A.; Ciezarek, G.; Cunliffe, S.; Currie, R.; Egede, U.; Fol, P.; Golutvin, A.; Hall, S.; McCann, M.; Owen, P.; Patel, M.; Petridis, K.; Redi, F.; Sepp, I.; Smith, E.; Sutcliffe, W.; Websdale, D.; Appleby, R. B.; Barlow, R. J.; Bird, T.; Bjomstad, P. M.; Borghi, S.; Brett, D.; Brodzicka, J.; Capriotti, L.; Chen, S.; De Capua, S.; Dujany, G.; Gersabeck, M.; Harrison, J.; Hombach, C.; Klaver, S.; Lafferty, G.; McNab, A.; Parkes, C.; Pearce, A.; Reichert, S.; Rodrigues, E.; Perez, P. Rodriguez; Smith, M.; Cheung, S-F.; Derkach, D.; Evans, T.; Gauld, R.; Greening, E.; Harnew, N.; Hill, D.; Hunt, P.; Hussain, N.; Jalocha, J.; John, M.; Lupton, O.; Malde, S.; Smith, E.; Stevenson, S.; Thomas, C.; Topp-Joergensen, S.; Torr, N.; Wilkinson, G.; Counts, I.; Ilten, P.; Williams, M.; Andreassen, R.; Davis, A.; De Silva, W.; Meadows, B.; Sokoloff, M. D.; Sun, L.; Todd, J.; Andrews, J. E.; Hamilton, B.; Jawahery, A.; Wimberley, J.; Artuso, M.; Blusk, S.; Borgia, A.; Britton, T.; Ely, S.; Gandini, P.; Garofoli, J.; Gui, B.; Hadjivasiliou, C.; Jurik, N.; Kelsey, M.; Mountain, R.; Pal, B. K.; Skwarnicki, T.; Stone, S.; Wang, J.; Xing, Z.; Zhang, L.; Baesso, C.; Torres, M. Cruz; Goebel, C.; Rodriguez, J. Molina; Xie, Y.; Milanes, D. A.; Gruenberg, O.; Hess, M.; Voss, C.; Waldi, R.; Likhomanenko, T.; Malinin, A.; Shevchenko, V.; Ustyuzhanin, A.; Vidal, F. Martinez; Oyanguren, A.; Valls, P. Ruiz; Mayordomo, C. Sanchez; Onderwater, C. J. G.; Wilschut, H. W.; Pesen, E.		CMS Collaboration; CMS Collaboration; LHCb Collaboration	Observation of the rare B-s(0)->mu(+)mu(-) decay from the combined analysis of CMS and LHCb data	NATURE			English	Article							B-MESON DECAYS; P(P)OVER-BAR COLLISIONS; BRANCHING FRACTION; ROOT-S=1.96 TEV; SEARCH; MU(+)MU(-); B-0; B-S(0); VIOLATION; MODELS	The standard model of particle physics describes the fundamental particles and their interactions via the strong, electromagnetic and weak forces. It provides precise predictions for measurable quantities that can be tested experimentally. The probabilities, or branching fractions, of the strange B meson (B-s(0)) and the B-0 meson decaying into two oppositely charged muons (mu(+) and mu(-)) are especially interesting because of their sensitivity to theories that extend the standard model. The standard model predicts that the B-s(0)->mu(+)mu(-) and B-0 ->mu(+)mu(-) decays are very rare, with about four of the former occurring for every billion B-s(0) mesons produced, and one of the latter occurring for every ten billion B-0 mesons(1). A difference in the observed branching fractions with respect to the predictions of the standard model would provide a direction in which the standard model should be extended. Before the Large Hadron Collider (LHC) at CERN2 started operating, no evidence for either decay mode had been found. Upper limits on the branching fractions were an order of magnitude above the standard model predictions. The CMS (Compact Muon Solenoid) and LHCb(Large Hadron Collider beauty) collaborations have performed a joint analysis of the data from proton-proton collisions that they collected in 2011 at a centre-of-mass energy of seven teraelectronvolts and in 2012 at eight teraelectronvolts. Here we report the first observation of the B-s(0)->mu(+)mu(-) decay, with a statistical significance exceeding six standard deviations, and the best measurement so far of its branching fraction. Furthermore, we obtained evidence for the B-0 ->mu(+)mu(-) decay with a statistical significance of three standard deviations. Both measurements are statistically compatible with standard model predictions and allow stringent constraints to be placed on theories beyond the standard model. The LHC experiments will resume taking data in 2015, recording proton-proton collisions at a centre-of-mass energy of 13 teraelectronvolts, which will approximately double the production rates of B-s(0) and B-0 mesons and lead to further improvements in the precision of these crucial tests of the standard model.	[Khachatryan, V.; Sirunyan, A. M.; Tumasyan, A.] Yerevan Phys Inst, Yerevan 375036, Armenia; [Adam, W.; Bergauer, T.; Dragicevic, M.; Eroe, J.; Friedl, M.; Fruehwirth, R.; Ghete, V. M.; Hartl, C.; Hoermann, N.; Hrubec, J.; Jeitler, M.; Kiesenhofer, W.; Knuenz, V.; Krammer, M.; Kraetschmer, I.; Liko, D.; Mikulec, I.; Rabady, D.; Rahbaran, B.; Rohringer, H.; Schoefbeck, R.; Strauss, J.; Treberer-Treberspurg, W.; Waltenberger, W.; Wulz, C-E.] Inst Hochenergiephys OeAW, Vienna, Austria; [Mossolov, V.; Shumeiko, N.; Suarez Gonzalez, J.] Natl Ctr Particle & High Energy Phys, Minsk, BELARUS; [Alderweireldt, S.; Bansal, S.; Cornelis, T.; De Wolf, E. A.; Janssen, X.; Knutsson, A.; Lauwers, J.; Luyckx, S.; Ochesanu, S.; Rougny, R.; Van De Klundert, M.; Van Haevermaet, H.; Van Mechelen, P.; Van Remortel, N.; Van Spilbeeck, A.] Univ Antwerp, B-2020 Antwerp, Belgium; [Blekman, F.; Blyweert, S.; D'Hondt, J.; Daci, N.; Heracleous, N.; Keaveney, J.; Lowette, S.; Maes, M.; Olbrechts, A.; Python, Q.; Strom, D.; Tavernier, S.; Van Doninck, W.; Van Mulders, P.; Van Onsem, G. P.; Villella, I.] Vrije Univ Brussel, Brussels, Belgium; [Caillol, C.; Clerbaux, B.; De Lentdecker, G.; Dobur, D.; Favart, L.; Gay, A. P. R.; Grebenyuk, A.; Leonard, A.; Mohammadi, A.; Pernie, L.; Randle-Conde, A.; Reis, T.; Seva, T.; Thomas, L.; Vander Velde, C.; Vanlaer, P.; Wang, J.; Zenoni, F.] Univ Libre Bruxelles, Brussels, Belgium; [Adler, V.; Beernaert, K.; Benucci, L.; Cimmino, A.; Costantini, S.; Crucy, S.; Dildick, S.; Fagot, A.; Garcia, G.; Mccartin, J.; Ocampo Rios, A. A.; Ryckbosch, D.; Diblen, S. Salva; Sigamani, M.; Strobbe, N.; Thyssen, F.; Tytgat, M.; Yazgan, E.; Zaganidis, N.] Univ Ghent, B-9000 Ghent, Belgium; [Basegmez, S.; Beluffi, C.; Bruno, G.; Castello, R.; Caudron, A.; Ceard, L.; Da Silveira, G. G.; Delaere, C.; du Pree, T.; Favart, D.; Forthomme, L.; Giammanco, A.; Hollar, J.; Jafari, A.; Jez, P.; Komm, M.; Lemaitre, V.; Nuttens, C.; Pagano, D.; Perrini, L.; Pin, A.; Piotrzkowski, K.; Popov, A.; Quertenmont, L.; Selvaggi, M.; Marono, M. Vidal; Garcia, J. M. Vizan] Catholic Univ Louvain, Louvain, Belgium; [Beliy, N.; Caebergs, T.; Daubie, E.; Hammad, G. H.] Univ Mons, B-7000 Mons, Belgium; [Alda Junior, W. L.; Alves, G. A.; Brito, L.; Correa Martins Junior, M.; Mora Herrera, C.; Pol, M. E.; Rebello Teles, P.] Ctr Brasileiro Pesquisas Fis, Rio De Janeiro, Brazil; [Carvalho, W.; Chinellato, J.; Custodio, A.; Da Costa, E. M.; De Jesus Damiao, D.; De Oliveira Martins, C.; Fonseca De Souza, S.; Malbouisson, H.; Matos Figueiredo, D.; Mundim, L.; Nogima, H.; Prado Da Silva, W. L.; Santaolalla, J.; Santoro, A.; Sznajder, A.; Tonelli Manganote, E. J.; Vilela Pereira, A.] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, Brazil; Univ Fed ABC, Univ Estadual Paulista, Sao Paulo, Brazil; [Dogra, S.; Fernandez Perez Tomei, T. R.; Novaes, S. F.; Padula, Sandra S.] Univ Estadual Paulista, Sofia, Bulgaria; [Bernardes, C. A.; Gregores, E. M.; Mercadante, P. G.] Univ Fed ABC, Sofia, Bulgaria; [Aleksandrov, A.; Genchev, V.; Hadjiiska, R.; Iaydjiev, P.; Marinov, A.; Piperov, S.; Rodozov, M.; Sultanov, G.; Vutova, M.] Bulgarian Acad Sci, Inst Nucl Res & Nucl Energy, Sofia, Bulgaria; [Dimitrov, A.; Glushkov, I.; Litov, L.; Pavlov, B.; Petkov, P.] Univ Sofia, BU-1126 Sofia, Bulgaria; [Bian, J. G.; Chen, G. M.; Chen, H. S.; Chen, M.; Cheng, T.; Du, R.; Jiang, C. H.; Plestina, R.; Romeo, F.; Tao, J.; Wang, Z.] Inst High Energy Phys, Beijing 100039, Peoples R China; [Asawatangtrakuldee, C.; Ban, Y.; Li, Q.; Liu, S.; Mao, Y.; Qian, S. J.; Wang, D.; Xu, Z.; Zou, W.] Peking Univ, State Key Lab Nucl Phys & Technol, Beijing 100871, Peoples R China; [Avila, C.; Cabrera, A.; Chaparro Sierra, L. F.; Florez, C.; Gomez, J. P.; Gomez Moreno, B.; Sanabria, J. C.] Univ Los Andes, Bogota, Colombia; [Godinovic, N.; Lelas, D.; Polic, D.; Puljak, I.] Univ Split, Fac Elect Engn Mech Engn & Naval Architecture, Split, Croatia; [Antunovic, Z.; Kovac, M.] Univ Split, Fac Sci, Split, Croatia; [Brigljevic, V.; Kadija, K.; Luetic, J.; Mekterovic, D.; Sudic, L.] Rudjer Boskovic Inst, Zagreb, Croatia; [Attikis, A.; Mavromanolakis, G.; Mousa, J.; Nicolaou, C.; Ptochos, F.; Razis, P. A.] Univ Cyprus, CY-1678 Nicosia, Cyprus; [Bodlak, M.; Finger, M.; Finger, M., Jr.] Charles Univ Prague, Prague, Czech Republic; [Assran, Y.; Ellithi Kamel, A.; Mahmoud, M. A.; Radi, A.] Acad Sci Res & Technol Arab Republ Egypt, Egyptian Network High Energy Phys, Cairo, Egypt; [Kadastik, M.; Murumaa, M.; Raidal, M.; Tiko, A.] NICPB, Tallinn, Estonia; [Eerola, P.; Fedi, G.; Voutilainen, M.] Univ Helsinki, Dept Phys, Helsinki, Finland; [Harkonen, J.; Karimaki, V.; Kinnunen, R.; Kortelainen, M. J.; Lampen, T.; Lassila-Perini, K.; Lehti, S.; Linden, T.; Luukka, P.; Maenpaa, T.; Peltola, T.; Tuominen, E.; Tuominiemi, J.; Tuovinen, E.; Wendland, L.] Helsinki Inst Phys, Helsinki, Finland; [Talvitie, J.; Tuuva, T.] Lappeenranta Univ Technol, Lappeenranta, Finland; [Besancon, M.; Couderc, F.; Dejardin, M.; Denegri, D.; Fabbro, B.; Faure, J. L.; Favaro, C.; Ferri, F.; Ganjour, S.; Givernaud, A.; Gras, P.; Hamel de Monchenault, G.; Jarry, P.; Locci, E.; Malcles, J.; Rander, J.; Rosowsky, A.; Titov, M.] CEA Saclay, IRFU, DSM, F-91191 Gif Sur Yvette, France; [Baffioni, S.; Beaudette, F.; Busson, P.; Charlot, C.; Dahms, T.; Dalchenko, M.; Dobrzynski, L.; Filipovic, N.; Florent, A.; Granier de Cassagnac, R.; Mastrolorenzo, L.; Mine, P.; Mironov, C.; Naranjo, I. N.; Nguyen, M.; Ochando, C.; Ortona, G.; Paganini, P.; Regnard, S.; Salerno, R.; Sauvan, J. B.; Sirois, Y.; Veelken, C.; Yilmaz, Y.; Zabi, A.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Agram, J-L; Andrea, J.; Aubin, A.; Bloch, D.; Brom, J-M.; Chabert, E. C.; Collard, C.; Conte, E.; Fontaine, J-C.; Gele, D.; Goerlach, U.; Goetzmann, C.; Le Bihan, A-C.; Skovpen, K.; Van Hove, P.] Univ Haute Alsace Mulhouse, Univ Strasbourg, CNRS, Inst Pluridisciplinaire Hubert Curien,IN2P3, Strasbourg, France; [Gadrat, S.] CNRS, IN2P3, Inst Natl Phys Nucl & Phys Particules, Ctr Calcul, Villeurbanne, France; [Beauceron, S.; Beaupere, N.; Boudoul, G.; Bouvier, E.; Brochet, S.; Carrillo Montoya, C. A.; Chasserat, J.; Chierici, R.; Contardo, D.; Depasse, P.; El Mamouni, H.; Fan, J.; Fay, J.; Gascon, S.; Gouzevitch, M.; Ille, B.; Kurca, T.; Lethuillier, M.; Mirabito, L.; Perries, S.; Ruiz Alvarez, J. D.; Sabes, D.; Sgandurra, L.; Sordini, V.; Vander Donckt, M.; Verdier, P.; Viret, S.; Xiao, H.] Univ Lyon 1, CNRS, IN2P3, Inst Phys Nucl Lyon, F-69622 Villeurbanne, France; [Tsamalaidze, Z.] Tbilisi State Univ, Inst High Energy Phys & Informatizat, GE-380086 Tbilisi, Georgia; [Autermann, C.; Beranek, S.; Bontenackels, M.; Edelhoff, M.; Feld, L.; Heister, A.; Hindrichs, O.; Klein, K.; Ostapchuk, A.; Raupach, F.; Sammet, J.; Schael, S.; Schulte, J. F.; Weber, H.; Wittmer, B.; Zhukov, V.] Rhein Westfal TH Aachen, Phys Inst 1, Aachen, Germany; [Ata, M.; Brodski, M.; Dietz-Laursonn, E.; Duchardt, D.; Erdmann, M.; Fischer, R.; Gueth, A.; Hebbeker, T.; Heidemann, C.; Hoepfner, K.; Klingebiel, D.; Knutzen, S.; Kreuzer, P.; Merschmeyer, M.; Meyer, A.; Millet, P.; Olschewski, M.; Padeken, K.; Papacz, P.; Reithler, H.; Schmitz, S. A.; Sonnenschein, L.; Teyssier, D.; Thueer, S.; Weber, M.] Rhein Westfal TH Aachen, Phys Inst A 3, Aachen, Germany; [Cherepanov, V.; Erdogan, Y.; Fluegge, G.; Geenen, H.; Geisler, M.; Ahmad, W. Haj; Hoehle, F.; Kargoll, B.; Kress, T.; Kuessel, Y.; Kuensken, A.; Lingemann, J.; Nowack, A.; Nugent, I. M.; Pooth, O.; Stahl, A.] Rhein Westfal TH Aachen, Phys Inst B 3, Aachen, Germany; [Martin, M. Aldaya; Asin, I.; Bartosik, N.; Behr, J.; Behrens, U.; Bell, A. J.; Bethani, A.; Borras, K.; Burgmeier, A.; Cakir, A.; Calligaris, L.; Campbell, A.; Choudhury, S.; Costanza, F.; Pardos, C. Diez; Dolinska, G.; Dooling, S.; Dorland, T.; Eckerlin, G.; Eckstein, D.; Eichhorn, T.; Flucke, G.; Garcia, J. Garay; Geiser, A.; Gunnellini, P.; Hauk, J.; Hempel, M.; Jung, H.; Kalogeropoulos, A.; Kasemann, M.; Katsas, P.; Kieseler, J.; Kleinwort, C.; Korol, I.; Kruecker, D.; Lange, W.; Leonard, J.; Lipka, K.; Lobanov, A.; Lohmann, W.; Lutz, B.; Mankel, R.; Marfin, I.; Melzer-Pellmann, I-A.; Meyer, A. B.; Mittag, G.; Mnich, J.; Mussgiller, A.; Naumann-Emme, S.; Nayak, A.; Ntomari, E.; Perrey, H.; Pitzl, D.; Placakyte, R.; Raspereza, A.; Ribeiro Cipriano, P. M.; Roland, B.; Ron, E.; Sahin, M. Oe; Salfeld-Nebgen, J.; Saxena, P.; Schoerner-Sadenius, T.; Schroeder, M.; Seitz, C.; Spannagel, S.; Vargas Trevino, A. D. R.; Walsh, R.; Wissing, C.] DESY, Hamburg, Germany; [Blobel, V.; Centis Vignali, M.; Draeger, A. R.; Erfle, J.; Garutti, E.; Goebel, K.; Goerner, M.; Haller, J.; Hoffmann, M.; Hoeing, R. S.; Junkes, A.; Kirschenmann, H.; Klanner, R.; Kogler, R.; Lange, J.; Lapsien, T.; Lenz, T.; Marchesini, I.; Ott, J.; Peiffer, T.; Perieanu, A.; Pietsch, N.; Poehlsen, J.; Poehlsen, T.; Rathjens, D.; Sander, C.; Schettler, H.; Schleper, P.; Schlieckau, E.; Schmidt, A.; Seidel, M.; Sola, V.; Stadie, H.; Steinbrueck, G.; Troendle, D.; Usai, E.; Vanelderen, L.; Vanhoefer, A.] Univ Hamburg, Hamburg, Germany; [Barth, C.; Baus, C.; Berger, J.; Boeser, C.; Butz, E.; Chwalek, T.; De Boer, W.; Descroix, A.; Dierlamm, A.; Feindt, M.; Frensch, F.; Giffels, M.; Gilbert, A.; Hartmann, F.; Hauth, T.; Husemann, U.; Katkov, I.; Kornmayer, A.; Kuznetsova, E.; Pardo, P. Lobelle; Mozer, M. U.; Mueller, T.; Mueller, Th.; Nuernberg, A.; Quast, G.; Rabbertz, K.; Roecker, S.; Simonis, H. J.; Stober, F. M.; Ulrich, R.; Wagner-Kuhr, J.; Wayand, S.; Weiler, T.; Wolf, R.] Univ Karlsruhe, Inst Expt Kernphys, Karlsruhe, Germany; [Anagnostou, G.; Daskalakis, G.; Geralis, T.; Giakoumopoulou, V. A.; Kyriakis, A.; Loukas, D.; Markou, A.; Markou, C.; Psallidas, A.; Topsis-Giotis, I.] NCSR Demokritos, INPP, Aghia Paraskevi, Greece; [Agapitos, A.; Kesisoglou, S.; Panagiotou, A.; Saoulidou, N.; Stiliaris, E.] Univ Athens, Athens, Greece; [Aslanoglou, X.; Evangelou, I.; Flouris, G.; Foudas, C.; Kokkas, P.; Manthos, N.; Papadopoulos, I.; Paradas, E.; Strologas, J.] Univ Ioannina, GR-45110 Ioannina, Greece; [Bencze, G.; Hajdu, C.; Hidas, P.; Horvath, D.; Sikler, F.; Veszpremi, V.; Vesztergombi, G.; Zsigmond, A. J.] Wigner Res Ctr Phys, Budapest, Hungary; [Beni, N.; Czellar, S.; Karancsi, J.; Molnar, J.; Palinkas, J.; Szillasi, Z.] Inst Nucl Res ATOMKI, Debrecen, Hungary; [Makovec, A.; Raics, P.; Trocsanyi, Z. L.; Ujvari, B.] Debrecen Univ Med, H-4012 Debrecen, Hungary; [Sahoo, N.; Swain, S. K.] Natl Inst Sci Educ & Res, Bhubaneswar, Orissa, India; [Beri, S. B.; Bhatnagar, V.; Gupta, R.; Bhawandeep, U.; Kalsi, A. K.; Kaur, M.; Kumar, R.; Mittal, M.; Nishu, N.; Singh, J. B.] Panjab Univ, Chandigarh 160014, India; [Kumar, Ashok; Kumar, Arun; Ahuja, S.; Bhardwaj, A.; Choudhary, B. C.; Kumar, A.; Malhotra, S.; Naimuddin, M.; Ranjan, K.; Sharma, V.] Univ Delhi, Delhi 110007, India; [Banerjee, S.; Bhattacharya, S.; Chatterjee, K.; Dutta, S.; Gomber, B.; Jain, Sa.; Jain, Sh.; Khurana, R.; Modak, A.; Mukherjee, S.; Roy, D.; Sarkar, S.; Sharan, M.] Saha Inst Nucl Phys, Kolkata, India; [Abdulsalam, A.; Dutta, D.; Kailas, S.; Kumar, V.; Mohanty, A. K.; Pant, L. M.; Shukla, P.; Topkar, A.] Bhabha Atom Res Ctr, Bombay 400085, Maharashtra, India; [Aziz, T.; Banerjee, S.; Bhowmik, S.; Chatterjee, R. M.; Dewanjee, R. K.; Dugad, S.; Ganguly, S.; Ghosh, S.; Guchait, M.; Gurtu, A.; Kole, G.; Kumar, S.; Maity, M.; Majumder, G.; Mazumdar, K.; Mohanty, G. B.; Parida, B.; Sudhakar, K.; Wickramage, N.] Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India; [Bakhshiansohi, H.; Behnamian, H.; Etesami, S. M.; Fahim, A.; Goldouzian, R.; Khakzad, M.; Najafabadi, M. Mohammadi; Naseri, M.; Mehdiabadi, S. Paktinat; Hosseinabadi, F. Rezaei; Safarzadeh, B.; Zeinali, M.] Inst Res Fundamental Sci IPM, Tehran, Iran; [Felcini, M.; Grunewald, M.] Univ Coll Dublin, Dublin 2, Ireland; Univ Bari, Ist Nazl Fis Nucl, Sez Bari, Politecn Bari, Bari, Italy; [Abbrescia, M.; Calabria, C.; Chhibra, S. S.; Colaleo, A.; Creanza, D.; De Filippis, N.; De Palma, M.; Fiore, L.; Iaselli, G.; Maggi, G.; Maggi, M.; My, S.; Nuzzo, S.; Pompili, A.; Pugliese, G.; Radogna, R.; Selvaggi, G.; Sharma, A.; Silvestris, L.; Venditti, R.; Verwilligen, P.] Ist Nazl Fis Nucl, Sez Bari, I-40126 Bologna, Italy; [Abbrescia, M.; Calabria, C.; Chhibra, S. S.; De Palma, M.; Nuzzo, S.; Pompili, A.; Radogna, R.; Selvaggi, G.; Venditti, R.] Univ Bari, Bologna, Italy; [Creanza, D.; De Filippis, N.; Iaselli, G.; Maggi, G.; My, S.; Pugliese, G.] Politecn Bari, Bologna, Italy; Univ Bologna, Ist Nazl Fis Nucl, Sez Bologna, Bologna, Italy; [Abbiendi, G.; Benvenuti, A. C.; Bonacorsi, D.; Braibant-Giacomelli, S.; Brigliadori, L.; Campanini, R.; Capiluppi, P.; Castro, A.; Cavallo, F. R.; Codispoti, G.; Cuffiani, M.; Dallavalle, G. M.; Fabbri, F.; Fanfani, A.; Fasanella, D.; Giacomelli, P.; Grandi, C.; Guiducci, L.; Marcellini, S.; Masetti, G.; Montanari, A.; Navarria, F. L.; Perrotta, A.; Primavera, F.; Rossi, A. M.; Rovelli, T.; Siroli, G. P.; Tosi, N.; Travaglini, R.] Ist Nazl Fis Nucl, Sez Bologna, I-95129 Catania, Italy; [Bonacorsi, D.; Braibant-Giacomelli, S.; Brigliadori, L.; Campanini, R.; Capiluppi, P.; Castro, A.; Codispoti, G.; Cuffiani, M.; Fanfani, A.; Fasanella, D.; Guiducci, L.; Navarria, F. L.; Primavera, F.; Rossi, A. M.; Rovelli, T.; Siroli, G. P.; Tosi, N.; Travaglini, R.] Univ Bologna, Catania, Italy; Univ Catania, Ist Nazl Fis Nucl, Sez Catania, CSFNSM, Catania, Italy; [Albergo, S.; Cappello, G.; Chiorboli, M.; Costa, S.; Giordano, F.; Potenza, R.; Tricomi, A.; Tuve, C.] Ist Nazl Fis Nucl, Sez Catania, I-50125 Florence, Italy; [Albergo, S.; Chiorboli, M.; Costa, S.; Potenza, R.; Tricomi, A.; Tuve, C.] Univ Catania, Florence, Italy; CSFNSM, Florence, Italy; Univ Florence, Ist Nazl Fis Nucl, Sez Firenze, Florence, Italy; [Barbagli, G.; Ciulli, V.; Civinini, C.; D'Alessandro, R.; Focardi, E.; Gallo, E.; Gonzi, S.; Gori, V.; Lenzi, P.; Meschini, M.; Paoletti, S.; Sguazzoni, G.; Tropiano, A.] Ist Nazl Fis Nucl, Sez Firenze, Frascati, Italy; [Ciulli, V.; D'Alessandro, R.; Focardi, E.; Gonzi, S.; Gori, V.; Lenzi, P.; Tropiano, A.] Univ Florence, Frascati, Italy; [Benussi, L.; Bianco, S.; Fabbri, F.; Piccolo, D.] Ist Nazl Fis Nucl, Lab Nazl Frascati, I-00044 Frascati, Italy; Univ Genoa, Ist Nazl Fis Nucl, Sez Genova, Genoa, Italy; [Ferretti, R.; Ferro, F.; Lo Vetere, M.; Robutti, E.; Tosi, S.] Ist Nazl Fis Nucl, Sez Genova, I-20133 Milan, Italy; [Ferretti, R.; Lo Vetere, M.; Tosi, S.] Univ Genoa, Milan, Italy; Univ Milano Bicocca, Ist Nazl Fis Nucl, Sez Milano Bicocca, Milan, Italy; [Dinardo, M. E.; Fiorendi, S.; Gennai, S.; Gerosa, R.; Ghezzi, A.; Govoni, P.; Lucchini, M. T.; Malvezzi, S.; Manzoni, R. A.; Martelli, A.; Marzocchi, B.; Menasce, D.; Moroni, L.; Paganoni, M.; Pedrini, D.; Ragazzi, S.; Redaelli, N.; Tabarelli de Fatis, T.] Ist Nazl Fis Nucl, Sez Milano Bicocca, I-80125 Naples, Italy; [Dinardo, M. E.; Fiorendi, S.; Gerosa, R.; Ghezzi, A.; Govoni, P.; Lucchini, M. T.; Manzoni, R. A.; Martelli, A.; Marzocchi, B.; Paganoni, M.; Ragazzi, S.; Tabarelli de Fatis, T.] Univ Milano Bicocca, Naples, Italy; Univ Naples Federico II, Ist Nazl Fis Nucl, Sez Napoli, Naples, Italy; Univ Basilicata Potenza, Naples, Italy; Univ G Marconi Roma, Naples, Italy; [Buontempo, S.; Cavallo, N.; Di Guida, S.; Fabozzi, F.; Iorio, A. O. M.; Lista, L.; Meola, S.; Merola, M.; Paolucci, P.] Ist Nazl Fis Nucl, Sez Napoli, Naples, Italy; [Iorio, A. O. M.] Univ Naples Federico II, Naples, Italy; [Cavallo, N.; Fabozzi, F.] Univ Basilicata, Potenza, Italy; [Meola, S.] Univ G Marconi, Rome, Italy; Univ Padua, Ist Nazl Fis Nucl, Sez Padova, Padua, Italy; [Kanishchev, K.] Univ Trento, Trento, Italy; [Azzi, P.; Bacchetta, N.; Bisello, D.; Branca, A.; Carlin, R.; Checchia, P.; Dall'Osso, M.; Dorigo, T.; Dosselli, U.; Gasparini, F.; Gasparini, U.; Giubilato, P.; Gozzelino, A.; Kanishchev, K.; Lacaprara, S.; Margoni, M.; Meneguzzo, A. T.; Pazzini, J.; Pozzobon, N.; Ronchese, P.; Simonetto, F.; Torassa, E.; Tosi, M.; Zotto, P.; Zucchetta, A.; Zumerle, G.] Ist Nazl Fis Nucl, Sez Padova, Padua, Italy; [Bisello, D.; Branca, A.; Carlin, R.; Dall'Osso, M.; Gasparini, F.; Gasparini, U.; Giubilato, P.; Margoni, M.; Meneguzzo, A. T.; Pazzini, J.; Pozzobon, N.; Ronchese, P.; Simonetto, F.; Tosi, M.; Zotto, P.; Zucchetta, A.; Zumerle, G.] Univ Padua, I-35100 Padua, Italy; [Ratti, S. P.] Univ Pavia, Ist Nazl Fis Nucl, Sez Pavia, I-27100 Pavia, Italy; [Gabusi, M.; Ratti, S. P.; Re, V.; Riccardi, C.; Salvini, P.; Vitulo, P.] Ist Nazl Fis Nucl, Sez Pavia, I-06100 Perugia, Italy; [Gabusi, M.; Riccardi, C.; Vitulo, P.] Univ Pavia, Perugia, Italy; Univ Perugia, Ist Nazl Fis Nucl, Sez Perugia, I-06100 Perugia, Italy; [Biasini, M.; Bilei, G. M.; Ciangottini, D.; Fano, L.; Lariccia, P.; Mantovani, G.; Menichelli, M.; Saha, A.; Santocchia, A.; Spiezia, A.] Ist Nazl Fis Nucl, Sez Perugia, Perugia, Italy; [Biasini, M.; Ciangottini, D.; Fano, L.; Lariccia, P.; Mantovani, G.; Santocchia, A.; Spiezia, A.] Univ Perugia, I-06100 Perugia, Italy; Univ Pisa, Scuola Normale Super Pisa, Ist Nazl Fis Nucl, Sez Pisa, Pisa, Italy; [Androsov, K.; Azzurri, P.; Bagliesi, G.; Bernardini, J.; Boccali, T.; Broccolo, G.; Castaldi, R.; Ciocci, M. A.; Dell'Orso, R.; Donato, S.; Fiori, F.; Foa, L.; Giassi, A.; Grippo, M. T.; Ligabue, F.; Lomtadze, T.; Martini, L.; Messineo, A.; Moon, C. S.; Palla, F.; Rizzi, A.; Savoy-Navarro, A.; Serban, A. T.; Spagnolo, P.; Squillacioti, P.; Tenchini, R.; Tonelli, G.; Venturi, A.; Verdini, P. G.; Vernieri, C.] Ist Nazl Fis Nucl, Sez Pisa, Pisa, Italy; [Martini, L.; Messineo, A.; Rizzi, A.; Tonelli, G.] Univ Pisa, I-56100 Pisa, Italy; [Broccolo, G.; Donato, S.; Fiori, F.; Foa, L.; Ligabue, F.; Vernieri, C.] Scuola Normale Super Pisa, Rome, Italy; Univ Roma, Ist Nazl Fis Nucl, Sez Roma, Rome, Italy; [Barone, L.; Cavallari, F.; D'imperio, G.; Del Re, D.; Diemoz, M.; Jorda, C.; Longo, E.; Margaroli, F.; Meridiani, P. M.; Micheli, F.; Nourbakhsh, S.; Organtini, G.; Paramatti, R.; Rahatlou, S.; Rovelli, C.; Santanastasio, F.; Soffi, L.; Traczyk, P.] Ist Nazl Fis Nucl, Sez Roma, Rome, Italy; [Barone, L.; D'imperio, G.; Del Re, D.; Longo, E.; Margaroli, F.; Micheli, F.; Nourbakhsh, S.; Organtini, G.; Rahatlou, S.; Santanastasio, F.; Soffi, L.; Traczyk, P.] Univ Roma Tor Vergata, I-00173 Rome, Italy; Univ Turin, Univ Piemonte Orientale Novara, Ist Nazl Fis Nucl, Sez Torino, Turin, Italy; [Amapane, N.; Arcidiacono, R.; Argiro, S.; Arneodo, M.; Bellan, R.; Biino, C.; Cartiglia, N.; Casasso, S.; Costa, M.; Degano, A.; Demaria, N.; Finco, L.; Mariotti, C.; Maselli, S.; Migliore, E.; Monaco, V.; Musich, M.; Obertino, M. M.; Pacher, L.; Pastrone, N.; Pelliccioni, M.; Angioni, G. L. Pinna; Potenza, A.; Romero, A.; Ruspa, M.; Sacchi, R.; Solano, A.; Staiano, A.; Tamponi, U.] Ist Nazl Fis Nucl, Sez Torino, Turin, Italy; [Amapane, N.; Argiro, S.; Bellan, R.; Casasso, S.; Costa, M.; Degano, A.; Finco, L.; Migliore, E.; Monaco, V.; Pacher, L.; Angioni, G. L. Pinna; Potenza, A.; Romero, A.; Sacchi, R.; Solano, A.] Univ Turin, I-10124 Turin, Italy; [Arcidiacono, R.; Arneodo, M.; Obertino, M. M.; Ruspa, M.] Univ Piemonte Orientale, Novara, Italy; Univ Trieste, Ist Nazl Fis Nucl, Sez Trieste, Trieste, Italy; [Belforte, S.; Candelise, V.; Casarsa, M.; Cossutti, F.; Della Ricca, G.; Gobbo, B.; La Licata, C.; Marone, M.; Schizzi, A.; Umer, T.; Zanetti, A.] Ist Nazl Fis Nucl, Sez Trieste, Trieste, Italy; [Candelise, V.; Della Ricca, G.; La Licata, C.; Marone, M.; Schizzi, A.; Umer, T.] Univ Trieste, I-34127 Trieste, Italy; [Chang, S.; Kropivnitskaya, A.; Nam, S. K.] Kangwon Natl Univ, Chunchon, South Korea; [Kim, D. H.; Kim, G. N.; Kim, M. S.; Kong, D. J.; Lee, S.; Oh, Y. D.; Park, H.; Sakharov, A.; Son, D. C.] Kyungpook Natl Univ, Taegu, South Korea; [Kim, T. J.] Chonbuk Natl Univ, Jeonju 561756, South Korea; [Kim, J. Y.; Song, S.] Chonnam Natl Univ, Inst Universe & Elementary Particles, Kwangju, South Korea; [Choi, S.; Gyun, D.; Hong, B.; Jo, M.; Kim, H.; Kim, Y.; Lee, B.; Lee, K. S.; Park, S. K.; Roh, Y.] Korea Univ, Seoul, South Korea; [Yoo, H. D.] Seoul Natl Univ, Seoul, South Korea; [Choi, M.; Kim, J. H.; Park, I. C.; Ryu, G.; Ryu, M. S.] Univ Seoul, Seoul, South Korea; [Choi, Y.; Choi, Y. K.; Goh, J.; Kim, D.; Kwon, E.; Lee, J.; Yu, I.] Sungkyunkwan Univ, Suwon, South Korea; [Juodagalvis, A.] Vilnius State Univ, Vilnius, Lithuania; [Komaragiri, J. R.; Ali, M. A. B. Md] Univ Malaya, Natl Ctr Particle Phys, Kuala Lumpur, Malaysia; [Linares, E. Casimiro; Castilla-Valdez, H.; De La Cruz-Burelo, E.; Heredia-de la Cruz, I.; Hernandez-Almada, A.; Lopez-Fernandez, R.; Sanchez-Hernandez, A.] IPN, Ctr Invest & Estudios Avanzados, Mexico City 07738, DF, Mexico; [Carrillo Moreno, S.; Vazquez Valencia, F.] Univ Iberoamer, Mexico City, DF, Mexico; [Pedraza, I.; Salazar Ibarguen, H. A.] Benemerita Univ Autonoma Puebla, Puebla, Mexico; [Morelos Pineda, A.] Univ Autonoma San Luis Potosi, San Luis Potosi, Mexico; [Krofcheck, D.] Univ Auckland, Auckland 1, New Zealand; [Butler, P. H.; Reucroft, S.] Univ Canterbury, Christchurch 1, New Zealand; [Ahmad, A.; Ahmad, M.; Hassan, Q.; Hoorani, H. R.; Khan, W. A.; Khurshid, T.; Shoaib, M.] Quaid I Azam Univ, Natl Ctr Phys, Islamabad, Pakistan; [Bialkowska, H.; Bluj, M.; Boimska, B.; Frueboes, T.; Gorski, M.; Kazana, M.; Nawrocki, K.; Romanowska-Rybinska, K.; Szleper, M.; Zalewski, P.] Natl Ctr Nucl Res, Otwock, Poland; [Brona, G.; Bunkowski, K.; Cwiok, M.; Dominik, W.; Doroba, K.; Kalinowski, A.; Konecki, M.; Krolikowski, J.; Misiura, M.; Olszewski, M.; Wolszczak, W.] Univ Warsaw, Inst Expt Phys, Fac Phys, Warsaw, Poland; [Bargassa, P.; Beirao Da Cruz E Silva, C.; Faccioli, P.; Ferreira Parracho, P. G.; Gallinaro, M.; Lloret Iglesias, L.; Nguyen, F.; Rodrigues Antunes, J.; Seixas, J.; Varela, J.; Vischia, P.] Lab Instrumentacao & Fis Expt Particulas, Lisbon, Portugal; [Afanasiev, S.; Bunin, P.; Gavrilenko, M.; Golutvin, I.; Gorbunov, I.; Kamenev, A.; Karjavin, V.; Konoplyanikov, V.; Lanev, A.; Malakhov, A.; Matveev, V.; Moisenz, P.; Palichik, V.; Perelygin, V.; Shmatov, S.; Skatchkov, N.; Smirnov, V.; Zarubin, A.] Joint Nucl Res Inst, Dubna, Russia; [Golovtsov, V.; Ivanov, Y.; Kim, V.; Levchenko, P.; Murzin, V.; Oreshkin, V.; Smirnov, I.; Sulimov, V.; Uvarov, L.; Vavilov, S.; Vorobyev, A.; Vorobyev, An.] Petersburg Nucl Phys Inst, Gatchina, Russia; [Andreev, Yu.; Dermenev, A.; Gninenko, S.; Golubev, N.; Kirsanov, M.; Krasnikov, N.; Pashenkov, A.; Tlisov, D.; Toropin, A.] Russian Acad Sci, Inst Nucl Res, Moscow 117312, Russia; [Epshteyn, V.; Gavrilov, V.; Lychkovskaya, N.; Popov, V.; Pozdnyakov, I.; Safronov, G.; Semenov, S.; Spiridonov, A.; Stolin, V.; Vlasov, E.; Zhokin, A.] Inst Theoret & Expt Phys, Moscow 117259, Russia; [Andreev, V.; Azarkin, M.; Dremin, I.; Kirakosyan, M.; Leonidov, A.; Mesyats, G.; Rusakov, S. V.; Vinogradov, A.] PN Lebedev Phys Inst, Moscow 117924, Russia; [Belyaev, A.; Boos, E.; Dubinin, M.; Dudko, L.; Ershov, A.; Gribushin, A.; Klyukhin, V.; Kodolova, O.; Lokhtin, I.; Obraztsov, S.; Petrushanko, S.; Savrin, V.; Snigirev, A.] Moscow MV Lomonosov State Univ, Skobeltsyn Inst Nucl Phys, Moscow, Russia; [Azhgirey, I.; Bayshev, I.; Bitioukov, S.; Kachanov, V.; Kalinin, A.; Konstantinov, D.; Krychkine, V.; Petrov, V.; Ryutin, R.; Sobol, A.; Tourtchanovitch, L.; Troshin, S.; Tyurin, N.; Uzunian, A.; Volkov, A.] State Res Ctr Russian Federat, Inst High Energy Phys, Protvino, Russia; [Adzic, P.; Ekmedzic, M.; Milosevic, J.; Rekovic, V.] Univ Belgrade, Fac Phys, Belgrade 11001, Serbia; [Adzic, P.; Ekmedzic, M.; Milosevic, J.; Rekovic, V.] Univ Belgrade, Vinca Inst Nucl Sci, Belgrade, Serbia; [Alcaraz Maestre, J.; Battilana, C.; Calvo, E.; Cerrada, M.; Llatas, M. Chamizo; Colino, N.; De La Cruz, B.; Delgado Peris, A.; Dominguez Vazquez, D.; Escalante Del Valle, A.; Fernandez Bedoya, C.; Fernandez Ramos, J. P.; Flix, J.; Fouz, M. C.; Garcia-Abia, P.; Gonzalez Lopez, O.; Goy Lopez, S.; Hernandez, J. M.; Josa, M. I.; Navarro De Martino, E.; Perez-Calero Yzquierdo, A.; Puerta Pelayo, J.; Quintario Olmeda, A.; Redondo, I.; Romero, L.; Soares, M. S.] CIEMAT, E-28040 Madrid, Spain; [Albajar, C.; de Troconiz, J. F.; Missiroli, M.; Moran, D.] Univ Autonoma Madrid, Madrid, Spain; [Brun, H.; Cuevas, J.; Menendez, J. Fernandez; Folgueras, S.; Gonzalez Caballero, I.] Univ Oviedo, Oviedo, Spain; [Brochero Cifuentes, J. A.; Cabrillo, I. J.; Calderon, A.; Duarte Campderros, J.; Fernandez, M.; Gomez, G.; Graziano, A.; Lopez Virto, A.; Marco, J.; Marco, R.; Martinez Rivero, C.; Matorras, F.; Munoz Sanchez, F. J.; Piedra Gomez, J.; Rodrigo, T.; Rodriguez-Marrero, A. Y.; Ruiz-Jimeno, A.; Scodellaro, L.; Vila, I.; Vilar Cortabitarte, R.] Univ Cantabria, CSIC, Inst Fis Cantabria IFCA, E-39005 Santander, Spain; [Abbaneo, D.; Auffray, E.; Auzinger, G.; Bachtis, M.; Baillon, P.; Ball, A. H.; Barney, D.; Benaglia, A.; Bendavid, J.; Benhabib, L.; Benitez, J. F.; Bernet, C.; Bloch, P.; Bocci, A.; Bonato, A.; Bondu, O.; Botta, C.; Breuker, H.; Camporesi, T.; Cerminara, G.; Colafranceschi, S.; D'Alfonso, M.; d'Enterria, D.; Dabrowski, A.; David, A.; De Guio, F.; De Roeck, A.; De Visscher, S.; Di Marco, E.; Dobson, M.; Dordevic, M.; Dupont-Sagorin, N.; Elliott-Peisert, A.; Franzoni, G.; Funk, W.; Gigi, D.; Gill, K.; Giordano, D.; Girone, M.; Glege, F.; Guida, R.; Gundacker, S.; Guthoff, M.; Hammer, J.; Hansen, M.; Harris, P.; Hegeman, J.; Innocente, V.; Janot, P.; Kousouris, K.; Krajczar, K.; Lecoq, P.; Loureno, C.; Magini, N.; Malgeri, L.; Mannelli, M.; Marrouche, J.; Masetti, L.; Meijers, F.; Mersi, S.; Meschi, E.; Moortgat, F.; Morovic, S.; Mulders, M.; Orsini, L.; Pape, L.; Perez, E.; Perrozzi, L.; Petrilli, A.; Petrucciani, G.; Pfeiffer, A.; Pimiae, M.; Piparo, D.; Plagge, M.; Racz, A.; Rolandi, G.; Rovere, M.; Sakulin, H.; Schaefer, C.; Schwick, C.; Sharma, A.; Siegrist, P.; Silva, P.; Simon, M.; Sphicas, P.; Spiga, D.; Steggemann, J.; Stieger, B.; Stoye, M.; Takahashi, Y.; Treille, D.; Tsirou, A.; Veres, G. I.; Wardle, N.; Woehri, H. K.; Wollny, H.; Zeuner, W. D.] CERN, European Org Nucl Res, CH-1211 Geneva, Switzerland; [Bertl, W.; Deiters, K.; Erdmann, W.; Horisberger, R.; Ingram, Q.; Kaestli, H. C.; Kotlinski, D.; Renker, D.; Rohe, T.] Paul Scherrer Inst, Villigen, Switzerland; [Bachmair, F.; Baeni, L.; Bianchini, L.; Buchmann, M. A.; Casal, B.; Chanon, N.; Dissertori, G.; Dittmar, M.; Donega, M.; Duenser, M.; Eller, P.; Grab, C.; Hits, D.; Hoss, J.; Lustermann, W.; Mangano, B.; Marini, A. C.; Marionneau, M.; Martinez Ruiz del Arbol, P.; Masciovecchio, M.; Meister, D.; Mohr, N.; Musella, P.; Naegeli, C.; Nessi-Tedaldi, F.; Pandolfi, F.; Pauss, F.; Peruzzi, M.; Quittnat, M.; Rebane, L.; Rossini, M.; Starodumov, A.; Takahashi, M.; Theofilatos, K.; Wallny, R.; Weber, H. A.] ETH, Inst Particle Phys, Zurich, Switzerland; [Amsler, C.; Canelli, M. F.; Chiochia, V.; De Cosa, A.; Hinzmann, A.; Hreus, T.; Kilminster, B.; Lange, C.; Millan Mejias, B.; Ngadiuba, J.; Pinna, D.; Robmann, P.; Ronga, F. J.; Taroni, S.; Verzetti, M.; Yang, Y.] Univ Zurich, Zurich, Switzerland; [Cardaci, M.; Chen, K. H.; Ferro, C.; Kuo, C. M.; Lin, W.; Lu, Y. J.; Volpe, R.; Yu, S. S.] Natl Cent Univ, Chungli 32054, Taiwan; [Chang, P.; Chang, Y. H.; Chang, Y. W.; Chao, Y.; Chen, K. F.; Chen, P. H.; Dietz, C.; Grundler, U.; Hou, W-S.; Kao, K. Y.; Liu, Y. F.; Lu, R-S.; Majumder, D.; Petrakou, E.; Tzeng, Y. M.; Wilken, R.] Natl Taiwan Univ, Taipei 10764, Taiwan; [Asavapibhop, B.; Singh, G.; Srimanobhas, N.; Suwonjandee, N.] Chulalongkorn Univ, Fac Sci, Dept Phys, Bangkok, Thailand; [Adiguzel, A.; Bakirci, M. N.; Cerci, S.; Dozen, C.; Dumanoglu, I.; Eskut, E.; Girgis, S.; Gokbulut, G.; Gurpinar, E.; Hos, I.; Kangal, E. E.; Topaksu, A. Kayis; Onengut, G.; Ozdemir, K.; Ozturk, S.; Polatoz, A.; Cerci, D. Sunar; Tali, B.; Topakli, H.; Vergili, M.] Cukurova Univ, Adana, Turkey; [Akin, I. V.; Bilin, B.; Bilmis, S.; Gamsizkan, H.; Isildak, B.; Karapinar, G.; Ocalan, K.; Sekmen, S.; Surat, U. E.; Yalvac, M.; Zeyrek, M.] Middle E Tech Univ, Dept Phys, TR-06531 Ankara, Turkey; [Albayrak, E. A.; Guelmez, E.; Kaya, M.; Kaya, O.; Yetkin, T.] Bogazici Univ, Istanbul, Turkey; [Cankocak, K.; Vardarli, F. I.] Istanbul Tech Univ, TR-80626 Istanbul, Turkey; [Levchuk, L.; Sorokin, P.] Ctr Nat Sci, Kharkov Inst Phys & Technol, Kharkov, Ukraine; [Brooke, J. J.; Clement, E.; Cussans, D.; Flacher, H.; Goldstein, J.; Grimes, M.; Heath, G. P.; Heath, H. F.; Jacob, J.; Kreczko, L.; Lucas, C.; Meng, Z.; Newbold, D. M.; Paramesvaran, S.; Poll, A.; Sakuma, T.; Senkin, S.; Smith, V. J.] Univ Bristol, Bristol, Avon, England; [Bell, K. W.; Belyaev, A.; Brew, C.; Brown, R. M.; Cockerill, D. J. A.; Coughlan, J. A.; Harder, K.; Harper, S.; Olaiya, E.; Petyt, D.; Shepherd-Themistocleous, C. H.; Thea, A.; Tomalin, I. R.; Williams, T.; Womersley, W. J.; Worm, S. D.] Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England; [Baber, M.; Bainbridge, R.; Buchmuller, O.; Burton, D.; Colling, D.; Cripps, N.; Dauncey, P.; Davies, G.; Della Negra, M.; Dunne, P.; Ferguson, W.; Fulcher, J.; Futyan, D.; Hall, G.; Iles, G.; Jarvis, M.; Karapostoli, G.; Kenzie, M.; Lane, R.; Lucas, R.; Lyons, L.; Magnan, A-M.; Malik, S.; Mathias, B.; Nash, J.; Nikitenko, A.; Pela, J.; Pesaresi, M.; Petridis, K.; Raymond, D. M.; Rogerson, S.; Rose, A.; Seez, C.; Sharp, P.; Tapper, A.; Vazquez Acosta, M.; Virdee, T.; Zenz, S. C.] Univ London Imperial Coll Sci Technol & Med, London, England; [Cole, J. E.; Hobson, P. R.; Khan, A.; Kyberd, P.; Leggat, D.; Leslie, D.; Reid, I. D.; Symonds, P.; Teodorescu, L.; Turner, M.] Brunel Univ, Uxbridge UB8 3PH, Middx, England; [Dittmann, J.; Hatakeyama, K.; Kasmi, A.; Liu, H.; Scarborough, T.] Baylor Univ, Waco, TX 76798 USA; [Charaf, O.; Cooper, S. I.; Henderson, C.; Rumerio, P.] Univ Alabama, Tuscaloosa, AL USA; [Avetisyan, A.; Bose, T.; Fantasia, C.; Lawson, P.; Richardson, C.; Rohlf, J.; St John, J.; Sulak, L.] Boston Univ, Boston, MA 02215 USA; [Alimena, J.; Berry, E.; Bhattacharya, S.; Christopher, G.; Cutts, D.; Demiragli, Z.; Dhingra, N.; Ferapontov, A.; Garabedian, A.; Heintz, U.; Kukartsev, G.; Laird, E.; Landsberg, G.; Luk, M.; Narain, M.; Segala, M.; Sinthuprasith, T.; Speer, T.; Swanson, J.] Brown Univ, Providence, RI 02912 USA; [Breedon, R.; Breto, G.; Calderon De La Barca Sanchez, M.; Chauhan, S.; Chertok, M.; Conway, J.; Conway, R.; Cox, P. T.; Erbacher, R.; Gardner, M.; Ko, W.; Lander, R.; Mulhearn, M.; Pellett, D.; Pilot, J.; Ricci-Tam, F.; Shalhout, S.; Smith, J.; Squires, M.; Stolp, D.; Tripathi, M.; Wilbur, S.; Yohay, R.] Univ Calif Davis, Davis, CA 95616 USA; [Cousins, R.; Everaerts, P.; Farrell, C.; Hauser, J.; Ignatenko, M.; Rakness, G.; Takasugi, E.; Valuev, V.; Weber, M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Burt, K.; Clare, R.; Ellison, J.; Gary, J. W.; Hanson, G.; Heilman, J.; Rikova, M. Ivova; Jandir, P.; Kennedy, E.; Lacroix, F.; Long, O. R.; Luthra, A.; Malberti, M.; Olmedo Negrete, M.; Shrinivas, A.; Sumowidagdo, S.; Wimpenny, S.] Univ Calif Riverside, Riverside, CA 92521 USA; [Branson, J. G.; Cerati, G. B.; Cittolin, S.; D'Agnolo, R. T.; Holzner, A.; Kelley, R.; Klein, D.; Kovalskyi, D.; Letts, J.; Macneill, I.; Olivito, D.; Padhi, S.; Palmer, C.; Pieri, M.; Sani, M.; Sharma, V.; Simon, S.; Tu, Y.; Vartak, A.; Welke, C.; Wuerthwein, F.; Yagil, A.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Barge, D.; Bradmiller-Feld, J.; Campagnari, C.; Danielson, T.; Dishaw, A.; Dutta, V.; Flowers, K.; Sevilla, M. Franco; Geffert, P.; George, C.; Golf, F.; Gouskos, L.; Incandela, J.; Justus, C.; Mccoll, N.; Richman, J.; Stuart, D.; To, W.; West, C.; Yoo, J.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Apresyan, A.; Bornheim, A.; Bunn, J.; Chen, Y.; Duarte, J.; Mott, A.; Newman, H. B.; Pena, C.; Pierini, M.; Spiropulu, M.; Vlimant, J. R.; Wilkinson, R.; Xie, S.; Zhu, R. Y.] CALTECH, Pasadena, CA 91125 USA; [Azzolini, V.; Calamba, A.; Carlson, B.; Ferguson, T.; Iiyama, Y.; Paulini, M.; Russ, J.; Vogel, H.; Vorobiev, I.] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Cumalat, J. P.; Ford, W. T.; Gaz, A.; Krohn, M.; Luiggi Lopez, E.; Nauenberg, U.; Smith, J. G.; Stenson, K.; Wagner, S. R.] Univ Colorado, Boulder, CO 80309 USA; [Alexander, J.; Chatterjee, A.; Chaves, J.; Chu, J.; Dittmer, S.; Eggert, N.; Mirman, N.; Kaufman, G. Nicolas; Patterson, J. R.; Ryd, A.; Salvati, E.; Skinnari, L.; Sun, W.; Teo, W. D.; Thom, J.; Thompson, J.; Tucker, J.; Weng, Y.; Winstrom, L.; Wittich, P.] Cornell Univ, Ithaca, NY USA; [Winn, D.] Fairfield Univ, Fairfield, CT 06430 USA; [Abdullin, S.; Albrow, M.; Anderson, J.; Apollinari, G.; Bauerdick, L. A. T.; Beretvas, A.; Berryhill, J.; Bhat, P. C.; Bolla, G.; Burkett, K.; Butler, J. N.; Cheung, H. W. K.; Chlebana, F.; Cihangir, S.; Elvira, V. D.; Fisk, I.; Freeman, J.; Gao, Y.; Gottschalk, E.; Gray, L.; Green, D.; Gruenendahl, S.; Gutsche, O.; Hanlon, J.; Hare, D.; Harris, R. M.; Hirschauer, J.; Hooberman, B.; Jindariani, S.; Johnson, M.; Joshi, U.; Kaadze, K.; Klima, B.; Kreis, B.; Kwan, S.; Linacre, J.; Lincoln, D.; Lipton, R.; Liu, T.; Lykken, J.; Maeshima, K.; Marraffino, J. M.; Outschoorn, V. I. Martinez; Maruyama, S.; Mason, D.; McBride, P.; Merkel, P.; Mishra, K.; Mrenna, S.; Nahn, S.; Newman-Holmes, C.; O'Dell, V.; Prokofyev, O.; Sexton-Kennedy, E.; Sharma, S.; Soha, A.; Spalding, W. J.; Spiegel, L.; Taylor, L.; Tkaczyk, S.; Tran, N. V.; Uplegger, L.; Vaandering, E. W.; Vidal, R.; Whitbeck, A.; Whitmore, J.; Yang, F.] Fermilab Natl Accelerator Lab, Batavia, IL 60510 USA; [Acosta, D.; Avery, P.; Bortignon, P.; Bourilkov, D.; Carver, M.; Curry, D.; Das, S.; De Gruttola, M.; Di Giovanni, G. P.; Field, R. D.; Fisher, M.; Furic, I. K.; Hugon, J.; Konigsberg, J.; Korytov, A.; Kypreos, T.; Low, J. F.; Matchev, K.; Mei, H.; Milenovic, P.; Mitselmakher, G.; Muniz, L.; Rinkevicius, A.; Shchutska, L.; Snowball, M.; Sperka, D.; Yelton, J.; Zakaria, M.] Univ Florida, Gainesville, FL USA; [Hewamanage, S.; Linn, S.; Markowitz, P.; Martinez, G.; Rodriguez, J. L.] Florida Int Univ, Miami, FL 33199 USA; [Adams, T.; Askew, A.; Bochenek, J.; Diamond, B.; Haas, J.; Hagopian, S.; Hagopian, V.; Johnson, K. F.; Prosper, H.; Veeraraghavan, V.; Weinberg, M.] Florida State Univ, Tallahassee, FL 32306 USA; [Baarmand, M. M.; Hohlmann, M.; Kalakhety, H.; Yumiceva, F.] Florida Inst Technol, Melbourne, FL 32901 USA; [Adams, M. R.; Apanasevich, L.; Berry, D.; Betts, R. R.; Bucinskaite, I.; Cavanaugh, R.; Evdokimov, O.; Gauthier, L.; Gerber, C. E.; Hofman, D. J.; Kurt, P.; Moon, D. H.; O'Brien, C.; Gonzalez, I. D. Sandoval; Silkworth, C.; Turner, P.; Varelas, N.] Univ Illinois, Chicago, IL USA; [Bilki, B.; Clarida, W.; Dilsiz, K.; Haytmyradov, M.; Merlo, J-P.; Mermerkaya, H.; Mestvirishvili, A.; Moeller, A.; Nachtman, J.; Ogul, H.; Onel, Y.; Ozok, F.; Penzo, A.; Rahmat, R.; Sen, S.; Tan, P.; Tiras, E.; Wetzel, J.; Yi, K.] Univ Iowa, Iowa City, IA USA; [Barnett, B. A.; Blumenfeld, B.; Bolognesi, S.; Fehling, D.; Gritsan, A. V.; Maksimovic, P.; Martin, C.; Swartz, M.] Johns Hopkins Univ, Baltimore, MD USA; [Baringer, P.; Bean, A.; Benelli, G.; Bruner, C.; Kenny, R. P., III; Malek, M.; Murray, M.; Noonan, D.; Sanders, S.; Sekaric, J.; Stringer, R.; Wang, Q.; Wood, J. S.] Univ Kansas, Lawrence, KS 66045 USA; [Chakaberia, I.; Ivanov, A.; Khalil, S.; Makouski, M.; Maravin, Y.; Saini, L. K.; Skhirtladze, N.; Svintradze, I.] Kansas State Univ, Manhattan, KS 66506 USA; [Gronberg, J.; Lange, D.; Rebassoo, F.; Wright, D.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Baden, A.; Belloni, A.; Calvert, B.; Eno, S. C.; Gomez, J. A.; Hadley, N. J.; Kellogg, R. G.; Kolberg, T.; Lu, Y.; Mignerey, A. C.; Pedro, K.; Skuja, A.; Tonjes, M. B.; Tonwar, S. C.] Univ Maryland, College Pk, MD 20742 USA; [Apyan, A.; Barbieri, R.; Bauer, G.; Busza, W.; Cali, I. A.; Chan, M.; Di Matteo, L.; Gomez Ceballos, G.; Goncharov, M.; Gulhan, D.; Klute, M.; Lai, Y. S.; Lee, Y-J.; Levin, A.; Luckey, P. D.; Ma, T.; Paus, C.; Ralph, D.; Roland, C.; Roland, G.; Stephans, G. S. F.; Sumorok, K.; Velicanu, D.; Veverka, J.; Wyslouch, B.; Yang, M.; Zanetti, M.; Zhukova, V.] MIT, Cambridge, MA 02139 USA; [Dahmes, B.; Gude, A.; Kao, S. C.; Klapoetke, K.; Kubota, Y.; Mans, J.; Pastika, N.; Rusack, R.; Singovsky, A.; Tambe, N.; Turkewitz, J.] Univ Minnesota, Minneapolis, MN USA; [Acosta, J. G.; Oliveros, S.] Univ Mississippi, Oxford, MS USA; [Avdeeva, E.; Bloom, K.; Bose, S.; Claes, D. R.; Dominguez, A.; Suarez, R. Gonzalez; Keller, J.; Knowlton, D.; Kravchenko, I.; Lazo-Flores, J.; Meier, F.; Ratnikov, F.; Snow, G. R.; Zvada, M.] Univ Nebraska, Lincoln, NE USA; [Dolen, J.; Godshalk, A.; Iashvili, I.; Kharchilava, A.; Kumar, A.; Rappoccio, S.] SUNY Buffalo, Buffalo, NY 14260 USA; [Alverson, G.; Barberis, E.; Baumgartel, D.; Chasco, M.; Massironi, A.; Morse, D. M.; Nash, D.; Orimoto, T.; Trocino, D.; Wang, R-J; Wood, D.; Zhang, J.] Northeastern Univ, Boston, MA 02115 USA; [Hahn, K. A.; Kubik, A.; Mucia, N.; Odell, N.; Pollack, B.; Pozdnyakov, A.; Schmitt, M.; Stoynev, S.; Sung, K.; Velasco, M.; Won, S.] Northwestern Univ, Evanston, IL USA; [Brinkerhoff, A.; Chan, K. M.; Drozdetskiy, A.; Hildreth, M.; Jessop, C.; Karmgard, D. J.; Kellams, N.; Lannon, K.; Lynch, S.; Marinelli, N.; Musienko, Y.; Pearson, T.; Planer, M.; Ruchti, R.; Smith, G.; Valls, N.; Wayne, M.; Wolf, M.; Woodard, A.] Univ Notre Dame, Notre Dame, IN 46556 USA; [Antonelli, L.; Brinson, J.; Bylsma, B.; Durkin, L. S.; Flowers, S.; Hart, A.; Hill, C.; Hughes, R.; Kotov, K.; Ling, T. Y.; Luo, W.; Puigh, D.; Rodenburg, M.; Winer, B. L.; Wolfe, H.; Wulsin, H. W.] Ohio State Univ, Columbus, OH 43210 USA; [Driga, O.; Elmer, P.; Hardenbrook, J.; Hebda, P.; Hunt, A.; Koay, S. A.; Lujan, P.; Marlow, D.; Medvedeva, T.; Mooney, M.; Olsen, J.; Piroue, P.; Quan, X.; Saka, H.; Stickland, D.; Tully, C.; Werner, J. S.; Zuranski, A.; Brownson, E.] Princeton Univ, Princeton, NJ 08544 USA; [Malik, S.; Mendez, H.; Vargas, J. E. Ramirez] Univ Puerto Rico, Mayaguez, PR USA; [Barnes, V. E.; Benedetti, D.; Bortoletto, D.; De Mattia, M.; Gutay, L.; Hu, Z.; Jha, M. K.; Jones, M.; Jung, K.; Kress, M.; Leonardo, N.; Miller, D. H.; Neumeister, N.; Radburn-Smith, B. C.; Shi, X.; Shipsey, I.; Silvers, D.; Svyatkovskiy, A.; Wang, F.; Xie, W.; Xu, L.; Zablocki, J.] Purdue Univ, W Lafayette, IN 47907 USA; [Parashar, N.; Stupak, J.] Purdue Univ Calumet, Hammond, LA USA; [Adair, A.; Akgun, B.; Ecklund, K. M.; Geurts, F. J. M.; Li, W.; Michlin, B.; Padley, B. P.; Redjimi, R.; Roberts, J.; Zabel, J.] Rice Univ, Houston, TX USA; [Betchart, B.; Bodek, A.; Covarelli, R.; De Barbaro, P.; Demina, R.; Eshaq, Y.; Ferbel, T.; Garcia-Bellido, A.; Goldenzweig, P.; Han, J.; Harel, A.; Khukhunaishvili, A.; Korjenevski, S.; Petrillo, G.; Vishnevskiy, D.] Univ Rochester, Rochester, NY 14627 USA; [Ciesielski, R.; Demortier, L.; Goulianos, K.; Mesropian, C.] Rockefeller Univ, New York, NY 10021 USA; [Arora, S.; Barker, A.; Chou, J. P.; Contreras-Campana, C.; Contreras-Campana, E.; Duggan, D.; Ferencek, D.; Gershtein, Y.; Gray, R.; Halkiadakis, E.; Hidas, D.; Kaplan, S.; Lath, A.; Panwalkar, S.; Park, M.; Patel, R.; Salur, S.; Schnetzer, S.; Somalwar, S.; Stone, R.; Thomas, S.; Thomassen, P.; Walker, M.] Rutgers State Univ, Piscataway, NJ USA; [Rose, K.; Spanier, S.; York, A.] Univ Tennessee, Knoxville, TN USA; [Bouhali, O.; Hernandez, A. Castaneda; Eusebi, R.; Flanagan, W.; Gilmore, J.; Kamon, T.; Khotilovich, V.; Krutelyov, V.; Montalvo, R.; Osipenkov, I.; Pakhotin, Y.; Perloff, A.; Roe, J.; Rose, A.; Safonov, A.; Suarez, I.; Tatarinov, A.; Ulmer, K. A.] Texas A&M Univ, College Stn, TX USA; [Akchurin, N.; Cowden, C.; Damgov, J.; Dragoiu, C.; Dudero, P. R.; Faulkner, J.; Kovitanggoon, K.; Kunori, S.; Lee, S. W.; Libeiro, T.; Volobouev, I.] Texas Tech Univ, Lubbock, TX 79409 USA; [Appelt, E.; Delannoy, A. G.; Greene, S.; Gurrola, A.; Johns, W.; Maguire, C.; Mao, Y.; Melo, A.; Sharma, M.; Sheldon, P.; Snook, B.; Tuo, S.; Velkovska, J.] Vanderbilt Univ, Nashville, TN 37235 USA; [Arenton, M. W.; Boutle, S.; Cox, B.; Francis, B.; Goodell, J.; Hirosky, R.; Ledovskoy, A.; Li, H.; Lin, C.; Neu, C.; Wood, J.] Univ Virginia, Charlottesville, VA USA; [Clarke, C.; Harr, R.; Karchin, P. E.; Don, C. Kottachchi Kankanamge; Lamichhane, P.; Sturdy, J.] Wayne State Univ, Detroit, MI USA; [Belknap, D. A.; Carlsmith, D.; Cepeda, M.; Dasu, S.; Dodd, L.; Duric, S.; Friis, E.; Hall-Wilton, R.; Herndon, M.; Herve, A.; Klabbers, P.; Lanaro, A.; Lazaridis, C.; Levine, A.; Loveless, R.; Mohapatra, A.; Ojalvo, I.; Perry, T.; Pierro, G. A.; Polese, G.; Ross, I.; Sarangi, T.; Savin, A.; Smith, W. H.; Taylor, D.; Vuosalo, C.; Woods, N.] Univ Wisconsin, Madison, WI 53706 USA; [Fruehwirth, R.; Jeitler, M.; Krammer, M.; Wulz, C-E.] Vienna Univ Technol, A-1040 Vienna, Austria; [Rabady, D.; Pernie, L.; Genchev, V.; Boudoul, G.; Contardo, D.; Lingemann, J.; Hartmann, F.; Kornmayer, A.; Mohanty, A. K.; Radogna, R.; Silvestris, L.; Giordano, F.; Gennai, S.; Gerosa, R.; Lucchini, M. T.; Marzocchi, B.; Di Guida, S.; Meola, S.; Paolucci, P.; Ciangottini, D.; Spiezia, A.; Donato, S.; Palla, F.; Micheli, F.; Traczyk, P.; Casasso, S.; Finco, L.; Candelise, V.; Stickland, D.] CERN, European Org Nucl Res, CH-1211 Geneva, Switzerland; [Beluffi, C.] Univ Strasbourg, Univ Haute Alsace Mulhouse, Inst Pluridisciplinaire Hubert Curien, CNRS,IN2P3, Strasbourg, France; [Giammanco, A.] NICPB, Tallinn, Estonia; [Popov, A.; Zhukov, V.; Katkov, I.] Moscow MV Lomonosov State Univ, Skobeltsyn Inst Nucl Phys, Moscow, Russia; [Chinellato, J.; Tonelli Manganote, E. J.] Univ Estadual Campinas, Campinas, SP, Brazil; [Plestina, R.; Bernet, C.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Finger, M., Jr.; Tsamalaidze, Z.] Joint Inst Nucl Res, Dubna, Russia; [Assran, Y.] Suez Univ, Suez, Egypt; [Ellithi Kamel, A.] Cairo Univ, Cairo, Egypt; [Mahmoud, M. A.] Fayoum Univ, Al Fayyum, Egypt; [Radi, A.] Ain Shams Univ, Cairo, Egypt; [Agram, J-L; Conte, E.; Fontaine, J-C.] Univ Haute Alsace, Mulhouse, France; [Hempel, M.; Lohmann, W.; Marfin, I.] Brandenburg Tech Univ Cottbus, Cottbus, Germany; [Horvath, D.] Inst Nucl Res ATOMKI, Debrecen, Hungary; [Vesztergombi, G.; Veres, G. I.] Eotvos Lorand Univ, Budapest, Hungary; [Karancsi, J.] Debrecen Univ Med, H-4012 Debrecen, Hungary; [Bhowmik, S.; Maity, M.] Visva Bharati Univ, Santini Ketan, W Bengal, India; [Wickramage, N.] Univ Ruhuna, Matara, Sri Lanka; [Etesami, S. M.] Isfahan Univ Technol, Esfahan, Iran; [Fahim, A.] Univ Tehran, Dept Engn Sci, Tehran, Iran; [Safarzadeh, B.] Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran; [Androsov, K.; Ciocci, M. A.; Grippo, M. T.; Squillacioti, P.] Univ Siena, I-53100 Siena, Italy; [Moon, C. S.] CNRS, IN2P3, Paris, France; [Savoy-Navarro, A.] Purdue Univ, W Lafayette, IN 47907 USA; [Heredia-de la Cruz, I.] Univ Michoacana, Morelia, Michoacan, Mexico; [Matveev, V.; Musienko, Y.] Russian Acad Sci, Inst Nucl Res, Moscow 117312, Russia; [Kim, V.] St Petersburg State Polytech Univ, St Petersburg, Russia; [Dubinin, M.] CALTECH, Pasadena, CA 91125 USA; [Adzic, P.] Univ Belgrade, Fac Phys, Belgrade 11001, Serbia; [Colafranceschi, S.] Univ Rome, Fac Ingn, Rome, Italy; [Rolandi, G.] Ist Nazl Fis Nucl, Scuola Normale & Sez, Pisa, Italy; [Sphicas, P.] Univ Athens, Athens, Greece; [Naegeli, C.] Paul Scherrer Inst, Villigen, Switzerland; [Starodumov, A.; Nikitenko, A.] Inst Theoret & Expt Phys, Moscow 117259, Russia; [Amsler, C.] Albert Einstein Ctr Fundamental Phys, Bern, Switzerland; [Bakirci, M. N.; Ozturk, S.; Topakli, H.] Gaziosmanpasa Univ, Tokat, Turkey; [Cerci, S.; Cerci, D. Sunar; Tali, B.] Adiyaman Univ, Adiyaman, Turkey; [Onengut, G.] Cag Univ, Mersin, Turkey; [Gamsizkan, H.] Anadolu Univ, Eskisehir, Turkey; [Isildak, B.] Ozyegin Univ, Istanbul, Turkey; [Karapinar, G.] Izmir Inst Technol, Izmir, Turkey; [Ocalan, K.] Necmettin Erbakan Univ, Konya, Turkey; [Albayrak, E. A.; Ozok, F.] Mimar Sinan Univ, Istanbul, Turkey; [Kaya, M.] Marmara Univ, Istanbul, Turkey; [Kaya, O.] Kafkas Univ, Kars, Turkey; [Yetkin, T.] Yildiz Tech Univ, Istanbul, Turkey; [Newbold, D. M.; Lucas, R.] Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England; [Belyaev, A.] Univ Southampton, Sch Phys & Astron, Southampton, Hants, England; [Milenovic, P.] Univ Belgrade, Fac Phys, Belgrade 11001, Serbia; [Milenovic, P.] Vinca Inst Nucl Sci, Belgrade, Serbia; [Bilki, B.] Argonne Natl Lab, Argonne, IL 60439 USA; [Mermerkaya, H.] Erzincan Univ, Erzincan, Turkey; [Bouhali, O.] Texas A&M Univ, Doha, Qatar; [Kamon, T.] Kyungpook Natl Univ, Taegu, South Korea; [Bediaga, I.; De Miranda, J. M.; Rodrigues, F. Ferreira; Gomes, A.; Massafferri, A.; Dos Reis, A. C.; Rodrigues, A. B.] CBPF, Rio De Janeiro, Brazil; [Amato, S.; Akiba, K. Carvalho; De Paula, L.; Francisco, O.; Gandelman, M.; Hicheur, A.; Lopes, J. H.; Tostes, D. Martins; Nasteva, I.; Goicochea, J. M. Otalora; Polycarpo, E.; Potterat, C.; Rangel, M. S.; Guimaraes, V. Salustino; De Paula, B. Souza; Vieira, D.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [An, L.; Gao, Y.; Jing, F.; Li, Y.; Yang, Z.; Yuan, X.; Zhang, Y.; Zhong, L.] Tsinghua Univ, Ctr High Energy Phys, Beijing 100084, Peoples R China; [Beaucourt, L.; Chefdeville, M.; Decamp, D.; Deleage, N.; Ghez, Ph.; Lees, J-P.; Marchand, J. F.; Minard, M-N.; Pietrzyk, B.; Qian, W.; T'Jampens, S.; Tisserand, V.; Tournefier, E.] Univ Savoie, CNRS, IN2P3, LAPP, Annecy Le Vieux, France; [Ajaltouni, Z.; Baalouch, M.; Cogneras, E.; Deschamps, O.; El Rifai, I.; Grabalosa Gandara, M.; Henrard, P.; Hoballah, M.; Lefevre, R.; Maratas, J.; Monteil, S.; Niess, V.; Perret, P.] Univ Blaise Pascal, Clermont Univ, CNRS, IN2P3,LPC, Clermont Ferrand, France; [Adrover, C.; Akar, S.; Aslanides, E.; Cogan, J.; Kanso, W.; Le Gac, R.; Leroy, O.; Mancinelli, G.; Morda, A.; Perrin-Terrin, M.; Serrano, J.; Tsaregorodtsev, A.] Aix Marseille Univ, CPPM, CNRS, IN2P3, Marseille, France; [Amhis, Y.; Barsuk, S.; Borsato, M.; Kochebina, O.; Lefrancois, J.; Machefert, F.; Martin Sanchez, A.; Nicol, M.; Robbe, P.; Schune, M-H.; Teklishyn, M.; Vallier, A.; Viaud, B.; Wormser, G.] Univ Paris Sud, CNRS, IN2P3, LAL, F-91405 Orsay, France; [Ben-Haim, E.; Charles, M.; Coquereau, S.; David, P.; Del Buono, L.; Henry, L.; Polci, F.] Univ Paris Diderot, Univ Paris 06, LPNHE, CNRS,IN2P3, Paris, France; [Albrecht, J.; Brambach, T.; Cauet, Ch.; Deckenhoff, M.; Eitschberger, U.; Ekelhof, R.; Gavardi, L.; Kruse, F.; Meier, F.; Niet, R.; Parkinson, C. J.; Schlupp, M.; Shires, A.; Spaan, B.; Swientek, S.; Wishahi, J.] Tech Univ Dortmund, Fak Phys, Dortmund, Germany; [Gutierrez, O. Aquines; Blouw, J.; Britsch, M.; Fontana, M.; Popov, D.; Schmelling, M.; Volyanskyy, D.; Zavertyaev, M.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Bachmann, S.; Bien, A.; Comerma-Montells, A.; De Cian, M.; Dordei, F.; Esen, S.; Faerber, C.; Gersabeck, E.; Grillo, L.; Han, X.; Hansmann-Menzemer, S.; Jaeger, A.; Kolpin, M.; Kreplin, K.; Krocker, G.; Leverington, B.; Marks, J.; Meissner, M.; Neuner, M.; Nikodem, T.; Seyfert, P.; Stahl, M.; Stahl, S.; Uwer, U.; Vesterinen, M.; Wandernoth, S.; Wiedner, D.; Zhelezov, A.] Heidelberg Univ, Inst Phys, Heidelberg, Germany; [McNulty, R.; Wallace, R.; Zhang, W. C.] Univ Coll Dublin, Sch Phys, Dublin 2, Ireland; [Palano, A.] Sez INFN Bari, Bari, Italy; [Carbone, A.; Falabella, A.; Galli, D.; Marconi, U.; Moggi, N.; Mussini, M.; Perazzini, S.; Vagnoni, V.; Valenti, G.; Zangoli, M.] Sez INFN Bologna, Bologna, Italy; [Bonivento, W.; Cadeddu, S.; Cardini, A.; Cogoni, V.; Contu, A.; Lai, A.; Liu, B.; Manca, G.; Oldeman, R.; Saitta, B.; Vacca, C.] Sez INFN Cagliari, Cagliari, Italy; [Andreotti, M.; Baldini, W.; Bozzi, C.; Calabrese, R.; Corvo, M.; Fiore, M.; Fiorini, M.; Luppi, E.; Pappalardo, L. L.; Shapoval, I.; Tellarini, G.; Tomassetti, L.; Vecchi, S.] Sez INFN Ferrara, Ferrara, Italy; [Anderlini, L.; Bizzeti, A.; Frosini, M.; Graziani, G.; Passaleva, G.; Veltri, M.] Sez INFN Firenze, Florence, Italy; [Bencivenni, G.; Campana, P.; De Simone, P.; Lanfranchi, G.; Palutan, M.; Rama, M.; Sarti, A.; Sciascia, B.; Gomez, R. Vazquez] INFN Frascati, Lab Nazl, Frascati, Italy; [Cardinale, R.; Fontanelli, F.; Gambetta, S.; Patrignani, C.; Petrolini, A.; Pistone, A.] Sez INFN Genova, Genoa, Italy; [Calvi, M.; Cassina, L.; Gotti, C.; Khanji, B.; Kucharczyk, M.; Matteuzzi, C.] Sez INFN Milano Bicocca, Milan, Italy; [Fu, J.; Geraci, A.; Neri, N.; Palombo, F.] Sez INFN Milano, Milan, Italy; [Amerio, S.; Collazuol, G.; Gallorini, S.; Gianelle, A.; Lucchesi, D.; Lupato, A.; Morandin, M.; Rotondo, M.; Sestini, L.; Simi, G.; Stroili, R.] Sez INFN Padova, Padua, Italy; [Bedeschi, F.; Cenci, R.; Leo, S.; Marino, P.; Morello, M. J.; Punzi, G.; Stracka, S.; Walsh, J.] Sez INFN Pisa, Pisa, Italy; [Carboni, G.; Furfaro, E.; Santovetti, E.; Satta, A.] Sez INFN Roma Tor Vergata, Rome, Italy; [Alves, A. A., Jr.; Auriemma, G.; Bocci, V.; Martellotti, G.; Penso, G.; Pinci, D.; Santacesaria, R.; Satriano, C.; Sciubba, A.] Sez INFN Roma La Sapienza, Rome, Italy; [Kucharczyk, M.; Dziurda, A.; Kucewicz, W.; Lesiak, T.; Rachwal, B.; Witek, M.; Chrzaszcz, M.] Polish Acad Sci, Henryk Niewodniczanski Inst Nucl Phys, Krakow, Poland; [Firlej, M.; Fiutowski, T.; Idzik, M.; Morawski, P.; Moron, J.; Oblakowska-Mucha, A.; Swientek, K.; Szumlak, T.] AGH Univ Sci & Technol, Fac Phys & Appl Comp Sci, Krakow, Poland; [Batozskaya, V.; Klimaszewski, K.; Kurek, K.; Szczekowski, M.; Ukleja, A.; Wislicki, W.] Natl Ctr Nucl Res NCBJ, Warsaw, Poland; [Cojocariu, L.; Giubega, L.; Grecu, A.; Maciuc, F.; Orlandea, M.; Popovici, B.; Stoica, S.; Straticiuc, M.] Horia Hulubei Natl Inst Phys & Nucl Engn, Bucharest 077125, Romania; [Alkhazov, G.; Bondar, N.; Dzyuba, A.; Maev, O.; Sagidova, N.; Shcheglov, Y.; Vorobyev, A.] PNPI, Gatchina, Russia; [Belogurov, S.; Belyaev, I.; Egorychev, V.; Golubkov, D.; Kvaratskheliya, T.; Machikhiliyan, I. V.; Polyakov, I.; Savrina, D.; Semennikov, A.; Zhokhov, A.; Golutvin, A.] ITEP, Moscow, Russia; [Savrina, D.; Berezhnoy, A.; Korolev, M.; Leflat, A.] Moscow MV Lomonosov State Univ, SINP, Inst Nucl Phys, Moscow, Russia; [Nikitin, N.; Filippov, S.; Gushchin, E.] Russian Acad Sci, Inst Nucl Res, INR RAN, Moscow 117312, Russia; [Kravchuk, L.; Bondar, A.; Eidelman, S.; Krokovny, P.; Kudryavtsev, V.; Shekhtman, L.; Poluektov, A.] Budker Inst Nucl Phys SB RAS, Novosibirsk, Russia; [Kravchuk, L.; Bondar, A.; Eidelman, S.; Krokovny, P.; Kudryavtsev, V.; Shekhtman, L.; Poluektov, A.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Vorobyev, V.; Artamonov, A.; Belous, K.; Dzhelyadin, R.; Guz, Yu.; Novoselov, A.; Obraztsov, V.; Popov, A.; Romanovsky, V.; Shapkin, M.; Stenyakin, O.; Yushchenko, O.; Badalov, A.] IHEP, Protvino, Russia; [Gomez, M. Calvo; Garrido, L.; Gascon, D.; Diaz, R. Graciani; Grauges, E.; Benito, C. Marin; Olloqui, E. Picatoste; Molina, V. Rives; Ruiz, H.; Vilasis-Cardona, X.] Univ Barcelona, Barcelona, Spain; [Adeva, B.; Cartelle, P. Alvarez; Suarez, A. Dosil; Albor, V. Fernandez; Torreira, A. Gallas; Pardinas, J. Garcia; Morata, J. A. Hernando; Casasus, M. Plo; Vidal, A. Romero; Silva, J. J. Saborido; Sedes, B. Sanmartin; Rios, C. Santamarina; Regueiro, P. Vazquez; Sierra, C. Vazquez; Diaz, M. Vieites] Univ Santiago de Compostela, Santiago De Compostela, Spain; [Bonivento, W.; Contu, A.; Cardinale, R.; Khanji, B.; Fu, J.; Gallorini, S.; Alves, A. A., Jr.; Oblakowska-Mucha, A.; Bondar, N.; Guz, Yu.; Alessio, F.; Archilli, F.; Barschel, C.; Benson, S.; Buytaert, J.; Perez, D. Campora; Garcia, L. Castillo; Cattaneo, M.; Charpentier, Ph.; Vidal, X. Cid; Clemencic, M.; Closier, J.; Coco, V.; Collins, P.; Corti, G.; Couturier, B.; D'Ambrosio, C.; Dettori, F.; Di Canto, A.; Dijkstra, H.; Durante, P.; Ferro-Luzzi, M.; Forty, R.; Frank, M.; Frei, C.; Gaspar, C.; Gligorov, V. V.; Cardoso, L. A. Granado; Gys, T.; Haen, C.; He, J.; Head, T.; van Herwijnen, E.; Jacobsson, R.; Johnson, D.; Joram, C.; Jost, B.; Karacson, M.; Karbach, T. M.; Lacarrere, D.; Langhans, B.; Lindner, R.; Linn, C.; Lohn, S.; Mapelli, A.; Matev, R.; Mathe, Z.; Neubert, S.; Neufeld, N.; Otto, A.; Panman, J.; Altarelli, M. Pepe; Rauschmayr, N.; Rihl, M.; Roiser, S.; Ruf, T.; Schindler, H.; Schmidt, B.; Schopper, A.; Schwemmer, R.; Sridharan, S.; Stagni, F.; Subbiah, V. K.; Teubert, F.; Thomas, E.; Tonelli, D.; Trisovic, A.; Garcia, M. Ubeda; Wicht, J.; Wyllie, K.; Koppenburg, P.; Santos, D. Martinez; Easo, S.; Papanestis, A.; Golutvin, A.; Wilkinson, G.] CERN, European Org Nucl Res, CH-1211 Geneva, Switzerland; [Battista, V.; Bay, A.; Blanc, F.; Dorigo, M.; Dupertuis, F.; Fitzpatrick, C.; Giani, S.; Haefeli, G.; Jaton, P.; Khurewathanakul, C.; Komarov, I.; La Thi, V. N.; Lopez-March, N.; Maerki, R.; Martinelli, M.; Muster, B.; Nakada, T.; Nguyen, A. D.; Nguyen, T. D.; Nguyen-Mau, C.; Prisciandaro, J.; Navarro, A. Puig; Rakotomiaramanana, B.; Rouvinet, J.; Schneider, O.; Soomro, F.; Szczypka, P.; Tobin, M.; Tourneur, S.; Tran, M. T.; Veneziano, G.; Xu, Z.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Anderson, J.; Bernet, R.; Bowen, E.; Bursche, A.; Chiapolini, N.; Chrzaszcz, M.; Elsasser, Ch.; Graverini, E.; Lionetto, F.; Lowdon, P.; Mueller, K.; Serra, N.; Steinkamp, O.; Storaci, B.; Straumann, U.; Tresch, M.; Vollhardt, A.] Univ Zurich, Inst Phys, Zurich, Switzerland; [Aaij, R.; Ali, S.; Van Beuzekom, M.; David, P. N. Y.; De Bruyn, K.; Farinelli, C.; Heijne, V.; Hulsbergen, W.; Jans, E.; Koppenburg, P.; Kozlinskiy, A.; van Leerdam, J.; Merk, M.; Oggero, S.; Pellegrino, A.; Snoek, H.; van Tilburg, J.; Tsopelas, P.; Tuning, N.; de Vries, J. A.; Ketel, T.; Koopman, R. F.; Lambert, R. W.; Santos, D. Martinez; Raven, G.; Schiller, M.; Syropoulos, V.; Tolk, S.] Nikhef Natl Inst Subat Phys, Amsterdam, Netherlands; [Ketel, T.; Koopman, R. F.; Lambert, R. W.; Santos, D. Martinez; Raven, G.; Schiller, M.; Syropoulos, V.; Tolk, S.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Shapoval, I.; Dovbnya, A.; Kandybei, S.] NSC KIPT, Kharkov, Ukraine; [Raniuk, I.; Okhrimenko, O.] Natl Acad Sci KINR, Inst Nucl Res, Kiev, Ukraine; [Niet, R.; Pugatch, V.; Bifani, S.; Farley, N.; Griffith, P.; Kenyon, I. R.; Lazzeroni, C.; Mazurov, A.; McCarthy, J.; Pescatore, L.; Watson, N. K.; Williams, M. P.] Univ Birmingham, Birmingham, W Midlands, England; [Adinolfi, M.; Benton, J.; Brook, N. H.; Cook, A.; Coombes, M.; Dalseno, J.; Hampson, T.; Harnew, S. T.; Naik, P.; Price, E.; Prouve, C.; Rademacker, J. H.; Richards, S.; Saunders, D. M.; Skidmore, N.; Souza, D.; Velthuis, J. J.; Voong, D.] Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England; [Barter, W.; Bettler, M-O.; Cliff, H. V.; Evans, H. -M.; Tico, J. Garra; Gibson, V.; Gregson, S.; Haines, S. C.; Jones, C. R.; Sirendi, M.; Smith, J.; Ward, D. R.; Wotton, S. A.; Wright, S.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Back, J. J.; Blake, T.; Craik, D. C.; Crocombe, A. C.; Dossett, D.; Gershon, T.; Kreps, M.; Langenbruch, C.; Latham, T.; O'Hanlon, D. P.; Pilar, T.; Poluektov, A.; Reid, M. M.; Coutinho, R. Silva; Wallace, C.; Whitehead, M.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Easo, S.; Nandakumar, R.; Papanestis, A.; Ricciardi, S.; Wilson, F. F.] STFC Rutherford Appleton Lab, Didcot, Oxon, England; [Carson, L.; Clarke, P. E. L.; Cowan, G. A.; Eisenhardt, S.; Ferguson, D.; Lambert, D.; Luo, H.; Morris, A. -B.; Muheim, F.; Needham, M.; Playfer, S.] Univ Edinburgh, Sch Phys & Astron, Edinburgh, Midlothian, Scotland; [Alexander, M.; Beddow, J.; Dean, C-T.; Eklund, L.; Hynds, D.; Karodia, S.; Longstaff, I.; Ogilvy, S.; Pappagallo, M.; Sail, P.; Skillicorn, I.; Soler, F. J. P.; Spradlin, P.] Univ Glasgow, Sch Phys & Astron, Glasgow, Lanark, Scotland; [Affolder, A.; Bowcock, T. J. V.; Brown, H.; Casse, G.; Donleavy, S.; Dreimanis, K.; Farry, S.; Fay, R.; Hennessy, K.; Hutchcroft, D.; Liles, M.; McSkelly, B.; Patel, G. D.; Price, J. D.; Pritchard, A.; Rinnert, K.; Shears, T.; Smith, N. A.] Univ Liverpool, Oliver Lodge Lab, Liverpool L69 3BX, Merseyside, England; [Ciezarek, G.; Cunliffe, S.; Currie, R.; Egede, U.; Fol, P.; Golutvin, A.; Hall, S.; McCann, M.; Owen, P.; Patel, M.; Petridis, K.; Redi, F.; Sepp, I.; Smith, E.; Sutcliffe, W.; Websdale, D.] Univ London Imperial Coll Sci Technol & Med, London, England; [Appleby, R. B.; Barlow, R. J.; Bird, T.; Bjomstad, P. M.; Borghi, S.; Brett, D.; Brodzicka, J.; Capriotti, L.; Chen, S.; De Capua, S.; Dujany, G.; Gersabeck, M.; Harrison, J.; Hombach, C.; Klaver, S.; Lafferty, G.; McNab, A.; Parkes, C.; Pearce, A.; Reichert, S.; Rodrigues, E.; Perez, P. Rodriguez; Smith, M.] Univ Manchester, Sch Phys & Astron, Manchester, Lancs, England; [Cheung, S-F.; Derkach, D.; Evans, T.; Gauld, R.; Greening, E.; Harnew, N.; Hill, D.; Hunt, P.; Hussain, N.; Jalocha, J.; John, M.; Lupton, O.; Malde, S.; Smith, E.; Stevenson, S.; Thomas, C.; Topp-Joergensen, S.; Torr, N.; Wilkinson, G.] Univ Oxford, Dept Phys, Oxford, England; [Counts, I.; Ilten, P.; Williams, M.] MIT, Cambridge, MA 02139 USA; [Andreassen, R.; Davis, A.; De Silva, W.; Meadows, B.; Sokoloff, M. D.; Sun, L.; Todd, J.] Univ Cincinnati, Cincinnati, OH USA; [Andrews, J. E.; Hamilton, B.; Jawahery, A.; Wimberley, J.] Univ Maryland, College Pk, MD 20742 USA; [Artuso, M.; Blusk, S.; Borgia, A.; Britton, T.; Ely, S.; Gandini, P.; Garofoli, J.; Gui, B.; Hadjivasiliou, C.; Jurik, N.; Kelsey, M.; Mountain, R.; Pal, B. K.; Skwarnicki, T.; Stone, S.; Wang, J.; Xing, Z.; Zhang, L.] Syracuse Univ, Syracuse, NY USA; [Baesso, C.; Torres, M. Cruz; Goebel, C.; Rodriguez, J. Molina] Pontificia Univ Catolica Rio de Janeiro, Rio De Janeiro, Brazil; [Baesso, C.; Torres, M. Cruz; Goebel, C.; Rodriguez, J. Molina] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Xie, Y.] Cent China Normal Univ, Inst Particle Phys, Wuhan, Hubei, Peoples R China; [Xie, Y.] Tsinghua Univ, Ctr High Energy Phys, Beijing 100084, Peoples R China; [Milanes, D. A.] Univ Nacl Colombia, Dept Fis, Bogota, Colombia; [Milanes, D. A.] Univ Paris 06, Univ Paris Diderot, CNRS, LPNHE,IN2P3, Paris, France; [Gruenberg, O.; Hess, M.; Voss, C.; Waldi, R.] Univ Rostock, Inst Phys, D-18055 Rostock, Germany; [Gruenberg, O.; Hess, M.; Voss, C.; Waldi, R.] Heidelberg Univ, Inst Phys, Heidelberg, Germany; [Likhomanenko, T.; Malinin, A.; Shevchenko, V.; Ustyuzhanin, A.] Natl Res Ctr Kurchatov Inst, Moscow, Russia; [Likhomanenko, T.; Malinin, A.; Shevchenko, V.; Ustyuzhanin, A.] ITEP, Moscow, Russia; [Vidal, F. Martinez; Oyanguren, A.; Valls, P. Ruiz; Mayordomo, C. Sanchez] Univ Valencia, CSIC, Inst Fis Corpuscular IFIC, Valencia, Spain; [Vidal, F. Martinez; Oyanguren, A.; Valls, P. Ruiz; Mayordomo, C. Sanchez] Univ Barcelona, Barcelona, Spain; [Onderwater, C. J. G.; Wilschut, H. W.] Univ Groningen, Van Swinderen Inst, Groningen, Netherlands; [Onderwater, C. J. G.; Wilschut, H. W.] Nikhef Natl Inst Subat Phys, Amsterdam, Netherlands; [Pesen, E.] Celal Bayar Univ, Manisa, Turkey; [Pesen, E.] CERN, European Org Nucl Res, CH-1211 Geneva, Switzerland; [Anderlini, L.; Frosini, M.] Univ Florence, Florence, Italy; [Andreotti, M.; Calabrese, R.; Corvo, M.; Fiore, M.; Fiorini, M.; Luppi, E.; Pappalardo, L. L.; Shapoval, I.; Tellarini, G.; Tomassetti, L.] Univ Ferrara, I-44100 Ferrara, Italy; [Auriemma, G.; Satriano, C.] Univ Basilicata, I-85100 Potenza, Italy; [Bizzeti, A.] Univ Modena & Reggio Emilia, Modena, Italy; [Calvi, M.; Cassina, L.; Gotti, C.; Khanji, B.; Kucharczyk, M.] Univ Milano Bicocca, Milan, Italy; [Gomez, M. Calvo; Vilasis-Cardona, X.] Univ Ramon Llull, LIFAELS, Barcelona, Spain; [Carbone, A.; Galli, D.; Perazzini, S.] Univ Bologna, Bologna, Italy; [Carboni, G.; Furfaro, E.; Santovetti, E.] Univ Roma Tor Vergata, Rome, Italy; [Cardinale, R.; Fontanelli, F.; Gambetta, S.; Patrignani, C.; Petrolini, A.] Univ Genoa, Genoa, Italy; [Cenci, R.; Marino, P.; Morello, M. J.; Stracka, S.] Scuola Normale Super Pisa, Pisa, Italy; [Geraci, A.] Politecn Milan, I-20133 Milan, Italy; [Gomes, A.] Univ Fed Triangulo Mineiro, Uberaba, MG, Brazil; [Kucewicz, W.] AGH Univ Sci & Technol, Fac Comp Sci Elect & Telecommun, Krakow, Poland; [Lucchesi, D.] Univ Padua, Padua, Italy; [Manca, G.; Oldeman, R.; Saitta, B.] Univ Cagliari, Cagliari, Italy; Hanoi Univ Sci, Hanoi, Vietnam; [Palano, A.] Univ Bari, Bari, Italy; [Palombo, F.] Univ Milan, Milan, Italy; [Sarti, A.; Penso, G.; Sciubba, A.] Univ Roma La Sapienza, I-00185 Rome, Italy; [Punzi, G.] Univ Pisa, Pisa, Italy; [Veltri, M.] Univ Urbino, I-61029 Urbino, Italy; [Zavertyaev, M.] Russian Acad Sci LPI RAS, PN Lebedev Phys Inst, Moscow, Russia	Yerevan Physics Institute; Belarusian State University; National Center of Particles & High Energy Physics - Belarus; University of Antwerp; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Ghent University; Universite Catholique Louvain; University of Mons; Centro Brasileiro de Pesquisas Fisicas; Universidade do Estado do Rio de Janeiro; Universidade Estadual Paulista; Universidade Federal do ABC (UFABC); Bulgarian Academy of Sciences; University of Sofia; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Peking University; Universidad de los Andes (Colombia); University of Split; University of Split; Rudjer Boskovic Institute; University of Cyprus; Charles University Prague; Egyptian Academy of Scientific Research & Technology (ASRT); Egyptian Knowledge Bank (EKB); Egyptian Network of High Energy Physics (ENHEP); National Institute of Chemical Physics & Biophysics (NICPB); University of Helsinki; Helsinki Institute of Physics; Lappeenranta University of Technology; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Haute-Alsace (UHA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ivane Javakhishvili Tbilisi State University; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; Helmholtz Association; Karlsruhe Institute of Technology; National Centre of Scientific Research "Demokritos"; National & Kapodistrian University of Athens; University of Ioannina; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute for Nuclear Research; University of Debrecen; National Institute of Science Education & Research (NISER); Panjab University; University of Delhi; Saha Institute of Nuclear Physics; Bhabha Atomic Research Center (BARC); Tata Institute of Fundamental Research (TIFR); University College Dublin; Istituto Nazionale di Fisica Nucleare (INFN); Politecnico di Bari; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Universita degli Studi di Bari Aldo Moro; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); University of Bologna; Istituto Nazionale di Fisica Nucleare (INFN); University of Bologna; Istituto Nazionale di Fisica Nucleare (INFN); University of Catania; Istituto Nazionale di Fisica Nucleare (INFN); University of Catania; Istituto Nazionale di Fisica Nucleare (INFN); University of Florence; Istituto Nazionale di Fisica Nucleare (INFN); University of Florence; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); University of Genoa; Istituto Nazionale di Fisica Nucleare (INFN); University of Genoa; Istituto Nazionale di Fisica Nucleare (INFN); University of Milano-Bicocca; Istituto Nazionale di Fisica Nucleare (INFN); University of Milano-Bicocca; Istituto Nazionale di Fisica Nucleare (INFN); University of Naples Federico II; University of Basilicata; Guglielmo Marconi University; Istituto Nazionale di Fisica Nucleare (INFN); University of Naples Federico II; University of Basilicata; Guglielmo Marconi University; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; University of Trento; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; Istituto Nazionale di Fisica Nucleare (INFN); University of Pavia; Istituto Nazionale di Fisica Nucleare (INFN); University of Pavia; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Istituto Nazionale di Fisica Nucleare (INFN); Scuola Normale Superiore di Pisa; University of Pisa; Istituto Nazionale di Fisica Nucleare (INFN); University of Pisa; Scuola Normale Superiore di Pisa; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome; University of Rome Tor Vergata; Istituto Nazionale di Fisica Nucleare (INFN); University of Rome Tor Vergata; Istituto Nazionale di Fisica Nucleare (INFN); University of Eastern Piedmont Amedeo Avogadro; University of Turin; Istituto Nazionale di Fisica Nucleare (INFN); University of Turin; University of Eastern Piedmont Amedeo Avogadro; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Kangwon National University; Kyungpook National University; Jeonbuk National University; Chonnam National University; Korea University; Seoul National University (SNU); University of Seoul; Sungkyunkwan University (SKKU); Vilnius University; Universiti Malaya; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Iberoamericana Ciudad de Mexico; Benemerita Universidad Autonoma de Puebla; Universidad Autonoma de San Luis Potosi; University of Auckland; University of Canterbury; National Centre for Physics - Pakistan; Quaid I Azam University; National Centre for Nuclear Research; University of Warsaw; Laboratorio de Instrumentacao e Fisica Experimental de Particulas; Joint Institute for Nuclear Research - Russia; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Russian Academy of Sciences; Institute for Nuclear Research of the Russian Academy of Sciences; National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; Lomonosov Moscow State University; National Research Centre - Kurchatov Institute; Institute of High Energy Physics - IHEP; University of Belgrade; University of Belgrade; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Autonomous University of Madrid; University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Fisica de Cantabria (IFCA); European Organization for Nuclear Research (CERN); Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; National Central University; National Taiwan University; Chulalongkorn University; Cukurova University; Middle East Technical University; Bogazici University; Istanbul Technical University; Kharkov Institute of Physics & Technology; University of Bristol; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Imperial College London; Brunel University; Baylor University; University of Alabama System; University of Alabama Tuscaloosa; Boston University; Brown University; University of California System; University of California Davis; University of California System; University of California Los Angeles; University of California System; University of California Riverside; University of California System; University of California San Diego; University of California System; University of California Santa Barbara; California Institute of Technology; Carnegie Mellon University; University of Colorado System; University of Colorado Boulder; Cornell University; Fairfield University; United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory; State University System of Florida; University of Florida; State University System of Florida; Florida International University; State University System of Florida; Florida State University; Florida Institute of Technology; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Iowa; Johns Hopkins University; University of Kansas; Kansas State University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University System of Maryland; University of Maryland College Park; Massachusetts Institute of Technology (MIT); University of Minnesota System; University of Minnesota Twin Cities; University of Mississippi; University of Nebraska System; University of Nebraska Lincoln; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Northeastern University; Northwestern University; University of Notre Dame; University System of Ohio; Ohio State University; Princeton University; University of Puerto Rico; University of Puerto Rico Mayaguez; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Rice University; University of Rochester; Rockefeller University; Rutgers State University New Brunswick; University of Tennessee System; University of Tennessee Knoxville; Texas A&M University System; Texas A&M University College Station; Texas Tech University System; Texas Tech University; Vanderbilt University; University of Virginia; Wayne State University; University of Wisconsin System; University of Wisconsin Madison; Technische Universitat Wien; European Organization for Nuclear Research (CERN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Haute-Alsace (UHA); National Institute of Chemical Physics & Biophysics (NICPB); Lomonosov Moscow State University; Universidade Estadual de Campinas; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Joint Institute for Nuclear Research - Russia; Egyptian Knowledge Bank (EKB); Suez University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Ain Shams University; Universites de Strasbourg Etablissements Associes; Universite de Haute-Alsace (UHA); Brandenburg University of Technology Cottbus; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute for Nuclear Research; Eotvos Lorand University; University of Debrecen; Visva Bharati University; University Ruhuna; Isfahan University of Technology; University of Tehran; Islamic Azad University; University of Siena; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universidad Michoacana de San Nicolas de Hidalgo; Russian Academy of Sciences; Institute for Nuclear Research of the Russian Academy of Sciences; Peter the Great St. Petersburg Polytechnic University; California Institute of Technology; University of Belgrade; Sapienza University Rome; Istituto Nazionale di Fisica Nucleare (INFN); National & Kapodistrian University of Athens; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics; University of Bern; Gaziosmanpasa University; Adiyaman University; Cag University - Turkey; Anadolu University; Ozyegin University; Izmir Institute of Technology; Necmettin Erbakan University; Mimar Sinan Guzel Sanatlar University; Marmara University; Kafkas University; Yildiz Technical University; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Southampton; University of Belgrade; University of Belgrade; United States Department of Energy (DOE); Argonne National Laboratory; Erzincan Binali Yildirim University; Qatar Foundation (QF); Texas A&M University Qatar; Kyungpook National University; Centro Brasileiro de Pesquisas Fisicas; Universidade Federal do Rio de Janeiro; Tsinghua University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Dortmund University of Technology; Max Planck Society; Ruprecht Karls University Heidelberg; University College Dublin; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; AGH University of Science & Technology; National Centre for Nuclear Research; Horia Hulubei National Institute of Physics & Nuclear Engineering; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics; Lomonosov Moscow State University; National Research Centre - Kurchatov Institute; Institute of High Energy Physics - IHEP; Russian Academy of Sciences; Institute for Nuclear Research of the Russian Academy of Sciences; Russian Academy of Sciences; Budker Institute of Nuclear Physics; Novosibirsk State University; National Research Centre - Kurchatov Institute; Institute of High Energy Physics - IHEP; University of Barcelona; Universidade de Santiago de Compostela; European Organization for Nuclear Research (CERN); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Zurich; FOM National Institute for Subatomic Physics; Vrije Universiteit Amsterdam; National Academy of Sciences Ukraine; Institute for Nuclear Research of NASU; V. M. Glushkov Institute of Cybernetics, National Academy of Sciences of Ukraine; University of Birmingham; University of Bristol; University of Cambridge; University of Warwick; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Edinburgh; University of Glasgow; University of Liverpool; Imperial College London; University of Manchester; University of Oxford; Massachusetts Institute of Technology (MIT); University System of Ohio; University of Cincinnati; University System of Maryland; University of Maryland College Park; Syracuse University; Pontificia Universidade Catolica do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Central China Normal University; Tsinghua University; Universidad Nacional de Colombia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Rostock; Ruprecht Karls University Heidelberg; National Research Centre - Kurchatov Institute; National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fisica Corpuscular (IFIC); University of Valencia; University of Barcelona; University of Groningen; FOM National Institute for Subatomic Physics; Celal Bayar University; European Organization for Nuclear Research (CERN); University of Florence; University of Ferrara; University of Basilicata; Universita di Modena e Reggio Emilia; University of Milano-Bicocca; Universitat Ramon Llull; University of Bologna; University of Rome Tor Vergata; University of Genoa; Scuola Normale Superiore di Pisa; Polytechnic University of Milan; Universidade Federal do Triangulo Mineiro; AGH University of Science & Technology; University of Padua; University of Cagliari; Vietnam National University Hanoi; Universita degli Studi di Bari Aldo Moro; University of Milan; Sapienza University Rome; University of Pisa; University of Urbino; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute	Khachatryan, V (corresponding author), Yerevan Phys Inst, Yerevan 375036, Armenia.		Malinin, Alexander G./J-4195-2014; Alamillo, Enrique Calvo/L-1203-2014; Worm, Steven D/I-3575-2012; Galli, Domenico/A-1606-2012; Gerosa, Raffaele/AGL-5921-2022; Scodellaro, Luca/K-9091-2014; Meridiani, Paolo/ABH-1655-2020; Tsaregorodtsev, Andrei/E-3873-2016; Vidal, F* Martinez/L-7563-2014; Ogul, Hasan/S-7951-2016; De La Cruz Burelo, Eduard/Q-6021-2019; Archilli, Flavio/AFP-2856-2022; LECOQ, Paul/S-7246-2019; Kumar, Ramandeep/AAY-6388-2020; Titov, Maxim/AAM-2140-2020; Mussgiller, Andreas/AAF-6933-2019; TOPAKSU, Aysel KAYİS/B-8910-2018; Sierra, Carlos Vázquez/AGX-6908-2022; Traczyk, Piotr/ABA-8929-2020; Iorio, Alberto Orso Maria/GXA-0233-2022; Lesiak, Tadeusz/P-2206-2017; Fiutowski, Tomasz/A-1943-2017; Shekhtman, Lev I/O-5912-2017; Cardini, Alessandro/J-5736-2012; Vischia, Pietro/AAB-7811-2021; Gomez, Ricardo Vazquez/O-5789-2018; Zhu, Ren-Yuan/V-8966-2019; Verwilligen, Piet/M-2968-2014; Sguazzoni, Giacomo/J-4620-2015; Duarte, Javier Mauricio/AAA-5414-2020; Ligabue, Franco/F-3432-2014; Majumder, Devdatta/X-2542-2019; BARRILLON, Stephanie/ABA-6873-2021; Vogel, Helmut/N-8882-2014; Leonidov, Andrey/M-4440-2013; Schiller, Manuel Tobias/B-1229-2017; Flix, Josep/G-5414-2012; Rotondo, Marcello/AFS-0456-2022; Malvezzi, Sandra/B-8524-2009; Collazuol, Gianmaria/C-5670-2012; de la Hoz, Santiago Gonzalez/AHC-7576-2022; Fiorendi, Sara/ABA-3311-2021; Colafranceschi, Stefano/M-1807-2016; Pesen, Erhan/B-1753-2017; Benaglia, Andrea/AGF-5495-2022; Gandini, Paolo/AAB-2496-2021; Sanchez, Francisca J. Munoz/AAH-3909-2019; Hoorani, Hafeez R/D-1791-2013; candelise, vieri/H-2195-2015; Özdemir, Kadri/P-8058-2014; Dorigo, Tommaso/AAY-6673-2020; Cimmino, Anna/AAA-1673-2020; KIM, Tae Jeong/P-7848-2015; March, Neus Lopez/P-4411-2014; Dunne, Patrick/AAX-2876-2020; Leonidov, Andrey/ABI-6671-2020; Yzquierdo, Antonio Pérez-Calero/F-2235-2013; Cakir, Altan/P-1024-2015; Passaleva, Giovanni/ABF-5558-2021; Giammanco, Andrea/O-5017-2019; MAESTRE, JUAN ALCARAZ/I-5763-2015; Menasce, Dario/A-2168-2016; polatoz, ayse/AAV-1190-2020; Acosta, Monica Vazquez/AAB-2841-2019; Theofilatos, Konstantinos/AAL-9162-2021; Safronov, Grigory/F-8494-2017; Diaz, Ricardo Graciani/I-5152-2016; , Claire/AAA-7507-2021; Paulini, Manfred/N-7794-2014; De La Cruz Burelo, Eduard/AAR-9103-2021; D'Hondt, Jorgen/ABD-7930-2020; Graverini, Elena/R-3713-2019; Adeva, Bernardo/L-1378-2014; Dhingra, Nitish/ABA-9507-2020; Gandini, Paolo/AFV-2857-2022; Chinellato, Jose Augusto A/I-7972-2012; Schneider, Olivier P/R-9566-2018; Herrera, Maria Clemencia Mora/AAD-6466-2021; Ratnikov, Fedor/D-5137-2016; Volpe, Roberta/AAR-4100-2021; Velthuis, Jaap/AAL-4020-2020; Daskalakis, Georgios/M-4480-2013; de Paula Carvalho, Wagner/V-3343-2019; de la Cruz, Begona/K-7552-2014; Patrignani, Claudia/C-5223-2009; Najafabadi, Mojtaba Mohammadi/AAF-7564-2019; ciocci, maria agnese/I-2153-2015; Chaparro Sierra, Luisa Fernanda/AHD-3083-2022; Tuominen, Eija M/A-5288-2017; Grecu, Alexandru Tudor/B-8977-2011; Canelli, Florencia/AAI-1616-2021; khurshid, taimoor/AAA-5677-2021; Travaglini, Riccardo/AAR-1089-2021; Ocalan, Kadir/AAX-5235-2021; de Paula, Leandro/I-9278-2012; Golutvin, Andrey/R-8166-2016; Anderlini, Lucio/AFQ-8262-2022; Witek, Mariusz/GNP-4213-2022; Dogra, Sunil/B-5330-2013; Lopez, Oscar Gonzalez/AAH-3533-2019; Faccioli, Pietro/AAF-1499-2019; kaya, mithat/D-8062-2011; Amapane, Nicola/HDN-9630-2022; Nasteva, Irina N/M-8764-2014; khurshid, taimoor/AAF-4900-2019; Gokbulut, Gul/G-2141-2018; Mesyats, Gennady A/L-3138-2015; Bodek, Arie/AAD-2811-2019; Seixas, Joao C/F-5441-2013; Grandi, Claudio/B-5654-2015; Teles, Patricia/ABF-9723-2021; Cavallo, Nicola/F-8913-2012; de gruttola, michele/AAN-7271-2020; Cepeda, Maria/AAF-4992-2019; Witek, Mariusz/V-4567-2018; M, F/HGF-3166-2022; Gallas Torreira, Abraham/K-6508-2014; Amapane, Nicola/J-3683-2012; Dosil, Alvaro/L-2530-2017; Govoni, Pietro/K-9619-2016; Gamsızkan, Halil/AAF-5296-2019; Pinna Angioni, Gian Luca/AAZ-6834-2021; Della Ricca, Giuseppe/B-6826-2013; Eskut, Eda/B-8905-2018; Krücker, Dirk/X-1844-2019; Filippov, Sergey/J-3600-2014; Adiguzel, Aytul/AAC-9049-2020; garcia, lucia/GXV-8296-2022; Morovic, Srecko/T-9019-2019; Pavlov, Borislav/O-8491-2018; Bifani, Simone/AAI-2336-2019; Mundim, Luiz M/A-1291-2012; Rovelli, Tiziano/K-4432-2015; Fanò, Livio/K-2460-2015; Belogurov, Sergey/N-1029-2015; Yagil, Avi/GMX-0958-2022; radi, amr/Y-1592-2019; Gundacker, Stefan/FBD-4491-2022; Rivero, Celso Martinez/V-6916-2017; Martinelli, Maurizio/AAC-8282-2021; Derkach, Denis/AAY-5330-2020; García Abia, Pablo/K-3595-2017; Sznajder, Andre/L-1621-2016; Casarsa, Massimo/L-3623-2018; Morandin, Mauro/A-3308-2016; Bortignon, Pierluigi/AAF-6561-2020; Bernardes, Cesar Augusto/D-2408-2015; Arcidiacono, Roberta/ABF-3918-2020; Gülmez, Erhan/P-9518-2015; Garrido, Lluis/D-6358-2017; ozok, ferhat/A-6803-2018; Zeyrek, Mehmet/ABA-7235-2020; Ramos, Juan Pablo Fernández/AAF-3114-2019; Polatoz, Ayse/AAF-6722-2021; Rodrigues, Fernando Luiz Ferreira/U-1507-2019; de la Hoz, Santiago Gonzalez/E-2494-2016; Guz, Yury/AAV-1769-2021; My, Salvatore/I-5160-2015; Shchutska, Lesya/M-7052-2017; Matorras, Francisco/I-4983-2015; Obraztsov, Vladimir/AAV-2815-2021; Stracka, Simone/M-3931-2015; Vidal, Antonio Romero/AAA-5902-2019; Parkinson, Christopher John/AAA-4740-2021; Biino, Cristina/AAF-1585-2020; Golubkov, Dmitry/E-4881-2017; Sunar Cerci, Deniz/AHE-1706-2022; Watson, N/GLQ-5703-2022; Luppi, Eleonora/A-4902-2015; GULER, E GURPINAR/AAH-4748-2019; Markowitz, Pete/AAC-3382-2020; Redi, Federico Leo/AAG-7585-2021; hou, wei/GWM-4800-2022; Tomassetti, Luca/G-5065-2012; Benussi, Luigi/O-9684-2014; Novoselov, Alexey/K-4244-2014; Petkov, Peicho Stoev/M-2080-2016; Giacomelli, Paolo/B-8076-2009; de Mello, Carla Göbel Burlamaqui/H-4721-2016; Lutz, Benjamin/U-4283-2017; Ferretti, Roberta/P-3724-2018; COJOCARIU, Lucian-Nicolae/Z-5818-2019; Dalseno, Jeremy/AAA-5567-2020; Duarte-Campderrós, Jordi/F-5025-2018; Orlandea, Marius Ciprian/J-7784-2013; Civinini, Carlo/AAL-6403-2020; Satriano, Celestina/J-2374-2012; Obertino, Maria Margherita/ABH-1662-2020; Lanfranchi, Gaia/P-5174-2015; Isildak, Bora/AAW-4994-2020; Smirnov, Vitaly A/B-5001-2017; Bedoya, Cristina F/K-8066-2014; Boimska, Bożena/Z-6088-2019; Vidal, Antonio Romero/L-4997-2014; Lannon, Kevin/HGU-5755-2022; Bagliesi, Giuseppe/C-2230-2013; Paktinat Mehdiabadi, Saeid/AAY-8501-2020; Puerta Pelayo, Jesus/L-1632-2014; Shmatov, Sergei/J-5621-2014; Kirakosyan, Martin R./N-2701-2015; Waltenberger, Wolfgang/H-9330-2018; Puig, Albert/L-5196-2017; Grecu, Alexandru Tudor/GZH-2139-2022; De Guio, Federico/ABI-2018-2020; Petrushanko, Sergey/D-6880-2012; Mousa, Jehad/I-8019-2019; Doroba, krzysztof/AAA-3419-2021; Bornheim, Adi/L-2750-2019; Battilana, Carlo/AAA-7345-2020; Ocalan, Kadir/ABA-7004-2021; Lista, Luca/M-2912-2019; Xie, Si/O-6830-2016; yagil, avi/I-3278-2018; Wulz, Claudia-Elisabeth E/H-5657-2011; Martinelli, Maurizio/L-7337-2017; brodzicka, Jolanta/S-2523-2016; Ulrich, Ralf/Q-3882-2019; Bourilkov, Dimitri/AAO-4908-2020; Andreev, Vladimir F/M-8665-2015; gao, yi/HCI-8298-2022; Ahmad, Wael Haj/E-6738-2016; Manganote, Edmilson J.T./K-8251-2013; Vetere, Maurizio Lo/J-5049-2012; ., MOHD. ADLI BIN MD. ALI/AAD-2818-2019; Gao, Yu/HGE-1937-2022; Mekterović, Darko/S-7270-2018; Hulsbergen, Wouter/HGT-8583-2022; Sanchez-Hernandez, Alberto/AAH-3473-2020; Josa, Isabel/K-5184-2014; Fouz, Maria Cruz/AAF-1105-2019; Calderon, Alicia/K-3658-2014; d'Enterria, David/W-7763-2019; Tiras, Emrah/ABG-2354-2020; Capriotti, Lorenzo/AAV-3851-2021; Gascon, David/AAD-2052-2022; VARDARLI, Fuat Ilkehan/B-6360-2013; Rangel, Murilo Santana/AAG-1861-2021; Szumlak, Tomasz/B-3131-2018; Strologas, John/GWR-2036-2022; Heredia-De La Cruz, Ivan/L-2610-2018; Canelli, Florencia/O-9693-2016; Dziurda, Agnieszka/V-4342-2018; Cerrada, Marcos/J-6934-2014; Gomez, Miriam Calvo/Z-3404-2019; Azarkin, Maxim/N-2578-2015; Lokhtin, Igor/D-7004-2012; Pappalardo, Luciano/AAB-2380-2021; Khachatryan, Vardan/O-1456-2015; D'IMPERIO, GIULIA/ABC-7181-2020; cartiglia, nicolo/ABF-1008-2021; Singh, J B/ABF-5574-2021; Pompili, Alexis/ABG-3556-2021; Gil Da Silveira, Gustavo/N-7279-2014; Asavapibhop, Burin/X-1477-2019; Dremin, Igor/K-8053-2015; Swientek, Krzysztof/O-4242-2017; Krammer, Manfred/A-6508-2010; Pereira, Antonio Vilela/L-4142-2016; Ligabue, Franco/ABI-1681-2020; Bartosik, Nazar/ABF-2326-2020; Tsirou, Andromachi/HHC-6869-2022; Hos, ilknur/T-1165-2019; Raidal, Martti/F-4436-2012; Tytgat, Michael G./F-3732-2018; Peris, Antonio Delgado/AAA-5165-2019; Pappagallo, Marco/R-3305-2016; Diaz, Ricardo Graciani/AAH-1683-2020; Dudko, Lev/D-7127-2012; Juodagalvis, Andrius/F-6952-2018; Casasús, Máximo Pló/M-1445-2014; Padula, Sandra S./AAE-4304-2020; stoica, sabin/J-3898-2014; Torassa, Ezio/I-1788-2012; Di Canto, Angelo/CAI-1408-2022; Yang, Fan/GYU-4249-2022; dumanoglu, isa/C-3627-2018; Fasanella, Daniele/ABD-9759-2020; Loukas, Dimitris/ABF-1478-2020; polatoz, ayse/C-3463-2018; de Souza Sandro, Fonseca/ABB-8505-2020; Menichelli, Mauro/AAQ-4026-2020; Krokovny, Pavel/G-4421-2016; Tomei, Thiago R F P/E-7091-2012; González Caballero, Isidro/E-7350-2010; Selvaggi, Michele/CAJ-2129-2022; Mahmoud, Mohammed Attia/AAD-1249-2019; Goh, Junghwan/Q-3720-2016; fahim, ali/C-2400-2016; Dallavalle, Gaetano Marco/AFW-4654-2022; Egorychev, Victor Yu./H-1076-2014; Blekman, Freya/ABD-7916-2020; Kravchuk, Leonid/L-4317-2017; Malbouisson, H./N-6733-2015; Dahms, Torsten/A-8453-2015; Yetkin, Taylan/ABH-2774-2021; Ruiz, Alberto/E-4473-2011; Kim, Victor T/L-1648-2013; Sanchez-Hernandez, Alberto/L-4955-2017; Steggemann, Jan/AAL-5700-2020; Tinoco Mendes, Andre David/D-4314-2011; Soares, Mara Senghi/GZM-6676-2022; Fiorini, Massimiliano/A-5354-2015; Ciulli, Vitaliano/ABC-5440-2020; Ríos, Cibrán Santamarina/K-4686-2014; Novaes, Sergio F./D-3532-2012; del Arbol, Pablo Martinez Ruiz/Z-4358-2019; Sierra, Carlos Vázquez/L-3012-2017; Cankocak, Kerem/A-1507-2018; Saoulidou, Niki/AAA-2891-2020; Belyaev, Alexander/F-6637-2015; Perieanu, Adrian/D-3347-2018; Lange, Clemens/AAL-6635-2020; Carbone, Angelo/C-8289-2012; Dubinin, Mikhail N/I-3942-2016; Coquereau, Samuel/N-7467-2018; Montanari, Alessandro/J-2420-2012; Leonardo, Nuno T/M-6940-2016; Salt, Jose/F-4928-2016; Ozturk, Sertac/AGO-2476-2022; D'Alessandro, Raffaello/P-4138-2019; McNab, Andrew/HHS-6972-2022; Vidal, Xabier Cid/L-2900-2014; Petrolini, Alessandro/H-3782-2011; Tamponi, Umberto/AGG-5576-2022; banerjee, swagato/AAN-3165-2021; Piperov, Stefan/Q-1980-2017; de Jesus Damiao, Dilson/G-6218-2012; Borsato, Martino/AAY-1582-2020; van Herwijnen, Eric/T-1668-2019; Bondar, Alexander E./O-9312-2017; Polycarpo, Erica/AAF-3528-2021; Silva, Juan José Saborido/K-1775-2014; Ragazzi, Stefano/D-2463-2009; Popovici, Bogdan/B-6521-2012; Gao, Y./GWZ-3665-2022; Herrera, Maria Clemencia Mora/L-3893-2016; Tuo, Shengquan/ABA-9032-2021; Fitzpatrick, Conor/ABC-5676-2021; Pardinas, Julian Garcia/AAA-4486-2021; Klyukhin, Vyacheslav I/D-6850-2012; Hall-Wilton, Richard/U-6918-2019; Alexander, Semennikov/P-4601-2017; Yazgan, Efe/C-4521-2014; Gomez, Jaime Arturo/P-5242-2018; TUVE', Cristina/P-3933-2015; Romero, Luciano/B-8917-2018; Zavertyaev, Mikhail/M-6844-2015; Cortabitarte, Rocio Vilar/P-8480-2014; Fabozzi, Francesco/T-6468-2019; KUMAR, ASHOK/AAF-4055-2021; Abdulsalam, Abdulla/B-3386-2019; Felcini, Marta A./S-2684-2019; Rodrigo, Teresa/F-6183-2018; Melo da Costa, Eliza Melo/AAX-2394-2021; De Filippis, Nicola/AAD-6280-2019; Potterat, Cédric/H-8190-2013; Ferencek, Dinko/G-6411-2015; Appleby, Robert/A-3224-2016; Stahl, Achim/E-8846-2011; Vorobyev, Vitaly/H-9799-2018; Nguyen, Federico/Q-8994-2016; Bedeschi, Franco/AAA-6068-2021; gushchin, evgeny/J-3648-2014; Morello, Michael Joseph/H-9738-2017; Wimpenny, Stephen J/K-8848-2013; MACIUC, Florin/AAD-1756-2020; Marino, Pietro/N-7030-2015; Hernández, José M./H-9127-2015; Marconi, Umberto/J-2263-2012; Konecki, Marcin/G-4164-2015; Idzik, Marek/A-2487-2017; Demortier, Luc/AAE-6344-2020; Vieites Diaz, Maria/Q-7309-2018; Gersabeck, Evelina/ABI-6869-2020; Amato, Sandra/AAH-4430-2021; Graugés, Eugeni/M-6601-2017; Banerjee, Swagato/AAN-3326-2021; Lychkovskaya, Natalia/F-8341-2017; Polyakov, Ivan/I-9736-2014; Gascon, David/L-8464-2014; Kenzie, Matthew/AAK-5674-2021; Oyanguren, Arantza/K-6454-2014; Vázquez Regueiro, Pablo/F-7610-2010; Spagnolo, Paolo/G-3401-2017; Soler, Paul/E-8464-2011; Rabady, Dinyar/GSN-9210-2022; Shi, Xin/G-8453-2015; Paganoni, Marco/A-4235-2016; Nasteva, Irina/AAU-1303-2020; Filippov, Sergey/GXG-4925-2022; CAKIR, Altan/ABD-4450-2020; Verwilligen, Piet Omer J/AAA-8819-2019; Pedraza Morales, Maria Isabel/ABC-7289-2021; Luukka, Panja-Riina/S-8956-2018; Moon, Chang-Seong/J-3619-2014; Kim, Min Suk/E-4161-2015; Trocino, Daniele/AGI-2155-2022; Gomez, Gervasio/K-2860-2014; Malik, Sudhir/D-6621-2018; Fiori, Francesco/H-1454-2018; Picatoste, Eduardo/K-2918-2017; Lenzi, Piergiulio/I-9542-2016; Marco de Lucas, Jesus/B-8735-2008; Redondo, Ignacio/K-8639-2014; Akgun, Bora/AAM-8311-2021; Fernandez Menendez, Javier/B-6550-2014; Contu, Andrea/B-8054-2018; Luo, Wuming/J-4263-2018; Calabrese, Roberto/G-4405-2015; Tabarelli de Fatis, Tommaso/A-7306-2010; Rolandi, Luigi (Gigi)/E-8563-2013; Martinez Santos, Diego/I-2743-2015; Ivanov, Andrew/A-7982-2013; Calligaris, Luigi/K-2018-2017; Dettori, Francesco/N-3963-2016; Azzi, Patrizia/H-5404-2012; Hobson, Peter/C-8919-2016; Popov, Andrey/E-1052-2012; Neri, Nicola/G-3991-2012; Gonzalez Suarez, Rebeca/L-6128-2014; Kyberd, Paul/P-1092-2014; Andreev, Yuri/J-5779-2014	Malinin, Alexander G./0000-0002-3731-9977; Alamillo, Enrique Calvo/0000-0002-1100-2963; Worm, Steven D/0000-0002-3865-4996; Galli, Domenico/0000-0003-2375-6030; Scodellaro, Luca/0000-0002-4974-8330; Meridiani, Paolo/0000-0002-8480-2259; Tsaregorodtsev, Andrei/0000-0003-4618-520X; Vidal, F* Martinez/0000-0001-6841-6035; Ogul, Hasan/0000-0002-5121-2893; Kumar, Ramandeep/0000-0002-5754-5410; Mussgiller, Andreas/0000-0002-8331-8166; TOPAKSU, Aysel KAYİS/0000-0001-5819-6913; Traczyk, Piotr/0000-0001-5422-4913; Iorio, Alberto Orso Maria/0000-0002-3798-1135; Lesiak, Tadeusz/0000-0002-3966-2998; Fiutowski, Tomasz/0000-0003-2342-8854; Cardini, Alessandro/0000-0002-6649-0298; Vischia, Pietro/0000-0002-7088-8557; Gomez, Ricardo Vazquez/0000-0001-5319-1128; Zhu, Ren-Yuan/0000-0003-3091-7461; Verwilligen, Piet/0000-0002-9285-8631; Sguazzoni, Giacomo/0000-0002-0791-3350; Duarte, Javier Mauricio/0000-0002-5076-7096; Ligabue, Franco/0000-0002-1549-7107; Majumder, Devdatta/0000-0002-7578-0027; BARRILLON, Stephanie/0000-0002-7075-1673; Vogel, Helmut/0000-0002-6109-3023; Schiller, Manuel Tobias/0000-0001-8750-863X; Flix, Josep/0000-0003-2688-8047; Rotondo, Marcello/0000-0001-5704-6163; Malvezzi, Sandra/0000-0002-0218-4910; Collazuol, Gianmaria/0000-0002-7876-6124; Fiorendi, Sara/0000-0003-3273-9419; Colafranceschi, Stefano/0000-0002-7335-6417; Benaglia, Andrea/0000-0003-1124-8450; Gandini, Paolo/0000-0001-7267-6008; Sanchez, Francisca J. Munoz/0000-0002-6374-458X; Özdemir, Kadri/0000-0002-0103-1488; Cimmino, Anna/0000-0001-7510-4996; KIM, Tae Jeong/0000-0001-8336-2434; March, Neus Lopez/0000-0001-6586-0675; Dunne, Patrick/0000-0001-7543-1882; Yzquierdo, Antonio Pérez-Calero/0000-0003-3036-7965; Passaleva, Giovanni/0000-0002-8077-8378; Giammanco, Andrea/0000-0001-9640-8294; MAESTRE, JUAN ALCARAZ/0000-0003-0914-7474; Menasce, Dario/0000-0002-9918-1686; Acosta, Monica Vazquez/0000-0002-2409-9792; Theofilatos, Konstantinos/0000-0001-8448-883X; Diaz, Ricardo Graciani/0000-0001-7166-5198; , Claire/0000-0003-2000-6306; Paulini, Manfred/0000-0002-6714-5787; De La Cruz Burelo, Eduard/0000-0002-7469-6974; D'Hondt, Jorgen/0000-0002-9598-6241; Graverini, Elena/0000-0003-4647-6429; Adeva, Bernardo/0000-0001-9756-3712; Gandini, Paolo/0000-0001-7267-6008; Chinellato, Jose Augusto A/0000-0002-3240-6270; Schneider, Olivier P/0000-0002-6014-7552; Herrera, Maria Clemencia Mora/0000-0003-3915-3170; Volpe, Roberta/0000-0003-1782-2978; Velthuis, Jaap/0000-0002-4649-3221; Daskalakis, Georgios/0000-0001-6070-7698; de Paula Carvalho, Wagner/0000-0003-0738-6615; de la Cruz, Begona/0000-0001-9057-5614; Patrignani, Claudia/0000-0002-5882-1747; Najafabadi, Mojtaba Mohammadi/0000-0001-6131-5987; ciocci, maria agnese/0000-0003-0002-5462; Chaparro Sierra, Luisa Fernanda/0000-0002-6570-9075; Tuominen, Eija M/0000-0002-7073-7767; Grecu, Alexandru Tudor/0000-0002-7770-1839; Canelli, Florencia/0000-0001-6361-2117; Travaglini, Riccardo/0000-0002-5288-1407; de Paula, Leandro/0000-0002-4984-7734; Anderlini, Lucio/0000-0001-6808-2418; Witek, Mariusz/0000-0002-8317-385X; Lopez, Oscar Gonzalez/0000-0002-4532-6464; Faccioli, Pietro/0000-0003-1849-6692; Amapane, Nicola/0000-0001-9449-2509; Nasteva, Irina N/0000-0001-7115-7214; khurshid, taimoor/0000-0001-9816-3630; Gokbulut, Gul/0000-0002-0175-6454; Bodek, Arie/0000-0003-0409-0341; Seixas, Joao C/0000-0002-7531-0842; Grandi, Claudio/0000-0001-5998-3070; Teles, Patricia/0000-0001-9029-8506; de gruttola, michele/0000-0003-4835-8688; Cepeda, Maria/0000-0002-6076-4083; Witek, Mariusz/0000-0002-8317-385X; Gallas Torreira, Abraham/0000-0002-2745-7954; Amapane, Nicola/0000-0001-9449-2509; Dosil, Alvaro/0000-0003-4091-837X; Govoni, Pietro/0000-0002-0227-1301; Gamsızkan, Halil/0000-0002-2578-6295; Della Ricca, Giuseppe/0000-0003-2831-6982; Krücker, Dirk/0000-0003-1610-8844; Filippov, Sergey/0000-0003-3900-3914; Adiguzel, Aytul/0000-0001-6644-0517; Pavlov, Borislav/0000-0003-3635-0646; Bifani, Simone/0000-0001-7072-4854; Mundim, Luiz M/0000-0001-9964-7805; Rovelli, Tiziano/0000-0002-9746-4842; Fanò, Livio/0000-0002-9007-629X; Rivero, Celso Martinez/0000-0002-3224-956X; Martinelli, Maurizio/0000-0003-4792-9178; Derkach, Denis/0000-0001-5871-0628; García Abia, Pablo/0000-0001-8809-8927; Sznajder, Andre/0000-0001-6998-1108; Casarsa, Massimo/0000-0002-1353-8964; Morandin, Mauro/0000-0003-4708-4240; Bortignon, Pierluigi/0000-0002-5360-1454; Bernardes, Cesar Augusto/0000-0001-5790-9563; Gülmez, Erhan/0000-0002-6353-518X; Garrido, Lluis/0000-0001-8883-6539; ozok, ferhat/0000-0001-9630-7362; Zeyrek, Mehmet/0000-0002-9270-7403; Ramos, Juan Pablo Fernández/0000-0002-0122-313X; Polatoz, Ayse/0000-0001-9516-0821; de la Hoz, Santiago Gonzalez/0000-0001-5304-5390; Guz, Yury/0000-0001-7552-400X; My, Salvatore/0000-0002-9938-2680; Shchutska, Lesya/0000-0003-0700-5448; Matorras, Francisco/0000-0003-4295-5668; Stracka, Simone/0000-0003-0013-4714; Parkinson, Christopher John/0000-0003-0344-7361; Golubkov, Dmitry/0000-0001-6216-1596; Sunar Cerci, Deniz/0000-0002-5412-4688; Luppi, Eleonora/0000-0002-1072-5633; GULER, E GURPINAR/0000-0002-6172-0285; Redi, Federico Leo/0000-0001-9728-8984; Tomassetti, Luca/0000-0003-4184-1335; Benussi, Luigi/0000-0002-2363-8889; Novoselov, Alexey/0000-0002-0019-1498; Petkov, Peicho Stoev/0000-0002-0420-9480; Giacomelli, Paolo/0000-0002-6368-7220; de Mello, Carla Göbel Burlamaqui/0000-0003-0523-495X; Lutz, Benjamin/0000-0003-3057-7831; Ferretti, Roberta/0000-0002-1985-2145; COJOCARIU, Lucian-Nicolae/0000-0002-1281-5923; Dalseno, Jeremy/0000-0003-3288-4683; Duarte-Campderrós, Jordi/0000-0003-0687-5214; Orlandea, Marius Ciprian/0000-0001-7851-5184; Civinini, Carlo/0000-0002-4952-3799; Satriano, Celestina/0000-0002-4976-0460; Obertino, Maria Margherita/0000-0002-8781-8192; Lanfranchi, Gaia/0000-0002-9467-8001; Isildak, Bora/0000-0002-0283-5234; Bedoya, Cristina F/0000-0001-8057-9152; Boimska, Bożena/0000-0002-4200-1541; Vidal, Antonio Romero/0000-0002-8830-1486; Lannon, Kevin/0000-0002-9706-0098; Bagliesi, Giuseppe/0000-0003-4298-1620; Paktinat Mehdiabadi, Saeid/0000-0001-7303-0217; Puerta Pelayo, Jesus/0000-0001-7390-1457; Shmatov, Sergei/0000-0001-5354-8350; Waltenberger, Wolfgang/0000-0002-6215-7228; Puig, Albert/0000-0001-8868-2947; Grecu, Alexandru Tudor/0000-0002-7770-1839; De Guio, Federico/0000-0001-5927-8865; Mousa, Jehad/0000-0002-2978-2718; Doroba, krzysztof/0000-0002-7818-2364; Battilana, Carlo/0000-0002-3753-3068; Ocalan, Kadir/0000-0002-8419-1400; Lista, Luca/0000-0001-6471-5492; Xie, Si/0000-0003-2509-5731; yagil, avi/0000-0002-6108-4004; Wulz, Claudia-Elisabeth E/0000-0001-9226-5812; Martinelli, Maurizio/0000-0003-4792-9178; brodzicka, Jolanta/0000-0002-8556-0597; Ulrich, Ralf/0000-0002-2535-402X; Bourilkov, Dimitri/0000-0003-0260-4935; Andreev, Vladimir F/0000-0002-5492-6920; Ahmad, Wael Haj/0000-0003-1491-0446; Manganote, Edmilson J.T./0000-0003-2459-8521; Vetere, Maurizio Lo/0000-0002-6520-4480; ., MOHD. ADLI BIN MD. ALI/0000-0001-7203-0610; Mekterović, Darko/0000-0001-6220-5958; Sanchez-Hernandez, Alberto/0000-0001-9548-0358; Josa, Isabel/0000-0002-4985-6964; Fouz, Maria Cruz/0000-0003-2950-976X; Calderon, Alicia/0000-0002-7205-2040; d'Enterria, David/0000-0002-5754-4303; Tiras, Emrah/0000-0002-5628-7464; Capriotti, Lorenzo/0000-0003-4899-0587; Rangel, Murilo Santana/0000-0002-8690-5198; Szumlak, Tomasz/0000-0002-2562-7163; Heredia-De La Cruz, Ivan/0000-0002-8133-6467; Canelli, Florencia/0000-0001-6361-2117; Dziurda, Agnieszka/0000-0003-4338-7156; Cerrada, Marcos/0000-0003-0112-1691; Gomez, Miriam Calvo/0000-0001-5588-1448; Azarkin, Maxim/0000-0002-7448-1447; D'IMPERIO, GIULIA/0000-0002-2945-0983; Singh, J B/0000-0001-9029-2462; Gil Da Silveira, Gustavo/0000-0003-3514-7056; Swientek, Krzysztof/0000-0001-6086-4116; Krammer, Manfred/0000-0003-2257-7751; Pereira, Antonio Vilela/0000-0003-3177-4626; Ligabue, Franco/0000-0002-1549-7107; Bartosik, Nazar/0000-0002-7196-2237; Hos, ilknur/0000-0002-7678-1101; Raidal, Martti/0000-0001-7040-9491; Tytgat, Michael G./0000-0002-3990-2074; Peris, Antonio Delgado/0000-0002-8511-7958; Pappagallo, Marco/0000-0001-7601-5602; Diaz, Ricardo Graciani/0000-0001-7166-5198; Dudko, Lev/0000-0002-4462-3192; Juodagalvis, Andrius/0000-0002-1501-3328; Casasús, Máximo Pló/0000-0002-2289-918X; Padula, Sandra S./0000-0003-3071-0559; stoica, sabin/0000-0003-4632-7327; Torassa, Ezio/0000-0003-2321-0599; Di Canto, Angelo/0000-0003-1233-3876; Loukas, Dimitris/0000-0002-7431-3857; de Souza Sandro, Fonseca/0000-0001-7830-0837; Menichelli, Mauro/0000-0002-9004-735X; Krokovny, Pavel/0000-0002-1236-4667; Tomei, Thiago R F P/0000-0002-1809-5226; González Caballero, Isidro/0000-0002-8087-3199; Mahmoud, Mohammed Attia/0000-0001-8692-5458; Goh, Junghwan/0000-0002-1129-2083; fahim, ali/0000-0001-5736-6001; Dallavalle, Gaetano Marco/0000-0002-8614-0420; Blekman, Freya/0000-0002-7366-7098; Dahms, Torsten/0000-0003-4274-5476; Yetkin, Taylan/0000-0003-3277-5612; Ruiz, Alberto/0000-0002-3639-0368; Kim, Victor T/0000-0001-7161-2133; Sanchez-Hernandez, Alberto/0000-0001-9548-0358; Steggemann, Jan/0000-0003-4420-5510; Tinoco Mendes, Andre David/0000-0001-5854-7699; Soares, Mara Senghi/0000-0001-9676-6059; Fiorini, Massimiliano/0000-0001-6559-2084; Ríos, Cibrán Santamarina/0000-0002-9810-1816; Novaes, Sergio F./0000-0003-0471-8549; del Arbol, Pablo Martinez Ruiz/0000-0002-7737-5121; Sierra, Carlos Vázquez/0000-0002-5865-0677; Cankocak, Kerem/0000-0002-3829-3481; Saoulidou, Niki/0000-0001-6958-4196; Belyaev, Alexander/0000-0002-1733-4408; Lange, Clemens/0000-0002-3632-3157; Carbone, Angelo/0000-0002-7045-2243; Dubinin, Mikhail N/0000-0002-7766-7175; Montanari, Alessandro/0000-0003-2748-6373; Leonardo, Nuno T/0000-0002-9746-4594; Salt, Jose/0000-0003-4181-2788; Ozturk, Sertac/0000-0001-6533-6144; D'Alessandro, Raffaello/0000-0001-7997-0306; Vidal, Xabier Cid/0000-0002-0468-541X; Petrolini, Alessandro/0000-0003-0222-7594; banerjee, swagato/0000-0001-8852-2409; Piperov, Stefan/0000-0002-9266-7819; de Jesus Damiao, Dilson/0000-0002-3769-1680; Borsato, Martino/0000-0001-5760-2924; Silva, Juan José Saborido/0000-0002-6270-130X; Ragazzi, Stefano/0000-0001-8219-2074; Popovici, Bogdan/0000-0001-6825-8954; Herrera, Maria Clemencia Mora/0000-0003-3915-3170; Fitzpatrick, Conor/0000-0003-3674-0812; Pardinas, Julian Garcia/0000-0003-2316-8829; Klyukhin, Vyacheslav I/0000-0002-8577-6531; Hall-Wilton, Richard/0000-0003-3221-2086; Alexander, Semennikov/0000-0003-1130-2197; Yazgan, Efe/0000-0001-5732-7950; Gomez, Jaime Arturo/0000-0003-3958-9054; TUVE', Cristina/0000-0003-0739-3153; Romero, Luciano/0000-0002-9055-0385; Zavertyaev, Mikhail/0000-0002-4655-715X; Cortabitarte, Rocio Vilar/0000-0003-2045-8054; Fabozzi, Francesco/0000-0001-9821-4151; KUMAR, ASHOK/0000-0002-9244-0622; Abdulsalam, Abdulla/0000-0002-5424-7418; Felcini, Marta A./0000-0002-2051-9331; Melo da Costa, Eliza Melo/0000-0002-5016-6434; Potterat, Cédric/0000-0002-0027-1316; Ferencek, Dinko/0000-0001-9116-1202; Stahl, Achim/0000-0002-8369-7506; Vorobyev, Vitaly/0000-0002-6660-868X; Nguyen, Federico/0000-0002-6713-1596; Bedeschi, Franco/0000-0002-8315-2119; gushchin, evgeny/0000-0001-8857-1665; Morello, Michael Joseph/0000-0003-4190-1078; Wimpenny, Stephen J/0000-0003-0505-4908; Marino, Pietro/0000-0003-0554-3066; Hernández, José M./0000-0001-6436-7547; Marconi, Umberto/0000-0002-5055-7224; Konecki, Marcin/0000-0001-9482-4841; Demortier, Luc/0000-0002-0499-4298; Vieites Diaz, Maria/0000-0002-0944-4340; Amato, Sandra/0000-0002-3277-0662; Graugés, Eugeni/0000-0001-6571-4096; Banerjee, Swagato/0000-0001-8852-2409; Gascon, David/0000-0001-9607-6154; Kenzie, Matthew/0000-0001-7910-4109; Oyanguren, Arantza/0000-0002-8240-7300; Vázquez Regueiro, Pablo/0000-0002-0767-9736; Spagnolo, Paolo/0000-0001-7962-5203; Soler, Paul/0000-0002-4893-3729; Rabady, Dinyar/0000-0001-9239-0605; Shi, Xin/0000-0001-9910-9345; Paganoni, Marco/0000-0003-2461-275X; Nasteva, Irina/0000-0001-7115-7214; Filippov, Sergey/0000-0003-3900-3914; CAKIR, Altan/0000-0002-8627-7689; Verwilligen, Piet Omer J/0000-0002-9285-8631; Pedraza Morales, Maria Isabel/0000-0002-2669-4659; Luukka, Panja-Riina/0000-0003-2340-4641; Moon, Chang-Seong/0000-0001-8229-7829; Trocino, Daniele/0000-0002-2830-5872; Kolberg, Ted/0000-0002-0211-6109; Poluektov, Anton/0000-0003-2222-9925; Kreczko, Luke/0000-0003-2341-8330; Rinkevicius, Aurelijus/0000-0002-7510-255X; Alvarez Cartelle, Paula/0000-0003-1652-2834; Adams, Todd/0000-0001-8049-5143; Delaere, Christophe/0000-0001-8707-6021; Idzik, Marek/0000-0001-6349-0033; Smith, Wesley/0000-0003-3195-0909; Ciulli, Vitaliano/0000-0003-1947-3396; Gomez, Gervasio/0000-0002-1077-6553; Sarti, Alessio/0000-0001-5419-7951; Padhi, Shaktikant/0000-0002-2002-2704; Tonelli, Diego/0000-0002-1494-7882; Adler, Volker/0000-0002-4469-4468; Rappoccio, Salvatore/0000-0002-5449-2560; Belforte, Stefano/0000-0001-8443-4460; Brigljevic, Vuko/0000-0001-5847-0062; Mitselmakher, Guenakh/0000-0001-5745-3658; Carrillo Montoya, Camilo/0000-0002-6245-6535; Matev, Rosen/0000-0001-8713-6119; Senkin, Sergey/0000-0001-5848-005X; Bondar, Alexander/0000-0002-5089-5338; Galli Mercadante, Pedro/0000-0001-8333-4302; Carrera Jarrin, Edgar/0000-0002-0857-8507; Wardle, Nicholas/0000-0003-1344-3356; Hamel de Monchenault, Gautier/0000-0002-3872-3592; Malik, Sudhir/0000-0002-6356-2655; Fiori, Francesco/0000-0001-8770-9343; Chen, Shanzhen/0000-0002-8647-1828; serrano, justine/0000-0003-2489-7812; Bansal, Sunil/0000-0003-1992-0336; Marchand, Jean-Francois/0000-0002-4111-0797; Bloom, Kenneth/0000-0002-4272-8900; Zenz, Seth/0000-0002-9720-1794; Figueiredo, Diego/0000-0003-2514-6930; Kilminster, Benjamin/0000-0002-6657-0407; Litov, Leandar/0000-0002-8511-6883; Janssen, Tahys/0000-0002-3998-4081; Perrin-Terrin, Mathieu/0000-0002-3568-1956; Ukleja, Artur/0000-0003-0480-4850; Wendland, Lauri/0000-0003-4506-2486; Grunewald, Martin/0000-0002-5754-0388; Bilki, Burak/0000-0001-9515-3306; FORD, WILLIAM/0000-0001-8703-6943; Picatoste, Eduardo/0000-0002-4958-644X; Donega, Mauro/0000-0001-9830-0412; Pugliese, Gabriella/0000-0001-5460-2638; Lenzi, Piergiulio/0000-0002-6927-8807; Erdmann, Martin/0000-0002-1653-1303; Buchmueller, Oliver/0000-0002-3293-3759; Dewanjee, Ram Krishna/0000-0001-6645-6244; Dossett, David/0000-0002-5670-5582; Deschamps, Olivier/0000-0002-7047-6042; Staiano, Amedeo/0000-0003-1803-624X; Dominik, Wojciech/0000-0001-7444-9239; Gozzelino, Andrea/0000-0002-6284-1126; Gligorov, Vladimir/0000-0002-8189-8267; Carboni, Giovanni/0000-0003-1128-8276; Di Matteo, Leonardo/0000-0001-6698-1735; Dittmann, Jay R./0000-0002-1911-3158; Gotti, Claudio/0000-0003-2501-9608; de Vries, Jacco/0000-0003-4712-9816; Keaveney, James/0000-0003-0766-5307; needham, matthew/0000-0002-8297-6714; artuso, marina/0000-0002-5991-7273; Fernandez, Victor/0000-0001-5733-494X; Sciubba, Adalberto/0000-0002-3301-9176; Shapoval, Illya/0000-0001-9350-8281; Dzyuba, Alexey/0000-0003-3612-3195; Patel, Mitesh/0000-0003-3871-5602; Giubilato, Piero/0000-0003-4358-5355; Tu, Yanjun/0000-0002-5865-183X; Lai, Yue Shi/0000-0002-5610-2327; Klanner, Robert/0000-0002-7004-9227; Marco de Lucas, Jesus/0000-0001-7914-8494; Tapper, Alexander/0000-0003-4543-864X; Roy, Debarati/0000-0001-9858-1357; Usai, Emanuele/0000-0001-9323-2107; Comerma, Albert/0000-0002-8980-6048; Schindler, Heinrich/0000-0002-1468-0479; Smith, Eluned/0000-0002-9740-0574; Kalinowski, Artur/0000-0002-1280-5493; Vartak, Adish/0000-0003-1507-1365; Tao, Junquan/0000-0003-2006-3490; Steinkamp, Olaf/0000-0001-7055-6467; Bethani, Agni/0000-0002-8150-7043; Niess, Valentin/0000-0001-7148-6819; Buontempo, Salvatore/0000-0001-9526-556X; Jacob, Jeson/0000-0001-6895-5493; Stiliaris, Efstathios/0000-0001-9496-7762; Gaz, Alessandro/0000-0001-6754-3315; Silvestris, Lucia/0000-0002-8985-4891; Pedrini, Daniele/0000-0003-2414-4175; ORTONA, Giacomo/0000-0001-8411-2971; Redondo, Ignacio/0000-0003-3737-4121; Fu, Jinlin/0000-0003-3177-2700; Autermann, Christian/0000-0002-0057-0033; Alves Junior, Antonio Augusto/0000-0003-0073-3231; PESEN, ERHAN/0000-0001-8701-7291; Pieri, Marco/0000-0003-3303-6301; Re, Valerio/0000-0003-0697-3420; Heath, Helen/0000-0001-6576-9740; Branca, Antonio/0000-0001-8813-2128; Santovetti, Emanuele/0000-0002-5605-1662; Ciesielski, Robert/0000-0001-9422-9129; Ilten, Philip/0000-0001-5534-1732; Massironi, Andrea/0000-0002-0782-0883; Gorski, Maciej/0000-0003-2146-187X; Regnard, Simon/0000-0002-9818-6725; Feld, Lutz/0000-0001-9813-8646; Li, Qiang/0000-0002-8290-0517; Gallo, Elisabetta/0000-0001-7200-5175; Radogna, Raffaella/0000-0002-1094-5038; Pagano, Davide/0000-0003-0333-448X; Margaroli, Fabrizio/0000-0002-3869-0153; Low, Jia Fu/0000-0003-4318-5968; Akgun, Bora/0000-0001-8888-3562; Tricomi, Alessia Rita/0000-0002-5071-5501; Zalewski, Piotr/0000-0003-4429-2888; Belloni, Alberto/0000-0002-1727-656X; Cruz Torres, Melissa Maria/0000-0003-2607-131X; Androsov, Konstantin/0000-0003-2694-6542; Dordei, Francesca/0000-0002-2571-5067; Fernandez Menendez, Javier/0000-0002-5213-3708; Wolszczak, Weronika/0000-0001-7819-6945; Contu, Andrea/0000-0002-3545-2969; Bowcock, Themistocles/0000-0002-3505-6915; Venturi, Andrea/0000-0002-0249-4142; Koppenburg, Patrick/0000-0001-8614-7203; Goy Lopez, Silvia/0000-0001-6508-5090; Pierini, Maurizio/0000-0003-1939-4268; Ramirez, Juan Eduardo/0000-0002-4897-5857; Alderweireldt, Sara/0000-0002-8224-7036; Ghezzi, Alessio/0000-0002-8184-7953; Cattaneo, Marco/0000-0001-7707-169X; Mooney, Michael/0000-0001-8348-4167; Moran, Dermot/0000-0002-1941-9333; KARAPINAR, GULER/0000-0003-2026-3185; Robert, Schoefbeck/0000-0002-2332-8784; Bhowmik, Sandeep/0000-0003-1260-973X; Wislicki, Wojciech/0000-0001-5765-6308; Ecklund, Karl/0000-0002-6976-4637; Martinez, German Ruben/0000-0001-5443-9383; Kandybei, Sergii/0000-0003-3598-0427; Gerosa, Raffaele/0000-0001-8359-3734; Barbieri, Richard/0000-0002-7945-005X; Bachtis, Michail/0000-0003-3110-0701; Sciascia, Barbara/0000-0003-0670-006X; Lychkovskaya, Natalia/0000-0001-5084-9019; Sordini, Viola/0000-0003-0885-824X; Benitez, J.F./0000-0002-2633-6712; Luo, Wuming/0000-0003-0137-1797; Pozzobon, Nicola/0000-0002-9674-0809; Alverson, George/0000-0001-6651-1178; Esen, Sevda/0000-0003-2437-8078; Coco, Victor/0000-0002-5310-6808; Petrucciani, Giovanni/0000-0003-0889-4726; Lazzeroni, Cristina/0000-0003-4074-4787; Ghosh, Saranya/0000-0001-6717-0803; Collard, Caroline/0000-0002-5230-8387; Eskut, Eda/0000-0001-8328-3314; Calabrese, Roberto/0000-0002-1354-5400; Klaver, Suzanne/0000-0001-7909-1272; Wallny, Rainer/0000-0001-8038-1613; Golf, Frank/0000-0003-3567-9351; Levchuk, Leonid/0000-0001-5889-7410; CHANG, PAO-TI/0000-0003-4064-388X; Carvalho Akiba, Kazuyoshi/0000-0002-6736-471X; Dorigo, Mirco/0000-0002-0681-6946; Tully, Christopher/0000-0001-6771-2174; Li, Hengne/0000-0002-2366-9554; Lange, Joern/0000-0003-1307-1441; Tosi, Nicolo/0000-0002-0474-0247; Gritsan, Andrei/0000-0002-3545-7970; Tabarelli de Fatis, Tommaso/0000-0001-6262-4685; Rolandi, Luigi (Gigi)/0000-0002-0635-274X; Martinez Santos, Diego/0000-0002-6438-4483; Raven, Gerhard/0000-0002-2897-5323; Dragicevic, Marko/0000-0003-1967-6783; Martelli, Arabella/0000-0003-3530-2255; Chakaberia, Irakli/0000-0002-9614-4046; PERRIES, Stephane/0000-0003-2213-3579; Vernieri, Caterina/0000-0002-0235-1053; Schulte, Jan-Frederik/0000-0003-4421-680X; Gianelle, Alessio/0000-0003-3586-0046; Lafferty, George/0000-0003-0658-4919; Pfeiffer, Andreas/0000-0001-5328-448X; Szleper, Michal/0000-0002-1697-004X; Gallinaro, Michele/0000-0003-1261-2277; Zanetti, Marco/0000-0003-4281-4582; Rodrigues, Fernando/0000-0002-4274-5583; Leroy, Olivier/0000-0002-2589-240X; Lethuillier, Morgan/0000-0001-6185-2045; Ivanov, Andrew/0000-0002-9270-5643; Kogler, Roman/0000-0002-5336-4399; Heracleous, Natalie/0000-0002-2744-7238; Malgeri, Luca/0000-0002-0113-7389; Marzocchi, Badder/0000-0001-6687-6214; Egede, Ulrik/0000-0001-5493-0762; Missiroli, Marino/0000-0002-1780-1344; Assran, Yasser/0000-0001-6974-9595; Wetzel, James/0000-0003-4687-7302; Kumar, Ajay/0000-0002-8477-9079; Mancinelli, Giampiero/0000-0003-1144-3678; Piotrzkowski, Krzysztof/0000-0002-6226-957X; Rizzi, Andrea/0000-0002-4543-2718; Gersabeck, Evelina/0000-0002-2860-6528; Kratschmer, Ilse/0000-0002-5636-9259; Colaleo, Anna/0000-0002-0711-6319; Dujany, Giulio/0000-0002-1345-8163; Bluj, Michal/0000-0003-1229-1442; Cardinale, Roberta/0000-0002-7835-7638; Dogra, Sunil Manohar/0000-0002-0812-0758; Goldstein, Joel/0000-0003-1591-6014; Mapelli, Alessandro/0000-0002-4128-1019; Markowitz, Pete/0000-0002-5661-586X; Safonov, Alexei/0000-0001-9497-5471; Verdier, Patrice/0000-0003-3090-2948; Hall, Geoffrey/0000-0002-6299-8385; Ricci-Tam, Francesca/0000-0001-9750-7702; T'Jampens, Stephane/0000-0003-4249-6641; Sharma, Varun/0000-0003-1287-1471; Abbiendi, Giovanni/0000-0003-4499-7562; Brinkerhoff, Andrew/0000-0002-4819-7995; Shopova, Mariana/0000-0001-6664-2493; Vidal Marono, Miguel/0000-0002-2590-5987; Gutsche, Oliver/0000-0002-8015-9622; Stober, Fred/0000-0003-2620-3159; Dutta, Deepanwita/0000-0002-1191-3978; Kasemann, Matthias/0000-0002-0429-2448; Weber, Hannsjorg/0000-0002-5074-0539; CHEN, KAI-FENG/0000-0003-1304-3782; Spiga, Daniele/0000-0002-2991-6384; Ptochos, Fotios/0000-0002-3432-3452; Taylor, Lucas/0000-0002-6584-2538; Tisserand, Vincent/0000-0003-4916-0446; Kumar, Arun/0000-0002-5180-6595; Forthomme, Laurent/0000-0002-3302-336X; Pinna, Deborah/0000-0002-0947-1357; Reis, Thomas/0000-0003-3703-6624; Rahatlou, Shahram/0000-0001-9794-3360; Lai, Adriano/0000-0003-1633-0496; Molina Rodriguez, Josue Danilo/0000-0002-8025-0768; Maity, Manas/0000-0002-3237-3608; Trisovic, Ana/0000-0003-1991-0533; Papadopoulos, Ioannis/0000-0002-9937-3063; Eisenhardt, Stephan/0000-0002-4860-6779; Baarmand, Marc/0000-0002-9792-8619; Wang, Ren-Jie/0000-0002-5059-8456; Yang, Zhenwei/0000-0003-2937-9782; Merola, Mario/0000-0002-7082-8108; Rosowsky, Andre/0000-0001-7803-6650; Lefevre, Regis/0000-0002-6917-6210; Cogneras, Eric/0000-0002-8933-9427; Stone, Sheldon/0000-0002-2122-771X; Naimuddin, Md/0000-0003-4542-386X; Perazzini, Stefano/0000-0002-1862-7122; Costa, Salvatore/0000-0001-9919-0569; Ruiz, Jose/0000-0002-3306-0363; Pistone, Alessandro/0000-0002-1550-0361; Calligaris, Luigi/0000-0002-9951-9448; Le Gac, Renaud/0000-0002-7551-6971; Park, HyangKyu/0000-0002-6966-1689; van Tilburg, Jeroen/0000-0003-2655-8742; Dettori, Francesco/0000-0003-0256-8663; Titov, Maxim/0000-0002-1119-6614; Azzi, Patrizia/0000-0002-3129-828X; Schroder, Matthias/0000-0001-8058-9828; Seyfert, Paul/0000-0001-5419-2763; Brook, Nicholas/0000-0002-1818-0113; Landsberg, Greg/0000-0002-4184-9380; Van Onsem, Gerrit/0000-0002-1664-2337; Belyaev, Ivan/0000-0002-7458-7030; Cunliffe, Sam/0000-0003-0167-8641; Watson, Nigel/0000-0002-8142-4678; Lucchini, Marco Toliman/0000-0002-7497-7450; Pastrone, Nadia/0000-0001-7291-1979; Gonzi, Sandro/0000-0003-4754-645X; Beaudette, Florian/0000-0002-1194-8556; Vieira de Castro Ferreira da Silva, Pedro Manuel/0000-0002-5725-041X; Parkes, Chris/0000-0003-4174-1334; Campora Perez, Daniel Hugo/0000-0001-8998-9975; Vagnoni, Vincenzo Maria/0000-0003-2206-311X; Donato, Silvio/0000-0001-7646-4977; Storaci, Barbara/0000-0002-0219-2750; Everaerts, Pieter/0000-0003-3848-324X; Hobson, Peter/0000-0002-5645-5253; Azzurri, Paolo/0000-0002-1717-5654; Nishu, Nishu/0000-0002-9048-1332; Stroili, Roberto/0000-0002-3453-142X; Chahal, Gurpreet Singh/0000-0003-0320-4407; Krolikowski, Jan/0000-0002-3055-0236; Alexander, Michael/0000-0002-8148-2392; Popov, Andrey/0000-0002-1207-0984; Arneodo, Michele/0000-0002-7790-7132; Mrenna, Stephen/0000-0001-8731-160X; David, Pieter/0000-0001-9260-9371; Stupak III, John/0000-0001-9610-0783; Neri, Nicola/0000-0002-6106-3756; Kayis Topaksu, Aysel/0000-0002-3169-4573; Boccali, Tommaso/0000-0002-9930-9299; Tonelli, Guido Emilio/0000-0003-2606-9156; Haller, Johannes/0000-0001-9347-7657; Bernet, Colin/0000-0002-9923-8734; Gonzalez Suarez, Rebeca/0000-0002-6126-7230; Kyberd, Paul/0000-0002-7353-7090; Zhang, Yanxi/0000-0002-0157-188X; Hutchcroft, David/0000-0002-4174-6509; Souza Covacich, Daniel/0000-0003-2671-9227; Escalante del Valle, Alberto/0000-0002-9702-6359; Rodrigues, Eduardo/0000-0003-2846-7625; Evdokimov, Olga/0000-0002-1250-8931; De Cian, Michel/0000-0002-1268-9621; Rodriguez, Jorge/0000-0001-6680-7761; Rabbertz, Klaus/0000-0001-7040-9846; Andreev, Yuri/0000-0002-7397-9665; Wang, Dayong/0000-0002-9013-1199; Botta, Cristina/0000-0002-8072-795X; CONTE, Eric/0000-0003-3154-3123; Lupton, Oliver/0000-0002-3500-7398; Albrecht, Johannes/0000-0001-8636-1621; Klimaszewski, Konrad/0000-0003-0741-5922; MANCA, GIULIA/0000-0003-1960-4413; Serra, Nicola/0000-0002-5033-0580; Fehling, David/0000-0003-4520-7219; Latham, Thomas/0000-0002-7195-8537; Veltri, Michele/0000-0001-7917-9661; Jafari, Abideh/0000-0001-7327-1870; Craik, Daniel/0000-0002-3684-1560; Arcidiacono, Roberta/0000-0001-5904-142X; Gershtein, Yuri/0000-0002-4871-5449; Blanc, Frederic/0000-0001-5775-3132; Boutle, Sarah/0000-0002-8732-2963; Dominguez, Aaron/0000-0002-7420-5493; Cole, Joanne/0000-0001-5638-7599; Lacroix, Florent/0000-0002-4304-8843; Ronga, Frederic/0000-0002-9912-9677	CAPES (Brazil); CNPq (Brazil); FAPERJ (Brazil); FINEP (Brazil); NSFC (China); CNRS/IN2P3 (France); BMBF (Germany); DFG (Germany); HGF (Germany); SFI (Ireland); INFN (Italy); NASU (Ukraine); STFC (UK); NSF (USA); BMWFW (Austria); FWF (Austria); FNRS (Belgium); FWO (Belgium); FAPESP (Brazil); MES (Bulgaria); CAS (China); MoST (China); COLCIENCIAS (Colombia); MSES (Croatia); CSF (Croatia); RPF (Cyprus); MoER (Estonia); ERC IUT (Estonia); ERDF (Estonia); Academy of Finland (Finland); MEC (Finland); HIP (Finland); CEA (France); GSRT (Greece); OTKA (Hungary); NIH (Hungary); DAE (India); DST (India); IPM (Iran); NRF (Republic of Korea); WCU (Republic of Korea); LAS (Lithuania); MOE (Malaysia); UM (Malaysia); CINVESTAV (Mexico); CONACYT (Mexico); SEP (Mexico); UASLP-FAI (Mexico); MBIE (New Zealand); PAEC (Pakistan); MSHE (Poland); NSC (Poland); FCT (Portugal); JINR (Dubna); MON (Russia); RosAtom (Russia); RAS (Russia); RFBR (Russia); MESTD (Serbia); SEIDI (Spain); CPAN (Spain); MST (Taipei); ThEPCenter (Thailand); IPST (Thailand); STAR (Thailand); NSTDA (Thailand); TUBITAK (Turkey); TAEK (Turkey); SFFR (Ukraine); DOE (USA); MPG (Germany); FOM (The Netherlands); NWO (The Netherlands); MNiSW (Poland); NCN (Poland); MEN/IFA (Romania); MinES (Russia); FANO (Russia); MinECo (Spain); SNSF (Switzerland); SER (Switzerland); Marie-Curie programme; European Research Council; EPLANET (European Union); Leventis Foundation; A. P. Sloan Foundation; Alexander von Humboldt Foundation; Belgian Federal Science Policy Office; Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIABelgium); Agentschap voor Innovatie door Wetenschap en Technologie (IWT-Belgium); Ministry of Education, Youth and Sports (MEYS) of the Czech Republic; Council of Science and Industrial Research, India; Foundation for Polish Science; European Union, Regional Development Fund; Compagnia di San Paolo (Torino); Consorzio per la Fisica (Trieste); MIUR (Italy) [20108T4XTM]; Thalis programme; Aristeia programme; EU-ESF; Greek NSRF; National Priorities Research Program by Qatar National Research Fund; EPLANET; Marie Sklodowska-Curie Actions; ERC (European Union); Conseil general de Haute-Savoie; Labex ENIGMASS; OCEVU; Region Auvergne (France); XuntaGal (Spain); GENCAT (Spain); Royal Society (UK); Royal Commission for the Exhibition of 1851 (UK); STFC [ST/H00100X/2, ST/L00609X/1, ST/H00081X/2, ST/I505580/1, ST/K000705/1, ST/J005665/1, ST/K001302/1, ST/J004901/1, ST/L005603/1, LHCb Upgrades, ST/K003410/1, ST/K001639/1, ST/J004332/1, ST/K00137X/1, ST/L003112/1, ST/K003542/1, LHCb, ST/I005912/1, ST/K003844/1, ST/L003538/1, ST/L001195/1, ST/M004775/1, ST/M005356/1, PP/E000355/1, ST/H00100X/1, ST/J50094X/1, ST/H006737/1, ST/M001407/1] Funding Source: UKRI; Direct For Mathematical & Physical Scien [1505719] Funding Source: National Science Foundation; Division Of Physics [1314131, 1120138, 1205805, 1506168, 1306951, 1211067, 1506130, 1306040, 1151640] Funding Source: National Science Foundation; Science and Technology Facilities Council [ST/K001604/1, ST/H006737/1, CMS] Funding Source: researchfish	CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FINEP (Brazil)(Financiadora de Inovacao e Pesquisa (Finep)); NSFC (China)(National Natural Science Foundation of China (NSFC)); CNRS/IN2P3 (France)(Centre National de la Recherche Scientifique (CNRS)); BMBF (Germany)(Federal Ministry of Education & Research (BMBF)); DFG (Germany)(German Research Foundation (DFG)); HGF (Germany); SFI (Ireland)(Science Foundation Ireland); INFN (Italy)(Istituto Nazionale di Fisica Nucleare (INFN)); NASU (Ukraine); STFC (UK)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NSF (USA)(National Science Foundation (NSF)); BMWFW (Austria); FWF (Austria)(Austrian Science Fund (FWF)); FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS); FWO (Belgium)(FWO); FAPESP (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); MES (Bulgaria); CAS (China)(Chinese Academy of Sciences); MoST (China)(Ministry of Science and Technology, China); COLCIENCIAS (Colombia)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); MSES (Croatia); CSF (Croatia); RPF (Cyprus); MoER (Estonia); ERC IUT (Estonia)(Estonian Research Council); ERDF (Estonia); Academy of Finland (Finland)(Academy of Finland); MEC (Finland); HIP (Finland); CEA (France)(French Atomic Energy Commission); GSRT (Greece)(Greek Ministry of Development-GSRT); OTKA (Hungary)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NIH (Hungary)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DAE (India)(Department of Atomic Energy (DAE)); DST (India)(Department of Science & Technology (India)); IPM (Iran); NRF (Republic of Korea)(National Research Foundation of Korea); WCU (Republic of Korea); LAS (Lithuania); MOE (Malaysia); UM (Malaysia); CINVESTAV (Mexico); CONACYT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); SEP (Mexico); UASLP-FAI (Mexico); MBIE (New Zealand)(New Zealand Ministry of Business, Innovation and Employment (MBIE)); PAEC (Pakistan); MSHE (Poland); NSC (Poland); FCT (Portugal)(Portuguese Foundation for Science and TechnologyEuropean Commission); JINR (Dubna); MON (Russia); RosAtom (Russia); RAS (Russia)(Russian Academy of Sciences); RFBR (Russia)(Russian Foundation for Basic Research (RFBR)); MESTD (Serbia)(Ministry of Education, Science & Technological Development, Serbia); SEIDI (Spain); CPAN (Spain); MST (Taipei); ThEPCenter (Thailand); IPST (Thailand); STAR (Thailand); NSTDA (Thailand); TUBITAK (Turkey)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); TAEK (Turkey)(Ministry of Energy & Natural Resources - Turkey); SFFR (Ukraine)(State Fund for Fundamental Research (SFFR)); DOE (USA)(United States Department of Energy (DOE)); MPG (Germany)(Max Planck Society); FOM (The Netherlands)(FOM (The Netherlands)Netherlands Government); NWO (The Netherlands)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); MNiSW (Poland)(Ministry of Science and Higher Education, Poland); NCN (Poland); MEN/IFA (Romania); MinES (Russia); FANO (Russia); MinECo (Spain)(Spanish Government); SNSF (Switzerland)(Swiss National Science Foundation (SNSF)); SER (Switzerland); Marie-Curie programme(European Commission); European Research Council(European Research Council (ERC)European Commission); EPLANET (European Union); Leventis Foundation; A. P. Sloan Foundation(Alfred P. Sloan Foundation); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIABelgium)(Fonds de la Recherche Scientifique - FNRS); Agentschap voor Innovatie door Wetenschap en Technologie (IWT-Belgium)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Ministry of Education, Youth and Sports (MEYS) of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Council of Science and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union, Regional Development Fund(European Commission); Compagnia di San Paolo (Torino)(Compagnia di San Paolo); Consorzio per la Fisica (Trieste); MIUR (Italy)(Ministry of Education, Universities and Research (MIUR)); Thalis programme; Aristeia programme; EU-ESF(European Commission); Greek NSRF(Greek Ministry of Development-GSRT); National Priorities Research Program by Qatar National Research Fund(Qatar National Research Fund (QNRF)); EPLANET; Marie Sklodowska-Curie Actions; ERC (European Union)(European Research Council (ERC)); Conseil general de Haute-Savoie(Region Auvergne-Rhone-Alpes); Labex ENIGMASS; OCEVU; Region Auvergne (France)(Region Auvergne-Rhone-Alpes); XuntaGal (Spain); GENCAT (Spain); Royal Society (UK)(Royal Society of London); Royal Commission for the Exhibition of 1851 (UK); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We express our gratitude to colleagues in the CERN accelerator departments for the excellent performance of the LHC. We thank the technical and administrative staff at CERN, at the CMS institutes and at the LHCb institutes. In addition, we gratefully acknowledge the computing centres and personnel of the Worldwide LHC Computing Grid for delivering so effectively the computing infrastructure essential to our analyses. Finally, we acknowledge the enduring support for the construction and operation of the LHC, the CMS and the LHCb detectors provided by CERN and by many funding agencies. The following agencies provide support for both CMS and LHCb: CAPES, CNPq, FAPERJ and FINEP (Brazil); NSFC (China); CNRS/IN2P3 (France); BMBF, DFG and HGF (Germany); SFI (Ireland); INFN (Italy); NASU (Ukraine); STFC (UK); and NSF (USA). Agencies that provide support for CMS only are BMWFW and FWF (Austria); FNRS and FWO (Belgium); FAPESP (Brazil); MES (Bulgaria); CAS and MoST (China); COLCIENCIAS (Colombia); MSES and CSF (Croatia); RPF (Cyprus); MoER, ERC IUT and ERDF (Estonia); Academy of Finland, MEC, and HIP (Finland); CEA (France); GSRT (Greece); OTKA and NIH (Hungary); DAE and DST (India); IPM (Iran); NRF and WCU (Republic of Korea); LAS (Lithuania); MOE and UM (Malaysia); CINVESTAV, CONACYT, SEP, and UASLP-FAI (Mexico); MBIE (New Zealand); PAEC (Pakistan); MSHE and NSC (Poland); FCT (Portugal); JINR (Dubna); MON, RosAtom, RAS and RFBR (Russia); MESTD (Serbia); SEIDI and CPAN (Spain); Swiss Funding Agencies (Switzerland); MST (Taipei); ThEPCenter, IPST, STAR and NSTDA (Thailand); TUBITAK and TAEK (Turkey); SFFR (Ukraine); and DOE (USA). Agencies that provide support for only LHCb are: FINEP (Brazil); MPG (Germany); FOM and NWO (The Netherlands); MNiSW and NCN (Poland); MEN/IFA (Romania); MinES and FANO (Russia); MinECo (Spain); SNSF and SER (Switzerland). Individuals from the CMS collaboration have received support from the Marie-Curie programme and the European Research Council and EPLANET (European Union); the Leventis Foundation; the A. P. Sloan Foundation; the Alexander von Humboldt Foundation; the Belgian Federal Science Policy Office; the Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIABelgium); the Agentschap voor Innovatie door Wetenschap en Technologie (IWT-Belgium); the Ministry of Education, Youth and Sports (MEYS) of the Czech Republic; the Council of Science and Industrial Research, India; the HOMING PLUS programme of Foundation for Polish Science, cofinanced from European Union, Regional Development Fund; the Compagnia di San Paolo (Torino); the Consorzio per la Fisica (Trieste); MIUR project 20108T4XTM (Italy); the Thalis and Aristeia programmes cofinanced by EU-ESF and the Greek NSRF; and the National Priorities Research Program by Qatar National Research Fund. Individual groups or members of the LHCb collaboration have received support from EPLANET, Marie Sklodowska-Curie Actions and ERC (European Union), Conseil general de Haute-Savoie, Labex ENIGMASS and OCEVU, Region Auvergne (France), RFBR (Russia), XuntaGal and GENCAT (Spain), Royal Society and Royal Commission for the Exhibition of 1851 (UK). LHCb is also thankful for the computing resources and the access to software R&D tools provided by Yandex LLC (Russia). The CMS and LHCb collaborations are indebted to the communities behind the multiple open source software packages on which they depend.	Aad G, 2012, PHYS LETT B, V713, P387, DOI 10.1016/j.physletb.2012.06.013; Aaij R, 2014, PHYS LETT B, V734, P122, DOI 10.1016/j.physletb.2014.05.021; Aaij R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.101805; Aaij R, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2013)001; Aaij R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.021801; Aaij R, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.231801; Aaij R, 2012, PHYS LETT B, V708, P55, DOI 10.1016/j.physletb.2012.01.038; Aaij R, 2011, PHYS LETT B, V699, P330, DOI 10.1016/j.physletb.2011.04.031; Aaij R, 2013, PP COLL; Aaji R, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.032008; Aaltonen T, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.072003; Aaltonen T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.191801; Abazov VM, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.072006; Abazov VM, 2010, PHYS LETT B, V693, P539, DOI 10.1016/j.physletb.2010.09.024; Abazov V.M., 2007, PHYS REV D, V76; Abazov VM, 2005, PHYS REV LETT, V94, DOI [10.1103/PhysRevLett.94.071802, 10.1103/PhysRevLett.94.091802]; Abbott B, 1998, PHYS LETT B, V423, P419, DOI 10.1016/S0370-2693(98)00161-0; Abe F, 1996, PHYS REV LETT, V76, P4675, DOI 10.1103/PhysRevLett.76.4675; Abe F, 1998, PHYS REV D, V57, pR3811, DOI 10.1103/PhysRevD.57.R3811; Abulencia A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.221805; Acciarri M, 1997, PHYS LETT B, V391, P474, DOI 10.1016/S0370-2693(96)01583-3; Acousta D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.032001; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; ALBAJAR C, 1991, PHYS LETT B, V262, P163, DOI 10.1016/0370-2693(91)90660-I; ALBAJAR C, 1988, PHYS LETT B, V209, P397, DOI 10.1016/0370-2693(88)90969-0; ALBRECHT H, 1987, PHYS LETT B, V199, P451, DOI 10.1016/0370-2693(87)90952-X; Alves AA, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/08/S08005; Amhis Y, 2012, PREPRINT; AMMAR R, 1994, PHYS REV D, V49, P5701, DOI 10.1103/PhysRevD.49.5701; Aoki S, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-2890-7; ATLAS and CMS Collaborations, 2011, PROC LHC HIGGS BOS S; Aubert B, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.221803; Aubert B, 2008, PHYS REV D, V77, DOI [10.1103/PhysRevD.77.051103, 10.1103/PhysRevD.77.011107, 10.1103/PhysRevD.77.031101, 10.1103/PhysRevD.77.011101]; AVERY P, 1987, PHYS LETT B, V183, P429, DOI 10.1016/0370-2693(87)90990-7; AVERY P, 1989, PHYS LETT B, V223, P470, DOI 10.1016/0370-2693(89)91635-3; Babu KS, 2000, PHYS REV LETT, V84, P228, DOI 10.1103/PhysRevLett.84.228; Bazavov A, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.114506; Bergfeld T, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.091102; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Bobeth C, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.074014; Bobeth C, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.101801; Breiman L., 1984, CLASSIFICATION REGRE; Buras AJ, 2003, PHYS LETT B, V566, P115, DOI 10.1016/S0370-2693(03)00561-6; Chang MC, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.111101; Chatrchyan S, 2012, EUR PHYS J C, V72, DOI 10.1140/epjc/s10052-012-2012-3; Chatrchyan S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.101804; Chatrchyan S, 2012, PHYS LETT B, V711, P15, DOI 10.1016/j.physletb.2012.03.029; Chatrchyan S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.191802; Chatrchyan S, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/08/S08004; Choudhury SR, 1999, PHYS LETT B, V451, P86, DOI 10.1016/S0370-2693(99)00203-8; CMS Collaboration, 2012, Physics Letters B, V716, P30, DOI 10.1016/j.physletb.2012.08.021; D'Ambrosio G, 2002, NUCL PHYS B, V645, P155, DOI 10.1016/S0550-3213(02)00836-2; De Bruyn K, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.041801; Evans L, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/08/S08001; Feldman GJ, 1998, PHYS REV D, V57, P3873, DOI 10.1103/PhysRevD.57.3873; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; GAVELA MB, 1994, NUCL PHYS B, V430, P345, DOI 10.1016/0550-3213(94)00409-9; GILES R, 1984, PHYS REV D, V30, P2279, DOI 10.1103/PhysRevD.30.2279; Huang C.- S., 1998, PHYS REV D, V59; Khodjamirian A, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2011)106; Na H, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.034506; RBC- UKQCD Collaborations, 2013, PREPRINT; Therhaag J, 2012, AIP CONF PROC, V1504, P1013, DOI 10.1063/1.4771869; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360	64	331	333	12	462	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					68	+		10.1038/nature14474	http://dx.doi.org/10.1038/nature14474			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	26047778	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000355543400030
J	Wahl, MC; Luhrmann, R				Wahl, Markus C.; Luehrmann, Reinhard			SnapShot: Spliceosome Dynamics I	CELL			English	Editorial Material									[Wahl, Markus C.] Free Univ Berlin, Lab Struct Biochem, D-14195 Berlin, Germany; [Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany	Free University of Berlin; Max Planck Society	Wahl, MC (corresponding author), Free Univ Berlin, Lab Struct Biochem, Takustr 6, D-14195 Berlin, Germany.		Wahl, Markus C./D-6365-2017	Wahl, Markus C./0000-0002-2811-5307				Anokhina M, 2013, EMBO J, V32, P2804, DOI 10.1038/emboj.2013.198; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009	5	42	44	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1474	U267		10.1016/j.cell.2015.05.050	http://dx.doi.org/10.1016/j.cell.2015.05.050			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26046445	Bronze			2022-12-28	WOS:000355935000026
J	Roberts, I; Ker, K; Edwards, P; Beecher, D; Manno, D; Sydenham, E				Roberts, Ian; Ker, Katharine; Edwards, Phil; Beecher, Deirdre; Manno, Daniela; Sydenham, Emma			The knowledge system underpinning healthcare is not fit for purpose and must change	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYDROXYETHYL STARCH; TRIAL REGISTRATION; PUBLICATION BIAS; METAANALYSES		[Roberts, Ian; Ker, Katharine; Edwards, Phil; Beecher, Deirdre; Manno, Daniela; Sydenham, Emma] Univ London London Sch Hyg & Trop Med, Cochrane Injuries Grp, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Roberts, I (corresponding author), Univ London London Sch Hyg & Trop Med, Cochrane Injuries Grp, Keppel St, London WC1E 7HT, England.	ian.roberts@lshtm.ac.uk		Manno, Daniela/0000-0002-7026-3581; Ker, Katharine/0000-0002-1514-5005; Beecher, Deirdre/0000-0002-3899-8844; Edwards, Phil/0000-0003-4431-8822				AlBalawi Z, 2013, INT J CARDIOL, V168, P1102, DOI 10.1016/j.ijcard.2012.11.048; ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Bunn F, 2001, COCHRANE DB SYST REV, V2; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; De Angelis C, 2004, LANCET, V364, P911, DOI 10.1016/S0140-6736(04)17034-7; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Ioannidis JPA, 2013, JAMA-J AM MED ASSOC, V309, P2209, DOI 10.1001/jama.2013.5817; Ioannidis JPA, 2012, J PSYCHOSOM RES, V73, P408, DOI 10.1016/j.jpsychores.2012.09.014; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Loder E, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c950; Perel P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub5; Pogue J, 1998, LANCET, V351, P47, DOI 10.1016/S0140-6736(97)08461-4; Pogue JM, 1997, CONTROL CLIN TRIALS, V18, P580, DOI 10.1016/S0197-2456(97)00051-2; Roberts I, 2007, BRIT MED J, V334, P392, DOI 10.1136/bmj.39118.480023.BE; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Thorlund K., 2011, USER MANUAL TRIAL SE; Thorlund K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025491; Wager E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5248; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430	23	73	73	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2015	350								h2463	10.1136/bmj.h2463	http://dx.doi.org/10.1136/bmj.h2463			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK0TY	26041754	Green Accepted			2022-12-28	WOS:000355919100001
J	Malani, PN				Malani, Preeti N.			Bundled Approaches for Surgical Site Infection Prevention The Continuing Quest to Get to Zero	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OLDER-ADULTS; DECOLONIZATION; SURGERY		[Malani, Preeti N.] Univ Michigan Hlth Syst, Dept Internal Med, Div Infect Dis, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Malani, PN (corresponding author), 3119 Taubman Ctr, Ann Arbor, MI 48109 USA.	pmalani@umich.edu						Anderson DJ, 2014, INFECT CONT HOSP EP, V35, P605, DOI [10.1086/676022, 10.1017/S0899823X00193869]; Big C, 2010, J AM GERIATR SOC, V58, P300, DOI 10.1111/j.1532-5415.2009.02666.x; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Chassin MR, 2015, JAMA-J AM MED ASSOC, V313, P1795, DOI 10.1001/jama.2015.3818; Kline S, 2014, INFECT CONT HOSP EP, V35, P880, DOI 10.1086/676866; Malani PN, 2013, JAMA-J AM MED ASSOC, V309, P1408, DOI 10.1001/jama.2013.3382; Merkow RP, 2015, JAMA-J AM MED ASSOC, V313, P483, DOI 10.1001/jama.2014.18614; Schweizer M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2743; Schweizer ML, 2014, JAMA SURG, V149, P575, DOI 10.1001/jamasurg.2013.4663; Schweizer ML, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2015.5387, DOI 10.1001/JAMA.2015]; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Young MH, 2008, DRUG AGING, V25, P399, DOI 10.2165/00002512-200825050-00004	12	4	4	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2131	2132		10.1001/jama.2015.6018	http://dx.doi.org/10.1001/jama.2015.6018			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ4CC	26034954				2022-12-28	WOS:000355430900012
J	Hu, XQ; Antony, JW; Creery, JD; Vargas, IM; Bodenhausen, GV; Paller, KA				Hu, Xiaoqing; Antony, James W.; Creery, Jessica D.; Vargas, Iliana M.; Bodenhausen, Galen V.; Paller, Ken A.			Unlearning implicit social biases during sleep	SCIENCE			English	Article							SLOW-WAVE SLEEP; ASSOCIATION TEST; MEMORY REACTIVATION; RACE BIAS; PREJUDICE; STEREOTYPES; REDUCTION; ATTITUDES; BEHAVIOR; SCIENCE	Although people may endorse egalitarianism and tolerance, social biases can remain operative and drive harmful actions in an unconscious manner. Here, we investigated training to reduce implicit racial and gender bias. Forty participants processed counterstereotype information paired with one sound for each type of bias. Biases were reduced immediately after training. During subsequent slow-wave sleep, one sound was unobtrusively presented to each participant, repeatedly, to reactivate one type of training. Corresponding bias reductions were fortified in comparison with the social bias not externally reactivated during sleep. This advantage remained 1 week later, the magnitude of which was associated with time in slow-wave and rapid-eye-movement sleep after training. We conclude that memory reactivation during sleep enhances counterstereotype training and that maintaining a bias reduction is sleep-dependent.	[Hu, Xiaoqing; Antony, James W.; Creery, Jessica D.; Vargas, Iliana M.; Bodenhausen, Galen V.; Paller, Ken A.] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Hu, Xiaoqing] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Antony, James W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	Northwestern University; University of Texas System; University of Texas Austin; Princeton University	Paller, KA (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.	kap@northwestern.edu	Paller, Ken/M-2676-2019	Creery, Jessica/0000-0002-0170-6190; Bodenhausen, Galen/0000-0002-6327-1612; Paller, Ken/0000-0003-4415-4143; Hu, Xiaoqing/0000-0001-8112-9700	Northwestern University; NSF [BCS-1025697, BCS-1461088, DGE-0824162]; NIH [T32-AG020418, F31-MH100958]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH100958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020506, T32AG020418] Funding Source: NIH RePORTER	Northwestern University; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support was provided by Northwestern University and by NSF grants BCS-1025697, BCS-1461088, and DGE-0824162, and by NIH grants T32-AG020418 and F31-MH100958. Data are archived and available on the Open Science Framework (https://osf.io/b3k9a/). K.A.P. served as an advisor to Sheepdog Sciences (a company developing educational technologies related to sleep) in exchange for equity compensation. The authors declare no conflict of interests.	Allport G., 1979, NATURE PREJUDICE, V25th; Ambrosini MV, 2001, SLEEP MED REV, V5, P477, DOI 10.1053/smrv.2001.0180; Antony JW, 2012, NAT NEUROSCI, V15, P1114, DOI 10.1038/nn.3152; Arkes HR, 2004, PSYCHOL INQ, V15, P257, DOI 10.1207/s15327965pli1504_01; Arzi A, 2014, J NEUROSCI, V34, P15382, DOI 10.1523/JNEUROSCI.2291-14.2014; Bobo L, 1996, SOC FORCES, V74, P883, DOI 10.2307/2580385; Correll J, 2007, J PERS SOC PSYCHOL, V92, P1006, DOI 10.1037/0022-3514.92.6.1006; Crandall CS, 2002, J PERS SOC PSYCHOL, V82, P359, DOI 10.1037//0022-3514.82.3.359; Devine PG, 2012, J EXP SOC PSYCHOL, V48, P1267, DOI 10.1016/j.jesp.2012.06.003; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.5.680; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Fiske S. T, 1998, HDB SOCIAL PSYCHOL, P357, DOI DOI 10.1002/9780470561119; Gawronski B, 2008, J EXP SOC PSYCHOL, V44, P370, DOI 10.1016/j.jesp.2006.12.004; Glaser, 2014, SUSPECT RACE CAUSES; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Nosek BA, 2009, P NATL ACAD SCI USA, V106, P10593, DOI 10.1073/pnas.0809921106; Olsson A, 2005, SCIENCE, V309, P785, DOI 10.1126/science.1113551; Oudiette D, 2013, TRENDS COGN SCI, V17, P142, DOI 10.1016/j.tics.2013.01.006; Paller K.A., 2009, ENCY NEUROSCIENCE, P741, DOI [DOI 10.1016/B978-008045046-9.00770-1, 10.1016/B978-008045046-9.00770-1]; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; Stanley DA, 2011, P NATL ACAD SCI USA, V108, P7710, DOI 10.1073/pnas.1014345108; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; Weisbuch M, 2009, SCIENCE, V326, P1711, DOI 10.1126/science.1178358; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	31	57	60	8	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					1013	1015		10.1126/science.aaa3841	http://dx.doi.org/10.1126/science.aaa3841			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ1WU	26023137	Green Accepted			2022-12-28	WOS:000355276600043
J	Attaran, A				Attaran, Amir			Unanimity on Death with Dignity - Legalizing Physician-Assisted Dying in Canada	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Attaran, Amir] Univ Ottawa, Fac Law, Ottawa, ON, Canada; [Attaran, Amir] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Attaran, Amir] Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Attaran, A (corresponding author), Univ Ottawa, Fac Law, Ottawa, ON, Canada.							Vincent D., 2015, TORONTO STAR	1	24	25	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2015	372	22					2080	2082		10.1056/NEJMp1502442	http://dx.doi.org/10.1056/NEJMp1502442			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ0EI	26017821				2022-12-28	WOS:000355146800002
J	LeCun, Y; Bengio, Y; Hinton, G				LeCun, Yann; Bengio, Yoshua; Hinton, Geoffrey			Deep learning	NATURE			English	Review							NEURAL-NETWORK; ARCHITECTURE; RECOGNITION; ALGORITHM	Deep learning allows computational models that are composed of multiple processing layers to learn representations of data with multiple levels of abstraction. These methods have dramatically improved the state-of-the-art in speech recognition, visual object recognition, object detection and many other domains such as drug discovery and genomics. Deep learning discovers intricate structure in large data sets by using the backpropagation algorithm to indicate how a machine should change its internal parameters that are used to compute the representation in each layer from the representation in the previous layer. Deep convolutional nets have brought about breakthroughs in processing images, video, speech and audio, whereas recurrent nets have shone light on sequential data such as text and speech.	[LeCun, Yann] Facebook Al Res, New York, NY 10003 USA; [LeCun, Yann] New York Univ, New York, NY 10003 USA; [Bengio, Yoshua] Univ Montreal, Dept Comp Sci & Operat Res, Montreal, PQ H3C 3J7, Canada; [Hinton, Geoffrey] Google, Mountain View, CA 94043 USA; [Hinton, Geoffrey] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3G4, Canada	Facebook Inc; New York University; Universite de Montreal; Google Incorporated; University of Toronto	LeCun, Y (corresponding author), Facebook Al Res, 770 Broadway, New York, NY 10003 USA.	yann@cs.nyu.edu	Jeong, Yongwook/N-7413-2016; Ma, Jialin/ABG-2965-2021		Natural Sciences and Engineering Research Council of Canada; Canadian Institute For Advanced Research (CIFAR); National Science Foundation; Office of Naval Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute For Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research)	The authors would like to thank the Natural Sciences and Engineering Research Council of Canada, the Canadian Institute For Advanced Research (CIFAR), the National Science Foundation and Office of Naval Research for support. Y.L. and Y.B. are CIFAR fellows.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Ba J., 2014, P INT C LEARN REPR; Bahdanau D., 2015, P 3 INT C LEARN REPR; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; Bengio Y, 2001, ADV NEUR IN, V13, P932; Bengio Y., 2005, ADV NEURAL INFORM PR, V18, P107; Bengio Y, 2014, PR MACH LEARN RES, V32, P226; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Bengio Y, 2009, FOUND TRENDS MACH LE, V2, P1, DOI 10.1561/2200000006; BOSER BE, 1991, IEEE J SOLID-ST CIRC, V26, P2017, DOI 10.1109/4.104196; Bottou L., 1989, P EUR, V89, P537; Bottou L, 2014, MACH LEARN, V94, P133, DOI 10.1007/s10994-013-5335-x; Bousquet O., 2007, ADV NEURAL INFORM PR, V20, P161; Cadieu CF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003963; Cho K., 2014, C EMPIRICAL METHODS, P1724; Choromanska A., 2014, P C AI STAT; Ciodaro T, 2012, J PHYS CONF SER, V368, DOI 10.1088/1742-6596/368/1/012030; Ciresan D, 2012, NEURAL NETWORKS, V32, P333, DOI 10.1016/j.neunet.2012.02.023; Collobert R, 2011, J MACH LEARN RES, V12, P2493; Dahl GE, 2012, IEEE T AUDIO SPEECH, V20, P30, DOI 10.1109/TASL.2011.2134090; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Dauphin Y.N., 2014, P 27 INT C NEUR INF, P2933, DOI DOI 10.5555/2969033.2969154; Duda R.O., 2000, PATTERN CLASSIFICATI; ElHihi S., 1995, P ADV NEUR INF PROC, P8; Farabet C., 2011, SCALING MACHINE LEAR, V13, P399; Farabet C, 2013, IEEE T PATTERN ANAL, V35, P1915, DOI 10.1109/TPAMI.2012.231; Farabet Clement, 2012, P INT C MACH LEARN; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FUKUSHIMA K, 1982, PATTERN RECOGN, V15, P455, DOI 10.1016/0031-3203(82)90024-3; Girshick R, 2014, PROC CVPR IEEE, P580, DOI 10.1109/CVPR.2014.81; Glorot X., 2011, PROC 14 INT C ARTIFI, V15, P315; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Graves A., 2014, ARXIV14105401; Graves A, 2013, INT CONF ACOUST SPEE, P6645, DOI 10.1109/ICASSP.2013.6638947; Gregor K., 2010, ICML, P399, DOI DOI 10.5555/3104322.3104374; Hadsell R, 2009, J FIELD ROBOT, V26, P120, DOI 10.1002/rob.20276; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; HINTON GE, 1995, SCIENCE, V268, P1158, DOI 10.1126/science.7761831; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hinton GE, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P1765; Hochreiter S, 1991, THESIS TU MNICH; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jean S, 2015, P ACL IJCNLP; Kaggle, 2014, HIGGS BOS MACH LEARN; Kavukcuoglu K., 2010, ADV NEURAL INFORM PR, P1090; Kingma D. P., 2014, P 27 INT C NEUR INF, P3581, DOI DOI 10.5555/2969033.2969226; Krizhevsky A., P 25 INT C NEUR INF, P1097; Lakoff G., 1980, METAPHORS WE LIVE; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; LeCun Y., 1990, ADV NEURAL INFORM PR, V2, P396, DOI DOI 10.1111/DSU.12130; Lecun Y., 1985, PROC COGNITIVA, P599; Leung MKK, 2014, BIOINFORMATICS, V30, P121, DOI 10.1093/bioinformatics/btu277; Ma JS, 2015, J CHEM INF MODEL, V55, P263, DOI 10.1021/ci500747n; Mikolov T., 2011, 2011 IEEE Workshop on Automatic Speech Recognition & Understanding (ASRU), P196, DOI 10.1109/ASRU.2011.6163930; Mikolov T., 2013, ADV NEURAL INFORM PR, V26, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Mohamed AR, 2012, IEEE T AUDIO SPEECH, V20, P14, DOI 10.1109/TASL.2011.2109382; Montufar G., 2014, J DISCRETE MATH, V29, P321; Montufar G., 2014, ADV NEURAL INFORM PR, V4, P2924; Ning F, 2005, IEEE T IMAGE PROCESS, V14, P1360, DOI 10.1109/TIP.2005.852470; Nowlan S. J., 1995, Advances in Neural Information Processing Systems 7, P901; Osadchy M, 2007, J MACH LEARN RES, V8, P1197; Parker D. B., 1985, TR47; Pascanu T., 2013, INT C MACH LEARN, P1310; Raina R., 2009, P 26 ANN INT C MACH, P1, DOI DOI 10.1145/1553374.1553486; Ranzato M.A., 2006, ADV NEURAL INFORM PR, V19, P1137, DOI DOI 10.7551/MITPRESS/7503.003.0147; Ranzato M, 2013, IEEE T PATTERN ANAL, V35, P2206, DOI 10.1109/TPAMI.2013.29; Rogers T. T., 2004, SEMANTIC COGNITION P; Rosenblatt F., 1957, PERCEPTRON PERCEIVIN; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Sainath TN, 2013, INT CONF ACOUST SPEE, P8614, DOI 10.1109/ICASSP.2013.6639347; Scholkopf B., 2002, LEARNING KERNELS; Schwenk H, 2007, COMPUT SPEECH LANG, V21, P492, DOI 10.1016/j.csl.2006.09.003; Selfridge O. G., 1958, P S HELD NAT PHYS LA, P513; Sermanet P., 2013, P INT C COMP VIS PAT; Sermanet P., 2013, COMPUT VIS PATTERN R, V1312, P6229; Simard PY, 2003, PROC INT CONF DOC, P958; Socher R, 2011, INT C MACHINE LEARNI; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Sutskever I., 2014, NEURAL INFORM PROCES, P3104; Sutskever I., 2012, THESIS U TORONTO; Sutskever I., 2011, P 28 INT C MACH LEAR; Szegedy Christian, 2014, ARXIV; Taigman Y, 2014, PROC CVPR IEEE, P1701, DOI 10.1109/CVPR.2014.220; Tompson J., 2014, P C COMP VIS PATT RE; Tompson J.J., 2014, ADV NEURAL INF PROCE, P1799, DOI DOI 10.5555/2968826.2969027; Turaga SC, 2010, NEURAL COMPUT, V22, P511, DOI 10.1162/neco.2009.10-08-881; VAILLANT R, 1994, IEE P-VIS IMAGE SIGN, V141, P245, DOI 10.1049/ip-vis:19941301; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vincent P., 2008, P 25 INT C MACHINE L, P1096, DOI 10.1145/1390156.1390294; Vinyals O., 2014, P INT C MACH LEARN; Werbos P.J., 1974, THESIS HARVARD U CAM; Weston J., 2014, P EMP METH NAT LANG; Weston J., 2015, AI COMPLETE QUESTION; Weston J., 2015, P ICLR 2015 C BLIND; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Xu K., 2015, P INT C LEARN REPR	103	22148	22204	1157	1157	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					436	444		10.1038/nature14539	http://dx.doi.org/10.1038/nature14539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	26017442				2022-12-28	WOS:000355286600030
J	Jarvinen, TLN; Michaelsson, K; Jokihaara, J; Collins, GS; Perry, TL; Mintzes, B; Musini, V; Erviti, J; Gorricho, J; Wright, JM; Sievanen, H				Jarvinen, Teppo L. N.; Michaelsson, Karl; Jokihaara, Jarkko; Collins, Gary S.; Perry, Thomas L.; Mintzes, Barbara; Musini, Vijaya; Erviti, Juan; Gorricho, Javier; Wright, James M.; Sievanen, Harri			TOO MUCH MEDICINE Overdiagnosis of bone fragility in the quest to prevent hip fracture	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTMENOPAUSAL WOMEN; VITAMIN-D; ZOLEDRONIC ACID; RISK; OSTEOPOROSIS; COST; BISPHOSPHONATES; THRESHOLDS; MANAGEMENT; DENOSUMAB		[Jarvinen, Teppo L. N.] Univ Helsinki, Dept Orthopaed & Traumatol, Helsinki, Finland; [Jarvinen, Teppo L. N.] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Michaelsson, Karl] Uppsala Univ, Sect Orthopaed, Dept Surg Sci, Uppsala, Sweden; [Jokihaara, Jarkko] Tampere Univ Hosp, Dept Hand Surg, Tampere, Finland; [Collins, Gary S.] Univ Oxford, Botnar Res Ctr, Ctr Stat Med, Oxford, England; [Perry, Thomas L.; Musini, Vijaya; Wright, James M.] Univ British Columbia, Dept Anesthesiol, Vancouver, BC V5Z 1M9, Canada; [Perry, Thomas L.; Musini, Vijaya; Wright, James M.] Univ British Columbia, Dept Pharmacol, Vancouver, BC V5Z 1M9, Canada; [Perry, Thomas L.; Musini, Vijaya; Wright, James M.] Univ British Columbia, Dept Therapeut & Med, Vancouver, BC V5Z 1M9, Canada; [Mintzes, Barbara] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Mintzes, Barbara] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Erviti, Juan] Navarre Reg Hlth Serv, Drug Informat Unit, Pamplona, Navarre, Spain; [Gorricho, Javier] Govt Navarre, Dept Hlth, Pamplona, Navarre, Spain; [Sievanen, Harri] UKK Inst Hlth Promot Res, Tampere, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Uppsala University; Tampere University; Tampere University Hospital; University of Oxford; University of British Columbia; University of British Columbia; University of British Columbia; University of Sydney; University of Sydney; UKK Institute	Jarvinen, TLN (corresponding author), Univ Helsinki, Dept Orthopaed & Traumatol, Helsinki, Finland.	teppo.jarvinen@helsinki.fi	Gorricho, javier/H-2065-2015; Jokihaara, Jarkko/C-5817-2017; Shah, Syed Imran Ali/D-1324-2012; Collins, Gary Stephen/A-2258-2014; Mintzes, Barbara/AFK-6613-2022; Järvinen, Teppo/B-8189-2013; Michaelsson, Karl/AAM-9094-2021; Erviti, Juan/G-8150-2012	Gorricho, javier/0000-0003-3609-9922; Jokihaara, Jarkko/0000-0001-6153-2180; Shah, Syed Imran Ali/0000-0002-0833-0771; Collins, Gary Stephen/0000-0002-2772-2316; Mintzes, Barbara/0000-0002-8671-915X; Järvinen, Teppo/0000-0003-3713-956X; Erviti, Juan/0000-0003-3396-2102; Michaelsson, Karl/0000-0003-2815-1217; Musini, Vijaya/0000-0002-8096-6563	MRC [G1100513] Funding Source: UKRI; Medical Research Council [G1100513] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; Abrahamsen B, 2010, J CLIN ENDOCR METAB, V95, P5258, DOI 10.1210/jc.2010-1571; Alonso-Coello P, 2008, BMJ-BRIT MED J, V336, P126, DOI 10.1136/bmj.39435.656250.AD; Aspenberg P, 2014, ACTA ORTHOP, V85, P1, DOI 10.3109/17453674.2013.859423; Ballane G, 2014, J BONE MINER RES, V29, P1745, DOI 10.1002/jbmr.2218; Bolland MJ, 2014, LANCET DIABETES ENDO, V2, P307, DOI 10.1016/S2213-8587(13)70212-2; Bolland Mark J, 2011, BMJ, V342, pd2040, DOI 10.1136/bmj.d2040; Boonen S, 2010, J AM GERIATR SOC, V58, P292, DOI 10.1111/j.1532-5415.2009.02673.x; Collins GS, 2012, CURR OSTEOPOROS REP, V10, P199, DOI 10.1007/s11914-012-0108-1; Compston J, 2013, MATURITAS, V75, P392, DOI 10.1016/j.maturitas.2013.05.013; Crilly RG, 2014, OSTEOPOROSIS INT, V25, P205, DOI 10.1007/s00198-013-2453-z; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Donaldson MG, 2009, J BONE MINER RES, V24, P675, DOI [10.1359/jbmr.081203, 10.1359/JBMR.081203]; El-Khoury F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6234; European Medicines Agency, EMEAH595210AR; European Medicines Agency, 2010, EMEAHC001120; Feldstein AC, 2009, BONE, V44, P153, DOI 10.1016/j.bone.2008.09.006; Feskanich D, 2002, JAMA-J AM MED ASSOC, V288, P2300, DOI 10.1001/jama.288.18.2300; Food and Drug Administration, 2011, BACKGR DOC M ADV COM; Food and Drug Administration, 2010, STAT REV PROT 200905; Greenspan SL, 2015, JAMA INT MED; Herndon MB, 2007, HEALTH AFFAIR, V26, P1702, DOI 10.1377/hlthaff.26.6.1702; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Jarvinen TLN, 2008, BRIT MED J, V336, P124, DOI 10.1136/bmj.39428.470752.AD; Jarvinen TLN, 2014, CAN MED ASSOC J, V186, P165, DOI 10.1503/cmaj.121874; Jarvinen TLN, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2175; Jarvinen TL, 2011, BMJ-BRIT MED J, V343, pd5040; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2011, OSTEOPOROSIS INT, V22, P2395, DOI 10.1007/s00198-011-1713-z; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2000, BONE, V27, P585, DOI 10.1016/S8756-3282(00)00381-1; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P417, DOI 10.1007/s001980170112; Kannus P, 2002, J BONE MINER RES, V17, P1363, DOI 10.1359/jbmr.2002.17.8.1363; Kherad M, 2015, SPINE J, V15, P281, DOI 10.1016/j.spinee.2014.09.016; Korhonen N, 2013, OSTEOPOROSIS INT, V24, P1599, DOI 10.1007/s00198-012-2190-8; LAW MR, 1991, BMJ-BRIT MED J, V303, P453, DOI 10.1136/bmj.303.6800.453; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Michaelsson K, 2007, PLOS MED, V4, P1094, DOI 10.1371/journal.pmed.0040199; Musini VM, 2011, THER LETT, V83, P1; Olofsson H, 2005, J BONE MINER RES, V20, P1208, DOI 10.1359/JBMR.050208; Poole KE, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3211; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Reid IR, 2014, OSTEOPOROSIS INT, V25, P2347, DOI 10.1007/s00198-014-2749-7; Reid Ian R, 2014, J Bone Metab, V21, P21, DOI 10.11005/jbm.2014.21.1.21; Reid IR, 2011, SKELETAL RADIOL, V40, P1191, DOI 10.1007/s00256-011-1164-9; RUBIN SM, 1992, ANN INTERN MED, V116, P990, DOI 10.7326/0003-4819-116-12-990; Sanders KM, 2006, BONE, V38, P694, DOI 10.1016/j.bone.2005.06.004; Schilcher J, 2014, NEW ENGL J MED, V371, P974, DOI 10.1056/NEJMc1403799; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Sievanen H, 2007, PLOS MED, V4, P407, DOI 10.1371/journal.pmed.0040027; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Tosteson ANA, 2008, OSTEOPOROSIS INT, V19, P437, DOI 10.1007/s00198-007-0550-6; Ulmner M, 2014, J ORAL MAXIL SURG, V72, P76, DOI 10.1016/j.joms.2013.06.221; Wagner H, 2009, AM J EPIDEMIOL, V169, P143, DOI 10.1093/aje/kwn379; Whitaker M, 2012, NEW ENGL J MED, V366, P2048, DOI 10.1056/NEJMp1202619	61	85	85	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2015	350								h2088	10.1136/bmj.h2088	http://dx.doi.org/10.1136/bmj.h2088			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0AF	26013536				2022-12-28	WOS:000355132600001
J	Smalley, KSM; Sondak, VK				Smalley, Keiran S. M.; Sondak, Vernon K.			Inhibition of BRAF and MEK in BRAF-mutant melanoma	LANCET			English	Editorial Material							UNTREATED MELANOMA; RESISTANCE; VEMURAFENIB; TRAMETINIB; DABRAFENIB; NIVOLUMAB		[Smalley, Keiran S. M.] H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA; [Smalley, Keiran S. M.; Sondak, Vernon K.] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Sondak, VK (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL 33612 USA.	vernon.sondak@moffitt.org		Smalley, Keiran/0000-0003-1089-9307				Fedorenko IV, 2015, BRIT J CANCER, V112, P217, DOI 10.1038/bjc.2014.476; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Johnson DB, 2014, J CLIN ONCOL, V32, P3697, DOI 10.1200/JCO.2014.57.3535; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Long G. V., 2015, LANCET; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Smyth T, 2014, MOL CANCER THER, V13, P2793, DOI 10.1158/1535-7163.MCT-14-0452; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Yadav V, 2014, MOL CANCER THER, V13, P2253, DOI 10.1158/1535-7163.MCT-14-0257	12	8	8	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 1	2015	386	9992					410	412		10.1016/S0140-6736(15)60972-2	http://dx.doi.org/10.1016/S0140-6736(15)60972-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN9IY	26037942				2022-12-28	WOS:000358761700007
J	Cannon, CP; Blazing, MA; Giugliano, RP; McCagg, A; White, JA; Theroux, P; Darius, H; Lewis, BS; Ophuis, TO; Jukema, JW; De Ferrari, GM; Ruzyllo, W; De Lucca, P; Im, K; Bohula, EA; Reist, C; Wiviott, SD; Tershakovec, AM; Musliner, TA; Braunwald, E; Califf, RM				Cannon, Christopher P.; Blazing, Michael A.; Giugliano, Robert P.; McCagg, Amy; White, Jennifer A.; Theroux, Pierre; Darius, Harald; Lewis, Basil S.; Ophuis, Ton Oude; Jukema, J. Wouter; De Ferrari, Gaetano M.; Ruzyllo, Witold; De Lucca, Paul; Im, KyungAh; Bohula, Erin A.; Reist, Craig; Wiviott, Stephen D.; Tershakovec, Andrew M.; Musliner, Thomas A.; Braunwald, Eugene; Califf, Robert M.		IMPROVW-IT Investigators	Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR OUTCOMES; CHOLESTEROL ABSORPTION; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; CARDIAC OUTCOMES; CLINICAL-TRIALS; IMPROVE-IT; ATORVASTATIN; EFFICACY; SIMVASTATIN	BACKGROUND Statin therapy reduces low-density lipoprotein (LDL) cholesterol levels and the risk of cardiovascular events, but whether the addition of ezetimibe, a nonstatin drug that reduces intestinal cholesterol absorption, can reduce the rate of cardiovascular events further is not known. METHODS We conducted a double-blind, randomized trial involving 18,144 patients who had been hospitalized for an acute coronary syndrome within the preceding 10 days and had LDL cholesterol levels of 50 to 100 mg per deciliter (1.3 to 2.6 mmol per liter) if they were receiving lipid-lowering therapy or 50 to 125 mg per deciliter (1.3 to 3.2 mmol per liter) if they were not receiving lipid-lowering therapy. The combination of simvastatin (40 mg) and ezetimibe (10 mg) (simvastatin-ezetimibe) was compared with simvastatin (40 mg) and placebo (simvastatin monotherapy). The primary end point was a composite of cardiovascular death, nonfatal myocardial infarction, unstable angina requiring rehospitalization, coronary revascularization (>= 30 days after randomization), or nonfatal stroke. The median follow-up was 6 years. RESULTS The median time-weighted average LDL cholesterol level during the study was 53.7 mg per deciliter (1.4 mmol per liter) in the simvastatin-ezetimibe group, as compared with 69.5 mg per deciliter (1.8 mmol per liter) in the simvastatin-monotherapy group (P< 0.001). The Kaplan-Meier event rate for the primary end point at 7 years was 32.7% in the simvastatin-ezetimibe group, as compared with 34.7% in the simvastatin-monotherapy group (absolute risk difference, 2.0 percentage points; hazard ratio, 0.936; 95% confidence interval, 0.89 to 0.99; P = 0.016). Rates of pre-specified muscle, gallbladder, and hepatic adverse effects and cancer were similar in the two groups. CONCLUSIONS When added to statin therapy, ezetimibe resulted in incremental lowering of LDL cholesterol levels and improved cardiovascular outcomes. Moreover, lowering LDL cholesterol to levels below previous targets provided additional benefit.	[Cannon, Christopher P.; Giugliano, Robert P.; McCagg, Amy; Im, KyungAh; Bohula, Erin A.; Wiviott, Stephen D.; Braunwald, Eugene] Brigham & Womens Hosp, Thrombolysis Myocardial Infarct TIMI Study Grp, Boston, MA 02115 USA; [Cannon, Christopher P.; Giugliano, Robert P.; McCagg, Amy; Im, KyungAh; Bohula, Erin A.; Wiviott, Stephen D.; Braunwald, Eugene] Harvard Univ, Sch Med, Boston, MA USA; [Blazing, Michael A.; White, Jennifer A.; Reist, Craig; Califf, Robert M.] DCRI, Durham, NC USA; [Theroux, Pierre] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Darius, Harald] Vivantes Neukolln Med Ctr, Berlin, Germany; [Lewis, Basil S.] Lady Davis Carmel Med Ctr, Haifa, Israel; [Ophuis, Ton Oude] Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; [Jukema, J. Wouter] Netherlands Leiden Univ, Med Ctr, Leiden, Netherlands; [De Ferrari, Gaetano M.] Fdn IRCCS Policlin San Matteo, Pavia, Italy; [De Ferrari, Gaetano M.] Univ Pavia, I-27100 Pavia, Italy; [Ruzyllo, Witold] Natl Inst Cardiol, Warsaw, Poland; [De Lucca, Paul; Tershakovec, Andrew M.; Musliner, Thomas A.] Merck, Kenilworth, NJ USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Duke University; Universite de Montreal; VIivantes Klinikum Neukolln; Clalit Health Services; Carmel Medical Center; Canisius-Wilhelmina Hospital; Leiden University; Leiden University Medical Center (LUMC); IRCCS Fondazione San Matteo; University of Pavia; Institute of Cardiology - Poland; Merck & Company	Cannon, CP (corresponding author), Brigham & Womens Hosp, Cardiovasc Div, 350 Long Wood Ave,1st Fl, Boston, MA 02115 USA.	cpcannon@partners.org	Motovska, Zuzana/J-1122-2016; Linhart, Ales/O-2375-2017; Ponikowski, Piotr/O-6454-2015; Hradec, Jaromir/S-2388-2016; Bansal, Manish/O-7899-2015; De Caterina, Raffaele/K-3857-2016; Karaçağlar, Emir/ABI-6723-2020; Kobayashi, Junjiro/J-8547-2015; Miranda, Luísa AV/N-6353-2013; Coelho, Otavio R/E-5716-2019; Garcia-Garcia, Cosme/E-2406-2016; Cannon, Christopher P/AAY-7644-2020; Senni, Michele/J-9380-2018; Pavesi, Claudia/AAB-3446-2020; Barnett, Olga/N-7091-2018; Torres, Ferran/D-1296-2011; Munzel, Thomas/A-2912-2014; Bohula, Erin/AAW-7276-2020; De Ferrari, Gaetano M/K-5188-2016; Nagy, Ivan/I-7419-2013; Spratt, James/AAH-3589-2020; Clarke, Aileen/I-5679-2012; Nesterak, Roxolana/D-5995-2019; Kapoor, Anil/AAQ-7184-2021; Jukema, J. Wouter/ABD-6503-2021; YILDIRIR, Aylin/A-4947-2018; Prunier, Fabrice/A-5210-2011; Nicolau, Jose C/E-1487-2012; Wainstein, Marco Vugman/AAQ-1248-2020; Wiviott, Stephen/HIK-2534-2022; Marin-Neto, Jose Antonio/F-6099-2012; Giugliano, Robert/N-7233-2017; Tycinska, Agnieszka/U-7935-2018; Laukkanen, Jari/I-4528-2017; Catarino, Cristina/K-5492-2013; CIUTI, Gastone/T-6377-2018; FUENTES JIMENEZ, FRANCISCO/G-4311-2016; Modena, Maria Grazia/N-2442-2015	Motovska, Zuzana/0000-0002-5319-473X; Linhart, Ales/0000-0002-3372-7850; Ponikowski, Piotr/0000-0002-3391-7064; Hradec, Jaromir/0000-0001-7597-8239; Bansal, Manish/0000-0002-2125-8073; De Caterina, Raffaele/0000-0003-1637-574X; Karaçağlar, Emir/0000-0002-2538-1642; Miranda, Luísa AV/0000-0002-7553-6059; Garcia-Garcia, Cosme/0000-0001-6330-1677; Cannon, Christopher P/0000-0003-4596-2791; Senni, Michele/0000-0001-5502-7882; Pavesi, Claudia/0000-0003-4208-3388; Torres, Ferran/0000-0002-7355-7913; Munzel, Thomas/0000-0001-5503-4150; De Ferrari, Gaetano M/0000-0003-4940-0876; Spratt, James/0000-0001-8719-4538; Clarke, Aileen/0000-0001-8299-3146; Nesterak, Roxolana/0000-0002-4062-0939; Kapoor, Anil/0000-0001-9180-8029; Jukema, J. Wouter/0000-0002-3246-8359; YILDIRIR, Aylin/0000-0001-8750-5287; Nicolau, Jose C/0000-0002-9680-3689; Wainstein, Marco Vugman/0000-0002-7284-1453; Sacco, Alice/0000-0002-8150-474X; Giugliano, Robert/0000-0003-4110-7675; Rizzi Coelho, Otavio/0000-0002-9822-2685; Lehto, Seppo/0000-0003-0414-5285; jourdain, patrick/0000-0002-5202-6902; Tycinska, Agnieszka/0000-0001-7855-7261; Seong, In-Whan/0000-0003-4628-0258; Nikonov, Vadim/0000-0002-0078-9991; Mourilhe-Rocha, Ricardo/0000-0003-2501-302X; Shaher, Motaz/0000-0003-3248-708X; Gil, Robert/0000-0002-9041-3313; Fedacko, Jan/0000-0002-4940-0393; Gavina, Cristina/0000-0003-2553-8264; Grice, Rachel/0000-0001-6186-525X; Reddy, K Srinath/0000-0003-3416-3548; Johanson, Per/0000-0001-9802-4147; Zingarelli, Antonio/0000-0002-8240-2622; Hutt, Erika/0000-0002-8271-6648; Gazmuri, Raul J./0000-0002-3848-7227; de la Guia Galipienso, Fernando/0000-0001-8044-8558; Pella, Daniel/0000-0001-9999-6271; Monteiro, Pedro/0000-0002-6631-207X; Naslund, Ulf/0000-0003-4100-8298; Ciuti, Gabriele/0000-0001-6957-5919; Sinnaeve, Peter/0000-0003-4716-5892; Katz, Amos/0000-0003-0422-934X; Kaplan, Pavel/0000-0003-0455-2630; Ruiz, Alvaro J/0000-0001-6528-4268; De Maria, Elia/0000-0001-9211-0810; Aylward, Philip/0000-0002-5358-8552; A. Samad, Bassem/0000-0001-9440-5073; Marenzi, Giancarlo/0000-0003-4410-4461; Bohorquez, Ricardo/0000-0002-9297-1060; Marin-Neto, Jose Antonio/0000-0002-8651-8833; Airaksinen, Juhani/0000-0002-0193-568X; Juonala, Markus/0000-0001-9498-364X; tavano, davide/0000-0002-0938-0076; Nowalany-Kozielska, Ewa/0000-0002-5977-513X; Jeong, Jin-Ok/0000-0003-0763-4754; CARRIE, didier/0000-0003-2479-8144; Laukkanen, Jari/0000-0002-3738-1586; Bell, Katy/0000-0002-0137-3218; ELBAZ, Meyer/0000-0002-3520-7883; Chew, Derek/0000-0003-3593-296X; Manzur, Fernando/0000-0001-6679-5609; Bozkurt, Biykem/0000-0002-6362-0253; Catarino, Cristina/0000-0002-3229-1434; CIUTI, Gastone/0000-0002-0855-7976; Volpe, Massimo/0000-0002-9642-8380; Albuquerque, Denilson/0000-0003-1883-6546; DUARTE VERA, YAN CARLOS/0000-0003-4685-6907; McDonough, Caitrin/0000-0001-6393-7288; Alexander, John/0000-0002-1444-2462; Gidding, Samuel/0000-0002-8557-7225; FUENTES JIMENEZ, FRANCISCO/0000-0002-4584-7366; Lin, Ming-shyan/0000-0001-9348-8153; Modena, Maria Grazia/0000-0002-4704-4663; McEneaney, David/0000-0002-1734-0736; Wilhelm, Matthias/0000-0003-4541-3995; Martin, Seth/0000-0002-7021-7622; Townend, Jonathan/0000-0002-5881-5806; Maurer, Gerald/0000-0002-9043-7657; Nahhas, Prof. Dr. Ahmed/0000-0002-2887-8187; Jaramillo, Monica/0000-0003-0100-5682; Palomaki, Ari/0000-0001-9759-4332; GALINIER, Michel/0000-0003-1735-3390; Garg, Manohar/0000-0003-0514-0865; Kumar, Gautam/0000-0002-4284-846X; Gajek, Jacek/0000-0002-0038-1750; Ballantyne, Christie/0000-0002-6432-1730; Gziut, Aneta/0000-0002-7627-8813	Merck	Merck(Merck & Company)	Funded by Merck; IMPROVE-IT ClinicalTrials.gov number, NCT00202878.	[Anonymous], 2000, Ital Heart J, V1, P810; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Ballantyne CM, 2004, AM J CARDIOL, V93, P1487, DOI 10.1016/j.amjcard.2004.02.060; Blazing MA, 2014, AM HEART J, V168, P205, DOI 10.1016/j.ahj.2014.05.004; Boden WE, 2011, NEW ENGL J MED, V365, P2255; Califf RM, 2010, AM HEART J, V159, P705, DOI 10.1016/j.ahj.2010.03.004; Califf RM, 2009, NEW ENGL J MED, V361, P712, DOI 10.1056/NEJMsr0900910; Campeau L, 1997, NEW ENGL J MED, V336, P153; Cannon CP, 2008, AM HEART J, V156, P826, DOI 10.1016/j.ahj.2008.07.023; Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Germano G, 2012, EUR HEART J, V33, P137; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Giugliano RP, 2009, NEW ENGL J MED, V360, P2176, DOI 10.1056/NEJMoa0901316; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Kosoglou T, 2002, BRIT J CLIN PHARMACO, V54, P309, DOI 10.1046/j.1365-2125.2002.01633.x; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Laufs U, 2014, EUR HEART J, V35, P1996, DOI 10.1093/eurheartj/ehu228; Morrone D, 2012, ATHEROSCLEROSIS, V223, P251, DOI 10.1016/j.atherosclerosis.2012.02.016; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Stitziel NO, 2014, NEW ENGL J MED, V371, P2072, DOI 10.1056/NEJMoa1405386; Sudhop T, 2002, CIRCULATION, V106, P1943, DOI 10.1161/01.CIR.0000034044.95911.DC; Taylor AJ, 2008, CIRC-CARDIOVASC QUAL, V1, P54, DOI 10.1161/CIRCOUTCOMES.108.811901; Tonkin A, 1998, NEW ENGL J MED, V339, P1349	40	2454	2579	2	257	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 18	2015	372	25					2387	2397		10.1056/NEJMoa1410489	http://dx.doi.org/10.1056/NEJMoa1410489			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK6RF	26039521	Green Published			2022-12-28	WOS:000356354600005
J	Lee, SJ; Masliah, E				Lee, Seung-Jae; Masliah, Eliezer			NEURODEGENERATION Aggregates feel the strain	NATURE			English	Editorial Material							LEWY BODY DISEASES; ALPHA-SYNUCLEIN; FIBRILS		[Lee, Seung-Jae] Seoul Natl Univ, Coll Med, Dept Med, Neurosci Res Inst, Seoul 110799, South Korea; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol & Neurosci, La Jolla, CA 92093 USA	Seoul National University (SNU); University of California System; University of California San Diego	Lee, SJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Med, Neurosci Res Inst, Seoul 110799, South Korea.	sjlee66@snu.ac.kr; emasliah@ucsd.edu		Lee, Seung-Jae/0000-0002-5155-5335				Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Bruck D., 2015, NEUROBIOL DIS; Kim WS, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0073-2; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Lashuel HA, 2000, J AM CHEM SOC, V122, P5262, DOI 10.1021/ja9937831; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lee HJ, 2014, NAT REV NEUROL, V10, P92, DOI 10.1038/nrneurol.2013.275; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Mollenhauer B, 2010, BIOMARK MED, V4, P683, DOI 10.2217/BMM.10.90; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547	12	11	11	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					296	297		10.1038/nature14526	http://dx.doi.org/10.1038/nature14526			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26061764				2022-12-28	WOS:000356425400043
J	Reid, DW; Nicchitta, CV				Reid, David W.; Nicchitta, Christopher V.			Comment on "Principles of ER cotranslational translocation revealed by proximity-specific ribosome profiling"	SCIENCE			English	Editorial Material							MEMBRANE-BOUND RIBOSOMES; PROTEIN-SYNTHESIS; MAMMALIAN-CELLS	Jan et al. (Research Articles, 7 November 2014, p. 716) propose that ribosomes translating secretome messenger RNAs (mRNAs) traffic from the cytosol to the endoplasmic reticulum (ER) upon emergence of the signal peptide and return to the cytosol after termination. An accounting of controls demonstrates that mRNAs initiate translation on ER-bound ribosomes and that ribosomes are retained on the ER through many cycles of translation.	[Reid, David W.] Duke NUS Grad Med Sch, Program Cardiovasc & Metab Disorders, Singapore 169857, Singapore; [Nicchitta, Christopher V.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	National University of Singapore; Duke University	Nicchitta, CV (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	christopher.nicchitta@duke.edu			NIGMS NIH HHS [GM101533, R01 GM101533] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101533] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Diehn M, 2006, PLOS GENET, V2, P39, DOI 10.1371/journal.pgen.0020011; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Seiser RM, 2000, J BIOL CHEM, V275, P33820, DOI 10.1074/jbc.M004462200; Stephens SB, 2008, MOL BIOL CELL, V19, P623, DOI 10.1091/mbc.E07-07-0677; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Zhou CK, 2014, CELL, V159, P530, DOI 10.1016/j.cell.2014.09.026	11	11	11	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240								10.1126/science.aaa7257	http://dx.doi.org/10.1126/science.aaa7257			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068841	Green Accepted			2022-12-28	WOS:000356011500039
J	Kleypas, J				Kleypas, Joan			Invisible barriers to dispersal	SCIENCE			English	Editorial Material							RANGE SHIFTS; CLIMATE; AUSTRALIA; MARINE; TAXA		Natl Ctr Atmospher Res, Climate & Global Dynam, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	Kleypas, J (corresponding author), Natl Ctr Atmospher Res, Climate & Global Dynam, POB 3000, Boulder, CO 80307 USA.	kleypas@ucar.edu						Baird AH, 2012, CORAL REEFS, V31, P1063, DOI 10.1007/s00338-012-0928-6; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Deutsch C, 2015, SCIENCE, V348, P1132, DOI 10.1126/science.aaa1605; Greenstein BJ, 2008, GLOBAL CHANGE BIOL, V14, P513, DOI 10.1111/j.1365-2486.2007.01506.x; Manuel SA, 2013, MAR ENVIRON RES, V89, P63, DOI 10.1016/j.marenvres.2013.05.003; Muir PR, 2015, SCIENCE, V348, P1135, DOI 10.1126/science.1259911; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Sugihara K, 2009, J JPN CORAL REEF SOC, V11, P51, DOI DOI 10.3755/JCRS.11.51; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	12	2	2	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1086	1087		10.1126/science.aab4122	http://dx.doi.org/10.1126/science.aab4122			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045419				2022-12-28	WOS:000355590500021
J	Koh, J; Blobel, G				Koh, Junseock; Blobel, Guenter			Allosteric Regulation in Gating the Central Channel of the Nuclear Pore Complex	CELL			English	Article							INTRINSIC DISORDER; IMPORTIN-BETA; CONFORMATIONAL SPREAD; FG-NUCLEOPORINS; TRANSPORT; BINDING; MECHANISM; PROTEINS; EXPORT; CONFIGURATIONS	The nuclear pore complex (NPC) arose in evolution as the cell's largest and most versatile transport channel. Current models for selective transport mediated by NPCs are focused on properties of intrinsically disordered regions of nucleoporins that bind transport factors. In contrast, structured regions are considered to provide static anchoring sites for the disordered regions without affecting transport factor binding. Here, we demonstrate allosteric coupling between a structured domain of a channel nucleoporin (Nup58) and its neighboring disordered domain in interaction with another channel nucleoporin (Nup54) and a transport factor (Kap beta 1). Analysis of multiple equilibria showed that multivalent interactions of Kapb1 with the disordered domains of Nup58 stabilize the neighboring structured domain associated with Nup54, shifting conformational equilibria from homo-oligomers to hetero-oligomers. Based on these and previous crystallographic results, a quantitative framework was established to describe constriction and dilation of the central channel as a function of transport factor occupancy.	[Koh, Junseock; Blobel, Guenter] Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Koh, J (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10065 USA.	jkoh@rockefeller.edu; blobel@rockefeller.edu						AKEY CW, 1990, BIOPHYS J, V58, P341, DOI 10.1016/S0006-3495(90)82381-X; Au S, 2012, J STRUCT BIOL, V177, P90, DOI 10.1016/j.jsb.2011.11.006; Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Duke TAJ, 2001, J MOL BIOL, V308, P541, DOI 10.1006/jmbi.2001.4610; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Johnson AW, 2002, TRENDS BIOCHEM SCI, V27, P580, DOI 10.1016/S0968-0004(02)02208-9; Kapinos LE, 2014, BIOPHYS J, V106, P1751, DOI 10.1016/j.bpj.2014.02.021; Kiseleva E, 1998, J CELL SCI, V111, P223; Kumar R, 1999, J BIOL CHEM, V274, P24737, DOI 10.1074/jbc.274.35.24737; Lim RYH, 2008, INT REV CEL MOL BIO, V267, P299, DOI 10.1016/S1937-6448(08)00632-1; Lo KY, 2009, MOL BIOL CELL, V20, P1545, DOI 10.1091/mbc.E08-10-1000; Lowe AR, 2010, NATURE, V467, P600, DOI 10.1038/nature09285; Ma J, 2012, P NATL ACAD SCI USA, V109, P7326, DOI 10.1073/pnas.1201724109; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Solmaz SR, 2013, P NATL ACAD SCI USA, V110, P5858, DOI 10.1073/pnas.1302655110; Solmaz SR, 2011, CELL, V147, P590, DOI 10.1016/j.cell.2011.09.034; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Tu LC, 2013, EMBO J, V32, P3220, DOI 10.1038/emboj.2013.239; Wong I, 1995, METHOD ENZYMOL, V259, P95; WYMAN J, 1969, J MOL BIOL, V39, P523, DOI 10.1016/0022-2836(69)90142-9; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053	35	36	36	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1361	1373		10.1016/j.cell.2015.05.013	http://dx.doi.org/10.1016/j.cell.2015.05.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26046439	Bronze			2022-12-28	WOS:000355935000015
J	Chluba, C; Ge, WW; de Miranda, RL; Strobel, J; Kienle, L; Quandt, E; Wuttig, M				Chluba, Christoph; Ge, Wenwei; de Miranda, Rodrigo Lima; Strobel, Julian; Kienle, Lorenz; Quandt, Eckhard; Wuttig, Manfred			Ultralow-fatigue shape memory alloy films	SCIENCE			English	Article							NITINOL; NI; REVERSIBILITY; SYMMETRY	Functional shape memory alloys need to operate reversibly and repeatedly. Quantitative measures of reversibility include the relative volume change of the participating phases and compatibility matrices for twinning. But no similar argument is known for repeatability. This is especially crucial for many future applications, such as artificial heart valves or elastocaloric cooling, in which more than 10 million transformation cycles will be required. We report on the discovery of an ultralow-fatigue shape memory alloy film system based on TiNiCu that allows at least 10 million transformation cycles. We found that these films contain Ti2Cu precipitates embedded in the base alloy that serve as sentinels to ensure complete and reproducible transformation in the course of each memory cycle.	[Chluba, Christoph; de Miranda, Rodrigo Lima; Strobel, Julian; Kienle, Lorenz; Quandt, Eckhard] Univ Kiel, Fac Engn, Inst Mat Sci, Kiel, Germany; [Ge, Wenwei; Wuttig, Manfred] Univ Maryland, Dept Mat Sci & Engn, College Pk, MD 20742 USA	University of Kiel; University System of Maryland; University of Maryland College Park	Quandt, E (corresponding author), Univ Kiel, Fac Engn, Inst Mat Sci, Kiel, Germany.	eq@tf.uni-kiel.de; wuttig@umd.edu	Ge, Wenwei/GSD-8019-2022	Quandt, Eckhard/0000-0002-2314-5179; Strobel, Julian/0000-0002-8679-0685	Deutsche Forschungsgemeinschaft (DFG) via the Priority Program [1599]; DOE [DESC0005448]; U.S. Department of Energy (DOE) Office of Science [DE-AC02-06CH11357]; Direct For Mathematical & Physical Scien [1206397] Funding Source: National Science Foundation	Deutsche Forschungsgemeinschaft (DFG) via the Priority Program(German Research Foundation (DFG)); DOE(United States Department of Energy (DOE)); U.S. Department of Energy (DOE) Office of Science(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The work at the University of Kiel was supported by the Deutsche Forschungsgemeinschaft (DFG) via the Priority Program 1599. L.K. and J.S. appreciate the assistance of V. Duppel (Max Planck Institute for solid state research) for recording the electron diffraction patterns, B. V. Lotsch for enabling electron microscopy, and C. Szillus for TEM sample preparation. The work at the University of Maryland was supported by grant DOE DESC0005448; use of the Advanced Photon Source - Argonne National Laboratory was supported by the U.S. Department of Energy (DOE) Office of Science, under contract DE-AC02-06CH11357. M.W. and W.G. thank P. Zavalij for his guidance with the Rietveld refinement and J. Steiner for the compatibility calculations. The synchrotron diffraction data are available from the corresponding author. Other data are available in the main text and the supplementary materials.	Bechtold C, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4748307; Bhattacharya K, 2005, SCIENCE, V307, P53, DOI 10.1126/science.1100892; Bhattacharya K, 2004, NATURE, V428, P55, DOI 10.1038/nature02378; Bhattacharya K, 1996, ACTA MATER, V44, P529, DOI 10.1016/1359-6454(95)00198-0; Bhattacharya K., 2003, MICROSTRUCTURE MARTE; Bonnot E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.125901; BUEHLER WJ, 1963, J APPL PHYS, V34, P1475, DOI 10.1063/1.1729603; Cui J, 2006, NAT MATER, V5, P286, DOI 10.1038/nmat1593; de Miranda RL, 2013, ADV ENG MATER, V15, P66, DOI 10.1002/adem.201200197; Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4; Eggeler G, 2004, MAT SCI ENG A-STRUCT, V378, P24, DOI 10.1016/j.msea.2003.10.327; Gall K, 2002, ACTA MATER, V50, P4643, DOI 10.1016/S1359-6454(02)00315-4; Hornbogen E, 2004, J MATER SCI, V39, P385, DOI 10.1023/B:JMSC.0000011492.88523.d3; James RD, 2005, SPRINGER SERIES MATE, V79, P159; Jani JM, 2014, MATER DESIGN, V56, P1078, DOI 10.1016/j.matdes.2013.11.084; Larson A. C., 2004, 86748 LAUR LOS AL NA; Miyazaki S, 1999, MAT SCI ENG A-STRUCT, V273, P658, DOI 10.1016/S0921-5093(99)00344-5; Miyazaki S., 2009, THIN FILM SHAPE MEMO; Morgan NB, 2004, MAT SCI ENG A-STRUCT, V378, P16, DOI 10.1016/j.msea.2003.10.326; Moya X, 2014, NAT MATER, V13, P439, DOI [10.1038/NMAT3951, 10.1038/nmat3951]; Otsuka K, 2005, PROG MATER SCI, V50, P511, DOI 10.1016/j.pmatsci.2004.10.001; Otsuka K., 1999, SHAPE MEMORY MAT; Pelton AR, 2011, J MATER ENG PERFORM, V20, P613, DOI 10.1007/s11665-011-9864-9; Raboud DW, 2000, SMART MATER STRUCT, V9, P684, DOI 10.1088/0964-1726/9/5/313; SCOTT HG, 1983, J APPL CRYSTALLOGR, V16, P159, DOI 10.1107/S0021889883010195; Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69; Siekmeyer G, 2014, J MATER ENG PERFORM, V23, P2437, DOI 10.1007/s11665-014-1101-x; Song YT, 2013, NATURE, V502, P85, DOI 10.1038/nature12532; Stephens PW, 1999, J APPL CRYSTALLOGR, V32, P281, DOI 10.1107/S0021889898006001; Zamponi C, 2007, SCRIPTA MATER, V56, P1075, DOI 10.1016/j.scriptamat.2007.02.021	30	291	295	17	432	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					1004	1007		10.1126/science.1261164	http://dx.doi.org/10.1126/science.1261164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	26023135				2022-12-28	WOS:000355276600041
J	Patch, AM; Christie, EL; Etemadmoghadam, D; Garsed, DW; George, J; Fereday, S; Nones, K; Cowin, P; Alsop, K; Bailey, PJ; Kassahn, KS; Newell, F; Quinn, MCJ; Kazakoff, S; Quek, K; Wilhelm-Benartzi, C; Curry, E; Leong, HS; Hamilton, A; Mileshkin, L; Au-Yeung, G; Kennedy, C; Hung, JL; Chiew, YE; Harnett, P; Friedlander, M; Quinn, M; Pyman, J; Cordner, S; O'Brien, P; Leditschke, J; Young, G; Strachan, K; Waring, P; Azar, W; Mitchell, C; Traficante, N; Hendley, J; Thorne, H; Shackleton, M; Miller, DK; Arnau, GM; Tothill, RW; Holloway, TP; Semple, T; Harliwong, I; Nourse, C; Nourbakhsh, E; Manning, S; Idrisoglu, S; Bruxner, TJC; Christ, AN; Poudel, B; Holmes, O; Anderson, M; Leonard, C; Lonie, A; Hall, N; Wood, S; Taylor, DF; Xu, QY; Fink, JL; Waddell, N; Drapkin, R; Stronach, E; Gabra, H; Brown, R; Jewell, A; Nagaraj, SH; Markham, E; Wilson, PJ; Ellul, J; McNally, O; Doyle, MA; Vedururu, R; Stewart, C; Lengyel, E; Pearson, JV; Waddell, N; deFazio, A; Grimmond, SM; Bowtell, DDL				Patch, Ann-Marie; Christie, Elizabeth L.; Etemadmoghadam, Dariush; Garsed, Dale W.; George, Joshy; Fereday, Sian; Nones, Katia; Cowin, Prue; Alsop, Kathryn; Bailey, Peter J.; Kassahn, Karin S.; Newell, Felicity; Quinn, Michael C. J.; Kazakoff, Stephen; Quek, Kelly; Wilhelm-Benartzi, Charlotte; Curry, Ed; Leong, Huei San; Hamilton, Anne; Mileshkin, Linda; Au-Yeung, George; Kennedy, Catherine; Hung, Jillian; Chiew, Yoke-Eng; Harnett, Paul; Friedlander, Michael; Quinn, Michael; Pyman, Jan; Cordner, Stephen; O'Brien, Patricia; Leditschke, Jodie; Young, Greg; Strachan, Kate; Waring, Paul; Azar, Walid; Mitchell, Chris; Traficante, Nadia; Hendley, Joy; Thorne, Heather; Shackleton, Mark; Miller, David K.; Arnau, Gisela Mir; Tothill, Richard W.; Holloway, Timothy P.; Semple, Timothy; Harliwong, Ivon; Nourse, Craig; Nourbakhsh, Ehsan; Manning, Suzanne; Idrisoglu, Senel; Bruxner, Timothy J. C.; Christ, Angelika N.; Poudel, Barsha; Holmes, Oliver; Anderson, Matthew; Leonard, Conrad; Lonie, Andrew; Hall, Nathan; Wood, Scott; Taylor, Darrin F.; Xu, Qinying; Fink, J. Lynn; Waddell, Nick; Drapkin, Ronny; Stronach, Euan; Gabra, Hani; Brown, Robert; Jewell, Andrea; Nagaraj, Shivashankar H.; Markham, Emma; Wilson, Peter J.; Ellul, Jason; McNally, Orla; Doyle, Maria A.; Vedururu, Ravikiran; Stewart, Collin; Lengyel, Ernst; Pearson, John V.; Waddell, Nicola; deFazio, Anna; Grimmond, Sean M.; Bowtell, David D. L.		Australian Ovarian Canc Study Grp	Whole-genome characterization of chemoresistant ovarian cancer	NATURE			English	Article							COPY-NUMBER ALTERATION; CHEMOTHERAPY RESISTANCE; MUTATIONAL PROCESSES; INTERNAL SHOCKS; CLINICAL-TRIALS; M87 JET; EVOLUTION; SIGNATURES; BRCA1; DISCOVERY	Patients with high-grade serous ovarian cancer (HGSC) have experienced little improvement in overall survival, and standard treatment has not advanced beyond platinum-based combination chemotherapy, during the past 30 years. To understand the drivers of clinical phenotypes better, here we use whole-genome sequencing of tumour and germline DNA samples from 92 patients with primary refractory, resistant, sensitive and matched acquired resistant disease. We show that gene breakage commonly inactivates the tumour suppressors RB1, NF1, RAD51B and PTEN in HGSC, and contributes to acquired chemotherapy resistance. CCNE1 amplification was common in primary resistant and refractory disease. We observed several molecular events associated with acquired resistance, including multiple independent reversions of germline BRCA1 or BRCA2 mutations in individual patients, loss of BRCA1 promoter methylation, an alteration in molecular subtype, and recurrent promoter fusion associated with overexpression of the drug efflux pump MDR1.	[Patch, Ann-Marie; Nones, Katia; Bailey, Peter J.; Kassahn, Karin S.; Newell, Felicity; Quinn, Michael C. J.; Kazakoff, Stephen; Quek, Kelly; Miller, David K.; Harliwong, Ivon; Nourse, Craig; Nourbakhsh, Ehsan; Manning, Suzanne; Idrisoglu, Senel; Bruxner, Timothy J. C.; Christ, Angelika N.; Poudel, Barsha; Holmes, Oliver; Anderson, Matthew; Leonard, Conrad; Wood, Scott; Taylor, Darrin F.; Xu, Qinying; Fink, J. Lynn; Waddell, Nick; Nagaraj, Shivashankar H.; Markham, Emma; Wilson, Peter J.; Pearson, John V.; Waddell, Nicola; Grimmond, Sean M.] Univ Queensland, Inst Mol Biosci, Queensland Ctr Med Genom, Brisbane, Qld 4067, Australia; [Patch, Ann-Marie; Nones, Katia; Quinn, Michael C. J.; Kazakoff, Stephen; Holmes, Oliver; Leonard, Conrad; Wood, Scott; Xu, Qinying; Pearson, John V.; Waddell, Nicola] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia; [Christie, Elizabeth L.; Etemadmoghadam, Dariush; Garsed, Dale W.; Fereday, Sian; Cowin, Prue; Alsop, Kathryn; Leong, Huei San; Hamilton, Anne; Mileshkin, Linda; Au-Yeung, George; Azar, Walid; Mitchell, Chris; Traficante, Nadia; Hendley, Joy; Thorne, Heather; Shackleton, Mark; Arnau, Gisela Mir; Tothill, Richard W.; Holloway, Timothy P.; Semple, Timothy; Ellul, Jason; Doyle, Maria A.; Vedururu, Ravikiran; Bowtell, David D. L.] Peter MacCallum Canc Ctr, East Melbourne, Vic 3002, Australia; [Etemadmoghadam, Dariush; Waring, Paul; Bowtell, David D. L.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Etemadmoghadam, Dariush; Mileshkin, Linda; Shackleton, Mark; Tothill, Richard W.; Bowtell, David D. L.] Univ Melbourne, Sir Peter MacCallum Canc Ctr, Dept Oncol, Parkville, Vic 3052, Australia; [George, Joshy] Jackson Lab Genom Med, Farmington, CT 06030 USA; [Bailey, Peter J.; Grimmond, Sean M.] Univ Glasgow, Inst Canc Sci, WolfsonWohl Canc Res Ctr, Glasgow G61 1QH, Lanark, Scotland; [Kassahn, Karin S.] SA Pathol, Technol Adv Unit, Genet & Mol Pathol, Adelaide, SA 5000, Australia; [Wilhelm-Benartzi, Charlotte; Curry, Ed; Stronach, Euan; Gabra, Hani; Brown, Robert; Bowtell, David D. L.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Ovarian Canc Act Res Ctr, London W12 0HS, England; [Hamilton, Anne] Univ Melbourne, Dept Med, Parkville, Vic 3052, Australia; [Hamilton, Anne; Quinn, Michael; Pyman, Jan] Royal Womens Hosp, Parkville, Vic 3052, Australia; [Kennedy, Catherine; Hung, Jillian; Chiew, Yoke-Eng; McNally, Orla; deFazio, Anna] Univ Sydney, Westmead Millennium Inst, Ctr Canc Res, Sydney, NSW 2145, Australia; [Kennedy, Catherine; Hung, Jillian; Chiew, Yoke-Eng; McNally, Orla; deFazio, Anna] Westmead Hosp, Dept Gynaecol Oncol, Sydney, NSW 2145, Australia; [Harnett, Paul] Crown Princess Mary Canc Ctr, Sydney, NSW 2145, Australia; [Harnett, Paul] Univ Sydney, Westmead Hosp, Sydney, NSW 2145, Australia; [Friedlander, Michael] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2031, Australia; [Cordner, Stephen; O'Brien, Patricia; Leditschke, Jodie; Young, Greg; Strachan, Kate] Victorian Inst Forens Med, Southbank, Vic 3006, Australia; [Lonie, Andrew] Victorian Life Sci Computat Initiat, Carlton, Vic 3053, Australia; [Hall, Nathan] La Trobe Inst Mol Sci, Bundoora, Vic 3083, Australia; [Drapkin, Ronny] Dana Farber Canc Inst, Boston, MA 02115 USA; [Jewell, Andrea; Lengyel, Ernst] Univ Chicago, Chicago, IL 60637 USA; [Stewart, Collin] Univ Western Australia, Crawley, WA 6009, Australia; [Bowtell, David D. L.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Jackson Laboratory; University of Glasgow; SA Pathology; Imperial College London; University of Melbourne; University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney; University of New South Wales Sydney; Harvard University; Dana-Farber Cancer Institute; University of Chicago; University of Western Australia; University of Melbourne	Bowtell, DDL (corresponding author), Peter MacCallum Canc Ctr, East Melbourne, Vic 3002, Australia.	david.bowtell@petermac.org	Christie, Elizabeth/J-9961-2019; Nones, Katia/AAX-6453-2021; Leonard, Conrad/AAD-2587-2020; Waddell, Nicola/H-4929-2015; Newell, Felicity/AAN-1253-2020; DeFazio, Anna/O-2385-2019; Pearson, John V/F-2249-2011; Bowtell, David/H-1007-2016; Drapkin, Ronny/E-9944-2016; Grimmond, Sean M/J-5304-2016; Patch, Ann-Marie/C-4201-2018; George, Joshy/K-4841-2019; Fink, Lynn/C-2031-2008; Nicklin, James L/F-8035-2013; Haviv, Izhak/E-3782-2015; Harnett, Paul R/D-4090-2014; Lonie, Andrew/F-3258-2017; Pearson, John/AAT-4211-2020; Grimmond, Sean/K-3246-2019; Wyld, David/B-8893-2015; Lengyel, Ernst/D-9220-2014	Christie, Elizabeth/0000-0002-9959-7024; Nones, Katia/0000-0003-1925-5196; Leonard, Conrad/0000-0002-4131-2065; Waddell, Nicola/0000-0002-3950-2476; DeFazio, Anna/0000-0003-0057-4744; Pearson, John V/0000-0003-0904-4598; Bowtell, David/0000-0001-9089-7525; Drapkin, Ronny/0000-0002-6912-6977; Grimmond, Sean M/0000-0002-8102-7998; Patch, Ann-Marie/0000-0001-6121-4019; Fink, Lynn/0000-0003-2912-6048; Nicklin, James L/0000-0001-5857-3723; Haviv, Izhak/0000-0002-0837-5005; Harnett, Paul R/0000-0001-7021-0642; Lonie, Andrew/0000-0002-2006-3856; Grimmond, Sean/0000-0002-8102-7998; Wyld, David/0000-0001-9523-4333; Bailey, Peter/0000-0002-0857-2041; Curry, Edward/0000-0002-5603-6956; Kassahn, Karin/0000-0002-1662-3355; Alsop, Kathryn/0000-0002-4107-3041; friedlander, michael/0000-0003-3090-795X; Chenevix-Trench, Georgia/0000-0002-1878-2587; Fereday, Sian/0000-0002-8559-8579; Garsed, Dale/0000-0003-1223-0121; Mir Arnau, Gisela/0000-0002-9005-3485; Tothill, Richard William/0000-0003-4522-1184; Thorne, Heather/0000-0003-3610-2511; Traficante, Nadia/0000-0001-7459-8576; Bruxner, Timothy/0000-0002-8088-316X; Brown, Robert/0000-0001-7960-5755; Vedururu, Ravikiran/0000-0002-8816-1807; Wilhelm-Benartzi, Charlotte/0000-0003-4927-6158; Ellul, Jason/0000-0002-6046-5139; Gabra, Hani/0000-0002-3322-4399; Hall, Nathan/0000-0001-8942-0498; Lengyel, Ernst/0000-0001-8624-1507; Doyle, Maria/0000-0003-4847-8436; Christ, Angelika/0000-0002-8680-2367	National Health and Medical Research Council of Australia (NHMRC) [ID631701, ID400413, ID400281]; Worldwide Cancer Research [09-0676]; Cancer Australia [1004673]; US Army Medical Research and Materiel Command [DAMD17-01-1-0729]; Cancer Council Victoria; Queensland Cancer Fund; Cancer Council New South Wales; Cancer Council South Australia; Cancer Foundation of Western Australia; Cancer Council Tasmania; Agar family; Ovarian Cancer Australia; Ovarian Cancer Action (UK); NHMRC [ID 310670, ID628903]; Cancer Institute of New South Wales; Peter MacCallum Cancer Centre Foundation; Cancer Research UK [15954, 13086] Funding Source: researchfish; Ovarian Cancer Action [OCA2] Funding Source: researchfish; Worldwide Cancer Research [11-0748] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Worldwide Cancer Research; Cancer Australia; US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Queensland Cancer Fund; Cancer Council New South Wales(Cancer Council New South Wales); Cancer Council South Australia(Cancer Council South Australia); Cancer Foundation of Western Australia(Cancer Council Western Australia); Cancer Council Tasmania(Cancer Council Tasmania); Agar family; Ovarian Cancer Australia; Ovarian Cancer Action (UK); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute of New South Wales; Peter MacCallum Cancer Centre Foundation; Cancer Research UK(Cancer Research UK); Ovarian Cancer Action(Ovarian Cancer Action); Worldwide Cancer Research; National Breast Cancer Foundation	The AOCS gratefully acknowledge the cooperation of the participating institutions in Australia, and also acknowledge the contribution of the study nurses, research assistants and all clinical and scientific collaborators including L. Galletta, C. Emmanuel, L. Bowes and J. Hallo. The authors acknowledge assistance from C. Anderson and D. Gwynne. The CASCADE investigators would like to thank the CASCADE Management Committee, all staff at the Victorian Institute of Forensic Medicine, D. Stevens and Tobin Brothers Funerals. The investigators would like to thank the Australia New Zealand Gynaecological Oncology Group (ANZGOG) and the women, and their families, who participated in these research programs. This work was supported by the National Health and Medical Research Council of Australia (NHMRC ID631701), Worldwide Cancer Research (09-0676) and Cancer Australia (1004673). The Australian Ovarian Cancer Study was supported by the US Army Medical Research and Materiel Command under DAMD17-01-1-0729, The Cancer Council Victoria, Queensland Cancer Fund, The Cancer Council New South Wales, The Cancer Council South Australia, The Cancer Foundation of Western Australia, The Cancer Council Tasmania and the National Health and Medical Research Council of Australia (NHMRC; ID400413, ID400281). The AOCS gratefully acknowledges additional support from S. Boldeman, the Agar family, Ovarian Cancer Australia and Ovarian Cancer Action (UK). The Gynaecological Oncology Biobank at Westmead, a member of the Australasian Biospecimen Network-Oncology group, was supported by grants from the NHMRC (ID 310670, ID628903) and the Cancer Institute of New South Wales. The CASCADE study was supported by the Peter MacCallum Cancer Centre Foundation, and in kind by the Victorian Institute of Forensic Medicine and Tobin Brothers Funerals.	ABELL GO, 1979, NATURE, V279, P701, DOI 10.1038/279701a0; Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Baum SA, 1997, ASTROPHYS J, V483, P178, DOI 10.1086/304221; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Binkhathlan Z, 2013, CURR CANCER DRUG TAR, V13, P326, DOI 10.2174/15680096113139990076; Biretta JA, 1999, ASTROPHYS J, V520, P621, DOI 10.1086/307499; Castellarin M, 2013, J PATHOL, V229, P515, DOI 10.1002/path.4105; Cheung CC, 2007, ASTROPHYS J, V663, pL65, DOI 10.1086/520510; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Clarke B, 2009, MODERN PATHOL, V22, P393, DOI 10.1038/modpathol.2008.191; Cowin PA, 2012, CANCER RES, V72, P4060, DOI 10.1158/0008-5472.CAN-12-0203; CRANE P, 1993, ASTROPHYS J, V402, pL37, DOI 10.1086/186694; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Dhawan V, 2000, ASTROPHYS J, V543, P373, DOI 10.1086/317088; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Fender RP, 2004, MON NOT R ASTRON SOC, V355, P1105, DOI 10.1111/j.1365-2966.2004.08384.x; Fomalont EB, 2001, ASTROPHYS J, V558, P283, DOI 10.1086/322479; Friedlander ML, 2013, J CLIN ONCOL, V31, P2362, DOI 10.1200/JCO.2012.47.7927; Geisler JP, 2002, JNCI-J NATL CANCER I, V94, P61; George J, 2013, CLIN CANCER RES, V19, P3474, DOI 10.1158/1078-0432.CCR-13-0066; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GOFFE WL, 1994, J ECONOMETRICS, V60, P65, DOI 10.1016/0304-4076(94)90038-8; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Gundem G, 2010, NAT METHODS, V7, P92, DOI 10.1038/nmeth0210-92; Harris DE, 2002, ASTROPHYS J, V565, P244, DOI 10.1086/324544; HJELLMING RM, 1995, NATURE, V375, P464, DOI 10.1038/375464a0; Jaspers JE, 2013, CANCER DISCOV, V3, P68, DOI 10.1158/2159-8290.CD-12-0049; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kannan K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004216; Kassahn KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074380; Kinsella M, 2012, J COMPUT BIOL, V19, P662, DOI 10.1089/cmb.2012.0020; Kobayashi S, 1997, ASTROPHYS J, V490, P92, DOI 10.1086/512791; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Krist J. E., 2001, P SPIE, V8127; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lara L, 1999, ASTROPHYS J, V513, P197, DOI 10.1086/306852; Lara L, 2004, ASTRON ASTROPHYS, V415, P905, DOI 10.1051/0004-6361:20034317; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lhomme C, 2008, J CLIN ONCOL, V26, P2674, DOI 10.1200/JCO.2007.14.9807; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livio M, 1999, PHYS REP, V311, P225, DOI 10.1016/S0370-1573(98)00102-1; Marscher AP, 2010, ASTROPHYS J LETT, V710, pL126, DOI 10.1088/2041-8205/710/2/L126; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medvedev MV, 1999, ASTROPHYS J, V526, P697, DOI 10.1086/308038; Meier B, 2014, GENOME RES, V24, P1624, DOI 10.1101/gr.175547.114; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Meyer ET, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/2/L21; Migliari S, 2002, SCIENCE, V297, P1673, DOI 10.1126/science.1073660; MIRABEL IF, 1994, NATURE, V371, P46, DOI 10.1038/371046a0; Mukhopadhyay A, 2010, CLIN CANCER RES, V16, P2344, DOI 10.1158/1078-0432.CCR-09-2758; Murray S, 2012, CANCER TREAT REV, V38, P890, DOI 10.1016/j.ctrv.2012.02.011; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nones K, 2014, INT J CANCER, V135, P1110, DOI 10.1002/ijc.28765; Norquist B, 2011, J CLIN ONCOL, V29, P3008, DOI 10.1200/JCO.2010.34.2980; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; PACZYNSKI B, 1994, ASTROPHYS J, V427, P708, DOI 10.1086/174178; Perlman ES, 2010, ASTROPHYS J, V708, P171, DOI 10.1088/0004-637X/708/1/171; Popova T, 2012, CANCER RES, V72, P5454, DOI 10.1158/0008-5472.CAN-12-1470; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; REES MJ, 1994, ASTROPHYS J, V430, pL93, DOI 10.1086/187446; REES MJ, 1978, MON NOT R ASTRON SOC, V184, pP61, DOI 10.1093/mnras/184.1.61P; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rustin GJS, 2011, INT J GYNECOL CANCER, V21, P419, DOI 10.1097/IGC.0b013e3182070f17; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Salzman J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001156; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Soslow RA, 2012, MODERN PATHOL, V25, P625, DOI 10.1038/modpathol.2011.183; Spada M, 2001, MON NOT R ASTRON SOC, V325, P1559, DOI 10.1046/j.1365-8711.2001.04557.x; Sparks WB, 2000, ASTROPHYS J, V542, P667, DOI 10.1086/317064; Stawarz L, 2006, MON NOT R ASTRON SOC, V370, P981, DOI 10.1111/j.1365-2966.2006.10525.x; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Swisher EM, 2008, CANCER RES, V68, P2581, DOI 10.1158/0008-5472.CAN-08-0088; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wilhelm-Benartzi CS, 2013, BRIT J CANCER, V109, P1394, DOI 10.1038/bjc.2013.496; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	89	891	912	7	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					489	494		10.1038/nature14410	http://dx.doi.org/10.1038/nature14410			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	26017449				2022-12-28	WOS:000355286600037
J	Nishimura, MT; Monteiro, F; Dangl, JL				Nishimura, Marc T.; Monteiro, Freddy; Dangl, Jeffery L.			Treasure Your Exceptions: Unusual Domains in Immune Receptors Reveal Host Virulence Targets	CELL			English	Editorial Material							PLANT; SYSTEM	A mechanistic understanding of how plant pathogens modulate their hosts is critical for rationally engineered disease resistance in agricultural systems. Two new studies show that genomically paired plant immune receptors have incorporated decoy domains that structurally mimic pathogen virulence targets to monitor attempted host immunosuppression.	[Nishimura, Marc T.; Monteiro, Freddy; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Nishimura, Marc T.; Dangl, Jeffery L.] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu	Monteiro, Freddy/E-4043-2019	Monteiro, Freddy/0000-0002-9080-6715; Nishimura, Marc Tad/0000-0003-4666-6900	Division Of Integrative Organismal Systems [1257373] Funding Source: National Science Foundation	Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Bateson W, 1908, METHODS SCOPE GENETI; Cesari S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00606; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Le Roux C, 2015, CELL, V161, P1074, DOI 10.1016/j.cell.2015.04.025; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Ntoukakis V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003123; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sarris PF, 2015, CELL, V161, P1089, DOI 10.1016/j.cell.2015.04.024; Sweat TA, 2007, PLANT CELL, V19, P673, DOI 10.1105/tpc.106.047563; Williams SJ, 2014, SCIENCE, V344, P299, DOI 10.1126/science.1247357	10	22	22	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					957	960		10.1016/j.cell.2015.05.017	http://dx.doi.org/10.1016/j.cell.2015.05.017			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000473	Bronze			2022-12-28	WOS:000355152600002
J	Lebwohl, M				Lebwohl, Mark			Do we need more psoriasis therapies?	LANCET			English	Editorial Material							RHEUMATOID-ARTHRITIS; CONSENSUS; EFFICACY; MODERATE; SAFETY; RISK		Icahn Sch Med Mt Sinai, Kimberly & Eric J Waldman Dept Dermatol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Lebwohl, M (corresponding author), Icahn Sch Med Mt Sinai, Kimberly & Eric J Waldman Dept Dermatol, New York, NY 10029 USA.	lebwohl@aol.com						Abuabara K, 2013, J AM ACAD DERMATOL, V68, P262, DOI 10.1016/j.jaad.2012.07.007; Bachelez H, 2015, LANCET, V386, P552, DOI 10.1016/S0140-6736(14)62113-9; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Brown G, 2015, J DERMATOL TREAT, V26, P32, DOI 10.3109/09546634.2013.878448; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2905, DOI 10.1002/art.22809; Gottlieb AB, 2013, J DRUGS DERMATOL, V12, P888; GutierrezUrena S, 1996, ARTHRITIS RHEUM, V39, P272, DOI 10.1002/art.1780390214; Hochberg MC, 2005, SEMIN ARTHRITIS RHEU, V34, P819, DOI 10.1016/j.semarthrit.2004.11.006; Kimball AB, 2008, J AM ACAD DERMATOL, V58, P1031, DOI 10.1016/j.jaad.2008.01.006; Kurd SK, 2010, ARCH DERMATOL, V146, P891, DOI 10.1001/archdermatol.2010.186; Langley RG, 2015, BRIT J DERMATOL, V172, P1371, DOI 10.1111/bjd.13469; Lebwohl MG, 2014, J AM ACAD DERMATOL, V70, P871, DOI 10.1016/j.jaad.2013.12.018; Levin EC, 2014, J DERMATOL TREAT, V25, P78, DOI 10.3109/09546634.2013.826341	13	3	3	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2015	386	9993					512	514		10.1016/S0140-6736(15)60205-7	http://dx.doi.org/10.1016/S0140-6736(15)60205-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8PG	26051367				2022-12-28	WOS:000359431900008
J	Milloy, MJ; Wood, E				Milloy, M-J; Wood, Evan			Withdrawal from methadone in US prisons: cruel and unusual?	LANCET			English	Editorial Material							DRUG-USERS; INCARCERATION; RISK		[Milloy, M-J; Wood, Evan] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Milloy, M-J; Wood, Evan] Univ British Columbia, Dept Med, Div AIDS, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia	Milloy, MJ (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	uhri-mjsm@cfenet.ubc.ca	Milloy, M-J/AAY-3618-2020					Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Boucher R., 2003, V LAW REV, V27, P453; Buavirat A, 2003, BRIT MED J, V326, P308, DOI 10.1136/bmj.326.7384.308; Dumont DM, 2013, J HEALTH CARE POOR U, V24, P78, DOI 10.1353/hpu.2013.0000; Fiscella K, 2004, J URBAN HEALTH, V81, P645, DOI 10.1093/jurban/jth147; Fiscella K, 2004, AM J PUBLIC HEALTH, V94, P1522, DOI 10.2105/AJPH.94.9.1522; Milloy MJ, 2014, CURR HIV-AIDS REP, V11, P308, DOI 10.1007/s11904-014-0214-z; Milloy MJ, 2011, J INFECT DIS, V203, P1215, DOI 10.1093/infdis/jir032; Rich J. D., 2015, LANCET	9	13	13	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2015	386	9991					316	318		10.1016/S0140-6736(15)60073-3	http://dx.doi.org/10.1016/S0140-6736(15)60073-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN5CX	26028122				2022-12-28	WOS:000358448400006
J	Alexandrova, EM; Yallowitz, AR; Li, D; Xu, S; Schulz, R; Proia, DA; Lozano, G; Dobbelstein, M; Moll, UM				Alexandrova, E. M.; Yallowitz, A. R.; Li, D.; Xu, S.; Schulz, R.; Proia, D. A.; Lozano, G.; Dobbelstein, M.; Moll, U. M.			Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment	NATURE			English	Article							MOUSE MODEL; HSP90 COMPLEX; CANCER-CELLS; IN-VITRO; GAIN; GANETESPIB; INHIBITOR; GELDANAMYCIN; METASTASIS; SPECTRUM	Missense mutations in p53 generate aberrant proteins with abrogated tumour suppressor functions that can also acquire oncogenic gain-of-function activities that promote malignant progression, invasion, metastasis and chemoresistance(1-5). Mutant p53 (mutp53) proteins undergo massive constitutive stabilization specifically in tumours, which is the key requisite for the acquisition of gain-of-functions activities(6-8). Although currently 11 million patients worldwide live with tumours expressing highly stabilized mutp53, it is unknown whether mutp53 is a therapeutic target in vivo. Here we use a novel mutp53 mouse model expressing an inactivatable R248Q hotspot mutation (floxQ) to show that tumours depend on sustained mutp53 expression. Upon tamoxifen-induced mutp53 ablation, allotransplanted and autochthonous tumours curb their growth, thus extending animal survival by 37%, and advanced tumours undergo apoptosis and tumour regression or stagnation. The HSP90/HDAC6 chaperone machinery, which is significantly upregulated in cancer compared with normal tissues, is a major determinant of mutp53 stabilization(9-12). We show that long-term HSP90 inhibition significantly extends the survival of mutp53 Q/- (R248Q allele(2)) and H/H (R172H allele(3)) mice by 59% and 48%, respectively, but not their corresponding p53(-/-) (also known as Trp53(-/-)) littermates. This mutp53-dependent drug effect occurs in H/H mice treated with 17DMAG+SAHA and in H/H and Q/- mice treated with the potent Hsp90 inhibitor ganetespib. Notably, drug activity correlates with induction of mutp53 degradation, tumour apoptosis and prevention of T-cell lymphomagenesis. These proof-of-principle data identify mutp53 as an actionable cancer-specific drug target.	[Alexandrova, E. M.; Yallowitz, A. R.; Li, D.; Xu, S.; Moll, U. M.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Schulz, R.; Dobbelstein, M.; Moll, U. M.] Univ Gottingen, Inst Mol Oncol, D-37077 Gottingen, Germany; [Proia, D. A.] Synta Pharmaceut Corp, Lexington, MA 02421 USA; [Lozano, G.] Univ Texas MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Gottingen; University of Texas System; UTMD Anderson Cancer Center	Moll, UM (corresponding author), SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA.	Ute.Moll@stonybrookmedicine.edu		Dobbelstein, Matthias/0000-0001-5052-3967; Li, Dun/0000-0001-6789-0763	National Cancer Institute [1RO1CA176647]; Deutsche Forschungsgemeinschaft [MO 1998/2-1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA176647] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to S. Schlick, D. Mott and P. Yang for technical assistance. This work was supported by National Cancer Institute award 1RO1CA176647 and Deutsche Forschungsgemeinschaft award MO 1998/2-1.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Blagosklonny MV, 1996, P NATL ACAD SCI USA, V93, P8379, DOI 10.1073/pnas.93.16.8379; Bougeard G, 2008, J MED GENET, V45, P535, DOI 10.1136/jmg.2008.057570; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dobbelstein M, 2014, NAT REV DRUG DISCOV, V13, P179, DOI 10.1038/nrd4201; Doyle B, 2010, J PATHOL, V222, P129, DOI 10.1002/path.2748; Gorska M, 2012, FRONT BIOSCI-LANDMRK, V17, P2269, DOI 10.2741/4050; Hanel W, 2013, CELL DEATH DIFFER, V20, P898, DOI 10.1038/cdd.2013.17; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Hrzenjak A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-49; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Landmann H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.378; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Li D, 2011, CELL DEATH DIFFER, V18, P1904, DOI 10.1038/cdd.2011.71; Li D, 2011, MOL CANCER RES, V9, P577, DOI 10.1158/1541-7786.MCR-10-0534; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Proia DA, 2014, CANCER RES, V74, P1294, DOI 10.1158/0008-5472.CAN-13-3263; Proia DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018552; Siegel D, 2012, BIOCHEM PHARMACOL, V83, P1033, DOI 10.1016/j.bcp.2011.12.017; Slingerland M, 2014, ANTI-CANCER DRUG, V25, P140, DOI 10.1097/CAD.0000000000000040; Socinski MA, 2013, CLIN CANCER RES, V19, P3068, DOI 10.1158/1078-0432.CCR-12-3381; Suh YA, 2011, CANCER RES, V71, P7168, DOI 10.1158/0008-5472.CAN-11-0459; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Whitesell L, 1998, MOL CELL BIOL, V18, P1517, DOI 10.1128/MCB.18.3.1517; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755; Zerdoumi Y, 2013, HUM MUTAT, V34, P453, DOI 10.1002/humu.22254; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	36	228	232	2	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					352	+		10.1038/nature14430	http://dx.doi.org/10.1038/nature14430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26009011	Green Accepted			2022-12-28	WOS:000357950900043
J	Frechin, M; Stoeger, T; Daetwyler, S; Gehin, C; Battich, N; Damm, EM; Stergiou, L; Riezman, H; Pelkmans, L				Frechin, Mathieu; Stoeger, Thomas; Daetwyler, Stephan; Gehin, Charlotte; Battich, Nico; Damm, Eva-Maria; Stergiou, Lilli; Riezman, Howard; Pelkmans, Lucas			Cell-intrinsic adaptation of lipid composition to local crowding drives social behaviour	NATURE			English	Article							PLASMA-MEMBRANE; KINASE; RAFT; TRANSPORTERS; MICRODOMAINS; ADHESION; YEAST	Cells sense the context in which they grow to adapt their phenotype and allow multicellular patterning by mechanisms of autocrine and paracrine signalling(1,2). However, patterns also form in cell populations exposed to the same signalling molecules and substratum, which often correlate with specific features of the population context of single cells, such as local cell crowding(3). Here we reveal a cell-intrinsic molecular mechanism that allows multicellular patterning without requiring specific communication between cells. It acts by sensing the local crowding of a single cell through its ability to spread and activate focal adhesion kinase (FAK, also known as PTK2), resulting in adaptation of genes controlling membrane homeostasis. In cells experiencing low crowding, FAK suppresses transcription of the ABC transporter A1 (ABCA1) by inhibiting FOXO3 and TAL1. Agent-based computational modelling and experimental confirmation identified membrane-based signalling and feedback control as crucial for the emergence of population patterns of ABCA1 expression, which adapts membrane lipid composition to cell crowding and affects multiple signalling activities, including the suppression of ABCA1 expression itself. The simple design of this cell-intrinsic system and its broad impact on the signalling state of mammalian single cells suggests a fundamental role for a tunable membrane lipid composition in collective cell behaviour.	[Frechin, Mathieu; Stoeger, Thomas; Daetwyler, Stephan; Battich, Nico; Pelkmans, Lucas] Univ Zurich, Inst Mol Life Sci, Fac Sci, CH-8057 Zurich, Switzerland; [Stoeger, Thomas; Battich, Nico] ETH, Life Sci Zurich Grad Sch, PhD Program Syst Biol, CH-8057 Zurich, Switzerland; [Stoeger, Thomas; Battich, Nico] Univ Zurich, CH-8057 Zurich, Switzerland; [Gehin, Charlotte; Riezman, Howard] Univ Geneva, Dept Biochem, CH-1205 Geneva, Switzerland; [Damm, Eva-Maria; Stergiou, Lilli] ETH, Inst Mol Syst Biol, CH-8057 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Geneva; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pelkmans, L (corresponding author), Univ Zurich, Inst Mol Life Sci, Fac Sci, CH-8057 Zurich, Switzerland.	lucas.pelkmans@imls.uzh.ch	Battich, Nico/AAL-3955-2020	Battich, Nico/0000-0002-1700-1590; Mathieu, FRECHIN/0000-0003-2385-5688; Gehin, Charlotte/0000-0003-1164-2968; Riezman, Howard/0000-0003-4680-9422; Daetwyler, Stephan/0000-0002-7444-4734; Stoeger, Thomas/0000-0002-5540-4278; Pelkmans, Lucas/0000-0002-6754-9730	EMBO; Marie Curie fellowship [301650]; Oncosuisse fellowship; Bonizzi Theler fellowship; University of Zurich; SystemsX.ch RTD Project LipidX	EMBO(European Molecular Biology Organization (EMBO)); Marie Curie fellowship(European Commission); Oncosuisse fellowship; Bonizzi Theler fellowship; University of Zurich; SystemsX.ch RTD Project LipidX	We thank B. Snijder for help with single-cell Laurdan quantification, P. Liberali for help with imaging of cell-to-cell variability, Y. Yakimovich for IT infrastructure support, and all members of the laboratory for discussions and support. M.F. was supported by an EMBO and a Marie Curie (301650) fellowship. E.-M.D. was supported by an Oncosuisse fellowship, L.S. was supported by a Bonizzi Theler fellowship. This work is supported by the University of Zurich and the SystemsX.ch RTD Project LipidX.	Battich N, 2013, NAT METHODS, V10, P1127, DOI 10.1038/nmeth.2657; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CLARKE NG, 1981, BIOCHEM J, V195, P301, DOI 10.1042/bj1950301; Costet P, 2000, J BIOL CHEM, V275, P28240; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Epstein S, 2012, J LIPID RES, V53, P412, DOI 10.1194/jlr.M022186; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; Guan XL, 2010, METHOD ENZYMOL, V470, P369, DOI 10.1016/S0076-6879(10)70015-X; Holcombe M, 2012, INTEGR BIOL-UK, V4, P53, DOI 10.1039/c1ib00042j; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kicheva A, 2012, SCIENCE, V338, P210, DOI 10.1126/science.1225182; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Lee BH, 2013, CANCER RES, V73, P1211, DOI 10.1158/0008-5472.CAN-12-3128; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Palamarchuk A, 2005, CANCER RES, V65, P4515, DOI 10.1158/0008-5472.CAN-05-0751; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Shah M, 2002, J BIOL CHEM, V277, P45662, DOI 10.1074/jbc.M205935200; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Tabata T, 2001, NAT REV GENET, V2, P620, DOI 10.1038/35084577; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Wippich F, 2013, CELL, V152, P791, DOI 10.1016/j.cell.2013.01.033; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zarubica A, 2009, FASEB J, V23, P1775, DOI 10.1096/fj.08-122192	38	62	62	2	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 2	2015	523	7558					88	+		10.1038/nature14429	http://dx.doi.org/10.1038/nature14429			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL7RN	26009010				2022-12-28	WOS:000357169500037
J	Lander, ES				Lander, Eric S.			Brave New Genome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Lander, Eric S.] Presidents Council Advisors Sci & Technol, Washington, DC USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Lander, ES (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.							Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Lanphier E, 2015, NATURE, V519, P410, DOI 10.1038/519410a; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a	4	80	86	1	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2015	373	1					5	8		10.1056/NEJMp1506446	http://dx.doi.org/10.1056/NEJMp1506446			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL8IS	26039524	Green Published			2022-12-28	WOS:000357218700002
J	Avorn, J; Kesselheim, AS				Avorn, Jerry; Kesselheim, Aaron S.			The 21st Century Cures Act - Will It Take Us Back in Time?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							APPROVAL; FDA		[Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Avorn, J (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Avorn J, 2013, JAMA-J AM MED ASSOC, V309, P1349, DOI 10.1001/jama.2013.623; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Kesselheim AS, 2015, HEALTH AFFAIR, V34, P286, DOI 10.1377/hlthaff.2014.1038	4	77	79	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2015	372	26					2473	2475		10.1056/NEJMp1506964	http://dx.doi.org/10.1056/NEJMp1506964			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL2QD	26039522				2022-12-28	WOS:000356788200002
J	Smith, MEB; Haney, E; McDonagh, M; Pappas, M; Daeges, M; Wasson, N; Fu, RW; Nelson, HD				Smith, M. E. Beth; Haney, Elizabeth; McDonagh, Marian; Pappas, Miranda; Daeges, Monica; Wasson, Ngoc; Fu, Rongwei; Nelson, Heidi D.			Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop	ANNALS OF INTERNAL MEDICINE			English	Review							COGNITIVE-BEHAVIOR THERAPY; RANDOMIZED CONTROLLED-TRIAL; GRADED-EXERCISE; PRAGMATIC REHABILITATION; DOUBLE-BLIND; INTERVENTIONS; SYMPTOMS; HYDROCORTISONE; PARTICIPANTS; INDIVIDUALS	Background: Myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is a debilitating multisystem condition affecting more than 1 million adults in the United States. Purpose: To determine benefits and harms of treatments for adults with ME/CFS and identify future research needs. Data Sources: MEDLINE, PsycINFO, and Cochrane databases (January 1988 to September 2014); clinical trial registries; reference lists; and manufacturer information. Study Selection: English-language randomized trials of the effectiveness and adverse effects of ME/CFS treatments. Data Extraction: Data on participants, study design, analysis, follow-up, and results were extracted and confirmed. Study quality was dual-rated by using prespecified criteria; discrepancies were resolved through consensus. Data Synthesis: Among 35 treatment trials enrolling participants primarily meeting the 1994 Centers for Disease Control and Prevention and Oxford case definitions of CFS, the immune modulator rintatolimod improved some measures of exercise performance compared with placebo in 2 trials (low strength of evidence). Trials of galantamine, hydrocortisone, IgG, valganci-clovir, isoprinosine, fluoxetine, and various complementary medicines were inconclusive (insufficient evidence). Counseling therapies and graded exercise therapy compared with no treatment, relaxation, or support improved fatigue, function, global improvement, and work impairment in some trials; counseling therapies also improved quality of life (low to moderate strength of evidence). Harms were rarely reported across studies (insufficient evidence). Limitation: Trials were heterogeneous and were limited by size, number, duration, applicability, and methodological quality. Conclusion: Trials of rintatolimod, counseling therapies, and graded exercise therapy suggest benefit for some patients meeting case definitions for CFS, whereas evidence for other treatments and harms is insufficient. More definitive studies comparing participants meeting different case definitions, including ME, and providing subgroup analysis are needed to fill research gaps.			Smith, MEB (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	smithbet@ohsu.edu			Agency for Healthcare Research and Quality, Rockville, Maryland [290-2012-00014-I]	Agency for Healthcare Research and Quality, Rockville, Maryland(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality (contract 290-2012-00014-I, task order 4), Rockville, Maryland.	Alraek T, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-87; Bazelmans E, 2005, PSYCHOTHER PSYCHOSOM, V74, P218, DOI 10.1159/000085145; Blacker CVR, 2004, JAMA-J AM MED ASSOC, V292, P1195, DOI 10.1001/jama.292.10.1195; Blockmans D, 2003, AM J MED, V114, P736, DOI 10.1016/S0002-9343(03)00182-7; Burgess M, 2012, BEHAV COGN PSYCHOTH, V40, P175, DOI 10.1017/S1352465811000543; Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Carruthers BM., 2012, MYALGIC ENCEPHALOMYE; Center for Drug Evaluation and Research; US Food and Drug Administration, VOIC PAT SER REP US; Chambers D, 2006, J ROY SOC MED, V99, P506, DOI 10.1258/jrsm.99.10.506; Chan JSM, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/485341; Davenport TE, 2010, PHYS THER, V90, P602, DOI 10.2522/ptj.20090047; Deale A, 1997, AM J PSYCHIAT, V154, P408; Deale A, 2001, AM J PSYCHIAT, V158, P2038, DOI 10.1176/appi.ajp.158.12.2038; Diaz-Mitoma F., 2003, J CHRONIC FATIGUE SY, V11, P71, DOI [10.1300/J092v11n02_06, DOI 10.1300/J092V11N02_06, DOI 10.1300/J092V11N02_]; Dougall D, 2014, J PSYCHOSOM RES, V77, P20, DOI 10.1016/j.jpsychores.2014.04.002; Dowsett E., 1994, REPORT NATL TASK FOR REPORT NATL TASK FOR, P96; Edmonds M, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003200.PUB2; Fluge O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026358; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fulcher KY, 1997, BRIT MED J, V314, P1647, DOI 10.1136/bmj.314.7095.1647; Ganiats TG, 2015, ANN INTERN MED, V162, P653, DOI 10.7326/M15-0357; Goudsmit EM, 2009, PATIENT EDUC COUNS, V77, P231, DOI 10.1016/j.pec.2009.05.015; Haney E, 2015, ANN INTERN MED, V162, P834, DOI 10.7326/M15-0443; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Hlavaty LE, 2011, REHABIL PSYCHOL, V56, P212, DOI 10.1037/a0024118; Ho RTH, 2012, ANN BEHAV MED, V44, P160, DOI 10.1007/s12160-012-9381-6; Hobday RA, 2008, J HUM NUTR DIET, V21, P141, DOI 10.1111/j.1365-277X.2008.00857.x; HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387; Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Jason L, 2009, PATIENT EDUC COUNS, V77, P237, DOI 10.1016/j.pec.2009.02.015; Jason LA, 2007, J CLIN PSYCHOL MED S, V14, P275, DOI 10.1007/s10880-007-9090-7; Jason LA, 2013, FATIGUE, V1, P168, DOI 10.1080/21641846.2013.774556; Jason LA, 2012, EVAL HEALTH PROF, V35, P280, DOI 10.1177/0163278711424281; Jason LA, 2010, J CLIN PSYCHOL, V66, P249, DOI 10.1002/jclp.20648; Knoop H, 2008, BRIT J PSYCHIAT, V193, P340, DOI 10.1192/bjp.bp.108.051292; Komaroff AL, 2011, SEMIN NEUROL, V31, P325, DOI 10.1055/s-0031-1287654; Larun L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003200.pub3; Lopez C, 2011, J PSYCHOSOM RES, V70, P328, DOI 10.1016/j.jpsychores.2010.11.010; McKenzie R, 1998, JAMA-J AM MED ASSOC, V280, P1061, DOI 10.1001/jama.280.12.1061; Montoya JG, 2013, J MED VIROL, V85, P2101, DOI 10.1002/jmv.23713; Morris G, 2013, METAB BRAIN DIS, V28, P523, DOI 10.1007/s11011-012-9324-8; Moss-Morris R, 2005, J HEALTH PSYCHOL, V10, P245, DOI 10.1177/1359105305049774; Nunez M, 2011, CLIN RHEUMATOL, V30, P381, DOI 10.1007/s10067-010-1677-y; O'Dowd H, 2006, HEALTH TECHNOL ASSES, V10, P1; Ockerman P., 2000, CLIN PRACT ALTERNATI, V1, P88; Owens D, 2011, METHODS GUIDE EFFECT; PETERSON PK, 1990, AM J MED, V89, P554, DOI 10.1016/0002-9343(90)90172-A; Reeves William C, 2007, Popul Health Metr, V5, P5; Reyes M, 2003, ARCH INTERN MED, V163, P1530, DOI 10.1001/archinte.163.13.1530; Sharpe M, 1996, BRIT MED J, V312, P22, DOI 10.1136/bmj.312.7022.22; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; Smith M.E.B., 2014, AHRQ PUBLICATION; Smith ME, 2015, DIAGNOSIS TREATMENT; STRAUS SE, 1988, NEW ENGL J MED, V319, P1692, DOI 10.1056/NEJM198812293192602; Strayer DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031334; STRAYER DR, 1994, CLIN INFECT DIS, V18, pS88, DOI 10.1093/clinids/18.Supplement_1.S88; Sutcliffe K, 2010, EUR J CLIN INVEST, V40, P18, DOI 10.1111/j.1365-2362.2009.02225.x; Taylor RR, 2004, AM J OCCUP THER, V58, P35, DOI 10.5014/ajot.58.1.35; The Gerard K H, 2007, PLoS Clin Trials, V2, pe19, DOI 10.1371/journal.pctr.0020019; Tummers M, 2012, PSYCHOL MED, V42, P2205, DOI 10.1017/S0033291712000232; Tummers M, 2013, J PSYCHOSOM RES, V74, P373, DOI 10.1016/j.jpsychores.2013.01.007; Tummers M, 2010, J CONSULT CLIN PSYCH, V78, P724, DOI 10.1037/a0020052; Vermeulen RCW, 2004, PSYCHOSOM MED, V66, P276, DOI 10.1097/01.psy.0000116249.60477.e9; Walach H, 2008, PSYCHOTHER PSYCHOSOM, V77, P158, DOI 10.1159/000116609; Wearden AJ, 2012, BRIT J PSYCHIAT, V201, P227, DOI 10.1192/bjp.bp.111.107474; Wearden AJ, 1998, BRIT J PSYCHIAT, V172, P485, DOI 10.1192/bjp.172.6.485; Wearden AJ, 2013, J CONSULT CLIN PSYCH, V81, P831, DOI 10.1037/a0033561; Wearden AJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1777; Weatherley-Jones E, 2004, J PSYCHOSOM RES, V56, P189, DOI 10.1016/S0022-3999(03)00377-5; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2; Whiting P, 2001, JAMA-J AM MED ASSOC, V286, P1360, DOI 10.1001/jama.286.11.1360; Williams G, 2002, EUR J CLIN INVEST, V32, P831, DOI 10.1046/j.1365-2362.2002.01058.x	73	82	84	0	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12					841	+		10.7326/M15-0114	http://dx.doi.org/10.7326/M15-0114			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK8VC	26075755				2022-12-28	WOS:000356516300019
J	Guglielmi, Y; Cappa, F; Avouac, JP; Henry, P; Elsworth, D				Guglielmi, Yves; Cappa, Frederic; Avouac, Jean-Philippe; Henry, Pierre; Elsworth, Derek			Seismicity triggered by fluid injection-induced aseismic slip	SCIENCE			English	Article							FAULT ZONE; EARTHQUAKE	Anthropogenic fluid injections are known to induce earthquakes. The mechanisms involved are poorly understood, and our ability to assess the seismic hazard associated with geothermal energy or unconventional hydrocarbon production remains limited. We directly measure fault slip and seismicity induced by fluid injection into a natural fault. We observe highly dilatant and slow [similar to 4 micrometers per second (mm/s)] aseismic slip associated with a 20-fold increase of permeability, which transitions to faster slip (similar to 10 mu m/s) associated with reduced dilatancy and micro-earthquakes. Most aseismic slip occurs within the fluid-pressurized zone and obeys a rate-strengthening friction law mu = 0.67 +/- 0.045ln (v/v(0)) with v(0) = 0.1 mu m/s. Fluid injection primarily triggers aseismic slip in this experiment, with micro-earthquakes being an indirect effect mediated by aseismic creep.	[Guglielmi, Yves; Henry, Pierre] Univ Aix Marseille, Ctr Rech & Enseignement Geosci Environm, CNRS, UMR7330,IRD, F-13545 Aix En Provence, France; [Cappa, Frederic] Univ Nice Sophia Antipolis, Geoazur, CNRS, UMR 7329,IRD,Cote Azur Observ, F-06560 Sophia Antipolis, France; [Cappa, Frederic; Avouac, Jean-Philippe] CALTECH, Geol & Planetary Sci, Pasadena, CA 91125 USA; [Elsworth, Derek] Penn State Univ, Energy & Mineral Engn & Geosci, Earth & Mineral Sci Energy Inst, University Pk, PA 16802 USA; [Elsworth, Derek] Penn State Univ, G3 Ctr, University Pk, PA 16802 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; California Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Guglielmi, Y (corresponding author), Univ Aix Marseille, Ctr Rech & Enseignement Geosci Environm, CNRS, UMR7330,IRD, F-13545 Aix En Provence, France.	guglielmi@cerege.fr	Elsworth, Derek/D-2844-2015; Cappa, Frédéric/I-3024-2013; Guglielmi, Yves/J-1516-2016; Henry, Pierre/A-4045-2011; Avouac, Jean-Philippe/B-5699-2015	Elsworth, Derek/0000-0002-4942-1151; Cappa, Frédéric/0000-0003-4859-8024; Avouac, Jean-Philippe/0000-0002-3060-8442	Agence Nationale de la Recherche (ANR); PACA through PETRO-PRO; French Academy of Sciences, the California Institute of Technology Tectonics Observatory; ANR HYDROSEIS [ANR-13-JS06-0004-01]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); PACA through PETRO-PRO; French Academy of Sciences, the California Institute of Technology Tectonics Observatory; ANR HYDROSEIS(French National Research Agency (ANR))	The experimental work was funded by the Agence Nationale de la Recherche (ANR) Captage de CO<INF>2</INF> through the HPPP-CO<INF>2</INF> project and by PACA through the PETRO-PRO project. The rate-and-state fault models for this study were supported by the French Academy of Sciences, the California Institute of Technology Tectonics Observatory, and the ANR HYDROSEIS under contract ANR-13-JS06-0004-01. We thank the SITES S.A.S. engineers H. Caron, C. Micollier, R. Blin, and H. Lancon, and the Petrometalic S.A. engineer J. B. Janovczyk, who jointly developed and operated the probe that enabled this experiment. We also thank the Laboratoire Souterrain a Bas Bruit (LSBB) engineers' team for their technical support during the installation of the experiment in one of the LSBB boreholes (www.lsbb.eu). Experimental data are available in the supplementary materials.	Bourouis S, 2007, GEOPHYS J INT, V169, P723, DOI 10.1111/j.1365-246X.2006.03325.x; Cappa F, 2011, INT J GREENH GAS CON, V5, P336, DOI 10.1016/j.ijggc.2010.08.005; Cappa F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028980; Carpenter BM, 2014, J GEOPHYS RES-SOL EA, V119, P9062, DOI 10.1002/2014JB011337; Cornet FH, 1997, PURE APPL GEOPHYS, V150, P563, DOI 10.1007/s000240050093; Das I., 2011, LEADING EDGE TULSA O, V30, P778; Ellsworth WL, 2013, SCIENCE, V341, P142, DOI 10.1126/science.1225942; Guglielmi Y, 2014, ROCK MECH ROCK ENG, V47, P303, DOI 10.1007/s00603-013-0517-1; Haimson BC, 2003, INT J ROCK MECH MIN, V40, P1011, DOI 10.1016/j.ijrmms.2003.08.002; HUBBERT MK, 1959, GEOL SOC AM BULL, V70, P115; Jeanne P, 2012, J STRUCT GEOL, V44, P93, DOI 10.1016/j.jsg.2012.08.016; Majer EL, 2007, GEOTHERMICS, V36, P185, DOI 10.1016/j.geothermics.2007.03.003; Marone C, 1998, ANNU REV EARTH PL SC, V26, P643, DOI 10.1146/annurev.earth.26.1.643; MARONE CJ, 1991, J GEOPHYS RES-SOLID, V96, P8441, DOI 10.1029/91JB00275; NICHOLSON C, 1992, PURE APPL GEOPHYS, V139, P561, DOI 10.1007/BF00879951; Nicholson C., 1990, US GEOL SURV B, V1951; Noda H, 2013, NATURE, V493, P518, DOI 10.1038/nature11703; Perfettini H, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002488; RALEIGH CB, 1976, SCIENCE, V191, P1230, DOI 10.1126/science.191.4233.1230; Rutqvist J, 2003, HYDROGEOL J, V11, P7, DOI 10.1007/s10040-002-0241-5; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097; SCOTTI O, 1994, INT J ROCK MECH MIN, V31, P347, DOI 10.1016/0148-9062(94)90902-4; SEGALL P, 1995, J GEOPHYS RES-SOL EA, V100, P22155, DOI 10.1029/95JB02403; Tesei T, 2014, EARTH PLANET SC LETT, V408, P307, DOI 10.1016/j.epsl.2014.10.021; Verberne BA, 2010, B SEISMOL SOC AM, V100, P2767, DOI 10.1785/0120090287; Zoback M., 2012, SOC PETR ENG AM UNC	26	369	373	17	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1224	1226		10.1126/science.aab0476	http://dx.doi.org/10.1126/science.aab0476			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068845				2022-12-28	WOS:000356011500046
J	Hochberg, YV; Fehder, DC				Hochberg, Yael V.; Fehder, Daniel C.			Accelerators and ecosystems	SCIENCE			English	Editorial Material									[Hochberg, Yael V.] Rice Univ, Houston, TX 77251 USA; [Hochberg, Yael V.; Fehder, Daniel C.] MIT, Cambridge, MA 02139 USA; [Hochberg, Yael V.] Natl Bur Econ Res, Cambridge, MA 02138 USA	Rice University; Massachusetts Institute of Technology (MIT); National Bureau of Economic Research	Hochberg, YV (corresponding author), Rice Univ, Houston, TX 77251 USA.	hochberg@rice.edu	Fehder, Daniel/E-5254-2019	Fehder, Daniel/0000-0001-7851-5491				Fehder D.C., 2014, ACCELERATORS REGIONA	1	12	12	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1202	1203		10.1126/science.aab3351	http://dx.doi.org/10.1126/science.aab3351			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068829				2022-12-28	WOS:000356011500025
J	Ormerod, AD; Thomas, KS; Craig, FE; Mitchell, E; Greenlaw, N; Norrie, J; Mason, JM; Walton, S; Johnston, GA; Williams, HC				Ormerod, Anthony D.; Thomas, Kim S.; Craig, Fiona E.; Mitchell, Eleanor; Greenlaw, Nicola; Norrie, John; Mason, James M.; Walton, Shernaz; Johnston, Graham A.; Williams, Hywel C.		Uk Dermatology Clinical Trials Net	Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							UNITED-KINGDOM; CYCLOSPORINE; MULTICENTER; MANAGEMENT; DIAGNOSIS; UPDATE; INDEX	Objective To determine whether ciclosporin is superior to prednisolone for the treatment of pyoderma gangrenosum, a painful, ulcerating skin disease with a poor evidence base for management. Design Multicentre, parallel group, observer blind, randomised controlled trial. Setting 39 UK hospitals, recruiting from June 2009 to November 2012. Participants 121 patients (73 women, mean age 54 years) with clinician diagnosed pyoderma gangrenosum. Clinical diagnosis was revised in nine participants after randomisation, leaving 112 participants in the analysis set (59 ciclosporin; 53 prednisolone). Intervention Oral prednisolone 0.75 mg/kg/day compared with ciclosporin 4 mg/kg/day, to a maximum dose of 75 and 400 mg/day, respectively. Main outcome measures The primary outcome was speed of healing over six weeks, captured using digital images and assessed by blinded investigators. Secondary outcomes were time to healing, global treatment response, resolution of inflammation, self reported pain, quality of life, number of treatment failures, adverse reactions, and time to recurrence. Outcomes were assessed at baseline and six weeks and when the ulcer had healed (to a maximum of six months). Results Of the 112 participants, 108 had complete primary outcome data at baseline and six weeks (57 ciclosporin; 51 prednisolone). Groups were balanced at baseline. The mean (SD) speed of healing at six weeks was -0.21 (1.00) cm(2)/day in the ciclosporin group compared with -0.14 (0.42) cm(2)/day in the prednisolone group. The adjusted mean difference showed no between group difference (0.003 cm(2)/day, 95% confidence interval -0.20 to 0.21; P=0.97). By six months, ulcers had healed in 28/59 (47%) participants in the ciclosporin group compared with 25/53 (47%) in the prednisolone group. In those with healed ulcers, eight (30%) receiving ciclosporin and seven (28%) receiving prednisolone had a recurrence. Adverse reactions were similar for the two groups (68% ciclosporin and 66% prednisolone), but serious adverse reactions, especially infections, were more common in the prednisolone group. Conclusion Prednisolone and ciclosporin did not differ across a range of objective and patient reported outcomes. Treatment decisions for individual patients may be guided by the different side effect profiles of the two drugs and patient preference.	[Ormerod, Anthony D.] Univ Aberdeen, Div Appl Med, Aberdeen, Scotland; [Thomas, Kim S.; Williams, Hywel C.] Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2NR, England; [Craig, Fiona E.] Aberdeen Royal Infirm, Dept Dermatol, Aberdeen, Scotland; [Mitchell, Eleanor] Univ Nottingham, Nottingham Clin Trials Unit, Nottingham NG7 2RD, England; [Greenlaw, Nicola] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Norrie, John] Univ Aberdeen, Ctr Healthcare Randomised Trials, Aberdeen, Scotland; [Mason, James M.] Univ Durham, Sch Med Pharm & Hlth, Durham, England; [Walton, Shernaz] Hull Royal Infirm, Dept Dermatol, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Johnston, Graham A.] Leicester Royal Infirm, Dept Dermatol, Leicester, Leics, England	University of Aberdeen; University of Nottingham; University of Aberdeen; University of Nottingham; University of Glasgow; University of Aberdeen; Durham University; University of Hull; University of Leicester	Thomas, KS (corresponding author), Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2NR, England.	kim.thomas@nottingham.ac.uk	Mitchell, Eleanor/AAD-2359-2020; Mason, James M/D-9904-2011; Johnston, Graham/Y-2348-2019; Mitchell, Eleanor/GXW-2022-2022	Mitchell, Eleanor/0000-0002-6998-4533; Mason, James M/0000-0001-9210-4082; Johnston, Graham/0000-0001-7494-0765; Langan, Sinead/0000-0002-7022-7441; Layton, Alison/0000-0003-0473-3319; Levell, Nick/0000-0003-3393-8305; Piguet, Vincent/0000-0001-6079-4517; Ravenscroft, Jane/0000-0002-1609-7084; Thomas, Kim/0000-0001-7785-7465; williams, hywel/0000-0002-5646-3093	National Institute for Health Research (NIHR) [RP-PG-0407-10177]; Nottingham Clinical Trials Unit; UK Dermatology Clinical Trials Network; Robertson Centre for Biostatistics; Centre for Healthcare Randomised Trials; Medical Research Council [MC_UU_12010/5] Funding Source: researchfish; National Institute for Health Research [NIHR/CS/010/014, RP-PG-0407-10177] Funding Source: researchfish; MRC [MC_UU_12010/5] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Nottingham Clinical Trials Unit; UK Dermatology Clinical Trials Network; Robertson Centre for Biostatistics; Centre for Healthcare Randomised Trials; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This publication presents independent research funded by the National Institute for Health Research (NIHR) under its programme grants for applied research (RP-PG-0407-10177). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. Support for this trial was provided through Nottingham Clinical Trials Unit, the UK Dermatology Clinical Trials Network, the Robertson Centre for Biostatistics, and the Centre for Healthcare Randomised Trials. There was no commercial support for this study. The writing team all had input into the design and conduct of the trial, writing of the paper and/or performed the statistical analysis. All the authors vouch for the completeness and accuracy of the data presented and for the fidelity of the study to the protocol.	Agarwal A, 2013, ALIMENT PHARM THER, V38, P563, DOI 10.1111/apt.12431; Arguelles-Arias F, 2013, DIGEST DIS SCI, V58, P2949, DOI 10.1007/s10620-013-2762-2; Binus AM, 2011, BRIT J DERMATOL, V165, P1244, DOI 10.1111/j.1365-2133.2011.10565.x; British Association of Dermatologists, 2013, PAT INF LEAFL PYOD G; Brooklyn TN, 2006, GUT, V55, P505, DOI 10.1136/gut.2005.074815; Brooklyn T, 2006, BRIT MED J, V333, P181, DOI 10.1136/bmj.333.7560.181; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Capella GL, 1999, SCAND J GASTROENTERO, V34, P220; Cardinal M, 2009, BMC DERMATOL, V9, DOI 10.1186/1471-5945-9-2; Craig FF, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-51; ELGART G, 1991, J AM ACAD DERMATOL, V24, P83, DOI 10.1016/0190-9622(91)70016-U; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Foss CE, 2008, J EUR ACAD DERMATOL, V22, P943, DOI 10.1111/j.1468-3083.2008.02680.x; Friedman S, 2001, INFLAMM BOWEL DIS, V7, P1; Kantor J, 2000, BRIT J DERMATOL, V142, P960, DOI 10.1046/j.1365-2133.2000.03478.x; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Langan SM, 2012, J INVEST DERMATOL, V132, P2166, DOI 10.1038/jid.2012.130; Layfield C., 2014, Clinical Investigation, V4, P209; MATIS WL, 1992, ARCH DERMATOL, V128, P1060, DOI 10.1001/archderm.128.8.1060; Miller J, 2010, J AM ACAD DERMATOL, V62, P646, DOI 10.1016/j.jaad.2009.05.030; RALLOC, 1997, RALLOC STAT MOD DES; Reichrath J, 2005, J AM ACAD DERMATOL, V53, P273, DOI 10.1016/j.jaad.2004.10.006; Su WPD, 2004, INT J DERMATOL, V43, P790, DOI 10.1111/j.1365-4632.2004.02128.x; Tremezaygues L, 2010, HAUTARZT, V61, P345, DOI 10.1007/s00105-009-1909-8; Vidal D, 2004, J Dermatolog Treat, V15, P146; Zuo KJ, 2015, J PLAST RECONSTR AES, V68, P295, DOI 10.1016/j.bjps.2014.12.036	26	125	127	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2015	350								h2958	10.1136/bmj.h2958	http://dx.doi.org/10.1136/bmj.h2958			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK7DN	26071094	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000356391300001
J	Bartle, H				Bartle, Harvey			The Employment and Placement of Handicapped Persons in Industry (Reprinted from vol 121, pg 1002-1003, 1943)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Bartle H, 1943, J AMER MED ASSOC, V121, P1002, DOI 10.1001/jama.1943.02840130016006	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2289	2289		10.1001/jama.2014.11800	http://dx.doi.org/10.1001/jama.2014.11800			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1VH	26057301				2022-12-28	WOS:000355995300033
J	Luo, CY; Ecker, JR				Luo, Chongyuan; Ecker, Joseph R.			Exceptional epigenetics in the brain	SCIENCE			English	Editorial Material							CPG-BINDING PROTEIN-2; RETT-SYNDROME; METHYLATION; DNA; GENOME; MECP2		[Luo, Chongyuan] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Luo, CY (corresponding author), Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ecker@salk.edu	Ecker, Joseph R/B-9144-2008	Ecker, Joseph R/0000-0001-5799-5895	NIMH NIH HHS [U01 MH105985, R01 MH094670] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094670, U01MH105985] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Chen L, 2015, P NATL ACAD SCI USA, V112, P5509, DOI 10.1073/pnas.1505909112; Gabel HW, 2015, NATURE, V522, P89, DOI 10.1038/nature14319; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Insel TR, 2013, SCIENCE, V340, P687, DOI 10.1126/science.1239276; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Morselli M, 2015, ELIFE, V4, DOI 10.7554/eLife.06205; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Sugino K, 2014, J NEUROSCI, V34, P12877, DOI 10.1523/JNEUROSCI.2674-14.2014; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Zeng J, 2012, AM J HUM GENET, V91, P455, DOI 10.1016/j.ajhg.2012.07.024	13	9	9	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1094	1095		10.1126/science.aac5832	http://dx.doi.org/10.1126/science.aac5832			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045424	Green Accepted			2022-12-28	WOS:000355590500027
J	Kolling, N; Rushworth, MFS				Kolling, Nils; Rushworth, Matthew F. S.			What's Worth the Risk? A Neural Circuit for Trade-Offs	CELL			English	Editorial Material							DECISION-MAKING; CINGULATE CORTEX; MECHANISMS	Cost-benefit analysis in decision making takes place in everyday life for animals and humans alike. In this issue, a neural circuit specific for modulating these behaviors is identified in rats and reveals elusive functional distinctions between long-mysterious anatomical features of the brain.	[Kolling, Nils; Rushworth, Matthew F. S.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Rushworth, MFS (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	matthew.rushworth@psy.ox.ac.uk		Kolling, Nils/0000-0002-0283-6966; Rushworth, Matthew/0000-0002-5578-9884	MRC [G0700399, G0902373] Funding Source: UKRI; Medical Research Council [G0700399, G0902373] Funding Source: Medline; Wellcome Trust [100973] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Amemori KI, 2012, NAT NEUROSCI, V15, P776, DOI 10.1038/nn.3088; Friedman A, 2015, CELL, V161, P1320, DOI 10.1016/j.cell.2015.04.049; Kolling N, 2014, NEURON, V81, P1190, DOI 10.1016/j.neuron.2014.01.033; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Neubert FX, 2015, P NATL ACAD SCI USA, V112, pE2695, DOI 10.1073/pnas.1410767112; Nicolle A, 2012, NEURON, V75, P1114, DOI 10.1016/j.neuron.2012.07.023; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Rudebeck PH, 2014, NEURON, V84, P1143, DOI 10.1016/j.neuron.2014.10.049; Stalnaker TA, 2015, NAT NEUROSCI, V18, P620, DOI 10.1038/nn.3982; Wan XH, 2015, NAT NEUROSCI, V18, P752, DOI 10.1038/nn.3999	10	3	3	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1243	1244		10.1016/j.cell.2015.05.031	http://dx.doi.org/10.1016/j.cell.2015.05.031			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26046432	Bronze			2022-12-28	WOS:000355935000003
J	Zhou, TQ; Lynch, RM; Chen, L; Acharya, P; Wu, XL; Doria-Rose, NA; Joyce, MG; Lingwood, D; Soto, C; Bailer, RT; Ernandes, MJ; Kong, R; Longo, NS; Louder, MK; McKee, K; O'Dell, S; Schmidt, SD; Tran, LL; Yang, ZJ; Druz, A; Luongo, TS; Moquin, S; Srivatsan, S; Yang, YP; Zhang, BS; Zheng, AQ; Pancera, M; Kirys, T; Georgiev, IS; Gindin, T; Peng, HP; Yang, AS; Mullikin, JC; Gray, MD; Stamatatos, L; Burton, DR; Koff, WC; Cohen, MS; Haynes, BF; Casazza, JP; Connors, M; Corti, D; Lanzavecchia, A; Sattentau, QJ; Weiss, RA; West, AP; Bjorkman, PJ; Scheid, JF; Nussenzweig, MC; Shapiro, L; Mascola, JR; Kwong, PD				Zhou, Tongqing; Lynch, Rebecca M.; Chen, Lei; Acharya, Priyamvada; Wu, Xueling; Doria-Rose, Nicole A.; Joyce, M. Gordon; Lingwood, Daniel; Soto, Cinque; Bailer, Robert T.; Ernandes, Michael J.; Kong, Rui; Longo, Nancy S.; Louder, Mark K.; McKee, Krisha; O'Dell, Sijy; Schmidt, Stephen D.; Tran, Lillian; Yang, Zhongjia; Druz, Aliaksandr; Luongo, Timothy S.; Moquin, Stephanie; Srivatsan, Sanjay; Yang, Yongping; Zhang, Baoshan; Zheng, Anqi; Pancera, Marie; Kirys, Tatsiana; Georgiev, Ivelin S.; Gindin, Tatyana; Peng, Hung-Pin; Yang, An-Suei; Mullikin, James C.; Gray, Matthew D.; Stamatatos, Leonidas; Burton, Dennis R.; Koff, Wayne C.; Cohen, Myron S.; Haynes, Barton F.; Casazza, Joseph P.; Connors, Mark; Corti, Davide; Lanzavecchia, Antonio; Sattentau, Quentin J.; Weiss, Robin A.; West, Anthony P., Jr.; Bjorkman, Pamela J.; Scheid, Johannes F.; Nussenzweig, Michel C.; Shapiro, Lawrence; Mascola, John R.; Kwong, Peter D.		NISC Comparative Sequencing	Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors	CELL			English	Article							NEUTRALIZING HIV-1 ANTIBODY; CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; POTENT NEUTRALIZATION; CD4-BINDING SITE; BROAD; COMPLEX; DETERMINANTS; RECOGNITION; MATURATION	The site on the HIV-1 gp120 glycoprotein that binds the CD4 receptor is recognized by broadly reactive antibodies, several of which neutralize over 90% of HIV-1 strains. To understand how antibodies achieve such neutralization, we isolated CD4-binding-site (CD4bs) antibodies and analyzed 16 co-crystal structures -8 determined here- of CD4bs antibodies from 14 donors. The 16 antibodies segregated by recognition mode and developmental ontogeny into two types: CDR H3-dominated and V-H-gene-restricted. Both could achieve greater than 80% neutralization breadth, and both could develop in the same donor. Although paratope chemistries differed, all 16 gp120-CD4bs antibody complexes showed geometric similarity, with antibody-neutralization breadth correlating with antibody-angle of approach relative to the most effective antibody of each type. The repertoire for effective recognition of the CD4 supersite thus comprises antibodies with distinct paratopes arrayed about two optimal geometric orientations, one achieved by CDR H3 ontogenies and the other achieved by V-H-gene-restricted ontogenies.	[Zhou, Tongqing; Lynch, Rebecca M.; Chen, Lei; Acharya, Priyamvada; Wu, Xueling; Doria-Rose, Nicole A.; Joyce, M. Gordon; Lingwood, Daniel; Soto, Cinque; Bailer, Robert T.; Ernandes, Michael J.; Kong, Rui; Longo, Nancy S.; Louder, Mark K.; McKee, Krisha; O'Dell, Sijy; Schmidt, Stephen D.; Tran, Lillian; Yang, Zhongjia; Druz, Aliaksandr; Luongo, Timothy S.; Moquin, Stephanie; Srivatsan, Sanjay; Yang, Yongping; Zhang, Baoshan; Zheng, Anqi; Pancera, Marie; Kirys, Tatsiana; Georgiev, Ivelin S.; Casazza, Joseph P.; Shapiro, Lawrence; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Zhou, Tongqing; Lynch, Rebecca M.; Chen, Lei; Acharya, Priyamvada; Wu, Xueling; Doria-Rose, Nicole A.; Joyce, M. Gordon; Lingwood, Daniel; Soto, Cinque; Bailer, Robert T.; Ernandes, Michael J.; Kong, Rui; Longo, Nancy S.; Louder, Mark K.; McKee, Krisha; O'Dell, Sijy; Schmidt, Stephen D.; Tran, Lillian; Yang, Zhongjia; Druz, Aliaksandr; Luongo, Timothy S.; Moquin, Stephanie; Srivatsan, Sanjay; Yang, Yongping; Zhang, Baoshan; Zheng, Anqi; Pancera, Marie; Kirys, Tatsiana; Georgiev, Ivelin S.; Casazza, Joseph P.; Shapiro, Lawrence; Mascola, John R.; Kwong, Peter D.] NIH, Bethesda, MD 20892 USA; [Gindin, Tatyana; Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Gindin, Tatyana; Shapiro, Lawrence] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Peng, Hung-Pin; Yang, An-Suei] Acad Sinica, Genom Res Ctr, Taipei 11221, Taiwan; [Peng, Hung-Pin; Yang, An-Suei] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 11221, Taiwan; [Mullikin, James C.; NISC Comparative Sequencing] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Gray, Matthew D.; Stamatatos, Leonidas] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02142 USA; [Koff, Wayne C.] Int AIDS Vaccine Initiat, New York, NY 10038 USA; [Cohen, Myron S.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Microbiol, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Dept Immunol, Chapel Hill, NC 27599 USA; [Haynes, Barton F.] Duke Univ, Sch Med, Human Vaccine Inst, Dept Med, Durham, NC 27710 USA; [Haynes, Barton F.] Duke Univ, Sch Med, Human Vaccine Inst, Dept Surg, Durham, NC 27710 USA; [Haynes, Barton F.] Duke Univ, Sch Med, Human Vaccine Inst, Dept Pediat, Durham, NC 27710 USA; [Haynes, Barton F.] Duke Univ, Sch Med, Human Vaccine Inst, Dept Immunol, Durham, NC 27710 USA; [Haynes, Barton F.] Duke Univ, Ctr HIV AIDS Vaccine Immunol Immunogen Discovery, Durham, NC 27710 USA; [Connors, Mark] NIAID, HIV Specif Immun Sect, Immunoregulat Lab, Bethesda, MD 20892 USA; [Connors, Mark] NIH, Bethesda, MD 20892 USA; [Corti, Davide] Humabs BioMed SA, CH-6500 Bellinzona, Switzerland; [Corti, Davide; Lanzavecchia, Antonio] Univ Svizzera Italiana, Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Sattentau, Quentin J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RF, England; [Weiss, Robin A.] UCL, Div Infect Immun, London WC1E 6BT, England; [West, Anthony P., Jr.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Bjorkman, Pamela J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Scheid, Johannes F.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; Columbia University; Columbia University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Fred Hutchinson Cancer Center; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; International AIDS Vaccine Initiative; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; Universita della Svizzera Italiana; University of Oxford; University of London; University College London; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Mascola, JR (corresponding author), NIAID, Vaccine Res Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jmascola@nih.gov; pdkwong@nih.gov	Schmidt, Stephen/AAC-6967-2019; Zhou, Tongqing/A-6880-2010; Luongo, Timothy/AAY-1073-2020; Mascola, John/AAI-7193-2021; Shapiro, Lawrence/AAE-7172-2019; Nussenzweig, Michel/AAE-7292-2019; Schmidt, Stephen/B-5398-2012	Zhou, Tongqing/0000-0002-3935-4637; Ernandes, Michael/0000-0001-8218-0145; Yang, An-Suei/0000-0002-4699-873X; Moquin, Stephanie/0000-0002-8696-4315; Acharya, Priyamvada/0000-0002-0089-277X; Luongo, Timothy/0000-0001-7621-7992	Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health; Division of AIDS, NIAID, National Institutes of Health [AI037526, AI072529, AI0678501, P01 AI094419, P01 AI100148, P01 AI104722, 1UM1 AI100663, UM1 AI100645]; Howard Hughes Medical Institute; Bill and Melinda Gates Foundation [38637, 1040753]; International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); UK Department for International Development (DFID); United States Agency for International Development (USAID); MRC [G0000635] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001090, P01AI104722, R01AI072529, R37AI037526, ZIAAI005022, P01AI094419, ZICAI005113, ZIAAI005095, UM1AI100645, P01AI100148, ZICAI005111, R01AI037526, UM1AI100663] Funding Source: NIH RePORTER; Medical Research Council [G0000635] Funding Source: researchfish	Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health; Division of AIDS, NIAID, National Institutes of Health; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium; US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); UK Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center, for discussions and comments on the manuscript and B. Honig for structural biology mentorship. We thank J. Baalwa, D. Ellenberger, F. Gao, B. Hahn, K. Hong, J. Kim, F. McCutchan, D. Montefiori, L. Morris, J. Overbaugh, E. Sanders-Buell, G. Shaw, R. Swanstrom, M. Thomson, S. Tovanabutra, C. Williamson, and L. Zhang for contributing the HIV-1 Envelope plasmids used in our neutralization panel. The authors acknowledge the contributions of the Center for HIV/AIDS Vaccine Discovery (CHAVI) Clinical Core Team. Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, by the Howard Hughes Medical Institute (M.C.N. and P.J.B. are investigators), and by grants from the Division of AIDS, NIAID, National Institutes of Health (AI037526, AI072529, AI0678501, P01 AI094419, P01 AI100148, P01 AI104722, and 1UM1 AI100663 and UM1 AI100645), from the Bill and Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery Grant IDs 38637 and 1040753), and from the International AIDS Vaccine Initiative's (IAVI's) Neutralizing Antibody Consortium. IAVI's work is made possible by support from many donors, including: the Bill and Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the UK Department for International Development (DFID); and the United States Agency for International Development (USAID). The full list of IAVI donors is available at http://www.iavi.org. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BRADEN BC, 1994, J MOL BIOL, V243, P767, DOI 10.1016/0022-2836(94)90046-9; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; HOXIE JA, 1988, J VIROL, V62, P2557, DOI 10.1128/JVI.62.8.2557-2568.1988; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; MCCLURE MO, 1987, NATURE, V330, P487, DOI 10.1038/330487a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Petrey D, 2000, PROTEIN SCI, V9, P2181, DOI 10.1110/ps.9.11.2181; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu JXX, 2013, SCI CHINA CHEM, V56, P1, DOI 10.1007/s11426-012-4811-7	50	214	227	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1280	1292		10.1016/j.cell.2015.05.007	http://dx.doi.org/10.1016/j.cell.2015.05.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26004070	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000355935000009
J	Graham, KL; Wilker, EH; Howell, MD; Davis, RB; Marcantonio, ER				Graham, Kelly L.; Wilker, Elissa H.; Howell, Michael D.; Davis, Roger B.; Marcantonio, Edward R.			Differences Between Early and Late Readmissions Among Patients: A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							HOSPITAL READMISSION; HEART-FAILURE; INPATIENT; MORTALITY; RATES; RISK; CARE; PNEUMONIA; QUALITY; PROGRAM	Background: Early and late readmissions may have different causal factors, requiring different prevention strategies. Objective: To determine whether predictors of readmission change within 30 days after discharge. Design: Retrospective cohort study. Setting: Academic medical center. Participants: Patients admitted between 1 January 2009 and 31 December 2010. Measurements: Factors related to the index hospitalization (acute illness burden, inpatient care process factors, and clinical indicators of instability at discharge) and unrelated factors (chronic illness burden and social determinants of health) and how they affect early readmissions (0 to 7 days after discharge) and late readmissions (8 to 30 days after discharge). Results: 13 334 admissions, representing 8078 patients, were included in the analysis. Early readmissions were associated with markers of acute illness burden, including length of hospital stay (odds ratio [OR], 1.02 [95% Cl, 1.00 to 1.03]) and whether a rapid response team was called for assessment (OR, 1.48 [Cl, 1.15 to 1.89]); markers of chronic illness burden, including receiving a medication indicating organ failure (OR, 1.19 [Cl, 1.02 to 1.40]); and social determinants of health, including barriers to learning (OR, 1.18 [Cl, 1.01 to 1.38]). Early readmissions were less likely if a patient was discharged between 8:00 a.m. and 12:59 p.m. (OR, 0.76 [Cl, 0.58 to 0.99]). Late readmissions were associated with markers of chronic illness burden, including receiving a medication indicating organ failure (OR, 1.24 [Cl, 1.08 to 1.41]) or hemodialysis (OR, 1.61 [Cl, 1.12 to 2.17]), and social determinants of health, including barriers to learning (OR, 1.24 [Cl; 1.09 to 1.42]) and having unsupplemented Medicare or Medicaid (OR, 1.16 [Cl, 1.01 to 1.33]). Limitation: Readmissions were ascertained at 1 institution. Conclusion: The time frame of 30 days after hospital discharge may not be homogeneous. Causal factors and readmission prevention strategies may differ for the early versus late periods.	Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Chicago, Ctr Qual, Chicago, IL 60637 USA; Univ Chicago, Sect Pulm & Crit Care, Chicago, IL 60637 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Chicago; University of Chicago	Graham, KL (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Med, 330 Brookline Ave,E Shapiro 607D, Boston, MA 02215 USA.	kgraham@bidmc.harvard.edu	Marcantonio, Edward R/U-3929-2017	Marcantonio, Edward R/0000-0002-2911-4250	Health Resources and Services Administration; National Institute on Aging; National Institutes of Health; Harvard Catalyst; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES022243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG035075] Funding Source: NIH RePORTER	Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Health Resources and Services Administration, National Institute on Aging, National Institutes of Health, Harvard Catalyst, and Harvard University.	ASHTON CM, 1995, ANN INTERN MED, V122, P415, DOI 10.7326/0003-4819-122-6-199503150-00003; Calvillo-King L, 2013, J GEN INTERN MED, V28, P269, DOI 10.1007/s11606-012-2235-x; Centers for Medicare and Medicaid Services, READM RED PROGR; Escobar GJ, 2008, MED CARE, V46, P232, DOI 10.1097/MLR.0b013e3181589bb6; Fontanarosa PB, 2013, JAMA-J AM MED ASSOC, V309, P398, DOI 10.1001/jama.2013.42; Gorodeski EZ, 2010, NEW ENGL J MED, V363, P297, DOI 10.1056/NEJMc1001882; Halfon P, 2006, MED CARE, V44, P972, DOI 10.1097/01.mlr.0000228002.43688.c2; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2013, NEW ENGL J MED, V368, P1175, DOI 10.1056/NEJMp1300122; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Joynt KE, 2012, NEW ENGL J MED, V366, P1366, DOI 10.1056/NEJMp1201598; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Kravet SJ, 2007, HEALTH CARE MANAG, V26, P142, DOI 10.1097/01.HCM.0000268617.33491.60; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333; National Quality Forum, 2014, RISK ADJ SOC STAT OT; Powell ES, 2012, J EMERG MED, V42, P186, DOI 10.1016/j.jemermed.2010.06.028; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Stefan MS, 2013, J GEN INTERN MED, V28, P377, DOI 10.1007/s11606-012-2229-8; van Walraven C, 2011, CAN MED ASSOC J, V183, pE1067, DOI 10.1503/cmaj.110400	20	65	67	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 2	2015	162	11					741	749		10.7326/M14-2159	http://dx.doi.org/10.7326/M14-2159			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ5ZH	26030632	Green Accepted			2022-12-28	WOS:000355572300001
J	Melgar, M				Melgar, Michael			Penny Wise	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									North Shore Med Associates PC, Great Neck, NY 11021 USA	Northwell Health	Melgar, M (corresponding author), North Shore Med Associates PC, Great Neck, NY 11021 USA.	mmelgar@doctormelgar.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2123	2123		10.1001/jama.2015.5487	http://dx.doi.org/10.1001/jama.2015.5487			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ4CC	26034953				2022-12-28	WOS:000355430900008
J	Benham-Pyle, BW; Pruitt, BL; Nelson, WJ				Benham-Pyle, Blair W.; Pruitt, Beth L.; Nelson, W. James			Mechanical strain induces E-cadherin-dependent Yap1 and beta-catenin activation to drive cell cycle entry	SCIENCE			English	Article							TUMOR-SUPPRESSOR; NEGATIVE REGULATOR; SIGNALING-PATHWAY; ALPHA-CATENIN; COMPLEX; GROWTH; WNT; PROLIFERATION; EXPRESSION; YAP/TAZ	Mechanical strain regulates the development, organization, and function of multicellular tissues, but mechanisms linking mechanical strain and cell-cell junction proteins to cellular responses are poorly understood. Here, we showed that mechanical strain applied to quiescent epithelial cells induced rapid cell cycle reentry, mediated by independent nuclear accumulation and transcriptional activity of first Yap1 and then beta-catenin. Inhibition of Yap1- and beta-catenin-mediated transcription blocked cell cycle reentry and progression through G(1) into S phase, respectively. Maintenance of quiescence, Yap1 nuclear exclusion, and beta-catenin transcriptional responses to mechanical strain required E-cadherin extracellular engagement. Thus, activation of Yap1 and beta-catenin may represent a master regulator of mechanical strain-induced cell proliferation, and cadherins provide signaling centers required for cellular responses to externally applied force.	[Benham-Pyle, Blair W.; Nelson, W. James] Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA; [Pruitt, Beth L.] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Pruitt, Beth L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Pruitt, Beth L.; Nelson, W. James] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Nelson, W. James] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Nelson, WJ (corresponding author), Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA.	wjnelson@stanford.edu		Benham-Pyle, Blair/0000-0003-0514-7039; Pruitt, Beth L./0000-0002-4861-2124	NSF [DGE-114747, EFRI-1136790]; NIH [EB006745, GM 35527]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615, R01GM035527, R37GM035527] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NSF Predoctoral Fellowship to B.W.B.-P. (DGE-114747) and by grants from the NSF (EFRI-1136790) to B.L.P. and W.J.N. and the NIH to B.L.P. (EB006745) and W.J.N. (GM 35527). C. S. Simmons, B. L. Pruitt, J. Y. Sim, and P. R. Bachtold filed U.S. Patent Application Serial No. 14/376,739 on "Cell Culture Strain Array Systems and Methods for Using the Same." Data reported in this paper are further detailed in the supplementary materials.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Montross WT, 2000, J CELL SCI, V113, P1759; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; Simmons CS, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054016; Streichan SJ, 2014, P NATL ACAD SCI USA, V111, P5586, DOI 10.1073/pnas.1323016111; Torre C, 2011, J HEPATOL, V55, P86, DOI 10.1016/j.jhep.2010.10.021; Troxell ML, 2000, J CELL SCI, V113, P985; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Whitehead J, 2008, HFSP J, V2, P286, DOI 10.2976/1.2955566; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	35	319	325	5	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					1024	1027		10.1126/science.aaa4559	http://dx.doi.org/10.1126/science.aaa4559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	26023140	Green Accepted			2022-12-28	WOS:000355276600046
J	Vinogradova, Y; Coupland, C; Hippisley-Cox, J				Vinogradova, Yana; Coupland, Carol; Hippisley-Cox, Julia			Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NATIONAL-SURVEY; DROSPIRENONE; WOMEN; LEVONORGESTREL; THROMBOSIS; NORGESTIMATE; CYPROTERONE; COMBINATION; VALIDATION; IMPACT	OBJECTIVE To investigate the association between use of combined oral contraceptives and risk of venous thromboembolism, taking the type of progestogen into account. DESIGN Two nested case-control studies. SETTING General practices in the United Kingdom contributing to the Clinical Practice Research Datalink (CPRD; 618 practices) and QResearch primary care database (722 practices). PARTICIPANTS Women aged 15-49 years with a first diagnosis of venous thromboembolism in 2001-13, each matched with up to five controls by age, practice, and calendar year. MAIN OUTCOME MEASURES Odds ratios for incident venous thromboembolism and use of combined oral contraceptives in the previous year, adjusted for smoking status, alcohol consumption, ethnic group, body mass index, comorbidities, and other contraceptive drugs. RESULTS were combined across the two datasets. Results 5062 cases of venous thromboembolism from CPRD and 5500 from QResearch were analysed. Current exposure to any combined oral contraceptive was associated with an increased risk of venous thromboembolism (adjusted odds ratio 2.97, 95% confidence interval 2.78 to 3.17) compared with no exposure in the previous year. Corresponding risks associated with current exposure to desogestrel (4.28, 3.66 to 5.01), gestodene (3.64, 3.00 to 4.43), drospirenone (4.12, 3.43 to 4.96), and cyproterone (4.27, 3.57 to 5.11) were significantly higher than those for second generation contraceptives levonorgestrel (2.38, 2.18 to 2.59) and norethisterone (2.56, 2.15 to 3.06), and for norgestimate (2.53, 2.17 to 2.96). The number of extra cases of venous thromboembolism per year per 10 000 treated women was lowest for levonorgestrel (6, 95% confidence interval 5 to 7) and norgestimate (6, 5 to 8), and highest for desogestrel (14, 11 to 17) and cyproterone (14, 11 to 17). CONCLUSIONS In these population based, case-control studies using two large primary care databases, risks of venous thromboembolism associated with combined oral contraceptives were, with the exception of norgestimate, higher for newer drug preparations than for second generation drugs.	[Vinogradova, Yana; Coupland, Carol; Hippisley-Cox, Julia] Div Primary Care, Nottingham NG2 7RD, England		Vinogradova, Y (corresponding author), Div Primary Care, Univ Pk, Nottingham NG2 7RD, England.	yana.vinogradova@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Vinogradova, Yana/0000-0002-3030-5257; Coupland, Carol/0000-0002-2327-3306				Bird ST, 2013, CAN MED ASSOC J, V185, pE115, DOI 10.1503/cmaj.120677; Bjerre LM, 2000, BRIT MED J, V320, P503, DOI 10.1136/bmj.320.7233.503; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Briggs PE, 2013, J FAM PLAN REPROD H, V39, P190, DOI 10.1136/jfprhc-2012-100376; Department of Economic and Social Affairs, 2013, WORLD CONTR PATT 201; Dinger JC, 2007, CONTRACEPTION, V75, P344, DOI 10.1016/j.contraception.2006.12.019; Dunn N, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2519; Eastwood BJ, 1996, INT J EPIDEMIOL, V25, P763, DOI 10.1093/ije/25.4.763; Etminan M, 2004, PHARMACOTHERAPY, V24, P1105, DOI 10.1592/phco.24.13.1105.38083; Farmer RDT, 2000, BRIT J CLIN PHARMACO, V49, P580, DOI 10.1046/j.1365-2125.2000.00198.x; Farmer RDT, 1997, LANCET, V349, P83, DOI 10.1016/S0140-6736(96)07496-X; French RS, 2009, J FAM PLAN REPROD H, V35, P9, DOI 10.1783/147118909787072360; Gronich N, 2011, CAN MED ASSOC J, V183, pE1319, DOI 10.1503/cmaj.110463; Heinemann K, 2011, J FAM PLAN REPROD H, V37, P132, DOI 10.1136/jfprhc-2011-14524; Heinemann LAJ, 2002, CONTRACEPTION, V65, P207, DOI 10.1016/S0010-7824(01)00309-2; Heinemann LAJ, 1997, BRIT MED J, V315, P1502, DOI 10.1136/bmj.315.7121.1502; Heinemann LAJ, 2007, CONTRACEPTION, V75, P328, DOI 10.1016/j.contraception.2006.12.018; Heinemann LAJ, 2010, CONTRACEPTION, V81, P401, DOI 10.1016/j.contraception.2009.12.014; Hippisley-Cox J, 2004, HLTH INFORMATICS J, V10, P91, DOI 10.1177/1460458204042230; Hippisley-Cox J., 2013, VALIDITY COMPLETENES; Hippisley-Cox J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003482; Hippisley-Cox J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4656; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Jick SS, 2006, CONTRACEPTION, V73, P566, DOI 10.1016/j.contraception.2006.02.002; Jick SS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2151; KUHNZ W, 1994, CONTRACEPTION, V49, P255, DOI 10.1016/0010-7824(94)90043-4; Lader D, 2009, 41 NHS INF CTR HLTH; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Lawrenson R, 2000, CONTRACEPTION, V62, p21S, DOI 10.1016/S0010-7824(00)00147-5; Lewis MA, 1999, HUM REPROD, V14, P1493, DOI 10.1093/humrep/14.6.1493; Lewis MA, 1996, CONTRACEPTION, V54, P5, DOI 10.1016/0010-7824(96)00112-6; Lidegaard O, 2012, ACTA OBSTET GYN SCAN, V91, P769, DOI 10.1111/j.1600-0412.2012.01444.x; Lidegaard O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6423; Lindqvist PG, 2009, BRIT J HAEMATOL, V144, P234, DOI 10.1111/j.1365-2141.2008.07460.x; National Institute for Health and Care Excellence, 2012, NHS EV; Parker C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4245; Parkin L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2139; POULTER NR, 1995, LANCET, V346, P1575; ROTHMAN KJ, 1988, INT J EPIDEMIOL, V17, P955, DOI 10.1093/ije/17.4.955; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Seaman HE, 2004, PHARMACOEPIDEM DR S, V13, P427, DOI 10.1002/pds.896; Seeger JD, 2007, OBSTET GYNECOL, V110, P587, DOI 10.1097/01.AOG.0000279448.62221.a8; Stegeman BH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5298; Sultan AA, 2012, BRIT J HAEMATOL, V156, P366, DOI 10.1111/j.1365-2141.2011.08956.x; The Health and Social Care Information Centre, 2005, NHS CONTR SERV ENGL; van Hylckama Vlieg A, 2009, BMJ, V339, pb2921, DOI 10.1136/bmj.b2921; Vasilakis-Scaramozza C, 2001, LANCET, V358, P1427, DOI 10.1016/S0140-6736(01)06522-9; Vaughan B, 2008, CONTRACEPTION, V78, P271, DOI 10.1016/j.contraception.2008.05.007; Vinogradova Y, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004499; White RH, 1998, ANN INTERN MED, V128, P737, DOI 10.7326/0003-4819-128-9-199805010-00006	50	119	129	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2015	350								h2135	10.1136/bmj.h2135	http://dx.doi.org/10.1136/bmj.h2135			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0AF	26013557	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000355132600002
J	Eberl, G; Colonna, M; Di Santo, JP; McKenzie, ANJ				Eberl, Gerard; Colonna, Marco; Di Santo, James P.; McKenzie, Andrew N. J.			Innate lymphoid cells: A new paradigm in immunology	SCIENCE			English	Review							ROR-GAMMA-T; NATURAL-KILLER-CELLS; TISSUE-INDUCER CELLS; NK CELLS; INTESTINAL HOMEOSTASIS; TYPE-2 IMMUNITY; RETINOIC-ACID; B-CELL; LUNG INFLAMMATION; INTERFERON-GAMMA	Innate lymphoid cells (ILCs) are a growing family of immune cells that mirror the phenotypes and functions of T cells. However, in contrast to T cells, ILCs do not express acquired antigen receptors or undergo clonal selection and expansion when stimulated. Instead, ILCs react promptly to signals from infected or injured tissues and produce an array of secreted proteins termed cytokines that direct the developing immune response into one that is adapted to the original insult. The complex cross-talk between microenvironment, ILCs, and adaptive immunity remains to be fully deciphered. Only by understanding these complex regulatory networks can the power of ILCs be controlled or unleashed in order to regulate or enhance immune responses in disease prevention and therapy.	[Eberl, Gerard] Inst Pasteur, Microenvironm & Immun Unit, F-75724 Paris, France; [Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Di Santo, James P.] Inst Pasteur, Innate Immun Unit, INSERM U668, F-75724 Paris, France; [McKenzie, Andrew N. J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Washington University (WUSTL); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; MRC Laboratory Molecular Biology	Eberl, G (corresponding author), Inst Pasteur, Microenvironm & Immun Unit, F-75724 Paris, France.	gerard.eberl@pasteur.fr	Eberl, Gerard/A-1160-2013; Di Santo, James P/M-4298-2014	Di Santo, James P/0000-0002-7146-1862; Colonna, Marco/0000-0001-5222-4987; Eberl, Gerard/0000-0002-1119-5638	NATIONAL CANCER INSTITUTE [R21CA167192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021255] Funding Source: NIH RePORTER; Wellcome Trust [100963/Z/13/Z] Funding Source: researchfish; MRC [MC_U105178805] Funding Source: UKRI; Medical Research Council [MC_U105178805] Funding Source: Medline; NCI NIH HHS [R21 CA167192, R21CA16719] Funding Source: Medline; NIAID NIH HHS [1U01AI095542, U01 AI095542] Funding Source: Medline; NIDCR NIH HHS [R01 DE021255, R01DE021255] Funding Source: Medline; Wellcome Trust [100963] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Wellcome Trust(Wellcome Trust)		Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Allen JE, 2014, SEMIN IMMUNOL, V26, P329, DOI 10.1016/j.smim.2014.06.003; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Bartlett BL, 2008, LANCET, V371, P1639, DOI 10.1016/S0140-6736(08)60702-3; Beale J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009124; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Burcelin R, 2012, SEMIN IMMUNOL, V24, P67, DOI 10.1016/j.smim.2011.11.011; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Coyle AJ, 1999, J EXP MED, V190, P895, DOI 10.1084/jem.190.7.895; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Doherty TA, 2014, J ALLERGY CLIN IMMUN, V133, P1203, DOI 10.1016/j.jaci.2013.12.1086; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Eberl G, 2005, NAT REV IMMUNOL, V5, P413, DOI 10.1038/nri1600; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2015, NAT IMMUNOL, V16, P1, DOI 10.1038/ni.3059; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Garcia-Ojeda ME, 2013, BLOOD, V121, P1749, DOI 10.1182/blood-2012-06-440065; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Gasteiger G, 2014, NAT REV IMMUNOL, V14, P631, DOI 10.1038/nri3726; Gauvreau GM, 2014, NEW ENGL J MED, V370, P2102, DOI 10.1056/NEJMoa1402895; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Glatzer T, 2013, IMMUNITY, V38, P1223, DOI 10.1016/j.immuni.2013.05.013; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hong JY, 2014, J ALLERGY CLIN IMMUN, V134, P429, DOI 10.1016/j.jaci.2014.04.020; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Hughes T, 2010, IMMUNITY, V32, P803, DOI 10.1016/j.immuni.2010.06.007; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Jiao L, 2011, J IMMUNOL, V187, P401, DOI 10.4049/jimmunol.1002519; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; KIESSLING R, 1976, J EXP MED, V143, P772, DOI 10.1084/jem.143.4.772; Kim BS, 2014, J IMMUNOL, V193, P3717, DOI 10.4049/jimmunol.1401307; Kim BS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005374; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Li J, 2014, J CLIN INVEST, V124, P3241, DOI 10.1172/JCI73742; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lloyd CM, 2013, NAT MED, V19, P976, DOI 10.1038/nm.3296; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Male V, 2014, J EXP MED, V211, P635, DOI 10.1084/jem.20132398; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McDonald KG, 2007, AM J PATHOL, V170, P1229, DOI 10.2353/ajpath.2007.060817; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; McSorley HJ, 2014, MUCOSAL IMMUNOL, V7, P1068, DOI 10.1038/mi.2013.123; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Mielke LA, 2013, J IMMUNOL, V191, P4383, DOI 10.4049/jimmunol.1301228; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nakahiro T, 2010, BIOCHEM BIOPH RES CO, V399, P416, DOI 10.1016/j.bbrc.2010.07.090; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Perry JSA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004140; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Salimi M, 2013, J EXP MED, V210, P2939, DOI 10.1084/jem.20130351; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Satoh-Takayama N, 2009, J IMMUNOL, V183, P6579, DOI 10.4049/jimmunol.0901935; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Seillet C, 2014, J EXP MED, V211, P1733, DOI 10.1084/jem.20140145; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Songhet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022459; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Unanue ER, 1996, RES IMMUNOL, V147, P499, DOI 10.1016/S0923-2494(97)85214-5; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Vicente-Suarez I, 2015, MUCOSAL IMMUNOL, V8, P141, DOI 10.1038/mi.2014.51; von Burg N, 2014, P NATL ACAD SCI USA, V111, P12835, DOI 10.1073/pnas.1406908111; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Vosshenrich CAJ, 2005, J IMMUNOL, V174, P1213, DOI 10.4049/jimmunol.174.3.1213; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Xu W, 2015, CELL REP, V10, P2043, DOI 10.1016/j.celrep.2015.02.057; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yu XF, 2013, SCIENCE, V342, P727, DOI 10.1126/science.1243884; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhang P, 2013, J IMMUNOL, V191, P726, DOI 10.4049/jimmunol.1202134	132	513	530	9	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237							aaa6566	10.1126/science.aaa6566	http://dx.doi.org/10.1126/science.aaa6566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999512	Green Accepted, Green Published			2022-12-28	WOS:000354877900036
J	Goldman, M; Spaeth-Rublee, B; Pincus, HA				Goldman, MatthewL.; Spaeth-Rublee, Brigitta; Pincus, Harold Alan			Quality Indicators for Physical and Behavioral Health Care Integration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Goldman, MatthewL.; Spaeth-Rublee, Brigitta; Pincus, Harold Alan] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA; [Goldman, MatthewL.; Spaeth-Rublee, Brigitta; Pincus, Harold Alan] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Goldman, MatthewL.; Pincus, Harold Alan] New York Presbyterian Hosp, New York, NY USA	Columbia University; New York State Psychiatry Institute; NewYork-Presbyterian Hospital	Pincus, HA (corresponding author), Columbia Univ Coll Phys & Surg, Dept Psychiat, NewYork Presbyterian Hosp, 1051 Riverside Dr,Unit 09, New York, NY 10032 USA.	pincush@nyspi.columbia.edu			NCRR NIH HHS [UL1 RR024156-06] Funding Source: Medline; NIMH NIH HHS [R25 MH086466] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH086466] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Blumenthal D, 2015, JAMA-J AM MED ASSOC, V313, P1901, DOI 10.1001/jama.2015.4862; BOYD C, CLARIFYING MULTIMORB; Hines AL, 2006, CONDITIONS LARGEST N; Institute of Medicine (US) Committee on Crossing the Quality Chasm, QUAL HLTH CAR MENT S; National Association of State Mental Health Program Directors (NASMHPD) Medical Directors Council, MORBIDITY MORTALITY; National Quality Forum, MEAS REP TOOLS; Unutzer JHH, COLLABORATIVE CARE M; World Health Organization, 2003, INV MENT HLTH	8	29	29	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2015	314	8					769	770		10.1001/jama.2015.6447	http://dx.doi.org/10.1001/jama.2015.6447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP6SA	26043185	Green Accepted			2022-12-28	WOS:000360017200012
J	D'Cruz, AK; Vaish, R; Kapre, N; Dandekar, M; Gupta, S; Hawaldar, R; Agarwal, JP; Pantvaidya, G; Chaukar, D; Deshmukh, A; Kane, S; Arya, S; Ghosh-Laskar, S; Chaturvedi, P; Pai, P; Nair, S; Nair, D; Badwe, R				D'Cruz, Anil K.; Vaish, Richa; Kapre, Neeti; Dandekar, Mitali; Gupta, Sudeep; Hawaldar, Rohini; Agarwal, Jai Prakash; Pantvaidya, Gouri; Chaukar, Devendra; Deshmukh, Anuja; Kane, Shubhada; Arya, Supreeta; Ghosh-Laskar, Sarbani; Chaturvedi, Pankaj; Pai, Prathamesh; Nair, Sudhir; Nair, Deepa; Badwe, Rajendra		Head Neck Dis Management Grp	Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SQUAMOUS-CELL CARCINOMA; TONGUE CANCER; N0 NECK; CAVITY CANCERS; MANAGEMENT; SURVIVAL; T1/T2; TRIAL; HEAD	BACKGROUND Whether patients with early-stage oral cancers should be treated with elective neck dissection at the time of the primary surgery or with therapeutic neck dissection after nodal relapse has been a matter of debate. METHODS In this prospective, randomized, controlled trial, we evaluated the effect on survival of elective node dissection (ipsilateral neck dissection at the time of the primary surgery) versus therapeutic node dissection (watchful waiting followed by neck dissection for nodal relapse) in patients with lateralized stage T1 or T2 oral squamous-cell carcinomas. Primary and secondary end points were overall survival and disease-free survival, respectively. RESULTS Between 2004 and 2014, a total of 596 patients were enrolled. As prespecified by the data and safety monitoring committee, this report summarizes results for the first 500 patients (245 in the elective-surgery group and 255 in the therapeutic-surgery group), with a median follow-up of 39 months. There were 81 recurrences and 50 deaths in the elective-surgery group and 146 recurrences and 79 deaths in the therapeutic-surgery group. At 3 years, elective node dissection resulted in an improved rate of overall survival (80.0%; 95% confidence interval [CI], 74.1 to 85.8), as compared with therapeutic dissection (67.5%; 95% CI, 61.0 to 73.9), for a hazard ratio for death of 0.64 in the elective-surgery group (95% CI, 0.45 to 0.92; P = 0.01 by the log-rank test). At that time, patients in the elective-surgery group also had a higher rate of disease-free survival than those in the therapeutic-surgery group (69.5% vs. 45.9%, P < 0.001). Elective node dissection was superior in most subgroups without significant interactions. Rates of adverse events were 6.6% and 3.6% in the elective-surgery group and the therapeutic-surgery group, respectively. CONCLUSIONS Among patients with early-stage oral squamous-cell cancer, elective neck dissection resulted in higher rates of overall and disease-free survival than did therapeutic neck dissection. (Funded by the Tata Memorial Centre; ClinicalTrials. gov number, NCT00193765.)	[D'Cruz, Anil K.; Vaish, Richa; Kapre, Neeti; Dandekar, Mitali; Pantvaidya, Gouri; Chaukar, Devendra; Deshmukh, Anuja; Chaturvedi, Pankaj; Pai, Prathamesh; Nair, Sudhir; Nair, Deepa] Tata Mem Hosp, Head & Neck Serv, Bombay 400012, Maharashtra, India; [Gupta, Sudeep] Tata Mem Hosp, Dept Med Oncol, Adv Ctr Treatment Res & Educ Canc, Bombay 400012, Maharashtra, India; [Hawaldar, Rohini] Tata Mem Hosp, Clin Res Secretariat, Bombay 400012, Maharashtra, India; [Agarwal, Jai Prakash; Ghosh-Laskar, Sarbani] Tata Mem Hosp, Dept Radiat Oncol, Bombay 400012, Maharashtra, India; [Kane, Shubhada] Tata Mem Hosp, Dept Head Cytol, Bombay 400012, Maharashtra, India; [Arya, Supreeta] Tata Mem Hosp, Dept Radiodiag, Bombay 400012, Maharashtra, India; [Badwe, Rajendra] Tata Mem Hosp, Dept Surg Oncol, Bombay 400012, Maharashtra, India	Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital	D'Cruz, AK (corresponding author), Tata Mem Hosp, Head & Neck Serv, Bombay 400012, Maharashtra, India.	docdcruz@gmail.com	Vaish, Richa/AAT-4252-2021; Teh, Muy-Teck/B-9284-2016	Teh, Muy-Teck/0000-0002-7725-8355; Nair, Sudhir V/0000-0003-4977-3779; Pai, Prathamesh/0000-0001-9989-5534; Chaturvedi, Pankaj/0000-0002-3520-1342	Tata Memorial Centre	Tata Memorial Centre	Funded by the Tata Memorial Centre; ClinicalTrials. gov number, NCT00193765.	Bradley PJ, 2011, HEAD NECK-J SCI SPEC, V33, P1060, DOI 10.1002/hed.21495; Capote A, 2007, HEAD NECK-J SCI SPEC, V29, P3, DOI 10.1002/hed.20482; Civantos FJ, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000200750.74249.79; D'Cruz AK, 2011, ORAL ONCOL, V47, P780, DOI 10.1016/j.oraloncology.2011.06.013; D'Cruz AK, 2009, HEAD NECK-J SCI SPEC, V31, P618, DOI 10.1002/hed.20988; Dunne AA, 2004, EUR ARCH OTO-RHINO-L, V261, P295, DOI 10.1007/s00405-003-0680-1; FAKIH AR, 1989, AM J SURG, V158, P309, DOI 10.1016/0002-9610(89)90122-0; Fasunla AJ, 2011, ORAL ONCOL, V47, P320, DOI 10.1016/j.oraloncology.2011.03.009; Haddadin KJ, 1999, HEAD NECK-J SCI SPEC, V21, P517, DOI 10.1002/(SICI)1097-0347(199909)21:6<517::AID-HED4>3.0.CO;2-C; Huang SF, 2008, CANCER, V112, P1066, DOI 10.1002/cncr.23278; Huang SF, 2015, LARYNGOSCOPE, V125, P128, DOI 10.1002/lary.24840; Jones HB, 2009, ORAL ONCOL, V45, P10, DOI 10.1016/j.oraloncology.2008.03.009; Keski-Santti H, 2006, ORAL ONCOL, V42, P96, DOI 10.1016/j.oraloncology.2005.06.018; KLIGERMAN J, 1994, AM J SURG, V168, P391, DOI 10.1016/S0002-9610(05)80082-0; Kramer D, 2001, J OTOLARYNGOL, V30, P283, DOI 10.2310/7070.2001.19563; LYDIATT DD, 1993, HEAD NECK-J SCI SPEC, V15, P308, DOI 10.1002/hed.2880150407; Pinsolle V., 1997, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V98, P138; Thiagarajan S, 2014, J SURG ONCOL, V109, P639, DOI 10.1002/jso.23583; van den Brekel MWM, 1999, ARCH OTOLARYNGOL, V125, P153, DOI 10.1001/archotol.125.2.153; VANDENBROUCK C, 1980, CANCER-AM CANCER SOC, V46, P386, DOI 10.1002/1097-0142(19800715)46:2<386::AID-CNCR2820460229>3.0.CO;2-9; Werning JW, 2003, ARCH OTOLARYNGOL, V129, P83, DOI 10.1001/archotol.129.1.83; Yuen APW, 2009, HEAD NECK-J SCI SPEC, V31, P765, DOI 10.1002/hed.21033; Yuen APW, 1997, HEAD NECK-J SCI SPEC, V19, P583, DOI 10.1002/(SICI)1097-0347(199710)19:7<583::AID-HED4>3.0.CO;2-3	23	597	604	4	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 6	2015	373	6					521	529		10.1056/NEJMoa1506007	http://dx.doi.org/10.1056/NEJMoa1506007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO2LM	26027881	Bronze			2022-12-28	WOS:000358987700006
J	Molloy, PJ; Telford, SR; Chowdri, HR; Lepore, TJ; Gugliotta, JL; Weeks, KE; Hewins, ME; Goethert, HK; Berardi, VP				Molloy, Philip J.; Telford, Sam R., III; Chowdri, Hanumara Ram; Lepore, Timothy J.; Gugliotta, Joseph L.; Weeks, Karen E.; Hewins, Mary Ellen; Goethert, Heidi K.; Berardi, Victor P.			Borrelia miyamotoi Disease in the Northeastern United States A Case Series	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN GRANULOCYTIC ANAPLASMOSIS; RELAPSING FEVER; LYME-DISEASE; SENSU-LATO; BURGDORFERI; MENINGOENCEPHALITIS; SURVEILLANCE; BABESIOSIS; INFECTION; GLPQ	Background: The first recognized cases of Borrelia miyamotoi disease (BMD) in North America were reported in the northeastern United States in 2013. Objective: To further describe the clinical spectrum and laboratory findings for BMD. Design: Case series. Setting: Patients presenting to primary care offices, emergency departments, or urgent care clinics in 2013 and 2014. Participants: Acutely febrile patients from the northeastern United States in whom the treating health care providers suspected and ordered testing for tick-transmitted infections. Measurements: Whole-blood polymerase chain reaction (PCR) testing was performed for the presence of specific DNA sequences of common tickborne infections (including BMD). Serologic testing for B. miyamotoi was performed using a recombinant glycerophosphodiester phosphodiesterase (rGlpQ) protein. Clinical records were analyzed to identify the major features of acute disease. Results: Among 11 515 patients tested, 97 BMD cases were identified by PCR. Most of the 51 case patients on whom clinical histories were reviewed presented with high fever, chills, marked headache, and myalgia or arthralgia. Twenty-four percent were hospitalized. Elevated liver enzyme levels, neutropenia, and thrombocytopenia were common. At presentation, 16% of patients with BMD were seropositive for IgG and/or IgM antibody to B. miyamotoi rGlpQ. Most (78%) had seropositive convalescent specimens. Symptoms resolved after treatment with doxycycline, and no chronic sequelae or symptoms were observed. Limitation: Findings were based on specimens submitted for testing to a reference laboratory, and medical records of only 51 of the 97 case patients with BMD were reviewed. Conclusion: Patients with BMD presented with nonspecific symptoms, including fever, headache, chills, myalgia, and arthralgia. Laboratory confirmation of BMD was possible by PCR on blood from acutely symptomatic patients who were seronegative at presentation. Borrelia miyamotoi disease may be an emerging tickborne infection in the northeastern United States.	[Berardi, Victor P.] IMUGEN, Reference Diagnost Div, Norwood, MA 02062 USA; Tufts Univ, Cummings Sch Vet Med, North Grafton, MA 01536 USA; Hawthorn Med Associates & South Coast Hosp Syst, New Bedford, MA 02740 USA; Nantucket Cottage Hosp, Nantucket, MA 02554 USA; Hunterdon Med Ctr, Flemington, NJ 08822 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA	Tufts University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Berardi, VP (corresponding author), IMUGEN, Reference Diagnost Div, 315 Norwood Pk South, Norwood, MA 02062 USA.	vberardi@imugen.com		Goethert, Heidi/0000-0001-5145-9047	IMUGEN; National Institutes of Health [R41 AI 078631]; Evelyn Lilly Lutz Foundation; Dorothy Harrison Egan Foundation; Tufts Innovation Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI078631] Funding Source: NIH RePORTER	IMUGEN; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Evelyn Lilly Lutz Foundation; Dorothy Harrison Egan Foundation; Tufts Innovation Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was internally funded by IMUGEN. Drs. Telford and Goethert are funded, in part, by grants from the National Institutes of Health (R41 AI 078631), the Evelyn Lilly Lutz Foundation, the Dorothy Harrison Egan Foundation, and the Tufts Innovation Institute.	Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Bacon RM, 2004, J CLIN MICROBIOL, V42, P2326, DOI 10.1128/JCM.42.5.2326-2328.2004; Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; BERARDI VP, 1988, J INFECT DIS, V158, P754, DOI 10.1093/infdis/158.4.754; BRYCESON AD, 1970, Q J MED, V39, P129; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Chowdri HR, 2013, ANN INTERN MED, V159, P21, DOI 10.7326/0003-4819-159-1-201307020-00005; Courtney JW, 2004, J CLIN MICROBIOL, V42, P3164, DOI 10.1128/JCM.42.7.3164-3168.2004; El Khoury MY, 2013, CLIN INFECT DIS, V56, pE40, DOI 10.1093/cid/cis938; Gugliotta JL, 2013, NEW ENGL J MED, V368, P240, DOI 10.1056/NEJMoa1209039; Hovius JWR, 2013, LANCET, V382, P658, DOI 10.1016/S0140-6736(13)61644-X; Johnson ST, 2013, TRANSFUSION, V53, P2644, DOI 10.1111/trf.12125; Krause PJ, 2015, CLIN MICROBIOL INFEC, V21, P631, DOI 10.1016/j.cmi.2015.02.006; Krause PJ, 2014, EMERG INFECT DIS, V20, P1183, DOI 10.3201/eid2007.131587; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Molloy PJ, 2000, CLIN INFECT DIS, V31, P42, DOI 10.1086/313920; Moritz ED, 2014, TRANSFUSION, V54, P2226, DOI 10.1111/trf.12693; Ogden NH, 2011, APPL ENVIRON MICROB, V77, P3244, DOI 10.1128/AEM.02636-10; Paddock CD, 2011, CRITICAL NEEDS GAPS, P1; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Sarksyan DS, 2012, TERAPEVT ARKH, V84, P34; Sato K, 2014, EMERG INFECT DIS, V20, P1391, DOI 10.3201/eid2008.131761; Schwan TG, 1996, J CLIN MICROBIOL, V34, P2483, DOI 10.1128/JCM.34.10.2483-2492.1996; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; STEERE AC, 1990, J INFECT DIS, V161, P1203, DOI 10.1093/infdis/161.6.1203; Tavakoli NP, 2009, NEW ENGL J MED, V360, P2099, DOI 10.1056/NEJMoa0806326; Telford SR, 2008, TICKS: BIOLOGY, DISEASE AND CONTROL, P344, DOI 10.1017/CBO9780511551802.017; Ullmann AJ, 2005, J MED ENTOMOL, V42, P1057, DOI 10.1603/0022-2585(2005)042[1057:TMAFDO]2.0.CO;2; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Young C, 2012, TRANSFUSION, V52, P1523, DOI 10.1111/j.1537-2995.2012.03612.x	30	127	129	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2					91	+		10.7326/M15-0333	http://dx.doi.org/10.7326/M15-0333			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	26053877				2022-12-28	WOS:000358407500016
J	Mochida, K; Oikawa, Y; Kimura, Y; Kirisako, H; Hirano, H; Ohsumi, Y; Nakatogawa, H				Mochida, Keisuke; Oikawa, Yu; Kimura, Yayoi; Kirisako, Hiromi; Hirano, Hisashi; Ohsumi, Yoshinori; Nakatogawa, Hitoshi			Receptor-mediated selective autophagy degrades the endoplasmic reticulum and the nucleus	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; VACUOLAR HYDROLASES; YEAST; PROTEINS; MUTANTS; RECOGNITION; DEGRADATION; DELIVERY; TRIGGERS; STRAINS	Macroautophagy (hereafter referred to as autophagy) degrades various intracellular constituents to regulate a wide range of cellular functions, and is also closely linked to several human diseases(1,2). In selective autophagy, receptor proteins recognize degradation targets and direct their sequestration by double-membrane vesicles called autophagosomes, which transport them into lysosomes or vacuoles(3). Although recent studies have shown that selective autophagy is involved in quality/quantity control of some organelles, including mitochondria and peroxisomes(4), it remains unclear how extensively it contributes to cellular organelle homeostasis. Here we describe selective autophagy of the endoplasmic reticulum (ER) and nucleus in the yeast Saccharomyces cerevisiae. We identify two novel proteins, Atg39 and Atg40, as receptors specific to these pathways. Atg39 localizes to the perinuclear ER (or the nuclear envelope) and induces autophagic sequestration of part of the nucleus. Atg40 is enriched in the cortical and cytoplasmic ER, and loads these ER subdomains into autophagosomes. Atg39-dependent autophagy of the perinuclear ER/nucleus is required for cell survival under nitrogen-deprivation conditions. Atg40 is probably the functional counterpart of FAM134B, an autophagy receptor for the ER in mammals that has been implicated in sensory neuropathy(5). Our results provide fundamental insight into the pathophysiological roles and mechanisms of 'ER-phagy' and 'nucleophagy' in other organisms.	[Mochida, Keisuke; Kirisako, Hiromi; Nakatogawa, Hitoshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268503, Japan; [Oikawa, Yu; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Kimura, Yayoi; Hirano, Hisashi] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa 2360004, Japan; [Kirisako, Hiromi; Nakatogawa, Hitoshi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Yokohama City University; Japan Science & Technology Agency (JST)	Nakatogawa, H (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268503, Japan.	hnakatogawa@bio.titech.ac.jp	Nakatogawa, Hitoshi/D-5155-2015; Ohsumi, Yoshinori/C-6449-2009	Nakatogawa, Hitoshi/0000-0002-5828-0741; Ohsumi, Yoshinori/0000-0003-2384-2166; Mochida, Keisuke/0000-0003-2090-0543	Ministry of Education, Culture, Sports, Science and Technology of Japan [25111003, 25711005, 23000015]; Grants-in-Aid for Scientific Research [25711005] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the members of our laboratory for materials, discussions, and technical and secretarial support; Biomaterial Analysis Center, Technical Department at Tokyo Institute of Technology for DNA sequencing service; T. Yoshihisa and T. Endo for providing antibodies. This work was supported in part by Grants-in-Aid for Scientific Research 25111003 (to H.N.), 25711005 (to H.N.), and 23000015 (to Y.Oh.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Brachmann CB, 1998, YEAST, V14, P115; Farre JC, 2013, EMBO REP, V14, P441, DOI 10.1038/embor.2013.40; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Hamasaki M, 2005, TRAFFIC, V6, P56, DOI 10.1111/j.1600-0854.2004.00245.x; James P, 1996, GENETICS, V144, P1425; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JONES EW, 1982, GENETICS, V102, P665; Khaminets A., 2015, NATURE; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kvam E, 2007, AUTOPHAGY, V3, P85, DOI 10.4161/auto.3586; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Mijaljica D, 2013, J CELL SCI, V126, P4325, DOI 10.1242/jcs.133090; Mochida K, 2014, FEBS LETT, V588, P3862, DOI 10.1016/j.febslet.2014.09.032; Nakatogawa H, 2012, AUTOPHAGY, V8, P177, DOI 10.4161/auto.8.2.18373; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Okamoto K, 2014, J CELL BIOL, V205, P435, DOI 10.1083/jcb.201402054; Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Schneider JL, 2014, CURR OPIN GENET DEV, V26, P16, DOI 10.1016/j.gde.2014.04.003; Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716; Shoji JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015650; SIKORSKI RS, 1989, GENETICS, V122, P19; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanaka C, 2014, J CELL BIOL, V207, P91, DOI 10.1083/jcb.201402128; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047	32	388	404	7	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					359	+		10.1038/nature14506	http://dx.doi.org/10.1038/nature14506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26040717				2022-12-28	WOS:000356425400057
J	Kling, A; Lukat, P; Almeida, DV; Bauer, A; Fontaine, E; Sordello, S; Zaburannyi, N; Herrmann, J; Wenzel, SC; Konig, C; Ammerman, NC; Barrio, MB; Borchers, K; Bordon-Pallier, F; Bronstrup, M; Courtemanche, G; Gerlitz, M; Geslin, M; Hammann, P; Heinz, DW; Hoffmann, H; Klieber, S; Kohlmann, M; Kurz, M; Lair, C; Matter, H; Nuermberger, E; Tyagi, S; Fraisse, L; Grosset, JH; Lagrange, S; Muller, R				Kling, Angela; Lukat, Peer; Almeida, Deepak V.; Bauer, Armin; Fontaine, Evelyne; Sordello, Sylvie; Zaburannyi, Nestor; Herrmann, Jennifer; Wenzel, Silke C.; Koenig, Claudia; Ammerman, Nicole C.; Barrio, Maria Belen; Borchers, Kai; Bordon-Pallier, Florence; Broenstrup, Mark; Courtemanche, Gilles; Gerlitz, Martin; Geslin, Michel; Hammann, Peter; Heinz, Dirk W.; Hoffmann, Holger; Klieber, Sylvie; Kohlmann, Markus; Kurz, Michael; Lair, Christine; Matter, Hans; Nuermberger, Eric; Tyagi, Sandeep; Fraisse, Laurent; Grosset, Jacques H.; Lagrange, Sophie; Mueller, Rolf			Targeting DnaN for tuberculosis therapy using novel griselimycins	SCIENCE			English	Article							BACTERIAL SLIDING CLAMP; MYCOBACTERIUM-SMEGMATIS; REPLICATION; ORIGIN; MODEL	The discovery of Streptomyces-produced streptomycin founded the age of tuberculosis therapy. Despite the subsequent development of a curative regimen for this disease, tuberculosis remains a worldwide problem, and the emergence of multidrug-resistant Mycobacterium tuberculosis has prioritized the need for new drugs. Here we show that new optimized derivatives from Streptomyces-derived griselimycin are highly active against M. tuberculosis, both in vitro and in vivo, by inhibiting the DNA polymerase sliding clamp DnaN. We discovered that resistance to griselimycins, occurring at very low frequency, is associated with amplification of a chromosomal segment containing dnaN, as well as the ori site. Our results demonstrate that griselimycins have high translational potential for tuberculosis treatment, validate DnaN as an antimicrobial target, and capture the process of antibiotic pressure-induced gene amplification.	[Kling, Angela; Lukat, Peer; Zaburannyi, Nestor; Herrmann, Jennifer; Wenzel, Silke C.; Mueller, Rolf] Univ Saarland, Helmholtz Ctr Infect Res & Pharmaceut Biotechnol, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Microbial Nat Prod, D-66123 Saarbrucken, Germany; [Kling, Angela; Lukat, Peer; Zaburannyi, Nestor; Herrmann, Jennifer; Wenzel, Silke C.; Heinz, Dirk W.; Mueller, Rolf] German Ctr Infect Res DZIF, Partner Site Hannover Braunschweig, Hannover, Germany; [Lukat, Peer; Broenstrup, Mark; Heinz, Dirk W.] Helmholtz Ctr Infect Res HZI, D-38124 Braunschweig, Germany; [Almeida, Deepak V.; Ammerman, Nicole C.; Nuermberger, Eric; Tyagi, Sandeep; Grosset, Jacques H.] Johns Hopkins Univ, Ctr TB Res, Sch Med, Baltimore, MD 21231 USA; [Almeida, Deepak V.; Ammerman, Nicole C.; Grosset, Jacques H.] KwaZulu Natal Res Inst TB & HIV K RITH, ZA-4001 Durban, South Africa; [Bauer, Armin; Koenig, Claudia; Borchers, Kai; Broenstrup, Mark; Gerlitz, Martin; Hoffmann, Holger; Kohlmann, Markus; Kurz, Michael; Matter, Hans] Sanofi Aventis R&D, LGCR Chem, D-65926 Frankfurt, Germany; [Fontaine, Evelyne; Sordello, Sylvie; Barrio, Maria Belen; Courtemanche, Gilles; Geslin, Michel; Lair, Christine; Fraisse, Laurent; Lagrange, Sophie] Sanofi Aventis R&D, Infect Dis Therapeut Strateg Unit, F-31036 Toulouse, France; [Bordon-Pallier, Florence] Sanofi Aventis R&D, Strategy Sci Policy & External Innovat S&I, F-75008 Paris, France; [Hammann, Peter] Sanofi Aventis R&D, Infect Dis Therapeut Strateg Unit, D-65926 Frankfurt, Germany; [Klieber, Sylvie] Sanofi Aventis R&D, Disposit Safety & Anim Res, F-34184 Montpellier, France	Helmholtz Association; Saarland University; German Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Johns Hopkins University; Sanofi-Aventis; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi-Aventis; Sanofi France	Muller, R (corresponding author), Univ Saarland, Helmholtz Ctr Infect Res & Pharmaceut Biotechnol, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Microbial Nat Prod, D-66123 Saarbrucken, Germany.	rolf.mueller@helmholtz-hzi.de	Müller, Rolf/B-1559-2008; Brönstrup, Mark/AAP-7598-2020	Müller, Rolf/0000-0002-1042-5665; Brönstrup, Mark/0000-0002-8971-7045; Courtemanche, Gilles/0000-0002-4887-9961; Ammerman, Nicole C./0000-0001-9359-9144; Herrmann, Jennifer/0000-0003-3398-9938	German Ministry for Education and Research (BMBF) [fZ031598]; Sanofi; KwaZulu-Natal Research Institute for Tuberculosis and HIV; Howard Hughes Medical Institute; Sanofi-Aventis [111937, 103671]	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Sanofi; KwaZulu-Natal Research Institute for Tuberculosis and HIV; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sanofi-Aventis(Sanofi-Aventis)	We thank the staff at beamlines P11 at PETRA III (DESY, Hamburg, Germany), X06DA at the Swiss Light Source (PSI, Villigen, Switzerland), and BL14.1 at BESSY II (Berlin, Germany) for assistance during data collection. R.M.'s research laboratory was supported by the German Ministry for Education and Research (BMBF) with grant fZ031598. Sanofi funded its contribution. D.V.A., N.C.A., and J.H.G. are supported by the KwaZulu-Natal Research Institute for Tuberculosis and HIV and the Howard Hughes Medical Institute. D.V.A., S.T., E.N., and J.H.G. were supported by two grants from Sanofi-Aventis (Amd. 14, grant 111937, and Amd. 7, grant 103671). We thank C. Wylegalla for technical assistance. We acknowledge the GMAK group at HZI for assistance with genome sequencing of bacterial mutants; S. Franzblau from the University of Illinois at Chicago for performing the in vitro MIC assays both under hypoxic conditions and with different strains of M. tuberculosis (testing agreement) and for the gift of luciferase-expressing M. tuberculosis; and P. Brodin from the Pasteur Institute, Lille, France, for the gift of GFP-expressing M. tuberculosis H37Rv. We thank A. Upton from the TB Alliance for analysis of the manuscript. The sequence of the Streptomyces sp. DSM-40835 GM biosynthetic gene cluster has been deposited in GenBank (accession number KP211414). Atomic coordinates and structure factors for the reported crystal structures have been deposited in the Protein Data Bank (identification numbers listed in table S12). A.B., E.F., S.S., M.B.B., F.B.-P., M.B., G.C., M. G., P.H., S.K., C.L., H.M., C.K., K.B., M.Ger., H.H., M.Ko., M.Ku., L.F., and S.L. are employed by Sanofi-Aventis R&D. Sanofi has filed patent applications on GM derivatives. Author contributions: A.K. performed resistance studies and DnaN expression and physicochemical analysis of the interaction of the protein with GM derivatives. P.L. performed expression of M. smegmatis DnaN and all structural biology experiments. P.L. and D.W.H. were involved in structural analyses and data interpretation. P.H. and F.B.P. identified the GM series from the Rhone-Poulenc archives. G.C., M.Ges., H.H., A. B., and E.F. designed and synthesized all GM derivatives. S.S., M. B. B., E.F., and A. B. managed the drug optimization program. S.L., M. B., and L.F. supervised the overall GM program at Sanofi. C.L. and M. B. B. designed and performed the in vitro experiments with M. tuberculosis H37Rv. S.K. and M. Ko. designed and performed the pharmacokinetic evaluations. M. Ko. and K.B. elucidated the metabolic degradation of GM and its derivatives. M.Ger. and M.Ku. performed analytics and structure confirmation of GM and its derivatives. M.Ku. and H.M. performed conformational analysis and designed models for GM derivatives with improved pharmacokinetic properties. D.V.A., N.C.A., E.N., S.T., and J.H.G. designed and performed all animal infection experiments, including associated assays, and analyzed all resulting data. N.Z. analyzed all genome data. J.H. performed activity assays and identified and analyzed resistant M. smegmatis strains. S.C.W. and C.K. identified and characterized the GM biosynthetic gene cluster. A.K., P.L., A.B., N.C.A., S.L., M.B., and R.M. conceived the studies and wrote the paper. A.K. and P.L. contributed equally to the study. All authors discussed the results and commented on the manuscript.	Aakre CD, 2013, MOL CELL, V52, P617, DOI 10.1016/j.molcel.2013.10.014; ANGEL JH, 1984, BRIT J DIS CHEST, V78, P330; [Anonymous], 1964, G.B. Patent, Patent No. [966,124, 966124]; Benazet F., 1966, ANTIBIOTICS ADVANCES, P262; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bouchaudon J., 1981, Fr. Patent, Patent No. [2,469,395, 2469395]; Broenstrup M, 2013, Patent No. [WO2013053857 A2, 2013053857]; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; Burnouf DY, 2004, J MOL BIOL, V335, P1187, DOI 10.1016/j.jmb.2003.11.049; Dohrmann PR, 2005, J MOL BIOL, V350, P228, DOI 10.1016/j.jmb.2005.04.065; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Georgescu RE, 2008, P NATL ACAD SCI USA, V105, P11116, DOI 10.1073/pnas.0804754105; Grosset J, 1998, MYCOBACTERIA, VII, P51; Hartkoorn RC, 2012, EMBO MOL MED, V4, P1032, DOI 10.1002/emmm.201201689; Jolles G, 1971, GB Patent, Patent No. [1,252,553, 1252553]; Lee RE, 2014, NAT MED, V20, P152, DOI 10.1038/nm.3458; Movahedzadeh Farahnaz, 2008, V465, P217, DOI 10.1007/978-1-59745-207-6_14; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Noufflard-Guy-Loe H, 1965, Rev Tuberc Pneumol (Paris), V29, P301; Nuermberger EL, 2011, PROG RESPIR RES, V40, P145; Qin MH, 1999, GENE, V233, P121, DOI 10.1016/S0378-1119(99)00148-1; SAITO H, 1988, ZBL BAKT-INT J MED M, V268, P448; Salazar L, 2003, MICROBIOL-SGM, V149, P773, DOI 10.1099/mic.0.25832-0; Salazar L, 1996, MOL MICROBIOL, V20, P283, DOI 10.1111/j.1365-2958.1996.tb02617.x; Smith A., 1946, BMJ-BRIT MED J, V1, P278; TERLAIN B, 1969, CR ACAD SCI C CHIM, V269, P1546; TERLAIN B, 1971, B SOC CHIM FR, P2349; TERLAIN B, 1971, B SOC CHIM FR, P2357; TOYOHARA M, 1987, ANN INST PASTEUR MIC, V138, P737, DOI 10.1016/0769-2609(87)90151-7; Wijffels G, 2005, IUBMB LIFE, V57, P413, DOI 10.1080/15216540500138246; Wijffels G, 2011, J MED CHEM, V54, P4831, DOI 10.1021/jm2004333; World Health Organization, 2016, ANTIMICROBIAL RESIST; Yin Z, 2014, J MED CHEM, V57, P2799, DOI 10.1021/jm500122r	33	201	208	2	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1106	1112		10.1126/science.aaa4690	http://dx.doi.org/10.1126/science.aaa4690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045430				2022-12-28	WOS:000355590500040
J	Kamerow, D; Graham, R				Kamerow, Douglas; Graham, Robert			YANKEE DOODLING Why don't people exercise, even a little?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICAL-ACTIVITY		[Kamerow, Douglas] Georgetown Univ, Washington, DC 20057 USA; [Graham, Robert] Georgetown Univ, Ctr Policy Studies Primary Care, Family Med, Washington, DC 20057 USA	Georgetown University; Georgetown University	Kamerow, D (corresponding author), Georgetown Univ, Washington, DC 20057 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Centers for Disease Control and Prevention, 2014, FACTS PHYS ACT; Centers for Disease Control and Prevention, 2011, BEN PHYS ACT; Department of Health and Human Services Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion Division of Nutrition Physical Activity and Obesity, NUTR PHYS ACT OB DAT; Germano S., 2015, WALL STREET J; Lin JS, 2010, ANN INTERN MED, V153, P736, DOI 10.7326/0003-4819-153-11-201012070-00007; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Physical Activity Council, 2015, 2013 PART REP; Reiner M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-813; Reynolds G., 2013, NY TIMES; World Health Organization, 2014, HLTH TOP PHYS ACT	10	3	3	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2015	350								h3024	10.1136/bmj.h3024	http://dx.doi.org/10.1136/bmj.h3024			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK0UD	26043741				2022-12-28	WOS:000355919600010
J	Limardo, AJ; Worden, AZ				Limardo, Alexander J.; Worden, Alexandra Z.			MICROBIOLOGY Exclusive networks in the sea	NATURE			English	Editorial Material							BACTERIA	The identification of an exchange of nutrients and signalling molecules between a planktonic alga and a bacterium demonstrates that targeted mutualistic interactions occur across domains of life in the oceans. See Letter p.98	[Limardo, Alexander J.; Worden, Alexandra Z.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Limardo, Alexander J.; Worden, Alexandra Z.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Worden, Alexandra Z.] Canadian Inst Adv Res, Toronto, ON, Canada	University of California System; University of California Santa Cruz; Monterey Bay Aquarium Research Institute; Canadian Institute for Advanced Research (CIFAR)	Limardo, AJ (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.		Worden, Alexandra Z./AAD-6567-2019	Worden, Alexandra/0000-0002-9888-9324				Amin SA, 2015, NATURE, V522, P98, DOI 10.1038/nature14488; Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; BELL W, 1972, BIOL BULL, V143, P265, DOI 10.2307/1540052; Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; Cziczo DJ, 2013, SCIENCE, V340, P1320, DOI 10.1126/science.1234145; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Foster RA, 2011, ISME J, V5, P1484, DOI 10.1038/ismej.2011.26; Park JR, 2007, INT J SYST EVOL MICR, V57, P692, DOI 10.1099/ijs.0.64267-0; SMITH DC, 1995, DEEP-SEA RES PT II, V42, P75, DOI 10.1016/0967-0645(95)00005-B; Stefels J, 2007, BIOGEOCHEMISTRY, V83, P245, DOI 10.1007/s10533-007-9091-5; Sukumar P, 2013, PLANT CELL ENVIRON, V36, P909, DOI 10.1111/pce.12036; Thompson JA, 2015, CELL REP, V10, P1861, DOI 10.1016/j.celrep.2015.02.049; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Worden AZ, 2015, SCIENCE, V347, DOI 10.1126/science.1257594	15	6	6	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					36	37		10.1038/nature14530	http://dx.doi.org/10.1038/nature14530			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	26017309				2022-12-28	WOS:000355543400020
J	Pelechano, V; Wei, W; Steinmetz, LM				Pelechano, Vicent; Wei, Wu; Steinmetz, Lars M.			Widespread Co-translational RNA Decay Reveals Ribosome Dynamics	CELL			English	Article							GENOME-WIDE ANALYSIS; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; IN-VIVO; EUKARYOTIC TRANSLATION; NUCLEOTIDE RESOLUTION; PROTEIN TRANSLATION; SECONDARY STRUCTURE; MESSENGER-RNAS; YEAST-CELLS	It is generally assumed that mRNAs undergoing translation are protected from decay. Here, we show that mRNAs are, in fact, co-translationally degraded. This is a widespread and conserved process affecting most genes, where 5'-3' transcript degradation follows the last translating ribosome, producing an in vivo ribosomal footprint. By sequencing the ends of 5' phosphorylated mRNA degradation intermediates, we obtain a genome-wide drug-free measurement of ribosome dynamics. We identify general translation termination pauses in both normal and stress conditions. In addition, we describe novel codon-specific ribosomal pausing sites in response to oxidative stress that are dependent on the RNase Rny1. Our approach is simple and straightforward and does not require the use of translational inhibitors or in vitro RNA footprinting that can alter ribosome protection patterns.	[Pelechano, Vicent; Steinmetz, Lars M.] EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany; [Wei, Wu; Steinmetz, Lars M.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Wei, Wu; Steinmetz, Lars M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	European Molecular Biology Laboratory (EMBL); Stanford University; Stanford University	Steinmetz, LM (corresponding author), EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany.	larsms@embl.de	Wei, Wu/AAC-8285-2020; Pelechano, Vicent/A-8431-2011; Pelechano, Vicent/ABF-2597-2020	Wei, Wu/0000-0001-5643-8739; Pelechano, Vicent/0000-0002-9415-788X; Pelechano, Vicent/0000-0002-9415-788X; Steinmetz, Lars/0000-0002-3962-2865	NIH [R01 GM068717, P01 HG000205]; Deutsche Forschungsgemeinschaft [1422/3-1]; European Research Council [AdG-294542]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068717] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the L.M.S. laboratory for helpful discussions and critical comments on the manuscript. We thank P. Jacob for technical assistance, and we thank M. Petitt, A. Jones, and R. Aiyar for help with editing the manuscript. This study was technically supported by the EMBL Genomics Core Facility. This study was financially supported by the NIH (grants R01 GM068717 and P01 HG000205), Deutsche Forschungsgemeinschaft (1422/3-1), and a European Research Council Advanced Investigator Grant (AdG-294542) to L.M.S.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Arava Y, 2005, NUCLEIC ACIDS RES, V33, P2421, DOI 10.1093/nar/gki331; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bentele K, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.32; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gerashchenko MV, 2012, P NATL ACAD SCI USA, V109, P17394, DOI 10.1073/pnas.1120799109; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Guydosh NR, 2014, CELL, V156, P950, DOI 10.1016/j.cell.2014.02.006; Han Y, 2014, CELL RES, V24, P842, DOI 10.1038/cr.2014.74; Harigaya Y, 2012, P NATL ACAD SCI USA, V109, P11764, DOI 10.1073/pnas.1119741109; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ito K, 2013, ANNU REV BIOCHEM, V82, P171, DOI 10.1146/annurev-biochem-080211-105026; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; KLOPOTOW.T, 1965, ARCH BIOCHEM BIOPHYS, V112, P562, DOI 10.1016/0003-9861(65)90096-2; Lareau LF, 2014, ELIFE, V3, DOI 10.7554/eLife.01257; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Letzring DP, 2010, RNA, V16, P2516, DOI 10.1261/rna.2411710; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Mortimer SA, 2014, NAT REV GENET, V15, P469, DOI 10.1038/nrg3681; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Pelechano V, 2014, NAT PROTOC, V9, P1740, DOI 10.1038/nprot.2014.121; Pelechano V, 2013, NATURE, V497, P127, DOI 10.1038/nature12121; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Roy B, 2013, TRENDS GENET, V29, P691, DOI 10.1016/j.tig.2013.09.002; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; STEVENS A, 1987, ARCH BIOCHEM BIOPHYS, V252, P339, DOI 10.1016/0003-9861(87)90040-3; Subramaniam AR, 2014, CELL, V159, P1200, DOI 10.1016/j.cell.2014.10.043; Tarrant D, 2014, CELL MOL LIFE SCI, V71, P4195, DOI 10.1007/s00018-014-1684-2; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Tuck AC, 2013, CELL, V154, P996, DOI 10.1016/j.cell.2013.07.047; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Yang JR, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001910	48	161	162	3	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1400	1412		10.1016/j.cell.2015.05.008	http://dx.doi.org/10.1016/j.cell.2015.05.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26046441	Green Accepted, Bronze			2022-12-28	WOS:000355935000018
J	Stevens, LA; Behn, MD; McGuire, JJ; Das, SB; Joughin, I; Herring, T; Shean, DE; King, MA				Stevens, Laura A.; Behn, Mark D.; McGuire, Jeffrey J.; Das, Sarah B.; Joughin, Ian; Herring, Thomas; Shean, David E.; King, Matt A.			Greenland supraglacial lake drainages triggered by hydrologically induced basal slip	NATURE			English	Article							ICE-SHEET; SURFACE MELT; ACCELERATION; MELTWATER; FLOW; DEFORMATION; GLACIER; ZONE	Water-driven fracture propagation beneath supraglacial lakes rapidly transports large volumes of surface meltwater to the base of the Greenland Ice Sheet(1). These drainage events drive transient ice-sheet acceleration(1-3) and establish conduits for additional surface-to-bed meltwater transport for the remainder of the melt season(1,4-6). Although it is well established that cracks must remain water-filled to propagate to the bed(7-9), the precise mechanisms that initiate hydro-fracture events beneath lakes are unknown. Here we show that, for a lake on the western Greenland Ice Sheet, drainage events are preceded by a 6-12 hour period of ice-sheet uplift and/or enhanced basal slip. Our observations from a dense Global Positioning System (GPS) network allow us to determine the distribution of meltwater at the ice-sheet bed before, during, and after three rapid drainages in 2011-2013, each of which generates tensile stresses that promote hydro-fracture beneath the lake. We hypothesize that these precursors are associated with the introduction of meltwater to the bed through neighbouring moulin systems (vertical conduits connecting the surface and base of the ice sheet). Our results imply that as lakes form in less crevassed, interior regions of the ice sheet(10-14), where water at the bed is currently less pervasive(5,14-16), the creation of new surface-to-bed conduits caused by lake-draining hydro-fractures may be limited.	[Stevens, Laura A.] MIT, Woods Hole Oceanog Inst, Joint Program Oceanog Appl Ocean Sci & Engn, Woods Hole, MA 02543 USA; [Behn, Mark D.; McGuire, Jeffrey J.; Das, Sarah B.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Joughin, Ian; Shean, David E.] Univ Washington, Polar Sci Ctr, Appl Phys Lab, Seattle, WA 98105 USA; [Herring, Thomas] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [King, Matt A.] Univ Tasmania, Sch Land & Food, Hobart, Tas 7001, Australia; [King, Matt A.] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution; University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); University of Tasmania; Newcastle University - UK	Stevens, LA (corresponding author), 360 Woods Hole Rd, Woods Hole, MA 02543 USA.	stevensl@mit.edu	Joughin, Ian/AAR-7778-2021; Behn, Mark D/F-5813-2012; Joughin, Ian R/A-2998-2008; King, Matt/B-4622-2008	Joughin, Ian/0000-0001-6229-679X; Behn, Mark D/0000-0002-2001-1335; Joughin, Ian R/0000-0001-6229-679X; King, Matt/0000-0001-5611-9498; Shean, David/0000-0003-3840-3860; /0000-0003-0480-8018; Herring, Thomas/0000-0002-6030-0545	National Science Foundation's Office of Polar Programs (NSF-OPP); National Aeronautics and Space Administration's (NASA's) Cryospheric Sciences Program [ARC-0520077, ARC-1023364, NNX10AI30G, ARC-0520382, ARC-1023382, NNX10AI33G]; Australian Research Council [FT110100207]; NSF [ANT-1043681]; National Science Foundation; Directorate For Geosciences [1023382] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [1023364] Funding Source: National Science Foundation	National Science Foundation's Office of Polar Programs (NSF-OPP)(National Science Foundation (NSF)); National Aeronautics and Space Administration's (NASA's) Cryospheric Sciences Program; Australian Research Council(Australian Research Council); NSF(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Support was provided by the National Science Foundation's Office of Polar Programs (NSF-OPP) and National Aeronautics and Space Administration's (NASA's) Cryospheric Sciences Program through ARC-0520077, ARC-1023364, and NNX10AI30G to S.B.D. and M.D.B., and through ARC-0520382, ARC-1023382, and NNX10AI33G to I.J. M.A.K. is a recipient of an Australian Research Council Future Fellowship (project number FT110100207). WorldView image data used for this work was provided by the Polar Geospatial Center at the University of Minnesota with support from NSF grant ANT-1043681. L.A.S. was also supported by a National Science Foundation Graduate Research Fellowship. Logistical and instrumental support was provided by UNAVCO, PASSCAL, and CH2MHILL Polar Field Services. We thank J. Carmichael, L. Kehrl, T. Moon, and K. Poinar for their assistance.	Andrews LC, 2014, NATURE, V514, P80, DOI 10.1038/nature13796; Arnold NS, 2014, CRYOSPHERE, V8, P1149, DOI 10.5194/tc-8-1149-2014; Bamber JL, 2013, CRYOSPHERE, V7, P499, DOI 10.5194/tc-7-499-2013; Bartholomew ID, 2011, EARTH PLANET SC LETT, V307, P271, DOI 10.1016/j.epsl.2011.04.014; Bartholomew I, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002220; Bevis M, 2012, P NATL ACAD SCI USA, V109, P11944, DOI 10.1073/pnas.1204664109; BUDD WF, 1989, COLD REG SCI TECHNOL, V16, P107, DOI 10.1016/0165-232X(89)90014-1; Catania GA, 2008, J GLACIOL, V54, P567, DOI 10.3189/002214308786570854; Chen G., 1998, THESIS MIT; Clason C, 2012, J GLACIOL, V58, P361, DOI 10.3189/2012JoG11J129; Das SB, 2008, SCIENCE, V320, P778, DOI 10.1126/science.1153360; Doyle SH, 2013, CRYOSPHERE, V7, P129, DOI 10.5194/tc-7-129-2013; Doyle SH, 2014, GEOPHYS RES LETT, V41, P899, DOI 10.1002/2013GL058933; Fitzpatrick AAW, 2014, CRYOSPHERE, V8, P107, DOI 10.5194/tc-8-107-2014; GLEN JW, 1955, PROC R SOC LON SER-A, V228, P519, DOI 10.1098/rspa.1955.0066; Hindmarsh RCA, 2006, PHILOS T R SOC A, V364, P1733, DOI 10.1098/rsta.2006.1797; Hobbs P. V., 1974, ICE PHYSICS, P258; Hoffman MJ, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001934; Howat IM, 2013, CRYOSPHERE, V7, P201, DOI 10.5194/tc-7-201-2013; Joughin I, 2013, CRYOSPHERE, V7, P1185, DOI 10.5194/tc-7-1185-2013; Joughin I, 2008, SCIENCE, V320, P781, DOI 10.1126/science.1153288; KAMB B, 1986, J GLACIOL, V32, P267, DOI 10.3189/S0022143000015604; KANAMORI H, 1983, TECTONOPHYSICS, V93, P185, DOI 10.1016/0040-1951(83)90273-1; Krawczynski MJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036765; Lampkin DJ, 2011, HYDROL PROCESS, V25, P3347, DOI 10.1002/hyp.8170; Leeson AA, 2015, NAT CLIM CHANGE, V5, P51, DOI [10.1038/NCLIMATE2463, 10.1038/nclimate2463]; Miyazaki S, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000456; Miyazaki S, 2011, EARTH PLANETS SPACE, V63, P637, DOI 10.5047/eps.2011.07.001; Moratto Z. M., 2010, 41 LPSC, P2364; OKADA Y, 1985, B SEISMOL SOC AM, V75, P1135; Parizek BR, 2004, QUATERNARY SCI REV, V23, P1013, DOI 10.1016/j.quascirev.2003.12.024; Pimentel S, 2011, P ROY SOC A-MATH PHY, V467, P537, DOI 10.1098/rspa.2010.0211; Poinar K, 2015, GEOPHYS RES LETT, V42, P1800, DOI 10.1002/2015GL063192; Price SF, 2008, J GLACIOL, V54, P213, DOI 10.3189/002214308784886117; Segall P, 1997, J GEOPHYS RES-SOL EA, V102, P22391, DOI 10.1029/97JB01795; Selmes N, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047872; Sergienko OV, 2013, J GLACIOL, V59, P3, DOI 10.3189/2013JoG12J040; Smith LC, 2015, P NATL ACAD SCI USA, V112, P1001, DOI 10.1073/pnas.1413024112; Sundal AV, 2009, REMOTE SENS ENVIRON, V113, P2164, DOI 10.1016/j.rse.2009.05.018; Tedesco M, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034007; Tsai VC, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001474; van Angelen JH, 2014, SURV GEOPHYS, V35, P1155, DOI 10.1007/s10712-013-9261-z; van der Veen CJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028385; van der Veen CJ, 1998, COLD REG SCI TECHNOL, V27, P31, DOI 10.1016/S0165-232X(97)00022-0; Weertman, 1973, IASH PUBL, V95, P139; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	46	67	68	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					73	U163		10.1038/nature14480	http://dx.doi.org/10.1038/nature14480			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	26040890	Green Published			2022-12-28	WOS:000355543400031
J	Bowes, L; Joinson, C; Wolke, D; Lewis, G				Bowes, Lucy; Joinson, Carol; Wolke, Dieter; Lewis, Glyn			Peer victimisation during adolescence and its impact on depression in early adulthood: prospective cohort study in the United Kingdom	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BULLYING VICTIMIZATION; SUICIDAL IDEATION; SCHOOL CHILDREN; CHILDHOOD; OUTCOMES; ASSOCIATION; MODERATORS; SYMPTOMS; STRESS; RISK	OBJECTIVE To investigate the strength of the association between victimisation by peers at age 13 years and depression at 18 years. DESIGN Longitudinal observational study. SETTING Avon Longitudinal Study of Parents and Children, a UK community based birth cohort. PARTICIPANTS 6719 participants who reported on peer victimisation at age 13 years. MAIN OUTCOME MEASURES Depression defined according to international classification of diseases, 10th revision (ICD-10) criteria, assessed using the clinical interview schedule-revised during clinic assessments with participants when they were aged 18 years. 3898 participants had data on both victimisation by peers at age 13 years and depression at age 18 years. RESULTS Of the 683 participants who reported frequent victimisation at age 13 years, 101 (14.8%) were depressed according to ICD-10 criteria at 18 years; of the 1446 participants reporting some victimisation at age 13 years, 103 (7.1%) were depressed at age 18 years; and of the 1769 participants reporting no victimisation at age 13 years, 98 (5.5%) were depressed at age 18 years. Compared with children who were not victimised those who were frequently victimised by peers had over a twofold increase in odds of depression (odds ratio 2.96, 95% confidence interval 2.21 to 3.97, P<0.001). This association was slightly reduced when adjusting for confounders (2.32, 1.49 to 3.63, P<0.001). The population attributable fraction suggested that 29.2% (95% confidence interval 10.9% to 43.7%) of depression at age 18 years could be explained by peer victimisation if this were a causal relation. CONCLUSION When using observational data it is impossible to be certain that associations are causal. However, our results are consistent with the hypothesis that victimisation by peers in adolescence is associated with an increase in the risk of developing depression as an adult.	[Bowes, Lucy] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Joinson, Carol] Univ Bristol, Sch Social & Community Med, Ctr Acad Mental Hlth, Bristol, Avon, England; [Wolke, Dieter] Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England; [Wolke, Dieter] Univ Warwick, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England; [Lewis, Glyn] UCL, Fac Brain Sci, Div Psychiat, London, England	University of Oxford; University of Bristol; University of Warwick; University of Warwick; University of London; University College London	Bowes, L (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	lucy.bowes@psy.ox.ac.uk	Wolke, Dieter/C-5372-2008; Lewis, Glyn/E-9944-2012	Wolke, Dieter/0000-0003-0304-268X; Lewis, Glyn/0000-0001-5205-8245; Joinson, Carol/0000-0002-5651-097X; Bowes, Lucy/0000-0001-5645-3875	Wellcome Trust [092731, 084268/Z/07/Z]; University of Bristol; Jacobs Foundation; Leverhulme Trust; Economic and Social Research Council [ES/K003593/1]; UK Medical Research Council; ESRC [ES/K003593/1] Funding Source: UKRI; Medical Research Council [MC_PC_15018] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; Jacobs Foundation; Leverhulme Trust(Leverhulme Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council and the Wellcome Trust (grant reference 092731) and the University of Bristol provide core support for ALSPAC. This research was specifically funded by a Wellcome Trust grant held by GL (grant reference 084268/Z/07/Z). LB was partly supported by a grant from the Jacobs Foundation, and is supported by a Leverhulme Trust Early Career Fellowship; DW was partly supported by grant ES/K003593/1 of the Economic and Social Research Council.	Angold A, 1995, INT J METHOD PSYCH, V5, P237; Arseneault L, 2008, ARCH PEDIAT ADOL MED, V162, P145, DOI 10.1001/archpediatrics.2007.53; B, 2011, BBC NEWS; BBC, 2014, BBC; BBC News, 2013, BBC NEWS; Beckman L, 2012, EMOT BEHAV DIFFIC, V17, P421, DOI 10.1080/13632752.2012.704228; Bingham B, 2011, NEUROPSYCHOPHARMACOL, V36, P896, DOI 10.1038/npp.2010.229; Bond L, 2001, BRIT MED J, V323, P480, DOI 10.1136/bmj.323.7311.480; BOULTON MJ, 1994, BRIT J DEV PSYCHOL, V12, P315, DOI 10.1111/j.2044-835X.1994.tb00637.x; Bowes L, 2009, J AM ACAD CHILD PSY, V48, P545, DOI 10.1097/CHI.0b013e31819cb017; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Copeland WE, 2013, JAMA PSYCHIAT, P1; Copeland WE, 2013, JAMA PSYCHIAT, V70, P419, DOI 10.1001/jamapsychiatry.2013.504; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dale A, 1993, 1991 CENSUS USERS GU; Due P, 2005, EUR J PUBLIC HEALTH, V15, P128, DOI 10.1093/eurpub/cki105; Gibb SJ, 2011, J AGGRESS CONFL PEAC, V3, P82, DOI 10.1108/17596591111132891; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Hawker DSJ, 2000, J CHILD PSYCHOL PSYC, V41, P441, DOI 10.1017/S0021963099005545; Hunter SC, 2010, J CHILD PSYCHOL PSYC, V51, P1141, DOI 10.1111/j.1469-7610.2010.02253.x; Jaffee SR, 2002, J AM ACAD CHILD PSY, V41, P1095, DOI 10.1097/00004583-200209000-00010; Kaltiala-Heino R, 1999, BRIT MED J, V319, P348, DOI 10.1136/bmj.319.7206.348; Kaltiala-Heino R, 2010, EUR CHILD ADOLES PSY, V19, P45, DOI 10.1007/s00787-009-0039-2; Klomek AB, 2008, J AFFECT DISORDERS, V109, P47, DOI 10.1016/j.jad.2007.12.226; Klomek AB, 2011, SUICIDE LIFE-THREAT, V41, P501, DOI 10.1111/j.1943-278X.2011.00046.x; Kochenderfer-Ladd B, 2001, CHILD DEV, V72, P134, DOI 10.1111/1467-8624.00270; LEWIS G, 1994, J EPIDEMIOL COMMUN H, V48, P207, DOI 10.1136/jech.48.2.207; Little R.J.A., 2002, STAT ANAL MISSING DA; McLaughlin KA, 2009, J CONSULT CLIN PSYCH, V77, P894, DOI 10.1037/a0015760; Meltzer H, 2011, EUR PSYCHIAT, V26, P498, DOI 10.1016/j.eurpsy.2010.11.006; Nansel TR, 2004, ARCH PEDIAT ADOL MED, V158, P730, DOI 10.1001/archpedi.158.8.730; Olweus D, 2012, EUR J DEV PSYCHOL, V9, P520, DOI [10.1080/17405629.2012.682358, 10.1080/17405629.2012.705086]; Ouellet-Morin I, 2013, PSYCHOL MED, V43, P1813, DOI 10.1017/S0033291712002784; Ouellet-Morin I, 2011, BIOL PSYCHIAT, V70, P1016, DOI 10.1016/j.biopsych.2011.06.017; Prinstein MJ, 2004, J ABNORM CHILD PSYCH, V32, P147, DOI 10.1023/B:JACP.0000019767.55592.63; Schwartz D, 2015, J CLIN CHILD ADOLESC, V44, P393, DOI 10.1080/15374416.2014.881293; Shakoor S, 2011, J ABNORM CHILD PSYCH, V39, P379, DOI 10.1007/s10802-010-9463-5; Smith PK, 1999, EDUC RES, V41, P267, DOI 10.1080/0013188990410303; Stallard P, 2012, BMJ-BRIT MED J, V345; Stapinski LA, 2014, DEPRESS ANXIETY, V31, P574, DOI 10.1002/da.22270; Stringaris A, 2014, BRIT J PSYCHIAT, V205, P17, DOI 10.1192/bjp.bp.113.134221; Takizawa R, 2014, AM J PSYCHIAT, V171, P777, DOI 10.1176/appi.ajp.2014.13101401; Ttofi MM, 2011, J EXP CRIMINOL, V7, P27, DOI 10.1007/s11292-010-9109-1; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wolke D, 2001, BRIT J PSYCHOL, V92, P673, DOI 10.1348/000712601162419; World Health Organization, 2008, GLOB BURD DIS 2004 U; Zwierzynska K, 2012, J ABNORM CHILD PSYCH, P1	48	89	92	0	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2015	350								h2469	10.1136/bmj.h2469	http://dx.doi.org/10.1136/bmj.h2469			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK0TW	26037951	Green Published, hybrid			2022-12-28	WOS:000355918900003
J	Minisola, S; Pepe, J; Piemonte, S; Cipriani, C				Minisola, Salvatore; Pepe, Jessica; Piemonte, Sara; Cipriani, Cristiana			The diagnosis and management of hypercalcaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PRIMARY HYPERPARATHYROIDISM PROCEEDINGS; ZOLEDRONIC ACID; PREVALENCE; MALIGNANCY; EPIDEMIOLOGY; PAMIDRONATE; CLODRONATE		[Minisola, Salvatore; Pepe, Jessica; Piemonte, Sara; Cipriani, Cristiana] Univ Roma La Sapienza, Dept Internal Med & Med Disciplines, I-00161 Rome, Italy	Sapienza University Rome	Minisola, S (corresponding author), Univ Roma La Sapienza, Dept Internal Med & Med Disciplines, I-00161 Rome, Italy.	salvatore.minisola@uniroma1.it	Cipriani, Cristiana/K-9497-2016	Cipriani, Cristiana/0000-0002-0141-1202				Bilezikian JP, 2014, J CLIN ENDOCR METAB, V99, P3561, DOI 10.1210/jc.2014-1413; Carnevale V, 2004, CLIN CHEM, V50, P626, DOI 10.1373/clinchem.2003.026328; Dalemo S, 2012, SCAND J PRIM HEALTH, V30, P48; Dionisi S, 2002, MAYO CLIN PROC, V77, P866, DOI 10.4065/77.8.866; Eastell R, 2014, J CLIN ENDOCR METAB, V99, P3570, DOI 10.1210/jc.2014-1414; Gastanaga V, 2013, EUR J CANCER, V49, pS302; Grieff M, 2011, SEMIN NEPHROL, V31, P535, DOI 10.1016/j.semnephrol.2011.09.008; Horwitz MJ, 2013, PRIMER METABOLIC BON, V8, P562; Hu MI, 2014, J CLIN ENDOCR METAB, V99, P3144, DOI 10.1210/jc.2014-1001; Jameson Jl, 2012, HARRISONS PRINCIPLES, V2, P3096; Kawada K, 2005, JPN J CLIN ONCOL, V35, P28, DOI 10.1093/jjco/hyi005; Kindgen-Milles D, 2008, ASAIO J, V54, P442, DOI 10.1097/MAT.0b013e31817dc3be; Kohut B, 2010, BURNS, V36, P360, DOI 10.1016/j.burns.2009.05.001; LeGrand SB, 2008, ANN INTERN MED, V149, P259, DOI 10.7326/0003-4819-149-4-200808190-00007; Lindner G, 2013, AM J EMERG MED, V31, P657, DOI 10.1016/j.ajem.2012.11.010; Lowe H, 2011, J CLIN ENDOCR METAB, V96, P291, DOI 10.1210/jc.2010-1999; Major P, 2001, J CLIN ONCOL, V19, P558, DOI 10.1200/JCO.2001.19.2.558; Marcocci C, 2014, J CLIN ENDOCR METAB, V99, P3607, DOI 10.1210/jc.2014-1417; MCKAY C, 1993, CANCER-AM CANCER SOC, V72, P256, DOI 10.1002/1097-0142(19930701)72:1<256::AID-CNCR2820720145>3.0.CO;2-D; MINISOLA S, 1993, BONE, V14, P703, DOI 10.1016/8756-3282(93)90199-K; Minisola S, 2015, PARATHYROIDS: BASIC AND CLINICAL CONCEPTS, 3RD EDITION, P617, DOI 10.1016/B978-0-12-397166-1.00042-4; Minisola S, 2014, J ENDOCRINOL INVEST, V37, P413, DOI 10.1007/s40618-014-0060-2; National Cancer Institute, 2013, CANCER; PUROHIT OP, 1995, BRIT J CANCER, V72, P1289, DOI 10.1038/bjc.1995.502; Reagan P, 2014, AM J KIDNEY DIS, V63, P141, DOI 10.1053/j.ajkd.2013.06.025; Roemer-Becuwe C, 2003, J PAIN SYMPTOM MANAG, V26, P843, DOI 10.1016/S0885-3924(03)00252-5; Sato Y, 2005, MOVEMENT DISORD, V20, P1598, DOI 10.1002/mds.20658; Schwarz P, 2014, EUR J ENDOCRINOL, V171, P727, DOI 10.1530/EJE-14-0355; Silverberg SJ, 2014, J CLIN ENDOCR METAB, V99, P3580, DOI 10.1210/jc.2014-1415; Streeten EA, 2014, DIFFERENTIAL DIAGNOS, P607; Wermers RA, 2006, J BONE MINER RES, V21, P171, DOI 10.1359/JBMR.050910; Wermers RA, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.07.044; Yeh MW, 2013, J CLIN ENDOCR METAB, V98, P1122, DOI 10.1210/jc.2012-4022; Yu N, 2009, CLIN ENDOCRINOL, V71, P485, DOI 10.1111/j.1365-2265.2008.03520.x	34	90	94	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2015	350								h2723	10.1136/bmj.h2723	http://dx.doi.org/10.1136/bmj.h2723			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK0TW	26037642				2022-12-28	WOS:000355918900009
J	O'Sullivan, D; Pearce, EL				O'Sullivan, David; Pearce, Erika L.			Expanding the role of metabolism in T cells	SCIENCE			English	Editorial Material							INFECTION		[O'Sullivan, David; Pearce, Erika L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	O'Sullivan, D (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	erikapearce@path.wustl.edu						Chung HK, 2003, J BIOL CHEM, V278, P28079, DOI 10.1074/jbc.M212835200; Frebel H, 2012, J EXP MED, V209, P2485, DOI 10.1084/jem.20121015; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Okoye I, 2015, SCIENCE, V348, P995, DOI 10.1126/science.aaa7516; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740	8	19	19	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					976	977		10.1126/science.aac4997	http://dx.doi.org/10.1126/science.aac4997			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	26023125				2022-12-28	WOS:000355276600027
J	Guedes, JD; Bocinsky, RK; Butler, EE				Guedes, Jade d'Alpoim; Bocinsky, R. Kyle; Butler, Ethan E.			Comment on "Agriculture facilitated permanent human occupation of the Tibetan Plateau after 3600 BP"	SCIENCE			English	Editorial Material							GLOBALIZATION; SPREAD; CHINA	Chen et al. (Reports, 16 January 2015, p. 248) argued that early Tibetan agriculturalists pushed the limits of farming up to 4000 meters above sea level. We contend that this argument is incompatible with the growing requirements of barley. It is necessary to clearly define past crop niches to create better models for the complex history of the occupation of the plateau.	[Guedes, Jade d'Alpoim; Bocinsky, R. Kyle] Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA; [Butler, Ethan E.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Washington State University; Harvard University	Guedes, JD (corresponding author), Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA.	jade.dalpoimguedes@wsu.edu	Butler, Ethan/AAG-2034-2019	d'Alpoim Guedes, Jade/0000-0002-2627-7863; Bocinsky, R. Kyle/0000-0003-1862-3428				An CB, 2013, QUATERNARY SCI REV, V81, P148, DOI 10.1016/j.quascirev.2013.09.010; Bocinsky RK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6618; Boivin N, 2012, WORLD ARCHAEOL, V44, P452, DOI 10.1080/00438243.2012.729404; Brantingham PJ, 2013, GEOARCHAEOLOGY, V28, P413, DOI 10.1002/gea.21448; Chen FH, 2015, SCIENCE, V347, P248, DOI 10.1126/science.1259172; D'Alpoim Guedes J, 2013, THESIS HARVARD U CAM; d'Alpoim Guedes J, 2014, ARCHAEOL ANTHROP SCI, V6, P255, DOI 10.1007/s12520-013-0153-4; Guedes JD, 2014, QUATERN INT, V349, P29, DOI 10.1016/j.quaint.2014.08.003; Harlan JR, 1972, MAN SETTLEMENT URBAN, P239; HEADLAND TN, 1989, CURR ANTHROPOL, V30, P43, DOI 10.1086/203710; Jamieson RW, 2010, J ANTHROPOL ARCHAEOL, V29, P208, DOI 10.1016/j.jaa.2010.02.003; Jarvis A., 2008, CGIAR CSI SRTM 90 M, DOI DOI 10.1111/ecog.00774; Jones M, 2011, WORLD ARCHAEOL, V43, P665, DOI 10.1080/00438243.2011.624764; Menne MJ, 2012, GLOBAL HIST CLIMATOL; Stein GJ, 2002, AM ANTHROPOL, V104, P903, DOI 10.1525/aa.2002.104.3.903	15	16	17	9	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237								10.1126/science.aaa4819	http://dx.doi.org/10.1126/science.aaa4819			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI6NW	25999499				2022-12-28	WOS:000354877900028
J	Kim, JY; Evans, T				Kim, Jim Yong; Evans, Timothy			Promoting women's health for sustainable development	LANCET			English	Editorial Material									[Kim, Jim Yong; Evans, Timothy] World Bank Grp, Washington, DC 20433 USA	The World Bank	Kim, JY (corresponding author), World Bank Grp, Washington, DC 20433 USA.	president@worldbank.org						Abouzahr C, 2015, LANCET; Canning D, AFRICAS DEM IN PRESS; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Langer A, 2015, LANCET; McDonald C., 2010, SCALING NUTR WHAT WI; UN, 2012, UN REV INT C POP DEV; UN, 1995, 4 WORLD C WOM BEIJ D; United Nations Population Fund, 2015, 56 MILL NEED PROV SE; Van Luling Todd, 2015, HUFFINGTON POST 0427; WHO, 2014, NEW WHO GUID PREV CO; Workie NW, 2013, HLTH EXTENSION PROGR; World Bank Group, 2015, UPD WORLD BANK GROUP; World Bank Group, 2015, GLOB FIN FAC SUPP EV	13	4	4	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2015	386	9999					E9	E10		10.1016/S0140-6736(15)60942-4	http://dx.doi.org/10.1016/S0140-6736(15)60942-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CR5GE	26051371				2022-12-28	WOS:000361368000001
J	Atun, R				Atun, Rifat			Transitioning health systems for multimorbidity	LANCET			English	Editorial Material							REVOLUTION		Harvard Univ, Boston, MA 02115 USA	Harvard University	Atun, R (corresponding author), Harvard Univ, Boston, MA 02115 USA.	ratun@hsph.harvard.edu	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983				Atun R, 2015, LANCET, V385, P917, DOI 10.1016/S0140-6736(15)60499-8; Atun R, 2014, LANCET, V384, P937, DOI 10.1016/S0140-6736(14)61062-X; Atun R, 2014, LANCET, V384, P384, DOI 10.1016/S0140-6736(14)60728-5; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Bloom DE, 2015, LANCET, V385, P649, DOI 10.1016/S0140-6736(14)61464-1; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Global Burden of Disease Study Collaborators, 2015, LANCET; Horton R, 2014, LANCET, V383, P1620, DOI 10.1016/S0140-6736(14)60769-8; Institute of Medicine, 2014, INV GLOB HLTH SYST S	9	56	58	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2015	386	9995					721	722		10.1016/S0140-6736(14)62254-6	http://dx.doi.org/10.1016/S0140-6736(14)62254-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0LR	26063473				2022-12-28	WOS:000360287900007
J	Glassock, R; Delanaye, P; El Nahas, M				Glassock, Richard; Delanaye, Pierre; El Nahas, Meguid			An Age-Calibrated Classification of Chronic Kidney Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EPIDEMIOLOGY		[Glassock, Richard] Univ Calif Los Angeles, Geffen Sch Med, Laguna Niguel, CA 92677 USA; [Delanaye, Pierre] Univ Liege, Dept Nephrol Dialysis & Transplantat, Liege, Belgium; [El Nahas, Meguid] Global Kidney Acad, Sheffield Kidney Inst, Sheffield, S Yorkshire, England	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Liege	Glassock, R (corresponding author), Univ Calif Los Angeles, Geffen Sch Med, 8 Bethany, Laguna Niguel, CA 92677 USA.	glassock@cox.net	Delanaye, Pierre/T-4225-2019	Delanaye, Pierre/0000-0002-1480-5761				Carville S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4507; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Hoerger TJ, 2015, AM J KIDNEY DIS, V65, P403, DOI 10.1053/j.ajkd.2014.09.023; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Marks A, 2012, NEPHROL DIAL TRANSPL, V27, P65, DOI 10.1093/ndt/gfr746; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; Qaseem A, 2013, ANN INTERN MED, V159, P835, DOI 10.7326/0003-4819-159-12-201312170-00726; US Renal Data System, 2014 ANN REP; Wetzels JFM, 2008, KIDNEY INT, V73, P657, DOI 10.1038/sj.ki.5002755	10	79	82	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2015	314	6					559	560		10.1001/jama.2015.6731	http://dx.doi.org/10.1001/jama.2015.6731			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8BD	26023760	Green Published			2022-12-28	WOS:000359388600011
J	Crane, E; Bian, Q; McCord, RP; Lajoie, BR; Wheeler, BS; Ralston, EJ; Uzawa, S; Dekker, J; Meyer, BJ				Crane, Emily; Bian, Qian; McCord, Rachel Patton; Lajoie, Bryan R.; Wheeler, Bayly S.; Ralston, Edward J.; Uzawa, Satoru; Dekker, Job; Meyer, Barbara J.			Condensin-driven remodelling of X chromosome topology during dosage compensation	NATURE			English	Article							C. ELEGANS; GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; CHROMATIN INTERACTIONS; HUMAN-CELLS; HI-C; ORGANIZATION; GENOME; COMPLEX; ARCHITECTURE	The three-dimensional organization of a genome plays a critical role in regulating gene expression, yet little is known about the machinery and mechanisms that determine higher-order chromosome structure(1,2). Here we perform genome-wide chromosome conformation capture analysis, fluorescent in situ hybridization (FISH), and RNA-seq to obtain comprehensive three-dimensional (3D) maps of the Caenorhabditis elegans genome and to dissect X chromosome dosage compensation, which balances gene expression between XX hermaphrodites and XO males. The dosage compensation complex (DCC), a condensin complex, binds to both hermaphrodite X chromosomes via sequence-specific recruitment elements on X (rex sites) to reduce chromosome-wide gene expression by half(3-7). Most DCC condensin subunits also act in other condensin complexes to control the compaction and resolution of all mitotic and meiotic chromosomes(5,6). By comparing chromosome structure in wild-type and DCC-defective embryos, we show that the DCC remodels hermaphrodite X chromosomes into a sex-specific spatial conformation distinct from autosomes. Dosage-compensated X chromosomes consist of self-interacting domains (similar to 1 Mb) resembling mammalian topologically associating domains (TADs)(8,9). TADs on X chromosomes have stronger boundaries andmore regular spacing than on autosomes. Many TAD boundaries on X chromosomes coincide with the highest-affinity rex sites and become diminished or lost in DCC-defective mutants, thereby converting the topology of X to a conformation resembling autosomes. rex sites engage in DCC-dependent long-range interactions, with the most frequent interactions occurring between rex sites at DCC-dependent TAD boundaries. These results imply that the DCC reshapes the topology of X chromosomes by forming new TAD boundaries and reinforcing weak boundaries through interactions between its highest-affinity binding sites. As this model predicts, deletion of an endogenous rex site at a DCC-dependent TAD boundary using CRISPR/Cas9 greatly diminished the boundary. Thus, the DCC imposes a distinct higher-order structure onto X chromosomes while regulating gene expression chromosome-wide.	[Crane, Emily; Bian, Qian; Wheeler, Bayly S.; Ralston, Edward J.; Uzawa, Satoru; Meyer, Barbara J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Crane, Emily; Bian, Qian; Wheeler, Bayly S.; Ralston, Edward J.; Uzawa, Satoru; Meyer, Barbara J.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [McCord, Rachel Patton; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Program Syst Biol, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Massachusetts System; University of Massachusetts Worcester	Meyer, BJ (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	Job.Dekker@umassmed.edu; bjmeyer@berkeley.edu		Meyer, Barbara/0000-0002-6530-4588; McCord, Rachel/0000-0003-0010-5323; Bian, Qian/0000-0001-7022-2213	NIGMS [R01 GM030702]; NHGRI [R01 HG003143]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029668] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM100647, R01GM030702] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Mets for the computer script to analyse FISH data; A. Michel for the initial conformation experiments; D. Stalford for figures; Vincent J. Coates Genomics Sequencing Laboratory (NIHS10RR029668); and K. Brejc, T. Cline and A. Freund for manuscript comments. Research was supported in part by NIGMS grant R01 GM030702 to B.J.M. and NHGRI grant R01 HG003143 to J.D. B.J.M. is an investigator of the Howard Hughes Medical Institute.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Belton JM, 2012, METHODS, V58, P268, DOI 10.1016/j.ymeth.2012.05.001; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen H, 1996, J STRUCT BIOL, V116, P56, DOI 10.1006/jsbi.1996.0010; Chen RAJ, 2014, GENOME RES, V24, P1138, DOI 10.1101/gr.161992.113; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Csankovszki G, 2009, CURR BIOL, V19, P9, DOI 10.1016/j.cub.2008.12.006; Dawes HE, 1999, SCIENCE, V284, P1800, DOI 10.1126/science.284.5421.1800; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Jans J, 2009, GENE DEV, V23, P602, DOI 10.1101/gad.1751109; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kruesi WS, 2013, ELIFE, V2, DOI 10.7554/eLife.00808; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; McDonel P, 2006, NATURE, V444, P614, DOI 10.1038/nature05338; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Pferdehirt RR, 2011, GENE DEV, V25, P499, DOI 10.1101/gad.2016011; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sharma R, 2014, GENE DEV, V28, P2591, DOI 10.1101/gad.248864.114; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; van Berkum NL, 2009, METHODS MOL BIOL, V567, P189, DOI 10.1007/978-1-60327-414-2_13; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	38	424	430	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 9	2015	523	7559					240	U299		10.1038/nature14450	http://dx.doi.org/10.1038/nature14450			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM4ZO	26030525	Green Accepted			2022-12-28	WOS:000357695900041
J	Le, DT; Uram, JN; Wang, H; Bartlett, BR; Kemberling, H; Eyring, AD; Skora, AD; Luber, BS; Azad, NS; Laheru, D; Biedrzycki, B; Donehower, RC; Zaheer, A; Fisher, GA; Crocenzi, TS; Lee, JJ; Duffy, SM; Goldberg, RM; de la Chapelle, A; Koshiji, M; Bhaijee, F; Huebner, T; Hruban, RH; Wood, LD; Cuka, N; Pardoll, DM; Papadopoulos, N; Kinzler, KW; Zhou, S; Cornish, TC; Taube, JM; Anders, RA; Eshleman, JR; Vogelstein, B; Diaz, LA				Le, D. T.; Uram, J. N.; Wang, H.; Bartlett, B. R.; Kemberling, H.; Eyring, A. D.; Skora, A. D.; Luber, B. S.; Azad, N. S.; Laheru, D.; Biedrzycki, B.; Donehower, R. C.; Zaheer, A.; Fisher, G. A.; Crocenzi, T. S.; Lee, J. J.; Duffy, S. M.; Goldberg, R. M.; de la Chapelle, A.; Koshiji, M.; Bhaijee, F.; Huebner, T.; Hruban, R. H.; Wood, L. D.; Cuka, N.; Pardoll, D. M.; Papadopoulos, N.; Kinzler, K. W.; Zhou, S.; Cornish, T. C.; Taube, J. M.; Anders, R. A.; Eshleman, J. R.; Vogelstein, B.; Diaz, L. A., Jr.			PD-1 Blockade in Tumors with Mismatch-Repair Deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MICROSATELLITE INSTABILITY; COLORECTAL CARCINOMAS; ANTI-PD-L1 ANTIBODY; GERMLINE MUTATIONS; CLINICAL ACTIVITY; CANCER; SAFETY; DNA; LYMPHOCYTES; PREDISPOSE	BACKGROUND Somatic mutations have the potential to encode "non-self" immunogenic antigens. We hypothesized that tumors with a large number of somatic mutations due to mismatch-repair defects may be susceptible to immune checkpoint blockade. METHODS We conducted a phase 2 study to evaluate the clinical activity of pembrolizumab, an anti-programmed death 1 immune checkpoint inhibitor, in 41 patients with progressive metastatic carcinoma with or without mismatch-repair deficiency. Pembrolizumab was administered intravenously at a dose of 10 mg per kilogram of body weight every 14 days in patients with mismatch repair-deficient colorectal cancers, patients with mismatch repair-proficient colorectal cancers, and patients with mismatch repair-deficient cancers that were not colorectal. The coprimary end points were the immune-related objective response rate and the 20-week immune-related progression-free survival rate. RESULTS The immune-related objective response rate and immune-related progression-free survival rate were 40% (4 of 10 patients) and 78% (7 of 9 patients), respectively, for mismatch repair-deficient colorectal cancers and 0% (0 of 18 patients) and 11% (2 of 18 patients) for mismatch repair-proficient colorectal cancers. The median progression- free survival and overall survival were not reached in the cohort with mismatch repair-deficient colorectal cancer but were 2.2 and 5.0 months, respectively, in the cohort with mismatch repair-proficient colorectal cancer (hazard ratio for disease progression or death, 0.10 [P< 0.001], and hazard ratio for death, 0.22 [P = 0.05]). Patients with mismatch repair-deficient noncolorectal cancer had responses similar to those of patients with mismatch repair-deficient colorectal cancer (immune-related objective response rate, 71% [5 of 7 patients]; immune-related progression-free survival rate, 67% [4 of 6 patients]). Whole-exome sequencing revealed a mean of 1782 somatic mutations per tumor in mismatch repair-deficient tumors, as compared with 73 in mismatch repair-proficient tumors (P = 0.007), and high somatic mutation loads were associated with prolonged progression-free survival (P = 0.02). CONCLUSIONS This study showed that mismatch-repair status predicted clinical benefit of immune checkpoint blockade with pembrolizumab.	[Le, D. T.; Uram, J. N.; Bartlett, B. R.; Diaz, L. A., Jr.] Johns Hopkins Univ, Sch Med, Swim Across America Lab, Baltimore, MD USA; [Le, D. T.; Uram, J. N.; Wang, H.; Kemberling, H.; Eyring, A. D.; Skora, A. D.; Luber, B. S.; Azad, N. S.; Laheru, D.; Biedrzycki, B.; Donehower, R. C.; Pardoll, D. M.; Papadopoulos, N.; Kinzler, K. W.; Zhou, S.; Vogelstein, B.; Diaz, L. A., Jr.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Bartlett, B. R.; Skora, A. D.; Papadopoulos, N.; Kinzler, K. W.; Zhou, S.; Vogelstein, B.; Diaz, L. A., Jr.] Johns Hopkins Univ, Sch Med, Ludwig Ctr, Baltimore, MD USA; [Bartlett, B. R.; Skora, A. D.; Papadopoulos, N.; Kinzler, K. W.; Zhou, S.; Vogelstein, B.; Diaz, L. A., Jr.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Zaheer, A.] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Bhaijee, F.; Huebner, T.; Hruban, R. H.; Wood, L. D.; Cuka, N.; Cornish, T. C.; Taube, J. M.; Anders, R. A.; Eshleman, J. R.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Fisher, G. A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Crocenzi, T. S.] Providence Hlth & Serv, Providence Canc Ctr, Portland, OR USA; [Lee, J. J.] Univ Pittsburgh, Sch Med, Dept Med, Univ Pittsburgh Canc Inst, Pittsburgh, PA USA; [Duffy, S. M.] Bon Secours Canc Inst, Richmond, VA USA; [Goldberg, R. M.; de la Chapelle, A.] Ohio State Univ, Comprehens Canc Ctr, Div Med Oncol, James Canc Ctr, Columbus, OH 43210 USA; [Goldberg, R. M.; de la Chapelle, A.] Ohio State Univ, Comprehens Canc Ctr, Solove Res Inst, Columbus, OH 43210 USA; [Goldberg, R. M.; de la Chapelle, A.] Ohio State Univ, Comprehens Canc Ctr, Human Canc Genet Program, Columbus, OH 43210 USA; [Koshiji, M.] Merck, Kenilworth, NJ USA; [Koshiji, M.] Merck, N Wales, PA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Merck & Company	Diaz, LA (corresponding author), Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St,Rm 590, Baltimore, MD 21287 USA.	ldiaz1@jhmi.edu	Ijichi, Hideaki/V-2720-2019; Wood, Laura/ABF-1531-2020; Goldberg, Richard/O-1871-2017; Bartlett, Bjarne/AAI-7358-2021; Cornish, Toby C/A-4394-2015	Goldberg, Richard/0000-0003-3713-6895; Bartlett, Bjarne/0000-0001-8579-0379; Cornish, Toby C/0000-0002-1902-2109; Diaz, Luis/0000-0002-7079-8914	Johns Hopkins University; NATIONAL CANCER INSTITUTE [R37CA057345, R01CA067941, P50CA062924, R01CA043460, R37CA043460, R01CA057345, U01CA067941, P30CA006973, K23CA163672, P30CA016058] Funding Source: NIH RePORTER	Johns Hopkins University(Johns Hopkins University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Johns Hopkins University and others; ClinicalTrials.gov number, NCT01876511.	Agaram NP, 2010, AM J CLIN PATHOL, V133, P772, DOI 10.1309/AJCPGDDE8PLLDRCC; Alexander J, 2001, AM J PATHOL, V158, P527, DOI 10.1016/S0002-9440(10)63994-6; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; BODMER W, 1994, NAT GENET, V6, P217, DOI 10.1038/ng0394-217; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Dolcetti R, 1999, AM J PATHOL, V154, P1805, DOI 10.1016/S0002-9440(10)65436-3; ESHLEMAN JR, 1995, ONCOGENE, V10, P33; Garg K, 2009, AM J SURG PATHOL, V33, P925, DOI 10.1097/PAS.0b013e318197a046; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Goldstein J, 2014, ANN ONCOL, V25, P1032, DOI 10.1093/annonc/mdu100; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Jones S, 2002, HUM MOL GENET, V11, P2961, DOI 10.1093/hmg/11.23.2961; Jones S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7161; KIM HG, 1994, AM J PATHOL, V145, P148; Koopman M, 2009, BRIT J CANCER, V100, P266, DOI 10.1038/sj.bjc.6604867; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Lipson EJ, 2013, CLIN CANCER RES, V19, P462, DOI 10.1158/1078-0432.CCR-12-2625; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Maple JT, 2005, PANCREATOLOGY, V5, P220, DOI 10.1159/000085275; MELTZER SJ, 1994, CANCER RES, V54, P3379; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakata B, 2002, CLIN CANCER RES, V8, P2536; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Smyrk TC, 2001, CANCER, V91, P2417, DOI 10.1002/1097-0142(20010615)91:12<2417::AID-CNCR1276>3.3.CO;2-L; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Timmermann B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015661; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Williams AS, 2013, PATHOLOGY, V45, P540, DOI 10.1097/PAT.0b013e3283653307; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Yamamoto H, 2002, J GASTROENTEROL, V37, P153, DOI 10.1007/s005350200015; Young J, 2001, AM J PATHOL, V159, P2107, DOI 10.1016/S0002-9440(10)63062-3	53	5760	6017	23	521	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2015	372	26					2509	2520		10.1056/NEJMoa1500596	http://dx.doi.org/10.1056/NEJMoa1500596			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL2QD	26028255	Green Accepted			2022-12-28	WOS:000356788200007
J	Hussey, NE; Kessel, ST; Aarestrup, K; Cooke, SJ; Cowley, PD; Fisk, AT; Harcourt, RG; Holland, KN; Iverson, SJ; Kocik, JF; Flemming, JEM; Whoriskey, FG				Hussey, Nigel E.; Kessel, Steven T.; Aarestrup, Kim; Cooke, Steven J.; Cowley, Paul D.; Fisk, Aaron T.; Harcourt, Robert G.; Holland, Kim N.; Iverson, Sara J.; Kocik, John F.; Flemming, Joanna E. Mills; Whoriskey, Fred G.			Aquatic animal telemetry: A panoramic window into the underwater world	SCIENCE			English	Review							STELLER SEA LIONS; DIVING BEHAVIOR; HABITAT USE; SCIENCE TECHNOLOGIES; MOVEMENT PATTERNS; PACIFIC SALMON; JUMBO SQUID; MIGRATION; TRACKING; PHYSIOLOGY	The distribution and interactions of aquatic organisms across space and time structure our marine, freshwater, and estuarine ecosystems. Over the past decade, technological advances in telemetry have transformed our ability to observe aquatic animal behavior and movement. These advances are now providing unprecedented ecological insights by connecting animal movements with measures of their physiology and environment. These developments are revolutionizing the scope and scale of questions that can be asked about the causes and consequences of movement and are redefining how we view and manage individuals, populations, and entire ecosystems. The next advance in aquatic telemetry will be the development of a global collaborative effort to facilitate infrastructure and data sharing and management over scales not previously possible.	[Hussey, Nigel E.; Kessel, Steven T.; Fisk, Aaron T.] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; [Aarestrup, Kim] Tech Univ Denmark, Natl Inst Aquat Resources, DK-8600 Silkeborg, Denmark; [Cooke, Steven J.] Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada; [Cooke, Steven J.] Carleton Univ, Inst Environm Sci, Ottawa, ON K1S 5B6, Canada; [Cowley, Paul D.] South African Inst Aquat Biodivers, ZA-6140 Grahamstown, South Africa; [Harcourt, Robert G.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Holland, Kim N.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Iverson, Sara J.; Whoriskey, Fred G.] Dalhousie Univ, Dept Biol, Ocean Tracking Network, Halifax, NS B3H 4R2, Canada; [Kocik, John F.] Natl Ocean & Atmospher Adm Fisheries, Northeast Fisheries Sci Ctr, Orono, ME 04473 USA; [Flemming, Joanna E. Mills] Dalhousie Univ, Dept Math & Stat, Halifax, NS B3H 4R2, Canada	University of Windsor; Technical University of Denmark; Carleton University; Carleton University; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; Macquarie University; University of Hawaii System; University of Hawaii Manoa; Dalhousie University; National Oceanic Atmospheric Admin (NOAA) - USA; Dalhousie University	Iverson, SJ (corresponding author), Dalhousie Univ, Dept Biol, Ocean Tracking Network, 1355 Oxford Rd, Halifax, NS B3H 4R2, Canada.	sara.iverson@dal.ca	Holland, Kim/ABH-1490-2021; Aarestrup, Kim/AAK-9155-2021; Hussey, Nigel E/F-9699-2015; Cooke, Steven J/F-4193-2010; Kocik, John/AAV-7558-2021; Cowley, Paul/M-4264-2017	Aarestrup, Kim/0000-0001-8521-6270; Cooke, Steven J/0000-0002-5407-0659; Cowley, Paul/0000-0003-1246-4390; Iverson, Sara/0000-0003-2842-4094; Mills Flemming, Joanna/0000-0002-3517-3089; Harcourt, Robert/0000-0003-4666-2934; Kocik, John/0000-0002-1136-2870	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Financial and logistical support for this work was provided to the Ocean Tracking Network's International Scientific Advisory Committee through funding from the Canada Foundation for Innovation and the Natural Sciences and Engineering Research Council of Canada. We thank J. Landry and T. Rounds for administrative assistance in assembling the telemetry databases.	Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Arnold G., 2001, ELECT TAGS MARINE FI, P7, DOI 10.1007/978-94-017-1402-0_2; Beger M, 2010, BIOL CONSERV, V143, P565, DOI 10.1016/j.biocon.2009.11.006; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Bestley S, 2015, ECOLOGY, V96, P417, DOI 10.1890/14-0469.1; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2002, OCEANOL ACTA, V25, P255, DOI 10.1016/S0399-1784(02)01212-4; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Cheke RA, 2007, BIOSCIENCE, V57, P145, DOI 10.1641/B570209; Clark CM, 2013, J FIELD ROBOT, V30, P309, DOI 10.1002/rob.21450; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cooke SJ, 2008, FISHERIES, V33, P321, DOI 10.1577/1548-8446-33.7.321; Cooke SJ, 2011, FISHERIES, V36, P583, DOI 10.1080/03632415.2011.633464; Cortes E, 2010, AQUAT LIVING RESOUR, V23, P25, DOI 10.1051/alr/2009044; Costa DP, 2012, ANNU REV ECOL EVOL S, V43, P73, DOI 10.1146/annurev-ecolsys-102710-145045; Crossin GT, 2007, MAR BIOL, V152, P905, DOI 10.1007/s00227-007-0741-x; Crossin GT, 2014, MAR ECOL PROG SER, V496, P1, DOI 10.3354/meps10691; Dagorn L, 2007, AQUAT LIVING RESOUR, V20, P307, DOI 10.1051/alr:2008001; Dahl K., 1917, STUDIER FORSOK ORRET; Davis RW, 2007, MAR ECOL PROG SER, V333, P291, DOI 10.3354/meps333291; Dean MJ, 2014, ICES J MAR SCI, V71, P1474, DOI 10.1093/icesjms/fsu040; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Domeier M. L., 2013, Animal Biotelemetry, V1, P1; Donaldson MR, 2014, FRONT ECOL ENVIRON, V12, P565, DOI 10.1890/130283; Evans K, 2013, DEEP-SEA RES PT II, V88-89, P1, DOI 10.1016/j.dsr2.2012.10.005; Fagan WF, 2013, ECOL LETT, V16, P1316, DOI 10.1111/ele.12165; Farmer NA, 2011, MAR ECOL PROG SER, V433, P169, DOI 10.3354/meps09198; Farrell AP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P697, DOI 10.1086/592057; Fedak MA, 2013, DEEP-SEA RES PT II, V88-89, P7, DOI 10.1016/j.dsr2.2012.07.007; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gallagher AJ, 2014, MAR ECOL PROG SER, V496, P207, DOI 10.3354/meps10490; Gilly WF, 2006, MAR ECOL PROG SER, V324, P1, DOI 10.3354/meps324001; Grist JP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048204; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Guzman HM, 2013, MAR MAMMAL SCI, V29, P629, DOI 10.1111/j.1748-7692.2012.00605.x; Halpin PN, 2006, MAR ECOL PROG SER, V316, P239, DOI 10.3354/meps316239; Harrison PM, 2013, CAN J FISH AQUAT SCI, V70, P1765, DOI 10.1139/cjfas-2013-0183; Hays GC, 2006, ECOLOGY, V87, P2647, DOI 10.1890/0012-9658(2006)87[2647:FFMOLT]2.0.CO;2; Hazen EL, 2013, NAT CLIM CHANGE, V3, P234, DOI 10.1038/NCLIMATE1686; Hazen EL, 2012, MAR ECOL PROG SER, V457, P221, DOI 10.3354/meps09857; Hindell MA, 2002, MAR ECOL PROG SER, V242, P275, DOI 10.3354/meps242275; Hobday AJ, 2010, FISH OCEANOGR, V19, P243, DOI 10.1111/j.1365-2419.2010.00540.x; Holland Kim N., 2010, Endangered Species Research, V10, P287; HOLLAND KN, 1992, NATURE, V358, P410, DOI 10.1038/358410a0; Hooker Sascha K., 2011, Endangered Species Research, V13, P203, DOI 10.3354/esr00322; Horning M, 2014, FISH B-NOAA, V112, P297, DOI 10.7755/FB.112.4.6; Huey R.B., 1991, American Naturalist, V137, P91; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Kelly RL., 2007, FORAGING SPECTRUM DI, DOI 10.2307/j.ctv2sx9gc9; Kessel ST, 2014, MAR ECOL PROG SER, V514, P175, DOI 10.3354/meps10966; Kitagawa T, 2007, FISH OCEANOGR, V16, P409, DOI 10.1111/j.1365-2419.2007.00441.x; KLIMLEY AP, 1988, J FISH BIOL, V33, P751, DOI 10.1111/j.1095-8649.1988.tb05520.x; Laidre KL, 2012, ICES J MAR SCI, V69, P1226, DOI 10.1093/icesjms/fss095; LECREN ED, 1965, J ANIM ECOL, V34, P453; Lidgard DC, 2014, MAR ECOL PROG SER, V501, P157, DOI 10.3354/meps10670; Lowther AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074348; Luo JG, 2012, MAR ECOL PROG SER, V467, P167, DOI 10.3354/meps09957; Lydersen C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015462; Maljkovic A, 2011, BIOL CONSERV, V144, P859, DOI 10.1016/j.biocon.2010.11.019; Maxwell SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019905; Metcalfe JD, 2012, PHILOS T R SOC B, V367, P1746, DOI 10.1098/rstb.2012.0017; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Miller KM, 2011, SCIENCE, V331, P214, DOI 10.1126/science.1196901; Moriarty PE, 2012, MAR ECOL PROG SER, V455, P1, DOI 10.3354/meps09783; Moyes CD, 2006, T AM FISH SOC, V135, P1389, DOI 10.1577/T05-224.1; Naito Y, 2013, FUNCT ECOL, V27, P710, DOI 10.1111/1365-2435.12083; Naylor E, 2005, SCI MAR, V69, P157, DOI 10.3989/scimar.2005.69s1157; O'Toole AC, 2012, SCI TOTAL ENVIRON, V427, P98, DOI 10.1016/j.scitotenv.2011.11.053; Padman L, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007301; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; Parsons TR, 2013, BIOL OCEANOGRAPHIC P; Payne NL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2363; Peklova I, 2012, MAR ECOL PROG SER, V467, P193, DOI 10.3354/meps09899; Pittman SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096028; Pollock KH, 2004, T AM FISH SOC, V133, P639, DOI 10.1577/T03-029.1; PRIEDE IG, 1984, FISH RES, V2, P201, DOI 10.1016/0165-7836(84)90003-1; Raymond B, 2015, ECOGRAPHY, V38, P121, DOI 10.1111/ecog.01021; Rechisky EL, 2013, P NATL ACAD SCI USA, V110, P6883, DOI 10.1073/pnas.1219910110; Renkawitz MD, 2012, T AM FISH SOC, V141, P1219, DOI 10.1080/00028487.2012.688916; Robinson SA, 2002, MAR FRESHWATER RES, V53, P1071, DOI 10.1071/MF01218; Roquet F, 2013, GEOPHYS RES LETT, V40, P6176, DOI 10.1002/2013GL058304; Rosenblatt AE, 2011, J ANIM ECOL, V80, P786, DOI 10.1111/j.1365-2656.2011.01830.x; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sadovy Y., 2011, REEF FISH SPAWNING A, V35; Schick RS, 2013, J ANIM ECOL, V82, P1300, DOI 10.1111/1365-2656.12102; Semmens JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01471; Shepard ELC, 2006, MAR ECOL PROG SER, V328, P205, DOI 10.3354/meps328205; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Skomal GB, 2009, CURR BIOL, V19, P1019, DOI 10.1016/j.cub.2009.04.019; Stramma L, 2012, NAT CLIM CHANGE, V2, P33, DOI 10.1038/NCLIMATE1304; Taylor MD, 2011, MAR BIOL, V158, P835, DOI 10.1007/s00227-010-1610-6; Thorrold SR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5274; Thums M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0477; Ueda H, 2014, MAR ECOL PROG SER, V496, P219, DOI 10.3354/meps10636; Waite JN, 2012, J EXP MAR BIOL ECOL, V416, P41, DOI 10.1016/j.jembe.2012.02.009; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; Wilson SM, 2014, BIOL CONSERV, V171, P61, DOI 10.1016/j.biocon.2014.01.020	101	747	755	12	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240							1255642	10.1126/science.1255642	http://dx.doi.org/10.1126/science.1255642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068859	Green Submitted			2022-12-28	WOS:000356011500043
J	Kays, R; Crofoot, MC; Jetz, W; Wikelski, M				Kays, Roland; Crofoot, Margaret C.; Jetz, Walter; Wikelski, Martin			Terrestrial animal tracking as an eye on life and planet	SCIENCE			English	Review							HABITAT SELECTION; TELEMETRY SYSTEM; GPS COLLARS; FINE-SCALE; MOVEMENT; DISPERSAL; POPULATION; MIGRATION; DYNAMICS; WILDLIFE	Moving animals connect our world, spreading pollen, seeds, nutrients, and parasites as they go about the their daily lives. Recent integration of high-resolution Global Positioning System and other sensors into miniaturized tracking tags has dramatically improved our ability to describe animal movement. This has created opportunities and challenges that parallel big data transformations in other fields and has rapidly advanced animal ecology and physiology. New analytical approaches, combined with remotely sensed or modeled environmental information, have opened up a host of new questions on the causes of movement and its consequences for individuals, populations, and ecosystems. Simultaneous tracking of multiple animals is leading to new insights on species interactions and, scaled up, may enable distributed monitoring of both animals and our changing environment.	[Kays, Roland] North Carolina Museum Nat Sci, Raleigh, NC 27601 USA; [Kays, Roland] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Kays, Roland; Crofoot, Margaret C.; Wikelski, Martin] Smithsonian Trop Res Inst, Balboa, Panama; [Crofoot, Margaret C.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Crofoot, Margaret C.; Wikelski, Martin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Jetz, Walter] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Jetz, Walter] Imperial Coll London, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Wikelski, Martin] Univ Konstanz, Dept Biol, Constance, Germany	University of North Carolina; North Carolina State University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Davis; Max Planck Society; Yale University; Imperial College London; University of Konstanz	Kays, R (corresponding author), North Carolina Museum Nat Sci, Raleigh, NC 27601 USA.	roland.kays@ncsu.edu	Jetz, Walter/ABF-1517-2020	Jetz, Walter/0000-0002-1971-7277; Kays, Roland/0000-0002-2947-6665	NASA [NNX11AP72G]; NSF [EF 1232442, DBI 0756920, DBI 0960550, DBI-1262600, BCS 1440755, DEB 1026764, DEB-1441737, IOS 1250895]; Direct For Biological Sciences [1262600, 1026764] Funding Source: National Science Foundation; Division Of Environmental Biology [1441737] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	B. Carlson, J. Hody, K. Mertes, and J. Perrine read a previous draft and offered constructive comments. S. Dodge helped with data for Fig. 5. Work on this study was supported by NASA Biodiversity Grant NNX11AP72G and NSF grants EF 1232442, DBI 0756920, DBI 0960550, DBI-1262600, BCS 1440755, DEB 1026764, DEB-1441737, and IOS 1250895. The range map for Fig. 1 was provided by BirdLife International and NatureServe and the photograph by M. Kaatz. M. Berger and R. Weinzierl made the animation. Photographs are courtesy of D. Brown, R. Henrik, C. Markham, M. McGaw, K. Thorup, and N. Weber.	Alba-Mejia L, 2013, INT J PRIMATOL, V34, P1281, DOI 10.1007/s10764-013-9740-6; Avgar T, 2013, ECOL MODEL, V251, P158, DOI 10.1016/j.ecolmodel.2012.12.002; Barnier F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0446; Bateman AW, 2015, J ANIM ECOL, V84, P260, DOI 10.1111/1365-2656.12267; Benhamou S, 2014, ANIM BEHAV, V90, P171, DOI 10.1016/j.anbehav.2014.01.030; Benhamou S, 2012, ECOL MODEL, V227, P112, DOI 10.1016/j.ecolmodel.2011.12.015; Benson E., 2010, WIRED WILDERNESS TEC; Bildstein KL, 2004, ORNITOL NEOTROP, V15, P83; Bohrer G, 2012, ECOL LETT, V15, P96, DOI 10.1111/j.1461-0248.2011.01713.x; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Brown DD, 2013, ANIM BIOTELEM, V1, P20, DOI DOI 10.1186/2050-3385-1-20; Cagnacci F, 2008, ENVIRON MODELL SOFTW, V23, P957, DOI 10.1016/j.envsoft.2008.01.003; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cheke RA, 2007, BIOSCIENCE, V57, P145, DOI 10.1641/B570209; Ciucci P, 2009, J WILDLIFE MANAGE, V73, P1300, DOI 10.2193/2008-510; Cochran W.W., 1985, Illinois Natural History Survey Bulletin, V33, P297; Collins C, 2011, ANIM CONSERV, V14, P474, DOI 10.1111/j.1469-1795.2011.00458.x; Cortes MC, 2013, BIOL REV, V88, P255, DOI 10.1111/j.1469-185X.2012.00250.x; Courbin N, 2014, ECOL MONOGR, V84, P265, DOI 10.1890/12-2118.1; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Creel S, 2013, ECOL EVOL, V3, P5189, DOI 10.1002/ece3.896; Crofoot MC, 2008, P NATL ACAD SCI USA, V105, P577, DOI 10.1073/pnas.0707749105; Crofoot MC, 2013, AM J PHYS ANTHROPOL, V152, P79, DOI 10.1002/ajpa.22330; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; Dettki H., 2014, INT CONGR ENV MODEL, P7; Dodge S, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-3; Donovan TM, 2011, BIOL CONSERV, V144, P2799, DOI 10.1016/j.biocon.2011.06.026; Elliot NB, 2014, J APPL ECOL, V51, P1169, DOI 10.1111/1365-2664.12282; Fagan WF, 2013, ECOL LETT, V16, P1316, DOI 10.1111/ele.12165; Fattebert J, 2013, S AFR J WILDL RES, V43, P61, DOI 10.3957/056.043.0108; Fieberg J, 2010, PHILOS T R SOC B, V365, P2233, DOI 10.1098/rstb.2010.0079; Flack A., 2015, MPIO WHITE STORK LIF, DOI [10.5441/001/1.78152p3q, DOI 10.5441/001/1.78152P3Q]; Forester JD, 2007, ECOL MONOGR, V77, P285, DOI 10.1890/06-0534; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Goetz SJ, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034013; Grant RA, 2010, J ZOOL, V281, P263, DOI 10.1111/j.1469-7998.2010.00700.x; Hanson MA, 2009, COMPUTER, V42, P58, DOI 10.1109/MC.2009.5; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Jetz W, 2009, ECOL LETT, V12, P1137, DOI 10.1111/j.1461-0248.2009.01369.x; Kays M., 2010, MOVEBANK ARCHIVE ANA; Kays R, 2011, COMPUT J, V54, P1931, DOI 10.1093/comjnl/bxr072; Kerth G, 2009, BIOL CONSERV, V142, P270, DOI 10.1016/j.biocon.2008.10.022; Killeen J, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0015-4; King AJ, 2012, CURR BIOL, V22, pR561, DOI 10.1016/j.cub.2012.05.008; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; Kojola I, 2006, J MAMMAL, V87, P281, DOI 10.1644/05-MAMM-A-061R2.1; Kranstauber B, 2011, ENVIRON MODELL SOFTW, V26, P834, DOI 10.1016/j.envsoft.2010.12.005; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Kuenzer C, 2014, INT J REMOTE SENS, V35, P6599, DOI 10.1080/01431161.2014.964349; Kummerow C, 1998, J ATMOS OCEAN TECH, V15, P809, DOI 10.1175/1520-0426(1998)015<0809:TTRMMT>2.0.CO;2; LaPoint S, 2013, LANDSCAPE ECOL, V28, P1615, DOI 10.1007/s10980-013-9910-0; Lenz J, 2011, P ROY SOC B-BIOL SCI, V278, P2257, DOI 10.1098/rspb.2010.2383; Li J., 2015, AAAI WORKSHOP; Li ZH, 2013, PROC VLDB ENDOW, V7, P157, DOI 10.14778/2732232.2732235; Long JA, 2014, J ANIM ECOL, V83, P1216, DOI 10.1111/1365-2656.12198; LORD RD, 1962, SCIENCE, V137, P39, DOI 10.1126/science.137.3523.39; Luhrs ML, 2013, BEHAV ECOL SOCIOBIOL, V67, P1731, DOI 10.1007/s00265-013-1581-y; Markham AC, 2012, ANIM BEHAV, V84, P399, DOI 10.1016/j.anbehav.2012.05.009; Matthews A, 2013, AUST MAMMAL, V35, P65, DOI 10.1071/AM12021; Middleton AD, 2013, ECOL LETT, V16, P1023, DOI 10.1111/ele.12133; Millspaugh J. J., 2012, WILDLIFE TECHNIQUES, V1, P258; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; Moorcroft P. R., 2006, MONOGR POPUL BIOL, V43, P208, DOI DOI 10.2193/2007-147; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Mosser A, 2009, ECOL LETT, V12, P1050, DOI 10.1111/j.1461-0248.2009.01359.x; Mueller T, 2014, J APPL ECOL, V51, P684, DOI 10.1111/1365-2664.12247; Murray DL, 2000, METH C CONS, P15; Nagy M, 2013, P NATL ACAD SCI USA, V110, P13049, DOI 10.1073/pnas.1305552110; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Newman S. H., 2005, MLO MED LAB OBS, V37, P20; Newman S. H., 2005, MLO MED LAB OBS, V37, P18; Newman S. H., 2005, MLO MED LAB OBS, V37, P14; Newman Scott H, 2005, MLO Med Lab Obs, V37, P10; Newman SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030636; Parmentier B, 2014, REMOTE SENS-BASEL, V6, P8639, DOI 10.3390/rs6098639; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Pettit B, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0529; Ponchon A, 2013, METHODS ECOL EVOL, V4, P143, DOI 10.1111/j.2041-210x.2012.00259.x; Potts JR, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0333; Potts JR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0231; Qian FW, 2009, J FIELD ORNITHOL, V80, P19, DOI 10.1111/j.1557-9263.2009.00201.x; Rattenborg NC, 2008, BIOL LETTERS, V4, P402, DOI 10.1098/rsbl.2008.0203; Recio MR, 2013, BIOL INVASIONS, V15, P1807, DOI 10.1007/s10530-013-0410-6; Riley SPD, 2014, CURR BIOL, V24, P1989, DOI 10.1016/j.cub.2014.07.029; Sachs G, 2013, J EXP BIOL, V216, P4222, DOI 10.1242/jeb.085209; Sapir N, 2011, BEHAV ECOL SOCIOBIOL, V65, P1353, DOI 10.1007/s00265-011-1146-x; Scantlebury DM, 2014, SCIENCE, V346, P79, DOI 10.1126/science.1256424; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Sergio F, 2014, NATURE, V515, P410, DOI 10.1038/nature13696; Shafer ABA, 2012, ECOLOGY, V93, P1317; Shamoun-Baranes J, 2011, IBIS, V153, P411, DOI 10.1111/j.1474-919X.2010.01096.x; Signer C, 2010, METHODS ECOL EVOL, V1, P75, DOI 10.1111/j.2041-210X.2009.00010.x; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Takekawa JY, 2010, AVIAN DIS, V54, P466, DOI 10.1637/8914-043009-Reg.1; Thaker M, 2011, ECOLOGY, V92, P398, DOI 10.1890/10-0126.1; Thompson DJ, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00028.1; Thurfjell H, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-4; Trierweiler C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2897; Trierweiler C, 2013, J ANIM ECOL, V82, P107, DOI 10.1111/j.1365-2656.2012.02036.x; Urbano F, 2010, PHILOS T R SOC B, V365, P2177, DOI 10.1098/rstb.2010.0081; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; van Wijk RE, 2012, OIKOS, V121, P655, DOI 10.1111/j.1600-0706.2011.20083.x; Vandenabeele SP, 2013, FRONT ECOL ENVIRON, V11, P10, DOI 10.1890/13.WB.002; Vyssotski AL, 2009, CURR BIOL, V19, P1159, DOI 10.1016/j.cub.2009.05.070; Wall J, 2014, ECOL APPL, V24, P593, DOI 10.1890/13-1971.1; Wikelski M., 2014, Disaster alert mediation using nature, Patent No. [EP20120167197 20120508, 20120167197]; Wikelski M., 2014, Patent No. [WO2013167661, 2013167661]; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487; Williams TM, 2014, SCIENCE, V346, P81, DOI 10.1126/science.1254885; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295; Wilson JW, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0620	117	765	782	34	380	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240							aaa2478	10.1126/science.aaa2478	http://dx.doi.org/10.1126/science.aaa2478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068858	Green Submitted			2022-12-28	WOS:000356011500044
J	Knouse, KA; Amon, A				Knouse, Kristin A.; Amon, Angelika			CELL BIOLOGY The micronucleus gets its big break	NATURE			English	Editorial Material							ERRORS		[Knouse, Kristin A.; Amon, Angelika] MIT, Dept Biol, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Knouse, KA (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu		Amon, Angelika/0000-0001-9837-0314; /0000-0003-0649-7428	NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493	6	7	8	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					162	163		10.1038/nature14528	http://dx.doi.org/10.1038/nature14528			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	26017308				2022-12-28	WOS:000356016700026
J	McShane, M; Mitchell, E				McShane, Martin; Mitchell, Edward			Person centred coordinated care: where does the QOF point us?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY		[McShane, Martin] NHS England, Med Directorate, Leeds LS2 7UE, W Yorkshire, England; [Mitchell, Edward] Warneford Hosp, Oxford Hlth NHS Trust, Oxford OX3 7JX, England		McShane, M (corresponding author), NHS England, Med Directorate, Leeds LS2 7UE, W Yorkshire, England.	m.mcshane@nhs.net						Checkland K, 2010, QUALITY OUTCOMES FRA, P93; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Department of Health, 2012, LONG TERM CONDITIONS; Dixon A, 2011, IMPACT QUALITY OUTCO; Dixon A., 2013, DELIVERING BETTER SE; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Gillam S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f659; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Hawkes N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6541; Health and Social Care Information Centre, 2015, NHS PAYM GEN PRACT E; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jones IR, 2013, HLTH SERV J; Kontopantelis E, 2014, BMJ-BRIT MED J; Lester H, 2010, QUAL PRIM CARE, P18103; National Voices, 2012, NARR PERS CENTR COOR; NHS England, 2014, 5 YEAR FORW VIEW; Parish E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h412; Reeves D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1717; Roland M, 2011, QUALITY OUTCOMES FRA, P8; Shohet C, 2007, SEIZURE-EUR J EPILEP, V16, P351, DOI 10.1016/j.seizure.2007.02.005; Spence D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1899; Spooner A, 2000, PRICCE PROJECT PRIMA; Starfield B, 2011, QUALITY OUTCOMES FRA, P147; Steel N, 2010, QUALITY OUTCOMES FRA, P31; Wagner E H, 1998, Eff Clin Pract, V1, P2; Walker S, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X501859; Wallace E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h176	27	10	10	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2015	350								h2540	10.1136/bmj.h2540	http://dx.doi.org/10.1136/bmj.h2540			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK7DD	26067130				2022-12-28	WOS:000356390100001
J	Novembre, J				Novembre, John			HUMAN EVOLUTION Ancient DNA steps into the language debate	NATURE			English	Editorial Material									Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago	Novembre, J (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	jnovembre@uchicago.edu						Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Anthony DW, 2007, HORSE, THE WHEEL, AND LANGUAGE: HOW BRONZE-AGE RIDERS FROM THE EURASIAN STEPPES SHAPED THE MODERN WORLD, P1; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; Brandt G, 2015, J HUM EVOL, V79, P73, DOI 10.1016/j.jhevol.2014.06.017; GIMBUTAS Marija, 1956, PREHISTORY E EUROP 1; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Mathieson I., 2015, PREPRINT AT BIORXIV; Moorjani P, 2013, AM J HUM GENET, V93, P422, DOI 10.1016/j.ajhg.2013.07.006; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Wang CL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002886	12	6	6	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					164	165		10.1038/522164a	http://dx.doi.org/10.1038/522164a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK2CI	26062506				2022-12-28	WOS:000356016700028
J	Hill, E; Goldstein, D				Hill, Eve; Goldstein, Daniel			The ADA, Disability, and Identity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hill, Eve] US Dept Justice, Washington, DC 20530 USA; [Goldstein, Daniel] Brown Goldstein & Levy, Baltimore, MD USA		Hill, E (corresponding author), US Dept Justice, Washington, DC 20530 USA.	eve.hill@usdoj.gov						Longmore PK, 2003, WHY I BURNED MY BOOK, p[204, 230]; Shapiro Joseph P., 1993, NO PITY PEOPLE DISAB	2	3	3	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2227	2228		10.1001/jama.2015.4936	http://dx.doi.org/10.1001/jama.2015.4936			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1VH	26057281				2022-12-28	WOS:000355995300014
J	Brunauer, R; Kennedy, BK				Brunauer, Regina; Kennedy, Brian K.			Progeria accelerates adult stem cell aging	SCIENCE			English	Editorial Material									[Brunauer, Regina; Kennedy, Brian K.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Brunauer, R (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	bkennedy@buckinstitute.org	Brunauer, Regina/AAA-5101-2022; Brunauer, Regina/R-7151-2019	Brunauer, Regina/0000-0001-9384-5501; Kennedy, Brian/0000-0002-5754-1874				Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Cecco M, 2013, AGING CELL, V12, P247, DOI 10.1111/acel.12047; Liu GH, 2011, NATURE, V472, P221, DOI 10.1038/nature09879; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Pegoraro G, 2009, AGING-US, V1, P1017, DOI 10.18632/aging.100106; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Singh L, 2013, STEM CELLS, V31, P607, DOI 10.1002/stem.1294; Tsurumi A, 2012, EPIGENETICS-US, V7, P680, DOI 10.4161/epi.20540; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002; Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356	12	14	15	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1093	1094		10.1126/science.aac4214	http://dx.doi.org/10.1126/science.aac4214			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045423				2022-12-28	WOS:000355590500026
J	Deutsch, C; Ferrel, A; Seibel, B; Portner, HO; Huey, RB				Deutsch, Curtis; Ferrel, Aaron; Seibel, Brad; Poertner, Hans-Otto; Huey, Raymond B.			Climate change tightens a metabolic constraint on marine habitats	SCIENCE			English	Article							OXYGEN LEVELS; FISHES; TEMPERATURE; SIZE; LIMITATION; TOLERANCE; ANIMALS; LIFE; MASS	Warming of the oceans and consequent loss of dissolved oxygen (O-2) will alter marine ecosystems, but a mechanistic framework to predict the impact of multiple stressors on viable habitat is lacking. Here, we integrate physiological, climatic, and biogeographic data to calibrate and then map a key metabolic index-the ratio of O-2 supply to resting metabolic O-2 demand-across geographic ranges of several marine ectotherms. These species differ in thermal and hypoxic tolerances, but their contemporary distributions are all bounded at the equatorward edge by a minimum metabolic index of similar to 2 to 5, indicative of a critical energetic requirement for organismal activity. The combined effects of warming and O-2 loss this century are projected to reduce the upper ocean's metabolic index by similar to 20% globally and by similar to 50% in northern high-latitude regions, forcing poleward and vertical contraction of metabolically viable habitats and species ranges.	[Deutsch, Curtis] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Ferrel, Aaron] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Seibel, Brad] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [Poertner, Hans-Otto] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Huey, Raymond B.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of Rhode Island; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Washington; University of Washington Seattle	Deutsch, C (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	cdeutsch@uw.edu	Pörtner, Hans-O./K-9429-2016; Huey, Raymond/F-1597-2010	Pörtner, Hans-O./0000-0001-6535-6575; Seibel, Brad/0000-0002-5391-0492	National Science Foundation [OCE-1419323, OCE-1458967, OCE-1459243, ID 1038016]; Gordon and Betty Moore Foundation [GBMF3775]; Polar regions and Coasts in a changing Earth System program (Alfred Wegener Institute); Direct For Biological Sciences [1641200] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Polar regions and Coasts in a changing Earth System program (Alfred Wegener Institute); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Research was supported by the National Science Foundation (grants OCE-1419323, OCE-1458967, OCE-1459243, and ID 1038016), the Gordon and Betty Moore Foundation (grant GBMF3775 to C.D.), and the Polar regions and Coasts in a changing Earth System program (Alfred Wegener Institute). We thank the originators of the laboratory physiological data used here (available in the supplementary materials) and the individual climate modeling groups (table S4) and the World Climate Research Programme for producing and making available the CMIP5 model output. The technical support of H. Frenzel and the suggestions of K. Nagy, D. Jacobs, and two anonymous reviewers are gratefully acknowledged.	Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Childress JJ, 1998, J EXP BIOL, V201, P1223; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; Friedman JR, 2012, LIMNOL OCEANOGR, V57, P1701, DOI 10.4319/lo.2012.57.6.1701; Fry F.E.J, 1947, U TORONTO STUDIES BI, V55; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; HILLS BA, 1970, RESP PHYSIOL, V9, P126, DOI 10.1016/0034-5687(70)90065-4; HOCHACHKA PW, 1990, T AM FISH SOC, V119, P622, DOI 10.1577/1548-8659(1990)119<0622:SFSACT>2.3.CO;2; Killen SS, 2010, ECOL LETT, V13, P184, DOI 10.1111/j.1461-0248.2009.01415.x; Koslow JA, 2011, MAR ECOL PROG SER, V436, P207, DOI 10.3354/meps09270; Nilsson GE, 2008, BIOL REV, V83, P173, DOI 10.1111/j.1469-185X.2008.00038.x; PIIPER J, 1971, RESP PHYSIOL, V13, P292, DOI 10.1016/0034-5687(71)90034-X; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Speakman JR, 2000, ADV ECOL RES, V30, P177; Stewart JS, 2013, DEEP-SEA RES PT II, V95, P197, DOI 10.1016/j.dsr2.2012.06.005; Verberk WCEP, 2011, ECOLOGY, V92, P1565, DOI 10.1890/10-2369.1; Woods HA, 1999, AM ZOOL, V39, P244; 2014, CLIMATE CHANGE 2014, P1133	22	376	382	7	286	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1132	1135		10.1126/science.aaa1605	http://dx.doi.org/10.1126/science.aaa1605			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045435				2022-12-28	WOS:000355590500047
J	Roehr, B				Roehr, Bob			Comfortable in their bodies: the rise of transgender care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												bobroehr@aol.com						Gates Gary J., 2011, MANY PEOPLE ARE LESB; Olson KR, 2015, PSYCHOL SCI, V26, P467, DOI 10.1177/0956797614568156	2	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 5	2015	350								h3083	10.1136/bmj.h3083	http://dx.doi.org/10.1136/bmj.h3083			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK0UI	26047624				2022-12-28	WOS:000355920200005
J	Cox, TR; Rumney, RMH; Schoof, EM; Perryman, L; Hoye, AM; Agrawal, A; Bird, D; Ab Latif, N; Forrest, H; Evans, HR; Huggins, ID; Lang, G; Linding, R; Gartland, A; Erler, JT				Cox, Thomas R.; Rumney, Robin M. H.; Schoof, Erwin M.; Perryman, Lara; Hoye, Anette M.; Agrawal, Ankita; Bird, Demelza; Ab Latif, Norain; Forrest, Hamish; Evans, Holly R.; Huggins, Iain D.; Lang, Georgina; Linding, Rune; Gartland, Alison; Erler, Janine T.			The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase	NATURE			English	Article							GENE-EXPRESSION; PROLIFERATION; RECRUITMENT; RESORPTION; RECEPTOR	Tumour metastasis is a complex process involving reciprocal interplay between cancer cells and host stroma at both primary and secondary sites, and is strongly influenced by microenvironmental factors such as hypoxia(1). Tumour-secreted proteins play a crucial role in these interactions(2-5) and present strategic therapeutic potential. Metastasis of breast cancer to the bone affects approximately 85% of patients with advanced disease and renders them largely untreatable(6). Specifically, osteolytic bone lesions, where bone is destroyed, lead to debilitating skeletal complications and increased patient morbidity and mortality(6,7). The molecular interactions governing the early events of osteolytic lesion formation are currently unclear. Here we show hypoxia to be specifically associated with bone relapse in patients with oestrogen-receptor negative breast cancer. Global quantitative analysis of the hypoxic secretome identified lysyl oxidase (LOX) as significantly associated with bone-tropism and relapse. High expression of LOX in primary breast tumours or systemic delivery of LOX leads to osteolytic lesion formation whereas silencing or inhibition of LOX activity abrogates tumour-driven osteolytic lesion formation. We identify LOX as a novel regulator of NFATc1-driven osteoclastogenesis, independent of RANK ligand, which disrupts normal bone homeostasis leading to the formation of focal pre-metastatic lesions. We show that these lesions subsequently provide a platform for circulating tumour cells to colonize and form bone metastases. Our study identifies a novel mechanism of regulation of bone homeostasis and metastasis, opening up opportunities for novel therapeutic intervention with important clinical implications.	[Cox, Thomas R.; Perryman, Lara; Hoye, Anette M.; Linding, Rune; Erler, Janine T.] Univ Copenhagen UCPH, Biotech Res & Innovat Ctr BRIC, DK-2200 Copenhagen, Denmark; [Cox, Thomas R.; Bird, Demelza; Lang, Georgina; Erler, Janine T.] Inst Canc Res, Hypoxia & Metastasis Team, Canc Res UK Tumour Cell Signalling Unit, London SW3 6JB, England; [Rumney, Robin M. H.; Agrawal, Ankita; Ab Latif, Norain; Forrest, Hamish; Evans, Holly R.; Huggins, Iain D.; Gartland, Alison] Univ Sheffield, Mellanby Ctr Bone Res, Sheffield S10 2RX, S Yorkshire, England; [Schoof, Erwin M.; Linding, Rune] Tech Univ Denmark, Cellular Signal Integrat Grp C SIG, DK-2800 Lyngby, Denmark	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Sheffield; Technical University of Denmark	Erler, JT (corresponding author), Univ Copenhagen UCPH, Biotech Res & Innovat Ctr BRIC, DK-2200 Copenhagen, Denmark.	a.gartland@shef.ac.uk; janine.erler@bric.ku.dk	Agrawal, Ankita/R-2437-2016; Rumney, Robin M H/H-6805-2019	Agrawal, Ankita/0000-0003-1055-9142; Rumney, Robin M H/0000-0002-4266-5962; Hoye, Anette/0000-0001-7830-2146; Schoof, Erwin Marten/0000-0002-3117-7832; Linding, Rune/0000-0003-0420-4839; Ab.Latif, Norain Binti/0000-0003-1499-9049; Gartland, Alison/0000-0002-3712-2437; Cox, Thomas/0000-0001-9294-1745; Huggins, Iain/0000-0001-5356-9207; Erler, Janine/0000-0001-8675-6527	Cancer Research UK [C107/A10433]; Biotech Research and Innovation Centre (BRIC, University of Copenhagen); University of Sheffield; National Institute for Health Research Sheffield Clinical Research Facility; Breast Cancer Campaign [2012MayPR086]; Danish Cancer Society [R56-A2971-12-S2]; Lundbeck Foundation; Velux Foundations (VKR) [VKR 022758]; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF12OC1015992] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Biotech Research and Innovation Centre (BRIC, University of Copenhagen); University of Sheffield; National Institute for Health Research Sheffield Clinical Research Facility; Breast Cancer Campaign; Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Velux Foundations (VKR); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank the animal welfare staff at the Institute of Cancer Research and Biocentre (University of Copenhagen); the Bone Analysis Laboratory (The University of Sheffield); M. Smid, J. W. M. Martens and J. A. Foekens (Erasmus MC Cancer Institute, Rotterdam, The Netherlands) for in-depth patient data analyses; and A. J. Giaccia and members of our laboratories for comments. This research was supported by funding from Cancer Research UK (C107/A10433) (T.R.C., D.B., G.L.J.T.E.), the Biotech Research and Innovation Centre (BRIC, University of Copenhagen) (T.R.C.), The University of Sheffield (A.G., I.D.H.), National Institute for Health Research Sheffield Clinical Research Facility (A.G.), Breast Cancer Campaign (#2012MayPR086) (A.G., R.M.H.R.), and the Danish Cancer Society (R56-A2971-12-S2) (A.M.H.). Experiments in the laboratory of R.L. were funded by The Lundbeck Foundation and the work was supported by the Velux Foundations (VKR)-funded Instrument Center for Systems Proteomics (VKR 022758). L.P. and J.T.E. are supported by a Hallas Moller Stipendum from the Novo Nordisk Foundation.	Agrawal A, 2012, METHODS MOL BIOL, V806, P357, DOI 10.1007/978-1-61779-367-7_23; Baker AM, 2013, ONCOGENE, V32, P1863, DOI 10.1038/onc.2012.202; Baker AM, 2011, JNCI-J NATL CANCER I, V103, P407, DOI 10.1093/jnci/djq569; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; BAX BE, 1992, BIOCHEM BIOPH RES CO, V183, P1153, DOI 10.1016/S0006-291X(05)80311-0; Blanco MA, 2012, CELL RES, V22, P1339, DOI 10.1038/cr.2012.89; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; El-Haibi CP, 2012, P NATL ACAD SCI USA, V109, P17460, DOI 10.1073/pnas.1206653109; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Feres EJ, 1995, J BIOL CHEM, V270, P30797, DOI 10.1074/jbc.270.51.30797; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Gartland A, 2001, J BONE MINER RES, V16, P846, DOI 10.1359/jbmr.2001.16.5.846; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Jin L, 2012, CELL RES, V22, P1356, DOI 10.1038/cr.2012.90; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Monteiro AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068171; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pischon N, 2009, CALCIFIED TISSUE INT, V85, P119, DOI 10.1007/s00223-009-9252-8; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vora SR, 2010, J BIOL CHEM, V285, P7384, DOI 10.1074/jbc.M109.033597; Wang N, 2012, MOL ENDOCRINOL, V26, P142, DOI 10.1210/me.2011-1083	30	342	360	1	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					106	U279		10.1038/nature14492	http://dx.doi.org/10.1038/nature14492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	26017313	Green Accepted			2022-12-28	WOS:000355543400039
J	Dey, S; Chamero, P; Pru, JK; Chien, MS; Ibarra-Soria, X; Spencer, KR; Logan, DW; Matsunami, H; Peluso, JJ; Stowers, L				Dey, Sandeepa; Chamero, Pablo; Pru, James K.; Chien, Ming-Shan; Ibarra-Soria, Ximena; Spencer, Kathryn R.; Logan, Darren W.; Matsunami, Hiroaki; Peluso, John J.; Stowers, Lisa			Cyclic Regulation of Sensory Perception by a Female Hormone Alters Behavior	CELL			English	Article							MEMBRANE COMPONENT 1; PHOSPHOLIPASE-C; VENTROMEDIAL HYPOTHALAMUS; VOMERONASAL ORGAN; PROGESTERONE; PHEROMONES; NEURONS; GENES; RECEPTORS; SIGNALS	Females may display dramatically different behavior depending on their state of ovulation. This is thought to occur through sex-specific hormones acting on behavioral centers in the brain. Whether incoming sensory activity also differs across the ovulation cycle to alter behavior has not been investigated. Here, we show that female mouse vomeronasal sensory neurons (VSNs) are temporarily and specifically rendered "blind'' to a subset of male-emitted pheromone ligands during diestrus yet fully detect and respond to the same ligands during estrus. VSN silencing occurs through the action of the female sex-steroid progesterone. Not all VSNs are targeted for silencing; those detecting cat ligands remain continuously active irrespective of the estrous state. We identify the signaling components that account for the capacity of progesterone to target specific subsets of male-pheromone responsive neurons for inactivation. These findings indicate that internal physiology can selectively and directly modulate sensory input to produce state-specific behavior.	[Dey, Sandeepa; Spencer, Kathryn R.; Stowers, Lisa] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Chamero, Pablo] Univ Saarland, Sch Med, Dept Physiol, D-66424 Homburg, Germany; [Pru, James K.] Washington State Univ, Dept Anim Sci, Ctr Reprod Biol, Pullman, WA 99164 USA; [Chien, Ming-Shan; Matsunami, Hiroaki] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Ibarra-Soria, Ximena; Logan, Darren W.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Peluso, John J.] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06030 USA; [Peluso, John J.] Univ Connecticut, Ctr Hlth, Dept Obstet & Ginecol, Farmington, CT 06030 USA	Scripps Research Institute; Saarland University; Washington State University; Duke University; Wellcome Trust Sanger Institute; University of Connecticut; University of Connecticut	Stowers, L (corresponding author), Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA.	stowers@scripps.edu	Stowers, Lisa/K-6137-2015; Ibarra-Soria, Ximena/ABF-1624-2021	Stowers, Lisa/0000-0002-4403-1269; Ibarra-Soria, Ximena/0000-0002-9387-3841; Chamero, Pablo/0000-0002-4305-1073; Logan, Darren/0000-0003-1545-5510	NIH-NIDCD grants [DC009413, DC006885]; Ellison Medical Foundation [NR-SS-0107-12, R21 RR030264]; Wellcome Trust [098051]; NIH [DC010857, DC012095]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040372] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR030264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010857, R01DC006885, R01DC012095, R01DC009413] Funding Source: NIH RePORTER	NIH-NIDCD grants; Ellison Medical Foundation(Lawrence Ellison Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH-NIDCD grants DC009413 and DC006885 (L.S.), the Ellison Medical Foundation NR-SS-0107-12 (L.S.), R21 RR030264 (J.J.P. and J.K.P.), the Wellcome Trust (098051) (D.W.L. and X.I.-S.), and NIH DC010857 and DC012095 (H.M). S.D. is grateful to J. Lat, J. Orman, and D. Huff for animal care support.	Bashour NM, 2012, ENDOCRINOLOGY, V153, P4457, DOI 10.1210/en.2012-1122; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chamero P, 2012, TRENDS NEUROSCI, V35, P597, DOI 10.1016/j.tins.2012.04.011; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Ibarra-Soria X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004593; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kaluka D, 2015, BIOCHEMISTRY-US, V54, P1638, DOI 10.1021/bi501177e; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kaur A, 2013, METHODS MOL BIOL, V1068, P189, DOI 10.1007/978-1-62703-619-1_13; Kaur AW, 2014, CELL, V157, P676, DOI 10.1016/j.cell.2014.02.025; Keydar I, 2013, HUM MUTAT, V34, P32, DOI 10.1002/humu.22212; Lee H, 2014, NATURE, V509, P627, DOI 10.1038/nature13169; Liberles SD, 2014, ANNU REV PHYSIOL, V76, P151, DOI 10.1146/annurev-physiol-021113-170334; Litosch I, 2002, IUBMB LIFE, V54, P253, DOI 10.1080/15216540215673; Liu MY, 1996, NATURE, V382, P83, DOI 10.1038/382083a0; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Manoli DS, 2013, CURR OPIN NEUROBIOL, V23, P330, DOI 10.1016/j.conb.2013.04.005; Meyer C, 1996, EUR J BIOCHEM, V239, P726, DOI 10.1111/j.1432-1033.1996.0726u.x; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Peluso JJ, 2008, ENDOCRINOLOGY, V149, P534, DOI 10.1210/en.2007-1050; Petersen SL, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00164; Roberts SA, 2012, SCIENCE, V338, P1462, DOI 10.1126/science.1225638; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P770, DOI 10.1016/j.conb.2010.08.015; Su C, 2012, ENDOCRINOLOGY, V153, P4389, DOI 10.1210/en.2011-2177; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Wyatt TD, 2010, J COMP PHYSIOL A, V196, P685, DOI 10.1007/s00359-010-0564-y; Yang CF, 2014, NEURON, V82, P261, DOI 10.1016/j.neuron.2014.03.029; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017	37	114	115	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1334	1344		10.1016/j.cell.2015.04.052	http://dx.doi.org/10.1016/j.cell.2015.04.052			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26046438	Bronze, Green Accepted			2022-12-28	WOS:000355935000013
J	Drake, N				Drake, Nadia			HOW TO CATCH A CLOUD	NATURE			English	Editorial Material																			0	4	4	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					115	116		10.1038/522115a	http://dx.doi.org/10.1038/522115a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	26040891	Bronze			2022-12-28	WOS:000355543400041
J	Shah, N				Shah, Neel			A NICE Delivery - The Cross-Atlantic Divide over Treatment Intensity in Childbirth	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shah, Neel] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Shah, Neel] Ariadne Labs Hlth Syst Innovat, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Shah, N (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA.							[Anonymous], 2014, Obstet Gynecol, V123, P693, DOI 10.1097/01.AOG.0000444441.04111.1d; [Anonymous], 2014, NY TIMES; HOLLOWELL J, 2011, BIRTHPLACE NATL PR 4; National Institute for Clinical Excellence (NICE), 2014, INTR CAR CAR HLTH WO	4	23	24	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2015	372	23					2181	2183		10.1056/NEJMp1501461	http://dx.doi.org/10.1056/NEJMp1501461			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK1GK	26039599				2022-12-28	WOS:000355955100002
J	Wang, X; Zhao, BS; Roundtree, IA; Lu, ZK; Han, DL; Ma, HH; Weng, XC; Chen, K; Shi, HL; He, C				Wang, Xiao; Zhao, Boxuan Simen; Roundtree, Ian A.; Lu, Zhike; Han, Dali; Ma, Honghui; Weng, Xiaocheng; Chen, Kai; Shi, Hailing; He, Chuan			N-6-methyladenosine Modulates Messenger RNA Translation Efficiency	CELL			English	Article							GENE-EXPRESSION; YTH DOMAIN; M(6)A RNA; METHYLATED NUCLEOSIDES; NUCLEOTIDE-SEQUENCES; NUTRITIONAL CONTROL; STRESS GRANULES; BINDING PROTEIN; MAPPING REVEALS; NUCLEAR-RNA	N-6-methyladenosine (m(6)A) is the most abundant internal modification in mammalian mRNA. This modification is reversible and non-stoichiometric and adds another layer to the dynamic control of mRNA metabolism. The stability of m(6)A-modified mRNA is regulated by an m(6)A reader protein, human YTHDF2, which recognizes m(6)A and reduces the stability of target transcripts. Looking at additional functional roles for the modification, we find that another m(6)A reader protein, human YTHDF1, actively promotes protein synthesis by interacting with translation machinery. In a unified mechanism of m(6)A-based regulation in the cytoplasm, YTHDF2-mediated degradation controls the lifetime of target transcripts, whereas YTHDF1-mediated translation promotion increases translation efficiency, ensuring effective protein production from dynamic transcripts that are marked by m(6)A. Therefore, the m(6)A modification in mRNA endows gene expression with fast responses and controllable protein production through these mechanisms.	[Wang, Xiao; Zhao, Boxuan Simen; Lu, Zhike; Han, Dali; Ma, Honghui; Weng, Xiaocheng; Chen, Kai; Shi, Hailing; He, Chuan] Univ Chicago, Dept Chem & Inst Biophys Dynam, Chicago, IL 60637 USA; [Wang, Xiao; Zhao, Boxuan Simen; Roundtree, Ian A.; Lu, Zhike; Han, Dali; Ma, Honghui; Weng, Xiaocheng; Chen, Kai; Shi, Hailing; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Roundtree, Ian A.; He, Chuan] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago	He, C (corresponding author), Univ Chicago, Dept Chem & Inst Biophys Dynam, 929 East 57th St, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Han, Dali/I-4145-2016; Zhao, Boxuan/Q-2159-2019; Shi, Hailing/AAW-5351-2021	Zhao, Boxuan/0000-0002-3729-4511; Shi, Hailing/0000-0001-7355-378X; Wang, Xiao/0000-0002-3090-9894	HHMI International Student Fellowship; Postdoctoral International Exchange Program of the China Postdoctoral Council (CPC); China Scholarship Council (CSC); National Science Foundation [CHE-1048528]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440, T32GM007281, R01GM113194] Funding Source: NIH RePORTER	HHMI International Student Fellowship; Postdoctoral International Exchange Program of the China Postdoctoral Council (CPC); China Scholarship Council (CSC)(China Scholarship Council); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Professor Tao Pan for insightful discussion and kindly providing the ribosome profiling instrument. We thank Mr. Wesley Clark for help in the ribosome profiling experiment. We thank Professor Anne E. Willis for providing the IRES reporter plasmids. We thank Institutes of Biomedical Sciences at Fudan University for protein mass spectrometry experiments. We thank Ms. Sarah Frank Reichard for editing the manuscript. C.H. is an investigator of the Howard Hughes Medical Institute (HHMI). B.S.Z. is supported by an HHMI International Student Fellowship. H.M. is supported by the Postdoctoral International Exchange Program of the China Postdoctoral Council (CPC). X. Weng is partially supported by the China Scholarship Council (CSC). The Mass Spectrometry Facility of the University of Chicago is funded by the National Science Foundation (CHE-1048528).	Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bokar JA, 1997, RNA, V3, P1233; Bokar JA, 2005, TOP CURR GENET, V12, P141, DOI 10.1007/b106365; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Deschenes-Furry J, 2006, BIOESSAYS, V28, P822, DOI 10.1002/bies.20449; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Do R, 2008, DIABETES, V57, P1147, DOI 10.2337/db07-1267; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gao XW, 2015, NAT METHODS, V12, P147, DOI 10.1038/nmeth.3208; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Gratacos FM, 2010, WIRES RNA, V1, P457, DOI 10.1002/wrna.26; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Hertz MI, 2013, MOL CELL BIOL, V33, P1016, DOI 10.1128/MCB.00879-12; Hiriart E, 2012, EMBO J, V31, P2296, DOI 10.1038/emboj.2012.105; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; Hussain S, 2013, GENOME BIOL, V14, DOI 10.1186/gb4143; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kang HJ, 2014, BIOCHEM J, V457, P391, DOI 10.1042/BJ20130862; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Lee M, 2014, CELL, V158, P980, DOI 10.1016/j.cell.2014.08.005; Li FD, 2014, CELL RES, V24, P1490, DOI 10.1038/cr.2014.153; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Luo SK, 2014, P NATL ACAD SCI USA, V111, P13834, DOI 10.1073/pnas.1412742111; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nilsen TW, 2014, SCIENCE, V343, P1207, DOI 10.1126/science.1249340; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; SHAH JC, 1992, MOL CELL BIOL, V12, P1078, DOI 10.1128/MCB.12.3.1078; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Siciliano V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3364; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Theler D, 2014, NUCLEIC ACIDS RES, V42, P13911, DOI 10.1093/nar/gku1116; TUCK MT, 1992, BIOCHEM J, V288, P233, DOI 10.1042/bj2880233; Wang X, 2014, MOL CELL, V56, P5, DOI 10.1016/j.molcel.2014.09.001; Wang X, 2014, RNA BIOL, V11, P669, DOI 10.4161/rna.28829; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Yaman I, 2002, J BIOL CHEM, V277, P41539, DOI 10.1074/jbc.M204850200; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883	61	1601	1673	34	374	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1388	1399		10.1016/j.cell.2015.05.014	http://dx.doi.org/10.1016/j.cell.2015.05.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26046440	Bronze, Green Accepted			2022-12-28	WOS:000355935000017
J	Cole, TB				Cole, Thomas B.			The Last Civil War Veteran Larry Rivers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2015	313	20					2006	2007		10.1001/jama.2014.11765	http://dx.doi.org/10.1001/jama.2014.11765			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0DC	26010617				2022-12-28	WOS:000355142400033
J	Vasiljevic, A; Poreau, B; Bouvier, R; Lachaux, A; Arnoult, C; Faure, J; Cordier, MP; Ray, PF				Vasiljevic, Alexandre; Poreau, Brice; Bouvier, Raymonde; Lachaux, Alain; Arnoult, Christophe; Faure, Julien; Cordier, Marie Pierre; Ray, Pierre F.			Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome and recurrent intrauterine fetal death	LANCET			English	Editorial Material							IPEX		[Vasiljevic, Alexandre; Bouvier, Raymonde] CHU Lyon GH Est, Ctr Pathol & Neuropathol Est, Bron, France; [Lachaux, Alain] CHU Lyon GH Est, Serv Hepatol Gastroenterol & Nutr Pediat, Bron, France; [Cordier, Marie Pierre] CHU Lyon GH Est, Serv Genet Clin, Bron, France; [Poreau, Brice; Faure, Julien; Ray, Pierre F.] CHU Grenoble, Lab Biochim & Genet Mol, F-38043 Grenoble 9, France; [Poreau, Brice] CHU Grenoble, Serv Genet Clin, F-38043 Grenoble 9, France; [Arnoult, Christophe; Faure, Julien; Ray, Pierre F.] Univ Grenoble Alpes, Grenoble, France; [Arnoult, Christophe] INSERM, U823, Inst Albert Bonniot, Equipe Genet Epigenet & Therapies Infertilite, Grenoble, France; [Faure, Julien] Grenoble Inst Neurosci, INSERM, U836, Equipe Muscle & Pathol, Grenoble, France	CHU Lyon; CHU Lyon; CHU Lyon; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Ray, PF (corresponding author), CHU Grenoble, Inst Biol & Pathol, Lab Biochim & Genet Mol, Dept Biochim Toxicol & Pharmacol, BP 217, F-38043 Grenoble 9, France.	pray@chu-grenoble.fr	Ray, Pierre F/D-7315-2019; Fauré, julien/AAJ-1845-2020; ARNOULT, christophe/E-8312-2013	Ray, Pierre F/0000-0003-1544-7449; Fauré, julien/0000-0002-3660-9809; alain, lachaux/0000-0003-3852-788X; ARNOULT, christophe/0000-0002-3753-5901				Gambineri Eleonora, 2008, J Allergy Clin Immunol, V122, P1105, DOI 10.1016/j.jaci.2008.09.027; Harbuz R, 2010, PRENATAL DIAG, V30, P1072, DOI 10.1002/pd.2613; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Verbsky JW, 2013, CURR OPIN PEDIATR, V25, P708, DOI 10.1097/MOP.0000000000000029	4	18	19	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2120	2120		10.1016/S0140-6736(15)60773-5	http://dx.doi.org/10.1016/S0140-6736(15)60773-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI7XK	26009232				2022-12-28	WOS:000354979100032
J	Wouters, B; Martin-Espanol, A; Helm, V; Flament, T; van Wessem, JM; Ligtenberg, SRM; van den Broeke, MR; Bamber, JL				Wouters, B.; Martin-Espanol, A.; Helm, V.; Flament, T.; van Wessem, J. M.; Ligtenberg, S. R. M.; van den Broeke, M. R.; Bamber, J. L.			Dynamic thinning of glaciers on the Southern Antarctic Peninsula	SCIENCE			English	Article							AMUNDSEN SEA EMBAYMENT; ICE-SHELF; WEST ANTARCTICA; COLLAPSE; RETREAT; DRIVEN; FLOW	Growing evidence has demonstrated the importance of ice shelf buttressing on the inland grounded ice, especially if it is resting on bedrock below sea level. Much of the Southern Antarctic Peninsula satisfies this condition and also possesses a bed slope that deepens inland. Such ice sheet geometry is potentially unstable. We use satellite altimetry and gravity observations to show that a major portion of the region has, since 2009, destabilized. Ice mass loss of the marine-terminating glaciers has rapidly accelerated from close to balance in the 2000s to a sustained rate of -56 +/- 8 gigatons per year, constituting a major fraction of Antarctica's contribution to rising sea level. The widespread, simultaneous nature of the acceleration, in the absence of a persistent atmospheric forcing, points to an oceanic driving mechanism.	[Wouters, B.; Martin-Espanol, A.; Bamber, J. L.] Univ Bristol, Bristol Glaciol Ctr, Bristol, Avon, England; [Helm, V.] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Bremerhaven, Germany; [Flament, T.] Lab Etud Geophys & Oceanog Spatiales, Toulouse, France; [van Wessem, J. M.; Ligtenberg, S. R. M.; van den Broeke, M. R.] Univ Utrecht, Inst Marine & Atmospher Res, NL-3508 TC Utrecht, Netherlands	University of Bristol; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; Utrecht University	Wouters, B (corresponding author), Univ Bristol, Bristol Glaciol Ctr, Bristol, Avon, England.	bert.wouters@bristol.ac.uk	Bamber, Jonathan/C-7608-2011; Wouters, Bert/A-5301-2017; Ligtenberg, Stefan/AAF-8290-2020; Van den Broeke, Michiel R./F-7867-2011; van Wessem, Melchior/AAB-1987-2019; Wouters, Bert/AAA-4254-2019	Bamber, Jonathan/0000-0002-2280-2819; Wouters, Bert/0000-0002-1086-2435; Van den Broeke, Michiel R./0000-0003-4662-7565; Wouters, Bert/0000-0002-1086-2435; Martin, Alba/0000-0001-9495-9092; Flament, Thomas/0000-0001-9702-302X; van Wessem, Melchior/0000-0003-3221-791X	European Community [FP7-PEOPLE-2011-IOF-301260]; Natural Environment Research Council [NE/I027401/1]; European Space Agency [4000107393/12/I-NB]; German Ministry of Economics and Technology [50EE1331]; Netherlands Polar Program of the Netherlands Organization for Scientific Research, section Earth and Life Sciences (NWO/ALW/NPP); NERC [NE/I027401/1] Funding Source: UKRI	European Community(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Space Agency(European Space AgencyEuropean Commission); German Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi)); Netherlands Polar Program of the Netherlands Organization for Scientific Research, section Earth and Life Sciences (NWO/ALW/NPP); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	B.W. and J.L.B. jointly conceived the study, interpreted the results, and wrote the article. B.W. processed the GRACE and Cryosat-2 L2 data. A.M.-E. combined the ICESat-Envisat elevation rates and derived the GVIIS front positions. V.H. developed the Cryosat-2 retracker and processed the L1B data. T.F. processed the Envisat data. J.M.v.W., S.R.M.L., and M.R.v.d.B. developed and ran the SMB and firn model. All authors commented on the manuscript. We thank J. Wahr and G. A for their help with the Glacial Isostatic Adjustment correction and elastic loading. G. Moholdt and A. Gardner are acknowledged for the fruitful discussions on altimetry. B.W. is funded by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (FP7-PEOPLE-2011-IOF-301260). J.L.B. and A.M.-E. were supported by Natural Environment Research Council grant NE/I027401/1. J.L.B., B.W., and A.M-E. also acknowledge support through European Space Agency contract 4000107393/12/I-NB, "REGINA." V.H. was supported by the German Ministry of Economics and Technology (grant 50EE1331). J.M.v.W., S.R.M.L., and M.R.v.d.B. acknowledge support from the Netherlands Polar Program of the Netherlands Organization for Scientific Research, section Earth and Life Sciences (NWO/ALW/NPP). The data sets used in this study can be found at http://pangaea.de.	Bamber JL, 2009, SCIENCE, V324, P901, DOI 10.1126/science.1169335; Bingham RG, 2012, NATURE, V487, P468, DOI 10.1038/nature11292; Cook AJ, 2010, CRYOSPHERE, V4, P77, DOI 10.5194/tc-4-77-2010; De Angelis H, 2003, SCIENCE, V299, P1560, DOI 10.1126/science.1077987; Depoorter MA, 2013, NATURE, V502, P89, DOI 10.1038/nature12567; Dupont TK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022024; Dutrieux P, 2014, SCIENCE, V343, P174, DOI 10.1126/science.1244341; Favier L, 2014, NAT CLIM CHANGE, V4, P117, DOI [10.1038/nclimate2094, 10.1038/NCLIMATE2094]; Flament T, 2012, J GLACIOL, V58, P830, DOI 10.3189/2012JoG11J118; Helm V, 2014, CRYOSPHERE, V8, P1539, DOI 10.5194/tc-8-1539-2014; Holland DM, 2008, NAT GEOSCI, V1, P659, DOI 10.1038/ngeo316; Holt TO, 2013, CRYOSPHERE, V7, P797, DOI 10.5194/tc-7-797-2013; Huss M, 2014, CRYOSPHERE, V8, P1261, DOI 10.5194/tc-8-1261-2014; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; King MA, 2012, NATURE, V491, P586, DOI 10.1038/nature11621; Ligtenberg SRM, 2011, CRYOSPHERE, V5, P809, DOI 10.5194/tc-5-809-2011; McMillan M, 2014, GEOPHYS RES LETT, V41, P3899, DOI 10.1002/2014GL060111; Mouginot J, 2014, GEOPHYS RES LETT, V41, P1576, DOI 10.1002/2013GL059069; Paolo F. S., 2015, SCIENCE, V26; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Rebesco M, 2014, SCIENCE, V345, P1354, DOI 10.1126/science.1256697; Rignot E, 2013, SCIENCE, V341, P266, DOI 10.1126/science.1235798; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Rott H, 2002, ANN GLACIOL-SER, V34, P277, DOI 10.3189/172756402781817716; Scambos TA, 2014, CRYOSPHERE, V8, P2135, DOI 10.5194/tc-8-2135-2014; Schmidtko S, 2014, SCIENCE, V346, P1227, DOI 10.1126/science.1256117; Schoof C., 2007, J GEOPHYS RES, V112, P3; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Sutterley TC, 2014, GEOPHYS RES LETT, V41, P8421, DOI 10.1002/2014GL061940; Tapley BD, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019920; The Scientific Committee on Antarctic Research, SCAR ANT DIG DAT; Thomas ER, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032529; van Wessem JM, 2014, J GLACIOL, V60, P761, DOI 10.3189/2014JoG14J051; Vaughan DG, 1996, NATURE, V379, P328, DOI 10.1038/379328a0; Wingham DJ, 2006, ADV SPACE RES-SERIES, V37, P841, DOI 10.1016/j.asr.2005.07.027; Zwally H.J., 2012, ANTARCTIC GREENLAND	36	142	145	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					899	903		10.1126/science.aaa5727	http://dx.doi.org/10.1126/science.aaa5727			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999505				2022-12-28	WOS:000354877900041
J	Dear, K; Wang, Z				Dear, Keith; Wang, Zhan			Climate and health: mortality attributable to heat and cold	LANCET			English	Editorial Material							AMBIENT-TEMPERATURE		[Dear, Keith; Wang, Zhan] Duke Kunshan Univ, Global Hlth Res Ctr, Kunshan 215316, Jiangsu, Peoples R China	Duke Kunshan University	Dear, K (corresponding author), Duke Kunshan Univ, Global Hlth Res Ctr, Kunshan 215316, Jiangsu, Peoples R China.	keith.dear@dku.edu.cn		Dear, Keith/0000-0002-0788-7404; Wang, Zhan/0000-0002-1612-4759				Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bennett CM, 2014, INT J BIOMETEOROL, V58, P835, DOI 10.1007/s00484-013-0663-x; BULL G M, 1978, Age and Ageing, V7, P210, DOI 10.1093/ageing/7.4.210; Christidis N, 2015, NAT CLIM CHANGE, V5, P46, DOI [10.1038/nclimate2468, 10.1038/NCLIMATE2468]; Dear K, 2005, ARCH ENVIRON OCCUP H, V60, P205, DOI 10.3200/AEOH.60.4.205-212; Gasparrini A., 2015, LANCET; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Kunreuther H, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P151; McGeehin MA, 2001, ENVIRON HEALTH PERSP, V109, P185, DOI 10.2307/3435008; Staddon PL, 2014, NAT CLIM CHANGE, V4, P190, DOI [10.1038/NCLIMATE2121, 10.1038/nclimate2121]; UN, 2013, WORLD POP AG 2013; Yu WW, 2012, INT J BIOMETEOROL, V56, P569, DOI 10.1007/s00484-011-0497-3	14	10	10	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2015	386	9991					320	322		10.1016/S0140-6736(15)60897-2	http://dx.doi.org/10.1016/S0140-6736(15)60897-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN5CX	26003381	hybrid			2022-12-28	WOS:000358448400008
J	Eckel-Passow, JE; Lachance, DH; Molinaro, AM; Walsh, KM; Decker, PA; Sicotte, H; Pekmezci, M; Rice, T; Kosel, ML; Smirnov, IV; Sarkar, G; Caron, AA; Kollmeyer, TM; Praska, CE; Chada, AR; Halder, C; Hansen, HM; Mccoy, LS; Bracci, PM; Marshall, R; Zheng, S; Reis, GF; Pico, AR; O'Neill, BP; Buckner, JC; O'Neill, P; Huse, JT; Perry, A; Tihan, T; Berger, MS; Chang, SM; Prados, MD; Wiemels, J; Wiencke, JK; Wrensch, MR; Jenkins, RB				Eckel-Passow, Jeanette E.; Lachance, Daniel H.; Molinaro, Annette M.; Walsh, Kyle M.; Decker, Paul A.; Sicotte, Hugues; Pekmezci, Melike; Rice, Terri; Kosel, Matt L.; Smirnov, Ivan V.; Sarkar, Gobinda; Caron, Alissa A.; Kollmeyer, Thomas M.; Praska, Corinne E.; Chada, Anisha R.; Halder, Chandralekha; Hansen, Helen M.; Mccoy, Lucie S.; Bracci, Paige M.; Marshall, Roxanne; Zheng, Shichun; Reis, Gerald F.; Pico, Alexander R.; O'Neill, Brian P.; Buckner, Jan C.; Giannini, Caterina; Huse, Jason T.; Perry, Arie; Tihan, Tarik; Berger, Mitchell S.; Chang, Susan M.; Prados, Michael D.; Wiemels, Joseph; Wiencke, John K.; Wrensch, Margaret R.; Jenkins, Robert B.			Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; OLIGODENDROGLIAL TUMORS; SUSCEPTIBILITY LOCI; GRADE; VARIANT; CANCER; PROCARBAZINE; VINCRISTINE; SUBCLASSES; PROGNOSIS	BACKGROUND The prediction of clinical behavior, response to therapy, and outcome of infiltrative glioma is challenging. On the basis of previous studies of tumor biology, we defined five glioma molecular groups with the use of three alterations: mutations in the TERT promoter, mutations in IDH, and codeletion of chromosome arms 1p and 19q (1p/19q codeletion). We tested the hypothesis that within groups based on these features, tumors would have similar clinical variables, acquired somatic alterations, and germline variants. METHODS We scored tumors as negative or positive for each of these markers in 1087 gliomas and compared acquired alterations and patient characteristics among the five primary molecular groups. Using 11,590 controls, we assessed associations between these groups and known glioma germline variants. RESULTS Among 615 grade II or III gliomas, 29% had all three alterations (i. e., were triple-positive), 5% had TERT and IDH mutations, 45% had only IDH mutations, 7% were triple-negative, and 10% had only TERT mutations; 5% had other combinations. Among 472 grade IV gliomas, less than 1% were triple-positive, 2% had TERT and IDH mutations, 7% had only IDH mutations, 17% were triple-negative, and 74% had only TERT mutations. The mean age at diagnosis was lowest (37 years) among patients who had gliomas with only IDH mutations and was highest (59 years) among patients who had gliomas with only TERT mutations. The molecular groups were independently associated with overall survival among patients with grade II or III gliomas but not among patients with grade IV gliomas. The molecular groups were associated with specific germline variants. CONCLUSIONS Gliomas were classified into five principal groups on the basis of three tumor markers. The groups had different ages at onset, overall survival, and associations with germline variants, which implies that they are characterized by distinct mechanisms of pathogenesis.	[Eckel-Passow, Jeanette E.; Decker, Paul A.; Sicotte, Hugues; Kosel, Matt L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Lachance, Daniel H.; Sarkar, Gobinda; Caron, Alissa A.; Kollmeyer, Thomas M.; Praska, Corinne E.; Chada, Anisha R.; Halder, Chandralekha; Giannini, Caterina; Jenkins, Robert B.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Lachance, Daniel H.; O'Neill, Brian P.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Buckner, Jan C.] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Molinaro, Annette M.; Walsh, Kyle M.; Rice, Terri; Smirnov, Ivan V.; Hansen, Helen M.; Mccoy, Lucie S.; Zheng, Shichun; Perry, Arie; Berger, Mitchell S.; Chang, Susan M.; Prados, Michael D.; Wiencke, John K.; Wrensch, Margaret R.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Molinaro, Annette M.; Bracci, Paige M.; Wiemels, Joseph; Wiencke, John K.; Wrensch, Margaret R.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Pekmezci, Melike; Marshall, Roxanne; Reis, Gerald F.; Perry, Arie; Tihan, Tarik] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Wiemels, Joseph; Wiencke, John K.; Wrensch, Margaret R.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Pico, Alexander R.] Gladstone Inst, Bioinformat Core, San Francisco, CA USA; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Pathol & Human Oncol, New York, NY 10021 USA; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Pathogenesis Program, New York, NY 10021 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Jenkins, RB (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	rjenkins@mayo.edu	Pico, Alexander/HCH-4305-2022; Giannini, Caterina/AAB-7551-2022; Prados, Michael/N-5220-2019; Tihan, Tarik/AAU-6371-2021; Buckner, Jan/AAE-6388-2019	Praska, Corinne/0000-0002-4937-1377; Tihan, Tarik/0000-0003-4551-2555; Walsh, Kyle/0000-0002-5879-9981; Pico, Alexander/0000-0001-5706-2163	National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA139020, R01CA163687, P50CA108961, R01CA052689, P50CA097257, R01CA126831, R25CA112355, P30CA015083] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institutes of Health and others.	Bainbridge Matthew N, 2015, J Natl Cancer Inst, V107, P384, DOI 10.1093/jnci/dju384; Bielinski SJ, 2011, MAYO CLIN PROC, V86, P606, DOI 10.4065/mcp.2011.0178; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Cairncross JG, 2014, J CLIN ONCOL, V32, P783, DOI 10.1200/JCO.2013.49.3726; Di Stefano AL, 2013, NEURO-ONCOLOGY, V15, P542, DOI 10.1093/neuonc/nos284; Enciso-Mora V, 2013, HUM MOL GENET, V22, P2293, DOI 10.1093/hmg/ddt063; Gorovets D, 2012, CLIN CANCER RES, V18, P2490, DOI 10.1158/1078-0432.CCR-11-2977; Guan XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091216; Guo CC, 2011, CURR OPIN NEUROL, V24, P648, DOI 10.1097/WCO.0b013e32834cd415; Huse JT, 2014, NEUROONCOL S3, V16, piii45; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Jenkins RB, 2012, NAT GENET, V44, P1122, DOI 10.1038/ng.2388; Jenkins RB, 2011, CANCER GENET-NY, V204, P13, DOI 10.1016/j.cancergencyto.2010.10.002; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kim T, 2014, P NATL ACAD SCI USA, V111, P4173, DOI 10.1073/pnas.1400350111; Labussiere M, 2014, NEUROLOGY, V83, P1200, DOI 10.1212/WNL.0000000000000814; Louis DN, 2014, BRAIN PATHOL, V24, P429, DOI 10.1111/bpa.12171; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Rice T, 2013, NEURO-ONCOLOGY, V15, P535, DOI 10.1093/neuonc/nos324; Schrijver I., 2013, 2013 SURVEYS ANATOMI, P203; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; van den Bent MJ, 2013, J CLIN ONCOL, V31, P344, DOI 10.1200/JCO.2012.43.2229; Vinagre J, 2014, VIRCHOWS ARCH, V465, P119, DOI 10.1007/s00428-014-1608-4; Walsh KM, 2014, NAT GENET, V46, P731, DOI 10.1038/ng.3004; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408	30	1218	1250	4	156	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 25	2015	372	26					2499	2508		10.1056/NEJMoa1407279	http://dx.doi.org/10.1056/NEJMoa1407279			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL2QD	26061753	Green Accepted, Green Published			2022-12-28	WOS:000356788200006
J	Chang, L; Dhruva, SS; Chu, J; Bero, LA; Redberg, RF				Chang, Lee; Dhruva, Sanket S.; Chu, Janet; Bero, Lisa A.; Redberg, Rita F.			Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICAL DEVICES; PUBLICATION; CLINICALTRIALS.GOV; ACCESS; STENT; TIME	OBJECTIVE To investigate characteristics of clinical trials and results on safety and effectiveness reported in US Food and Drug Administration (FDA) documents for recently approved high risk cardiovascular devices compared with the characteristics and results reported in peer reviewed publications. DESIGN A search of the publicly available FDA database was performed for all cardiovascular devices that received premarket approval from 1 January 2000 to 31 December 2010. For each study listed in the premarket approval documents, a Medline search was conducted to obtain the corresponding publication. MAIN OUTCOME MEASURES Clinical trial characteristics, primary endpoints, and safety and efficacy results in the FDA documents and corresponding publications. RESULTS 106 cardiovascular devices received premarket approval from 1 January 2000 to 31 December 2010. FDA premarket approval documents for these devices contained 177 studies, of which 86 (49%) had been published by 1 January 2013. These 86 publications corresponded to 60 distinct devices. The mean time from FDA approval to publication in a peer reviewed journal was 6.5 months (range -4.8-7.5 years). In 22 (26%) of the 86 compared studies the number of participants enrolled in the study differed in the FDA summary and the corresponding publications. Of 152 primary endpoints identified in the FDA documents, in the corresponding publications three (2%) were labeled as secondary, 43 (28%) were unlabeled, and 15 (10%) were not found. Among the primary results, 69 (45%) were identical, 35 (23%) were similar, 17 (11%) were substantially different, and 31 (20%) could not be compared. CONCLUSIONS Many clinical trials for high risk cardiovascular devices approved by the FDA remain unpublished. Even when trials are published, the study population, primary endpoints, and results can differ substantially from data submitted to the FDA.	[Chang, Lee] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Dhruva, Sanket S.] Univ Calif Davis, Div Cardiovasc Med, Sacramento, CA 95817 USA; [Chu, Janet] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Bero, Lisa A.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Redberg, Rita F.] Univ Calif San Francisco, Div Cardiol, San Francisco, CA 94143 USA	Harvard University; Massachusetts General Hospital; University of California System; University of California Davis; University of California System; University of California San Francisco; University of Sydney; University of California System; University of California San Francisco	Redberg, RF (corresponding author), Univ Calif San Francisco, Div Cardiol, Suite M-1180,505 Parnassus Ave, San Francisco, CA 94143 USA.	redberg@medicine.ucsf.edu		Bero, Lisa/0000-0003-1893-6651				[Anonymous], LAL IH STENT GRAFT S; [Anonymous], XIENCE V RAP EXCH RX; [Anonymous], FREEZ CARD CRYOABL C; [Anonymous], PREM APPR; Basu S, 2012, NEW ENGL J MED, V367, P485, DOI 10.1056/NEJMp1204170; Becker JE, 2014, JAMA-J AM MED ASSOC, V311, P1063, DOI 10.1001/jama.2013.285634; Chen CE, 2012, JAMA-J AM MED ASSOC, V308, P1740, DOI 10.1001/jama.2012.14491; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Dwan Kerry, 2011, Cochrane Database Syst Rev, pMR000031, DOI 10.1002/14651858.MR000031.pub2; Eichler HG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001202; Fairman RM, 2008, J VASC SURG, V48, P546, DOI 10.1016/j.jvs.2008.03.061; Friedman PL, 2004, HEART RHYTHM, V1, P129, DOI 10.1016/j.hrthm.2004.02.022; Gordon D, 2013, NEW ENGL J MED, V369, P1926, DOI 10.1056/NEJMsa1300237; Kramer DB, 2012, NEW ENGL J MED, V366, P848, DOI 10.1056/NEJMhle1113918; Maisel WH, 2006, JAMA-J AM MED ASSOC, V295, P1901, DOI 10.1001/jama.295.16.1901; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Ross JS, 2013, JAMA INTERN MED, V173, P825, DOI 10.1001/jamainternmed.2013.136; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Schroll JB, 2015, J CLIN EPIDEMIOL, V68, P102, DOI 10.1016/j.jclinepi.2014.06.019; Schroll JB, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2231; Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903; Torjesen I, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3432; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Vedula SS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001378; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Wolfe N, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-31	28	25	25	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2015	350								h2613	10.1136/bmj.h2613	http://dx.doi.org/10.1136/bmj.h2613			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK7CZ	26063311	Green Published, hybrid			2022-12-28	WOS:000356389600002
J	Burnim, I				Burnim, Ira			The Promise of the Americans With Disabilities Act for People With Mental Illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Bazelon Ctr, Washington, DC 20005 USA		Burnim, I (corresponding author), Bazelon Ctr, 1101 15th St NW,Ste 1212, Washington, DC 20005 USA.	irab@bazelon.org						Culhane DP, PUBLIC SERVICE REDUC; Frey WD, MENTAL HLTH TREATMEN; New Freedom Commission on Mental Health, AMERICA; Sledge WH, EFFECTIVENESS PEER S; Substance Abuse and Mental Health Services Administration, ASS COMM TREATM EV; Substance Abuse and Mental Health Services Administration, CRIS SERV EFF COST E; Vera Institute, TREATM ALT INC PEOPL	7	12	12	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2015	313	22					2223	2224		10.1001/jama.2015.4015	http://dx.doi.org/10.1001/jama.2015.4015			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK1VH	26057279				2022-12-28	WOS:000355995300012
J	Babbin, AR; Bianchi, D; Jayakumar, A; Ward, BB				Babbin, Andrew R.; Bianchi, Daniele; Jayakumar, Amal; Ward, Bess B.			Rapid nitrous oxide cycling in the suboxic ocean	SCIENCE			English	Article							TROPICAL NORTH PACIFIC; ARABIAN SEA; N2O; DENITRIFICATION; NITRIFICATION; EMISSIONS; RATES; RATIO	Nitrous oxide (N2O) is a powerful greenhouse gas and a major cause of stratospheric ozone depletion, yet its sources and sinks remain poorly quantified in the oceans. We used isotope tracers to directly measure N2O reduction rates in the eastern tropical North Pacific. Because of incomplete denitrification, N2O cycling rates are an order of magnitude higher than predicted by current models in suboxic regions, and the spatial distribution suggests strong dependence on both organic carbon and dissolved oxygen concentrations. Furthermore, N2O turnover is 20 times higher than the net atmospheric efflux. The rapid rate of this cycling coupled to an expected expansion of suboxic ocean waters implies future increases in N2O emissions.	[Babbin, Andrew R.; Jayakumar, Amal; Ward, Bess B.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Babbin, Andrew R.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Bianchi, Daniele] Univ Washington, Sch Oceanog, Seattle, WA 98105 USA	Princeton University; Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle	Babbin, AR (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	babbin@mit.edu	Jayakumar, Amal/AAM-1748-2020	Jayakumar, Amal/0000-0002-3568-1403; Bianchi, Daniele/0000-0002-6621-0858; Babbin, Andrew/0000-0002-5046-0609	National Defense Science and Engineering Graduate Fellowship; NSF [1029951, 1402109]; University of Washington; Div Of Biological Infrastructure [1402109] Funding Source: National Science Foundation	National Defense Science and Engineering Graduate Fellowship; NSF(National Science Foundation (NSF)); University of Washington(University of Washington); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the captain and crew of the R/V Thomas G. Thompson and chief scientist A. H. Devol for assistance in sampling and A. Morello and X. Peng for help with nitrite and N<INF>2</INF>O measurements, respectively. J. L. Sarmiento provided valuable inputs in the development of the oxygen minimum zone model. This work was funded by a National Defense Science and Engineering Graduate Fellowship to A.R.B., NSF grant no. 1029951 to B.B.W. and A. J., and University of Washington funding to D.B. A.R.B. was additionally supported by a NSF Postdoctoral Research Fellowship in Biology (no. 1402109) while preparing the paper. All data measurements presented in this paper are included in table S3. The 1D MATLAB model code and output are available in the supplementary materials. A.R.B. and B.B.W. designed and conducted the shipboard experiments and analysis, D.B. designed and implemented the 1D model, and A. J. measured N<INF>2</INF>O concentrations. All authors analyzed the data and model results and wrote the paper.	Babbin AR, 2014, SCIENCE, V344, P406, DOI 10.1126/science.1248364; Bange HW, 2006, ATMOS ENVIRON, V40, P198, DOI 10.1016/j.atmosenv.2005.09.030; Bange HW, 2001, ATMOS CHEM PHYS, V1, P61, DOI 10.5194/acp-1-61-2001; BETLACH MR, 1981, APPL ENVIRON MICROB, V42, P1074, DOI 10.1128/AEM.42.6.1074-1084.1981; Bianchi D, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004209; Codispoti LA, 2010, SCIENCE, V327, P1339, DOI 10.1126/science.1184945; COHEN Y, 1979, J GEOPHYS RES-OCEANS, V84, P347, DOI 10.1029/JC084iC01p00347; Dalsgaard T, 2014, MBIO, V5, DOI 10.1128/mBio.01966-14; de Wilde HPJ, 2000, MAR CHEM, V69, P203, DOI 10.1016/S0304-4203(99)00106-1; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; DeVries T, 2013, BIOGEOSCIENCES, V10, P2481, DOI 10.5194/bg-10-2481-2013; DeVries T, 2012, NAT GEOSCI, V5, P547, DOI [10.1038/ngeo1515, 10.1038/NGEO1515]; ELKINS JW, 1978, NATURE, V275, P602, DOI 10.1038/275602a0; Farias L, 2009, LIMNOL OCEANOGR, V54, P132, DOI 10.4319/lo.2009.54.1.0132; Fluckiger J, 1999, SCIENCE, V285, P227, DOI 10.1126/science.285.5425.227; GOREAU TJ, 1980, APPL ENVIRON MICROB, V40, P526, DOI 10.1128/AEM.40.3.526-532.1980; Ito T, 2013, GLOBAL BIOGEOCHEM CY, V27, P1119, DOI 10.1002/2013GB004567; Jin X, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018458; JORGENSEN KS, 1984, CAN J MICROBIOL, V30, P1073, DOI 10.1139/m84-167; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; KORNER H, 1989, APPL ENVIRON MICROB, V55, P1670; LIPSCHULTZ F, 1981, NATURE, V294, P641, DOI 10.1038/294641a0; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Martinez-Rey J., 2014, BIOGEOSCI DISCUSS, V11, P16703; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Naqvi SWA, 1998, P INDIAN AS-EARTH, V107, P367; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Nevison C, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002068; Nicholls JC, 2007, LIMNOL OCEANOGR, V52, P156, DOI 10.4319/lo.2007.52.1.0156; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Suntharalingam P, 2000, GLOBAL BIOGEOCHEM CY, V14, P429, DOI 10.1029/1999GB900032; Suntharalingam P, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050778; Yamagishi H, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000227; YOSHIDA N, 1984, NATURE, V307, P442, DOI 10.1038/307442a0; Yoshinari T, 1997, MAR CHEM, V56, P253, DOI 10.1016/S0304-4203(96)00073-4	38	90	95	7	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1127	1129		10.1126/science.aaa8380	http://dx.doi.org/10.1126/science.aaa8380			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045434				2022-12-28	WOS:000355590500045
J	Littman, ML				Littman, Michael L.			Reinforcement learning improves behaviour from evaluative feedback	NATURE			English	Review								Reinforcement learning is a branch of machine learning concerned with using experience gained through interacting with the world and evaluative feedback to improve a system's ability to make behavioural decisions. It has been called the artificial intelligence problem in a microcosm because learning algorithms must act autonomously to perform well and achieve their goals. Partly driven by the increasing availability of rich data, recent years have seen exciting advances in the theory and practice of reinforcement learning, including developments in fundamental technical areas such as generalization, planning, exploration and empirical methodology, leading to increasing applicability to real-life problems.	Brown Univ, Dept Comp Sci, Providence, RI 02912 USA	Brown University	Littman, ML (corresponding author), Brown Univ, Dept Comp Sci, Providence, RI 02912 USA.	mlittman@cs.brown.edu						Auer P, 2002, MACH LEARN, V47, P235, DOI 10.1023/A:1013689704352; BabeVroman M., 2011, P 28 INT C MACHINE L, P897; Baird L., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P30; Bellemare MG, 2013, J ARTIF INTELL RES, V47, P253, DOI 10.1613/jair.3912; Bellman R., 1957, DYNAMIC PROGRAMMING; Berry D A, 1985, BANDIT PROBLEMS SEQU; Bubeck, 2013, ADV NEURAL INFORM PR, P638; Campbell M, 2002, ARTIF INTELL, V134, P57, DOI 10.1016/S0004-3702(01)00129-1; Cushman F, 2013, PERS SOC PSYCHOL REV, V17, P273, DOI 10.1177/1088868313495594; Dayana P, 2008, CURR OPIN NEUROBIOL, V18, P185, DOI 10.1016/j.conb.2008.08.003; Gershman SJ, 2012, J MATH PSYCHOL, V56, P1, DOI 10.1016/j.jmp.2011.08.004; Jaakkola T., 1994, ADV NEURAL INFORM PR; Kaelbling L.P., 1993, LEARNING EMBEDDED SY; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Kearns M, 2002, MACH LEARN, V49, P209, DOI 10.1023/A:1017984413808; Knox W., 2009, P 5 INT C KNOWL CAPT, P9; Kober J, 2013, INT J ROBOT RES, V32, P1238, DOI 10.1177/0278364913495721; Kocsis L, 2006, LECT NOTES COMPUT SC, V4212, P282, DOI 10.1007/11871842_29; Langley P., 1988, Machine Learning, V3, P5, DOI 10.1023/A:1022623814640; Leffler B., 2009, P 26 INT C MACH LEAR, P32; Li L., 2011, P 4 ACM INT C WEB SE, P297, DOI DOI 10.1145/1935826.1935878; Li LH, 2011, MACH LEARN, V82, P399, DOI 10.1007/s10994-010-5225-4; Li Lihong, 2010, P 19 INT C WORLD WID, DOI DOI 10.1145/1772690.1772758; Loftin Robert, 2014, P 28 ASS ADV ART INT; Marivate V. N., 2013, P MACH LEARN CLIN DA; Minsky M. L., 1958, P S MECH THOUGHT PRO, P24; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Murphy SA, 2005, STAT MED, V24, P1455, DOI 10.1002/sim.2022; Newell A, 1955, P MARCH 1 3 1955 W J, P101, DOI DOI 10.1145/1455292.1455312; Ng A.Y., 2000, MACHINE LEARNING, V1, P2; Ng A.Y., 2003, P ADV NEURAL INFORM; Ng AY, 1999, MACHINE LEARNING, PROCEEDINGS, P278; Niv Y, 2013, NATURE, V500, P533, DOI 10.1038/500533a; Norvig P., 1994, ARTIF INTELL; Nouri A., 2009, P MULT S REINF LEARN; SAMUEL AL, 1959, IBM J RES DEV, V3, P211, DOI 10.1147/rd.441.0206; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SHAPLEY LS, 1953, P NATL ACAD SCI USA, V39, P1095, DOI 10.1073/pnas.39.10.1095; Shrager J, 2014, NAT REV CLIN ONCOL, V11, P109, DOI 10.1038/nrclinonc.2013.244; Singh S, 2010, IEEE T AUTON MENT DE, V2, P70, DOI 10.1109/TAMD.2010.2051031; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; Sutton R. S., 1990, Machine Learning: Proceedings of the Seventh International Conference (1990), P216; Sutton R. S., 2009, ADV NEURAL INFORM PR, V21, P1609; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Tesauro G, 2012, IBM J RES DEV, V56, DOI 10.1147/JRD.2012.2188931; Thomaz AL, 2008, ARTIF INTELL, V172, P716, DOI 10.1016/j.artint.2007.09.009; Thompson WR, 1933, BIOMETRIKA, V25, P285, DOI 10.2307/2332286; van Hasselt H., 2014, P 30 C UNC ART INT, P324; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; West RF, 2003, MEM COGNITION, V31, P243, DOI 10.3758/BF03194383	60	159	173	10	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					445	451		10.1038/nature14540	http://dx.doi.org/10.1038/nature14540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2AN	26017443				2022-12-28	WOS:000355286600031
J	Sherlock, JP; Taylor, PC; Buckley, CD; Cua, DJ				Sherlock, Jonathan P.; Taylor, Peter C.; Buckley, Christopher D.; Cua, Daniel J.			Spondyloarthropathy: interleukin 23 and disease modification	LANCET			English	Editorial Material							INTESTINAL INFLAMMATION; T-CELLS; ASSOCIATION; IL-23; CYTOKINE; IL23R; P19		[Sherlock, Jonathan P.; Buckley, Christopher D.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Rheumatol Res Grp, Birmingham B15 2TT, W Midlands, England; [Taylor, Peter C.] Univ Oxford, Kennedy Inst Rheumatol, Oxford OX1 2JD, England; [Sherlock, Jonathan P.; Taylor, Peter C.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX1 2JD, England; [Cua, Daniel J.] Merck Res Labs, Palo Alto, CA USA	University of Birmingham; University of Oxford; University of Oxford; Merck & Company	Sherlock, JP (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Rheumatol Res Grp, Birmingham B15 2TT, W Midlands, England.		Buckley, Christopher/AAN-6378-2021	Buckley, Christopher/0000-0001-6924-6402	Arthritis Research UK [19791] Funding Source: Medline; Versus Arthritis [19791] Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)		Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Ciccia F, 2009, ARTHRITIS RHEUM-US, V60, P955, DOI 10.1002/art.24389; Colbert RA, 2010, IMMUNOL REV, V233, P181, DOI 10.1111/j.0105-2896.2009.00865.x; Cua DJ, 2011, NAT MED, V17, P1055, DOI 10.1038/nm0911-1055; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; McGonagle D, 1998, LANCET, V352, P1137, DOI 10.1016/S0140-6736(97)12004-9; MIELANTS H, 1995, J RHEUMATOL, V22, P2273; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817	16	12	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2017	2018		10.1016/S0140-6736(15)60970-9	http://dx.doi.org/10.1016/S0140-6736(15)60970-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI7XK	26009213				2022-12-28	WOS:000354979100004
J	Kurti, L				Kuerti, Laszlo			Streamlining amine synthesis Bulky amine groups that help make many drugs more bioavailable can be added readily to organic compounds	SCIENCE			English	Editorial Material							CHEMISTRY		[Kuerti, Laszlo] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Kurti, L (corresponding author), Rice Univ, Dept Chem, POB 1892, Houston, TX 77005 USA.	kurti.laszlo@rice.edu		Kurti, Laszlo/0000-0002-3412-5894				Castle SL, 2014, NATURE, V516, P332, DOI 10.1038/516332a; de Meijere A., 2014, METAL CATALYZED CROS, V1-3; Gui JH, 2015, SCIENCE, V348, P886, DOI 10.1126/science.aab0245; Ishihara Y., 2013, PORTABLE CHEM CONSUL; Lo JC, 2014, J AM CHEM SOC, V136, P1304, DOI 10.1021/ja4117632; Rappoport Z., 2007, PATAI SERIES 2; Rapport Zoi, 2007, PATAIS CHEM FUNCTION, P1; Ricci A., 2008, AMINO GROUP CHEM SYN; Roughley SD, 2011, J MED CHEM, V54, P3451, DOI 10.1021/jm200187y; Wanka L, 2013, CHEM REV, V113, P3516, DOI 10.1021/cr100264t; Yudin A. K, 2011, CATALYZED CARBON HET	11	18	18	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					863	864		10.1126/science.aab2812	http://dx.doi.org/10.1126/science.aab2812			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999493				2022-12-28	WOS:000354877900019
J	O'Brien, EJ; Monk, JM; Palsson, BO				O'Brien, Edward J.; Monk, Jonathan M.; Palsson, Bernhard O.			Using Genome-scale Models to Predict Biological Capabilities	CELL			English	Article							ALTERNATE OPTIMAL-SOLUTIONS; CONSTRAINT-BASED MODELS; ESCHERICHIA-COLI; METABOLIC NETWORK; GLOBAL RECONSTRUCTION; CELLULAR-METABOLISM; ADAPTIVE EVOLUTION; HIGH-THROUGHPUT; EXPRESSION; PHENOTYPE	Constraint-based reconstruction and analysis (COBRA) methods at the genome scale have been under development since the first whole-genome sequences appeared in the mid-1990s. A few years ago, this approach began to demonstrate the ability to predict a range of cellular functions, including cellular growth capabilities on various substrates and the effect of gene knockouts at the genome scale. Thus, much interest has developed in understanding and applying these methods to areas such as metabolic engineering, antibiotic design, and organismal and enzyme evolution. This Primer will get you started.	[O'Brien, Edward J.; Monk, Jonathan M.; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Monk, Jonathan M.] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA; [Palsson, Bernhard O.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [O'Brien, Edward J.] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Palsson, Bernhard O.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Technical University of Denmark	Palsson, BO (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	palsson@ucsd.edu		Monk, Jonathan M./0000-0002-3895-8949; Palsson, Bernhard/0000-0003-2357-6785	Novo Nordisk Foundation; National Institutes of Health [R01 GM057089]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [Network Reconstruction] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057089] Funding Source: NIH RePORTER	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by The Novo Nordisk Foundation and the National Institutes of Health grant number R01 GM057089.	Adkins J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00313; Agren R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002980; Agren R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002518; Barua D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000970; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Bordbar A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.68; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Campodonico MA, 2014, METAB ENG, V25, P140, DOI 10.1016/j.ymben.2014.07.009; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; Chang RL, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-102; Chang RL, 2013, SCIENCE, V340, P1220, DOI 10.1126/science.1234012; Collakova E, 2012, PLANT SCI, V191, P53, DOI 10.1016/j.plantsci.2012.04.010; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Cvijovic M, 2011, MICROB BIOTECHNOL, V4, P572, DOI 10.1111/j.1751-7915.2010.00233.x; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Edwards JS, 1999, J BIOL CHEM, V274, P17410, DOI 10.1074/jbc.274.25.17410; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Fong NL, 2013, FEMS MICROBIOL LETT, V342, P62, DOI 10.1111/1574-6968.12109; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Harcombe WR, 2014, CELL REP, V7, P1104, DOI 10.1016/j.celrep.2014.03.070; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; King Z.A., 2014, ESCHER ESCHER 1 0 0; Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002; Lerman JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1928; Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Lewis NE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.47; Liu JK, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0110-6; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; McCloskey D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.18; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Monk J, 2014, SCIENCE, V344, P1448, DOI 10.1126/science.1253388; Monk J, 2014, NAT BIOTECHNOL, V32, P447, DOI 10.1038/nbt.2870; Nagarajan H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3809; Nakahigashi K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.65; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; Notebaart RA, 2014, P NATL ACAD SCI USA, V111, P11762, DOI 10.1073/pnas.1406102111; O'Brien EJ, 2015, CURR OPIN BIOTECH, V34, P125, DOI 10.1016/j.copbio.2014.12.017; O'Brien EJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.52; Oberhardt MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001116; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2010, BIOTECHNOL BIOENG, V107, P403, DOI 10.1002/bit.22844; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Osterlund T, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-36; Palsson B, 2000, NAT BIOTECHNOL, V18, P1147, DOI 10.1038/81125; Plata G, 2015, NATURE, V517, P369, DOI 10.1038/nature13827; Ranganathan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000744; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Reed JL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002662; Reed JL, 2003, J BACTERIOL, V185, P2692, DOI 10.1128/JB.185.9.2692-2699.2003; Rolfsson O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-155; Scheibe TD, 2009, MICROB BIOTECHNOL, V2, P274, DOI 10.1111/j.1751-7915.2009.00087.x; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schellenberger J, 2009, J BIOL CHEM, V284, P5457, DOI 10.1074/jbc.R800048200; Schmidt BJ, 2013, BIOINFORMATICS, V29, P2900, DOI 10.1093/bioinformatics/btt493; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Shoval O, 2012, SCIENCE, V336, P1157, DOI 10.1126/science.1217405; Stolyar S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100131; Sun YK, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-240; Swainston N, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-186; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846; Tepper N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016274; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thiele I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045635; Thiele I, 2010, BIOPHYS J, V98, P2072, DOI 10.1016/j.bpj.2010.01.060; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thiele I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000312; Thorleifsson SG, 2011, BIOINFORMATICS, V27, P2009, DOI 10.1093/bioinformatics/btr308; Williams TCR, 2010, PLANT PHYSIOL, V154, P311, DOI 10.1104/pp.110.158535; Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58; Zhang Y, 2009, SCIENCE, V325, P1544, DOI 10.1126/science.1174671; Zhuang K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.34; Zhuang K, 2011, ISME J, V5, P305, DOI 10.1038/ismej.2010.117	91	387	392	17	199	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					971	987		10.1016/j.cell.2015.05.019	http://dx.doi.org/10.1016/j.cell.2015.05.019			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000478	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000355152600007
J	Levsky, JM; Spevack, DM; Travin, MI; Menegus, MA; Huang, PW; Clark, ET; Kim, CW; Hirschhorn, E; Freeman, KD; Tobin, JN; Haramati, LB				Levsky, Jeffrey M.; Spevack, Daniel M.; Travin, Mark I.; Menegus, Mark A.; Huang, Paul W.; Clark, Elana T.; Kim, Choo-won; Hirschhorn, Esther; Freeman, Katherine D.; Tobin, Jonathan N.; Haramati, Linda B.			Coronary Computed Tomography Angiography Versus Radionuclide Myocardial Perfusion Imaging in Patients With Chest Pain Admitted to Telemetry A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CT ANGIOGRAPHY; CLINICAL-OUTCOMES; DIAGNOSTIC PERFORMANCE; EMERGENCY-DEPARTMENT; HEART-ASSOCIATION; AMERICAN-COLLEGE; ARTERY STENOSIS; NATIONAL HEART; TASK-FORCE; DISEASE	Background: The role of coronary computed tomography angiography (CCTA) in the management of symptomatic patients suspected of having coronary artery disease is expanding. However, prospective intermediate-term outcomes are lacking. Objective: To compare CCTA with conventional noninvasive testing. Design: Randomized, controlled comparative effectiveness trial. (ClinicalTrials.gov: NCT00705458) Setting: Telemetry-monitored wards of an inner-city medical center. Patients: 400 patients with acute chest pain (mean age, 57 years); 63% women; 54% Hispanic and 37% African-American; and low socioeconomic status. Intervention: CCTA or radionuclide stress myocardial perfusion imaging (MPI). Measurements: The primary outcome was cardiac catheterization not leading to revascularization within 1 year. Secondary outcomes included length of stay, resource utilization, and patient experience. Safety outcomes included death, major cardiovascular events, and radiation exposure. Results: Thirty (15%) patients who had CCTA and 32 (16%) who had MPI underwent cardiac catheterization within 1 year. Fifteen (7.5%) and 20 (10%) of these patients, respectively, did not undergo revascularization (difference, -2.5 percentage points [95% CI, -8.6 to 3.5 percentage points]; hazard ratio, 0.77 [CI, 0.40 to 1.49]; P = 0.44). Median length of stay was 28.9 hours for the CCTA group and 30.4 hours for the MPI group (P = 0.057). Median follow-up was 40.4 months. For the CCTA and MPI groups, the incidence of death (0.5% versus 3%; P = 0.12), non-fatal cardiovascular events (4.5% versus 4.5%), rehospitalization (43% versus 49%), emergency department visit (63% versus 58%), and outpatient cardiology visit (23% versus 21%) did not differ. Long-term, all-cause radiation exposure was lower for the CCTA group (24 versus 29 mSv; P < 0.001). More patients in the CCTA group graded their experience favorably (P = 0.001) and would undergo the examination again (P = 0.003). Limitation: This was a single-site study, and the primary outcome depended on clinical management decisions. Conclusion: The CCTA and MPI groups did not significantly differ in outcomes or resource utilization over 40 months. Compared with MPI, CCTA was associated with less radiation exposure and with a more positive patient experience.	Montefiore Med Ctr, Bronx, NY 10467 USA; Albert Einstein Coll Med, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Levsky, JM (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiol, 111 E 210th St, Bronx, NY 10467 USA.	jlevsky@montefiore.org	Tobin, Jonathan N./R-2413-2019	Tobin, Jonathan/0000-0003-4722-539X	American Heart Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001071, UL1TR001073, TL1TR001072] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Primary Funding Source: American Heart Association.	Amsterdam EA, 2010, CIRCULATION, V122, P1756, DOI 10.1161/CIR.0b013e3181ec61df; Anderson JL, 2013, J AM COLL CARDIOL, V61, pE179, DOI 10.1016/j.jacc.2013.01.014; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Chen MY, 2013, RADIOLOGY, V267, P76, DOI 10.1148/radiol.13122621; Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516; Duvall WL, 2014, J NUCL CARDIOL, V21, P305, DOI 10.1007/s12350-013-9823-y; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goldstein JA, 2007, J AM COLL CARDIOL, V49, P863, DOI 10.1016/j.jacc.2006.08.064; Goldstein JA, 2011, J AM COLL CARDIOL, V58, P1414, DOI 10.1016/j.jacc.2011.03.068; Hadamitzky M, 2013, J AM COLL CARDIOL, V62, P468, DOI 10.1016/j.jacc.2013.04.064; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; Hendel RC, 2009, J AM COLL CARDIOL, V53, P2201, DOI 10.1016/j.jacc.2009.02.013; Hermann LK, 2013, JAMA INTERN MED, V173, P1128, DOI 10.1001/jamainternmed.2013.850; Hlatky MA, 2012, J AM COLL CARDIOL, V60, P569, DOI 10.1016/j.jacc.2011.12.057; Hoffmann U, 2012, NEW ENGL J MED, V367, P299, DOI 10.1056/NEJMoa1201161; Hulten E, 2013, J AM COLL CARDIOL, V61, P880, DOI 10.1016/j.jacc.2012.11.061; Hulten E, 2013, AM J CARDIOL, V111, P479, DOI 10.1016/j.amjcard.2012.10.028; Levsky Jeffrey M, 2009, J Cardiovasc Comput Tomogr, V3, P264, DOI 10.1016/j.jcct.2009.05.006; Litt HI, 2012, NEW ENGL J MED, V366, P1393, DOI 10.1056/NEJMoa1201163; Mc Ardle BA, 2012, J AM COLL CARDIOL, V60, P1828, DOI 10.1016/j.jacc.2012.07.038; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; MEINERT CL, 1995, SCIENCE, V269, P795, DOI 10.1126/science.7638594; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Min JK, 2012, EUR HEART J, V33, P3088, DOI 10.1093/eurheartj/ehs315; Min JK, 2012, JAMA-J AM MED ASSOC, V308, P1237, DOI 10.1001/2012.jama.11274; Min JK, 2011, J AM COLL CARDIOL, V58, P849, DOI 10.1016/j.jacc.2011.02.074; Murthy VL, 2011, CIRCULATION, V124, P2215, DOI 10.1161/CIRCULATIONAHA.111.050427; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Patel Manesh R, 2010, N Engl J Med, V362, P886, DOI 10.1056/NEJMoa0907272; Rochitte CE, 2014, EUR HEART J, V35, P1120, DOI 10.1093/eurheartj/eht488; Shaw LJ, 2012, J AM COLL CARDIOL, V60, P2103, DOI 10.1016/j.jacc.2012.05.062; Shreibati JB, 2011, JAMA-J AM MED ASSOC, V306, P2128, DOI 10.1001/jama.2011.1652; Zhang T, 2013, AM HEART J, V166, P52, DOI 10.1016/j.ahj.2013.03.022	34	49	49	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2015	163	3					174	+		10.7326/M14-2948	http://dx.doi.org/10.7326/M14-2948			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO6EX	26052677	Green Accepted			2022-12-28	WOS:000359251100006
J	Zhang, YX; Fang, B; Emmett, MJ; Damle, M; Sun, Z; Feng, D; Armour, SM; Remsberg, JR; Jager, J; Soccio, RE; Steger, DJ; Lazar, MA				Zhang, Yuxiang; Fang, Bin; Emmett, Matthew J.; Damle, Manashree; Sun, Zheng; Feng, Dan; Armour, Sean M.; Remsberg, Jarrett R.; Jager, Jennifer; Soccio, Raymond E.; Steger, David J.; Lazar, Mitchell A.			Discrete functions of nuclear receptor Rev-erb alpha couple metabolism to the clock	SCIENCE			English	Article							CIRCADIAN-RHYTHM; IN-VIVO; TRANSCRIPTION; EXPRESSION; GENE; BETA; PATHWAYS; FAMILY; HEME	Circadian and metabolic physiology are intricately intertwined, as illustrated by Rev-erb alpha, a transcription factor (TF) that functions both as a core repressive component of the cell-autonomous clock and as a regulator of metabolic genes. Here, we show that Rev-erba modulates the clock and metabolism by different genomic mechanisms. Clock control requires Rev-erba to bind directly to the genome at its cognate sites, where it competes with activating ROR TFs. By contrast, Rev-erba regulates metabolic genes primarily by recruiting the HDAC3 co-repressor to sites to which it is tethered by cell type-specific transcription factors. Thus, direct competition between Rev-erba and ROR TFs provides a universal mechanism for self-sustained control of the molecular clock across all tissues, whereas Rev-erba uses lineage-determining factors to convey a tissue-specific epigenomic rhythm that regulates metabolism tailored to the specific need of that tissue.	[Zhang, Yuxiang; Fang, Bin; Emmett, Matthew J.; Damle, Manashree; Sun, Zheng; Feng, Dan; Armour, Sean M.; Remsberg, Jarrett R.; Jager, Jennifer; Soccio, Raymond E.; Steger, David J.; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Div Endocrinol Diabet & Metab, Dept Med,Dept Genet, Philadelphia, PA 19104 USA; [Zhang, Yuxiang; Fang, Bin; Emmett, Matthew J.; Damle, Manashree; Sun, Zheng; Feng, Dan; Armour, Sean M.; Remsberg, Jarrett R.; Jager, Jennifer; Soccio, Raymond E.; Steger, David J.; Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Sun, Zheng] Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Baylor College of Medicine	Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Div Endocrinol Diabet & Metab, Dept Med,Dept Genet, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Soccio, Raymond/M-7517-2019; Lazar, Mitchell A/AAF-3738-2019	Emmett, Matthew/0000-0002-8855-423X; Feng, Dan/0000-0001-5926-8894; Jager, Jennifer/0000-0003-3740-9742	NIH [R01 DK45586, K08 DK094968, R00 DK099443, R01 DK098542, F32 DK102284, F30 DK104513, T32 GM0008275]; Cox Medical Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, R01DK045586, P30DK050306, R00DK099443, R01DK098542, F32DK102284, F30DK104513, K08DK094968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cox Medical Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ChIP-seq and microarray data have been deposited in the Gene Expression Omnibus (GSE67973). We thank S. Sidoli and B. A. Garcia for assistance with mass spectrometry. We acknowledge the Functional Genomics Core and the Viral Vector Core of the Penn Diabetes Research Center (P30 DK19525) for next-generation sequencing and virus preparation, respectively. We thank the Penn Digestives Disease Center Morphology Core (P30 DK050306) for histology studies and the Molecular Profiling Core for microarray analysis. This work was supported by NIH R01 DK45586 (M.A.L.), K08 DK094968 (R.E.S.), R00 DK099443 (Z.S.), R01 DK098542 (D.J.S.), F32 DK102284 (S.M.A.), F30 DK104513 (M.J.E.), T32 GM0008275 (J.R.R.), and the Cox Medical Research Institute.	Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Everett LJ, 2014, TRENDS ENDOCRIN MET, V25, P586, DOI 10.1016/j.tem.2014.06.011; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Faure AJ, 2012, GENOME RES, V22, P2163, DOI 10.1101/gr.136507.111; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; FORMAN BM, 1994, MOL ENDOCRINOL, V8, P1253, DOI 10.1210/me.8.9.1253; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Hardin PE, 2013, CURR OPIN NEUROBIOL, V23, P724, DOI 10.1016/j.conb.2013.02.018; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Heldring N, 2011, MOL ENDOCRINOL, V25, P564, DOI 10.1210/me.2010-0425; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Solt LA, 2012, TRENDS ENDOCRIN MET, V23, P619, DOI 10.1016/j.tem.2012.05.012; Stashi E, 2014, CELL REP, V6, P633, DOI 10.1016/j.celrep.2014.01.027; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takeda Y, 2012, NUCLEIC ACIDS RES, V40, P8519, DOI 10.1093/nar/gks630; Wang LG, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku846; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	28	195	201	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1488	1492		10.1126/science.aab3021	http://dx.doi.org/10.1126/science.aab3021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26044300	Green Accepted			2022-12-28	WOS:000356869100046
J	Madabhushi, R; Gao, F; Pfenning, AR; Pan, L; Yamakawa, S; Seo, J; Rueda, R; Phan, TX; Yamakawa, H; Pao, PC; Stott, RT; Gjoneska, E; Nott, A; Cho, S; Kellis, M; Tsai, LH				Madabhushi, Ram; Gao, Fan; Pfenning, Andreas R.; Pan, Ling; Yamakawa, Satoko; Seo, Jinsoo; Rueda, Richard; Phan, Trongha X.; Yamakawa, Hidekuni; Pao, Ping-Chieh; Stott, Ryan T.; Gjoneska, Elizabeta; Nott, Alexi; Cho, Sukhee; Kellis, Manolis; Tsai, Li-Huei			Activity-Induced DNA Breaks Govern the Expression of Neuronal Early-Response Genes	CELL			English	Article							TOPOISOMERASE-II-BETA; DOUBLE-STRAND BREAKS; CHROMATIN STATE; PROTEIN-KINASE; TRANSCRIPTION; GENOME; DAMAGE; REPAIR; HDAC1; PHOSPHORYLATION	Neuronal activity causes the rapid expression of immediate early genes that are crucial for experience-driven changes to synapses, learning, and memory. Here, using both molecular and genome-wide next-generation sequencing methods, we report that neuronal activity stimulation triggers the formation of DNA double strand breaks (DSBs) in the promoters of a subset of early-response genes, including Fos, Npas4, and Egr1. Generation of targeted DNA DSBs within Fos and Npas4 promoters is sufficient to induce their expression even in the absence of an external stimulus. Activity-dependent DSB formation is likely mediated by the type II topoisomerase, Topoisomerase IIb (Topo IIb), and knockdown of Topo IIb attenuates both DSB formation and early-response gene expression following neuronal stimulation. Our results suggest that DSB formation is a physiological event that rapidly resolves topological constraints to early-response gene expression in neurons.	[Madabhushi, Ram; Gao, Fan; Pan, Ling; Yamakawa, Satoko; Seo, Jinsoo; Rueda, Richard; Phan, Trongha X.; Yamakawa, Hidekuni; Pao, Ping-Chieh; Stott, Ryan T.; Gjoneska, Elizabeta; Nott, Alexi; Cho, Sukhee; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Pfenning, Andreas R.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Pfenning, Andreas R.; Gjoneska, Elizabeta; Kellis, Manolis; Tsai, Li-Huei] Broad Inst Harvard, Cambridge, MA 02139 USA; [Pfenning, Andreas R.; Gjoneska, Elizabeta; Kellis, Manolis; Tsai, Li-Huei] MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Seo, Jinsoo/AAD-4950-2019; Nott, Alexi/K-6103-2019; Kellis, Manolis/ABE-7385-2020; Pao, Ping-Chieh/AAG-9742-2019	Seo, Jinsoo/0000-0001-6432-6964; Nott, Alexi/0000-0002-2029-7193; Kellis, Manolis/0000-0001-7113-9630; Pao, Ping-Chieh/0000-0001-6788-7185; Rueda, Richard/0000-0002-0191-6921; /0000-0002-3447-9801	Lord Foundation Fellowship; NIH/NHGRI [R01HG004037-07, RC1HG005334]; NIH [R01AG046174]; Glenn Foundation; Belfer Neurodegeneration Consortium; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007610, RC1HG005334, R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046174] Funding Source: NIH RePORTER	Lord Foundation Fellowship; NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation; Belfer Neurodegeneration Consortium; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank Dr. Yingxi Lin (Massachusetts Institute of Technology) for kindly providing the Fos and Npas4 luciferase reporter constructs. This work was supported by the Lord Foundation Fellowship to R.T.S, the NIH/NHGRI (R01HG004037-07 and RC1HG005334) awards to M.K., and NIH R01AG046174, the Glenn Foundation, and the Belfer Neurodegeneration Consortium grants to L.-H.T.	Alvarez-Quilon A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4347; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Crowe SL, 2006, EUR J NEUROSCI, V23, P2351, DOI 10.1111/j.1460-9568.2006.04768.x; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Gomez-Herreros F, 2014, NAT GENET, V46, P516, DOI 10.1038/ng.2929; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Madabhushi R, 2014, NEURON, V83, P266, DOI 10.1016/j.neuron.2014.06.034; McKinnon PJ, 2013, NAT NEUROSCI, V16, P1523, DOI 10.1038/nn.3537; Nitiss J. L., 2012, CURR PROTOC PHARM; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sala C, 2003, J NEUROSCI, V23, P6327; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; Teves SS, 2014, NAT STRUCT MOL BIOL, V21, P88, DOI 10.1038/nsmb.2723; Tiwari VK, 2012, P NATL ACAD SCI USA, V109, pE934, DOI 10.1073/pnas.1119798109; Veuger SJ, 2003, CANCER RES, V63, P6008; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang WY, 2013, NAT NEUROSCI, V16, P1383, DOI 10.1038/nn.3514; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; YANKULOV K, 1995, J BIOL CHEM, V270, P23922, DOI 10.1074/jbc.270.41.23922	34	380	386	3	60	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1592	1605		10.1016/j.cell.2015.05.032	http://dx.doi.org/10.1016/j.cell.2015.05.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26052046	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000356618200016
J	Nedialkova, DD; Leidel, SA				Nedialkova, Danny D.; Leidel, Sebastian A.			Optimization of Codon Translation Rates via tRNA Modifications Maintains Proteome Integrity	CELL			English	Article							POLYPEPTIDE-ASSOCIATED COMPLEX; IN-VIVO; MISFOLDED PROTEINS; ELONGATOR COMPLEX; QUALITY-CONTROL; MODIFIER URM1; RIBOSOME; YEAST; AGGREGATION; DISEASES	Proteins begin to fold as they emerge from translating ribosomes. The kinetics of ribosome transit along a given mRNA can influence nascent chain folding, but the extent to which individual codon translation rates impact proteome integrity remains unknown. Here, we show that slower decoding of discrete codons elicits widespread protein aggregation in vivo. Using ribosome profiling, we find that loss of anticodon wobble uridine (U-34) modifications in a subset of tRNAs leads to ribosome pausing at their cognate codons in S. cerevisiae and C. elegans. Cells lacking U-34 modifications exhibit gene expression hallmarks of proteotoxic stress, accumulate aggregates of endogenous proteins, and are severely compromised in clearing stress-induced protein aggregates. Overexpression of hypomodified tRNAs alleviates ribosome pausing, concomitantly restoring protein homeostasis. Our findings demonstrate that modified U-34 is an evolutionarily conserved accelerator of decoding and reveal an unanticipated role for tRNA modifications in maintaining proteome integrity.	[Nedialkova, Danny D.; Leidel, Sebastian A.] Max Planck Inst Mol Biomed, Max Planck Res Grp RNA Biol, D-48149 Munster, Germany; [Nedialkova, Danny D.; Leidel, Sebastian A.] Univ Munster, Cells Mot Cluster Excellence, D-48149 Munster, Germany; [Leidel, Sebastian A.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; University of Munster; University of Munster	Leidel, SA (corresponding author), Max Planck Inst Mol Biomed, Max Planck Res Grp RNA Biol, Von Esmarch Str 54, D-48149 Munster, Germany.	sebastian.leidel@mpi-muenster.mpg.de	Leidel, Sebastian/K-9507-2019	Leidel, Sebastian/0000-0002-0523-6325; /0000-0001-8598-6021	NIH Office of Research Infrastructure Programs [P40 OD010440]; Max Planck Society; North Rhine-Westphalian Ministry for Innovation, Science and Research [314-40001009]; European Research Council [ERC-2012-StG 310489-tRNAmodi]; EMBO Long-Term Fellowship [ALTF1291-2010]	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck SocietyFoundation CELLEX); North Rhine-Westphalian Ministry for Innovation, Science and Research; European Research Council(European Research Council (ERC)European Commission); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO))	We thank K. Buhne for technical support, S. Mitani, S. Tuck, P. Gonczy, and E. Liebau for reagents, H. Drexler and A. Nolte for mass spectrometry, F. Konert and C. Graf for sequencing, D. Eccles, J.M. Vaquerizas, B. Habermann, R. Luna, and M. Delattre for advice, A. Bertolotti for insightful suggestions, and A.J. te Velthuis, S. Starck, P. Gonczy, G. Rabut, K. Bartscherer, and E.J. Snijder for comments on the manuscript. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). This work was supported by the Max Planck Society and grants from the North Rhine-Westphalian Ministry for Innovation, Science and Research (314-40001009), and the European Research Council (ERC-2012-StG 310489-tRNAmodi) (to S.A.L.); D.D.N. received an EMBO Long-Term Fellowship (ALTF1291-2010).	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Chen CC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000561; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Fluitt A, 2007, COMPUT BIOL CHEM, V31, P335, DOI 10.1016/j.compbiolchem.2007.07.003; Torres AG, 2014, TRENDS MOL MED, V20, P306, DOI 10.1016/j.molmed.2014.01.008; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Geiler-Samerotte KA, 2011, P NATL ACAD SCI USA, V108, P680, DOI 10.1073/pnas.1017570108; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Glatt S, 2013, CURR OPIN STRUC BIOL, V23, P235, DOI 10.1016/j.sbi.2013.02.009; Grosjean H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004363; Grosjean H, 2010, FEBS LETT, V584, P252, DOI 10.1016/j.febslet.2009.11.052; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kirstein-Miles J, 2013, EMBO J, V32, P1451, DOI 10.1038/emboj.2013.87; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Koplin A, 2010, J CELL BIOL, V189, P57, DOI 10.1083/jcb.200910074; Kramer EB, 2010, RNA, V16, P1797, DOI 10.1261/rna.2201210; Lareau LF, 2014, ELIFE, V3, DOI 10.7554/eLife.01257; Laxman S, 2013, CELL, V154, P416, DOI 10.1016/j.cell.2013.06.043; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Nakai Y, 2008, J BIOL CHEM, V283, P27469, DOI 10.1074/jbc.M804043200; O'Brien EP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3988; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Pechmann S, 2013, MOL CELL, V49, P411, DOI 10.1016/j.molcel.2013.01.020; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Phizicky EM, 2010, FEBS LETT, V584, P265, DOI 10.1016/j.febslet.2009.11.049; Preiss T, 2003, NAT STRUCT BIOL, V10, P1039, DOI 10.1038/nsb1015; Rezgui VAN, 2013, P NATL ACAD SCI USA, V110, P12289, DOI 10.1073/pnas.1300781110; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Schlieker CD, 2008, P NATL ACAD SCI USA, V105, P18255, DOI 10.1073/pnas.0808756105; Shigi N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00067; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; Stadler M, 2011, RNA, V17, P2063, DOI 10.1261/rna.02890211; Tarrant D, 2014, CELL MOL LIFE SCI, V71, P4195, DOI 10.1007/s00018-014-1684-2; Taylor R.C., 2011, COLD SPRING HARB PER, V3; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Walker J, 2011, GENETICS, V187, P1067, DOI 10.1534/genetics.110.123893; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Xu Y, 2013, NATURE, V495, P116, DOI 10.1038/nature11942; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833; Zinshteyn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003675	60	303	307	2	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1606	1618		10.1016/j.cell.2015.05.022	http://dx.doi.org/10.1016/j.cell.2015.05.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26052047	hybrid, Green Published			2022-12-28	WOS:000356618200017
J	Peelaerts, W; Bousset, L; Van der Perren, A; Moskalyuk, A; Pulizzi, R; Giugliano, M; Van den Haute, C; Melki, R; Baekelandt, V				Peelaerts, W.; Bousset, L.; Van der Perren, A.; Moskalyuk, A.; Pulizzi, R.; Giugliano, M.; Van den Haute, C.; Melki, R.; Baekelandt, V.			alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration	NATURE			English	Article							PARKINSONS-DISEASE; LEWY BODIES; SUBSTANTIA-NIGRA; PATHOLOGY; NEURONS; TRANSMISSION; NEURODEGENERATION; OVEREXPRESSION; FIBRILLAR; BRAIN	Misfolded protein aggregates represent a continuum with overlapping features in neurodegenerative diseases, but differences in protein components and affected brain regions(1). The molecular hallmark of synucleinopathies such as Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are megadalton alpha-synuclein-rich deposits suggestive of one molecular event causing distinct disease phenotypes. Glial alpha-synuclein (alpha-SYN) filamentous deposits are prominent in multiple system atrophy and neuronal alpha-SYN inclusions are found in Parkinson's disease and dementia with Lewy bodies(2). The discovery of alpha-SYN assemblies with different structural characteristics or 'strains' has led to the hypothesis that strains could account for the different clinicopathological traits within synucleinopathies(3,4). In this study we show that alpha-SYN strain conformation and seeding propensity lead to distinct histopathological and behavioural phenotypes. We assess the properties of structurally well-defined alpha-SYN assemblies (oligomers, ribbons and fibrils) after injection in rat brain. We prove that alpha-SYN strains amplify in vivo. Fibrils seem to be the major toxic strain, resulting in progressive motor impairment and cell death, whereas ribbons cause a distinct histopathological phenotype displaying Parkinson's disease and multiple system atrophy traits. Additionally, we show that alpha-SYN assemblies cross the blood-brain barrier and distribute to the central nervous system after intravenous injection. Our results demonstrate that distinct alpha-SYN strains display differential seeding capacities, inducing strain-specific pathology and neurotoxic phenotypes.	[Peelaerts, W.; Van der Perren, A.; Van den Haute, C.; Baekelandt, V.] Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Dept Neurosci, B-3000 Leuven, Belgium; [Bousset, L.; Melki, R.] CNRS, Paris Saclay Inst Neurosci, F-91198 Gif Sur Yvette, France; [Moskalyuk, A.; Pulizzi, R.; Giugliano, M.] Univ Antwerp, Dept Biomed Sci, Theoret Neurobiol & Neuroengn Lab, B-2610 Antwerp, Belgium; [Giugliano, M.] Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England; [Giugliano, M.] Swiss Fed Inst Technol Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Giugliano, M.] Neuroelect Res Flanders NERF, B-3001 Leuven, Belgium; [Van den Haute, C.] Katholieke Univ Leuven, Viral Vector Core, B-3000 Leuven, Belgium	KU Leuven; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Antwerp; University of Sheffield; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; KU Leuven	Baekelandt, V (corresponding author), Katholieke Univ Leuven, Lab Neurobiol & Gene Therapy, Dept Neurosci, B-3000 Leuven, Belgium.	ronald.melki@lebs.cnrs-gif.fr; veerle.baekelandt@med.kuleuven.be	Baekelandt, Veerle/ABB-9736-2020; Van der Perren, Anke/AAY-7274-2020; Giugliano, Michele/A-5666-2012	Baekelandt, Veerle/0000-0001-8966-2921; Giugliano, Michele/0000-0003-2626-594X; bousset, luc/0000-0002-0433-4337; Van der Perren, Anke/0000-0003-2924-7392; Moskalyuk, Anastasiya/0000-0002-4802-1877; peelaerts, WOUTER/0000-0003-3776-4162	FWO-Vlaanderen [G.0768.10, G.0927.14]; IWT-Vlaanderen [IWT SBO/80020 Neuro-TARGET, SBO/110068 OPTOBRAIN, SBO/130065 MIRIAD]; FP7 RTD project MEFOPA [HEALTH-2009-241791]; FP7 RTD project INMiND [HEALTH-F2-2011-278850]; KU Leuven [OT/08/052A, OT/14/120, IMIR PF/10/017]; Agence Nationale de la Recherche [ANR-09-MNPS-013-01, ANR-11-BSV8-021-01]; Centre National de la Recherche Scientifique; 'Coup d'Elan a la Recherche Francaise' award from Fondation Bettencourt Schueller; EC-FP7 (Marie Curie Initial Training Network "NAMASEN") [264872]; ICT-FET project "ENLIGHTENMENT"; ICT-FET project "BRAINLEAP" [284801, 306502]; Belgian Science Policy Office [IUAP-VII/20]	FWO-Vlaanderen(FWO); IWT-Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); FP7 RTD project MEFOPA; FP7 RTD project INMiND; KU Leuven(KU Leuven); Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); 'Coup d'Elan a la Recherche Francaise' award from Fondation Bettencourt Schueller; EC-FP7 (Marie Curie Initial Training Network "NAMASEN"); ICT-FET project "ENLIGHTENMENT"; ICT-FET project "BRAINLEAP"; Belgian Science Policy Office(Belgian Federal Science Policy Office)	We thank J. Van Asselbergs and C. van Heijningen for their technical assistance and Z. Debyser for revising the manuscript. We thank J. Hofkens and C. David for the use of the CLSM and V. Redeker for assessing the number of atto dyes bound to alpha-SYN by mass spectrometry. The authors thank the Leuven Viral Vector Core (LVVC) for the rAAV vector construction, optimization and production. M.G., R.P., and A.M. thank M. Wijnants and D. Van Dyck for their excellent technical assistance. Research was funded by the FWO-Vlaanderen (G.0768.10, G.0927.14 and PhD fellowship to W.P.), the IWT-Vlaanderen (IWT SBO/80020 Neuro-TARGET, SBO/110068 OPTOBRAIN and SBO/130065 MIRIAD), the FP7 RTD projects MEFOPA (HEALTH-2009-241791) and INMiND (HEALTH-F2-2011-278850), the KU Leuven (OT/08/052A, OT/14/120, IMIR PF/10/017), the Agence Nationale de la Recherche (ANR-09-MNPS-013-01 and ANR-11-BSV8-021-01), the Centre National de la Recherche Scientifique, a 'Coup d'Elan a la Recherche Francaise' award from Fondation Bettencourt Schueller, the EC-FP7 (Marie Curie Initial Training Network "NAMASEN", grant n. 264872, the ICT-FET projects "ENLIGHTENMENT" and "BRAINLEAP", grants no. 284801 and 306502), and the Belgian Science Policy Office (grant no. IUAP-VII/20). The authors declare that there is no actual or potential conflict of interest.	Baekelandt V, 2002, HUM GENE THER, V13, P841, DOI 10.1089/10430340252899019; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Holmqvist S, 2014, ACTA NEUROPATHOL, V128, P805, DOI 10.1007/s00401-014-1343-6; Janezic S, 2013, P NATL ACAD SCI USA, V110, pE4016, DOI 10.1073/pnas.1309143110; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Lee HJ, 2014, NAT REV NEUROL, V10, P92, DOI 10.1038/nrneurol.2013.275; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Linaro D, 2014, J NEUROSCI METH, V230, P5, DOI 10.1016/j.jneumeth.2014.04.003; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Mabbott NA, 2006, NAT REV MICROBIOL, V4, P201, DOI 10.1038/nrmicro1346; Mahmud M, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00026; Milber JM, 2012, NEUROLOGY, V79, P2307, DOI 10.1212/WNL.0b013e318278fe32; Oliveras-Salva M, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-44; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Redeker V, 2012, J BIOL CHEM, V287, P32630, DOI 10.1074/jbc.M112.387530; Reinartz S, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00071; Rey NL, 2013, ACTA NEUROPATHOL, V126, P555, DOI 10.1007/s00401-013-1160-3; Reyes JF, 2014, GLIA, V62, P387, DOI 10.1002/glia.22611; Sacino AN, 2014, P NATL ACAD SCI USA, V111, P10732, DOI 10.1073/pnas.1321785111; Sacino AN, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-38; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Ulusoy Ayse, 2010, Prog Brain Res, V184, P89, DOI 10.1016/S0079-6123(10)84005-1; Van der Perren A, 2011, GENE THER, V18, P517, DOI 10.1038/gt.2010.179; Van der Perren A, 2015, NEUROBIOL AGING, V36, P1543, DOI 10.1016/j.neurobiolaging.2014.11.015; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108	36	737	749	3	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 18	2015	522	7556					340	+		10.1038/nature14547	http://dx.doi.org/10.1038/nature14547			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7PU	26061766	Green Submitted			2022-12-28	WOS:000356425400053
J	Gerten, D; Rockstrom, J; Heinke, J; Steffen, W; Richardson, K; Cornell, S				Gerten, Dieter; Rockstrom, Johan; Heinke, Jens; Steffen, Will; Richardson, Katherine; Cornell, Sarah			Response to Comment on "Planetary boundaries: Guiding human development on a changing planet"	SCIENCE			English	Editorial Material							WATER-RESOURCES	Jaramillo and Destouni claim that freshwater consumption is beyond the planetary boundary, based on high estimates of water cycle components, different definitions of water consumption, and extrapolation from a single case study. The difference from our analysis, based on mainstream assessments of global water consumption, highlights the need for clearer definitions of water cycle components and improved models and databases.	[Gerten, Dieter; Heinke, Jens] Potsdam Inst Climate Impact Res, Res Domain Earth Syst Anal, D-14473 Potsdam, Germany; [Rockstrom, Johan; Steffen, Will; Cornell, Sarah] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Heinke, Jens] Int Livestock Res Inst, Nairobi 00100, Kenya; [Heinke, Jens] Commonwealth Sci & Ind Res Org, St Lucia, Qld 4067, Australia; [Steffen, Will] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT 2601, Australia; [Richardson, Katherine] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark	Potsdam Institut fur Klimafolgenforschung; Stockholm University; CGIAR; International Livestock Research Institute (ILRI); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; University of Copenhagen	Gerten, D (corresponding author), Potsdam Inst Climate Impact Res, Res Domain Earth Syst Anal, D-14473 Potsdam, Germany.	gerten@pik-potsdam.de	Gerten, Dieter/B-2975-2013; Richardson, Katherine/D-7592-2014; Cornell, Sarah/F-7003-2014	Gerten, Dieter/0000-0002-6214-6991; Richardson, Katherine/0000-0003-3785-2787; Cornell, Sarah/0000-0003-4367-1296; Rockstrom, Johan/0000-0001-8988-2983				Destouni G, 2013, NAT CLIM CHANGE, V3, P213, DOI [10.1038/NCLIMATE1719, 10.1038/nclimate1719]; Doll P, 2009, HYDROL EARTH SYST SC, V13, P2413; Gerten D, 2013, CURR OPIN ENV SUST, V5, P551, DOI 10.1016/j.cosust.2013.11.001; Gleick PH, 2003, SCIENCE, V302, P1524, DOI 10.1126/science.1089967; Gordon LJ, 2005, P NATL ACAD SCI USA, V102, P7612, DOI 10.1073/pnas.0500208102; Jaramillo F, 2015, SCIENCE, V348, DOI 10.1126/science.aaa9629; Molden D., 2009, NAT REP CLIM CHANGE, V1, P116, DOI [10.1038/climate.2009.97, DOI 10.1038/CLIMATE.2009.97]; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rost S, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006331; Shiklomanov IA., 2004, WORLD WATER RESOURCE; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Vorosmarty C. J., 2005, ECOSYSTEMS HUMAN WEL	13	20	22	7	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240							1217-d	10.1126/science.aab0031	http://dx.doi.org/10.1126/science.aab0031			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK2AK	26068844				2022-12-28	WOS:000356011500042
J	Kumar, NN; Velic, A; Soliz, J; Shi, YT; Li, KY; Wang, S; Weaver, JL; Sen, J; Abbott, SBG; Lazarenko, RM; Ludwig, MG; Perez-Reyes, E; Mohebbi, N; Bettoni, C; Gassmann, M; Suply, T; Seuwen, K; Guyenet, PG; Wagner, CA; Bayliss, DA				Kumar, Natasha N.; Velic, Ana; Soliz, Jorge; Shi, Yingtang; Li, Keyong; Wang, Sheng; Weaver, Janelle L.; Sen, Josh; Abbott, Stephen B. G.; Lazarenko, Roman M.; Ludwig, Marie-Gabrielle; Perez-Reyes, Edward; Mohebbi, Nilufar; Bettoni, Carla; Gassmann, Max; Suply, Thomas; Seuwen, Klaus; Guyenet, Patrice G.; Wagner, Carsten A.; Bayliss, Douglas A.			Regulation of breathing by CO2 requires the proton-activated receptor GPR4 in retrotrapezoid nucleus neurons	SCIENCE			English	Article							CENTRAL HYPOVENTILATION SYNDROME; CHEMORECEPTOR NEURONS; PH SENSOR; CHEMOSENSITIVITY; SENSITIVITY; ASTROCYTES; EXPRESSION; CONTRIBUTE; MUTATION; RATS	Blood gas and tissue pH regulation depend on the ability of the brain to sense CO2 and/or H+ and alter breathing appropriately, a homeostatic process called central respiratory chemosensitivity. We show that selective expression of the proton-activated receptor GPR4 in chemosensory neurons of the mouse retrotrapezoid nucleus (wRTN) is required for CO2-stimulated breathing. Genetic deletion of GPR4 disrupted acidosis-dependent activation of RTN neurons, increased apnea frequency, and blunted ventilatory responses to CO2. Reintroduction of GPR4 into RTN neurons restored CO2-dependent RTN neuronal activation and rescued the ventilatory phenotype. Additional elimination of TASK-2 (K(2P)5), a pH-sensitive K+ channel expressed in RTN neurons, essentially abolished the ventilatory response to CO2. The data identify GPR4 and TASK-2 as distinct, parallel, and essential central mediators of respiratory chemosensitivity.	[Kumar, Natasha N.; Shi, Yingtang; Li, Keyong; Wang, Sheng; Weaver, Janelle L.; Sen, Josh; Abbott, Stephen B. G.; Lazarenko, Roman M.; Perez-Reyes, Edward; Guyenet, Patrice G.; Bayliss, Douglas A.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Velic, Ana; Mohebbi, Nilufar; Bettoni, Carla; Wagner, Carsten A.] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Soliz, Jorge; Gassmann, Max] Univ Zurich, Inst Vet Physiol, Zurich, Switzerland; [Soliz, Jorge] Univ Laval, Fac Med, Dept Pediat, Ctr Rech,CHU Quebec, Quebec City, PQ G1K 7P4, Canada; [Wang, Sheng] Hebei Med Univ, Dept Physiol, Shijiazhuang 050017, Hebei, Peoples R China; [Abbott, Stephen B. G.] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Abbott, Stephen B. G.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Abbott, Stephen B. G.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Ludwig, Marie-Gabrielle; Suply, Thomas; Seuwen, Klaus] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland	University of Virginia; University of Zurich; University of Zurich; Laval University; Hebei Medical University; University of New South Wales Sydney; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Novartis	Wagner, CA (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	Wagnerca@access.uzh.ch; bayliss@virginia.edu	Kumar, Natasha N/C-1630-2016; LI, KEYONG/A-2394-2015; Soliz, Jorge/AAA-9752-2022	Kumar, Natasha N/0000-0003-4712-8792; LI, KEYONG/0000-0001-9682-7819; Gassmann, Max/0000-0003-2750-8878; Soliz, Jorge/0000-0002-2335-5862; Wang, Sheng/0000-0001-9579-4808; Abbott, Stephen BG/0000-0003-1244-3637; Weaver, Janelle/0000-0001-8677-8312	National Health and Medical Research Council of Australia Early Career Fellowship [GNT1052674]; Swiss National Science Foundation [31003A_155959/1]; National Institutes of Health [HL074011, HL108609]; Novartis [GPR65, GPR4 KO]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108609, R01HL074011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136, T32GM007267] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to members of the Bayliss and Guyenet laboratories and to Q. Al-Awqati (Columbia Univ., NYC) for useful suggestions on the studies. They thank S. Shu for technical assistance, R. L. Stornetta for advice on in situ hybridization, M. P. Beenhakker for the MATLAB routine used for Poincare analysis, and K. S. Ravichandran and P. Q. Barrett for comments on the manuscript. S.B.G.A. was supported by a National Health and Medical Research Council of Australia Early Career Fellowship (GNT1052674). The use of the ZIRP Core Facility for Rodent Phenotyping is acknowledged. The work was supported by the Swiss National Science Foundation (31003A_155959/1, C.A.W.) and the National Institutes of Health (HL074011, P.G.G.; HL108609, D.A.B.). GPR65 and GPR4 KO mice are available from M.-G.L. under a Material Transfer Agreement with Novartis. M.-G.L., T.S., and K.S. are inventors on patents WO 2004/1183A1 and WO 2008/071771A2 that pertain to the use of GPR4, GPR65, and GPR68 as pH sensors.	Abbott SBG, 2009, J NEUROSCI, V29, P5806, DOI 10.1523/JNEUROSCI.1106-09.2009; Antic NA, 2006, AM J RESP CRIT CARE, V174, P923, DOI 10.1164/rccm.200605-607CR; Chen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027586; Dong LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061991; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Fortuna MG, 2009, J PHYSIOL-LONDON, V587, P5121, DOI 10.1113/jphysiol.2009.176875; Garcia AJ, 2013, RESP PHYSIOL NEUROBI, V189, P288, DOI 10.1016/j.resp.2013.05.032; Gestreau C, 2010, P NATL ACAD SCI USA, V107, P2325, DOI 10.1073/pnas.0910059107; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Hwang DY, 2001, HUM GENE THER, V12, P1731, DOI 10.1089/104303401750476230; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Lazarenko RM, 2009, J COMP NEUROL, V517, P69, DOI 10.1002/cne.22136; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Ramanantsoa N, 2011, J NEUROSCI, V31, P12880, DOI 10.1523/JNEUROSCI.1721-11.2011; Sun XM, 2010, J AM SOC NEPHROL, V21, P1745, DOI 10.1681/ASN.2009050477; Teppema LJ, 1997, J COMP NEUROL, V388, P169, DOI 10.1002/(SICI)1096-9861(19971117)388:2<169::AID-CNE1>3.0.CO;2-#; Wang S, 2013, J NEUROSCI, V33, P16033, DOI 10.1523/JNEUROSCI.2451-13.2013; Wang S, 2013, J NEUROSCI, V33, P7756, DOI 10.1523/JNEUROSCI.5550-12.2013; Weese-Mayer DE, 2010, AM J RESP CRIT CARE, V181, P626, DOI 10.1164/rccm.200807-1069ST; Wenker IC, 2010, J NEUROPHYSIOL, V104, P3042, DOI 10.1152/jn.00544.2010; Wyder L, 2011, ANGIOGENESIS, V14, P533, DOI 10.1007/s10456-011-9238-9; Yang LV, 2007, MOL CELL BIOL, V27, P1334, DOI 10.1128/MCB.01909-06	25	143	144	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1255	1260		10.1126/science.aaa0922	http://dx.doi.org/10.1126/science.aaa0922			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068853	Green Accepted			2022-12-28	WOS:000356011500055
J	Zhang, YY; Desai, A; Yang, SY; Bae, KB; Antczak, MI; Fink, SP; Tiwari, S; Willis, JE; Williams, NS; Dawson, DM; Wald, D; Chen, WD; Wang, ZH; Kasturi, L; Larusch, GA; He, L; Cominelli, F; Di Martino, L; Djuric, Z; Milne, GL; Chance, M; Sanabria, J; Dealwis, C; Mikkola, D; Naidoo, J; Wei, SG; Tai, HH; Gerson, SL; Ready, JM; Posner, B; Willson, JKV; Markowitz, SD				Zhang, Yongyou; Desai, Amar; Yang, Sung Yeun; Bae, Ki Beom; Antczak, Monika I.; Fink, Stephen P.; Tiwari, Shruti; Willis, Joseph E.; Williams, Noelle S.; Dawson, Dawn M.; Wald, David; Chen, Wei-Dong; Wang, Zhenghe; Kasturi, Lakshmi; Larusch, Gretchen A.; He, Lucy; Cominelli, Fabio; Di Martino, Luca; Djuric, Zora; Milne, Ginger L.; Chance, Mark; Sanabria, Juan; Dealwis, Chris; Mikkola, Debra; Naidoo, Jacinth; Wei, Shuguang; Tai, Hsin-Hsiung; Gerson, Stanton L.; Ready, Joseph M.; Posner, Bruce; Willson, James K. V.; Markowitz, Sanford D.			Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration	SCIENCE			English	Article							15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; MEDICAL PROGRESS; STEM-CELLS; COLON; COLITIS; PROLIFERATION; HEPATECTOMY; ACTIVATION; SUPPRESSOR; SURVIVAL	Agents that promote tissue regeneration could be beneficial in a variety of clinical settings, such as stimulating recovery of the hematopoietic system after bone marrow transplantation. Prostaglandin PGE2, a lipid signaling molecule that supports expansion of several types of tissue stem cells, is a candidate therapeutic target for promoting tissue regeneration in vivo. Here, we show that inhibition of 15-hydroxyprostaglandin dehydrogenase (15-PGDH), a prostaglandin-degrading enzyme, potentiates tissue regeneration in multiple organs in mice. In a chemical screen, we identify a small-molecule inhibitor of 15-PGDH (SW033291) that increases prostaglandin PGE2 levels in bone marrow and other tissues. SW033291 accelerates hematopoietic recovery in mice receiving a bone marrow transplant. The same compound also promotes tissue regeneration in mouse models of colon and liver injury. Tissues from 15-PGDH knockout mice demonstrate similar increased regenerative capacity. Thus, 15-PGDH inhibition may be a valuable therapeutic strategy for tissue regeneration in diverse clinical contexts.	[Zhang, Yongyou; Desai, Amar; Yang, Sung Yeun; Bae, Ki Beom; Fink, Stephen P.; Tiwari, Shruti; Chen, Wei-Dong; Kasturi, Lakshmi; Larusch, Gretchen A.; He, Lucy; Cominelli, Fabio; Di Martino, Luca; Mikkola, Debra; Gerson, Stanton L.; Markowitz, Sanford D.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Yang, Sung Yeun] Inje Univ, Haeundae Paik Hosp, Dept Gastroenterol, Busan 612896, South Korea; [Bae, Ki Beom] Inje Univ, Dept Surg, Busan Paik Hosp, Busan, South Korea; [Bae, Ki Beom] Inje Univ, Paik Inst Clin Res, Busan, South Korea; [Bae, Ki Beom] Inje Univ, Ocular Neovasc Res Ctr, Busan, South Korea; [Antczak, Monika I.; Williams, Noelle S.; Naidoo, Jacinth; Wei, Shuguang; Ready, Joseph M.; Posner, Bruce] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Tiwari, Shruti; Willis, Joseph E.; Wald, David; Cominelli, Fabio; Sanabria, Juan; Gerson, Stanton L.; Markowitz, Sanford D.] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA; [Willis, Joseph E.; Dawson, Dawn M.; Wald, David; Wang, Zhenghe; Gerson, Stanton L.; Markowitz, Sanford D.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Willis, Joseph E.; Dawson, Dawn M.; Wald, David] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Wang, Zhenghe] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Djuric, Zora] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA; [Milne, Ginger L.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Chance, Mark] Case Western Reserve Univ, Prote Ctr, Cleveland, OH 44106 USA; [Sanabria, Juan] Case Western Reserve Univ, Dept Surg, Cleveland, OH 44106 USA; [Dealwis, Chris] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Tai, Hsin-Hsiung] Univ Kentucky, Coll Pharm, Lexington, KY 40536 USA; [Ready, Joseph M.; Posner, Bruce; Willson, James K. V.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA	Case Western Reserve University; Inje University; Inje University; Inje University; Inje University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Michigan System; University of Michigan; Vanderbilt University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Kentucky; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gerson, SL (corresponding author), Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA.	slg5@cwru.edu; joseph.ready@utsouthwestern.edu; bruce.posner@utsouthwestern.edu; james.willson@utsouthwestern.edu; sxm10@cwru.edu	Chen, Wei/GZK-7348-2022; Milne, Ginger/D-7648-2014; Djuric, Zora/H-5147-2013	Milne, Ginger/0000-0003-3890-151X; Djuric, Zora/0000-0002-8886-8853; zhang, yongyou/0000-0003-2413-9106; Fink, Stephen/0000-0003-4107-7912; Yang, Sung Yeun/0000-0002-9964-5743	NIH [P50 CA150964, P30 CA043703, R25CA148052, U54HL119810, 1P01CA95471-09, 5P30 CA142543-03]; Harrington Discovery Institute; Marguerite Wilson Foundation; Inje University; National Research Foundation, Ministry of Science, ICT and Future Planning of Korea [2014002213]; Welch Foundation [I-1612]; Cancer Prevention Research Institute of Texas [RP110708]; Howard Hughes Medical Institute;  [P50 CA130810];  [P30 DK097948]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA127590, P01CA095471, R25CA148052, P30CA142543, P50CA150964, P50CA130810] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL119810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097948, R01DK042191, P30DK020572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harrington Discovery Institute; Marguerite Wilson Foundation; Inje University; National Research Foundation, Ministry of Science, ICT and Future Planning of Korea; Welch Foundation(The Welch Foundation); Cancer Prevention Research Institute of Texas; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the members of the University of Texas Southwestern High-Throughput Screening (HTS) Core facility for their support of the high-throughput screen; A Dannenberg, D. Montrose, and M. Datt for helpful scientific discussions; and K. Lingas, B. Maitra, and J. Ren for helpful technical support. This work was funded by NIH grants P50 CA150964 (S.D.M.), P30 CA043703 (S.L.G.), R25CA148052 (Y.Z.), U54HL119810 (Paul DiCorleto), 1P01CA95471-09 (Steven McKnight and J.M.R.), and 5P30 CA142543-03 [The Simmons Cancer Center (J.K.V.W.)], which support the University of Texas Southwestern HTS Core Facility; P50 CA130810 (Dean Brenner); P30 DK097948 (F.C.); a Scholar Innovator Award from the Harrington Discovery Institute (S.D.M.); grants from the Marguerite Wilson Foundation (S.D.M.), Inje University (S.Y.Y. and K. B. B.), and National Research Foundation, Ministry of Science, ICT and Future Planning of Korea 2014002213 (K. B. B); the Welch Foundation (I-1612, J.M.R.); Cancer Prevention Research Institute of Texas (RP110708); a medical research fellowship from the Howard Hughes Medical Institute (L.H.); and gifts from the Leonard and Joan Horvitz Foundation (S.D.M) and the Richard Horvitz and Erica Hartman-Horvitz Foundation (S.D.M.). Case Western Reserve University, the University of Texas, and the University of Kentucky have filed patent applications (PCTq/US2013q/036790 and PCTq/US2013q/036790) related to SW033291 and other 15-PGDH inhibitors and their use in the treatment of disease.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Bendall LJ, 2014, CYTOKINE GROWTH F R, V25, P355, DOI 10.1016/j.cytogfr.2014.07.011; Benson AB, 2009, J NATL COMPR CANC NE, V7, P350, DOI 10.6004/jnccn.2009.0027; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Coggins KG, 2002, NAT MED, V8, P91, DOI 10.1038/nm0202-91; COOPER HS, 1993, LAB INVEST, V69, P238; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Copeland R.A., 2000, ENZYMES PRACTICAL IN, P305; Cutler C, 2013, BLOOD, V122, P3074, DOI 10.1182/blood-2013-05-503177; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Fink SP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008481; Frisch BJ, 2009, BLOOD, V114, P4054, DOI 10.1182/blood-2009-03-205823; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Hagedorn EJ, 2014, EXP CELL RES, V329, P220, DOI 10.1016/j.yexcr.2014.07.030; Hayashi M, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-27; Hoffman CM, 2014, MOL ENDOCRINOL, V28, P1592, DOI 10.1210/me.2014-1079; Hoggatt J, 2013, BLOOD, V122, P2997, DOI 10.1182/blood-2013-07-515288; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Lichtenstein GR, 2010, INFLAMM BOWEL DIS, V16, P338, DOI 10.1002/ibd.20997; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Norkin M, 2013, BONE MARROW TRANSPL, V48, P884, DOI 10.1038/bmt.2012.163; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pelus LM, 2011, CELL PROLIFERAT, V44, P22, DOI 10.1111/j.1365-2184.2010.00726.x; PELUS LM, 1979, J EXP MED, V150, P277, DOI 10.1084/jem.150.2.277; Porter RL, 2013, STEM CELLS, V31, P372, DOI 10.1002/stem.1286; Rudnick DA, 2001, P NATL ACAD SCI USA, V98, P8885, DOI 10.1073/pnas.151217998; Tai HH, 2002, PROSTAG OTH LIPID M, V68-9, P483, DOI 10.1016/S0090-6980(02)00050-3; Thompson CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064122; Tsai MS, 2007, ANN SURG ONCOL, V14, P786, DOI 10.1245/s10434-006-9215-5; Yan M, 2004, P NATL ACAD SCI USA, V101, P17468, DOI 10.1073/pnas.0406142101; Yan M, 2009, P NATL ACAD SCI USA, V106, P9409, DOI 10.1073/pnas.0902367106	41	165	176	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240							aaa2340	10.1126/science.aaa2340	http://dx.doi.org/10.1126/science.aaa2340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068857	Green Accepted			2022-12-28	WOS:000356011500045
J	Esen, I; Demirel, F				Esen, Ihsan; Demirel, Fatma			Preterm Ovarian Hyperstimulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Esen, Ihsan; Demirel, Fatma] Ankara Pediat Hematol & Oncol Training Hosp, Ankara, Turkey		Esen, I (corresponding author), Ankara Pediat Hematol & Oncol Training Hosp, Ankara, Turkey.	esen_ihsan@yahoo.com	esen, ihsan/V-8847-2018	esen, ihsan/0000-0003-1700-6778					0	5	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2015	372	24					2336	2336		10.1056/NEJMicm1402955	http://dx.doi.org/10.1056/NEJMicm1402955			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK2DB	26061838				2022-12-28	WOS:000356019200009
J	Lauby-Secretan, B; Scoccianti, C; Loomis, D; Benbrahim-Tallaa, L; Bouvard, V; Bianchini, F; Straif, K				Lauby-Secretan, Beatrice; Scoccianti, Chiara; Loomis, Dana; Benbrahim-Tallaa, Lamia; Bouvard, Veronique; Bianchini, Franca; Straif, Kurt		Int Agcy Res Canc Handbook Working	Breast-Cancer Screening - Viewpoint of the IARC Working Group	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONTROLLED-TRIAL; FOLLOW-UP; HIGH-RISK; MORTALITY; MAMMOGRAPHY; WOMEN; EFFICACY; METAANALYSIS; PROGRAM; NORWAY		[Lauby-Secretan, Beatrice; Scoccianti, Chiara; Loomis, Dana; Benbrahim-Tallaa, Lamia; Bouvard, Veronique; Straif, Kurt] Int Agcy Res Canc, F-69372 Lyon, France; [Bianchini, Franca] German Canc Res Ctr, Heidelberg, Germany	World Health Organization; International Agency for Research on Cancer (IARC); Helmholtz Association; German Cancer Research Center (DKFZ)	Lauby-Secretan, B (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.		Weiderpass, Elisabete/AAP-2747-2021; Loomis, Dana/AAE-3988-2019; Weiderpass, Elisabete/M-4029-2016; Qiao, You-Lin/B-4139-2012; de Bock, Geertruida H./F-6529-2014; Armstrong, Bruce/K-9464-2015	Weiderpass, Elisabete/0000-0003-2237-0128; Weiderpass, Elisabete/0000-0003-2237-0128; Qiao, You-Lin/0000-0001-6380-0871; Ellis, Ian/0000-0001-5292-8474; Segnan, Nereo/0000-0002-4730-5384; de Bock, Geertruida H./0000-0003-3104-4471; Loomis, Dana/0000-0003-3297-5200; Armstrong, Bruce/0000-0001-8940-7525; Lauby-Secretan, Beatrice/0000-0001-6559-3351				Advisory Group on Ionising Radiation Subgroup on Solid Cancer Risk Health Protection Agency (Great Britain) Health Protection Agency (Great Britain) and C. and E. H. Centre for Radiation, 2011, RISK SOL CANC FOLL R; Ancelle-Park R, 2012, J MED SCREEN, V19, P5, DOI 10.1258/jms.2012.012077; Ascunce EN, 2007, J MED SCREEN, V14, P14, DOI 10.1258/096914107780154558; Bond M, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17130; Ciatto S, 2013, LANCET ONCOL, V14, P583, DOI 10.1016/S1470-2045(13)70134-7; Colditz GA, 2014, CA-CANCER J CLIN, V64, P186, DOI 10.3322/caac.21225; Coldman A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju261; Elmore JG, 2005, JNCI-J NATL CANCER I, V97, P1035, DOI 10.1093/jnci/dji183; Ferlay J, 2014, C15 I X CANC INCIDEN, VI to X; Ferlay J, 2014, GLOBOCAN 2012 VOL 1; Hofvind S, 2013, CANCER-AM CANCER SOC, V119, P3106, DOI 10.1002/cncr.28174; Hofvind S, 2012, J MED SCREEN, V19, P57, DOI 10.1258/jms.2012.012083; Houssami N, 2011, PREV MED, V53, P123, DOI 10.1016/j.ypmed.2011.05.003; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; International Agency for Research on Cancer, 2015, IARC HDB CANC PREV, V15; International Agency for Research on Cancer, 2002, IARC HDB CANC PREV, V7; International Agency for Research on Cancer, 2014, WORK PROC IARC HDB C; Jansen-van der Weide MC, 2010, EUR RADIOL, V20, P2547, DOI 10.1007/s00330-010-1839-y; Jonsson H, 2003, CANCER DETECT PREV, V27, P360, DOI 10.1016/S0361-090X(03)00131-4; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Lord SJ, 2007, EUR J CANCER, V43, P1905, DOI 10.1016/j.ejca.2007.06.007; Miller AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g366; Mittra I, 2010, INT J CANCER, V126, P976, DOI 10.1002/ijc.24840; MORRISON, 1989, JNCI-J NATL CANCER I, V81, P1513, DOI 10.1093/jnci/81.19.1513-a; MORRISON AS, 1988, JNCI-J NATL CANCER I, V80, P1540, DOI 10.1093/jnci/80.19.1540; Moss SM, 1999, LANCET, V353, P1909, DOI 10.1016/S0140-6736(98)07412-1; Norman SA, 2007, CANCER CAUSE CONTROL, V18, P909, DOI 10.1007/s10552-007-9006-8; Olsen AH, 2013, INT J CANCER, V132, P208, DOI 10.1002/ijc.27609; Phi XA, 2015, J CLIN ONCOL, V33, P349, DOI 10.1200/JCO.2014.56.6232; Pisani P, 2006, INT J CANCER, V118, P149, DOI 10.1002/ijc.21343; Puliti D, 2012, J MED SCREEN, V19, P42, DOI 10.1258/jms.2012.012082; Roder D, 2008, BREAST CANCER RES TR, V108, P409, DOI 10.1007/s10549-007-9609-5; Sankaranarayanan R, 2011, JNCI-J NATL CANCER I, V103, P1476, DOI 10.1093/jnci/djr304; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; THOMPSON RS, 1994, AM J EPIDEMIOL, V140, P889, DOI 10.1093/oxfordjournals.aje.a117177; van Schoor G, 2010, EUR J CANCER, V46, P3137, DOI 10.1016/j.ejca.2010.09.041; vanDijck JAAM, 1997, DRUG AGING, V10, P69, DOI 10.2165/00002512-199710020-00001; von Karsa L, 2014, WORLD CANC REPORT 20, P322; Warner E, 2008, ANN INTERN MED, V148, P671, DOI 10.7326/0003-4819-148-9-200805060-00007; Weedon-Fekjaer H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3701; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C	41	483	513	3	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2015	372	24					2353	2358		10.1056/NEJMsr1504363	http://dx.doi.org/10.1056/NEJMsr1504363			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK2DB	26039523				2022-12-28	WOS:000356019200015
J	Erez, N				Erez, Neta			CANCER Opening LOX to metastasis	NATURE			English	Editorial Material							PREMETASTATIC NICHE; MICROENVIRONMENT	New findings implicate the enzyme lysyl oxidase (LOX), secreted by oxygen-deprived breast cancer cells, in inducing bone lesions that precede and facilitate the spread of the cancer cells to the bone. See Letter p.106	Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Erez, N (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Tel Aviv, Israel.	netaerez@post.tau.ac.il		Erez, Neta/0000-0001-6506-9074				Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Brown JE, 2012, NAT REV CLIN ONCOL, V9, P110, DOI 10.1038/nrclinonc.2011.197; Coleman RE, 2013, BREAST, V22, pS50, DOI 10.1016/j.breast.2013.07.010; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Erez N, 2011, INT J CANCER, V128, P2536, DOI 10.1002/ijc.26032; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Gilkes DM, 2013, FUTURE ONCOL, V9, P1623, DOI [10.2217/FON.13.92, 10.2217/fon.13.92]; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; PAGET S, 1989, CANCER METAST REV, V8, P98; Witz IP, 2008, CANCER RES, V68, P9, DOI 10.1158/0008-5472.CAN-07-2917	12	10	10	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					41	42		10.1038/nature14529	http://dx.doi.org/10.1038/nature14529			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ5QP	26017311				2022-12-28	WOS:000355543400024
J	Bland, JM; Altman, DG				Bland, J. Martin; Altman, Douglas G.			Statistics Notes: Bootstrap resampling methods	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Bland, J. Martin] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Altman, Douglas G.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford OX3 7LD, England	University of York - UK; University of Oxford	Bland, JM (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	martin.bland@york.ac.uk			Cancer Research UK [16895] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Altman DG, 2005, BRIT MED J, V331, P903, DOI 10.1136/bmj.331.7521.903; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3167; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Richards DA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4913; Schroeder E, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2292	5	69	70	2	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2015	350								h2622	10.1136/bmj.h2622	http://dx.doi.org/10.1136/bmj.h2622			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK0TW	26037412	Bronze			2022-12-28	WOS:000355918900004
J	Steinbrook, R; Kassirer, JP; Angell, M				Steinbrook, Robert; Kassirer, Jerome P.; Angell, Marcia			ESSAY Justifying conflicts of interest in medical journals: a very bad idea	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AUTHORS		[Steinbrook, Robert] Yale Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Kassirer, Jerome P.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Angell, Marcia] Harvard Univ, Sch Med, Boston, MA USA	Yale University; Tufts University; Harvard University; Harvard Medical School	Steinbrook, R (corresponding author), Yale Sch Med, Dept Internal Med, New Haven, CT 06520 USA.	robert.steinbrook@yale.edu						Angell M., 2009, NEW YORK REV BOOKS; Chew M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7197; Department of Health and Human Services Centers for Medicare and Medicaid Services, 2015, C OP PAYM PROGR FISC; Drazen JM, 2015, NEW ENGL J MED, V372, P1853, DOI 10.1056/NEJMe1503623; Drazen JM, 2002, NEW ENGL J MED, V346, P1901, DOI 10.1056/NEJMe020074; Kassirer JP, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5665; Lo B, 2009, CONFLICT INTEREST ME; RELMAN AS, 1984, NEW ENGL J MED, V310, P1182, DOI 10.1056/NEJM198405033101809; RELMAN AS, 1990, NEW ENGL J MED, V323, P56, DOI 10.1056/NEJM199007053230111; Rosenbaum L, 2015, NEW ENGL J MED, V372, P2064, DOI 10.1056/NEJMms1502498; Rosenbaum L, 2015, NEW ENGL J MED, V372, P1959, DOI 10.1056/NEJMms1502497; Rosenbaum L, 2015, NEW ENGL J MED, V372, P1860, DOI 10.1056/NEJMms1502493; Steinbrook R, 2012, J LAW MED ETHICS, V40, P488, DOI 10.1111/j.1748-720X.2012.00681.x; Thompson DF., 1993, NEW ENGL J MED, V372, P1853	14	54	55	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2015	350								h2942	10.1136/bmj.h2942	http://dx.doi.org/10.1136/bmj.h2942			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK0TW	26036926	Bronze			2022-12-28	WOS:000355918900021
J	Rosenberg, AA; Branscomb, LM; Eady, V; Frumhoff, PC; Goldman, GT; Halpern, M; Kimmell, K; Kothari, Y; Kramer, LD; Lane, NF; McCarthy, JJ; Phartiyal, P; Rest, K; Sims, R; Wexler, C				Rosenberg, A. A.; Branscomb, L. M.; Eady, V.; Frumhoff, P. C.; Goldman, G. T.; Halpern, M.; Kimmell, K.; Kothari, Y.; Kramer, L. D.; Lane, N. F.; McCarthy, J. J.; Phartiyal, P.; Rest, K.; Sims, R.; Wexler, C.			Congress's attacks on science-based rules	SCIENCE			English	Editorial Material									[Rosenberg, A. A.; Goldman, G. T.; Halpern, M.; Kothari, Y.; Wexler, C.] Union Concerned Scientists, Ctr Sci & Democracy, Cambridge, MA 02138 USA; [Branscomb, L. M.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Eady, V.] Conservat Law Fdn, Boston, MA 02110 USA; [Frumhoff, P. C.; Kimmell, K.; Rest, K.] Union Concerned Scientists, Cambridge, MA 02138 USA; [Kramer, L. D.] William & Flora Hewlett Fdn, Menlo Pk, CA 94025 USA; [Lane, N. F.] Rice Univ, Baker Inst Publ Policy, Houston, TX 77005 USA; [McCarthy, J. J.] Harvard Univ, Cambridge, MA 02138 USA	University of California System; University of California San Diego; Hewlett-Packard; Rice University; Harvard University	Rosenberg, AA (corresponding author), Union Concerned Scientists, Ctr Sci & Democracy, Cambridge, MA 02138 USA.	arosenberg@ucsusa.org						Center for Effective Government, 2014, BEN PUBL PROT 10 RUL; Center for Public Integrity, 2012, CONS SOURC CHAMB SPE; CLARK WC, 1985, SCI TECHNOL, V10, P6, DOI DOI 10.1177/016224398501000302; McGarrity T., 2008, BENDING SCI SPECIAL; [National Research Council Committee on Analysis of Global Change Assessments Board on Atmospheric Sciences and Climate Division on Earth and Life Studies], 2007, AN GLOB CHANG ASS LE; Percival R.V., 2013, ENV REGULATION LAW S	6	8	8	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					964	966		10.1126/science.aab2939	http://dx.doi.org/10.1126/science.aab2939			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ1WU	26023118				2022-12-28	WOS:000355276600020
J	Chouard, T; Venema, L				Chouard, Tanguy; Venema, Liesbeth			Machine intelligence	NATURE			English	Editorial Material														Venema, Liesbeth/0000-0002-5896-1766					0	15	17	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					435	435		10.1038/521435a	http://dx.doi.org/10.1038/521435a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	26017441	Bronze			2022-12-28	WOS:000355286600051
J	Meurer, WJ; Lewis, RJ				Meurer, William J.; Lewis, Roger J.			Cluster Randomized Trials Evaluating Treatments Applied to Groups	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Meurer, William J.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Lewis, Roger J.] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Lewis, Roger J.] Los Angeles Biomed Res Inst, Torrance, CA USA; [Lewis, Roger J.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Lewis, Roger J.] Berry Consultants, Austin, TX USA	University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lewis, RJ (corresponding author), Harbor UCLA Med Ctr, Dept Emergency Med, 1000 W Carson St,Bldg D9, Torrance, CA 90509 USA.	roger@emedharbor.edu	Meurer, William J/A-7547-2010; Trajman, Anete/C-7679-2016	Meurer, William J/0000-0002-1158-5302; Trajman, Anete/0000-0002-4000-4984				Anand KJS, 2010, PEDIATRICS, V125, pE1208, DOI 10.1542/peds.2009-0489; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Curley MAQ, 2015, JAMA-J AM MED ASSOC, V313, P379, DOI 10.1001/jama.2014.18399; DAWID AP, 1979, J ROY STAT SOC B MET, V41, P1; Detry MA, 2014, JAMA-J AM MED ASSOC, V312, P85, DOI 10.1001/jama.2014.7523; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Ivers NM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5886; Killip S, 2004, ANN FAM MED, V2, P204, DOI 10.1370/afm.141; Scott PA, 2013, LANCET NEUROL, V12, P139, DOI 10.1016/S1474-4422(12)70311-3; Wears RL, 2002, ACAD EMERG MED, V9, P330, DOI 10.1197/aemj.9.4.330	10	20	20	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2015	313	20					2068	2069		10.1001/jama.2015.5199	http://dx.doi.org/10.1001/jama.2015.5199			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0DC	26010636				2022-12-28	WOS:000355142400021
J	Meyer, G				Meyer, Gretchen			Playing the field	SCIENCE			English	Editorial Material									Univ Wisconsin, Field Stn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Meyer, G (corresponding author), Univ Wisconsin, Field Stn, Madison, WI 53706 USA.								0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237					938	938		10.1126/science.348.6237.938	http://dx.doi.org/10.1126/science.348.6237.938			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999510				2022-12-28	WOS:000354877900048
J	Oliver, D				Oliver, David			SOCIAL CARE We cannot keep ignoring the crisis in social care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Oliver, David] British Geriatr Soc, London, England		Oliver, D (corresponding author), Kings Fund, London, England.	d.oliver@kingsfund.org.uk						Age UK, 2015, LAT LIF UK FACT SHEE; Bardsley M, 2010, SOCIAL CARE HOSP USE; Bennett L, 2014, MAKING BEST USE BETT; British Geriatrics Society, 2013, CAR HOM COMM GUID 20; Crawford R, 2012, LOCAL GOVT SPENDING; Forder J, 2011, 2769 PSSRU; Guardian Social Care Network, 2015, CAN CAR ACT DEL ITS; House of Lords Committee on Public Service and Demographic Change, 2012, READY FOR AG; King's Fund, 2013, PAYING SOC CAR DILN; King's Fund, 2014, NEW SETTL HLTH SOC C; LaingBuisson, 2014, CAR OLD PEOPL MARK U; Lawson N, 1982, MEMOIRS TORY RADICAL; Local Government Association Association of Directors of Social Services, AD SOC CAR FUND 2014; NHS Information Centre, 2012, SOC CAR SERV ACT ENG; Office for National Statistics, 2014, MID 2013 POP STAT UK; Williams D, 2015, LOCAL GOVT CHRO 0415	16	6	6	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 21	2015	350								h2684	10.1136/bmj.h2684	http://dx.doi.org/10.1136/bmj.h2684			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI9ZD	25999479				2022-12-28	WOS:000355129300002
J	Li, ZF; Bishop, AC; Alyamani, M; Garcia, JA; Dreicer, R; Bunch, D; Liu, JY; Upadhyay, SK; Auchus, RJ; Sharifi, N				Li, Zhenfei; Bishop, Andrew C.; Alyamani, Mohammad; Garcia, Jorge A.; Dreicer, Robert; Bunch, Dustin; Liu, Jiayan; Upadhyay, Sunil K.; Auchus, Richard J.; Sharifi, Nima			Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer	NATURE			English	Article							3-BETA-HYDROXYSTEROID DEHYDROGENASE; CYP17A1 INHIBITION; INCREASED SURVIVAL; ANDROGEN RECEPTOR; TESTOSTERONE; ENZALUTAMIDE; RATIONALE; MECHANISM; EXPOSURE; TARGET	Prostate cancer resistance to castration occurs because tumours acquire the metabolic capability of converting precursor steroids to 5 alpha-dihydrotestosterone (DHT), promoting signalling by the androgen receptor and the development of castration-resistant prostate cancer(1-3). Essential for resistance, DHT synthesis from adrenal precursor steroids or possibly from de novo synthesis from cholesterol commonly requires enzymatic reactions by 3 beta-hydroxysteroid dehydrogenase (3 beta HSD), steroid-5 alpha-reductase (SRD5A) and 17 beta-hydroxysteroid dehydrogenase (17 beta HSD) isoenzymes(4,5). Abiraterone, a steroidal 17 alpha-hydroxylase/17,20-lyase (CYP17A1) inhibitor, blocks this synthetic process and prolongs survival(6,7). We hypothesized that abiraterone is converted by an enzyme to the more active Delta(4)-abiraterone (D4A), which blocks multiple steroidogenic enzymes and antagonizes the androgen receptor, providing an additional explanation for abiraterone's clinical activity. Here we show that abiraterone is converted to D4A in mice and patients with prostate cancer. D4A inhibits CYP17A1, 3 beta HSD and SRD5A, which are required for DHT synthesis. Furthermore, competitive androgen receptor antagonism by D4A is comparable to the potent antagonist enzalutamide. D4A also has more potent anti-tumour activity against xenograft tumours than abiraterone. Our findings suggest an additional explanation-conversion to a more active agent-for abiraterone's survival extension. We propose that direct treatment with D4A would be more clinically effective than abiraterone treatment.	[Li, Zhenfei; Bishop, Andrew C.; Alyamani, Mohammad; Sharifi, Nima] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Garcia, Jorge A.; Dreicer, Robert; Sharifi, Nima] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Oncol, Cleveland, OH 44195 USA; [Garcia, Jorge A.; Dreicer, Robert; Sharifi, Nima] Cleveland Clin, Glickman Urol & Kidney Inst, Dept Urol, Cleveland, OH 44195 USA; [Bunch, Dustin] Cleveland Clin, Dept Lab Med Pathol & Lab, Inst Med, Cleveland, OH 44195 USA; [Liu, Jiayan; Upadhyay, Sunil K.; Auchus, Richard J.] Univ Michigan, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Ann Arbor, MI 48109 USA; [Auchus, Richard J.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sharifi, N (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA.	sharifn@ccf.org	Alyamani, Mohammad/S-5905-2017; Li, Zhenfei/AAU-1097-2020; Bunch, Dustin/AAB-7922-2020	Alyamani, Mohammad/0000-0002-7127-0820; Li, Zhenfei/0000-0001-6520-431X; Bunch, Dustin/0000-0002-4947-1415	Howard Hughes Physician-Scientist Early Career Award; Prostate Cancer Foundation; American Cancer Society [12-038-01-CCE]; US Army Medical Research and Materiel Command [PC080193, PC121382]; National Cancer Institute [R01CA168899, R01CA172382, R01CA190289]; NATIONAL CANCER INSTITUTE [R01CA168899, R01CA172382, R01CA190289] Funding Source: NIH RePORTER	Howard Hughes Physician-Scientist Early Career Award; Prostate Cancer Foundation; American Cancer Society(American Cancer Society); US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work has been supported in part by funding from a Howard Hughes Physician-Scientist Early Career Award (to N.S.), by the Prostate Cancer Foundation (to N.S.), by an American Cancer Society Research Scholar Award (12-038-01-CCE; to N.S.), grants from the US Army Medical Research and Materiel Command (PC080193 to N.S. and PC121382 to Z.L.), and additional grants from the National Cancer Institute (R01CA168899, R01CA172382, and R01CA190289; to N.S.).	Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Attard G, 2012, J CLIN ENDOCR METAB, V97, P507, DOI 10.1210/jc.2011-2189; Balk S., 2014, P AM ASS CANC RES PR; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Carreira S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009448; Chang KH, 2013, CELL, V154, P1074, DOI 10.1016/j.cell.2013.07.029; Chang KH, 2012, NAT REV UROL, V9, P721, DOI 10.1038/nrurol.2012.175; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Efstathiou E, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.5000; Evaul K, 2010, ENDOCRINOLOGY, V151, P3514, DOI 10.1210/en.2010-0138; Ferraldeschi R, 2013, CLIN CANCER RES, V19, P3353, DOI 10.1158/1078-0432.CCR-12-0931; Fizazi K, 2015, J CLIN ONCOL, V33, P723, DOI 10.1200/JCO.2014.56.5119; Garrido M, 2014, J STEROID BIOCHEM, V143, P1, DOI 10.1016/j.jsbmb.2014.01.013; Hodgson MC, 2005, J BIOL CHEM, V280, P6511, DOI 10.1074/jbc.M408972200; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Kushnir MM, 2010, CLIN CHEM, V56, P1138, DOI 10.1373/clinchem.2010.143222; Li R, 2012, CLIN CANCER RES, V18, P3571, DOI 10.1158/1078-0432.CCR-12-0908; Li ZF, 2011, P NATL ACAD SCI USA, V108, P3116, DOI 10.1073/pnas.1009353108; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Papari-Zareei M, 2006, ENDOCRINOLOGY, V147, P1591, DOI 10.1210/en.2005-1141; Richards J, 2012, CANCER RES, V72, P2176, DOI 10.1158/0008-5472.CAN-11-3980; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175	26	183	190	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					347	+		10.1038/nature14406	http://dx.doi.org/10.1038/nature14406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26030522	Green Accepted			2022-12-28	WOS:000357950900042
J	Cubillos-Ruiz, JR; Silberman, PC; Rutkowski, MR; Chopra, S; Perales-Puchalt, A; Song, M; Zhang, S; Bettigole, SE; Gupta, D; Holcomb, K; Ellenson, LH; Caputo, T; Lee, AH; Conejo-Garcia, JR; Glimcher, LH				Cubillos-Ruiz, Juan R.; Silberman, Pedro C.; Rutkowski, Melanie R.; Chopra, Sahil; Perales-Puchalt, Alfredo; Song, Minkyung; Zhang, Sheng; Bettigole, Sarah E.; Gupta, Divya; Holcomb, Kevin; Ellenson, Lora H.; Caputo, Thomas; Lee, Ann-Hwee; Conejo-Garcia, Jose R.; Glimcher, Laurie H.			ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis	CELL			English	Article							UNFOLDED-PROTEIN-RESPONSE; OVARIAN-CANCER PROGRESSION; LIPID-PEROXIDATION; ENDOPLASMIC-RETICULUM; BREAST-CANCER; TRANSCRIPTION FACTOR; ACCUMULATION; RECURRENCE; INHIBITORS; NETWORKS	Dendritic cells (DCs) are required to initiate and sustain T cell-dependent anti-cancer immunity. However, tumors often evade immune control by crippling normal DC function. The endoplasmic reticulum (ER) stress response factor XBP1 promotes intrinsic tumor growth directly, but whether it also regulates the host anti-tumor immune response is not known. Here we show that constitutive activation of XBP1 in tumor-associated DCs (tDCs) drives ovarian cancer (OvCa) progression by blunting antitumor immunity. XBP1 activation, fueled by lipid peroxidation byproducts, induced a triglyceride biosynthetic program in tDCs leading to abnormal lipid accumulation and subsequent inhibition of tDC capacity to support anti-tumor T cells. Accordingly, DC-specific XBP1 deletion or selective nanoparticle-mediated XBP1 silencing in tDCs restored their immunostimulatory activity in situ and extended survival by evoking protective type 1 anti-tumor responses. Targeting the ER stress response should concomitantly inhibit tumor growth and enhance anti-cancer immunity, thus offering a unique approach to cancer immunotherapy.	[Cubillos-Ruiz, Juan R.; Silberman, Pedro C.; Chopra, Sahil; Song, Minkyung; Bettigole, Sarah E.; Glimcher, Laurie H.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Cubillos-Ruiz, Juan R.; Bettigole, Sarah E.; Glimcher, Laurie H.] Weill Cornell Med Coll, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA; [Rutkowski, Melanie R.; Perales-Puchalt, Alfredo; Conejo-Garcia, Jose R.] Wistar Inst Anat & Biol, Tumor Microenvironm & Metastasis Program, Philadelphia, PA 19104 USA; [Zhang, Sheng] Cornell Univ, Inst Biotechnol, Ithaca, NY 14853 USA; [Bettigole, Sarah E.] Harvard Univ, Harvard Grad Program Immunol, Boston, MA 02115 USA; [Gupta, Divya; Holcomb, Kevin; Caputo, Thomas] Weill Cornell Med Coll, Dept Obstet & Gynecol, New York, NY 10065 USA; [Ellenson, Lora H.; Lee, Ann-Hwee] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA	Cornell University; Cornell University; The Wistar Institute; Cornell University; Harvard University; Cornell University; Cornell University	Glimcher, LH (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	lglimche@med.cornell.edu	Conejo-Garcia, Jose R/V-1897-2019	Conejo-Garcia, Jose R/0000-0001-6431-4074; Rutkowski, Melanie/0000-0001-8604-815X; PERALES-PUCHALT, ALFREDO/0000-0003-4904-5050; Silberman, Pedro/0000-0002-1735-4679; Song, Minkyung/0000-0003-2668-7528	NIH [R01CA112663, R01CA157664, R01CA124515, 1S10RR025449-01]; Irvington Institute Fellowship Program of the Cancer Research Institute; Fundacion Alfonso Martin Escudero; NATIONAL CANCER INSTITUTE [R01CA112663, P30CA010815, R01CA157664, R01CA178687, R01CA124515] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025449] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irvington Institute Fellowship Program of the Cancer Research Institute; Fundacion Alfonso Martin Escudero; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by NIH grants R01CA112663 to L.H.G., R01CA157664 and R01CA124515 to J.R.C.-G., and 1S10RR025449-01 to S.Z. J.R.C.-R. was supported by the Irvington Institute Fellowship Program of the Cancer Research Institute. A.P.-P. was supported by Fundacion Alfonso Martin Escudero. We thank all members of the WCMC Epigenomics Core Facility for excellent assistance with NGS, J. Wickramasinghe and A. Kosenkov at the Bioinformatics Facility of TWI for outstanding computational biology support, and J. McCormick at WCMC for expert flow cytometry assistance. We also thank Diana K. Morales, Andres Cubillos-Ruiz, and the members of the Glimcher laboratory for helpful suggestions and critical reading of this manuscript. L.H.G. holds equity in and is on the board of directors of Bristol-Myers-Squibb.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; [Anonymous], 2006, SCIENCE, V314, P126; Bollard CM, 2007, BLOOD, V110, P2838, DOI 10.1182/blood-2007-05-091280; Cao W, 2014, J IMMUNOL, V192, P2920, DOI 10.4049/jimmunol.1302801; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cubillos-Ruiz JR, 2012, CANCER RES, V72, P1683, DOI 10.1158/0008-5472.CAN-11-3160; Cubillos-Ruiz JR, 2009, J CLIN INVEST, V119, P2231, DOI 10.1172/JCI37716; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; De Palma M, 2007, TRENDS IMMUNOL, V28, P519, DOI 10.1016/j.it.2007.09.004; Galvani S, 2008, FREE RADICAL BIO MED, V45, P1457, DOI 10.1016/j.freeradbiomed.2008.08.026; Gomez BP, 2007, FASEB J, V21, P4013, DOI 10.1096/fj.06-7990com; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Herrera ACS, 2014, CLIN BREAST CANCER, V14, P451, DOI 10.1016/j.clbc.2014.05.002; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Huarte E, 2008, CANCER RES, V68, P7684, DOI 10.1158/0008-5472.CAN-08-1167; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; Osorio F, 2014, NAT IMMUNOL, V15, P248, DOI 10.1038/ni.2808; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Scarlett UK, 2012, J EXP MED, V209, P495, DOI 10.1084/jem.20111413; Singh SP, 2008, BIOCHEMISTRY-US, V47, P3900, DOI 10.1021/bi702124u; Singh SP, 2009, AGING-US, V1, P68; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Tang CHA, 2014, J CLIN INVEST, V124, P2585, DOI 10.1172/JCI73448; Velez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018005; Vladykovskaya E, 2012, J BIOL CHEM, V287, P11398, DOI 10.1074/jbc.M111.320416; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	35	458	481	15	134	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 18	2015	161	7					1527	1538		10.1016/j.cell.2015.05.025	http://dx.doi.org/10.1016/j.cell.2015.05.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL0GG	26073941	Green Accepted, Bronze			2022-12-28	WOS:000356618200011
J	Hens, Z				Hens, Zeger			Economical routes to colloidal nanocrystals	SCIENCE			English	Editorial Material							METAL SULFIDE NANOCRYSTALS		[Hens, Zeger] Univ Ghent, Phys & Chem Nanostruct, B-9000 Ghent, Belgium; [Hens, Zeger] Univ Ghent, Ctr Nano & Biophoton, B-9000 Ghent, Belgium	Ghent University; Ghent University	Hens, Z (corresponding author), Univ Ghent, Phys & Chem Nanostruct, B-9000 Ghent, Belgium.	zeger.hens@ugent.be	Hens, Zeger/J-6366-2013					Abe S, 2012, ACS NANO, V6, P42, DOI 10.1021/nn204008q; Erickson CS, 2014, ACS NANO, V8, P3461, DOI 10.1021/nn406360w; Hendricks MP, 2015, SCIENCE, V348, P1226, DOI 10.1126/science.aaa2951; Kovalenko MV, 2015, ACS NANO, V9, P1012, DOI 10.1021/nn506223h; LAMER VK, 1950, J AM CHEM SOC, V72, P4847, DOI 10.1021/ja01167a001; Liu HT, 2007, J AM CHEM SOC, V129, P305, DOI 10.1021/ja0656696; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Owen JS, 2010, J AM CHEM SOC, V132, P18206, DOI 10.1021/ja106777j; Shirasaki Y, 2013, NAT PHOTONICS, V7, P13, DOI 10.1038/nphoton.2012.328; Zhang HT, 2012, NANO LETT, V12, P5856, DOI 10.1021/nl303207s	10	13	13	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1211	1212		10.1126/science.aab0866	http://dx.doi.org/10.1126/science.aab0866			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068836				2022-12-28	WOS:000356011500032
J	Roach, M; Sauermann, H				Roach, Michael; Sauermann, Henry			Founders and joiners	SCIENCE			English	Editorial Material									[Roach, Michael] Cornell Univ, Ithaca, NY 14850 USA; [Sauermann, Henry] Georgia Inst Technol, Atlanta, GA 30332 USA; [Sauermann, Henry] Natl Bur Econ Res, Cambridge, MA 02138 USA	Cornell University; University System of Georgia; Georgia Institute of Technology; National Bureau of Economic Research	Roach, M (corresponding author), Cornell Univ, Ithaca, NY 14850 USA.	michael.roach@cornell.edu		Roach, Michael/0000-0002-9781-8567				Roach M., 2015, MANAGE SCI, DOI 10.1287/mnsc.2014.2100	1	3	3	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1200	1201		10.1126/science.aab2804	http://dx.doi.org/10.1126/science.aab2804			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK2AK	26068826				2022-12-28	WOS:000356011500022
J	Billups, K				Billups, Katharina			CLIMATE SCIENCE Timing is everything during deglaciations	NATURE			English	Editorial Material							SEA-LEVEL; CIRCULATION; RECORD		Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA	University of Delaware	Billups, K (corresponding author), Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA.	kbillups@udel.edu						Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Grant KM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6076; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; Marino G, 2015, NATURE, V522, P197, DOI 10.1038/nature14499; Masson-Delmotte V, 2010, QUATERNARY SCI REV, V29, P113, DOI 10.1016/j.quascirev.2009.09.030; PISIAS NG, 1981, EARTH PLANET SC LETT, V52, P450, DOI 10.1016/0012-821X(81)90197-7; Ruddiman W. F., 2013, EARTHS CLIMATE FUTUR, V3rd	9	5	5	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					163	164		10.1038/522163a	http://dx.doi.org/10.1038/522163a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	26062505				2022-12-28	WOS:000356016700027
J	Molero, Y; Lichtenstein, P; Zetterqvist, J; Gumpert, CH; Fazel, S				Molero, Yasmina; Lichtenstein, Paul; Zetterqvist, Johan; Gumpert, Clara Hellner; Fazel, Seena			Varenicline and risk of psychiatric conditions, suicidal behaviour, criminal offending, and transport accidents and offences: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NEUROPSYCHIATRIC ADVERSE EVENTS; SMOKING-CESSATION; DOUBLE-BLIND; BIPOLAR DISORDER; DEPRESSION; SCHIZOPHRENIA; MEDICATIONS; BUPROPION; MORTALITY	OBJECTIVE To examine associations between varenicline and the incidence of a range of adverse outcomes. DESIGN Population based cohort study using within person analyses to control for confounding by indication. SETTING Whole population of Sweden. PARTICIPANTS 7 917 436 people aged 15 and over, of whom 69 757 were treated with varenicline between 2006 and 2009. MAIN OUTCOME MEASURES Incidence of new psychiatric conditions, suicidal behaviour, suspected and convicted criminal offending, transport accidents, and suspected and convicted traffic offences. RESULTS In the whole population, 337 393 new psychiatric conditions were diagnosed during follow-up. In addition, 507 823 suspected and 338 608 convicted crimes, 40 595 suicidal events, 124 445 transport accidents, and 99 895 suspected and 57 068 convicted traffic crimes were recorded. Within person analyses showed that varenicline was not associated with significant hazards of suicidal behaviour, criminal offending, transport accidents, traffic offences, or psychoses. However, varenicline was associated with a small increase in the risk of anxiety conditions (hazard ratio 1.23, 95% confidence interval 1.01 to 1.51) and mood conditions (1.31, 1.06 to 1.63), which was only seen in people with pre-existing psychiatric disorders. CONCLUSIONS Concerns that varenicline is associated with an increased risk of many adverse outcomes, including suicidality and accidents, are not supported in this observational study. The small increase in risk of two psychiatric conditions in people with pre-existing psychiatric disorders needs to be confirmed using other research designs.	[Molero, Yasmina; Gumpert, Clara Hellner] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, S-17176 Stockholm, Sweden; [Lichtenstein, Paul; Zetterqvist, Johan] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Fazel, Seena] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England	Karolinska Institutet; Karolinska Institutet; University of Oxford	Fazel, S (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	seena.fazel@psych.ox.ac.uk	Fazel, Seena/B-5307-2008	Fazel, Seena/0000-0002-5383-5365; Molero, Yasmina/0000-0002-5663-2010	Wellcome Trust [095806]; Karolinska Institutet; Swedish Research Council for Health, Working Life and Welfare; Swedish Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); Karolinska Institutet(Karolinska Institutet); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding for this study was provided by the Wellcome Trust (095806); Karolinska Institutet; the Swedish Research Council for Health, Working Life and Welfare; and the Swedish Research Council. The funders had no further role in the study design; in the collection, analysis, and interpretation of data; or in the writing of the paper.	Aagaard L, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-30; Ahmed AIA, 2013, J CLIN PSYCHOPHARM, V33, P55, DOI 10.1097/JCP.0b013e31827c0117; Annagur BB, 2012, THER ADV PSYCHOPHARM, V2, P35, DOI 10.1177/2045125311430111; Anthenelli RM, 2013, ANN INTERN MED, V159, P390, DOI 10.7326/0003-4819-159-6-201309170-00005; Baek JH, 2013, J AFFECT DISORDERS, V150, P1158, DOI 10.1016/j.jad.2013.05.082; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Chang Z, 2014, JAMA PSYCHIAT, V71, P319, DOI 10.1001/jamapsychiatry.2013.4174; Chen Q, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3769; Chengappa KNR, 2014, J CLIN PSYCHIAT, V75, P765, DOI 10.4088/JCP.13m08756; Cinciripini PM, 2013, JAMA PSYCHIAT, V70, P522, DOI 10.1001/jamapsychiatry.2013.678; Cinemre B, 2010, CNS SPECTRUMS, V15, P470, DOI 10.1017/S1092852900000407; Dakwar E, 2011, J PERS DISORD, V25, P645, DOI 10.1521/pedi.2011.25.5.645; DiPaula BA, 2009, PHARMACOTHERAPY, V29, P852, DOI 10.1592/phco.29.7.852; Evins AE, 2014, JAMA-J AM MED ASSOC, V311, P145, DOI 10.1001/jama.2013.285113; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Fazel S, 2014, LANCET, V384, P1206, DOI 10.1016/S0140-6736(14)60379-2; FDA, 2011, FDA DRUG SAF COMM SA; *FDA, 2008, FDA ISS PUBL HLTH AD; Forcen Fernando Espi, 2012, Clin Schizophr Relat Psychoses, V5, P221, DOI 10.3371/CSRP.5.4.7; Foulds J, 2013, NICOTINE TOB RES, V15, P1849, DOI 10.1093/ntr/ntt066; Garza D, 2011, BIOL PSYCHIAT, V69, P1075, DOI 10.1016/j.biopsych.2010.12.005; Gibbons RD, 2013, AM J PSYCHIAT, V170, P1460, DOI 10.1176/appi.ajp.2013.12121599; Gibbons RD, 2010, ANNU REV PUBL HEALTH, V31, P419, DOI 10.1146/annurev.publhealth.012809.103649; Gunnell D, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3805; Gupta A, 2012, AUST NZ J PSYCHIAT, V46, P1009, DOI 10.1177/0004867412444993; Harrison-Woolrych M, 2011, DRUG SAFETY, V34, P763, DOI 10.2165/11594450-000000000-00000; Hays JT, 2008, NEW ENGL J MED, V359, P2018, DOI 10.1056/NEJMct0800146; Holma IAK, 2013, DEPRESS ANXIETY, V30, P580, DOI 10.1002/da.22108; Hughes JR, 2008, DRUG ALCOHOL DEPEN, V98, P169, DOI 10.1016/j.drugalcdep.2008.06.003; *I SAF MED PRACT, 2008, STRONG SAF SIGN SEEN; Johansson LA, 2000, INT J EPIDEMIOL, V29, P495, DOI 10.1093/ije/29.3.495; Kalman D, 2005, AM J ADDICTION, V14, P106, DOI 10.1080/10550490590924728; Kaur K, 2009, CURR THER RES CLIN E, V70, P35, DOI 10.1016/j.curtheres.2009.02.004; Kuehn BM, 2012, JAMA-J AM MED ASSOC, V307, P129, DOI 10.1001/jama.2011.1924; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V302, P834, DOI 10.1001/jama.2009.1153; Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Mayet A, 2012, PUBLIC HEALTH, V126, P70, DOI 10.1016/j.puhe.2011.09.025; Medicines and Healthcare Products Regulatory Agency (MHRA), 2007, DRUG SAFETY UPDATE, V1, P12; Meyer TE, 2013, ADDICTION, V108, P203, DOI 10.1111/j.1360-0443.2012.04024.x; Moore TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027016; Moore TJ, 2010, ANN PHARMACOTHER, V44, P1389, DOI 10.1345/aph.1P172; Nahvi S, 2013, DRUG ALCOHOL DEPEN, V132, P47, DOI 10.1016/j.drugalcdep.2012.12.026; National Council for Crime Prevention, 2010, KRIM STAT 2010; National Institute for Health and Clinical Excellence, 2010, NICE IMPL UPT REP SM; Organisation for Economic Co-operation and Development, 2012, HLTH GLANC EUR 2012; Organization WH, 2009, GLOB HLTH RISKS MORT; Pasternak B, 2013, ADDICTION, V108, P1336, DOI 10.1111/add.12165; Schneider Barbara, 2014, J Affect Disord, V152-154, P416, DOI 10.1016/j.jad.2013.10.007; Shafey O, 2003, TOBACCO CONTROL COUN; Shim JC, 2012, NEUROPSYCHOPHARMACOL, V37, P660, DOI 10.1038/npp.2011.238; Thomas KH, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1109; Thomas KH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5704; Tonstad S, 2010, DRUG SAFETY, V33, P289, DOI 10.2165/11319180-000000000-00000; Wen CP, 2005, TOB CONTROL, V14, pI28, DOI 10.1136/tc.2003.005629; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Yiengprugsawan V, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004668	59	35	37	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2015	350								h2388	10.1136/bmj.h2388	http://dx.doi.org/10.1136/bmj.h2388			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK0TW	26037950	hybrid, Green Published			2022-12-28	WOS:000355918900002
J	Timmins, N				Timmins, Nicholas			HEALTH AND POLITICS Ten ways to be secretary of state for health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund & Inst Govt, London, England		Timmins, N (corresponding author), Kings Fund & Inst Govt, London, England.	nicholas.timmins@gmail.com						Timmins N., 2015, GLAZIERS WINDOW BREA	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2015	350								h2954	10.1136/bmj.h2954	http://dx.doi.org/10.1136/bmj.h2954			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK0TW	26037774				2022-12-28	WOS:000355918900024
J	Hinnebusch, AG				Hinnebusch, Alan G.			Blocking stress response for better memory?	SCIENCE			English	Editorial Material							NUCLEOTIDE EXCHANGE FACTOR; EIF2B COMPLEX; EIF2-ALPHA; SUBUNIT; TERM		NIH, Lab Gene Regulat & Dev, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Hinnebusch, AG (corresponding author), NIH, Lab Gene Regulat & Dev, Bldg 10, Bethesda, MD 20892 USA.	ahinnebusch@nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Di Prisco GV, 2014, NAT NEUROSCI, V17, P1073, DOI 10.1038/nn.3754; Gordiyenko Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4902; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Williams DD, 2001, J BIOL CHEM, V276, P24697, DOI 10.1074/jbc.M011788200; Wortham NC, 2014, FASEB J, V28, P2225, DOI 10.1096/fj.13-243329	13	1	3	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					967	968		10.1126/science.aac4832	http://dx.doi.org/10.1126/science.aac4832			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ1WU	26023119				2022-12-28	WOS:000355276600021
J	Russell, S				Russell, Stuart			Ethics of artificial intelligence	NATURE			English	Editorial Material									Univ Calif Berkeley, Comp Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Russell, S (corresponding author), Univ Calif Berkeley, Comp Sci, Berkeley, CA 94720 USA.								0	66	66	15	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					415	416		10.1038/521415a	http://dx.doi.org/10.1038/521415a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2AN	26017428	Bronze			2022-12-28	WOS:000355286600013
J	Rucker, JJH				Rucker, James J. H.			PERSONAL VIEW Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PSILOCYBIN		[Rucker, James J. H.] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, Adult Psychiat, London SE5 8AF, England; [Rucker, James J. H.] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London SE5 8AF, England	University of London; King's College London; University of London; King's College London	Rucker, JJH (corresponding author), Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, Adult Psychiat, London SE5 8AF, England.	james.rucker@kcl.ac.uk	Rucker, James/H-6374-2019	Rucker, James/0000-0003-4647-8088				Baum D., 2012, MOMENT WILD POIGNANT; Bogenschutz MP, 2015, J PSYCHOPHARMACOL, V29, P289, DOI 10.1177/0269881114565144; Gable RS, 2004, ADDICTION, V99, P686, DOI 10.1111/j.1360-0443.2004.00744.x; Goodman L.S., 2011, GOODMAN GILMANS PHAR, V13th ed.; Grinspoon L, 1981, Curr Psychiatr Ther, V20, P275; Grinspoon L., 1997, PSYCHEDELIC DRUGS RE; Grob CS, 2011, ARCH GEN PSYCHIAT, V68, P71, DOI 10.1001/archgenpsychiatry.2010.116; Hari J., 2015, CHASING THE SCREAM; Hendricks PS, 2015, J PSYCHOPHARMACOL, V29, P280, DOI 10.1177/0269881114565653; Higgins A., 2015, NYTIMES         0504; Johansen PO, 2015, J PSYCHOPHARMACOL, V29, P270, DOI 10.1177/0269881114568039; Johnson MW, 2014, J PSYCHOPHARMACOL, V28, P983, DOI 10.1177/0269881114548296; Krebs TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063972; Krebs TS, 2012, J PSYCHOPHARMACOL, V26, P994, DOI 10.1177/0269881112439253; Moreno FA, 2006, J CLIN PSYCHIAT, V67, P1735, DOI 10.4088/JCP.v67n1110; Nutt DJ, 2013, NAT REV NEUROSCI, V14, P577, DOI 10.1038/nrn3530; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; Sewell RA, 2006, NEUROLOGY, V66, P1920, DOI 10.1212/01.wnl.0000219761.05466.43; STRASSMAN RJ, 1984, J NERV MENT DIS, V172, P577, DOI 10.1097/00005053-198410000-00001; United Nations, 1971, CONV PSYCH SUBST	20	14	14	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2015	350								h2902	10.1136/bmj.h2902	http://dx.doi.org/10.1136/bmj.h2902			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0AF	26014506				2022-12-28	WOS:000355132600019
J	Le Roux, C; Huet, G; Jauneau, A; Camborde, L; Tremousaygue, D; Kraut, A; Zhou, BB; Levaillant, M; Adachi, H; Yoshioka, H; Raffaele, S; Berthome, R; Coute, Y; Parker, JE; Deslandes, L				Le Roux, Clementine; Huet, Gaelle; Jauneau, Alain; Camborde, Laurent; Tremousaygue, Dominique; Kraut, Alexandra; Zhou, Binbin; Levaillant, Marie; Adachi, Hiroaki; Yoshioka, Hirofumi; Raffaele, Sylvain; Berthome, Richard; Coute, Yohann; Parker, Jane E.; Deslandes, Laurent			A Receptor Pair with an Integrated Decoy Converts Pathogen Disabling of Transcription Factors to Immunity	CELL			English	Article							DISEASE RESISTANCE; RALSTONIA-SOLANACEARUM; STRUCTURAL BASIS; ARABIDOPSIS-THALIANA; WRKY-DOMAIN; PLANT; BINDING; EFFECTORS; ACTIVATION; RESPONSES	Microbial pathogens infect host cells by delivering virulence factors (effectors) that interfere with defenses. In plants, intracellular nucleotide-binding/leucine-rich repeat receptors (NLRs) detect specific effector interference and trigger immunity by an unknown mechanism. The Arabidopsis-interacting NLR pair, RRS1-R with RPS4, confers resistance to different pathogens, including Ralstonia solanacearum bacteria expressing the acetyltransferase effector PopP2. We show that PopP2 directly acetylates a key lysine within an additional C-terminal WRKY transcription factor domain of RRS1-R that binds DNA. This disrupts RRS1-R DNA association and activates RPS4-dependent immunity. PopP2 uses the same lysine acetylation strategy to target multiple defense-promoting WRKY transcription factors, causing loss of WRKY-DNA binding and transactivating functions needed for defense gene expression and disease resistance. Thus, RRS1-R integrates an effector target with an NLR complex at the DNA to switch a potent bacterial virulence activity into defense gene activation.	[Le Roux, Clementine; Huet, Gaelle; Tremousaygue, Dominique; Zhou, Binbin; Levaillant, Marie; Raffaele, Sylvain; Berthome, Richard; Deslandes, Laurent] INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France; [Le Roux, Clementine; Huet, Gaelle; Tremousaygue, Dominique; Zhou, Binbin; Levaillant, Marie; Raffaele, Sylvain; Berthome, Richard; Deslandes, Laurent] CNRS, LIPM, UMR2594, F-31326 Castanet Tolosan, France; [Le Roux, Clementine; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Jauneau, Alain] Inst Federatif Rech 3450, Plateforme Imagerie, Pole Biotechnol Vegetale, F-31326 Castanet Tolosan, France; [Camborde, Laurent] Univ Toulouse, Lab Rech Sci Vegetales, UPS, UMR 5546, F-31326 Castanet Tolosan, France; [Camborde, Laurent] CNRS, UMR 5546, F-31326 Castanet Tolosan, France; [Kraut, Alexandra; Coute, Yohann] Univ Grenoble Alpes, IRTSV BGE, F-38000 Grenoble, France; [Kraut, Alexandra; Coute, Yohann] CEA, IRTSV BGE, F-38000 Grenoble, France; [Kraut, Alexandra; Coute, Yohann] INSERM, BGE, F-38000 Grenoble, France; [Adachi, Hiroaki; Yoshioka, Hirofumi] Nagoya Univ, Grad Sch Bioagr Sci, Def Plant Pathogen Interact, Chikusa Ku, Nagoya, Aichi 4648601, Japan	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Nagoya University	Deslandes, L (corresponding author), INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France.	laurent.deslandes@toulouse.inra.fr	Couté, Yohann/G-2695-2015; Raffaele, Sylvain/F-7187-2012; Raffaele, Sylvain/K-6673-2019; Deslandes, Laurent/N-5752-2017; Le Roux, Clementine/B-4761-2018	Couté, Yohann/0000-0003-3896-6196; Raffaele, Sylvain/0000-0002-2442-9632; Raffaele, Sylvain/0000-0002-2442-9632; Zhou, Binbin/0000-0002-4495-8152; Le Roux, Clementine/0000-0003-1689-6211	Agence Nationale pour la Recherche (ANR) [ANR-10-JCJC-1706]; INRA Contrat Jeune Scientifique; Max Planck Society; French Laboratory of Excellence project "TULIP'' [ANR-10-LABX-41, ANR-11-IDEX-0002-02]; CNRS; INSERM; CEA; ANR (Investissement d'Avenir Infrastructures, ProFi project) [ANR-10-INBS-08-01]; Japan Society of the Promotion of Science [26292023]; European Research Council [ERC-StG 336808]; Max-Planck Society; DFG SFB grant [670]; Cluster of Excellence on Plant Sciences (CEPLAS); Grants-in-Aid for Scientific Research [14J04206] Funding Source: KAKEN	Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); INRA Contrat Jeune Scientifique; Max Planck Society(Max Planck SocietyFoundation CELLEX); French Laboratory of Excellence project "TULIP''; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission); ANR (Investissement d'Avenir Infrastructures, ProFi project)(French National Research Agency (ANR)); Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Research Council(European Research Council (ERC)European Commission); Max-Planck Society(Max Planck SocietyFoundation CELLEX); DFG SFB grant(German Research Foundation (DFG)); Cluster of Excellence on Plant Sciences (CEPLAS); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank I. Somssich and B. Ulker for providing anti-all-WRKY antibodies and AtWRKY clones. We also thank D. Rengel for help with statistical tests and Y. Marco for insightful comments on the manuscript. L.D. and G.H. were supported by a research grant from the Agence Nationale pour la Recherche (ANR; ANR-10-JCJC-1706). C.L.R. was funded by fellowships from INRA Contrat Jeune Scientifique and the Max Planck Society. This work was supported by the French Laboratory of Excellence project "TULIP'' (ANR-10-LABX-41; ANR-11-IDEX-0002-02). A.K. and Y.C. were supported by the CNRS, INSERM, CEA, and ANR (Investissement d'Avenir Infrastructures, ProFi project ANR-10-INBS-08-01). H.Y. is supported by Grant-in-Aid from Japan Society of the Promotion of Science (26292023). S.R. is supported by a Starting Grant of the European Research Council (ERC-StG 336808 project VariWhim). J.E.P. is supported by the Max-Planck Society, DFG SFB grant 670, and the Cluster of Excellence on Plant Sciences (CEPLAS).	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cesari S, 2014, EMBO J, V33, P1941, DOI 10.15252/embj.201487923; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Chang C, 2013, PLANT CELL, V25, P1158, DOI 10.1105/tpc.113.109942; Ciolkowski I, 2008, PLANT MOL BIOL, V68, P81, DOI 10.1007/s11103-008-9353-1; Cremazy FGE, 2005, EXP CELL RES, V309, P390, DOI 10.1016/j.yexcr.2005.06.007; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Deslandes L, 2002, P NATL ACAD SCI USA, V99, P2404, DOI 10.1073/pnas.032485099; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Griebel T, 2014, TRENDS IMMUNOL, V35, P562, DOI 10.1016/j.it.2014.09.005; Hinsch M, 1996, MOL PLANT MICROBE IN, V9, P55, DOI 10.1094/MPMI-9-0055; Hu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002589; Inoue H, 2013, P NATL ACAD SCI USA, V110, P9577, DOI 10.1073/pnas.1222155110; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Jiang SS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003715; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; Lewis JD, 2013, P NATL ACAD SCI USA, V110, P18722, DOI 10.1073/pnas.1315520110; Li GJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002767; Maekawa T, 2011, NAT IMMUNOL, V12, P818, DOI 10.1038/ni.2083; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Meinzer U, 2012, CELL HOST MICROBE, V11, P337, DOI 10.1016/j.chom.2012.02.009; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mukhtar MS, 2008, PLANT J, V56, P935, DOI 10.1111/j.1365-313X.2008.03651.x; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Nicaise V, 2013, EMBO J, V32, P701, DOI 10.1038/emboj.2013.15; Noutoshi Y, 2005, PLANT J, V43, P873, DOI 10.1111/j.1365-313X.2005.02500.x; Ntoukakis V, 2014, CURR OPIN PLANT BIOL, V20, P69, DOI 10.1016/j.pbi.2014.04.002; Oh HS, 2005, PLANT J, V44, P348, DOI 10.1111/j.1365-313X.2005.02529.x; Padmanabhan MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003235; Rivas S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00481; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sarris PF, 2015, CELL, V161, P1089, DOI 10.1016/j.cell.2015.04.024; Sohn KH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004655; Sohn KH, 2012, P NATL ACAD SCI USA, V109, P16371, DOI 10.1073/pnas.1212332109; Takken FLW, 2012, CURR OPIN PLANT BIOL, V15, P375, DOI 10.1016/j.pbi.2012.05.001; Tasset C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001202; Thao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015123; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Williams SJ, 2014, SCIENCE, V344, P299, DOI 10.1126/science.1247357; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Yamasaki K, 2005, PLANT CELL, V17, P944, DOI 10.1105/tpc.104.026435; Yamasaki K, 2012, J BIOL CHEM, V287, P7683, DOI 10.1074/jbc.M111.279844; Zhang HJ, 2012, MOL PLANT MICROBE IN, V25, P1639, DOI 10.1094/MPMI-11-11-0293	47	273	273	11	160	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1074	1088		10.1016/j.cell.2015.04.025	http://dx.doi.org/10.1016/j.cell.2015.04.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000483	Bronze			2022-12-28	WOS:000355152600015
J	Raunser, S; Gatsogiannis, C				Raunser, Stefan; Gatsogiannis, Christos			Deciphering the Tubulin Code	CELL			English	Editorial Material								Enzymes of the tubulin tyrosine ligase-like (TTLL) family posttranslationally modify and thereby mark microtubules by glutamylation, generating specific recognition sites for microtubule-interacting proteins. Garnham et al. report the first structure of a TTLL protein alone and in complex with microtubules, elucidating their mechanism of action.	[Raunser, Stefan; Gatsogiannis, Christos] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany	Max Planck Society	Raunser, S (corresponding author), Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany.	stefan.raunser@mpi-dortmund.mpg.de	Raunser, Stefan/AHE-1573-2022; Gatsogiannis, Christos/K-1012-2018	Gatsogiannis, Christos/0000-0002-4922-4545; Raunser, Stefan/0000-0001-9373-3016				Garnham CP, 2015, CELL, V161, P1112, DOI 10.1016/j.cell.2015.04.003; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Kuhlbrandt W, 2014, SCIENCE, V343, P1443, DOI 10.1126/science.1251652; Mukai M, 2009, BIOCHEMISTRY-US, V48, P1084, DOI 10.1021/bi802047y; Nam HJ, 2010, J BIOL CHEM, V285, P32888, DOI 10.1074/jbc.M110.162743; Szyk A, 2011, NAT STRUCT MOL BIOL, V18, P1250, DOI 10.1038/nsmb.2148; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260	9	7	8	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					960	961		10.1016/j.cell.2015.05.004	http://dx.doi.org/10.1016/j.cell.2015.05.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000474	Bronze			2022-12-28	WOS:000355152600003
J	Chung, WM; Smith, JC; Weil, LM; Hughes, SM; Joyner, SN; Hall, EM; Ritch, J; Srinath, D; Goodman, E; Chevalier, MS; Epstein, L; Hunter, JC; Kallen, AJ; Karwowski, MP; Kuhar, DT; Smith, C; Petersen, LR; Mahon, BE; Lakey, DL; Schrag, SJ				Chung, Wendy M.; Smith, Jessica C.; Weil, Lauren M.; Hughes, Sonya M.; Joyner, Sibeso N.; Hall, Emily M.; Ritch, Julia; Srinath, Divya; Goodman, Edward; Chevalier, Michelle S.; Epstein, Lauren; Hunter, Jennifer C.; Kallen, Alexander J.; Karwowski, Mateusz P.; Kuhar, David T.; Smith, Charnetta; Petersen, Lyle R.; Mahon, Barbara E.; Lakey, David L.; Schrag, Stephanie J.			Active Tracing and Monitoring of Contacts Associated With the First Cluster of Ebola in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							VIRUS DISEASE; HEMORRHAGIC-FEVER; RISK-FACTORS; TRANSMISSION; OUTBREAK; IMPORTATION; DALLAS; TEXAS; CONGO	Background: Following hospitalization of the first patient with Ebola virus disease diagnosed in the United States on 28 September 2014, contact tracing methods for Ebola were implemented. Objective: To identify, risk-stratify, and monitor contacts of patients with Ebola. Design: Descriptive investigation. Setting: Dallas County, Texas, September to November 2014. Participants: Contacts of symptomatic patients with Ebola. Measurements: Contact identification, exposure risk classification, symptom development, and Ebola. Results: The investigation identified 179 contacts, 139 of whom were contacts of the index patient. Of 112 health care personnel (HCP) contacts of the index case, 22 (20%) had known unprotected exposures and 37 (30%) did not have known unprotected exposures but interacted with a patient or contaminated environment on multiple days. Transmission was confirmed in 2 HCP who had substantial interaction with the patient while wearing personal protective equipment. These HCP had 40 additional contacts. Of 20 community contacts of the index patient or the 2 HCP, 4 had high-risk exposures. Movement restrictions were ex-tended to all 179 contacts; 7 contacts were quarantined. Seven percent (14 of 179) of contacts (1 community contact and 13 health care contacts) were evaluated for Ebola during the monitoring period. Limitation: Data cannot be used to infer whether in-person direct active monitoring is superior to active monitoring alone for early detection of symptomatic contacts. Conclusion: Contact tracing and monitoring approaches for Ebola were adapted to account for the evolving understanding of risks for unrecognized HCP transmission. HCP contacts in the United States without known unprotected exposures should be considered as having a low (but not zero) risk for Ebola and should be actively monitored for symptoms. Core challenges of contact tracing for high-consequence communicable diseases included rapid comprehensive contact identification, large-scale direct active monitoring of contacts, large-scale application of movement restrictions, and necessity of humanitarian support services to meet nonclinical needs of contacts.	Dallas Cty Hlth & Human Serv, Dallas, TX 75207 USA; Texas Hlth Resources, Dallas, TX USA; Ctr Dis Control & Atlanta, Atlanta, GA USA; Texas Dept State Hlth Serv, Austin, TX USA	Texas Department of State Health Services	Chung, WM (corresponding author), Dallas Cty Hlth & Human Serv, Epidemiol & Acute Communicable Dis Div, 2377 North Stemmons Freeway,Suite 502, Dallas, TX 75207 USA.	wendy.chung@dallascounty.org		Epstein, Lauren/0000-0002-1175-1112				[Anonymous], INT US GUID MON MOV; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Centers for Disease Control and Prevention, 2014, REV HUM TO HUM TRANS; Centers for Disease Control and Prevention, CASE DEFINITION FOR; Centers for Disease Control and Prevention, INT GUID EM MED SERV; Chevalier MS, 2014, MMWR-MORBID MORTAL W, V63, P1087; Dowell SF, 1999, J INFECT DIS, V179, pS87, DOI 10.1086/514284; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Francesconi P, 2003, EMERG INFECT DIS, V9, P1430, DOI 10.3201/eid0911.030339; Kilmarx PH, 2014, MMWR-MORBID MORTAL W, V63, P1168; Liddell AM, 2015, ANN INTERN MED, V163, P81, DOI 10.7326/M15-0530; Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838; McCarty CL, 2014, MMWR-MORBID MORTAL W, V63, P1089; Mirkovic K, 2014, MMWR-MORBID MORTAL W, V63, P873; Nkoghe D, 2011, T ROY SOC TROP MED H, V105, P466, DOI 10.1016/j.trstmh.2011.04.011; Regan JJ, 2015, MMWR-MORBID MORTAL W, V64, P63; Santibanez S, 2015, PUBLIC HEALTH REP, V130, P128, DOI 10.1177/003335491513000205; Shuaib F, 2014, MMWR-MORBID MORTAL W, V63, P867; Smith CL, 2015, MMWR-MORBID MORTAL W, V64, P121; Towner JS, 2007, J INFECT DIS, V196, pS205, DOI 10.1086/520601; World Health Organization, 2014, CONT TRAC OUTBR EB V; World Health Organization, 2014, SIT ASS UNPR NUMB ME; Yacisin K, 2015, MMWR-MORBID MORTAL W, V64, P321	25	17	17	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2015	163	3					164	+		10.7326/M15-0968	http://dx.doi.org/10.7326/M15-0968			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO6EX	26005809				2022-12-28	WOS:000359251100005
J	Trauer, JM; Qian, MY; Doyle, JS; Rajaratnam, SMW; Cunnington, D				Trauer, James M.; Qian, Mary Y.; Doyle, Joseph S.; Rajaratnam, Shantha M. W.; Cunnington, David			Cognitive Behavioral Therapy for Chronic Insomnia A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; NONPHARMACOLOGICAL INTERVENTIONS; CLINICAL EFFECTIVENESS; PSYCHIATRIC-DISORDERS; DIAGNOSTIC-CRITERIA; DAYTIME SLEEPINESS; MENTAL-DISORDERS; SEVERITY INDEX; OLDER-ADULTS; DSM-IV	Background: Because psychological approaches are likely to produce sustained benefits without the risk for tolerance or adverse effects associated with pharmacologic approaches, cognitive behavioral therapy for insomnia (CBT-i) is now commonly recommended as first-line treatment for chronic insomnia. Purpose: To determine the efficacy of CBT-i on diary measures of overnight sleep in adults with chronic insomnia. Data Sources: Searches of MEDLINE, EMBASE, PsycINFO, CINAHL, the Cochrane Library, and PubMed Clinical Queries from inception to 31 March 2015, supplemented with manual screening. Study Selection: Randomized, controlled trials assessing the efficacy of face-to-face, multimodal CBT-i compared with inactive comparators on overnight sleep in adults with chronic insomnia. Studies of insomnia comorbid with medical, sleep, or psychiatric disorders were excluded. Data Extraction: Study characteristics, quality, and data were assessed independently by 2 reviewers. Main outcome measures were sleep onset latency (SOL), wake after sleep onset (WASO), total sleep time (TST), and sleep efficiency (SE%). Data Synthesis: Among 292 citations and 91 full-text articles reviewed, 20 studies (1162 participants [64% female; mean age, 56 years]) were included. Approaches to CBT-i incorporated at least 3 of the following: cognitive therapy, stimulus control, sleep restriction, sleep hygiene, and relaxation. At the posttreatment time point, SOL improved by 19.03 (95% CI, 14.12 to 23.93) minutes, WASO improved by 26.00 (CI, 15.48 to 36.52) minutes, TST improved by 7.61 (CI, -0.51 to 15.74) minutes, and SE% improved by 9.91% (CI, 8.09% to 11.73%). Changes seemed to be sustained at later time points. No adverse outcomes were reported. Limitation: Narrow inclusion criteria limited applicability to patients with comorbid insomnia and other sleep problems, and accuracy of estimates at later time points was less clear. Conclusion: CBT-i is an effective treatment for adults with chronic insomnia, with clinically meaningful effect sizes.	[Trauer, James M.] Melbourne Sleep Disorders Ctr, East Melbourne, Vic 3002, Australia; Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; Monash Univ, Melbourne, Vic, Australia; Western Hlth, Footscray, Vic, Australia; Monash Univ, Clayton, Vic, Australia	Burnet Institute; Monash University; Monash University	Trauer, JM (corresponding author), Melbourne Sleep Disorders Ctr, Suite 508,Level 5, East Melbourne, Vic 3002, Australia.		Cunnington, David/I-2013-2019	Cunnington, David/0000-0002-8403-0420; Trauer, James/0000-0002-0991-1631; Doyle, Joseph S/0000-0001-7198-0833; Rajaratnam, Shantha/0000-0001-7527-8558	VANDA Pharmaceuticals; Philips Respironics; Cephalon	VANDA Pharmaceuticals; Philips Respironics; Cephalon	Dr. Rajaratnam reports consultancies for VANDA Pharmaceuticals, Philips Respironics, EdanSafe, organizations employing shift workers, the National Transport Commission, The Australian Workers' Union, and Tontine Group; expert testimony for organizations employing shift workers; grants from VANDA Pharmaceuticals, Philips Respironics, and Cephalon; personal fees from VANDA Pharmaceuticals; and equipment from Compumedics, Optalert, Tyco Healthcare, and Philips Lighting outside the submitted work. He also reports that he was 2014 President and board member of the Australasian Sleep Association and Program Leader of the Cooperative Research Centre for Alertness, Safety and Productivity. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org /authors/icmje/ConflictOfInterestForms.do?msNum=M14-2841.	Altena E, 2008, J SLEEP RES, V17, P335, DOI 10.1111/j.1365-2869.2008.00671.x; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Anderson SL, 2014, AM J HEALTH-SYST PH, V71, P394, DOI 10.2146/ajhp130221; [Anonymous], 1997, DIAGN STAT MAN MENT; [Anonymous], 1990, DIAGN COD MAN; [Anonymous], 2005, INT CLASS SLEEP DIS; [Anonymous], 1990, STRUCTURED CLIN INTE; Arnedt JT, 2013, SLEEP, V36, P353, DOI 10.5665/sleep.2448; Ashworth DK, 2015, J COUNS PSYCHOL, V62, P115, DOI 10.1037/cou0000059; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Belleville G, 2011, CLIN PSYCHOL REV, V31, P638, DOI 10.1016/j.cpr.2011.02.004; Bonnet MH, 2007, J CLIN SLEEP MED, V3, P271; Bothelius K, 2013, J SLEEP RES, V22, P688, DOI 10.1111/jsr.12067; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Buysse D J, 1989, Psychiatry Res, V28, P193; Buysse DJ, 2007, SLEEP MED, V8, P198, DOI 10.1016/j.sleep.2006.10.006; Buysse DJ, 2011, ARCH INTERN MED, V171, P887, DOI 10.1001/archinternmed.2010.535; Chang PP, 1997, AM J EPIDEMIOL, V146, P105; Charles J, 2009, AUST FAM PHYSICIAN, V38, P283; Cheng SK, 2012, PSYCHOTHER PSYCHOSOM, V81, P206, DOI 10.1159/000335379; Cochrane Collaboration, 2011, COCHR COLL TOOL ASS; Cunnington D, 2013, MED J AUSTRALIA, V199, pS36, DOI 10.5694/mja13.10718; Daley M, 2009, SLEEP MED, V10, P427, DOI 10.1016/j.sleep.2008.04.005; Daley M, 2009, SLEEP, V32, P55; de Niet GJ, 2009, INT J EVID-BASED HEA, V7, P233, DOI 10.1111/j.1744-1609.2009.00142.x; Edinger JD, 2007, SLEEP, V30, P203, DOI 10.1093/sleep/30.2.203; Edinger JD, 2009, SLEEP, V32, P499, DOI 10.1093/sleep/32.4.499; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; Edinger JD, 2003, SLEEP, V26, P177, DOI 10.1093/sleep/26.2.177; Edinger JD, 2001, JAMA-J AM MED ASSOC, V285, P1856, DOI 10.1001/jama.285.14.1856; Edinger JD, 2008, OVERCOMING INSOMNIA; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Espie CA, 2001, BEHAV RES THER, V39, P45, DOI 10.1016/S0005-7967(99)00157-6; Espie CA, 2007, SLEEP, V30, P574, DOI 10.1093/sleep/30.5.574; Espie CA, 2012, SLEEP, V35, P769, DOI 10.5665/sleep.1872; Fernandez M E, 2012, Rev Fac Cien Med Univ Nac Cordoba, V69, P191; Fernando A, 2013, J PRIM HEALTH CARE, V5, P5, DOI 10.1071/HC13005; Gu NY, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-119; Guilleminault C, 2002, J PSYCHOSOM RES, V53, P617, DOI 10.1016/S0022-3999(02)00463-4; Harvey AG, 2014, J CONSULT CLIN PSYCH, V82, P670, DOI 10.1037/a0036606; Hermes EDA, 2013, SLEEP, V36, P597, DOI 10.5665/sleep.2554; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofmann SG, 2012, COGNITIVE THER RES, V36, P427, DOI 10.1007/s10608-012-9476-1; Hoque R, 2009, J CLIN SLEEP MED, V5, P471; Huedo-Medina TB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8343; International Narcotics Control Board, 2014, PSYCH SUBST STAT 201; Irwin MR, 2006, HEALTH PSYCHOL, V25, P3, DOI 10.1037/0278-6133.25.1.3; Jacobs GD, 2004, ARCH INTERN MED, V164, P1888, DOI 10.1001/archinte.164.17.1888; Janson C, 2001, SLEEP, V24, P425, DOI 10.1093/sleep/24.4.425; Jansson M, 2005, J OCCUP REHABIL, V15, P177, DOI 10.1007/s10926-005-1217-9; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KALES A, 1991, CLIN PHARMACOL THER, V49, P468, DOI 10.1038/clpt.1991.55; Koffel EA, 2015, SLEEP MED REV, V19, P6, DOI 10.1016/j.smrv.2014.05.001; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Lacks p, 1987, BEHAV TREATMENT PERS; Lovato N, 2014, SLEEP, V37, P117, DOI 10.5665/sleep.3320; McCrae CS, 2007, AM J GERIAT PSYCHIAT, V15, P979, DOI 10.1097/JGP.0b013e31813547e6; McNair D., 1971, MANUAL PROFILE MOOD; Meltzer LJ, 2014, J PEDIATR PSYCHOL, V39, P932, DOI 10.1093/jpepsy/jsu041; Mimeault V, 1999, J CONSULT CLIN PSYCH, V67, P511, DOI 10.1037/0022-006X.67.4.511; Montgomery P, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003161, 10.1002/14651858.CD003161]; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Morin CM, 2012, LANCET, V379, P1129, DOI 10.1016/S0140-6736(11)60750-2; Morin CM, 2006, SLEEP MED, V7, P123, DOI 10.1016/j.sleep.2005.08.008; MORIN CM, 1993, J CONSULT CLIN PSYCH, V61, P137, DOI 10.1037/0022-006X.61.1.137; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; MORIN CM, 1993, PSYCHOL AGING, V8, P463, DOI 10.1037/0882-7974.8.3.463; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; Morin CM, 2003, INSOMNIA CLIN GUIDE; MURTAGH DRR, 1995, J CONSULT CLIN PSYCH, V63, P79, DOI 10.1037/0022-006X.63.1.79; Nowell PD, 1997, JAMA-J AM MED ASSOC, V278, P2170; Ohayon MM, 2009, SLEEP MED, V10, P952, DOI 10.1016/j.sleep.2009.07.008; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Ohayon MM, 1997, J PSYCHIATR RES, V31, P333, DOI 10.1016/S0022-3956(97)00002-2; Okajima I, 2011, SLEEP BIOL RHYTHMS, V9, P24, DOI 10.1111/j.1479-8425.2010.00481.x; Pallesen S, 1998, PSYCHOTHERAPY, V35, P472, DOI 10.1037/h0087829; Perlis ML, 2004, SLEEP, V27, P715, DOI 10.1093/sleep/27.4.715; Roth T, 2006, SLEEP, V29, P424, DOI 10.1093/sleep/29.4.424; Roth T, 2006, BIOL PSYCHIAT, V60, P1364, DOI 10.1016/j.biopsych.2006.05.039; Rybarczyk B, 2002, PSYCHOL AGING, V17, P288, DOI 10.1037/0882-7974.17.2.288; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Sivertsen B, 2006, JAMA-J AM MED ASSOC, V295, P2851, DOI 10.1001/jama.295.24.2851; Smith MT, 2005, CLIN PSYCHOL REV, V25, P559, DOI 10.1016/j.cpr.2005.04.004; Smith MT, 2004, SLEEP MED REV, V8, P119, DOI 10.1016/S1087-0792(03)00044-3; Smith MT, 2002, AM J PSYCHIAT, V159, P5, DOI 10.1176/appi.ajp.159.1.5; Soeffing JP, 2008, SLEEP MED, V9, P165, DOI 10.1016/j.sleep.2007.02.009; Spielberger C. D., 1973, MANUAL STATE TRAIT I; SPIELMAN AJ, 1987, SLEEP, V10, P45; Strom L, 2004, J CONSULT CLIN PSYCH, V72, P113, DOI 10.1037/0022-006X.72.1.113; Taylor DJ, 2014, INT REV PSYCHIATR, V26, P205, DOI 10.3109/09540261.2014.902808; Taylor DJ, 2014, BEHAV THER, V45, P376, DOI 10.1016/j.beth.2013.12.010; Taylor DJ, 2005, SLEEP, V28, P1457, DOI 10.1093/sleep/28.11.1457; Trauer J, 2012, COGNITIVE BEHAV THER; Vallieres A, 2005, J SLEEP RES, V14, P447, DOI 10.1111/j.1365-2869.2005.00480.x; Vgontzas AN, 2009, DIABETES CARE, V32, P1980, DOI 10.2337/dc09-0284; Vgontzas AN, 2009, SLEEP, V32, P491, DOI 10.1093/sleep/32.4.491; Vincent N, 2001, SLEEP, V24, P411, DOI 10.1093/sleep/24.4.411; Walsleben JA, 2004, SLEEP, V27, P293, DOI 10.1093/sleep/27.2.293; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Waters William F, 2003, Behav Sleep Med, V1, P81, DOI 10.1207/S15402010BSM0102_2; Wu RG, 2006, PSYCHOTHER PSYCHOSOM, V75, P220, DOI 10.1159/000092892; Zammit G, 2009, DRUG SAFETY, V32, P735, DOI 10.2165/11312920-000000000-00000	104	472	488	5	162	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 4	2015	163	3					191	+		10.7326/M14-2841	http://dx.doi.org/10.7326/M14-2841			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO6EX	26054060				2022-12-28	WOS:000359251100008
J	Jiang, WJ; Upadhyaya, P; Zhang, W; Yu, GQ; Jungfleisch, MB; Fradin, FY; Pearson, JE; Tserkovnyak, Y; Wang, KL; Heinonen, O; te Velthuis, SGE; Hoffmann, A				Jiang, Wanjun; Upadhyaya, Pramey; Zhang, Wei; Yu, Guoqiang; Jungfleisch, M. Benjamin; Fradin, Frank Y.; Pearson, John E.; Tserkovnyak, Yaroslav; Wang, Kang L.; Heinonen, Olle; te Velthuis, Suzanne G. E.; Hoffmann, Axel			Blowing magnetic skyrmion bubbles	SCIENCE			English	Article							DOMAIN-WALLS; SPIN-TORQUE; DYNAMICS; LATTICE; DRIVEN; FILMS	The formation of soap bubbles from thin films is accompanied by topological transitions. Here we show how a magnetic topological structure, a skyrmion bubble, can be generated in a solid-state system in a similar manner. Using an inhomogeneous in-plane current in a system with broken inversion symmetry, we experimentally "blow" magnetic skyrmion bubbles from a geometrical constriction. The presence of a spatially divergent spin-orbit torque gives rise to instabilities of the magnetic domain structures that are reminiscent of Rayleigh-Plateau instabilities in fluid flows. We determine a phase diagram for skyrmion formation and reveal the efficient manipulation of these dynamically created skyrmions, including depinning and motion. The demonstrated current-driven transformation from stripe domains to magnetic skyrmion bubbles could lead to progress in skyrmion-based spintronics.	[Jiang, Wanjun; Zhang, Wei; Jungfleisch, M. Benjamin; Fradin, Frank Y.; Pearson, John E.; Heinonen, Olle; te Velthuis, Suzanne G. E.; Hoffmann, Axel] Argonne Natl Lab, Mat Sci Div, Lemont, IL 60439 USA; [Upadhyaya, Pramey; Yu, Guoqiang; Wang, Kang L.] Univ Calif Los Angeles, Dept Elect Engn, Device Res Lab, Los Angeles, CA 90095 USA; [Tserkovnyak, Yaroslav] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Heinonen, Olle] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA; [Heinonen, Olle] Northwestern Univ, Northwestern Argonne Inst Sci & Engn, Evanston, IL 60208 USA; [Heinonen, Olle] Univ Chicago, Computat Inst, Chicago, IL 60637 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Northwestern University; Northwestern University; University of Chicago	Hoffmann, A (corresponding author), Argonne Natl Lab, Mat Sci Div, Lemont, IL 60439 USA.	hoffmann@anl.gov	Hoffmann, Axel F/A-8152-2009; Pearson, John/R-6356-2018; Yu, Guoqiang/F-1871-2013; te Velthuis, Suzanne G. E./I-6735-2013; Jungfleisch, Matthias Benjamin/G-1069-2015	Hoffmann, Axel F/0000-0002-1808-2767; Pearson, John/0000-0001-7552-9353; Yu, Guoqiang/0000-0002-7439-6920; te Velthuis, Suzanne G. E./0000-0002-1023-8384; Jungfleisch, Matthias Benjamin/0000-0001-8204-3677; Heinonen, Olle/0000-0002-3618-6092	U.S. Department of Energy (DOE), Office of Science, Materials Science and Engineering Division; DOE, Office of Science, Basic Energy Sciences [DE-AC02-06CH11357]; NSF Nanosystems Engineering Research Center for Translational Applications of Nanoscale Multiferroic Systems	U.S. Department of Energy (DOE), Office of Science, Materials Science and Engineering Division(United States Department of Energy (DOE)); DOE, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); NSF Nanosystems Engineering Research Center for Translational Applications of Nanoscale Multiferroic Systems	Work carried out at Argonne National Laboratory was supported by the U.S. Department of Energy (DOE), Office of Science, Materials Science and Engineering Division. Lithography was carried out at the Center for Nanoscale Materials, an Office of Science user facility, which is supported by the DOE, Office of Science, Basic Energy Sciences, under contract no. DE-AC02-06CH11357. Work performed at the University of California, Los Angeles, was partially supported by the NSF Nanosystems Engineering Research Center for Translational Applications of Nanoscale Multiferroic Systems. We thank I. Martin and I. Aronson for insightful discussion.	Bode M, 2007, NATURE, V447, P190, DOI 10.1038/nature05802; Boulle O, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.217203; Braun HB, 2012, ADV PHYS, V61, P1, DOI 10.1080/00018732.2012.663070; Chen G, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.177204; Chen G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3671; Choi J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.207205; Dupe B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5030; Eggers J, 1997, REV MOD PHYS, V69, P865, DOI 10.1103/RevModPhys.69.865; Emori S, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.184427; Emori S, 2013, NAT MATER, V12, P611, DOI [10.1038/NMAT3675, 10.1038/nmat3675]; Fert A, 2013, NAT NANOTECHNOL, V8, P152, DOI 10.1038/nnano.2013.29; Franken JH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05248; Heinze S, 2011, NAT PHYS, V7, P713, DOI [10.1038/NPHYS2045, 10.1038/nphys2045]; Hoffmann A, 2013, IEEE T MAGN, V49, P5172, DOI 10.1109/TMAG.2013.2262947; Hrabec A, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.020402; Hubert A., 2008, MAGNETIC DOMAINS ANA; Iwasaki J, 2013, NAT NANOTECHNOL, V8, P742, DOI 10.1038/nnano.2013.176; Jonietz F, 2010, SCIENCE, V330, P1648, DOI 10.1126/science.1195709; Khvalkovskiy AV, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.020402; Kim KW, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.216601; Lee OJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.024418; Li J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5704; Lin SZ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.207202; Liu LQ, 2012, SCIENCE, V336, P555, DOI 10.1126/science.1218197; Malozemoff A.P., 1979, MAGNETIC DOMAIN WALL; Miao BF, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.174411; Miron IM, 2011, NATURE, V476, P189, DOI 10.1038/nature10309; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Nagaosa N, 2013, NAT NANOTECHNOL, V8, P899, DOI [10.1038/nnano.2013.243, 10.1038/NNANO.2013.243]; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Perez N, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4867199; Rossler UK, 2006, NATURE, V442, P797, DOI 10.1038/nature05056; Rohart S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.184422; Romming N, 2013, SCIENCE, V341, P636, DOI 10.1126/science.1240573; Ryu KS, 2013, NAT NANOTECHNOL, V8, P527, DOI [10.1038/nnano.2013.102, 10.1038/NNANO.2013.102]; Sampaio J, 2013, NAT NANOTECHNOL, V8, P839, DOI [10.1038/nnano.2013.233, 10.1038/nnano.2013.210, 10.1038/NNANO.2013.210]; Seki S, 2012, SCIENCE, V336, P198, DOI 10.1126/science.1214143; Sun L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.167201; Tchoe Y, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.174416; Thiaville A, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/57002; Tomasello R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06784; Yu GQ, 2014, NAT NANOTECHNOL, V9, P548, DOI [10.1038/NNANO.2014.94, 10.1038/nnano.2014.94]; Yu GQ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.104421; Yu XZ, 2011, NAT MATER, V10, P106, DOI 10.1038/nmat2916; Yu XZ, 2010, NATURE, V465, P901, DOI 10.1038/nature09124; Zang JD, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.136804; Zhou Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5652	47	968	982	31	553	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 17	2015	349	6245			SI		283	286		10.1126/science.aaa1442	http://dx.doi.org/10.1126/science.aaa1442			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1ZB	26067256	Green Submitted			2022-12-28	WOS:000358218600045
J	Karl, TR; Arguez, A; Huang, BY; Lawrimore, JH; McMahon, JR; Menne, MJ; Peterson, TC; Vose, RS; Zhang, HM				Karl, Thomas R.; Arguez, Anthony; Huang, Boyin; Lawrimore, Jay H.; McMahon, James R.; Menne, Matthew J.; Peterson, Thomas C.; Vose, Russell S.; Zhang, Huai-Min			Possible artifacts of data biases in the recent global surface warming hiatus	SCIENCE			English	Article							PACIFIC	Much study has been devoted to the possible causes of an apparent decrease in the upward trend of global surface temperatures since 1998, a phenomenon that has been dubbed the global warming "hiatus." Here, we present an updated global surface temperature analysis that reveals that global trends are higher than those reported by the Intergovernmental Panel on Climate Change, especially in recent decades, and that the central estimate for the rate of warming during the first 15 years of the 21st century is at least as great as the last half of the 20th century. These results do not support the notion of a "slowdown" in the increase of global surface temperature.	[Karl, Thomas R.; Arguez, Anthony; Huang, Boyin; Lawrimore, Jay H.; Menne, Matthew J.; Peterson, Thomas C.; Vose, Russell S.; Zhang, Huai-Min] NOAA, NCEI, Asheville, NC 28801 USA; [McMahon, James R.] LMI, Mclean, VA USA	National Oceanic Atmospheric Admin (NOAA) - USA	Karl, TR (corresponding author), NOAA, NCEI, Asheville, NC 28801 USA.	thomas.r.karl@noaa.gov	Arguez, Anthony/I-9375-2017; Vose, Russell/GSI-5687-2022	Arguez, Anthony/0000-0002-4664-9767; 				Cowtan K, 2014, Q J ROY METEOR SOC, V140, P1935, DOI 10.1002/qj.2297; Ding H, 2013, J CLIMATE, V26, P7650, DOI 10.1175/JCLI-D-12-00626.1; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Fyfe JC, 2014, NAT CLIM CHANGE, V4, P150, DOI 10.1038/nclimate2111; Huang BY, 2015, J CLIMATE, V28, P911, DOI 10.1175/JCLI-D-14-00006.1; KENNEDY JJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI DOI 10.1029/2010JD015220; Kent EC, 2010, WIRES CLIM CHANGE, V1, P718, DOI 10.1002/wcc.55; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Lawrence JF, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007836; Lawrimore J. H., 2014, EOS, V94, P61; Meehl GA, 2014, NAT CLIM CHANGE, V4, P898, DOI [10.1038/NCLIMATE2357, 10.1038/nclimate2357]; Meehl GA, 2013, J CLIMATE, V26, P7298, DOI 10.1175/JCLI-D-12-00548.1; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Menne MJ, 2009, J CLIMATE, V22, P1700, DOI 10.1175/2008JCLI2263.1; Rennie JJ, 2014, GEOSCI DATA J, V1, P75, DOI 10.1002/gdj3.8; Reynolds RW, 2010, J CLIMATE, V23, P3545, DOI 10.1175/2010JCLI3294.1; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Santer BD, 2008, INT J CLIMATOL, V28, P1703, DOI 10.1002/joc.1756; Santer BD, 2014, NAT GEOSCI, V7, P185, DOI [10.1038/ngeo2098, 10.1038/NGEO2098]; Schmidt GA, 2014, NAT GEOSCI, V7, P158, DOI 10.1038/ngeo2105; Sillmann J, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/6/064023; Smith TM, 2003, J CLIMATE, V16, P1495, DOI 10.1175/1520-0442-16.10.1495; Stocker T. F., 2013, CLIMAT CHANGE 2013 P; Tollefson J, 2014, NATURE, V505, P276, DOI 10.1038/505276a; Trenberth KE, 2014, J CLIMATE, V27, P3129, DOI 10.1175/JCLI-D-13-00294.1; Watanabe M, 2013, GEOPHYS RES LETT, V40, P3175, DOI 10.1002/grl.50541; Williams CN, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016761	27	439	472	30	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 26	2015	348	6242					1469	1472		10.1126/science.aaa5632	http://dx.doi.org/10.1126/science.aaa5632			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL3RW	26044301				2022-12-28	WOS:000356869100041
J	Poulsen, CJ; Tabor, C; White, JD				Poulsen, Christopher J.; Tabor, Clay; White, Joseph D.			Long-term climate forcing by atmospheric oxygen concentrations	SCIENCE			English	Article							PALEOBOTANICAL EVIDENCE; PHANEROZOIC TIME; HYDROLOGIC-CYCLE; RAIN-FOREST; FOSSIL WOOD; MODEL; MIDDLE; WARM; PALEOCLIMATE; CIRCULATION	The percentage of oxygen in Earth's atmosphere varied between 10% and 35% throughout the Phanerozoic. These changes have been linked to the evolution, radiation, and size of animals but have not been considered to affect climate. We conducted simulations showing that modulation of the partial pressure of oxygen (pO(2)), as a result of its contribution to atmospheric mass and density, influences the optical depth of the atmosphere. Under low pO(2) and a reduced-density atmosphere, shortwave scattering by air molecules and clouds is less frequent, leading to a substantial increase in surface shortwave forcing. Through feedbacks involving latent heat fluxes to the atmosphere and marine stratus clouds, surface shortwave forcing drives increases in atmospheric water vapor and global precipitation, enhances greenhouse forcing, and raises global surface temperature. Our results implicate pO(2) as an important factor in climate forcing throughout geologic time.	[Poulsen, Christopher J.; Tabor, Clay] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [White, Joseph D.] Baylor Univ, Dept Biol, Waco, TX 76798 USA	University of Michigan System; University of Michigan; Baylor University	Poulsen, CJ (corresponding author), Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA.	poulsen@umich.edu	Poulsen, Christopher J/C-6213-2009	Poulsen, Christopher J/0000-0001-5104-4271; Tabor, Clay/0000-0002-9915-6157	NSF Sedimentary Geology and Paleobiology Program [F035175]; NSF [F033663]; Directorate For Geosciences [1261586, 1261562] Funding Source: National Science Foundation; Division Of Earth Sciences [1338200] Funding Source: National Science Foundation; Division Of Ocean Sciences [1261443] Funding Source: National Science Foundation	NSF Sedimentary Geology and Paleobiology Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Supported by NSF Sedimentary Geology and Paleobiology Program grant F035175 and NSF Marine Geology and Geophysics grant F033663. We thank R. Feng, R. Fiorella, I. Montanez, and three anonymous reviewers for discussion of and comments on this work. The model data are available at www.ncdc.noaa.gov/data-access/paleoclimatology-data/contributing.	Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Arvidson RS, 2006, AM J SCI, V306, P135, DOI 10.2475/ajs.306.3.135; BARRON EJ, 1983, EARTH-SCI REV, V19, P305, DOI 10.1016/0012-8252(83)90001-6; Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Berner RA, 2009, AM J SCI, V309, P603, DOI 10.2475/07.2009.03; Bice KL, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001203; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; Francis JE, 2002, PALAEOGEOGR PALAEOCL, V182, P47, DOI 10.1016/S0031-0182(01)00452-7; Friedrich O, 2012, GEOLOGY, V40, P107, DOI 10.1130/G32701.1; Glasspool IJ, 2010, NAT GEOSCI, V3, P627, DOI 10.1038/NGEO923; Greenwood DR, 2010, GEOLOGY, V38, P15, DOI 10.1130/G30218.1; Hasegawa H, 2012, CLIM PAST, V8, P1323, DOI 10.5194/cp-8-1323-2012; Hayes PA, 2006, GEOL SOC SPEC PUBL, V258, P49, DOI 10.1144/GSL.SP.2006.258.01.04; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Herman AB, 1996, NATURE, V380, P330, DOI 10.1038/380330a0; Huber M, 2011, CLIM PAST, V7, P603, DOI 10.5194/cp-7-603-2011; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jahren AH, 2003, GEOLOGY, V31, P463, DOI 10.1130/0091-7613(2003)031<0463:HEFTME>2.0.CO;2; Ludvigson GA, 1998, GEOLOGY, V26, P1039, DOI 10.1130/0091-7613(1998)026<1039:MSLATU>2.3.CO;2; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; Peralta-Medina E, 2012, GEOLOGY, V40, P219, DOI 10.1130/G32733.1; Poulsen CJ, 2004, NATURE, V432, P814, DOI 10.1038/432814a; Royer DL, 2006, GEOCHIM COSMOCHIM AC, V70, P5665, DOI 10.1016/j.gca.2005.11.031; Scott AC, 2006, P NATL ACAD SCI USA, V103, P10861, DOI 10.1073/pnas.0604090103; SPICER RA, 1986, GEOLOGY, V14, P703, DOI 10.1130/0091-7613(1986)14<703:PEFCNP>2.0.CO;2; Spicer RA, 2010, PALAEOGEOGR PALAEOCL, V295, P423, DOI 10.1016/j.palaeo.2010.02.025; Tappert R, 2013, GEOCHIM COSMOCHIM AC, V121, P240, DOI 10.1016/j.gca.2013.07.011; Trenberth KE, 2009, B AM METEOROL SOC, V90, P311, DOI 10.1175/2008BAMS2634.1; Vecchi GA, 2007, J CLIMATE, V20, P4316, DOI 10.1175/JCLI4258.1; White T, 2001, GEOLOGY, V29, P363, DOI 10.1130/0091-7613(2001)029<0363:MCGHCO>2.0.CO;2; Zhou J, 2012, CLIM PAST, V8, P565, DOI 10.5194/cp-8-565-2012	33	61	65	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1238	1241		10.1126/science.1260670	http://dx.doi.org/10.1126/science.1260670			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068848				2022-12-28	WOS:000356011500050
J	Sponberg, S; Dyhr, JP; Hall, RW; Daniel, TL				Sponberg, Simon; Dyhr, Jonathan P.; Hall, Robert W.; Daniel, Thomas L.			Luminance-dependent visual processing enables moth flight in low light	SCIENCE			English	Article							MACROGLOSSUM-STELLATARUM; NOCTURNAL HAWKMOTHS; COLOR-VISION; MOTION; PERFORMANCE; DETECTORS; NIGHT	Animals must operate under an enormous range of light intensities. Nocturnal and twilight flying insects are hypothesized to compensate for dim conditions by integrating light over longer times. This slowing of visual processing would increase light sensitivity but should also reduce movement response times. Using freely hovering moths tracking robotic moving flowers, we showed that the moth's visual processing does slow in dim light. These longer response times are consistent with models of how visual neurons enhance sensitivity at low light intensities, but they could pose a challenge for moths feeding from swaying flowers. Dusk-foraging moths avoid this sensorimotor tradeoff; their nervous systems slow down but not so much as to interfere with their ability to track the movements of real wind-blown flowers.	[Sponberg, Simon; Dyhr, Jonathan P.; Hall, Robert W.; Daniel, Thomas L.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Sponberg, Simon] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Sponberg, Simon] Georgia Inst Technol, Sch Appl Physiol, Atlanta, GA 30332 USA; [Dyhr, Jonathan P.] Northwest Univ, Dept Biol, Kirkland, WA 98033 USA	University of Washington; University of Washington Seattle; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Sponberg, S (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	sponberg@physics.gatech.edu		Dyhr, Jonathan/0000-0001-5463-0671	Komen Endowed Chair, an Air Force Research Laboratory [FA8651-13-1-0004]; Office of Naval Research Multi University Research Initiative [N00014-10-1-0952]; Army Research Office [W911NF-13-1-0435]; Air Force Office of Scientific Research [FA9550-14-1-0398]; NSF [DBI-1103768]; Direct For Mathematical & Physical Scien [1205878] Funding Source: National Science Foundation	Komen Endowed Chair, an Air Force Research Laboratory; Office of Naval Research Multi University Research Initiative; Army Research Office; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	J. Riffell kindly provided the artificial Datura wrightii scent. We are also grateful for valuable contributions from J. Lockey, M. Salcedo, S. Kazi, A. Molback, A. Hinterwirth, A. Mountcastle, E. Roth, and N. Cowan. Data are available on Dryad, accession no. 10.5061/dryad.jd7b9. This project was supported by the Komen Endowed Chair, an Air Force Research Laboratory grant (FA8651-13-1-0004), an Office of Naval Research Multi University Research Initiative grant (N00014-10-1-0952), an Army Research Office grant (W911NF-13-1-0435), and an Air Force Office of Scientific Research grant (FA9550-14-1-0398) to T.L.D, and by NSF fellowship DBI-1103768 to J.P.D.	BORST A, 1986, BIOL CYBERN, V55, P59, DOI 10.1007/BF00363978; Cowan NJ, 2014, INTEGR COMP BIOL, V54, P223, DOI 10.1093/icb/icu050; Dafni A, 1997, BIOL REV, V72, P239, DOI 10.1017/S0006323196005002; Dyhr JP, 2013, J EXP BIOL, V216, P1523, DOI 10.1242/jeb.077644; FARINA WM, 1994, J COMP PHYSIOL A, V174, P239; FARINA WM, 1995, J COMP PHYSIOL A, V176, P551, DOI 10.1007/BF00196420; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Hedrick TL, 2009, SCIENCE, V324, P252, DOI 10.1126/science.1168431; Ijspeert AJ, 2014, SCIENCE, V346, P196, DOI 10.1126/science.1254486; Kelber A, 2006, J EXP BIOL, V209, P781, DOI 10.1242/jeb.02060; Kelber A, 2002, NATURE, V419, P922, DOI 10.1038/nature01065; Ma KY, 2013, SCIENCE, V340, P603, DOI 10.1126/science.1231806; Madhav MS, 2013, J EXP BIOL, V216, P4272, DOI 10.1242/jeb.088922; O'Carroll D. C., 2011, Proceedings of the 2011 Seventh International Conference on Intelligent Sensors, Sensor Networks and Information Processing (ISSNIP), P119, DOI 10.1109/ISSNIP.2011.6146593; OCarroll DC, 1996, NATURE, V382, P63, DOI 10.1038/382063a0; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; Roth E, 2014, CURR OPIN NEUROBIOL, V25, P54, DOI 10.1016/j.conb.2013.11.005; Roth E, 2011, J EXP BIOL, V214, P1170, DOI 10.1242/jeb.048124; Sprayberry JDH, 2007, J EXP BIOL, V210, P37, DOI 10.1242/jeb.02616; Sprayberry JDH, 2011, ARTHROPOD-PLANT INTE, V5, P263, DOI 10.1007/s11829-011-9150-7; Theobald JC, 2010, P ROY SOC B-BIOL SCI, V277, P853, DOI 10.1098/rspb.2009.1677; Theobald JC, 2007, J EXP BIOL, V210, P4034, DOI 10.1242/jeb.003756; VANHATEREN JH, 1992, NATURE, V360, P68, DOI 10.1038/360068a0; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; Warrant E, 2004, J COMP PHYSIOL A, V190, P765, DOI 10.1007/s00359-004-0546-z; Warrant E. J., 2001, ECOLOGY SENSING, P187; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; Warrant E, 2011, ANNU REV ENTOMOL, V56, P239, DOI 10.1146/annurev-ento-120709-144852; Windsor SP, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0921	29	67	69	6	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1245	1248		10.1126/science.aaa3042	http://dx.doi.org/10.1126/science.aaa3042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068850				2022-12-28	WOS:000356011500052
J	Warrant, E				Warrant, Eric			Visual tracking in the dead of night	SCIENCE			English	Editorial Material							VISION; ORIENTATION; FLIGHT; LIGHT		Lund Univ, Dept Biol, S-22362 Lund, Sweden	Lund University	Warrant, E (corresponding author), Lund Univ, Dept Biol, S-22362 Lund, Sweden.	eric.warrant@biol.lu.se		Warrant, Eric/0000-0001-7480-7016				Dacke M, 2003, NATURE, V424, P33, DOI 10.1038/424033a; Dacke M, 2013, CURR BIOL, V23, P298, DOI 10.1016/j.cub.2012.12.034; Honkanen A, 2014, J EXP BIOL, V217, P4262, DOI 10.1242/jeb.112425; Kelber A, 2002, NATURE, V419, P922, DOI 10.1038/nature01065; O'Carroll D. C., 2011, P 7 ISSNIP C, P119; Reber T, 2015, J EXP BIOL, V218, P1339, DOI 10.1242/jeb.113886; Reid SF, 2011, J EXP BIOL, V214, P363, DOI 10.1242/jeb.049338; Sponberg S, 2015, SCIENCE, V348, P1245, DOI 10.1126/science.aaa3042; VANHATEREN JH, 1993, VISION RES, V33, P257, DOI 10.1016/0042-6989(93)90163-Q; Warrant EJ, 2004, CURR BIOL, V14, P1309, DOI 10.1016/j.cub.2004.07.057; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; Warrant E, 2011, ANNU REV ENTOMOL, V56, P239, DOI 10.1146/annurev-ento-120709-144852	12	1	1	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1212	1213		10.1126/science.aab2185	http://dx.doi.org/10.1126/science.aab2185			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068837				2022-12-28	WOS:000356011500033
J	[Anonymous]				[Anonymous]			Studying the start-up system	SCIENCE			English	Editorial Material																			0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1200	1200		10.1126/science.348.6240.1200-a	http://dx.doi.org/10.1126/science.348.6240.1200-a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068824				2022-12-28	WOS:000356011500061
J	Friedman, A; Homma, D; Gibb, LG; Amemori, KI; Rubin, SJ; Hood, AS; Riad, MH; Graybiel, AM				Friedman, Alexander; Homma, Daigo; Gibb, Leif G.; Amemori, Ken-ichi; Rubin, Samuel J.; Hood, Adam S.; Riad, Michael H.; Graybiel, Ann M.			A Corticostriatal Path Targeting Striosomes Controls Decision-Making under Conflict	CELL			English	Article							ANTERIOR CINGULATE CORTEX; APPROACH-AVOIDANCE CONFLICT; FRONTAL-CORTEX; RAT; DOPAMINE; NEURONS; PROJECTIONS; COMPARTMENTS; SELECTION; ANXIETY	A striking neurochemical form of compartmentalization has been found in the striatum of humans and other species, dividing it into striosomes and matrix. The function of this organization has been unclear, but the anatomical connections of striosomes indicate their relation to emotion-related brain regions, including the medial prefrontal cortex. We capitalized on this fact by combining pathway-specific optogenetics and electrophysiology in behaving rats to search for selective functions of striosomes. We demonstrate that a medial prefronto-striosomal circuit is selectively active in and causally necessary for cost-benefit decision-making under approach-avoidance conflict conditions known to evoke anxiety in humans. We show that this circuit has unique dynamic properties likely reflecting striatal interneuron function. These findings demonstrate that cognitive and emotion-related functions are, like sensory-motor processing, subject to encoding within compartmentally organized representations in the forebrain and suggest that striosome-targeting corticostriatal circuits can underlie neural processing of decisions fundamental for survival.	[Graybiel, Ann M.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Graybiel, AM (corresponding author), MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA.	graybiel@mit.edu	Amemori, Ken-ichi/L-4206-2013	Amemori, Ken-ichi/0000-0001-8500-6820; Graybiel, Ann/0000-0002-4326-7720	NIH/NIMH [R01 MH060379]; CHDI Foundation [A-5552]; Defense Advanced Research Projects Agency; U.S. Army Research Office [W911NF-10-1-0059]; Bachmann-Strauss Dystonia and Parkinson Foundation; William N. and Bernice E. Bumpus Foundation [RRDA Pilot: 2013.1]; Uehara Memorial Foundation; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060379] Funding Source: NIH RePORTER	NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); CHDI Foundation; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); U.S. Army Research Office; Bachmann-Strauss Dystonia and Parkinson Foundation; William N. and Bernice E. Bumpus Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Jannifer Lee, Dan Hu, Henry Hall, Yasuo Kubota, and Xiaojian Li for their help in many aspects of this work, Prof. Drazen Prelec for his valuable comments, and the undergraduate students who assisted in these experiments. This work was funded by NIH/NIMH (R01 MH060379 to A.M.G.), the CHDI Foundation (A-5552 to A.M.G.), the Defense Advanced Research Projects Agency and the U.S. Army Research Office (W911NF-10-1-0059 to A. M.G.), the Bachmann-Strauss Dystonia and Parkinson Foundation (to A.M.G.), the William N. and Bernice E. Bumpus Foundation (RRDA Pilot: 2013.1 to A.M.G.), and the Uehara Memorial Foundation and Japan Society for the Promotion of Science (to D.H.).	Amemori KI, 2012, NAT NEUROSCI, V15, P776, DOI 10.1038/nn.3088; Aupperle RL, 2015, HUM BRAIN MAPP, V36, P449, DOI 10.1002/hbm.22639; Aupperle RL, 2011, BEHAV BRAIN RES, V225, P455, DOI 10.1016/j.bbr.2011.08.003; Berke JD, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00045; Burguiere E, 2013, SCIENCE, V340, P1243, DOI 10.1126/science.1232380; Canales JJ, 2000, NAT NEUROSCI, V3, P377, DOI 10.1038/73949; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; Dickson JM, 2004, COGNITIVE THER RES, V28, P415, DOI 10.1023/B:COTR.0000031809.20488.ee; DONOGHUE JP, 1986, BRAIN RES, V365, P397, DOI 10.1016/0006-8993(86)91658-6; Dwyer DM, 2010, Q J EXP PSYCHOL, V63, P417, DOI 10.1080/17470210903411049; EBLEN F, 1995, J NEUROSCI, V15, P5999; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; FLAHERTY AW, 1993, J NEUROSCI, V13, P3222; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; GERFEN CR, 1984, NATURE, V311, P461, DOI 10.1038/311461a0; Gleichgerrcht E, 2010, NAT REV NEUROL, V6, P611, DOI 10.1038/nrneurol.2010.148; Glimcher P.W, 2014, NEUROECONOMICS DECIS; Goldstein RZ, 2009, P NATL ACAD SCI USA, V106, P9453, DOI 10.1073/pnas.0900491106; GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723, DOI 10.1073/pnas.75.11.5723; GRAYBIEL AM, 1990, TRENDS NEUROSCI, V13, P244, DOI 10.1016/0166-2236(90)90104-I; Hong S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00778; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; KITA H, 1988, BRAIN RES, V447, P346, DOI 10.1016/0006-8993(88)91138-9; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Lak A, 2014, P NATL ACAD SCI USA, V111, P2343, DOI 10.1073/pnas.1321596111; Milad MR, 2007, BIOL PSYCHIAT, V62, P1191, DOI 10.1016/j.biopsych.2007.04.032; Miller N.E., 1971, SELECTED PAPERS CONF; Newman H, 2015, J COMP NEUROL, V523, P943, DOI 10.1002/cne.23725; PARTHASARATHY HB, 1992, J NEUROSCI, V12, P4468; Pizzagalli DA, 2011, NEUROPSYCHOPHARMACOL, V36, P183, DOI 10.1038/npp.2010.166; Prensa L, 2001, J NEUROSCI, V21, P7247, DOI 10.1523/JNEUROSCI.21-18-07247.2001; RAJAKUMAR N, 1993, J COMP NEUROL, V331, P286, DOI 10.1002/cne.903310210; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Sangha S, 2014, NEUROPSYCHOPHARMACOL, V39, P2405, DOI 10.1038/npp.2014.89; Seamans JK, 1995, BEHAV NEUROSCI, V109, P1063, DOI 10.1037/0735-7044.109.6.1063; St Onge JR, 2010, CEREB CORTEX, V20, P1816, DOI 10.1093/cercor/bhp250; Stephenson-Jones M, 2013, P NATL ACAD SCI USA, V110, pE3670, DOI 10.1073/pnas.1314815110; Stopper CM, 2014, NEURON, V84, P177, DOI 10.1016/j.neuron.2014.08.033; Tippett LJ, 2007, BRAIN, V130, P206, DOI 10.1093/brain/awl243; VOGEL JR, 1971, PSYCHOPHARMACOLOGIA, V21, P1, DOI 10.1007/BF00403989; Walton ME, 2002, J NEUROSCI, V22, P10996; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017	48	178	178	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1320	1333		10.1016/j.cell.2015.04.049	http://dx.doi.org/10.1016/j.cell.2015.04.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26027737	Bronze, Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000355935000012
J	Sergeeva, OA; van der Goot, FG				Sergeeva, Oksana A.; van der Goot, F. Gisou			Kicking Out Pathogens in Exosomes	CELL			English	Editorial Material							MULTIVESICULAR BODIES; AUTOPHAGY; IMMUNITY	Host-pathogen interactions involve a series of attacks and counter-attacks. Miao et al. show that, although some invading bacteria can take shelter in lysosomes by neutralizing their pH, this respite is temporary, as host cells can expel them in exosomes.	[Sergeeva, Oksana A.; van der Goot, F. Gisou] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	van der Goot, FG (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Stn 19, CH-1015 Lausanne, Switzerland.	gisou.vandergoot@epfl.ch	van der Goot, Gisou/B-2279-2012	van der Goot, Gisou/0000-0002-8522-274X; Sergeeva, Oksana/0000-0002-4830-0518				Bishop BL, 2007, NAT MED, V13, P625, DOI 10.1038/nm1572; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Miao YX, 2015, CELL, V161, P1306, DOI 10.1016/j.cell.2015.05.009; Randow F, 2013, SCIENCE, V340, P701, DOI 10.1126/science.1233028; Toops Kimberly A, 2013, Commun Integr Biol, V6, pe24474, DOI 10.4161/cib.24474	8	7	9	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1241	1242		10.1016/j.cell.2015.05.040	http://dx.doi.org/10.1016/j.cell.2015.05.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26046431	Bronze			2022-12-28	WOS:000355935000002
J	Whittle, MC; Izeradjene, K; Rani, PG; Feng, LB; Carlson, MA; DelGiorno, KE; Wood, LD; Goggins, M; Hruban, RH; Chang, AE; Calses, P; Thorsen, SM; Hingorani, SR				Whittle, Martin C.; Izeradjene, Kamel; Rani, P. Geetha; Feng, Libing; Carlson, Markus A.; DelGiorno, Kathleen E.; Wood, Laura D.; Goggins, Michael; Hruban, Ralph H.; Chang, Amy E.; Calses, Philamer; Thorsen, Shelley M.; Hingorani, Sunil R.			RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma	CELL			English	Article							INTRAEPITHELIAL NEOPLASIA; CANCER; EXPRESSION; PROGRESSION; MOUSE; DPC4; INACTIVATION; COOPERATE; PHENOTYPE; CARCINOMA	For the majority of patients with pancreas cancer, the high metastatic proclivity is life limiting. Some patients, however, present with and succumb to locally destructive disease. A molecular understanding of these distinct disease manifestations can critically inform patient management. Using genetically engineered mouse models, we show that heterozygous mutation of Dpc4/Smad4 attenuates the metastatic potential of Kras(G12D/+); Trp53(R172H/+) pancreatic ductal adenocarcinomas while increasing their proliferation. Subsequent loss of heterozygosity of Dpc4 restores metastatic competency while further unleashing proliferation, creating a highly lethal combination. Expression levels of Runx3 respond to and combine with Dpc4 status to coordinately regulate the balance between cancer cell division and dissemination. Thus, Runx3 serves as both a tumor suppressor and promoter in slowing proliferation while orchestrating a metastatic program to stimulate cell migration, invasion, and secretion of proteins that favor distant colonization. These findings suggest a model to anticipate likely disease behaviors in patients and tailor treatment strategies accordingly.	[Whittle, Martin C.; Izeradjene, Kamel; Rani, P. Geetha; Feng, Libing; Carlson, Markus A.; DelGiorno, Kathleen E.; Chang, Amy E.; Calses, Philamer; Thorsen, Shelley M.; Hingorani, Sunil R.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Wood, Laura D.; Goggins, Michael; Hruban, Ralph H.] Johns Hopkins Med Inst, Dept Pathol & Oncol, Baltimore, MD 21231 USA; [Hingorani, Sunil R.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Hingorani, Sunil R.] Univ Washington, Div Med Oncol, Dept Med, Sch Med, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Hingorani, SR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA.	srh@fhcrc.org	DelGiorno, Kathy/AAJ-9911-2021; Wood, Laura/ABF-1531-2020	DelGiorno, Kathy/0000-0002-5749-8394; Hingorani, Sunil/0000-0002-3869-8729; Chang, Amy/0000-0003-4646-0558	NCI grants [CA129537, CA161112, CA114028, CA62924]; Sol Goldman Pancreatic Cancer Research Center; Giles W. and Elise G. Mead Foundation; National Pancreas Foundation; NATIONAL CANCER INSTITUTE [K08CA114028, P50CA062924, R01CA161112, R01CA129357, R01CA129537] Funding Source: NIH RePORTER	NCI grants; Sol Goldman Pancreatic Cancer Research Center; Giles W. and Elise G. Mead Foundation; National Pancreas Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank past and present members of the Hingorani Laboratory for technical assistance and helpful discussions. We thank John D. Potter for comments on the manuscript. We are grateful to Fiona Pakiam for histotechnical support and to Nathan Lee for assistance with figure preparation. We apologize to colleagues for our inability to cite many primary references due to space constraints. This work was supported by NCI grants CA129537, CA161112, and CA114028 to S.R.H., CA62924 and support from Sol Goldman Pancreatic Cancer Research Center to L.D.W., M.G., and R.H.H., and support to S.R.H. from the Giles W. and Elise G. Mead Foundation, the National Pancreas Foundation and David Jones and Maryanne Tagney-Jones. R.H.H. is a co-inventor on PALB2-related intellectual property managed by Johns Hopkins University and has the potential to receive royalty payments.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Allison DC, 1998, J SURG ONCOL, V67, P151, DOI 10.1002/(SICI)1096-9098(199803)67:3<151::AID-JSO2>3.3.CO;2-4; Armstrong T, 2004, CLIN CANCER RES, V10, P7427, DOI 10.1158/1078-0432.CCR-03-0825; Bae SC, 2004, ONCOGENE, V23, P4336, DOI 10.1038/sj.onc.1207286; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; BONALDO P, 1990, BIOCHEMISTRY-US, V29, P1245, DOI 10.1021/bi00457a021; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; Crippa S, 2008, ANN SURG, V247, P571, DOI 10.1097/SLA.0b013e31811f4449; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; FIDLER IJ, 1973, EUR J CANCER, V9, P223, DOI 10.1016/S0014-2964(73)80022-2; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Iacobuzio-Donahue CA, 2000, AM J SURG PATHOL, V24, P1544, DOI 10.1097/00000478-200011000-00011; Iacobuzio-Donahue CA, 2012, CLIN CANCER RES, V18, P4257, DOI 10.1158/1078-0432.CCR-12-0315; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Ito K, 2009, ONCOGENE, V28, P1379, DOI 10.1038/onc.2008.496; Katz MHG, 2010, ONCOLOGIST, V15, P1205, DOI 10.1634/theoncologist.2010-0121; Lee YS, 2013, CANCER CELL, V24, P603, DOI 10.1016/j.ccr.2013.10.003; Levanon D, 2011, EMBO MOL MED, V3, P593, DOI 10.1002/emmm.201100168; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Lunardi S, 2014, CANCER LETT, V343, P147, DOI 10.1016/j.canlet.2013.09.039; Perez-Mancera PA, 2012, GASTROENTEROLOGY, V142, P1079, DOI 10.1053/j.gastro.2012.03.002; Poruk KE, 2013, PANCREAS, V42, P193, DOI 10.1097/MPA.0b013e31825e354d; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; SCARPA A, 1993, AM J PATHOL, V142, P1534; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Stromnes IM, 2014, CARCINOGENESIS, V35, P1451, DOI 10.1093/carcin/bgu115; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Wilentz RE, 2000, CANCER RES, V60, P2002; Yachida S, 2012, CLIN CANCER RES, V18, P6339, DOI 10.1158/1078-0432.CCR-12-1215; Yamada C, 2010, J BIOL CHEM, V285, P16693, DOI 10.1074/jbc.M109.055525; Yarmus M, 2006, P NATL ACAD SCI USA, V103, P7384, DOI 10.1073/pnas.0602470103; Yu KH, 2009, J PROTEOME RES, V8, P1565, DOI 10.1021/pr800904z	38	129	134	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1345	1360		10.1016/j.cell.2015.04.048	http://dx.doi.org/10.1016/j.cell.2015.04.048			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26004068	Bronze, Green Accepted			2022-12-28	WOS:000355935000014
J	Smith, JM				Smith, Jeanette M.			Texas Windstorm Charles T. Bowling	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		BOWLING KDCT, 2003, COMING HOME AM PAINT, P76	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2106	2107		10.1001/jama.2014.11779	http://dx.doi.org/10.1001/jama.2014.11779			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ4CC	26034942				2022-12-28	WOS:000355430900028
J	Schwartlander, B; Pratt, A				Schwartlander, Bernhard; Pratt, Angela			Tobacco in China: taming the smoking dragon	LANCET			English	Editorial Material									[Schwartlander, Bernhard; Pratt, Angela] WHO, China Representat Off, Beijing 100600, Peoples R China	World Health Organization	Schwartlander, B (corresponding author), WHO, China Representat Off, Beijing 100600, Peoples R China.	pratta@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Caixeta Roberta B., 2012, Morbidity and Mortality Weekly Report, V61, P877; Campaign for Tobacco Free Kids, 2012, STUD SEC SMOK GREAT; Chinese Center for Disease Control and Prevention, 2011, GLOBAL ADULT TOBACCO; Eriksen M, 2015, TOBACCO ATLAS; Liu RL, 2010, TOB CONTROL, V19, DOI 10.1136/tc.2009.029959; Wang X. D., 2015, CHINA DAILY; WHO, 2006, INDIAN J MED RES; Yang GH, 2015, LANCET, V385, P1019, DOI 10.1016/S0140-6736(15)60174-X	8	10	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2123	2124		10.1016/S0140-6736(15)60996-5	http://dx.doi.org/10.1016/S0140-6736(15)60996-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ6DG	26068250				2022-12-28	WOS:000355583000004
J	Velian, A; Cummins, CC				Velian, Alexandra; Cummins, Christopher C.			Synthesis and characterization of P2N3-: An aromatic ion composed of phosphorus and nitrogen	SCIENCE			English	Article							CHEMICAL-SHIFTS NICS; DELOCALIZATION INDEX; CLICK CHEMISTRY; BIS(2,4,6-TRI-TERT-BUTYLPHENYL)DIPHOSPHENE; HYDROCARBONS; CRITERION; BORAZINE; SYSTEMS; QTAIM	Aromaticity is predominantly associated with carbon-rich compounds but can also occur in all-inorganic ones. We report the synthesis of the diphosphatriazolate anion, a rare example of a planar aromatic inorganic species. Treatment of azide (N-3(-)) in tetrahydrofuran solution with P(2)A(2) (A = C14H10), a source of P-2, produced P2N3-, which we isolated as its [Na-kryptofix-221](+) salt in 22% yield and characterized by single-crystal x-ray diffraction. Salts [Na-kryptofix-221] [P2N3] and [Na-kryptofix-221] [(P2NN2)-N-15] were analyzed by infrared and Raman spectroscopy, N-15 and P-31 nuclear magnetic resonance spectroscopy, and mass spectrometry. The formation of the P2N3- anion was investigated using density functional theory, and its aromatic character was confirmed by NICS (nucleus-independent chemical shift) and QTAIM (quantum theory of atoms in molecules) methods.	[Velian, Alexandra; Cummins, Christopher C.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Cummins, CC (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	ccummins@mit.edu		Velian, Alexandra/0000-0002-6782-7139	NSF [CHE-1362118]; Direct For Mathematical & Physical Scien [1362118] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This material is based on work supported by NSF grant CHE-1362118.	[Anonymous], 2013, NBOVIEW 2 0 NBO ORB; [Anonymous], 2001, NBO 5 0; BADER RFW, 1991, CHEM REV, V91, P893, DOI 10.1021/cr00005a013; BAUDLER M, 1988, ANGEW CHEM INT EDIT, V27, P280, DOI 10.1002/anie.198802801; BROOKS WVF, 1994, INORG CHEM, V33, P6230, DOI 10.1021/ic00104a037; Chen ZF, 2005, CHEM REV, V105, P3842, DOI 10.1021/cr030088+; Choong SL, 2013, DALTON T, V42, P7775, DOI 10.1039/c3dt50505g; Faraday M. Xx., 1825, PHILOS T R SOC LONDO, V115, P440; Firme CL, 2009, CHEM PHYS LETT, V468, P129, DOI 10.1016/j.cplett.2008.12.004; Foroutan-Nejad C, 2011, J PHYS CHEM A, V115, P12555, DOI 10.1021/jp202901f; Glendening ED, 1998, J COMPUT CHEM, V19, P628, DOI 10.1002/(SICI)1096-987X(19980430)19:6<628::AID-JCC5>3.0.CO;2-T; HAMAGUCHI H, 1984, J AM CHEM SOC, V106, P508, DOI 10.1021/ja00315a006; Herler S, 2005, ANGEW CHEM INT EDIT, V44, P7790, DOI 10.1002/anie.200502475; Hersh WH, 1997, J CHEM EDUC, V74, P1485, DOI 10.1021/ed074p1485; Huisgen R., 1963, ANGEW CHEM INT EDIT, V2, P565, DOI DOI 10.1002/ANIE.196305651; Islas R, 2007, STRUCT CHEM, V18, P833, DOI 10.1007/s11224-007-9229-z; Kiran B, 2001, INORG CHEM, V40, P3615, DOI 10.1021/ic001394y; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Neese F., 2013, ORCA AB INITIO DENSI; Poater J, 2003, CHEM-EUR J, V9, P400, DOI 10.1002/chem.200390041; Pople J.A., 1959, HIGH RESOLUTION NUCL; Pyykko P, 2009, CHEM-EUR J, V15, P12770, DOI 10.1002/chem.200901472; Scheer M, 2007, J AM CHEM SOC, V129, P13386, DOI 10.1021/ja075926m; SCHERER OJ, 1988, CHEM BER-RECL, V121, P935, DOI 10.1002/cber.19881210518; Schleyer PV, 2001, CHEM REV, V101, P1115, DOI 10.1021/cr0103221; Stanger A, 2006, J ORG CHEM, V71, P883, DOI 10.1021/jo051746o; Stock A, 1926, BER DTSCH CHEM GES, V59, P2215, DOI 10.1002/cber.19260590907; Velian A, 2014, J AM CHEM SOC, V136, P13586, DOI 10.1021/ja507922x; Vij A, 2002, ANGEW CHEM INT EDIT, V41, P3051, DOI 10.1002/1521-3773(20020816)41:16<3051::AID-ANIE3051>3.0.CO;2-T; Weinhold F, 2012, MOL PHYS, V110, P565, DOI 10.1080/00268976.2012.661478; YOSHIFUJI M, 1981, J AM CHEM SOC, V103, P4587, DOI 10.1021/ja00405a054; Zeng XQ, 2015, ANGEW CHEM INT EDIT, V54, P1327, DOI 10.1002/anie.201409868	32	74	74	6	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					1001	1004		10.1126/science.aab0204	http://dx.doi.org/10.1126/science.aab0204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	26023134				2022-12-28	WOS:000355276600040
J	Adami, C				Adami, Christoph			ARTIFICIAL INTELLIGENCE Robots with instincts	NATURE			English	Editorial Material									[Adami, Christoph] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Adami, Christoph] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Adami, C (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	adami@msu.edu	Adami, Chris/A-9675-2011	Adami, Chris/0000-0002-2915-9504				Adami C, 2006, SCIENCE, V314, P1093, DOI 10.1126/science.1135929; [Anonymous], 2007, BODY SHAPES WAY WE T; Bongard J, 2006, SCIENCE, V314, P1118, DOI 10.1126/science.1133687; Cully A, 2015, NATURE, V521, P503, DOI 10.1038/nature14422; Marstaller L, 2013, NEURAL COMPUT, V25, P2079, DOI 10.1162/NECO_a_00475	5	8	8	2	183	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					426	427		10.1038/521426a	http://dx.doi.org/10.1038/521426a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ2AN	26017437				2022-12-28	WOS:000355286600024
J	Cully, A; Clune, J; Tarapore, D; Mouret, JB				Cully, Antoine; Clune, Jeff; Tarapore, Danesh; Mouret, Jean-Baptiste			Robots that can adapt like animals	NATURE			English	Article							MODULAR ROBOTS; RESCUE ROBOTS; LOCOMOTION; DOGS	Robots have transformed many industries, most notably manufacturing(1), and have the power to deliver tremendous benefits to society, such as in search and rescue(2), disaster response(3), health care(4) and transportation(5). They are also invaluable tools for scientific exploration in environments inaccessible to humans, from distant planets(6) to deep oceans(7). A major obstacle to their widespread adoption in more complex environments outside factories is their fragility(6,8). Whereas animals can quickly adapt to injuries, current robots cannot 'think outside the box' to find a compensatory behaviour when they are damaged: they are limited to their pre-specified self-sensing abilities, can diagnose only anticipated failure modes(9), and require a pre-programmed contingency plan for every type of potential damage, an impracticality for complex robots(6,8). A promising approach to reducing robot fragility involves having robots learn appropriate behaviours in response to damage(10,11), but current techniques are slow even with small, constrained search spaces(12). Here we introduce an intelligent trial- and-error algorithm that allows robots to adapt to damage in less than two minutes in large search spaces without requiring self-diagnosis or pre-specified contingency plans. Before the robot is deployed, it uses a novel technique to create a detailed map of the space of high-performing behaviours. This map represents the robot's prior knowledge about what behaviours it can perform and their value. When the robot is damaged, it uses this prior knowledge to guide a trial-and-error learning algorithm that conducts intelligent experiments to rapidly discover a behaviour that compensates for the damage. Experiments reveal successful adaptations for a legged robot injured in five different ways, including damaged, broken, and missing legs, and for a robotic arm with joints broken in 14 different ways. This new algorithm will enable more robust, effective, autonomous robots, and may shed light on the principles that animals use to adapt to injury.	[Cully, Antoine; Tarapore, Danesh; Mouret, Jean-Baptiste] Univ Paris 06, Sorbonne Univ, UMR 7222, ISIR, F-75005 Paris, France; [Cully, Antoine; Tarapore, Danesh; Mouret, Jean-Baptiste] CNRS, UMR 7222, ISIR, F-75005 Paris, France; [Clune, Jeff] Univ Wyoming, Dept Comp Sci, Laramie, WY 82071 USA; [Mouret, Jean-Baptiste] Inria, Team Larsen, F-54600 Villers Les Nancy, France; [Mouret, Jean-Baptiste] CNRS, Loria, UMR 7503, F-54500 Vandoeuvre Les Nancy, France; [Mouret, Jean-Baptiste] Univ Lorraine, Loria, UMR 7503, F-54500 Vandoeuvre Les Nancy, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Wyoming; Inria; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Universite de Lorraine	Mouret, JB (corresponding author), Univ Paris 06, Sorbonne Univ, UMR 7222, ISIR, F-75005 Paris, France.	jean-baptiste.mouret@inria.fr	Mouret, Jean Baptiste/B-5166-2019	Mouret, Jean Baptiste/0000-0002-2513-027X; Cully, Antoine/0000-0002-3190-7073; Tarapore, Danesh/0000-0002-3226-6861	ANR Creadapt project [ANR-12-JS03-0009]; European Research Council (ERC) under European Union [637972]; Direction Generale de l'Armement (DGA) scholarship	ANR Creadapt project(French National Research Agency (ANR)); European Research Council (ERC) under European Union(European Research Council (ERC)); Direction Generale de l'Armement (DGA) scholarship	We thank L. Tedesco, S. Doncieux, N. Bredeche, S. Whiteson, R. Calandra, J. Droulez, P. Bessiere, F. Lesaint, C. Thurat, S. Ivaldi, C. Lan Sun Luk, J. Li, J. Huizinga, R. Velez, H. Mengistu, M. Norouzzadeh, T. Clune, and A. Nguyen for feedback and discussions. This work has been funded by the ANR Creadapt project (ANR-12-JS03-0009), the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement number 637972), and a Direction Generale de l'Armement (DGA) scholarship to A.C.	Antonelli G., 2008, SPRINGER HDB ROBOTIC, P987, DOI [10.1007/978-3-540-30301-5-44, DOI 10.1007/978-3-540-30301-5-44]; Argall BD, 2009, ROBOT AUTON SYST, V57, P469, DOI 10.1016/j.robot.2008.10.024; Benson-Amram S, 2012, P ROY SOC B-BIOL SCI, V279, P4087, DOI 10.1098/rspb.2012.1450; Blanke M., 2006, DIAGNOSIS FAULT TOLE, VVolume 2; Bongard J, 2006, SCIENCE, V314, P1118, DOI 10.1126/science.1133687; Borji A., 2013, ADV NEURAL INFORM PR, V26, P55; Broadbent E, 2009, INT J SOC ROBOT, V1, P319, DOI 10.1007/s12369-009-0030-6; Carlson J, 2005, IEEE T ROBOT, V21, P423, DOI 10.1109/TRO.2004.838027; Christensen DJ, 2013, ROBOT AUTON SYST, V61, P1021, DOI 10.1016/j.robot.2013.05.009; Chung W., 2008, SPRINGER HDB ROBOTIC; Deisenroth M. P., 2014, P IEEE INT C ROB AUT, P1951; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Fuchs A, 2014, VET J, V201, P307, DOI 10.1016/j.tvjl.2014.05.012; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Jarvis SL, 2013, AM J VET RES, V74, P1155, DOI 10.2460/ajvr.74.9.1155; Kluger J., 2006, APOLLO; Kober J, 2013, INT J ROBOT RES, V32, P1238, DOI 10.1177/0278364913495721; Kohl N, 2004, IEEE INT CONF ROBOT, P2619, DOI 10.1109/ROBOT.2004.1307456; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lizotte D, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P944; Mockus J, 2013, BAYESIAN APPROACH GL; Mouret J.-B., 2015, ILLUMINATING SEARCH; Murphy RR, 2004, IEEE ROBOT AUTOM MAG, V11, P50, DOI 10.1109/MRA.2004.1337826; Nagatani K, 2013, J FIELD ROBOT, V30, P44, DOI 10.1002/rob.21439; Pouget A, 2013, NAT NEUROSCI, V16, P1170, DOI 10.1038/nn.3495; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Sanderson K, 2010, NATURE, V463, P600, DOI 10.1038/463600a; Santello M, 1998, J NEUROSCI, V18, P10105; Sproewitz A, 2008, INT J ROBOT RES, V27, P423, DOI 10.1177/0278364907088401; Tesch M, 2011, IEEE INT C INT ROBOT, P1069, DOI 10.1109/IROS.2011.6048837; Thrun S, 2006, J FIELD ROBOT, V23, P661, DOI 10.1002/rob.20147; Verma V, 2004, IEEE ROBOT AUTOM MAG, V11, P56, DOI 10.1109/MRA.2004.1310942; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Wolpert DM, 2001, TRENDS COGN SCI, V5, P487, DOI 10.1016/S1364-6613(00)01773-3	35	468	478	44	472	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					503	U476		10.1038/nature14422	http://dx.doi.org/10.1038/nature14422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	26017452	Green Submitted, Green Accepted			2022-12-28	WOS:000355286600039
J	Hill, JA				Hill, Joseph A.			Braking Bad Hypertrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EXERCISE		Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Hill, JA (corresponding author), Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA.							Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Liu XJ, 2015, CELL METAB, V21, P584, DOI 10.1016/j.cmet.2015.02.014; Naci H, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5577; Pedersen BK, 2012, NEW ENGL J MED, V366, P1544, DOI 10.1056/NEJMcibr1201024; Schulkey CE, 2015, NATURE, V520, P230, DOI 10.1038/nature14361	5	13	15	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2015	372	22					2160	2162		10.1056/NEJMcibr1504187	http://dx.doi.org/10.1056/NEJMcibr1504187			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0EI	26017827				2022-12-28	WOS:000355146800016
J	Abraha, I; Cherubini, A; Cozzolino, F; De Florio, R; Luchetta, ML; Rimland, JM; Folletti, I; Marchesi, M; Germani, A; Orso, M; Eusebi, P; Montedori, A				Abraha, Iosief; Cherubini, Antonio; Cozzolino, Francesco; De Florio, Rita; Luchetta, Maria Laura; Rimland, Joseph M.; Folletti, Ilenia; Marchesi, Mauro; Germani, Antonella; Orso, Massimiliano; Eusebi, Paolo; Montedori, Alessandro			Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLACEBO-CONTROLLED TRIAL; ACUTE NECROTIZING PANCREATITIS; MODIFYING ANTIRHEUMATIC DRUGS; DOUBLE-BLIND; TO-TREAT; ANTIFUNGAL PROPHYLAXIS; REUPTAKE INHIBITOR; EXCLUDING PATIENTS; MTX MONOTHERAPY; CROHNS-DISEASE	Objective To examine whether deviation from the standard intention to treat analysis has an influence on treatment effect estimates of randomised trials. Design Meta-epidemiological study. Data sources Medline, via PubMed, searched between 2006 and 2010; 43 systematic reviews of interventions and 310 randomised trials were included. Eligibility criteria for selecting studies From each year searched, random selection of 5% of intervention reviews with a meta-analysis that included at least one trial that deviated from the standard intention to treat approach. Basic characteristics of the systematic reviews and randomised trials were extracted. Information on the reporting of intention to treat analysis, outcome data, risk of bias items, post-randomisation exclusions, and funding were extracted from each trial. Trials were classified as: ITT (reporting the standard intention to treat approach), mITT (reporting a deviation from the standard approach), and no ITT (reporting no approach). Within each meta-analysis, treatment effects were compared between mITT and ITT trials, and between mITT and no ITT trials. The ratio of odds ratios was calculated (value <1 indicated larger treatment effects in mITT trials than in other trial categories). Results 50 meta-analyses and 322 comparisons of randomised trials (from 84 ITT trials, 118 mITT trials, and 108 no ITT trials; 12 trials contributed twice to the analysis) were examined. Compared with ITT trials, mITT trials showed a larger intervention effect (pooled ratio of odds ratios 0.83 (95% confidence interval 0.71 to 0.96), P=0.01; between meta-analyses variance tau(2)=0.13). Adjustments for sample size, type of centre, funding, items of risk of bias, post-randomisation exclusions, and variance of log odds ratio yielded consistent results (0.80 (0.69 to 0.94), P=0.005; tau(2)=0.08). After exclusion of five influential studies, results remained consistent (0.85 (0.75 to 0.98); tau(2)=0.08). The comparison between mITT trials and no ITT trials showed no statistical difference between the two groups (adjusted ratio of odds ratios 0.92 (0.70 to 1.23); tau(2)=0.57). Conclusions Trials that deviated from the intention to treat analysis showed larger intervention effects than trials that reported the standard approach. Where an intention to treat analysis is impossible to perform, authors should clearly report who is included in the analysis and attempt to perform multiple imputations.	[Abraha, Iosief; Cozzolino, Francesco; Orso, Massimiliano; Eusebi, Paolo; Montedori, Alessandro] Reg Hlth Author Umbria, Dept Epidemiol, Hlth Planning Serv, I-06124 Perugia, Italy; [Cherubini, Antonio; Rimland, Joseph M.] Italian Natl Res Ctr Aging, Geriatr & Geriatr Emergency Care, Ancona, Italy; [De Florio, Rita] Azienda USL Umbria 2, Gen Med, Terni, Italy; [Luchetta, Maria Laura] Azienda USL Umbria 1, Gen Med, Perugia, Italy; [Marchesi, Mauro; Germani, Antonella] Azienda Osped Perugia, Transfus Med Serv, Perugia, Italy; [Folletti, Ilenia] Univ Perugia, Dept Clin & Expt Med, I-06100 Perugia, Italy	IRCCS INRCA; University of Perugia; Azienda Ospedaliera di Perugia; University of Perugia	Abraha, I (corresponding author), Reg Hlth Author Umbria, Dept Epidemiol, Hlth Planning Serv, I-06124 Perugia, Italy.	iosief_a@yahoo.it	Eusebi, Paolo/O-2721-2013; Orso, Massimiliano/L-1040-2018; Cherubini, Antonio/AAL-4632-2020; Abraha, Iosief/K-4327-2018; Rimland, Joseph/J-5992-2016	Eusebi, Paolo/0000-0002-0715-6396; Orso, Massimiliano/0000-0003-0200-1202; Abraha, Iosief/0000-0002-5440-775X; Rimland, Joseph/0000-0002-3397-6291; Cherubini, Antonio/0000-0003-0261-9897; MONTEDORI, ALESSANDRO/0000-0001-7719-573X	Ministry of Health, Italy [RF-2009-1549561]	Ministry of Health, Italy(Ministry of Health, Italy)	This study was funded by the Ministry of Health, Italy (RF-2009-1549561). The study sponsor was not involved in the study design and collection, analysis, and interpretation of data, or the writing of the article or the decision to submit it for publication. The authors were independent from study sponsors.	Abraha I, 2009, COCHRANE DATABASE S, P7; Abraha I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2697; Akl EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2809; [Anonymous], 2006, COCHRANE DB SYST REV; Asakura S, 2007, INT J NEUROPSYCHOPH, V10, P263, DOI 10.1017/S1461145706006602; Avouac J, 2008, ANN RHEUM DIS, V67, P808, DOI 10.1136/ard.2007.077149; Azim HA, 2009, LUNG CANCER, V64, P194, DOI 10.1016/j.lungcan.2008.08.011; Bai Y, 2008, AM J GASTROENTEROL, V103, P104, DOI 10.1111/j.1572-0241.2007.01575.x; Baker WL, 2009, PARKINSONISM RELAT D, V15, P287, DOI 10.1016/j.parkreldis.2008.07.004; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Baujat B, 2002, STAT MED, V21, P2641, DOI 10.1002/sim.1221; Benkert O, 1996, J PSYCHIAT RES, V30, P441, DOI 10.1016/S0022-3956(96)00029-5; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005593; Brok J, 2006, AM J GASTROENTEROL, V101, P842, DOI 10.1111/j.1572-0241.2006.00505.x; Cameron D, 2008, BREAST CANCER RES TR, V112, P533, DOI 10.1007/s10549-007-9885-0; Coomarasamy A, 2008, HUM REPROD, V23, P310, DOI 10.1093/humrep/dem305; Cranney A, 2009, OSTEOPOROSIS INT, V20, P291, DOI 10.1007/s00198-008-0653-8; Dechartres A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2304; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; Dmochowski RR, 2003, J UROLOGY, V170, P1259, DOI 10.1097/01.ju.0000080708.87092.cc; Dodd JM, 2006, COCHRANE DB SYST REV, V1; Dupont H, 2000, ANTIMICROB AGENTS CH, V44, P2028, DOI 10.1128/AAC.44.8.2028-2033.2000; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; FRASER SM, 1993, BRIT J RHEUMATOL, V32, P923; Gao F, 2009, COLORECTAL DIS, V11, P893, DOI 10.1111/j.1463-1318.2008.01746.x; Gravel J, 2007, CLIN TRIALS, V4, P350, DOI 10.1177/1740774507081223; Guaiana G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006815.pub2; Harris CA, 2011, ANN ONCOL, V22, P1308, DOI 10.1093/annonc/mdq593; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hollander E, 2003, INT J NEUROPSYCHOPH, V6, P397, DOI 10.1017/S1461145703003730; Humber CE, 2007, ANN ONCOL, V18, P409, DOI 10.1093/annonc/mdl417; Imran H, 2008, EUR J CLIN MICROBIOL, V27, P53, DOI 10.1007/s10096-007-0397-y; Jang YG, 2009, NEUROCRIT CARE, V10, P141, DOI 10.1007/s12028-008-9147-y; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Karkkainen MK, 2010, MATURITAS, V65, P359, DOI 10.1016/j.maturitas.2009.12.018; Katchamart W, 2009, ANN RHEUM DIS, V68, P1105, DOI 10.1136/ard.2008.099861; KIILERICH S, 1992, GUT, V33, P252, DOI 10.1136/gut.33.2.252; KOMOSSA K, 2010, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD008141.PUB2; Kosmas IP, 2008, FERTIL STERIL, V90, P367, DOI 10.1016/j.fertnstert.2007.06.064; Lachin JM, 2000, CONTROL CLIN TRIALS, V21, P167, DOI 10.1016/S0197-2456(00)00046-5; Lee YH, 2008, RHEUMATOL INT, V28, P553, DOI 10.1007/s00296-007-0475-6; Leizorovicz A, 2004, CIRCULATION, V110, P874, DOI 10.1161/01.CIR.0000138928.83266.24; Leucht S, 2009, MOL PSYCHIATR, V14, P429, DOI 10.1038/sj.mp.4002136; LEWIS JA, 1993, BRIT J CANCER, V68, P647, DOI 10.1038/bjc.1993.402; Mariappan P, 2007, EUR UROL, V51, P67, DOI 10.1016/j.eururo.2006.08.041; McKenna F, 2001, SCAND J RHEUMATOL, V30, P11; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Molenberghs G, 2004, BIOSTATISTICS, V5, P445, DOI 10.1093/biostatistics/kxh001; Montedori A, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-58; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Naber KG, 2009, INT J ANTIMICROB AG, V33, P111, DOI 10.1016/j.ijantimicag.2008.08.011; Navarro V, 2001, ACTA PSYCHIAT SCAND, V103, P435, DOI 10.1034/j.1600-0447.2001.00228.x; Nemeroff CB, 2007, J PSYCHIATR RES, V41, P351, DOI 10.1016/j.jpsychires.2005.07.009; NEWELL DJ, 1992, INT J EPIDEMIOL, V21, P837, DOI 10.1093/ije/21.5.837; Nikfar S, 2010, CURR PHARM DESIGN, V16, P3684, DOI 10.2174/138161210794079236; Nikfar S, 2009, DIGEST DIS SCI, V54, P1157, DOI 10.1007/s10620-008-0481-x; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Nuesch E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3244; Obonyo CO, 2006, EUR J CLIN MICROBIOL, V25, P90, DOI 10.1007/s10096-006-0092-4; Papageorgiou SN, 2014, J CLIN EPIDEMIOL, V67, P984, DOI 10.1016/j.jclinepi.2014.04.002; Papakostas GI, 2008, EUR NEUROPSYCHOPHARM, V18, P122, DOI 10.1016/j.euroneuro.2007.07.005; PEDERZOLI P, 1993, SURG GYNECOL OBSTET, V176, P480; Porta N, 2007, J CLIN EPIDEMIOL, V60, P663, DOI 10.1016/j.jclinepi.2006.09.013; Rahimi R, 2007, BIOMED PHARMACOTHER, V61, P75, DOI 10.1016/j.biopha.2006.06.022; Ravindran V, 2008, ANN RHEUM DIS, V67, P855, DOI 10.1136/ard.2007.072652; Rendell JM, 2006, COCHRANE DB SYST REV, V1; Rhorer J, 2009, VACCINE, V27, P1101, DOI 10.1016/j.vaccine.2008.11.093; Rodrigo GJ, 2007, PULM PHARMACOL THER, V20, P495, DOI 10.1016/j.pupt.2006.02.003; Roskell NS, 2011, PAIN PRACT, V11, P516, DOI 10.1111/j.1533-2500.2010.00441.x; Rotstein C, 1999, CLIN INFECT DIS, V28, P331, DOI 10.1086/515128; Rudolph RL, 1999, J AFFECT DISORDERS, V56, P171, DOI 10.1016/S0165-0327(99)00067-1; Savovic J, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16350; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; Schulz KF, 1996, BRIT MED J, V312, P742; Seo J, 2009, CANCER CHEMOTH PHARM, V63, P261, DOI 10.1007/s00280-008-0735-5; Siersma V, 2007, STAT MED, V26, P2745, DOI 10.1002/SIM.2752; Siler AC, 2011, J PAIN, V12, P407, DOI 10.1016/j.jpain.2010.09.007; Sjaelander A, 2008, J INTERN MED, V263, P52, DOI 10.1111/j.1365-2796.2007.01878.x; Sparano JA, 2009, J CLIN ONCOL, V27, P4522, DOI 10.1200/JCO.2008.20.5013; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Thigpen JT, 2004, J CLIN ONCOL, V22, P3902, DOI 10.1200/JCO.2004.02.088; Tierney JF, 2005, INT J EPIDEMIOL, V34, P79, DOI 10.1093/ije/dyh300; van den Broek WW, 2009, J PSYCHOPHARMACOL, V23, P708, DOI 10.1177/0269881108089821; Vardakas KZ, 2006, CRIT CARE MED, V34, P1216, DOI 10.1097/01.CCM.0000208357.05675.C3; Wang XF, 2010, TRANSPL P, V42, P4567, DOI 10.1016/j.transproceed.2010.09.169; Weinmann S, 2008, PSYCHOPHARMACOLOGY, V196, P511, DOI 10.1007/s00213-007-0975-9; Wood Angela M, 2004, Clin Trials, V1, P368; Xu HB, 2011, J CANCER RES CLIN, V137, P1005, DOI 10.1007/s00432-010-0967-8; Ziakas PD, 2010, CLIN THER, V32, P2316, DOI 10.1016/j.clinthera.2011.01.009; Zou Z, 2009, J HUM HYPERTENS, V23, P339, DOI 10.1038/jhh.2008.132	94	107	108	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2015	350								h2445	10.1136/bmj.h2445	http://dx.doi.org/10.1136/bmj.h2445			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0AH	26016488	Green Published, hybrid			2022-12-28	WOS:000355132900002
J	Cameron, FJ; Wherrett, DK				Cameron, Fergus J.; Wherrett, Diane K.			Care of diabetes in children and adolescents: controversies, changes, and consensus	LANCET			English	Review							INSULIN-PUMP THERAPY; IMPROVED METABOLIC-CONTROL; GLYCEMIC CONTROL; PITTSBURGH EPIDEMIOLOGY; COMPLICATIONS-TRIAL/EPIDEMIOLOGY; ARTIFICIAL PANCREAS; LIFE EXPECTANCY; GLUCOSE CONTROL; HOME-USE; TYPE-1	Diabetes is one of the most common chronic medical disorders in children. The management of diabetes remains a substantial burden on children with diabetes and their families, despite improvements in treatment and rates of morbidity and mortality. Although most children with diabetes have type 1 diabetes, the increasing recognition of type 2 diabetes and genetic forms of diabetes in the paediatric population has important treatment implications. Diabetes therapy focuses strongly on targets for good metabolic control to reduce the risk of long-term complications. A parallel goal is to minimise short-term complications of hypoglycaemia and diabetic ketoacidosis. Technology offers opportunity for improvement in care, but has not yet fully lived up to its potential. New insights into the pathogenesis of diabetes and the development of new therapies have led to clinical trials aimed at the prevention of diabetes.	[Cameron, Fergus J.] Univ Melbourne, Royal Childrens Hosp, Dept Endocrinol & Diabet, Ctr Hormone Res,Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Cameron, Fergus J.] Univ Melbourne, Dept Paediat, Fac Med Dent & Hlth Sci, Parkville, Vic 3052, Australia; [Wherrett, Diane K.] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Endocrinol, Toronto, ON M5G 1X8, Canada	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Wherrett, DK (corresponding author), Univ Toronto, Hosp Sick Children, Dept Paediat, Div Endocrinol, Toronto, ON M5G 1X8, Canada.	diane.wherrett@sickkids.ca	Cameron, Fergus J/N-9535-2015		National Institutes of Health; Novo Nordisk; Eli Lilly; Sanofi; Medtronic; Roche; Juvenile Diabetes Research Foundation; National Health and Medical Research Council	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk(Novo Nordisk); Eli Lilly(Eli Lilly); Sanofi; Medtronic(Medtronic); Roche(Roche Holding); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	DKW declares research grant funding from the National Institutes of Health. FJC declares research and travel funding support from Novo Nordisk, Eli Lilly, Sanofi, Medtronic, Roche, the Juvenile Diabetes Research Foundation, and the National Health and Medical Research Council. FJC is a member of the Hvidoere International Study group on Childhood Diabetes.	ALMDAL T, 1994, DIABETES CARE, V17, P120, DOI 10.2337/diacare.17.2.120; Amed S, 2010, DIABETES CARE, V33, P786, DOI 10.2337/dc09-1013; Anderson BJ, 2002, DIABETIC MED, V19, P635, DOI 10.1046/j.1464-5491.2002.00752.x; [Anonymous], 2015, DIABETES CARE, V38, pS70, DOI 10.2337/dc15-S014; Arif S, 2014, DIABETES, V63, P3835, DOI 10.2337/db14-0365; Arslanian S, 2013, DIABETES CARE, V36, P1749, DOI 10.2337/dc12-2393; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Battelino T, 2012, DIABETOLOGIA, V55, P3155, DOI 10.1007/s00125-012-2708-9; Bell KJ, 2014, LANCET DIABETES ENDO, V2, P133, DOI 10.1016/S2213-8587(13)70144-X; Bergenstal RM, 2010, NEW ENGL J MED, V363, P311, DOI 10.1056/NEJMoa1002853; Berhan Y, 2011, DIABETES, V60, P577, DOI 10.2337/db10-0813; Brink SJ, 1997, ANN MED, V29, P425, DOI 10.3109/07853899708999373; Broe R, 2014, ACTA DIABETOL, V51, P413, DOI 10.1007/s00592-013-0527-1; Bui H, 2010, J PEDIATR-US, V156, P472, DOI 10.1016/j.jpeds.2009.10.001; Cameron FJ, 2013, PEDIATR DIABETES, V14, P473, DOI 10.1111/pedi.12036; Cefalu WT, 2014, DIABETES CARE, V37, P5, DOI 10.2337/dc13-2369; Chase HP, 2014, DIABETES TECHNOL THE, V16, P623, DOI 10.1089/dia.2014.0050; Copeland KC, 2013, PEDIATRICS, V131, P364, DOI 10.1542/peds.2012-3494; Craig M., 2011, NATL EVIDENCE BASED; Cummins E, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14110; Cummins E, 2010, HEALTH TECHNOL ASSES, V14, P11; Cummins E, 2010, HEALTH TECHNOL ASSES, V14, piii; D'Adamo E, 2011, DIABETES CARE, V34, pS161, DOI 10.2337/dc11-s212; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Dabelea D, 2014, PEDIATRICS, V133, pE938, DOI 10.1542/peds.2013-2795; DAFNE Study Group, 2003, Diabet Med, V20 Suppl 3, P4; Dart AB, 2014, DIABETES CARE, V37, P436, DOI 10.2337/dc13-0954; de Beaufort CE, 2007, DIABETES CARE, V30, P2245, DOI 10.2337/dc07-0475; de Beaufort CE, 2013, PEDIATR DIABETES, V14, P422, DOI 10.1111/j.1399-5448.2012.00922.x; Deis D, 2006, DIABETES CARE, V29, P2730, DOI 10.2337/dc06-1134; Delamater AM, 2014, PEDIATR DIABETES, V15, P232, DOI 10.1111/pedi.12191; Doggen K, 2012, EUR J PEDIATR, V171, P1679, DOI 10.1007/s00431-012-1809-2; Dovc K, 2014, DIABETES TECHNOL THE, V16, P33, DOI 10.1089/dia.2013.0182; Elleri D, 2013, DIABETES CARE, V36, P838, DOI 10.2337/dc12-0816; Farsani SF, 2013, DIABETOLOGIA, V56, P1471, DOI 10.1007/s00125-013-2915-z; Fritsch M, 2013, J PEDIATR-US, V163, P1484, DOI 10.1016/j.jpeds.2013.06.033; Gale Edwin A M, 2007, Diabetes Care, V30, P2989, DOI 10.2337/dc07-0155; Gale EAM, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5675; Groop PH, 2009, DIABETES, V58, P1651, DOI 10.2337/db08-1543; Haidar A, 2015, LANCET DIABETES ENDO, V3, P17, DOI 10.1016/S2213-8587(14)70226-8; Harjutsalo V, 2013, JAMA-J AM MED ASSOC, V310, P427, DOI 10.1001/jama.2013.8399; Heise T, 2004, DIABETES, V53, P1614, DOI 10.2337/diabetes.53.6.1614; Helminen O, 2015, DIABETES, V64, P1719, DOI 10.2337/db14-0497; Hirsch IB, 2008, DIABETES TECHNOL THE, V10, P377, DOI 10.1089/dia.2008.0068; Holl RW, 2003, EUR J PEDIATR, V162, P22, DOI 10.1007/s00431-002-1037-2; Holleman F, 2007, DIABETOLOGIA, V50, P1783, DOI 10.1007/s00125-007-0763-4; Hovorka R, 2006, DIABETIC MED, V23, P1, DOI 10.1111/j.1464-5491.2005.01672.x; Karges B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001742; Karres J, 2014, DIABETES CARE, V37, P2665, DOI 10.2337/dc14-0494; King BR, 2012, PEDIATR DIABETES, V13, P647, DOI 10.1111/j.1399-5448.2012.00896.x; Klein BEK, 2015, JAMA OPHTHALMOL, V133, P503, DOI 10.1001/jamaophthalmol.2014.5108; Knip M, 2014, JAMA-J AM MED ASSOC, V311, P2279, DOI 10.1001/jama.2014.5610; Kovatchev BP, 2014, DIABETES CARE, V37, P1789, DOI 10.2337/dc13-2076; Kyto JP, 2011, DIABETES CARE, V34, P2005, DOI 10.2337/dc10-2391; LeCaire TJ, 2013, DIABETES CARE, V36, P631, DOI 10.2337/dc12-0863; Leelarathna L, 2014, DIABETES CARE, V37, P1931, DOI 10.2337/dc13-2911; Lernmark A, 2013, NAT REV ENDOCRINOL, V9, P92, DOI 10.1038/nrendo.2012.237; Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214; Livingstone SJ, 2015, JAMA-J AM MED ASSOC, V313, P37, DOI 10.1001/jama.2014.16425; Lokulo-Sodipe K, 2014, ARCH DIS CHILD, V99, P438, DOI 10.1136/archdischild-2013-304818; Maahs DM, 2014, DIABETOLOGIA, V57, P1578, DOI 10.1007/s00125-014-3272-2; Maahs DM, 2014, DIABETES CARE, V37, P1885, DOI 10.2337/dc13-2159; Marcovecchio ML, 2014, DIABETES CARE, V37, P805, DOI 10.2337/dc13-1634; McDonald TJ, 2013, ANN CLIN BIOCHEM, V50, P403, DOI 10.1177/0004563213483458; McKnight JA, 2015, DIABETIC MED, V32, P1036, DOI 10.1111/dme.12676; Miller RG, 2012, DIABETES, V61, P2987, DOI 10.2337/db11-1625; Misso ML, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005103.pub2; Morgan NG, 2014, TRENDS ENDOCRIN MET, V25, P611, DOI 10.1016/j.tem.2014.08.002; Nathan DM, 2009, ARCH INTERN MED, V169, P1307, DOI 10.1001/archinternmed.2009.193; NICE, 2005, GUID US LONG ACT INS; Nimri R, 2014, DIABETES CARE, V37, P3025, DOI 10.2337/dc14-0835; O'Connell SM, 2011, DIABETES CARE, V34, P2379, DOI 10.2337/dc11-0748; Orchard TJ, 2010, DIABETOLOGIA, V53, P2312, DOI 10.1007/s00125-010-1860-3; Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423; Parikka V, 2012, DIABETOLOGIA, V55, P1926, DOI 10.1007/s00125-012-2523-3; Patterson C, 2014, DIABETES RES CLIN PR, V103, P161, DOI 10.1016/j.diabres.2013.11.005; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Petitti DB, 2009, J PEDIAT, V155, DOI [10.1016/j.jpeds.2009.05.025, DOI 10.1016/J.JPEDS.2009.05.025]; Pettitt DJ, 2014, DIABETES CARE, V37, P402, DOI 10.2337/dc13-1838; Phillip M, 2013, NEW ENGL J MED, V368, P824, DOI 10.1056/NEJMoa1206881; Phillip M, 2012, PEDIATR DIABETES, V13, P215, DOI 10.1111/j.1399-5448.2011.00849.x; Pihoker C, 2013, J CLIN ENDOCR METAB, V98, P4055, DOI 10.1210/jc.2013-1279; PinhasHamiel O, 1997, DIABETES CARE, V20, P484, DOI 10.2337/diacare.20.4.484; Price K, 2013, PEDIAT DIABETES S18, V14, P34; Rabbone I, 2014, DIABETES RES CLIN PR, V103, P388, DOI 10.1016/j.diabres.2013.12.026; Rebrin K, 1999, AM J PHYSIOL-ENDOC M, V277, pE561, DOI 10.1152/ajpendo.1999.277.3.E561; Redon I, 2014, PEDIATR DIABETES, V15, P329, DOI 10.1111/pedi.12062; Roep BO, 2014, NAT REV ENDOCRINOL, V10, P229, DOI 10.1038/nrendo.2014.2; Rosenbauer J, 2012, DIABETES CARE, V35, P80, DOI 10.2337/dc11-0993; Rubio-Cabezas O, 2013, HORM RES PAEDIAT, V80, P137, DOI 10.1159/000354219; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; Savoye M, 2014, DIABETES CARE, V37, P317, DOI 10.2337/dc13-1571; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shankar RK, 2013, PEDIATR DIABETES, V14, P174, DOI 10.1111/pedi.12003; Skinner TC, 2010, DIABETIC MED, V27, P369, DOI 10.1111/j.1464-5491.2009.02895.x; Sosenko JM, 2014, DIABETES CARE, V37, P979, DOI 10.2337/dc13-2359; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Thabit H, 2014, LANCET DIABETES ENDO, V2, P701, DOI 10.1016/S2213-8587(14)70114-7; Usher-Smith JA, 2012, DIABETOLOGIA, V55, P2878, DOI 10.1007/s00125-012-2690-2; Vanelli Maurizio, 2007, Diabetes Care, V30, pe12, DOI 10.2337/dc07-0059; Waters E., 2013, COCHRANE DB SYST REV; Weber B, 1994, PEDIATRICS, V94, pA26; Weinzimer S, 2009, PEDIATR DIABETES, V10, P91, DOI 10.1111/j.1399-5448.2008.00476.x; Wysocki T, 2003, DIABETES CARE, V26, P2043, DOI 10.2337/diacare.26.7.2043; Zeitler P, 2014, PEDIATR DIABETES, V15, P26, DOI 10.1111/pedi.12179; Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285; Zisser H, 2014, DIABETES TECHNOL THE, V16, P613, DOI 10.1089/dia.2014.0066	109	64	65	0	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2096	2106		10.1016/S0140-6736(15)60971-0	http://dx.doi.org/10.1016/S0140-6736(15)60971-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI7XK	26009230				2022-12-28	WOS:000354979100029
J	Kirby, T				Kirby, Tony			Profile Fergus Cameron: getting the big picture in childhood diabetes	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 23	2015	385	9982					2038	2038		10.1016/S0140-6736(15)60981-3	http://dx.doi.org/10.1016/S0140-6736(15)60981-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CI7XK	26009219				2022-12-28	WOS:000354979100014
J	de Vargas, C; Audic, S; Henry, N; Decelle, J; Mahe, F; Logares, R; Lara, E; Berney, C; Le Bescot, N; Probert, I; Carmichael, M; Poulain, J; Romac, S; Colin, S; Aury, JM; Bittner, L; Chaffron, S; Dunthorn, M; Engelen, S; Flegontova, O; Guidi, L; Horak, A; Jaillon, O; Lima-Mendez, G; Lukes, J; Malviya, S; Morard, R; Mulot, M; Scalco, E; Siano, R; Vincent, F; Zingone, A; Dimier, C; Picheral, M; Searson, S; Kandels-Lewis, S; Acinas, SG; Bork, P; Bowler, C; Gorsky, G; Grimsley, N; Hingamp, P; Iudicone, D; Not, F; Ogata, H; Pesant, S; Raes, J; Sieracki, ME; Speich, S; Stemmann, L; Sunagawa, S; Weissenbach, J; Wincker, P; Karsenti, E				de Vargas, Colomban; Audic, Stephane; Henry, Nicolas; Decelle, Johan; Mahe, Frederic; Logares, Ramiro; Lara, Enrique; Berney, Cedric; Le Bescot, Noan; Probert, Ian; Carmichael, Margaux; Poulain, Julie; Romac, Sarah; Colin, Sebastien; Aury, Jean-Marc; Bittner, Lucie; Chaffron, Samuel; Dunthorn, Micah; Engelen, Stefan; Flegontova, Olga; Guidi, Lionel; Horak, Ales; Jaillon, Olivier; Lima-Mendez, Gipsi; Lukes, Julius; Malviya, Shruti; Morard, Raphael; Mulot, Matthieu; Scalco, Eleonora; Siano, Raffaele; Vincent, Flora; Zingone, Adriana; Dimier, Celine; Picheral, Marc; Searson, Sarah; Kandels-Lewis, Stefanie; Acinas, Silvia G.; Bork, Peer; Bowler, Chris; Gorsky, Gabriel; Grimsley, Nigel; Hingamp, Pascal; Iudicone, Daniele; Not, Fabrice; Ogata, Hiroyuki; Pesant, Stephane; Raes, Jeroen; Sieracki, Michael E.; Speich, Sabrina; Stemmann, Lars; Sunagawa, Shinichi; Weissenbach, Jean; Wincker, Patrick; Karsenti, Eric		Tara Oceans Coordinators	Eukaryotic plankton diversity in the sunlit ocean	SCIENCE			English	Article							EXTREME DIVERSITY; GENETIC DIVERSITY; SURFACE WATERS; MARINE; PICOPLANKTON; RADIOLARIA; EVOLUTION; TERRESTRIAL; PSEUDOGENES; SEQUENCES	Marine plankton support global biological and geochemical processes. Surveys of their biodiversity have hitherto been geographically restricted and have not accounted for the full range of plankton size. We assessed eukaryotic diversity from 334 size-fractionated photic-zone plankton communities collected across tropical and temperate oceans during the circumglobal Tara Oceans expedition. We analyzed 18S ribosomal DNA sequences across the intermediate plankton-size spectrum from the smallest unicellular eukaryotes (protists, > 0.8 micrometers) to small animals of a few millimeters. Eukaryotic ribosomal diversity saturated at similar to 150,000 operational taxonomic units, about one-third of which could not be assigned to known eukaryotic groups. Diversity emerged at all taxonomic levels, both within the groups comprising the similar to 11,200 cataloged morphospecies of eukaryotic plankton and among twice as many other deep-branching lineages of unappreciated importance in plankton ecology studies. Most eukaryotic plankton biodiversity belonged to heterotrophic protistan groups, particularly those known to be parasites or symbiotic hosts.	[de Vargas, Colomban; Audic, Stephane; Henry, Nicolas; Decelle, Johan; Mahe, Frederic; Berney, Cedric; Le Bescot, Noan; Carmichael, Margaux; Romac, Sarah; Colin, Sebastien; Bittner, Lucie; Morard, Raphael; Dimier, Celine; Not, Fabrice] CNRS, UMR 7144, Stn Biol Roscoff, F-29680 Roscoff, France; [de Vargas, Colomban; Audic, Stephane; Henry, Nicolas; Decelle, Johan; Mahe, Frederic; Berney, Cedric; Le Bescot, Noan; Carmichael, Margaux; Romac, Sarah; Colin, Sebastien; Bittner, Lucie; Morard, Raphael; Dimier, Celine; Not, Fabrice] Univ Paris 06, Sorbonne Univ, UMR 7144, Stn Biol Roscoff, F-29680 Roscoff, France; [Mahe, Frederic; Dunthorn, Micah] Univ Kaiserslautern, Dept Ecol, D-67663 Kaiserslautern, Germany; [Logares, Ramiro; Acinas, Silvia G.] CSIC, Inst Marine Sci ICM, Dept Marine Biol & Oceanog, E-08003 Barcelona, Spain; [Lara, Enrique; Mulot, Matthieu] Univ Neuchatel, Lab Soil Biol, CH-2000 Neuchatel, Switzerland; [Probert, Ian] CNRS, FR2424, Roscoff Culture Collect, Stn Biol Roscoff, F-29680 Roscoff, France; [Probert, Ian] Univ Paris 06, Sorbonne Univ, FR 2424, Roscoff Culture Collect,Stn Biol Roscoff, F-29680 Roscoff, France; [Carmichael, Margaux; Colin, Sebastien; Bittner, Lucie; Malviya, Shruti; Vincent, Flora; Dimier, Celine; Bowler, Chris; Karsenti, Eric] Ecole Normale Super, IBENS, F-75005 Paris, France; [Carmichael, Margaux; Colin, Sebastien; Bittner, Lucie; Malviya, Shruti; Vincent, Flora; Dimier, Celine; Bowler, Chris; Karsenti, Eric] INSERM, U1024, F-75005 Paris, France; [Carmichael, Margaux; Colin, Sebastien; Bittner, Lucie; Malviya, Shruti; Vincent, Flora; Dimier, Celine; Bowler, Chris; Karsenti, Eric] CNRS, UMR 8197, F-75005 Paris, France; [Poulain, Julie; Aury, Jean-Marc; Engelen, Stefan; Jaillon, Olivier; Weissenbach, Jean; Wincker, Patrick] Commissariat Energie Atom & Energies Alternat CEA, Inst Genom, GENOSCOPE, F-91000 Evry, France; [Bittner, Lucie] CNRS, FR3631, Inst Biol Paris Seine, F-75005 Paris, France; [Bittner, Lucie] Univ Paris 06, Sorbonne Univ, Inst Biol Paris Seine, F-75005 Paris, France; [Chaffron, Samuel; Lima-Mendez, Gipsi; Raes, Jeroen] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, B-3000 Leuven, Belgium; [Chaffron, Samuel; Lima-Mendez, Gipsi; Vincent, Flora; Raes, Jeroen] VIB, Ctr Biol Dis, B-3000 Leuven, Belgium; [Chaffron, Samuel; Lima-Mendez, Gipsi; Raes, Jeroen] Vrije Univ Brussel, Dept Appl Biol Sci, B-1050 Brussels, Belgium; [Flegontova, Olga; Horak, Ales; Lukes, Julius] Czech Acad Sci, Ctr Biol, Inst Parasitol, Ceske Budejovice 37005, Czech Republic; [Flegontova, Olga; Horak, Ales; Lukes, Julius] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Guidi, Lionel; Picheral, Marc; Searson, Sarah; Gorsky, Gabriel; Stemmann, Lars] CNRS, UMR 7093, LOV, Observ Oceanol, F-06230 Villefranche Sur Mer, France; [Guidi, Lionel; Picheral, Marc; Searson, Sarah; Gorsky, Gabriel; Stemmann, Lars] Univ Paris 06, Sorbonne Univ, UMR 7093, LOV,Observ Oceanol, F-06230 Villefranche Sur Mer, France; [Jaillon, Olivier; Weissenbach, Jean; Wincker, Patrick] CNRS, UMR 8030, CP5706, Evry, France; [Jaillon, Olivier; Weissenbach, Jean; Wincker, Patrick] Univ Evry, UMR 8030, CP5706, Evry, France; [Lukes, Julius] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada; [Morard, Raphael] Univ Bremen, Ctr Marine Environm Sci, MARUM, D-28359 Bremen, Germany; [Scalco, Eleonora; Zingone, Adriana; Iudicone, Daniele] Stn Zool A Dohrn, I-80121 Naples, Italy; [Siano, Raffaele] IFREMER, Ctr Brest, DYNECO Pelagos CS 10070, F-29280 Plouzane, France; [Kandels-Lewis, Stefanie; Bork, Peer; Sunagawa, Shinichi] European Mol Biol Lab, Struct & Computat Biol, D-69117 Heidelberg, Germany; [Kandels-Lewis, Stefanie; Karsenti, Eric] European Mol Biol Lab, Directors Res, D-69117 Heidelberg, Germany; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Grimsley, Nigel] CNRS, UMR 7232, BIOM, F-66650 Banyuls Sur Mer, France; [Grimsley, Nigel] Univ Paris 06, Sorbonne Univ, OOB, F-66650 Banyuls Sur Mer, France; [Hingamp, Pascal] Aix Marseille Univ, CNRS IGS UMR 7256, F-13288 Marseille, France; [Ogata, Hiroyuki] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Pesant, Stephane] Univ Bremen, Data Publisher Earth & Environm Sci, PANGAEA, D-28359 Bremen, Germany; [Sieracki, Michael E.] Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA; [Sieracki, Michael E.] Natl Sci Fdn, Arlington, VA 22230 USA; [Speich, Sabrina] Ecole Normale Super, LMD, Dept Geosci, F-75231 Paris 05, France; [Speich, Sabrina] UBO, IUEM, Lab Phys Oceans, F-29820 Plouzane, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; University of Kaiserslautern; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Neuchatel; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; KU Leuven; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Canadian Institute for Advanced Research (CIFAR); University of Bremen; Stazione Zoologica Anton Dohrn di Napoli; Ifremer; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Kyoto University; University of Bremen; Bigelow Laboratory for Ocean Sciences; National Science Foundation (NSF); Ecole des Ponts ParisTech; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	de Vargas, C (corresponding author), CNRS, UMR 7144, Stn Biol Roscoff, Pl Georges Teissier, F-29680 Roscoff, France.	vargas@sb-roscoff.fr; pwincker@genoscope.cns.fr; karsenti@embl.de	Horak, Ales/H-6723-2012; Lima-Mendez, Gipsi/AAV-4158-2021; Probert, Ian/M-9807-2019; Flegontova, Olga/U-7136-2017; Speich, Sabrina/L-3780-2014; Mulot, Matthieu/C-3954-2013; stemmann, lars/E-6899-2011; Boss, Emmanuel/AAF-2336-2019; Bittner, Lucie/ABF-4617-2020; Bowler, Chris/AAC-6256-2019; Mahé, Frédéric/AAR-8568-2021; Guidi, Lionel/B-3977-2012; Lima-Mendez, Gipsi/AAX-6291-2021; raes, jeroen/D-7835-2018; Sunagawa, Shinichi/Q-5950-2019; Chaffron, Samuel/K-1104-2019; Chaffron, Samuel/B-2300-2012; Jaillon, Olivier/GRY-6287-2022; Aury, Jean-Marc/N-1621-2019; Logares, Ramiro/D-5920-2011; Grimsley, Nigel/O-1359-2015; Bittner, Lucie/AAD-8921-2019; Zingone, Adriana/E-4518-2010; Hingamp, Pascal/AAO-1382-2020; Acinas, Silvia/F-7462-2016; Bork, Peer/F-1813-2013; Lukes, Julius/H-6760-2012; Logares, Ramiro/AAI-2306-2019; Lara, Enrique/N-3679-2017; stemmann, lars/Q-8458-2019	Horak, Ales/0000-0002-3364-7383; Lima-Mendez, Gipsi/0000-0002-5309-1845; Speich, Sabrina/0000-0002-5452-8287; Mulot, Matthieu/0000-0002-8039-5078; Boss, Emmanuel/0000-0002-8334-9595; Mahé, Frédéric/0000-0002-2808-0984; Guidi, Lionel/0000-0002-6669-5744; Lima-Mendez, Gipsi/0000-0002-5309-1845; raes, jeroen/0000-0002-1337-041X; Sunagawa, Shinichi/0000-0003-3065-0314; Chaffron, Samuel/0000-0001-5903-617X; Chaffron, Samuel/0000-0001-5903-617X; Aury, Jean-Marc/0000-0003-1718-3010; Logares, Ramiro/0000-0002-8213-0604; Grimsley, Nigel/0000-0001-9323-417X; Bittner, Lucie/0000-0001-8291-7063; Zingone, Adriana/0000-0001-5946-6532; Hingamp, Pascal/0000-0002-7463-2444; Acinas, Silvia/0000-0002-3439-0428; Bork, Peer/0000-0002-2627-833X; Lukes, Julius/0000-0002-0578-6618; Lara, Enrique/0000-0001-8500-522X; stemmann, lars/0000-0001-8935-4531; Berney, Cedric/0000-0001-8689-9907; VINCENT, Flora/0000-0001-6976-3004; Bowler, Chris/0000-0003-3835-6187; Audic, Stephane/0000-0001-6193-4374; Reynaud, Emmanuel/0000-0003-1502-661X; Decelle, Johan/0000-0002-4343-8358; Engelen, Stefan/0000-0003-0003-1192; Jaillon, Olivier/0000-0002-7237-9596; PESANT, Stephane/0000-0002-4936-5209; Iudicone, Daniele/0000-0002-7473-394X; Henry, Nicolas/0000-0002-7702-1382; Probert, Ian/0000-0002-1643-1759; Gorsky, Gabriel/0000-0002-1099-8711; Poulain, Julie/0000-0002-8744-3116	CNRS [GDR3280]; EMBL; Genoscope/CEA; UPMC; VIB; Stazione Zoologica Anton Dohrn; UNIMIB; Rega Institute; KU Leuven; Fund for Scientific Research - The French Ministry of Research; French Government [ANR-11-BTBR-0008, ANR-10-INBS-09-08, ANR-10-LABX-54]; PSL* Research University [ANR-11-IDEX-0001-02]; ANR [POSEIDON/ANR-09-BLAN-0348, PROMETHEUS/ANR-09-PCS-GENM-217, PHYTBACK/ANR-2010-1709-01, TARA-GIRUS/ANR-09-PCS-GENM-218]; EU FP7 [287589, IHMS/HEALTH-F4-2010-261376]; European Research Council [294823]; Gordon and Betty Moore Foundation [3790]; Spanish Ministry of Science and Innovation [CGL2011-26848/BOS]; Agency for Administration of University and Research Grants (AGAUR) [CONES 2010-0036]; Japan Society for the Promotion of Science [26430184]; Veolia Environment Foundation; Lorient Agglomeration; World Courier; Illumina; Electricite de France Foundation; Fondation pour la Recherche sur la Biodiversite; Prince Albert II de Monaco Foundation; Tara schooner; French Ministry of Foreign Affairs; EBI [PRJEB402, PRJEB6610]	CNRS(Centre National de la Recherche Scientifique (CNRS)); EMBL; Genoscope/CEA; UPMC; VIB; Stazione Zoologica Anton Dohrn; UNIMIB; Rega Institute; KU Leuven; Fund for Scientific Research - The French Ministry of Research; French Government; PSL* Research University; ANR(French National Research Agency (ANR)); EU FP7(European Commission); European Research Council(European Research Council (ERC)European Commission); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agency for Administration of University and Research Grants (AGAUR); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Veolia Environment Foundation; Lorient Agglomeration; World Courier; Illumina; Electricite de France Foundation; Fondation pour la Recherche sur la Biodiversite; Prince Albert II de Monaco Foundation; Tara schooner; French Ministry of Foreign Affairs; EBI	We thank the following people and sponsors for their commitment: CNRS (in particular, the GDR3280); EMBL; Genoscope/CEA; UPMC; VIB; Stazione Zoologica Anton Dohrn; UNIMIB; Rega Institute; KU Leuven; Fund for Scientific Research - The French Ministry of Research, the French Government "Investissements d'Avenir" programmes OCEANOMICS (ANR-11-BTBR-0008), FRANCE GENOMIQUE (ANR-10-INBS-09-08), and MEMO LIFE (ANR-10-LABX-54); PSL* Research University (ANR-11-IDEX-0001-02); ANR (projects POSEIDON/ANR-09-BLAN-0348, PROMETHEUS/ANR-09-PCS-GENM-217, PHYTBACK/ANR-2010-1709-01, and TARA-GIRUS/ANR-09-PCS-GENM-218); EU FP7 (MicroB3/No. 287589, IHMS/HEALTH-F4-2010-261376); European Research Council Advanced Grant Awards to C. Bowler (Diatomite: 294823); Gordon and Betty Moore Foundation grant 3790 to M.B.S.; Spanish Ministry of Science and Innovation grant CGL2011-26848/BOS MicroOcean PANGENOMICS and TANIT (CONES 2010-0036) grant from the Agency for Administration of University and Research Grants (AGAUR) to S.G.A.; and Japan Society for the Promotion of Science KAKENHI grant 26430184 to H.O. We also thank the following for their support and commitment: A. Bourgois, E. Bourgois, R. Trouble, Region Bretagne, G. Ricono, the Veolia Environment Foundation, Lorient Agglomeration, World Courier, Illumina, the Electricite de France Foundation, Fondation pour la Recherche sur la Biodiversite, the Prince Albert II de Monaco Foundation, and the Tara schooner and its captains and crew. We thank MERCATOR-CORIOLIS and ACRI-ST for providing daily satellite data during the expedition. We are also grateful to the French Ministry of Foreign Affairs for supporting the expedition and to the countries who granted sampling permissions. Tara Oceans would not exist without continuous support from 23 institutes (http://oceans.taraexpeditions.org). We also acknowledge assistance from European Bioinformatics Institute (EBI) (in particular, G. Cochrane and P. ten Hoopen) as well as the EMBL Advanced Light Microscopy Facility (in particular, R. Pepperkok). We thank F. Gaill, B. Kloareg, F. Lallier, D. Boltovskoy, A. Knoll, D. Richter, and E. Medard for help and advice on the manuscript. We declare that all data reported herein are fully and freely available from the date of publication, with no restrictions, and that all of the samples, analyses, publications, and ownership of data are free from legal entanglement or restriction of any sort by the various nations whose waters the Tara Oceans expedition sampled in. Data described herein are available at http://taraoceans.sb-roscoff.fr/EukDiv/, at EBI under the project IDs PRJEB402 and PRJEB6610, and at PANGAEA (see table S1). The data release policy regarding future public release of Tara Oceans data is described in (12). All authors approved the final manuscript. This article is contribution number 24 of Tara Oceans. The supplementary materials contain additional data.	Abida H, 2013, MAR DRUGS, V11, P4594, DOI 10.3390/md11114594; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Baas Becking L. G. M., 1934, GEOBIOLOGIE OF INLEI; Bachvaroff TR, 2012, APPL ENVIRON MICROB, V78, P334, DOI 10.1128/AEM.06678-11; Boltovskoy D, 2005, SCI MAR, V69, P17, DOI 10.3989/scimar.2005.69s217; Brate J, 2012, PROTIST, V163, P767, DOI 10.1016/j.protis.2012.04.004; Burki F, 2014, CURR BIOL, V24, pR103, DOI 10.1016/j.cub.2013.12.025; Caron DA, 2012, ANNU REV MAR SCI, V4, P467, DOI 10.1146/annurev-marine-120709-142802; Coats DW, 2002, J PHYCOL, V38, P520, DOI 10.1046/j.1529-8817.2002.t01-1-01200.x; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; Decelle Johan, 2013, Communicative & Integrative Biology, V6, pe24560, DOI 10.4161/cib.24560; Decelle J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104297; Decelle J, 2012, P NATL ACAD SCI USA, V109, P18000, DOI 10.1073/pnas.1212303109; Dennett MR, 2002, J PLANKTON RES, V24, P797, DOI 10.1093/plankt/24.8.797; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Godhe A, 2008, APPL ENVIRON MICROB, V74, P7174, DOI 10.1128/AEM.01298-08; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Haeckel E., 1887, ZOOLOGY; Halbert KMK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077011; Kim M, 2012, J PHYCOL, V48, P569, DOI 10.1111/j.1529-8817.2012.01150.x; Knoll AH, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016121; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Lima-Mendez G, 2015, SCIENCE, V348, DOI 10.1126/science.1262073; Liu H, 2009, P NATL ACAD SCI USA, V106, P12803, DOI 10.1073/pnas.0905841106; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Mahe F, 2014, PEERJ, V2, DOI 10.7717/peerj.593; Marquez LM, 2003, MOL BIOL EVOL, V20, P1077, DOI 10.1093/molbev/msg122; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; Massana R, 2014, ISME J, V8, P854, DOI 10.1038/ismej.2013.204; Massana R, 2011, ANNU REV MICROBIOL, V65, P91, DOI 10.1146/annurev-micro-090110-102903; McCallum HI, 2004, TRENDS ECOL EVOL, V19, P585, DOI 10.1016/j.tree.2004.08.009; MICHAELS AF, 1995, J PLANKTON RES, V17, P131, DOI 10.1093/plankt/17.1.131; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Oliver MJ, 2007, GENOME RES, V17, P594, DOI 10.1101/gr.6096207; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Peijnenburg KTCA, 2013, ECOL EVOL, V3, P2765, DOI 10.1002/ece3.644; Pesant S., 2015, OPEN SCIENCE RESOURC; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Probert I, 2014, J PHYCOL, V50, P388, DOI 10.1111/jpy.12174; Rueckert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018163; Santos SR, 2003, J EUKARYOT MICROBIOL, V50, P417, DOI 10.1111/j.1550-7408.2003.tb00264.x; SCHNEPF E, 1994, ARCH PROTISTENKD, V144, P63, DOI 10.1016/S0003-9365(11)80225-3; Shaked Y, 2006, MAR ECOL PROG SER, V325, P59, DOI 10.3354/meps325059; Siano R, 2011, BIOGEOSCIENCES, V8, P267, DOI 10.5194/bg-8-267-2011; Siano R, 2010, PROTIST, V161, P385, DOI 10.1016/j.protis.2010.01.002; Skovgaard A, 2014, ACTA PROTOZOOL, V53, P51, DOI 10.4467/16890027AP.14.006.1443; Skovgaard A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00305; Smetacek V, 2002, NATURE, V419, P565, DOI 10.1038/419565a; Smetacek V, 2001, NATURE, V411, P745, DOI 10.1038/35081210; SOURNIA A, 1991, J PLANKTON RES, V13, P1093, DOI 10.1093/plankt/13.5.1093; Stemmann L, 2008, ICES J MAR SCI, V65, P433, DOI 10.1093/icesjms/fsn010; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Swanberg N. R., 1974, THESIS; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Vaulot D, 2002, TRENDS MICROBIOL, V10, P266, DOI 10.1016/S0966-842X(02)02366-1; von der Heyden S, 2004, J EUKARYOT MICROBIOL, V51, P402; Wiebe PH, 2010, DEEP-SEA RES PT II, V57, P2157, DOI 10.1016/j.dsr2.2010.09.018; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	66	997	1018	52	729	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237							1261605	10.1126/science.1261605	http://dx.doi.org/10.1126/science.1261605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999516	Green Published, Green Submitted			2022-12-28	WOS:000354877900034
J	Liang, ZY; Zickler, D; Prentiss, M; Chang, FS; Witz, G; Maeshima, K; Kleckner, N				Liang, Zhangyi; Zickler, Denise; Prentiss, Mara; Chang, Frederick S.; Witz, Guillaume; Maeshima, Kazuhiro; Kleckner, Nancy			Chromosomes Progress to Metaphase in Multiple Discrete Steps via Global Compaction/Expansion Cycles	CELL			English	Article							SISTER-CHROMATID RESOLUTION; MITOTIC CHROMOSOME; CONDENSIN-II; SYNAPTONEMAL COMPLEX; LIVING CELLS; INTERFERENCE; ORGANIZATION; MODEL; CHECKPOINT; DYNAMICS	Mammalian mitotic chromosome morphogenesis was analyzed by 4D live-cell and snapshot deconvolution fluorescence imaging. Prophase chromosomes, whose organization was previously unknown, are revealed to comprise co-oriented sister linear loop arrays displayed along a single, peripheral, regularly kinked topoisomerase II/cohesin/condensin II axis. Thereafter, rather than smooth, progressive compaction as generally envisioned, progression to metaphase is a discontinuous process involving chromosome expansion as well as compaction. At late prophase, dependent on topoisomerase II and with concomitant cohesin release, chromosomes expand, axes split and straighten, and chromatin loops transit to a radial disposition around now-central axes. Finally, chromosomes globally compact, giving the metaphase state. These patterns are consistent with the hypothesis that the molecular events of chromosome morphogenesis are governed by accumulation and release of chromosome stress, created by chromatin compaction and expansion. Chromosome state could evolve analogously throughout the cell cycle.	[Liang, Zhangyi; Chang, Frederick S.; Witz, Guillaume; Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Prentiss, Mara] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Zickler, Denise] Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France; [Maeshima, Kazuhiro] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Maeshima, Kazuhiro] Grad Univ Adv Studies Sokendai, Mishima, Shizuoka 4118540, Japan	Harvard University; Harvard University; UDICE-French Research Universities; Universite Paris Saclay; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu	Prentiss, Mara/AAU-2940-2021	Maeshima, Kazuhiro/0000-0003-3909-0341; Witz, Guillaume/0000-0003-1562-4265	 [NIH-RO1-GM025326]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025326] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank T. Hirano, P.R. Cook, H. Kimura, J.L. Barbero, and G. Gorbsky for reagents, Kleckner laboratory members for helpful discussions, and B. Weiner and J. Henle for help with manuscript preparation. Work was supported by a grant to N.K. (NIH-RO1-GM025326).	Almagro S, 2004, J BIOL CHEM, V279, P5118, DOI 10.1074/jbc.M307221200; BAJER A, 1959, HEREDITAS, V45, P579; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Fisher JK, 2013, CELL, V153, P882, DOI 10.1016/j.cell.2013.04.006; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; GIMENEZABIAN JF, 1995, J CELL BIOL, V131, P7, DOI 10.1083/jcb.131.1.7; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Kawamura R, 2010, J CELL BIOL, V188, P653, DOI 10.1083/jcb.200910085; Kireeva N, 2004, J CELL BIOL, V166, P775, DOI 10.1083/jcb.200406049; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kleckner N, 2013, SCIENCE, V342, P940, DOI 10.1126/science.1247514; Kumar A, 2014, CELL, V158, P633, DOI 10.1016/j.cell.2014.05.046; KUWADA Y., 1939, Cytologia, V10, P213, DOI 10.1508/cytologia.10.213; Lebofsky R, 2006, MOL BIOL CELL, V17, P5337, DOI 10.1091/mbc.E06-04-0298; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Ma K, 1988, Yi Chuan Xue Bao, V15, P282; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; Maeshima K, 2008, J BIOCHEM, V143, P145, DOI 10.1093/jb/mvm214; MARSDEN MPF, 1979, CELL, V17, P849, DOI 10.1016/0092-8674(79)90325-8; MOENS PB, 1988, BIOESSAYS, V9, P151, DOI 10.1002/bies.950090503; MOENS PB, 1989, CHROMOSOMA, V98, P317, DOI 10.1007/BF00292383; Nakajima M, 2007, J CELL SCI, V120, P4188, DOI 10.1242/jcs.011528; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; OHNUKI Y, 1968, CHROMOSOMA, V25, P402, DOI 10.1007/BF02327721; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Ono T, 2013, J CELL BIOL, V200, P429, DOI 10.1083/jcb.201208008; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Peters J.-M., 2012, PERSPECT BIOL, V4, P4, DOI DOI 10.1101/CSHPERSPECT.A011130; Pope LH, 2006, MOL BIOL CELL, V17, P104, DOI 10.1091/mbc.e05-04-0321; Tavormina PA, 2002, J CELL BIOL, V158, P23, DOI 10.1083/jcb.200202053; Tedeschi A, 2013, NATURE, V501, P564, DOI 10.1038/nature12471; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Zhang LR, 2014, P NATL ACAD SCI USA, V111, pE5059, DOI 10.1073/pnas.1416411111; Zhang LR, 2014, NATURE, V511, P551, DOI 10.1038/nature13442; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zidovska A, 2013, P NATL ACAD SCI USA, V110, P15555, DOI 10.1073/pnas.1220313110	39	67	69	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1124	1137		10.1016/j.cell.2015.04.030	http://dx.doi.org/10.1016/j.cell.2015.04.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000485	Bronze, Green Accepted			2022-12-28	WOS:000355152600019
J	Gasparrini, A; Guo, YM; Hashizume, M; Lavigne, E; Zanobetti, A; Schwartz, J; Tobias, A; Tong, SL; Rocklov, J; Forsberg, B; Leone, M; De Sario, M; Bell, ML; Guo, YLL; Wu, CF; Kan, H; Yi, SM; Coelho, MDZS; Saldiva, PHN; Honda, Y; Kim, H; Armstrong, B				Gasparrini, Antonio; Guo, Yuming; Hashizume, Masahiro; Lavigne, Eric; Zanobetti, Antonella; Schwartz, Joel; Tobias, Aurelio; Tong, Shilu; Rocklov, Joacim; Forsberg, Bertil; Leone, Michela; De Sario, Manuela; Bell, Michelle L.; Guo, Yue-Liang Leon; Wu, Chang-fu; Kan, Haidong; Yi, Seung-Muk; Zanotti Stagliorio Coelho, Micheline de Sousa; Nascimento Saldiva, Paulo Hilario; Honda, Yasushi; Kim, Ho; Armstrong, Ben			Mortality risk attributable to high and low ambient temperature: a multicountry observational study	LANCET			English	Article							RED-CELL COUNTS; HEAT WAVES; BLOOD-VISCOSITY; WEATHER; IMPACT; COLD; PLATELET; CORONARY; ENGLAND	Background Although studies have provided estimates of premature deaths attributable to either heat or cold in selected countries, none has so far offered a systematic assessment across the whole temperature range in populations exposed to different climates. We aimed to quantify the total mortality burden attributable to non-optimum ambient temperature, and the relative contributions from heat and cold and from moderate and extreme temperatures. Methods We collected data for 384 locations in Australia, Brazil, Canada, China, Italy, Japan, South Korea, Spain, Sweden, Taiwan, Thailand, UK, and USA. We fitted a standard time-series Poisson model for each location, controlling for trends and day of the week. We estimated temperature-mortality associations with a distributed lag non-linear model with 21 days of lag, and then pooled them in a multivariate metaregression that included country indicators and temperature average and range. We calculated attributable deaths for heat and cold, defined as temperatures above and below the optimum temperature, which corresponded to the point of minimum mortality, and for moderate and extreme temperatures, defined using cutoffs at the 2.5th and 97.5th temperature percentiles. Findings We analysed 74 225 200 deaths in various periods between 1985 and 2012. In total, 7.71% (95% empirical CI 7.43-7.91) of mortality was attributable to non-optimum temperature in the selected countries within the study period, with substantial differences between countries, ranging from 3.37% (3.06 to 3.63) in Thailand to 11.00% (9.29 to 12.47) in China. The temperature percentile of minimum mortality varied from roughly the 60th percentile in tropical areas to about the 80-90th percentile in temperate regions. More temperature-attributable deaths were caused by cold (7.29%, 7.02-7.49) than by heat (0.42%, 0.39-0.44). Extreme cold and hot temperatures were responsible for 0.86% (0.84-0.87) of total mortality. Interpretation Most of the temperature-related mortality burden was attributable to the contribution of cold. The effect of days of extreme temperature was substantially less than that attributable to milder but non-optimum weather. This evidence has important implications for the planning of public-health interventions to minimise the health consequences of adverse temperatures, and for predictions of future effect in climate-change scenarios. Copyright (C) Gasparrini et al. Open Access article distributed under the terms of CC BY.	[Gasparrini, Antonio] Univ London London Sch Hyg & Trop Med, Dept Med Stat, London WC1E 7HT, England; [Armstrong, Ben] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1E 7HT, England; [Guo, Yuming] Univ Queensland, Dept Epidemiol & Biostat, Sch Populat Hlth, Brisbane, Qld, Australia; [Hashizume, Masahiro] Nagasaki Univ, Dept Pediat Infect Dis, Inst Trop Med, Nagasaki 852, Japan; [Lavigne, Eric] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada; [Zanobetti, Antonella; Schwartz, Joel] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Tobias, Aurelio] Spanish Council Sci Res CSIC, Inst Environm Assessment & Water Res IDAEA, Barcelona, Spain; [Tong, Shilu] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4001, Australia; [Rocklov, Joacim; Forsberg, Bertil] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Leone, Michela; De Sario, Manuela] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy; [Bell, Michelle L.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Guo, Yue-Liang Leon] Natl Taiwan Univ, Dept Environm & Occupat Med, Taipei 10764, Taiwan; [Wu, Chang-fu] Natl Taiwan Univ, Dept Publ Hlth, Taipei 10764, Taiwan; [Kan, Haidong] Fudan Univ, Dept Environm Hlth, Shanghai 200433, Peoples R China; [Yi, Seung-Muk; Kim, Ho] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Yi, Seung-Muk; Kim, Ho] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Zanotti Stagliorio Coelho, Micheline de Sousa; Nascimento Saldiva, Paulo Hilario] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil; [Honda, Yasushi] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Queensland; Nagasaki University; University of Ottawa; Harvard University; Harvard T.H. Chan School of Public Health; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA); Queensland University of Technology (QUT); Umea University; Yale University; National Taiwan University; National Taiwan University; Fudan University; Seoul National University (SNU); Seoul National University (SNU); Universidade de Sao Paulo; University of Tsukuba	Gasparrini, A (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Med Stat, Keppel St, London WC1E 7HT, England.	antonio.gasparrini@lshtm.ac.uk	Guo, Yuming/I-8353-2018; Gasparrini, Antonio/F-7627-2012; Kim, Ho/AAS-2402-2021; Coelho, Micheline S. Z. S./A-4480-2012; Saldiva, Paulo HN/D-7385-2012; De sario, Manuela/K-1932-2016; Bell, Michelle/Y-4608-2018; Tobias, Aurelio/ABE-5682-2020; Lavigne, Eric/E-2948-2013	Guo, Yuming/0000-0002-1766-6592; Gasparrini, Antonio/0000-0002-2271-3568; Kim, Ho/0000-0001-7472-3752; Coelho, Micheline S. Z. S./0000-0002-9732-1278; Saldiva, Paulo HN/0000-0003-2005-8253; De sario, Manuela/0000-0002-1117-2735; Bell, Michelle/0000-0002-3965-1359; Tobias, Aurelio/0000-0001-6428-6755; Lavigne, Eric/0000-0001-6146-9839; Rocklov, Joacim/0000-0003-4030-0449; armstrong, benedict/0000-0003-4407-0409; Wu, Chang-fu/0000-0003-2244-1934; Hashizume, Masahiro/0000-0003-4720-1750; GUO, Yue Leon/0000-0002-8530-4809	UK Medical Research Council [G1002296]; University of Queensland Research Fellowship; Ministry of Education of the Spanish Government [PRX12/00515]; NHMRC research fellowship [553043]; ARC Discovery Grant [DP110100651]; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S-8, S10]; Global Research Laboratory through the National Research Foundation of Korea (NRF) [K21004000001-10A0500-00710]; MRC [G1002296] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER; Medical Research Council [G1002296] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Queensland Research Fellowship; Ministry of Education of the Spanish Government; NHMRC research fellowship(National Health and Medical Research Council (NHMRC) of Australia); ARC Discovery Grant(Australian Research Council); Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); Global Research Laboratory through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study and AG were supported by the UK Medical Research Council (grant G1002296). YG was supported by a University of Queensland Research Fellowship. AT was supported by the Ministry of Education of the Spanish Government (Salvador Madariaga's grant PRX12/00515). ST was supported by an NHMRC research fellowship (#553043) and an ARC Discovery Grant (DP110100651). YH was supported by the Environment Research and Technology Development Fund (S-8 & S10) of the Ministry of the Environment, Japan. MH, Y-LLG, C-fW, S-MY, YH, and HKi were supported by the Global Research Laboratory (grant K21004000001-10A0500-00710) through the National Research Foundation of Korea (NRF). We thank Benjawan Tawatsupa and Kornwipa Punnasiri for providing data for the 62 provinces in Thailand.	Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Baccini M, 2011, J EPIDEMIOL COMMUN H, V65, P64, DOI 10.1136/jech.2008.085639; Basagana X, 2011, EPIDEMIOLOGY, V22, P765, DOI 10.1097/EDE.0b013e31823031c5; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Carson C, DECLINING VULNERABIL; Eccles R, 2002, ACTA OTO-LARYNGOL, V122, P183, DOI 10.1080/00016480252814207; Gasparrini A, 2012, STAT MED, V31, P3821, DOI 10.1002/sim.5471; Gasparrini A, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-55; Gasparrini A, 2014, STAT MED, V33, P881, DOI 10.1002/sim.5963; Gasparrini A, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-1; Gasparrini A, 2012, OCCUP ENVIRON MED, V69, P56, DOI 10.1136/oem.2010.059782; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Hajat S, 2010, LANCET, V375, P856, DOI 10.1016/S0140-6736(09)61711-6; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; KEATINGE WR, 1984, BMJ-BRIT MED J, V289, P1405, DOI 10.1136/bmj.289.6456.1405; KEATINGE WR, 1986, AM J MED, V81, P795, DOI 10.1016/0002-9343(86)90348-7; Kirtman B., 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Le Tertre A, 2006, EPIDEMIOLOGY, V17, P75, DOI 10.1097/01.ede.0000187650.36636.1f; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Peng RD, 2011, ENVIRON HEALTH PERSP, V119, P701, DOI 10.1289/ehp.1002430; Post E, 2001, RISK ANAL, V21, P837, DOI 10.1111/0272-4332.215155; Rooney C, 1998, J EPIDEMIOL COMMUN H, V52, P482, DOI 10.1136/jech.52.8.482; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; WOODHOUSE PR, 1994, LANCET, V343, P435, DOI 10.1016/S0140-6736(94)92689-1; Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI [10.1289/ehp.1003198, 10.1289/ehp.120-a19]; Zanobetti A, 2013, EPIDEMIOLOGY, V24, P809, DOI 10.1097/01.ede.0000434432.06765.91	30	1123	1179	57	125	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 25	2015	386	9991					369	375		10.1016/S0140-6736(14)62114-0	http://dx.doi.org/10.1016/S0140-6736(14)62114-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN5CX	26003380	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000358448400026
J	Uno, H; Wittes, J; Fu, HD; Solomon, SD; Claggett, B; Tian, L; Cai, TX; Pfeffer, MA; Evans, SR; Wei, LJ				Uno, Hajime; Wittes, Janet; Fu, Haoda; Solomon, Scott D.; Claggett, Brian; Tian, Lu; Cai, Tianxi; Pfeffer, Marc A.; Evans, Scott R.; Wei, Lee-Jen			Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies	ANNALS OF INTERNAL MEDICINE			English	Article							2 SURVIVAL FUNCTIONS; NON-INFERIORITY; PROPORTIONAL HAZARDS; DIFFERENCE; REGRESSION; TRIALS; TIME; LIFE	A noninferiority study is often used to investigate whether a treatment's efficacy or safety profile is acceptable compared with an alternative therapy regarding the time to a clinical event. The empirical quantification of the treatment difference for such a study is routinely based on the hazard ratio (HR) estimate. The HR, which is not a relative risk, may be difficult to interpret clinically, especially when the underlying proportional hazards assumption is violated. The precision of the HR estimate depends primarily on the number of observed events but not directly on exposure times or sample size of the study population. If the event rate is low, the study may require an impractically large number of events to ensure that the prespecified noninferiority criterion for the HR is attainable. This article discusses deficiencies in the current approach for the design and analysis of a noninferiority study. Alternative procedures are provided, which do not depend on any model assumption, to compare 2 treatments. For a noninferiority safety study, the patients' exposure times are more clinically important than the observed number of events. If the patients' exposure times are long enough to evaluate safety reliably, then these alternative procedures can effectively provide clinically interpretable evidence on safety, even with relatively few observed events. These procedures are illustrated with data from 2 studies. One explores the cardiovascular safety of a pain medicine; the second examines the cardiovascular safety of a new treatment for diabetes. These alternative strategies to evaluate safety or efficacy of an intervention lead to more meaningful interpretations of the analysis results than the conventional strategy that uses the HR estimate.	Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Boston, MA 02115 USA; Stat Collaborat, Washington, DC 20036 USA; Eli Lilly & Co, Indianapolis, IN 46285 USA; Stanford Univ, Sch Med, Palo Alto, CA 94304 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Eli Lilly; Stanford University	Wei, LJ (corresponding author), Harvard Univ, Dept Biostat, Sch Publ Hlth, 655 Huntington Ave, Boston, MA 02115 USA.	wei@hsph.harvardedu	Wei, Lee-Jen/CAI-0175-2022; Uno, Hajime/W-4099-2019	Uno, Hajime/0000-0003-0622-8471	National Institute of Health [UM1AI104681]; NATIONAL CANCER INSTITUTE [R21CA185704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024643, UM1AI104681, UM1AI068634, UM1AI068636] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Partially supported by the National Institute of Health (grant UM1AI104681 [Dr. Evans]) and contracts.	COX DR, 1972, J R STAT SOC B, V34, P187; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; Fleming TR, 1991, COUNTING PROCESSES S; Guyot P, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-9; Head SJ, 2012, EUR HEART J, V33, P1318, DOI 10.1093/eurheartj/ehs099; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; Hiatt WR, 2013, NEW ENGL J MED, V369, P1285, DOI 10.1056/NEJMp1309610; Hirshberg B, 2013, DIABETES CARE, V36, pS253, DOI 10.2337/dcS13-2041; Hirshberg B, 2011, DIABETES CARE, V34, pS101, DOI 10.2337/dc11-s202; Klein JP, 2008, COMPUT METH PROG BIO, V89, P289, DOI 10.1016/j.cmpb.2007.11.017; Munoz A, 2014, CRIT CARE, V18, DOI 10.1186/cc13892; Parner ET, 2010, STATA J, V10, P408, DOI 10.1177/1536867X1001000308; Parzen MI, 1997, SCAND J STAT, V24, P309, DOI 10.1111/1467-9469.t01-1-00065; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-152; Royston P, 2011, STAT MED, V30, P2409, DOI 10.1002/sim.4274; Schumi J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-106; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Solomon SD, 2006, CIRCULATION, V114, P1028, DOI 10.1161/CIRCULATIONAHA.106.636746; SU JQ, 1993, BIOMETRICS, V49, P603, DOI 10.2307/2532572; Tian L, 2014, BIOSTATISTICS, V15, P222, DOI 10.1093/biostatistics/kxt050; Uno H, 2014, J CLIN ONCOL, V32, P2380, DOI 10.1200/JCO.2014.55.2208; US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research, GUID IND DIAB MELL E; WEI LJ, 1992, STAT MED, V11, P1871, DOI 10.1002/sim.4780111409; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Zhao LH, 2012, CLIN TRIALS, V9, P570, DOI 10.1177/1740774512455464; Zucker DM, 1998, J AM STAT ASSOC, V93, P702, DOI 10.2307/2670120	27	139	142	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 21	2015	163	2					127	+		10.7326/M14-1741	http://dx.doi.org/10.7326/M14-1741			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN4NS	26054047	Green Accepted			2022-12-28	WOS:000358407500020
J	Brahmer, J; Reckamp, KL; Baas, P; Crino, L; Eberhardt, WEE; Poddubskaya, E; Antonia, S; Pluzanski, A; Vokes, EE; Holgado, E; Waterhouse, D; Ready, N; Gainor, J; Frontera, OA; Havel, L; Steins, M; Garassino, MC; Aerts, JG; Domine, M; Paz-Ares, L; Reck, M; Baudelet, C; Harbison, CT; Lestini, B; Spigel, DR				Brahmer, Julie; Reckamp, Karen L.; Baas, Paul; Crino, Lucio; Eberhardt, Wilfried E. E.; Poddubskaya, Elena; Antonia, Scott; Pluzanski, Adam; Vokes, Everett E.; Holgado, Esther; Waterhouse, David; Ready, Neal; Gainor, Justin; Aren Frontera, Osvaldo; Havel, Libor; Steins, Martin; Garassino, Marina C.; Aerts, Joachim G.; Domine, Manuel; Paz-Ares, Luis; Reck, Martin; Baudelet, Christine; Harbison, Christopher T.; Lestini, Brian; Spigel, David R.			Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-III TRIAL; LIGAND-1 EXPRESSION; ANTI-PD-1 ANTIBODY; SAFETY; CHEMOTHERAPY; BLOCKADE	BACKGROUND Patients with advanced squamous-cell non-small-cell lung cancer (NSCLC) who have disease progression during or after first-line chemotherapy have limited treatment options. This randomized, open-label, international, phase 3 study evaluated the efficacy and safety of nivolumab, a fully human IgG4 programmed death 1 (PD-1) immune-checkpoint-inhibitor antibody, as compared with docetaxel in this patient population. METHODS We randomly assigned 272 patients to receive nivolumab, at a dose of 3 mg per kilogram of body weight every 2 weeks, or docetaxel, at a dose of 75 mg per square meter of body-surface area every 3 weeks. The primary end point was overall survival. RESULTS The median overall survival was 9.2 months (95% confidence interval [CI], 7.3 to 13.3) with nivolumab versus 6.0 months (95% CI, 5.1 to 7.3) with docetaxel. The risk of death was 41% lower with nivolumab than with docetaxel (hazard ratio, 0.59; 95% CI, 0.44 to 0.79; P<0.001). At 1 year, the overall survival rate was 42% (95% CI, 34 to 50) with nivolumab versus 24% (95% CI, 17 to 31) with docetaxel. The response rate was 20% with nivolumab versus 9% with docetaxel (P = 0.008). The median progression-free survival was 3.5 months with nivolumab versus 2.8 months with docetaxel (hazard ratio for death or disease progression, 0.62; 95% CI, 0.47 to 0.81; P<0.001). The expression of the PD-1 ligand (PD-L1) was neither prognostic nor predictive of benefit. Treatment-related adverse events of grade 3 or 4 were reported in 7% of the patients in the nivolumab group as compared with 55% of those in the docetaxel group. CONCLUSIONS Among patients with advanced, previously treated squamous-cell NSCLC, overall survival, response rate, and progression-free survival were significantly better with nivolumab than with docetaxel, regardless of PD-L1 expression level.	[Brahmer, Julie] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21287 USA; [Reckamp, Karen L.] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Baas, Paul] Netherlands Canc Inst, Amsterdam, Netherlands; [Baas, Paul] Antoni van Leeuwenhoek Hosp, Amsterdam, Netherlands; [Aerts, Joachim G.] Erasmus MC Canc Inst, Rotterdam, Netherlands; [Aerts, Joachim G.] Ziekenhuis Amphia, Breda, Netherlands; [Crino, Lucio] Univ Hosp Perugia, Perugia, Italy; [Garassino, Marina C.] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Eberhardt, Wilfried E. E.] Univ Duisburg Essen, Univ Klinikum Essen, West German Canc Ctr, Dept Med Oncol, Essen, Germany; [Eberhardt, Wilfried E. E.] Univ Duisburg Essen, Ruhrlandklin, Essen, Germany; [Steins, Martin] Univ Heidelberg Hosp, Thoraxklin, Heidelberg, Germany; [Reck, Martin] LungenClin Grosshansdorf, Grosshansdorf, Germany; [Poddubskaya, Elena] NN Blokhin Russian Canc Res Ctr, Moscow, Russia; [Antonia, Scott] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Pluzanski, Adam] Inst Marii Sklodowskiej Curie, Ctr Onkol, Warsaw, Poland; [Vokes, Everett E.] Univ Chicago Med & Biol Sci, Chicago, IL USA; [Holgado, Esther] Hosp Madrid Norte Sanchinarro, Madrid, Spain; [Domine, Manuel] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain; [Paz-Ares, Luis] Hosp Univ Virgen Rocio, Seville, Spain; [Waterhouse, David] Oncol Hematol Care, Cincinnati, OH USA; [Ready, Neal] Duke Univ, Med Ctr, Durham, NC USA; [Gainor, Justin] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Aren Frontera, Osvaldo] Ctr Int Estudios Clin, Santiago, Chile; [Havel, Libor] Nemocnice Bulovce, Prague, Czech Republic; [Baudelet, Christine; Harbison, Christopher T.; Lestini, Brian] Bristol Myers Squibb Co, Princeton, NJ USA; [Spigel, David R.] Sarah Cannon Res Inst, Nashville, TN USA; [Spigel, David R.] Tennessee Oncol, Nashville, TN USA	Johns Hopkins University; Johns Hopkins Medicine; City of Hope; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Amphia Hospital; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Duisburg Essen; University of Duisburg Essen; Ruprecht Karls University Heidelberg; Grosshansdorf Hospital; N.N. Blokhin Russian Cancer Research Center; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Maria Sklodowska-Curie National Research Institute of Oncology; Virgen del Rocio University Hospital; Duke University; Harvard University; Massachusetts General Hospital; Bulovka University Hospital; Bristol-Myers Squibb; Sarah Cannon Research Institute; Tennessee Oncology	Brahmer, J (corresponding author), Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Bunting Blaustein Canc Res Bldg,1650 Orleans St, Baltimore, MD 21287 USA.	brahmju@jhmi.edu	Reck, Martin/ABF-5721-2020; Vokes, Everett/Q-2146-2019; Pluzanski, Adam/AAF-9531-2021; Paz-Ares, Luis/AAH-2750-2019; Gainor, Justin/T-5411-2019; Garassino, Marina C/D-7128-2017; Poddubskaya, Elena/AAU-9664-2020; Aerts, Joachim GJV/I-7885-2018; Poddubskaya, Elena/AAK-7600-2021	Reck, Martin/0000-0002-5348-4462; Pluzanski, Adam/0000-0002-3710-6445; Garassino, Marina C/0000-0002-3821-5598; Reckamp, Karen/0000-0002-9213-0325; Eberhardt, Wilfried Ernst Erich/0000-0003-4284-3586; Poddubskaya, Elena/0000-0001-6476-6337	Bristol-Myers Squibb; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Bristol-Myers Squibb; CheckMate 017 ClinicalTrials.gov number, NCT01642004.	[Anonymous], 2010, TAX DOC US PRESCR IN; [Anonymous], 2014, CYR RAM US PRESCR IN; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Chen YB, 2012, TUMORI, V98, P751, DOI 10.1700/1217.13499; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Garon EB, 2014, ANN ONCOL S5, V25; Garon EB, 2014, LANCET, V384, P665, DOI 10.1016/S0140-6736(14)60845-X; Gettinger SN, 2015, J CLIN ONCOL; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; National Comprehensive Cancer Network, 2021, CLIN PRACTICE GUIDEL; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Penrod JR, 2014, J CLIN ONCOL S, V32, P15; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rizvi NA, 2015, LANCET ONCOL, V16, P257, DOI 10.1016/S1470-2045(15)70054-9; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Soria JC, 2013, EUR J CANC S2, V49; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Travis WD, 2011, CLIN CHEST MED, V32, P669, DOI 10.1016/j.ccm.2011.08.005; Velcheti V, 2014, LAB INVEST, V94, P107, DOI 10.1038/labinvest.2013.130; Wang CY, 2014, CANCER IMMUNOL RES, V2, P846, DOI 10.1158/2326-6066.CIR-14-0040	22	4617	4792	13	536	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 9	2015	373	2					123	135		10.1056/NEJMoa1504627	http://dx.doi.org/10.1056/NEJMoa1504627			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM3QP	26028407	Bronze, Green Accepted			2022-12-28	WOS:000357598600005
J	Mays, D; Kraemer, J				Mays, Darren; Kraemer, John			FDA Regulation of Indoor Tanning Devices and Opportunities for Skin Cancer Prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mays, Darren] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Med Ctr, Washington, DC 20007 USA; [Kraemer, John] Georgetown Univ, Sch Nursing & Hlth Studies, Dept Hlth Syst Adm, Washington, DC 20007 USA; [Kraemer, John] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC 20007 USA	Georgetown University; Georgetown University; Georgetown University	Mays, D (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Med Ctr, 3300 Whitehaven St NW,Ste 4100, Washington, DC 20007 USA.	dmm239@georgetown.edu						Fell GL, 2014, CELL, V157, P1527, DOI 10.1016/j.cell.2014.04.032; Guy GP, 2014, AM J PUBLIC HEALTH, V104, pE69, DOI [10.2105/AJPH.2013.301850, 10.1016/j.amepre.2014.08.036]; US Department of Health and Human Services, SURG GEN CALL ACT PR; Wehner MR, 2014, JAMA DERMATOL, V150, P390, DOI 10.1001/jamadermatol.2013.6896	4	4	4	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2015	313	24					2423	2424		10.1001/jama.2015.5975	http://dx.doi.org/10.1001/jama.2015.5975			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL0WK	26018657				2022-12-28	WOS:000356663600007
J	Haney, E; Smith, MEB; McDonagh, M; Pappas, M; Daeges, M; Wasson, N; Nelson, HD				Haney, Elizabeth; Smith, M. E. Beth; McDonagh, Marian; Pappas, Miranda; Daeges, Monica; Wasson, Ngoc; Nelson, Heidi D.			Diagnostic Methods for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop	ANNALS OF INTERNAL MEDICINE			English	Review							BECK DEPRESSION INVENTORY; FUNCTIONAL STATUS; HOSPITAL ANXIETY; SCALE; VALIDITY; INDIVIDUALS; DEFINITION; CRITERIA; FIBROMYALGIA; RELIABILITY	Background: The diagnosis of myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is based on clinical criteria, yet there has been no consensus regarding which set of criteria best identifies patients with the condition. The Institute of Medicine has recently proposed a new case definition and diagnostic algorithm. Purpose: To review methods to diagnose ME/CFS in adults and identify research gaps and needs for future research. Data Sources: MEDLINE, PsycINFO, and Cochrane databases (January 1988 to September 2014); clinical trial registries; and reference lists. Study Selection: English-language studies describing methods of diagnosis of ME/CFS and their accuracy. Data Extraction: Data on participants, study design, analysis, follow-up, and results were extracted and confirmed. Study quality was dual-rated by using prespecified criteria, and discrepancies were resolved through consensus. Data Synthesis: Forty-four studies met inclusion criteria. Eight case definitions have been used to define ME/CFS; a ninth, recently proposed by the Institute of Medicine, includes principal elements of previous definitions. Patients meeting criteria for ME represent a more symptomatic subset of the broader ME/CFS population. Scales rating self-reported symptoms differentiate patients with ME/CFS from healthy controls under study conditions but have not been evaluated in clinically undiagnosed patients to determine validity and generalizability. Limitations: Studies were heterogeneous and were limited by size, number, applicability, and methodological quality. Most methods were tested in highly selected patient populations. Conclusion: Nine sets of clinical criteria are available to define ME/CFS, yet none of the current diagnostic methods have been adequately tested to identify patients with ME/CFS when diagnostic uncertainty exists. More definitive studies in broader populations are needed to address these research gaps. Primary Funding Source: Agency for Healthcare Research			Haney, E (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	haneye@ohsu.edu			Agency for Healthcare Research and Quality, Rockville, Maryland [290-2012-00014-i]	Agency for Healthcare Research and Quality, Rockville, Maryland(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality (contract 290-2012-00014-i, task order 4), Rockville, Maryland.	Agency for Healthcare Research and Quality, 2012, AHRQ PUBL; [Anonymous], 1956, LANCET, V270, P789; Asbring P, 2002, QUAL HEALTH RES, V12, P148, DOI 10.1177/104973202129119801; Aslakson E, 2006, PHARMACOGENOMICS, V7, P365, DOI 10.2217/14622416.7.3.365; Assefi NP, 2003, J RHEUMATOL, V30, P804; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Brimmer Dana J, 2013, BMC Res Notes, V6, P309, DOI 10.1186/1756-0500-6-309; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Brown Abigail A, 2013, N Am J Psychol, V15, P103; Brown M, 2012, J HEALTH PSYCHOL, V17, P799, DOI 10.1177/1359105311424470; Brurberg KG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003973; Buchwald D, 1996, AM J MED, V101, P364, DOI 10.1016/S0002-9343(96)00234-3; Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Carruthers BM., 2012, MYALGIC ENCEPHALOMYE; Cella M, 2010, J PSYCHOSOM RES, V69, P17, DOI 10.1016/j.jpsychores.2009.10.007; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Davenport TE, 2011, DISABIL REHABIL, V33, P2596, DOI 10.3109/09638288.2011.582925; Davenport TE, 2011, DISABIL REHABIL, V33, P1768, DOI 10.3109/09638288.2010.546936; Deale A, 2000, J ROY SOC MED, V93, P310, DOI 10.1177/014107680009300608; Devasahayam Anoop, 2012, JRSM Short Rep, V3, P4, DOI 10.1258/shorts.2011.011127; Dickson A, 2007, PSYCHOL HEALTH, V22, P851, DOI 10.1080/14768320600976224; Dowsett E., 1994, REPORT NATL TASK FOR REPORT NATL TASK FOR, P96; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gaab J, 2005, PSYCHONEUROENDOCRINO, V30, P188, DOI 10.1016/j.psyneuen.2004.06.008; Gaab J, 2004, J PSYCHOSOM RES, V56, P419, DOI 10.1016/S0022-3999(03)00625-1; Gaab J, 2002, PSYCHOSOM MED, V64, P311, DOI 10.1097/00006842-200203000-00015; GRIECO A, 1984, HEALTH PSYCHOL, V3, P129, DOI 10.1037/0278-6133.3.2.129; Guise J, 2010, J HEALTH PSYCHOL, V15, P426, DOI 10.1177/1359105309350515; Hadzi-Pavlovic D, 2000, SOC PSYCH PSYCH EPID, V35, P471, DOI 10.1007/s001270050266; Hawk C, 2007, J CHRONIC FATIGUE SY, V13, P41, DOI DOI 10.1300/J092V13N04_; HICKIE I, 1990, BRIT J PSYCHIAT, V156, P534, DOI 10.1192/bjp.156.4.534; HICKIE I, 1995, PSYCHOL MED, V25, P925, DOI 10.1017/S0033291700037417; HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387; Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Jackson CA, 2006, OCCUP MED-OXFORD, V56, P263, DOI 10.1093/occmed/kql021; Jason L, 2010, AM J BIOCH BIOTECHNO, V6, P120, DOI [DOI 10.3844/AJBBSP.2010.120, DOI 10.3844/AJBBSP.2010.120.135]; Jason L. A., 2010, PSYCHOLOGY, V1, P9, DOI [10.4236/psych.2010.11002, DOI 10.4236/PSYCH.2010.11002]; Jason L. A., 2004, J CHRONIC FATIGUE SY, V12, P37, DOI DOI 10.1300/J092V12N01_03; Jason LA, 2001, J HEALTH PSYCHOL, V6, P61, DOI 10.1177/135910530100600105; Jason LA, 2001, J CLIN PSYCHOL MED S, V8, P337, DOI 10.1023/A:1011981132735; JASON LA, 2014, J HLTH PSYCHOL; Jason LA, 1997, J CHRONIC FATIGUE SY, V3, P39, DOI DOI 10.1300/J092V03N01_04; Jason LA, 2001, J CHRONIC FATIGUE SY, V8, P31; Jason L, 2011, DISABIL REHABIL, V33, P589, DOI 10.3109/09638288.2010.503256; Jason LA, 2013, FATIGUE, V1, P168, DOI 10.1080/21641846.2013.774556; Jason LA, 2012, EVAL HEALTH PROF, V35, P280, DOI 10.1177/0163278711424281; KARNOFSKY DA, 1948, CANCER-AM CANCER SOC, V1, P634, DOI 10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L; KATON WJ, 1991, J GEN INTERN MED, V6, P277, DOI 10.1007/BF02597420; Komaroff AL, 1996, AM J MED, V101, P281, DOI 10.1016/S0002-9343(96)00174-X; Lawn Tara, 2010, JRSM Short Rep, V1, P28, DOI 10.1258/shorts.2010.010042; Lewis I, 2013, EUR J CLIN INVEST, V43, P302, DOI 10.1111/eci.12046; Lin Jin-Mann S, 2009, Popul Health Metr, V7, P18, DOI 10.1186/1478-7954-7-18; Linder R, 2002, IN VIVO, V16, P37; MAIN CJ, 1983, J PSYCHOSOM RES, V27, P503, DOI 10.1016/0022-3999(83)90040-5; Mccue P, 2006, BRIT J CLIN PSYCHOL, V45, P483, DOI 10.1348/014466505X82379; Morriss RK, 1998, J PSYCHOSOM RES, V45, P411, DOI 10.1016/S0022-3999(98)00022-1; Morriss RK, 1998, J ROY SOC MED, V91, P365, DOI 10.1177/014107689809100706; Natelson BH., 1999, J CHRONIC FATIGUE SY, V5, P63, DOI DOI 10.1300/J092V05N02_04; Newton JL, 2010, J ROY COLL PHYS EDIN, V40, P304, DOI 10.4997/JRCPE.2010.404; Pennebaker J.W., 1982, PSYCHOL PHYS SYMPTOM; Ramsay M., 1986, MYALGIC ENCEPHALOMYE; Reeves WC, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-19; Reeves William C, 2007, Popul Health Metr, V5, P5; Reyes M, 2003, ARCH INTERN MED, V163, P1530, DOI 10.1001/archinte.163.13.1530; Schmitz N, 2000, QUAL LIFE RES, V9, P185, DOI 10.1023/A:1008931926181; Schrezenmaier C, 2005, MAYO CLIN PROC, V80, P330, DOI 10.4065/80.3.330; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Smith M, 2014, AHRQ PUBLICATION; Smith ME, 2015, DIAGNOSIS TREATMENT; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Tiev MP, 2003, CLIN DIAGN LAB IMMUN, V10, P315, DOI 10.1128/CDLI.10.2.315-316.2003; Van Hoof E, 2005, N AM J PSYCHOL, V7, P189; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watson Samuel P., 2014, International Journal of Machine Learning and Computing, V4, P133, DOI 10.7763/IJMLC.2014.V4.400; WOODWARD RV, 1995, J ROY SOC MED, V88, P325; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	82	48	50	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12					834	+		10.7326/M15-0443	http://dx.doi.org/10.7326/M15-0443			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK8VC	26075754				2022-12-28	WOS:000356516300018
J	Doshi, P				Doshi, Peter			PATIENT INFORMATION FDA drug summaries: a simplification too far?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												pdoshi@bmj.com						Center for Drug Evaluation and Research, 2015, DRUG EV RES MED REV, P90; Center for Drug Evaluation and Research, 2015, STAT REV CEFT AV; FDA, MOR INF DALV DALB; FDA, 2015, DRUG TRAILS SNAPSH S; FDA, CDER CONV DRUG TRAIL; FDA, 2015, HIGHL PRESCR INF CEF; FDA, 2010, GUID IND NON CLIN TR; Whyte J., DRUG TRIAL SNAPSH MA; Woloshin S, 2011, N Y TIMES, pA21	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2015	350								h3135	10.1136/bmj.h3135	http://dx.doi.org/10.1136/bmj.h3135			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK7DN	26070648				2022-12-28	WOS:000356391300008
J	Vietri, M; Schink, KO; Campsteijn, C; Wegner, CS; Schultz, SW; Christ, L; Thoresen, SB; Brech, A; Raiborg, C; Stenmark, H				Vietri, Marina; Schink, Kay O.; Campsteijn, Coen; Wegner, Catherine Sem; Schultz, Sebastian W.; Christ, Liliane; Thoresen, Sigrid B.; Brech, Andreas; Raiborg, Camilla; Stenmark, Harald			Spastin and ESCRT-III coordinate mitotic spindle disassembly and nuclear envelope sealing	NATURE			English	Article							MEDIATED ABSCISSION CHECKPOINT; MEMBRANE DEFORMATION; PROTEIN CHMP1B; CYTOKINESIS; MIDBODY; COMPLEX; FILAMENTS; SYSTEM; CELLS; MOTIF	At the onset of metazoan cell division the nuclear envelope breaks down to enable capture of chromosomes by the microtubule-containing spindle apparatus(1). During anaphase, when chromosomes have separated, the nuclear envelope is reassembled around the forming daughter nuclei(1,2). How the nuclear envelope is sealed, and how this is coordinated with spindle disassembly, is largely unknown. Here we show that endosomal sorting complex required for transport (ESCRT)-III, previously found to promote membrane constriction and sealing during receptor sorting, virus budding, cytokinesis and plasma membrane repair(3-6), is transiently recruited to the reassembling nuclear envelope during late anaphase. ESCRT-III and its regulatory AAA (ATPase associated with diverse cellular activities) ATPase VPS4 are specifically recruited by the ESCRT-III-like protein CHMP7 to sites where the reforming nuclear envelope engulfs spindle microtubules. Subsequent association of another ESCRT-III-like protein, IST1, directly recruits the AAA ATPase spastin to sever microtubules. Disrupting spastin function impairs spindle disassembly and results in extended localization of ESCRT-III at the nuclear envelope. Interference with ESCRT-III functions in anaphase is accompanied by delayed microtubule disassembly, compromised nuclear integrity and the appearance of DNA damage foci in subsequent interphase. We propose that ESCRT-III, VPS4 and spastin cooperate to coordinate nuclear envelope sealing and spindle disassembly at nuclear envelope-microtubule intersection sites during mitotic exit to ensure nuclear integrity and genome safeguarding, with a striking mechanistic parallel to cytokinetic abscission(7).	[Vietri, Marina; Schink, Kay O.; Campsteijn, Coen; Wegner, Catherine Sem; Schultz, Sebastian W.; Christ, Liliane; Thoresen, Sigrid B.; Brech, Andreas; Raiborg, Camilla; Stenmark, Harald] Univ Oslo, Fac Med, Ctr Canc Biomed, N-0379 Oslo, Norway; [Vietri, Marina; Schink, Kay O.; Campsteijn, Coen; Wegner, Catherine Sem; Schultz, Sebastian W.; Christ, Liliane; Thoresen, Sigrid B.; Brech, Andreas; Raiborg, Camilla; Stenmark, Harald] Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, N-0379 Oslo, Norway; [Stenmark, Harald] Norwegian Univ Sci & Technol, Fac Med, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway	University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU)	Campsteijn, C (corresponding author), Univ Oslo, Fac Med, Ctr Canc Biomed, N-0379 Oslo, Norway.	coen.campsteijn@rr-research.no; stenmark@ulrik.uio.no	Stenmark, Harald/B-8868-2008	Schink, Kay Oliver/0000-0002-5903-4059; Vietri, Marina/0000-0002-5859-322X; Brech, Andreas/0000-0002-9803-1774	European Research Council; Research Council of Norway through Centres of Excellence [179571]	European Research Council(European Research Council (ERC)European Commission); Research Council of Norway through Centres of Excellence	We thank T. Hoiby, T. Have and K. W. Tan for assistance with generation of stable cell lines, M. Smestad and L. Hermansen for assistance with EM, A. Engen, A. Al-Kayssi and B. M. Furulund for assistance with cell cultures, E. Ronning and A. Gro Bergersen for technical support, and C. Bassols for IT support. We thank C. Gonzalez, R. Syljuasen, V. Nahse-Kumpf and E. Wenzel for discussions. We are grateful to A. A. Hyman for the gift of CHMP4B-eGFP BAC HeLa cells, and E. Reid for providing spastin constructs. We especially thank J. Carlton for sharing results before publication. The Core Facilities for Confocal Microscopy, Super-Resolution Microscopy and Electron Microscopy at Oslo University Hospital are acknowledged for providing access to relevant microscopes. M. V. is a PhD student and S.B.T. a postdoctoral fellow of the South-Eastern Norway Regional Health Authority. C.C. is a postdoctoral fellow and C.R. a senior research fellow of the Norwegian Cancer Society. H.S. is the recipient of an Advanced Grant from the European Research Council. This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179571.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; Buchkovich NJ, 2013, DEV CELL, V27, P201, DOI 10.1016/j.devcel.2013.09.009; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dultz E, 2009, BIOPHYS J, V97, P1891, DOI 10.1016/j.bpj.2009.07.024; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Hatch E, 2014, J CELL BIOL, V205, P133, DOI 10.1083/jcb.201402003; Henne W. M., 2013, COLD SPRING HARB PER, V1, P5, DOI DOI 10.1101/CSHPERSPECT.A016766; Hetzer MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000539; Hill CP, 2012, BBA-MOL CELL RES, V1823, P172, DOI 10.1016/j.bbamcr.2011.08.017; Horii M, 2006, BIOCHEM J, V400, P23, DOI 10.1042/BJ20060897; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lattanzi G, 2012, EUR J HISTOCHEM, V56, P284, DOI 10.4081/ejh.2012.e45; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Lu L, 2011, J CELL BIOL, V194, P425, DOI 10.1083/jcb.201012063; Lumb JH, 2012, BBA-MOL CELL RES, V1823, P192, DOI 10.1016/j.bbamcr.2011.08.010; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Sagona AP, 2010, NAT CELL BIOL, V12, P362, DOI 10.1038/ncb2036; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Stauffer DR, 2001, J CELL SCI, V114, P2383; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Thoresen SB, 2014, NAT CELL BIOL, V16, P547, DOI 10.1038/ncb2959; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512	41	233	243	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					231	+		10.1038/nature14408	http://dx.doi.org/10.1038/nature14408			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	26040712				2022-12-28	WOS:000356016700042
J	Guo, F; Yan, LY; Guo, HS; Li, L; Hu, BQ; Zhao, YY; Yong, J; Hu, YQ; Wang, XY; Wei, Y; Wang, W; Li, R; Yan, J; Zhi, X; Zhang, Y; Jin, HY; Zhang, WX; Hou, Y; Zhu, P; Li, JY; Zhang, L; Liu, SR; Ren, YX; Zhu, XH; Wen, L; Gao, YQ; Tang, FC; Qiao, J				Guo, Fan; Yan, Liying; Guo, Hongshan; Li, Lin; Hu, Boqiang; Zhao, Yangyu; Yong, Jun; Hu, Yuqiong; Wang, Xiaoye; Wei, Yuan; Wang, Wei; Li, Rong; Yan, Jie; Zhi, Xu; Zhang, Yan; Jin, Hongyan; Zhang, Wenxin; Hou, Yu; Zhu, Ping; Li, Jingyun; Zhang, Ling; Liu, Sirui; Ren, Yixin; Zhu, Xiaohui; Wen, Lu; Gao, Yi Qin; Tang, Fuchou; Qiao, Jie			The Transcriptome and DNA Methylome Landscapes of Human Primordial Germ Cells	CELL			English	Article							EMBRYONIC STEM-CELLS; SINGLE-CELL; GENE-EXPRESSION; DEMETHYLATION; GENOME; DYNAMICS; MICE; SPECIFICATION; PATHWAY; ERASURE	Germ cells are vital for transmitting genetic information from one generation to the next and for maintaining the continuation of species. Here, we analyze the transcriptome of human primordial germ cells (PGCs) from the migrating stage to the gonadal stage at single-cell and single-base resolutions. Human PGCs show unique transcription patterns involving the simultaneous expression of both pluripotency genes and germline-specific genes, with a subset of them displaying developmental-stage-specific features. Furthermore, we analyze the DNA methylome of human PGCs and find global demethylation of their genomes. Approximately 10 to 11 weeks after gestation, the PGCs are nearly devoid of any DNA methylation, with only 7.8% and 6.0% of the median methylation levels in male and female PGCs, respectively. Our work paves the way toward deciphering the complex epigenetic reprogramming of the germline with the aim of restoring totipotency in fertilized oocytes.	[Guo, Fan; Yan, Liying; Guo, Hongshan; Li, Lin; Hu, Boqiang; Zhao, Yangyu; Yong, Jun; Hu, Yuqiong; Wang, Xiaoye; Wei, Yuan; Wang, Wei; Li, Rong; Yan, Jie; Zhi, Xu; Zhang, Yan; Jin, Hongyan; Zhang, Wenxin; Hou, Yu; Zhu, Ping; Li, Jingyun; Ren, Yixin; Zhu, Xiaohui; Wen, Lu; Tang, Fuchou; Qiao, Jie] Peking Univ, Hosp 3, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Guo, Fan; Yan, Liying; Guo, Hongshan; Li, Lin; Hu, Boqiang; Zhao, Yangyu; Yong, Jun; Hu, Yuqiong; Wang, Xiaoye; Wei, Yuan; Wang, Wei; Li, Rong; Yan, Jie; Zhi, Xu; Zhang, Yan; Jin, Hongyan; Zhang, Wenxin; Hou, Yu; Zhu, Ping; Li, Jingyun; Ren, Yixin; Zhu, Xiaohui; Wen, Lu; Tang, Fuchou; Qiao, Jie] Peking Univ, Dept Obstet & Gynecol, Coll Life Sci, Hosp 3, Beijing 100871, Peoples R China; [Yan, Liying; Zhao, Yangyu; Wang, Xiaoye; Wei, Yuan; Wang, Wei; Li, Rong; Yan, Jie; Zhi, Xu; Zhang, Yan; Jin, Hongyan; Zhang, Wenxin; Ren, Yixin; Zhu, Xiaohui; Qiao, Jie] Minist Educ, Key Lab Assisted Reprod, Beijing 100191, Peoples R China; [Wen, Lu; Tang, Fuchou] Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [Hu, Yuqiong; Zhu, Ping; Li, Jingyun; Tang, Fuchou; Qiao, Jie] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Zhang, Ling; Liu, Sirui; Gao, Yi Qin] Peking Univ, Coll Chem & Mol Engn, Inst Theoret & Computat Chem, Beijing 100871, Peoples R China; [Tang, Fuchou] Peking Univ, Ctr Mol & Translat Med, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Qiao, Jie] Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing 100191, Peoples R China; [Hu, Yuqiong] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University; Peking University	Tang, FC (corresponding author), Peking Univ, Hosp 3, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China.	tangfuchou@pku.edu.cn; jie.qiao@263.net	gao, yi/HCI-8298-2022; Li, Li/AEM-3636-2022; Guo, Fan/J-1857-2019; Guo, Fan/AAX-4952-2021; Wei, Yen/H-5329-2012; LI, LI/GVS-5344-2022; li, li/HII-4157-2022	Guo, Fan/0000-0002-0165-073X; Qiao, Jie/0000-0003-2126-1376; Zhu, Ping/0000-0002-4521-7524; Li, Lin/0000-0002-4479-7176; Hou, Yu/0000-0001-7875-7087	National Natural Science of China [31230047, 31322037, 31271543]; National Basic Research Program of China [2011CB944504, 2014CB943200, 2012CB966704, 2011CB966303]; Beijing Municipal Science and Technology Commission [Z131100005213006]; Peking University for translation research; National Natural Science Foundation of China [31440063]; Peking-Tsinghua Center for Life Sciences; Center for Molecular and Translational Medicine	National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Peking University for translation research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking-Tsinghua Center for Life Sciences; Center for Molecular and Translational Medicine	J.Q. and F.T. were supported by grants from the National Natural Science of China (31230047, 31322037, and 31271543) and the National Basic Research Program of China (2011CB944504, 2014CB943200, 2012CB966704, and 2011CB966303). J.Q. and F.T. were also supported by a grant from the Beijing Municipal Science and Technology Commission (Z131100005213006) and a grant from Peking University for translation research. L.Y. was supported by a grant (31440063) from the National Natural Science Foundation of China. F.G. was supported in part by a postdoctoral fellowship from Peking-Tsinghua Center for Life Sciences. This work was supported by a collaborative grant from the Center for Molecular and Translational Medicine.	Aramaki S, 2013, DEV CELL, V27, P516, DOI 10.1016/j.devcel.2013.11.001; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Chuma S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0338; Lopes SMCD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040030; Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Gkountela S, 2013, NAT CELL BIOL, V15, P113, DOI 10.1038/ncb2638; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kagiwada S, 2013, EMBO J, V32, P340, DOI 10.1038/emboj.2012.331; Kobayashi H, 2013, GENOME RES, V23, P616, DOI 10.1101/gr.148023.112; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Leitch HG, 2013, CURR TOP DEV BIOL, V104, P149, DOI 10.1016/B978-0-12-416027-9.00005-X; Magnusdottir E, 2013, NAT CELL BIOL, V15, P905, DOI 10.1038/ncb2798; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Okae H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004868; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Perrett RM, 2008, BIOL REPROD, V78, P852, DOI 10.1095/biolreprod.107.066175; Robinson LLL, 2001, MOL HUM REPROD, V7, P845, DOI 10.1093/molehr/7.9.845; Saitou M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008375; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Streets AM, 2014, P NATL ACAD SCI USA, V111, P7048, DOI 10.1073/pnas.1402030111; Surani MA, 2008, COLD SH Q B, V73, P9, DOI 10.1101/sqb.2008.73.015; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Vincent JJ, 2013, CELL STEM CELL, V12, P470, DOI 10.1016/j.stem.2013.01.016; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yamaguchi S, 2013, NATURE, V504, P460, DOI 10.1038/nature12805; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	45	358	382	12	148	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1437	1452		10.1016/j.cell.2015.05.015	http://dx.doi.org/10.1016/j.cell.2015.05.015			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26046443	Bronze			2022-12-28	WOS:000355935000021
J	Hayward, RA; Reaven, PD; Wiitala, WL; Bahn, GD; Reda, DJ; Ge, L; McCarren, M; Duckworth, WC; Emanuele, NV				Hayward, Rodney A.; Reaven, Peter D.; Wiitala, Wyndy L.; Bahn, Gideon D.; Reda, Domenic J.; Ge, Ling; McCarren, Madeline; Duckworth, William C.; Emanuele, Nicholas V.		VADT Investigators	Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; POSITIVE PREDICTIVE-VALUE; GLUCOSE CONTROL; CLINICAL-TRIALS; HEART-DISEASE; COMPLICATIONS; HEMOGLOBIN; DIAGNOSIS; MORTALITY	BACKGROUND The Veterans Affairs Diabetes Trial previously showed that intensive glucose lowering, as compared with standard therapy, did not significantly reduce the rate of major cardiovascular events among 1791 military veterans (median follow-up, 5.6 years). We report the extended follow-up of the study participants. METHODS After the conclusion of the clinical trial, we followed participants, using central databases to identify procedures, hospitalizations, and deaths (complete cohort, with follow-up data for 92.4% of participants). Most participants agreed to additional data collection by means of annual surveys and periodic chart reviews (survey cohort, with 77.7% follow-up). The primary outcome was the time to the first major cardiovascular event (heart attack, stroke, new or worsening congestive heart failure, amputation for ischemic gangrene, or cardiovascular-related death). Secondary outcomes were cardiovascular mortality and all-cause mortality. RESULTS The difference in glycated hemoglobin levels between the intensive-therapy group and the standard-therapy group averaged 1.5 percentage points during the trial (median level, 6.9% vs. 8.4%) and declined to 0.2 to 0.3 percentage points by 3 years after the trial ended. Over a median follow-up of 9.8 years, the intensive-therapy group had a significantly lower risk of the primary outcome than did the standard-therapy group (hazard ratio, 0.83; 95% confidence interval [CI], 0.70 to 0.99; P = 0.04), with an absolute reduction in risk of 8.6 major cardiovascular events per 1000 person-years, but did not have reduced cardiovascular mortality (hazard ratio, 0.88; 95% CI, 0.64 to 1.20; P = 0.42). No reduction in total mortality was evident (hazard ratio in the intensive-therapy group, 1.05; 95% CI, 0.89 to 1.25; P = 0.54; median follow-up, 11.8 years). CONCLUSIONS After nearly 10 years of follow-up, patients with type 2 diabetes who had been randomly assigned to intensive glucose control for 5.6 years had 8.6 fewer major cardiovascular events per 1000 person-years than those assigned to standard therapy, but no improvement was seen in the rate of overall survival.	[Hayward, Rodney A.; Wiitala, Wyndy L.] VA Ann Arbor Healthcare Syst, Vet Affairs VA Ctr Clin Management Res, Ann Arbor, MI USA; [Reaven, Peter D.; Duckworth, William C.] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Bahn, Gideon D.; Reda, Domenic J.; Ge, Ling; Emanuele, Nicholas V.] Hines VA Cooperat Studies Program Coordinating Ct, Hines, IL USA; [Bahn, Gideon D.; Reda, Domenic J.; Ge, Ling; Emanuele, Nicholas V.] Edward Hines Jr VA Hosp, Hines, IL USA; [McCarren, Madeline] VA Pharm Benefits Management Serv, Hines, IL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Hayward, RA (corresponding author), Robert Wood Johnson Fdn Clin Scholars Program, 2800 Plymouth Rd,North Campus Res Complex,Bldg 10, Ann Arbor, MI 48019 USA.	rhayward@umich.edu	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; , Domenic/0000-0003-1831-4270; tripathy, devjit/0000-0003-2797-0659; Sharon, Michal/0000-0003-3933-0595	VA Cooperative Studies Program; VADT; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094775, R01HL067690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER	VA Cooperative Studies Program; VADT; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the VA Cooperative Studies Program and others; VADT ClinicalTrials.gov number, NCT00032487.	Duckworth WC, 2001, DIABETES CARE, V24, P942, DOI 10.2337/diacare.24.5.942; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2014, LANCET, V384, P1936, DOI 10.1016/S0140-6736(14)60611-5; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hayward RA, 2004, DIABETES CARE, V27, pB54, DOI 10.2337/diacare.27.suppl_2.B54; Hayward RA, 2007, AM J MANAG CARE, V13, P126; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Pocock SJ, 1997, CONTROL CLIN TRIALS, V18, P530, DOI 10.1016/S0197-2456(97)00008-1; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; University of Oxford Diabetes Trials Unit, UKPDS RISK ENG; Vijan S, 2014, JAMA INTERN MED, V174, P1227, DOI 10.1001/jamainternmed.2014.2894	21	400	415	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2015	372	23					2197	2206		10.1056/NEJMoa1414266	http://dx.doi.org/10.1056/NEJMoa1414266			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1GK	26039600	Bronze			2022-12-28	WOS:000355955100004
J	Kelly, CR; Higgins, AR; Chandra, S				Kelly, Christopher R.; Higgins, Andrew R.; Chandra, Subani			Noninvasive Positive-Pressure Ventilation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESPIRATORY-FAILURE		[Kelly, Christopher R.; Higgins, Andrew R.; Chandra, Subani] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY 10032 USA	Columbia University; NewYork-Presbyterian Hospital	Kelly, CR (corresponding author), Columbia Univ, Med Ctr, New York Presbyterian Hosp, Dept Med, 622 W 168th St,PH-342, New York, NY 10032 USA.	crk2002@columbia.edu						Barach AL, 1938, ANN INTERN MED, V12, P754, DOI 10.7326/0003-4819-12-6-754; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Ferrer M, 2009, LANCET, V374, P1082, DOI 10.1016/S0140-6736(09)61038-2; Girault C, 2009, CRIT CARE MED, V37, P124, DOI 10.1097/CCM.0b013e3181928706; Gray A, 2008, NEW ENGL J MED, V359, P142, DOI 10.1056/NEJMoa0707992; Hilbert G, 2001, NEW ENGL J MED, V344, P481, DOI 10.1056/NEJM200102153440703; Lim WJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004360.pub4; Mehta S, 2001, AM J RESP CRIT CARE, V163, P540, DOI 10.1164/ajrccm.163.2.9906116; Nava S, 2013, LANCET ONCOL, V14, P219, DOI 10.1016/S1470-2045(13)70009-3; Navalesi P, 2000, CRIT CARE MED, V28, P1785, DOI 10.1097/00003246-200006000-00015; Schettino G, 2005, CRIT CARE MED, V33, P1976, DOI 10.1097/01.CCM.0000178176.51024.82; Zarbock A, 2009, CHEST, V135, P1252, DOI 10.1378/chest.08-1602	13	12	15	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2015	372	23								10.1056/NEJMvcm1313336	http://dx.doi.org/10.1056/NEJMvcm1313336			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1GK	26039621				2022-12-28	WOS:000355955100006
J	Slater, AG; Cooper, AI				Slater, Anna G.; Cooper, Andrew I.			Function-led design of new porous materials	SCIENCE			English	Review							METAL-ORGANIC FRAMEWORKS; CONJUGATED MICROPOROUS POLYMERS; MOLECULAR-DYNAMICS SIMULATIONS; CARBON-DIOXIDE CAPTURE; THERMAL-CONDUCTIVITY; AROMATIC FRAMEWORK; TARGETED SYNTHESIS; GAS-ADSORPTION; WATER; EFFICIENT	Porous solids are important as membranes, adsorbents, catalysts, and in other chemical applications. But for these materials to find greater use at an industrial scale, it is necessary to optimize multiple functions in addition to pore structure and surface area, such as stability, sorption kinetics, processability, mechanical properties, and thermal properties. Several different classes of porous solids exist, and there is no one-size-fits-all solution; it can therefore be challenging to choose the right type of porous material for a given job. Computational prediction of structure and properties has growing potential to complement experiment to identify the best porous materials for specific applications.	[Cooper, Andrew I.] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England; Univ Liverpool, Ctr Mat Discovery, Liverpool L69 7ZD, Merseyside, England	University of Liverpool; University of Liverpool	Cooper, AI (corresponding author), Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England.	aicooper@liv.ac.uk	Slater, Anna G/F-2627-2012; Cooper, Andrew/ABE-7766-2020	Slater, Anna Grace/0000-0002-1435-4331	Engineering and Physical Sciences Research Council [EP/H000925/1] Funding Source: researchfish; EPSRC [EP/H000925/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Abbott LJ, 2011, MACROMOLECULES, V44, P4511, DOI 10.1021/ma200303p; Aguilera-Sigalat J, 2014, CHEM COMMUN, V50, P4711, DOI 10.1039/c4cc00659c; Amirjalayer S, 2012, J PHYS CHEM C, V116, P4921, DOI 10.1021/jp211280m; Bahr DF, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.184106; Bai P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6912; Beaudoin D, 2013, NAT CHEM, V5, P830, DOI [10.1038/NCHEM.1730, 10.1038/nchem.1730]; Ben T, 2009, ANGEW CHEM INT EDIT, V48, P9457, DOI 10.1002/anie.200904637; Bertrand GHV, 2013, P NATL ACAD SCI USA, V110, P4923, DOI 10.1073/pnas.1221824110; Bezzu CG, 2010, SCIENCE, V327, P1627, DOI 10.1126/science.1184228; Bloch ED, 2012, SCIENCE, V335, P1606, DOI 10.1126/science.1217544; Brutschy M, 2012, ADV MATER, V24, P6049, DOI 10.1002/adma.201202786; Budd PM, 2004, CHEM COMMUN, P230, DOI 10.1039/b311764b; Bureekaew S, 2009, NAT MATER, V8, P831, DOI [10.1038/NMAT2526, 10.1038/nmat2526]; Bushell AF, 2013, ANGEW CHEM INT EDIT, V52, P1253, DOI 10.1002/anie.201206339; Bux H, 2009, J AM CHEM SOC, V131, P16000, DOI 10.1021/ja907359t; Carta M, 2013, SCIENCE, V339, P303, DOI 10.1126/science.1228032; Cejka J, 2012, CATAL TODAY, V179, P2, DOI 10.1016/j.cattod.2011.10.006; Cheetham AK, 1999, ANGEW CHEM INT EDIT, V38, P3268, DOI 10.1002/(SICI)1521-3773(19991115)38:22<3268::AID-ANIE3268>3.0.CO;2-U; Chen L, 2014, NAT MATER, V13, P954, DOI [10.1038/NMAT4035, 10.1038/nmat4035]; Chen LJ, 2013, J AM CHEM SOC, V135, P15763, DOI 10.1021/ja403453g; Chung YG, 2014, CHEM MATER, V26, P6185, DOI 10.1021/cm502594j; Colson JW, 2011, SCIENCE, V332, P228, DOI 10.1126/science.1202747; Corma A, 2010, CHEM REV, V110, P4606, DOI 10.1021/cr9003924; Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411; Coudert FX, 2009, J AM CHEM SOC, V131, P11329, DOI 10.1021/ja904123f; Dawson R, 2012, PROG POLYM SCI, V37, P530, DOI 10.1016/j.progpolymsci.2011.09.002; Dawson R, 2009, MACROMOLECULES, V42, P8809, DOI 10.1021/ma901801s; DeCoste JB, 2013, J MATER CHEM A, V1, P11922, DOI 10.1039/c3ta12497e; Deng HX, 2012, SCIENCE, V336, P1018, DOI 10.1126/science.1220131; Deng HX, 2010, SCIENCE, V327, P846, DOI 10.1126/science.1181761; Duren T, 2009, CHEM SOC REV, V38, P1237, DOI 10.1039/b803498m; Dyer MS, 2013, SCIENCE, V340, P847, DOI 10.1126/science.1226558; Fang ZL, 2014, J AM CHEM SOC, V136, P9627, DOI 10.1021/ja503218j; Farha OK, 2012, J AM CHEM SOC, V134, P15016, DOI 10.1021/ja3055639; Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275; First EL, 2014, AICHE J, V60, P1767, DOI 10.1002/aic.14441; First EL, 2013, MICROPOR MESOPOR MAT, V165, P32, DOI 10.1016/j.micromeso.2012.07.049; Furukawa H, 2014, J AM CHEM SOC, V136, P4369, DOI 10.1021/ja500330a; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Furukawa H, 2010, SCIENCE, V329, P424, DOI 10.1126/science.1192160; Gomez-Gualdron DA, 2014, J PHYS CHEM C, V118, P6941, DOI 10.1021/jp502359q; Han LP, 2014, COMP MATER SCI, V94, P292, DOI 10.1016/j.commatsci.2014.06.008; Hasell T, 2012, ANGEW CHEM INT EDIT, V51, P7154, DOI 10.1002/anie.201202849; Hasell T, 2012, CHEM COMMUN, V48, P4689, DOI 10.1039/c2cc31212c; Henke S, 2014, CHEM SCI, V5, P2392, DOI 10.1039/c4sc00497c; Herm ZR, 2013, SCIENCE, V340, P960, DOI 10.1126/science.1234071; Holden D, 2014, J PHYS CHEM C, V118, P12734, DOI 10.1021/jp500293s; Huang BL, 2007, INT J HEAT MASS TRAN, V50, P405, DOI 10.1016/j.ijheatmasstransfer.2006.10.001; Jelfs KE, 2013, J AM CHEM SOC, V135, P9307, DOI 10.1021/ja404253j; Jelfs KE, 2011, ANGEW CHEM INT EDIT, V50, P10653, DOI 10.1002/anie.201105104; Jiang JX, 2008, J AM CHEM SOC, V130, P7710, DOI 10.1021/ja8010176; Jiang JX, 2007, ANGEW CHEM INT EDIT, V46, P8574, DOI 10.1002/anie.200701595; Jiang JX, 2013, MACROMOLECULES, V46, P8779, DOI 10.1021/ma402104h; Jiang JX, 2011, CHEM SCI, V2, P1777, DOI 10.1039/c1sc00329a; Jiang JX, 2011, ANGEW CHEM INT EDIT, V50, P1072, DOI 10.1002/anie.201005864; Jiang S, 2013, J AM CHEM SOC, V135, P17818, DOI 10.1021/ja407374k; Jones JTA, 2011, NATURE, V474, P367, DOI 10.1038/nature10125; Karger J., 2012, DIFFUSION NANOPOROUS; Kondo M, 1997, ANGEW CHEM INT EDIT, V36, P1725, DOI 10.1002/anie.199717251; Kong XQ, 2013, SCIENCE, V341, P882, DOI 10.1126/science.1238339; Kou Y, 2011, ANGEW CHEM INT EDIT, V50, P8753, DOI 10.1002/anie.201103493; Kuhn P, 2008, ANGEW CHEM INT EDIT, V47, P3450, DOI 10.1002/anie.200705710; Kundu DS, 2012, ANGEW CHEM INT EDIT, V51, P5456, DOI 10.1002/anie.201109072; Laberty-Robert C, 2011, CHEM SOC REV, V40, P961, DOI 10.1039/c0cs00144a; Lau CH, 2014, ANGEW CHEM INT EDIT, V53, P5322, DOI 10.1002/anie.201402234; Li BY, 2014, J AM CHEM SOC, V136, P8654, DOI 10.1021/ja502119z; Lin X, 2006, ANGEW CHEM INT EDIT, V45, P7358, DOI 10.1002/anie.200601991; Liu JW, 2014, CHEM SOC REV, V43, P6011, DOI 10.1039/c4cs00094c; Liu J, 2015, SCIENCE, V347, P970, DOI 10.1126/science.aaa3145; Liu M, 2014, J AM CHEM SOC, V136, P7583, DOI 10.1021/ja503223j; Lu WG, 2012, ANGEW CHEM INT EDIT, V51, P7480, DOI 10.1002/anie.201202176; Lu WG, 2011, J AM CHEM SOC, V133, P18126, DOI 10.1021/ja2087773; Lukose B, 2012, J PHYS CHEM C, V116, P22878, DOI 10.1021/jp3067102; Lukose B, 2012, PHYS STATUS SOLIDI B, V249, P335, DOI 10.1002/pssb.201100634; Luo J, 2015, ACS CATAL, V5, P2250, DOI 10.1021/acscatal.5b00025; Ma SQ, 2008, J AM CHEM SOC, V130, P1012, DOI 10.1021/ja0771639; MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367; Makiura R, 2010, NAT MATER, V9, P565, DOI [10.1038/NMAT2769, 10.1038/nmat2769]; Rodriguez-Albelo LM, 2009, J AM CHEM SOC, V131, P16078, DOI 10.1021/ja905009e; Mastalerz M, 2012, ANGEW CHEM INT EDIT, V51, P5252, DOI 10.1002/anie.201201174; McDermott AG, 2014, J MATER CHEM A, V2, P11742, DOI 10.1039/c4ta02165g; McDonald TM, 2015, NATURE, V519, P303, DOI 10.1038/nature14327; McKeown NB, 2010, J MATER CHEM, V20, P10588, DOI 10.1039/c0jm01867h; Mellot-Draznieks C, 2004, ANGEW CHEM INT EDIT, V43, P6290, DOI 10.1002/anie.200454251; Mitra T, 2013, NAT CHEM, V5, P276, DOI [10.1038/NCHEM.1550, 10.1038/nchem.1550]; Morigami Y, 2001, SEP PURIF TECHNOL, V25, P251, DOI 10.1016/S1383-5866(01)00109-5; Mottillo C, 2014, ANGEW CHEM INT EDIT, V53, P7471, DOI 10.1002/anie.201402082; Nugent P, 2013, NATURE, V495, P80, DOI 10.1038/nature11893; Qu YQ, 2013, CHEM SOC REV, V42, P2568, DOI 10.1039/c2cs35355e; Rabone J, 2010, SCIENCE, V329, P1053, DOI 10.1126/science.1190672; Ranjan R, 2009, CHEM MATER, V21, P4920, DOI 10.1021/cm902032y; Rezakazemi M, 2014, PROG POLYM SCI, V39, P817, DOI 10.1016/j.progpolymsci.2014.01.003; Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030; Rolison DR, 2003, SCIENCE, V299, P1698, DOI 10.1126/science.1082332; Roth WJ, 2014, CHEM REV, V114, P4807, DOI 10.1021/cr400600f; Sakata Y, 2013, SCIENCE, V339, P193, DOI 10.1126/science.1231451; Sanders DE, 2013, POLYMER, V54, P4729, DOI 10.1016/j.polymer.2013.05.075; Sato H, 2014, SCIENCE, V343, P167, DOI 10.1126/science.1246423; Seo YK, 2012, ADV MATER, V24, P806, DOI 10.1002/adma.201104084; Sheberla D, 2014, J AM CHEM SOC, V136, P8859, DOI 10.1021/ja502765n; Sprick RS, 2015, J AM CHEM SOC, V137, P3265, DOI 10.1021/ja511552k; Sumida K, 2012, CHEM REV, V112, P724, DOI 10.1021/cr2003272; Tan JC, 2011, CHEM SOC REV, V40, P1059, DOI 10.1039/c0cs00163e; Taylor JM, 2013, J AM CHEM SOC, V135, P1193, DOI 10.1021/ja310435e; Thomas A, 2010, ANGEW CHEM INT EDIT, V49, P8328, DOI 10.1002/anie.201000167; Thomas JMH, 2014, J PHYS CHEM C, V118, P19712, DOI 10.1021/jp502336a; Tozawa T, 2009, NAT MATER, V8, P973, DOI [10.1038/nmat2545, 10.1038/NMAT2545]; Umeyama D, 2015, J AM CHEM SOC, V137, P864, DOI 10.1021/ja511019u; Uribe-Romo FJ, 2009, J AM CHEM SOC, V131, P4570, DOI 10.1021/ja8096256; Wan S, 2008, ANGEW CHEM INT EDIT, V47, P8826, DOI 10.1002/anie.200803826; Wang XC, 2009, NAT MATER, V8, P76, DOI [10.1038/nmat2317, 10.1038/NMAT2317]; Watanabe T, 2012, LANGMUIR, V28, P14114, DOI 10.1021/la301915s; Wilmer CE, 2012, NAT CHEM, V4, P83, DOI [10.1038/NCHEM.1192, 10.1038/nchem.1192]; Woodward RT, 2014, J AM CHEM SOC, V136, P9028, DOI 10.1021/ja5031968; Wright PA, 2008, RSC MATER MONOGR, P1; Wu CD, 2005, J AM CHEM SOC, V127, P8940, DOI 10.1021/ja052431t; Wu TJ, 2010, CHEM COMMUN, V46, P6120, DOI 10.1039/c0cc01170c; Xu H, 2014, CHEM COMMUN, V50, P1292, DOI 10.1039/c3cc48813f; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Yang QY, 2013, CHEM REV, V113, P8261, DOI 10.1021/cr400005f; Yang SH, 2015, NAT CHEM, V7, P121, DOI 10.1038/nchem.2114; Yoon M, 2013, ANGEW CHEM INT EDIT, V52, P2688, DOI 10.1002/anie.201206410; Yoon M, 2011, ANGEW CHEM INT EDIT, V50, P7870, DOI 10.1002/anie.201101777; Zhang G, 2014, ANGEW CHEM INT EDIT, V53, P1516, DOI 10.1002/anie.201308924; Zhang XL, 2013, J PHYS CHEM C, V117, P18441, DOI 10.1021/jp405156y; Zhang YB, 2013, J AM CHEM SOC, V135, P16336, DOI 10.1021/ja409033p; Zwijnenburg MA, 2013, MACROMOLECULES, V46, P7696, DOI 10.1021/ma401311s	127	1007	1018	110	1733	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238							aaa8075	10.1126/science.aaa8075	http://dx.doi.org/10.1126/science.aaa8075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	26023142				2022-12-28	WOS:000355276600037
J	Gohel, MS; Chetter, I				Gohel, M. S.; Chetter, Ian			Are clinical trials units essential for a successful trial?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERMITTENT CLAUDICATION; SUPERVISED EXERCISE; ANGIOPLASTY; EXPLANATION		[Gohel, M. S.] Cambridge Univ Hosp, London, England; [Gohel, M. S.] Univ London Imperial Coll Sci Technol & Med, London, England; [Chetter, Ian] Hull York Med Sch, Surg, Kingston Upon Hull HU3 2JZ, N Humberside, England	Imperial College London; University of Hull; University of York - UK	Gohel, MS (corresponding author), Cambridge Univ Hosp, London, England.	m.gohel@imperial.ac.uk; ian.chetter@hey.nhs.uk		chetter, ian/0000-0002-2566-6859				[Anonymous], 1948, Br Med J, V2, P769; Campbell M K, 2007, Health Technol Assess, V11, pix; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Europe Economics, 2012, EC ENV CLIN RES DEV; Fang FC, 2012, P NATL ACAD SCI USA, V109, P17028, DOI 10.1073/pnas.1212247109; Farrell B, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-78; Hobbs SD, 2006, J VASC SURG, V44, P432, DOI 10.1016/j.jvs.2006.04.005; Katz Seymour, 2011, Gastroenterol Hepatol (N Y), V7, P100; Mazari FAK, 2013, BRIT J SURG, V100, P1172, DOI 10.1002/bjs.9200; Mazari FAK, 2012, BRIT J SURG, V99, P39, DOI 10.1002/bjs.7710; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; PRESCOTT RJ, 1999, HLTH TECHNOL ASSESS, V3; Seife C., 2015, JAMA INTERN MED; UKCRC Clinical Trials Network, CTU ROL SERV; UKCRC Registered Clinical Trials Unit Network, REG CTUS; Zielinski SM, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-5	16	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2015	350								h2823	10.1136/bmj.h2823	http://dx.doi.org/10.1136/bmj.h2823			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0AH	26019297				2022-12-28	WOS:000355132900004
J	Attard, G; Parker, C; Eeles, RA; Schroder, F; Tomlins, SA; Tannock, I; Drake, CG; de Bono, JS				Attard, Gerhardt; Parker, Chris; Eeles, Ros A.; Schroder, Fritz; Tomlins, Scott A.; Tannock, Ian; Drake, Charles G.; de Bono, Johann S.			Prostate cancer	LANCET			English	Review							ANDROGEN-DEPRIVATION THERAPY; MITOXANTRONE PLUS PREDNISONE; CIRCULATING TUMOR-CELLS; I CLINICAL-TRIAL; PHASE-III TRIAL; ABIRATERONE ACETATE; RADICAL PROSTATECTOMY; ANTITUMOR-ACTIVITY; SURVIVAL ANALYSIS; ZOLEDRONIC ACID	Much progress has been made in research for prostate cancer in the past decade. There is now greater understanding for the genetic basis of familial prostate cancer with identification of rare but high-risk mutations (eg, BRCA2, HOXB13) and low-risk but common alleles (77 identified so far by genome-wide association studies) that could lead to targeted screening of patients at risk. This is especially important because screening for prostate cancer based on prostate-specific antigen remains controversial due to the high rate of overdiagnosis and unnecessary prostate biopsies, despite evidence that it reduces mortality. Classification of prostate cancer into distinct molecular subtypes, including mutually exclusive ETS-gene-fusion-positive and SPINK1-overexpressing, CHD1-loss cancers, could allow stratification of patients for different management strategies. Presently, men with localised disease can have very different prognoses and treatment options, ranging from observation alone through to radical surgery, with few good-quality randomised trials to inform on the best approach for an individual patient. The survival of patients with metastatic prostate cancer progressing on androgen-deprivation therapy (castration-resistant prostate cancer) has improved substantially. In addition to docetaxel, which has been used for more than a decade, in the past 4 years five new drugs have shown efficacy with improvements in overall survival leading to licensing for the treatment of metastatic castration-resistant prostate cancer. Because of this rapid change in the therapeutic landscape, no robust data exist to inform on the selection of patients for a specific treatment for castration-resistant prostate cancer or the best sequence of administration. Moreover, the high cost of the newer drugs limits their widespread use in several countries. Data from continuing clinical and translational research are urgently needed to improve, and, crucially, to personalise management.	[Attard, Gerhardt; de Bono, Johann S.] Inst Canc Res, Div Clin Studies, London SW3 6JB, England; [Attard, Gerhardt; de Bono, Johann S.] Royal Marsden NHS Fdn Trust, Prostate Canc Targeted Therapy Grp, Sutton SM2 5PT, Surrey, England; [Parker, Chris] Royal Marsden NHS Fdn Trust, Acad Urol Unit, Sutton SM2 5PT, Surrey, England; [Eeles, Ros A.] Royal Marsden NHS Fdn Trust, Clin Acad Canc Genet Unit, Sutton SM2 5PT, Surrey, England; [Eeles, Ros A.] Inst Canc Res, Oncogenet Team, Div Canc Genet & Epidemiol, London SW3 6JB, England; [Schroder, Fritz] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [Tomlins, Scott A.] Univ Michigan, Sch Med, Dept Pathol Urol, Ctr Comprehens Canc, Ann Arbor, MI USA; [Tomlins, Scott A.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI USA; [Tannock, Ian] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Tannock, Ian] Univ Toronto, Toronto, ON, Canada; [Drake, Charles G.] Johns Hopkins Univ Hosp, Div Med Oncol, Baltimore, MA USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Erasmus University Rotterdam; Erasmus MC; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Johns Hopkins University; Johns Hopkins Medicine	de Bono, JS (corresponding author), Royal Marsden NHS Fdn Trust, Div Clin Studies, Inst Canc Res, Sutton SM2 5PT, Surrey, England.	jdebono@icr.ac.uk		de Bono, Johann S/0000-0002-2034-595X; Eeles, Rosalind/0000-0002-3698-6241; Attard, Gerhardt/0000-0002-4811-7983	Prostate Cancer Foundation; Prostate Cancer UK (PCUK); Movember; Department of Defence; Cancer Research UK; Cancer Research UK (CRUK) Clinician Scientist Fellowship; CRUK; PCUK; Ronald and Rita McAulay Foundation; European Union Seventh Framework Programme; Career Development Award from the University of Michigan Prostate Cancer Specialised Programmes of Research Excellence; SU2C; National Institutes of Health [R01 CA127153, 1P50CA58236-15]; Patrick C Walsh Fund; OneInSix Foundation; Koch Foundation; Experimental Cancer Medicine Centre; National Institute for Health Research (NIHR); Cancer Research UK [19727, 13239] Funding Source: researchfish; National Institute for Health Research [CL-2008-22-001] Funding Source: researchfish; Prostate Cancer UK [PG12-49] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P50CA058236, P30CA006973, R01CA127153] Funding Source: NIH RePORTER	Prostate Cancer Foundation; Prostate Cancer UK (PCUK); Movember; Department of Defence; Cancer Research UK(Cancer Research UK); Cancer Research UK (CRUK) Clinician Scientist Fellowship; CRUK(Cancer Research UK); PCUK; Ronald and Rita McAulay Foundation; European Union Seventh Framework Programme(European Commission); Career Development Award from the University of Michigan Prostate Cancer Specialised Programmes of Research Excellence; SU2C; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patrick C Walsh Fund; OneInSix Foundation; Koch Foundation; Experimental Cancer Medicine Centre; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Prostate Cancer UK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	GA and JSdB are supported by the Prostate Cancer Foundation, Prostate Cancer UK (PCUK), and Movember. JSdB is also funded by the Department of Defence and Cancer Research UK. GA is also funded by a Cancer Research UK (CRUK) Clinician Scientist Fellowship. RAE is supported by CRUK, PCUK, The Ronald and Rita McAulay Foundation, and the European Union Seventh Framework Programme. SAT was supported by a Career Development Award from the University of Michigan Prostate Cancer Specialised Programmes of Research Excellence and has been supported by the Prostate Cancer Foundation and SU2C. CGD is supported by National Institutes of Health R01 CA127153, 1P50CA58236-15, the Patrick C Walsh Fund, the OneInSix Foundation, the Koch Foundation, and the Prostate Cancer Foundation. We were supported by Experimental Cancer Medicine Centre and National Institute for Health Research (NIHR) funding to the Biomedical Research Centre at The Institute of Cancer Research and Royal Marsden NHS Foundation Trust. We thank Nina Tunariu, consultant radiologist at the Royal Marsden NHS Foundation Trust, for providing MRI images.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Aryee MJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005211; Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Attard G, 2009, J CLIN ONCOL, V27, P3742, DOI 10.1200/JCO.2008.20.0642; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Balbas MD, 2013, ELIFE, V2, DOI 10.7554/eLife.00499; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Beltran H, 2013, CLIN CANCER RES, V19, P517, DOI 10.1158/1078-0432.CCR-12-1452; Beltran H, 2013, EUR UROL, V63, P920, DOI 10.1016/j.eururo.2012.08.053; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Berthold DR, 2008, J CLIN ONCOL, V26, P242, DOI 10.1200/JCO.2007.12.4008; Bhalla R, 2013, MODERN PATHOL, V26, P835, DOI 10.1038/modpathol.2012.234; Bianchini D, 2014, EUR J CANCER, V50, P78, DOI 10.1016/j.ejca.2013.08.020; Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Borno ST, 2012, CANCER DISCOV, V2, P1024, DOI 10.1158/2159-8290.CD-12-0041; Bolla M, 2010, LANCET ONCOL, V11, P1066, DOI 10.1016/S1470-2045(10)70223-0; Bolla M, 2009, NEW ENGL J MED, V360, P2516, DOI 10.1056/NEJMoa0810095; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Bussemakers MJG, 1999, CANCER RES, V59, P5975; Cai CM, 2011, CANCER RES, V71, P6503, DOI 10.1158/0008-5472.CAN-11-0532; Cancer Research UK, 2011, CANC RISK; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Castro E, 2013, J CLIN ONCOL, V31, P1748, DOI 10.1200/JCO.2012.43.1882; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cheng L, 1998, J NATL CANCER I, V90, P233, DOI 10.1093/jnci/90.3.233; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Clark J, 2008, ONCOGENE, V27, P1993, DOI 10.1038/sj.onc.1210843; Cybulski C, 2006, J MED GENET, V43, P863, DOI 10.1136/jmg.2006.044974; Cybulski C, 2004, CANCER RES, V64, P2677, DOI 10.1158/0008-5472.CAN-04-0341; Dalesio O, 2000, LANCET, V355, P1491; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Denham JW, 2011, LANCET ONCOL, V12, P451, DOI 10.1016/S1470-2045(11)70063-8; Djulbegovic M, 2011, BMJ-BRIT MED J, V341, pc4543, DOI DOI 10.1136/BMJ.C4543; Dyer M, 2012, LANCET ONCOL, V13, P762, DOI 10.1016/S1470-2045(12)70289-9; Eeles R, 2014, NAT REV UROL, V11, P18, DOI 10.1038/nrurol.2013.266; Epstein JI, 2014, AM J SURG PATHOL, V38, pE6, DOI 10.1097/PAS.0000000000000238; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Etzioni R, 2013, MED CARE, V51, P304, DOI 10.1097/MLR.0b013e31828a7e1a; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fizazi K, 2012, LANCET ONCOL, V13, P983, DOI 10.1016/S1470-2045(12)70379-0; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Franke RM, 2010, J CLIN ONCOL, V28, P4562, DOI 10.1200/JCO.2010.30.7025; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gan L, 2009, CANCER RES, V69, P8386, DOI 10.1158/0008-5472.CAN-09-1504; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gravis G, 2013, LANCET ONCOL, V14, P149, DOI 10.1016/S1470-2045(12)70560-0; GRONBERG H, 1994, J UROLOGY, V152, P1484, DOI 10.1016/S0022-5347(17)32452-7; Grubb RL, 2008, BJU INT, V102, P1524, DOI 10.1111/j.1464-410X.2008.08214.x; Hambrock T, 2012, EUR UROL, V61, P177, DOI 10.1016/j.eururo.2011.08.042; Hebbring SJ, 2006, CANCER EPIDEM BIOMAR, V15, P935, DOI 10.1158/1055-9965.EPI-05-0910; Heijnsdijk EAM, 2012, NEW ENGL J MED, V367, P595, DOI 10.1056/NEJMoa1201637; Hemminki K, 1998, INT J CANCER, V77, P386, DOI 10.1002/(SICI)1097-0215(19980729)77:3<386::AID-IJC13>3.0.CO;2-6; Horwitz EM, 2008, J CLIN ONCOL, V26, P2497, DOI 10.1200/JCO.2007.14.9021; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Huang S, 2012, ONCOGENE, V31, P4164, DOI 10.1038/onc.2011.590; Huber ML, 2012, J NATL CANCER I, V104, P273, DOI 10.1093/jnci/djr514; Ilic D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004720.pub3; Johns LE, 2003, BJU INT, V91, P789, DOI 10.1046/j.1464-410X.2003.04232.x; Jones CU, 2011, NEW ENGL J MED, V365, P107, DOI 10.1056/NEJMoa1012348; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Kearns B, 2013, PHARMACOECONOMICS, V31, P479, DOI 10.1007/s40273-013-0050-9; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Kote-Jarai Z, 2011, BRIT J CANCER, V105, P1230, DOI 10.1038/bjc.2011.383; Kote-Jarai Z, 2009, BRIT J CANCER, V100, P426, DOI 10.1038/sj.bjc.6604847; Kumar S, 2006, COCHRANE DB SYST REV, V4; Lapuk AV, 2012, J PATHOL, V227, P286, DOI 10.1002/path.4047; Lecouvet FE, 2012, EUR UROL, V62, P68, DOI 10.1016/j.eururo.2012.02.020; Lee Joanne, 2007, Cancer Control, V14, P78; Leongamornlert D, 2012, BRIT J CANCER, V106, P1697, DOI 10.1038/bjc.2012.146; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Lindberg J, 2013, EUR UROL, V63, P702, DOI 10.1016/j.eururo.2012.11.053; Lindberg J, 2013, EUR UROL, V63, P347, DOI 10.1016/j.eururo.2012.03.050; Liu W, 2012, ONCOGENE, V31, P3939, DOI 10.1038/onc.2011.554; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Logothetis CJ, 2012, LANCET ONCOL, V13, P1210, DOI 10.1016/S1470-2045(12)70473-4; Loriot Y, 2013, ANN ONCOL, V24, P1807, DOI 10.1093/annonc/mdt136; MacInnis RJ, 2010, GENET EPIDEMIOL, V34, P42, DOI 10.1002/gepi.20433; Mani RS, 2010, NAT REV GENET, V11, P819, DOI 10.1038/nrg2883; Mao XY, 2010, CANCER RES, V70, P5207, DOI 10.1158/0008-5472.CAN-09-4074; Marugame T, 2006, JPN J CLIN ONCOL, V36, P399, DOI 10.1093/jjco/hyl049; McKeage K, 2008, PHARMACOECONOMICS, V26, P251, DOI 10.2165/00019053-200826030-00007; Mendiratta P, 2009, J CLIN ONCOL, V27, P2022, DOI 10.1200/JCO.2008.17.2882; Mezynski J, 2012, ANN ONCOL, V23, P2943, DOI 10.1093/annonc/mds119; Mitra A, 2008, BRIT J CANCER, V98, P502, DOI 10.1038/sj.bjc.6604132; Miyamoto DT, 2012, CANCER DISCOV, V2, P995, DOI 10.1158/2159-8290.CD-12-0222; Mosquera JM, 2013, NEOPLASIA, V15, P1, DOI 10.1593/neo.121550; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Noonan KL, 2013, ANN ONCOL, V24, P1802, DOI 10.1093/annonc/mdt138; Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755; Parker C, 2004, LANCET ONCOL, V5, P101, DOI 10.1016/S1470-2045(04)01384-1; Pezaro CJ, 2014, EUR UROL, V66, P459, DOI 10.1016/j.eururo.2013.11.044; Pinsky PF, 2010, CLIN TRIALS, V7, P303, DOI 10.1177/1740774510374091; Richards J, 2012, CANCER RES, V72, P2176, DOI 10.1158/0008-5472.CAN-11-3980; Roobol MJ, 2010, EUR UROL, V58, P475, DOI 10.1016/j.eururo.2010.06.039; Roobol MJ, 2010, EUR UROL, V57, P79, DOI 10.1016/j.eururo.2009.08.025; Rosen P, 2012, NAT REV UROL; Rubin MA, 2011, J CLIN ONCOL, V29, P3659, DOI 10.1200/JCO.2011.35.1916; Ryan CJ, 2015, LANCET ONCOL, V16, P152, DOI 10.1016/S1470-2045(14)71205-7; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Ryan CJ, 2010, J CLIN ONCOL, V28, P1481, DOI 10.1200/JCO.2009.24.1281; Saad F, 2002, JNCI-J NATL CANCER I, V94, P1458, DOI 10.1093/jnci/94.19.1458; Sboner A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-8; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072; Schaid DJ, 1998, AM J HUM GENET, V63, P935, DOI 10.1086/302077; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Selvadurai ED, 2013, EUR UROL, V64, P981, DOI 10.1016/j.eururo.2013.02.020; Small EJ, 2004, J CLIN ONCOL, V22, P1025, DOI 10.1200/JCO.2004.06.037; Snedecor Sonya J, 2013, J Med Econ, V16, P19, DOI 10.3111/13696998.2012.719054; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Sternberg CN, 2013, ANN ONCOL, V24, P1017, DOI 10.1093/annonc/mds585; Stoyanova T, 2013, P NATL ACAD SCI USA, V110, P20111, DOI 10.1073/pnas.1320565110; Sydes MR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-168; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Vickers AJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2023; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Warde P, 2011, LANCET, V378, P2104, DOI 10.1016/S0140-6736(11)61095-7; Widmark A, 2009, LANCET, V373, P301, DOI 10.1016/S0140-6736(08)61815-2; Wilke DR, 2010, CANCER-AM CANCER SOC, V116, P1909, DOI 10.1002/cncr.24905; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Young A, 2012, AM J CLIN PATHOL, V138, P685, DOI 10.1309/AJCPU7PPWUPYG8OH; Zeigler-Johnson CM, 2008, CAN J UROL, V15, P4056	150	632	662	9	305	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2016	387	10013					70	82		10.1016/S0140-6736(14)61947-4	http://dx.doi.org/10.1016/S0140-6736(14)61947-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ9ZU	26074382				2022-12-28	WOS:000367457300029
J	Lonial, S; Dimopoulos, M; Palumbo, A; White, D; Grosicki, S; Spicka, I; Walter-Croneck, A; Moreau, P; Mateos, MV; Magen, H; Belch, A; Reece, D; Beksac, M; Spencer, A; Oakervee, H; Orlowski, RZ; Taniwaki, M; Rollig, C; Einsele, H; Wu, KL; Singhal, A; San-Miguel, J; Matsumoto, M; Katz, J; Bleickardt, E; Poulart, V; Anderson, KC; Richardson, P				Lonial, Sagar; Dimopoulos, Meletios; Palumbo, Antonio; White, Darrell; Grosicki, Sebastian; Spicka, Ivan; Walter-Croneck, Adam; Moreau, Philippe; Mateos, Maria-Victoria; Magen, Hila; Belch, Andrew; Reece, Donna; Beksac, Meral; Spencer, Andrew; Oakervee, Heather; Orlowski, Robert Z.; Taniwaki, Masafumi; Roellig, Christoph; Einsele, Hermann; Wu, Ka Lung; Singhal, Anil; San-Miguel, Jesus; Matsumoto, Morio; Katz, Jessica; Bleickardt, Eric; Poulart, Valerie; Anderson, Kenneth C.; Richardson, Paul		ELOQUENT-2 Investigators	Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOCLONAL-ANTIBODY; SERUM-PROTEIN; DEXAMETHASONE; LENALIDOMIDE; INTERFERENCE; CYTOTOXICITY; CS1	BACKGROUND Elotuzumab, an immunostimulatory monoclonal antibody targeting signaling lymphocytic activation molecule F7 (SLAMF7), showed activity in combination with lenalidomide and dexamethasone in a phase 1b-2 study in patients with relapsed or refractory multiple myeloma. METHODS In this phase 3 study, we randomly assigned patients to receive either elotuzumab plus lenalidomide and dexamethasone (elotuzumab group) or lenalidomide and dexamethasone alone (control group). Coprimary end points were progression-free survival and the overall response rate. Final results for the coprimary end points are reported on the basis of a planned interim analysis of progression-free survival. RESULTS Overall, 321 patients were assigned to the elotuzumab group and 325 to the control group. After a median follow-up of 24.5 months, the rate of progression-free survival at 1 year in the elotuzumab group was 68%, as compared with 57% in the control group; at 2 years, the rates were 41% and 27%, respectively. Median progression-free survival in the elotuzumab group was 19.4 months, versus 14.9 months in the control group (hazard ratio for progression or death in the elotuzumab group, 0.70; 95% confidence interval, 0.57 to 0.85; P<0.001). The overall response rate in the elotuzumab group was 79%, versus 66% in the control group (P<0.001). Common grade 3 or 4 adverse events in the two groups were lymphocytopenia, neutropenia, fatigue, and pneumonia. Infusion reactions occurred in 33 patients (10%) in the elotuzumab group and were grade 1 or 2 in 29 patients. CONCLUSIONS Patients with relapsed or refractory multiple myeloma who received a combination of elotuzumab, lenalidomide, and dexamethasone had a significant relative reduction of 30% in the risk of disease progression or death. (Funded by Bristol-Myers Squibb and AbbVie Biotherapeutics; ELOQUENT-2 ClinicalTrials.gov number, NCT01239797.)	[Lonial, Sagar] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Dimopoulos, Meletios] Natl & Kapodistrian Univ Athens, Athens, Greece; [Palumbo, Antonio] AOU San Giovanni Battista Torino Osped Molinette, Turin, Italy; [White, Darrell] QEII Hlth Sci Ctr, Halifax, NS, Canada; [White, Darrell] Dalhousie Univ, Halifax, NS, Canada; [Belch, Andrew] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Belch, Andrew] Univ Alberta, Edmonton, AB, Canada; [Reece, Donna] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Grosicki, Sebastian] Silesian Med Univ, Katowice, Poland; [Walter-Croneck, Adam] Med Univ Lublin, Lublin, Poland; [Spicka, Ivan] Charles Univ Hosp, Prague, Czech Republic; [Moreau, Philippe] Univ Hosp, Nantes, France; [Mateos, Maria-Victoria] Complejo Asistencial Univ Salamanca, Inst Invest Biomed Salamanca, Salamanca, Spain; [San-Miguel, Jesus] Univ Navarra Clin, Ctr Invest Med Aplicada, Inst Invest Sanitaria Navarra, Pamplona, Spain; [Magen, Hila] Rabin Med Ctr, Davidoff Canc Ctr, Petah Tiqwa, Israel; [Magen, Hila] Tel Aviv Univ, Ramat Aviv, Israel; [Beksac, Meral] Ankara Univ, TR-06100 Ankara, Turkey; [Spencer, Andrew] Monash Univ, Alfred Health, Melbourne, Vic 3004, Australia; [Oakervee, Heather] Barts & London NHS Trust, London, England; [Orlowski, Robert Z.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Taniwaki, Masafumi] Kyoto Prefectural Univ Med, Kyoto, Japan; [Matsumoto, Morio] Nishigunma Natl Hosp, Shibukawa, Japan; [Roellig, Christoph] Tech Univ Dresden, Univ Klinikum, D-01062 Dresden, Germany; [Einsele, Hermann] Univ Klinikum Wurzburg, Wurzburg, Germany; [Wu, Ka Lung] Zeikenhuis Netwerk Antwerpen, Antwerp, Belgium; [Singhal, Anil] AbbVie Biotherapeut, Redwood City, CA USA; [Katz, Jessica] Bristol Myers Squibb Co, Princeton, NJ USA; [Anderson, Kenneth C.; Richardson, Paul] Dana Farber Canc Inst, Boston, MA 02115 USA	Emory University; National & Kapodistrian University of Athens; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Alberta; University of Alberta; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Medical University Silesia; Medical University of Lublin; Charles University Prague; General University Hospital Prague; Nantes Universite; CHU de Nantes; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Navarra; Rabin Medical Center; Tel Aviv University; Ankara University; Monash University; Barts Health NHS Trust; University of Texas System; UTMD Anderson Cancer Center; Kyoto Prefectural University of Medicine; Technische Universitat Dresden; University of Wurzburg; AbbVie; Bristol-Myers Squibb; Harvard University; Dana-Farber Cancer Institute	Lonial, S (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA.	sloni01@emory.edu	San-Miguel, Jesús F./V-8977-2018; Grosicki, Sebastian/AAG-2917-2019; Dimopoulos, Meletios Athanasios/AAD-4130-2019	San-Miguel, Jesús F./0000-0002-9183-4857; Spicka, Ivan/0000-0002-5451-5283; moreau, philippe/0000-0003-1780-8746; Orlowski, Robert/0000-0002-5723-4129; Dimopoulos, Meletios/0000-0001-8990-3254; Walter-Croneck, Adam/0000-0003-0908-0396; Grosicki, Sebastian/0000-0003-2644-1050	Bristol-Myers Squibb; AbbVie Biotherapeutics; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); AbbVie Biotherapeutics(AbbVie); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Bristol-Myers Squibb and AbbVie Biotherapeutics; ELOQUENT-2 ClinicalTrials.gov number, NCT01239797.	[Anonymous], 2013, PLOS ONE, V8; Axel AE, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-2563; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Collins SM, 2013, CANCER IMMUNOL IMMUN, V62, P1841, DOI 10.1007/s00262-013-1493-8; Dimopoulos MA, 2009, LEUKEMIA, V23, P2147, DOI 10.1038/leu.2009.147; Genzen JR, 2011, BRIT J HAEMATOL, V155, P123, DOI 10.1111/j.1365-2141.2011.08644.x; Guo HJ, 2015, MOL CELL BIOL, V35, P41, DOI 10.1128/MCB.01107-14; Hsi ED, 2008, CLIN CANCER RES, V14, P2775, DOI 10.1158/1078-0432.CCR-07-4246; McCudden CR, 2010, CLIN CHEM, V56, P1897, DOI 10.1373/clinchem.2010.152116; National Comprehensive Cancer Network (NCCN), 2015, NCCN CLIN PRACT GUID; Perez-Quintero LA, 2014, J EXP MED, V211, P727, DOI 10.1084/jem.20132038; Richardson P, 2014, BLOOD, V124, P302; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Stewart AK, 2015, NEW ENGL J MED, V372, P142, DOI 10.1056/NEJMoa1411321; Tai YT, 2008, BLOOD, V112, P1329, DOI 10.1182/blood-2007-08-107292	15	928	951	3	70	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 13	2015	373	7					621	631		10.1056/NEJMoa1505654	http://dx.doi.org/10.1056/NEJMoa1505654			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP2LE	26035255	Green Published			2022-12-28	WOS:000359707700007
J	Kang, S				Kang, Sokbom			Neoadjuvant chemotherapy for ovarian cancer: do we have enough evidence?	LANCET			English	Editorial Material									Natl Canc Ctr, Goyang 411769, South Korea	National Cancer Center - Korea (NCC)	Kang, S (corresponding author), Natl Canc Ctr, Goyang 411769, South Korea.	sokbom@gmail.com		Kang, Sokbom/0000-0002-8428-9555				Chi DS, 2011, J CLIN ONCOL, V29, P4073, DOI 10.1200/JCO.2011.35.9935; Kang S, 2011, ANN SURG ONCOL, V18, P3824, DOI 10.1245/s10434-011-1830-0; Kehoe S, 2015, LANCET; ONDA T, 2014, J CLIN ONCOL S, V32; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806	5	21	21	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 18	2015	386	9990					223	224		10.1016/S0140-6736(14)62259-5	http://dx.doi.org/10.1016/S0140-6736(14)62259-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN1XI	26002110				2022-12-28	WOS:000358213700006
J	Kapczynski, A				Kapczynski, Amy			The Trans-Pacific Partnership - Is It Bad for Your Health?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Law, New Haven, CT 06520 USA	Yale University	Kapczynski, A (corresponding author), Yale Univ, Sch Law, New Haven, CT 06520 USA.							Kapczynski A, 2013, NEW ENGL J MED, V369, P497, DOI 10.1056/NEJMp1304400; MoF, 2016, NAT BUDG FIN YEAR 20; Public Citizen, 2015, MEM 3 BURN QUEST LEA, DOI 10.1056/NEJMp1506158	3	15	17	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 16	2015	373	3					201	203		10.1056/NEJMp1506158	http://dx.doi.org/10.1056/NEJMp1506158			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM8MS	26061752				2022-12-28	WOS:000357956200001
J	Briesacher, BA; Madden, JM; Zhang, F; Fouayzi, H; Ross-Degnan, D; Gurwitz, JH; Soumerai, SB				Briesacher, Becky A.; Madden, Jeanne M.; Zhang, Fang; Fouayzi, Hassan; Ross-Degnan, Dennis; Gurwitz, Jerry H.; Soumerai, Stephen B.			Did Medicare Part D Affect National Trends in Health Outcomes or Hospitalizations? A Time-Series Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							DRUG-USE; IMPLEMENTATION; NONADHERENCE	Background: Medicare Part D increased economic access to medications, but its effect on population-level health outcomes and use of other medical services remains unclear. Objective: To examine changes in health outcomes and medical services in the Medicare population after implementation of Part D. Design: Population-level longitudinal time-series analysis with generalized linear models. Setting: Community. Patients: Nationally representative sample of Medicare beneficiaries (n = 56 293 [unweighted and unique]) from 2000 to 2010. Measurements: Changes in self-reported health status, limitations in activities of daily living (ADLs) (ADLs and instrumental ADLs), emergency department visits and hospital admissions (prevalence, counts, and spending), and mortality. Medicare claims data were used for confirmatory analyses. Results: Five years after Part D implementation, no clinically or statistically significant reductions in the prevalence of fair or poor health status or limitations in ADLs or instrumental ADLs, relative to historical trends, were detected. Compared with trends before Part D, no changes in emergency department visits, hospital admissions or days, inpatient costs, or mortality after Part D were seen. Confirmatory analyses were consistent. Limitations: Only total population-level outcomes were studied. Self-reported measures may lack sensitivity. Conclusion: Five years after implementation, and contrary to previous reports, no evidence was found of Part D's effect on a range of population-level health indicators among Medicare enrollees. Further, there was no clear evidence of gains in medical care efficiencies.	[Briesacher, Becky A.] Northeastern Univ, Sch Pharm, Boston, MA 02115 USA; [Madden, Jeanne M.; Zhang, Fang; Ross-Degnan, Dennis; Soumerai, Stephen B.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02215 USA; [Madden, Jeanne M.; Zhang, Fang; Ross-Degnan, Dennis; Soumerai, Stephen B.] Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA; [Fouayzi, Hassan; Gurwitz, Jerry H.] Univ Massachusetts, Sch Med, Dept Med, Div Geriatr Med, Worcester, MA 01605 USA	Northeastern University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Massachusetts System; University of Massachusetts Worcester	Briesacher, BA (corresponding author), Northeastern Univ, Sch Pharm, 360 Huntington Ave,R218 TF, Boston, MA 02115 USA.	b.briesacher@neu.edu	Zhang, Fang/HHN-2153-2022; Fouayzi, Hassan/AHD-0143-2022		National Institute on Aging (NIA) [R01AG028745, R01AG022362]; NIA [K01AG031836]; Agency for Healthcare Research and Quality [R01AG032249, R01HS018577]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028745, R01AG022362, R01AG032249, K01AG031836] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the National Institute on Aging (NIA) (grants R01AG028745 and R01AG022362; Dr. Soumerai [principal investigator]), a Research Scientist Award from the NIA (K01AG031836; Dr. Briesacher), and related support from the NIA and Agency for Healthcare Research and Quality (grants R01AG032249 and R01HS018577, respectively; Drs. Madden, Zhang, Ross-Degnan, and Soumerai).	Adler G S, 1994, Health Care Financ Rev, V15, P153; Afendulis CC, 2011, HEALTH SERV RES, V46, P1022, DOI 10.1111/j.1475-6773.2011.01244.x; [Anonymous], 2014, HLTH CAR SPEND MED P; [Anonymous], 2010, 2010 COST US COD; Briesacher BA, 2011, MED CARE, V49, P834, DOI 10.1097/MLR.0b013e3182162afb; Cook TD, 2002, EXPT QUASIEXPERIMENT, P1, DOI 10.1198/jasa.2005.s22; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Ingber MJ, 2011, MEDICARE D; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Madden JM, 2008, JAMA-J AM MED ASSOC, V299, P1922, DOI 10.1001/jama.299.16.1922; Madden JM, 2009, JAMA-J AM MED ASSOC, V302, P1755, DOI 10.1001/jama.2009.1516; Majumdar SR, 2009, HEALTH AFFAIR, V28, pW900, DOI 10.1377/hlthaff.28.5.w900; McWilliams JM, 2011, JAMA-J AM MED ASSOC, V306, P402, DOI 10.1001/jama.2011.1026; Polinski JM, 2010, J AM GERIATR SOC, V58, P1764, DOI 10.1111/j.1532-5415.2010.03025.x; Sarndal C. E., 2003, MODEL ASSISTED SURVE; *US BUR LAB STAT, 2007, CONS EXP 2005; US Congressional Budget Office, 2012, OFFS EFF PRESCR DRUG; Zhang Y, 2009, NEW ENGL J MED, V361, P52, DOI 10.1056/NEJMsa0807998	18	6	6	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12					825	+		10.7326/M14-0726	http://dx.doi.org/10.7326/M14-0726			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK8VC	26075753	Green Accepted			2022-12-28	WOS:000356516300017
J	Green, CR; Cowan, P; Elk, R; O'Neil, KM; Rasmussen, AL				Green, Carmen R.; Cowan, Penney; Elk, Ronit; O'Neil, Kathleen M.; Rasmussen, Angela L.			National Institutes of Health Pathways to Prevention Workshop: Advancing the Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome	ANNALS OF INTERNAL MEDICINE			English	Article								The National Institutes of Health (NIH) Pathways to Prevention Workshop: Advancing the Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome was cosponsored by the NIH Office of Disease Prevention and the Trans-NIH Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Research Working Group. A multidisciplinary working group developed the agenda, and an Evidence-based Practice Center prepared an evidence report through a contract with the Agency for Healthcare Research and Quality to facilitate the discussion. During the 1.5-day workshop, invited experts discussed the body of evidence and attendees had the opportunity to comment during open discussions. After weighing evidence from the evidence report, expert presentations, and public comments, an unbiased, independent panel prepared a draft report that identified research gaps and future research priorities. The report was posted on the NIH Office of Disease Prevention Web site for 4 weeks for public comment.	[Green, Carmen R.] Univ Michigan Hlth Syst, Off Hlth Equ & Inclus, Ann Arbor, MI 48109 USA; [Cowan, Penney] Amer Chron Pain Assoc, Rocklin, CA 95677 USA; [Elk, Ronit] Univ S Carolina, Coll Nursing, Columbia, SC 29208 USA; [O'Neil, Kathleen M.] Indiana Univ Hlth, Riley Hosp Children, Indianapolis, IN 46202 USA; [Rasmussen, Angela L.] Univ Washington, Katze Lab, Seattle, WA 98109 USA	University of Michigan System; University of Michigan; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Indiana University System; James Whitcomb Riley Hospital Children; University of Washington; University of Washington Seattle	Green, CR (corresponding author), NIH, Off Dis Prevent, 6100 Execut Blvd,Room 2B03,MSC 7523, Rockville, MD 20852 USA.			Rasmussen, Angela/0000-0001-9462-3169					0	45	46	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 16	2015	162	12					860	+		10.7326/M15-0338	http://dx.doi.org/10.7326/M15-0338			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK8VC	26075757				2022-12-28	WOS:000356516300021
J	FitzGerald, GA				FitzGerald, Garret A.			Bringing PGE(2) in from the cold	SCIENCE			English	Editorial Material							PROSTAGLANDIN; INHIBITION; LESSONS; CELLS		Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	FitzGerald, GA (corresponding author), Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.	garret@exchange.upenn.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Fabre JE, 2001, J CLIN INVEST, V107, P603, DOI 10.1172/JCI10881; Fitzgerald DJ, 2013, CIRC RES, V112, P174, DOI 10.1161/CIRCRESAHA.111.300271; Glas J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052873; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; Guda K, 2014, CANCER PREV RES, V7, P805, DOI 10.1158/1940-6207.CAPR-14-0108; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Ishikawa TO, 2011, CARCINOGENESIS, V32, P417, DOI 10.1093/carcin/bgq268; Kochel T. J., 2015, PROSTAG OTH LIPID M, V116-117C, P99; Li HJ, 2012, CANCER DISCOV, V2, P840, DOI 10.1158/2159-8290.CD-12-0101; Montrose D. C., 2015, PROSTAG OTH LIPID M, V116-117, P26; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Uppal S, 2008, NAT GENET, V40, P789, DOI 10.1038/ng.153; Yuan C, 2015, J BIOL CHEM, V290, P5606, DOI 10.1074/jbc.M114.632463; Zhang YY, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2340	15	16	16	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1208	1209		10.1126/science.aac5515	http://dx.doi.org/10.1126/science.aac5515			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068834				2022-12-28	WOS:000356011500030
J	Jan, CH; Williams, CC; Weissman, JS				Jan, Calvin H.; Williams, Christopher C.; Weissman, Jonathan S.			Response to Comment on "Principles of ER cotranslational translocation revealed by proximity-specific ribosome profiling"	SCIENCE			English	Editorial Material								Reid and Nicchitta propose that most cellular translation is carried out by a noncycling pool of endoplasmic reticulum (ER)-associated ribosomes. However, proximity-specific ribosome profiling data place an upper bound of about 7 to 16% on the fraction of cytosolic protein translation carried out by ribosomes accessible to ER-tethered biotin ligases. Moreover, yeast pulse-labeling experiments argue against there being a static population of ER-associated ribosomes.	[Jan, Calvin H.; Williams, Christopher C.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, Calif Inst Quantitat Biosci,Ctr RNA Syst Biol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, Calif Inst Quantitat Biosci,Ctr RNA Syst Biol, San Francisco, CA 94158 USA.	jonathan.weissman@ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Alberts B, 2015, MOLECULAR BIOLOGY OF THE CELL, SIXTH EDITION, P1; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Reid DW, 2015, SCIENCE, V348, DOI 10.1126/science.aaa7257; Reid DW, 2015, NAT REV MOL CELL BIO, V16, P221, DOI 10.1038/nrm3958	4	10	10	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240								10.1126/science.aaa8299	http://dx.doi.org/10.1126/science.aaa8299			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068842				2022-12-28	WOS:000356011500040
J	Peppe, DJ; Royer, DL				Peppe, Daniel J.; Royer, Dana L.			Can climate feel the pressure?	SCIENCE			English	Editorial Material							ATMOSPHERIC OXYGEN; EVOLUTION		[Peppe, Daniel J.] Baylor Univ, Terr Paleoclimatol Res Grp, Dept Geol, Waco, TX 76706 USA; [Royer, Dana L.] Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT 06459 USA	Baylor University; Wesleyan University	Peppe, DJ (corresponding author), Baylor Univ, Terr Paleoclimatol Res Grp, Dept Geol, Waco, TX 76706 USA.	damiel_peppe@baylor.edu	Peppe, Daniel/O-5010-2019	Peppe, Daniel/0000-0003-4263-133X; Royer, Dana/0000-0003-0976-953X				Arvidson RS, 2013, CHEM GEOL, V362, P287, DOI 10.1016/j.chemgeo.2013.10.012; Berner RA, 2007, SCIENCE, V316, P557, DOI 10.1126/science.1140273; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; Glasspool IJ, 2010, NAT GEOSCI, V3, P627, DOI 10.1038/NGEO923; Greenwood DR, 2010, GEOLOGY, V38, P15, DOI 10.1130/G30218.1; Huber M, 2011, CLIM PAST, V7, P603, DOI 10.5194/cp-7-603-2011; Montanez IP, 2013, ANNU REV EARTH PL SC, V41, P629, DOI 10.1146/annurev.earth.031208.100118; Poulsen CJ, 2015, SCIENCE, V348, P1238, DOI 10.1126/science.1260670; Royer D.L., 2014, TREATISE GEOCHEMISTR, P251, DOI DOI 10.1016/B978-0-08-095975-7.01311-5; Royer DL, 2014, AM J SCI, V314, P1259, DOI 10.2475/09.2014.01; Soreghan GS, 2008, GEOLOGY, V36, P659, DOI 10.1130/G24822A.1; Tappert R, 2013, GEOCHIM COSMOCHIM AC, V121, P240, DOI 10.1016/j.gca.2013.07.011	12	2	2	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1210	1211		10.1126/science.aac5264	http://dx.doi.org/10.1126/science.aac5264			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068835				2022-12-28	WOS:000356011500031
J	Ringh, M; Rosenqvist, M; Hollenberg, J; Jonsson, M; Fredman, D; Nordberg, P; Jarnbert-Pettersson, H; Hasselqvist-Ax, I; Riva, G; Svensson, L				Ringh, Mattias; Rosenqvist, Marten; Hollenberg, Jacob; Jonsson, Martin; Fredman, David; Nordberg, Per; Jarnbert-Pettersson, Hans; Hasselqvist-Ax, Ingela; Riva, Gabriel; Svensson, Leif			Mobile-Phone Dispatch of Laypersons for CPR in Out-of-Hospital Cardiac Arrest	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOPULMONARY-RESUSCITATION; SURVIVAL; DEFIBRILLATION; SYSTEM; SCALE	BACKGROUND Cardiopulmonary resuscitation (CPR) performed by bystanders is associated with increased survival rates among persons with out-of-hospital cardiac arrest. We investigated whether rates of bystander-initiated CPR could be increased with the use of a mobile-phone positioning system that could instantly locate mobile-phone users and dispatch lay volunteers who were trained in CPR to a patient nearby with out-of-hospital cardiac arrest. METHODS We conducted a blinded, randomized, controlled trial in Stockholm from April 2012 through December 2013. A mobile-phone positioning system that was activated when ambulance, fire, and police services were dispatched was used to locate trained volunteers who were within 500 m of patients with out-of-hospital cardiac arrest; volunteers were then dispatched to the patients (the intervention group) or not dispatched to them (the control group). The primary outcome was bystander-initiated CPR before the arrival of ambulance, fire, and police services. RESULTS A total of 5989 lay volunteers who were trained in CPR were recruited initially, and overall 9828 were recruited during the study. The mobile-phone positioning system was activated in 667 out-of-hospital cardiac arrests: 46% (306 patients) in the intervention group and 54% (361 patients) in the control group. The rate of bystander-initiated CPR was 62% (188 of 305 patients) in the intervention group and 48% (172 of 360 patients) in the control group (absolute difference for intervention vs. control, 14 percentage points; 95% confidence interval, 6 to 21; P< 0.001). CONCLUSIONS A mobile-phone positioning system to dispatch lay volunteers who were trained in CPR was associated with significantly increased rates of bystander-initiated CPR among persons with out-of-hospital cardiac arrest.	[Ringh, Mattias; Hollenberg, Jacob; Jonsson, Martin; Fredman, David; Nordberg, Per; Hasselqvist-Ax, Ingela; Riva, Gabriel; Svensson, Leif] Karolinska Inst, Ctr Resuscitat Sci, Dept Med, Solna, Sweden; [Rosenqvist, Marten] Karolinska Inst, Danderyd Univ Hosp, Dept Clin Sci, Danderyd, Sweden; [Jarnbert-Pettersson, Hans] Soder Sjukhuset, Karolinska Inst, Dept Clin Sci & Educ, S-10064 Stockholm, Sweden	Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital	Svensson, L (corresponding author), Soder Sjukhuset, Ctr Resuscitat Sci, Sjukhusbacken 10, S-11883 Stockholm, Sweden.	leif.svensson@ki.se	Jonsson, Martin/AEF-9167-2022; Fredman, David/C-6139-2015	Jonsson, Martin/0000-0002-3539-8317; Riva, Gabriel/0000-0003-3038-0027; Fredman, David/0000-0002-4138-6515	Swedish Heart-Lung Foundation; Stockholm County	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County(Stockholm County Council)	Funded by the Swedish Heart-Lung Foundation and Stockholm County; ClinicalTrials.gov number, NCT01789554.	[Anonymous], BEF BEF; Bradley SM, 2011, CURR OPIN CRIT CARE, V17, P219, DOI 10.1097/MCC.0b013e32834697d8; Chen MY, 2006, LECT NOTES COMPUT SC, V4206, P225; Dorph E, 2003, RESUSCITATION, V56, P265, DOI 10.1016/S0300-9572(02)00374-X; Drane C, 1998, IEEE COMMUN MAG, V36, P46, DOI 10.1109/35.667413; Folke F, 2010, CIRCULATION, V122, P623, DOI 10.1161/CIRCULATIONAHA.109.924423; Groeneveld PW, 2005, AM J MED, V118, P58, DOI 10.1016/j.amjmed.2004.08.014; Hasselqvist-Ax I, 2015, NEW ENGL J MED, V372, P2307, DOI 10.1056/NEJMoa1405796; Holmberg M, 1998, RESUSCITATION, V36, P29, DOI 10.1016/S0300-9572(97)00089-0; Isbye DL, 2007, CIRCULATION, V116, P1380, DOI 10.1161/CIRCULATIONAHA.107.710616; Iwami T, 2006, RESUSCITATION, V69, P221, DOI 10.1016/j.resuscitation.2005.08.018; Kuth DE, 1981, ART COMPUTER PROGRAM, V2; Merchant RM, 2013, CIRC-CARDIOVASC QUAL, V6, P229, DOI 10.1161/CIRCOUTCOMES.113.000140; Newcombe RG, 1998, STAT MED, V17, P2635, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2635::AID-SIM954>3.0.CO;2-C; Nordberg P, 2014, EUR HEART J-ACUTE CA, V3, P293, DOI 10.1177/2048872614532415; Rea TD, 2003, CIRCULATION, V107, P2780, DOI 10.1161/01.CIR.0000070950.17208.2A; Ringh M, 2011, RESUSCITATION, V82, P1514, DOI 10.1016/j.resuscitation.2011.07.033; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Valenzuela TD, 1997, CIRCULATION, V96, P3308; Waalewijn RA, 2001, RESUSCITATION, V50, P273, DOI 10.1016/S0300-9572(01)00354-9; Wissenberg M, 2013, JAMA-J AM MED ASSOC, V310, P1377, DOI 10.1001/jama.2013.278483; Yonekawa C, 2014, J TELEMED TELECARE, V20, P75, DOI 10.1177/1357633X14524152; Zijlstra JA, 2014, RESUSCITATION, V85, P1444, DOI 10.1016/j.resuscitation.2014.07.020	23	301	316	2	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2015	372	24					2316	2325		10.1056/NEJMoa1406038	http://dx.doi.org/10.1056/NEJMoa1406038			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK2DB	26061836				2022-12-28	WOS:000356019200007
J	Lam, L				Lam, Lui			From physics to revolution and back	SCIENCE			English	Editorial Material									San Jose State Univ Calif, San Jose, CA 95192 USA	California State University System; San Jose State University	Lam, L (corresponding author), San Jose State Univ Calif, San Jose, CA 95192 USA.								0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1170	1170		10.1126/science.348.6239.1170	http://dx.doi.org/10.1126/science.348.6239.1170			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045438				2022-12-28	WOS:000355590500055
J	Muir, PR; Wallace, CC; Done, T; Aguirre, JD				Muir, Paul R.; Wallace, Carden C.; Done, Terence; Aguirre, J. David			Limited scope for latitudinal extension of reef corals	SCIENCE			English	Article							RAPID CLIMATE-CHANGE; BUILDING CORALS; RANGE SHIFTS; BIODIVERSITY; OCEAN; TAXA	An analysis of present-day global depth distributions of reef-building corals and underlying environmental drivers contradicts a commonly held belief that ocean warming will promote tropical coral expansion into temperate latitudes. Using a global data set of a major group of reef corals, we found that corals were confined to shallower depths at higher latitudes (up to 0.6 meters of predicted shallowing per additional degree of latitude). Latitudinal attenuation of the most important driver of this phenomenon-the dose of photosynthetically available radiation over winter-would severely constrain latitudinal coral range extension in response to ocean warming. Latitudinal gradients in species richness for the group also suggest that higher winter irradiance at depth in low latitudes allowed a deep-water fauna that was not viable at higher latitudes.	[Muir, Paul R.; Wallace, Carden C.; Done, Terence] Museum Trop Queensland, Townsville, Qld 4810, Australia; [Done, Terence] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Aguirre, J. David] Massey Univ, Inst Nat & Math Sci, Albany, New Zealand; [Aguirre, J. David] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia	Australian Institute of Marine Science; Massey University; University of Queensland	Muir, PR (corresponding author), Museum Trop Queensland, Townsville, Qld 4810, Australia.	paul.muir@qm.qld.gov.au	Aguirre, David/I-3759-2014	Aguirre, David/0000-0001-7520-441X	Rutherford Foundation of New Zealand	Rutherford Foundation of New Zealand(Royal Society of New Zealand)	We thank the many colleagues who assisted with collection of data and specimens, W. Gregg for providing source code and advice for PAR modeling, S. Connolly and R. Dunne for assistance early in this study, M. Geraci for advice regarding analyses, and J. Doyle, M. Beger, P. Bongaerts, S. Blomberg, J. Dwyer, J. Bennett, M. Sams, N. Bruce, J. Pandolfi, R. Berkelmans, R. Kelley, L. Liggins, A. Smith, M. Pawley, and A. Kozyr for critical comments and advice. J.D.A. is supported by a Rutherford Foundation of New Zealand postdoctoral fellowship. Data access: Species occurrence records for each depth and latitude as well as the environmental surfaces are available on Dryad (https://datadryad.org/resource/doi:10.5061/dryad.3b568).	Anthony KRN, 2005, FUNCT ECOL, V19, P17, DOI 10.1111/j.0269-8463.2005.00925.x; Anthony KRN, 2003, OECOLOGIA, V134, P23, DOI 10.1007/s00442-002-1095-1; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; CAMPBELL JW, 1989, LIMNOL OCEANOGR, V34, P1490, DOI 10.4319/lo.1989.34.8.1490; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Couce E, 2012, J BIOGEOGR, V39, P1508, DOI 10.1111/j.1365-2699.2012.02706.x; Done Terry, 2011, P281; Frade PR, 2008, LIMNOL OCEANOGR, V53, P2711, DOI 10.4319/lo.2008.53.6.2711; Gattuso JP, 2006, BIOGEOSCIENCES, V3, P489, DOI 10.5194/bg-3-489-2006; Greenstein BJ, 2008, GLOBAL CHANGE BIOL, V14, P513, DOI 10.1111/j.1365-2486.2007.01506.x; Grigg R.W., 1982, Coral Reefs, V1, P29, DOI 10.1007/BF00286537; Grigg RW, 2006, CORAL REEFS, V25, P77, DOI 10.1007/s00338-005-0073-6; Guinotte JM, 2003, CORAL REEFS, V22, P551, DOI 10.1007/s00338-003-0331-4; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Keith SA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0818; Kleypas JA, 1999, AM ZOOL, V39, P146; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Stella JS, 2010, CORAL REEFS, V29, P957, DOI 10.1007/s00338-010-0648-8; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Veron J.E.N., 2000, CORALS WORLD, V1-3; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Wallace C. C., 2001, WHERE WORLDS COLLIDE, P168; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474; Yentsch CS, 2002, J EXP MAR BIOL ECOL, V268, P171, DOI 10.1016/S0022-0981(01)00379-3	30	113	113	3	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1135	1138		10.1126/science.1259911	http://dx.doi.org/10.1126/science.1259911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045436				2022-12-28	WOS:000355590500048
J	Desai, MM; Walczak, AM				Desai, Michael M.; Walczak, Aleksandra M.			Flexible gene pools	SCIENCE			English	Editorial Material							ARCHAEAL POPULATION; BACTERIAL; GENOMICS		[Desai, Michael M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Desai, Michael M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Walczak, Aleksandra M.] Ecole Normale Super, CNRS, Lab Phys Theor, F-75231 Paris 05, France	Harvard University; Harvard University; Centre National de la Recherche Scientifique (CNRS)	Desai, MM (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	awalczak@lpt.ens.fr		Desai, Michael/0000-0002-9581-1150				Allen EE, 2007, P NATL ACAD SCI USA, V104, P1883, DOI 10.1073/pnas.0604851104; Cadillo-Quiroz H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001265; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cordero OX, 2014, NAT REV MICROBIOL, V12, P263, DOI 10.1038/nrmicro3218; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Rosen MJ, 2015, SCIENCE, V348, P1019, DOI 10.1126/science.aaa4456; Rosen MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-283; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198	9	0	0	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					977	978		10.1126/science.aab3957	http://dx.doi.org/10.1126/science.aab3957			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	26023126				2022-12-28	WOS:000355276600028
J	Qin, XC; Suga, M; Kuang, TY; Shen, JR				Qin, Xiaochun; Suga, Michihiro; Kuang, Tingyun; Shen, Jian-Ren			Structural basis for energy transfer pathways in the plant PSI-LHCI supercomplex	SCIENCE			English	Article							LIGHT-HARVESTING COMPLEX; PHOTOSYSTEM-I; ANGSTROM RESOLUTION; ARABIDOPSIS-THALIANA; ZEAXANTHIN FORMATION; XANTHOPHYLL CYCLE; CRYSTAL-STRUCTURE; ANTENNA SYSTEM; PROTEINS; SUBUNIT	Photosynthesis converts solar energy to chemical energy by means of two large pigment-protein complexes: photosystem I (PSI) and photosystem II (PSII). In higher plants, the PSI core is surrounded by a large light-harvesting complex I (LHCI) that captures sunlight and transfers the excitation energy to the core with extremely high efficiency. We report the structure of PSI-LHCI, a 600-kilodalton membrane protein supercomplex, from Pisum sativum (pea) at a resolution of 2.8 angstroms. The structure reveals the detailed arrangement of pigments and other cofactors-especially within LHCI-as well as numerous specific interactions between the PSI core and LHCI. These results provide a firm structural basis for our understanding on the energy transfer and photoprotection mechanisms within the PSI-LHCI supercomplex.	[Qin, Xiaochun; Kuang, Tingyun; Shen, Jian-Ren] Chinese Acad Sci, Inst Bot, Photosynth Res Ctr, Key Lab Photobiol, Beijing 100093, Peoples R China; [Qin, Xiaochun; Suga, Michihiro; Shen, Jian-Ren] Okayama Univ, Grad Sch Nat Sci & Technol, Photosynth Res Ctr, Okayama 7008530, Japan	Chinese Academy of Sciences; Institute of Botany, CAS; Okayama University	Kuang, TY (corresponding author), Chinese Acad Sci, Inst Bot, Photosynth Res Ctr, Key Lab Photobiol, Beijing 100093, Peoples R China.	kuangty@ibcas.ac.cn; shen@cc.okayama-u.ac.jp	Shen, Jian-Ren/B-2558-2011	Qin, Xiaochun/0000-0001-6211-6840	National Basic Research Program of China [2011CBA00901, 2015CB150101]; Chinese Academy of Sciences [KGZD-EW-T05]; JSPS KAKENHI from MEXT, Japan [24000018, 26840023]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); JSPS KAKENHI from MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank C. Lu, W. Wang, and G. Han for discussions and help during sample preparation and K. Wang and C. Yang for HPLC analysis. X-ray data were collected at beamlines BL41XU and BL44XU of SPring-8, Japan, and we thank the staff members of these beamlines for their extensive support. This work was supported by National Basic Research Program of China grants 2011CBA00901 and 2015CB150101, Chinese Academy of Sciences grant KGZD-EW-T05, and JSPS KAKENHI grants 24000018 (J.-R.S.) and 26840023 (M.S.) from MEXT, Japan. The atomic coordinates have been deposited in the Protein Data Bank with accession code 4XK8. Author contributions: T.K. and J.-R.S. conceived the project; X.Q. prepared the sample and made the crystals; M.S. and X.Q. conducted the diffraction experiments; M.S. analyzed the structure; X.Q., M.S., and J.-R.S. wrote the manuscript; and all authors discussed and commented on the results and the manuscript.	Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Ballottari M, 2014, P NATL ACAD SCI USA, V111, pE2431, DOI 10.1073/pnas.1404377111; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Castelletti S, 2003, BIOCHEMISTRY-US, V42, P4226, DOI 10.1021/bi027398r; Croce R, 2002, BBA-BIOENERGETICS, V1556, P29, DOI 10.1016/S0005-2728(02)00304-3; Croce R, 2013, PHOTOSYNTH RES, V116, P153, DOI 10.1007/s11120-013-9838-x; DEMMIG B, 1987, PLANT PHYSIOL, V84, P218, DOI 10.1104/pp.84.2.218; Fiedor L, 2008, BBA-BIOENERGETICS, V1777, P1491, DOI 10.1016/j.bbabio.2008.09.005; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Gobets B, 2001, BBA-BIOENERGETICS, V1507, P80, DOI 10.1016/S0005-2728(01)00203-1; HE WZ, 1992, FEBS LETT, V308, P298, DOI 10.1016/0014-5793(92)81297-Y; Jansson S, 1996, PLANT PHYSIOL, V112, P409, DOI 10.1104/pp.112.1.409; Jensen PE, 2004, J BIOL CHEM, V279, P24212, DOI 10.1074/jbc.M403147200; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; KJAERULFF S, 1993, J BIOL CHEM, V268, P18912; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; KUANG TY, 1984, ARCH BIOCHEM BIOPHYS, V235, P618, DOI 10.1016/0003-9861(84)90236-4; LAM E, 1984, FEBS LETT, V168, P10, DOI 10.1016/0014-5793(84)80197-0; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Morosinotto T, 2005, J BIOL CHEM, V280, P31050, DOI 10.1074/jbc.M502935200; Morosinotto T, 2005, J BIOL CHEM, V280, P20612, DOI 10.1074/jbc.M500705200; Morosinotto T, 2003, PHYSIOL PLANTARUM, V119, P347, DOI 10.1034/j.1399-3054.2003.00213.x; Morosinotto T, 2003, J BIOL CHEM, V278, P49223, DOI 10.1074/jbc.M309203200; Mozzo M, 2008, BBA-BIOENERGETICS, V1777, P1263, DOI 10.1016/j.bbabio.2008.04.036; Naver H, 1999, J BIOL CHEM, V274, P10784, DOI 10.1074/jbc.274.16.10784; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nelson N, 2009, J NANOSCI NANOTECHNO, V9, P1709, DOI [10.1166/jnn.2009.S101, 10.1166/jnn.2009.SI01]; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Pan XW, 2011, NAT STRUCT MOL BIOL, V18, P309, DOI 10.1038/nsmb.2008; Qin XC, 2006, PHOTOSYNTH RES, V90, P195, DOI 10.1007/s11120-006-9104-6; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Schmid VHR, 2002, J BIOL CHEM, V277, P37307, DOI 10.1074/jbc.M205889200; Scholes GD, 2011, NAT CHEM, V3, P763, DOI [10.1038/NCHEM.1145, 10.1038/nchem.1145]; Wehner A, 2004, J BIOL CHEM, V279, P26823, DOI 10.1074/jbc.M402399200; Wientjes E, 2011, BIOCHEM J, V433, P477, DOI 10.1042/BJ20101538	37	273	292	20	293	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					989	995		10.1126/science.aab0214	http://dx.doi.org/10.1126/science.aab0214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	26023133				2022-12-28	WOS:000355276600038
J	Blessberger, H; Kammler, J; Steinwender, C				Blessberger, Hermann; Kammler, Juergen; Steinwender, Clemens			Perioperative Use of beta-Blockers in Cardiac and Noncardiac Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								CLINICAL QUESTION Are beta-blockers associated with lower rates of mortality and morbidity after cardiac or noncardiac surgery? BOTTOM LINE In cardiac surgery, beta-blockers are associated with a lower incidence of supraventricular tachycardias (SVTs) and ventricular arrhythmias. In noncardiac surgery, beta-blockers are associated with a possible increase in mortality and strokes, a lower incidence of acute myocardial infarctions (AMIs) and SVTs, and an increase in bradycardia and hypotension. If tolerated, long-term beta-blocker treatment should be continued perioperatively, whereas the decision to start a beta-blocker should be individualized, weighing risks and benefits.	[Blessberger, Hermann; Kammler, Juergen; Steinwender, Clemens] Johannes Kepler Univ Linz, Sch Med, Linz Gen Hosp, Dept Internal Med Cardiol 1, A-4020 Linz, Austria	Johannes Kepler University Linz; Kepler University Hospital	Blessberger, H (corresponding author), Johannes Kepler Univ Linz, Sch Med, Linz Gen Hosp, Dept Internal Med Cardiol 1, Krankenhausstr 9, A-4020 Linz, Austria.	hermann.blessberger@akh.linz.at						Blessberger H, 2014, COCHRANE DB SYST REV, V9; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Fleisher LA, 2014, CIRCULATION, V130, pE278, DOI 10.1161/CIR.0000000000000106; Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e; Kristensen SD, 2014, EUR HEART J, V35, P2383, DOI 10.1093/eurheartj/ehu282	5	10	12	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2015	313	20					2070	2071		10.1001/jama.2015.1883	http://dx.doi.org/10.1001/jama.2015.1883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0DC	26010637				2022-12-28	WOS:000355142400022
J	Ren, B; Dixon, JR				Ren, Bing; Dixon, Jesse R.			A CRISPR Connection between Chromatin Topology and Genetic Disorders	CELL			English	Editorial Material							GENOME; DOMAINS; CTCF	Structural variations are common in the human genome, but their contributions to human diseases have been hard to define. Lupianez et al. demonstrate that some structural variants can interrupt chromatin topology, resulting in ectopic enhancer-promoter interactions, altered spatiotemporal gene expression patterns, and developmental disorders.	[Ren, Bing; Dixon, Jesse R.] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Ren, B (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	biren@ucsd.edu	Dixon, Jesse/AAT-2914-2020; Visel, Axel/A-9398-2009	Dixon, Jesse/0000-0002-6273-2181; Visel, Axel/0000-0002-4130-7784	NHGRI NIH HHS [U54 HG006997] Funding Source: Medline; NIGMS NIH HHS [T32 GM007198] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Geetha-Loganathan P, 2005, DEV BIOL, V288, P221, DOI 10.1016/j.ydbio.2005.09.035; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Sexton T, 2015, CELL, V160, P1049, DOI 10.1016/j.cell.2015.02.040; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Yang Y, 1998, DEVELOPMENT, V125, P3123	9	5	5	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					955	957		10.1016/j.cell.2015.04.047	http://dx.doi.org/10.1016/j.cell.2015.04.047			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000472	Green Accepted, Bronze			2022-12-28	WOS:000355152600001
J	Weinberger, AD; Gilmore, MS				Weinberger, Ariel D.; Gilmore, Michael S.			A CRISPR View of Cleavage	CELL			English	Editorial Material							RNA CLEAVAGE; SYSTEM	Seminal studies showed that CRISPR-Cas systems provide adaptive immunity in prokaryotes and promising gene-editing tools from bacteria to humans. Yet, reports diverged on whether some CRISPR systems naturally target DNA or RNA. Here, Samai and colleagues unify the studies, showing that a single type III CRISPR-Cas system cleaves both DNA and RNA targets, independently.	[Weinberger, Ariel D.] Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Gilmore, Michael S.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Gilmore, Michael S.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School	Weinberger, AD (corresponding author), Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	ariel.weinberger@wyss.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI102520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM106337] Funding Source: NIH RePORTER; NIAID NIH HHS [F32AI102520] Funding Source: Medline; NIGMS NIH HHS [GM106337] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2014, J BACTERIOL, V196, P310, DOI 10.1128/JB.01130-13; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Weinberger AD, 2012, MBIO, V3, DOI 10.1128/mBio.00456-12	9	2	2	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					964	966		10.1016/j.cell.2015.05.003	http://dx.doi.org/10.1016/j.cell.2015.05.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000476	Bronze			2022-12-28	WOS:000355152600005
J	Martinez-Cabriales, S; Ocampo-Garza, J; Barbosa-Moreno, L; Chavez-Alvarez, S; Ocampo-Candiani, J				Martinez-Cabriales, Sylvia; Ocampo-Garza, Jorge; Barbosa-Moreno, Laura; Chavez-Alvarez, Sonia; Ocampo-Candiani, Jorge			Purpura fulminans 10 years after contaminated cocaine use	LANCET			English	Editorial Material									[Martinez-Cabriales, Sylvia; Ocampo-Garza, Jorge; Barbosa-Moreno, Laura; Chavez-Alvarez, Sonia; Ocampo-Candiani, Jorge] Univ Hosp, Dept Dermatol, Monterrey, Mexico	Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon	Ocampo-Candiani, J (corresponding author), Univ Hosp, Dept Dermatol, Dr Jose Eleuterio Gonzalez, Monterrey, Mexico.	jocampo2000@yahoo.com.mx	Chavez-Alvarez, Sonia/AAD-5927-2019; Ocampo-Candiani, Jorge/B-6853-2015	Chavez-Alvarez, Sonia/0000-0003-1637-7956; Ocampo-Candiani, Jorge/0000-0002-0213-0031					0	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2015	386	10004					E21	E21		10.1016/S0140-6736(15)60069-1	http://dx.doi.org/10.1016/S0140-6736(15)60069-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0HS	26028121	Bronze			2022-12-28	WOS:000363197500001
J	Maskell, DP; Renault, L; Serrao, E; Lesbats, P; Matadeen, R; Hare, S; Lindemann, D; Engelman, AN; Costa, A; Cherepanov, P				Maskell, Daniel P.; Renault, Ludovic; Serrao, Erik; Lesbats, Paul; Matadeen, Rishi; Hare, Stephen; Lindemann, Dirk; Engelman, Alan N.; Costa, Alessandro; Cherepanov, Peter			Structural basis for retroviral integration into nucleosomes	NATURE			English	Article							CRYSTAL-STRUCTURE; VIRUS INTEGRASE; CORE PARTICLE; SEQUENCE; SITES; SUITE; DETERMINANTS; INHIBITION; REVEALS; BINDING	Retroviral integration is catalysed by a tetramer of integrase (IN) assembled on viral DNA ends in a stable complex, known as the intasome(1,2). How the intasome interfaces with chromosomal DNA, which exists in the form of nucleosomal arrays, is currently unknown. Here we show that the prototype foamy virus (PFV) intasome is proficient at stable capture of nucleosomes as targets for integration. Single-particle cryo-electron microscopy reveals a multivalent intasome-nucleosome interface involving both gyres of nucleosomal DNA and one H2A-H2B heterodimer. While the histone octamer remains intact, the DNA is lifted from the surface of the H2A-H2B heterodimer to allow integration at strongly preferred superhelix location +/- 3.5 positions. Amino acid substitutions disrupting these contacts impinge on the ability of the intasome to engage nucleosomes in vitro and redistribute viral integration sites on the genomic scale. Our findings elucidate the molecular basis for nucleosome capture by the viral DNA recombination machinery and the underlying nucleosome plasticity that allows integration.	[Maskell, Daniel P.; Lesbats, Paul; Cherepanov, Peter] Francis Crick Inst, Chromatin Struct & Mobile DNA, S Mimms EN6 3LD, Herts, England; [Renault, Ludovic; Costa, Alessandro] Francis Crick Inst, Clare Hall Labs, Architecture & Dynam Macromol Machines, S Mimms EN6 3LD, Herts, England; [Renault, Ludovic] Natl Inst Biol Stand & Control Microscopy & Imagi, S Mimms EN6 3QG, Herts, England; [Serrao, Erik; Engelman, Alan N.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; [Matadeen, Rishi] Gorlaeus Lab, NeCEN, NL-2333 Leiden, Netherlands; [Hare, Stephen; Cherepanov, Peter] Univ London Imperial Coll Sci Technol & Med, Div Med, London W2 1PG, England; [Lindemann, Dirk] Tech Univ Dresden, Inst Virol, D-01307 Dresden, Germany	National Institute for Biological Standards & Control; Harvard University; Dana-Farber Cancer Institute; Imperial College London; Technische Universitat Dresden	Costa, A (corresponding author), Francis Crick Inst, Clare Hall Labs, Architecture & Dynam Macromol Machines, Blanche Lane, S Mimms EN6 3LD, Herts, England.	alessandro.costa@crick.ac.uk; peter.cherepanov@crick.ac.uk	Cherepanov, Peter P/F-6859-2010; Lindemann, Dirk/H-5857-2013	Cherepanov, Peter P/0000-0002-0634-538X; Lindemann, Dirk/0000-0002-0320-4223; Renault, Ludovic/0000-0001-6464-8808; Hare, Stephen/0000-0003-2951-1595	European Union [305137]; US National Institute of General Medical Sciences [GM082251-06]; US National Institutes of Health [AI070042-08]; Netherlands Centre for Electron Nanoscopy (NeCEN); Nederlandse Organisatie voor Wetenschappelijk Onderzoek [175.010.2009.001]; European Union's Regional Development Fund through 'Kansen voor West' [21Z.014]; Cancer Research UK [15272, 19342, 15852] Funding Source: researchfish; The Francis Crick Institute [10063, 10065, 10061] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	European Union(European Commission); US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Centre for Electron Nanoscopy (NeCEN); Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); European Union's Regional Development Fund through 'Kansen voor West'; Cancer Research UK(Cancer Research UK); The Francis Crick Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the European Union FP7 HIVINNOV consortium grant 305137 (to P.C.), the US National Institute of General Medical Sciences P50 grant GM082251-06 (to P.C.) and the US National Institutes of Health R01 grant AI070042-08 (to A.N.E.). Data collection was in part funded by the Netherlands Centre for Electron Nanoscopy (NeCEN) by grants from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (project 175.010.2009.001) and by the European Union's Regional Development Fund through 'Kansen voor West' (project 21Z.014). We would like to thank L. Collinson, R. Carzaniga and Kirsty MacLellan-Gibson for EM access, R. Horton-Harpin for provision of HeLa cell pellets and assistance with tissue culture. We also thank F. Santoni, N. Sweeny and all our colleagues for helpful discussions.	Baller JA, 2012, GENOME RES, V22, P704, DOI 10.1101/gr.129585.111; Chatterjee AG, 2014, NUCLEIC ACIDS RES, V42, P8449, DOI 10.1093/nar/gku534; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Deyle DR, 2014, NAT STRUCT MOL BIOL, V21, P969, DOI 10.1038/nsmb.2895; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Gupta K, 2012, STRUCTURE, V20, P1918, DOI 10.1016/j.str.2012.08.023; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Heinkelein M, 2002, J VIROL, V76, P3774, DOI 10.1128/JVI.76.8.3774-3783.2002; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Matreyek KA, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0090-z; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Montano SP, 2012, NATURE, V491, P413, DOI 10.1038/nature11602; Mullers E, 2011, J VIROL, V85, P1452, DOI 10.1128/JVI.01731-10; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; Nowrouzi A, 2006, J GEN VIROL, V87, P1339, DOI 10.1099/vir.0.81554-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRUSS D, 1994, P NATL ACAD SCI USA, V91, P5913, DOI 10.1073/pnas.91.13.5913; PRYCIAK PM, 1992, EMBO J, V11, P291, DOI 10.1002/j.1460-2075.1992.tb05052.x; PRYCIAK PM, 1992, CELL, V69, P769, DOI 10.1016/0092-8674(92)90289-O; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Roth SL, 2011, J VIROL, V85, P7393, DOI 10.1128/JVI.00635-11; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schnitzler G R, 2001, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2105s50; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Shaytan AK, 2015, CURR OPIN STRUC BIOL, V32, P48, DOI 10.1016/j.sbi.2015.02.004; Stange A, 2008, J VIROL, V82, P9858, DOI 10.1128/JVI.00949-08; Stirnnagel K, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-71; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Trobridge GD, 2006, P NATL ACAD SCI USA, V103, P1498, DOI 10.1073/pnas.0510046103; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Yin ZQ, 2012, PROTEIN SCI, V21, P1849, DOI 10.1002/pro.2166	49	105	107	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 16	2015	523	7560					366	+		10.1038/nature14495	http://dx.doi.org/10.1038/nature14495			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM8KY	26061770	Green Accepted, Green Submitted			2022-12-28	WOS:000357950900046
J	Pommier, A; Leinenweber, K; Kohlstedt, DL; Qi, C; Garnero, EJ; Mackwell, SJ; Tyburczy, JA				Pommier, Anne; Leinenweber, Kurt; Kohlstedt, David L.; Qi, Chao; Garnero, Edward J.; Mackwell, Stephen J.; Tyburczy, James A.			Experimental constraints on the electrical anisotropy of the lithosphere-asthenosphere system	NATURE			English	Article							MELT SEGREGATION; SURFACE-TENSION; CONDUCTIVITY; OLIVINE; MANTLE; BOUNDARY; DRIVEN; STRESS; FLOW; PERIDOTITE	The relative motion of lithospheric plates and underlying mantle produces localized deformation near the lithosphere-asthenosphere boundary(1). The transition from rheologically stronger lithosphere to weaker asthenosphere may result from a small amount of melt or water in the asthenosphere, reducing viscosity(1-3). Either possibility may explain the seismic and electrical anomalies that extend to a depth of about 200 kilometres(4,5). However, the effect of melt on the physical properties of deformed materials at upper-mantle conditions remains poorly constrained(6). Here we present electrical anisotropy measurements at high temperatures and quasi-hydrostatic pressures of about three gigapascals on previously deformed olivine aggregates and sheared partially molten rocks. For all samples, electrical conductivity is highest when parallel to the direction of prior deformation. The conductivity of highly sheared olivine samples is ten times greater in the shear direction than for undeformed samples. At temperatures above 900 degrees Celsius, a deformed solid matrix with nearly isotropic melt distribution has an electrical anisotropy factor less than five. To obtain higher electrical anisotropy (up to a factor of 100), we propose an experimentally based model in which layers of sheared olivine are alternated with layers of sheared olivine plus MORB or of pure melt. Conductivities are up to 100 times greater in the shear direction than when perpendicular to the shear direction and reproduce stress-driven alignment of the melt. Our experimental results and the model reproduce mantle conductivity-depth profiles for melt-bearing geological contexts. The field data are best fitted by an electrically anisotropic asthenosphere overlain by an isotropic, high-conductivity lower most lithosphere. The high conductivity could arise from partial melting associated with localized deformation resulting from differential plate velocities relative to the mantle, with subsequent upward melt percolation from the asthenosphere.	[Pommier, Anne] Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA; [Pommier, Anne; Garnero, Edward J.; Tyburczy, James A.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Leinenweber, Kurt] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Kohlstedt, David L.; Qi, Chao] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA; [Mackwell, Stephen J.] Univ Space Res Assoc, Lunar & Planetary Inst, Houston, TX 77058 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Minnesota System; University of Minnesota Twin Cities; Universities Space Research Association (USRA)	Pommier, A (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA.	pommier@ucsd.edu	; Mackwell, Stephen/H-2772-2013	Qi, Chao/0000-0001-7449-0434; Mackwell, Stephen/0000-0002-0996-1348	NSF through Cooperative Studies of the Earth's Deep Interior (CSEDI) [1461594, 1265395, 1265428]; COMPRES (the Consortium for Materials Properties Research in Earth Sciences) under National Science Foundation (NSF) [EAR 11-57758]; Division Of Earth Sciences [1265428] Funding Source: National Science Foundation	NSF through Cooperative Studies of the Earth's Deep Interior (CSEDI)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); COMPRES (the Consortium for Materials Properties Research in Earth Sciences) under National Science Foundation (NSF); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work benefited from funding by the NSF through Cooperative Studies of the Earth's Deep Interior (CSEDI) projects number 1461594 to the University of California San Diego, number 1265395 to Arizona State University, and number 1265428 to the University of Minnesota. This research was partially supported by COMPRES (the Consortium for Materials Properties Research in Earth Sciences) under National Science Foundation (NSF) Cooperative Agreement EAR 11-57758 (cell assembly development project). We thank A. von der Handt (University of Minnesota) and H. Cathey (Arizona State University) for their assistance with the electron microprobe and scanning electron microscope imaging, respectively. A.P. appreciates help with calibration experiments from staff and scientists at Bayerisches GeoInstitut (BGI). This paper is Lunar and Planetary Institute (LPI) contribution number 1840.	Baba K, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003598; Caricchi L, 2011, EARTH PLANET SC LETT, V302, P81, DOI 10.1016/j.epsl.2010.11.041; Constable S, 2006, GEOPHYS J INT, V166, P435, DOI 10.1111/j.1365-246X.2006.03041.x; Dai LD, 2010, MINERAL MAG, V74, P849, DOI 10.1180/minmag.2010.074.5.849; Evans RL, 2014, EARTH PLANET SC LETT, V402, P265, DOI 10.1016/j.epsl.2013.04.021; Havlin C, 2013, EARTH PLANET SC LETT, V376, P20, DOI 10.1016/j.epsl.2013.06.010; Hirschmann MM, 2010, PHYS EARTH PLANET IN, V179, P60, DOI 10.1016/j.pepi.2009.12.003; Hoink T, 2012, GEOPHYS J INT, V191, P30, DOI 10.1111/j.1365-246X.2012.05621.x; Holtzman BK, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003296; Holtzman BK, 2003, SCIENCE, V301, P1227, DOI 10.1126/science.1087132; Jung H, 2006, TECTONOPHYSICS, V421, P1, DOI 10.1016/j.tecto.2006.02.011; Karato SI, 2012, EARTH PLANET SC LETT, V321, P95, DOI 10.1016/j.epsl.2012.01.001; Kawakatsu H, 2009, SCIENCE, V324, P499, DOI 10.1126/science.1169499; King DSH, 2011, EARTH PLANET SC LETT, V307, P349, DOI 10.1016/j.epsl.2011.05.009; King DSH, 2010, J PETROL, V51, P21, DOI 10.1093/petrology/egp062; Kohlstedt DL, 1996, ANNU REV EARTH PL SC, V24, P41, DOI 10.1146/annurev.earth.24.1.41; Marti A, 2014, SURV GEOPHYS, V35, P179, DOI 10.1007/s10712-013-9233-3; Matsuno T, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003101; Naif S, 2013, NATURE, V495, P356, DOI 10.1038/nature11939; Ni HW, 2011, CONTRIB MINERAL PETR, V162, P637, DOI 10.1007/s00410-011-0617-4; Ni HW, 2011, CONTRIB MINERAL PETR, V162, P501, DOI 10.1007/s00410-011-0608-5; Parsons RA, 2008, EARTH PLANET SC LETT, V267, P548, DOI 10.1016/j.epsl.2007.11.064; Poe BT, 2010, PHYS EARTH PLANET IN, V181, P103, DOI 10.1016/j.pepi.2010.05.003; Pommier A, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005269; Reynard B, 2011, EARTH PLANET SC LETT, V307, P387, DOI 10.1016/j.epsl.2011.05.013; Roberts JJ, 1999, J GEOPHYS RES-SOL EA, V104, P7055, DOI 10.1029/1998JB900111; Sakamaki T, 2013, NAT GEOSCI, V6, P1041, DOI [10.1038/NGEO1982, 10.1038/ngeo1982]; Stagno V, 2010, EARTH PLANET SC LETT, V300, P72, DOI 10.1016/j.epsl.2010.09.038; Tasaka M., EARTH PLANE IN PRESS; Xu YS, 2000, PHYS EARTH PLANET IN, V118, P149, DOI 10.1016/S0031-9201(99)00135-1; YOSHINO T, 2012, EARTH PLANET SC LETT, V194, P1; Yoshino T, 2006, NATURE, V443, P973, DOI 10.1038/nature05223; Yoshino T, 2010, EARTH PLANET SC LETT, V295, P593, DOI 10.1016/j.epsl.2010.04.050; Zhang BH, 2014, EARTH PLANET SC LETT, V405, P98, DOI 10.1016/j.epsl.2014.08.018	34	45	52	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					202	+		10.1038/nature14502	http://dx.doi.org/10.1038/nature14502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	26062512				2022-12-28	WOS:000356016700036
J	Auerbach, PS				Auerbach, Paul S.			Preparedness explains some differences between Haiti and Nepal's response to earthquake	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Stanford Univ, Div Emergency Med, Surg, Stanford, CA 94305 USA	Stanford University	Auerbach, PS (corresponding author), Stanford Univ, Div Emergency Med, Surg, Stanford, CA 94305 USA.	auerbach@stanford.edu						Auerbach P., 2015, NEPAL AMBULANCE 0508; Chipp J., 2012, DOMINION POST   0921; Earthquake Country Alliance, PROT YOURS EARTHQ; Office for Coordination of Humanitarian Affairs, 2015, NEP EARTHQ 2015 SIT; Sanderson D, 2012, RESPONDING URBAN DIS; Showstack R., 2015, EOS T AM GEOPHYS UN, P96, DOI [10.1029/2015EO029415, DOI 10.1029/2015EO029415]; Venugopal R, 2012, WILDERNESS MED, P1747; Walker R, 2014, WILD ENVIRON MED, V25, P311, DOI 10.1016/j.wem.2014.04.006; Wellcome Trust, 2015, EARTH SHOOK VIEW PAT	9	7	7	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 5	2015	350								h3059	10.1136/bmj.h3059	http://dx.doi.org/10.1136/bmj.h3059			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK0UI	26047830				2022-12-28	WOS:000355920200004
J	Matsubara, M; Manz, S; Mochizuki, M; Kubacka, T; Iyama, A; Aliouane, N; Kimura, T; Johnson, SL; Meier, D; Fiebig, M				Matsubara, Masakazu; Manz, Sebastian; Mochizuki, Masahito; Kubacka, Teresa; Iyama, Ayato; Aliouane, Nadir; Kimura, Tsuyoshi; Johnson, Steven L.; Meier, Dennis; Fiebig, Manfred			Magnetoelectric domain control in multiferroic TbMnO3	SCIENCE			English	Article							DRIVEN	The manipulation of domains by external fields in ferroic materials is of major interest for applications. In multiferroics with strongly coupled magnetic and electric order, however, the magnetoelectric coupling on the level of the domains is largely unexplored. We investigated the field-induced domain dynamics of TbMnO3 in the multiferroic ground state and across a first-order spin-flop transition. In spite of the discontinuous nature of this transition, the reorientation of the order parameters is deterministic and preserves the multiferroic domain pattern. Landau-Lifshitz-Gilbert simulations reveal that this behavior is intrinsic. Such magnetoelectric correlations in spin-driven ferroelectrics may lead to domain wall-based nanoelectronics devices.	[Matsubara, Masakazu; Manz, Sebastian; Meier, Dennis; Fiebig, Manfred] ETH, Dept Mat, CH-8093 Zurich, Switzerland; [Matsubara, Masakazu] Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan; [Mochizuki, Masahito] Aoyama Gakuin Univ, Dept Phys & Math, Sagamihara, Kanagawa 2298558, Japan; [Mochizuki, Masahito] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kubacka, Teresa; Johnson, Steven L.] ETH, Dept Phys, CH-8093 Zurich, Switzerland; [Iyama, Ayato; Kimura, Tsuyoshi] Osaka Univ, Grad Sch Engn Sci, Div Mat Phys, Toyonaka, Osaka 5608531, Japan; [Aliouane, Nadir] Paul Scherrer Inst, Lab Neutron Scattering & Imaging, CH-5232 Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Tohoku University; Aoyama Gakuin University; Japan Science & Technology Agency (JST); Swiss Federal Institutes of Technology Domain; ETH Zurich; Osaka University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Matsubara, M (corresponding author), ETH, Dept Mat, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland.	m-matsubara@m.tohoku.ac.jp; sebastian.manz@mat.ethz.ch	Mochizuki, Masahito M/E-9173-2012; Meier, Dennis/GXZ-6216-2022; Johnson, Steven Lee/B-3252-2008; Kimura, Tsuyoshi/F-8090-2018	Meier, Dennis/0000-0002-8623-6705; Johnson, Steven Lee/0000-0001-6074-4894; Kubacka, Teresa/0000-0002-0968-1311	Swiss National Science Foundation (SNSF) [200021_147080/1, 200021_144115]; NCCR Molecular Ultrafast Science and Technology (NCCR MUST) of the SNSF; Japan Society for the Promotion of Science (JSPS KAKENHI), MEXT, Japan [24244058, 25870169, 25287088]; JSPS KAKENHI [25870169, 25287088]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); NCCR Molecular Ultrafast Science and Technology (NCCR MUST) of the SNSF; Japan Society for the Promotion of Science (JSPS KAKENHI), MEXT, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Trassin and T. Arima for fruitful discussions. This work was supported by the Swiss National Science Foundation (SNSF) (grant nos. 200021_147080/1 and 200021_144115), the NCCR Molecular Ultrafast Science and Technology (NCCR MUST) research instrument of the SNSF, and Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science (JSPS KAKENHI) (grant nos. 24244058, 25870169, and 25287088), MEXT, Japan. M.Mo. was supported by JSPS KAKENHI (grant nos. 25870169 and 25287088).	Abe N, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.060403; Abe N, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.020402; Abe N, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.227206; Aliouane N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.207205; Aoyama T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5927; Denev SA, 2011, J AM CERAM SOC, V94, P2699, DOI 10.1111/j.1551-2916.2011.04740.x; Fiebig M, 2005, J OPT SOC AM B, V22, P96, DOI 10.1364/JOSAB.22.000096; Fina I, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.257601; Hoffmann T, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.184404; Kagawa F, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.054413; Kagawa F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.057604; Katsura H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.057205; Kenzelmann M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.087206; Kimura T, 2008, NAT MATER, V7, P291, DOI 10.1038/nmat2125; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Kimura T, 2012, ANNU REV CONDEN MA P, V3, P93, DOI 10.1146/annurev-conmatphys-020911-125101; Kolmogorov A.N., 1937, B ACAD SCI USSR MATH, V1, P355; Kubacka T, 2014, SCIENCE, V343, P1333, DOI 10.1126/science.1242862; Lorenz Bernd, 2013, ISRN Condensed Matter Physics, DOI 10.1155/2013/497073; Meier D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.107202; Meier D, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/4/100; Mochizuki M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.144409; Mochizuki M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.187601; Mochizuki M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.147202; Mostovoy M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.067601; Murakawa H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.197207; Noda K, 2006, J APPL PHYS, V99, DOI 10.1063/1.2177207; Picozzi S, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/30/303201; Rocquefelte X, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3511; Schierle E, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.167207; Sedff D, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.174419; Tagantsev AK, 2010, DOMAINS IN FERROIC CRYSTALS AND THIN FILMS, P1, DOI 10.1007/978-1-4419-1417-0; Toledano P, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.094416; Walker HC, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.214415	34	86	87	4	311	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1112	1115		10.1126/science.1260561	http://dx.doi.org/10.1126/science.1260561			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045431				2022-12-28	WOS:000355590500041
J	Bianchi, DW				Bianchi, Diana W.			Prepare for unexpected prenatal test results	NATURE			English	Editorial Material							ANEUPLOIDY		[Bianchi, Diana W.] Tufts Univ Sch Med, Mother Infant Res Inst, Tufts Med Ctr, Boston, MA 02111 USA; [Bianchi, Diana W.] Tufts Univ Sch Med, Paediat Obstet & Gynaecol, Boston, MA USA	Tufts Medical Center; Tufts University; Tufts University	Bianchi, DW (corresponding author), Tufts Univ Sch Med, Mother Infant Res Inst, Tufts Med Ctr, Boston, MA 02111 USA.	dbianchi@tuftsmedicalcenter.org						Allyse M, 2013, TRENDS BIOTECHNOL, V31, P439, DOI 10.1016/j.tibtech.2013.04.006; Bianchi DW, 2015, OBSTET GYNECOL, V125, P375, DOI 10.1097/AOG.0000000000000637; Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037; Bianchi DW, 2014, CLIN CHEM, V60, P78, DOI 10.1373/clinchem.2013.202663; Dar P, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.08.006; Dharajiya N, 2014, J MOL DIAGN, V16, P709; Wang YL, 2014, CLIN CHEM, V60, P251, DOI 10.1373/clinchem.2013.215145; Wapner RJ, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.041; Warsof S.L, 2015, PRENAT DIAGN	9	41	44	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					29	30		10.1038/522029a	http://dx.doi.org/10.1038/522029a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ5QP	26040879	Bronze			2022-12-28	WOS:000355543400012
J	Safdar, N; Odden, A; Abad, CL; Thapa, R; Saint, S				Safdar, Nasia; Odden, Andrew; Abad, Cybele L.; Thapa, Rameet; Saint, Sanjay			In Sight and Out of Mind	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RUBELLA VACCINATION; MEASLES; MUMPS		[Safdar, Nasia; Thapa, Rameet] Univ Wisconsin, Sch Med, William S Middleton Mem Vet Hosp, Madison, WI 53705 USA; [Safdar, Nasia; Thapa, Rameet] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Odden, Andrew; Saint, Sanjay] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Saint, Sanjay] Dept Vet Affairs Hlth Serv, Res & Dev Ctr Excellence, Ann Arbor, MI USA; [Abad, Cybele L.] Univ Philippines, Philippine Gen Hosp, Dept Med, Manila, Philippines	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan; University of the Philippines System; University of the Philippines Manila	Safdar, N (corresponding author), Univ Wisconsin, Div Infect Dis, 1685 Highland Ave, Madison, WI 53705 USA.	ns2@medicine.wisc.edu	Saint, Sanjay/AAF-5126-2019		Doximity; Jvion	Doximity; Jvion	Dr. Saint reports receiving fees for board membership from Doximity and Jvion. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1999, EPIDEMIC MODELLING I; [Anonymous], MEASL RUB HEALTHC PR; [Anonymous], RED BOOK 2012 REP CO; [Anonymous], YEARL SUMM SEL GEN C; [Anonymous], [No title captured]; Katz SL, 2004, J INFECT DIS, V189, pS43, DOI 10.1086/377696; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; McLean HQ, 2013, MMWR RECOMM REP, V62, P1; Orenstein W, 2014, NEW ENGL J MED, V371, P1661, DOI 10.1056/NEJMp1408696; Santos JI, 2004, J INFECT DIS, V189, pS243, DOI 10.1086/378520; Taylor B, 2002, BRIT MED J, V324, P393, DOI 10.1136/bmj.324.7334.393; Zipprich J, 2015, MMWR-MORBID MORTAL W, V64, P153; Zipprich J, 2014, MMWR-MORBID MORTAL W, V63, P362	13	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 4	2015	372	23					2218	2223		10.1056/NEJMcps1413402	http://dx.doi.org/10.1056/NEJMcps1413402			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK1GK	26039603				2022-12-28	WOS:000355955100009
J	Binagwaho, A; Crisp, N				Binagwaho, Agnes; Crisp, Nigel			African health leaders: claiming the future	LANCET			English	Editorial Material									[Binagwaho, Agnes] Minist Hlth, Kigali, Rwanda; [Binagwaho, Agnes] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Binagwaho, Agnes] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Crisp, Nigel] House Lords, London, England; [Crisp, Nigel] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Crisp, Nigel] London Sch Hyg & Trop Med, London WC1, England; [Crisp, Nigel] Inst Healthcare Improvement, Cambridge, MA USA	Harvard University; Harvard Medical School; Dartmouth College; Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine; Institute for Healthcare Improvement	Binagwaho, A (corresponding author), Minist Hlth, Kigali, Rwanda.	agnes_binagwaho@hms.harvard.edu		Crisp, Nigel/0000-0002-9452-095X				Binagwaho A, 2014, AFRICAN HLTH LEADERS, P235; Binagwaho A, 2014, LANCET, V384, P371, DOI 10.1016/S0140-6736(14)60574-2; Coffeng LE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002032; Crisp Nigel., 2010, TURNING WORLD UPSIDE; Ezeh A., 2015, LANCET, V385, P2141, DOI DOI 10.1016/S0140-6736(15)61010-8; Farmer PE, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f65; Omaswa F, 2014, AFRICAN HLTH LEADERS; Pereira C, 2007, BJOG-INT J OBSTET GY, V114, P1530, DOI 10.1111/j.1471-0528.2007.01489.x; Swanson RC, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0090-3; Were M, 1982, ORG MANAGEMENT COMMU	10	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2134	2135		10.1016/S0140-6736(15)60934-5	http://dx.doi.org/10.1016/S0140-6736(15)60934-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ6DG	26068251				2022-12-28	WOS:000355583000010
J	Watts, G				Watts, Geoff			Frans Stephanus Hough Obituary	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2146	2146		10.1016/S0140-6736(15)61014-5	http://dx.doi.org/10.1016/S0140-6736(15)61014-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ6DG	26068258				2022-12-28	WOS:000355583000016
J	Luu, TT; Garg, M; Kruchinin, SY; Moulet, A; Hassan, MT; Goulielmakis, E				Luu, T. T.; Garg, M.; Kruchinin, S. Yu.; Moulet, A.; Hassan, M. Th.; Goulielmakis, E.			Extreme ultraviolet high-harmonic spectroscopy of solids	NATURE			English	Article							ATTOSECOND CONTROL; GENERATION; DYNAMICS; FIELD	Extreme ultraviolet (EUV) high-harmonic radiation(1,2) emerging from laser-driven atoms, molecules or plasmas underlies powerful attosecond spectroscopy techniques(3-5) and provides insight into fundamental structural and dynamic properties of matter(6,7). The advancement of these spectroscopy techniques to study strong-field electron dynamics in condensed matter calls for the generation and manipulation of EUV radiation in bulk solids, but this capability has remained beyond the reach of optical sciences. Recent experiments(8,9) and theoretical predictions(10-12) paved the way to strong-field physics in solids by demonstrating the generation and optical control of deep ultraviolet radiation(8) in bulk semiconductors, driven by femtosecond mid-infrared fields or the coherent up-conversion of terahertz fields to multi-octave spectra in the mid-infrared and optical frequencies(9). Here we demonstrate that thin films of SiO2 exposed to intense, few-cycle to sub-cycle pulses give rise to wideband coherent EUV radiation extending in energy to about 40 electronvolts. Our study indicates the association of the emitted EUV radiation with intraband currents of multi-petahertz frequency, induced in the lowest conduction band of SiO2. To demonstrate the applicability of high-harmonic spectroscopy to solids, we exploit the EUV spectra to gain access to fine details of the energy dispersion profile of the conduction band that are as yet inaccessible by photoemission spectroscopy in wide-bandgap dielectrics. In addition, we use the EUV spectra to trace the attosecond control of the intraband electron motion induced by synthesized optical transients. Our work advances light-wave electronics(5,13-15) in condensed matter into the realm of multi-petahertz frequencies and their attosecond control, and marks the advent of solid-state EUV photonics.	[Luu, T. T.; Garg, M.; Kruchinin, S. Yu.; Moulet, A.; Hassan, M. Th.; Goulielmakis, E.] Max Planck Inst Quantum Opt, D-85748 Garching, Germany	Max Planck Society	Goulielmakis, E (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	elgo@mpq.mpg.de	Goulielmakis, Eleftherios/AAZ-1052-2020; Garg, Manish/P-7273-2016; Hassan, Mohammed TH/I-5793-2019; Goulielmakis, Eleftherios/F-1693-2011; Kruchinin, Stanislav Yu/A-1110-2013; Luu, Tran Trung/HCH-4815-2022	Garg, Manish/0000-0002-1744-7445; Hassan, Mohammed TH/0000-0002-9669-534X; Goulielmakis, Eleftherios/0000-0003-3386-0245; Kruchinin, Stanislav Yu/0000-0002-6495-3375; Luu, Tran Trung/0000-0003-3772-3379	European Research Council [Attoelectronics-258501]; Deutsche Forschungsgemeinschaft Cluster of Excellence: Munich Centre for Advanced Photonics; Max Planck Society; European Research Training Network ATTOFEL	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft Cluster of Excellence: Munich Centre for Advanced Photonics(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Training Network ATTOFEL	We thank M. Wismer for support in calculations, and A. Jain for help during experiments. This work was supported by a European Research Council grant (Attoelectronics-258501), the Deutsche Forschungsgemeinschaft Cluster of Excellence: Munich Centre for Advanced Photonics (www.munich-photonics.de), the Max Planck Society and the European Research Training Network ATTOFEL.	Baker S, 2006, SCIENCE, V312, P424, DOI 10.1126/science.1123904; Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; Cabasse A, 2012, OPT LETT, V37, P4618, DOI 10.1364/OL.37.004618; CHELIKOWSKY JR, 1977, PHYS REV B, V15, P4020, DOI 10.1103/PhysRevB.15.4020; Corkum PB, 2007, NAT PHYS, V3, P381, DOI 10.1038/nphys620; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Damascelli A, 2004, PHYS SCRIPTA, VT109, P61, DOI 10.1238/Physica.Topical.109a00061; Feise MW, 1999, APPL PHYS LETT, V75, P3536, DOI 10.1063/1.125380; FERRAY M, 1988, J PHYS B-AT MOL OPT, V21, pL31, DOI 10.1088/0953-4075/21/3/001; Ghimire S, 2011, NAT PHYS, V7, P138, DOI 10.1038/NPHYS1847; Golde D, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075330; Goulielmakis E, 2007, SCIENCE, V317, P769, DOI 10.1126/science.1142855; Hassan MT, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4758310; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; KELDYSH LV, 1965, SOV PHYS JETP-USSR, V20, P1307; Kruger M, 2011, NATURE, V475, P78, DOI 10.1038/nature10196; Levenson M. D., 1988, INTRO NONLINEAR LASE; LHUILLIER A, 1993, PHYS REV LETT, V70, P774, DOI 10.1103/PhysRevLett.70.774; Mucke OD, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.081202; Remetter T, 2006, NAT PHYS, V2, P323, DOI 10.1038/nphys290; Schiffrin A, 2013, NATURE, V493, P70, DOI 10.1038/nature11567; Schubert O, 2014, NAT PHOTONICS, V8, P119, DOI [10.1038/NPHOTON.2013.349, 10.1038/nphoton.2013.349]; Schultze M, 2013, NATURE, V493, P75, DOI 10.1038/nature11720; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; WASCHKE C, 1993, PHYS REV LETT, V70, P3319, DOI 10.1103/PhysRevLett.70.3319; Wegener M., 2005, ADV TEXTS PHYS; Wirth A, 2011, SCIENCE, V334, P195, DOI 10.1126/science.1210268; Worner HJ, 2010, NATURE, V466, P604, DOI 10.1038/nature09185	29	516	526	15	384	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 28	2015	521	7553					498	502		10.1038/nature14456	http://dx.doi.org/10.1038/nature14456			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ2AN	26017451				2022-12-28	WOS:000355286600038
J	Regelin, N; Montaruli, E				Regelin, Nora; Montaruli, Ernesto			Disseminated Lyme Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Regelin, Nora; Montaruli, Ernesto] Hop Valais, Sion, Switzerland		Regelin, N (corresponding author), Hop Valais, Sion, Switzerland.	ernesto.montaruli@gmail.com							0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2015	372	22					2136	2136		10.1056/NEJMicm1408084	http://dx.doi.org/10.1056/NEJMicm1408084			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0EI	26017824				2022-12-28	WOS:000355146800010
J	Lacroix, A; Feelders, RA; Stratakis, CA; Nieman, LK				Lacroix, Andre; Feelders, Richard A.; Stratakis, Constantine A.; Nieman, Lynnette K.			Cushing's syndrome	LANCET			English	Article							MACRONODULAR ADRENAL-HYPERPLASIA; QUALITY-OF-LIFE; MULTIPLE-ENDOCRINE-NEOPLASIA; NODULAR ADRENOCORTICAL-DISEASE; INFERIOR PETROSAL SINUS; PROTEIN-KINASE-A; SECRETING PITUITARY-ADENOMAS; HORMONE STIMULATION TEST; LONG-TERM REMISSION; DIFFERENTIAL-DIAGNOSIS	Chronic exposure to excess glucorticoids results in diverse manifestations of Cushing's syndrome, including debilitating morbidities and increased mortality. Genetic and molecular mechanisms responsible for excess cortisol secretion by primary adrenal lesions and adrenocorticotropic hormone (ACTH) secretion from corticotroph or ectopic tumours have been identified. New biochemical and imaging diagnostic approaches and progress in surgical and radiotherapy techniques have improved the management of patients. The therapeutic goal is to normalise tissue exposure to cortisol to reverse increased morbidity and mortality. Optimum treatment consisting of selective and complete resection of the causative tumour is necessay to allow eventual normalisation of the hypothalamic-pituitary-adrenal axis, maintenance of pituitary function, and avoidance of tumour recurrence. The development of new drugs offers clinicians several choices to treat patients with residual cortisol excess. However, for patients affected by this challenging syndrome, the long-term effects and comorbidities associated with hypercortisolism need ongoing care.	[Lacroix, Andre] Univ Montreal, Dept Med, Ctr Hosp, Div Endocrinol,CHUM, Montreal, PQ H2W 1T8, Canada; [Lacroix, Andre] Univ Montreal, Res Ctr, Ctr Hosp, CHUM, Montreal, PQ H2W 1T8, Canada; [Feelders, Richard A.] Erasmus MC, Div Endocrinol, Dept Internal Med, Rotterdam, Netherlands; [Stratakis, Constantine A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Genet & Endocrinol, NIH, Bethesda, MD USA; [Nieman, Lynnette K.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA	Universite de Montreal; Universite de Montreal; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lacroix, A (corresponding author), Univ Montreal, Dept Med, Ctr Hosp, Div Endocrinol, Montreal, PQ H2W 1T8, Canada.	andre.lacroix@umontreal.ca	Stratakis, Constantine/AAP-4745-2020; Lacroix, Andre/AAI-5645-2020		Canadian Institutes of Health Research; Intramural Research Program, National Institute of Child Health and Human Development (NICHD), National Institute of Health (NIH); Intramural Research Program, NICHD, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008920, ZIAHD000638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075121, ZIADK075122] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Intramural Research Program, National Institute of Child Health and Human Development (NICHD), National Institute of Health (NIH); Intramural Research Program, NICHD, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	AL receives grant support from the Canadian Institutes of Health Research. CAS is supported by the Intramural Research Program, National Institute of Child Health and Human Development (NICHD), National Institute of Health (NIH). LKN is supported by the Intramural Research Program, NICHD, NIH.	Agarwal SK, 2009, J CLIN ENDOCR METAB, V94, P1826, DOI 10.1210/jc.2008-2083; Alencar GA, 2014, J CLIN ENDOCR METAB, V99, pE1501, DOI 10.1210/jc.2013-4237; Alexandraki KI, 2013, EUR J ENDOCRINOL, V168, P639, DOI 10.1530/EJE-12-0921; Almeida MQ, 2011, J CLIN ENDOCR METAB, V96, pE728, DOI 10.1210/jc.2010-2420; Anselmo J, 2012, J CLIN ENDOCR METAB, V97, P351, DOI 10.1210/jc.2011-2244; Arlt W, 2011, J CLIN ENDOCR METAB, V96, P3775, DOI 10.1210/jc.2011-1565; Arnaldi G, 2003, J CLIN ENDOCR METAB, V88, P5593, DOI 10.1210/jc.2003-030871; Aron DC, 1997, J CLIN ENDOCR METAB, V82, P1780, DOI 10.1210/jc.82.6.1780; Assie G, 2007, J CLIN ENDOCR METAB, V92, P172, DOI 10.1210/jc.2006-1328; Assie G, 2014, NAT GENET, V46, P607, DOI 10.1038/ng.2953; Assie G, 2013, NEW ENGL J MED, V369, P2105, DOI 10.1056/NEJMoa1304603; Assie G, 2010, J CLIN ENDOCR METAB, V95, pE253, DOI 10.1210/jc.2009-2281; Barber TM, 2010, EUR J ENDOCRINOL, V163, P495, DOI 10.1530/EJE-10-0466; Barbot M, 2014, PITUITARY, V17, P109, DOI 10.1007/s11102-013-0475-3; Batista D, 2005, J CLIN ENDOCR METAB, V90, P5134, DOI 10.1210/jc.2004-1778; Baudry C, 2012, EUR J ENDOCRINOL, V167, P473, DOI 10.1530/EJE-12-0358; Beckers A, 2013, ENDOCR REV, V34, P239, DOI 10.1210/er.2012-1013; Bertagna X, 2014, J CLIN ENDOCR METAB, V99, P1375, DOI 10.1210/jc.2013-2117; Bertagna X, 2013, J CLIN ENDOCR METAB, V98, P1307, DOI 10.1210/jc.2012-3200; Bertherat J, 2003, CANCER RES, V63, P5308; Bertherat J, 2009, J CLIN ENDOCR METAB, V94, P2085, DOI 10.1210/jc.2008-2333; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; Biller BMK, 2008, J CLIN ENDOCR METAB, V93, P2454, DOI 10.1210/jc.2007-2734; Bilodeau S, 2006, GENE DEV, V20, P2871, DOI 10.1101/gad.1444606; Bolland MJ, 2011, CLIN ENDOCRINOL, V75, P436, DOI 10.1111/j.1365-2265.2011.04124.x; Boscaro M, 2009, J CLIN ENDOCR METAB, V94, P3121, DOI 10.1210/jc.2009-0612; Bourdeau I, 2005, ENDOCRIN METAB CLIN, V34, P357, DOI 10.1016/j.ecl.2005.01.016; Bourdeau I, 2003, J CLIN ENDOCR METAB, V88, P3931, DOI 10.1210/jc.2002-022001; Bourdeau I, 2005, ENDOCRIN METAB CLIN, V34, pix; Brito LP, 2010, J CLIN ENDOCR METAB, V95, pE271, DOI 10.1210/jc.2010-0047; Cao YN, 2014, SCIENCE, V344, P913, DOI 10.1126/science.1249480; Carney JA, 2012, AM J SURG PATHOL, V36, P1452, DOI 10.1097/PAS.0b013e31825d538b; Carney JA, 2011, AM J SURG PATHOL, V35, P1311, DOI 10.1097/PAS.0b013e31821ec4ce; Castinetti F, 2009, EUR J ENDOCRINOL, V160, P1003, DOI 10.1530/EJE-09-0098; Castinetti F, 2014, J CLIN ENDOCR METAB, V99, P1623, DOI 10.1210/jc.2013-3628; Castinetti F, 2009, J CLIN ENDOCR METAB, V94, P1897, DOI 10.1210/jc.2008-2234; Casulari LA, 2004, HORM RES, V62, P300, DOI 10.1159/000082235; Chiodini I, 2007, ANN INTERN MED, V147, P541, DOI 10.7326/0003-4819-147-8-200710160-00006; Clayton RN, 2011, J CLIN ENDOCR METAB, V96, P632, DOI 10.1210/jc.2010-1942; Colao A, 2012, NEW ENGL J MED, V366, P914, DOI 10.1056/NEJMoa1105743; Crespo I, 2014, CLIN ENDOCRINOL, V81, P826, DOI 10.1111/cen.12564; Daly AF, 2009, BEST PRACT RES CL EN, V23, P543, DOI 10.1016/j.beem.2009.05.008; Danet-Lamasou M, 2015, CLIN ENDOCRINOL, V82, P260, DOI 10.1111/cen.12534; de Bruin C, 2012, J CLIN ENDOCR METAB, V97, P455, DOI 10.1210/jc.2011-1264; de Bruin C, 2009, J CLIN ENDOCR METAB, V94, P1118, DOI 10.1210/jc.2008-2101; de Kock L, 2014, ACTA NEUROPATHOL, V128, P111, DOI 10.1007/s00401-014-1285-z; Debono M, 2014, J CLIN ENDOCR METAB, V99, P4462, DOI 10.1210/jc.2014-3007; Dekkers OM, 2013, J CLIN ENDOCR METAB, V98, P2277, DOI 10.1210/jc.2012-3582; Delgado V, 2012, CLIN ENDOCRINOL, V77, P99, DOI 10.1111/j.1365-2265.2011.04326.x; Di Dalmazi G, 2014, J CLIN ENDOCR METAB, V99, pE2093, DOI 10.1210/jc.2014-2152; Di Dalmazi G, 2014, LANCET DIABETES ENDO, V2, P396, DOI 10.1016/S2213-8587(13)70211-0; Dickerman RD, 2002, J NEUROSURG, V97, P1343, DOI 10.3171/jns.2002.97.6.1343; Dimopoulou C, 2014, EUR J ENDOCRINOL, V170, P283, DOI 10.1530/EJE-13-0634; Doppman JL, 1999, J CLIN ENDOCR METAB, V84, P533, DOI 10.1210/jc.84.2.533; Du L, 2013, P NATL ACAD SCI USA, V110, P8555, DOI 10.1073/pnas.1306182110; Elbelt U, 2015, J CLIN ENDOCR METAB, V100, pE119, DOI 10.1210/jc.2014-2648; Else T, 2014, ENDOCR REV, V35, P282, DOI 10.1210/er.2013-1029; Estrada J, 1997, NEW ENGL J MED, V336, P172, DOI 10.1056/NEJM199701163360303; Faggiano A, 2003, J CLIN ENDOCR METAB, V88, P2527, DOI 10.1210/jc.2002-021558; Fassnacht M, 2011, NAT REV ENDOCRINOL, V7, P323, DOI 10.1038/nrendo.2010.235; Faucz FR, 2014, J CLIN ENDOCR METAB, V99, pE1113, DOI 10.1210/jc.2013-4280; Feelders RA, 2012, EUR J ENDOCRINOL, V167, P311, DOI 10.1530/EJE-11-1095; Feelders RA, 2013, J CLIN ENDOCR METAB, V98, P425, DOI 10.1210/jc.2012-3126; Feelders RA, 2010, NEW ENGL J MED, V362, P1846, DOI 10.1056/NEJMc1000094; Findling JW, 2004, J CLIN ENDOCR METAB, V89, P6005, DOI 10.1210/jc.2004-1378; Fleseriu M, 2012, J CLIN ENDOCR METAB, V97, P2039, DOI 10.1210/jc.2011-3350; Fragoso MCBV, 2003, J CLIN ENDOCR METAB, V88, P2147, DOI 10.1210/jc.2002-021362; Fukuoka H, 2011, J CLIN INVEST, V121, P4712, DOI 10.1172/JCI60417; Gagliardi L, 2014, J CLIN ENDOCR METAB, V99, pE1784, DOI 10.1210/jc.2014-1265; Georgitsi M, 2007, J CLIN ENDOCR METAB, V92, P3321, DOI 10.1210/jc.2006-2843; Giraldi FP, 2012, J CLIN ENDOCR METAB, V97, P3577, DOI 10.1210/jc.2012-2328; Giraldi FP, 2011, EUR J ENDOCRINOL, V164, P505, DOI 10.1530/EJE-10-0962; Godbout A, 2010, EUR J ENDOCRINOL, V163, P709, DOI 10.1530/EJE-10-0382; Goh G, 2014, NAT GENET, V46, P613, DOI 10.1038/ng.2956; Goodarzi MO, 2003, J CLIN ENDOCR METAB, V88, P73, DOI 10.1210/jc.2002-021292; Graham UM, 2013, J CLIN ENDOCR METAB, V98, pE72, DOI 10.1210/jc.2012-2925; Graversen D, 2012, EUR J INTERN MED, V23, P278, DOI 10.1016/j.ejim.2011.10.013; Gunther DF, 2004, J CLIN ENDOCR METAB, V89, P3173, DOI 10.1210/jc.2003-032247; Hassan-Smith ZK, 2012, J CLIN ENDOCR METAB, V97, P1194, DOI 10.1210/jc.2011-2957; Henry RR, 2013, J CLIN ENDOCR METAB, V98, P3446, DOI 10.1210/jc.2013-1771; Hofland J, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-142; Horvath A, 2008, EUR J HUM GENET, V16, P1245, DOI 10.1038/ejhg.2008.85; Horvath A, 2006, NAT GENET, V38, P794, DOI 10.1038/ng1809; Horvath A, 2010, HUM MUTAT, V31, P369, DOI 10.1002/humu.21178; Hsiao HP, 2009, J CLIN ENDOCR METAB, V94, P2930, DOI 10.1210/jc.2009-0516; Ilias I, 2005, J CLIN ENDOCR METAB, V90, P4955, DOI 10.1210/jc.2004-2527; Isidori AM, 2006, J CLIN ENDOCR METAB, V91, P371, DOI 10.1210/jc.2005-1542; Kamenicky P, 2011, J CLIN ENDOCR METAB, V96, P2796, DOI 10.1210/jc.2011-0536; Karl M, 1996, J CLIN ENDOCR METAB, V81, P124, DOI 10.1210/jc.81.1.124; Katznelson L, 2013, J CLIN ENDOCR METAB, V98, P1803, DOI 10.1210/jc.2013-1497; Kawashima ST, 2009, CLIN ENDOCRINOL, V70, P656, DOI 10.1111/j.1365-2265.2008.03404.x; Keil MF, 2013, J CLIN ENDOCR METAB, V98, P2667, DOI 10.1210/jc.2013-1123; Khalil RB, 2011, EUR J ENDOCRINOL, V165, P729, DOI 10.1530/EJE-11-0424; Koopmans KP, 2006, LANCET ONCOL, V7, P728, DOI 10.1016/S1470-2045(06)70801-4; Krarup T, 2012, DIABETES-METAB RES, V28, P219, DOI 10.1002/dmrr.2262; Lacroix A, 1999, NEW ENGL J MED, V341, P1577, DOI 10.1056/NEJM199911183412104; Lacroix A, 1997, NEW ENGL J MED, V337, P1429, DOI 10.1056/NEJM199711133372004; Lacroix A, 2013, NEW ENGL J MED, V369, P2147, DOI 10.1056/NEJMe1312792; Lacroix A, 2010, CLIN ENDOCRINOL, V73, P1, DOI 10.1111/j.1365-2265.2009.03689.x; Lacroix A, 2009, BEST PRACT RES CL EN, V23, P245, DOI 10.1016/j.beem.2008.10.011; Lamas C, 2002, EUR J ENDOCRINOL, V146, P237, DOI 10.1530/eje.0.1460237; Lampron A, 2006, J CLIN ENDOCR METAB, V91, P3611, DOI 10.1210/jc.2006-0221; Lekarev O, 2011, BEST PRACT RES CL EN, V25, P959, DOI 10.1016/j.beem.2011.08.004; Libe R, 2008, CLIN CANCER RES, V14, P4016, DOI 10.1158/1078-0432.CCR-08-0106; Libe R, 2010, EUR J ENDOCRINOL, V163, P129, DOI 10.1530/EJE-10-0195; Lindholm J, 2001, J CLIN ENDOCR METAB, V86, P117, DOI 10.1210/jc.86.1.117; Lindsay JR, 2005, J CLIN ENDOCR METAB, V90, P3077, DOI 10.1210/jc.2004-2361; Liu NA, 2011, P NATL ACAD SCI USA, V108, P8414, DOI 10.1073/pnas.1018091108; Louiset E, 2013, NEW ENGL J MED, V369, P2115, DOI 10.1056/NEJMoa1215245; Ma ZY, 2015, CELL RES, V25, P306, DOI 10.1038/cr.2015.20; Manenschijn L, 2012, J CLIN ENDOCR METAB, V97, pE1836, DOI 10.1210/jc.2012-1852; Manetti L, 2013, EUR J ENDOCRINOL, V168, P315, DOI 10.1530/EJE-12-0685; Matsuzaki LN, 2004, CLIN ENDOCRINOL, V60, P142, DOI 10.1111/j.1365-2265.2004.01943.x; Mazzuco TL, 2012, CLIN ENDOCRINOL, V77, P1, DOI 10.1111/j.1365-2265.2012.04403.x; Mazzuco TL, 2009, ENDOCR J, V56, P867, DOI 10.1507/endocrj.K08E-370; Monteith SJ, 2012, J NEUROSURG, V116, P721, DOI 10.3171/2011.12.JNS11886; Morin E, 2012, J CLIN ENDOCR METAB, V97, pE202, DOI 10.1210/jc.2011-2321; Mullan Karen R, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P317, DOI 10.1097/MED.0b013e3281a477b3; Nehs MA, 2011, CURR OPIN ENDOCRINOL, V18, P193, DOI 10.1097/MED.0b013e32834693bf; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; Newell-Price J, 2002, J CLIN ENDOCR METAB, V87, P1640, DOI 10.1210/jc.87.4.1640; NIEMAN LK, 1993, J CLIN ENDOCR METAB, V77, P1308, DOI 10.1210/jc.77.5.1308; NIEMAN LK, 1986, ANN INTERN MED, V105, P862, DOI 10.7326/0003-4819-105-6-862; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; ORTH DN, 1995, NEW ENGL J MED, V332, P791, DOI 10.1056/NEJM199503233321207; Oyesiku Nelson M, 2007, Neurosurg Focus, V23, pE14; Ozawa A, 2007, J CLIN ENDOCR METAB, V92, P1948, DOI 10.1210/jc.2006-2563; Patronas N, 2003, J CLIN ENDOCR METAB, V88, P1565, DOI 10.1210/jc.2002-021438; Pereira AM, 2010, NEUROENDOCRINOLOGY, V92, P65, DOI 10.1159/000314317; Pereira AM, 2010, EUR J ENDOCRINOL, V162, P331, DOI 10.1530/EJE-09-0621; Pereira AM, 2010, J CLIN ENDOCR METAB, V95, P338, DOI 10.1210/jc.2009-0993; Pivonello R, 2005, NEW ENGL J MED, V352, P2457, DOI 10.1056/NEJM200506093522322; Pivonello R, 2007, J CLIN ENDOCR METAB, V92, P65, DOI 10.1210/jc.2006-0728; Pivonello R, 2009, J CLIN ENDOCR METAB, V94, P223, DOI 10.1210/jc.2008-1533; Poncin J, 1999, EUR J ENDOCRINOL, V140, P573, DOI 10.1530/eje.0.1400573; Preda VA, 2012, EUR J ENDOCRINOL, V167, P137, DOI 10.1530/EJE-12-0274; Preumont V, 2011, HORM METAB RES, V43, P287, DOI 10.1055/s-0030-1270523; RAM Z, 1994, J NEUROSURG, V80, P37, DOI 10.3171/jns.1994.80.1.0037; Rebellato A, 2014, ENDOCRINE, V47, P557, DOI 10.1007/s12020-014-0164-7; Reincke M, 2015, NAT GENET, V47, P31, DOI 10.1038/ng.3166; Reznik Y, 2004, CLIN ENDOCRINOL, V61, P311, DOI 10.1111/j.1365-2265.2004.02048.x; Ritzel K, 2013, J CLIN ENDOCR METAB, V98, P3939, DOI 10.1210/jc.2013-1470; Rothenbuhler A, 2012, CLIN ENDOCRINOL, V77, P195, DOI 10.1111/j.1365-2265.2012.04366.x; Sandrini F, 2002, J Med Genet, V39, pe78, DOI 10.1136/jmg.39.12.e78; Santos A, 2014, EUR J ENDOCRINOL, V171, P461, DOI 10.1530/EJE-14-0371; Sato Y, 2014, SCIENCE, V344, P917, DOI 10.1126/science.1252328; Savage MO, 2007, PITUITARY, V10, P365, DOI 10.1007/s11102-007-0056-4; Schmid HA, 2008, MOL CELL ENDOCRINOL, V286, P69, DOI 10.1016/j.mce.2007.09.006; Steffensen C, 2010, NEUROENDOCRINOLOGY, V92, P1, DOI 10.1159/000314297; Stratakis CA, 2010, CLIN GENET, V78, P457, DOI 10.1111/j.1399-0004.2010.01406.x; Stratakis CA, 2007, NAT CLIN PRACT ENDOC, V3, P748, DOI 10.1038/ncpendmet0648; Stratakis CA, 2013, MOL CELL ENDOCRINOL, V371, P208, DOI 10.1016/j.mce.2013.01.015; Stratakis CA, 2012, ENDOCRIN METAB CLIN, V41, P793, DOI 10.1016/j.ecl.2012.08.002; Stratakis Constantine A., 2008, V13, P117, DOI 10.1159/000134829; Stuijver DJF, 2011, J CLIN ENDOCR METAB, V96, P3525, DOI 10.1210/jc.2011-1661; Swearingen B, 1999, ANN INTERN MED, V130, P821, DOI 10.7326/0003-4819-130-10-199905180-00015; Tabarin A, 2011, NAT REV ENDOCRINOL, V7, P445, DOI 10.1038/nrendo.2011.51; Terzolo M, 2012, J CLIN ENDOCR METAB, V97, P3467, DOI 10.1210/jc.2012-1323; Thompson SK, 2007, ANN SURG, V245, P790, DOI 10.1097/01.sla.0000251578.03883.2f; Tichomirowa MA, 2011, EUR J ENDOCRINOL, V165, P509, DOI 10.1530/EJE-11-0304; Tsagarakis S, 2002, J CLIN ENDOCR METAB, V87, P1646, DOI 10.1210/jc.87.4.1646; Valassi E, 2012, CLIN ENDOCRINOL, V77, P735, DOI 10.1111/j.1365-2265.2012.04424.x; Valassi E, 2011, EUR J ENDOCRINOL, V165, P383, DOI 10.1530/EJE-11-0272; van Aken MO, 2005, J CLIN ENDOCR METAB, V90, P3279, DOI 10.1210/jc.2004-1375; van der Pas R, 2012, ENDOCR-RELAT CANCER, V19, pR205, DOI 10.1530/ERC-12-0191; Vilar L, 2010, PITUITARY, V13, P123, DOI 10.1007/s11102-009-0209-8; Webb SM, 2008, EUR J ENDOCRINOL, V158, P623, DOI 10.1530/EJE-07-0762; Wind JJ, 2013, J CLIN ENDOCR METAB, V98, P2285, DOI 10.1210/jc.2012-3943; Wong KK, 2010, ACAD RADIOL, V17, P291, DOI 10.1016/j.acra.2009.08.015; Xekouki P, 2012, ENDOCR-RELAT CANCER, V19, pC33, DOI 10.1530/ERC-12-0118; Zemskova MS, 2010, J CLIN ENDOCR METAB, V95, P1207, DOI 10.1210/jc.2009-2282	171	451	487	1	95	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2015	386	9996					913	927		10.1016/S0140-6736(14)61375-1	http://dx.doi.org/10.1016/S0140-6736(14)61375-1			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ0MJ	26004339				2022-12-28	WOS:000360290000034
J	Bachelez, H; van de Kerkhof, PCM; Strohal, R; Kubanov, A; Valenzuela, F; Lee, JH; Yakusevich, V; Chimenti, S; Papacharalambous, J; Proulx, J; Gupta, P; Tan, HM; Tawadrous, M; Valdez, H; Wolk, R				Bachelez, Herve; van de Kerkhof, Peter C. M.; Strohal, Robert; Kubanov, Alexey; Valenzuela, Fernando; Lee, Joo-Heung; Yakusevich, Vladimir; Chimenti, Sergio; Papacharalambous, Jocelyne; Proulx, James; Gupta, Pankaj; Tan, Huaming; Tawadrous, Margaret; Valdez, Hernan; Wolk, Robert		OPT Compare Investigators	Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial	LANCET			English	Article							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; JANUS KINASE INHIBITOR; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; CP-690,550; MANAGEMENT; EFFICACY; PATIENT; SAFETY; METHOTREXATE	Background New therapeutic options are needed for patients with psoriasis. Tofacitinib, an oral Janus kinase inhibitor, is being investigated as a treatment for moderate-to-severe chronic plaque psoriasis. In this study, we aimed to compare two tofacitinib doses with high-dose etanercept or placebo in this patient population. Methods In this phase 3, randomised, multicentre, double-dummy, placebo-controlled, 12-week, non-inferiority trial, adult patients with chronic stable plaque psoriasis (for >= 12 months) who were candidates for systemic or phototherapy and had a Psoriasis Area and Severity Index (PASI) score of 12 or higher and a Physician's Global Assessment (PGA) of moderate or severe, and had failed to respond to, had a contraindication to, or were intolerant to at least one conventional systemic therapy, were enrolled from 122 investigational dermatology centres worldwide. Eligible patients were randomly assigned in a 3: 3: 3: 1 ratio to receive tofacitinib 5 mg or 10 mg twice daily at about 12 h intervals, etanercept 50 mg subcutaneously twice weekly at about 3-4 day intervals, or placebo. Randomisation was done by a computer-generated randomisation schedule, and all patients and study personnel were masked to treatment assignment. The co-primary endpoints were the proportion of patients at week 12 with at least a 75% reduction in the PASI score from baseline (PASI75 response) and the proportion of patients achieving a PGA score of "clear" or "almost clear" (PGA response), analysed in the full analysis set (all patients who were randomised and received at least one dose of study drug). This study is registered with ClinicalTrials.gov, number NCT01241591. Findings Between Nov 29, 2010, and Sept 13, 2012, we enrolled 1106 eligible adult patients with chronic plaque psoriasis and randomly assigned them to the four treatment groups (330 to tofacitinib 5 mg twice daily, 332 to tofacitinib 10 mg twice daily, 336 to etanercept 50 mg twice weekly, and 108 to placebo). Of these patients, 1101 actually received their assigned study medication (329 in the tofactinib 5 mg group, 330 in the tofacitinib 10 mg group, 335 in the etanercept group, and 107 in the placebo group). At week 12, PASI75 responses were recorded in 130 (39.5%) of 329 patients in the tofacitinib 5 mg group, 210 (63.6%) of 330 in the tofacitinib 10 mg group, 197 (58.8%) of 335 in the etanercept group, and six (5.6%) of 107 in the placebo group. A PGA response was achieved by 155 (47.1%) of 329 patients in the tofacitinib 5 mg group, 225 (68.2%) of 330 in the tofacitinib 10 mg group, 222 (66.3%) of 335 in the etanercept group, and 16 (15.0%) of 107 in the placebo group. The rate of adverse events was similar across the four groups, with serious adverse events occurring in seven (2%) of 329 patients in the tofacitinib 5 mg group, five (2%) of 330 in the tofacitinib 10 mg group, seven (2%) of 335 in the etanercept group, and two (2%) of 107 in the placebo group. Three (1%) of 329 patients in the tofacitinib 5 mg group, ten (3%) of 330 in the tofacitinib 10 mg group, 11 (3%) of 335 in the etanercept group, and four (4%) of 107 patients in the placebo group discontinued their assigned treatment because of adverse events. Interpretation In patients with moderate-to-severe plaque psoriasis, the 10 mg twice daily dose of tofacitinib was non-inferior to etanercept 50 mg twice weekly and was superior to placebo, but the 5 mg twice daily dose did not show non-inferiority to etanercept 50 mg twice weekly. The adverse event rates over 12 weeks were similar for tofacitinib and etanercept. This study indicates that in the future tofacitinib could provide a convenient and well-tolerated therapeutic option for patients with moderate-to-severe plaque psoriasis.	[Bachelez, Herve] Univ Paris Diderot, Hop St Louis, APHP, Sorbonne Paris Cite,Dept Dermatol, Paris, France; [van de Kerkhof, Peter C. M.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Strohal, Robert] Fed Acad Teaching Hosp Feldkirch, Feldkirch, Austria; [Kubanov, Alexey] Minist Hlth, State Res Ctr Dermatol & Venereol, Moscow, Russia; [Valenzuela, Fernando] Univ Chile, Clin Hosp, Dept Dermatol, Santiago, Chile; [Valenzuela, Fernando] Prob Med Res, Waterloo, ON, Canada; [Lee, Joo-Heung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Yakusevich, Vladimir] Solovievs Clin Hosp Urgent Med Care, Yaroslavl, Russia; [Chimenti, Sergio] Univ Rome, Dept Dermatol, Rome, Italy; [Papacharalambous, Jocelyne; Proulx, James; Gupta, Pankaj; Tan, Huaming; Tawadrous, Margaret; Valdez, Hernan; Wolk, Robert] Pfizer Inc, Groton, CT 06340 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Radboud University Nijmegen; Ministry of Health of the Russian Federation; Universidad de Chile; Sungkyunkwan University (SKKU); Samsung Medical Center; Sapienza University Rome; Pfizer	Bachelez, H (corresponding author), Hop St Louis, Serv Dermatol, 1 Ave Claude Vellefaux, F-75475 Paris 10, France.	herve.bachelez@sls.aphp.fr	Estebaranz, Jose Luis Lopez/AAF-1756-2019; Arenberger, Petr/C-7481-2018; Kemeny, Lajos/ABF-1339-2021; gospodinov, dimitar k/T-3064-2018; Ettler, Karel/M-4762-2017; Thaci, Prof. Dr Diamant/K-5455-2012; Tawadrous, Margaret/AAY-3551-2020; Estebaranz, José Luis López/L-2920-2018; van de Kerkhof, P.C.M./H-8059-2014; Perlamutrov, Yuri/AAL-7884-2020; Valenzuela, Fernando/AAX-5037-2020; Kubanov, Alexey/L-3008-2014	Estebaranz, Jose Luis Lopez/0000-0002-8816-1989; Arenberger, Petr/0000-0002-4800-5877; Kemeny, Lajos/0000-0002-2119-9501; gospodinov, dimitar k/0000-0001-6800-4671; Ettler, Karel/0000-0002-7986-4885; Estebaranz, José Luis López/0000-0002-8816-1989; Perlamutrov, Yuri/0000-0002-4837-8489; Bang, Bo/0000-0003-1837-3393; Prens, Errol/0000-0002-8158-660X; Kubanov, Alexey/0000-0002-7625-0503; bachelez, herve/0000-0003-3567-9095; Valenzuela, Fernando/0000-0003-1032-9347; Aubin, Francois/0000-0002-1421-4996; Paul, Carle/0000-0003-0165-5263	Pfizer Inc.	Pfizer Inc.(Pfizer)	Pfizer Inc.	Armstrong AW, 2013, JAMA DERMATOL, V149, P1180, DOI 10.1001/jamadermatol.2013.5264; Armstrong EJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000062; Bonafede M, 2012, ADV THER, V29, P664, DOI 10.1007/s12325-012-0037-5; Burmester GR, 2013, LANCET, V381, P451, DOI 10.1016/S0140-6736(12)61424-X; Carroll CL, 2004, BRIT J DERMATOL, V151, P895, DOI 10.1111/j.1365-2133.2004.06174.x; Chang BY, 2009, J IMMUNOL, V183, P2183, DOI 10.4049/jimmunol.0804063; Dubois D.S, 2013, SCI WORLD J, V2013; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Gniadecki R, 2011, BRIT J DERMATOL, V164, P1091, DOI 10.1111/j.1365-2133.2011.10213.x; Hsu S, 2012, ARCH DERMATOL, V148, P95, DOI 10.1001/archdermatol.2011.1410; Lebwohl MG, 2014, J AM ACAD DERMATOL, V70, P871, DOI 10.1016/j.jaad.2013.12.018; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Mamolo C, 2014, J EUR ACAD DERMATOL, V28, P192, DOI 10.1111/jdv.12081; Mamolo CM, 2014, J DERMATOL TREAT, DOI [10.3109/09546634.2014.906033, DOI 10.3109/095]; Mazzotti E, 2003, BRIT J DERMATOL, V149, P318, DOI 10.1046/j.1365-2133.2003.05378.x; Naldi L, 2005, BRIT J DERMATOL, V152, P597, DOI 10.1111/j.1365-2133.2005.06563.x; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nograles KE, 2010, SEMIN CUTAN MED SURG, V29, P3, DOI 10.1016/j.sder.2010.03.001; Papp KA, 2012, BRIT J DERMATOL, V167, P668, DOI 10.1111/j.1365-2133.2012.11168.x; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Pathirana D, 2009, J EUR ACAD DERMATOL, V23, P1, DOI 10.1111/j.1468-3083.2009.03389.x; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Smith CH, 2009, BRIT J DERMATOL, V161, P987, DOI 10.1111/j.1365-2133.2009.09505.x; Stern RS, 1997, NEW ENGL J MED, V336, P1041, DOI 10.1056/NEJM199704103361501; STUDNIBERG HM, 1993, J AM ACAD DERMATOL, V29, P1013, DOI 10.1016/0190-9622(93)70283-Y; Tan H, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.22; Uhlenhake EE, 2010, J DERMATOL TREAT, V21, P6, DOI 10.3109/09546630903085328; van der Heijde D, 2013, ARTHRITIS RHEUM-US, V65, P559, DOI 10.1002/art.37816; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Vijayakrishnan L, 2011, TRENDS PHARMACOL SCI, V32, P25, DOI 10.1016/j.tips.2010.10.004; Weger W, 2010, BRIT J PHARMACOL, V160, P810, DOI 10.1111/j.1476-5381.2010.00702.x; Yeung H, 2013, J AM ACAD DERMATOL, V68, P64, DOI 10.1016/j.jaad.2012.06.035	33	263	277	4	55	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2015	386	9993					552	561		10.1016/S0140-6736(14)62113-9	http://dx.doi.org/10.1016/S0140-6736(14)62113-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO8PG	26051365				2022-12-28	WOS:000359431900029
J	Cornet, FH				Cornet, Francois H.			Earthquakes induced by fluid injections	SCIENCE			English	Editorial Material							INDUCED ASEISMIC SLIP; FAULT		Inst Phys Globe, F-67084 Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Cornet, FH (corresponding author), Inst Phys Globe, 5 Rue Rene Descartes, F-67084 Strasbourg, France.	francois.cornet@unistra.fr						Calo M, 2011, GEOPHYS J INT, V186, P1295, DOI 10.1111/j.1365-246X.2011.05108.x; Cornet FH, 1997, PURE APPL GEOPHYS, V150, P563, DOI 10.1007/s000240050093; Guglielmi Y, 2015, SCIENCE, V348, P1224, DOI 10.1126/science.aab0476; HEALY JH, 1968, SCIENCE, V161, P1301, DOI 10.1126/science.161.3848.1301; Prioul R, 2000, J GEOPHYS RES-SOL EA, V105, P13595, DOI 10.1029/2000JB900052; RALEIGH CB, 1972, FLOW FRACTURE ROCKS, P275, DOI DOI 10.1029/GM016P0275; SCOTTI O, 1994, INT J ROCK MECH MIN, V31, P347, DOI 10.1016/0148-9062(94)90902-4	7	7	7	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240					1204	1205		10.1126/science.aab3820	http://dx.doi.org/10.1126/science.aab3820			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2AK	26068831				2022-12-28	WOS:000356011500027
J	Bartal, G				Bartal, Guy			NANOPHOTONICS Bright future for hyperbolic chips	NATURE			English	Editorial Material							OPTICAL HYPERLENS; METAMATERIALS; REFRACTION; INDEX		[Bartal, Guy] Technion Israel Inst Technol, Dept Elect Engn, IL-32000 Haifa, Israel; [Bartal, Guy] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Bartal, G (corresponding author), Technion Israel Inst Technol, Dept Elect Engn, IL-32000 Haifa, Israel.	guy@ee.technion.ac.il						Almeida VR, 2004, NATURE, V431, P1081, DOI 10.1038/nature02921; Bomzon Z, 2002, OPT LETT, V27, P1141, DOI 10.1364/OL.27.001141; Cortes CL, 2012, J OPTICS-UK, V14, DOI 10.1088/2040-8978/14/6/063001; High AA, 2015, NATURE, V522, P192, DOI 10.1038/nature14477; Huang KCY, 2014, NAT PHOTONICS, V8, P244, DOI [10.1038/nphoton.2014.2, 10.1038/NPHOTON.2014.2]; Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247; Kapitanova PV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4226; Liu YM, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821444; Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; Poddubny A, 2013, NAT PHOTONICS, V7, P948, DOI [10.1038/NPHOTON.2013.243, 10.1038/nphoton.2013.243]; Salandrino A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075103; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Smolyaninov II, 2007, SCIENCE, V315, P1699, DOI 10.1126/science.1138746; Valentine J, 2008, NATURE, V455, P376, DOI 10.1038/nature07247; Yang XD, 2012, NAT PHOTONICS, V6, P450, DOI [10.1038/nphoton.2012.124, 10.1038/NPHOTON.2012.124]; Yao J, 2008, SCIENCE, V321, P930, DOI 10.1126/science.1157566	16	2	2	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					160	161		10.1038/522160a	http://dx.doi.org/10.1038/522160a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	26062504				2022-12-28	WOS:000356016700025
J	Bobrow, M				Bobrow, Martin			Funders must encourage scientists to share	NATURE			English	Editorial Material									[Bobrow, Martin] Univ Cambridge, Med Genet, Cambridge CB2 1TN, England	University of Cambridge	Bobrow, M (corresponding author), Univ Cambridge, Med Genet, Cambridge CB2 1TN, England.	mb238@cam.ac.uk							0	7	7	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					129	129		10.1038/522129a	http://dx.doi.org/10.1038/522129a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK2CI	26062475	Bronze			2022-12-28	WOS:000356016700003
J	Freitag, SK; Cunnane, ME; Yoon, MK; Barnes, JA; Winkfield, KM; Sohani, AR				Freitag, Suzanne K.; Cunnane, Mary E.; Yoon, Michael K.; Barnes, Jeffrey A.; Winkfield, Karen M.; Sohani, Aliyah R.			Case 18-2015: A 41-Year-Old Woman with Decreased Vision in the Left Eye and Diplopia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B-CELL LYMPHOMA; RITUXIMAB PLUS CYCLOPHOSPHAMIDE; RADIATION-THERAPY; CLASSIFICATION; VINCRISTINE; DOXORUBICIN; MANAGEMENT; EXPRESSION; DIAGNOSIS; PROGNOSIS		[Freitag, Suzanne K.; Yoon, Michael K.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [Cunnane, Mary E.] Massachusetts Eye & Ear Infirm, Dept Radiol, Boston, MA 02114 USA; [Barnes, Jeffrey A.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Winkfield, Karen M.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Sohani, Aliyah R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Freitag, Suzanne K.; Yoon, Michael K.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Barnes, Jeffrey A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Winkfield, Karen M.] Harvard Univ, Sch Med, Dept Radiat Oncol, Boston, MA USA; [Cunnane, Mary E.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Sohani, Aliyah R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Freitag, SK (corresponding author), Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA.			Yoon, Michael/0000-0002-8793-7685	Seattle Genetics	Seattle Genetics	Dr. Sohani reports receiving lecture fees from Seattle Genetics. No other potential conflict of interest relevant to this article was reported.	Cockerham GC, 1997, INT OPHTHALMOL CLIN, V37, P39, DOI 10.1097/00004397-199703740-00005; Dorth JA, 2011, ANN ONCOL, V22, P405, DOI 10.1093/annonc/mdq389; Ginat DT, 2013, OPHTHAL PLAST RECONS, V29, P261, DOI 10.1097/IOP.0b013e31829165ad; GORDON KB, 1995, INT J RADIAT ONCOL, V31, P1123, DOI 10.1016/0360-3016(95)00062-4; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; GUNALP I, 1995, JPN J OPHTHALMOL, V39, P65; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hu SM, 2013, BLOOD, V121, P2715, DOI 10.1182/blood-2012-10-461848; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Lowry L, 2011, RADIOTHER ONCOL, V100, P86, DOI 10.1016/j.radonc.2011.05.013; Tovilla-Canales JL, 2001, CURR OPIN OPHTHALMOL, V12, P335, DOI 10.1097/00055735-200110000-00002; Madge SN, 2008, ORBIT, V27, P267, DOI 10.1080/01676830802225152; Mahr MA, 2004, AM J OPHTHALMOL, V138, P396, DOI 10.1016/j.ajo.2004.04.026; Marcheselli L, 2011, LEUKEMIA LYMPHOMA, V52, P1867, DOI 10.3109/10428194.2011.585526; Mavrikakis I, 2007, AM J OPHTHALMOL, V144, P769, DOI 10.1016/j.ajo.2007.07.019; Miller TP, 1998, ONCOLOGY-NY, V12, P35; Muller K, 2014, ARCH PATHOL LAB MED, V138, P1110, DOI 10.5858/arpa.2013-0006-RS; Pfreundschuh M, 2008, LANCET ONCOL, V9, P435, DOI 10.1016/S1470-2045(08)70078-0; Phan Jack, 2010, J Clin Oncol, V28, P4170, DOI 10.1200/JCO.2009.27.3441; Rootman J, 2014, OPHTHAL PLAST RECONS, V30, P91, DOI 10.1097/IOP.0000000000000122; Shapey J, 2013, J CLIN NEUROSCI, V20, P1045, DOI 10.1016/j.jocn.2013.03.008; Shields JA, 2001, OPHTHAL PLAST RECONS, V17, P346, DOI 10.1097/00002341-200109000-00009; Stein H, 2008, WHO CLASSIFICATION T, V4th, P233; Warwar Ronald E., 1998, Orbit, V17, P237, DOI 10.1076/orbi.17.4.237.2742; Yuen SJA, 2003, ARCH OPHTHALMOL-CHIC, V121, P491, DOI 10.1001/archopht.121.4.491	25	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 11	2015	372	24					2337	2345		10.1056/NEJMcpc1415170	http://dx.doi.org/10.1056/NEJMcpc1415170			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK2DB	26061839				2022-12-28	WOS:000356019200011
J	Padhi, S; Glen, J; Pordes, BAJ; Thomas, ME				Padhi, Smita; Glen, Jessica; Pordes, Ben A. J.; Thomas, Mark E.		Guideline Dev Grp	GUIDELINES Management of anaemia in chronic kidney disease: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Padhi, Smita; Glen, Jessica; Pordes, Ben A. J.] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Thomas, Mark E.] Birmingham Heartlands Hosp, Dept Renal Med, Birmingham B9 5ST, W Midlands, England	Royal College of Physicians; Heart of England NHS Foundation Trust; University of Birmingham	Thomas, ME (corresponding author), Birmingham Heartlands Hosp, Dept Renal Med, Birmingham B9 5ST, W Midlands, England.	mark.thomas@heartofengland.nhs.uk		Wonderling, David/0000-0003-0315-6273				Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; de Lusignan S, 2005, FAM PRACT, V22, P234, DOI 10.1093/fampra/cmi026; National Institute for Health and Care Excellence, 2015, CLIN GUID, Vng8; National Institute for Health and Care Excellence, 2014, PSYCH SCHIZ AD PREV; National Institute for Health and Care Excellence, 2011, CLIN GUID	5	31	32	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2015	350								h2258	10.1136/bmj.h2258	http://dx.doi.org/10.1136/bmj.h2258			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK0UD	26044132				2022-12-28	WOS:000355919600002
J	von Meyenn, F; Reik, W				von Meyenn, Ferdinand; Reik, Wolf			Forget the Parents: Epigenetic Reprogramming in Human Germ Cells	CELL			English	Editorial Material							DYNAMICS; MICE	Epigenetic reprogramming in the germline resets genomic potential and erases epigenetic memory. Three studies by Gkountela et al., Guo et al., and Tang et al. analyze the transcriptional and epigenetic landscape of human primordial germ cells, revealing a unique transcriptional network and progressive and conserved global erasure of DNA methylation.	[von Meyenn, Ferdinand; Reik, Wolf] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England; [Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Reik, Wolf] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Wellcome Trust Sanger Institute	von Meyenn, F (corresponding author), Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England.	vonmeyenn@babraham.ac.uk; wolf.reik@babraham.ac.uk	Reik, Wolf/I-6794-2012; von Meyenn, Ferdinand/O-4517-2017	von Meyenn, Ferdinand/0000-0001-9920-3075	Wellcome Trust [095645] Funding Source: Medline; BBSRC [BBS/E/B/0000S266, BBS/E/B/000C0403, BBS/E/B/0000H334] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000S266, BBS/E/B/000C0403, BBS/E/B/0000H334] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Gkountela S, 2015, CELL, V161, P1425, DOI 10.1016/j.cell.2015.05.012; Gkountela S, 2013, NAT CELL BIOL, V15, P113, DOI 10.1038/ncb2638; Guo F, 2015, CELL, V161, P1437, DOI 10.1016/j.cell.2015.05.015; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Kobayashi H, 2013, GENOME RES, V23, P616, DOI 10.1101/gr.148023.112; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053	9	53	53	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1248	1251		10.1016/j.cell.2015.05.039	http://dx.doi.org/10.1016/j.cell.2015.05.039			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26046435	Bronze			2022-12-28	WOS:000355935000006
J	Sedgwick, P; Joekes, K				Sedgwick, Philip; Joekes, Katherine			STATISTICAL QUESTION What are the risks?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sedgwick, Philip; Joekes, Katherine] St Georges Univ London, Inst Med & Biomed Educ, London, England	St Georges University London	Sedgwick, P (corresponding author), St Georges Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P, 2010, BMJ-BRIT MED J, V341, pc3983; Sedgwick P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h420; Tappin D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h134	3	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2015	350								h2931	10.1136/bmj.h2931	http://dx.doi.org/10.1136/bmj.h2931			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK0TW	26037334				2022-12-28	WOS:000355918900018
J	Zarbock, A; Schmidt, C; Van Aken, H; Wempe, C; Martens, S; Zahn, PK; Wolf, B; Goebel, U; Schwer, CI; Rosenberger, P; Haeberle, H; Gorlich, D; Kellum, JA; Meersch, M				Zarbock, Alexander; Schmidt, Christoph; Van Aken, Hugo; Wempe, Carola; Martens, Sven; Zahn, Peter K.; Wolf, Britta; Goebel, Ulrich; Schwer, Christian I.; Rosenberger, Peter; Haeberle, Helene; Goerlich, Dennis; Kellum, John A.; Meersch, Melanie		RenalRIPC Investigators	Effect of Remote Ischemic Preconditioning on Kidney Injury Among High-Risk Patients Undergoing Cardiac Surgery A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BYPASS GRAFT-SURGERY; MORTALITY; REPERFUSION; MECHANISMS; PROGNOSIS; CHILDREN; SURVIVAL; COSTS	IMPORTANCE No interventions have yet been identified to reduce the risk of acute kidney injury in the setting of cardiac surgery. OBJECTIVE To determine whether remote ischemic preconditioning reduces the rate and severity of acute kidney injury in patients undergoing cardiac surgery. DESIGN, SETTING, AND PARTICIPANTS In this multicenter trial, we enrolled 240 patients at high risk for acute kidney injury, as identified by a Cleveland Clinic Foundation score of 6 or higher, between August 2013 and June 2014 at 4 hospitals in Germany. We randomized them to receive remote ischemic preconditioning or sham remote ischemic preconditioning (control). All patients completed follow-up 30 days after surgery and were analyzed according to the intention-to-treat principle. INTERVENTIONS Patients received either remote ischemic preconditioning (3 cycles of 5-minute ischemia and 5-minute reperfusion in one upper arm after induction of anesthesia) or sham remote ischemic preconditioning (control), both via blood pressure cuff inflation. MAIN OUTCOMES AND MEASURES The primary end point was the rate of acute kidney injury defined by Kidney Disease: Improving Global Outcomes criteria within the first 72 hours after cardiac surgery. Secondary end points included use of renal replacement therapy, duration of intensive care unit stay, occurrence of myocardial infarction and stroke, in-hospital and 30-day mortality, and change in acute kidney injury biomarkers. RESULTS Acute kidney injury was significantly reduced with remote ischemic preconditioning (45 of 120 patients [37.5%]) compared with control (63 of 120 patients [52.5%]; absolute risk reduction, 15%; 95% CI, 2.56%-27.44%; P =.02). Fewer patients receiving remote ischemic preconditioning received renal replacement therapy (7 [5.8%] vs 19 [15.8%]; absolute risk reduction, 10%; 95% CI, 2.25%-17.75%; P =.01), and remote ischemic preconditioning reduced intensive care unit stay (3 days [interquartile range, 2-5]) vs 4 days (interquartile range, 2-7) (P =.04). There was no significant effect of remote ischemic preconditioning on myocardial infarction, stroke, or mortality. Remote ischemic preconditioning significantly attenuated the release of urinary insulinlike growth factor-binding protein 7 and tissue inhibitor of metalloproteinases 2 after surgery (remote ischemic preconditioning, 0.36 vs control, 0.97 ng/mL(2)/1000; difference, 0.61; 95% CI, 0.27-0.86; P <.001). No adverse events were reported with remote ischemic preconditioning. CONCLUSIONS AND RELEVANCE Among high-risk patients undergoing cardiac surgery, remote ischemic preconditioning compared with no ischemic preconditioning significantly reduced the rate of acute kidney injury and use of renal replacement therapy. The observed reduction in the rate of acute kidney injury and the need for renal replacement warrants further investigation.	[Zarbock, Alexander; Schmidt, Christoph; Van Aken, Hugo; Wempe, Carola; Meersch, Melanie] Univ Hosp Munster, Dept Anaesthesiol Intens Care Med & Pain Med, D-48149 Munster, Germany; [Martens, Sven] Univ Munster, Dept Cardiac Surg, D-48149 Munster, Germany; [Zahn, Peter K.; Wolf, Britta] Univ Hosp Bochum, Dept Anaesthesiol Intens Care Med Palliat & Pain, Bochum, Germany; [Goebel, Ulrich; Schwer, Christian I.] Univ Hosp Freiburg, Dept Anaesthesiol & Intens Care Med, Freiburg, Germany; [Rosenberger, Peter; Haeberle, Helene] Univ Tubingen Hosp, Dept Anaesthesiol & Intens Care Med, Tubingen, Germany; [Goerlich, Dennis] Univ Munster, Inst Biostat & Clin Res, D-48149 Munster, Germany; [Kellum, John A.] Univ Pittsburgh, Dept Crit Care Med, Ctr Crit Care Nephrol, Pittsburgh, PA USA	University of Munster; University of Munster; Ruhr University Bochum; University of Freiburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munster; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zarbock, A (corresponding author), Univ Hosp Munster, Dept Anesthesiol Crit Care Med & Pain Therapy, Albert Schweitzer Campus 1,Gebaude A1, D-48149 Munster, Germany.	zarbock@uni-muenster.de	Görlich, Dennis/C-8950-2012; Kellum, John A/HCH-2944-2022; Göbel, Ulrich/Q-7613-2016; Goebel, Ulrich M./AGG-1495-2022; Zahn, Peter/AAB-9377-2021; Kellum, John/AAP-3072-2020	Görlich, Dennis/0000-0002-2574-9419; Kellum, John A/0000-0003-1995-2653; Göbel, Ulrich/0000-0002-9991-3226; Kellum, John/0000-0003-1995-2653; NOIRI, Eisei/0000-0002-9515-7582	German Research Foundation [ZA428/6-1]	German Research Foundation(German Research Foundation (DFG))	The study was funded by the German Research Foundation (ZA428/6-1 to Dr Zarbock).	Ali ZA, 2007, CIRCULATION, V116, pI98, DOI 10.1161/circulationaha.106.679167; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Chertow GM, 1997, CIRCULATION, V95, P878; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Choi YS, 2011, J THORAC CARDIOV SUR, V142, P148, DOI 10.1016/j.jtcvs.2010.11.018; Dasta JF, 2008, NEPHROL DIAL TRANSPL, V23, P1970, DOI 10.1093/ndt/gfm908; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Domanski MJ, 2011, JAMA-J AM MED ASSOC, V305, P585, DOI 10.1001/jama.2011.99; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Endre ZH, 2011, KIDNEY INT, V80, P796, DOI 10.1038/ki.2011.193; Engler RL, 1996, CIRCULATION, V94, P2297, DOI 10.1161/01.CIR.94.9.2297; Gallagher SM, 2015, KIDNEY INT, V87, P473, DOI 10.1038/ki.2014.259; Gassanov N, 2014, J AM SOC NEPHROL, V25, P216, DOI 10.1681/ASN.2013070708; Gomez H, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000052; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hausenloy DJ, 2013, CARDIOVASC RES, V98, P7, DOI 10.1093/cvr/cvt004; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; Kharbanda RK, 2009, LANCET, V374, P1557, DOI 10.1016/S0140-6736(09)61421-5; Kottenberg E, 2012, ACTA ANAESTH SCAND, V56, P30, DOI 10.1111/j.1399-6576.2011.02585.x; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Landoni G, 2007, J CARDIOTHOR VASC AN, V21, P502, DOI 10.1053/j.jvca.2007.02.013; Landoni G, 2013, J CARDIOTHOR VASC AN, V27, P1384, DOI 10.1053/j.jvca.2013.06.028; Meersch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093460; Murphy GS, 2009, ANESTH ANALG, V108, P1394, DOI 10.1213/ane.0b013e3181875e2e; Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Ryckwaert F, 2002, CRIT CARE MED, V30, P1495, DOI 10.1097/00003246-200207000-00016; Thakar CV, 2007, AM J KIDNEY DIS, V50, P703, DOI 10.1053/j.ajkd.2007.07.021; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Thielmann M, 2013, LANCET, V382, P597, DOI 10.1016/S0140-6736(13)61450-6; Tsung A, 2014, J INTERN MED, V276, P425, DOI 10.1111/joim.12276; Venugopal V, 2010, AM J KIDNEY DIS, V56, P1043, DOI 10.1053/j.ajkd.2010.07.014; Wu HL, 2014, KIDNEY INT, V85, P824, DOI 10.1038/ki.2013.475; Yang QH, 2009, J INFECTION, V58, P459, DOI 10.1016/j.jinf.2009.04.003; Yu CH, 2006, CAN J ANAESTH, V53, P906, DOI 10.1007/BF03022834; Zappitelli M, 2009, KIDNEY INT, V76, P885, DOI 10.1038/ki.2009.270; Zimmerman RF, 2011, KIDNEY INT, V80, P861, DOI 10.1038/ki.2011.156	41	295	303	1	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2015	313	21					2133	2141		10.1001/jama.2015.4189	http://dx.doi.org/10.1001/jama.2015.4189			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ4CC	26024502	Bronze			2022-12-28	WOS:000355430900013
J	Ali, FR; Ho, P; Chaudhry, IH; Motta, L; Chalmers, RJG				Ali, Faisal R.; Ho, Pauline; Chaudhry, Iskander H.; Motta, Luisa; Chalmers, Robert J. G.			Dossekker's atypical tuberous myxoedema, a rare variant of scleromyxoedema	LANCET			English	Editorial Material									[Ali, Faisal R.; Chalmers, Robert J. G.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Royal Infirm, Dept Dermatol, Manchester, Lancs, England; [Ho, Pauline] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Royal Infirm, Kellgren Ctr Rheumatol, Manchester, Lancs, England; [Chaudhry, Iskander H.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Royal Infirm, Dept Cellular Pathol, Manchester, Lancs, England; [Motta, Luisa] Salford Royal NHS Fdn Trust, Dept Cellular Pathol, Eccles, England	University of Manchester; University of Manchester; University of Manchester; Salford Royal NHS Foundation Trust	Chalmers, RJG (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Salford Royal NHS Fdn Trust, Dermatol Ctr, Manchester M6 8HD, Lancs, England.	r.chalmers@man.ac.uk		Ali, Faisal/0000-0002-8588-791X				Dossekker W, 1916, ARCH DERMATOL SYPH-G, V123, P76, DOI 10.1007/BF01826221; Rongioletti F, 2001, J AM ACAD DERMATOL, V44, P273, DOI 10.1067/mjd.2001.111630; Rongioletti F, 2013, J AM ACAD DERMATOL, V69, P66, DOI 10.1016/j.jaad.2013.01.007	3	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 30	2015	385	9983					2222	2222		10.1016/S0140-6736(15)60734-6	http://dx.doi.org/10.1016/S0140-6736(15)60734-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ6DG	26068270				2022-12-28	WOS:000355583000033
J	Croce, R				Croce, Roberta			A close view of photosystem I	SCIENCE			English	Editorial Material							ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE		Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Croce, R (corresponding author), Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands.	r.croce@vu.nl	Croce, Roberta/HGU-9554-2022; Croce, Roberta/ABG-3595-2021; Croce, Roberta/N-4067-2014	Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X				Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Blankenship RE, 2013, CURR OPIN CHEM BIOL, V17, P457, DOI 10.1016/j.cbpa.2013.03.031; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; Croce R, 2013, PHOTOSYNTH RES, V116, P153, DOI 10.1007/s11120-013-9838-x; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Nelson N, 2009, J NANOSCI NANOTECHNO, V9, P1709, DOI [10.1166/jnn.2009.S101, 10.1166/jnn.2009.SI01]; Ort DR, 2011, PLANT PHYSIOL, V155, P79, DOI 10.1104/pp.110.165886; Pan XW, 2013, CURR OPIN STRUC BIOL, V23, P515, DOI 10.1016/j.sbi.2013.04.004; Qin XC, 2015, SCIENCE, V348, P989, DOI 10.1126/science.aab0214; Sonoike K, 2011, PHYSIOL PLANTARUM, V142, P56, DOI 10.1111/j.1399-3054.2010.01437.x	12	8	11	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 29	2015	348	6238					970	971		10.1126/science.aab3387	http://dx.doi.org/10.1126/science.aab3387			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ1WU	26023121				2022-12-28	WOS:000355276600023
J	Lima-Mendez, G; Faust, K; Henry, N; Decelle, J; Colin, S; Carcillo, F; Chaffron, S; Ignacio-Espinosa, JC; Roux, S; Vincent, F; Bittner, L; Darzi, Y; Wang, J; Audic, S; Berline, L; Bontempi, G; Cabello, AM; Coppola, L; Cornejo-Castillo, FM; d'Ovidio, F; De Meester, L; Ferrera, I; Garet-Delmas, MJ; Guidi, L; Lara, E; Pesant, S; Royo-Llonch, M; Salazar, G; Sanchez, P; Sebastian, M; Souffreau, C; Dimier, C; Picheral, M; Searson, S; Kandels-Lewis, S; Gorsky, G; Not, F; Ogata, H; Speich, S; Stemmann, L; Weissenbach, J; Wincker, P; Acinas, SG; Sunagawa, S; Bork, P; Sullivan, MB; Karsenti, E; Bowler, C; de Vargas, C; Raes, J; Acinas, SG; Bork, P; Boss, E; Bowler, C; De Vargas, C; Follows, M; Gorsky, G; Grimsley, N; Hingamp, P; Iudicone, D; Jaillon, O; Kandels-Lewis, S; Karp-Boss, L; Karsenti, E; Krzic, U; Not, F; Ogata, H; Pesant, S; Raes, J; Reynaud, EG; Sardet, C; Sieracki, M; Speich, S; Stemmann, L; Sullivan, MB; Sunagawa, S; Velayoudon, D; Weissenbach, J; Wincker, P				Lima-Mendez, Gipsi; Faust, Karoline; Henry, Nicolas; Decelle, Johan; Colin, Sebastien; Carcillo, Fabrizio; Chaffron, Samuel; Ignacio-Espinosa, J. Cesar; Roux, Simon; Vincent, Flora; Bittner, Lucie; Darzi, Youssef; Wang, Jun; Audic, Stephane; Berline, Leo; Bontempi, Gianluca; Cabello, Ana M.; Coppola, Laurent; Cornejo-Castillo, Francisco M.; d'Ovidio, Francesco; De Meester, Luc; Ferrera, Isabel; Garet-Delmas, Marie-Jose; Guidi, Lionel; Lara, Elena; Pesant, Stephane; Royo-Llonch, Marta; Salazar, Guillem; Sanchez, Pablo; Sebastian, Marta; Souffreau, Caroline; Dimier, Celine; Picheral, Marc; Searson, Sarah; Kandels-Lewis, Stefanie; Gorsky, Gabriel; Not, Fabrice; Ogata, Hiroyuki; Speich, Sabrina; Stemmann, Lars; Weissenbach, Jean; Wincker, Patrick; Acinas, Silvia G.; Sunagawa, Shinichi; Bork, Peer; Sullivan, Matthew B.; Karsenti, Eric; Bowler, Chris; de Vargas, Colomban; Raes, Jeroen; Acinas, Silvia G.; Bork, Peer; Boss, Emmanuel; Bowler, Chris; De Vargas, Colomban; Follows, Michael; Gorsky, Gabriel; Grimsley, Nigel; Hingamp, Pascal; Iudicone, Daniele; Jaillon, Olivier; Kandels-Lewis, Stefanie; Karp-Boss, Lee; Karsenti, Eric; Krzic, Uros; Not, Fabrice; Ogata, Hiroyuki; Pesant, Stephane; Raes, Jeroen; Reynaud, Emmanuel G.; Sardet, Christian; Sieracki, Mike; Speich, Sabrina; Stemmann, Lars; Sullivan, Matthew B.; Sunagawa, Shinichi; Velayoudon, Didier; Weissenbach, Jean; Wincker, Patrick		Tara Oceans Coordinators	Determinants of community structure in the global plankton interactome	SCIENCE			English	Article							RIBOSOMAL-RNA SEQUENCES; SPATIAL COMPONENT; TOP-DOWN; MARINE; BACTERIA; NETWORK; MORPHOLOGY; INFECTION; EVOLUTION; MICROBES	Species interaction networks are shaped by abiotic and biotic factors. Here, as part of the Tara Oceans project, we studied the photic zone interactome using environmental factors and organismal abundance profiles and found that environmental factors are incomplete predictors of community structure. We found associations across plankton functional types and phylogenetic groups to be nonrandomly distributed on the network and driven by both local and global patterns. We identified interactions among grazers, primary producers, viruses, and (mainly parasitic) symbionts and validated networkgenerated hypotheses using microscopy to confirm symbiotic relationships. We have thus provided a resource to support further research on ocean food webs and integrating biological components into ocean models.	[Lima-Mendez, Gipsi; Faust, Karoline; Carcillo, Fabrizio; Chaffron, Samuel; Wang, Jun; Raes, Jeroen] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Herestr 49, B-3000 Leuven, Belgium; [Lima-Mendez, Gipsi; Faust, Karoline; Carcillo, Fabrizio; Chaffron, Samuel; Vincent, Flora; Darzi, Youssef; Wang, Jun; Raes, Jeroen] VIB, VIB Ctr Biol Dis, B-3000 Leuven, Belgium; [Lima-Mendez, Gipsi; Faust, Karoline; Carcillo, Fabrizio; Chaffron, Samuel; Darzi, Youssef; Raes, Jeroen] Vrije Univ Brussel, Dept Appl Biol Sci DBIT, B-1050 Brussels, Belgium; [Henry, Nicolas; Decelle, Johan; Colin, Sebastien; Bittner, Lucie; Audic, Stephane; Garet-Delmas, Marie-Jose; Dimier, Celine; Not, Fabrice; de Vargas, Colomban] CNRS, UMR 7144, Stn Biol Roscoff, F-29680 Roscoff, France; [Henry, Nicolas; Decelle, Johan; Colin, Sebastien; Bittner, Lucie; Audic, Stephane; Garet-Delmas, Marie-Jose; Dimier, Celine; Not, Fabrice; de Vargas, Colomban] Univ Paris 06, Sorbonne Univ, UMR 7144, Stn Biol Roscoff, F-29680 Roscoff, France; [Colin, Sebastien; Vincent, Flora; Bittner, Lucie; Dimier, Celine; Karsenti, Eric; Bowler, Chris] Ecole Normale Super, IBENS, Inserm U1024, CNRS UMR 8197, F-75005 Paris, France; [Carcillo, Fabrizio; Bontempi, Gianluca] Univ Libre Bruxelles, Dept Comp Sci, ULB Machine Learning Grp, Interuniv Inst Bioinformat Brussels, Brussels, Belgium; [Ignacio-Espinosa, J. Cesar; Sullivan, Matthew B.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Bittner, Lucie] CNRS, FR3631, Inst Biol Paris Seine, F-75005 Paris, France; [Berline, Leo; Coppola, Laurent; Guidi, Lionel; Picheral, Marc; Searson, Sarah; Gorsky, Gabriel; Stemmann, Lars] CNRS, UMR 7093, LOV, Observ Oceanol, F-06230 Villefranche Sur Mer, France; [Berline, Leo; Coppola, Laurent; Guidi, Lionel; Picheral, Marc; Searson, Sarah; Gorsky, Gabriel; Stemmann, Lars] Univ Paris 06, Sorbonne Univ, UMR 7093, LOV,Observ Oceanol, F-06230 Villefranche Sur Mer, France; [Cabello, Ana M.; Cornejo-Castillo, Francisco M.; Ferrera, Isabel; Lara, Elena; Royo-Llonch, Marta; Salazar, Guillem; Sanchez, Pablo; Sebastian, Marta; Acinas, Silvia G.] CSIC, Inst Marine Sci ICM, Dept Marine Biol & Oceanog, E-08003 Barcelona, Spain; [d'Ovidio, Francesco] Univ Paris 06, Sorbonne Univ, CNRS, Museum Natl Hist Nat,Inst Rech & Dev,LOCEAN Lab, F-75005 Paris, France; [De Meester, Luc; Souffreau, Caroline] Katholieke Univ Leuven, Lab Aquat Ecol Evolut & Conservat, B-3000 Leuven, Belgium; [Pesant, Stephane] Univ Bremen, Data Publisher Earth & Environm Sci, PANGAEA, D-28359 Bremen, Germany; Univ Bremen, Ctr Marine Environm Sci, MARUM, D-28359 Bremen, Germany; [Kandels-Lewis, Stefanie; Sunagawa, Shinichi; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol, D-69117 Heidelberg, Germany; [Kandels-Lewis, Stefanie; Karsenti, Eric] European Mol Biol Lab, Directors Res, D-69117 Heidelberg, Germany; [Ogata, Hiroyuki] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Speich, Sabrina] Ecole Normale Super, LMD, Dept Geosci, F-75231 Paris 05, France; [Speich, Sabrina] UBO, IUEM, Lab Phys Ocean, F-29820 Plouzane, France; [Weissenbach, Jean; Wincker, Patrick] CEA, Genoscope, F-91000 Evry, France; [Weissenbach, Jean; Wincker, Patrick] CNRS, UMR 8030, F-91000 Evry, France; [Weissenbach, Jean; Wincker, Patrick] Univ Evry, UMR 8030, CP5706, Evry, France; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Acinas, Silvia G.] CSIC, Inst Marine Sci ICM, Dept Marine Biol & Oceanog, Barcelona, Spain; [Bork, Peer; Kandels-Lewis, Stefanie; Sunagawa, Shinichi] European Mol Biol Lab, Struct & Computat Biol, Heidelberg, Germany; [Boss, Emmanuel; Karp-Boss, Lee] Univ Maine, Sch Marine Sci, Orono, ME USA; [Bowler, Chris; Karsenti, Eric] Ecole Normale Super, INSERM, CNRS,Unite Mixte Rech 8197,U1024, Environm & Evolutionary Genom Sect,Inst Biol, Paris, France; [De Vargas, Colomban; Not, Fabrice] CNRS, UMR 7144, Stn Biol Roscoff, Roscoff, France; [De Vargas, Colomban; Not, Fabrice] Univ Paris 06, Sorbonne Univ, UMR 7144, Stn Biol Roscoff, Roscoff, France; [Follows, Michael] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA USA; [Gorsky, Gabriel; Sardet, Christian; Stemmann, Lars] CNRS, UMR 7093, Lab Oceanog Villefranche LOV, Observ Oceanol, F-06230 Villefranche Sur Mer, France; [Gorsky, Gabriel] Univ Paris 06, Sorbonne Univ, UMR 7093, Lab Oceanog Villefranche LOV,Observ Oceanol, F-06230 Villefranche Sur Mer, France; [Grimsley, Nigel] CNRS, UMR 7232, BIOM, Banyuls Sur Mer, France; [Grimsley, Nigel] Univ Paris 06, Sorbonne Univ, OOB, Banyuls Sur Mer, France; [Hingamp, Pascal] Aix Marseille Univ, CNRS, IGS UMR 7256, Marseille, France; [Iudicone, Daniele] Lab Ecol & Evolut Plankton, Stn Zool Anton Dohrn, Naples, Italy; [Jaillon, Olivier; Weissenbach, Jean; Wincker, Patrick] CEA, Genoscope, Evry, France; [Jaillon, Olivier; Weissenbach, Jean; Wincker, Patrick] CNRS, UMR 8030, Evry, France; [Jaillon, Olivier; Weissenbach, Jean; Wincker, Patrick] Univ Evry, UMR 8030, Evry, France; [Karsenti, Eric] European Mol Biol Lab, Directors Res, Heidelberg, Germany; [Krzic, Uros] European Mol Biol Lab, Cell Biol Biophys, Heidelberg, Germany; [Ogata, Hiroyuki] Kyoto Univ, Inst Chem Res, Kyoto 606, Japan; [Pesant, Stephane] Univ Bremen, PANGAEA, Data Publisher Earth & Environm Sci, D-28359 Bremen, Germany; [Pesant, Stephane] Univ Bremen, MARUM, Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Raes, Jeroen] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Leuven, Belgium; [Raes, Jeroen] VIB, Ctr Biol Dis, Leuven, Belgium; [Raes, Jeroen] Vrije Univ Brussel, Microbiol Lab, Brussels, Belgium; [Reynaud, Emmanuel G.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Sieracki, Mike] Bigelow Lab Ocean Sci, East Boothbay, ME USA; [Speich, Sabrina] Ecole Normale Super, Dept Geosci, Lab Meteorol Dynam, 24 Rue Lhomond, F-75231 Paris, France; [Speich, Sabrina] UBO IUEM, Lab Phys Ocean, Polouzane, France; [Sullivan, Matthew B.] Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA; [Velayoudon, Didier] DVIP Consulting, Sevres, France	KU Leuven; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Libre de Bruxelles; University of Arizona; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; KU Leuven; University of Bremen; University of Bremen; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Kyoto University; Ecole des Ponts ParisTech; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); European Molecular Biology Laboratory (EMBL); University of Maine System; University of Maine Orono; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Stazione Zoologica Anton Dohrn di Napoli; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Kyoto University; University of Bremen; University of Bremen; KU Leuven; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University College Dublin; Bigelow Laboratory for Ocean Sciences; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; University of Arizona	Raes, J (corresponding author), Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Herestr 49, B-3000 Leuven, Belgium.	karsenti@embl.de; cbowler@biologie.ens.fr; vargas@sb-roscoff.fr; jeroen.raes@vib-kuleuven.be	Roux, Simon/ABE-6255-2020; Royo-Llonch, Marta/AAA-2351-2019; Darzi, Youssef/I-8920-2019; Bork, Peer/F-1813-2013; Bittner, Lucie/ABF-4617-2020; Reynaud, Emamnuel/H-2928-2019; Sullivan, Matthew B/H-3256-2011; Sebastian, Marta/ABE-2946-2021; Boss, Emmanuel/AAF-2336-2019; stemmann, lars/E-6899-2011; Ferrera, Isabel/L-7200-2014; Hingamp, Pascal/AAO-1382-2020; Bontempi, Gianluca/ABE-4365-2020; Bontempi, Gianluca/J-7121-2012; Coppola, Laurent/M-3776-2019; Lima-Mendez, Gipsi/AAV-4158-2021; Sebastian, Marta/J-9856-2014; Sunagawa, Shinichi/Q-5950-2019; Berline, Leo/AAJ-5885-2021; Acinas, Silvia/F-7462-2016; Lima-Mendez, Gipsi/AAX-6291-2021; Bowler, Chris/AAC-6256-2019; De Meester, Luc/F-3832-2015; Jaillon, Olivier/GRY-6287-2022; Bittner, Lucie/AAD-8921-2019; Guidi, Lionel/B-3977-2012; Chaffron, Samuel/B-2300-2012; Grimsley, Nigel/O-1359-2015; raes, jeroen/D-7835-2018; Speich, Sabrina/L-3780-2014; d'Ovidio, Francesco/ABA-8461-2021; Royo-Llonch, Marta/H-9255-2015; Salazar, Guillem/L-5868-2014; Faust, Karoline/P-7578-2017; Berline, Leo/AAM-8802-2021; Chaffron, Samuel/K-1104-2019; stemmann, lars/Q-8458-2019; Coppola, Laurent/F-7880-2017; Sanchez, Pablo/H-8992-2015	Roux, Simon/0000-0002-5831-5895; Royo-Llonch, Marta/0000-0003-2966-9093; Darzi, Youssef/0000-0001-7655-5764; Bork, Peer/0000-0002-2627-833X; Reynaud, Emamnuel/0000-0003-1502-661X; Sullivan, Matthew B/0000-0003-4040-9831; Boss, Emmanuel/0000-0002-8334-9595; Ferrera, Isabel/0000-0003-3484-516X; Hingamp, Pascal/0000-0002-7463-2444; Bontempi, Gianluca/0000-0001-8621-316X; Bontempi, Gianluca/0000-0001-8621-316X; Coppola, Laurent/0000-0003-0473-1129; Lima-Mendez, Gipsi/0000-0002-5309-1845; Sebastian, Marta/0000-0001-7175-8941; Sunagawa, Shinichi/0000-0003-3065-0314; Acinas, Silvia/0000-0002-3439-0428; Lima-Mendez, Gipsi/0000-0002-5309-1845; De Meester, Luc/0000-0001-5433-6843; Bittner, Lucie/0000-0001-8291-7063; Guidi, Lionel/0000-0002-6669-5744; Chaffron, Samuel/0000-0001-5903-617X; Grimsley, Nigel/0000-0001-9323-417X; raes, jeroen/0000-0002-1337-041X; Speich, Sabrina/0000-0002-5452-8287; Royo-Llonch, Marta/0000-0003-2966-9093; Salazar, Guillem/0000-0002-9786-1493; Faust, Karoline/0000-0001-7129-2803; Chaffron, Samuel/0000-0001-5903-617X; stemmann, lars/0000-0001-8935-4531; Coppola, Laurent/0000-0003-0473-1129; Sanchez, Pablo/0000-0003-2787-822X; de Vargas, Colomban/0000-0002-6476-6019; Bowler, Chris/0000-0003-3835-6187; d'Ovidio, Francesco/0000-0002-9664-7778; PESANT, Stephane/0000-0002-4936-5209; Wang, Jun/0000-0002-8859-7707; Henry, Nicolas/0000-0002-7702-1382; Gorsky, Gabriel/0000-0002-1099-8711; Decelle, Johan/0000-0002-4343-8358; Berline, Leo/0000-0002-5831-7399; Cornejo-Castillo, Francisco M./0000-0001-8431-9278; Lara, Elena/0000-0002-4625-348X; Ignacio Espinoza, J. Cesar/0000-0001-9303-7504; VINCENT, Flora/0000-0001-6976-3004; Cabello Perez, Ana Maria/0000-0002-7165-5632; Jaillon, Olivier/0000-0002-7237-9596; Audic, Stephane/0000-0001-6193-4374; Iudicone, Daniele/0000-0002-7473-394X	Centre National de la Recherche Scientifique (CNRS) [GDR3280]; European Molecular Biology Laboratory (EMBL); Genoscope/CEA; VIB; Stazione Zoologica Anton Dohrn; UNIMIB; Fund for Scientific Research - Flanders; Rega Institute, KU Leuven; French Ministry of Research; French Government [ANR-11-BTBR-0008, ANR-10-INBS-09-08, ANR-10-LABX-54]; PSL* Research University [ANR-11-IDEX-0001-02]; ANR [POSEIDON/ANR-09-BLAN-0348, PHYTBACK/ANR-2010-1709-01, PROMETHEUS/ANR-09-PCS-GENM-217, TARA GIRUS/ANR-09-PCS-GENM-218]; European Union [287589, IHMS/HEALTH-F4-2010-261376]; European Union (EC) [294823]; Gordon and Betty Moore Foundation [3790]; Spanish Ministry of Science and Innovation [CGL2011-26848/BOS]; Agencia de Gesto d'Ajusts Universitaris i Reserca [CONES 2010-0036]; JSPS [26430184]; FWO, BIO5, Biosphere 2; Agnes b.; Veolia Environment Foundation; Region Bretagne; Lorient Agglomeration; World Courier; Illumina; EDF Foundation; FRB; Prince Albert II de Monaco Foundation; Etienne Bourgois; Tara schooner; French Ministry of Foreign Affairs; EBI [PRJEB402, PRJEB6610]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); European Molecular Biology Laboratory (EMBL); Genoscope/CEA; VIB; Stazione Zoologica Anton Dohrn; UNIMIB; Fund for Scientific Research - Flanders(FWO); Rega Institute, KU Leuven; French Ministry of Research(Ministry of Research, FranceEuropean Commission); French Government; PSL* Research University; ANR(French National Research Agency (ANR)); European Union(European Commission); European Union (EC)(European CommissionEuropean Commission Joint Research Centre); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia de Gesto d'Ajusts Universitaris i Reserca; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); FWO, BIO5, Biosphere 2; Agnes b.; Veolia Environment Foundation; Region Bretagne(Region Bretagne); Lorient Agglomeration; World Courier; Illumina; EDF Foundation; FRB; Prince Albert II de Monaco Foundation; Etienne Bourgois; Tara schooner; French Ministry of Foreign Affairs; EBI	We thank the commitment of the following people and sponsors: Centre National de la Recherche Scientifique (CNRS) (in particular, Groupement de Recherche GDR3280), European Molecular Biology Laboratory (EMBL), Genoscope/CEA, VIB, Stazione Zoologica Anton Dohrn, UNIMIB, Fund for Scientific Research - Flanders (G.L.M., K.F., S.C., and J.R.), Rega Institute (J.R.), KU Leuven (J.R.), The French Ministry of Research, the French Government "Investissements d'Avenir" programmes OCEANOMICS (ANR-11-BTBR-0008), FRANCE GENOMIQUE (ANR-10-INBS-09-08), MEMO LIFE (ANR-10-LABX-54), PSL* Research University (ANR-11-IDEX-0001-02), ANR (projects POSEIDON/ANR-09-BLAN-0348, PHYTBACK/ANR-2010-1709-01, PROMETHEUS/ANR-09-PCS-GENM-217, TARA GIRUS/ANR-09-PCS-GENM-218, European Union FP7 (MicroB3/No. 287589, IHMS/HEALTH-F4-2010-261376, ERC Advanced Grant Awards to CB (Diatomite: 294823), Gordon and Betty Moore Foundation grant (3790) to M.B.S., Spanish Ministry of Science and Innovation grant CGL2011-26848/BOS MicroOcean PANGENOMICS to S.G.A., TANIT (CONES 2010-0036) from the Agencia de Gesto d'Ajusts Universitaris i Reserca funded to S.G.A., JSPS KAKENHI grant number 26430184 to H.O., FWO, BIO5, Biosphere 2, Agnes b., the Veolia Environment Foundation, Region Bretagne, Lorient Agglomeration, World Courier, Illumina, the EDF Foundation, FRB, the Prince Albert II de Monaco Foundation, Etienne Bourgois, the Tara schooner, and its captain and crew. We are also grateful to the French Ministry of Foreign Affairs for supporting the expedition and to the countries that graciously granted sampling permissions. Tara Oceans would not exist without continuous support from 23 institutes (http://oceans.taraexpeditions.org). We also acknowledge the EMBL Advanced Light Microscopy Facility (ALMF), and in particular R. Pepperkok. The authors further declare that all data reported herein are fully and freely available from the date of publication, with no restrictions, and that all of the samples, analyses, publications, and ownership of data are free from legal entanglement or restriction of any sort by the various nations whose waters the Tara Oceans expedition sampled in. Data described herein is available at www.raeslab.org/companion/ocean-interactome.html, at the EBI under the projects PRJEB402 and PRJEB6610, and at Pangaea http://doi.pangaea.de/10.1594/PANGAEA. 840721, http://doi.pangaea.de/10.1594/PANGAEA. 840718, http://doi.pangaea.de/10.1594/PANGAEA. 843018 and http://doi.pangaea.de/10.1594/PANGAEA. 843022 and on table S1. The data release policy regarding future public release of Tara Oceans data are described in Pesant et al. (67). All authors approved the final manuscript. This article is contribution number 25 of Tara Oceans. The supplementary materials contain additional data.	Assmy P., 2009, ENCY MICROBIOLOGY, P27, DOI DOI 10.1016/B978-012373944-5.00001-8; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Beman JM, 2011, ISME J, V5, P1077, DOI 10.1038/ismej.2010.204; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Brum J. R., 2014, SCIENCE, V348, pXXX; Cachon J., 1964, Annales des Sciences Naturelles (12), V6, P1; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Chambouvet A, 2008, SCIENCE, V322, P1254, DOI 10.1126/science.1164387; Chow CET, 2014, ISME J, V8, P816, DOI 10.1038/ismej.2013.199; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; de Vargas C., 2014, SCIENCE, V348, pXXX; Decelle J, 2012, P NATL ACAD SCI USA, V109, P18000, DOI 10.1073/pnas.1212303109; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Feizi S, 2013, NAT BIOTECHNOL, V31, P726, DOI 10.1038/nbt.2635; Fuhrman JA, 2015, NAT REV MICROBIOL, V13, P133, DOI 10.1038/nrmicro3417; Gasol J. M., 1997, BIOMASS DISTRIBUTION, V42; Gast RJ, 2000, J PHYCOL, V36, P172, DOI 10.1046/j.1529-8817.2000.99133.x; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gomez F, 2011, ENVIRON MICROBIOL, V13, P193, DOI 10.1111/j.1462-2920.2010.02320.x; Gomez F, 2009, SYST PARASITOL, V74, P65, DOI 10.1007/s11230-009-9199-1; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; JOLLEY ET, 1977, BRIT PHYCOL J, V12, P315, DOI 10.1080/00071617700650341; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Le Quere C, 2005, GLOBAL CHANGE BIOL, V11, P2016, DOI 10.1111/j.1365-2468.2005.01004.x; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; Mahe F, 2014, PEERJ, V2, DOI 10.7717/peerj.593; Martinez-Garcia M, 2012, ISME J, V6, P703, DOI 10.1038/ismej.2011.126; McManus G. B., 2012, THE BIOLOGY AND ECOL; Meot A, 1998, ENVIRON ECOL STAT, V5, P1, DOI 10.1023/A:1009693501830; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Miller TR, 2004, APPL ENVIRON MICROB, V70, P3383, DOI 10.1128/AEM.70.6.3383-3391.2004; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Ohtsuka S, 2004, MAR ECOL PROG SER, V282, P129, DOI 10.3354/meps282129; Pesant S., 2015, OPEN SCIENCE RESOURC; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raes J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.6; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; Sabo J. L., 2014, TROPHIC ECOLOGY; Salomon PS, 2009, AQUAT MICROB ECOL, V55, P143, DOI 10.3354/ame01293; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Skovgaard A, 2014, ACTA PROTOZOOL, V53, P51, DOI 10.4467/16890027AP.14.006.1443; Skovgaard A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00305; Smetacek V, 2012, J BIOSCIENCES, V37, P589, DOI 10.1007/s12038-012-9240-4; Stemmann L, 2008, ICES J MAR SCI, V65, P433, DOI 10.1093/icesjms/fsn010; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Sunagawa S., 2014, SCIENCE, V348, pXXX; Thompson AW, 2012, SCIENCE, V337, P1546, DOI 10.1126/science.1222700; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; Villar E., 2014, SCIENCE, V348, pXXX; von der Heyden S, 2004, J EUKARYOT MICROBIOL, V51, P402; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward BA, 2014, J PLANKTON RES, V36, P31, DOI 10.1093/plankt/fbt097; Weitz JS, 2013, TRENDS MICROBIOL, V21, P82, DOI 10.1016/j.tim.2012.11.003; Worden AZ, 2015, SCIENCE, V347, DOI 10.1126/science.1257594; Xin L., 2009, WEB INTELLIGENCE AND, V1, P50	69	503	517	42	545	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 22	2015	348	6237							1262073	10.1126/science.1262073	http://dx.doi.org/10.1126/science.1262073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI6NW	25999517	Green Submitted			2022-12-28	WOS:000354877900035
J	Fan, WW; Evans, RM				Fan, Weiwei; Evans, Ronald M.			Turning Up the Heat on Membrane Fluidity	CELL			English	Editorial Material							ELEGANS	How do cells maintain the fluidity of cellular membrane in response to temperature fluctuation? In this issue of Cell, Ma et al. identify a regulatory circuit involving a heat-induced acyl-CoA dehydrogenase that controls the lipid saturation level and the fluidity of cellular membranes by transcriptionally regulating a lipid desaturase.	[Fan, Weiwei; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	evans@salk.edu	Frank, Viki/GXZ-9902-2022; Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965				IZAI K, 1992, J BIOL CHEM, V267, P1027; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Mullican SE, 2013, J MOL ENDOCRINOL, V51, pT115, DOI 10.1530/JME-13-0212; Murray P, 2007, P NATL ACAD SCI USA, V104, P5489, DOI 10.1073/pnas.0609590104; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; Svensk E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003801; Svensson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021343; Tiku PE, 1996, SCIENCE, V271, P815, DOI 10.1126/science.271.5250.815; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053	9	20	20	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					962	963		10.1016/j.cell.2015.04.046	http://dx.doi.org/10.1016/j.cell.2015.04.046			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000475	Bronze			2022-12-28	WOS:000355152600004
J	Klein, AM; Mazutis, L; Akartuna, I; Tallapragada, N; Veres, A; Li, V; Peshkin, L; Weitz, DA; Kirschner, MW				Klein, Allon M.; Mazutis, Linas; Akartuna, Ilke; Tallapragada, Naren; Veres, Adrian; Li, Victor; Peshkin, Leonid; Weitz, David A.; Kirschner, Marc W.			Droplet Barcoding for Single-Cell Transcriptomics Applied to Embryonic Stem Cells	CELL			English	Article							GENE-EXPRESSION; RNA-SEQ; NAIVE PLURIPOTENCY; SELF-RENEWAL; HETEROGENEITY; DIFFERENTIATION; IDENTIFICATION; MICROFLUIDICS; STOCHASTICITY; PATHWAYS	It has long been the dream of biologists to map gene expression at the single-cell level. With such data one might track heterogeneous cell sub-populations, and infer regulatory relationships between genes and pathways. Recently, RNA sequencing has achieved single-cell resolution. What is limiting is an effective way to routinely isolate and process large numbers of individual cells for quantitative in-depth sequencing. We have developed a high-throughput droplet-microfluidic approach for barcoding the RNA from thousands of individual cells for subsequent analysis by next-generation sequencing. The method shows a surprisingly low noise profile and is readily adaptable to other sequencing-based assays. We analyzed mouse embryonic stem cells, revealing in detail the population structure and the heterogeneous onset of differentiation after leukemia inhibitory factor (LIF) withdrawal. The reproducibility of these high-throughput single-cell data allowed us to deconstruct cell populations and infer gene expression relationships.	[Klein, Allon M.; Tallapragada, Naren; Veres, Adrian; Li, Victor; Peshkin, Leonid; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Mazutis, Linas; Akartuna, Ilke; Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Mazutis, Linas] Vilnius Univ Inst Biotechnol, LT-02241 Vilnius, Lithuania; [Veres, Adrian] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Veres, Adrian] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Vilnius University; Harvard University; Harvard University	Weitz, DA (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	weitz@seas.harvard.edu; marc@hms.harvard.edu	Mazutis, Linas/A-5408-2012	Mazutis, Linas/0000-0002-5552-6427; Veres, Adrian/0000-0002-3849-3475; Peshkin, Leonid/0000-0002-6420-848X	NIH SCAP [R21DK098818]; Burroughs-Wellcome Fund; Marie Curie International Outgoing Fellowship [300121]; HSCI Medical Scientist Training Fellowship; Harvard Presidential Scholars Fund; NIH [5R01HD073104-03, R01 GM026875, R01 GM103785, R01 HD073104, P01HL120839]; NSF [DMR-1310266]; Harvard Materials Research Science and Engineering Center [DMR-1420570]; DARPA [HR0011-11-C-0093]; Direct For Mathematical & Physical Scien [1310266] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073104] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL120839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK098818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103785, R01GM026875, P01GM096971] Funding Source: NIH RePORTER	NIH SCAP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Marie Curie International Outgoing Fellowship(European Commission); HSCI Medical Scientist Training Fellowship; Harvard Presidential Scholars Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Harvard Materials Research Science and Engineering Center(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Mira Guo for guidance in hydrogel synthesis; Diego Jaitin for guidance on the CEL-SEQ/MARS-SEQ protocol; Clarissa Scholes and Angela DePace for feedback and for creating Figures 1 and 3; Rebecca Ward for help in editing. This study was supported by NIH SCAP Grant R21DK098818. A.M.K. holds a Career Award at the Scientific Interface from the Burroughs-Wellcome Fund; L.M. holds a Marie Curie International Outgoing Fellowship (300121); A.V. is supported by the HSCI Medical Scientist Training Fellowship and the Harvard Presidential Scholars Fund. L.P. is supported by NIH Grant 5R01HD073104-03. Work in the M.W.K. lab was supported by NIH (R01 GM026875, R01 GM103785, R01 HD073104), and in the D.A.W. lab by NSF (DMR-1310266), the Harvard Materials Research Science and Engineering Center (DMR-1420570), DARPA (HR0011-11-C-0093), and NIH (P01HL120839). A.M.K., L.M., I.A., D.A.W. and M.W.K. have submitted patent applications (US62/065,348, US62/066,188, US62/072,944) for the work described.	Abate AR, 2009, LAB CHIP, V9, P2628, DOI 10.1039/b909386a; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Ariasi AM, 2011, CURR OPIN CELL BIOL, V23, P650, DOI 10.1016/j.ceb.2011.09.007; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Baret JC, 2009, LAB CHIP, V9, P1850, DOI 10.1039/b902504a; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chiang MK, 2003, DEV CELL, V4, P383, DOI 10.1016/S1534-5807(03)00035-2; Eastburn DJ, 2013, ANAL CHEM, V85, P8016, DOI 10.1021/ac402057q; Faast R, 2004, ONCOGENE, V23, P491, DOI 10.1038/sj.onc.1207133; Fu GK, 2011, P NATL ACAD SCI USA, V108, P9026, DOI 10.1073/pnas.1017621108; Gao F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01588; Golan-Mashiach M, 2004, FASEB J, V18, P147, DOI 10.1096/fj.04-2417fje; Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Guo MT, 2012, LAB CHIP, V12, P2146, DOI 10.1039/c2lc21147e; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; He F, 2009, J BIOTECHNOL, V144, P190, DOI 10.1016/j.jbiotec.2009.07.013; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kegl B., 2002, ADV NEUR INF PROC SY; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Lecault V, 2012, CURR OPIN CHEM BIOL, V16, P381, DOI 10.1016/j.cbpa.2012.03.022; Li A, 2007, BIOINFORMATICS, V23, P222, DOI 10.1093/bioinformatics/btl581; Loewer A, 2011, CURR OPIN GENET DEV, V21, P753, DOI 10.1016/j.gde.2011.09.010; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Marcenko V. A., 1967, MATH USSR, V1, P457, DOI [10.1070/SM1967v001n04ABEH001994, DOI 10.1070/SM1967V001N04ABEH001994]; Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Ohnishi Y, 2014, NAT CELL BIOL, V16, P27, DOI 10.1038/ncb2881; OKA C, 1995, DEVELOPMENT, V121, P3291; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Phillips Jennifer, 1996, Methods (Orlando), V10, P283, DOI 10.1006/meth.1996.0104; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Plerou V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066126; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Scerbo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085104; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Streets AM, 2014, P NATL ACAD SCI USA, V111, P7048, DOI 10.1073/pnas.1402030111; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Teh SY, 2008, LAB CHIP, V8, P198, DOI 10.1039/b715524g; Torres-Padilla ME, 2014, DEVELOPMENT, V141, P2173, DOI 10.1242/dev.102624; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wardle FC, 2004, DEVELOPMENT, V131, P4687, DOI 10.1242/dev.01340; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Yang SH, 2014, CELL REP, V7, P1968, DOI 10.1016/j.celrep.2014.05.037	63	1749	1925	37	623	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1187	1201		10.1016/j.cell.2015.04.044	http://dx.doi.org/10.1016/j.cell.2015.04.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000487	Green Accepted, Bronze			2022-12-28	WOS:000355152600024
J	Sarris, PF; Duxbury, Z; Huh, SU; Ma, Y; Segonzac, C; Sklenar, J; Derbyshire, P; Cevik, V; Rallapalli, G; Saucet, SB; Wirthmueller, L; Menke, FLH; Sohn, KH; Jones, JDG				Sarris, Panagiotis F.; Duxbury, Zane; Huh, Sung Un; Ma, Yan; Segonzac, Cecile; Sklenar, Jan; Derbyshire, Paul; Cevik, Volkan; Rallapalli, Ghanasyam; Saucet, Simon B.; Wirthmueller, Lennart; Menke, Frank L. H.; Sohn, Kee Hoon; Jones, Jonathan D. G.			A Plant Immune Receptor Detects Pathogen Effectors that Target WRKY Transcription Factors	CELL			English	Article							RESISTANCE PROTEIN; DISEASE-RESISTANCE; DNA-BINDING; FLAX RUST; BACTERIAL LIGANDS; DEFENSE RESPONSES; ARABIDOPSIS EDS1; STRUCTURAL BASIS; GENE-PRODUCTS; NLR FUNCTIONS	Defense against pathogens in multicellular eukaryotes depends on intracellular immune receptors, yet surveillance by these receptors is poorly understood. Several plant nucleotide-binding, leucinerich repeat (NB-LRR) immune receptors carry fusions with other protein domains. The Arabidopsis RRS1-R NB-LRR protein carries a C-terminal WRKY DNA binding domain and forms a receptor complex with RPS4, another NB-LRR protein. This complex detects the bacterial effectors AvrRps4 or PopP2 and then activates defense. Both bacterial proteins interact with the RRS1 WRKY domain, and PopP2 acetylates lysines to block DNA binding. PopP2 and AvrRps4 interact with other WRKY domain-containing proteins, suggesting these effectors interfere with WRKY transcription factor-dependent defense, and RPS4/RRS1 has integrated a "decoy'' domain that enables detection of effectors that target WRKY proteins. We propose that NB-LRR receptor pairs, one member of which carries an additional protein domain, enable perception of pathogen effectors whose function is to target that domain.	[Sarris, Panagiotis F.; Duxbury, Zane; Huh, Sung Un; Ma, Yan; Sklenar, Jan; Derbyshire, Paul; Cevik, Volkan; Rallapalli, Ghanasyam; Saucet, Simon B.; Wirthmueller, Lennart; Menke, Frank L. H.; Jones, Jonathan D. G.] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Segonzac, Cecile; Sohn, Kee Hoon] Massey Univ, Inst Agr & Environm, Bioprotect Res Ctr, Palmerston North 4442, New Zealand	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Massey University	Sarris, PF (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	panagiotis.sarris@tsl.ac.uk; jonathan.jones@tsl.ac.uk	Jones, Jonathan DG/J-5129-2012; Huh, Sung/AAF-5832-2020; Sarris, Panagiotis F./N-9978-2015; Wirthmueller, Lennart/H-3310-2019; Menke, Frank/F-2739-2014	Jones, Jonathan DG/0000-0002-4953-261X; Wirthmueller, Lennart/0000-0003-0667-5343; Rallapalli, Ghanasyam/0000-0002-7268-7759; Saucet, Simon/0000-0002-0255-3886; Ma, Yan/0000-0003-3663-9060; Sarris, Panagiotis/0000-0001-7000-8997; Menke, Frank/0000-0003-2490-4824; Huh, Sung Un/0000-0003-2288-9579; Duxbury, Zane/0000-0001-8623-0525; Segonzac, Cecile/0000-0002-5537-7556	Rural Development Administration (Korea) Project [PJ007850201006]; Gatsby Foundation (UK); EC FP7-PEOPLE-Intra-European Fellowships [299621]; Biotechnology and Biological Sciences Research Council (BBSRC) grant [BB/M008193/1]; ERC Advanced Investigator grant; BBSRC grant [BB/K003550/1, BB/K009176/1]; BBSRC [BB/K003550/1, BB/M008193/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K003550/1, BB/M008193/1] Funding Source: researchfish	Rural Development Administration (Korea) Project(Rural Development Administration (RDA), Republic of Korea); Gatsby Foundation (UK); EC FP7-PEOPLE-Intra-European Fellowships; Biotechnology and Biological Sciences Research Council (BBSRC) grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC Advanced Investigator grant; BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Rural Development Administration (Korea) Project PJ007850201006, and the Gatsby Foundation (UK) for funding. P.F.S was supported by the EC FP7-PEOPLE-2011-Intra-European Fellowships (299621) and by Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/M008193/1. V.C. was supported by ERC Advanced Investigator grant to J.D.G.J. "ALBUGON.'' G.R. was supported by BBSRC grant BB/K003550/1. L.W. was supported by BBSRC grant BB/K009176/1. We thank Icon Genetics and S. Marillonnet for early access to vectors, and Jeff Dangl, Mark Nishimura, Mark Banfield, Jane Parker, and Laurent Deslandes for helpful discussions.	Bhattacharjee S, 2011, SCIENCE, V334, P1405, DOI 10.1126/science.1211592; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Birker D, 2009, PLANT J, V60, P602, DOI 10.1111/j.1365-313X.2009.03984.x; Catanzariti AM, 2010, MOL PLANT MICROBE IN, V23, P49, DOI 10.1094/MPMI-23-1-0049; Cesari S, 2014, EMBO J, V33, P1941, DOI 10.15252/embj.201487923; Cesari S, 2013, PLANT CELL, V25, P1463, DOI 10.1105/tpc.112.107201; Chi YJ, 2013, MOL PLANT, V6, P287, DOI 10.1093/mp/sst026; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Duan MR, 2007, NUCLEIC ACIDS RES, V35, P1145, DOI 10.1093/nar/gkm001; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; FOGH RH, 1994, EMBO J, V13, P3936, DOI 10.1002/j.1460-2075.1994.tb06709.x; Gassmann W, 1999, PLANT J, V20, P265, DOI 10.1046/j.1365-313X.1999.t01-1-00600.x; Heidrich K, 2011, SCIENCE, V334, P1401, DOI 10.1126/science.1211641; Jacob F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00297; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Le Roux C, 2015, CELL, V161, P1074, DOI 10.1016/j.cell.2015.04.025; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Maekawa T, 2011, NAT IMMUNOL, V12, P818, DOI 10.1038/ni.2083; Maeo K, 2001, BIOSCI BIOTECH BIOCH, V65, P2428, DOI 10.1271/bbb.65.2428; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Narusaka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055954; Noutoshi Y, 2005, PLANT J, V43, P873, DOI 10.1111/j.1365-313X.2005.02500.x; Ravensdale M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003004; Saucet SB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7338; Sinapidou E, 2004, PLANT J, V38, P898, DOI 10.1111/j.1365-313X.2004.02099.x; Sohn KH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004655; Sohn KH, 2012, P NATL ACAD SCI USA, V109, P16371, DOI 10.1073/pnas.1212332109; Sohn KH, 2009, PLANT J, V57, P1079, DOI 10.1111/j.1365-313X.2008.03751.x; Stuart LM, 2013, NAT REV IMMUNOL, V13, P199, DOI 10.1038/nri3398; Takken FLW, 2012, CURR OPIN PLANT BIOL, V15, P375, DOI 10.1016/j.pbi.2012.05.001; Tasset C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001202; Tenthorey JL, 2014, MOL CELL, V54, P17, DOI 10.1016/j.molcel.2014.02.018; Thomas WJ, 2009, PLANT J, V60, P919, DOI 10.1111/j.1365-313X.2009.03998.x; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Williams SJ, 2014, SCIENCE, V344, P299, DOI 10.1126/science.1247357; Williams SJ, 2011, MOL PLANT MICROBE IN, V24, P897, DOI 10.1094/MPMI-03-11-0052; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449	50	311	328	9	211	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 21	2015	161	5					1089	1100		10.1016/j.cell.2015.04.024	http://dx.doi.org/10.1016/j.cell.2015.04.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ0GA	26000484	Bronze			2022-12-28	WOS:000355152600016
J	Stewart, DE				Stewart, Donna E.			Battling perinatal depression	LANCET			English	Editorial Material							MENTAL-DISORDERS		[Stewart, Donna E.] Univ Toronto, Univ Hlth Network, Toronto, ON M5G 2C4, Canada	University of Toronto; University Health Network Toronto	Stewart, DE (corresponding author), Univ Toronto, Univ Hlth Network, Toronto, ON M5G 2C4, Canada.	donna.stewart@uhn.ca	Stewart, Donna Eileen E/J-2844-2016	Stewart, Donna Eileen E/0000-0002-8157-7746				Cox GR, 2012, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD007504.PUB2; Herrman H, 2011, CAN J PSYCHIAT, V56, P258, DOI 10.1177/070674371105600504; Howard LM, 2014, LANCET, V384, P1775, DOI 10.1016/S0140-6736(14)61276-9; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kinderman P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076564; Patton GC, 2015, LANCET, V386, P875, DOI 10.1016/S0140-6736(14)62248-0; Rice S.M., 2014, J MED INTERNET RES, V16, pe206, DOI [10.2196/jmir.3304, DOI 10.2196/JMIR.3304]; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Stewart DE, 2011, NEW ENGL J MED, V365, P1605, DOI 10.1056/NEJMcp1102730; Vos T, 2004, ARCH GEN PSYCHIAT, V61, P1097, DOI 10.1001/archpsyc.61.11.1097; Wisner KL, 2013, JAMA PSYCHIAT, V70, P490, DOI 10.1001/jamapsychiatry.2013.87; Yasamy M.T., 2012, DEPRESSION GLOBAL PU	12	4	4	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 29	2015	386	9996					835	837		10.1016/S0140-6736(15)61033-9	http://dx.doi.org/10.1016/S0140-6736(15)61033-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ0MJ	26072107				2022-12-28	WOS:000360290000006
J	Thompson, SG; Willeit, P				Thompson, Simon G.; Willeit, Peter			UK Biobank comes of age	LANCET			English	Editorial Material							PREVENTION		[Thompson, Simon G.; Willeit, Peter] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England	University of Cambridge	Thompson, SG (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England.	sgt27@medschl.cam.ac.uk	Willeit, Peter/HCI-7091-2022	Willeit, Peter/0000-0002-1866-7159	Wellcome Trust [093707] Funding Source: Medline; MRC [MR/L003120/1] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Bonner C, 2014, J MED INTERNET RES, V16, P118, DOI 10.2196/jmir.3190; Burgess S., 2015, MENDELIAN RANDOMIZAT, DOI [10.1201/b18084, DOI 10.1201/B18084]; Ganna A, 2015, LANCET, V386, P533, DOI 10.1016/S0140-6736(15)60175-1; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; McClure JB, 2002, AM J PREV MED, V22, P200, DOI 10.1016/S0749-3797(01)00425-1; Palmer LJ, 2007, LANCET, V369, P1980, DOI 10.1016/S0140-6736(07)60924-6; UK Biobank Access Team, 2015, 140090002 UK BIOB AC; White RW, 2009, ACM T INFORM SYST, V27, DOI 10.1145/1629096.1629101; Zannad F, 2012, EUR J PREV CARDIOL, V19, P1454, DOI 10.1177/1741826711424873	9	17	17	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 8	2015	386	9993					509	510		10.1016/S0140-6736(15)60578-5	http://dx.doi.org/10.1016/S0140-6736(15)60578-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CO8PG	26049251				2022-12-28	WOS:000359431900006
J	Obal, G; Trajtenberg, F; Carrion, F; Tome, L; Larrieux, N; Zhang, X; Pritsch, O; Buschiazzo, A				Obal, G.; Trajtenberg, F.; Carrion, F.; Tome, L.; Larrieux, N.; Zhang, X.; Pritsch, O.; Buschiazzo, A.			Conformational plasticity of a native retroviral capsid revealed by x-ray crystallography	SCIENCE			English	Article							BOVINE LEUKEMIA-VIRUS; DIMERIZATION DOMAIN; TERMINAL DOMAIN; BETA-HAIRPIN; PROTEIN; HIV; RESOLUTION; PARTICLES; ARCHITECTURE; DYNAMICS	Retroviruses depend on self-assembly of their capsid proteins (core particle) to yield infectious mature virions. Despite the essential role of the retroviral core, its high polymorphism has hindered high-resolution structural analyses. Here, we report the x-ray structure of the native capsid (CA) protein from bovine leukemia virus. CA is organized as hexamers that deviate substantially from sixfold symmetry, yet adjust to make two-dimensional pseudohexagonal arrays that mimic mature retroviral cores. Intra-and interhexameric quasi-equivalent contacts are uncovered, with flexible trimeric lateral contacts among hexamers, yet preserving very similar dimeric interfaces making the lattice. The conformation of each capsid subunit in the hexamer is therefore dictated by long-range interactions, revealing how the hexamers can also assemble into closed core particles, a relevant feature of retrovirus biology.	[Obal, G.; Carrion, F.; Tome, L.; Pritsch, O.] Inst Pasteur Montevideo, Unit Prot Biophys, Montevideo 11400, Uruguay; [Obal, G.; Tome, L.; Pritsch, O.] Univ Republica, Fac Med, Dept Inmunobiol, Montevideo 11800, Uruguay; [Trajtenberg, F.; Larrieux, N.; Buschiazzo, A.] Inst Pasteur Montevideo, Unit Prot Crystallog, Montevideo 11400, Uruguay; [Zhang, X.] Inst Pasteur, Dept Virol, Unite Virol Struct, F-75015 Paris, France; [Zhang, X.] CNRS, Unite Mixte Rech 3569, F-75015 Paris, France; [Buschiazzo, A.] Inst Pasteur, Dept Struct Biol & Chem, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Pritsch, O (corresponding author), Inst Pasteur Montevideo, Unit Prot Biophys, Mataojo 2020, Montevideo 11400, Uruguay.	pritsch@pasteur.edu.uy; alebus@pasteur.edu.uy	Zhang, Xiaokang/AHE-3776-2022; Buschiazzo, Alejandro/W-1095-2018	Zhang, Xiaokang/0000-0001-5073-2582; Buschiazzo, Alejandro/0000-0002-2509-6526; Trajtenberg, Felipe/0000-0003-0427-5549	Centre National de la Recherche Scientifique (France, program Laboratoire International Associe) [316]; Agencia Nacional de Investigacion e Innovacion (Uruguay); Centro de Biologia Estructural del Mercosur; Fondo para la Convergencia Estructural del MERCOSUR [COF 03/11]	Centre National de la Recherche Scientifique (France, program Laboratoire International Associe); Agencia Nacional de Investigacion e Innovacion (Uruguay); Centro de Biologia Estructural del Mercosur; Fondo para la Convergencia Estructural del MERCOSUR	The crystal structures (model coordinates and structure factors) are available in the Protein Data Bank under accession codes 4PH0, 4PH1, 4PH2, and 4PH3. We acknowledge funding from Centre National de la Recherche Scientifique (France, program Laboratoire International Associe 316), Agencia Nacional de Investigacion e Innovacion (Uruguay), Centro de Biologia Estructural del Mercosur (www.cebem.org.ar) and Fondo para la Convergencia Estructural del MERCOSUR (COF 03/11). We thank P. Guardado-Calvo and T. Krey for helpful comments. We acknowledge the Recombinant Proteins Unit (Institut Pasteur de Montevideo) for the access to protein expression and purification facilities. Thanks to A. Lebedev for tailor-made programs to analyze NCS and B. Guimaraes at beamline Proxima 1 (synchrotron Soleil) for assistance with full-length CA data collection. We thank F. Rey for the lively discussions.	Aida Y, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00328; Benjamin J, 2005, J MOL BIOL, V346, P577, DOI 10.1016/j.jmb.2004.11.064; Briggs JAG, 2011, J MOL BIOL, V410, P491, DOI 10.1016/j.jmb.2011.04.021; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Chen K, 2013, J BIOL CHEM, V288, P1511, DOI 10.1074/jbc.M112.425140; Cornilescu CC, 2001, J MOL BIOL, V306, P783, DOI 10.1006/jmbi.2000.4395; Du SC, 2011, J MOL BIOL, V406, P371, DOI 10.1016/j.jmb.2010.11.027; Fujii M, 2013, FIELDS VIROLOGY, V2, P1474; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2012, ADV EXP MED BIOL, V726, P441, DOI 10.1007/978-1-4614-0980-9_20; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gillet N, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-18; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Gres AT, 2015, SCIENCE, V349, P99, DOI 10.1126/science.aaa5936; Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998; Khorasanizadeh S, 1999, J MOL BIOL, V291, P491, DOI 10.1006/jmbi.1999.2986; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Obr M, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0094-8; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Price AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004459; Rodriguez SM, 2011, VIRUSES-BASEL, V3, P1210, DOI 10.3390/v3071210; Schur FKM, 2015, NATURE, V517, P505, DOI 10.1038/nature13838; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Yang HT, 2012, P NATL ACAD SCI USA, V109, P18372, DOI 10.1073/pnas.1210903109; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	31	26	26	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 3	2015	349	6243					95	98		10.1126/science.aaa5182	http://dx.doi.org/10.1126/science.aaa5182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL9FG	26044299				2022-12-28	WOS:000357280800067
J	Jaramillo, F; Destouni, G				Jaramillo, Fernando; Destouni, Georgia			Comment on "Planetary boundaries: Guiding human development on a changing planet"	SCIENCE			English	Editorial Material							SAFE OPERATING SPACE; CLIMATE; DRIVERS	Steffen et al. (Research Articles, 13 February 2015, p. 736) recently assessed current global freshwater use, finding it to be well below a corresponding planetary boundary. However, they ignored recent scientific advances implying that the global consumptive use of freshwater may have already crossed the associated planetary boundary.	[Jaramillo, Fernando; Destouni, Georgia] Stockholm Univ, Dept Phys Geog, SE-10691 Stockholm, Sweden; [Jaramillo, Fernando; Destouni, Georgia] Stockholm Univ, Bolin Ctr Climate Res, SE-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Jaramillo, F (corresponding author), Stockholm Univ, Dept Phys Geog, SE-10691 Stockholm, Sweden.	fernando.jaramillo@natgeo.su.se	Jaramillo, Fernando/T-4713-2017; Destouni, Georgia/M-9662-2016; Destouni, Georgia/AAS-5375-2020	Jaramillo, Fernando/0000-0002-6769-0136; Destouni, Georgia/0000-0001-9408-4425; Destouni, Georgia/0000-0001-9408-4425				Degu AM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046482; Destouni G, 2014, J HYDROL, V516, P131, DOI 10.1016/j.jhydrol.2014.01.059; Destouni G, 2013, NAT CLIM CHANGE, V3, P213, DOI [10.1038/NCLIMATE1719, 10.1038/nclimate1719]; Gordon LJ, 2005, P NATL ACAD SCI USA, V102, P7612, DOI 10.1073/pnas.0500208102; Jaramillo F, 2014, GEOPHYS RES LETT, V41, P8377, DOI 10.1002/2014GL061848; Jaramillo F, 2013, J HYDROL, V484, P55, DOI 10.1016/j.jhydrol.2013.01.010; Levi L, 2015, AMBIO, V44, P624, DOI 10.1007/s13280-015-0641-0; Loarie SR, 2011, NAT CLIM CHANGE, V1, P105, DOI [10.1038/nclimate1067, 10.1038/NCLIMATE1067]; Rockstrom J, 2009, ECOL SOC, V14; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Shiklomanov I.A., 2004, WORLD WATER RESOURCE, P417; Shikomanov I. A., 1997, ASSESSMENT WATER RES; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wang DB, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010283	15	62	64	14	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 12	2015	348	6240							1217-c	10.1126/science.aaa9629	http://dx.doi.org/10.1126/science.aaa9629			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK2AK	26068843				2022-12-28	WOS:000356011500041
J	Wang, X; Yamamoto, Y; Wilson, LH; Zhang, T; Howitt, BE; Farrow, MA; Kern, F; Ning, G; Hong, Y; Khor, CC; Chevalier, B; Bertrand, D; Wu, LY; Nagarajan, N; Sylvester, FA; Hyams, JS; Devers, T; Bronson, R; Lacy, DB; Ho, KY; Crum, CP; McKeon, F; Xian, W				Wang, Xia; Yamamoto, Yusuke; Wilson, Lane H.; Zhang, Ting; Howitt, Brooke E.; Farrow, Melissa A.; Kern, Florian; Ning, Gang; Hong, Yue; Khor, Chiea Chuen; Chevalier, Benoit; Bertrand, Denis; Wu, Lingyan; Nagarajan, Niranjan; Sylvester, Francisco A.; Hyams, Jeffrey S.; Devers, Thomas; Bronson, Roderick; Lacy, D. Borden; Ho, Khek Yu; Crum, Christopher P.; McKeon, Frank; Xian, Wa			Cloning and variation of ground state intestinal stem cells	NATURE			English	Article							IN-VITRO; TOXIN-B; REGENERATION; MARKER; COLON; VIVO; GENERATION; VIRULENCE; PATHWAYS; RENEWAL	Stem cells of the gastrointestinal tract, pancreas, liver and other columnar epithelia collectively resist cloning in their elemental states. Here we demonstrate the cloning and propagation of highly clonogenic, 'ground state' stem cells of the human intestine and colon. We show that derived stem-cell pedigrees sustain limited copy number and sequence variation despite extensive serial passaging and display exquisitely precise, cell-autonomous commitment to epithelial differentiation consistent with their origins along the intestinal tract. This developmentally patterned and epigenetically maintained commitment of stem cells is likely to enforce the functional specificity of the adult intestinal tract. Using clonally derived colonic epithelia, we show that toxins A or B of the enteric pathogen Clostridium difficile recapitulate the salient features of pseudomembranous colitis. The stability of the epigenetic commitment programs of these stem cells, coupled with their unlimited replicative expansion and maintained clonogenicity, suggests certain advantages for their use in disease modelling and regenerative medicine.	[Wang, Xia; Yamamoto, Yusuke; Wilson, Lane H.; Ning, Gang; Hong, Yue; Chevalier, Benoit; McKeon, Frank; Xian, Wa] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Wilson, Lane H.; Xian, Wa] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06032 USA; [Zhang, Ting; Kern, Florian; Khor, Chiea Chuen; Bertrand, Denis; Wu, Lingyan; Nagarajan, Niranjan; McKeon, Frank] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore; [Howitt, Brooke E.; Crum, Christopher P.; Xian, Wa] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02118 USA; [Farrow, Melissa A.; Lacy, D. Borden] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Khor, Chiea Chuen] Natl Univ Singapore, Dept Ophthalmol, Yong Loo Lin Sch Med, Singapore 119228, Singapore; [Sylvester, Francisco A.] Univ N Carolina, Dept Pediat, Div Gastroenterol, Chapel Hill, NC 27599 USA; [Hyams, Jeffrey S.] Connecticut Childrens Med Ctr, Div Digest Dis Hepatol & Nutr, Hartford, CT 06106 USA; [Devers, Thomas] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06032 USA; [Bronson, Roderick] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Ho, Khek Yu; McKeon, Frank; Xian, Wa] Natl Univ Singapore, Dept Med, Singapore 119228, Singapore; [McKeon, Frank; Xian, Wa] Multiclonal Therapeut Inc, Farmington, CT 06032 USA	Jackson Laboratory; University of Connecticut; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Harvard University; Brigham & Women's Hospital; Vanderbilt University; National University of Singapore; University of North Carolina; University of North Carolina Chapel Hill; Connecticut Children's Medical Center; University of Connecticut; Harvard University; Harvard Medical School; National University of Singapore	Xian, W (corresponding author), Jackson Lab Genom Med, Farmington, CT 06032 USA.	mckeon.xian@gmail.com; xianmckeon2014@gmail.com	Wu, Ling/GZN-2235-2022; Lacy, D. Borden/AFQ-2203-2022	Khor, Chiea Chuen/0000-0002-1128-4729; Nagarajan, Niranjan/0000-0003-0850-5604; Chevalier, Benoit/0000-0003-0863-6022; Lacy, Borden/0000-0003-2273-8121; Howitt, Brooke/0000-0002-0309-6680	Connecticut Innovations; Joint Council Office of the Agency for Science Technology Research Agency (A*STAR), Singapore; National Medical Research Council, Singapore [BNB101677A, BnB11dec063]; Department of Defense [W81XWH-10-1-0289]; National Institute of Health [AI09575504]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095755] Funding Source: NIH RePORTER	Connecticut Innovations; Joint Council Office of the Agency for Science Technology Research Agency (A*STAR), Singapore; National Medical Research Council, Singapore(National Medical Research Council, Singapore); Department of Defense(United States Department of Defense); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Connecticut Innovations (W.X., F.M.), the Joint Council Office of the Agency for Science Technology Research Agency (A*STAR), Singapore (W.X., F.M.), the National Medical Research Council, Singapore (BNB101677A to H.K.Y., F.M., and W.X.; BnB11dec063 to N.N., F.M. and W.X.), the Department of Defense (W81XWH-10-1-0289 to C.P.C.) and the National Institute of Health (AI09575504 to D.B.L.). We thank M. LaLande, B. Lane and B. Seet for support, B. Tennent, B. Knowles and T. McLaughlin for comments on the manuscript, J. Hammer for artwork, L. Lapierre and J. Franklin for histology evaluation. We thank H. Green for advice and support.	Aktories K, 2000, BIOL CHEM, V381, P421, DOI 10.1515/BC.2000.054; Amabile G, 2013, BLOOD, V121, P1255, DOI 10.1182/blood-2012-06-434407; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Avery S, 2013, STEM CELL REP, V1, P379, DOI 10.1016/j.stemcr.2013.10.005; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Battle MA, 2008, GASTROENTEROLOGY, V135, P1676, DOI 10.1053/j.gastro.2008.07.074; Bonde S, 2008, TRANSPLANTATION, V86, P1803, DOI 10.1097/TP.0b013e31818fe741; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Brandl K, 2012, CURR OPIN IMMUNOL, V24, P678, DOI 10.1016/j.coi.2012.10.005; Carter GP, 2012, TRENDS MICROBIOL, V20, P21, DOI 10.1016/j.tim.2011.11.003; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Dusing MR, 2010, PHYSIOL GENOMICS, V42, P115, DOI 10.1152/physiolgenomics.00017.2010; Farrow MA, 2013, P NATL ACAD SCI USA, V110, P18674, DOI 10.1073/pnas.1313658110; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Helgason CD, 1996, BLOOD, V87, P2740, DOI 10.1182/blood.V87.7.2740.bloodjournal8772740; Huelsenbeck J, 2007, BIOCHEMISTRY-US, V46, P4923, DOI 10.1021/bi602465z; Iuchi S, 2006, P NATL ACAD SCI USA, V103, P1792, DOI 10.1073/pnas.0510953103; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; MacFie TS, 2014, INFLAMM BOWEL DIS, V20, P514, DOI 10.1097/01.MIB.0000442012.45038.0e; Matsuura R, 2006, STEM CELLS, V24, P624, DOI 10.1634/stemcells.2005-0344; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Middendorp S, 2014, STEM CELLS, V32, P1083, DOI 10.1002/stem.1655; MULLER AM, 1993, DEVELOPMENT, V118, P1343; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Okano H, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-22; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sheaffer KL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008284; Shultz L. D., 2014, COLD SPRING HARB PRO; Suzuki N, 2013, MOL THER, V21, P1424, DOI 10.1038/mt.2013.71; Tabar V, 2014, NAT REV GENET, V15, P82, DOI 10.1038/nrg3563; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Walker EM, 2014, DEV BIOL, V392, P283, DOI 10.1016/j.ydbio.2014.05.017; Wang FC, 2013, GASTROENTEROLOGY, V145, P383, DOI 10.1053/j.gastro.2013.04.050; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Yin XL, 2014, NAT METHODS, V11, P106, DOI 10.1038/nmeth.2737; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	50	116	128	3	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 11	2015	522	7555					173	+		10.1038/nature14484	http://dx.doi.org/10.1038/nature14484			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK2CI	26040716	Green Submitted, Green Accepted			2022-12-28	WOS:000356016700030
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Trust the patient	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Elwyn G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7645; McCartney M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1331	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2015	350								h3181	10.1136/bmj.h3181	http://dx.doi.org/10.1136/bmj.h3181			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK7CZ	26063114	Bronze			2022-12-28	WOS:000356389600017
J	Park, TW; Saitz, R; Ganoczy, D; Ilgen, MA; Bohnert, ASB				Park, Tae Woo; Saitz, Richard; Ganoczy, Dara; Ilgen, Mark A.; Bohnert, Amy S. B.			Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK; MORTALITY; PRESCRIPTIONS; PREVENTION; SUICIDE	OBJECTIVE To study the association between benzodiazepine prescribing patterns including dose, type, and dosing schedule and the risk of death from drug overdose among US veterans receiving opioid analgesics. DESIGN Case-cohort study. Setting Veterans Health Administration (VHA), 2004-09. Participants US veterans, primarily male, who received opioid analgesics in 2004-09. All veterans who died from a drug overdose (n=2400) while receiving opioid analgesics and a random sample of veterans (n=420 386) who received VHA medical services and opioid analgesics. MAIN OUTCOME MEASURE Death from drug overdose, defined as any intentional, unintentional, or indeterminate death from poisoning caused by any drug, determined by information on cause of death from the National Death Index. RESULTS During the study period 27% (n=112 069) of veterans who received opioid analgesics also received benzodiazepines. About half of the deaths from drug overdose (n=1185) occurred when veterans were concurrently prescribed benzodiazepines and opioids. Risk of death from drug overdose increased with history of benzodiazepine prescription: adjusted hazard ratios were 2.33 (95% confidence interval 2.05 to 2.64) for former prescriptions versus no prescription and 3.86 (3.49 to 4.26) for current prescriptions versus no prescription. Risk of death from drug overdose increased as daily benzodiazepine dose increased. Compared with clonazepam, temazepam was associated with a decreased risk of death from drug overdose (0.63, 0.48 to 0.82). Benzodiazepine dosing schedule was not associated with risk of death from drug overdose. CONCLUSIONS Among veterans receiving opioid analgesics, receipt of benzodiazepines was associated with an increased risk of death from drug overdose in a dose-response fashion.	[Park, Tae Woo] Brown Univ, Warren Alpert Med Sch, Dept Med, Providence, RI 02903 USA; [Park, Tae Woo] Brown Univ, Warren Alpert Med Sch, Dept Psychiat, Providence, RI 02903 USA; [Park, Tae Woo] Brown Univ, Warren Alpert Med Sch, Dept Human Behav, Providence, RI 02903 USA; [Saitz, Richard] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA 02118 USA; [Ganoczy, Dara; Ilgen, Mark A.; Bohnert, Amy S. B.] HSR&D, Dept Vet Affairs, Ann Arbor, MI 48105 USA; [Bohnert, Amy S. B.] Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48109 USA	Brown University; Brown University; Brown University; Boston University; University of Michigan System; University of Michigan	Park, TW (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Med, 111 Plain St, Providence, RI 02903 USA.	tpark1@lifespan.org		/0000-0002-2535-1427	Veteran Affairs Health Services Research and Development Service Career Development Award [CDA-09-204]; National Institutes of Health [R03 AG042899]; NATIONAL INSTITUTE ON AGING [R03AG042899] Funding Source: NIH RePORTER	Veteran Affairs Health Services Research and Development Service Career Development Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funding from a Veteran Affairs Health Services Research and Development Service Career Development Award (CDA-09-204; ASBB.) and by the National Institutes of Health (R03 AG042899). The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript of the decision to submit.	Arbogast PG, 2009, STAT METHODS MED RES, V18, P67, DOI 10.1177/0962280208092347; Beletsky L, 2012, JAMA-J AM MED ASSOC, V308, P1863, DOI 10.1001/jama.2012.14205; Bohnert ASB, 2012, AM J PSYCHIAT, V169, P64, DOI 10.1176/appi.ajp.2011.10101476; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Bohnert ASB, 2011, MED CARE, V49, P393, DOI 10.1097/MLR.0b013e318202aa27; Buckley NA, 1995, BMJ-BRIT MED J, V310, P21; Center for Substance Abuse Treatment, 2005, DHHS PUBL NO SMA, V(SMA) 05-4048; Centers for Disease Control and Prevention, NAT VIT STAT; Centers for Disease Control and Prevention, NAT DEATH IND; Cone EJ, 2004, J ANAL TOXICOL, V28, P616, DOI 10.1093/jat/28.7.616; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Ekstrom MP, 2014, BMJ-BRIT MED J, V348, pg445, DOI DOI 10.1136/BMJ.G445; Galanter M, 2008, TXB SUBSTANCE ABUSE; Gammaitoni AR, 2003, CLIN J PAIN, V19, P286, DOI 10.1097/00002508-200309000-00002; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Hawkins EJ, 2013, J ADDICT MED, V7, P354, DOI 10.1097/ADM.0b013e31829e3957; Hermos JA, 2004, ARCH INTERN MED, V164, P2361, DOI 10.1001/archinte.164.21.2361; Isbister GK, 2004, BRIT J CLIN PHARMACO, V58, P88, DOI 10.1111/j.1365-2125.2004.02089.x; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Krieger N, GEOCODING MONITORING; Langholz B, 2007, COMPUT STAT DATA AN, V51, P3737, DOI 10.1016/j.csda.2006.12.028; Lindqvist P, 2002, FORENSIC SCI INT, V128, P136, DOI 10.1016/S0379-0738(02)00188-3; Morasco BJ, 2010, PAIN, V151, P625, DOI 10.1016/j.pain.2010.08.002; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Paulozzi LJ, 2012, J SAFETY RES, V43, P283, DOI 10.1016/j.jsr.2012.08.009; Pfeiffer PN, 2009, DEPRESS ANXIETY, V26, P752, DOI 10.1002/da.20583; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Prommer E, 2006, SUPPORT CARE CANCER, V14, P109, DOI 10.1007/s00520-005-0917-1; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Salas M, 1999, AM J EPIDEMIOL, V149, P981; SALZMAN C, 1991, AM J PSYCHIAT, V148, P151; Saunders KW, 2012, J PAIN, V13, P266, DOI 10.1016/j.jpain.2011.11.004; Sgadari A, 2000, J CLIN PSYCHOPHARM, V20, P234, DOI 10.1097/00004714-200004000-00017; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Valenstein M, 2004, AM J PSYCHIAT, V161, P654, DOI 10.1176/appi.ajp.161.4.654; Wysowski DK, 2007, DRUG SAFETY, V30, P533, DOI 10.2165/00002018-200730060-00007	37	351	353	2	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2015	350								h2698	10.1136/bmj.h2698	http://dx.doi.org/10.1136/bmj.h2698			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK7CZ	26063215	hybrid, Green Published			2022-12-28	WOS:000356389600003
J	Seiki, N; Shoji, Y; Kajitani, T; Ishiwari, F; Kosaka, A; Hikima, T; Takata, M; Someya, T; Fukushima, T				Seiki, Noriya; Shoji, Yoshiaki; Kajitani, Takashi; Ishiwari, Fumitaka; Kosaka, Atsuko; Hikima, Takaaki; Takata, Masaki; Someya, Takao; Fukushima, Takanori			Rational synthesis of organic thin films with exceptional long-range structural integrity	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; CRYSTAL; POLYMER; GROWTH	Highly oriented, domain-boundary-free organic thin films could find use in various high-performance organic materials and devices. However, even with state-of-the-art supramolecular chemistry, it is difficult to construct organic thin films with structural integrity in a size regime beyond the micrometer length scale. We show that a space-filling design, relying on the two-dimensional (2D) nested hexagonal packing of a particular type of triptycene, enables the formation of large-area molecular films with long-range 2D structural integrity up to the centimeter length scale by vacuum evaporation, spin-coating, and cooling from the isotropic liquid of the triptycene. X-ray diffraction analysis and microscopic observations reveal that triptycene molecules form a completely oriented 2D (hexagonal triptycene array) + 1D (layer stacking) structure, which is key for the long-range propagation of structural order.	[Seiki, Noriya; Shoji, Yoshiaki; Kajitani, Takashi; Ishiwari, Fumitaka; Kosaka, Atsuko; Fukushima, Takanori] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Kajitani, Takashi; Kosaka, Atsuko; Someya, Takao; Fukushima, Takanori] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Bioharmonized Elect Project, Bunkyo Ku, Tokyo 1138656, Japan; [Hikima, Takaaki; Takata, Masaki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	Tokyo Institute of Technology; Japan Science & Technology Agency (JST); RIKEN	Shoji, Y (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	yshoji@res.titech.ac.jp; fukushima@res.titech.ac.jp	Ishiwari, Fumitaka/D-3074-2015; Someya, Takao/H-3052-2015; Shoji, Yoshiaki/D-4672-2014; Kajitani, Takashi/C-9775-2015; Fukushima, Takanori/D-2474-2015; Ishiwari, Fumitaka/J-4713-2016	Ishiwari, Fumitaka/0000-0002-0200-4510; Someya, Takao/0000-0003-3051-1138; Shoji, Yoshiaki/0000-0001-8437-1965; Kajitani, Takashi/0000-0001-9814-654X; Fukushima, Takanori/0000-0001-5586-9238; 	KAKENHI [24350055]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [26102001]; NAGASE Science Technology Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NAGASE Science Technology Foundation	This work was supported by KAKENHI (no. 24350055); a Grant-in-Aid for Scientific Research on Innovative Areas "pi-Figuration" (no. 26102001) of The Ministry of Education, Culture, Sports, Science, and Technology, Japan; and a grant from the NAGASE Science Technology Foundation (2012). The synchrotron XRD experiments were performed at the BL44B2 and BL45XU in the SPring-8 with the approval of the RIKEN SPring-8 Center (proposal nos. 20130025 and 20140056). We thank H. Sato (Rigaku Corporation) for the single-crystal x-ray crystallography of Trip-C12 and T. Tada (Tokyo Institute of Technology) for the density functional theory calculations. We acknowledge Pascal Co. for the measurement of TOFLAS spectroscopy. Crystal data for Trip-C12 and Trip-C1 are available from the Cambridge Crystallographic Data Center under reference numbers CCDC-1031109 and CCDC-1031110, respectively, via www.ccdc.cam.ac.uk/data_request/cif.	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; [Anonymous], 2014, CAMBRIDGE STRUCTURAL; ARDEBILI MHP, 1978, J AM CHEM SOC, V100, P7994, DOI 10.1021/ja00493a032; Asari T, 2006, MACROMOLECULES, V39, P2232, DOI 10.1021/ma0524880; Chen CF, 2011, CHEM COMMUN, V47, P1674, DOI 10.1039/c0cc04852f; Chmiel J, 2010, EUR J ORG CHEM, V2010, P3897, DOI 10.1002/ejoc.201000354; De Greef TFA, 2009, CHEM REV, V109, P5687, DOI 10.1021/cr900181u; De Yoreo JJ, 2003, REV MINERAL GEOCHEM, V54, P57, DOI 10.2113/0540057; Hazell R. G., 1971, Journal of Crystal and Molecular Structure, V1, P319, DOI 10.1007/BF01200806; Janssen D, 2006, THIN SOLID FILMS, V515, P1433, DOI 10.1016/j.tsf.2006.04.006; Jinnai H, 2010, MACROMOLECULES, V43, P1675, DOI 10.1021/ma902035p; Kissel P, 2014, NAT CHEM, V6, P774, DOI 10.1038/nchem.2008; KWOLEK SL, 1977, MACROMOLECULES, V10, P1390, DOI 10.1021/ma60060a041; Mastalerz M, 2012, ANGEW CHEM INT EDIT, V51, P5252, DOI 10.1002/anie.201201174; NORVEZ S, 1993, J ORG CHEM, V58, P2414, DOI 10.1021/jo00061a012; Osawa T, 2012, ANGEW CHEM INT EDIT, V51, P7990, DOI 10.1002/anie.201203077; Swager TM, 2008, ACCOUNTS CHEM RES, V41, P1181, DOI 10.1021/ar800107v; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357; WITTMANN JC, 1991, NATURE, V352, P414, DOI 10.1038/352414a0; Yamamura K, 2005, J MOL STRUCT, V737, P1, DOI 10.1016/j.molstruc.2004.10.002; ZAMIR S, 1994, J AM CHEM SOC, V116, P1973, DOI 10.1021/ja00084a042	21	82	83	3	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 5	2015	348	6239					1122	1126		10.1126/science.aab1391	http://dx.doi.org/10.1126/science.aab1391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ6FY	26045433				2022-12-28	WOS:000355590500044
J	Wallace, EWJ; Drummond, DA				Wallace, Edward W. J.; Drummond, D. Allan			Dying mRNA Tells a Story of Its Life	CELL			English	Editorial Material								In this issue of Cell, Pelechano et al. report that sequencing of mRNA decay intermediates shows surprisingly tight coupling of a major decay pathway to the movement of the last translating ribosome, revealing stress- and starvation-dependent modulation of translation elongation.	[Wallace, Edward W. J.; Drummond, D. Allan] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago	Wallace, EWJ (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA.	ewallace@uchicago.edu; dadrummond@uchicago.edu	Drummond, D. Allan/A-1250-2015	Drummond, D. Allan/0000-0001-7018-7059; Wallace, Edward/0000-0001-8025-6361				Chathoth KT, 2014, MOL CELL, V53, P779, DOI 10.1016/j.molcel.2014.01.017; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Pelechano V, 2015, CELL, V161, P1400, DOI 10.1016/j.cell.2015.05.008; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; Subramaniam AR, 2014, CELL, V159, P1200, DOI 10.1016/j.cell.2014.10.043	7	2	2	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 4	2015	161	6					1246	1248		10.1016/j.cell.2015.05.043	http://dx.doi.org/10.1016/j.cell.2015.05.043			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CK0ZR	26046434	Bronze, Green Accepted			2022-12-28	WOS:000355935000005
J	Goel, RM; Hullah, E				Goel, Rishi Mahendra; Hullah, Esther			Orofacial Fistulae Associated with Crohn's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goel, Rishi Mahendra; Hullah, Esther] Guys & St Thomas Hosp, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Goel, RM (corresponding author), Guys & St Thomas Hosp, London SE1 9RT, England.	rgoel50@hotmail.com							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 28	2015	372	22							e29	10.1056/NEJMicm1402919	http://dx.doi.org/10.1056/NEJMicm1402919			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0EI	26017845				2022-12-28	WOS:000355146800011
J	Thangarajah, T; Lambert, S				Thangarajah, Tanujan; Lambert, Simon			Management of the unstable shoulder	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ARTHROSCOPIC STABILIZATION; RECURRENT INSTABILITY; ANTERIOR DISLOCATION; CLOSED REDUCTION; RISK; IMMOBILIZATION; EPIDEMIOLOGY; ARTHROGRAPHY; METAANALYSIS; STABILITY		[Thangarajah, Tanujan] Univ Coll London, Royal Natl Orthopaed Hosp, Div Surg & Intervent Sci, John Scales Ctr Biomed Engn,Inst Orthopaed & Musc, Stanmore HA7 4LP, Middx, England; [Lambert, Simon] Royal Natl Orthopaed Hosp, Shoulder & Elbow Serv, Stanmore HA7 4LP, Middx, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Thangarajah, T (corresponding author), Univ Coll London, Royal Natl Orthopaed Hosp, Div Surg & Intervent Sci, John Scales Ctr Biomed Engn,Inst Orthopaed & Musc, Stanmore HA7 4LP, Middx, England.	tanujan1@hotmail.com						Belangero PS, 2014, J ORTHOP RES, V32, P1311, DOI 10.1002/jor.22680; Bessiere C, 2014, CLIN ORTHOP RELAT R, V472, P2345, DOI 10.1007/s11999-014-3550-9; Chalmers PN, 2015, ARTHROSCOPY, V31, P355, DOI 10.1016/j.arthro.2014.07.008; Crall TS, 2012, ARTHROSCOPY, V28, P1755, DOI 10.1016/j.arthro.2012.05.885; Fallahi F, 2013, SKELETAL RADIOL, V42, P1225, DOI 10.1007/s00256-013-1644-1; Gomberawalla MM, 2014, CLIN ORTHOP RELAT R, V472, P2448, DOI 10.1007/s11999-013-3290-2; Gordins V, 2015, J SHOULDER ELB SURG, V24, P691, DOI 10.1016/j.jse.2014.09.021; Grahame R, 2000, J RHEUMATOL, V27, P1777; Hegedus EJ, 2012, BRIT J SPORT MED, V46, P964, DOI 10.1136/bjsports-2012-091066; Heidari K, 2014, J SHOULDER ELB SURG, V23, P759, DOI 10.1016/j.jse.2014.01.018; Horst K, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130673; Hovelius L, 1996, J BONE JOINT SURG AM, V78A, P1677, DOI 10.2106/00004623-199611000-00006; Hovelius L, 2009, J SHOULDER ELB SURG, V18, P339, DOI 10.1016/j.jse.2008.11.004; Jakobsen BW, 2007, ARTHROSCOPY, V23, P118, DOI 10.1016/j.arthro.2006.11.004; Jiang N, 2014, J CLIN ANESTH, V26, P350, DOI 10.1016/j.jclinane.2013.12.013; Kim SH, 2005, AM J SPORT MED, V33, P1188, DOI 10.1177/0363546504272687; Kosiyatrakul A, 2009, INJURY, V40, P1327, DOI 10.1016/j.injury.2009.05.015; Leroux T, 2014, AM J SPORT MED, V42, P442, DOI 10.1177/0363546513510391; Lewis A, 2004, CURR ORTHOPAED, V18, P97, DOI 10.1016/j.cuor.2004.04.002; Longo UG, 2014, ARTHROSCOPY, V30, P506, DOI 10.1016/j.arthro.2014.01.003; Milgrom C, 2014, J SHOULDER ELB SURG, V23, P1838, DOI 10.1016/j.jse.2014.07.013; Mohtadi NGH, 2014, J BONE JOINT SURG AM, V96A, P353, DOI 10.2106/JBJS.L.01656; Owens BD, 2013, AM J SPORT MED, V41, P2645, DOI 10.1177/0363546513501508; Owens MAJBD, 2007, AM J SPORT MED, V35, P1168, DOI 10.1177/0363546506295179; Ozaki R, 2014, AM J SPORT MED, V42, P2597, DOI 10.1177/0363546514549543; Paterson WH, 2010, J BONE JOINT SURG AM, V92A, P2924, DOI 10.2106/JBJS.J.00631; Porcellini G, 2007, AM J SPORT MED, V35, P2067, DOI 10.1177/0363546507305011; Postacchini F, 2000, J SHOULDER ELB SURG, V9, P470, DOI 10.1067/mse.2000.108385; Robinson CM, 2006, J BONE JOINT SURG AM, V88A, P2326, DOI 10.2106/JBJS.E.01327; ROWE CR, 1956, J BONE JOINT SURG AM, V38, P957, DOI 10.2106/00004623-195638050-00001; Schaeffeler C, 2014, EUR RADIOL, V24, P1376, DOI 10.1007/s00330-014-3133-x; Thangarajah T, 2014, BONE JOINT J, V96B, P1525, DOI 10.1302/0301-620X.96B11.33754; van Kampen DA, 2013, J SHOULDER ELB SURG, V22, P1310, DOI 10.1016/j.jse.2013.05.006; Whelan DB, 2014, CLIN ORTHOP RELAT R, V472, P2380, DOI 10.1007/s11999-013-3432-6; Zacchilli MA, 2010, J BONE JOINT SURG AM, V92A, P542, DOI 10.2106/JBJS.I.00450	35	5	8	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 28	2015	350								h2537	10.1136/bmj.h2537	http://dx.doi.org/10.1136/bmj.h2537			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ5UP	26023096				2022-12-28	WOS:000355557100002
J	Payne, D				Payne, David			THE BMJ WEBSITE Doctors online: "Like flies to honey"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London, England		Payne, D (corresponding author), BMJ, London, England.	dpayne@bmj.com						Crossan L, 1998, BRIT MED J, V316, P1406, DOI 10.1136/bmj.316.7142.1406; Delamothe T, 2004, BRIT MED J, V329, P814, DOI 10.1136/bmj.329.7470.814; Delamothe T, 1997, BRIT MED J, V315, P1558, DOI 10.1136/bmj.315.7122.1558; DELAMOTHE T, 1995, BRIT MED J, V310, P1343, DOI 10.1136/bmj.310.6991.1343; LAPORTE RE, 1994, BRIT MED J, V308, P1651, DOI 10.1136/bmj.308.6945.1651; Sack J, 2005, LEARN PUBL, V18, P131, DOI 10.1087/0953151053584948	6	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2015	350								h2767	10.1136/bmj.h2767	http://dx.doi.org/10.1136/bmj.h2767			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ0AF	26014134	Bronze			2022-12-28	WOS:000355132600005
J	Hoag, H				Hoag, Hannah			RESEARCH CONTINUITY Be prepared	NATURE			English	Editorial Material							POLLEN											Chretien ML, 2010, J CELL PHYSIOL, V224, P352, DOI 10.1002/jcp.22125; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Pisaric MFJ, 2001, QUATERNARY SCI REV, V20, P235, DOI 10.1016/S0277-3791(00)00120-7; Pisaric MFJ, 2001, ARCT ANTARCT ALP RES, V33, P19, DOI 10.2307/1552273	4	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 4	2015	522	7554					117	119		10.1038/nj7554-117a	http://dx.doi.org/10.1038/nj7554-117a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ5QP	26046134	Bronze			2022-12-28	WOS:000355543400042
J	Buchbinder, R; Harris, IA; Sprowson, A				Buchbinder, Rachelle; Harris, Ian A.; Sprowson, Andrew			PRACTICE POINTER Management of degenerative meniscal tears and the role of surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							KNEE OSTEOARTHRITIS; RISK-FACTORS; ARTHROSCOPIC SURGERY; MRI; MENISCECTOMY; PREVALENCE; ABNORMALITIES; DIAGNOSIS; PATHOLOGY; ACCURACY		[Buchbinder, Rachelle] Cabrini Inst, Monash Dept Clin Epidemiol, Clin Epidemiol, Malvern, Vic 3144, Australia; [Buchbinder, Rachelle] Monash Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med, Clin Epidemiol,Alfred Ctr, Melbourne, Vic 3004, Australia; [Harris, Ian A.] Univ New S Wales, South Western Sydney Clin Sch, Ingham Inst Appl Med Res, Whitlam Orthopaed Res Ctr,Orthopaed Surg, Liverpool, NSW, Australia; [Sprowson, Andrew] Univ Warwick, Warwick Clin Trials Unit, Trauma & Orthopaed, Coventry CV4 7AL, W Midlands, England	Cabrini Health; Monash University; Monash University; Ingham Institute for Applied Medical Research; University of New South Wales Sydney; University of Warwick	Buchbinder, R (corresponding author), Cabrini Inst, Monash Dept Clin Epidemiol, Clin Epidemiol, Malvern, Vic 3144, Australia.	rachelle.buchbinder@monash.edu	Buchbinder, Rachelle/G-2952-2011	Buchbinder, Rachelle/0000-0002-0597-0933				Alizadeh Ahmad, 2013, Eur J Orthop Surg Traumatol, V23, P927, DOI 10.1007/s00590-012-1111-z; American Academy of Orthopaedic Surgeons, 2013, TREATM OST KNEE; Bhattacharyya T, 2003, J BONE JOINT SURG AM, V85A, P4, DOI 10.2106/00004623-200301000-00002; Dervin GF, 2001, CAN J SURG, V44, P267; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Englund M, 2011, ANN RHEUM DIS, V70, P1733, DOI 10.1136/ard.2011.150052; Felson DT, 2007, ANN INTERN MED, V147, P534, DOI 10.7326/0003-4819-147-8-200710160-00005; Guermazi A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5339; Hegedus EJ, 2007, J ORTHOP SPORT PHYS, V37, P541, DOI 10.2519/jospt.2007.2560; Herrlin S, 2007, KNEE SURG SPORT TR A, V15, P393, DOI 10.1007/s00167-006-0243-2; Jarvinen TLN, 2014, ACTA ORTHOP, V85, P215, DOI 10.3109/17453674.2014.922736; Katz JN, 2013, NEW ENGL J MED, V368, P1675, DOI 10.1056/NEJMoa1301408; Kemp MA, 2011, KNEE, V18, P252, DOI 10.1016/j.knee.2010.05.011; Kirkley A, 2008, NEW ENGL J MED, V359, P1097, DOI 10.1056/NEJMoa0708333; Laberge MA, 2012, SKELETAL RADIOL, V41, P633, DOI 10.1007/s00256-011-1259-3; Malliaropoulos N, 2013, LASER MED SCI, V28, P1183, DOI 10.1007/s10103-012-1219-8; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; National Institute for Health and Care Excellence, 2014, OST CAR MAN AD; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; Niu NNN, 2011, ARTHRIT CARE RES, V63, P208, DOI 10.1002/acr.20354; Papalia R, 2011, BRIT MED BULL, V99, P89, DOI 10.1093/bmb/ldq043; Riddle DL, 2015, OSTEOARTHR CARTILAGE, V23, P391, DOI 10.1016/j.joca.2014.12.013; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; Snoeker BAM, 2013, J ORTHOP SPORT PHYS, V43, P352, DOI 10.2519/jospt.2013.4295; Subhas N, 2012, AM J ROENTGENOL, V198, pW575, DOI 10.2214/AJR.11.7226; Vermesan D, 2013, EUR REV MED PHARMACO, V17, P3192; Yim JH, 2013, AM J SPORT MED, V41, P1565, DOI 10.1177/0363546513488518	28	21	21	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 4	2015	350								h2212	10.1136/bmj.h2212	http://dx.doi.org/10.1136/bmj.h2212			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK0UD	27802970				2022-12-28	WOS:000355919600001
J	Valsecchi, ME				Valsecchi, Matias E.			Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									Huntington Internal Med Grp, Huntington, WV 25705 USA		Valsecchi, ME (corresponding author), Huntington Internal Med Grp, Huntington, WV 25705 USA.	meval78@yahoo.com	Carlino, Matteo/GRS-7198-2022; Rutkowski, Piotr/B-3907-2013; Marquez-Rodas, Ivan/ABD-5532-2021; Haanen, John/AAD-8578-2022; Haanen, John/AAD-8534-2022; Ascierto, Paolo A/J-9106-2016; gonzález, rene/W-2081-2019; sileni, vanna chiarion/B-9042-2018; Long, Georgina V/C-1771-2013; Ferrucci, Pier Francesco/AAQ-9002-2020; Schadendorf, Dirk/AAE-8206-2019	Rutkowski, Piotr/0000-0002-8920-5429; Marquez-Rodas, Ivan/0000-0002-2476-668X; Haanen, John/0000-0001-5884-7704; Ascierto, Paolo A/0000-0002-8322-475X; sileni, vanna chiarion/0000-0001-9191-9124; Long, Georgina V/0000-0001-8894-3545; Bastholt, Lars/0000-0001-5478-9826; Maio, Michele/0000-0002-0323-6321; McArthur, Grant/0000-0001-8908-6071; Sznol, Mario/0000-0002-4359-8749; Carlino, Matteo/0000-0002-7861-4104; Larkin, James/0000-0001-5569-9523; Melucci, Maria Teresa/0000-0002-1677-3345; coral, sandra/0000-0002-1308-3082; Grob, Jean-Jacques/0000-0002-0667-153X; Wagstaff, John/0000-0002-1140-5981; Ferrucci, Pier Francesco/0000-0001-6255-5851	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Hodi FS, 2015, ASCO ANN M CHIC MAY; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]	3	5383	5585	14	534	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2015	373	13					1270	1270		10.1056/NEJMc1509660	http://dx.doi.org/10.1056/NEJMc1509660			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR8WP	26027431	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000361635200016
J	Larkin, J; Hodi, FS; Wolchok, JD				Larkin, James; Hodi, F. Stephen; Wolchok, Jedd D.			Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma REPLY	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Larkin, James] Royal Marsden Hosp, London SW3 6JJ, England; [Hodi, F. Stephen] Dana Farber Canc Inst, Boston, MA 02115 USA; [Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Royal Marsden NHS Foundation Trust; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center	Larkin, J (corresponding author), Royal Marsden Hosp, London SW3 6JJ, England.	wolchokj@mskcc.org	Carlino, Matteo/GRS-7198-2022; Rutkowski, Piotr/B-3907-2013; Marquez-Rodas, Ivan/ABD-5532-2021; Haanen, John/AAD-8578-2022; Haanen, John/AAD-8534-2022; Ascierto, Paolo A/J-9106-2016; gonzález, rene/W-2081-2019; sileni, vanna chiarion/B-9042-2018; Long, Georgina V/C-1771-2013; Ferrucci, Pier Francesco/AAQ-9002-2020; Schadendorf, Dirk/AAE-8206-2019	Rutkowski, Piotr/0000-0002-8920-5429; Marquez-Rodas, Ivan/0000-0002-2476-668X; Haanen, John/0000-0001-5884-7704; Ascierto, Paolo A/0000-0002-8322-475X; sileni, vanna chiarion/0000-0001-9191-9124; Long, Georgina V/0000-0001-8894-3545; Bastholt, Lars/0000-0001-5478-9826; Maio, Michele/0000-0002-0323-6321; McArthur, Grant/0000-0001-8908-6071; Sznol, Mario/0000-0002-4359-8749; Carlino, Matteo/0000-0002-7861-4104; Larkin, James/0000-0001-5569-9523; Melucci, Maria Teresa/0000-0002-1677-3345; coral, sandra/0000-0002-1308-3082; Grob, Jean-Jacques/0000-0002-0667-153X; Wagstaff, John/0000-0002-1140-5981; Ferrucci, Pier Francesco/0000-0001-6255-5851	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428	1	5383	5585	14	534	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2015	373	13					1270	1271						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR8WP	26027431				2022-12-28	WOS:000361635200017
J	Larkin, J; Chiarion-Sileni, V; Gonzalez, R; Grob, JJ; Cowey, CL; Lao, CD; Schadendorf, D; Dummer, R; Smylie, M; Rutkowski, P; Ferrucci, PF; Hill, A; Wagstaff, J; Carlino, MS; Haanen, JB; Maio, M; Marquez-Rodas, I; McArthur, GA; Ascierto, PA; Long, GV; Callahan, MK; Postow, MA; Grossmann, K; Sznol, M; Dreno, B; Bastholt, L; Yang, A; Rollin, LM; Horak, C; Hodi, FS; Wolchok, JD				Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Schadendorf, D.; Dummer, R.; Smylie, M.; Rutkowski, P.; Ferrucci, P. F.; Hill, A.; Wagstaff, J.; Carlino, M. S.; Haanen, J. B.; Maio, M.; Marquez-Rodas, I.; McArthur, G. A.; Ascierto, P. A.; Long, G. V.; Callahan, M. K.; Postow, M. A.; Grossmann, K.; Sznol, M.; Dreno, B.; Bastholt, L.; Yang, A.; Rollin, L. M.; Horak, C.; Hodi, F. S.; Wolchok, J. D.			Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLUS DACARBAZINE; BRAF; SURVIVAL; VEMURAFENIB	BACKGROUND Nivolumab (a programmed death 1 [PD-1] checkpoint inhibitor) and ipilimumab (a cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4] checkpoint inhibitor) have been shown to have complementary activity in metastatic melanoma. In this randomized, double-blind, phase 3 study, nivolumab alone or nivolumab plus ipilimumab was compared with ipilimumab alone in patients with metastatic melanoma. METHODS We assigned, in a 1:1:1 ratio, 945 previously untreated patients with unresectable stage III or IV melanoma to nivolumab alone, nivolumab plus ipilimumab, or ipilimumab alone. Progression-free survival and overall survival were coprimary end points. Results regarding progression-free survival are presented here. RESULTS The median progression-free survival was 11.5 months (95% confidence interval [CI], 8.9 to 16.7) with nivolumab plus ipilimumab, as compared with 2.9 months (95% CI, 2.8 to 3.4) with ipilimumab (hazard ratio for death or disease progression, 0.42; 99.5% CI, 0.31 to 0.57; P<0.001), and 6.9 months (95% CI, 4.3 to 9.5) with nivolumab (hazard ratio for the comparison with ipilimumab, 0.57; 99.5% CI, 0.43 to 0.76; P<0.001). In patients with tumors positive for the PD-1 ligand (PD-L1), the median progression-free survival was 14.0 months in the nivolumab-plus-ipilimumab group and in the nivolumab group, but in patients with PD-L1-negative tumors, progression-free survival was longer with the combination therapy than with nivolumab alone (11.2 months [95% CI, 8.0 to not reached] vs. 5.3 months [95% CI, 2.8 to 7.1]). Treatment-related adverse events of grade 3 or 4 occurred in 16.3% of the patients in the nivolumab group, 55.0% of those in the nivolumab-plus-ipilimumab group, and 27.3% of those in the ipilimumab group. CONCLUSIONS Among previously untreated patients with metastatic melanoma, nivolumab alone or combined with ipilimumab resulted in significantly longer progression-free survival than ipilimumab alone. In patients with PD-L1-negative tumors, the combination of PD-1 and CTLA-4 blockade was more effective than either agent alone. (Funded by Bristol-Myers Squibb; CheckMate 067 ClinicalTrials.gov number, NCT01844505.)	[Larkin, J.] Royal Marsden Hosp, Dept Med Oncol, London SW3 6JJ, England; [Wagstaff, J.] Singleton Hosp, South West Wales Canc Inst, Swansea SA2 8QA, W Glam, Wales; [Chiarion-Sileni, V.] Veneto Reg Oncol Res Inst, Melanoma Oncol Unit, Padua, Italy; [Ferrucci, P. F.] European Inst Oncol, Oncol Melanoma Unit, Milan, Italy; [Maio, M.] Univ Hosp Siena, Siena, Italy; [Ascierto, P. A.] Ist Nazl Tumori, Fdn Pascale, Naples, Italy; [Gonzalez, R.] Univ Colorado, Div Med Oncol, Denver, CO 80202 USA; [Grob, J. J.] Aix Marseille Univ, Hop La Timone, AP HM, Marseille, France; [Dreno, B.] Hop Hotel Dieu, Nantes, France; [Cowey, C. L.] Baylor Charles A Sammons Canc Ctr, Dallas, TX USA; [Lao, C. D.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Lao, C. D.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Schadendorf, D.] Univ Essen Gesamthsch, Dept Dermatol, Essen, Germany; [Dummer, R.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Smylie, M.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Rutkowski, P.] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Warsaw, Poland; [Hill, A.] Tasman Oncol Res, Southport Gold Coast, Qld, Australia; [Carlino, M. S.] Univ Sydney, Westmead Hosp, Sydney, NSW 2006, Australia; [Carlino, M. S.] Univ Sydney, Blacktown Hosp, Sydney, NSW 2006, Australia; [Carlino, M. S.; Long, G. V.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW 2006, Australia; [Long, G. V.] Mater Hosp, Sydney, NSW, Australia; [McArthur, G. A.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [McArthur, G. A.] Univ Melbourne, Melbourne, Vic, Australia; [Haanen, J. B.] Netherlands Canc Inst, Div Med Oncol, Amsterdam, Netherlands; [Marquez-Rodas, I.] Hosp Gen Univ Gregorio Maranon, Med Oncol Serv, Madrid, Spain; [Callahan, M. K.; Postow, M. A.; Wolchok, J. D.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10021 USA; [Callahan, M. K.; Postow, M. A.; Wolchok, J. D.] Weill Cornell Med Coll, New York, NY USA; [Grossmann, K.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Sznol, M.] Yale Univ, Sch Med, Yale New Haven Hosp, Yale Canc Ctr,Smilow Canc Hosp, New Haven, CT USA; [Bastholt, L.] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark; [Yang, A.; Rollin, L. M.] Bristol Myers Squibb Co, Wallingford, CT 06492 USA; [Horak, C.] Bristol Myers Squibb Co, Lawrenceville, NJ USA; [Hodi, F. S.] Dana Farber Canc Inst, Boston, MA 02115 USA	Royal Marsden NHS Foundation Trust; Singleton Hospital; IRCCS Istituto Oncologico Veneto (IOV); IRCCS European Institute of Oncology (IEO); University of Siena; University Hospital of Siena; IRCCS Fondazione Pascale; University of Colorado System; University of Colorado Denver; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Nantes Universite; CHU de Nantes; Baylor University Medical Center; Texas Oncology-Baylor Charles A Sammons Cancer Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Duisburg Essen; University of Zurich; University Zurich Hospital; University of Alberta; Maria Sklodowska-Curie National Research Institute of Oncology; University of Sydney; Blacktown & Mount Druitt Hospital; University of Sydney; Melanoma Institute Australia; University of Sydney; Peter Maccallum Cancer Center; University of Melbourne; Netherlands Cancer Institute; General University Gregorio Maranon Hospital; Memorial Sloan Kettering Cancer Center; Cornell University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Yale University; University of Southern Denmark; Odense University Hospital; Bristol-Myers Squibb; Bristol-Myers Squibb; Harvard University; Dana-Farber Cancer Institute	Hodi, FS (corresponding author), Royal Marsden Hosp, Dept Med Oncol, London SW3 6JJ, England.	stephen_hodi@dfci.harvard.edu; wolchokj@mskcc.org	Carlino, Matteo/GRS-7198-2022; Rutkowski, Piotr/B-3907-2013; Marquez-Rodas, Ivan/ABD-5532-2021; Haanen, John/AAD-8578-2022; Haanen, John/AAD-8534-2022; Ascierto, Paolo A/J-9106-2016; gonzález, rene/W-2081-2019; sileni, vanna chiarion/B-9042-2018; Long, Georgina V/C-1771-2013; Ferrucci, Pier Francesco/AAQ-9002-2020; Schadendorf, Dirk/AAE-8206-2019	Rutkowski, Piotr/0000-0002-8920-5429; Marquez-Rodas, Ivan/0000-0002-2476-668X; Haanen, John/0000-0001-5884-7704; Ascierto, Paolo A/0000-0002-8322-475X; sileni, vanna chiarion/0000-0001-9191-9124; Long, Georgina V/0000-0001-8894-3545; Bastholt, Lars/0000-0001-5478-9826; Maio, Michele/0000-0002-0323-6321; McArthur, Grant/0000-0001-8908-6071; Sznol, Mario/0000-0002-4359-8749; Carlino, Matteo/0000-0002-7861-4104; Larkin, James/0000-0001-5569-9523; Melucci, Maria Teresa/0000-0002-1677-3345; coral, sandra/0000-0002-1308-3082; Grob, Jean-Jacques/0000-0002-0667-153X; Wagstaff, John/0000-0002-1140-5981; Ferrucci, Pier Francesco/0000-0001-6255-5851	Bristol-Myers Squibb; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Bristol-Myers Squibb; CheckMate 067 ClinicalTrials.gov number, NCT01844505.	Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Dummer R, 2015, J TRANSL MED, V13, P2062, DOI [10.1016/ S0140-6736(14) 60958-2, DOI 10.1016/S0140-6736(14)60958-2]; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Maio M, 2015, J CLIN ONCOL, V33, P1191, DOI 10.1200/JCO.2014.56.6018; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Ramanujam S, 2015, CHIN CLIN ONCOL, V4, DOI 10.3978/j.issn.2304-3865.2015.06.06; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Shtivelman E, 2014, ONCOTARGET, V5, P1701, DOI 10.18632/oncotarget.1892; Sznol M, 2014, J CLIN ONCOL S, V52; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	17	5383	5585	14	534	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 2	2015	373	1					23	34		10.1056/NEJMoa1504030	http://dx.doi.org/10.1056/NEJMoa1504030			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL8IS	26027431	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000357218700005
J	Buchbinder, R; Harris, IA; Sprowson, A				Buchbinder, Rachelle; Harris, Ian A.; Sprowson, Andrew			Management of degenerative meniscal tears and the role of surgery	BRITISH JOURNAL OF SPORTS MEDICINE			English	Editorial Material							KNEE OSTEOARTHRITIS; RISK-FACTORS; ARTHROSCOPIC SURGERY; MRI; MENISCECTOMY; PREVALENCE; ABNORMALITIES; DIAGNOSIS; PATHOLOGY; ACCURACY		[Buchbinder, Rachelle] Cabrini Inst, Monash Dept Clin Epidemiol, Malvern, Australia; [Buchbinder, Rachelle] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Alfred Ctr, Melbourne, Vic, Australia; [Harris, Ian A.] Univ New South Wales, South Western Sydney Clin Sch, Ingham Inst Appl Med Res, Whitlam Orthopaed Res Ctr, Sydney, NSW, Australia; [Sprowson, Andrew] Univ Warwick, Warwick Clin Trials Unit, Coventry, W Midlands, England	Cabrini Health; Monash University; Monash University; Ingham Institute for Applied Medical Research; University of New South Wales Sydney; University of Warwick	Buchbinder, R (corresponding author), Cabrini Inst, Monash Dept Clin Epidemiol, Malvern, Australia.; Buchbinder, R (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Alfred Ctr, Melbourne, Vic, Australia.	buchbinder@monash.edu	Buchbinder, Rachelle/G-2952-2011	Buchbinder, Rachelle/0000-0002-0597-0933				Alizadeh A, EUR J ORTHOP SURG TR; American Academy of Orthopaedic Surgeons, 2013, TREATM OST KNEE; Bhattacharyya T, 2003, J BONE JOINT SURG AM, V85A, P4, DOI 10.2106/00004623-200301000-00002; Dervin GF, 2001, CAN J SURG, V44, P267; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Englund M, 2011, ANN RHEUM DIS, V70, P1733, DOI 10.1136/ard.2011.150052; Felson DT, 2007, ANN INTERN MED, V147, P534, DOI 10.7326/0003-4819-147-8-200710160-00005; Guermazi A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5339; Hegedus EJ, 2007, J ORTHOP SPORT PHYS, V37, P541, DOI 10.2519/jospt.2007.2560; Herrlin S, 2007, KNEE SURG SPORT TR A, V15, P393, DOI 10.1007/s00167-006-0243-2; Jarvinen TLN, 2014, ACTA ORTHOP, V85, P215, DOI 10.3109/17453674.2014.922736; Katz JN, 2013, NEW ENGL J MED, V368, P1675, DOI 10.1056/NEJMoa1301408; Kemp MA, 2011, KNEE, V18, P252, DOI 10.1016/j.knee.2010.05.011; Kirkley A, 2008, NEW ENGL J MED, V359, P1097, DOI 10.1056/NEJMoa0708333; Laberge MA, 2012, SKELETAL RADIOL, V41, P633, DOI 10.1007/s00256-011-1259-3; Malliaropoulos N, 2013, LASER MED SCI, V28, P1183, DOI 10.1007/s10103-012-1219-8; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; National Institute for Health and Care Excellence, 2014, OST CAR MAN AD; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; Niu NNN, 2011, ARTHRIT CARE RES, V63, P208, DOI 10.1002/acr.20354; Papalia R, 2011, BRIT MED BULL, V99, P89, DOI 10.1093/bmb/ldq043; Riddle DL, 2015, OSTEOARTHR CARTILAGE, V23, P391, DOI 10.1016/j.joca.2014.12.013; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; Snoeker BAM, 2013, J ORTHOP SPORT PHYS, V43, P352, DOI 10.2519/jospt.2013.4295; Subhas N, 2012, AM J ROENTGENOL, V198, pW575, DOI 10.2214/AJR.11.7226; Vermesan D, 2013, EUR REV MED PHARMACO, V17, P3192; Yim JH, 2013, AM J SPORT MED, V41, P1565, DOI 10.1177/0363546513488518	28	21	21	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	NOV	2016	50	22					1413	1416		10.1136/bmj.h2212	http://dx.doi.org/10.1136/bmj.h2212			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EC2XV	27802970				2022-12-28	WOS:000387988700015
